PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mooney, G				Mooney, Graham			The Dangers of Ignoring History Lessons During a Pandemic	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INFLUENZA; INTERVENTIONS; EPIDEMIC		[Mooney, Graham] Johns Hopkins Univ, Baltimore, MD USA	Johns Hopkins University	Mooney, G (corresponding author), Johns Hopkins Univ, Dept Hist Med, 1900 East Monument St, Baltimore, MD 21205 USA.	gmooney3@jhmi.edu						American Historical Society, BIBL HIST RESP COVID; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Morse SS, 2007, P NATL ACAD SCI USA, V104, P7313, DOI 10.1073/pnas.0702659104; Registrar-General, 1920, MORT INFL ENGL WAL S; Smallman-Raynor M, 2002, T I BRIT GEOGR, V27, P452, DOI 10.1111/1475-5661.00065; Staub K, 2021, ANN INTERN MED, V174, P533, DOI 10.7326/M20-6231	7	3	3	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2021	174	4					556	557		10.7326/M21-0449	http://dx.doi.org/10.7326/M21-0449			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RU1WZ	33556270	Green Published			2022-12-28	WOS:000644942400047
J	Li, T; Huang, TZ; Du, MJ; Chen, X; Du, FH; Ren, JY; Chen, ZJ				Li, Tuo; Huang, Tuozhi; Du, Mingjian; Chen, Xiang; Du, Fenghe; Ren, Junyao; Chen, Zhijian J.			Phosphorylation and chromatin tethering prevent cGAS activation during mitosis	SCIENCE			English	Article							CYCLIC GMP-AMP; STRUCTURAL BASIS; STING PATHWAY; DNA; AURORA; 2ND-MESSENGER; INFLAMMATION; SENESCENCE; INHIBITORS; INDUCTION	The cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase (cGAS) detects microbial and self-DNA in the cytosol to activate immune and inflammatory programs. cGAS also associates with chromatin, especially after nuclear envelope breakdown when cells enter mitosis. How cGAS is regulated during cell cycle transition is not clear. Here, we found direct biochemical evidence that cGAS activity was selectively suppressed during mitosis in human cell lines and uncovered two parallel mechanisms underlying this suppression. First, cGAS was hyperphosphorylated at the N terminus by mitotic kinases, including Aurora kinase B. The N terminus of cGAS was critical for sensing nuclear chromatin but not mitochondrial DNA. Chromatin sensing was blocked by hyperphosphorylation. Second, oligomerization of chromatin-bound cGAS, which is required for its activation, was prevented. Together, these mechanisms ensure that cGAS is inactive when associated with chromatin during mitosis, which may help to prevent autoimmune reaction.	[Li, Tuo; Huang, Tuozhi; Du, Mingjian; Chen, Xiang; Du, Fenghe; Ren, Junyao; Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Li, Tuo; Huang, Tuozhi; Du, Mingjian; Chen, Xiang; Du, Fenghe; Ren, Junyao; Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Ctr Inflammat Res, Dallas, TX 75390 USA; [Li, Tuo; Chen, Xiang; Du, Fenghe; Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.; Chen, ZJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Ctr Inflammat Res, Dallas, TX 75390 USA.; Chen, ZJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu		huang, tuozhi/0000-0002-7923-973X; CHEN, ZHIJIAN/0000-0002-8475-8251; Du, Mingjian/0000-0002-9464-4098	National Cancer Institute [U54CA244719]; Welch Foundation [I-1389]; Cancer Prevention and Research Institute of Texas [RP180725]; Cancer Research Institute	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas; Cancer Research Institute	Work in the Chen laboratory is supported by grants from the National Cancer Institute (U54CA244719), Welch Foundation (I-1389), and Cancer Prevention and Research Institute of Texas (RP180725). T.L. was supported by a postdoctoral fellowship from the Cancer Research Institute. Z.J.C. is an investigator of the Howard Hughes Medical Institute.	Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890; Barnett KC, 2019, CELL, V176, P1432, DOI 10.1016/j.cell.2019.01.049; Bartsch K, 2017, HUM MOL GENET, V26, P3960, DOI 10.1093/hmg/ddx283; Boyer JA, 2020, SCIENCE, V370, P450, DOI 10.1126/science.abd0609; Cabantous S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02854; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Du MJ, 2018, SCIENCE, V361, P704, DOI 10.1126/science.aat1022; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kujirai T, 2020, SCIENCE, V370, P455, DOI 10.1126/science.abd0237; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Michalski S, 2020, NATURE, V587, P678, DOI 10.1038/s41586-020-2748-0; Mortlock AA, 2007, J MED CHEM, V50, P2213, DOI 10.1021/jm061335f; Pathare GR, 2020, NATURE, V587, P668, DOI 10.1038/s41586-020-2750-6; Payton M, 2010, CANCER RES, V70, P9846, DOI 10.1158/0008-5472.CAN-10-3001; Pollard JR, 2009, J MED CHEM, V52, P2629, DOI 10.1021/jm8012129; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Seo GJ, 2015, CELL REP, V13, P440, DOI 10.1016/j.celrep.2015.09.007; Shang GJ, 2019, NATURE, V567, P389, DOI 10.1038/s41586-019-0998-5; Spadafora D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154684; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tao JL, 2017, J IMMUNOL, V198, P3627, DOI 10.4049/jimmunol.1601909; Volkman HE, 2019, ELIFE, V8, DOI 10.7554/eLife.47491; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018618; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Zhang CG, 2019, NATURE, V567, P394, DOI 10.1038/s41586-019-1000-2; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhao BY, 2020, NATURE, V587, P673, DOI 10.1038/s41586-020-2749-z; Zierhut C, 2019, CELL, V178, P302, DOI 10.1016/j.cell.2019.05.035	45	56	56	14	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2021	371	6535					1221	+	eabc5386	10.1126/science.abc5386	http://dx.doi.org/10.1126/science.abc5386			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RE3JJ	33542149	Green Accepted			2022-12-28	WOS:000634054600032
J	Gao, CX				Gao, Caixia			Genome engineering for crop improvement and future agriculture	CELL			English	Review							TARGETED MUTAGENESIS; BASE; DNA; GENES; WHEAT; CAS9; RECOMBINATION; ENDONUCLEASE; ARABIDOPSIS; CRISPR/CAS9	Feeding the ever-growing population is a major challenge, especially in light of rapidly changing climate conditions. Genome editing is set to revolutionize plant breeding and could help secure the global food supply. Here, I review the development and application of genome editing tools in plants while highlighting newly developed techniques. I describe new plant breeding strategies based on genome editing and discuss their impact on crop production, with an emphasis on recent advancements in genome editing-based plant improvements that could not be achieved by conventional breeding, I also discuss challenges facing genome editing that must be overcome before realizing the full potential of this technology toward future crops and food production.	[Gao, Caixia] Chinese Acad Sci, Innovat Acad Seed Design, Ctr Genome Editing, Inst Genet & Dev Biol,State Key Lab Plant Cell &, Beijing, Peoples R China; [Gao, Caixia] Univ Chinese Acad Sci, Coll Adv Agr Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, CX (corresponding author), Chinese Acad Sci, Innovat Acad Seed Design, Ctr Genome Editing, Inst Genet & Dev Biol,State Key Lab Plant Cell &, Beijing, Peoples R China.; Gao, CX (corresponding author), Univ Chinese Acad Sci, Coll Adv Agr Sci, Beijing, Peoples R China.	cxgao@genetics.ac.cn			Strategic Priority Research Program of the Chinese Academy of Sciences [XDA24020102]; National Natural Science Foundation of China [31788103]; National Key Research and Development Program of China [2016YFD0101804]; Chinese Academy of Sciences [QYZDY-SSW-SMC030]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Chinese Academy of Sciences(Chinese Academy of Sciences)	The author is grateful to Jin-Long Qiu for critical reading of the manuscript and Yanpeng Wang for assistance in figure drawing. This work was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (Precision Seed Design and Breeding, XDA24020102), the National Natural Science Foundation of China (31788103), the National Key Research and Development Program of China (2016YFD0101804), and the Chinese Academy of Sciences (QYZDY-SSW-SMC030). I apologize to those whose work is not cited due to the space limitation.	Abe F, 2019, CELL REP, V28, P1362, DOI 10.1016/j.celrep.2019.06.090; Ali Z, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0768-9; Altpeter F, 2016, PLANT CELL, V28, P1510, DOI 10.1105/tpc.16.00196; Anzalone AV, 2020, NAT BIOTECHNOL, V38, P824, DOI 10.1038/s41587-020-0561-9; Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; Arif I, 2020, TRENDS BIOTECHNOL, V38, P1385, DOI 10.1016/j.tibtech.2020.04.015; Atkins PAP, 2020, CURR OPIN PLANT BIOL, V54, P79, DOI 10.1016/j.pbi.2020.01.002; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Bai MY, 2020, PLANT BIOTECHNOL J, V18, P721, DOI 10.1111/pbi.13239; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Berger F, 2008, TRENDS PLANT SCI, V13, P437, DOI 10.1016/j.tplants.2008.05.011; Beying N, 2020, NAT PLANTS, V6, P638, DOI 10.1038/s41477-020-0663-x; Butt H, 2019, GENES-BASEL, V10, DOI 10.3390/genes10080596; Capdeville N, 2020, SCI CHINA LIFE SCI, V63, P613, DOI 10.1007/s11427-020-1655-9; Chen KL, 2020, FRONT AGRIC SCI ENG, V7, P181, DOI 10.15302/J-FASE-2020332; Chen KL, 2019, ANNU REV PLANT BIOL, V70, P667, DOI 10.1146/annurev-arplant-050718-100049; Chen MJ, 2016, CROP J, V4, P177, DOI 10.1016/j.cj.2016.03.004; Christian M, 2013, G3-GENES GENOM GENET, V3, P1697, DOI 10.1534/g3.113.007104; Cooper M, 2009, CURR OPIN PLANT BIOL, V12, P231, DOI 10.1016/j.pbi.2009.01.006; Cunningham FJ, 2018, TRENDS BIOTECHNOL, V36, P882, DOI 10.1016/j.tibtech.2018.03.009; Debernardi JM, 2020, NAT BIOTECHNOL, V38, P1274, DOI 10.1038/s41587-020-0703-0; Demirer GS, 2019, NAT NANOTECHNOL, V14, P456, DOI 10.1038/s41565-019-0382-5; Dong OXO, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14981-y; Ellison EE, 2020, NAT PLANTS, V6, P620, DOI 10.1038/s41477-020-0670-y; Eshed Y, 2019, SCIENCE, V366, P705, DOI 10.1126/science.aax0025; FAO, 2017, FUT FOOD AGR TRENDS; Fauser F, 2012, P NATL ACAD SCI USA, V109, P7535, DOI 10.1073/pnas.1202191109; Friedrichs S, 2019, TRENDS BIOTECHNOL, V37, P1029, DOI 10.1016/j.tibtech.2019.05.005; Gaillochet Christophe, 2020, Plant Cell, DOI 10.1105/tpc.20.00463; Gao HR, 2020, NAT BIOTECHNOL, V38, P579, DOI 10.1038/s41587-020-0444-0; Gardiner LJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1675-6; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; GILHUMANES J, 2018, CURR BIOL, V16, P902; Gionfriddo M, 2019, TRENDS PLANT SCI, V24, P999, DOI 10.1016/j.tplants.2019.08.004; Gunn LH, 2020, P NATL ACAD SCI USA, V117, P25890, DOI [10.1073/pnas.2011641117, 10.1073/pnas.2011641117FreePMCarticle]; Hickey LT, 2019, NAT BIOTECHNOL, V37, P744, DOI 10.1038/s41587-019-0152-9; Holme IB, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01468; Huang SW, 2016, NAT GENET, V48, P109, DOI 10.1038/ng.3484; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Hyams G, 2018, J MOL BIOL, V430, P2184, DOI 10.1016/j.jmb.2018.03.019; Jacobs TB, 2017, PLANT PHYSIOL, V174, P2023, DOI 10.1104/pp.17.00489; Jiang YY, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02170-5; Jin S, 2021, NAT PROTOC, V16, P431, DOI 10.1038/s41596-020-00423-y; Jin S, 2020, MOL CELL, V79, P728, DOI 10.1016/j.molcel.2020.07.005; Jin S, 2019, SCIENCE, V364, P292, DOI 10.1126/science.aaw7166; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnsson M, 2019, GENET SEL EVOL, V51, DOI 10.1186/s12711-019-0456-8; JORGENSEN JH, 1992, EUPHYTICA, V63, P141, DOI 10.1007/BF00023919; Jouanin A, 2020, FRONT NUTR, V7, DOI 10.3389/fnut.2020.00051; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Kelliher T, 2019, NAT BIOTECHNOL, V37, P287, DOI 10.1038/s41587-019-0038-x; Khanday I, 2019, NATURE, V565, P91, DOI 10.1038/s41586-018-0785-8; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; Klompe SE, 2019, NATURE, V571, P219, DOI 10.1038/s41586-019-1323-z; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kong JX, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.572319; Kuppu S, 2020, PLANT BIOTECHNOL J, V18, P2068, DOI 10.1111/pbi.13365; Kurt IC, 2021, NAT BIOTECHNOL, V39, P41, DOI 10.1038/s41587-020-0609-x; Kushwah A, 2020, CHICKPEA: CROP WILD RELATIVES FOR ENHANCING GENETIC GAINS, P131, DOI 10.1016/B978-0-12-818299-4.00006-3; LASSOUED R, 2019, CHICKPEA CROP WILD R, V28, P247; Lassoued Rim, 2020, Biotechnology Reports, V26, pe00460, DOI 10.1016/j.btre.2020.e00460; LEE K, 2020, TRANSGENIC RES, V6, P600; Lemmon ZH, 2018, NAT PLANTS, V4, P766, DOI 10.1038/s41477-018-0259-x; LI C, 2018, NAT PLANTS, V19, P59; Li C, 2020, NAT BIOTECHNOL, V38, P875, DOI 10.1038/s41587-019-0393-7; Li J, 2020, J GENET GENOMICS, V47, P263, DOI 10.1016/j.jgg.2020.05.004; Li JY, 2019, PLANT BIOTECHNOL J, V17, P858, DOI 10.1111/pbi.13020; Li J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.139, 10.1038/nplants.2016.139]; LI T, 2018, GENOME BIOL, V36, P1160; Liang Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14261; Lin QP, 2020, NAT BIOTECHNOL, V38, P582, DOI 10.1038/s41587-020-0455-x; Liu HJ, 2020, PLANT CELL, V32, P1397, DOI 10.1105/tpc.19.00934; Liu XS, 2020, PLANT BIOTECHNOL J, V18, P1845, DOI 10.1111/pbi.13348; Lopez-Marques RL, 2020, J EXP BOT, V71, P5333, DOI 10.1093/jxb/eraa285; LOWE K, 2016, J EXP BOT, V28, P1998; Lowe K, 2018, IN VITRO CELL DEV-PL, V54, P240, DOI 10.1007/s11627-018-9905-2; LU Y, 2020, MOL PLANT, V38, P1402; LU Y, 2017, IN VITRO CELL DEV-PL, V10, P1242; Lv J, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0728-4; Macnaghten P, 2020, PLANTS PEOPLE PLANET, V2, P353, DOI 10.1002/ppp3.10107; Maher MF, 2020, NAT BIOTECHNOL, V38, P84, DOI 10.1038/s41587-019-0337-2; MENG X, 2017, NAT BIOTECHNOL, V10, P1238; Merker L, 2020, PLANT BIOTECHNOL J, V18, P2382, DOI 10.1111/pbi.13426; MING M, 2020, PLANT BIOTECHNOL J, V6, P202; MINKENBERG B, 2017, NAT PLANTS, P111; MUELLER UG, 2015, PROG MOL BIOL TRANSL, V23, P606; NADEAU JH, 2000, TRENDS MICROBIOL, V25, P381; Nekrasov V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00578-x; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; NUNN N, 2011, SCIENCE, V126, P593; RAMAN R, 2017, Q J ECON, V8, P195; RAN Y, 2017, GM CROPS FOOD, V60, P490; REN B, 2018, SCI CHINA LIFE SCI, V11, P623; RODRILEAL D, 2017, MOL PLANT, V171, P470; Roldan MVG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04556-1; Rubin BE., 2020, BIORXIV, DOI [10.1101/2020.07.17.209189, DOI 10.1101/2020.07.17.209189]; SAILER C, 2016, SCI REP-UK, V26, P331; SCHEBEN A, 2018, PLANT BIOTECHNOL J, V19, P178; SCHMIDT C, 2019, GENOME BIOL, V98, P577; Schmidt Carla, 2020, Abiotech, V1, P21, DOI 10.1007/s42994-019-00002-0; Schwartz C, 2020, NAT PLANTS, V6, P1427, DOI 10.1038/s41477-020-00817-6; SHAN Q, 2015, MOL PLANT, V13, P791; SHAN Q, 2013, NAT BIOTECHNOL, V6, P1365; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shen L, 2018, J INTEGR PLANT BIOL, V60, P89, DOI 10.1111/jipb.12501; SHIMATANI Z, 2017, J INTEGR PLANT BIOL, V35, P441; South PF, 2019, SCIENCE, V363, P45, DOI 10.1126/science.aat9077; SPRINGMANN M, 2018, SCIENCE, V562, P519; Steinert J, 2016, PLANT CELL REP, V35, P1429, DOI 10.1007/s00299-016-1981-3; STRECKER J, 2019, PLANT CELL REP, V365, P48; SVITASHEV S, 2016, SCIENCE, V7, P13274; TAN J, 2020, NAT COMMUN, V18, P2161; Tang X, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1458-5; Van Tassel DL, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00789; VASIL IK, 1972, FRONT PLANT SCI, V8, P117; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; WAN DY, 2020, PLOS BIOL, V7, P116; Wang BB, 2019, MOL PLANT, V12, P597, DOI 10.1016/j.molp.2019.03.006; Wang C, 2019, NAT BIOTECHNOL, V37, P283, DOI 10.1038/s41587-018-0003-0; Wang F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146453; Wang SX, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0566-4; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Willmann MR, 2019, CRISPR J, V2, P11, DOI 10.1089/crispr.2019.29046.mrw; WOLTER F, 2019, NAT BIOTECHNOL, V100, P1083; Wolter F, 2018, PLANT J, V94, P735, DOI 10.1111/tpj.13893; XING S, 2020, PLANT J, V21, P230; Xu RF, 2020, PLANT COMMUN, V1, DOI 10.1016/j.xplc.2020.100043; XU W, 2020, GENOME BIOL, V13, P675; Yin KQ, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.107; Yu H, 2021, CELL, V184, P1156, DOI 10.1016/j.cell.2021.01.013; Zaman QU, 2019, CROP J, V7, P141, DOI 10.1016/j.cj.2018.07.004; Zhang HW, 2018, NAT BIOTECHNOL, V36, P894, DOI 10.1038/nbt.4202; Zhang QW, 2020, SCI CHINA LIFE SCI, V63, P1918, DOI 10.1007/s11427-020-1671-6; Zhang R, 2021, SCI CHINA LIFE SCI, V64, P1624, DOI 10.1007/s11427-020-1800-5; Zhang R, 2019, NAT PLANTS, V5, P480, DOI 10.1038/s41477-019-0405-0; Zhang Y, 2020, NAT FOOD, V1, P200, DOI 10.1038/s43016-020-0051-8; Zhang YX, 2019, NAT PLANTS, V5, P778, DOI 10.1038/s41477-019-0461-5; ZHAO D, 2020, NAT FOOD, DOI DOI 10.1038/S41587-020-0592-2; Zhong Y, 2019, NAT PLANTS, V5, P575, DOI 10.1038/s41477-019-0443-7; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zhu HC, 2020, NAT REV MOL CELL BIO, V21, P661, DOI 10.1038/s41580-020-00288-9; Zong Y, 2018, NAT BIOTECHNOL, V36, P950, DOI 10.1038/nbt.4261; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811; Zsogon A, 2018, NAT BIOTECHNOL, V36, P1211, DOI 10.1038/nbt.4272	145	151	163	100	390	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2021	184	6					1621	1635		10.1016/j.cell.2021.01.005	http://dx.doi.org/10.1016/j.cell.2021.01.005		MAR 2021	15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QY9LN	33581057	Bronze			2022-12-28	WOS:000630357400023
J	Delaux, PM; Schornack, S				Delaux, Pierre-Marc; Schornack, Sebastian			Plant evolution driven by interactions with symbiotic and pathogenic microbes	SCIENCE			English	Review							ARBUSCULAR MYCORRHIZAL SYMBIOSIS; LAND PLANTS; PHOSPHATE TRANSPORTERS; STREPTOPHYTE ALGAE; GENOME REVEALS; INSIGHTS; GENES; PATHWAY; COLONIZATION; PROTEINS	During 450 million years of diversification on land, plants and microbes have evolved together. This is reflected in today's continuum of associations, ranging from parasitism to mutualism. Through phylogenetics, cell biology, and reverse genetics extending beyond flowering plants into bryophytes, scientists have started to unravel the genetic basis and evolutionary trajectories of plant-microbe associations. Protection against pathogens and support of beneficial, symbiotic, microorganisms are sustained by a blend of conserved and clade-specific plant mechanisms evolving at different speeds. We propose that symbiosis consistently emerges from the co-option of protection mechanisms and general cell biology principles. Exploring and harnessing the diversity of molecular mechanisms used in nonflowering plant-microbe interactions may extend the possibilities for engineering symbiosis-competent and pathogen-resilient crops.	[Delaux, Pierre-Marc] Univ Toulouse, CNRS UPS, Lab Rech Sci Vegetates LRSV, Castanet Tolosan, France; [Schornack, Sebastian] Univ Cambridge, Sainsbury Lab, 47 Bateman St, Cambridge CB2 1LR, England	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Cambridge	Delaux, PM (corresponding author), Univ Toulouse, CNRS UPS, Lab Rech Sci Vegetates LRSV, Castanet Tolosan, France.; Schornack, S (corresponding author), Univ Cambridge, Sainsbury Lab, 47 Bateman St, Cambridge CB2 1LR, England.	pierre-marc.delaux@lrsv.ups-tlse.fr; sebastian.schornack@slcu.cam.ac.uk	; Schornack, Sebastian/A-3650-2011	Delaux, Pierre-Marc/0000-0002-6211-157X; Schornack, Sebastian/0000-0002-7836-5881; , Ali/0000-0001-5475-181X	Gatsby Charitable Foundation [GAT3395/GLD]; Royal Society [UF160413, RGF\EA\180002]; BBSRC [BB/L014130/1]; European Research Council [ERC-2014-STG, 637537]; Agence Nationale de la Recherche (ANR) grant EVOLSYM [ANR-17-CE20-0006-01]; project Engineering Nitrogen Symbiosis for Africa (ENSA) by the Bill AMP; Melinda Gates Foundation [OPP1172165]; UK government's Department for International Development (DFID); TULIP Laboratoire d'Excellence [ANR-10-LABX-41]	Gatsby Charitable Foundation; Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Agence Nationale de la Recherche (ANR) grant EVOLSYM(French National Research Agency (ANR)); project Engineering Nitrogen Symbiosis for Africa (ENSA) by the Bill AMP; Melinda Gates Foundation; UK government's Department for International Development (DFID); TULIP Laboratoire d'Excellence	Work in the laboratories of S.S and P.-M.D. is supported by funding from the Gatsby Charitable Foundation (GAT3395/GLD), Royal Society (UF160413; RGF\EA\180002), BBSRC (BB/L014130/1), and European Research Council (ERC-2014-STG, H2020, 637537) to S.S. and by the Agence Nationale de la Recherche (ANR) grant EVOLSYM (ANR-17-CE20-0006-01) to P.-M.D. and was supported by the project Engineering Nitrogen Symbiosis for Africa (ENSA), which is currently supported through a grant to the University of Cambridge by the Bill & Melinda Gates Foundation (OPP1172165) and the UK government's Department for International Development (DFID). The Laboratoire de Recherche en Sciences Vegetales (LRSV) belongs to the TULIP Laboratoire d'Excellence (ANR-10-LABX-41).	Adachi H, 2019, CURR OPIN PLANT BIOL, V50, P121, DOI 10.1016/j.pbi.2019.04.007; Adams D. G., 2000, ECOLOGY CYANOBACTERI, P523; Albalat R, 2016, NAT REV GENET, V17, P379, DOI 10.1038/nrg.2016.39; Albert I, 2020, PLANT PHYSIOL, V182, P1582, DOI 10.1104/pp.19.01299; Ali S, 2018, MICROBIOL RES, V212, P29, DOI 10.1016/j.micres.2018.04.008; Andolfo G, 2019, GENOME BIOL EVOL, V11, P3466, DOI 10.1093/gbe/evz248; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Bar-On YM, 2018, P NATL ACAD SCI USA, V115, P6506, DOI 10.1073/pnas.1711842115; Beerling D. J., 2008, EMERALD PLANET PLANT, V83; Bentham AR, 2020, J BIOL CHEM, V295, P14916, DOI 10.1074/jbc.REV120.010852; Berland H, 2019, P NATL ACAD SCI USA, V116, P20232, DOI 10.1073/pnas.1912741116; Bowles AMC, 2020, CURR BIOL, V30, P530, DOI 10.1016/j.cub.2019.11.090; Bowman JL, 2017, CELL, V171, P287, DOI 10.1016/j.cell.2017.09.030; Bozsoki Z, 2020, SCIENCE, V369, P663, DOI 10.1126/science.abb3377; Bravo A, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2015.208, 10.1038/NPLANTS.2015.208]; Bressendorff S, 2016, PLANT CELL, V28, P1328, DOI 10.1105/tpc.15.00774; Burger M, 2019, CELL HOST MICROBE, V26, P163, DOI 10.1016/j.chom.2019.07.006; Buscaill P, 2019, SCIENCE, V364, P145, DOI 10.1126/science.aav0748; Carella P, 2019, CURR BIOL, V29, P2282, DOI 10.1016/j.cub.2019.05.078; Carella P, 2018, CURR OPIN PLANT BIOL, V44, P175, DOI 10.1016/j.pbi.2018.04.019; Carella P, 2018, PLANT CELL PHYSIOL, V59, P656, DOI 10.1093/pcp/pcx182; Carella P, 2018, P NATL ACAD SCI USA, V115, pE3846, DOI 10.1073/pnas.1717900115; Castrillo G, 2017, NATURE, V543, P513, DOI 10.1038/nature21417; Cheng SF, 2019, CELL, V179, P1057, DOI 10.1016/j.cell.2019.10.019; Chiu WL, 2005, PLANT PHYSIOL, V139, P224, DOI 10.1104/pp.105.064931; Chomicki G, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0602; Cohen MF, 2000, J BACTERIOL, V182, P4644, DOI 10.1128/JB.182.16.4644-4646.2000; Cope KR, 2019, PLANT CELL, V31, P2386, DOI 10.1105/tpc.18.00676; Dagdas YF, 2018, ELIFE, V7, DOI [10.7554/eLife.37476, 10.7554/elife.37476]; de Sousa F, 2019, NEW PHYTOL, V222, P565, DOI 10.1111/nph.15587; de Vries J, 2017, PLANT CELL PHYSIOL, V58, P934, DOI 10.1093/pcp/pcx037; Delaux PM, 2019, CURR BIOL, V29, pR1110, DOI 10.1016/j.cub.2019.09.044; Delaux PM, 2015, P NATL ACAD SCI USA, V112, P13390, DOI 10.1073/pnas.1515426112; Delaux PM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004487; Feehan JM, 2020, CURR OPIN PLANT BIOL, V56, P99, DOI 10.1016/j.pbi.2020.04.006; Feng F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12999-5; Fischer I, 2016, PLANT PHYSIOL, V170, P1595, DOI 10.1104/pp.15.01470; Floss DS, 2017, CURR BIOL, V27, P1206, DOI 10.1016/j.cub.2017.03.003; Floss DS, 2013, P NATL ACAD SCI USA, V110, pE5025, DOI 10.1073/pnas.1308973110; Galotto G, 2020, MOL PLANT MICROBE IN, V33, P911, DOI 10.1094/MPMI-03-20-0064-R; Garcia K, 2015, NEW PHYTOL, V208, P79, DOI 10.1111/nph.13423; Gimenez-Ibanez S, 2019, CURR BIOL, V29, P2270, DOI 10.1016/j.cub.2019.05.079; Griesmann M, 2018, SCIENCE, V361, DOI 10.1126/science.aat1743; Han GZ, 2019, NEW PHYTOL, V222, P70, DOI 10.1111/nph.15596; Hilbert M, 2020, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01678; Hiruma K, 2016, CELL, V165, P464, DOI 10.1016/j.cell.2016.02.028; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; Ishizaki K, 2017, BIOSCI BIOTECH BIOCH, V81, P73, DOI 10.1080/09168451.2016.1224641; Ivanov S, 2012, P NATL ACAD SCI USA, V109, P8316, DOI 10.1073/pnas.1200407109; Jacott CN, 2020, NEW PHYTOL, V227, P343, DOI 10.1111/nph.16465; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Jiao C, 2020, CELL, V181, P1097, DOI 10.1016/j.cell.2020.04.019; Kenrick P, 2017, SCIENCE, V358, P1538, DOI 10.1126/science.aan2923; Kiirika LM, 2012, PLANT PHYSIOL, V159, P501, DOI 10.1104/pp.112.193706; Knack JJ, 2015, INT J PLANT SCI, V176, P405, DOI 10.1086/681161; Kohler A, 2015, NAT GENET, V47, P410, DOI 10.1038/ng.3223; Labbe J, 2019, NAT PLANTS, V5, P676, DOI 10.1038/s41477-019-0469-x; Li FW, 2020, NAT PLANTS, V6, P259, DOI 10.1038/s41477-020-0618-2; Li FW, 2018, NAT PLANTS, V4, P460, DOI 10.1038/s41477-018-0188-8; Li LZ, 2020, NAT ECOL EVOL, V4, P1280, DOI 10.1038/s41559-020-1268-5; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Lutzoni F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07849-9; MacLean AM, 2017, PLANT CELL, V29, P2319, DOI 10.1105/tpc.17.00555; Marchant DB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53968-8; Martin R, 2020, SCIENCE, V370, P1185, DOI 10.1126/science.abd9993; Martinez AE, 2012, REV BIOL TROP, V60, P857; Matsui H, 2020, PLANT CELL PHYSIOL, V61, P442, DOI 10.1093/pcp/pcz214; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Monte I, 2020, CURR BIOL, V30, P962, DOI 10.1016/j.cub.2020.01.023; Monte I, 2018, NAT CHEM BIOL, V14, P480, DOI 10.1038/s41589-018-0033-4; Nagy R, 2005, PLANT J, V42, P236, DOI 10.1111/j.1365-313X.2005.02364.x; Nishiyama T, 2018, CELL, V174, P448, DOI 10.1016/j.cell.2018.06.033; Oliver JP, 2009, PLANTA, V230, P569, DOI 10.1007/s00425-009-0969-4; Parniske M, 2000, CURR OPIN PLANT BIOL, V3, P320, DOI 10.1016/S1369-5266(00)00088-1; Parniske M, 2018, CURR OPIN PLANT BIOL, V44, P164, DOI 10.1016/j.pbi.2018.05.016; Paszkowski U, 2002, P NATL ACAD SCI USA, V99, P13324, DOI 10.1073/pnas.202474599; Pimprikar P, 2016, CURR BIOL, V26, P987, DOI [10.1016/j.cub.2016.04.021, 10.1016/j.cub.2016.01.069]; Puttick MN, 2018, CURR BIOL, V28, P733, DOI 10.1016/j.cub.2018.01.063; Radhakrishnan GV, 2020, NAT PLANTS, V6, P280, DOI 10.1038/s41477-020-0613-7; Rathgeb U, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.181762; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Renzaglia KS, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00567; Rey T, 2017, J EXP BOT, V68, P5871, DOI 10.1093/jxb/erx398; Ried MK, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007747; Romani F, 2020, CURR BIOL, V30, P2815, DOI 10.1016/j.cub.2020.05.081; Roy S, 2020, PLANT CELL, V32, P15, DOI 10.1105/tpc.19.00279; Ruiz-Lozano JM, 1999, MYCORRHIZA, V9, P237, DOI 10.1007/s005720050273; Rush TA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17615-5; Rutten L, 2020, PLANT PHYSIOL, V184, P1004, DOI 10.1104/pp.19.01420; Sarris PF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0228-7; Shao ZQ, 2019, TRENDS PLANT SCI, V24, P9, DOI 10.1016/j.tplants.2018.10.015; Shao ZQ, 2016, PLANT PHYSIOL, V170, P2095, DOI 10.1104/pp.15.01487; Sheth RU, 2019, NAT BIOTECHNOL, V37, P877, DOI 10.1038/s41587-019-0183-2; Shirakawa M, 2014, PLANT CELL, V26, P4039, DOI 10.1105/tpc.114.129874; Skiada V, 2020, NEW PHYTOL, V226, P1429, DOI 10.1111/nph.16457; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd; Steinbrenner AD, 2020, CURR OPIN PLANT BIOL, V56, P135, DOI 10.1016/j.pbi.2020.05.001; Strullu-Derrien C, 2018, NEW PHYTOL, V220, P1012, DOI 10.1111/nph.15076; Strullu-Derrien C, 2014, NEW PHYTOL, V203, P964, DOI 10.1111/nph.12805; Tamborski J, 2020, ANNU REV PLANT BIOL, V71, P355, DOI 10.1146/annurev-arplant-081519-035901; TAYLOR TN, 1992, NATURE, V357, P493, DOI 10.1038/357493a0; Tedersoo L, 2017, ECOL STUD-ANAL SYNTH, V230, P407, DOI 10.1007/978-3-319-56363-3_19; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Upson JL, 2018, CURR OPIN PLANT BIOL, V44, P108, DOI 10.1016/j.pbi.2018.03.003; van Schie CCN, 2014, ANNU REV PHYTOPATHOL, V52, P551, DOI 10.1146/annurev-phyto-102313-045854; van Velzen R, 2018, P NATL ACAD SCI USA, V115, pE4700, DOI 10.1073/pnas.1721395115; Wan T, 2018, NAT PLANTS, V4, P82, DOI 10.1038/s41477-017-0097-2; Wang ET, 2012, CURR BIOL, V22, P2242, DOI 10.1016/j.cub.2012.09.043; Wang JZ, 2019, SCIENCE, V364, P44, DOI 10.1126/science.aav5870; Wang SB, 2020, NAT PLANTS, V6, P95, DOI 10.1038/s41477-019-0560-3; Wewer V, 2014, PLANT J, V79, P398, DOI 10.1111/tpj.12566; Wu CH, 2018, SCIENCE, V360, P1300, DOI 10.1126/science.aat2623; Yu N, 2014, CELL RES, V24, P130, DOI 10.1038/cr.2013.167; Zaveska Drabkova L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125411; Zhang J, 2020, NAT PLANTS, V6, P107, DOI 10.1038/s41477-019-0588-4; Zhang XW, 2015, PLANT J, V81, P258, DOI 10.1111/tpj.12723; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	119	57	58	104	322	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					796	+	eaba6605	10.1126/science.aba6605	http://dx.doi.org/10.1126/science.aba6605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QJ4MB	33602828	Green Submitted			2022-12-28	WOS:000619664700042
J	Borchiellini, D; Barthelemy, P				Borchiellini, Delphine; Barthelemy, Philippe			Cabozantinib: a new first-line option for papillary renal cell carcinoma? Comment	LANCET			English	Editorial Material							PHASE-II; OPEN-LABEL; TYPE-1; MET		[Borchiellini, Delphine] Univ Cote Azur, Ctr Antoine Lacassagne, F-06189 Nice, France; [Barthelemy, Philippe] Inst Cancerol Strasbourg Europe, Strasbourg, France	UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne	Borchiellini, D (corresponding author), Univ Cote Azur, Ctr Antoine Lacassagne, F-06189 Nice, France.	delphine.borchiellini@nice.unicancer.fr						Albiges L, 2014, CLIN CANCER RES, V20, P3411, DOI 10.1158/1078-0432.CCR-13-2173; Changa NM, 2019, LANCET ONCOL, V20, P581, DOI 10.1016/S1470-2045(18)30907-0; Choueiri TK, 2020, JAMA ONCOL, V6, P1247, DOI 10.1001/jamaoncol.2020.2218; Choueiri TK, 2017, J CLIN ONCOL, V35, P2893, DOI 10.1200/JCO.2017.72.2967; Choueiri TK, 2013, J CLIN ONCOL, V31, P181, DOI 10.1200/JCO.2012.43.3383; Escudier B, 2019, ANN ONCOL, V30, P706, DOI 10.1093/annonc/mdz056; Escudier B, 2016, EUR J CANCER, V69, P226, DOI 10.1016/j.ejca.2016.08.004; Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917; Negrier S, 2020, EUR J CANCER, V129, P107, DOI 10.1016/j.ejca.2020.02.001; Pal SK, 2021, LANCET, V397, P695, DOI 10.1016/S0140-6736(21)00152-5; Ravaud A, 2015, ANN ONCOL, V26, P1123, DOI 10.1093/annonc/mdv149; Schoffski P, 2017, EUR J CANCER, V87, P147, DOI 10.1016/j.ejca.2017.10.014; Zoumpourlis P, 2021, CLIN GENITOURIN CANC, V19, P103, DOI 10.1016/j.clgc.2020.11.005	13	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					645	647		10.1016/S0140-6736(21)00316-0	http://dx.doi.org/10.1016/S0140-6736(21)00316-0		FEB 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL3PK	33592177				2022-12-28	WOS:000620991800004
J	Kmietowicz, Z				Kmietowicz, Zosia			Every UK hospital should have a respiratory support unit, say doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, CLIN PRACTICE GUIDE	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2021	372								n466	10.1136/bmj.n466	http://dx.doi.org/10.1136/bmj.n466			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK7TO	33597158	Bronze			2022-12-28	WOS:000620584600010
J	Moberly, T				Moberly, Tom			Bruises in art work detail abuse directed at healthcare staff	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2021	372								n451	10.1136/bmj.n451	http://dx.doi.org/10.1136/bmj.n451			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QK7TO	33597129				2022-12-28	WOS:000620584600001
J	Jaklevic, MC				Jaklevic, Mary Chris			Advice for n-of-1 Drug Developers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2021	325	7					613	613		10.1001/jama.2021.0921	http://dx.doi.org/10.1001/jama.2021.0921			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ3QZ	33591332				2022-12-28	WOS:000619608000005
J	Albasri, A; Hattle, M; Koshiaris, C; Dunnigan, A; Paxton, B; Fox, SE; Smith, M; Archer, L; Levis, B; Payne, RA; Riley, RD; Roberts, N; Snell, KIE; Lay-Flurrie, S; Usher-Smith, J; Stevens, R; Hobbs, FDR; McManus, RJ; Sheppard, JP				Albasri, Ali; Hattle, Miriam; Koshiaris, Constantinos; Dunnigan, Anna; Paxton, Ben; Fox, Sarah Emma; Smith, Margaret; Archer, Lucinda; Levis, Brooke; Payne, Rupert A.; Riley, Richard D.; Roberts, Nia; Snell, Kym I. E.; Lay-Flurrie, Sarah; Usher-Smith, Juliet; Stevens, Richard; Hobbs, F. D. Richard; McManus, Richard J.; Sheppard, James P.		STRATIFY Investigators	Association between antihypertensive treatment and adverse events: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BLOOD-PRESSURE CONTROL; CONVERTING-ENZYME-INHIBITORS; CHRONIC HEART-FAILURE; VENTRICULAR SYSTOLIC FUNCTION; ACUTE MYOCARDIAL-INFARCTION; AGED 60 YEARS; RANDOMIZED-TRIAL; CARDIOVASCULAR EVENTS; HIGH-RISK; LOWERING TREATMENT	OBJECTIVE To examine the association between antihypertensive treatment and specific adverse events. DESIGN Systematic review and meta-analysis. ELIGIBILITY CRITERIA Randomised controlled trials of adults receiving antihypertensives compared with placebo or no treatment, more antihypertensive drugs compared with fewer antihypertensive drugs, or higher blood pressure targets compared with lower targets. To avoid small early phase trials, studies were required to have at least 650 patient years of follow-up. INFORMATION SOURCES Searches were conducted in Embase, Medline, CENTRAL, and the Science Citation Index databases from inception until 14 April 2020. MAIN OUTCOME MEASURES The primary outcome was falls during trial follow-up. Secondary outcomes were acute kidney injury, fractures, gout, hyperkalaemia, hypokalaemia, hypotension, and syncope. Additional outcomes related to death and major cardiovascular events were extracted. Risk of bias was assessed using the Cochrane risk of bias tool, and random effects meta-analysis was used to pool rate ratios, odds ratios, and hazard ratios across studies, allowing for between study heterogeneity (tau(2)). RESULTS Of 15 023 articles screened for inclusion, 58 randomised controlled trials were identified, including 280 638 participants followed up for a median of 3 (interquartile range 2-4) years. Most of the trials (n=40, 69%) had a low risk of bias. Among seven trials reporting data for falls, no evidence was found of an association with antihypertensive treatment (summary risk ratio 1.05, 95% confidence interval 0.89 to 1.24, tau(2)=0.009). Antihypertensives were associated with an increased risk of acute kidney injury (1.18, 95% confidence interval 1.01 to 1.39, tau(2)=0.037, n=15), hyperkalaemia (1.89, 1.56 to 2.30, tau(2)=0.122, n=26), hypotension (1.97, 1.67 to 2.32, tau(2)=0.132, n=35), and syncope (1.28, 1.03 to 1.59, tau(2)=0.050, n=16). The heterogeneity between studies assessing acute kidney injury and hyperkalaemia events was reduced when focusing on drugs that affect the renin angiotensin-aldosterone system. Results were robust to sensitivity analyses focusing on adverse events leading to withdrawal from each trial. Antihypertensive treatment was associated with a reduced risk of all cause mortality, cardiovascular death, and stroke, but not of myocardial infarction. CONCLUSIONS This meta-analysis found no evidence to suggest that antihypertensive treatment is associated with falls but found evidence of an association with mild (hyperkalaemia, hypotension) and severe adverse events (acute kidney injury, syncope). These data could be used to inform shared decision making between doctors and patients about initiation and continuation of antihypertensive treatment, especially in patients at high risk of harm because of previous adverse events or poor renal function.	[Albasri, Ali; Koshiaris, Constantinos; Smith, Margaret; Lay-Flurrie, Sarah; Stevens, Richard; Hobbs, F. D. Richard; McManus, Richard J.; Sheppard, James P.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Primary Care Bldg, Oxford OX2 6GG, England; [Hattle, Miriam; Archer, Lucinda; Levis, Brooke; Riley, Richard D.; Snell, Kym I. E.] Keele Univ, Sch Med, Keele, Staffs, England; [Dunnigan, Anna] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Paxton, Ben; Fox, Sarah Emma; Usher-Smith, Juliet] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England; [Smith, Margaret] Oxford Univ Hosp NHS Fdn Trust, NIHR Oxford Biomed Res Ctr, Oxford, England; [Payne, Rupert A.] Univ Bristol, Ctr Acad Primary Care, Populat Hlth Sci, Bristol, Avon, England; [Roberts, Nia] Univ Oxford, Bodleian Hlth Care Lib, Oxford, England	University of Oxford; Keele University; Oxford University Hospitals NHS Foundation Trust; University of Cambridge; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Bristol; University of Oxford	Sheppard, JP (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Primary Care Bldg, Oxford OX2 6GG, England.	james.sheppard@phc.ox.ac.uk	Riley, Richard David/ABE-5877-2020; Sheppard, James/AAR-6793-2021; Roberts, Nia W/F-9842-2010; Snell, Kym/L-1918-2015	Riley, Richard David/0000-0001-8699-0735; Sheppard, James/0000-0002-4461-8756; Roberts, Nia W/0000-0002-1142-6440; Archer, Lucinda/0000-0003-2504-2613; Snell, Kym/0000-0001-9373-6591; Smith, Margaret/0000-0002-0946-742X; Stevens, Richard/0000-0002-9258-4060; Dunnigan, Anna/0000-0003-4587-8020; Hattle, Miriam/0000-0003-1542-6277	Wellcome Trust; Royal Society through a Sir Henry Dale fellowship [211182/Z/18/Z]; National Institute for Health Research (NIHR) School for Primary Care [430]; NIHR Oxford Biomedical Research Centre (BRC) senior fellowship; NIHR senior investigator award; NIHR SPCR; NIHR CLAHRC Oxford; NIHR Oxford BRC; Fonds de recherche du Quebec - Sante Postdoctoral Training Fellowship; NIHR School for Primary Care Research launching fellowship; NIHR Applied Research Collaborations Oxford and Thames Valley [C55650/A21464]	Wellcome Trust(Wellcome Trust); Royal Society through a Sir Henry Dale fellowship; National Institute for Health Research (NIHR) School for Primary Care(National Institute for Health Research (NIHR)); NIHR Oxford Biomedical Research Centre (BRC) senior fellowship; NIHR senior investigator award; NIHR SPCR; NIHR CLAHRC Oxford; NIHR Oxford BRC; Fonds de recherche du Quebec - Sante Postdoctoral Training Fellowship; NIHR School for Primary Care Research launching fellowship; NIHR Applied Research Collaborations Oxford and Thames Valley	This study was funded by the Wellcome Trust and Royal Society through a Sir Henry Dale fellowship held by JPS (ref 211182/Z/18/Z) and the National Institute for Health Research (NIHR) School for Primary Care (project 430). JPS also receives funding through an NIHR Oxford Biomedical Research Centre (BRC) senior fellowship. RJMcM is supported by an NIHR senior investigator award. FDRH acknowledges part support from the NIHR SPCR, the NIHR CLAHRC Oxford, and the NIHR Oxford BRC. BL is supported by a Fonds de recherche du Quebec - Sante Postdoctoral Training Fellowship. KIES is funded by an NIHR School for Primary Care Research launching fellowship. MS is supported by the NIHR Oxford BRC. SLF is part funded by the NIHR Oxford BRC and NIHR Applied Research Collaborations Oxford and Thames Valley. JUS was funded by a Cancer Research UK Prevention fellowship (C55650/A21464). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. The sponsor and funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	ABRAMS J, 1988, NEW ENGL J MED, V319, P385; ALGRA A, 1993, STROKE, V24, P543; AMERY A, 1986, J HYPERTENS, V4, pS642; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1978, Ann N Y Acad Sci, V304, P267; [Anonymous], 1997, Chin Med J (Engl), V110, P834; BALL SG, 1993, LANCET, V342, P821; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Benetos A, 2019, CIRC RES, V124, P1045, DOI 10.1161/CIRCRESAHA.118.313236; Benetos A, 2015, JAMA INTERN MED, V175, P989, DOI 10.1001/jamainternmed.2014.8012; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Brignole M, 2006, AGE AGEING, V35, P46, DOI 10.1093/ageing/aflO86; Brunstrom M, 2018, JAMA INTERN MED, V178, P28, DOI 10.1001/jamainternmed.2017.6015; Cai AP, 2018, AM J HYPERTENS, V31, P281, DOI 10.1093/ajh/hpx203; Caparrotta TM, 2019, BRIT J CLIN PHARMACO, V85, P1907, DOI 10.1111/bcp.14024; Chalmers J, 2014, HYPERTENSION, V63, P259, DOI 10.1161/HYPERTENSIONAHA.113.02252; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Clayton JA, 2006, BRIT J CLIN PHARMACO, V61, P87, DOI 10.1111/j.1365-2125.2005.02531.x; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; da Silva RMFL, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00471; Dens JA, 2003, HEART, V89, P887, DOI 10.1136/heart.89.8.887; DEVITA C, 1994, LANCET, V343, P1115; Disertori M, 2009, NEW ENGL J MED, V360, P1606, DOI 10.1056/NEJMoa0805710; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Finsterer J, 2014, AM J HOSP PALLIAT ME, V31, P562, DOI 10.1177/1049909113494748; Fisher DJ, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j573; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; Fox KM, 2003, LANCET, V362, P782; Franse LV, 2000, HYPERTENSION, V35, P1025, DOI 10.1161/01.HYP.35.5.1025; Freemantle N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6409; Frey L, 2019, J HYPERTENS, V37, P2135, DOI 10.1097/HJH.0000000000002176; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; Gerstein HC, 2000, LANCET, V355, P253; Gianni M, 2007, EUR HEART J, V28, P1382, DOI 10.1093/eurheartj/ehm017; Golder S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002127; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Hartung J, 2001, STAT MED, V20, P3875, DOI 10.1002/sim.1009; Herlitz J, 1995, EUR HEART J, V16, P1825; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Imai E, 2011, DIABETOLOGIA, V54, P2978, DOI 10.1007/s00125-011-2325-z; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Kahlaee HR, 2018, AM J HYPERTENS, V31, P467, DOI 10.1093/ajh/hpx189; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; Lawlor B, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002660; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lipsitz LA, 2015, HYPERTENSION, V66, P183, DOI 10.1161/HYPERTENSIONAHA.115.05513; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; Mansfield KE, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012690; Margolis KL, 2014, J GEN INTERN MED, V29, P1599, DOI 10.1007/s11606-014-2961-3; Marrison VK, 2012, INT J CARDIOL, V155, P9, DOI 10.1016/j.ijcard.2010.10.055; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121; *MED RES COUNC WOR, 1985, BMJ-BRIT MED J, V29, P97; Menne J, 2012, J HYPERTENS, V30, P811, DOI 10.1097/HJH.0b013e328351856d; MIALL WE, 1982, CURR MED RES OPIN, V8, P47, DOI 10.1185/03007998209110130; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; National Institute for Health and Care Excellence, 2019, HYPERTENSION ADULTS; NICE, 2016, OV MULT CLIN ASS MAN; O'Brien H, 2014, EUR CARDIOL REV, V9, P28, DOI 10.15420/ecr.2014.9.1.28; Parving HH, 2012, J RENIN-ANGIO-ALDO S, V13, P387, DOI 10.1177/1470320311434818; PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801; Perneger TV, 2008, CONTEMP CLIN TRIALS, V29, P762, DOI 10.1016/j.cct.2008.06.002; Peters R, 2010, AGE AGEING, V39, P609, DOI 10.1093/ageing/afq071; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Phillips R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024537; Pitrou I, 2009, ARCH INTERN MED, V169, P1756, DOI 10.1001/archinternmed.2009.306; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Qaseem A, 2017, ANN INTERN MED, V166, P430, DOI 10.7326/M16-1785; Riley RD, 2020, STAT MED, V39, P2115, DOI 10.1002/sim.8516; Rucker G, 2017, RES SYNTH METHODS, V8, P392, DOI 10.1002/jrsm.1259; Sedgwick P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4773; Sheppard JP, 2020, J AM GERIATR SOC, V68, P2508, DOI 10.1111/jgs.16749; Sheppard JP, 2020, JAMA-J AM MED ASSOC, V323, P2039, DOI 10.1001/jama.2020.4871; Solomon SD, 2011, EUR HEART J, V32, P1227, DOI 10.1093/eurheartj/ehq522; Souverein PC, 2003, J INTERN MED, V254, P548, DOI 10.1111/j.1365-2796.2003.01227.x; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; STAESSEN J, 1991, AM J MED, V90, pS50; Stalenhoef' PA, 1999, PATIENT EDUC COUNS, V36, P23, DOI 10.1016/S0738-3991(98)00071-8; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stratton I, 1996, DIABETOLOGIA, V39, P1554, DOI 10.1007/s001250050614; Sun BC, 2013, PROG CARDIOVASC DIS, V55, P370, DOI 10.1016/j.pcad.2012.10.009; SWEDBERG K, 1992, NEW ENGL J MED, V327, P678, DOI 10.1056/NEJM199209033271002; Thomopoulos C, 2016, J HYPERTENS, V34, P1921, DOI 10.1097/HJH.0000000000001052; Thomopoulos C, 2016, J HYPERTENS, V34, P1451, DOI 10.1097/HJH.0000000000000972; Tinetti ME, 2014, JAMA INTERN MED, V174, P588, DOI 10.1001/jamainternmed.2013.14764; Ueda S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004576; Verdecchia P, 2009, LANCET, V374, P525, DOI 10.1016/S0140-6736(09)61340-4; Wei Y, 2013, J CLIN HYPERTENS, V15, P420, DOI 10.1111/jch.12094; Weir MR, 2009, J CLIN HYPERTENS, V11, P540, DOI 10.1111/j.1751-7176.2009.00121.x; Weiss J, 2017, ANN INTERN MED, V166, P419, DOI 10.7326/M16-1754; Whelton Paul K, 2018, Hypertension, V71, pe13, DOI [10.1016/j.jash.2018.06.010, 10.1161/HYP.0000000000000065]; White WB, 2019, CIRCULATION, V140, P1626, DOI 10.1161/CIRCULATIONAHA.119.041603; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Wright JT, 2002, ARCH INTERN MED, V162, P1636, DOI 10.1001/archinte.162.14.1636; Wu JL, 2016, INT J CLIN EXP MED, V9, P15689; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S., 1992, NEW ENGL J MED, V327, P685, DOI [DOI 10.1056/NEJM199209033271003, 10.1056/NEJM199209033271003.Erratumin]; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Yusuf S, 2016, NEW ENGL J MED, V374, P2032, DOI 10.1056/NEJMoa1600177; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	114	18	18	3	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2021	372								n189	10.1136/bmj.n189	http://dx.doi.org/10.1136/bmj.n189			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH9VF	33568342	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000618622900010
J	Iacobucci, G				Iacobucci, Gareth			Doctors can make deferred choice on pension contributions	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2020, BMA STAT GOV CONS PE; HM Treasury, 2021, PUBLIC SERVICE PENSI	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2021	372								n362	10.1136/bmj.n362	http://dx.doi.org/10.1136/bmj.n362			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM1AV	33558252				2022-12-28	WOS:000639394000004
J	Adams, JS; Chemburkar, A; Priyadarshini, P; Ricciardulli, T; Lu, YB; Maliekkal, V; Sampath, A; Winikoff, S; Karim, AM; Neurock, M; Flaherty, DW				Adams, Jason S.; Chemburkar, Ashwin; Priyadarshini, Pranjali; Ricciardulli, Tomas; Lu, Yubing; Maliekkal, Vineet; Sampath, Abinaya; Winikoff, Stuart; Karim, Ayman M.; Neurock, Matthew; Flaherty, David W.			Solvent molecules form surface redox mediators in situ and cocatalyze O-2 reduction on Pd	SCIENCE			English	Article								Solvent molecules influence the reactions of molecular hydrogen and oxygen on palladium nanoparticles. Organic solvents activate to form reactive surface intermediates that mediate oxygen reduction through pathways distinct from reactions in pure water. Kinetic measurements and ab Indio quantum chemical calculations indicate that methanol and water cocatalyze oxygen reduction by facilitating proton-electron transfer reactions. Methanol generates hydroxymethyl intermediates on palladium surfaces that efficiently transfer protons and electrons to oxygen to form hydrogen peroxide and formaldehyde. Formaldehyde subsequently oxidizes hydrogen to regenerate hydroxymethyl. Water, on the other hand, heterolytically oxidizes hydrogen to produce hydronium ions and electrons that reduce oxygen. These findings suggest that reactions of solvent molecules at solid-liquid interfaces can generate redox mediators in situ and provide opportunities to substantially increase rates and selectivities for catalytic reactions.	[Adams, Jason S.; Priyadarshini, Pranjali; Ricciardulli, Tomas; Sampath, Abinaya; Flaherty, David W.] Univ Illinois, Dept Chem & Biomol Engn, Champaign, IL 61801 USA; [Chemburkar, Ashwin; Maliekkal, Vineet; Winikoff, Stuart; Neurock, Matthew] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Lu, Yubing; Karim, Ayman M.] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Minnesota System; University of Minnesota Twin Cities; Virginia Polytechnic Institute & State University	Flaherty, DW (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Champaign, IL 61801 USA.; Neurock, M (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA.	mneurock@umn.edu; dwflhrty@illinois.edu	Karim, Ayman M/G-6176-2012; Lu, Yubing/J-8909-2019	Karim, Ayman M/0000-0001-7449-542X; Lu, Yubing/0000-0002-5791-9697; Priyadarshini, Pranjali/0000-0002-2223-7952; Adams, Jason/0000-0001-5320-200X; Sampath, Abinaya/0000-0003-0386-0754; Neurock, Matthew/0000-0003-1458-7837	Energy & Biosciences Institute through the EBI-Shell program; National Science Foundation [CBET-1511819, CCI-1740656]; National Science Foundation Graduate Research Fellowship program [DGE-1144245]; National Science Foundation Chemistry Division [CHE-1507370]; U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-76SF00515, 4938]	Energy & Biosciences Institute through the EBI-Shell program; National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship program(National Science Foundation (NSF)); National Science Foundation Chemistry Division(National Science Foundation (NSF)); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We acknowledge generous funding to support this work provided by the Energy & Biosciences Institute through the EBI-Shell program, support from the National Science Foundation (CBET-1511819 and CCI-1740656), and computational support from the Minnesota Supercomputing Institute. J.S.A. acknowledges the National Science Foundation Graduate Research Fellowship program (DGE-1144245). A.M.K. and Y.L. acknowledge funding from the National Science Foundation Chemistry Division (CHE-1507370). Use of the Stanford Synchrotron Radiation Light Source (beamline 9-3, user proposal 4938) was supported by the U.S. Department of Energy, Office of Basic Energy Sciences under contract no. DE-AC02-76SF00515. M.N. acknowledges helpful discussions with S. Stahl, M. Mahanthappa, and I. Tonks.	Akpa BS, 2012, J CATAL, V289, P30, DOI 10.1016/j.jcat.2012.01.011; [Anonymous], PROC R SOC, DOI [10.1098/rspa.2016.0156, DOI 10.1098/RSPA.2016.0156]; [Anonymous], 2019, J PHYS CHEM, DOI [10.1021/acs.jpcc.9b07097, DOI 10.1021/ACS.JPCC.9B07097]; [Anonymous], 2018, ACS CATAL, DOI [10.1021/acscatal.7b04107, DOI 10.1021/ACSCATAL.7B04107]; Au, 2020, J AM CHEM SOC, V142, P5760; Bregante DT, 2019, ACS CATAL, V9, P10951, DOI 10.1021/acscatal.9b03323; Burch R, 2003, APPL CATAL B-ENVIRON, V42, P203, DOI 10.1016/S0926-3373(02)00232-1; Crole DA, 2016, P ROY SOC A-MATH PHY, V472, DOI 10.1098/rspa.2016.0156; DAVIS RJ, 1989, PHYS REV B, V39, P10580, DOI 10.1103/PhysRevB.39.10580; Demchenko DO, 2008, SURF SCI, V602, P2552, DOI 10.1016/j.susc.2008.06.004; Dissanayake DP, 2003, J CATAL, V214, P113, DOI 10.1016/S0021-9517(02)00171-9; Dus R, 2005, J ALLOY COMPD, V404, P284, DOI 10.1016/j.jallcom.2004.12.165; Dyson PJ, 2016, CATAL SCI TECHNOL, V6, P3302, DOI 10.1039/c5cy02197a; Flaherty DW, 2018, ACS CATAL, V8, P1520, DOI 10.1021/acscatal.7b04107; Ford DC, 2010, SURF SCI, V604, P1565, DOI 10.1016/j.susc.2010.05.026; Gerken JB, 2015, ACS CENTRAL SCI, V1, P234, DOI 10.1021/acscentsci.5b00163; Han YF, 2005, J CATAL, V230, P313, DOI 10.1016/j.jcat.2004.12.001; Hibbitts D. D., 2013, J. Catal., V299, P261, DOI 10.1016/ i. icat. 2012.11.016; Hibbitts DD, 2013, ANGEW CHEM INT EDIT, V52, P12273, DOI 10.1002/anie.201304610; Hibbitts DD, 2013, J CATAL, V299, P261, DOI 10.1016/j.jcat.2012.11.016; Jeroro E, 2008, J AM CHEM SOC, V130, P10199, DOI 10.1021/ja8001265; Kohlpaintner CW, 2001, APPL CATAL A-GEN, V221, P219, DOI 10.1016/S0926-860X(01)00791-8; Kumar KBS, 2020, J AM CHEM SOC, V142, P5760, DOI 10.1021/jacs.9b13729; Liu QS, 2006, APPL CATAL A-GEN, V314, P94, DOI 10.1016/j.apcata.2006.08.014; Mellmer MA, 2018, NAT CATAL, V1, P199, DOI 10.1038/s41929-018-0027-3; Paunovic V, 2015, CHEMCATCHEM, V7, P1161, DOI 10.1002/cctc.201500050; Plauck A, 2016, P NATL ACAD SCI USA, V113, pE1973, DOI 10.1073/pnas.1602172113; Reece SY, 2009, ANNU REV BIOCHEM, V78, P673, DOI 10.1146/annurev.biochem.78.080207.092132; Selinsek M, 2018, ACS CATAL, V8, P2546, DOI 10.1021/acscatal.7b03514; Shangguan J, 2019, ACS CATAL, V9, P1763, DOI 10.1021/acscatal.8b03470; Sievers C, 2016, ACS CATAL, V6, P8286, DOI 10.1021/acscatal.6b02532; Song X, 2019, J PHYS CHEM C, V123, P26324, DOI 10.1021/acs.jpcc.9b07097; Thomas CA, 2001, CAN J CHEM, V79, P719, DOI 10.1139/v00-200; Todorovic R, 2011, CATAL TODAY, V160, P242, DOI 10.1016/j.cattod.2010.07.011; Tse ECM, 2016, J PHYS CHEM LETT, V7, P3542, DOI 10.1021/acs.jpclett.6b01235; Tu WF, 2019, J CATAL, V377, P494, DOI 10.1016/j.jcat.2019.07.047; Voloshin Y, 2007, CATAL TODAY, V125, P40, DOI 10.1016/j.cattod.2007.01.043; Welton T., 2010, SOLVENTS SOLVENT EFF, V4th ed.; Wilson NM, 2016, J AM CHEM SOC, V138, P574, DOI 10.1021/jacs.5b10669; Yang C., 2016, P NATL ACAD SCI US, V113, pE4439, DOI [10.1073/pnas.1609731113, DOI 10.1073/PNAS.1609731113, DOI 10.1073/PNAS.1602172113]; Zope BN, 2010, SCIENCE, V330, P74, DOI 10.1126/science.1195055	41	45	45	38	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		626	+		10.1126/science.abc1339	http://dx.doi.org/10.1126/science.abc1339			152	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QD7TF	33542136				2022-12-28	WOS:000615715300053
J	Baraniuk, C				Baraniuk, Chris			How to vaccinate the world against covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												chrisbaraniuk@gmail.com						[Anonymous], 2021, XINHUA; [Anonymous], 2021, S AFR UN RAT HITS NE; [Anonymous], 2020, AZD1222 VACC MET PRI; BBC, 2021, BBC; Goodwin H., 2020, LONDON EC       1220; Kansteiner F., 2021, FIERCE PHARM    0105; Ljunggren D, 2020, REUTERS; Miller J, 2021, FINANCIAL TIMES; Mohan G., 2021, INDIA TODAY; So AD, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4750; Sullivan H., 2021, GUARDIAN; World Health Organization, 2020, COV ANN ADD DEALS AC; World Health Organization, 2021, ACC ALL WILL THER BE	13	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2021	372								n211	10.1136/bmj.n211	http://dx.doi.org/10.1136/bmj.n211			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH2PI	33547042	Bronze			2022-12-28	WOS:000618119100015
J	Daiss, S; Langenfeld, S; Welte, S; Distante, E; Thomas, P; Hartung, L; Morin, O; Rempe, G				Daiss, Severin; Langenfeld, Stefan; Welte, Stephan; Distante, Emanuele; Thomas, Philip; Hartung, Lukas; Morin, Olivier; Rempe, Gerhard			A quantum-logic gate between distant quantum-network modules	SCIENCE			English	Article							SINGLE ATOMS; TELEPORTATION; QUBITS	The big challenge in quantum computing is to realize scalable multi-qubit systems with cross-talk-free addressability and efficient coupling of arbitrarily selected qubits. Quantum networks promise a solution by integrating smaller qubit modules to a larger computing cluster. Such a distributed architecture, however, requires the capability to execute quantum-logic gates between distant qubits. Here we experimentally realize such a gate over a distance of 60 meters. We employ an ancillary photon that we successively reflect from two remote qubit modules, followed by a heralding photon detection, which triggers a final qubit rotation. We use the gate for remote entanglement creation of all four Bell states, Our nonlocal quantum-logic gate could be extended both to multiple qubits and many modules for a tailor-made multi-qubit computing register.	[Daiss, Severin; Langenfeld, Stefan; Welte, Stephan; Distante, Emanuele; Thomas, Philip; Hartung, Lukas; Morin, Olivier; Rempe, Gerhard] Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany; [Distante, Emanuele] Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Mediterranean Technol Pk, Castelldefels 08860, Barcelona, Spain	Max Planck Society; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO)	Daiss, S (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	severin.daiss@mpq.mpg.de	MORIN, Olivier/A-1075-2017; Distante, Emanuele/ABC-9752-2021	MORIN, Olivier/0000-0002-0327-5646; Distante, Emanuele/0000-0001-5728-759X	Bundesministerium fur Bildung und Forschung via the Verbund Q.Link.X [16KIS0870]; Deutsche Forschungsgemeinschaft under Germany's Excellence [Strategy-EXC-2111-390814868]; European Union's Horizon 2020 research and innovation programme via the project Quantum Internet Alliance (QIA) [820445]; Cellex-ICFO-MPQ postdoctoral fellowship program	Bundesministerium fur Bildung und Forschung via the Verbund Q.Link.X(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft under Germany's Excellence; European Union's Horizon 2020 research and innovation programme via the project Quantum Internet Alliance (QIA); Cellex-ICFO-MPQ postdoctoral fellowship program	This work was supported by the Bundesministerium fur Bildung und Forschung via the Verbund Q.Link.X (16KIS0870), by the Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy-EXC-2111-390814868, and by the European Union's Horizon 2020 research and innovation programme via the project Quantum Internet Alliance (QIA, GA no. 820445). E.D. acknowledges support by the Cellex-ICFO-MPQ postdoctoral fellowship program.	Altepeter J.B., QUANTUM STATE ESTIMA, V649; Arute F, 2019, NATURE, V574, P505, DOI 10.1038/s41586-019-1666-5; Bhaskar MK, 2020, NATURE, V580, P60, DOI 10.1038/s41586-020-2103-5; Chou KS, 2018, NATURE, V561, P368, DOI 10.1038/s41586-018-0470-y; Cohen I, 2018, PHYS REV A, V98, DOI 10.1103/PhysRevA.98.030302; Daiss Severin, 2020, Zenodo, DOI 10.5281/ZENODO.4284323; Duan LM, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.032333; Endres M, 2016, SCIENCE, V354, P1024, DOI 10.1126/science.aah3752; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Gao WB, 2010, P NATL ACAD SCI USA, V107, P20869, DOI 10.1073/pnas.1005720107; Hacker B, 2019, NAT PHOTONICS, V13, P110, DOI 10.1038/s41566-018-0339-5; Hacker B, 2016, NATURE, V536, P193, DOI 10.1038/nature18592; Huang YF, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.240501; James D. F. V., 2004, QUANTUM STATE ESTIMA, V649; Johansson JR, 2012, COMPUT PHYS COMMUN, V183, P1760, DOI 10.1016/j.cpc.2012.02.021; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Langenfeld, 2020, **DATA OBJECT**, DOI [10.5281/zenodo.4284323., DOI 10.5281/ZENODO.4284323]; Langenfeld S, 2020, NPJ QUANTUM INFORM, V6, DOI 10.1038/s41534-020-00316-8; Levine H, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.170503; Lin XM, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012323; Lodahl P, 2015, REV MOD PHYS, V87, P347, DOI 10.1103/RevModPhys.87.347; Monroe C, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.022317; Pirandola S, 2015, NAT PHOTONICS, V9, P641, DOI [10.1038/NPHOTON.2015.154, 10.1038/nphoton.2015.154]; Reiserer A, 2015, REV MOD PHYS, V87, DOI 10.1103/RevModPhys.87.1379; Rosenfeld W, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.260403; Thompson JD, 2013, SCIENCE, V340, P1202, DOI 10.1126/science.1237125; Uphoff M, 2016, APPL PHYS B-LASERS O, V122, DOI 10.1007/s00340-015-6299-2; Wan Y, 2019, SCIENCE, V364, P875, DOI 10.1126/science.aaw9415; Wehner S, 2018, SCIENCE, V362, DOI 10.1126/science.aam9288; Welte S, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.011018; Wright K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13534-2	34	39	40	10	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		614	+		10.1126/science.abe3150	http://dx.doi.org/10.1126/science.abe3150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QD7TF	33542133	Green Submitted			2022-12-28	WOS:000615715300050
J	Alderson, TR; Kay, LE				Alderson, T. Reid; Kay, Lewis E.			NMR spectroscopy captures the essential role of dynamics in regulating biomolecular function	CELL			English	Review								Biomolecules are in constant motion. To understand how they function, and why malfunctions can cause disease, it is necessary to describe their three-dimensional structures in terms of dynamic conformational ensembles. Here, we demonstrate how nuclearmagnetic resonance (NMR) spectroscopy provides an essential, dynamic view of structural biology that captures biomolecular motions at atomic resolution. We focus on examples that emphasize the diversity of biomolecules and biochemical applications that are amenable to NMR, such as elucidating functional dynamics in large molecular machines, characterizing transient conformations implicated in the onset of disease, and obtaining atomic-level descriptions of intrinsically disordered regions that make weak interactions involved in liquid-liquid phase separation. Finally, we discuss the pivotal role that NMR has played in driving forward our understanding of the biomolecular dynamics-function paradigm.	[Alderson, T. Reid; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Alderson, T. Reid; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Alderson, T. Reid; Kay, Lewis E.] Univ Toronto, Dept Chem, Toronto, ON M5S A18, Canada; [Kay, Lewis E.] Hosp Sick Children, Program Mol Med, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Alderson, TR; Kay, LE (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.; Alderson, TR; Kay, LE (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada.; Alderson, TR; Kay, LE (corresponding author), Univ Toronto, Dept Chem, Toronto, ON M5S A18, Canada.; Kay, LE (corresponding author), Hosp Sick Children, Program Mol Med, Toronto, ON M5G 1X8, Canada.	reid.alderson@utoronto.ca; kay@pound.med.utoronto.ca	Alderson, T. Reid/G-2995-2016	Alderson, T. Reid/0000-0001-5163-2276	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Banting Postdoctoral Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Banting Postdoctoral Fellowship	We thank Dr. Zev Ripstein for preparing Figure 3A ii. This work was supported by grants from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada (to L.E.K.) and a Banting Postdoctoral Fellowship (to T.R.A). L.E.K. holds a Canada Research Chair in Biochemistry.	Abramov G, 2020, P NATL ACAD SCI USA, V117, P12836, DOI 10.1073/pnas.2004317117; Ahmad A, 2011, P NATL ACAD SCI USA, V108, P18966, DOI 10.1073/pnas.1111220108; Alberti S, 2019, ANNU REV GENET, V53, P171, DOI 10.1146/annurev-genet-112618-043527; Alderson TR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08557-8; Anthis NJ, 2015, Q REV BIOPHYS, V48, P35, DOI 10.1017/S0033583514000122; Augustyniak R, 2018, P NATL ACAD SCI USA, V115, pE4786, DOI 10.1073/pnas.1721811115; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Barnes CA, 2019, J AM CHEM SOC, V141, P13762, DOI 10.1021/jacs.9b06970; Baronti L, 2020, NATURE, V583, P139, DOI 10.1038/s41586-020-2336-3; Bax A, 2019, J MAGN RESON, V306, P187, DOI 10.1016/j.jmr.2019.07.037; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Boeszoermenyi A, 2019, NAT METHODS, V16, P333, DOI 10.1038/s41592-019-0334-x; Bothe JR, 2011, NAT METHODS, V8, P919, DOI [10.1038/NMETH.1735, 10.1038/nmeth.1735]; Bouvignies G, 2011, NATURE, V477, P111, DOI 10.1038/nature10349; Brady JP, 2017, P NATL ACAD SCI USA, V114, pE8194, DOI 10.1073/pnas.1706197114; Broom HR, 2014, ESSAYS BIOCHEM, V56, P149, DOI [10.1042/bse0560149, 10.1042/BSE0560149]; Buratti E, 2015, ADV GENET, V91, P1, DOI 10.1016/bs.adgen.2015.07.001; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Burmann BM, 2013, NAT STRUCT MOL BIOL, V20, P1265, DOI 10.1038/nsmb.2677; CAMPBELL ID, 1975, PROC R SOC SER B-BIO, V189, P503, DOI 10.1098/rspb.1975.0070; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Ceccon A, 2020, P NATL ACAD SCI USA, V117, P5844, DOI 10.1073/pnas.1922264117; Ceccon A, 2018, J AM CHEM SOC, V140, P6199, DOI 10.1021/jacs.8b02619; Charlier C, 2018, P NATL ACAD SCI USA, V115, pE4169, DOI 10.1073/pnas.1803642115; Charlier C, 2017, J AM CHEM SOC, V139, P12219, DOI 10.1021/jacs.7b05823; Chiliveri SC, 2021, ANGEW CHEM INT EDIT, V60, P166, DOI 10.1002/anie.202008804; Clouser AF, 2019, ELIFE, V8, DOI 10.7554/eLife.50259; Conicella AE, 2020, P NATL ACAD SCI USA, V117, P5883, DOI 10.1073/pnas.1912055117; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Culik RM, 2018, P NATL ACAD SCI USA, V115, pE2546, DOI 10.1073/pnas.1721022115; Damman R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12402-3; Delaforge E, 2018, J AM CHEM SOC, V140, P1148, DOI 10.1021/jacs.7b12407; Dyson HJ, 2019, J BIOMOL NMR, V73, P651, DOI 10.1007/s10858-019-00280-2; Faust O, 2020, NATURE, V587, P489, DOI 10.1038/s41586-020-2906-4; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Ganser LR, 2019, NAT REV MOL CELL BIO, V20, P474, DOI 10.1038/s41580-019-0136-0; Gerega A, 2005, J BIOL CHEM, V280, P42856, DOI 10.1074/jbc.M510592200; Gibbs E, 2020, J MAGN RESON, V310, DOI 10.1016/j.jmr.2019.106646; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Hansen DF, 2019, J BIOMOL NMR, V73, P577, DOI 10.1007/s10858-019-00265-1; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hoop CL, 2016, P NATL ACAD SCI USA, V113, P1546, DOI 10.1073/pnas.1521933113; Huang R, 2019, P NATL ACAD SCI USA, V116, P158, DOI 10.1073/pnas.1815495116; Huang R, 2016, P NATL ACAD SCI USA, V113, pE4190, DOI 10.1073/pnas.1603980113; Jeon J, 2019, P NATL ACAD SCI USA, V116, P16717, DOI 10.1073/pnas.1908006116; Jiang YJ, 2019, SCIENCE, V365, P1313, DOI 10.1126/science.aax1280; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Karamanos TK, 2019, P NATL ACAD SCI USA, V116, P21529, DOI 10.1073/pnas.1914999116; Karamanos TK, 2019, ELIFE, V8, DOI 10.7554/eLife.46574; Kerfah R, 2015, CURR OPIN STRUC BIOL, V32, P113, DOI 10.1016/j.sbi.2015.03.009; Kimsey IJ, 2018, NATURE, V554, P195, DOI 10.1038/nature25487; Kimsey IJ, 2015, NATURE, V519, P315, DOI 10.1038/nature14227; Kityk R, 2018, MOL CELL, V69, P227, DOI 10.1016/j.molcel.2017.12.003; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Konrat R, 2014, J MAGN RESON, V241, P74, DOI 10.1016/j.jmr.2013.11.011; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Kotler SA, 2019, P NATL ACAD SCI USA, V116, P3562, DOI 10.1073/pnas.1821216116; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Kumar A, 2020, BIOCHEMISTRY-US, V59, P57, DOI 10.1021/acs.biochem.9b00827; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lee JH, 2015, P NATL ACAD SCI USA, V112, pE4206, DOI 10.1073/pnas.1505173112; Libich DS, 2013, P NATL ACAD SCI USA, V110, P11361, DOI 10.1073/pnas.1305715110; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Mandala VS, 2019, CURR OPIN STRUC BIOL, V58, P183, DOI 10.1016/j.sbi.2019.03.027; Mateos B, 2020, J MOL BIOL, V432, P3093, DOI 10.1016/j.jmb.2019.11.015; Milles S, 2018, PROG NUCL MAG RES SP, V109, P79, DOI 10.1016/j.pnmrs.2018.07.001; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Morgado L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02196-7; Murray DT, 2020, BIOCHEMISTRY-US, V59, P364, DOI 10.1021/acs.biochem.9b00892; Murray DT, 2017, CELL, V171, P615, DOI 10.1016/j.cell.2017.08.048; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; Novakovic M, 2020, P NATL ACAD SCI USA, V117, P2449, DOI 10.1073/pnas.1916956117; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Palmer AG, 1996, J PHYS CHEM-US, V100, P13293, DOI 10.1021/jp9606117; Palmer AG, 2019, METHOD ENZYMOL, V615, P177, DOI 10.1016/bs.mie.2018.09.028; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pellecchia M, 1996, J MOL BIOL, V260, P236, DOI 10.1006/jmbi.1996.0395; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pritchard RB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09743-4; Pritisanac I, 2020, PROG NUCL MAG RES SP, V118-119, P54, DOI 10.1016/j.pnmrs.2020.04.001; Reichheld SE, 2017, P NATL ACAD SCI USA, V114, pE4408, DOI 10.1073/pnas.1701877114; Ripstein ZA, 2017, ELIFE, V6, DOI 10.7554/eLife.25754; Robinson CV, 2007, NATURE, V450, P973, DOI 10.1038/nature06523; Roche J, 2016, BIOCHEMISTRY-US, V55, P762, DOI 10.1021/acs.biochem.5b01259; Rosenzweig R, 2019, NAT REV MOL CELL BIO, V20, P665, DOI 10.1038/s41580-019-0133-3; Rosenzweig R, 2017, ELIFE, V6, DOI 10.7554/eLife.28030; Ryan VH, 2018, MOL CELL, V69, P465, DOI 10.1016/j.molcel.2017.12.022; Saio T, 2018, ELIFE, V7, DOI 10.7554/eLife.35731; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Saleh- T, 2017, NAT STRUCT MOL BIOL, V24, P893, DOI 10.1038/nsmb.3470; Salmon L, 2016, J AM CHEM SOC, V138, P9826, DOI 10.1021/jacs.6b02382; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schanda P, 2016, PROG NUCL MAG RES SP, V96, P1, DOI 10.1016/j.pnmrs.2016.02.001; Schuetz AK, 2016, ELIFE, V5, DOI 10.7554/eLife.20143; Schutz S, 2020, PROG NUCL MAG RES SP, V116, P56, DOI 10.1016/j.pnmrs.2019.09.004; Schutz AK, 2017, P NATL ACAD SCI USA, V114, pE6822, DOI 10.1073/pnas.1707974114; Schwalbe H, 2017, ANGEW CHEM INT EDIT, V56, P10252, DOI 10.1002/anie.201705936; Sekhar A, 2019, ANNU REV BIOPHYS, V48, P297, DOI 10.1146/annurev-biophys-052118-115647; Sekhar A, 2018, ELIFE, V7, DOI 10.7554/eLife.32764; Sekhar A, 2017, PROTEIN SCI, V26, P2207, DOI 10.1002/pro.3276; Sekhar A, 2016, P NATL ACAD SCI USA, V113, pE6939, DOI 10.1073/pnas.1611418113; Sekhar A, 2016, P NATL ACAD SCI USA, V113, pE2794, DOI 10.1073/pnas.1601846113; Sekhar A, 2015, P NATL ACAD SCI USA, V112, P10395, DOI 10.1073/pnas.1508504112; Sekhar A, 2015, ELIFE, V4, DOI 10.7554/eLife.07296; Sekhar A, 2013, P NATL ACAD SCI USA, V110, P12867, DOI 10.1073/pnas.1305688110; SNYDER GH, 1975, BIOCHEMISTRY-US, V14, P3765, DOI 10.1021/bi00688a008; Szekely O, 2020, J AM CHEM SOC, V142, P9267, DOI 10.1021/jacs.0c00807; Theillet FX, 2016, NATURE, V530, P45, DOI 10.1038/nature16531; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Toyama Y, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax1595; Toyama Y, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav8945; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Vallurupalli P, 2008, P NATL ACAD SCI USA, V105, P11766, DOI 10.1073/pnas.0804221105; Vallurupalli P, 2017, J BIOMOL NMR, V67, P243, DOI 10.1007/s10858-017-0099-4; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Vasa SK, 2018, ACCOUNTS CHEM RES, V51, P1386, DOI 10.1021/acs.accounts.8b00055; Walti MA, 2018, P NATL ACAD SCI USA, V115, pE11924, DOI 10.1073/pnas.1817477115; Wang AL, 2018, EMBO J, V37, DOI 10.15252/embj.201797452; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Weinhaupl K, 2018, CELL, V175, P1365, DOI 10.1016/j.cell.2018.10.039; Whittier SK, 2013, SCIENCE, V341, P899, DOI 10.1126/science.1241735; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; WUTHRICH K, 1975, FEBS LETT, V50, P265, DOI 10.1016/0014-5793(75)80504-7; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xie T, 2020, SCIENCE, V370, P189, DOI 10.1126/science.abc2754; Ye YH, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00039; Ying JF, 2017, J BIOMOL NMR, V68, P101, DOI 10.1007/s10858-016-0072-7; Yuwen TR, 2018, J AM CHEM SOC, V140, P2115, DOI 10.1021/jacs.7b09576; Zhang XY, 2015, P NATL ACAD SCI USA, V112, pE1705, DOI 10.1073/pnas.1418820112; Zhao B, 2017, NAT CHEM BIOL, V13, P968, DOI [10.1038/nchembio.2427, 10.1038/NCHEMBIO.2427]; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	145	38	38	8	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2021	184	3					577	595		10.1016/j.cell.2020.12.034	http://dx.doi.org/10.1016/j.cell.2020.12.034		FEB 2021	19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX8ZJ	33545034				2022-12-28	WOS:000629631400005
J	Cheng, SJ; Li, ZY; Gao, RR; Xing, BC; Gao, YN; Yang, Y; Qin, SS; Zhang, L; Ouyang, HQ; Du, P; Jiang, L; Zhang, B; Yang, Y; Wang, XL; Ren, XW; Bei, JX; Hu, XD; Bu, ZD; Ji, JF; Zhang, ZM				Cheng, Sijin; Li, Ziyi; Gao, Ranran; Xing, Baocai; Gao, Yunong; Yang, Yu; Qin, Shishang; Zhang, Lei; Ouyang, Hanqiang; Du, Peng; Jiang, Liang; Zhang, Bin; Yang, Yue; Wang, Xiliang; Ren, Xianwen; Bei, Jin-Xin; Hu, Xueda; Bu, Zhaode; Ji, Jiafu; Zhang, Zemin			A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells	CELL			English	Article							DENDRITIC CELLS; MAST-CELLS; LANGERHANS CELLS; T-CELLS; ACTIVATION; TARGET; PD-L1; QUANTIFICATION; IMMUNOTHERAPY; EXPRESSION	Tumor-infiltrating myeloid cells (TIMs) are key regulators in tumor progression, but the similarity and distinction of their fundamental properties across different tumors remain elusive. Here, by performing a pan-cancer analysis of single myeloid cells from 210 patients across 15 human cancer types, we identified distinct features of TIMs across cancer types. Mast cells in nasopharyngeal cancer were found to be associated with better prognosis and exhibited an anti-tumor phenotype with a high ratio of TNF+/VEGFA(+) cells. Systematic comparison between cDC1- and cDC2-derived LAMP3(+) cDCs revealed their differences in transcription factors and external stimulus. Additionally, pro-angiogenic tumor-associated macrophages (TAMs) were characterized with diverse markers across different cancer types, and the composition of TIMs appeared to be associated with certain features of somatic mutations and gene expressions. Our results provide a systematic view of the highly heterogeneous TIMs and suggest future avenues for rational, targeted immunotherapies.	[Cheng, Sijin; Li, Ziyi; Gao, Ranran; Yang, Yu; Qin, Shishang; Zhang, Lei; Wang, Xiliang; Ren, Xianwen; Hu, Xueda; Zhang, Zemin] Peking Univ, Beijing Adv Innovat Ctr Genom, Sch Life Sci, BIOPIC, Beijing 100871, Peoples R China; [Xing, Baocai] Peking Univ, Dept Hepatopancreatobiliary Surg 1, Key Lab Carcinogenesis & Translat Res Minist Educ, Canc Hosp & Inst, Beijing 100142, Peoples R China; [Gao, Yunong] Peking Univ, Dept Gynecol Oncol, Key Lab Carcinogenesis & Translat Res Minist Educ, Canc Hosp & Inst, Beijing 100142, Peoples R China; [Ouyang, Hanqiang; Jiang, Liang] Peking Univ, Dept Orthopaed, Beijing Key Lab Spinal Dis Res, Hosp 3, Beijing 100191, Peoples R China; [Du, Peng] Peking Univ, Dept Urol, Key Lab Carcinogenesis & Translat Res Minist Educ, Canc Hosp & Inst, Beijing 100142, Peoples R China; [Zhang, Bin] Peking Univ, Dept Head & Neck Surg, Key Lab Carcinogenesis & Translat Res Minist Educ, Canc Hosp & Inst, Beijing 100142, Peoples R China; [Yang, Yue] Peking Univ, Dept Thorac Surg 2, Key Lab Carcinogenesis & Translat Res, Canc Hosp & Inst,Minist Educ, Beijing 100142, Peoples R China; [Bei, Jin-Xin] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med,Minist Educ, State Key Lab Oncol South China,Canc Ctr, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, Guangzhou 510060, Peoples R China; [Bu, Zhaode] Peking Univ, Dept Gastrointestinal Surg, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp & Inst, Beijing 100142, Peoples R China; [Ji, Jiafu] Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Surg, Dept Biobank,Canc Hosp & Inst,Minist Educ, Beijing 100142, Peoples R China; [Zhang, Zemin] Inst Canc Res, Shenzhen Bay Lab, Shenzhen 518132, Peoples R China; [Zhang, Zemin] Peking Univ, Int Canc Inst, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University; Peking University; Peking University; State Key Lab Oncology South China; Sun Yat Sen University; Peking University; Peking University; Shenzhen Bay Laboratory; Peking University	Zhang, ZM (corresponding author), Peking Univ, Beijing Adv Innovat Ctr Genom, Sch Life Sci, BIOPIC, Beijing 100871, Peoples R China.; Bu, ZD (corresponding author), Peking Univ, Dept Gastrointestinal Surg, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp & Inst, Beijing 100142, Peoples R China.; Ji, JF (corresponding author), Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Surg, Dept Biobank,Canc Hosp & Inst,Minist Educ, Beijing 100142, Peoples R China.; Zhang, ZM (corresponding author), Inst Canc Res, Shenzhen Bay Lab, Shenzhen 518132, Peoples R China.; Zhang, ZM (corresponding author), Peking Univ, Int Canc Inst, Beijing 100191, Peoples R China.	buzhaode@cjcrcn.org; jijiafu@hsc.pku.edu.cn; zemin@pku.edu.cn	Bei, Jin-Xin/AAO-1259-2020	Li, ZIyi/0000-0003-0947-9137; Ouyang, Hanqiang/0000-0001-8397-6567	National Natural Science Foundation of China [81988101, 91742203, 91942307, 31991171]; Beijing Municipal Science and Technology Commission [Z201100005320014]; Beijing Advanced Innovation Center for Genomics; AOSpine 2019 Discovery and Innovation Award [AOSDIA2019-026]; Beijing Natural Science Foundation [7204327]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Beijing Advanced Innovation Center for Genomics; AOSpine 2019 Discovery and Innovation Award; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	We thank Drs. Nan Wu, Chao Lv, Jinfeng Chen, Zhen Liang (Department of Thoracic Surgery II), Ning Zhang (Department of Urology), Jinfeng Li (Breast Cancer Center), Hong Zheng (Department of gynecologic oncology), and Yang Li (Department of Gastrointestinal Surgery) from Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute and Hanqiang Ouyang and Liang Jiang from Peking University Third Hospital for clinical sample preparation. Part of the experiments were performed on the National Center for Protein Sciences at Peking University. Part of the analysis was performed on the High Performance Computing Platform of the Center for Life Science (Peking University). This project was supported by National Natural Science Foundation of China (81988101, 91742203, 91942307, and 31991171), Beijing Municipal Science and Technology Commission (Z201100005320014), and Beijing Advanced Innovation Center for Genomics. H.O. and L.J. were supported by AOSpine 2019 Discovery and Innovation Award (AOSDIA2019-026) and Beijing Natural Science Foundation (7204327).	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Barnes PJ, 1999, J ALLERGY CLIN IMMUN, V104, pS10, DOI 10.1016/S0091-6749(99)70269-1; Binnewies M, 2019, CELL, V177, P556, DOI 10.1016/j.cell.2019.02.005; Browaeys R, 2020, NAT METHODS, V17, P159, DOI 10.1038/s41592-019-0667-5; Brown CC, 2019, CELL, V179, P846, DOI 10.1016/j.cell.2019.09.035; Burr ML, 2017, NATURE, V549, P101, DOI 10.1038/nature23643; Carraway KL, 2009, FUTURE ONCOL, V5, P1631, DOI 10.2217/FON.09.125; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; D'Aniello C, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00776; DeNardo DG, 2019, NAT REV IMMUNOL, V19, P369, DOI 10.1038/s41577-019-0127-6; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dudeck J, 2015, CELL REP, V13, P399, DOI 10.1016/j.celrep.2015.08.078; Dutertre CA, 2019, IMMUNITY, V51, P573, DOI 10.1016/j.immuni.2019.08.008; Efremova M, 2020, NAT PROTOC, V15, P1484, DOI 10.1038/s41596-020-0292-x; Engblom C, 2016, NAT REV CANCER, V16, P447, DOI 10.1038/nrc.2016.54; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Gulati GS, 2020, SCIENCE, V367, P405, DOI 10.1126/science.aax0249; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Han XP, 2020, NATURE, V581, P303, DOI 10.1038/s41586-020-2157-4; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashimoto-Hill S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06341-8; Hie B, 2019, NAT BIOTECHNOL, V37, P685, DOI 10.1038/s41587-019-0113-3; Ishida T, 2006, CANCER SCI, V97, P1139, DOI 10.1111/j.1349-7006.2006.00307.x; Jang JE, 2017, CELL REP, V20, P558, DOI 10.1016/j.celrep.2017.06.062; Kenkel JA, 2017, CANCER RES, V77, P4158, DOI 10.1158/0008-5472.CAN-16-2212; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15523-2; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu BL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16904-3; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Loayza-Puch F, 2016, NATURE, V530, P490, DOI 10.1038/nature16982; Maciel Thiago T, 2015, F1000Prime Rep, V7, P09, DOI 10.12703/P7-09; Maeda M, 2007, IMMUNOBIOLOGY, V212, P537, DOI 10.1016/j.imbio.2007.03.007; Maier B, 2020, NATURE, V580, P257, DOI 10.1038/s41586-020-2134-y; Marone G, 2016, EUR J PHARMACOL, V778, P146, DOI 10.1016/j.ejphar.2015.03.088; Maynard A, 2020, CELL, V182, P1232, DOI 10.1016/j.cell.2020.07.017; Mellman I, 2013, CANCER IMMUNOL RES, V1, P145, DOI 10.1158/2326-6066.CIR-13-0102; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Mezzadra R, 2017, NATURE, V549, P106, DOI 10.1038/nature23669; Nakamura K, 2020, CELL MOL IMMUNOL, V17, P1, DOI 10.1038/s41423-019-0306-1; Peng JY, 2019, CELL RES, V29, P725, DOI 10.1038/s41422-019-0195-y; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Rankin EB, 2016, CANCERS, V8, DOI 10.3390/cancers8110103; Ren XW, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1593-z; Ribatti D, 2016, EUR J PHARMACOL, V778, P152, DOI 10.1016/j.ejphar.2015.02.056; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Saikh KU, 2001, CLIN EXP IMMUNOL, V126, P447, DOI 10.1046/j.1365-2249.2001.01672.x; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schmid MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/201026; Scott CL, 2019, TRENDS IMMUNOL, V40, P431, DOI 10.1016/j.it.2019.03.001; Sharma A, 2020, CELL, V183, P377, DOI 10.1016/j.cell.2020.08.040; Simon T, 2016, IMMUNITY, V45, P956, DOI 10.1016/j.immuni.2016.10.030; Sondka Z, 2018, NAT REV CANCER, V18, P696, DOI 10.1038/s41568-018-0060-1; Tokunaga R, 2018, CANCER TREAT REV, V63, P40, DOI 10.1016/j.ctrv.2017.11.007; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Vivian J, 2017, NAT BIOTECHNOL, V35, P314, DOI 10.1038/nbt.3772; Vogel DYS, 2014, IMMUNOBIOLOGY, V219, P695, DOI 10.1016/j.imbio.2014.05.002; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Woidacki K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00029; Wolf FA, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1663-x; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Wu H, 2018, MOL MED REP, V17, P4867, DOI 10.3892/mmr.2018.8537; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Young MD, 2018, SCIENCE, V361, P594, DOI 10.1126/science.aat1699; Zhang L, 2020, CELL, V181, P442, DOI 10.1016/j.cell.2020.03.048; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zhang QM, 2019, CELL, V179, P829, DOI 10.1016/j.cell.2019.10.003; Zhang X, 2016, ALLERGY, V71, P758, DOI 10.1111/all.12871; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	81	169	169	33	121	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2021	184	3					792	+		10.1016/j.cell.2021.01.010	http://dx.doi.org/10.1016/j.cell.2021.01.010		FEB 2021	41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX8ZJ	33545035	hybrid			2022-12-28	WOS:000629631400018
J	Mahase, E				Mahase, Elisabeth			Covid-19: Four in 10 people with evidence of past infection had no classic symptoms, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Biobank UK, 2021, SARS COV 2 SER STUD	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2021	372								n321	10.1136/bmj.n321	http://dx.doi.org/10.1136/bmj.n321			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC1TD	33536185	Bronze			2022-12-28	WOS:000686315900008
J	Hughes, CG; Mailloux, PT; Devlin, JW; Swan, JT; Sanders, RD; Anzueto, A; Jackson, JC; Hoskins, AS; Pun, BT; Orun, OM; Raman, R; Stollings, JL; Kiehl, AL; Duprey, MS; Bui, LN; O'Neal, HR; Snyder, A; Gropper, MA; Guntupalli, KK; Stashenko, GJ; Patel, MB; Brummel, NE; Girard, TD; Dittus, RS; Bernard, GR; Ely, EW; Pandharipande, PP				Hughes, C. G.; Mailloux, P. T.; Devlin, J. W.; Swan, J. T.; Sanders, R. D.; Anzueto, A.; Jackson, J. C.; Hoskins, A. S.; Pun, B. T.; Orun, O. M.; Raman, R.; Stollings, J. L.; Kiehl, A. L.; Duprey, M. S.; Bui, L. N.; O'Neal, H. R., Jr.; Snyder, A.; Gropper, M. A.; Guntupalli, K. K.; Stashenko, G. J.; Patel, M. B.; Brummel, N. E.; Girard, T. D.; Dittus, R. S.; Bernard, G. R.; Ely, E. W.; Pandharipande, P. P.		MENDS2 Study Investigators	Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE; INFLAMMATORY RESPONSES; BRAIN-DYSFUNCTION; DELIRIUM; MORTALITY; MIDAZOLAM; GUIDELINES; RELIABILITY; VALIDATION	BACKGROUND Guidelines currently recommend targeting light sedation with dexmedetomidine or propofol for adults receiving mechanical ventilation. Differences exist between these sedatives in arousability, immunity, and inflammation. Whether they affect outcomes differentially in mechanically ventilated adults with sepsis undergoing light sedation is unknown. METHODS In a multicenter, double-blind trial, we randomly assigned mechanically ventilated adults with sepsis to receive dexmedetomidine (0.2 to 1.5 mu g per kilogram of body weight per hour) or propofol (5 to 50 mu g per kilogram per minute), with doses adjusted by bedside nurses to achieve target sedation goals set by clinicians according to the Richmond Agitation-Sedation Scale (RASS, on which scores range from -5 [unresponsive] to +4 [combative]). The primary end point was days alive without delirium or coma during the 14-day intervention period. Secondary end points were ventilator-free days at 28 days, death at 90 days, and age-adjusted total score on the Telephone Interview for Cognitive Status questionnaire (TICS-T; scores range from 0 to 100, with a mean of 50 +/- 10 and lower scores indicating worse cognition) at 6 months. RESULTS Of 432 patients who underwent randomization, 422 were assigned to receive a trial drug and were included in the analyses - 214 patients received dexmedetomidine at a median dose of 0.27 mu g per kilogram per hour, and 208 received propofol at a median dose of 10.21 mu g per kilogram per minute. The median duration of receipt of the trial drugs was 3.0 days (interquartile range, 2.0 to 6.0), and the median RASS score was -2.0 (interquartile range, -3.0 to -1.0). We found no difference between dexmedetomidine and propofol in the number of days alive without delirium or coma (adjusted median, 10.7 vs. 10.8 days; odds ratio, 0.96; 95% confidence interval [CI], 0.74 to 1.26), ventilator-free days (adjusted median, 23.7 vs. 24.0 days; odds ratio, 0.98; 95% CI, 0.63 to 1.51), death at 90 days (38% vs. 39%; hazard ratio, 1.06; 95% CI, 0.74 to 1.52), or TICS-T score at 6 months (adjusted median score, 40.9 vs. 41.4; odds ratio, 0.94; 95% CI, 0.66 to 1.33). Safety end points were similar in the two groups. CONCLUSIONS Among mechanically ventilated adults with sepsis who were being treated with recommended light-sedation approaches, outcomes in patients who received dexmedetomidine did not differ from outcomes in those who received propofol.	[Hughes, C. G.; Jackson, J. C.; Hoskins, A. S.; Pun, B. T.; Orun, O. M.; Raman, R.; Stollings, J. L.; Kiehl, A. L.; Patel, M. B.; Brummel, N. E.; Girard, T. D.; Dittus, R. S.; Bernard, G. R.; Ely, E. W.; Pandharipande, P. P.] Vanderbilt Univ, Med Ctr, Crit Illness Brain Dysfunct & Survivorship Ctr, Nashville, TN USA; [Hughes, C. G.; Jackson, J. C.; Raman, R.; Patel, M. B.; Girard, T. D.; Dittus, R. S.; Ely, E. W.; Pandharipande, P. P.] Vanderbilt Univ, Med Ctr, Ctr Hlth Serv Res, Nashville, TN USA; [Hughes, C. G.; Pandharipande, P. P.] Vanderbilt Univ, Med Ctr, Div Anesthesiol Crit Care Med, Dept Anesthesiol, Nashville, TN USA; [Hughes, C. G.; Pun, B. T.; Bernard, G. R.; Ely, E. W.] Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN USA; [Dittus, R. S.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gen Internal Med & Publ Hlth, Nashville, TN USA; [Orun, O. M.; Raman, R.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Stollings, J. L.] Vanderbilt Univ, Med Ctr, Pharmaceut Serv, Nashville, TN USA; [Patel, M. B.] Vanderbilt Univ, Dept Surg, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN 37240 USA; [Hughes, C. G.; Pandharipande, P. P.] Tennessee Valley Healthcare Syst, Anesthesia Serv, Dept Vet Affairs Med Ctr, Nashville, TN USA; [Patel, M. B.] Tennessee Valley Healthcare Syst, Surg Serv, Dept Vet Affairs Med Ctr, Nashville, TN USA; [Dittus, R. S.; Ely, E. W.] Tennessee Valley Healthcare Syst, Geriatr Res Educ & Clin Ctr, Dept Vet Affairs Med Ctr, Nashville, TN USA; [Mailloux, P. T.] Maine Med Ctr, Neurosci Inst, Portland, ME 04102 USA; [Mailloux, P. T.] Maine Med Ctr, Dept Crit Care Med, Portland, ME 04102 USA; [Devlin, J. W.; Duprey, M. S.] Northeastern Univ, Dept Pharm & Hlth Syst Sci, Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Swan, J. T.; Bui, L. N.] Houston Methodist, Dept Pharm, Houston, TX USA; [Swan, J. T.] Houston Methodist, Dept Surg, Houston, TX USA; [Swan, J. T.] Houston Methodist, Ctr Outcomes Res, Houston, TX USA; [Guntupalli, K. K.] Baylor Coll Med, Pulm Crit Care & Sleep Med Sect, Ben Taub Hosp, Houston, TX 77030 USA; [Anzueto, A.] Univ Texas Hlth, Div Pulm Crit Care Med, San Antonio, TX USA; [Anzueto, A.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Snyder, A.] Texas Hlth Harris Methodist Hosp Ft Worth, Ft Worth, TX USA; [Sanders, R. D.] Univ Sydney, Sydney, NSW, Australia; [Sanders, R. D.] Royal Prince Alfred Hosp, Dept Anaesthet, Sydney, NSW, Australia; [Sanders, R. D.] Univ Wisconsin, Dept Anesthesiol, Madison, WI 53706 USA; [O'Neal, H. R., Jr.] Baton Rouge Gen Med Ctr, Pulm & Crit Care Med, Baton Rouge, LA USA; [O'Neal, H. R., Jr.] Our Lady Lake Reg Med Ctr, Baton Rouge, LA USA; [Gropper, M. A.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Stashenko, G. J.] Mission Hosp, Pulm & Crit Care, Asheville, NC USA; [Brummel, N. E.] Ohio State Univ, Div Pulm Crit Care & Sleep Med, Dept Internal Med, Wexner Med Ctr, Columbus, OH 43210 USA; [Girard, T. D.] Univ Pittsburgh, Sch Med, Clin Res Invest & Syst Modeling Acute Illness Ctr, Dept Crit Care Med, Pittsburgh, PA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Maine Medical Center; Maine Medical Center; Northeastern University; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Sydney; University of Sydney; University of Wisconsin System; University of Wisconsin Madison; Our Lady Lake Regional Medical Center; University of California System; University of California San Francisco; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hughes, CG (corresponding author), 1211 21st Ave S,422 MAB, Nashville, TN 37212 USA.	christopher.hughes@vumc.org	Swan, Joshua/AAC-5754-2019	Swan, Joshua/0000-0002-6390-2322; Rizk, Elsie/0000-0003-1390-1409; Girard, Timothy/0000-0002-9833-4871; Duprey, Matthew/0000-0002-2365-431X; Hughes, Christopher/0000-0002-9261-5875	National Institutes of Health (NIH) [HL111111]; NIH [TR000445, 1F31AG066460, HL135144]; National Heart Lung and Blood Institute [HL14678-01]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a grant (HL111111) from the National Institutes of Health (NIH), a grant (TR000445) from the NIH for the use of REDCap, grants from the NIH to Dr. Duprey (1F31AG066460) and to Dr. Girard (HL135144), and a grant from the National Heart Lung and Blood Institute to Dr. Pun (HL14678-01). Dexmedetomidine was provided by Pfizer (previously by Hospira).	Barnes-Daly MA, 2017, CRIT CARE MED, V45, P171, DOI 10.1097/CCM.0000000000002149; Chandrasekhar R, 2020, CRIT CARE RESUSC, V22, P63; Christie JD, 2006, J CRIT CARE, V21, P125, DOI 10.1016/j.jcrc.2005.11.004; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; Dhital R, 2018, J COMMUNITY HOSP INT, V8, P49, DOI 10.1080/20009666.2018.1450592; Djaiani G, 2016, ANESTHESIOLOGY, V124, P362, DOI 10.1097/ALN.0000000000000951; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Gelinas C, 2006, AM J CRIT CARE, V15, P420; Helmy SAK, 2001, ANAESTHESIA, V56, P4, DOI 10.1046/j.1365-2044.2001.01713.x; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kawazoe Y, 2017, JAMA-J AM MED ASSOC, V317, P1321, DOI 10.1001/jama.2017.2088; Kelbel I, 1999, ACTA ANAESTH SCAND, V43, P71, DOI 10.1034/j.1399-6576.1999.430115.x; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; Memis D, 2007, BRIT J ANAESTH, V98, P550, DOI 10.1093/bja/aem017; Nishina K, 1999, ANESTH ANALG, V88, P452, DOI 10.1097/00000539-199902000-00042; Olsen HT, 2020, NEW ENGL J MED, V382, P1103, DOI 10.1056/NEJMoa1906759; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Pandharipande PP, 2010, CRIT CARE, V14, DOI 10.1186/cc8916; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Pun BT, 2019, CRIT CARE MED, V47, P3, DOI 10.1097/CCM.0000000000003482; Qiao H, 2009, CRIT CARE, V13, DOI 10.1186/cc8012; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Schuler A, 2018, CRIT CARE MED, V46, P769, DOI 10.1097/01.ccm.0000529571.72014.b4; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Shehabi Y, 2019, NEW ENGL J MED, V380, P2506, DOI 10.1056/NEJMoa1904710; Shehabi Y, 2010, CRIT CARE MED, V38, P2311, DOI 10.1097/CCM.0b013e3181f85759; Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9; Venn RM, 2001, BRIT J ANAESTH, V86, P650, DOI 10.1093/bja/86.5.650; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Wang XB, 2011, CRIT CARE MED, V39, P738, DOI 10.1097/CCM.0b013e318206bd86	40	56	61	15	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2021	384	15					1424	1436		10.1056/NEJMoa2024922	http://dx.doi.org/10.1056/NEJMoa2024922			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RN7TA	33528922	Green Accepted, Bronze			2022-12-28	WOS:000640554500009
J	Khanna, P; Totten, D; Novik, L; Roberts, J; Morecraft, RJ; Ganguly, K				Khanna, Preeya; Totten, Douglas; Novik, Lisa; Roberts, Jeffrey; Morecraft, Robert J.; Ganguly, Karunesh			Low-frequency stimulation enhances ensemble co-firing and dexterity after stroke	CELL			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SHAM-CONTROLLED TRIAL; CELL ASSEMBLIES; MOTOR RECOVERY; CORTEX INJURY; ORGANIZATION; EXCITABILITY; DYNAMICS; REORGANIZATION; PROPAGATION	Electrical stimulation is a promising tool for modulating brain networks. However, it is unclear how stimulation interacts with neural patterns underlying behavior. Specifically, how might external stimulation that is not sensitive to the state of ongoing neural dynamics reliably augment neural processing and improve function? Here, we tested how low-frequency epidural alternating current stimulation (ACS) in non-human primates recovering from stroke interacted with task-related activity in perilesional cortex and affected grasping. We found that ACS increased co-firing within task-related ensembles and improved dexterity. Using a neural network model, we found that simulated ACS drove ensemble co-firing and enhanced propagation of neural activity through parts of the network with impaired connectivity, suggesting a mechanism to link increased co-firing to enhanced dexterity. Together, our results demonstrate that ACS restores neural processing in impaired networks and improves dexterity following stroke. More broadly, these results demonstrate approaches to optimize stimulation to target neural dynamics.	[Khanna, Preeya; Totten, Douglas; Ganguly, Karunesh] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Khanna, Preeya; Totten, Douglas; Novik, Lisa; Roberts, Jeffrey; Ganguly, Karunesh] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Morecraft, Robert J.] Univ South Dakota, Sanford Sch Med, Div Basic Biomed Sci, Lab Neurol Sci, Vermillion, SD 57069 USA	University of California System; University of California San Francisco; University of California System; University of California Davis; University of South Dakota	Ganguly, K (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.; Ganguly, K (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.	karunesh.ganguly@ucsf.edu		Khanna, Preeya/0000-0001-6402-6486; totten, douglas/0000-0003-2205-7238	NIMH of the NIH postdoctoral fellowship [BRAIN F32MH120891]; pilot grant from the California National Primate Research Center (Pilot Award) [8777]; Career Award for Medical Scientists from the Burroughs Wellcome Fund [1009855]; Weill Neurohub Pillars Program; NINDS of the NIH [R01NS112424]	NIMH of the NIH postdoctoral fellowship; pilot grant from the California National Primate Research Center (Pilot Award); Career Award for Medical Scientists from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Weill Neurohub Pillars Program; NINDS of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Christie, M.J. Lemoy, and K. Stotts for surgical assistance; L. Tatum for animal behavior assistance; and S. Gowda for helpful discussions. This research was funded by the NIMH of the NIH postdoctoral fellowship (BRAIN F32MH120891 to P.K.), a pilot grant from the California National Primate Research Center (Pilot Award 8777 to K.G.), a Career Award for Medical Scientists from the Burroughs Wellcome Fund (1009855 to K.G), and the Weill Neurohub Pillars Program (to K.G.). Research reported in this publication was supported by the NINDS of the NIH (R01NS112424 to K.G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Ali MM, 2013, J NEUROSCI, V33, P11262, DOI 10.1523/JNEUROSCI.5867-12.2013; Athalye VR, 2018, SCIENCE, V359, P1024, DOI 10.1126/science.aao6058; Athalye VR, 2017, NEURON, V93, P955, DOI 10.1016/j.neuron.2017.01.016; Aviel Y, 2005, NEURAL COMPUT, V17, P691, DOI 10.1162/0899766053019962; Bakker R, 2015, NEUROINFORMATICS, V13, P353, DOI 10.1007/s12021-014-9258-x; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Berenyi A, 2012, SCIENCE, V337, P735, DOI 10.1126/science.1223154; Bergmann TO, 2009, J NEUROPHYSIOL, V102, P2303, DOI 10.1152/jn.00437.2009; Bikson M, 2004, J PHYSIOL-LONDON, V557, P175, DOI 10.1113/jphysiol.2003.055772; BINDMAN LJ, 1962, NATURE, V196, P584, DOI 10.1038/196584a0; Bonstrup M, 2019, ANN NEUROL, V86, P853, DOI 10.1002/ana.25615; Brochier T, 1999, EXP BRAIN RES, V128, P31, DOI 10.1007/s002210050814; Buford JA, 2004, EXP BRAIN RES, V159, P284, DOI 10.1007/s00221-004-1956-4; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Chung JE, 2017, NEURON, V95, P1381, DOI 10.1016/j.neuron.2017.08.030; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Cooperrider J, 2014, J NEUROSCI, V34, P9040, DOI 10.1523/JNEUROSCI.0953-14.2014; Darling WG, 2018, J NEUROSCI, V38, P6323, DOI 10.1523/JNEUROSCI.0403-18.2018; Darling WG, 2016, EXP NEUROL, V281, P37, DOI 10.1016/j.expneurol.2016.04.004; Darling WG, 2009, EXP NEUROL, V220, P90, DOI 10.1016/j.expneurol.2009.07.034; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; DUM RP, 1991, J NEUROSCI, V11, P667; Dum RP, 2002, PHYSIOL BEHAV, V77, P677, DOI 10.1016/S0031-9384(02)00929-0; Fetz EE, 2000, CURR OPIN NEUROBIOL, V10, P699, DOI 10.1016/S0959-4388(00)00160-4; Feurra M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00013; Fregni F, 2006, STROKE, V37, P2115, DOI 10.1161/01.STR.0000231390.58967.6b; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Ganguly K, 2013, ANN NEUROL, V74, P373, DOI 10.1002/ana.23994; Ganguly K, 2011, NAT NEUROSCI, V14, P662, DOI 10.1038/nn.2797; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; Gewaltig MO, 2001, NEURAL NETWORKS, V14, P657, DOI 10.1016/S0893-6080(01)00070-3; GLEES P, 1950, J NEUROPHYSIOL, V13, P137, DOI 10.1152/jn.1950.13.2.137; Grossman N, 2017, CELL, V169, P1029, DOI 10.1016/j.cell.2017.05.024; Guggenmos DJ, 2013, P NATL ACAD SCI USA, V110, P21177, DOI 10.1073/pnas.1316885110; Gulati T, 2015, J NEUROSCI, V35, P8653, DOI 10.1523/JNEUROSCI.5007-14.2015; Hall TM, 2014, NEURON, V83, P1185, DOI 10.1016/j.neuron.2014.07.022; Hao ZL, 2013, SAO PAULO MED J, V131, P440, DOI [10.1590/1516-3180.20131316T2, 10.1002/14651858.CD008862.pub2]; Hardy NF, 2018, NEURAL COMPUT, V30, P378, DOI 10.1162/neco_a_01041; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harvey RL, 2018, STROKE, V49, P2138, DOI 10.1161/STROKEAHA.117.020607; Hatsopoulos NG, 2011, NEURON, V72, P477, DOI 10.1016/j.neuron.2011.10.020; He F, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1933; Huang Y, 2017, ELIFE, V6, DOI 10.7554/eLife.18834; Johnson L, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz2747; Kao JC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06029-x; Kao JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8759; Kar K, 2017, J NEUROSCI, V37, P2325, DOI 10.1523/JNEUROSCI.2266-16.2016; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; Krause MR, 2019, P NATL ACAD SCI USA, V116, P5747, DOI 10.1073/pnas.1815958116; Krause MR, 2017, CURR BIOL, V27, P3086, DOI 10.1016/j.cub.2017.09.020; Kumar A, 2008, J NEUROSCI, V28, P5268, DOI 10.1523/JNEUROSCI.2542-07.2008; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; Lebedev MA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54760-4; LECAS JC, 1986, J NEUROPHYSIOL, V56, P1680, DOI 10.1152/jn.1986.56.6.1680; Lemke SM, 2019, NAT NEUROSCI, V22, P1122, DOI 10.1038/s41593-019-0407-2; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Levy RM, 2016, NEUROREHAB NEURAL RE, V30, P107, DOI 10.1177/1545968315575613; Liu Y, 1999, EXP BRAIN RES, V128, P149, DOI 10.1007/s002210050830; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Michaels JA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005175; Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; Morecraft RJ, 2015, J COMP NEUROL, V523, P669, DOI 10.1002/cne.23703; Morris RGM, 1999, BRAIN RES BULL, V50, P437, DOI 10.1016/S0361-9230(99)00182-3; MUIR RB, 1983, BRAIN RES, V261, P312, DOI 10.1016/0006-8993(83)90635-2; MURPHY JT, 1985, J NEUROPHYSIOL, V53, P435, DOI 10.1152/jn.1985.53.2.435; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Nudo RJ, 1997, MOL PSYCHIATR, V2, P188, DOI 10.1038/sj.mp.4000188; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Radman T, 2009, BRAIN STIMUL, V2, P215, DOI 10.1016/j.brs.2009.03.007; Rajan K, 2016, NEURON, V90, P128, DOI 10.1016/j.neuron.2016.02.009; Ramanathan D, 2006, P NATL ACAD SCI USA, V103, P11370, DOI 10.1073/pnas.0601065103; Ramanathan DS, 2018, NAT MED, V24, P1257, DOI 10.1038/s41591-018-0058-y; Rawji V, 2018, BRAIN STIMUL, V11, P289, DOI 10.1016/j.brs.2017.11.001; Remington ED, 2018, TRENDS COGN SCI, V22, P938, DOI 10.1016/j.tics.2018.07.010; Riddle CN, 2009, J NEUROSCI, V29, P4993, DOI 10.1523/JNEUROSCI.3720-08.2009; Riehle A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00048; Rohlfing T, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00027; Rouse AG, 2016, J NEUROSCI, V36, P10640, DOI 10.1523/JNEUROSCI.1716-16.2016; Rouse AG, 2016, J NEUROPHYSIOL, V115, P3238, DOI 10.1152/jn.00008.2016; Russo AA, 2018, NEURON, V97, P953, DOI 10.1016/j.neuron.2018.01.004; Saleh M, 2012, J NEUROSCI, V32, P1220, DOI 10.1523/JNEUROSCI.2438-11.2012; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Shih AY, 2013, NAT NEUROSCI, V16, P55, DOI 10.1038/nn.3278; Stimberg M, 2019, ELIFE, V8, DOI 10.7554/eLife.47314; Sussillo D, 2015, NAT NEUROSCI, V18, P1025, DOI 10.1038/nn.4042; Totten D., 2018, BIORXIV; Trengove C, 2013, J COMPUT NEUROSCI, V34, P185, DOI 10.1007/s10827-012-0413-9; Veuthey TL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17902-1; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Voroslakos M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02928-3; Xu W, 2019, J NEUROSCI, V39, P3698, DOI 10.1523/JNEUROSCI.1408-18.2019; Zaaimi B, 2012, BRAIN, V135, P2277, DOI 10.1093/brain/aws115	103	13	13	3	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					912	+		10.1016/j.cell.2021.01.023	http://dx.doi.org/10.1016/j.cell.2021.01.023		FEB 2021	39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33571430	Green Accepted			2022-12-28	WOS:000629633400009
J	[Anonymous]				[Anonymous]			Seven days in medicine: 10-16 February 2021	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Liverpool School of Tropical Medicine, 2021, LSTM DIV FOSS FUEL C; Medicines and Healthcare Products Regulatory Agency, 2021, VIEWS SOUGHT ON MAKI; Vohra K, 2021, ENVIRON RES, V195, DOI 10.1016/j.envres.2021.110754; World Health Organization, 2021, DAT ACT ACH HIGH UPT	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2021	372								n444	10.1136/bmj.n444	http://dx.doi.org/10.1136/bmj.n444			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK7SF	33602673				2022-12-28	WOS:000620581100001
J	Conrado, AB; Ierodiakonou, D; Gowland, MH; Boyle, RJ; Turner, PJ				Conrado, Alessia Baseggio; Ierodiakonou, Despo; Gowland, M. Hazel; Boyle, Robert J.; Turner, Paul J.			Food anaphylaxis in the United Kingdom: analysis of national data, 1998-2018	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVE To describe time trends for hospital admissions due to food anaphylaxis in the United Kingdom over the past 20 years. DESIGN Analysis of national data, 1998-2018. SETTING Data relating to hospital admissions for anaphylaxis and deaths, and prescription data for adrenaline autoinjector devices. PARTICIPANTS UK population as a whole and devolved nations (England, Scotland, Wales, and Northern Ireland). MAIN OUTCOME MEASURES Time trends, age, and sex distributions for hospital admissions for anaphylaxis due to food and non-food triggers, and how these admission rates compare with the case fatality rate (number of fatalities as a proportion of hospital admissions). RESULTS Between 1998 and 2018, 101 891 people were admitted to hospital for anaphylaxis. Of these admissions, 30 700 (30.1%) were coded as due to a food trigger. Food anaphylaxis admissions increased from 1.23 to 4.04 per 100 000 population per year (from 1998 to 2018), an annual increase of 5.7% (95% confidence interval 5.5% to 5.9%, P<0.001). The largest increase in hospital admissions was observed in children younger than 15 years, with an increase from 2.1 to 9.2 admissions per 100 000 population per year (an annual increase of 6.6%, 95% confidence interval 6.3% to 7.0%). For comparison, the annual increase was 5.9% (5.6% to 6.2%) in people aged 15-59 years and 2.1% (1.8% to 3.1%) in those aged 60 years and older. 152 deaths were identified where the fatal event was probably caused by food induced anaphylaxis. The case fatality rate decreased from 0.7% to 0.19% for confirmed fatal food anaphylaxis (rate ratio 0.931, 95% confidence interval 0.904 to 0.959, P<0.001) and to 0.30% for suspected fatal food anaphylaxis (0.970, 0.945 to 0.996, P=0.024). At least 46% (86 of 187, which also includes 35 deaths in 1992-98) of deaths were triggered by peanut or tree nut. Cow's milk was responsible for 17 of 66 (26%) deaths in school aged children. Over the same time period, prescriptions for adrenaline autoinjectors increased by 336% (estimated rate ratio 1.113, 95% confidence interval 1.112 to 1.113; an increase of 11% per year). CONCLUSIONS Hospital admissions for food induced anaphylaxis have increased from 1998 to 2018, however the case fatality rate has decreased. In school aged children, cow's milk is now the most common single cause of fatal anaphylaxis.	[Conrado, Alessia Baseggio; Boyle, Robert J.; Turner, Paul J.] Imperial Coll London, Natl Heart & Lung Inst, Norfolk Pl, London W2 1PG, England; [Ierodiakonou, Despo] Univ Crete, Fac Med, Dept Social Med, Hlth Planning Unit, Iraklion, Greece; [Gowland, M. Hazel] Allergy Act, St Albans, England	Imperial College London; University of Crete	Turner, PJ (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Norfolk Pl, London W2 1PG, England.	p.turner@imperial.ac.uk	Baseggio Conrado, Alessia/P-8330-2019	Baseggio Conrado, Alessia/0000-0001-5775-424X; Ierodiakonou, Despo/0000-0002-7862-2016; Turner, Paul/0000-0001-9862-5161; Gowland, M Hazel/0000-0002-5513-5979; Boyle, Robert/0000-0002-4913-7580	UK Medical Research Council clinician scientist award [MR/K010468/1]; UK Food Standards Agency [FS101222]	UK Medical Research Council clinician scientist award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Food Standards Agency	This research was funded by a UK Medical Research Council clinician scientist award to PJT (reference MR/K010468/1) and by the UK Food Standards Agency (reference FS101222). The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.	[Anonymous], BBC; Barnett J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6117-y; Brough HA, 2015, CLIN EXP ALLERGY, V45, P859, DOI 10.1111/cea.12466; Gonzalez-Perez A, 2010, J ALLERGY CLIN IMMUN, V125, P1098, DOI 10.1016/j.jaci.2010.02.009; Grabenhenrich LB, 2016, J ALLERGY CLIN IMMUN, V137, P1128, DOI 10.1016/j.jaci.2015.11.015; Hoffer V, 2011, PEDIAT ALLERG IMM-UK, V22, P172, DOI 10.1111/j.1399-3038.2010.00990.x; Jensen-Jarolim E, 2008, ALLERGY, V63, P610, DOI 10.1111/j.1398-9995.2008.01645.x; Levy MB, 2012, ISR MED ASSOC J, V14, P29; Marrs T, 2013, PEDIAT ALLERG IMM-UK, V24, P222, DOI 10.1111/pai.12013; National Institute for Health and Care Excellence, 2011, AN ASS CONF AN EP DE; Ramsey NB, 2019, J ALLER CL IMM-PRACT, V7, P2241, DOI 10.1016/j.jaip.2019.04.025; Tanno LK, 2020, ALLERGY, V75, P2206, DOI 10.1111/all.14468; Tanno LK, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0607-3; Turner PJ, 2020, J ALLER CL IMM-PRACT, V8, P1169, DOI 10.1016/j.jaip.2019.11.027; Turner PJ, 2019, WORLD ALLERGY ORGAN, V12, DOI 10.1016/j.waojou.2019.100066; Turner PJ, 2016, CURR OPIN ALLERGY CL, V16, P441, DOI 10.1097/ACI.0000000000000305; Turner PJ, 2015, J ALLERGY CLIN IMMUN, V135, P956, DOI 10.1016/j.jaci.2014.10.021; Turner PJ, 2013, PEDIAT ALLERG IMM-UK, V24, P624, DOI 10.1111/pai.12148; Venter C, 2010, ALLERGY, V65, P103, DOI 10.1111/j.1398-9995.2009.02176.x	19	45	45	3	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2021	372								n251	10.1136/bmj.n251	http://dx.doi.org/10.1136/bmj.n251			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK7TO	33597169	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000620584600003
J	Rimmer, A				Rimmer, Abi			How to beat night shift dread	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2021	372								n395	10.1136/bmj.n395	http://dx.doi.org/10.1136/bmj.n395			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UD8KK	33589472	Bronze			2022-12-28	WOS:000687451600001
J	Peters, JW; Einsle, O; Dean, DR; DeBeer, S; Hoffman, BM; Holland, PL; Seefeldt, LC				Peters, John W.; Einsle, Oliver; Dean, Dennis R.; DeBeer, Serena; Hoffman, Brian M.; Holland, Patrick L.; Seefeldt, Lance C.			Comment on "Structural evidence for a dynamic metallocofactor during N2 reduction by Mo-nitrogenase"	SCIENCE			English	Editorial Material								Kang et al. (Reports, 19 June 2020, p. 1381) report a structure of the nitrogenase MoFe protein that is interpreted to indicate binding of N-2 or an N-2-derived species to the active-site FeMo cofactor. Independent refinement of the structure and consideration of biochemical evidence do not support this claim.	[Peters, John W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Einsle, Oliver] Albert Ludwigs Univ, Inst Biochem, Freiburg, Germany; [Dean, Dennis R.] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [DeBeer, Serena] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany; [Hoffman, Brian M.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Holland, Patrick L.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Seefeldt, Lance C.] Utah State Univ, Chem & Biochem, Logan, UT 84322 USA	Washington State University; University of Freiburg; Virginia Polytechnic Institute & State University; Max Planck Society; Northwestern University; Yale University; Utah System of Higher Education; Utah State University	Peters, JW (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.; Einsle, O (corresponding author), Albert Ludwigs Univ, Inst Biochem, Freiburg, Germany.	jw.peters@wsu.edu; einsle@bio.chemie.uni-freiburg.de	DeBeer, Serena/T-6420-2018	DeBeer, Serena/0000-0002-5196-3400; Seefeldt, Lance/0000-0002-6457-9504; Dean, Dennis/0000-0001-8960-6196; Peters, John/0000-0001-9117-9568	NIH [GM138592, GM111097, GM065313]; U.S. Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0018143, DE-SC0010834, DE-SC0010687]; NSF [MCB-1908587]; Deutsche Forschungsgemeinschaft [PP 1927, 311061829]; Max Planck Society	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	Supported by NIH grants GM138592 (J.W.P.), GM111097 (B.M.H.), and GM065313 (P.L.H.); U.S. Department of Energy, Office of Science, Basic Energy Sciences grants DE-SC0018143 (J.W.P.), DE-SC0010834 (D.R.D.), and DE-SC0010687 (L.C.S.); NSF grant MCB-1908587 (B.M.H.); Deutsche Forschungsgemeinschaft, PP 1927, project no. 311061829 (O.E.); and the Max Planck Society (S.D.)	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Einsle O, 2020, CHEM REV, V120, P4969, DOI 10.1021/acs.chemrev.0c00067; Kang W., 2020, Anomalous datasets, Version 1.0, DOI 10.5281/zenodo.3756201; Kang W, 2020, SCIENCE, V368, P1381, DOI 10.1126/science.aaz6748; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; Peters J. W., 2020, ZENODO, DOI [10.5281/zenodo.4279739, DOI 10.5281/ZENODO.4279739]; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Seefeldt LC, 2020, CHEM REV, V120, P5082, DOI 10.1021/acs.chemrev.9b00556; Singh D, 2020, CHEM REV, V120, P5517, DOI 10.1021/acs.chemrev.0c00042; THORNELEY RNF, 1978, NATURE, V272, P557, DOI 10.1038/272557a0; Van Stappen C, 2020, CHEM REV, V120, P5005, DOI 10.1021/acs.chemrev.9b00650	11	12	12	8	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530							abe5481	10.1126/science.abe5481	http://dx.doi.org/10.1126/science.abe5481			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ZG0HR	33574183	Green Accepted			2022-12-28	WOS:000759947200001
J	Vethaak, AD; Legler, J				Vethaak, A. Dick; Legler, Juliette			Microplastics and human health	SCIENCE			English	Editorial Material									[Vethaak, A. Dick] Vrije Univ Amsterdam, Dept Environm & Hlth, Amsterdam, Netherlands; [Vethaak, A. Dick] Deltares, Dept Marine & Coastal Syst, POB 177, NL-2600 MH Delft, Netherlands; [Legler, Juliette] Univ Utrecht, Fac Vet Med, Dept Populat Hlth Sci, Inst Risk Assessment Sci, Utrecht, Netherlands	Vrije Universiteit Amsterdam; Deltares; Utrecht University	Vethaak, AD (corresponding author), Vrije Univ Amsterdam, Dept Environm & Hlth, Amsterdam, Netherlands.; Vethaak, AD (corresponding author), Deltares, Dept Marine & Coastal Syst, POB 177, NL-2600 MH Delft, Netherlands.	dick.vethaak@deltares.nl			Netherlands Organisation for Health Research and Development (ZonMw)	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	The authors receive financial support from The Netherlands Organisation for Health Research and Development (ZonMw). We thank F. Pierik, program leader ZonMw Microplastics & Health program, and all collaborators in this program for helpful discussions.	Catarino AI, 2018, ENVIRON POLLUT, V237, P675, DOI 10.1016/j.envpol.2018.02.069; Gruber MM, 2020, J NANOBIOTECHNOL, V18, DOI 10.1186/s12951-020-00676-5; Kelly FJ, 2020, PHILOS T R SOC A, V378, DOI 10.1098/rsta.2019.0322; Koelmans AA, 2019, WATER RES, V155, P410, DOI 10.1016/j.watres.2019.02.054; Koelmans AA, 2016, ENVIRON SCI TECHNOL, V50, P3315, DOI 10.1021/acs.est.5b06069; Li DZ, 2020, NAT FOOD, V1, P746, DOI 10.1038/s43016-020-00171-y; Lu L, 2019, SCI TOTAL ENVIRON, V667, P94, DOI 10.1016/j.scitotenv.2019.02.380; Prust M, 2020, PART FIBRE TOXICOL, V17, DOI 10.1186/s12989-020-00358-y; Ribeiro F, 2019, TRAC-TREND ANAL CHEM, V111, P139, DOI 10.1016/j.trac.2018.12.010; Rochman CM, 2019, ENVIRON TOXICOL CHEM, V38, P703, DOI 10.1002/etc.4371; SAPEA, 2019, SCI PERSP MICR NAT S; Shi JH, 2021, SCI TOTAL ENVIRON, V765, DOI 10.1016/j.scitotenv.2020.142775; Wright SL, 2020, ENVIRON INT, V136, DOI 10.1016/j.envint.2019.105411; Wright SL, 2017, ENVIRON SCI TECHNOL, V51, P6634, DOI 10.1021/acs.est.7b00423; Yong CQY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051509	15	172	172	109	365	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					672	674		10.1126/science.abe5041	http://dx.doi.org/10.1126/science.abe5041			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4IS	33574197				2022-12-28	WOS:000617551600023
J	Torjesen, I				Torjesen, Ingrid			Fossil fuel air pollution blamed for 1 in 5 deaths worldwide	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cohen AJ, 2017, LANCET, V389, P1907, DOI [10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6]; Dyer C, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4902; Vodonos A, 2018, ENVIRON RES, V166, P677, DOI 10.1016/j.envres.2018.06.021; Vohra K, 2021, ENVIRON RES, V195, DOI 10.1016/j.envres.2021.110754	4	5	5	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2021	372								n406	10.1136/bmj.n406	http://dx.doi.org/10.1136/bmj.n406			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC1VA	33568356				2022-12-28	WOS:000686320800005
J	Kaka, AS; MacDonald, R; Greer, N; Vela, K; Duan-Porter, W; Obley, A; Wilt, TJ				Kaka, Anjum S.; MacDonald, Roderick; Greer, Nancy; Vela, Kathryn; Duan-Porter, Wei; Obley, Adam; Wilt, Timothy J.			Major Update: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points	ANNALS OF INTERNAL MEDICINE			English	Review								Background: Remdesivir is being studied and used for treatment of coronavirus disease 2019 (COVID-19). Purpose: To update a previous review of remdesivir for adults with COVID-19, including new meta-analyses of patients with COVID-19 of any severity compared with control. Data Sources: Several sources from 1 January 2020 through 7 December 2020. Study Selection: English-language, randomized controlled trials (RCTs) of remdesivir for COVID-19. New evidence is incorporated by using living review methods. Data Extraction: 1 reviewer abstracted data; a second reviewer verified the data. The Cochrane Risk of Bias Tool and GRADE (Grading of Recommendations Assessment, Development and Evaluation) method were used. Data Synthesis: The update includes 5 RCTs, incorporating data from a new large RCT and the final results of a previous RCT. Compared with control, a 10-day course of remdesivir probably results in little to no reduction in mortality (risk ratio [RR], 0.93 [95% CI, 0.82 to 1.06]; 4 RCTs) but may result in a small reduction in the proportion of patients receiving mechanical ventilation (RR, 0.71 [CI, 0.56 to 0.90]; 3 RCTs). Remdesivir probably results in a moderate increase in the percentage of patients who recovered and a moderate decrease in serious adverse events and may result in a large reduction in time to recovery. Effect on hospital length of stay or percentage remaining hospitalized is mixed. Compared with a 10-day course for those not requiring ventilation at baseline, a 5-day course may reduce mortality, the need for ventilation, and serious adverse events while increasing the percentage of patients who recovered or clinically improved. Limitation: Summarizing findings was challenging because of varying disease severity definitions and outcomes. Conclusion: In hospitalized adults with COVID-19, remdesivir probably results in little to no mortality difference but probably improves the percentage recovered and reduces serious harms and may result in a small reduction in the proportion receiving ventilation. For patients not receiving ventilation, a 5-day course may provide greater benefits and fewer harms with lower drug costs than a 10-day course.	[Kaka, Anjum S.] Minneapolis VA Hlth Care Syst, One Vet Dr 111-F, Minneapolis, MN 55417 USA; [MacDonald, Roderick; Greer, Nancy; Duan-Porter, Wei; Wilt, Timothy J.] Minneapolis VA Hlth Care Syst, One Vet Dr 111-0, Minneapolis, MN 55417 USA; [Kaka, Anjum S.; Duan-Porter, Wei; Wilt, Timothy J.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Greer, Nancy] VA Portland Hlth Care Syst, Portland, OR USA; [Vela, Kathryn] 5696 South Apsley Way, Boise, ID 83709 USA; [Obley, Adam] Portland VA Hlth Care Syst, 3710 Southwest US Vet Hosp Rd, Portland, OR 97239 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Wilt, TJ (corresponding author), Minneapolis VA Hlth Care Syst, One Vet Dr 111-0, Minneapolis, MN 55417 USA.	Tim.Wilt@va.gov		Kaka, Anjum/0000-0003-1817-8950; Vela, Kathryn/0000-0003-0221-2800				[Anonymous], 2020, ANN INTERN MED, DOI 10.7326/m20-5752; [Anonymous], STUDY EVALUATE EFFIC; [Anonymous], STUDY PARTICIPANTS E; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Bhimraj A, INFECT DIS SOC AM GU; Gilead Sciences, 2020, GIL RESP COVID 19; Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301; Harrington DP, 2021, NEW ENGL J MED, V384, P576, DOI 10.1056/NEJMe2034294; Higgins J.P.T., 2021, COCHRANE HDB SYSTEMA, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hsu J, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4457; Institute for Clinical and Economic Review, ICER 2 UPD PRIC MOD; Lamontagne F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3379; MacDonald, 2020, RAPID RESPONSE COVID; McCreary EK, 2020, JAMA-J AM MED ASSOC, V324, P1041, DOI 10.1001/jama.2020.16337; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; National Institutes of Health, 2020, THER MAN PAT COVID 1; Qaseem A, 2021, ANN INTERN MED, V174, P673, DOI 10.7326/M20-8101; Schunemann H., 2020, GRADE HDB GRADING QU; Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6; Spinner CD, 2020, JAMA-J AM MED ASSOC, V324, P1048, DOI 10.1001/jama.2020.16349; U.S. Food and Drug Administration, 2020, FDA APPR 1 TREATM CO; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184	26	48	48	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					663	+		10.7326/M20-8148	http://dx.doi.org/10.7326/M20-8148		FEB 2021	14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33560863	Green Published			2022-12-28	WOS:000652604800025
J	Gardner, TB				Gardner, Timothy B.			In the Clinic Acute Pancreatitis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							POST-ERCP PANCREATITIS; COMPUTED-TOMOGRAPHY; ORGAN FAILURE; APACHE-II; MANAGEMENT; MORTALITY; HEMOCONCENTRATION; PREDICTION; ADMISSION; RISK		[Gardner, Timothy B.] Dartmouth Hitchcock Med Ctr, Hanover, NH 03755 USA	Dartmouth College	Gardner, TB (corresponding author), Dartmouth Hitchcock Med Ctr, Hanover, NH 03755 USA.				American College of Physicians	American College of Physicians	American College of Physicians.	Arvanitakis M, 2004, GASTROENTEROLOGY, V126, P715, DOI 10.1053/j.gastro.2003.12.006; Badalov N, 2007, CLIN GASTROENTEROL H, V5, P648, DOI 10.1016/j.cgh.2006.11.023; Bakker OJ, 2014, NEW ENGL J MED, V371, P1983, DOI 10.1056/NEJMoa1404393; Banks PA, 2006, AM J GASTROENTEROL, V101, P2379, DOI 10.1111/j.1572-0241.2006.00856.x; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Bellin MD, 2016, CLIN GASTROENTEROL H, V14, P1317, DOI 10.1016/j.cgh.2016.02.027; BLAMEY SL, 1984, GUT, V25, P1340, DOI 10.1136/gut.25.12.1340; Blum T, 2001, PANCREATOLOGY, V1, P237, DOI 10.1159/000055817; Brown A, 2000, PANCREAS, V20, P367, DOI 10.1097/00006676-200005000-00005; Chatzicostas C, 2002, PANCREAS, V25, P331, DOI 10.1097/00006676-200211000-00002; Cheng CL, 2006, AM J GASTROENTEROL, V101, P139, DOI 10.1111/j.1572-0241.2006.00380.x; Crockett SD, 2018, GASTROENTEROLOGY, V154, P1096, DOI 10.1053/j.gastro.2018.01.032; De Bernardinis M, 1999, CRIT CARE MED, V27, P2272, DOI 10.1097/00003246-199910000-00035; Elmunzer BJ, 2012, NEW ENGL J MED, V366, P1414, DOI 10.1056/NEJMoa1111103; Gapp J, 2019, PANCREAS, V48, P548, DOI [10.1097/MPA.0000000000001275, 10.1097/mpa.0000000000001275]; Gardner TB, 2008, CLIN GASTROENTEROL H, V6, P1070, DOI 10.1016/j.cgh.2008.05.005; Gardner TB, 2006, PANCREAS, V33, P169, DOI 10.1097/01.mpa.0000226885.32957.17; Gardner TB, 2011, GASTROINTEST ENDOSC, V73, P718, DOI 10.1016/j.gie.2010.10.053; Johnson CD, 2004, GUT, V53, P1340, DOI 10.1136/gut.2004.039883; Johnson CD, 2004, PANCREATOLOGY, V4, P1, DOI 10.1159/000077021; Kristiansen L, 2008, AM J EPIDEMIOL, V168, P932, DOI 10.1093/aje/kwn222; Lai R, 2004, ENDOSCOPY, V36, P705, DOI 10.1055/s-2004-825663; Lankisch PG, 2009, AM J GASTROENTEROL, V104, P2797, DOI 10.1038/ajg.2009.405; Lankisch PG, 2009, CLIN GASTROENTEROL H, V7, P702, DOI 10.1016/j.cgh.2009.02.020; Lankisch PG, 2001, SCAND J GASTROENTERO, V36, P432, DOI 10.1080/003655201300051351; Liu CL, 2001, GASTROINTEST ENDOSC, V54, P325, DOI 10.1067/mge.2001.117513; Liu KJM, 2001, AM SURGEON, V67, P215; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; Makary MA, 2005, ANN SURG, V241, P119, DOI 10.1097/01.sla.0000149509.77666.94; Manjuck J, 2005, CHEST, V127, P246, DOI 10.1378/chest.127.1.246; MIQUEL JF, 1992, GASTROENTEROLOGY, V102, P2188, DOI 10.1016/0016-5085(92)90376-A; Mortele KJ, 2004, AM J ROENTGENOL, V183, P1261, DOI 10.2214/ajr.183.5.1831261; Murphy CC, 2019, GASTROENTEROLOGY, V156, P958, DOI [10.1053/j.gastro.2018.08.063, 10.1053/j.gastro.2018.11.060]; Nichols MT, 2006, PANCREAS, V33, P211, DOI 10.1097/01.mpa.0000227912.71202.2c; Nitsche CJ, 2010, BEST PRACT RES CL GA, V24, P143, DOI 10.1016/j.bpg.2010.02.002; Nordback I, 2009, GASTROENTEROLOGY, V136, P848, DOI 10.1053/j.gastro.2008.11.044; Papachristou GI, 2010, AM J GASTROENTEROL, V105, P435, DOI 10.1038/ajg.2009.622; Petrov MS, 2008, ANN SURG, V247, P250, DOI 10.1097/SLA.0b013e31815edddd; Schutte K, 2008, BEST PRACT RES CL GA, V22, P75, DOI 10.1016/j.bpg.2007.10.013; Sedlack R, 2002, GASTROINTEST ENDOSC, V56, P543, DOI 10.1067/mge.2002.128106; SENO T, 1995, AM J GASTROENTEROL, V90, P2002; Sinha A, 2015, PANCREATOLOGY, V15, P105, DOI 10.1016/j.pan.2015.02.005; Trivedi CD, 2005, J CLIN GASTROENTEROL, V39, P709, DOI 10.1097/01.mcg.0000173929.60115.b4; van Santvoort HC, 2010, NEW ENGL J MED, V362, P1491, DOI 10.1056/NEJMoa0908821; Vege SS, 2018, GASTROENTEROLOGY, V154, P1103, DOI 10.1053/j.gastro.2018.01.031; Villatoro E, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002941.pub3; WACHTER RM, 2005, HOSP MED; Wu BU, 2008, GUT, V57, P1698, DOI 10.1136/gut.2008.152702; Wu BU, 2011, CLIN GASTROENTEROL H, V9, P710, DOI 10.1016/j.cgh.2011.04.026; Wu BU, 2009, GASTROENTEROLOGY, V137, P129, DOI 10.1053/j.gastro.2009.03.056; Yadav D, 2003, J CLIN GASTROENTEROL, V36, P54, DOI 10.1097/00004836-200301000-00016; Yadav D, 2002, AM J GASTROENTEROL, V97, P1309, DOI 10.1016/S0002-9270(02)04122-9; Yadav D, 2010, NAT REV GASTRO HEPAT, V7, P131, DOI 10.1038/nrgastro.2010.6; Yang AL, 2020, PANCREATOLOGY, V20, P795, DOI 10.1016/j.pan.2020.06.005; Yuan X, 2020, SURGEON, DOI 10.1016/j.surge.2020.06.014	55	13	13	4	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2021	174	2					ITC17	ITC32		10.7326/AITC202102160	http://dx.doi.org/10.7326/AITC202102160			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ2CK	33556276				2022-12-28	WOS:000619497100003
J	Teles, A; Viana, F				Teles, Ana; Viana, Flavia			Science outreach in my mother tongue	NATURE			English	Editorial Material						Careers; Lab life; Culture		Ana Teles and Flavia Viana seized on a chance to communicate their passion for science to migrant children who shared their first language. Ana Teles and Flavia Viana seized on a chance to communicate their passion for science to migrant children who shared their first language.	[Viana, Flavia] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Teles, Ana] Max Planck Inst Evolutionary Biol Plon, Plon, Germany	Queens University Belfast; Max Planck Society	Teles, A (corresponding author), Max Planck Inst Evolutionary Biol Plon, Plon, Germany.		Viana, Flavia/AAA-6168-2020	Viana, Flavia/0000-0001-6286-4902					0	3	3	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847					678	678		10.1038/d41586-021-00389-1	http://dx.doi.org/10.1038/d41586-021-00389-1			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QJ3KZ	33580219				2022-12-28	WOS:000619592400003
J	Ingelfinger, JR				Ingelfinger, Julie R.			Emergency Intubation in Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Lamsal, Ritesh/0000-0003-4670-6909				Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849; Cook TM, 2020, ANAESTHESIA, V75, P785, DOI 10.1111/anae.15054; Orser BA, 2020, ANESTH ANALG, V130, P1109, DOI 10.1213/ANE.0000000000004803; Ramzy M, 2020, AM J EMERG MED, V38, P2693, DOI 10.1016/j.ajem.2020.08.011	4	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2021	384	7							e20	10.1056/NEJMvcm2007198	http://dx.doi.org/10.1056/NEJMvcm2007198			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2HH	33596358	Bronze			2022-12-28	WOS:000620900000001
J	Oliver, D				Oliver, David			Covid-19: NHS trusts deny restricting PPE during pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Pulla P, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n399	1	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2021	372								n442	10.1136/bmj.n442	http://dx.doi.org/10.1136/bmj.n442			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK7TO	33600352	Bronze			2022-12-28	WOS:000620584600008
J	Sauer, DB; Song, JM; Wang, B; Hilton, JK; Karpowich, NK; Mindell, JA; Rice, WJ; Wang, DN				Sauer, David B.; Song, Jinmei; Wang, Bing; Hilton, Jacob K.; Karpowich, Nathan K.; Mindell, Joseph A.; Rice, William J.; Wang, Da-Neng			Structure and inhibition mechanism of the human citrate transporter NaCT	NATURE			English	Article								Citrate is best known as an intermediate in the tricarboxylic acid cycle of the cell. In addition to this essential role in energy metabolism, the tricarboxylate anion also acts as both a precursor and a regulator of fatty acid synthesis(1-3). Thus, the rate of fatty acid synthesis correlates directly with the cytosolic concentration of citrate(4,5). Liver cells import citrate through the sodium-dependent citrate transporter NaCT (encoded by SLC13A5) and, as a consequence, this protein is a potential target for anti-obesity drugs. Here, to understand the structural basis of its inhibition mechanism, we determined cryo-electron microscopy structures of human NaCT in complexes with citrate or a small-molecule inhibitor. These structures reveal how the inhibitor-which binds to the same site as citrate-arrests the transport cycle of NaCT. The NaCT-inhibitor structure also explains why the compound selectively inhibits NaCT over two homologous human dicarboxylate transporters, and suggests ways to further improve the affinity and selectivity. Finally, the NaCT structures provide a framework for understanding how various mutations abolish the transport activity of NaCT in the brain and thereby cause epilepsy associated with mutations in SLC13A5 in newborns (which is known as SLC13A5-epilepsy)(6-8).	[Sauer, David B.; Song, Jinmei; Karpowich, Nathan K.; Wang, Da-Neng] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; [Sauer, David B.; Song, Jinmei; Karpowich, Nathan K.; Rice, William J.; Wang, Da-Neng] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Wang, Bing; Rice, William J.] New York Univ, Cryoelect Microscopy Core, Sch Med, New York, NY 10016 USA; [Hilton, Jacob K.; Mindell, Joseph A.] NINDS, Porter Neurosci Res Ctr, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Karpowich, Nathan K.] Janssen Pharmaceut, Spring House, PA USA	New York University; New York University; New York University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson USA	Wang, DN (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA.; Rice, WJ; Wang, DN (corresponding author), NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.; Rice, WJ (corresponding author), New York Univ, Cryoelect Microscopy Core, Sch Med, New York, NY 10016 USA.; Mindell, JA (corresponding author), NINDS, Porter Neurosci Res Ctr, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	mindellj@ninds.nih.gov; william.rice@med.nyu.edu; da-neng.wang@med.nyu.edu	; Mindell, Joseph/P-4461-2017	Wang, Da-Neng/0000-0002-6496-4699; Sauer, David/0000-0001-9291-4640; Mindell, Joseph/0000-0002-6952-8247; Rice, William/0000-0002-5187-255X	NIH [R01NS108151, R01GM121994]; G. Harold and Leila Y. Mathers Foundation; TESS Research Foundation; American Epilepsy Society; Pfizer; American Cancer Society Postdoctoral Fellowship [129844-PF-17-135-01-TBE]; Department of Defense Horizon Award [W81XWH-16-1-0153]; NINDS Intramural Program	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Foundation; TESS Research Foundation; American Epilepsy Society; Pfizer(Pfizer); American Cancer Society Postdoctoral Fellowship(American Cancer Society); Department of Defense Horizon Award; NINDS Intramural Program	This work was financially supported by the NIH (R01NS108151 and R01GM121994), the G. Harold and Leila Y. Mathers Foundation, the TESS Research Foundation, the American Epilepsy Society and Pfizer. D.B.S. was supported by the American Cancer Society Postdoctoral Fellowship (129844-PF-17-135-01-TBE) and Department of Defense Horizon Award (W81XWH-16-1-0153). J.K.H. and J.A.M. were supported by the NINDS Intramural Program. We thank the following colleagues for reagents, technical assistance and discussions: Y. Cheng, N. Coudray, K. Huard, T. Kawate, J. Li, R. Mancusso, J. Marden, F. Ono and J. Zhao; the staff at the following facilities for assistance in grid screening and data collection: K. Maruthi at the Simons Electron Microscopy Center at the New York Structural Biology Center, H. Scott at the Pacific Northwest Center for Cryo-EM and K. Dancel from the NYU Microscopy Core. Electron microscopy data processing used computing resources at the HPC Facility of NYULMC, and we were assisted by A. Siavosh-Haghighi and M. Costantino.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auer M, 2001, BIOCHEMISTRY-US, V40, P6628, DOI 10.1021/bi010138+; Bartesaghi A, 2014, P NATL ACAD SCI USA, V111, P11709, DOI 10.1073/pnas.1402809111; Bepler T, 2019, NAT METHODS, V16, P1153, DOI 10.1038/s41592-019-0575-8; Bergeron MJ, 2013, MOL ASPECTS MED, V34, P299, DOI 10.1016/j.mam.2012.12.001; Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; Brachs S, 2016, MOL METAB, V5, P1072, DOI 10.1016/j.molmet.2016.08.004; Colas C, 2015, BIOCHEMISTRY-US, V54, P4900, DOI 10.1021/acs.biochem.5b00388; Dang SY, 2017, NATURE, V552, P426, DOI 10.1038/nature25024; DeLano W.L, 2002, PYMOL USERS MANUAL, DOI [10.1038/s41586-021-03230-x, DOI 10.1038/S41586-021-03230-X]; Dewulf JP, 2019, ANN NEUROL, V85, P385, DOI 10.1002/ana.25412; Drew D, 2016, ANNU REV BIOCHEM, V85, P543, DOI 10.1146/annurev-biochem-060815-014520; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FANG M, 1967, BIOCHEM J, V105, P803, DOI 10.1042/bj1050803; Fei YJ, 2004, BIOCHEM J, V379, P191, DOI 10.1042/BJ20031807; Garaeva AA, 2020, BIOCHEM SOC T, V48, P1227, DOI 10.1042/BST20200290; Gopal E, 2007, AM J PHYSIOL-GASTR L, V292, pG402, DOI 10.1152/ajpgi.00371.2006; Gopal E, 2015, J PHARMACOL EXP THER, V353, P17, DOI 10.1124/jpet.114.221523; Hardies K, 2015, BRAIN, V138, DOI 10.1093/brain/awv263; Huard K, 2016, J MED CHEM, V59, P1165, DOI 10.1021/acs.jmedchem.5b01752; Huard K, 2015, SCI REP-UK, V5, DOI 10.1038/srep17391; Huynh KW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03271-3; Inoue K, 2004, BIOCHEM J, V378, P949, DOI 10.1042/BJ20031261; Inoue K, 2002, J BIOL CHEM, V277, P39469, DOI 10.1074/jbc.M207072200; Inoue K, 2003, BIOCHEM J, V374, P21, DOI 10.1042/BJ20030827; Joshi AD, 2006, BIOCHEMISTRY-US, V45, P4231, DOI 10.1021/bi052064y; Kendrick BS, 2001, ANAL BIOCHEM, V299, P136, DOI 10.1006/abio.2001.5411; Khamaysi A, 2020, J BIOL CHEM, V295, P8155, DOI 10.1074/jbc.RA119.010911; Klotz J, 2016, MOL MED, V22, P310, DOI 10.2119/molmed.2016.00077; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Law CJ, 2007, BIOCHEMISTRY-US, V46, P12190, DOI 10.1021/bi701383g; Law CJ, 2009, BIOPHYS J, V97, P1346, DOI 10.1016/j.bpj.2009.06.026; Li LH, 2015, MOL PHARMACOL, V87, P674, DOI 10.1124/mol.114.097287; Makwana KM, 2015, PROTEIN SCI, V24, P1920, DOI 10.1002/pro.2814; Mancusso R, 2012, NATURE, V491, P622, DOI 10.1038/nature11542; Mancusso R, 2011, METHODS, V55, P324, DOI 10.1016/j.ymeth.2011.07.008; Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529; Mulligan C, 2016, NAT STRUCT MOL BIOL, V23, P256, DOI 10.1038/nsmb.3166; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Nie RX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15009; Pajor AM, 2001, J BIOL CHEM, V276, P29961, DOI 10.1074/jbc.M011387200; Pajor AM, 2016, MOL PHARMACOL, V90, P755, DOI 10.1124/mol.116.105049; Pajor AM, 2014, PFLUG ARCH EUR J PHY, V466, P119, DOI 10.1007/s00424-013-1369-y; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2020, NAT METHODS, V17, P1214, DOI 10.1038/s41592-020-00990-8; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rice WJ, 2018, J STRUCT BIOL, V204, P38, DOI 10.1016/j.jsb.2018.06.007; Rives ML, 2016, MOL PHARMACOL, V90, P766, DOI 10.1124/mol.116.106575; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Sauer DB, 2020, ELIFE, V9, DOI 10.7554/eLife.61350; Schlessinger A, 2014, J BIOL CHEM, V289, P16998, DOI 10.1074/jbc.M114.554790; SHRAGO E, 1969, J BIOL CHEM, V244, P2761; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; SPENCER AF, 1962, J BIOL CHEM, V237, P3640; Sul HS, 2008, N COMP BIOC, P155, DOI 10.1016/B978-044453219-0.50008-8; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Thevenon J, 2014, AM J HUM GENET, V95, P113, DOI 10.1016/j.ajhg.2014.06.006; Waight AB, 2010, NAT STRUCT MOL BIOL, V17, P31, DOI 10.1038/nsmb.1740; Wang PY, 2009, P NATL ACAD SCI USA, V106, P9262, DOI 10.1073/pnas.0904115106; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Willmes DM, 2018, PHARMACOL THERAPEUT, V185, P1, DOI 10.1016/j.pharmthera.2017.10.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081	69	21	22	4	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					157	+		10.1038/s41586-021-03230-x	http://dx.doi.org/10.1038/s41586-021-03230-x		FEB 2021	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT9QO	33597751	Green Accepted			2022-12-28	WOS:000618965700003
J	Gee, RE; Shulkin, D; Romm, I				Gee, Rebekah E.; Shulkin, David; Romm, Iyah			A Blueprint for Comprehensive Medicaid Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint proposes broad principles to guide Medicaid reform as a means to advance health equity, including stabilization of its funding and coverage; coordination of its infrastructure; alignment of health care and social spending at the point of care; and a value-based approach to benefits.	[Gee, Rebekah E.] Louisiana State Univ, Hlth Care Serv Div, 2000 Tulane Ave, New Orleans, LA 70802 USA; [Shulkin, David] Sanford Hlth, Sioux Falls, SD USA; [Romm, Iyah] Cityblock Hlth, Brooklyn, NY USA	Louisiana State University System; Sanford Health	Gee, RE (corresponding author), Louisiana State Univ, Hlth Care Serv Div, 2000 Tulane Ave, New Orleans, LA 70802 USA.	rgee@lsuhsc.edu						[Anonymous], 2006, GALLUP; Centers for Medicare & Medicaid Services, 2020, NHE FACT SHEET; Congressional Research Service, MED FIN EXP; Corallo B, 2020, ANAL RECENT NATL TRE; Kaiser Family Foundation, 2020, DAT NOT 5 CHARTS PUB; Medicaid and CHIP Payment and Access Commission, 2020, MAT MORB WOM MED	6	11	11	2	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2021	325	7					619	620		10.1001/jama.2021.0013	http://dx.doi.org/10.1001/jama.2021.0013			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ3QZ	33591353				2022-12-28	WOS:000619608000008
J	Mahase, E				Mahase, Elisabeth			Sixty seconds on ... hotel quarantine	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Rimmer A., 2021, BMJ, V372	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2021	372								n446	10.1136/bmj.n446	http://dx.doi.org/10.1136/bmj.n446			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QI7RL	33589475	Bronze			2022-12-28	WOS:000619180700001
J	Ba, BA; Knox, D; Mummolo, J; Rivera, R				Ba, Bocar A.; Knox, Dean; Mummolo, Jonathan; Rivera, Roman			The role of officer race and gender in police-civilian interactions in Chicago	SCIENCE			English	Article							QUALITY; IMPACT; FORCE; BIAS	Diversification is a widely proposed policing reform, but its impact is difficult to assess. We used records of millions of daily patrol assignments, determined through fixed rules and preassigned rotations that mitigate self-selection, to compare the average behavior of officers of different demographic profiles working in comparable conditions. Relative to white officers, Black and Hispanic officers make far fewer stops and arrests, and they use force less often, especially against Black civilians. These effects are largest inmajority-Black areas of Chicago and stem from reduced focus on enforcing low-level offenses, with greatest impact on Black civilians. Female officers also use less force than males, a result that holds within all racial groups. These results suggest that diversity reforms can improve police treatment of minority communities.	[Ba, Bocar A.] Univ Calif Irvine, Dept Econ, Irvine, CA 92717 USA; [Knox, Dean] Univ Penn, Wharton Sch, Operat Informat & Decis Dept, Philadelphia, PA 19104 USA; [Mummolo, Jonathan] Princeton Univ, Dept Polit, Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Rivera, Roman] Columbia Univ, Dept Econ, New York, NY 10027 USA	University of California System; University of California Irvine; University of Pennsylvania; Princeton University; Columbia University	Knox, D (corresponding author), Univ Penn, Wharton Sch, Operat Informat & Decis Dept, Philadelphia, PA 19104 USA.; Mummolo, J (corresponding author), Princeton Univ, Dept Polit, Sch Publ & Int Affairs, Princeton, NJ 08544 USA.	dcknox@upenn.edu; jmummolo@princeton.edu	Knox, Dean/AGF-3054-2022	Rivera, Roman/0000-0003-3881-4766; /0000-0002-1945-7938; Ba, Bocar A./0000-0002-0685-7975				ACLU, 2015, STOP FRISK CHIC; Adams Megan Marie, 2012, THESIS U CALIF; Alexander M., 2012, NEW JIM CROW MASS IN; Ba B., 2021, **DATA OBJECT**, DOI [10.24433/CO.4519202.v1, DOI 10.24433/CO.4519202.V1]; Ba B. A., 2019, FACULTY SCHOLARSHIP, P2132; Ba B. A, 2019, COST COMPLAINT FILLI; Byrne J., 2018, THE CHICAGO TRIBUNE; C. P. Dept, 2019, ANN WATCH FURLOUGH S; C. P. Dept, 2015 OP CAL; Clinton JD, 2008, POLIT ANAL, V16, P3, DOI 10.1093/pan/mpm009; Dept C. P, 2008, ANN REPORT; Donohue JJ, 2001, J LAW ECON, V44, P367, DOI 10.1086/322810; Fagan J., 2016, FORDHAM URBAN LAW J, V43, P539; Fantz A., 2020, THE CNN; Fiske ST, 2002, CURR DIR PSYCHOL SCI, V11, P123, DOI 10.1111/1467-8721.00183; Forman Jr James, 2017, LOCKING OUR OWN CRIM; Garner M, 2020, INT REV LAW ECON, V62, DOI 10.1016/j.irle.2019.105881; Goff PA, 2012, SOC ISS POLICY REV, V6, P177, DOI 10.1111/j.1751-2409.2011.01039.x; Hoffman PB, 2005, J CRIM JUST, V33, P145, DOI 10.1016/j.jcrimjus.2004.12.006; Holliday D, 2015, DNAINFO; Kearns EM, 2017, JUSTICE Q, V34, P1213, DOI 10.1080/07418825.2017.1380837; Laveist TA, 2002, J HEALTH SOC BEHAV, V43, P296, DOI 10.2307/3090205; Legewie J., 2016, 14512 COL PUBL LAW, P1; Lerman Amy., 2014, ARRESTING CITIZENSHI; Lewis DE, 2010, INT PUBLIC MANAG J, V13, P46, DOI 10.1080/10967490903547233; Linos E, 2020, PUBLIC ADMIN REV, V80, P92, DOI 10.1111/puar.13115; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; Mattia T, 2019, REDUCING RACIAL DISP; McClelland E., 2018, **DROPPED REF**; McCrary J, 2007, AM ECON REV, V97, P318, DOI 10.1257/aer.97.1.318; MEIER KJ, 1975, AM POLIT SCI REV, V69, P526, DOI 10.2307/1959084; Miller AR, 2019, REV ECON STUD, V86, P2220, DOI 10.1093/restud/rdy051; Police Accountability Task Force, 2016, REC REF REST TRUST C; Qian Z., 2002, RACE SOC, V5, P33, DOI [DOI 10.1016/J.RACSOC.2003.12.003, DOI 10.1016/J.RACS0C.2003.12.003]; Ray V, 2019, AM SOCIOL REV, V84, P26, DOI 10.1177/0003122418822335; Rivera R., 2021, **DROPPED REF**, DOI [10.24433/CO.4519202.v1, DOI 10.24433/CO.4519202.V1]; RUBIN DB, 1990, J STAT PLAN INFER, V25, P279, DOI 10.1016/0378-3758(90)90077-8; RUBIN DB, 1974, J EDUC PSYCHOL, V66, P688, DOI 10.1037/h0037350; Sklansky D. A, 2005, **DROPPED REF**, V96, P1225; Smith BW, 2003, POLICY STUD J, V31, P147, DOI 10.1111/1541-0072.t01-1-00009; Smitherman Geneva, 2012, ARTICULATE BLACK BAR; Turner J., 1979, SOCIAL PSYCHOL INTER, P55; U.S. Department of Justice, 2016, ADV DIVERSITY LAW EN; Weisburst EK, 2019, AEA PAP P, V109, P152, DOI 10.1257/pandp.20191028; West Jeremy, 2018, RACIAL BIAS POLICE I; Wilson J.Q, 1989, BUREAUCRACY; Worchel S, 1979, SOCIAL PSYCHOL INTER, P56; WTTW, POW POLIT PRID AFR A	51	55	55	3	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					696	+		10.1126/science.abd8694	http://dx.doi.org/10.1126/science.abd8694			62	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4IS	33574207				2022-12-28	WOS:000617551600041
J	Taylor, L				Taylor, Luke			Covid-19: Is Manaus the final nail in the coffin for natural herd immunity?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												lukestephentaylor@gmail.com						Alvarez-Antonio Carlos, 2021, SEROPREVALENCE ANTIB, DOI [10.1101/2021.01.17.21249913v1, DOI 10.1101/2021.01.17.21249913V1]; Buss LF, COVID 19 HERD IMMUNI; COVID-19 Genomics Consortium UK, 2020, PRELIMINARY GENOMIC; Le Page Michael, 2021, NEW SCI; Naveca F., 2021, GUARDIAN, DOI [10.21203/rs.3.rs-318392/v1, DOI 10.21203/RS.3.RS-318392/V1]; TAYLOR L, 2020, BMJ-BRIT MED J, V371, DOI DOI 10.1136/BMJ.M3938	6	12	13	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2021	372								n394	10.1136/bmj.n394	http://dx.doi.org/10.1136/bmj.n394			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH8HV	33579721	Bronze			2022-12-28	WOS:000618513500010
J	[Anonymous]				[Anonymous]			Seven days in medicine: 3-9 February 2021	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2021	372								n374	10.1136/bmj.n374	http://dx.doi.org/10.1136/bmj.n374			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM2MY	33574067				2022-12-28	WOS:000639500800002
J	Qaseem, A; Yost, J; Etxeandia-Ikobaltzeta, I; Abraham, GM; Jokela, JA; Forciea, MA; Miller, MC; Humphrey, LL				Qaseem, Amir; Yost, Jennifer; Etxeandia-Ikobaltzeta, Itziar; Abraham, George M.; Jokela, Janet A.; Forciea, Mary Ann; Miller, Matthew C.; Humphrey, Linda L.		Amer Coll Phys	Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)	ANNALS OF INTERNAL MEDICINE			English	Article									[Qaseem, Amir; Yost, Jennifer; Etxeandia-Ikobaltzeta, Itziar] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Yost, Jennifer] Villanova Univ, 800 Lancaster Ave, Villanova, PA 19085 USA; [Abraham, George M.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Abraham, George M.] St Vincent Hosp, 123 Summer St,Suite 370 North, Worcester, MA 01604 USA; [Jokela, Janet A.] Univ Illinois, Coll Med Urbana Champaign, Champaign, IL 61820 USA; [Forciea, Mary Ann; Miller, Matthew C.] Penn Med, 3615 Chestnut St, Philadelphia, PA 19104 USA; [Humphrey, Linda L.] Portland VA Med Ctr, Portland, OR USA; [Humphrey, Linda L.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Etxeandia-Ikobaltzeta, Itziar] 1 Santa Margarita Hosp St,Ground Floor 2,Off 1, Irun 20303, Gipuzkoa, Spain; [Jokela, Janet A.] Carle Forum, 611 West Pk, Urbana, IL 61801 USA; [Miller, Matthew C.] Penn Med Radnor, 145 King Prussia Rd, Radnor, PA 19087 USA; [Humphrey, Linda L.] 12310 Northwest Tualatin Ave, Portland, OR 97229 USA	American College of Physicians; Villanova University; University of Massachusetts System; University of Massachusetts Worcester; University of Illinois System; University of Illinois Urbana-Champaign; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org	ETXEANDIA-IKOBALTZETA, ITZIAR/AFK-4845-2022; ETXEANDIA-IKOBALTZETA, ITZIAR/AAG-3519-2022	ETXEANDIA-IKOBALTZETA, ITZIAR/0000-0001-6606-649X; ETXEANDIA-IKOBALTZETA, ITZIAR/0000-0001-6606-649X; Abraham, George/0000-0003-4296-8362; Yost, Jennifer/0000-0002-3170-1956; Miller, Matthew/0000-0001-7267-4897; Qaseem, Amir/0000-0001-6866-7985; Forciea, Mary Ann/0000-0002-1999-1145				Beigel JH, 2020, NEW ENGL J MED, V383, P994, DOI 10.1056/NEJMc2022236; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301; Kaka AS, 2021, ANN INTERN MED, V174, P663, DOI 10.7326/M20-8148; Lexicomp, REMD DRUG INF; ODay D., 2020, STORIES GILEAD; Spinner CD, 2020, JAMA-J AM MED ASSOC, V324, P1048, DOI 10.1001/jama.2020.16349; U.S. Food& Drug Administration, FDA APPR 1 TREATM CO; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Wilt TJ, 2021, ANN INTERN MED, V174, P209, DOI 10.7326/M20-5752; Wilt TJ, 2020, 09009 VA ESP HLTH SE	12	14	15	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					673	+		10.7326/M20-8101	http://dx.doi.org/10.7326/M20-8101		FEB 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33560862	Green Published			2022-12-28	WOS:000652604800026
J	Huang, WW; Feldman, SR				Huang, William W.; Feldman, Steven R.			The next quantum leap forward? Bimekizumab for psoriasis	LANCET			English	Editorial Material							BRITISH ASSOCIATION; BIOLOGIC THERAPIES; COHORT; RISK		[Huang, William W.; Feldman, Steven R.] Wake Forest Sch Med, Dept Dermatol, Winston Salem, NC 27157 USA	Wake Forest University	Feldman, SR (corresponding author), Wake Forest Sch Med, Dept Dermatol, Winston Salem, NC 27157 USA.	sfeldman@wakehealth.edu	Huang, WW/GXH-0977-2022; huang, wen/GXW-0661-2022					Afach S, 2021, BRIT J DERMATOL, V184, P415, DOI 10.1111/bjd.19244; Armstrong AW, 2017, J AM ACAD DERMATOL, V76, P290, DOI 10.1016/j.jaad.2016.10.017; Chiricozzi A, 2021, DERMATOL THER, DOI [10.1007/sl3555-020-00475-8, DOI 10.1007/SL3555-020-00475-8]; Feldman SR, 2016, J DERMATOL TREAT, V27, P224, DOI 10.3109/09546634.2015.1093589; Ferrandiz C, 2010, CLIN DERMATOL, V28, P81, DOI 10.1016/j.clindermatol.2009.03.002; Gelfand JM, 2020, J INVEST DERMATOL, V140, P1784, DOI 10.1016/j.jid.2020.01.025; Gordon KB, 2021, LANCET, V397, P475, DOI 10.1016/S0140-6736(21)00126-4; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Langley RG, 2019, J EUR ACAD DERMATOL, V33, P333, DOI 10.1111/jdv.15242; Mahil SK, 2020, BRIT J DERMATOL, V182, P1158, DOI 10.1111/bjd.18333; Mease PJ, 2000, LANCET, V356, P385, DOI 10.1016/S0140-6736(00)02530-7; Reich K, 2021, LANCET, V397, P487, DOI 10.1016/S0140-6736(21)00125-2; Saleem MD, 2017, J AM ACAD DERMATOL, V76, P531, DOI 10.1016/j.jaad.2016.11.037; SBIDIAN E, 2020, COCHRANE DB SYST REV, V1; Seneschal J, 2020, J EUR ACAD DERMATOL, V34, P2566, DOI 10.1111/jdv.16568; Targan SR, 2016, AM J GASTROENTEROL, V111, P1599, DOI 10.1038/ajg.2016.298; Warren RB, 2015, J INVEST DERMATOL, V135, P2632, DOI 10.1038/jid.2015.208; Yiu ZZN, 2018, J INVEST DERMATOL, V138, P534, DOI 10.1016/j.jid.2017.10.005	18	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2021	397	10273					446	448						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QF1LZ	33549176				2022-12-28	WOS:000616661900002
J	Meissner, HC				Meissner, H. Cody			A Viral Pandemic, Vaccine Safety, and Compensation for Adverse Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Meissner, H. Cody] Tufts Univ, Sch Med, Tufts Childrens Hosp, 800 Washington St, Boston, MA 02111 USA	Tufts University	Meissner, HC (corresponding author), Tufts Univ, Sch Med, Tufts Childrens Hosp, 800 Washington St, Boston, MA 02111 USA.	cmeissner@tuftsmedicalcenter.org						Food and Drug Administration, MED COUNT IN; Health and Human Services Department, 2020, FED REGISTER; Health Resources and Services Administration, COMP COUNT INJ COMP; Health Resources & Services Administration, 2020, COUNT INJ COMP PROGR; Health Resources & Services Administration, COUNT INJ COMP PROGR; Honein MA, 2020, MMWR-MORBID MORTAL W, V69, P1860, DOI 10.15585/mmwr.mm6949e2; Meissner HC, 2021, CLIN INFECT DIS, V72, P309, DOI 10.1093/cid/ciaa697; Meissner HC, 2019, JAMA-J AM MED ASSOC, V321, P343, DOI 10.1001/jama.2018.20421	8	6	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					721	722		10.1001/jama.2020.26792	http://dx.doi.org/10.1001/jama.2020.26792		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33544127	Bronze			2022-12-28	WOS:000614934900001
J	Woelk, CH; Snyder, A				Woelk, Christopher H.; Snyder, Alexandra			Modulating gut microbiota to treat cancer	SCIENCE			English	Editorial Material									[Woelk, Christopher H.] Merck & Co Inc, Exploratory Sci Ctr, Cambridge, MA USA; [Snyder, Alexandra] Merck & Co Inc, Global Clin Dev, Rahway, NJ 07065 USA	Merck & Company; Merck & Company	Snyder, A (corresponding author), Merck & Co Inc, Global Clin Dev, Rahway, NJ 07065 USA.	alex.snyder@merck.com			Merck Co.	Merck Co.(Merck & Company)	The authors acknowledge the support and input of E.Rubin and D. Hazuda (both at Merck & Co.).The authors are employees of Merck Sharp & Dohme Corp. (of Merck & Co.) and own stock in Merck & Co. A research group within Merck & Co.,separate from the authors', provided funding and drug supply for NCT03341143, a trial described in (6). Merck & Co. collaborates with 4D Pharma to evaluate live biotherapeutics in conjunction with pembrolizumab.	Baruch EN, 2021, SCIENCE, V371, P602, DOI 10.1126/science.abb5920; Beaver JA, 2018, LANCET ONCOL, V19, P229, DOI 10.1016/S1470-2045(17)30846-X; Davar D, 2021, SCIENCE, V371, P595, DOI 10.1126/science.abf3363; EISEMAN B, 1958, SURGERY, V44, P854; FDA, 2011, FED REGISTER, V84, P47911; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Hodi FS, 2016, J CLIN ONCOL, V34, P1510, DOI 10.1200/JCO.2015.64.0391; Peled JU, 2017, J CLIN ONCOL, V35, P1650, DOI 10.1200/JCO.2016.70.3348; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Stripling J, 2018, AM J MED SCI, V356, P424, DOI 10.1016/j.amjms.2018.08.010; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329	13	11	12	6	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		573	574		10.1126/science.abg2904	http://dx.doi.org/10.1126/science.abg2904			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QD7TF	33542126				2022-12-28	WOS:000615715300034
J	Altmann, DM; Boyton, RJ				Altmann, Daniel M.; Boyton, Rosemary J.			Decoding the unknowns in long covid	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Altmann, Daniel M.] Imperial Coll, Hammersmith Hosp, Dept Immunol & Inflammat, London, England; [Boyton, Rosemary J.] Imperial Coll London, Fac Med, Dept Infect Dis, London, England; [Boyton, Rosemary J.] Royal Brompton & Harefield NHS Fdn Trust, Lung Div, London, England	Imperial College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust	Altmann, DM (corresponding author), Imperial Coll, Hammersmith Hosp, Dept Immunol & Inflammat, London, England.	d.altmann@imperial.ac.uk						Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Dennis A, 2020, PREPRINT, DOI [10.1101/2020.10.14.20212555v1.full, DOI 10.1101/2020.10.14.20212555V1.FULL]; Gaebler C, 2020, PREPRINT, DOI [10.1101/2020.11.03.367391v1, DOI 10.1101/2020.11.03.367391V1]; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; National Institute for Health Research, 2020, LIV COVID 19 DYN REV	5	21	21	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2021	372								n132	10.1136/bmj.n132	http://dx.doi.org/10.1136/bmj.n132			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH2NH	33541867	Green Submitted, Bronze			2022-12-28	WOS:000618113700002
J	Ebinger, M; Siegerink, B; Kunz, A; Wendt, M; Weber, JE; Schwabauer, E; Geisler, F; Freitag, E; Lange, J; Behrens, J; Erdur, H; Ganeshan, R; Liman, T; Scheitz, JF; Schlemm, L; Harmel, P; Zieschang, K; Lorenz-Meyer, I; Napierkowski, I; Waldschmidt, C; Nolte, CH; Grittner, U; Wiener, E; Bohner, G; Nabavi, DG; Schmehl, I; Ekkernkamp, A; Jungehulsing, GJ; Mackert, BM; Hartmann, A; Rohmann, JL; Endres, M; Audebert, HJ				Ebinger, Martin; Siegerink, Bob; Kunz, Alexander; Wendt, Matthias; Weber, Joachim E.; Schwabauer, Eugen; Geisler, Frederik; Freitag, Erik; Lange, Julia; Behrens, Janina; Erdur, Hebun; Ganeshan, Ramanan; Liman, Thomas; Scheitz, Jan F.; Schlemm, Ludwig; Harmel, Peter; Zieschang, Katja; Lorenz-Meyer, Irina; Napierkowski, Ira; Waldschmidt, Carolin; Nolte, Christian H.; Grittner, Ulrike; Wiener, Edzard; Bohner, Georg; Nabavi, Darius G.; Schmehl, Ingo; Ekkernkamp, Axel; Jungehulsing, Gerhard J.; Mackert, Bruno-Marcel; Hartmann, Andreas; Rohmann, Jessica L.; Endres, Matthias; Audebert, Heinrich J.			Association Between Dispatch of Mobile Stroke Units and Functional Outcomes Among Patients With Acute Ischemic Stroke in Berlin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Importance Effects of thrombolysis in acute ischemic stroke are time-dependent. Ambulances that can administer thrombolysis (mobile stroke units [MSUs]) before arriving at the hospital have been shown to reduce time to treatment. Objective To determine whether dispatch of MSUs is associated with better clinical outcomes for patients with acute ischemic stroke. Design, Setting, and Participants This prospective, nonrandomized, controlled intervention study was conducted in Berlin, Germany, from February 1, 2017, to October 30, 2019. If an emergency call prompted suspicion of stroke, both a conventional ambulance and an MSU, when available, were dispatched. Functional outcomes of patients with final diagnosis of acute cerebral ischemia who were eligible for thrombolysis or thrombectomy were compared based on the initial dispatch (both MSU and conventional ambulance or conventional ambulance only). Exposure Simultaneous dispatch of an MSU (computed tomographic scanning with or without angiography, point-of-care laboratory testing, and thrombolysis capabilities on board) and a conventional ambulance (n = 749) vs conventional ambulance alone (n = 794). Main Outcomes and Measures The primary outcome was the distribution of modified Rankin Scale (mRS) scores (a disability score ranging from 0, no neurological deficits, to 6, death) at 3 months. The coprimary outcome was a 3-tier disability scale at 3 months (none to moderate disability; severe disability; death) with tier assignment based on mRS scores if available or place of residence if mRS scores were not available. Common odds ratios (ORs) were used to quantify the association between exposure and outcome; values less than 1.00 indicated a favorable shift in the mRS distribution and lower odds of higher levels of disability. Results Of the 1543 patients (mean age, 74 years; 723 women [47%]) included in the adjusted primary analysis, 1337 (87%) had available mRS scores (primary outcome) and 1506 patients (98%) had available the 3-tier disability scale assessment (coprimary outcome). Patients with an MSU dispatched had lower median mRS scores at month 3 (1; interquartile range [IQR], 0-3) than did patients without an MSU dispatched (2; IQR, 0-3; common OR for worse mRS, 0.71; 95% CI, 0.58-0.86; P < .001). Similarly, patients with an MSU dispatched had lower 3-month coprimary disability scores: 586 patients (80.3%) had none to moderate disability; 92 (12.6%) had severe disability; and 52 (7.1%) had died vs patients without an MSU dispatched: 605 (78.0%) had none to moderate disability; 103 (13.3%) had severe disability; and 68 (8.8%) had died (common OR for worse functional outcome, 0.73, 95% CI, 0.54-0.99; P = .04). Conclusions and Relevance In this prospective, nonrandomized, controlled intervention study of patients with acute ischemic stroke in Berlin, Germany, the dispatch of mobile stroke units, compared with conventional ambulances alone, was significantly associated with lower global disability at 3 months. Clinical trials in other regions are warranted. This cohort study compares global disability at 3 months among Berlin patients with out-of-hospital ischemic stroke brought to care via a mobile stroke unit ambulance (with prehospital CT scanning with or without angiography, point-of-care laboratory testing, prehospital thrombolysis) vs conventional ambulance alone. Question Is the dispatch of mobile stroke units in the out-of-hospital setting before arriving at the hospital associated with better functional outcomes among patients with acute ischemic stroke eligible for thrombolysis or thrombectomy? Findings In this prospective nonrandomized controlled intervention study involving 1543 patients in Berlin, Germany, the dispatch of mobile stroke units in addition to conventional ambulances vs conventional ambulances alone was significantly associated with lower levels of global disability at 3 months (common odds ratio for higher modified Rankin Scale scores [ie, worse outcome], 0.71). Meaning Among patients with acute ischemic stroke in Berlin, Germany, dispatch of a mobile stroke unit was associated with lower global disability at 3 months; further research in diverse settings is needed.	[Ebinger, Martin; Siegerink, Bob; Kunz, Alexander; Scheitz, Jan F.; Schlemm, Ludwig; Nolte, Christian H.; Rohmann, Jessica L.; Endres, Matthias; Audebert, Heinrich J.] Charite Univ Med Berlin, Ctr Stroke Res Berlin, Berlin, Germany; [Ebinger, Martin; Kunz, Alexander] Med Pk Berlin Humboldtmuhle, Neurol Klin, Berlin, Germany; [Wendt, Matthias; Zieschang, Katja; Schmehl, Ingo; Ekkernkamp, Axel] Unfallkrankenhaus Berlin, Klin Neurol Stroke Unit & Fruhrehabilitat, Berlin, Germany; [Weber, Joachim E.; Geisler, Frederik; Freitag, Erik; Lange, Julia; Behrens, Janina; Erdur, Hebun; Ganeshan, Ramanan; Liman, Thomas; Scheitz, Jan F.; Schlemm, Ludwig; Harmel, Peter; Lorenz-Meyer, Irina; Napierkowski, Ira; Waldschmidt, Carolin; Nolte, Christian H.; Endres, Matthias; Audebert, Heinrich J.] Charite Univ Med Berlin, Klin & Hochschulambulanz Neurol, Hindenburgdamm 30, D-12200 Berlin, Germany; [Schwabauer, Eugen; Nabavi, Darius G.] Vivantes Klinikum Neukolln, Klin Neurol Stroke Unit, Berlin, Germany; [Waldschmidt, Carolin] Zentrum Epilepsie, Klin Neurol Stroke Unit, Berlin, Germany; [Waldschmidt, Carolin] Vivantes Humboldt Klinikum, Berlin, Germany; [Nolte, Christian H.; Grittner, Ulrike; Endres, Matthias] Berlin Inst Hlth BIH, Berlin, Germany; [Weber, Joachim E.; Nolte, Christian H.; Endres, Matthias] German Ctr Cardiovasc Res DZHK, Partner Site Berlin, Berlin, Germany; [Grittner, Ulrike] Charite Univ Med Berlin, Inst Biometry & Clin Epidemiol, Berlin, Germany; [Wiener, Edzard; Bohner, Georg] Charite Univ Med Berlin, Inst Neuroradiol, Universitatsmedizin Berlin, Berlin, Germany; [Jungehulsing, Gerhard J.] Jud Krankenhaus Berlin, Neurol Klin, Berlin, Germany; [Mackert, Bruno-Marcel] Vivantes Auguste Viktoria Klinikum, Klin Neurol Stroke Unit, Berlin, Germany; [Hartmann, Andreas] Klinikum Frankfurt Oder, Neurol Klin, Frankfurt, Germany; [Rohmann, Jessica L.] Charite Univ Med Berlin, Inst Publ Hlth, Berlin, Germany; [Endres, Matthias] NeuroCure Cluster Excellence, Berlin, Germany; [Endres, Matthias] German Ctr Neurodegenerat Dis DZNE, Partner Site Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; VIivantes Klinikum Neukolln; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; German Centre for Cardiovascular Research; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Audebert, HJ (corresponding author), Charite Univ Med Berlin, Klin & Hochschulambulanz Neurol, Hindenburgdamm 30, D-12200 Berlin, Germany.	heinrich.audebert@charite.de	Nolte, Christian/AAA-2651-2022; Siegerink, Bob/K-1323-2012; Grittner, Ulrike/I-2026-2019	Nolte, Christian/0000-0001-5577-1775; Siegerink, Bob/0000-0002-8454-9142; Grittner, Ulrike/0000-0003-2595-0224; Scheitz, Jan/0000-0001-5835-4627; Weber, Joachim/0000-0002-1666-6021; Endres, Matthias/0000-0001-6520-3720; Schlemm, Ludwig/0000-0003-4165-2366; Ganeshan, Ramanan/0000-0003-4043-1115; Bohner, Georg/0000-0002-1919-092X; Rohmann, Jessica L./0000-0003-2420-5716; Audebert, Heinrich J./0000-0002-4785-0366; Rohrpasser-Napierkowski, Ira/0000-0003-0072-524X; Liman, Thomas/0000-0002-8471-8049; Erdur, Hebun/0000-0001-5383-9625				Audebert H, 2017, INT J STROKE, V12, P932, DOI 10.1177/1747493017729268; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Dietrich M, 2014, CEREBROVASC DIS, V38, P457, DOI 10.1159/000371427; Ebinger M, 2017, INT J STROKE, V12, P653, DOI 10.1177/1747493017700152; Ebinger M, 2015, JAMA NEUROL, V72, P25, DOI 10.1001/jamaneurol.2014.3188; Ebinger M, 2014, JAMA-J AM MED ASSOC, V311, P1622, DOI 10.1001/jama.2014.2850; Fassbender K, 2003, STROKE, V34, pE44, DOI 10.1161/01.STR.0000075573.22885.3B; Fassbender K, 2017, LANCET NEUROL, V16, P227, DOI 10.1016/S1474-4422(17)30008-X; Gyrd-Hansen D, 2015, NEUROLOGY, V84, P1090, DOI 10.1212/WNL.0000000000001366; Helwig SA, 2019, JAMA NEUROL, V76, P1484, DOI 10.1001/jamaneurol.2019.2829; Kaplan Robert M, 2005, COPD, V2, P91; Kim JT, 2017, CIRCULATION, V135, P128, DOI 10.1161/CIRCULATIONAHA.116.023336; Kobayashi A, 2018, EUR J NEUROL, V25, P425, DOI 10.1111/ene.13539; Kunz A, 2017, CIRCULATION, V135, P1765, DOI 10.1161/CIRCULATIONAHA.117.027693; Kunz A, 2016, LANCET NEUROL, V15, P1035, DOI 10.1016/S1474-4422(16)30129-6; Nolte CH, 2018, STROKE, V49, P646, DOI 10.1161/STROKEAHA.117.019060; Powers WJ, 2019, STROKE, V50, pE344, DOI 10.1161/STR.0000000000000211; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rahlfs VW, 2014, STROKE, V45, P627, DOI 10.1161/STROKEAHA.113.003151; Rajan S, 2015, JAMA NEUROL, V72, P229, DOI 10.1001/jamaneurol.2014.3618; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Walter S, 2012, LANCET NEUROL, V11, P397, DOI 10.1016/S1474-4422(12)70057-1; Wendt M, 2015, STROKE, V46, P740, DOI 10.1161/STROKEAHA.114.008159; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; Wilson JTL, 2005, STROKE, V36, P777, DOI 10.1161/01.STR.0000157596.13234.95; Yamal JM, 2018, INT J STROKE, V13, P321, DOI 10.1177/1747493017711950; Zhao H, 2020, STROKE, V51, P922, DOI 10.1161/STROKEAHA.119.027843; Zhao YD, 2008, STAT MED, V27, P462, DOI 10.1002/sim.2912	29	73	73	3	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2021	325	5					454	466		10.1001/jama.2020.26345	http://dx.doi.org/10.1001/jama.2020.26345			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QC6JP	33528537	Green Published, Bronze			2022-12-28	WOS:000614941900018
J	Reid, PD; Cifu, AS; Bass, AR				Reid, Pankti D.; Cifu, Adam S.; Bass, Anne R.			Management of Immunotherapy-Related Toxicities in Patients Treated With Immune Checkpoint Inhibitor Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Reid, Pankti D.; Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA; [Bass, Anne R.] Weill Cornell Med, Hosp Special Surg, New York, NY USA	University of Chicago; Cornell University	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu	Reid, Pankti/AHA-0817-2022	Reid, Pankti/0000-0002-7645-0919				Abu-Sbeih H, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0577-1; Bergqvist V, 2017, CANCER IMMUNOL IMMUN, V66, P581, DOI 10.1007/s00262-017-1962-6; Cappelli LC, 2017, IMMUNOTHERAPY-UK, V9, P5, DOI 10.2217/imt-2016-0117; Faje AT, 2018, CANCER-AM CANCER SOC, V124, P3706, DOI 10.1002/cncr.31629; Johnson DB, 2018, JAMA-J AM MED ASSOC, V320, P1702, DOI 10.1001/jama.2018.13995; Mahmood SS, 2018, J AM COLL CARDIOL, V71, P1755, DOI 10.1016/j.jacc.2018.02.037; National Institutes of Health, 2018, COMM TERM CRIT ADV E; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Wang YH, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0346-6	9	18	18	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2021	325	5					482	483		10.1001/jama.2020.17308	http://dx.doi.org/10.1001/jama.2020.17308			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QC6JP	33528524				2022-12-28	WOS:000614941900021
J	Ren, RQ; Zhang, YP; Li, Q; McGoogan, JM; Feng, ZJ; Gao, GRF; Wu, ZY				Ren, Ruiqi; Zhang, Yanping; Li, Qun; McGoogan, Jennifer M.; Feng, Zijian; Gao, George F.; Wu, Zunyou			Asymptomatic SARS-CoV-2 Infections Among Persons Entering China From April 16 to October 12, 2020	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ren, Ruiqi; Zhang, Yanping; Li, Qun; McGoogan, Jennifer M.; Feng, Zijian; Gao, George F.; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, 155 Changbai Rd, Beijing 102206, Peoples R China.	wuzy@263.net	Gao, George Fu/ABD-5229-2021		Chinese Ministry of Science and Technology [2020YFC0846300]; Fogarty International Center at the US National Institutes of Health [1G11TW010941]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Fogarty International Center at the US National Institutes of Health	This study was supported by grant 2020YFC0846300 from the Chinese Ministry of Science and Technology and grant 1G11TW010941 from the Fogarty International Center at the US National Institutes of Health.	Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; World Health Organization, WHO COVID 19 CAS DEF; Wu ZY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00679-2; Zhou L, 2021, CLIN INFECT DIS, V72, P332, DOI 10.1093/cid/ciaa725	5	18	21	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2021	325	5					489	492		10.1001/jama.2020.23942	http://dx.doi.org/10.1001/jama.2020.23942			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QC6JP	33528529	Green Published, Bronze			2022-12-28	WOS:000614941900024
J	Freedman, MS; Bernstein, H; Ault, KA				Freedman, Mark S.; Bernstein, Henry; Ault, Kevin A.		Advisory Comm Immunization	Recommended Adult Immunization Schedule, United States, 2021	ANNALS OF INTERNAL MEDICINE			English	Article							PRACTICES INTERIM RECOMMENDATION; ADVISORY-COMMITTEE; UPDATED RECOMMENDATIONS; COVID-19 VACCINE; PREVENTION		[Freedman, Mark S.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Bernstein, Henry] Cohen Childrens Med Ctr, New Hyde Pk, NY USA; [Bernstein, Henry] Zucker Sch Med Hofstra Northwell, New York, NY USA; [Ault, Kevin A.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Freedman, Mark S.] Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,Mailstop H24-6, Atlanta, GA 30329 USA; [Bernstein, Henry] Donald & Barbara Zucker Sch Med Hofstra Northwell, 410 Lakeville Rd,Suite 311, New Hyde Pk, NY 11042 USA; [Ault, Kevin A.] Univ Kansas, Med Ctr, Dept Obstet & Gynecol, 3901 Rainbow Blvd,Mailstop 2028, Kansas City, KS 66160 USA	Centers for Disease Control & Prevention - USA; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; University of Kansas; University of Kansas Medical Center; Centers for Disease Control & Prevention - USA; University of Kansas; University of Kansas Medical Center	Freedman, MS (corresponding author), Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,Mailstop H24-6, Atlanta, GA 30329 USA.			Meites, Elissa/0000-0002-0077-2591				[Anonymous], 2020, MENQUADFI; CDC, 2020, CHART ADV COMM IMM P; Centers for Disease Control and Prevention, 2021, CTR DIS CONTR PREV; Control CfD Prevention, 1998, MMWR-MORBID MORTAL W, V47, pi, DOI DOI 10.1001/jamahealthforum.2021.0325; Dooling KL, 2018, MMWR-MORBID MORTAL W, V67, P103, DOI 10.15585/mmwr.mm6703a5; Doshani M, 2019, MMWR-MORBID MORTAL W, V68, P153, DOI 10.15585/mmwr.mm6806a6; Marin Mona, 2007, Morbidity and Mortality Weekly Report, V56, P1; Matanock A, 2019, MMWR-MORBID MORTAL W, V68, P1069, DOI 10.15585/mmwr.mm6846a5; Mbaeyi SA, 2020, MMWR RECOMM REP, V69, DOI 10.15585/mmwr.rr6909a1; Meites E, 2019, MMWR-MORBID MORTAL W, V68, P698, DOI [10.15585/mmwr.mm6832a3, 10.1111/ajt.15633]; Oliver SE, 2021, MMWR-MORBID MORTAL W, V69, P1653, DOI 10.15585/mmwr.mm695152e1; Oliver SE, 2020, MMWR-MORBID MORTAL W, V69, P1922, DOI 10.15585/mmwr.mm6950e2; Schillie S, 2018, MMWR RECOMM REP, V67, P1, DOI 10.15585/mmwr.rr6701a1	15	8	8	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2021	174	3					374	+		10.7326/M20-8080	http://dx.doi.org/10.7326/M20-8080			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QX4DA	33571011				2022-12-28	WOS:000629294000020
J	Arnould, C; Rocher, V; Finoux, AL; Clouaire, T; Li, K; Zhou, FL; Caron, P; Mangeot, PE; Ricci, EP; Mourad, R; Haber, JE; Noordermeer, D; Legube, G				Arnould, Coline; Rocher, Vincent; Finoux, Anne-Laure; Clouaire, Thomas; Li, Kevin; Zhou, Felix; Caron, Pierre; Mangeot, Philippe. E.; Ricci, Emiliano P.; Mourad, Raphael; Haber, James E.; Noordermeer, Daan; Legube, Gaelle			Loop extrusion as a mechanism for formation of DNA damage repair foci	NATURE			English	Article								The repair of DNA double-strand breaks (DSBs) is essential for safeguarding genome integrity. When a DSB forms, the PI3K-related ATM kinase rapidly triggers the establishment of megabase-sized, chromatin domains decorated with phosphorylated histone H2AX (gamma H2AX), which act as seeds for the formation of DNA-damage response foci(1). It is unclear how these foci are rapidly assembled to establish a 'repair-prone' environment within the nucleus. Topologically associating domains are a key feature of 3D genome organization that compartmentalize transcription and replication, but little is known about their contribution to DNA repair processes(2,3). Here we show that topologically associating domains are functional units of the DNA damage response, and are instrumental for the correct establishment of gamma H2AX-53BP1 chromatin domains in a manner that involves one-sided cohesin-mediated loop extrusion on both sides of the DSB. We propose a model in which H2AX-containing nucleosomes are rapidly phosphorylated as they actively pass by DSB-anchored cohesin. Our work highlights the importance of chromosome conformation in the maintenance of genome integrity and demonstrates the establishment of a chromatin modification by loop extrusion.	[Arnould, Coline; Rocher, Vincent; Finoux, Anne-Laure; Clouaire, Thomas; Caron, Pierre; Mourad, Raphael; Legube, Gaelle] CNRS, Mol Cellular & Dev Biol Unit MCD, Ctr Biol Integrat CBI, UPS, Toulouse, France; [Li, Kevin; Zhou, Felix; Haber, James E.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA; [Li, Kevin; Zhou, Felix; Haber, James E.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Mangeot, Philippe. E.] Univ Lyon, Univ Claude Bernard Lyon 1, CIRI Int Ctr Infectiol Res, Inserm U1111,CNRS,UMR5308,Ecole Normale Super Lyo, Lyon, France; [Ricci, Emiliano P.] Univ Claude Bernard Lyon 1, Lab Biol & Modelisat Cellule, Univ Lyon, INSERM U1293,CNRS UMR 5239,Ecole Normale Super Ly, Lyon, France; [Noordermeer, Daan] Univ Paris Saclay, CEA, CNRS, Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Brandeis University; Brandeis University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Legube, G (corresponding author), CNRS, Mol Cellular & Dev Biol Unit MCD, Ctr Biol Integrat CBI, UPS, Toulouse, France.	gaelle.legube@univ-tlse3.fr	LEGUBE, Gaelle/AAX-9772-2021; Ricci, Emiliano/G-7619-2012; CLOUAIRE, THOMAS/L-7396-2017; Noordermeer, Daan/F-3306-2011	Ricci, Emiliano/0000-0002-9789-5837; Zhou, Felix/0000-0002-8619-7160; Arnould, Coline/0000-0002-4421-1681; Caron, Pierre/0000-0003-2353-5684; MANGEOT, Philippe/0000-0003-3819-5440; Li, Kevin/0000-0002-5290-2378; CLOUAIRE, THOMAS/0000-0003-3238-1496; Noordermeer, Daan/0000-0002-9296-7002	US National Institutes of Health [R35 GM127029]; National Institute of General Medical Sciences Training Grant [TM32GM007122]; Labex Ecofect of the Universite de Lyon [ANR-11-LABX-0048]; Fondation FINOVI; European Research Council under the European Union's Horizon 2020 research and innovation programmes [ERC-StG-LS6-805500]; Agence Nationale pour la Recherche [ANR-14-CE10-0002-01, ANR-18-CE12-0015]; Institut National Contre le Cancer (INCA); Ligue Nationale Contre le Cancer (LNCC); Fondation pour la Recherche Medicale [FDT201904007941]; European Research Council [ERC-2014-CoG 647344]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences Training Grant; Labex Ecofect of the Universite de Lyon; Fondation FINOVI; European Research Council under the European Union's Horizon 2020 research and innovation programmes; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut National Contre le Cancer (INCA)(Institut National du Cancer (INCA) France); Ligue Nationale Contre le Cancer (LNCC)(Ligue nationale contre le cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Research Council(European Research Council (ERC)European Commission)	We thank the genomics core facility of EMBL for high-throughput sequencing; the high-throughput sequencing core facility of the I2BC (Centre de Recherche de Gif) for facilities and expertise; F. Beckouet for advice on yeast work; J. Rispal and N. Firmin for occasional experimental help; and C. Normand for discussions. Work in the Haber laboratory was funded by grant R35 GM127029 from the US National Institutes of Health. F.Z. was supported by the National Institute of General Medical Sciences Training Grant TM32GM007122. E.R. is supported by Labex Ecofect (ANR-11-LABX-0048) of the Universite de Lyon, Fondation FINOVI and by the European Research Council (ERC-StG-LS6-805500) under the European Union's Horizon 2020 research and innovation programmes. Funding in the Legube laboratory was provided by grants from the European Research Council (ERC-2014-CoG 647344), the Agence Nationale pour la Recherche (ANR-14-CE10-0002-01 and ANR-18-CE12-0015), the Institut National Contre le Cancer (INCA), and the Ligue Nationale Contre le Cancer (LNCC). This work was supported by the Fondation pour la Recherche Medicale, grant number FDT201904007941, to C.A.	Arnould C, 2020, J MOL BIOL, V432, P724, DOI 10.1016/j.jmb.2019.07.036; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Barrington C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10725-9; Canela A, 2019, MOL CELL, V75, P252, DOI 10.1016/j.molcel.2019.04.030; Caron P, 2015, CELL REP, V13, P1, DOI 10.1016/j.celrep.2015.10.024; Caron P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002460; Chang LH, 2020, J MOL BIOL, V432, P643, DOI 10.1016/j.jmb.2019.11.025; Clouaire T, 2018, MOL CELL, V72, P250, DOI 10.1016/j.molcel.2018.08.020; Clouaire T, 2017, DNA REPAIR, V56, P84, DOI 10.1016/j.dnarep.2017.06.010; Collins PL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16926-x; Covo S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001006; Dauban L, 2020, MOL CELL, V77, P1279, DOI 10.1016/j.molcel.2020.01.019; David FPA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085879; Davidson IF, 2019, SCIENCE, V366, P1338, DOI 10.1126/science.aaz3418; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Gelot C, 2016, MOL CELL, V61, P15, DOI 10.1016/j.molcel.2015.11.002; Gothe HJ, 2019, MOL CELL, V75, P267, DOI 10.1016/j.molcel.2019.05.015; Haarhuis JHI, 2017, CELL, V169, P693, DOI 10.1016/j.cell.2017.04.013; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Kim BJ, 2010, J BIOL CHEM, V285, P22782, DOI 10.1074/jbc.M110.134577; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kim Y, 2019, SCIENCE, V366, P1345, DOI 10.1126/science.aaz4475; Klein FA, 2015, BIOINFORMATICS, V31, P3085, DOI 10.1093/bioinformatics/btv335; Kojic A, 2018, NAT STRUCT MOL BIOL, V25, P496, DOI 10.1038/s41594-018-0070-4; Lee CS, 2014, NAT STRUCT MOL BIOL, V21, P103, DOI 10.1038/nsmb.2737; Lee SH, 2019, NATURE, V570, P344, DOI 10.1038/s41586-019-1305-1; Li KV, 2020, P NATL ACAD SCI USA, V117, P21354, DOI 10.1073/pnas.2002126117; Liu Y, 2020, SCIENCE, V368, P1265, DOI 10.1126/science.aay8204; Mangeot PE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07845-z; Marnef A, 2019, GENE DEV, V33, P1175, DOI 10.1101/gad.324012.119; Matelot M, 2016, METHODS MOL BIOL, V1480, P223, DOI 10.1007/978-1-4939-6380-5_20; McCord RP, 2020, MOL CELL, V77, P688, DOI 10.1016/j.molcel.2019.12.021; Meisenberg C, 2019, MOL CELL, V73, P212, DOI 10.1016/j.molcel.2018.11.001; Mirny LA, 2019, CURR OPIN CELL BIOL, V58, P142, DOI 10.1016/j.ceb.2019.05.001; Morawska M, 2013, YEAST, V30, P341, DOI 10.1002/yea.2967; Natale F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15760; Ochs F, 2019, NATURE, V574, P571, DOI 10.1038/s41586-019-1659-4; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sanders JT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20047-w; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Schwarzer W, 2017, NATURE, V551, P51, DOI 10.1038/nature24281; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Vian L, 2018, CELL, V173, P1165, DOI 10.1016/j.cell.2018.03.072; Wutz G, 2017, EMBO J, V36, P3573, DOI 10.15252/embj.201798004; Zhang Y, 2019, NATURE, V573, P600, DOI 10.1038/s41586-019-1547-y	49	62	64	15	40	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847								10.1038/s41586-021-03193-z	http://dx.doi.org/10.1038/s41586-021-03193-z		FEB 2021	28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM2BL	33597753	Green Submitted, Green Accepted			2022-12-28	WOS:000618965700004
J	Arnold, C				Arnold, Carrie			Covid-19: How the lessons of HIV can help end the pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Kutscher Eric, 2020, JAMA Health Forum, V1, pe200656, DOI 10.1001/jamahealthforum.2020.0656	1	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2021	372								n216	10.1136/bmj.n216	http://dx.doi.org/10.1136/bmj.n216			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RA8YP	33593746	Bronze			2022-12-28	WOS:000631706300001
J	Kuehn, BM				Kuehn, Bridget M.			Clinical Trials Overlook Diseases of Low-Income Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2021	325	7					612	612		10.1001/jama.2021.0842	http://dx.doi.org/10.1001/jama.2021.0842			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ3QZ	33591355				2022-12-28	WOS:000619608000003
J	Rimmer, A				Rimmer, Abi			Cap on public sector exit payments is lifted after BMA's legal challenge	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Blackburn P., 2020, BMA LAUNCHES LEGAL C; HM Treasury, 2021, RESTR PUBL SECT EX P; NHS Employers, 2020, GUID PUBL SECT EX PA	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2021	372								n456	10.1136/bmj.n456	http://dx.doi.org/10.1136/bmj.n456			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RA8YP	33593760				2022-12-28	WOS:000631706300017
J	Singh, NS; Lokot, M; Undie, CC; Onyango, MA; Morgan, R; Harmer, A; Freedman, J; Heidari, S				Singh, Neha S.; Lokot, Michelle; Undie, Chi-Chi; Onyango, Monica A.; Morgan, Rosemary; Harmer, Anne; Freedman, Jane; Heidari, Shirin			Research in forced displacement: guidance for a feminist and decolonial approach	LANCET			English	Editorial Material									[Singh, Neha S.; Lokot, Michelle] London Sch Hyg & Trop Med, Hlth Humanitarian Crises Ctr, London WC1H 9SH, England; [Undie, Chi-Chi] Populat Council, Nairobi, Kenya; [Onyango, Monica A.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Morgan, Rosemary] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Harmer, Anne] Elrha, London, England; [Freedman, Jane] Univ Paris 08, Paris, France; [Heidari, Shirin] GENDRO, Geneva, Switzerland; [Heidari, Shirin] Grad Inst Int & Dev Studies, Global Hlth Ctr, Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; Boston University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universite Paris-VIII	Singh, NS (corresponding author), London Sch Hyg & Trop Med, Hlth Humanitarian Crises Ctr, London WC1H 9SH, England.	neha.singh@lshtm.ac.uk		Singh, Neha/0000-0003-0057-121X; Freedman, Jane/0000-0003-2440-7131; Morgan, Rosemary/0000-0001-5009-8470	RECAP project by UK Research and Innovation as part of the Global Challenges Research Fund [ES/P010873/1]; Global Health Centre; Graduate Institute of International and Development Studies; GENDRO; ESRC [ES/P010873/1] Funding Source: UKRI	RECAP project by UK Research and Innovation as part of the Global Challenges Research Fund; Global Health Centre; Graduate Institute of International and Development Studies; GENDRO; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	NSS reports salary support from the RECAP project by UK Research and Innovation as part of the Global Challenges Research Fund, grant number ES/P010873/1. All other authors declare no competing interests. The thinking underpinning this Comment began in a virtual workshop on the Ethical and Gender Considerations in Remote Data Collection and Research in Forced Displacement Settings, hosted by the authors on June 29, 2020, with the support of the Global Health Centre, the Graduate Institute of International and Development Studies, and GENDRO.	Brooks Abigail, 2007, FEMINIST RES PRACTIC; Brun C, 2010, DEV PRACT, V20, P812, DOI 10.1080/09614524.2010.508107; Calia C, 2021, ETHICS BEHAV, V1, P1; Davies SE, 2019, LANCET, V393, P601, DOI 10.1016/S0140-6736(18)32472-3; Kapilashrami A, 2018, LANCET, V391, P2589, DOI 10.1016/S0140-6736(18)31431-4; Lokot M., 2019, GENDER DEV, V27, P467; Mballa C., 2020, UNHCR PARTNER PRACTI; Medecins Sans Frontieres, 2020, STIGM DISR CAR FAC C; Nwajiaku-Dahou K., 2020, CONFRONT RACE RACISM; Schroeder D, 2018, USE NONHUMAN PRIMATE; Slim H., 2020, IS RACISM PART OUR R; United Nations High Commissioner for Refugees, 2020, GLOBAL TRENDS FORCED; United Nations HighCommissioner for Refugees, 2019, DIG LIV REF WHATS NE	13	10	10	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2021	397	10274					560	562						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2TN	33581808	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000620934000006
J	Fujiwara, R				Fujiwara, Ryoichi			Balancing act	SCIENCE			English	Editorial Material									[Fujiwara, Ryoichi] Univ Arkansas Med Sci, Coll Pharm, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Fujiwara, R (corresponding author), Univ Arkansas Med Sci, Coll Pharm, Little Rock, AR 72205 USA.								0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					750	750		10.1126/science.371.6530.750	http://dx.doi.org/10.1126/science.371.6530.750			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4IS	33574213				2022-12-28	WOS:000617551600051
J	Hall, AM; Aubrey-Bassler, K; Thorne, B; Maher, CG				Hall, Amanda M.; Aubrey-Bassler, Kris; Thorne, Bradley; Maher, Chris G.			Do not routinely offer imaging for uncomplicated low back pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-PRACTICE; HEALTH-CARE; CONSEQUENCES; GUIDELINES		[Hall, Amanda M.; Aubrey-Bassler, Kris; Thorne, Bradley] Mem Univ Newfoundland, Fac Med, Primary Healthcare Res Unit, St John, NF A1B 3V6, Canada; [Maher, Chris G.] Univ Sydney, Inst Musculoskeletal Hlth, Sydney, NSW, Australia; [Maher, Chris G.] Sydney Local Hlth Dist, Sydney, NSW, Australia	Memorial University Newfoundland; University of Sydney	Hall, AM (corresponding author), Mem Univ Newfoundland, Fac Med, Primary Healthcare Res Unit, St John, NF A1B 3V6, Canada.	amanda.Hall@med.mun.ca	Maher, Christopher/AAC-6267-2019	Maher, Christopher/0000-0002-1628-7857				Bardin LD, 2017, MED J AUSTRALIA, V206, P268, DOI 10.5694/mja16.00828; Braeuninger-Weimer K, 2019, EUR J PAIN, V23, P1464, DOI 10.1002/ejp.1412; Brinjikji W, 2015, AM J NEURORADIOL, V36, P811, DOI 10.3174/ajnr.A4173; Chou R, 2017, ANN INTERN MED, V166, P493, DOI 10.7326/M16-2459; Chou R, 2012, RADIOL CLIN N AM, V50, P569, DOI 10.1016/j.rcl.2012.04.005; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Downie A, 2020, BRIT J SPORT MED, V54, P642, DOI 10.1136/bjsports-2018-100087; Fisher ES, 1999, JAMA-J AM MED ASSOC, V281, P446, DOI 10.1001/jama.281.5.446; Ganguli I, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.13325; Graves JM, 2014, HEALTH SERV RES, V49, P645, DOI 10.1111/1475-6773.12098; Hall AM, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-019-0884-4; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Jacobs JC, 2020, J GEN INTERN MED, V35, P3605, DOI 10.1007/s11606-020-06181-7; Jenkins HJ, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3526-7; Jenkins HJ, 2018, SPINE J, V18, P2266, DOI 10.1016/j.spinee.2018.05.004; Lemmers GPG, 2019, EUR SPINE J, V28, P937, DOI 10.1007/s00586-019-05918-1; Lim YZ, 2019, J PHYSIOTHER, V65, P124, DOI 10.1016/j.jphys.2019.05.010; Maher C, 2017, LANCET, V389, P736, DOI 10.1016/S0140-6736(16)30970-9; O'Connell NE, 2016, BEST PRACT RES CL RH, V30, P968, DOI 10.1016/j.berh.2017.05.001; Traeger A, 2017, CAN MED ASSOC J, V189, pE1386, DOI 10.1503/cmaj.170527; Webster BS, 2013, SPINE, V38, P1939, DOI 10.1097/BRS.0b013e3182a42eb6; Webster BS, 2010, J OCCUP ENVIRON MED, V52, P900, DOI 10.1097/JOM.0b013e3181ef7e53	23	12	12	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2021	372								n291	10.1136/bmj.n291	http://dx.doi.org/10.1136/bmj.n291			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH8HV	33579691	hybrid, Green Published			2022-12-28	WOS:000618513500001
J	Kuna, VM; Nabelek, JL				Kuna, Vaclav M.; Nabelek, John L.			Seismic crustal imaging using fin whale songs	SCIENCE			English	Article							MARGIN; OCEAN; BLUE	Fin whale calls are among the strongest animal vocalizations that are detectable over great distances in the oceans. We analyze fin whale songs recorded at ocean-bottom seismometers in the northeast Pacific Ocean and show that in addition to the waterborne signal, the song recordings also contain signals reflected and refracted from crustal interfaces beneath the stations. With these data, we constrain the thickness and seismic velocity of the oceanic sediment and basaltic basement and the P-wave velocity of the gabbroic lower crust beneath and around the ocean bottom seismic stations. The abundant and globally available fin whale calls may be used to complement seismic studies in situations where conventional air-gun surveys are not available.	[Kuna, Vaclav M.; Nabelek, John L.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Kuna, Vaclav M.] CAS, Inst Geophys, Prague 14131, Czech Republic	Oregon State University; Czech Academy of Sciences; Institute of Geophysics of the Czech Academy of Sciences	Kuna, VM (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.; Kuna, VM (corresponding author), CAS, Inst Geophys, Prague 14131, Czech Republic.	kuna@ig.cas.cz		Kuna, Vaclav/0000-0001-6328-4176; Nabelek, John/0000-0001-6433-207X	National Science Foundation (NSF) [OCE-1031858, OCE-1131767]	National Science Foundation (NSF)(National Science Foundation (NSF))	The seismic stations for the project were provided by the U.S. Ocean Bottom Seismograph Instrument Pool (www.obsip.org), funded by the National Science Foundation (NSF). This research was supported by NSF grants OCE-1031858 and OCE-1131767.	[Anonymous], MAT METHODS ARE AVAI; Carretta J.V., 2014, NOAA TECHNICAL MEMOR; Christeson GL, 2019, REV GEOPHYS, V57, P504, DOI 10.1029/2019RG000641; Cooke J. G., 2018, IUCN RED LIST THREAT, V2019, DOI 10.2305/IUCN.UK.2018-2.RLTS.T2478A50349982.en; Dondurur D., 2018, ACQUISITION PROCESSI, P37; Horning G, 2016, J GEOPHYS RES-SOL EA, V121, P5859, DOI 10.1002/2016JB013228; Iwase R, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.07HG03; Kuna VM, 2019, NAT GEOSCI, V12, P138, DOI 10.1038/s41561-018-0287-1; MCDONALD MA, 1995, J ACOUST SOC AM, V98, P712, DOI 10.1121/1.413565; Mizroch SA, 2009, MAMMAL REV, V39, P193, DOI 10.1111/j.1365-2907.2009.00147.x; Nabelek J. L., 2012, R V MELVILLE CRUISE; Nabelek John, 2012, IRIS DMC, DOI 10.7914/SN/X9_2012; Perrin W. F., 2008, ENCY MARINE MAMMALS, P433; Rebull OG, 2006, J ACOUST SOC AM, V120, P2077, DOI 10.1121/1.2336751; Richardson W.J., 2013, MARINE MAMMALS NOISE; Rolling Deck to Repository (R2R) Program, 2015, R2R, V1, DOI 10.7284/902871; Sawyer DE, 2015, GEOPHYS RES LETT, V42, P10216, DOI 10.1002/2015GL066603; Simon M, 2010, J ACOUST SOC AM, V128, P3200, DOI 10.1121/1.3495946; Sirovic A, 2007, J ACOUST SOC AM, V122, P1208, DOI 10.1121/1.2749452; Soule DC, 2013, J ACOUST SOC AM, V133, P1751, DOI 10.1121/1.4774275; Stimpert A. K., 2015, ANIM BIOTELEM, V3, P23, DOI [10.1186/s40317-015-0058-3, DOI 10.1186/S40317-015-0058-3]; Stockwell J. W., 2015, CWP SU SEISMIC UN X; WATKINS W A, 1981, Scientific Reports of the Whales Research Institute Tokyo, P83; WATKINS WA, 1987, J ACOUST SOC AM, V82, P1901, DOI 10.1121/1.395685; WATKINS WA, 1981, SCI REP WHALES RES, V33, P83; Weirathmueller MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186127; Weirathmueller MJ, 2013, J ACOUST SOC AM, V133, P741, DOI 10.1121/1.4773277; Wilcock WSD, 2012, J ACOUST SOC AM, V132, P2408, DOI 10.1121/1.4747017; WILSON DS, 1993, J GEOPHYS RES-SOL EA, V98, P16053, DOI 10.1029/93JB01227; ZELT CA, 1992, GEOPHYS J INT, V108, P16, DOI 10.1111/j.1365-246X.1992.tb00836.x; Zhu J, 2020, J GEOPHYS RES-SOL EA, V125, DOI 10.1029/2019JB019239	32	8	8	3	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					731	+		10.1126/science.abf3962	http://dx.doi.org/10.1126/science.abf3962			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4IS	33574212				2022-12-28	WOS:000617551600048
J	Raayoni, G; Gottlieb, S; Manor, Y; Pisha, G; Harris, Y; Mendlovic, U; Haviv, D; Hadad, Y; Kaminer, I				Raayoni, Gal; Gottlieb, Shahar; Manor, Yahel; Pisha, George; Harris, Yoav; Mendlovic, Uri; Haviv, Doron; Hadad, Yaron; Kaminer, Ido			Generating conjectures on fundamental constants with the Ramanujan Machine	NATURE			English	Article							APPROXIMATIONS; PROOF	Fundamental mathematical constants such as e and are ubiquitous in diverse fields of science, from abstract mathematics and geometry to physics, biology and chemistry(1,2). Nevertheless, for centuries new mathematical formulas relating fundamental constants have been scarce and usually discovered sporadically(3-6). Such discoveries are often considered an act of mathematical ingenuity or profound intuition by great mathematicians such as Gauss and Ramanujan(7). Here we propose a systematic approach that leverages algorithms to discover mathematical formulas for fundamental constants and helps to reveal the underlying structure of the constants. We call this approach 'the Ramanujan Machine'. Our algorithms find dozens of well known formulas as well as previously unknown ones, such as continued fraction representations of pi, e, Catalan's constant, and values of the Riemann zeta function. Several conjectures found by our algorithms were (in retrospect) simple to prove, whereas others remain as yet unproved. We present two algorithms that proved useful in finding conjectures: a variant of the meet-in-the-middle algorithm and a gradient descent optimization algorithm tailored to the recurrent structure of continued fractions. Both algorithms are based on matching numerical values; consequently, they conjecture formulas without providing proofs or requiring prior knowledge of the underlying mathematical structure, making this methodology complementary to automated theorem proving(8-13). Our approach is especially attractive when applied to discover formulas for fundamental constants for which no mathematical structure is known, because it reverses the conventional usage of sequential logic in formal proofs. Instead, our work supports a different conceptual framework for research: computer algorithms use numerical data to unveil mathematical structures, thus trying to replace the mathematical intuition of great mathematicians and providing leads to further mathematical research. An approach called the Ramanujan Machine demonstrates the use of algorithms to find mathematical conjectures in the form of formulas of fundamental constants, some of which remain unproved.	[Raayoni, Gal; Gottlieb, Shahar; Manor, Yahel; Pisha, George; Harris, Yoav; Haviv, Doron; Hadad, Yaron; Kaminer, Ido] Technion Israel Inst Technol, Haifa, Israel; [Manor, Yahel] Preuniv Educ, Youth Ctr, Technion Harry & Lou Stern Family Sci & Technol, Haifa, Israel; [Mendlovic, Uri] Google, Tel Aviv, Israel	Technion Israel Institute of Technology; Google Incorporated	Kaminer, I (corresponding author), Technion Israel Inst Technol, Haifa, Israel.	kaminer@technion.ac.il		/0000-0003-2691-1892	Azrieli Faculty Fellowship; Israeli Alpha Program for Excellent High-School Students	Azrieli Faculty Fellowship; Israeli Alpha Program for Excellent High-School Students	We thank M. Soljacic, B. Weiss, D. Soudry and D. Carmon for helpful discussions. I.K. is grateful for the support of R. Magid and B. Magid and for the support of the Azrieli Faculty Fellowship. Y.M. acknowledges the support and guidance of the Israeli Alpha Program for Excellent High-School Students.	Alessandretti L., 2019, MACHINE LEARNING MEE; Apery R., 1979, ASTERISQUE, V61, P1; Appel K. I., 1989, EVERY PLANAR MAP IS, V98; Asimov I., 1988, I ASIMOV BOOK SCI NA; Bailey D, 1997, MATH COMPUT, V66, P903, DOI 10.1090/S0025-5718-97-00856-9; Bailey D. H., 1994, EXP MATH, V3, P17, DOI DOI 10.1080/10586458.1994.10504573; Bailey DH, 1997, MATH INTELL, V19, P50, DOI 10.1007/BF03024340; Bailey DH, 2001, MATH COMPUT, V70, P1719, DOI 10.1090/S0025-5718-00-01278-3; Berndt B. C, 2012, RAMANUJANS NOTEBOOKS; Bohr N., 1954, RYDBERGS DISCOVERY S; BORWEIN JM, 1989, AM MATH MON, V96, P201, DOI 10.2307/2325206; Bowman D, 2002, ACTA ARITH, V103, P329, DOI 10.4064/aa103-4-3; BUCHBERGER B, 2006, J APPL LOGIC, V4, P470; Chen WYC, 2016, J DIFFER EQU APPL, V22, P780, DOI 10.1080/10236198.2016.1142541; Cranmer M., 2020, ADV NEURAL INF PROCE; Cuyt A. A., 2008, HDB CONTINUED FRACTI; DAVIS R, 1982, KNOWLEDGE BASED SYST; Dougherty-Bliss R., 2020, AUTOMATIC CONJECTURI; Euler Leonhard, 1748, INTRO ANAL INFINITOR, V2; FAJTLOWICZ S, 1988, DISCRETE MATH, V72, P113, DOI 10.1016/0012-365X(88)90199-9; Ferguson HRP, 1999, MATH COMPUT, V68, P351, DOI 10.1090/S0025-5718-99-00995-3; Finch S.R., 2003, MATH CONSTANTS; Greydanus S, 2019, ADV NEUR IN, V32; Hales TC, 2005, ANN MATH, V162, P1065, DOI 10.4007/annals.2005.162.1065; Hardy G. H., 1980, INTRO THEORY NUMBERS; He Y.-H, 2017, DEEP LEARNING LANDSC; Iten R, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.010508; Kim S, 2019, NORMALITY ANAL CURRE; Lample G., 2020, ICLR C; LENAT DB, 1984, ARTIF INTELL, V23, P269, DOI 10.1016/0004-3702(84)90016-X; LENAT DB, 1982, ARTIF INTELL, V19, P189, DOI 10.1016/0004-3702(82)90036-4; McCune W, 1997, J AUTOM REASONING, V19, P263, DOI 10.1023/A:1005843212881; McLaughlin J, 2005, ACTA ARITH, V116, P63, DOI 10.4064/aa116-1-6; Nesterenko YV, 2016, P STEKLOV I MATH+, V292, P153, DOI 10.1134/S0081543816010107; Pilehrood KH, 2010, DISCRETE MATH THEOR, V12, P223; Poorten A.v.d., 1979, MATH INTELL, V1, P195, DOI 10.1007/BF03028234; Press W. H, 2009, SEEMINGLY REMARKABLE; Raayoni G, 2019, RAMANUJAN MACHINE AU; Rivoal T, 2009, T AM MATH SOC, V361, P6115, DOI 10.1090/S0002-9947-09-04905-8; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Scott J. F, 1938, MATH WORK J WALLIS 1; SHIMURA G, 1973, MODULAR FUNCTIONS ON, P57; Smale S, 1998, MATH INTELL, V20, P7, DOI 10.1007/BF03025291; Tshitoyan V, 2019, NATURE, V571, P95, DOI 10.1038/s41586-019-1335-8; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; Udrescu SM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay2631; WANG H, 1960, IBM J RES DEV, V4, P2, DOI 10.1147/rd.41.0002; WILES A, 1995, ANN MATH, V141, P443, DOI 10.2307/2118559; Wilf H., 1990, J AM MATH SOC, V3, P147, DOI [10.1090/S0894-0347-1990-1007910-7, DOI 10.1090/S0894-0347-1990-1007910-7]; Wolfram S., 2002, NEW KIND SCI; Wu TL, 2019, PHYS REV E, V100, DOI 10.1103/PhysRevE.100.033311; Zeilberger D., 2020, MOSCOW J COMB NUMB T, V9, P407, DOI [10.2140/moscow.2020.9.407, DOI 10.2140/MOSCOW.2020.9.407]; Zudilin VV, 2002, MATH NOTES+, V72, P733, DOI 10.1023/A:1021473409544; Zudilin W, 2003, ELECTRON J COMB, V10; Zudilin W., 2003, J THEOR NOMBRES BORD, P593; Zudilin W, 2018, SYMMETRY INTEGR GEOM, V14, DOI 10.3842/SIGMA.2018.028	56	13	14	4	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2021	590	7844					67	+		10.1038/s41586-021-03229-4	http://dx.doi.org/10.1038/s41586-021-03229-4			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TY5GY	33536657	Green Submitted			2022-12-28	WOS:000683814000002
J	Mahase, E				Mahase, Elisabeth			Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	129	132	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2021	372								n296	10.1136/bmj.n296	http://dx.doi.org/10.1136/bmj.n296			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QE0LS	33526412	Bronze			2022-12-28	WOS:000615899800003
J	Shih, YTC; Dong, W; Xu, Y				Shih, Y. T. C.; Dong, W.; Xu, Y.			Summary for Patients: Incorporating Baseline Breast Density When Screening Women at Average Risk for Breast Cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					I16	I16		10.7326/M20-2912	http://dx.doi.org/10.7326/M20-2912			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33556274	Green Accepted			2022-12-28	WOS:000652604800003
J	McCarthy, KR; Rennick, LJ; Nambulli, S; Robinson-McCarthy, LR; Bain, WG; Haidar, G; Duprex, WP				McCarthy, Kevin R.; Rennick, Linda J.; Nambulli, Sham; Robinson-McCarthy, Lindsey R.; Bain, William G.; Haidar, Ghady; Duprex, W. Paul			Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape	SCIENCE			English	Article							MAFFT	Zoonotic pandemics, such as that caused by severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2), can follow the spillover of animal viruses into highly susceptible human populations. The descendants of these viruses have adapted to the human host and evolved to evade immune pressure. Coronaviruses acquire substitutions more slowly than other RNA viruses. In the spike glycoprotein, we found that recurrent deletions overcome this slow substitution rate. Deletion variants arise in diverse genetic and geographic backgrounds, transmit efficiently, and are present in novel lineages, including those of current global concern. They frequently occupy recurrent deletion regions (RDRs), which map to defined antibody epitopes. Deletions in RDRs confer resistance to neutralizing antibodies. By altering stretches of amino acids, deletions appear to accelerate SARS- CoV-2 antigenic evolution and may, more generally, drive adaptive evolution.	[McCarthy, Kevin R.; Rennick, Linda J.; Nambulli, Sham; Duprex, W. Paul] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA 15213 USA; [McCarthy, Kevin R.; Rennick, Linda J.; Nambulli, Sham; Duprex, W. Paul] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [McCarthy, Kevin R.] Harvard Med Sch, Lab Mol Med, Boston Childrens Hosp, Boston, MA 02115 USA; [Robinson-McCarthy, Lindsey R.] UPMC, Dept Internal Med, Dept Genet, Pittsburgh, PA USA; [Bain, William G.] UPMC, Dept Internal Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Bain, William G.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Bain, William G.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Haidar, Ghady] Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15213 USA; [Haidar, Ghady] UPMC, Div Infect Dis, Dept Internal Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Boston Children's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McCarthy, KR; Duprex, WP (corresponding author), Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA 15213 USA.; McCarthy, KR; Duprex, WP (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA.; McCarthy, KR (corresponding author), Harvard Med Sch, Lab Mol Med, Boston Childrens Hosp, Boston, MA 02115 USA.	krm@pitt.edu; pduprex@pitt.edu		/0000-0001-5974-6921; Nambulli, Sham/0000-0002-9781-9703; Bain, William/0000-0001-8506-0552; Duprex, W Paul/0000-0003-1716-6376	University of Pittsburgh; Center for Vaccine Research; Commonwealth of Pennsylvania Department of Community and Economic Development; Richard King Mellon Foundation; Henry L. Hillman Foundation; National Heart, Lung, and Blood Institute [P01HL114453]; U.S. Department of Veterans Affairs Career Development Award [IK2 BX004886]; UPMC Immune Transplant and Therapy Center	University of Pittsburgh(University of Pittsburgh); Center for Vaccine Research; Commonwealth of Pennsylvania Department of Community and Economic Development; Richard King Mellon Foundation; Henry L. Hillman Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Department of Veterans Affairs Career Development Award(US Department of Veterans Affairs); UPMC Immune Transplant and Therapy Center	Supported by the University of Pittsburgh, the Center for Vaccine Research, the Commonwealth of Pennsylvania Department of Community and Economic Development, the Richard King Mellon Foundation, the Henry L. Hillman Foundation (W.P.D.), National Heart, Lung, and Blood Institute award P01HL114453 and U.S. Department of Veterans Affairs Career Development Award IK2 BX004886 (W.G.B.), and UPMC Immune Transplant and Therapy Center (W.G.B., G.H.).	Avanzato VA, 2020, CELL, V183, P1901, DOI 10.1016/j.cell.2020.10.049; Aydillo T, 2020, NEW ENGL J MED, V383, P2586, DOI 10.1056/NEJMc2031670; Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]; Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; Denison MR, 2011, RNA BIOL, V8, P270, DOI 10.4161/rna.8.2.15013; Hensley M. K, 2020, PROLONGED SARS COV 2; Hensley MK, 2021, CLIN INFECT DIS, V73, pE815, DOI 10.1093/cid/ciab072; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kemp S. A., 2020, BIORXIV, DOI [10.1101/2020.12.14.422555v2, DOI 10.1101/2020.12.14.422555V2]; Klimstra William B, 2020, bioRxiv, DOI 10.1101/2020.06.19.154930; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0; Li Dapeng, 2021, bioRxiv, DOI 10.1101/2020.12.31.424729; Liu L, 2022, IEEE T KNOWL DATA EN, V34, P2293, DOI [10.1109/TKDE.2020.3004939, 10.1101/2020.06.17.153486]; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; McNamara RP, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108352; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tegally H, 2020, MEDRXIV, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640]; Volz Erik, 2021, Cell, V184, P64, DOI 10.1016/j.cell.2020.11.020; Voss William N, 2020, bioRxiv, DOI 10.1101/2020.12.20.423708; WATANABE A, CELL; Watanabe A, 2019, CELL, V177, P1124, DOI 10.1016/j.cell.2019.03.048; Weisblum Yiska, 2020, bioRxiv, DOI 10.1101/2020.07.21.214759; WHO, 2020, EM PREP RESP PNEUM U; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xue KS, 2017, ELIFE, V6, DOI [10.7554/elife.26875, 10.7554/eLife.26875]; Zhou H, 2020, CURR BIOL, V30, P3896, DOI 10.1016/j.cub.2020.09.030; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	36	261	269	4	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2021	371	6534					1139	+		10.1126/science.abf6950	http://dx.doi.org/10.1126/science.abf6950			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY5RG	33536258	Green Submitted, Green Published			2022-12-28	WOS:000630096400030
J	Heeg, KP; Kaldun, A; Strohm, C; Ott, C; Subramanian, R; Lentrodt, D; Haber, J; Wille, HC; Goerttler, S; Ruffer, R; Keitel, CH; Rohlsberger, R; Pfeifer, T; Evers, J				Heeg, Kilian P.; Kaldun, Andreas; Strohm, Cornelius; Ott, Christian; Subramanian, Rajagopalan; Lentrodt, Dominik; Haber, Johann; Wille, Hans-Christian; Goerttler, Stephan; Rueffer, Rudolf; Keitel, Christoph H.; Rohlsberger, Ralf; Pfeifer, Thomas; Evers, Jorg			Coherent X-ray-optical control of nuclear excitons	NATURE			English	Article							RESONANT SCATTERING; SPECTROSCOPY; EXCITATION; RADIATION; DYNAMICS; TIME	Coherent control of quantum dynamics is key to a multitude of fundamental studies and applications(1). In the visible or longer-wavelength domains, near-resonant light fields have become the primary tool with which to control electron dynamics(2). Recently, coherent control in the extreme-ultraviolet range was demonstrated(3), with a few-attosecond temporal resolution of the phase control. At hard-X-ray energies (above 5-10 kiloelectronvolts), Mossbauer nuclei feature narrow nuclear resonances due to their recoilless absorption and emission of light, and spectroscopy of these resonances is widely used to study the magnetic, structural and dynamical properties of matter(4,5). It has been shown that the power and scope of Mossbauer spectroscopy can be greatly improved using various control techniques(6-16). However, coherent control of atomic nuclei using suitably shaped near-resonant X-ray fields remains an open challenge. Here we demonstrate such control, and use the tunable phase between two X-ray pulses to switch the nuclear exciton dynamics between coherent enhanced excitation and coherent enhanced emission. We present a method of shaping single pulses delivered by state-of-the-art X-ray facilities into tunable double pulses, and demonstrate a temporal stability of the phase control on the few-zeptosecond timescale. Our results unlock coherent optical control for nuclei, and pave the way for nuclear Ramsey spectroscopy(17) and spin-echo-like techniques, which should not only advance nuclear quantum optics(18), but also help to realize X-ray clocks and frequency standards(19). In the long term, we envision time-resolved studies of nuclear out-of-equilibrium dynamics, which is a long-standing challenge in Mossbauer science(20). Suitably shaped X-ray pulses are used to coherently steer the quantum dynamics of atoms' nuclei rather than their electrons, with few-zeptosecond temporal stability of the phase control.	[Heeg, Kilian P.; Kaldun, Andreas; Ott, Christian; Subramanian, Rajagopalan; Lentrodt, Dominik; Goerttler, Stephan; Keitel, Christoph H.; Pfeifer, Thomas; Evers, Jorg] Max Planck Inst Kernphys, Heidelberg, Germany; [Strohm, Cornelius; Haber, Johann; Wille, Hans-Christian; Rohlsberger, Ralf] DESY, Deutsch Elektronen Synchrotron, Hamburg, Germany; [Rueffer, Rudolf] European Synchrotron Radiat Facil ESRF, Grenoble, France; [Rohlsberger, Ralf] Hamburg Ctr Ultrafast Imaging, Hamburg, Germany; [Rohlsberger, Ralf] Helmholtz Inst Jena, Jena, Germany; [Rohlsberger, Ralf] GSI Helmholtzzentrum Schwerionenforsch GmbH, Darmstadt, Germany; [Rohlsberger, Ralf] Friedrich Schiller Univ Jena, Inst Opt & Quantenelekt, Jena, Germany	Max Planck Society; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); European Synchrotron Radiation Facility (ESRF); University of Hamburg; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Friedrich Schiller University of Jena	Evers, J (corresponding author), Max Planck Inst Kernphys, Heidelberg, Germany.	joerg.evers@mpi-hd.mpg.de	Ott, Christian/GXV-1144-2022	Ott, Christian/0000-0003-4110-0916; Lentrodt, Dominik/0000-0001-7400-9575	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	Open access funding provided by Max Planck Society.	Adams BW, 2013, J MOD OPTIC, V60, P2, DOI 10.1080/09500340.2012.752113; Agarwal G. S, 1974, QUANTUM STAT THEORIE, P1; ALLAN DW, 1966, PR INST ELECTR ELECT, V54, P221, DOI 10.1109/PROC.1966.4634; Bocklage L, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.257202; Callens R, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.081402; Chumakov AI, 1997, PHYS REV B, V56, pR8455, DOI 10.1103/PhysRevB.56.R8455; Chumakov AI, 2018, NAT PHYS, V14, P261, DOI 10.1038/s41567-017-0001-z; Hannon JP, 1999, HYPERFINE INTERACT, V123, P127, DOI 10.1023/A:1017011621007; Heeg KP, 2017, SCIENCE, V357, P376, DOI 10.1126/science.aan3512; Heeg KP, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.207401; Heeg K. P., 2016, INDUCING DETECTING C; HEIDMANN A, 1985, J PHYS-PARIS, V46, P1937, DOI 10.1051/jphys:0198500460110193700; HELISTO P, 1991, PHYS REV LETT, V66, P2037, DOI 10.1103/PhysRevLett.66.2037; Jaynes E.T., 2003, PROBABILITY THEORY L; KAGAN Y, 1979, J PHYS C SOLID STATE, V12, P615, DOI 10.1088/0022-3719/12/3/027; Kohler J, 2011, OPT EXPRESS, V19, P11638, DOI 10.1364/OE.19.011638; Laban DE, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.263902; Liao WT, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.197403; LYNCH FJ, 1960, PHYS REV, V120, P513, DOI 10.1103/PhysRev.120.513; Mandel L, 1995, OPTICAL COHERENCE QU; Mukamel S., 1995, PRINCIPLES NONLINEAR, V1st; Mukamel S, 2013, ANNU REV PHYS CHEM, V64, P101, DOI 10.1146/annurev-physchem-040412-110021; Palffy A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.017401; Prince KC, 2016, NAT PHOTONICS, V10, P176, DOI [10.1038/nphoton.2016.13, 10.1038/NPHOTON.2016.13]; Reichegger A, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.053810; Riehle F., 2006, FREQUENCY STANDARDS; Rohlsberger R, 2012, NATURE, V482, P199, DOI 10.1038/nature10741; Rohlsberger R, 2010, SCIENCE, V328, P1248, DOI 10.1126/science.1187770; Rohlsberger R, 2005, NUCL CONDENSED MATTE, P67; Ruffer R, 1996, HYPERFINE INTERACT, V97-8, P589, DOI 10.1007/BF02150199; SAKSHATH S, 2017, HYPERFINE INTERACT, V238, pNIL11; Schindelmann P, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.023804; Shakhmuratov RN, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.013807; Shapiro M, 2000, ADV ATOM MOL OPT PHY, V42, P287, DOI 10.1016/S1049-250X(08)60189-5; Shenoy GK, 2008, HYPERFINE INTERACT, V182, P157, DOI 10.1007/s10751-008-9720-y; Shvyd'ko YV, 1999, PHYS REV B, V59, P9132, DOI 10.1103/PhysRevB.59.9132; Shvydko YV, 1996, PHYS REV LETT, V77, P3232, DOI 10.1103/PhysRevLett.77.3232; Smirnov GV, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.043811; Smirnov G. V., 2012, RUDOLF MOSSBAUER STO, P317; Smirnov GV, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.023804; Sturhahn W, 2000, HYPERFINE INTERACT, V125, P149, DOI 10.1023/A:1012681503686; Ullrich J, 2012, ANNU REV PHYS CHEM, V63, P635, DOI [10.1146/annurev-physchem-032511-143720, 10.1146/annurev-physchem-032511-443720]; Vagizov FG, 2013, JETP LETT+, V96, P812, DOI 10.1134/S0021364012240137; Vagizov F, 2014, NATURE, V508, P80, DOI 10.1038/nature13018; Zewail AH, 2000, J PHYS CHEM A, V104, P5660, DOI 10.1021/jp001460h	46	15	15	8	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846								10.1038/s41586-021-03276-x	http://dx.doi.org/10.1038/s41586-021-03276-x			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TY5YS	33597757	Green Published, hybrid			2022-12-28	WOS:000683860300001
J	Iacobucci, G				Iacobucci, Gareth			Flu vaccination: Lansley reforms caused London to fall behind in uptake, report finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Royal Society for Public Health, 2021, MIND GAP LONDONS LOW	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2021	372								n480	10.1136/bmj.n480	http://dx.doi.org/10.1136/bmj.n480			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK7SF	33602671	Bronze			2022-12-28	WOS:000620581100002
J	Jayne, DRW; Merkel, PA; Schall, TJ; Bekker, P				Jayne, David R. W.; Merkel, Peter A.; Schall, Thomas J.; Bekker, Pirow		ADVOCATE Study Grp	Avacopan for the Treatment of ANCA-Associated Vasculitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND The C5a receptor inhibitor avacopan is being studied for the treatment of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. METHODS In this randomized, controlled trial, we assigned patients with ANCA-associated vasculitis in a 1:1 ratio to receive oral avacopan at a dose of 30 mg twice daily or oral prednisone on a tapering schedule. All the patients received either cyclophosphamide (followed by azathioprine) or rituximab. The first primary end point was remission, defined as a Birmingham Vasculitis Activity Score (BVAS) of 0 (on a scale from 0 to 63, with higher scores indicating greater disease activity) at week 26 and no glucocorticoid use in the previous 4 weeks. The second primary end point was sustained remission, defined as remission at both weeks 26 and 52. Both end points were tested for noninferiority (by a margin of 20 percentage points) and for superiority. RESULTS A total of 331 patients underwent randomization; 166 were assigned to receive avacopan, and 165 were assigned to receive prednisone. The mean BVAS at baseline was 16 in both groups. Remission at week 26 (the first primary end point) was observed in 120 of 166 patients (72.3%) receiving avacopan and in 115 of 164 patients (70.1%) receiving prednisone (estimated common difference, 3.4 percentage points; 95% confidence interval [CI], -6.0 to 12.8; P<0.001 for noninferiority; P = 0.24 for superiority). Sustained remission at week 52 (the second primary end point) was observed in 109 of 166 patients (65.7%) receiving avacopan and in 90 of 164 patients (54.9%) receiving prednisone (estimated common difference, 12.5 percentage points; 95% CI, 2.6 to 22.3; P<0.001 for noninferiority; P = 0.007 for superiority). Serious adverse events (excluding worsening vasculitis) occurred in 37.3% of the patients receiving avacopan and in 39.0% of those receiving prednisone. CONCLUSIONS In this trial involving patients with ANCA-associated vasculitis, avacopan was noninferior but not superior to prednisone taper with respect to remission at week 26 and was superior to prednisone taper with respect to sustained remission at week 52. All the patients received cyclophosphamide or rituximab. The safety and clinical effects of avacopan beyond 52 weeks were not addressed in the trial.	[Jayne, David R. W.] Addenbrookes Hosp, Cambridge, England; [Merkel, Peter A.] Univ Penn, Philadelphia, PA 19104 USA; [Schall, Thomas J.; Bekker, Pirow] ChemoCentryx, Mountain View, CA USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Pennsylvania	Jayne, DRW (corresponding author), Addenbrookes Hosp, Dept Med, Box 157,Hills Rd, Cambridge CB2 2QQ, England.	dj106@cam.ac.uk	Lamprecht, Peter/F-1063-2013; Alberici, Federico/AAC-5289-2022; Tesar, Vladimir/O-2312-2017; Garibotto, Giacomo/AAB-1190-2019; Belot, Alexandre/C-7378-2013; Little, Mark/E-7072-2014	Lamprecht, Peter/0000-0001-5929-868X; Alberici, Federico/0000-0002-1686-5709; Tesar, Vladimir/0000-0001-6982-0689; Garibotto, Giacomo/0000-0001-6432-2429; Belot, Alexandre/0000-0003-4902-5332; Kotter, Ina/0000-0002-9262-005X; Little, Mark/0000-0001-6003-397X; El-Husseini, amr/0000-0001-9072-5029; Jayne, David/0000-0002-1712-0637; DIAZ ENCARNACION, MONTSERRAT MERCEDES/0000-0001-5172-3370; Schonermarck, Ulf/0000-0002-3266-9791; Jourde-Chiche, Noemie/0000-0001-9315-1577; Bergner, Raoul/0000-0002-7965-1273; Quintana, Luis F/0000-0001-7582-8476; Vogt, Bruno/0000-0002-1548-6387; de Zoysa, Janak/0000-0001-7528-9230; Mount, Peter/0000-0001-7637-3661; Fulladosa, Xavier/0000-0003-1974-9874; harper, lorraine/0000-0003-1343-9234	ChemoCentryx	ChemoCentryx	Supported by ChemoCentryx.	Basu N, 2014, ANN RHEUM DIS, V73, P207, DOI 10.1136/annrheumdis-2012-202750; Bekker P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164646; Charlier C, 2009, ANN RHEUM DIS, V68, P658, DOI 10.1136/ard.2008.088302; Corral-Gudino L, 2011, RHEUMATOLOGY, V50, P1414, DOI 10.1093/rheumatology/ker112; Duru N, 2013, ANN RHEUM DIS, V72, P1905, DOI 10.1136/annrheumdis-2013-203249; Exley AR, 1997, ARTHRITIS RHEUM, V40, P371, DOI 10.1002/art.1780400222; FALK RJ, 1988, NEW ENGL J MED, V318, P1651, DOI 10.1056/NEJM198806233182504; Furuta S, 2013, KIDNEY INT, V84, P244, DOI 10.1038/ki.2013.24; Goupil R, 2013, CLIN J AM SOC NEPHRO, V8, P416, DOI 10.2215/CJN.07300712; Halbwachs L, 2012, J AM SOC NEPHROL, V23, P1449, DOI 10.1681/ASN.2012020119; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Jayne D, 2000, RHEUMATOLOGY, V39, P585, DOI 10.1093/rheumatology/39.6.585; Jayne DRW, 2017, J AM SOC NEPHROL, V28, P2756, DOI 10.1681/ASN.2016111179; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Jones RB, 2010, NEW ENGL J MED, V363, P211, DOI 10.1056/NEJMoa0909169; Kettritz R, 2014, J AM SOC NEPHROL, V25, P207, DOI 10.1681/ASN.2013101043; Koldingsnes W, 2002, RHEUMATOLOGY, V41, P572, DOI 10.1093/rheumatology/41.5.572; Koutantji M, 2003, ARTHRIT RHEUM-ARTHR, V49, P826, DOI 10.1002/art.11471; McDowell PJ, 2020, J ALLERGY CLIN IMMUN; McGregor JG, 2012, CLIN J AM SOC NEPHRO, V7, P240, DOI 10.2215/CJN.05610611; Merkel PA, 2020, ACR OPEN RHEUMATOL, V2, P662, DOI 10.1002/acr2.11185; Merkel PA, 2020, JMIR RES PROTOC, V9, DOI 10.2196/16664; Miloslavsky EM, 2017, ANN RHEUM DIS, V76, P543, DOI 10.1136/annrheumdis-2016-210002; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P1827, DOI 10.1136/ard.2008.101279; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Robson J, 2015, RHEUMATOLOGY, V54, P471, DOI 10.1093/rheumatology/keu366; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Takala JH, 2011, SCAND J RHEUMATOL, V40, P283, DOI 10.3109/03009742.2010.533693; Tomasson G, 2012, ARTHRIT CARE RES, V64, P273, DOI 10.1002/acr.20649; Ware JE, 1993, SF36 HLTH SURVEY MAN; Xiao H, 2014, J AM SOC NEPHROL, V25, P225, DOI 10.1681/ASN.2013020143	31	188	193	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2021	384	7					599	609		10.1056/NEJMoa2023386	http://dx.doi.org/10.1056/NEJMoa2023386			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL2HH	33596356	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000620900000007
J	Rimmer, A				Rimmer, Abi			Anne Longfield: Children must be at the heart of "building back better"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2021	372								n488	10.1136/bmj.n488	http://dx.doi.org/10.1136/bmj.n488			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UD4NC	33602790				2022-12-28	WOS:000687183600001
J	Zila, V; Margiotta, E; Turonova, B; Muller, TG; Zimmerli, CE; Mattei, S; Allegretti, M; Borner, K; Rada, J; Muller, B; Lusic, M; Krausslich, HG; Beck, M				Zila, Vojtech; Margiotta, Erica; Turonova, Beata; Muller, Thorsten G.; Zimmerli, Christian E.; Mattei, Simone; Allegretti, Matteo; Borner, Kathleen; Rada, Jona; Muller, Barbara; Lusic, Marina; Krausslich, Hans-Georg; Beck, Martin			Cone-shaped HIV-1 capsids are transported through intact nuclear pores	CELL			English	Article							CRYOELECTRON TOMOGRAPHY; STRUCTURAL ORGANIZATION; MOLECULAR SOCIOLOGY; VIRUS; VISUALIZATION; FLUORESCENCE; REPLICATION; TEMPERATURE; COMPLEXES; PLATFORM	Human immunodeficiency virus (HIV-1) remains a major health threat. Viral capsid uncoating and nuclear import of the viral genome are critical for productive infection. The size of the HIV-1 capsid is generally believed to exceed the diameter of the nuclear pore complex (NPC), indicating that capsid uncoating has to occur prior to nuclear import. Here, we combined correlative light and electron microscopy with subtomogram averaging to capture the structural status of reverse transcription-competent HIV-1 complexes in infected T cells. We demonstrated that the diameter of the NPC in cellulo is sufficient for the import of apparently intact, cone-shaped capsids. Subsequent to nuclear import, we detected disrupted and empty capsid fragments, indicating that uncoating of the replication complex occurs by breaking the capsid open, and not by disassembly into individual subunits. Our data directly visualize a key step in HIV-1 replication and enhance our mechanistic understanding of the viral life cycle.	[Zila, Vojtech; Muller, Thorsten G.; Borner, Kathleen; Rada, Jona; Muller, Barbara; Lusic, Marina; Krausslich, Hans-Georg] Heidelberg Univ, Dept Infect Dis, Virol, D-69120 Heidelberg, Germany; [Margiotta, Erica; Turonova, Beata; Zimmerli, Christian E.; Mattei, Simone; Allegretti, Matteo; Beck, Martin] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Margiotta, Erica] Fac Biosci, Collaborat Joint PhD Degree EMBL & Heidelberg Uni, Heidelberg, Germany; [Mattei, Simone] Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland; [Mattei, Simone] European Mol Biol Lab, Imaging Ctr, D-69117 Heidelberg, Germany; [Borner, Kathleen; Lusic, Marina; Krausslich, Hans-Georg] German Ctr Infect Res, Partner Site Heidelberg, D-69120 Heidelberg, Germany; [Beck, Martin] Max Planck Inst Biophys, Dept Mol Sociol, D-60438 Frankfurt, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Swiss Federal Institutes of Technology Domain; ETH Zurich; European Molecular Biology Laboratory (EMBL); German Center for Infection Research; Max Planck Society	Krausslich, HG (corresponding author), Heidelberg Univ, Dept Infect Dis, Virol, D-69120 Heidelberg, Germany.; Beck, M (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.; Krausslich, HG (corresponding author), German Ctr Infect Res, Partner Site Heidelberg, D-69120 Heidelberg, Germany.; Beck, M (corresponding author), Max Planck Inst Biophys, Dept Mol Sociol, D-60438 Frankfurt, Germany.	hans-georg.kraeusslich@med.uni-heidelberg.de; martin.beck@biophys.mpg.de	Lusic, Marina/AAS-9704-2020; Beck, Martin/B-5589-2011	Lusic, Marina/0000-0002-0120-3569; Muller, Barbara/0000-0001-5726-5585; Mattei, Simone/0000-0002-2005-8977; Zila, Vojtech/0000-0003-2032-3600; Turonova, Beata/0000-0002-5457-4478; Zimmerli, Christian Eugen/0000-0003-4388-1349; Muller, Thorsten/0000-0002-4197-6224; Beck, Martin/0000-0002-7397-1321	Cryo-Electron Microscopy Service Platform of EMBL; Electron Microscopy Core Facility at Heidelberg University; Infectious Diseases Imaging Platform (IDIP) at the Center for Integrative Infectious Disease Research; AIDS Reagent Program, Division of AIDS, NIAID, NIH: efavirenz from the Division of AIDS, NIAID, and anti-HIV-1 p24 Hybridoma [183-H12-5C, 1513]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [240245660-SFB 1129]; TTU HIV in the DZIF; EMBL; Max Planck Society	Cryo-Electron Microscopy Service Platform of EMBL; Electron Microscopy Core Facility at Heidelberg University; Infectious Diseases Imaging Platform (IDIP) at the Center for Integrative Infectious Disease Research; AIDS Reagent Program, Division of AIDS, NIAID, NIH: efavirenz from the Division of AIDS, NIAID, and anti-HIV-1 p24 Hybridoma; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); TTU HIV in the DZIF; EMBL; Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank Dirk Grimm, Robert Doms, Anna Cereseto, David Bejarano, and Jessica Daecke for reagents. We are grateful to Maria Anders-Osswein, Vera Sonntag-Buck, Tina Holdt, William Wan, Julia Mahamid, Robin Burk, Janina Baumbach, Kar Ho Herman Fung, Ines de Castro, Wim Hagen, Felix Weis, Charlotta Funaya, Stefan Hillmer, and Vibor Laketa for technical assistance and valuable discussions. We acknowledge support by the Cryo-Electron Microscopy Service Platform of EMBL, the Electron Microscopy Core Facility at Heidelberg University, and the Infectious Diseases Imaging Platform (IDIP) at the Center for Integrative Infectious Disease Research. The following reagents were obtained through the AIDS Reagent Program, Division of AIDS, NIAID, NIH: efavirenz from the Division of AIDS, NIAID, and anti-HIV-1 p24 Hybridoma (183-H12-5C) (Cat#1513) from Dr. Bruce Chesebro. This work was funded in part by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Projektnummer 240245660-SFB 1129 project 5 (H.-G.K.), project 6 (B.M.), and project 20 (M.L. and M.B.), by the TTU HIV in the DZIF (H.-G.K.), EMBL, and the Max Planck Society (M.B.).	Achuthan V, 2018, CELL HOST MICROBE, V24, P392, DOI 10.1016/j.chom.2018.08.002; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Albanese A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002413; Allegretti M, 2020, NATURE, V586, P796, DOI 10.1038/s41586-020-2670-5; Ambrose Z, 2014, VIROLOGY, V454, P371, DOI 10.1016/j.virol.2014.02.004; [Anonymous], FEBS LETT, V563, P113; [Anonymous], J STRUCT BIOL, V199, P187; [Anonymous], ELIFE, V4; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740; Beck, 2020, NUCLEAR PORES CONSTR, DOI [10.1101/2020.07.30.228585, DOI 10.1101/2020.07.30.228585]; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Beck M, 2017, NAT REV MOL CELL BIO, V18, P73, DOI 10.1038/nrm.2016.147; Beck M, 2016, TRENDS CELL BIOL, V26, P825, DOI 10.1016/j.tcb.2016.08.006; Bejarano DA, 2019, ELIFE, V8, DOI 10.7554/eLife.41800; Bejarano DA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110620; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Borner K, 2020, MOL THER, V28, P1016, DOI 10.1016/j.ymthe.2020.02.009; Borner K, 2010, BIOTECHNOL J, V5, P39, DOI 10.1002/biot.200900226; Bohne J, 2004, MUTATION MAJOR 5; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Burdick RC, 2020, P NATL ACAD SCI USA, V117, P5486, DOI 10.1073/pnas.1920631117; Burdick RC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006570; Campbell EM, 2015, NAT REV MICROBIOL, V13, P471, DOI 10.1038/nrmicro3503; Carnes SK, 2018, J VIROL, V92, DOI 10.1128/JVI.00358-18; Chen B, 2019, TRENDS MICROBIOL, V27, P878, DOI 10.1016/j.tim.2019.06.002; Chen NY, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0262-0; Chin CR, 2015, CELL REP, V13, P1717, DOI 10.1016/j.celrep.2015.10.036; Chowdhury S, 2015, NAT STRUCT MOL BIOL, V22, P345, DOI 10.1038/nsmb.2996; Christensen DE, 2020, SCIENCE, V370, P187, DOI 10.1126/science.abc8420; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Dharan A, 2020, NAT MICROBIOL, V5, P1088, DOI 10.1038/s41564-020-0735-8; Dharan A, 2017, P NATL ACAD SCI USA, V114, pE10707, DOI 10.1073/pnas.1712033114; Dharan A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005700; Di Nunzio F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046037; Engelman AN, 2018, CELL MOL LIFE SCI, V75, P2491, DOI 10.1007/s00018-018-2772-5; Fernandez J, 2019, NAT MICROBIOL, V4, P1840, DOI 10.1038/s41564-019-0575-6; Fernandez J, 2015, J BIOL CHEM, V290, P4631, DOI 10.1074/jbc.M114.613133; Francis AC, 2018, CELL HOST MICROBE, V23, P536, DOI 10.1016/j.chom.2018.03.009; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Grant T, 2015, MEASURING OPTIMAL EX; Grotjahn DA, 2018, NAT STRUCT MOL BIOL, V25, P203, DOI 10.1038/s41594-018-0027-7; Hagen WJH, 2017, J STRUCT BIOL, V197, P191, DOI 10.1016/j.jsb.2016.06.007; Hampoelz B, 2019, CELL, V179, P671, DOI 10.1016/j.cell.2019.09.022; Hayles MF, 2007, J MICROSC-OXFORD, V226, P263, DOI 10.1111/j.1365-2818.2007.01775.x; Henderson HI, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-36; Hilditch L, 2014, CURR OPIN VIROL, V4, P32, DOI 10.1016/j.coviro.2013.11.003; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hu Wei-Shau, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006882; Hulme AE, 2015, J VIROL, V89, P5350, DOI 10.1128/JVI.00476-15; Kerssemakers J, 2006, P NATL ACAD SCI USA, V103, P15812, DOI 10.1073/pnas.0510400103; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Lau D, 2020, LANGMUIR, V36, P3624, DOI 10.1021/acs.langmuir.0c00103; Lusic K, 2020, HIV 1 UNCOATING RELE; Lusic M, 2017, NAT REV MICROBIOL, V15, P69, DOI 10.1038/nrmicro.2016.162; Mahamid J, 2016, SCIENCE, V351, P969, DOI 10.1126/science.aad8857; Malikov V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7660; Mamede JI, 2017, P NATL ACAD SCI USA, V114, pE7169, DOI 10.1073/pnas.1706245114; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Matreyek KA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003693; Matsushita T, 1998, GENE THER, V5, P938, DOI 10.1038/sj.gt.3300680; Mattei S, 2016, SCIENCE, V354, P1434, DOI 10.1126/science.aah4972; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Michler T, 2016, EMBO MOL MED, V8, P1082, DOI 10.15252/emmm.201506172; Monette A, 2011, J CELL BIOL, V193, P619, DOI 10.1083/jcb.201008064; Moron-Lopez S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175899; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Novikova M, 2019, VIROL SIN, V34, P119, DOI 10.1007/s12250-019-00095-3; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Paul-Gilloteaux P, 2017, NAT METHODS, V14, P102, DOI 10.1038/nmeth.4170; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Peng K, 2014, ELIFE, V3, DOI 10.7554/eLife.04114; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Price AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004459; Puertas MC, 2018, J ANTIMICROB CHEMOTH, V73, P1940, DOI 10.1093/jac/dky106; Punnonen EL, 1998, EUR J CELL BIOL, V75, P344, DOI 10.1016/S0171-9335(98)80067-8; Qu K, 2018, P NATL ACAD SCI USA, V115, pE11751, DOI 10.1073/pnas.1811580115; Rankovic S, 2017, J VIROL, V91, DOI 10.1128/JVI.00289-17; Revelo NH, 2014, J CELL BIOL, V205, P591, DOI 10.1083/jcb.201402066; Rigort A, 2012, P NATL ACAD SCI USA, V109, P4449, DOI 10.1073/pnas.1201333109; Roseman AM, 2003, ULTRAMICROSCOPY, V94, P225, DOI 10.1016/S0304-3991(02)00333-9; Rouzina I, 2014, EUR PHYS J-SPEC TOP, V223, P1745, DOI 10.1140/epjst/e2014-02223-x; Saito A, 2016, J VIROL, V90, P6918, DOI 10.1128/JVI.00019-16; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schorb M, 2017, J STRUCT BIOL, V197, P83, DOI 10.1016/j.jsb.2016.06.020; Splinter D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000350; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Stultz RD, 2017, J VIROL, V91, DOI 10.1128/JVI.00034-17; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Turonova B., 2017, EFFICIENT 3D CTF COR; von Appen A, 2015, NATURE, V526, P140, DOI 10.1038/nature15381; Wan W, 2017, NATURE, V551, P394, DOI 10.1038/nature24490; WEIGEL PH, 1981, J BIOL CHEM, V256, P2615; Welker R, 2000, J VIROL, V74, P1168, DOI 10.1128/JVI.74.3.1168-1177.2000; Wolff G, 2019, J STRUCT BIOL, V208, DOI 10.1016/j.jsb.2019.09.006; Yamashita M, 2017, TRENDS MICROBIOL, V25, P741, DOI 10.1016/j.tim.2017.04.004; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhou LH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002194; Zila V, 2019, MBIO, V10, DOI 10.1128/mBio.02501-19	107	80	81	6	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					1032	+		10.1016/j.cell.2021.01.025	http://dx.doi.org/10.1016/j.cell.2021.01.025		FEB 2021	33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33571428	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000629633400017
J	Raschke, RA; Agarwal, S; Rangan, P; Heise, CW; Curry, SC				Raschke, Robert A.; Agarwal, Sumit; Rangan, Pooja; Heise, C. William; Curry, Steven C.			Discriminant Accuracy of the SOFA Score for Determining the Probable Mortality of Patients With COVID-19 Pneumonia Requiring Mechanical Ventilation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CRITERIA	This cohort study investigates whether the Sequential Organ Failure Assessment (SOFA) score is accurate enough to discriminate death from survival, and thus perhaps be a ventilator triage tool, for US patients with coronavirus disease 2019 (COVID-19) hospitalized in intensive care units and requiring mechanical ventilation.	[Raschke, Robert A.; Heise, C. William; Curry, Steven C.] Univ Arizona, Coll Med, Div Clin Data Analyt & Decis Support, Phoenix, AZ USA; [Agarwal, Sumit] Univ Arizona, Coll Med, Phoenix, AZ USA; [Rangan, Pooja] Banner Univ, Med Ctr Phoenix, Dept Internal Med, Phoenix, AZ USA	University of Arizona; University of Arizona	Raschke, RA (corresponding author), 475 N Fifth St, Phoenix, AZ 85004 USA.	raschkebob@gmail.com		Raschke, Robert/0000-0003-3495-7065	Flinn Foundation [2196]	Flinn Foundation	Funded in part by grant 2196 from the Flinn Foundation.	Antommaria AHM, 2020, ANN INTERN MED, V173, P188, DOI 10.7326/M20-1738; Gupta S, 2020, JAMA INTERN MED, V180, P1436, DOI 10.1001/jamainternmed.2020.3596; Kovach CP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222563; Raith EP, 2017, JAMA-J AM MED ASSOC, V317, P290, DOI 10.1001/jama.2016.20328; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Truog RD, 2020, NEW ENGL J MED, V382, P1973, DOI 10.1056/NEJMp2005689	6	66	66	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2021	325	14					1469	1470		10.1001/jama.2021.1545	http://dx.doi.org/10.1001/jama.2021.1545		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RN9GZ	33595630	Green Published, Bronze			2022-12-28	WOS:000619613600004
J	Boytchev, H				Boytchev, Hristio			Why did a German newspaper insist the Oxford AstraZeneca vaccine was inefficacious for older people-without evidence?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												hristio@yahoo.com						[Anonymous], 2021, EPIDEMIOLOGISCHES B; [Anonymous], 2021, TAGESSCHAU      0128; [Anonymous], 2021, SCI MEDIA CTR   0129; [Anonymous], 2021, FRANKFURTER ALLGEMEI; [Anonymous], 2021, BRISANT         0126; [Anonymous], 2021, SPIEGEL; [Anonymous], 2021, HANDELSBLATT    0126; BBC, 2021, BBC; European Medicines Agency, 2021, EMA REC COV 19 VACC EMA REC COV 19 VACC; Evans S., 2021, SCI MEDIA CTR   0125; Sizochenko N, 2021, MOLECULES, V26, DOI 10.3390/molecules26010008; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Waschinski G., 2021, WASHINGTONSKI   0125; Waschinski G, 2021, HANDELSBLATT; Wickham A., 2021, POLITICO LONDON PLAY	15	12	13	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2021	372								n414	10.1136/bmj.n414	http://dx.doi.org/10.1136/bmj.n414			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH8HV	33579678	Bronze			2022-12-28	WOS:000618513500005
J	Nelson, MI				Nelson, Martha I.			Tracking the UK SARS-CoV-2 outbreak	SCIENCE			English	Editorial Material									[Nelson, Martha I.] NIAID, Parasit Dis Lab, Div Intramural Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nelson, MI (corresponding author), NIAID, Parasit Dis Lab, Div Intramural Res, Bethesda, MD 20892 USA.	nelsonma@mail.nih.gov						Aanensen DM, 2020, LANCET MICROBE, V1, pE99, DOI 10.1016/S2666-5247(20)30054-9; Candido DS, 2020, SCIENCE, V369, P1255, DOI 10.1126/science.abd2161; du Plessis L, 2021, SCIENCE, V371, P708, DOI 10.1126/science.abf2946; Gonzalez-Reiche AS, 2020, SCIENCE, V369, P297, DOI 10.1126/science.abc1917; Grantz KH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18190-5; Grubaugh ND, 2019, NAT MICROBIOL, V4, P10, DOI 10.1038/s41564-018-0296-2; Hu T., 2021, BRIEF BIOINFORM; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Lemey P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18877-9; Lemieux J.E., 2020, SCIENCE, V371; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Sun K., 2021, SCIENCE, V371; Volz E., 2021, MEDRXIV, DOI [10.1101/2020.12.30.20249034, DOI 10.1101/2020.12.30.20249034]; Volz E, 2021, CELL, V184, P64, DOI 10.1016/j.cell.2020.11.020; Worobey M, 2020, SCIENCE, V370, P564, DOI 10.1126/science.abc8169	15	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					680	681		10.1126/science.abg2297	http://dx.doi.org/10.1126/science.abg2297			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4IS	33574202				2022-12-28	WOS:000617551600028
J	Baraniuk, C				Baraniuk, Chris			Covid-19: People with mild asthma won't get early vaccination	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS, WHOS HIGH RISK COR; Public Health England, 2021, INF COV 19 VACC EAS; UK Health Security Agency, 2021, COVID 19 INF	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2021	372								n430	10.1136/bmj.n430	http://dx.doi.org/10.1136/bmj.n430			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM2MY	33574065	Bronze			2022-12-28	WOS:000639500800011
J	Sacks, CA				Sacks, Chana A.			Heart-Shaped Lesion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 63-year-old man with lung cancer presented for staging imaging. PET-CT revealed a heart-shaped lesion in the right upper lobe.											0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2021	384	6					562	562		10.1056/NEJMicm2024088	http://dx.doi.org/10.1056/NEJMicm2024088			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QG5JQ	33567479				2022-12-28	WOS:000617621800013
J	Rasmussen, SA; Jamieson, DJ				Rasmussen, Sonja A.; Jamieson, Denise J.			Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This JAMA Insights review summarizes the epidemiology of SARS-CoV-2 infection in pregnant and lactating women, its effects on perinatal outcomes, and compiles guidance from the CDC, FDA, and obstetrics-gynecology specialty organizations on the safety of coronavirus vaccines during pregnancy and while breastfeeding.	[Rasmussen, Sonja A.] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA; [Rasmussen, Sonja A.] Univ Florida, Coll Med, Dept Obstet & Gynecol, Gainesville, FL 32610 USA; [Rasmussen, Sonja A.] Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Rasmussen, Sonja A.] Coll Med, Gainesville, FL USA; [Jamieson, Denise J.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Woodruff Mem Res Bldg,101 Woodruff Circle, Atlanta, GA 30322 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Emory University	Jamieson, DJ (corresponding author), Emory Univ, Sch Med, Dept Gynecol & Obstet, Woodruff Mem Res Bldg,101 Woodruff Circle, Atlanta, GA 30322 USA.	djamieson@emory.edu						Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320; Chambers C, 2020, JAMA-J AM MED ASSOC, V324, P1347, DOI 10.1001/jama.2020.15580; Egerup P, 2021, OBSTET GYNECOL, V137, P49, DOI 10.1097/AOG.0000000000004199; Joseph NT, 2020, EMERG INFECT DIS, V26, P2786, DOI 10.3201/eid2611.203091; Khalil A, 2020, JAMA-J AM MED ASSOC, V324, P705, DOI 10.1001/jama.2020.12746; Pique-Regi R, 2020, ELIFE, V9, DOI 10.7554/eLife.58716; Rasmussen SA, 2020, OBSTET GYNECOL, DOI [10.1097/AOG.0000000000004290, DOI 10.1097/A0G.0000000000004290]; Salvatore CM, 2020, LANCET CHILD ADOLESC, V4, P721, DOI 10.1016/S2352-4642(20)30235-2; Vivanti AJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17436-6	10	33	33	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2021	325	11					1099	1100		10.1001/jama.2021.1683	http://dx.doi.org/10.1001/jama.2021.1683		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QZ1BV	33555287	Bronze			2022-12-28	WOS:000617177400001
J	Houchens, N; Hartley, S; Commins, SP; Claar, D; Saint, S				Houchens, Nathan; Hartley, Sarah; Commins, Scott P.; Claar, Dru; Saint, Sanjay			Hunting for a Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CETUXIMAB; TICK; ALLERGY; MEAT		[Houchens, Nathan; Hartley, Sarah; Claar, Dru; Saint, Sanjay] Vet Affairs VA Ann Arbor Healthcare Syst Med Serv, Ann Arbor, MI USA; [Houchens, Nathan; Hartley, Sarah; Claar, Dru; Saint, Sanjay] Univ Michigan, Dept Internal Med, Med Sch, Ann Arbor, MI 48109 USA; [Saint, Sanjay] Dept VA Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA; [Commins, Scott P.] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA	University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill	Houchens, N (corresponding author), VA Ann Arbor Healthcare Syst Med Serv, 2215 Fuller Rd,Mail Code 111, Ann Arbor, MI 48105 USA.	nathanho@umich.edu			NIAID NIH HHS [R01 AI135049] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], TICKS YOUR HLTH PREV; Binder AM, 2021, ANN ALLERGY ASTHMA I; Choi GS, 2010, ALLERGY, V65, P1065, DOI 10.1111/j.1398-9995.2009.02293.x; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Commins SP, 2020, EXPERT REV CLIN IMMU, V16, P667, DOI 10.1080/1744666X.2020.1782745; Commins SP, 2011, J ALLERGY CLIN IMMUN, V127, P1286, DOI 10.1016/j.jaci.2011.02.019; Commins SP, 2009, J ALLERGY CLIN IMMUN, V123, P426, DOI 10.1016/j.jaci.2008.10.052; Molaei G, 2019, NEW ENGL J MED, V381, P2189, DOI 10.1056/NEJMp1911661; O'Neil BH, 2007, J CLIN ONCOL, V25, P3644, DOI 10.1200/JCO.2007.11.7812; Qian J, 2007, ANAL BIOCHEM, V364, P8, DOI 10.1016/j.ab.2007.01.023; Roman-Carrasco P, 2019, ALLERGY, V74, P1956, DOI 10.1111/all.13873; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Steinke JW, 2015, J ALLERGY CLIN IMMUN, V135, P589, DOI 10.1016/j.jaci.2014.12.1947; van Nunen SA, 2018, MED J AUSTRALIA, V208, P316, DOI 10.5694/mja17.00591; Wilson JM, 2019, J ALLER CL IMM-PRACT, V7, P2348, DOI 10.1016/j.jaip.2019.03.031	15	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2021	384	5					462	467		10.1056/NEJMcps2017588	http://dx.doi.org/10.1056/NEJMcps2017588			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QX4QW	33534979	Green Accepted			2022-12-28	WOS:000629333200015
J	Crozier, A; Rajan, S; Buchan, I; McKee, M				Crozier, Alex; Rajan, Selina; Buchan, Iain; McKee, Martin			Put to the test: use of rapid testing technologies for covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Crozier, Alex] UCL, Div Biosci, London, England; [Rajan, Selina; McKee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England; [Buchan, Iain] Univ Liverpool, Inst Populat Hlth, Liverpool, Merseyside, England; [McKee, Martin] European Observ Hlth Syst & Policies, London, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of Liverpool; European Observatory on Health Systems & Policies	Crozier, A (corresponding author), UCL, Div Biosci, London, England.	alexander.crozier.20@ucl.ac.uk	Buchan, Iain/H-5767-2013	Buchan, Iain/0000-0003-3392-1650; Crozier, Alex/0000-0001-8719-5426				Aggarwal DD, 2020, GENOMIC EPIDEMIOLOGY; Aghaali M, 2020, TRANSBOUND EMERG DIS, V67, P2860, DOI 10.1111/tbed.13656; [Anonymous], 2020, LIVERPOOL COVID 19 C; Bullard J, 2020, CLIN INFECT DIS, V71, P2663, DOI 10.1093/cid/ciaa638; Centers for Disease Control and Prevention, 2020, OPT RED QUAR CONT PE; Centers for Disease Control and Prevention, 2020, INT GUID ANT TEST SA; Cevik M., 2020, SARS COV 2 SARS COV, DOI 10.1101/2020.07.25.20162107; Cevik M, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3862; Crozier A, 2020, J ROY SOC MED, V113, P422, DOI 10.1177/0141076820965533; Delaunay CL, 2020, J AM MED DIR ASSOC, V21, P1574, DOI 10.1016/j.jamda.2020.08.022; Department of Health and Social Care (DHSC), 2020, WEEKL STAT NHS TEST; Dinnes J, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013705.pub2, 10.1002/14651858.CD013705]; Endo Akira, 2020, Wellcome Open Res, V5, P239, DOI 10.12688/wellcomeopenres.16344.1; Ettelt S., 2020, RAPID COVID 19 TESTI; Grassly NC, 2020, LANCET INFECT DIS, V20, P1381, DOI 10.1016/S1473-3099(20)30630-7; Houlihan C., 2020, SARS COV 2 VIRUS ANT, DOI [10.1101/2020.06.08.20120584, DOI 10.1101/2020.06.08.20120584V1]; Kerkhoff AD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239400; Kissler SM., 2020, VIRAL DYNAMICS SARS, DOI [10.1101/2020.10.21.20217042v1, DOI 10.1101/2020.10.21.20217042V1]; Kohmer N, 2021, J CLIN MED, V10, DOI 10.3390/jcm10020328; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; Larremore DB, 2021, SCI ADV, V7, DOI [10.1126/sciadv.abd5393, 10.1101/2020.06.22.20136309]; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lee S, 2020, JAMA INTERN MED, V180, P1447, DOI 10.1001/jamainternmed.2020.3862; Lennard YWL, 2021, OBSERVATIONAL STUDY; McCartney M, 2021, BMJ EVID-BASED MED, V26, P143, DOI 10.1136/bmjebm-2020-111541; McCulloch DJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16382; Mina MJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2025631; Muhlemann B, 2020, COMP 7 COMMERCIAL SA, DOI [10.1101/2020.11.12.20230292v1.article-metrics, DOI 10.1101/2020.11.12.20230292V1.ARTICLE-METRICS]; Porton Down PHE University of Oxford, 2020, PREL REP RAP EV LAT; Quilty BJ, 2021, LANCET, V267, P1; Rolfes MA, 2021, MMWR-MORBID MORTAL W, V69, P1633, DOI 10.15585/mmwr.mm695152a1; Scientific Advisory Group for Emergencies, 2020, MULT TASK FIN GROUP; Watson J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1808; Wells CR, 2020, OPTIMAL COVID 19 QUA, DOI [10.1101/2020.10.27.20211631v4, DOI 10.1101/2020.10.27.20211631V4]; World Health Organization, 2020, COV 19 CAS DEF; World Health Organization, 2020, DIG TOOLS COVID 19 C	36	91	92	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2021	372								n208	10.1136/bmj.n208	http://dx.doi.org/10.1136/bmj.n208			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QE0PP	33536228	Bronze, Green Published			2022-12-28	WOS:000615909900004
J	Morgan, M				Morgan, Matt			Matt Morgan: I'm a celebrity, get me remdesivir!	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Morgan, Matt] Univ Hosp Wales, Cardiff, S Glam, Wales	Cardiff University	Morgan, M (corresponding author), Univ Hosp Wales, Cardiff, S Glam, Wales.			Morgan, Matt/0000-0002-2357-7190				Morgan M, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4516	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2021	372								n273	10.1136/bmj.n273	http://dx.doi.org/10.1136/bmj.n273			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC1TD	33536161	Bronze			2022-12-28	WOS:000686315900005
J	Cakir, B				Cakir, Beril			Addressing Patient Bias Toward Health Care Workers	ANNALS OF INTERNAL MEDICINE			English	Letter									[Cakir, Beril] Atrium Hlth, Carolinas Med Ctr, Carolinas Hospitalist Grp, Charlotte, NC 28204 USA	Carolinas Medical Center	Cakir, B (corresponding author), Atrium Hlth, Carolinas Med Ctr, Carolinas Hospitalist Grp, Charlotte, NC 28204 USA.							Coombs AAT, 2005, J NATL MED ASSOC, V97, P467; DeLoughery EP, 2019, NETH J MED, V77, P366; Nunez-Smith M, 2009, J GEN INTERN MED, V24, P1198, DOI 10.1007/s11606-009-1103-9; Paul-Emile K, 2020, ANN INTERN MED, V173, P468, DOI 10.7326/M20-0176; Zelek Barbara, 2003, Int J Equity Health, V2, P1, DOI 10.1186/1475-9276-2-1	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2021	174	2					288	288		10.7326/L20-1397	http://dx.doi.org/10.7326/L20-1397			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ2CK	33587881				2022-12-28	WOS:000619497100049
J	[Anonymous]				[Anonymous]			Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Branswell Helen, 2021, STAT; Dan JM, 2020, PREPRINT, DOI [10.1101/2020.11.15.383323v1, DOI 10.1101/2020.11.15.383323V1]; Institute for Health Metrics and Evaluation, 2020, COVID 19 RES BRIEF U; Kirby T, 2021, LANCET RESP MED, V9, pE20, DOI 10.1016/S2213-2600(21)00005-9; Moore S, 2020, MODELLING OPTIMAL VA, DOI [10.1101/2020.09.22.20194183v2, DOI 10.1101/2020.09.22.20194183V2]; Paltiel AD, 2021, HEALTH AFFAIR, V40, P42, DOI 10.1377/hlthaff.2020.02054; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Rasmussen A, 2021, GUARDIAN; Tuite AR, 2021, ANN INTERN MED	11	42	42	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2021	384	9								10.1056/NEJMclde2101987	http://dx.doi.org/10.1056/NEJMclde2101987			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QS8DS	33596347	Bronze			2022-12-28	WOS:000626124800002
J	Gopinath, A; Thachuk, C; Mitskovets, A; Atwater, HA; Kirkpatrick, D; Rothemund, PWK				Gopinath, Ashwin; Thachuk, Chris; Mitskovets, Anya; Atwater, Harry A.; Kirkpatrick, David; Rothemund, Paul W. K.			Absolute and arbitrary orientation of single-molecule shapes	SCIENCE			English	Article							DNA-ORIGAMI; FOLDING DNA; ALIGNMENT; PLACEMENT; CAVITY; ARRAYS; EMISSION; SPIN	DNA origami is a modular platform for the combination of molecular and colloidal components to create optical, electronic, and biological devices. Integration of such nanoscale devices with microfabricated connectors and circuits is challenging: Large numbers of freely diffusing devices must be fixed at desired locations with desired alignment. We present a DNA origami molecule whose energy landscape on lithographic binding sites has a unique maximum. This property enabled device alignment within 3.2 degrees on silica surfaces. Orientation was absolute (all degrees of freedom were specified) and arbitrary (the orientation of every molecule was independently specified). The use of orientation to optimize device performance was shown by aligning fluorescent emission dipoles within microfabricated optical cavities. Large-scale integration was demonstrated with an array of 3456 DNA origami with 12 distinct orientations that indicated the polarization of excitation light.	[Gopinath, Ashwin; Rothemund, Paul W. K.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; [Gopinath, Ashwin] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Thachuk, Chris; Rothemund, Paul W. K.] CALTECH, Dept Comp & Math Sci, Pasadena, CA 91125 USA; [Thachuk, Chris] Univ Washington, Paul G Allen Sch Comp Sci & Engn, Seattle, WA 98195 USA; [Mitskovets, Anya; Atwater, Harry A.] CALTECH, Dept Appl Phys & Mat Sci, Pasadena, CA 91125 USA; [Kirkpatrick, David] Univ British Columbia, Dept Comp Sci, Vancouver, BC, Canada; [Rothemund, Paul W. K.] CALTECH, Computat & Neural Syst, Pasadena, CA 91125 USA	California Institute of Technology; Massachusetts Institute of Technology (MIT); California Institute of Technology; University of Washington; University of Washington Seattle; California Institute of Technology; University of British Columbia; California Institute of Technology	Gopinath, A; Rothemund, PWK (corresponding author), CALTECH, Dept Bioengn, Pasadena, CA 91125 USA.; Gopinath, A (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.; Rothemund, PWK (corresponding author), CALTECH, Dept Comp & Math Sci, Pasadena, CA 91125 USA.; Rothemund, PWK (corresponding author), CALTECH, Computat & Neural Syst, Pasadena, CA 91125 USA.	agopi@mit.edu; pwkr@dna.caltech.edu		Rothemund, Paul/0000-0002-1653-3202; Kirkpatrick, David/0000-0002-3276-2734; Gopinath, Ashwin/0000-0002-2874-9457	Office of Naval Research [N00014-14-1-0702, N00014-17-1-2610]; NSF [1636364, 1317694]; Air Force Office of Scientific Research [FA9550-16-1-0019]; Natural Sciences and Engineering Research Council of Canada; Banting Fellowship; Orr Family Foundation; Abedin Institute	Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Banting Fellowship; Orr Family Foundation; Abedin Institute	Supported by Office of Naval Research awards N00014-14-1-0702 and N00014-17-1-2610, NSF grants 1636364 and 1317694 (Expedition in Computing, Molecular Programming Project, http://molecular-programming.org), Air Force Office of Scientific Research grant FA9550-16-1-0019 (A.M.), the Natural Sciences and Engineering Research Council of Canada (D.K.), a Banting Fellowship (C.T.), the Orr Family Foundation, and the Abedin Institute.	Afshinmanesh F, 2012, NANOPHOTONICS-BERLIN, V1, P125, DOI 10.1515/nanoph-2012-0004; Alu A, 2008, NAT PHOTONICS, V2, P307, DOI 10.1038/nphoton.2008.53; Arbona JM, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.051912; Armani AM, 2007, SCIENCE, V317, P783, DOI 10.1126/science.1145002; Backer AS, 2016, OPTICA, V3, P659, DOI 10.1364/OPTICA.3.000659; Barth M, 2010, NANO LETT, V10, P891, DOI 10.1021/nl903555u; Bennink ML, 1999, CYTOMETRY, V36, P200, DOI 10.1002/(SICI)1097-0320(19990701)36:3<200::AID-CYTO9>3.0.CO;2-T; BENSIMON D, 1995, PHYS REV LETT, V74, P4754, DOI 10.1103/PhysRevLett.74.4754; Benson O, 2011, NATURE, V480, P193, DOI 10.1038/nature10610; Correa-Duarte MA, 2005, J PHYS CHEM B, V109, P19060, DOI 10.1021/jp0544890; Cruz CAV, 2016, P NATL ACAD SCI USA, V113, pE820, DOI 10.1073/pnas.1516811113; Decker M, 2007, OPT LETT, V32, P856, DOI 10.1364/OL.32.000856; Demirors AF, 2010, LANGMUIR, V26, P14466, DOI 10.1021/la102134w; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Ding BQ, 2010, NANO LETT, V10, P5065, DOI 10.1021/nl1033073; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Emaminejad S, 2015, P NATL ACAD SCI USA, V112, P1995, DOI 10.1073/pnas.1424592112; Englund D, 2010, NANO LETT, V10, P3922, DOI 10.1021/nl101662v; Gopinath A., 2016, P 28 CAN C COMP GEOM, P230; Gopinath A, 2016, NATURE, V535, P401, DOI 10.1038/nature18287; Gopinath A, 2014, ACS NANO, V8, P12030, DOI 10.1021/nn506014s; Guan JJ, 2005, P NATL ACAD SCI USA, V102, P18321, DOI 10.1073/pnas.0506902102; Ha T, 1999, J PHYS CHEM B, V103, P6839, DOI 10.1021/jp990948j; Hennessy K, 2007, NATURE, V445, P896, DOI 10.1038/nature05586; Hettich C, 2002, SCIENCE, V298, P385, DOI 10.1126/science.1075606; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Huang JX, 2007, ANGEW CHEM INT EDIT, V46, P2414, DOI 10.1002/anie.200604789; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; Ke YG, 2012, CHEM SCI, V3, P2587, DOI 10.1039/c2sc20446k; Kershner RJ, 2009, NAT NANOTECHNOL, V4, P557, DOI [10.1038/nnano.2009.220, 10.1038/NNANO.2009.220]; Kim SO, 2003, NATURE, V424, P411, DOI 10.1038/nature01775; Kuzyk A, 2008, SMALL, V4, P447, DOI 10.1002/smll.200701320; Lesik M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869103; Lethiec C, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021037; Li B, 2015, ANGEW CHEM INT EDIT, V54, P4250, DOI 10.1002/anie.201412388; Liang SH, 2004, PROC IEEE MICR ELECT, P9, DOI 10.1109/MEMS.2004.1290509; Liddle JA, 2004, J VAC SCI TECHNOL B, V22, P3409, DOI 10.1116/1.1821572; Lim SH, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.107402; Lyasota A, 2015, J CRYST GROWTH, V414, P192, DOI 10.1016/j.jcrysgro.2014.10.028; Marchi AN, 2014, NANO LETT, V14, P5740, DOI 10.1021/nl502626s; Maune HT, 2010, NAT NANOTECHNOL, V5, P61, DOI [10.1038/nnano.2009.311, 10.1038/NNANO.2009.311]; Mehta SB, 2016, P NATL ACAD SCI USA, V113, pE6352, DOI 10.1073/pnas.1607674113; Michl J, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868128; Milanovich N, 1996, J PHYS CHEM-US, V100, P9181, DOI 10.1021/jp9600625; Morales P, 2016, SMALL, V12, P169, DOI 10.1002/smll.201501782; Mueller JPB, 2016, OPTICA, V3, P42, DOI 10.1364/OPTICA.3.000042; Novotny L, 2011, PHYS TODAY, V64, P47, DOI 10.1063/PT.3.1167; Pal S, 2011, J AM CHEM SOC, V133, P17606, DOI 10.1021/ja207898r; Pearson AC, 2011, NANO LETT, V11, P1981, DOI 10.1021/nl200306w; Penzo E, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3646900; Persson F, 2009, SMALL, V5, P190, DOI 10.1002/smll.200800423; Peyer KE, 2013, NANOSCALE, V5, P1259, DOI 10.1039/c2nr32554c; Pfab RJ, 2004, CHEM PHYS LETT, V387, P490, DOI 10.1016/j.cplett.2004.02.040; Riedrich-Moller J, 2014, NANO LETT, V14, P5281, DOI 10.1021/nl502327b; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Schins JM, 1999, CYTOMETRY, V37, P230, DOI 10.1002/(SICI)1097-0320(19991101)37:3<230::AID-CYTO10>3.0.CO;2-#; Schreiber R, 2014, NAT NANOTECHNOL, V9, P74, DOI [10.1038/nnano.2013.253, 10.1038/NNANO.2013.253]; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shaw A, 2015, ACS NANO, V9, P4968, DOI 10.1021/nn507035g; Shulaker MM, 2013, NATURE, V501, P526, DOI 10.1038/nature12502; Sick B, 2000, PHYS REV LETT, V85, P4482, DOI 10.1103/PhysRevLett.85.4482; Smith PA, 2000, APPL PHYS LETT, V77, P1399, DOI 10.1063/1.1290272; SPIELMANN HP, 1995, BIOCHEMISTRY-US, V34, P8542, DOI 10.1021/bi00027a004; Tanase M, 2001, NANO LETT, V1, P155, DOI 10.1021/nl005532s; Van Dyck C, 2015, NANO LETT, V15, P1577, DOI 10.1021/nl504091v; Vega RA, 2005, ANGEW CHEM INT EDIT, V44, P6013, DOI 10.1002/anie.200501978; Vybornyi M, 2014, BIOCONJUGATE CHEM, V25, P1785, DOI 10.1021/bc500297e; Wang DW, 2005, ANGEW CHEM INT EDIT, V44, P2925, DOI 10.1002/anie.200500291; Wang MCP, 2009, MATER TODAY, V12, P34, DOI 10.1016/S1369-7021(09)70158-0; Wang YH, 2006, P NATL ACAD SCI USA, V103, P2026, DOI 10.1073/pnas.0511022103; Woo S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5889; Xiong XR, 2004, IEEE INT CONF ROBOT, P1141; Ye WM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11930; Yuzvinsky TD, 2006, NANOTECHNOLOGY, V17, P434, DOI 10.1088/0957-4484/17/2/015; Zhang L, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3079655; Zhang YG, 2001, APPL PHYS LETT, V79, P3155, DOI 10.1063/1.1415412	76	27	27	14	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					800	+	eabd6179	10.1126/science.abd6179	http://dx.doi.org/10.1126/science.abd6179			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QJ4MB	33602826	Green Accepted, Green Submitted			2022-12-28	WOS:000619664700046
J	Phillips, N				Phillips, Nicky			The coronavirus is here to stay - here's what that means	NATURE			English	News Item						SARS-CoV-2; Virology		A Nature survey shows many scientists expect the virus that causes COVID-19 to become endemic, but it could pose less danger over time. A Nature survey shows many scientists expect the virus that causes COVID-19 to become endemic, but it could pose less danger over time.										Cele S., 2021, MEDRXIV, DOI [10.1101/2021.01.26.21250224, DOI 10.1101/2021.01.26.21250224]; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Eguia R, 2020, PREPRINT BIORXIV, DOI [10.1101/2020.12.17.423313, DOI 10.1101/2020.12.17.423313]; Hogan AB., 2020, REPORT 33 MODELLING; Lavine JS, 2021, SCIENCE, V371, P741, DOI 10.1126/science.abe6522	5	211	213	4	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846					382	384		10.1038/d41586-021-00396-2	http://dx.doi.org/10.1038/d41586-021-00396-2			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QJ5CU	33594289	Bronze			2022-12-28	WOS:000619709400021
J	Vayena, E				Vayena, Effy			Value from health data: European opportunity to catalyse progress in digital health Comment	LANCET			English	Editorial Material									[Vayena, Effy] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Hlth Ethics & Policy Lab, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Vayena, E (corresponding author), Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Hlth Ethics & Policy Lab, CH-8092 Zurich, Switzerland.	effy.vayena@hest.ethz.ch	Vayena, Effy/ABD-8272-2021	Vayena, Effy/0000-0003-1303-5467				[Anonymous], 2020, NAT MACH INTELL, V2, P291, DOI 10.1038/s42256-020-0196-z; [Anonymous], 2019, EX BOARD 146 26 DAT; [Anonymous], 2004, OFFICIAL J EUROPEAN, V47, P1; Blasimme A, 2020, SCIENCE, V370, P760, DOI 10.1126/science.abd9006; Blasimme A, 2018, HEALTH AFFAIR, V37, P702, DOI 10.1377/hlthaff.2017.1558; Cosgriff CV, 2020, LANCET DIGIT HEALTH, V2, pE224, DOI 10.1016/S2589-7500(20)30082-0; Ferretti A, 2019, LANCET DIGIT HEALTH, V1, pE55, DOI 10.1016/S2589-7500(19)30027-5; Gardner L, 2020, LANCET INFECT DIS, V21, pE80, DOI 10.1016/S1473-3099(20)30635-6; Horgan D, 2020, BIOMED HUB, V5, P43; Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151	10	8	8	6	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					652	653		10.1016/S0140-6736(21)00203-8	http://dx.doi.org/10.1016/S0140-6736(21)00203-8		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL3PK	33571452	Bronze			2022-12-28	WOS:000620991800008
J	Featherston, AL; Kwon, Y; Pompeo, MM; Engl, OD; Leahy, DK; Miller, SJ				Featherston, Aaron L.; Kwon, Yongseok; Pompeo, Matthew M.; Engl, Oliver D.; Leahy, David K.; Miller, Scott J.			Catalytic asymmetric and stereodivergent oligonucleotide synthesis	SCIENCE			English	Article							ENANTIOSELECTIVE SYNTHESIS; BOND FORMATION; BRONSTED ACID; STEREOCHEMISTRY; ANALOGS; DNA; PHOSPHOROTHIOATES; PHOSPHOTHREONINE; PHOSPHORYLATION; CLASSIFICATION	We report the catalytic stereocontrolled synthesis of dinucleotides. We have demonstrated, for the first time to our knowledge, that chiral phosphoric acid (CPA) catalysts control the formation of stereogenic phosphorous centers during phosphoramidite transfer. Unprecedented levels of diastereodivergence have also been demonstrated, enabling access to either phosphite diastereomer. Two different CPA scaffolds have proven to be essential for achieving stereodivergence: peptide-embedded phosphothreonine-derived CPAs, which reinforce and amplify the inherent substrate preference, and C2-symmetric BINOL-derived CPAs, which completely overturn this stereochemical preference. The presently reported catalytic method does not require stoichiometric activators or chiral auxiliaries and enables asymmetric catalysis with readily available phosphoramidites. The method was applied to the stereocontrolled synthesis of diastereomeric dinucleotides as well as cyclic dinucleotides, which are of broad interest in immuno-oncology as agonists of the stimulator of interferon genes (STING) pathway.	[Featherston, Aaron L.; Kwon, Yongseok; Pompeo, Matthew M.; Miller, Scott J.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Engl, Oliver D.; Leahy, David K.] Takeda Pharmaceut Int Co, Proc Chem Dev, Cambridge, MA 02139 USA; [Featherston, Aaron L.] AbbVie Inc, Proc Res & Dev, Chicago, IL 60064 USA; [Kwon, Yongseok] Sogang Univ, Dept Chem, Seoul 121742, South Korea; [Leahy, David K.] Biohaven Pharmaceut, New Haven, CT 06510 USA	Yale University; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.; AbbVie; Sogang University	Miller, SJ (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.; Leahy, DK (corresponding author), Takeda Pharmaceut Int Co, Proc Chem Dev, Cambridge, MA 02139 USA.; Leahy, DK (corresponding author), Biohaven Pharmaceut, New Haven, CT 06510 USA.	david.leahy@biohavenpharma.com; scott.miller@yale.edu	; Miller, Scott/N-7761-2017	/0000-0001-7761-085X; Leahy, David/0000-0003-4128-7792; Miller, Scott/0000-0001-7817-1318; Featherston, Aaron/0000-0003-0918-067X	Takeda Pharmaceuticals International Co.; National Institute of General Medical Sciences (NIH) [R35 GM132092]	Takeda Pharmaceuticals International Co.(Takeda Pharmaceutical Company Ltd); National Institute of General Medical Sciences (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Takeda Pharmaceuticals International Co. and the National Institute of General Medical Sciences (NIH grant R35 GM132092 to S.J.M.).	Akiyama T, 2004, ANGEW CHEM INT EDIT, V43, P1566, DOI 10.1002/anie.200353240; [Anonymous], [No title captured]; [Anonymous], S35 WAS PREPARED N4; [Anonymous], **DROPPED REF**; [Anonymous], 2020, MEDLINE, DOI [10.1021/acsomega.0c01942, DOI 10.1021/ACSOMEGA.0C01942]; [Anonymous], S37 WAS PREPARED N2; [Anonymous], ADEQUATE STIRRING WA; [Anonymous], S11 WAS PREPARED ACC; [Anonymous], MEDLINE, DOI [10.1021/acs.joc.9b00658, DOI 10.1021/ACS.JOC.9B00658]; [Anonymous], MEDLINE, DOI [10.1126/science.1232458, DOI 10.1126/SCIENCE.1232458]; [Anonymous], 2015, CRYSALISPRO; [Anonymous], 1991, CHEM-US, V56, P3861, DOI [10.1021/jo00012a017, DOI 10.1021/JO00012A017]; Awad AM, 2012, TETRAHEDRON LETT, V53, P3792, DOI 10.1016/j.tetlet.2012.05.055; Brady PB, 2009, TETRAHEDRON LETT, V50, P975, DOI 10.1016/j.tetlet.2008.12.065; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Clivio P, 2013, CHEM REV, V113, P7354, DOI 10.1021/cr300011s; Crouch IT, 2013, J AM CHEM SOC, V135, P4970, DOI 10.1021/ja401606e; DAHL BH, 1987, NUCLEIC ACIDS RES, V15, P1729, DOI 10.1093/nar/15.4.1729; DiRocco DA, 2017, SCIENCE, V356, P426, DOI 10.1126/science.aam7936; Dutartre M, 2016, CHEM SOC REV, V45, P5771, DOI 10.1039/c6cs00031b; El-Faham A, 2011, CHEM REV, V111, P6557, DOI 10.1021/cr100048w; FARNHAM WB, 1970, J AM CHEM SOC, V92, P5808, DOI 10.1021/ja00722a082; Featherston AL, 2019, ACS CATAL, V9, P242, DOI 10.1021/acscatal.8b04132; Fulmer GR, 2010, ORGANOMETALLICS, V29, P2176, DOI 10.1021/om100106e; Gaffney B. L., 2012, CURR PROTOC NUCL ACI; Gaffney BL, 2010, ORG LETT, V12, P3269, DOI 10.1021/ol101236b; Haque TS, 1996, J AM CHEM SOC, V118, P6975, DOI 10.1021/ja960429j; Hara RI, 2019, J ORG CHEM, V84, P7971, DOI 10.1021/acs.joc.9b00658; Hayakawa Y, 2001, J AM CHEM SOC, V123, P8165, DOI 10.1021/ja010078v; Hayakawa Y, 1997, J AM CHEM SOC, V119, P11758, DOI 10.1021/ja970685b; Henningfeld KA, 1996, J AM CHEM SOC, V118, P11701, DOI 10.1021/ja961788h; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Iwamoto N, 2017, NAT BIOTECHNOL, V35, P845, DOI 10.1038/nbt.3948; Jordan PA, 2012, ANGEW CHEM INT EDIT, V51, P2907, DOI 10.1002/anie.201109033; Jordan PA, 2010, P NATL ACAD SCI USA, V107, P20620, DOI 10.1073/pnas.1001111107; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; Knouse KW, 2018, SCIENCE, V361, P1234, DOI 10.1126/science.aau3369; Krautwald S, 2017, J AM CHEM SOC, V139, P5627, DOI 10.1021/jacs.6b13340; Kwon Y, 2019, J AM CHEM SOC, V141, P6698, DOI 10.1021/jacs.9b01911; Lebedev AV, 1996, PERSPECT DRUG DISCOV, V4, P17, DOI 10.1007/BF02172106; Li JQ, 2019, ACS CATAL, V9, P9794, DOI 10.1021/acscatal.9b03535; Li LY, 2014, NAT CHEM BIOL, V10, P1043, DOI [10.1038/NChemBio.1661, 10.1038/nchembio.1661]; Lim J, 2020, ACS OMEGA, V5, P14173, DOI 10.1021/acsomega.0c01942; Lioux T, 2016, J MED CHEM, V59, P10253, DOI 10.1021/acs.jmedchem.6b01300; Longo CM, 2009, ANGEW CHEM INT EDIT, V48, P4158, DOI 10.1002/anie.200900480; McAlpine K. E., 2020, INT J MOL SCI, V101; Metrano AJ, 2020, CHEM REV, V120, P11479, DOI 10.1021/acs.chemrev.0c00523; Montalbetti CAGN, 2005, TETRAHEDRON, V61, P10827, DOI 10.1016/j.tet.2005.08.031; NIELSEN J, 1988, J AM CHEM SOC, V110, P6275, DOI 10.1021/ja00226a069; Oka N, 2003, J AM CHEM SOC, V125, P8307, DOI 10.1021/ja034502z; Oka N, 2002, J AM CHEM SOC, V124, P4962, DOI 10.1021/ja017275e; Park YS, 2011, ANGEW CHEM INT EDIT, V50, P3730, DOI 10.1002/anie.201007298; Parmar D, 2014, CHEM REV, V114, P9047, DOI 10.1021/cr5001496; Petrillo DE, 2012, ORG LETT, V14, P1206, DOI 10.1021/ol203332j; Powles N, 2012, ORG BIOMOL CHEM, V10, P5940, DOI 10.1039/c2ob07130d; Rauniyar V, 2011, J AM CHEM SOC, V133, P8486, DOI 10.1021/ja202959n; Romanov-Michailidis F, 2015, CHEM-EUR J, V21, P5561, DOI 10.1002/chem.201406133; Romanov-Michailidis F, 2013, ORG LETT, V15, P5890, DOI 10.1021/ol402981z; Roy B, 2016, CHEM REV, V116, P7854, DOI 10.1021/acs.chemrev.6b00174; Russell MA, 2008, ORG BIOMOL CHEM, V6, P3270, DOI 10.1039/b808999j; Ryss JM, 2018, ORG LETT, V20, P1621, DOI 10.1021/acs.orglett.8b00364; Salvi L, 2012, ORG LETT, V14, P170, DOI 10.1021/ol202955h; Scotson JL, 2016, ORG BIOMOL CHEM, V14, P8301, DOI 10.1039/c6ob01531j; Sculimbrene BR, 2001, J AM CHEM SOC, V123, P10125, DOI 10.1021/ja016779+; SEELA F, 1991, J ORG CHEM, V56, P3861, DOI 10.1021/jo00012a017; Semenyuk A, 2006, J AM CHEM SOC, V128, P12356, DOI 10.1021/ja0636587; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shugrue CR, 2015, ANGEW CHEM INT EDIT, V54, P11173, DOI 10.1002/anie.201505898; Sobkowski M, 2010, NUCLEOS NUCLEOT NUCL, V29, P628, DOI 10.1080/15257770.2010.497014; STEC WJ, 1984, J AM CHEM SOC, V106, P6077, DOI 10.1021/ja00332a054; Steinreiber J, 2008, CHEM-EUR J, V14, P8060, DOI 10.1002/chem.200701643; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Uraguchi D, 2004, J AM CHEM SOC, V126, P5356, DOI 10.1021/ja0491533; Van Ostrand R, 2017, NUCLEOS NUCLEOT NUCL, V36, P181, DOI 10.1080/15257770.2016.1250906; Vargeese C, 1998, NUCLEIC ACIDS RES, V26, P1046, DOI 10.1093/nar/26.4.1046; Xu DM, 2020, J AM CHEM SOC, V142, P5785, DOI 10.1021/jacs.9b13898; Yoshikawa M., 2018, U.S. Patent, Patent No. [WO2018100558, 2018100558]; Zhang H, 2020, J MED CHEM, V63, P3785, DOI 10.1021/acs.jmedchem.9b01039; Zhang LH, 1997, J ORG CHEM, V62, P6918, DOI 10.1021/jo9702756	79	21	21	23	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					702	+		10.1126/science.abf4359	http://dx.doi.org/10.1126/science.abf4359			268	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4IS	33574208	Green Accepted			2022-12-28	WOS:000617551600042
J	Liu, Y; Ibanez, M				Liu, Yu; Ibanez, Maria			Tidying up the mess	SCIENCE			English	Editorial Material									[Liu, Yu; Ibanez, Maria] IST Austria, Campus 1, A-3400 Klosterneuburg, Austria	Institute of Science & Technology - Austria	Ibanez, M (corresponding author), IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	mibanez@ist.ac.at		Liu, Yu/0000-0001-7313-6740				Armstrong R. W., 1960, J APPL PHYS, V31, P1954; Barabash SV, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.155704; Beretta D, 2019, MAT SCI ENG R, V138, P210, DOI 10.1016/j.mser.2018.09.001; Biswas K, 2012, NATURE, V489, P414, DOI 10.1038/nature11439; Ibanez M, 2017, CHEM MATER, V29, P7093, DOI 10.1021/acs.chemmater.7b02967; Roychowdhury S, 2021, SCIENCE, V371, P722, DOI 10.1126/science.abb3517; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Tan GJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12167; Wojciechowski KT, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.184202; Zeier WG, 2016, ANGEW CHEM INT EDIT, V55, P6826, DOI 10.1002/anie.201508381; Zevalkink A, 2018, APPL PHYS REV, V5, DOI 10.1063/1.5021094; Zhao LD, 2014, ENERG ENVIRON SCI, V7, P251, DOI 10.1039/c3ee43099e	12	8	8	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					678	679		10.1126/science.abg0886	http://dx.doi.org/10.1126/science.abg0886			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4IS	33574201				2022-12-28	WOS:000617551600027
J	Saelens, X; Schepens, B				Saelens, Xavier; Schepens, Bert			Single-domain antibodies make a difference	SCIENCE			English	Editorial Material							SARS-COV-2		[Saelens, Xavier; Schepens, Bert] UGent VIB, Ctr Med Biotechnol, Ghent, Belgium; [Saelens, Xavier; Schepens, Bert] Univ Ghent, Dept Biochem & Microbiol, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Saelens, X (corresponding author), UGent VIB, Ctr Med Biotechnol, Ghent, Belgium.; Saelens, X (corresponding author), Univ Ghent, Dept Biochem & Microbiol, Ghent, Belgium.	xavier.saelens@vib-ugent.be; bert.schepens@vib-ugent.be						Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]; Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849; Custodio TF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19204-y; Esparza TJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79036-0; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hanke L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18174-5; Huo JD, 2020, NAT STRUCT MOL BIOL, V27, P846, DOI [10.1038/s41594-020-0469-6, 10.1038/s41594-020-00527-9]; Koenig P.-A., 2021, SCIENCE, V371; Leung K, 2021, EUROSURVEILLANCE, V26, P15, DOI 10.2807/1560-7917.ES.2020.26.1.2002106; Li W, 2020, CELL, V183, P429, DOI 10.1016/j.cell.2020.09.007; Schoof M, 2020, SCIENCE, V370, P1473, DOI 10.1126/science.abe3255; Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002; Wrapp D, 2020, CELL, V181, P1004, DOI 10.1016/j.cell.2020.04.031; Xiang YF, 2020, SCIENCE, V370, P1479, DOI 10.1126/science.abe4747; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6	15	8	8	3	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					681	682		10.1126/science.abg2294	http://dx.doi.org/10.1126/science.abg2294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4IS	33574203				2022-12-28	WOS:000617551600029
J	Mundoor, H; Wu, JS; Wensink, HH; Smalyukh, II				Mundoor, Haridas; Wu, Jin-Sheng; Wensink, Henricus H.; Smalyukh, Ivan I.			Thermally reconfigurable monoclinic nematic colloidal fluids	NATURE			English	Article								Fundamental relationships are believed to exist between the symmetries of building blocks and the condensed matter phases that they form(1). For example, constituent molecular and colloidal rods and disks impart their uniaxial symmetry onto nematic liquid crystals, such as those used in displays(1,2). Low-symmetry organizations could form in mixtures of rods and disks(3-5), but entropy tends to phase-separate them at the molecular and colloidal scales, whereas strong elasticity-mediated interactions drive the formation of chains and crystals in nematic colloids(6-11). To have a structure with few or no symmetry operations apart from trivial ones has so far been demonstrated to be a property of solids alone(1), but not of their fully fluid condensed matter counterparts, even though such symmetries have been considered theoretically(12-15) and observed in magnetic colloids(16). Here we show that dispersing highly anisotropic charged colloidal disks in a nematic host composed of molecular rods provides a platform for observing many low-symmetry phases. Depending on the temperature, concentration and surface charge of the disks, we find nematic, smectic and columnar organizations with symmetries ranging from uniaxial(1,2) to orthorhombic(17-21) and monoclinic(12-15). With increasing temperature, we observe unusual transitions from less- to more-ordered states and re-entrant(22) phases. Most importantly, we demonstrate the presence of reconfigurable monoclinic colloidal nematic order, as well as the possibility of thermal and magnetic control of low-symmetry self-assembly(2,23,24). Our experimental findings are supported by theoretical modelling of the colloidal interactions between disks in the nematic host and may provide a route towards realizing many low-symmetry condensed matter phases in systems with building blocks of dissimilar shapes and sizes, as well as their technological applications. Dispersion of colloidal disks in a nematic liquid crystal reveals several low-symmetry phases, including monoclinic colloidal nematic order, with interchange between them achieved through variations in temperature, concentration and surface charge.	[Mundoor, Haridas; Smalyukh, Ivan I.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Wu, Jin-Sheng; Smalyukh, Ivan I.] Univ Colorado, Dept Chem, Chem Phys Program, Boulder, CO 80309 USA; [Wu, Jin-Sheng; Smalyukh, Ivan I.] Univ Colorado, Dept Phys, Chem Phys Program, Boulder, CO 80309 USA; [Wensink, Henricus H.] Univ Paris Saclay, Lab Phys Solides, CNRS, Orsay, France; [Smalyukh, Ivan I.] Univ Colorado, Mat Sci & Engn Program, Dept Elect Comp & Energy Engn, Boulder, CO 80309 USA; [Smalyukh, Ivan I.] Natl Renewable Energy Lab, Renewable & Sustainable Energy Inst, Boulder, CO 80309 USA; [Smalyukh, Ivan I.] Univ Colorado, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Smalyukh, II (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.; Smalyukh, II (corresponding author), Univ Colorado, Dept Chem, Chem Phys Program, Boulder, CO 80309 USA.; Smalyukh, II (corresponding author), Univ Colorado, Dept Phys, Chem Phys Program, Boulder, CO 80309 USA.; Smalyukh, II (corresponding author), Univ Colorado, Mat Sci & Engn Program, Dept Elect Comp & Energy Engn, Boulder, CO 80309 USA.; Smalyukh, II (corresponding author), Natl Renewable Energy Lab, Renewable & Sustainable Energy Inst, Boulder, CO 80309 USA.; Smalyukh, II (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	ivan.smalyukh@colorado.edu	Smalyukh, Ivan/AAC-9232-2020; Wensink, H. H./AAF-6474-2019; Liu, Qing/GWC-9222-2022	Smalyukh, Ivan/0000-0003-3444-1966; Wu, Jin-Sheng/0000-0001-7377-3002				ALBEN R, 1973, J CHEM PHYS, V59, P4299, DOI 10.1063/1.1680625; Anderson VJ, 2002, NATURE, V416, P811, DOI 10.1038/416811a; [Anonymous], 2007, PRINCIPLES CONDENSED; Berardi R, 2012, SOFT MATTER, V8, P2017, DOI 10.1039/c1sm06838e; Besseling TH, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/19/194109; CLADIS PE, 1975, PHYS REV LETT, V35, P48, DOI 10.1103/PhysRevLett.35.48; Conkey DB, 2011, OPT EXPRESS, V19, P3835, DOI 10.1364/OE.19.003835; de Gennes P. G., 1993, PHYS LIQUID CRYSTALS; Evans JS, 2011, J APPL PHYS, V110, DOI 10.1063/1.3620550; FREISER MJ, 1970, PHYS REV LETT, V24, P1041, DOI 10.1103/PhysRevLett.24.1041; Gasser U, 2001, SCIENCE, V292, P258, DOI 10.1126/science.1058457; Graf C, 2003, LANGMUIR, V19, P6693, DOI 10.1021/la0347859; He MX, 2020, NATURE, V585, P524, DOI 10.1038/s41586-020-2718-6; Helbing D, 2000, PHYS REV LETT, V84, P1240, DOI 10.1103/PhysRevLett.84.1240; Hsiao LLC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9507; Jakli A, 2001, PHYS REV LETT, V86, P5715, DOI 10.1103/PhysRevLett.86.5715; JEROME B, 1991, REP PROG PHYS, V54, P391, DOI 10.1088/0034-4885/54/3/002; Lee T, 2010, OPT LETT, V35, P3447, DOI 10.1364/OL.35.003447; Liu QK, 2016, P NATL ACAD SCI USA, V113, P10479, DOI 10.1073/pnas.1601235113; Liu QK, 2014, NANO LETT, V14, P4071, DOI 10.1021/nl501581y; Loudet JC, 2004, SCIENCE, V306, P1525, DOI 10.1126/science.1102864; Lubensky TC, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.031704; Luckhurst GR, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011704; Luckhurst GR, 2015, BIAXIAL NEMATIC LIQU; Lydon J, 2010, J MATER CHEM, V20, P10071, DOI 10.1039/b926374h; Mamlock L, 1982, J PHYS LETT, V43, P641; Mertelj A, 2013, NATURE, V504, P237, DOI 10.1038/nature12863; Mettout B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041701; Moynihan HA, 2002, INT J PHARM, V247, P179, DOI 10.1016/S0378-5173(02)00420-9; Mundoor H, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax4257; Mundoor H, 2018, SCIENCE, V360, P768, DOI 10.1126/science.aap9359; Mundoor H, 2016, SCIENCE, V352, P69, DOI 10.1126/science.aaf0801; Mundoor H, 2015, SMALL, V11, P5572, DOI 10.1002/smll.201501788; Musevic I, 2006, SCIENCE, V313, P954, DOI 10.1126/science.1129660; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; Senyuk B, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062507; Severing K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.125501; Shah RR, 2001, J PHYS CHEM B, V105, P4936, DOI 10.1021/jp004073g; Silvestre NM, 2004, J PHYS-CONDENS MAT, V16, pS1921, DOI 10.1088/0953-8984/16/19/005; Smalyukh II, 2007, OPT EXPRESS, V15, P4359, DOI 10.1364/OE.15.004359; Smalyukh II, 2018, ANNU REV CONDEN MA P, V9, P207, DOI 10.1146/annurev-conmatphys-033117-054102; van den Pol E, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.258301; van der Kooij FM, 2000, LANGMUIR, V16, P10144, DOI 10.1021/la000875r; Vaupotic N, 2009, SOFT MATTER, V5, P2281, DOI 10.1039/b900722a; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; Yang JP, 2012, CHEM-EUR J, V18, P13642, DOI 10.1002/chem.201202336; Yeh P., 1999, OPTICS LIQUID CRYSTA; YU LJ, 1980, PHYS REV LETT, V45, P1000, DOI 10.1103/PhysRevLett.45.1000; Zheng ZY, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.065702; Zhou JJ, 2013, NANO LETT, V13, P2241, DOI 10.1021/nl400807m	50	15	14	4	49	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2021	590	7845								10.1038/s41586-021-03249-0	http://dx.doi.org/10.1038/s41586-021-03249-0			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG0TV	33568825	Green Submitted			2022-12-28	WOS:000617300400016
J	Ratnayake, D; Nguyen, PD; Rossello, FJ; Wimmer, VC; Tan, JL; Galvis, LA; Julier, Z; Wood, AJ; Boudier, T; Isiaku, AI; Berger, S; Oorschot, V; Sonntag, C; Rogers, KL; Marcelle, C; Lieschke, GJ; Martino, MM; Bakkers, J; Currie, PD				Ratnayake, Dhanushika; Nguyen, Phong D.; Rossello, Fernando J.; Wimmer, Verena C.; Tan, Jean L.; Galvis, Laura A.; Julier, Ziad; Wood, Alasdair J.; Boudier, Thomas; Isiaku, Abdulsalam I.; Berger, Silke; Oorschot, Viola; Sonntag, Carmen; Rogers, Kelly L.; Marcelle, Christophe; Lieschke, Graham J.; Martino, Mikael M.; Bakkers, Jeroen; Currie, Peter D.			Macrophages provide a transient muscle stem cell niche via NAMPT secretion	NATURE			English	Article							SKELETAL-MUSCLE; TRANSGENIC ZEBRAFISH; PROGENITOR CELLS; MYOGENIC CELLS; BETA-CELLS; DYNAMICS; MODEL; DIFFERENTIATION; QUANTIFICATION; PROLIFERATION	Skeletal muscle regenerates through the activation of resident stem cells. Termed satellite cells, these normally quiescent cells are induced to proliferate by wound-derived signals(1). Identifying the source and nature of these cues has been hampered by an inability to visualize the complex cell interactions that occur within the wound. Here we use muscle injury models in zebrafish to systematically capture the interactions between satellite cells and the innate immune system after injury, in real time, throughout the repair process. This analysis revealed that a specific subset of macrophages 'dwell' within the injury, establishing a transient but obligate niche for stem cell proliferation. Single-cell profiling identified proliferative signals that are secreted by dwelling macrophages, which include the cytokine nicotinamide phosphoribosyltransferase (Nampt, which is also known as visfatin or PBEF in humans). Nampt secretion from the macrophage niche is required for muscle regeneration, acting through the C-C motif chemokine receptor type 5 (Ccr5), which is expressed on muscle stem cells. This analysis shows that in addition to their ability to modulate the immune response, specific macrophage populations also provide a transient stem-cell-activating niche, directly supplying proliferation-inducing cues that govern the repair process that is mediated by muscle stem cells. This study demonstrates that macrophage-derived niche signals for muscle stem cells, such as NAMPT, can be applied as new therapeutic modalities for skeletal muscle injury and disease.	[Ratnayake, Dhanushika; Rossello, Fernando J.; Tan, Jean L.; Galvis, Laura A.; Julier, Ziad; Wood, Alasdair J.; Isiaku, Abdulsalam I.; Berger, Silke; Sonntag, Carmen; Marcelle, Christophe; Lieschke, Graham J.; Martino, Mikael M.; Currie, Peter D.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Ratnayake, Dhanushika; Tan, Jean L.; Julier, Ziad; Wood, Alasdair J.; Berger, Silke; Sonntag, Carmen; Martino, Mikael M.; Currie, Peter D.] Monash Univ, EMBL Australia, Clayton, Vic, Australia; [Nguyen, Phong D.; Bakkers, Jeroen] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Utrecht, Netherlands; [Nguyen, Phong D.; Bakkers, Jeroen] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Nguyen, Phong D.; Bakkers, Jeroen] Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, Utrecht, Netherlands; [Rossello, Fernando J.] Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia; [Wimmer, Verena C.; Boudier, Thomas; Rogers, Kelly L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Wimmer, Verena C.; Boudier, Thomas; Rogers, Kelly L.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Oorschot, Viola] Monash Univ, Monash Ramaciotti Ctr Cryo Electron Microscopy, Melbourne, Vic, Australia; [Galvis, Laura A.; Marcelle, Christophe] Univ Claude Bernard Lyon 1, Inst NeuroMyoGene INMG, CNRS UMR 5310, INSERM U1217, Lyon, France; [Oorschot, Viola] European Mol Biol Lab, Electron Microscopy Core Facil, Heidelberg, Germany	Australian Regenerative Medicine Institute; Monash University; European Molecular Biology Laboratory (EMBL); Monash University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Monash University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; European Molecular Biology Laboratory (EMBL)	Currie, PD (corresponding author), Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia.; Currie, PD (corresponding author), Monash Univ, EMBL Australia, Clayton, Vic, Australia.	peter.currie@monash.edu	Rossello, Fernando/B-1208-2015; Martino, Mikael/N-9345-2013	Rossello, Fernando/0000-0003-3885-8777; Ratnayake, Dhanushika/0000-0003-2476-127X; Isiaku, Abdulsalam/0000-0002-8354-8674; Galvis, Laura/0000-0002-8778-2572; Tan, Jean/0000-0001-9672-2531; Currie, Peter/0000-0001-8874-8862; Rogers, Kelly L./0000-0002-6755-0221; Martino, Mikael/0000-0002-5012-4605; Sonntag, Carmen/0000-0003-2560-1710; Lieschke, Graham/0000-0003-0325-798X; Boudier, Thomas/0000-0002-0148-7733; Nguyen, Phong Dang/0000-0003-1889-3276	EMBO Long Term Fellowship [ALTF1129-2015]; HFSPO Fellowship [LT001404/2017-L]; NWO-ZonMW Veni grant [016.186.017-3]; National Health and Medical Research Council of Australia [APP1041885, APP1136567, APP1104190, APP1159278, APP1044754, APP1069284, APP1086020, APP1140229, APP1176213]; State Government of Victoria; Australian Government	EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); HFSPO Fellowship; NWO-ZonMW Veni grant; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); State Government of Victoria; Australian Government(Australian GovernmentCGIAR)	We thank Monash Micro Imaging and Monash Ramaciotti Centre for Cryo-Electron Microscopy for microscopy support, Hubrecht Institute single-cell sequencing facility for sequencing service, Hubrecht Institute flow cytometry core facility and Monash FlowCore for sorting of cells using FACS and Monash Fishcore staff for technical assistance, A. Kawakami for the mmp9:eGFP and mmp9:eGFP-NTR BAC transgenic lines, F. J. Tulenko for advice on phylogenetic tree construction, H. Janovjak for advice on in vitro assays, A.-M. Tichy, E. Gerrard and A. Ruparelia for technical assistance and B. T. Kile, P. Gonczy and R. P. Currie for comments on the manuscript. P.D.N. is supported by an EMBO Long Term Fellowship (ALTF1129-2015), HFSPO Fellowship (LT001404/2017-L) and a NWO-ZonMW Veni grant (016.186.017-3). This work was supported by the National Health and Medical Research Council of Australia (APP1041885, APP1136567, APP1104190, APP1159278 to P.D.C.; APP1044754, APP1069284, APP1086020 to G.J.L.; and APP1140229, APP1176213 to M.M.M.). The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government.	Ando K, 2017, DEV CELL, V43, P643, DOI 10.1016/j.devcel.2017.10.015; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Berger J, 2012, BIOCHEM BIOPH RES CO, V423, P785, DOI 10.1016/j.bbrc.2012.06.040; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cole NJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001168; Corona BT, 2013, AM J PHYSIOL-CELL PH, V305, pC761, DOI 10.1152/ajpcell.00189.2013; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; de Vrieze E, 2011, BONE, V48, P704, DOI 10.1016/j.bone.2010.12.017; Deshmukh AS, 2015, J PROTEOME RES, V14, P4885, DOI 10.1021/acs.jproteome.5b00720; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dort J, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/4761427; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellett F, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007063; Ellett Felix, 2011, Blood, V117, pe49, DOI 10.1182/blood-2010-10-314120; Evans RJ, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007597; Fang CC, 2015, FEBS J, V282, P2858, DOI 10.1111/febs.13327; Figeac N, 2014, DEV BIOL, V386, P135, DOI 10.1016/j.ydbio.2013.11.017; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117; Gilliam BL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S9; Grube L, 2018, J PROTEOME RES, V17, P879, DOI 10.1021/acs.jproteome.7b00684; Grun D, 2016, CELL STEM CELL, V19, P266, DOI 10.1016/j.stem.2016.05.010; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Gurevich DB, 2016, SCIENCE, V353, DOI 10.1126/science.aad9969; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Hirata A, 2003, AM J PATHOL, V163, P203, DOI 10.1016/S0002-9440(10)63644-9; Hong SM, 2019, CANCER SCI, V110, P629, DOI 10.1111/cas.13886; Inoue D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019713; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Junker JP, 2014, CELL, V159, P662, DOI 10.1016/j.cell.2014.09.038; Kim Jeong Seok, 2014, J Exerc Nutrition Biochem, V18, P259, DOI 10.5717/jenb.2014.18.3.259; Krzysik-Walker SM, 2011, COMP BIOCHEM PHYS A, V159, P413, DOI 10.1016/j.cbpa.2011.04.007; Lalezari J, 2011, JAIDS-J ACQ IMM DEF, V57, P118, DOI 10.1097/QAI.0b013e318213c2c0; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; McInnes L., 2018, UMAP UNIFORM MANIFOL, DOI DOI 10.21105/JOSS.00861; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Milona MA, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-86; Ming GF, 2016, BIOCHEM BIOPH RES CO, V478, P1382, DOI 10.1016/j.bbrc.2016.08.133; Morsch M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00321; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Okuda KS, 2015, BIOL OPEN, V4, P1270, DOI 10.1242/bio.013540; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Nguyen PD, 2017, CELL STEM CELL, V21, P107, DOI 10.1016/j.stem.2017.06.003; Pipalia TG, 2016, DIS MODEL MECH, V9, P671, DOI 10.1242/dmm.022251; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Pisharath Harshan, 2009, V546, P133, DOI 10.1007/978-1-60327-977-2_9; Quarta M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15613; Ratnayake D., 2019, MYOGENESIS, P245; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rougeot J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00832; Sax MJ, 2016, ONCOTARGET, V7, P85437, DOI 10.18632/oncotarget.13387; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Seger C, 2011, DEV DYNAM, V240, P2440, DOI 10.1002/dvdy.22745; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Uderhardt S, 2019, CELL, V177, P541, DOI 10.1016/j.cell.2019.02.028; Van den Bergh R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035074; Venter G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097378; Wang SF, 2015, ROCK SOIL MECH, V36, P104, DOI 10.16285/j.rsm.2015.S2.013; Watanabe R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123047; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wolf FA, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1663-x; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Xue CB, 2011, ACS MED CHEM LETT, V2, P913, DOI 10.1021/ml200199c; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yahiaoui L, 2008, J PHYSIOL-LONDON, V586, P3991, DOI 10.1113/jphysiol.2008.152090; Zhang LQ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.132; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	84	53	53	20	90	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 11	2021	591	7849					281	+		10.1038/s41586-021-03199-7	http://dx.doi.org/10.1038/s41586-021-03199-7		FEB 2021	34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8UA	33568815	Green Submitted			2022-12-28	WOS:000616954000001
J	Christie, B				Christie, Bryan			Scotland approves MS drug that was rejected in England and Wales	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Cohen JA, 2016, LANCET NEUROL, V15, P373, DOI 10.1016/S1474-4422(16)00018-1	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2021	372								n391	10.1136/bmj.n391	http://dx.doi.org/10.1136/bmj.n391			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RG0MZ	33563601				2022-12-28	WOS:000635231900009
J	Cowper, A				Cowper, Andy			Leaked government white paper ends England's NHS internal market and returns power to health secretary	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												andycowper@hotmail.com						Department of Health, 2019, NHS LONG TERM PLAN; Department of Health and Social Care, 2010, LIB NHS WHIT PAP; Exclusive-Government's new Health White Paper draft text, 2021, HLTH POLICY INSIGHT; Health Foundation, WORK PAT WHIT PAP PU; Iacobucci G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n377; National Health Service (NHS), 2014, 5 YEAR FORW VIEW	6	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2021	372								n384	10.1136/bmj.n384	http://dx.doi.org/10.1136/bmj.n384			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RG0MZ	33563614				2022-12-28	WOS:000635231900008
J	Katz, JN; Arant, KR; Loeser, RF				Katz, Jeffrey N.; Arant, Kaetlyn R.; Loeser, Richard F.			Diagnosis and Treatment of Hip and Knee Osteoarthritis A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BONE-MARROW EDEMA; UNITED-STATES; EULAR RECOMMENDATIONS; STANDING-COMMITTEE; PHYSICAL-THERAPY; TASK-FORCE; POSTTRAUMATIC OSTEOARTHRITIS; CLINICAL EXAMINATION; AFRICAN-AMERICANS; CONTROLLED-TRIAL	Importance Osteoarthritis (OA) is the most common joint disease, affecting an estimated more than 240 million people worldwide, including an estimated more than 32 million in the US. Osteoarthritis is the most frequent reason for activity limitation in adults. This Review focuses on hip and knee OA. Observations Osteoarthritis can involve almost any joint but typically affects the hands, knees, hips, and feet. It is characterized by pathologic changes in cartilage, bone, synovium, ligament, muscle, and periarticular fat, leading to joint dysfunction, pain, stiffness, functional limitation, and loss of valued activities, such as walking for exercise and dancing. Risk factors include age (33% of individuals older than 75 years have symptomatic and radiographic knee OA), female sex, obesity, genetics, and major joint injury. Persons with OA have more comorbidities and are more sedentary than those without OA. The reduced physical activity leads to a 20% higher age-adjusted mortality. Several physical examination findings are useful diagnostically, including bony enlargement in knee OA and pain elicited with internal hip rotation in hip OA. Radiographic indicators include marginal osteophytes and joint space narrowing. The cornerstones of OA management include exercises, weight loss if appropriate, and education-complemented by topical or oral nonsteroidal anti-inflammatory drugs (NSAIDs) in those without contraindications. Intra-articular steroid injections provide short-term pain relief and duloxetine has demonstrated efficacy. Opiates should be avoided. Clinical trials have shown promising results for compounds that arrest structural progression (eg, cathepsin K inhibitors, Wnt inhibitors, anabolic growth factors) or reduce OA pain (eg, nerve growth factor inhibitors). Persons with advanced symptoms and structural damage are candidates for total joint replacement. Racial and ethnic disparities persist in the use and outcomes of joint replacement. Conclusions and Relevance Hip and knee OA are highly prevalent and disabling. Education, exercise and weight loss are cornerstones of management, complemented by NSAIDs (for patients who are candidates), corticosteroid injections, and several adjunctive medications. For persons with advanced symptoms and structural damage, total joint replacement effectively relieves pain. This narrative review summarizes the pathophysiology, diagnosis, and treatment of osteoarthritis (OA) of the hip and knee, including use of structured exercise, acetaminophen and NSAIDs, corticosteroid injections, and surgery to manage symptoms.	[Katz, Jeffrey N.; Arant, Kaetlyn R.] Harvard Med Sch, Brigham & Womens Hosp, Dept Orthoped Surg, Orthoped & Arthrit Ctr Outcomes Res, Boston, MA 02115 USA; [Katz, Jeffrey N.] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, Boston, MA 02115 USA; [Katz, Jeffrey N.] Harvard TH Chan Sch Publ Hlth Boston, Dept Epidemiol, Boston, MA USA; [Loeser, Richard F.] Univ N Carolina, Div Rheumatol Allergy & Immunol, Chapel Hill, NC USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill	Katz, JN (corresponding author), Brigham & Womens Hosp, Orthoped & Arthrit Ctr Outcomes Res, 75 Francis St,Hale 5016, Boston, MA 02115 USA.	jnkatz@bwh.harvard.edu						Agency for Healthcare Research and Quality, HEALTHC COST UT PROJ; ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Bannuru RR, 2019, OSTEOARTHR CARTILAGE, V27, P1578, DOI 10.1016/j.joca.2019.06.011; Bannuru RR, 2015, ANN INTERN MED, V162, P46, DOI 10.7326/M14-1231; Barbour KE, 2017, MMWR-MORBID MORTAL W, V66, P246, DOI 10.15585/mmwr.mm6609e1; Bastick AN, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0670-x; Beswick AD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000435; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Brouwer GM, 2007, ARTHRITIS RHEUM, V56, P1204, DOI 10.1002/art.22515; Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef; Byrne MM, 2006, J CLIN EPIDEMIOL, V59, P1078, DOI 10.1016/j.jclinepi.2006.01.010; Cavanaugh AM, 2019, OSTEOARTHR CARTILAGE, V27, P1746, DOI 10.1016/j.joca.2019.07.015; Chapple CM, 2011, ARTHRIT CARE RES, V63, P1115, DOI 10.1002/acr.20492; Cheng OT, 2012, PAIN MED, V13, P740, DOI 10.1111/j.1526-4637.2012.01394.x; Collins JE, 2014, OSTEOARTHR CARTILAGE, V22, P622, DOI 10.1016/j.joca.2014.03.009; Conaghan PG, 2020, ANN INTERN MED, V172, P86, DOI 10.7326/M19-0675; Conaghan PG, 2018, J BONE JOINT SURG AM, V100, P666, DOI 10.2106/JBJS.17.00154; Deveza LA, 2019, CLIN EXP RHEUMATOL, V37, P64; Deyle GD, 2020, NEW ENGL J MED, V382, P1420, DOI 10.1056/NEJMoa1905877; Duncan R, 2009, OSTEOARTHR CARTILAGE, V17, P1151, DOI 10.1016/j.joca.2009.03.016; Enteshari-Moghaddam A, 2019, CLIN RHEUMATOL, V38, P2873, DOI 10.1007/s10067-019-04573-7; Evans JT, 2019, LANCET, V393, P655, DOI 10.1016/S0140-6736(18)32531-5; Evans JT, 2019, LANCET, V393, P647, DOI 10.1016/S0140-6736(18)31665-9; Felson DT, 2016, OSTEOARTHR CARTILAGE, V24, P458, DOI 10.1016/j.joca.2015.09.013; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Felson DT, 2003, ANN INTERN MED, V139, P330, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00008; Fernandes L, 2013, ANN RHEUM DIS, V72, P1125, DOI 10.1136/annrheumdis-2012-202745; Fleischmann RM, 2019, ARTHRITIS RHEUMATOL, V71, P1056, DOI 10.1002/art.40840; GBD 2015 Risk Factors Collaborators, 2016, Lancet, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Gold GE, 2015, OSTEOARTHR CARTILAGE, V23, P716, DOI 10.1016/j.joca.2015.03.004; Haugen IK, 2011, ANN RHEUM DIS, V70, P1581, DOI 10.1136/ard.2011.150078; Hausmann LRM, 2010, J GEN INTERN MED, V25, P982, DOI 10.1007/s11606-010-1399-5; Hawker G, 2016, OSTEOARTHRITIS SERIO; Hochberg MC, 2015, OSTEOARTHR CARTILAGE, V23, pS18, DOI 10.1016/j.joca.2014.10.005; Hochberg MC, 2019, JAMA-J AM MED ASSOC, V322, P1360, DOI 10.1001/jama.2019.14735; Hochberg MC, 2012, J RHEUMATOL, V39, P352, DOI 10.3899/jrheum.110307; Huang ZP, 2018, RHEUMATOLOGY, V57, P108, DOI 10.1093/rheumatology/kex496; Hunter DJ, 2011, OSTEOARTHR CARTILAGE, V19, P557, DOI 10.1016/j.joca.2010.10.029; Ibrahim SA, 2002, MED CARE, V40, P44; Inacio Maria C S, 2017, Perm J, V21, P16, DOI 10.7812/TPP/16-171; Jasper LL, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1025-8; Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324; Jevsevar DS, 2013, J AM ACAD ORTHOP SUR, V21, P571, DOI 10.5435/JAAOS-21-09-571; Jordan JM, 2007, J RHEUMATOL, V34, P172; Jordan JM, 2009, J RHEUMATOL, V36, P809, DOI 10.3899/jrheum.080677; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Katz JN, 2016, J BONE JOINT SURG AM, V98, DOI 10.2106/JBJS.15.01466; Katz JN, 2013, NEW ENGL J MED, V368, P1675, DOI 10.1056/NEJMoa1301408; Katz JN, 2012, J BONE JOINT SURG AM, V94A, P1825, DOI 10.2106/JBJS.K.00569; Katz JN, 2001, J BONE JOINT SURG AM, V83A, P1622, DOI 10.2106/00004623-200111000-00002; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kloppenburg M, 2019, ANN RHEUM DIS, V78, P413, DOI 10.1136/annrheumdis-2018-213336; Kloppenburg M, 2018, ANN RHEUM DIS, V77, P1757, DOI 10.1136/annrheumdis-2018-213202; Kohn MD, 2016, CLIN ORTHOP RELAT R, V474, P1886, DOI 10.1007/s11999-016-4732-4; Kolasinski SL, 2020, ARTHRITIS RHEUMATOL, V72, P220, DOI [10.1002/art.41142, 10.1002/acr.24131]; KOVAR PA, 1992, ANN INTERN MED, V116, P529, DOI 10.7326/0003-4819-116-7-529; Kraus VB, 2015, OSTEOARTHR CARTILAGE, V23, P1233, DOI 10.1016/j.joca.2015.03.036; Lane NE, 2010, NEW ENGL J MED, V363, P1521, DOI 10.1056/NEJMoa0901510; Lanza FL, 2009, AM J GASTROENTEROL, V104, P728, DOI 10.1038/ajg.2009.115; Lee C, 2004, ARTHRIT RHEUM-ARTHR, V51, P746, DOI 10.1002/art.20698; Leopoldino AO, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013273; Lieberthal J, 2015, OSTEOARTHR CARTILAGE, V23, P1825, DOI 10.1016/j.joca.2015.08.015; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Losina E, 2015, ARTHRIT CARE RES, V67, P203, DOI 10.1002/acr.22412; Losina E, 2013, ARTHRIT CARE RES, V65, P703, DOI 10.1002/acr.21898; Machado GC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1225; Mahomed NN, 2003, J BONE JOINT SURG AM, V85A, P27, DOI 10.2106/00004623-200301000-00005; Mahomed NN, 2005, J BONE JOINT SURG AM, V87A, P1222, DOI 10.2106/JBJS.D.02546; McAlindon TE, 2017, JAMA-J AM MED ASSOC, V317, P1967, DOI 10.1001/jama.2017.5283; Memtsoudis SG, 2010, J ARTHROPLASTY, V25, P19, DOI 10.1016/j.arth.2008.11.010; Messier SP, 2013, JAMA-J AM MED ASSOC, V310, P1263, DOI 10.1001/jama.2013.277669; Metcalfe D, 2019, JAMA-J AM MED ASSOC, V322, P2323, DOI 10.1001/jama.2019.19413; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Nelson AE, 2019, OSTEOARTHR CARTILAGE, V27, P994, DOI 10.1016/j.joca.2018.12.027; Nwachukwu BU, 2010, J BONE JOINT SURG AM, V92A, P338, DOI 10.2106/JBJS.I.00510; Orlowsky EW, 2015, J RHEUMATOL, V42, P363, DOI 10.3899/jrheum.140382; Osani MC, 2019, KOREAN J INTERN MED, V34, P966, DOI 10.3904/kjim.2018.460; Pendleton A, 2000, ANN RHEUM DIS, V59, P936, DOI 10.1136/ard.59.12.936; Podlipska J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22365; Prokopetz JJZ, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-251; Reichenbach S, 2020, JAMA-J AM MED ASSOC, V323, P1802, DOI 10.1001/jama.2020.3565; Sanga P, 2017, ARTHRITIS RHEUMATOL, V69, P763, DOI 10.1002/art.39943; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; Schieker M, 2020, ANN INTERN MED, V173, P509, DOI 10.7326/M20-0527; Schnitzer TJ, 2019, JAMA-J AM MED ASSOC, V322, P37, DOI 10.1001/jama.2019.8044; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Skou ST, 2015, NEW ENGL J MED, V373, P1597, DOI 10.1056/NEJMoa1505467; Sohn DH, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3555; Srikanth VK, 2005, OSTEOARTHR CARTILAGE, V13, P769, DOI 10.1016/j.joca.2005.04.014; Taljanovic MS, 2008, SKELETAL RADIOL, V37, P423, DOI 10.1007/s00256-008-0446-3; US Bureau of Labor Statistics, CONS PRIC IND; van den Bosch MHJ, 2020, OSTEOARTHR CARTILAGE, V28, P532, DOI 10.1016/j.joca.2020.01.016; Wood MJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125325; Yazici Y, 2017, OSTEOARTHR CARTILAGE, V25, P1598, DOI 10.1016/j.joca.2017.07.006; Zeng C, 2019, OSTEOARTHR CARTILAGE, V27, P855, DOI 10.1016/j.joca.2019.01.007; Zhang W, 2005, ANN RHEUM DIS, V64, P669, DOI 10.1136/ard.2004.028886; Zhang W, 2016, J BONE JOINT SURG AM, V98, P1243, DOI 10.2106/JBJS.15.01009; Zhu XY, 2018, CLIN EXP RHEUMATOL, V36, P595	99	212	222	115	280	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2021	325	6					568	578		10.1001/jama.2020.22171	http://dx.doi.org/10.1001/jama.2020.22171			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG0MD	33560326	Green Accepted			2022-12-28	WOS:000617279600020
J	Dyer, C				Dyer, Clare			NHS agrees to pay 13m pound for boy who was left brain damaged from lack of nutrition after birth	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1711; OP. v Lancashire Teaching Hospitals NHS Foundation Trust, 2021, EWHC, V165	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2021	372								n371	10.1136/bmj.n371	http://dx.doi.org/10.1136/bmj.n371			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM1AV	33558218				2022-12-28	WOS:000639394000002
J	Zarocostas, J				Zarocostas, John			WHO team begins COVID-19 origin investigation	LANCET			English	Editorial Material																			0	3	3	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2021	397	10273					459	459						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QF1LZ	33549178	Bronze, Green Published			2022-12-28	WOS:000616661900008
J	Iacobucci, G				Iacobucci, Gareth			Millions face potential health risks from climate change in UK, report warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		The Climate Coalition, 2021, THIS REP COM HLTH WA	1	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2021	372								n342	10.1136/bmj.n342	http://dx.doi.org/10.1136/bmj.n342			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH2PI	33541862				2022-12-28	WOS:000618119100016
J	Kemp, SA; Collier, DA; Datir, RP; Ferreira, IATM; Gayed, S; Jahun, A; Hosmillo, M; Rees-Spear, C; Mlcochova, P; Lumb, IU; Roberts, DJ; Chandra, A; Temperton, N; Sharrocks, K; Blane, E; Modis, Y; Leigh, KE; Briggs, JAG; van Gils, MJ; Smith, KGC; Bradley, JR; Smith, C; Doffinger, R; Ceron-Gutierrez, L; Barcenas-Morales, G; Pollock, DD; Goldstein, RA; Smielewska, A; Skittrall, JP; Gouliouris, T; Goodfellow, IG; Gkrania-Klotsas, E; Illingworth, CJR; McCoy, LE; Gupta, RK				Kemp, Steven A.; Collier, Dami A.; Datir, Rawlings P.; Ferreira, Isabella A. T. M.; Gayed, Salma; Jahun, Aminu; Hosmillo, Myra; Rees-Spear, Chloe; Mlcochova, Petra; Lumb, Ines Ushiro; Roberts, David J.; Chandra, Anita; Temperton, Nigel; Sharrocks, Katherine; Blane, Elizabeth; Modis, Yorgo; Leigh, Kendra E.; Briggs, John A. G.; van Gils, Marit J.; Smith, Kenneth G. C.; Bradley, John R.; Smith, Chris; Doffinger, Rainer; Ceron-Gutierrez, Lourdes; Barcenas-Morales, Gabriela; Pollock, David D.; Goldstein, Richard A.; Smielewska, Anna; Skittrall, Jordan P.; Gouliouris, Theodore; Goodfellow, Ian G.; Gkrania-Klotsas, Effrossyni; Illingworth, Christopher J. R.; McCoy, Laura E.; Gupta, Ravindra K.		CITIID-NIHR BioResource COVID-19 C; COVID-19 Genomics UK COG-UK Consor	SARS-CoV-2 evolution during treatment of chronic infection	NATURE			English	Article							ACE2; RESISTANCE; MULTIPLE	The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for virus infection through the engagement of the human ACE2 protein(1) and is a major antibody target. Here we show that chronic infection with SARS-CoV-2 leads to viral evolution and reduced sensitivity to neutralizing antibodies in an immunosuppressed individual treated with convalescent plasma, by generating whole-genome ultra-deep sequences for 23 time points that span 101 days and using in vitro techniques to characterize the mutations revealed by sequencing. There was little change in the overall structure of the viral population after two courses of remdesivir during the first 57 days. However, after convalescent plasma therapy, we observed large, dynamic shifts in the viral population, with the emergence of a dominant viral strain that contained a substitution (D796H) in the S2 subunit and a deletion (Delta H69/Delta V70) in the S1 N-terminal domain of the spike protein. As passively transferred serum antibodies diminished, viruses with the escape genotype were reduced in frequency, before returning during a final, unsuccessful course of convalescent plasma treatment. In vitro, the spike double mutant bearing both Delta H69/Delta V70 and D796H conferred modestly decreased sensitivity to convalescent plasma, while maintaining infectivity levels that were similar to the wild-type virus.The spike substitution mutant D796H appeared to be the main contributor to the decreased susceptibility to neutralizing antibodies, but this mutation resulted in an infectivity defect. The spike deletion mutant Delta H69/Delta V70 had a twofold higher level of infectivity than wild-type SARS-CoV-2, possibly compensating for the reduced infectivity of the D796H mutation. These data reveal strong selection on SARS-CoV-2 during convalescent plasma therapy, which is associated with the emergence of viral variants that show evidence of reduced susceptibility to neutralizing antibodies in immunosuppressed individuals.	[Kemp, Steven A.; Collier, Dami A.; Rees-Spear, Chloe; Goldstein, Richard A.; McCoy, Laura E.] UCL, Div Infect & Immun, London, England; [Collier, Dami A.; Datir, Rawlings P.; Ferreira, Isabella A. T. M.; Mlcochova, Petra; Chandra, Anita; Modis, Yorgo; Leigh, Kendra E.; Smith, Kenneth G. C.; Gupta, Ravindra K.] Cambridge Inst Therapeut Immunol & Infect Dis CIT, Cambridge, England; [Collier, Dami A.; Datir, Rawlings P.; Ferreira, Isabella A. T. M.; Mlcochova, Petra; Chandra, Anita; Blane, Elizabeth; Modis, Yorgo; Leigh, Kendra E.; Smith, Kenneth G. C.; Bradley, John R.; Gupta, Ravindra K.] Univ Cambridge, Dept Med, Cambridge, England; [Gayed, Salma; Sharrocks, Katherine; Skittrall, Jordan P.; Gouliouris, Theodore; Gkrania-Klotsas, Effrossyni] Cambridge Univ NHS Hosp Fdn Trust, Dept Infect Dis, Cambridge, England; [Jahun, Aminu; Hosmillo, Myra; Smielewska, Anna; Goodfellow, Ian G.] Univ Cambridge, Dept Pathol, Cambridge, England; [Lumb, Ines Ushiro; Roberts, David J.] NHS Blood & Transplant, Oxford, England; [Lumb, Ines Ushiro; Roberts, David J.] Univ Oxford, BRC Haematol Theme, Oxford, England; [Temperton, Nigel] Univ Kent, Medway Sch Pharm, Viral Pseudotype Unit, Canterbury, Kent, England; [Modis, Yorgo; Leigh, Kendra E.; Briggs, John A. G.] MRC, Lab Mol Biol, Cambridge, England; [van Gils, Marit J.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [Bradley, John R.] NIHR Cambridge Bioresource, Cambridge, England; [Smith, Chris; Smielewska, Anna] Cambridge Univ NHS Hosp Fdn Trust, Dept Virol, Cambridge, England; [Doffinger, Rainer; Ceron-Gutierrez, Lourdes; Barcenas-Morales, Gabriela] Addenbrookes Hosp, Dept Clin Biochem & Immunol, Cambridge, England; [Barcenas-Morales, Gabriela] UNAM, FES Cuautitlan, Cuautitlan, Mexico; [Pollock, David D.] Univ Colorado, Biochem & Mol Genet, Sch Med, Aurora, CO USA; [Skittrall, Jordan P.; Illingworth, Christopher J. R.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge, England; [Skittrall, Jordan P.] Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Cambridge, England; [Illingworth, Christopher J. R.] Univ Cambridge, MRC Biostat Unit, Cambridge, England; [Gupta, Ravindra K.] Africa Hlth Res Inst, Durban, South Africa	University of London; University College London; University of Cambridge; University of Cambridge; University of Oxford; University of Kent; MRC Laboratory Molecular Biology; University of Amsterdam; Academic Medical Center Amsterdam; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universidad Nacional Autonoma de Mexico; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; MRC Biostatistics Unit; University of Cambridge; Africa Health Research Institute	Gupta, RK (corresponding author), Cambridge Inst Therapeut Immunol & Infect Dis CIT, Cambridge, England.; Gupta, RK (corresponding author), Univ Cambridge, Dept Med, Cambridge, England.; Gupta, RK (corresponding author), Africa Hlth Res Inst, Durban, South Africa.	rkg20@cam.ac.uk	Gkrania-Klotsas, Effrossyni/AAT-8424-2021; McClure, Patrick/J-4619-2019; van Gils, Marit J./H-4791-2019; Temperton, Nigel James/K-5158-2013; Bunclark, Katherine/GLN-3109-2022; Temperton, Nigel James/M-1164-2019; Coudert, Jerome D/B-2628-2008; Betancor, Gilberto/AAB-5872-2021; Fraser, Christophe/A-8109-2008; Dorman, Matthew J/M-6603-2013; Beggs, Andrew D/A-6912-2013; Summers, Charlotte/A-6973-2012; O'Grady, Justin/I-2982-2012; Golubchik, Tanya/B-4226-2018; Payne, Brendan/I-1233-2016	Gkrania-Klotsas, Effrossyni/0000-0002-0930-8330; McClure, Patrick/0000-0002-1710-1049; van Gils, Marit J./0000-0003-3422-8161; Temperton, Nigel James/0000-0002-7978-3815; Bunclark, Katherine/0000-0002-8785-0715; Temperton, Nigel James/0000-0002-7978-3815; Coudert, Jerome D/0000-0001-6081-8494; Betancor, Gilberto/0000-0003-0548-7690; Fraser, Christophe/0000-0003-2399-9657; Dorman, Matthew J/0000-0001-7064-6163; Beggs, Andrew D/0000-0003-0784-2967; Summers, Charlotte/0000-0002-7269-2873; Ferreira, Isabella/0000-0001-5232-4670; O'Grady, Justin/0000-0001-5412-7152; Ledesma, Juan/0000-0002-0871-5065; Partridge, David/0000-0002-0417-2016; Allara, Elias/0000-0002-1634-8330; Lackenby, Angie/0000-0002-1557-0415; Smith, Darren/0000-0003-4925-467X; Torok, Mili Estee/0000-0001-9098-8590; Walker, Neil/0000-0001-9796-7688; Chappell, Joseph/0000-0002-8205-4242; Spencer Chapman, Michael/0000-0002-5320-8193; Vancollie, Valerie/0000-0003-1547-1975; Beckett, Angela/0000-0003-4948-1004; Bashton, Matthew/0000-0002-6847-1525; Jahun, Aminu/0000-0002-4585-1701; Prieto, Jacqui/0000-0002-5524-6775; Goldstein, Richard/0000-0001-5148-4672; McCann, Clare M/0000-0003-3395-820X; Gouliouris, Theodore/0000-0002-2011-1205; Leigh, Kendra/0000-0002-6467-3330; Bewshea, Claire/0000-0002-0965-9587; McNally, Alan/0000-0002-3099-630X; Golubchik, Tanya/0000-0003-2765-9828; Bayzid, Nadua/0000-0002-7209-9471; Kemp, Steven/0000-0001-7077-6793; Illingworth, Chris/0000-0002-0030-2784; Wang, Dennis/0000-0003-0068-1005; Blacow, Rachel/0000-0002-0946-5539; Saeed, Kordo/0000-0003-0123-0302; Breuer, Judith/0000-0001-8246-0534; Moore, Catherine/0000-0001-8934-0930; Palmalux, Natasha/0000-0002-4246-6082; de Silva, Thushan/0000-0002-6498-9212; Bradley, John/0000-0002-7774-8805; Rudder, Steven/0000-0003-0050-9037; Crook, Derrick/0000-0002-0590-2850; Young, Gregory/0000-0001-5342-1421; Glaysher, Sharon/0000-0002-9584-0621; Payne, Brendan/0000-0002-3101-3512; Collier, Dami Aderonke/0000-0001-5446-4423; Signell, Adrian/0000-0003-4620-6891; Oszlanczi, Agnes/0000-0001-6148-6591; Pinckert, Malte/0000-0002-6072-5949; Nelson, Andrew/0000-0001-6665-4929; Kingston, Nathalie/0000-0002-9190-2231; Smith, Kenneth/0000-0003-3829-4326; Datir, Rawlings/0000-0003-0521-2144; Flaviani, Flavia/0000-0002-4210-0451; Gallis, Marta/0000-0003-0222-2398	Medical Research Council (MRC) part of UK Research & Innovation (UKRI); National Institute of Health Research (NIHR); Genome Research Limited; Wellcome Trust [WT108082AIA, 207498/Z/17/Z]; Medical Research Council Career Development Award [MR/R008698/1]; Bill and Melinda Gates Foundation via PANGEA grant [OPP1175094]; Wellcome Trust; MRC [MC_UU_00002/11]; National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; Cambridge Clinical Trials Unit (CCTU); UCL Coronavirus Response Fund; Medical Research Council [MC_UP_1201/16]; NIH [GM083127]; BBSRC [BBS/E/F/000PR10348, BB/P007562/1] Funding Source: UKRI; MRC [MR/R008698/1, MC_PC_19027] Funding Source: UKRI	Medical Research Council (MRC) part of UK Research & Innovation (UKRI)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Genome Research Limited; Wellcome Trust(Wellcome Trust); Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation via PANGEA grant; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Clinical Trials Unit (CCTU); UCL Coronavirus Response Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the patient and his family. We thank the staff at CUH and the NIHR Cambridge Clinical Research Facility; R. Kugathasan and W. Barclay for discussions; M. Curran, W. Hamilton and D. Sparkes, A. Floto and F. Gallagher; J. Voss for the gift of HeLa cells stably expressing ACE2; and J. Nathan for the RBD protein and L. James for the nucleocapsid protein. COG-UK is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) and Genome Research Limited, operating as the Wellcome Sanger Institute. R.K.G. is supported by a Wellcome Trust Senior Fellowship in Clinical Science (WT108082AIA). L.E.M. is supported by a Medical Research Council Career Development Award (MR/R008698/1). S.A.K. is supported by the Bill and Melinda Gates Foundation via PANGEA grant (OPP1175094). D.A.C. is supported by a Wellcome Trust Clinical PhD Research Fellowship. C.J.R.I. acknowledges MRC funding (MC_UU_00002/11). This research was supported by the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre, the Cambridge Clinical Trials Unit (CCTU) and by the UCL Coronavirus Response Fund and made possible through generous donations from UCL's supporters, alumni, and friends (to L.E.M.). J.A.G.B. is supported by the Medical Research Council (MC_UP_1201/16). I.G.G. is a Wellcome Senior Fellow and supported by the Wellcome Trust (207498/Z/17/Z). D.D.P. is supported by NIH GM083127.	Avanzato VA, 2020, CELL, V183, P1901, DOI 10.1016/j.cell.2020.10.049; Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]; Boshier F.A.T., 2020, PREPRINT, DOI [10.1101/2020.11.18.20230599, DOI 10.1101/2020.11.18.20230599]; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Bull RA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20075-6; Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]; CDC, 2020, DISCONTINUATION TRAN; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Collier DA, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100062; Didelot X, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004041; Gregson J, 2020, J INFECT DIS, V222, P1108, DOI 10.1093/infdis/jiz631; Gupta RK, 2010, AIDS, V24, P1651, DOI 10.1097/QAD.0b013e3283398216; Harvey, 2020, SSRN ELECT J, DOI [DOI 10.2139/SSRN.3780277, 10.1101/2020.12.14.422555]; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Illingworth CJR, 2016, BIOINFORMATICS, V32, P2208, DOI 10.1093/bioinformatics/btw205; Jordan MR, 2010, J VIROL METHODS, V168, P114, DOI 10.1016/j.jviromet.2010.04.030; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kim, 2020, PREPRINT, DOI [10.21203/rs.3.rs-105996/v1, DOI 10.21203/RS.3.RS-105996/V1]; Leonard AS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006203; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Loman N., 2020, NCOV 2019 NOVEL CORO; Lumby CK, 2020, ELIFE, V9, DOI 10.7554/eLife.56915; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meredith LW, 2020, LANCET INFECT DIS, V20, P1263, DOI 10.1016/S1473-3099(20)30562-4; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Mlcochova P, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100099; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Quick J., 2020, PROTOCOLSIO, DOI [10.17504/protocols.io.bbmuik6w.https://doi.org/10.17504/protocols.io.bbmuik6w, DOI 10.17504/PROTOCOLS.IO.BBMUIK6W.HTTPS://DOI.ORG/10.17504/PROTOCOLS.IO.BBMUIK6W]; Rambaut A., PRELIMINARY GENOMIC; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Richard M, 2018, J VIROL, V92, DOI 10.1128/JVI.02063-17; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Schmidt F, 2020, J EXP MED, V217, DOI 10.1084/jem.20201181; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Shrock E, 2020, SCIENCE, V370, P1058, DOI 10.1126/science.abd4250; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Simonovich VA, 2021, NEW ENGL J MED, V384, P619, DOI 10.1056/NEJMoa2031304; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Vermeire J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050859; Wrobel AG, 2020, NAT STRUCT MOL BIOL, V27, P763, DOI 10.1038/s41594-020-0468-7; Xiong XL, 2020, NAT STRUCT MOL BIOL, V27, P934, DOI 10.1038/s41594-020-0478-5; Zussman ME, 2012, PEDIATR RES, V71, P697, DOI 10.1038/pr.2012.16	48	339	343	10	99	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 8	2021	592	7853					277	+		10.1038/s41586-021-03291-y	http://dx.doi.org/10.1038/s41586-021-03291-y		FEB 2021	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8ZE	33545711	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000625125600001
J	Wible, B				Wible, Brad			Complicated legacies: The human genome at 20	SCIENCE			English	Editorial Material														Callier, Shawneequa/0000-0002-1007-333X; Moreau, Yves/0000-0002-4647-6560; Zielinski, Dina/0000-0002-6188-9590; Stevens, Hallam/0000-0002-9083-3131	NCI NIH HHS [R01 CA237118, R01 CA221870] Funding Source: Medline; NHGRI NIH HHS [U01 HG009599] Funding Source: Medline; NICHD NIH HHS [P2C HD044964] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))			0	5	5	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		564	564		10.1126/science.abg5266	http://dx.doi.org/10.1126/science.abg5266			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QD7TF	33542123	Green Accepted, Green Submitted			2022-12-28	WOS:000615715300022
J	Pizzo, PA; Spiegel, D; Mello, MM				Pizzo, Philip A.; Spiegel, David; Mello, Michelle M.			When Physicians Engage in Practices That Threaten the Nation's Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pizzo, Philip A.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Pizzo, Philip A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Spiegel, David] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Law Sch, Stanford, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Pizzo, PA (corresponding author), Stanford Univ, Dept Pediat, Lorry I Lokey Res Bldg,265 Campus Dr,G1078, Stanford, CA 94305 USA.; Pizzo, PA (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Lorry I Lokey Res Bldg,265 Campus Dr,G1078, Stanford, CA 94305 USA.	ppizzo@stanford.edu		Mello, Michelle/0000-0003-2877-4270; Spiegel, David/0000-0002-9476-9173				Christakis NA., 2020, APOLLOS ARROW PROFOU; Federation of State Medical Boards, 2018, GUID STRUCT FUNCT ST; Haynes BF, 2021, NEW ENGL J MED, V384, P470, DOI 10.1056/NEJMe2035557; Kesselheim AS, 2007, JAMA-J AM MED ASSOC, V298, P2907, DOI 10.1001/jama.298.24.2907; Koh HK, 2021, JAMA-J AM MED ASSOC, V325, P133, DOI 10.1001/jama.2020.25381; Webeck E., 2020, SAN JOSE MERCURY NEW; Weiland Noah, 2020, NY TIMES 0909	7	4	4	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					723	724		10.1001/jama.2021.0122	http://dx.doi.org/10.1001/jama.2021.0122		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33538765				2022-12-28	WOS:000614935100001
J	Burkholder, BM; Jabs, DA				Burkholder, Bryn M.; Jabs, Douglas A.			Uveitis for the non-ophthalmologist	BMJ-BRITISH MEDICAL JOURNAL			English	Review								The uveitides are a heterogeneous group of diseases characterized by inflammation inside the eye. The uveitides are classified as infectious or non-infectious. The noninfectious uveitides, which are presumed to be immune mediated, can be further divided into those that are associated with a known systemic disease and those that are eye limited,-ie, not associated with a systemic disease. The ophthalmologist identifies the specific uveitic entity by medical history, clinical examination, and ocular imaging, as well as supplemental laboratory testing, if indicated. Treatment of the infectious uveitides is tailored to the particular infectious organism and may include regional and/or systemic medication. First line treatment for non-infectious uveitides is corticosteroids that can be administered topically, as regional injections or surgical implants, or systemically. Systemic immunosuppressive therapy is used in patients with severe disease who cannot tolerate corticosteroids, require chronic corticosteroids at >7.5 mg/day prednisone, or in whom the disease is known to respond better to immunosuppression. Management of many of these diseases is optimized by coordination between the ophthalmologist and rheumatologist or internist.	[Burkholder, Bryn M.; Jabs, Douglas A.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Jabs, Douglas A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Clin Trials & Evidence Synth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Burkholder, BM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Wilmer Eye Inst, Baltimore, MD 21205 USA.	bburkho1@jhmi.edu			National Eye Institute, the National Institutes of Health, Bethesda, MD, US [R01 EY026593]	National Eye Institute, the National Institutes of Health, Bethesda, MD, US	Supported in part by grant R01 EY026593 from the National Eye Institute, the National Institutes of Health, Bethesda, MD, US.	Akpek EK, 2002, OPHTHALMOLOGY, V109, P1506, DOI 10.1016/S0161-6420(02)01097-7; Al Rashidi S, 2013, OCUL IMMUNOL INFLAMM, V21, P468, DOI 10.3109/09273948.2013.779727; Albini TA, 2008, AM J OPHTHALMOL, V146, P486, DOI 10.1016/j.ajo.2008.06.021; Androudi S, 2005, OCUL IMMUNOL INFLAMM, V13, P205, DOI 10.1080/09273940590933511; Antcliff RJ, 2001, OPHTHALMOLOGY, V108, P765, DOI 10.1016/S0161-6420(00)00658-8; Anwar Z, 2013, AM J OPHTHALMOL, V155, P781, DOI 10.1016/j.ajo.2012.12.008; Ayuso VK, 2011, AM J OPHTHALMOL, V151, P217, DOI 10.1016/j.ajo.2010.08.021; Baert F, 2003, NEW ENGL J MED, V348, P601, DOI 10.1056/NEJMoa020888; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; Birnbaum AD, 2011, ARCH OPHTHALMOL-CHIC, V129, P667, DOI 10.1001/archophthalmol.2011.82; Birolo C, 2016, J RHEUMATOL, V43, P2068, DOI 10.3899/jrheum.151389; BLOCHMICHEL E, 1987, AM J OPHTHALMOL, V103, P234, DOI 10.1016/S0002-9394(14)74235-7; Braun J, 2005, ARTHRITIS RHEUM, V52, P2447, DOI 10.1002/art.21197; Callanan DG, 2008, ARCH OPHTHALMOL-CHIC, V126, P1191, DOI 10.1001/archopht.126.9.1191; Calvo-Rio V, 2017, ARTHRITIS RHEUMATOL, V69, P668, DOI 10.1002/art.39940; Caplash S, 2019, OPHTHALMOLOGY, V126, P1726, DOI 10.1016/j.ophtha.2019.06.014; Cassidy J, 2006, PEDIATRICS, V117, P1843, DOI 10.1542/peds.2006-0421; Chang JH, 2005, SURV OPHTHALMOL, V50, P364, DOI 10.1016/j.survophthal.2005.04.003; Chang-Lin JE, 2011, INVEST OPHTH VIS SCI, V52, P80, DOI 10.1167/iovs.10-5285; Charkoudian LD, 2012, OCUL IMMUNOL INFLAMM, V20, P91, DOI 10.3109/09273948.2011.646382; Chee SP, 2008, AM J OPHTHALMOL, V145, P834, DOI 10.1016/j.ajo.2007.12.015; Da Silva JAP, 2006, ANN RHEUM DIS, V65, P285, DOI 10.1136/ard.2005.038638; Dana MR, 1996, OPHTHALMOLOGY, V103, P1846, DOI 10.1016/S0161-6420(96)30417-X; Daniel E, 2010, AM J OPHTHALMOL, V149, P423, DOI 10.1016/j.ajo.2009.09.026; Diaz-Llopis M, 2012, OPHTHALMOLOGY, V119, P1575, DOI 10.1016/j.ophtha.2012.02.018; Dick AD, 2018, OPHTHALMOLOGY, V125, P757, DOI 10.1016/j.ophtha.2017.11.017; Dick AD, 2013, OPHTHALMOLOGY, V120, P777, DOI 10.1016/j.ophtha.2012.09.040; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2896, DOI 10.1002/art.22808; Donaldson MJ, 2007, AM J OPHTHALMOL, V144, P812, DOI 10.1016/j.ajo.2007.08.023; Durrani OM, 2004, BRIT J OPHTHALMOL, V88, P1159, DOI 10.1136/bjo.2003.037226; Durrani OM, 2004, OPHTHALMOLOGICA, V218, P223, DOI 10.1159/000078612; Dworkin LL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1534, DOI 10.1001/archopht.120.11.1534; Edelsten C, 2002, BRIT J OPHTHALMOL, V86, P51, DOI 10.1136/bjo.86.1.51; Ferrante P, 2004, CLIN EXP OPHTHALMOL, V32, P563, DOI 10.1111/j.1442-9071.2004.00902.x; Foster C Stephen, 2003, Curr Opin Ophthalmol, V14, P395; Foster CS, 2010, J OCUL PHARMACOL TH, V26, P475, DOI 10.1089/jop.2010.0059; Foster CS, 2003, ARCH OPHTHALMOL-CHIC, V121, P437, DOI 10.1001/archopht.121.4.437; Friedman DS, 2013, OPHTHALMOLOGY, V120, P1571, DOI 10.1016/j.ophtha.2013.01.025; Gallagher K, 2015, JAMA OPHTHALMOL, V133, P1190, DOI 10.1001/jamaophthalmol.2015.2249; Galor A, 2008, OPHTHALMOLOGY, V115, P1826, DOI 10.1016/j.ophtha.2008.04.026; Galor A, 2006, OPHTHALMOLOGY, V113, P2317, DOI 10.1016/j.ophtha.2006.04.038; Gangaputra S, 2009, OPHTHALMOLOGY, V116, P2188, DOI 10.1016/j.ophtha.2009.04.020; Gangaputra SS, 2019, AM J OPHTHALMOL, V208, P68, DOI 10.1016/j.ajo.2019.07.008; Goldberg NR, 2014, AM J OPHTHALMOL, V158, P1310, DOI 10.1016/j.ajo.2014.08.039; Goldstein DA, 2002, OPHTHALMOLOGY, V109, P370, DOI 10.1016/S0161-6420(01)00942-3; Gregory AC, 2013, OPHTHALMOLOGY, V120, P186, DOI 10.1016/j.ophtha.2012.07.052; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Haroon M, 2015, ANN RHEUM DIS, V74, P1990, DOI 10.1136/annrheumdis-2014-205358; Harper TW, 2009, AM J OPHTHALMOL, V147, P140, DOI 10.1016/j.ajo.2008.07.043; HELM CJ, 1995, AM J OPHTHALMOL, V120, P55, DOI 10.1016/S0002-9394(14)73759-6; Herbort CP, 2009, OCUL IMMUNOL INFLAMM, V17, P160, DOI 10.1080/09273940902818861; Holland GN, 2004, AM J OPHTHALMOL, V137, P1, DOI 10.1016/j.ajo.2003.10.032; Holland GN, 2003, AM J OPHTHALMOL, V136, P973, DOI 10.1016/j.ajo.2003.09.040; Horton S, 2019, AM J OPHTHALMOL, V207, P170, DOI 10.1016/j.ajo.2019.06.007; Hwang YG, 2011, CLIN EXP RHEUMATOL, V29, pS104; Jabs DA, 2004, OCUL IMMUNOL INFLAMM, V12, P163, DOI 10.1080/09273940490883671; Jabs DA, 2000, AM J OPHTHALMOL, V130, P492, DOI 10.1016/S0002-9394(00)00659-0; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; JABS DA, 1986, AM J OPHTHALMOL, V102, P297, DOI 10.1016/0002-9394(86)90001-2; Jabs DA, 2006, RETINA-J RET VIT DIS, V4th, P1793, DOI [10.1016/B978-0-323-02598-0.50109-9, DOI 10.1016/B978-0-323-02598-0.50109-9]; Jabs DA, 2008, OPHTHAL EPIDEMIOL, V15, P283, DOI 10.1080/09286580802478724; Jabs DA, 2019, JAMA OPHTHALMOL, V137, P1449, DOI 10.1001/jamaophthalmol.2019.3964; Jabs DA, 2018, OPHTHALMOLOGY, V125, P193, DOI 10.1016/j.ophtha.2017.08.007; Jabs DA, 2016, JAMA OPHTHALMOL, V134, P1245, DOI 10.1001/jamaophthalmol.2016.3289; Jabs DA, 2013, AM J OPHTHALMOL, V156, P228, DOI 10.1016/j.ajo.2013.03.027; Jaffe GJ, 2000, OPHTHALMOLOGY, V107, P2024, DOI 10.1016/S0161-6420(00)00466-8; Jaffe GJ, 2020, OPHTHALMOLOGY, V127, P1395, DOI 10.1016/j.ophtha.2020.04.001; Jaffe GJ, 2019, OPHTHALMOLOGY, V126, P601, DOI 10.1016/j.ophtha.2018.10.033; Jaffe GJ, 2016, NEW ENGL J MED, V375, P932, DOI 10.1056/NEJMoa1509852; Jaffe GJ, 2016, OPHTHALMOLOGY, V123, P1940, DOI 10.1016/j.ophtha.2016.05.025; Juanola X, 2016, OPHTHALMOLOGY, V123, P1632, DOI 10.1016/j.ophtha.2016.03.010; Kacmaz RO, 2010, OPHTHALMOLOGY, V117, P576, DOI 10.1016/j.ophtha.2009.08.010; Kacmaz RO, 2008, AM J OPHTHALMOL, V146, P828, DOI 10.1016/j.ajo.2008.06.019; Kempen JH, 2017, JAMA-J AM MED ASSOC, V317, P1993, DOI 10.1001/jama.2017.5103; Kempen JH, 2015, OPHTHALMOLOGY, V122, P1967, DOI 10.1016/j.ophtha.2015.06.042; Kempen JH, 2011, OPHTHALMOLOGY, V118, P1916, DOI 10.1016/j.ophtha.2011.07.027; Kempen John H, 2009, BMJ, V339, pb2480, DOI 10.1136/bmj.b2480; Kempen JH, 2008, AM J OPHTHALMOL, V146, P802, DOI 10.1016/j.ajo.2008.04.035; Khachatryan N, 2015, OPHTHALMOLOGY, V122, P219, DOI 10.1016/j.ophtha.2014.11.023; Kotaniemi K, 2001, OPHTHALMOLOGY, V108, P2071, DOI 10.1016/S0161-6420(01)00773-4; Kruh JN, 2014, OPHTHALMOLOGY, V121, P358, DOI 10.1016/j.ophtha.2013.07.019; Kuppermann BD, 2007, ARCH OPHTHALMOL-CHIC, V125, P309, DOI 10.1001/archopht.125.3.309; Lardenoye CWTA, 2006, OPHTHALMOLOGY, V113, P1446, DOI 10.1016/j.ophtha.2006.03.027; Lee J, 2020, OPHTHALMOLOGY, V127, P1431, DOI 10.1016/j.ophtha.2020.04.009; Levy-Clarke G, 2014, OPHTHALMOLOGY, V121, P785, DOI 10.1016/j.ophtha.2013.09.048; Liberman P, 2021, OCUL IMMUNOL INFLAMM, V29, P1564, DOI 10.1080/09273948.2020.1749857; LINSSEN A, 1995, AM J OPHTHALMOL, V120, P351, DOI 10.1016/S0002-9394(14)72165-8; Lowder C, 2011, ARCH OPHTHALMOL-CHIC, V129, P545, DOI 10.1001/archophthalmol.2010.339; Lynch JP, 2003, SEMIN RESP CRIT CARE, V24, P393; MANA J, 1995, THORAX, V50, P1264, DOI 10.1136/thx.50.12.1264; MCCANN JD, 1995, AM J OPHTHALMOL, V120, P219, DOI 10.1016/S0002-9394(14)72610-8; McCannel CA, 1996, AM J OPHTHALMOL, V121, P35, DOI 10.1016/S0002-9394(14)70532-X; Monnet D, 2004, OPHTHALMOLOGY, V111, P802, DOI 10.1016/j.ophtha.2003.07.011; Montoya JG, 1999, OPHTHALMOLOGY, V106, P1554, DOI 10.1016/S0161-6420(99)90453-0; Murphy CC, 2005, ARCH OPHTHALMOL-CHIC, V123, P634, DOI 10.1001/archopht.123.5.634; NUSSENBLATT RB, 1991, AM J OPHTHALMOL, V112, P138, DOI 10.1016/S0002-9394(14)76692-9; NUSSENBLATT RB, 1990, INT OPHTHALMOL, V14, P303, DOI 10.1007/BF00163549; Pasadhika S, 2009, AM J OPHTHALMOL, V148, P500, DOI 10.1016/j.ajo.2009.05.008; Peterman T., 2008, Morbidity and Mortality Weekly Report, V57, P872; Petrushkin H, 2015, BRIT J OPHTHALMOL, V99, P1591, DOI 10.1136/bjophthalmol-2015-307269; Pujari SS, 2010, OPHTHALMOLOGY, V117, P356, DOI 10.1016/j.ophtha.2009.06.060; Nguyen QD, 2016, LANCET, V388, P1183, DOI 10.1016/S0140-6736(16)31339-3; RADIS CD, 1995, ARTHRITIS RHEUM, V38, P1120, DOI 10.1002/art.1780380815; Ramanan AV, 2017, NEW ENGL J MED, V376, P1637, DOI 10.1056/NEJMoa1614160; Ramanan AV, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-14; Rathinam SR, 2019, JAMA-J AM MED ASSOC, V322, P936, DOI 10.1001/jama.2019.12618; Rathinam SR, 2014, OPHTHALMOLOGY, V121, P1863, DOI 10.1016/j.ophtha.2014.04.023; Ravelli A, 2005, ARTHRITIS RHEUM, V52, P826, DOI 10.1002/art.20945; Reiff A, 2003, ARTHRITIS RHEUM, V48, P2079, DOI 10.1002/art.11155; Reiff A, 2001, ARTHRITIS RHEUM, V44, P1411, DOI 10.1002/1529-0131(200106)44:6<1411::AID-ART235>3.0.CO;2-O; Rifkin LM, 2021, OCUL IMMUNOL INFLAMM, V29, P149, DOI 10.1080/09273948.2019.1657904; Rosenbaum JT, 2015, CLIN RHEUMATOL, V34, P999, DOI 10.1007/s10067-015-2960-8; ROSENBAUM JT, 1990, ARCH OPHTHALMOL-CHIC, V108, P1291, DOI 10.1001/archopht.1990.01070110107034; ROSENBAUM JT, 1989, J RHEUMATOL, V16, P792; Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332; Rothova A, 2008, OPHTHALMOLOGY, V115, P306, DOI 10.1016/j.ophtha.2007.05.014; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P696, DOI 10.1136/ard.2008.092585; Salek SS, 2013, OCUL IMMUNOL INFLAMM, V21, P257, DOI 10.3109/09273948.2013.767353; Samudre SS, 2004, J OCUL PHARMACOL TH, V20, P533, DOI 10.1089/jop.2004.20.533; Saurenmann RK, 2007, ARTHRITIS RHEUM, V56, P647, DOI 10.1002/art.22381; Schoenberger SD, 2017, OPHTHALMOLOGY, V124, P382, DOI 10.1016/j.ophtha.2016.11.007; Sen HN, 2014, OPHTHALMOLOGY, V121, P2275, DOI 10.1016/j.ophtha.2014.05.021; Seo MR, 2015, CLIN RHEUMATOL, V34, P1397, DOI 10.1007/s10067-014-2768-y; SHERRY DD, 1991, AM J DIS CHILD, V145, P1026, DOI 10.1001/archpedi.1991.02160090078028; Slabaugh MA, 2012, AM J OPHTHALMOL, V153, P932, DOI 10.1016/j.ajo.2011.10.008; Smith JA, 2005, ARTHRIT RHEUM-ARTHR, V53, P18, DOI 10.1002/art.20904; Stroh IG, 2017, OCUL IMMUNOL INFLAMM, V25, P503, DOI 10.3109/09273948.2016.1142573; Suhler EB, 2018, OPHTHALMOLOGY, V125, P1075, DOI 10.1016/j.ophtha.2017.12.039; SuttorpSchulten MSA, 1996, BRIT J OPHTHALMOL, V80, P844, DOI 10.1136/bjo.80.9.844; Takeuchi M, 2014, OPHTHALMOLOGY, V121, P1877, DOI 10.1016/j.ophtha.2014.04.042; TAMESIS RR, 1990, OPHTHALMOLOGY, V97, P1281; Tanner V, 1998, EYE, V12, P679, DOI 10.1038/eye.1998.168; Tappeiner C, 2016, J RHEUMATOL, V43, P2183, DOI 10.3899/jrheum.160231; Tappeiner C, 2015, J RHEUMATOL, V42, P706, DOI 10.3899/jrheum.140410; Taravati Parisa, 2013, Curr Ophthalmol Rep, V1, DOI 10.1007/s40135-013-0025-1; TayKearney ML, 1996, AM J OPHTHALMOL, V121, P47, DOI 10.1016/S0002-9394(14)70533-1; Taylor SRJ, 2011, AM J OPHTHALMOL, V152, P1059, DOI 10.1016/j.ajo.2011.05.032; Thorne JE, 2007, AM J OPHTHALMOL, V143, P840, DOI 10.1016/j.ajo.2007.01.033; Thorne JE, 2019, OPHTHALMOLOGY, V126, P283, DOI 10.1016/j.ophtha.2018.08.021; Thorne JE, 2016, JAMA OPHTHALMOL, V134, P1237, DOI 10.1001/jamaophthalmol.2016.3229; Thorne JE, 2016, ACTA OPHTHALMOL, V94, pe331, DOI 10.1111/aos.12987; Thorne JE, 2006, OPHTHALMOLOGY, V113, P2310, DOI 10.1016/j.ophtha.2006.05.067; Thorne JE, 2010, OPHTHALMOLOGY, V117, P1436, DOI 10.1016/j.ophtha.2009.12.003; Thorne JE, 2008, OPHTHALMOLOGY, V115, P2146, DOI 10.1016/j.ophtha.2008.08.002; Tomkins-Netzer O, 2015, OPHTHALMOLOGY, V122, P2351, DOI 10.1016/j.ophtha.2015.07.036; Vallet H, 2016, ARTHRITIS RHEUMATOL, V68, P1522, DOI 10.1002/art.39667; van Bentum RE, 2019, J RHEUMATOL, V46, P153, DOI 10.3899/jrheum.180312; Van der Lelij A, 2000, OPHTHALMOLOGY, V107, P1164, DOI 10.1016/S0161-6420(00)00115-9; Vegas-Revenga N, 2019, AM J OPHTHALMOL, V200, P85, DOI 10.1016/j.ajo.2018.12.019; Wolfe F, 2007, ARTHRITIS RHEUM, V56, P2886, DOI 10.1002/art.22864; Wolfe F, 2007, ARTHRITIS RHEUM, V56, P1433, DOI 10.1002/art.22579; Yates WB, 2015, OPHTHALMOLOGY, V122, P265, DOI 10.1016/j.ophtha.2014.08.024; Yeh S, 2020, OPHTHALMOLOGY, V127, P948, DOI 10.1016/j.ophtha.2020.01.006; Young S, 2001, CLIN EXP OPHTHALMOL, V29, P2, DOI 10.1046/j.1442-9071.2001.00360.x; Zamecki KJ, 2010, AM J OPHTHALMOL, V149, P189, DOI 10.1016/j.ajo.2009.09.018; Zeboulon N, 2008, ANN RHEUM DIS, V67, P955, DOI 10.1136/ard.2007.075754	156	12	12	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2021	372								m4979	10.1136/bmj.m4979	http://dx.doi.org/10.1136/bmj.m4979			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QE0PP	33536186				2022-12-28	WOS:000615909900005
J	Iacobucci, G				Iacobucci, Gareth			BRIEFING Covid-19: Surge testing for the South Africa variant begins in England	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2021	372								n305	10.1136/bmj.n305	http://dx.doi.org/10.1136/bmj.n305			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UD4LK	33531353	Bronze			2022-12-28	WOS:000687179200001
J	Mahase, E				Mahase, Elisabeth			Covid-19: Russian vaccine efficacy is 91.6%, show phase III trial results	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8	1	6	6	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2021	372								n309	10.1136/bmj.n309	http://dx.doi.org/10.1136/bmj.n309			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UD4LK	33531342	Bronze			2022-12-28	WOS:000687179200005
J	Jones, H				Jones, Helen			Why we... cook for each other	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2021	372								n245	10.1136/bmj.n245	http://dx.doi.org/10.1136/bmj.n245			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QE0LS	33526438	Bronze			2022-12-28	WOS:000615899800008
J	Rosenbaum, L				Rosenbaum, Lisa			Escaping Catch-22-Overcoming Covid Vaccine Hesitancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SCIENCE											[Anonymous], 2021, Vaccine hesitancy. KFF COVID-19 Vaccine Monitor; Brewer NT, 2017, PSYCHOL SCI PUBL INT, V18, P149, DOI 10.1177/1529100618760521; Brown School of Public Health, 2020, COMMUNICATION 1001; Center for Strategic and International Studies, 2020, CSIS BOOK LAUNCH HEI; Gargano LM, 2013, HUM VACC IMMUNOTHER, V9, P2627, DOI 10.4161/hv.25823; Gauchat G, 2012, AM SOCIOL REV, V77, P167, DOI 10.1177/0003122412438225; Johnson NF, 2020, NATURE, V582, P230, DOI 10.1038/s41586-020-2281-1; Larson H.J., 2020, STUCK VACCINE RUMORS; McHugh KJ, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aay7162; Newman PA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019206; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Rosenthal SL, 2011, VACCINE, V29, P890, DOI 10.1016/j.vaccine.2009.12.063; Shapin Steven, 2019, ANGELES REV BOOKS; The Sabin-Aspen Vaccine Science and Policy Group, 2020, SABIN ASPEN VACCINE	14	62	62	2	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 8	2021	384	14					1367	1371		10.1056/NEJMms2101220	http://dx.doi.org/10.1056/NEJMms2101220			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RJ7RN	33577150	Bronze			2022-12-28	WOS:000637799800017
J	Tanne, JH				Tanne, Janice Hopkins			Report highlights "devastating impacts" of Trump on every aspect of US health	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, NY TIMES; Blumenthal D, 2021, LANCET; Woolhandler S, 2021, LANCET	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2021	372								n439	10.1136/bmj.n439	http://dx.doi.org/10.1136/bmj.n439			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH8HV	33579727	Bronze			2022-12-28	WOS:000618513500009
J	Baldwin, GT; Seth, P; Noonan, RK				Baldwin, Grant T.; Seth, Puja; Noonan, Rita K.			Continued Increases in Overdose Deaths Related to Synthetic Opioids Implications for Clinical Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STATES	This Viewpoint summarizes a 2021 MMWR report documenting a concerning rise in illicit and synthetic opioid overdose deaths in the US between 2013 and 2019 and proposes strategies to connect clinicians and health systems with public health, public safety, and other community partners to share data, monitor trends, and better respond to the overdose epidemic.	[Baldwin, Grant T.; Seth, Puja; Noonan, Rita K.] Ctr Dis Control & Prevent, Div Overdose Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Baldwin, GT (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, 4700 Buford Hwy NE, Atlanta, GA 30341 USA.	gfb3@cdc.gov						CDC Foundation, 2020, PUBL HLTH SAF TEAM P; Centers for Disease Control and Prevention, 2020, INCR FAT DRUG OV US; Hoots B, 2020, ADDICTION, V115, P946, DOI 10.1111/add.14878; Kariisa M, 2019, MMWR-MORBID MORTAL W, V68, P388, DOI 10.15585/mmwr.mm6817a3; Mattson CL, 2021, MMWR-MORBID MORTAL W, V70, P202, DOI 10.15585/mmwr.mm7006a4externalicon; National Academies of Science Engineering and Medicine, 2019, MED OP US DIS SAV LI; National Center for Injury Prevention and Control, OV DAT ACT OD2A; O'Donnell J, 2020, MMWR-MORBID MORTAL W, V69, P271, DOI 10.15585/mmwr.mm6910a4; Pardo B, 2019, FUTURE FENTANYL; Scholl Lawrence, 2018, MMWR Morb Mortal Wkly Rep, V67, P1419, DOI [10.15585/mmwr.mm675152e1, 10.15585/mmwr.mm6751521e1]	10	17	17	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2021	325	12					1151	1152		10.1001/jama.2021.1169	http://dx.doi.org/10.1001/jama.2021.1169		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ7PB	33571368				2022-12-28	WOS:000617177800002
J	Horby, PW; Roddick, A; Spata, E; Staplin, N; Emberson, J; Pessoa-Amorim, G; Brightling, C; Prudon, B; Chadwick, D; Ustianowski, A; Ashish, A; Todd, S; Yates, B; Buttery, R; Scott, S; Maseda, D; Baillie, JK; Buch, M; Chappell, L; Day, J; Faust, SN; Jaki, T; Jeffery, K; Juszczak, E; Lim, WS; Montgomery, A; Mumford, A; Rowan, K; Thwaites, G; Mafham, M; Haynes, R; Landray, MJ; Horby, PW; Landray, MJ; Baillie, JK; Buch, M; Chappell, L; Day, J; Faust, SN; Haynes, R; Jaki, T; Jeffery, K; Juszczak, E; Lim, WS; Mafham, M; Montgomery, A; Mumford, A; Rowan, K; Thwaites, G; Sandercock, P; Darbyshire, J; DeMets, D; Fowler, R; Lalloo, D; Roberts, I; Wittes, J; Horby, P; Landray, MJ; Haynes, R; Fletcher, L; Barton, J; Basoglu, A; Brown, R; Brudlo, W; Denis, E; Howard, S; McChlery, G; Taylor, K; Cui, G; Goodenough, B; King, A; Lay, M; Murray, D; Stevens, W; Wallendszus, K; Welsh, R; Crichton, C; Davies, J; Goldacre, R; Harper, C; Knight, F; Latham-Mollart, J; Mafham, M; Nunn, M; Salih, H; Welch, J; Campbell, M; Pessoa-Amorim, G; Peto, L; Roddick, A; Knott, C; Wiles, J; Bell, JL; Emberson, J; Juszczak, E; Linsell, L; Spata, E; Staplin, N; Bagley, G; Cameron, S; Chamberlain, S; Farrell, B; Freeman, H; Kennedy, A; Whitehouse, A; Wilkinson, S; Wood, C; Reith, C; Davies, K; Halls, H; Holland, L; Wilson, K; Howie, L; Lunn, M; Rodgers, P; Barnard, A; Beety, J; Birch, C; Brend, M; Chambers, E; Chappell, L; Crawshaw, S; Drake, C; Duckles-Leech, H; Graham, J; Harman, T; Harper, H; Lock, S; Lomme, K; McMillan, N; Nickson, I; Ohia, U; Okell, E; Poustie, V; Sam, S; Sharratt, P; Sheffield, J; Slade, H; Hoff, WV; Walker, S; Williamson, J; De Soyza, A; Dimitri, P; Faust, SN; Lemoine, N; Minton, J; Gilmour, K; Pearson, K; Armah, C; Campbell, D; Cate, H; Priest, A; Thomas, E; Usher, R; Johnson, G; Logan, M; Pratt, S; Price, A; Shirley, K; Walton, E; Williams, P; Yelnoorkar, F; Hanson, J; Membrey, H; Gill, L; Oliver, A; Das, S; Murphy, S; Sutu, M; Collins, J; Monaghan, H; Unsworth, A; Beddows, S; Williams, KB; Dowling, S; Gibbons, K; Pine, K; Asghar, A; Aubrey, P; Jewell, DB; Donaldson, K; Skinner, T; Luo, J; Mguni, N; Muzengi, N; Pleass, R; Wayman, E; Coe, A; Hicks, J; Hough, M; Levett, C; Potter, A; Taylor, J; Dolman, M; Gerdes, L; Hall, C; Lockett, T; Wessex, DP; Bartholomew, J; Dowden, L; Rook, C; Walters, J; Denton, E; Tinkler, H; Alexander, A; Campbell, H; Chapman, K; Hall, A; Rodgers, A; Boyle, P; Brookes, M; Callens, C; Duffy, H; Green, C; Hampshire, K; Harrison, S; Kirk, J; Naz, M; Porter, L; Ryan, P; Shenton, J; Warmington, J; Amezaga, M; Dicks, P; Goodwin, J; Hodgson, H; Jackson, S; Odam, M; Williamson, D; Faust, SN; Bamford, A; Bandi, S; Bernatoniene, J; Cathie, K; Dmitri, P; Drysdale, S; Emonts, M; Evans, J; Finn, A; Fleming, P; Furness, J; Gale, C; Haynes, R; Jones, CE; Juszczak, E; Jyotish, D; Kelly, D; Murray, C; Pathan, N; Pollock, L; Ramanan, A; Riordan, A; Roehr, C; Wan, M; Whittaker, E; Chappell, L; Hodson, K; Knight, M; Pavord, S; Williamson, C; Odam, M; Black, P; Gallagher, B; MacInnes, L; O'Brien, R; Priestley, K; Saunderson, A; Bowman, L; Chen, F; Clarke, R; Goonasekara, M; Haynes, R; Herrington, W; Judge, P; Mafham, M; Ng, S; Preiss, D; Reith, C; Sammons, E; Zhu, D; Pinches, H; Bowker, P; Byrne-Watts, V; Chapman, G; Coleman, G; Gray, J; Rees, A; Landray, MJ; Mafham, M; Mather, N; Stephenson, C; Denwood, T; Harrison, D; Turner, G; Bruce, J; Arkley, C; Rees, S; Brightling, C; Brunskill, N; Wiselka, M; Adenwalla, S; Andreou, P; Bakoulas, P; Bandi, S; Batham, S; Beaver, T; Bhandal, K; Bourne, M; Boyles, L; Cannon, M; Charalambou, A; Cheung, CK; Cotter, R; Diver, S; Dunphy, A; Elneima, O; Fawke, J; Finch, J; Gardiner-Hill, C; Genato, G; Graham-Brown, M; Haines, C; Hargadon, B; Holdsworth, H; Ibrahim, W; Ingram, L; Silva, JAJ; Kaul, K; Joshi, M; Kapoor, S; Kim, JW; Kuverji, A; Kyriaki, K; Lea, A; Lee, T; Lewszuk, A; Lock, L; Macconaill, K; Major, R; McAuley, H; McCourt, P; Kutten, DM; Palfreeman, A; Parker, E; Patel, K; Patterson, M; Phillips, R; Plummer, L; Russell, R; Debbie, S; Selvaskandan, H; Southin, SM; Tsilimpari, KK; Wiesender, C; Yousuf, A; Ustianowski, A; Raw, J; Tully, R; Abdusamad, K; Antonina, Z; Ayaz, E; Blackledge, B; Bradley, P; Bray, F; Bruce, M; Carty, C; Charles, B; Connolly, G; Corbett, C; Dermody, S; Durrans, L; Falconer, E; Flaherty, J; Fox, C; Hadfield, D; Harris, J; Hoggett, L; Horsley, A; Hussain, S; Irving, R; Jacob, P; Johnstone, D; Joseph, R; Melville, JJ; Kamath, P; Khatun, T; Lamb, T; Law, H; Lazo, M; Lindergard, G; Lokanathan, S; Macfarlane, L; Mathen, S; McCullough, S; McMaster, P; McSorland, D; Mishra, B; Munt, S; Neal, A; Newport, R; O'Connor, G; O'Riordan, D; Page, I; Parambil, V; Philbin, J; Pinjala, MT; Rishton, C; Riste, M; Rothwell, J; Sam, M; Sarwar, Z; Scarratt, L; Sengupta, A; Sharaf, H; Prudon, B; Jagannathan, V; Adams, C; Aung, N; Barker, D; Campbell, B; Collins, V; Deane, J; Fenner, I; Gowans, S; Hartrey, W; Nafei, M; Poole, L; Purvi, S; Quigley, J; Ramshaw, A; Shepherd, L; Skelton, J; Srinivasan, R; Taylor, R; Walker, M; Weetman, M; Wetherall, B; Wild, S; Wilson, D; Lim, WS; Ali, M; Andrews, A; Anderson, L; Ashraf, S; Ashton, D; Babingto, G; Bartlett, G; Batra, D; Bendall, L; Benetti, N; Brear, T; Buck, A; Bugg, G; Butler, J; Butler, J; Cammack, RFD; Cantliff, J; Clark, L; Connor, E; Davies, P; Dent, M; Dobson, C; Fatemi, M; Fatemi, A; Fleming, L; Grundy, J; Hallas, J; Hodgen, L; Hodgson, S; Hodgkinson, S; Howard, L; Hutchinson, C; Jackson, B; Kaur, J; Keddie-Gray, E; Khurana, C; Langley, M; Looby, L; Meredith, M; Morris, L; Navarra, H; Nicol, R; Oliver, J; Peters, C; Petrova, B; Rose, Z; Ryan, L; Sampson, J; Squires, G; Squires, J; Taylor, R; Thomas, A; Thornton, J; Topham, K; Warburton, S; Wardle, S; Waterfall, H; Wei, S; Wildsmith, T; Wilson, L; Chadwick, D; Armstrong, S; Athorne, D; Branch, M; Brolly, J; Brown, S; Cheaveau, J; Chen, HM; Chua, Y; Cunningham, N; Dodds, J; Dorgan, S; Dunn, D; Harper, P; Harwood, H; Hebbron, K; Hunt, F; Bhushan, AK; Lambert, P; Leaning, D; Manders, T; McCarron, B; Miller-Biot, N; Milne, C; Mohammad, W; Mollet, M; Murad, A; Owston, M; Potts, J; Proctor, C; Rao, S; Seelarbokus, MA; Singh, P; Srirathan, V; Swithenbank, L; Thompson, L; Wardy, H; Wibli, L; Widdrington, J; Williams, J; Winder, P; Wroe, C; Elmahi, E; Zaman, M; Abdul, B; Abdulmumeen, A; Abdulshukkoor, N; Adnan, A; Nazeer, MHA; Bazli, A; Benesh, N; Chin, WJ; Cunningham, N; Daggett, H; Davies, E; Enyi, H; Fawohunre, S; Geoghegan, N; Glover, J; Hague, JW; Hall, K; Hallett, C; Haresh, K; Hassan, WU; Hewertson, J; Hosea, J; Htoon, NZ; Idrees, M; Igwe, C; Imtiaz, H; Irshad, M; Ismail, A; Jeffrey, R; Jith, J; Joshi, P; Periyasami, RK; Khalid, A; Khalid, MU; Kodituwakku, R; Lopez, P; Mahmood, A; Malanca, M; Mapfunde, IT; Maruthamuthu, VK; Masood, S; Masood, SSME; Matharu, M; Merchant, A; Merchant, F; Naqvi, S; Natarajan, R; Natarajan, N; Nawaz, K; Ndefo, O; Ogunkeye, O; Paranamana, S; Pugh, N; Raj, A; Rashid, K; Rogers, M; Saad, M; Selvadurai, G; Shah, A; Shahzeb, M; Shrestha, N; Singh, A; Smith, K; Sohail, B; Spinks, M; Stockham, L; Takyi, A; Teoh, YH; Ullah, S; Vayalaman, H; Wafa, SEI; Ward, T; Watson, R; White, D; Melly, LY; Zulaikha, R; Green, C; Whitehouse, T; Ahmed, I; Anderson, N; Armstrong, C; Bamford, A; Bancroft, H; Bates, M; Begum, S; Bellamy, M; Bergin, C; Bhandal, K; Brandl-Salutz, E; Buckingham, E; Burke, E; Carmody, M; Cooper, L; Daglish, J; Dasgin, J; Desai, A; Dhani, S; Dosanjh, D; Ellis, H; Gardiner, D; Forster, E; Grobovaite, E; Hopkin, B; Hull, D; Hussain, Y; Jones, J; Khan, L; Lenton, D; Lewis, M; Lovell, M; Lowe, F; Lynch, D; McGhee, C; McNeill, C; Moore, F; Nilsson, A; Nunnick, J; Prest, C; Price, V; Rhodes, J; Sale, J; Sangombe, M; Smith, H; Storey, I; Thrasyvoulou, L; Tsakiridou, K; Walsh, D; Welch, S; Willis, H; Wood, L; Woodford, J; Wooldridge, G; Zullo, C; Desai, P; Appleyard, D; Bromley, D; Chambers, N; Dale, S; Gledhill, L; Goddard, J; Greig, J; Haigh, A; Hallas, K; Hanson, K; Holroyd, K; Home, M; Kelly, D; Maharajh, A; Matapure, L; Mellor, S; Merwaha, E; Riley, H; Robinson, M; Sandhu, K; Schwarz, K; Shaw, L; Terrett, L; Usher, M; Wilson, A; Wood, T; Felton, T; Abbas, M; Rasheed, AA; Abraham, T; Aggarwal, S; Akili, S; Alexander, PDG; Allanson, A; Al-Sheklly, B; Arora, D; Avery, M; Avram, C; Aya, A; Banda, J; Banks, H; Baptist, M; Barrera, M; Bazaz, R; Behrouzi, R; Benson, V; Bentley, A; Bhadi, A; Biju, A; Bikov, A; Birchall, K; Blane, S; Bokhari, S; Bradley, P; Bradley-Potts, J; Dean, K; Dhillon, R; Dolan, D; Duggan, A; Duran, B; Durrington, H; Eades, C; Eatough, R; Clark, R; Clayton-Smith, J; Conway, R; Cook, E; Cummings-Fosong, G; Currie, S; Dalgleish, H; Davies, C; Dean, K; Dhillon, R; Dolan, D; Duggan, A; Duran, B; Durrington, H; Eades, C; Eatough, R; Elyoussfi, S; Evans, G; Fairclough, A; Faluyi, D; Ferguson, S; Fielding, J; Fiouniz, S; Fogarty, G; Fowler, S; Giannopoulou, S; Gillott, R; Gipson, A; Glasgow, S; Gorsuch, T; Grana, G; Gray, G; Grayson, A; Grey, G; Griffin, B; Hackney, P; Hameed, B; Hamid, I; Handrean, S; Henry, J; Higgins, L; Holt, L; Horsley, A; Howard, L; Hughes, S; Hulme, A; Hulme, P; Hyslop, M; Ingham, J; Ismail, O; Jafar, A; Jamal, S; James, L; John, A; Johnstone, E; Karunaratne, N; Kausar, Z; Kayappurathu, JN; Kelly, R; Khan, A; Khan, W; Knight, S; Kolakalurix, E; Kolakaluri, E; Kosmidis, C; Kothandaraman, E; Krizak, S; Kyi, NM; Lalloo, F; Logue, C; Lord, RW; Macfarlane, L; Madden, A; Mahaveer, A; Manderson, L; Margaritopoulos, G; Marsden, P; Mathews, J; McCarthy, E; McGrath, B; Mendonca, C; Metryka, A; Micallef, D; Mishra, A; Mistry, H; Mitra, S; Moss, S; Muazzam, A; Mudawi, D; Murray, C; Naguib, M; Naveed, S; Ninan, P; Nirmalan, M; Norton, R; Odell, N; Osborne, R; Padden, G; Palacios, A; Panes, A; Pantin, CT; Parker, B; Peacock, L; Peasley, A; Pomery, F; Power, N; Pursell, M; Ratcliffe, S; Reilly, M; Reynard, C; Rice, E; Rice, M; Riley, P; Rivera-Ortega, P; Rogers, J; Rogers, T; Santosh, R; Scott, A; Sellers, K; Sen, N; Shanahan, T; Shawcross, A; Shibly, S; Simpson, A; Sivanadarajah, S; Skehan, N; Smith, C; Smith, J; Smith, L; Soren, J; Spiller, W; Stratton, J; Stubbs, A; Swist-Szulik, K; Tallon, B; Thomas, S; Thorpe, S; Tohfa, M; Tousis, R; Trafford, MT; Turgut, T; Varghese, M; Varnier, G; Venables, I; Vinay, S; Wang, R; Ward, L; Warner, C; Watson, E; Watterson, D; Wentworth, L; Whitehead, C; Wilcock, D; Williams, JR; Willis, E; Woodhead, L; Worton, S; Xavier, B; Rege, K; Agbo, C; Akindolie, O; Al-Rabahi, A; Ambrogetti, R; Aung, KT; Shah, AA; Babs-Osibodu, AO; Bahadori, K; Bhayani, J; Bond, T; Boughton, H; Brooks, S; Butterworth-Cowin, N; Buttery, R; Carter, P; Catana, AM; Cave, L; Choi, S; Corogeanu, D; Croysdill, R; Davies, M; de Souza, J; Duff, N; Dufour, L; Ebigbola, O; Eddings, C; Faccenda, J; Feroz, A; Finch, L; Freer, C; Goodyear, P; Gooentilleke, R; Gosling, R; Halford, W; Havlik, S; Hoskins, T; Huson, C; Ishak, M; Javed, H; Jones, T; Kasianczuk, N; Kaur, D; Kerr, A; Khan, A; Koshy, G; Eskenazia, AK; Lahane, S; Lami, MKG; Marshall, J; McDevitt, K; Muru, N; Mustafa, AMM; Nazir, S; Okpala, I; Old, T; Oleszkiewicz, G; Orme, H; O'Sullivan, S; Paczko, P; Pandey, A; Patel, A; Pathak, S; Poon, S; Rather, MI; Vattekkat, RR; Rizvi, SHM; Samyraju, M; Sanyal, J; Shah, SH; Smith, E; Stacpoole, S; Tan, BTT; Temple, N; Thazhatheyil, K; Uddin, MS; Veale, N; Walter, D; Ashish, A; Cooper, J; Heaton, D; Hough, S; Parkinson, V; Robinson, E; Taylor, T; Tierney, C; Verma, A; Waddington, N; Williams, C; Zipitis, C; Tiberi, S; Aboaba, A; Adeyeye, E; Agwada-Akeru, J; Ali, FR; Allen, R; Ardley, C; Astin-Chamberlain, R; Bacon, G; Baillie, H; Batha, R; Bloom, B; Bolton, M; Borra, C; Boyapati, G; Buchanan, R; Chan, C; Chitsenga, C; Cipriano, B; Cofie, PF; DeLuna, M; Elia, S; El-Shakankery, K; Fikree, A; Ghosh, A; Goiriz, R; Goldsmith, P; Gouldbourne, M; Grant, A; Greenfield, L; Grigoriadou, S; Gritton, R; Gunganah, K; Hand, J; Harwood, C; Hemmila, U; Higgins, J; Hobden, D; Howaniec, L; Hsu, D; Iliodromiti, S; Issa, S; Jones, P; Juan, M; Kassam, J; Keith-Jopp, C; Khan, M; Khaw, CR; Kunst, H; Lai, J; Lee, I; Lieberman, D; Liebeschuetz, S; Magavern, E; Maniero, C; Maitland, J; Malcolm, H; Marshall, H; Matin, N; May, P; McDermott, R; Menacho, K; Millin, L; Mohammed, A; Moriarty, K; Naeem, S; Newman, T; Fhogartaigh, CN; Omar, M; Pakozdi, A; Parrott, M; Pfeffer, P; Pott, J; Powell, J; Ricketts, W; Riddell, A; Rughani, P; Sahdev, N; Sarodaya, V; Selvarajah, B; Skene, I; Smallshaw, KD; So, A; Stevenson, D; Suarez, C; Swaine, T; Thomas, S; Thomas, A; Thomson, J; Thorn, N; Tierney, C; Ullah, S; Vathenen, R; Velauthar, L; Ward, K; Wiles, K; Woodland, P; Youssouf, S; Zdanaviciene, A; Fegan, C; Balan, A; Basker, B; Bird, S; Boult, Z; Britten, V; Broad, L; Cendl, H; Chakraborty, M; Cole, J; Edgar, M; Evans, T; Evans, J; Evans, M; Forton, J; Frayling, S; Greaves, F; Harrhy, S; Haynes, M; Hill, H; Hilton, Z; Jones, L; Jorgensen, S; Kelly, A; Knibbs, L; Lau, D; Maureen, E; May, J; McGough, E; McQueen, A; Milner, J; Norman, R; Nyland, K; Oliver, C; Paradowski, K; Patal, M; Rahilly, K; Robinson, C; Scourfield, S; Starr, M; Struik, S; Thomas, E; Thomas-Turner, R; Williams, G; Williams, J; Williams, M; Zaher, S; Hine, P; Todd, S; Welters, I; Wootton, D; Ahmed, M; Ahmed, RA; Al Balushi, A; Barr, D; Bennett, A; Bond, H; Burston, C; Byrne, J; Chambers, L; Coey, D; Cross, T; Cruise, J; Fenlon, K; Gould, S; Haigh, K; Hall, C; Harrison, M; Hazenberg, P; Hicks, SR; Hope, S; Hunter, K; Islim, A; Iyer, S; Jackson, A; Jaime, F; Keogan, L; Knowles, K; Krasauskas, K; Lewis, J; Lopez, P; Lowe, C; Mediana, A; Middleton, M; Nugent, M; Pauls, L; Pringle, S; Quayle, I; Raghunath, S; Riley, M; Sedano, J; Shaw, D; Smith, C; Stevenson, S; Stockdale, A; Tangney, R; Tempany, J; Waugh, V; Williams, K; Yates, B; Ashbrook-Raby, C; Campbell, H; Charlton, D; Dodds, S; Ferguson, V; Hall, T; Hamoodi, I; Heslop, P; Luke, J; McLarty, N; Patterson, L; Pick, S; Reynolds, J; Robinson, S; Tanney, C; Taylor, L; Winder, L; Walker, C; Scott, S; Abouibrahim, M; Ahmad, M; Ahmed, SH; Ajibode, A; Alomari, L; Asrar, A; Austin, E; Bamford, P; Barclay, A; Barker, L; Barker-Williams, K; Barnsley, W; Batty, H; Benton, I; Billingham, S; Brearey, S; Brigham, S; Brooker, V; Burchett, C; Burgess, M; Cade, R; Cameron, F; Cannan, R; Cawley, K; Chavasse, N; Cheng, Z; Clarke, R; Cole, E; Cotton, C; Davidson, A; Doi, Y; Dragos, C; Ellerton, LN; Gamble, L; Grant, M; Grounds, J; Hodgkins, H; Irshad, MS; Iyer, M; Johari, A; Jones, C; Kearsley, N; Lim, B; Llanera, DK; Loh, SY; London, E; Martin, E; Maskell, P; McBurney, J; McCarthy, M; McEwen, R; Meeks, E; Metcalf-Cuenca, G; Middleton, S; Mihalca-Mason, L; Nayyar, M; Naz, F; Okpo, E; Parry, HC; Pearson, SA; Phillips, D; Pickering, C; Ponnuswamy, A; Prescott, V; Prince, J; Rahman, SU; Scott, S; Steele, C; Thorne, C; Tomlin, S; Trussell, T; Webster, T; Zammit, L; Zin, ET; Grahamx, C; Graham, C; Abdelaziz, A; Ali, O; Atkinson, J; Bell, G; Brewer, C; Clapham, M; Gregory, J; Hanif, S; Harper, R; Lane, M; McSkeane, A; Poultney, U; Poulton, K; Pritchard, S; Shah, S; Smit, C; Tzavaras, P; Vasadi, V; Wilson, A; Wilson, T; Zehnde, D; Shaw, D; Tariq, S; Ahmed, N; Ali, S; Allen, S; Alzetani, M; Ambrose, C; Aneke, K; Angel, T; Aung, ZM; Banerjee, R; Baqai, T; Batla, A; Bergstrom, M; Bhakta, S; Bibi, N; Chapman, T; David, A; Dirmantaite, L; Edmondson, M; Elfar, E; Elgamal, MM; El-Sbahi, H; Fishman, D; Fornolles, C; Forshall, T; Francioni, A; Gent, S; George, N; Ibrahim, A; Ingram, A; James, R; Dawa, KK; Khan, F; Khan, MA; Lee, S; Lingam, C; Luximon, CN; Marcus, N; Masood, M; Mejri, R; Moharram, A; Moss, C; Naik, G; Ng, AYKC; Nicholls, L; Nisar, M; Parmar, V; Raj, FP; Puisa, V; Quick, V; Ramabhadran, B; Reddy, A; Riaz, N; Rudran, B; Sabaretnam, S; Sagoo, H; Sarma, S; Savlani, K; Shah, P; Shaw, D; Soo, S; Sothirajah, P; Southern, I; Tate, ML; Travill, C; Uppal, VS; Wakeford, W; Brown, T; Andrews, J; Baker-Moffatt, M; Bamgboye, A; Barnes, D; Baryschpolec, S; Bell, L; Borbone, J; Broadway, M; Brogan, F; Bungue-Tuble, R; Burrows, K; Chauhan, A; Chauhan, M; Cowan, E; Darbyshire, A; Davey, M; David, M; Denham, J; Downe, H; Edwards, C; Fox, L; Garner, Z; Giles, B; Gribbin, A; Harrington-Davies, Y; Hawes, L; Hicks, A; Hossain, E; Howe, S; Jones, B; Lameirinhas, C; Longhurst, B; Mamman, M; McCready, S; Minnis, C; Moon, M; Mouland, J; Murray, L; Rose, S; Rupani, H; Rutgers, M; Scorrer, T; Scott, K; Thornton, R; Tiller, A; Turner, C; Wands, M; Watkins, L; White, M; Wiffen, L; Winter, J; Winn, S; Wake, R; Sadiq, SA; Aldana, A; Al-Hakim, B; Agyapong, KA; Azzopardi, G; Chicano, R; Chukwulobelu, I; Colbeck, N; Cole, N; Dogra, R; Doherty, E; Elradi, A; Emberton, J; Evans, TJ; Ganapathy, R; Haque, M; Hayre, R; Jain, S; Jian, K; Johnson, L; Johnson, A; Kotecha, J; Kundu, A; Langer, D; Mashhoudi, Y; Mathias, K; Maxan, ME; Mellor, F; Morgan, M; Nafees, S; Sai, VBP; Phanish, M; Rahimi, HR; Ramanna, S; Ratoff, J; Rozewicz, S; Samuel, TDL; Shah, B; Shahnazari, S; Shail, R; Sharif, A; Somalanka, S; Suckling, R; Swift, P; Tyagi, V; Vilimiene, N; Wells, C; Maseda, D; Ball, C; Best, K; Bridgwood, G; Broadhurst, R; Brockelsby, C; Brockley, T; Brown, J; Bujazia, R; Clarke, S; Cremona, J; Dixon, C; Dowson, S; Drogan, H; Duncan, F; Emmett, C; Emms, M; Farooq, H; Fullerton, D; Gabriel, C; Hammersley, S; Hum, R; Jones, T; Kay, S; Kelly, E; Kidd, M; Lees, D; Lowsby, R; Matovu, E; McIntyre, K; Moulton, H; Nourein, K; Nytianandan, G; O'Brian, M; Pagett, K; Ritchings, A; Smith, S; Taylor, J; Thomas, K; Turbitt, K; Yasmin, S; Spittle, N; Weatherly, N; Beavis, S; Beghini, S; Blundell, L; Bradder, J; Cort, J; Cresswell, J; Dale, K; Foo, A; Gardner, J; Gascoyne, R; Hall, E; Kelly-Baxter, M; Mackay, E; Moxham, K; Padmakumar, A; Pritchard, K; Salmon, J; Smith, A; Sorice, V; Stevenson, L; Whileman, A; Wolodimeroff, E; Meda, M; Democratis, J; Barnes, N; Brooks, N; Chapman, L; da Rocha, J; Dolman, R; Edwards, A; Foster, T; Fowe, F; Gaywood, E; Gee, S; Jaiswal, S; Molloholli, M; Raguro, A; Regan, F; Rowe-Leete, L; Smith, C; van de Venne, M; Weerasinghe, T; Jeffery, K; Ainsworth, M; Arnison-Newgass, C; Bashyal, A; Beer, S; Bloss, A; Buttress, D; Byrne, W; Capp, A; Carter, P; Cicconi, P; Corrigan, R; Coston, C; Cowen, L; Davidson, N; Downs, L; Edwards, J; Evans, R; Gardiner, S; Georgiou, D; Gillesen, A; Harin, A; Havinden-Williams, M; Haynes, R; Hird, C; Hudak, A; Hutton, P; Irons, R; Jastrzebska, P; Johnston, S; Kamfose, M; Lewis, K; Lockett, T; del Rocio, FMM; Garrido, JCM; Masih, S; Mentzer, A; Morris, S; O'Callaghan, C; Oliver, Z; Paulus, S; Perez, E; Periyasamy, L; Peto, L; Porter, D; Prasath, S; Purdue, C; Ramasamy, M; Roehr, CC; Rudenko, A; Sanchez, V; Sarfatti, A; Segovia, M; Sewdin, T; Seymour, J; Skinner, V; Smith, L; Diaz, AS; Taylor-Siddons, M; Thraves, H; Tsang, C; Vatish, M; Warren, Y; Wilcock, E; Khan, B; Ail, D; Aldouri, R; Awadzi, G; Bassoy, B; Bhalla, R; Billings, J; Bokhari, S; Boniface, G; Cernova, J; Chen, T; Chimbo, P; Chitalia, N; Bamfo, SD; Depala, D; Dhanoa, A; Edmunds, T; Fernandez, E; Ferrari, T; Fuller, B; Gherman, A; Heire, R; Ilves, L; Lacey, L; Lawrence, E; Lewis, M; Maric, A; Martin, W; Min, Z; Newman, C; Nicholas, R; Olufuwa, O; Pieniazek, N; Qadeer, T; Rathore, S; Sathianandan, S; Scott, C; Shonubi, A; Siddique, S; Sisson, G; Soan, M; Streit, D; Stuart, C; Szekely, M; Umeojiako, W; Urruela, S; Warner, B; Waterstone, M; White, S; Yip, K; Zafar, AM; Zaman, S; West, R; Abrams, J; Baldwin, A; Bannister, O; Barker, J; Beddall, H; Blamey, H; Chan, E; Chaplin, J; Chisnall, B; Cleaver, C; Crotty, S; Dey, P; Downs, L; Kononen, M; Kudsk-Iversen, S; Kudzinskas, A; Laurenson, M; Mandeville, J; McLure, S; Morgan-Smith, E; Ngumo, A; Oxlade, R; Parekh, A; Rahman, M; Robertson, C; Shah, S; Tebbutt, J; Vella, N; Veres, M; Watson, AJR; Wong, N; Zammit-Mangion, M; Zia, M; Gray, A; Baillie, K; Adam, M; Anand, A; Anderson, R; Baird, D; Balaskas, T; Balfour, J; Black, P; Blackstock, C; Brady, S; Campbell, R; Carter, J; Chapman, P; Cheyne, C; Christides, A; Christmas, D; Crisp, L; Cryans, D; Dear, J; Dhaliwal, K; Docherty, M; R, D; Donald, L; Dummer, S; Eddleston, M; Fethers, N; Foster, E; Frake, R; Gaughan, E; D, G; Godson, E; Grahamslaw, J; Grant, A; Grubb, N; Hainey, S; Harding, Z; Harris, M; Harvey, M; Henshall, D; Hobson, S; Hunter, N; Jaly, Y; Jameson, J; Japp, D; Khin, HHE; Kitto, L; Krupej, S; Langoya, C; Lawrie, R; Lloyd, A; Lyell, B; Lynch, D; Macfarlane, J; MacInnes, L; MacRaild, A; Marecka, M; Marshall, A; Martin, M; McCann, C; McCurrach, F; Moatt, E; Morley, W; Morrissey, M; Newby, D; Din, KNU; O'Brien, R; O'Sullivan, E; Odam, M; Peterson, A; Phelan, P; Pickering, G; Quinn, T; Robertson, N; Rooney, L; Rowan, N; Salman, R; Small, E; Stefanowska, P; Stevenson, A; Stock, S; Summers, A; Teasdale, J; Walker, I; Walker, K; Williams, A; Wight, A; Bailey, L; Bokhari, SO; Brownlee, S; Bull, A; Corless, J; Denmade, C; Ellard, N; Farrell, A; Hufton, A; Jacob, R; Jones, KE; Kerss, H; McEntee, J; Morris, N; Myagerimath, R; Newcombe, T; Parsonage, M; Peake, H; Pearson, D; Penfold, R; Rath, S; Saunders, R; Sharp, A; Spencer, B; Suliman, A; Sutton, S; Tan, H; Tarpey, D; Thompson, L; Thornton, T; Twohey, E; Wagstaff, D; Wahbi, Z; Williams, S; Phull, M; Umaipalan, A; Ah-Chuen, J; Ainsley, A; Baijiu, G; Basumatary, A; Calderwood, C; Dugh, P; Dunne, K; Greaves, P; Hunt, K; Islam, M; Katsande, V; Khan, MR; King, S; Loverdou, A; McGregor, A; Misbahuddin, A; Mohamed, A; Nagesh, N; Nicholls, D; O'Brien, N; Parker, L; Pogreban, T; Rosaro, L; Salciute, E; Sharma, M; Smith, H; Visentin, E; Walshaw, L; Saralaya, D; Akhtar, N; Beckett, V; Brear, L; Drew, V; Eedle, J; Hawes, N; Kmachia, S; Moss, S; Oddie, S; Paget, J; Regan, K; Ryan-Wakeling, D; Shenoy, A; Storton, K; Swingler, R; Syson, J; Todd, J; Wane, R; Wilson, A; Fuller, E; MacNair, A; Brown, C; Burns, A; Caroline, C; Davidson, R; Dickson, M; Duncan, B; Elkaram, N; Emmerson, I; Fairlie, L; Hashimm, M; Henderson, J; Hinshaw, K; Holden, J; Hovvels, R; Laybourne, S; Madgwick, P; Martin, K; Mckee, M; Moore, J; Mullen, N; Murphy, P; Palmer, L; Parish, G; Rangar, M; Shahrul, R; Smith, A; Smith, L; Smith, M; Stidolph, B; Terry, L; Trotter, A; Wakinshaw, F; Walton, E; Walton, M; Frise, M; Arimoto, R; Black, S; Camm, C; Coles, H; De Berker, H; Fries, A; Gabbitas, E; Hasan, N; Htet, Z; Jacques, N; Kashif, S; Keating, L; Leafe, S; Milne, Z; Mitchell, B; Okeke, T; Orchard, W; Parmar, A; Raffles, M; Shields, N; Thakker, M; Thomas, M; Wakefield, H; Walden, A; Moreno-Cuesta, J; Rokadiya, S; Govind, A; Haldeos, A; Leigh-Ellis, K; van Someren, C; Vincent, R; Walker, L; Thomas, K; George, T; Cannon, E; Ikomi, A; Jayasekera, L; Kittridge, L; Maloney, G; Manoharan, B; Mushabe, M; Nicholson, A; Pai, A; Riches, J; Samuel, J; Setty, N; Solesbury, A; Southam, D; Tisi, S; Vertue, M; Wadsworth, K; Yung, B; Limb, J; Atkinson, V; Birt, M; Brown, E; Cowton, A; Craig, V; Egginton, D; Fernandes, D; Ivy, A; Jayachandran, D; Jennings, J; Kay, A; Kent, M; McAuliffe, S; Naylor, S; Nyamugunduru, G; O'Brien, J; Postlethwaite, K; Potts, K; Ranka, P; Rogers, G; Sen, S; Temple, J; Wadd, S; Walters, H; Yorke, J; Whittington, A; Adamus, M; Barrett, J; Cawa, F; Chhabra, S; Chita, S; Dhillon, E; Filson, SA; Goodall, J; Gravell, R; Gupta-Wright, A; Gurram, S; Houston, H; Hulston, G; Isralls, S; Kukadiya, C; Lang, M; MaeLow, J; Macleod, C; Milburn, J; Muralidhara, K; Nayar, B; Ojo, O; Papineni, P; Parris, V; Patel, M; Quaid, S; Sethi, J; Sturdy, A; Tyagi, B; Vaccari, LC; van der Stelt, N; Wallis, G; Watson, E; Sarkar, R; Ahmed, I; Ahmed, S; Ambler, S; Babatunde, F; Banerjee, S; Bhatia, N; Brassington, L; Brokke, F; Bruce, D; Cassimon, B; Chauhan, RS; Chengappa, A; Divikar, N; Donnelly, C; Froneman, C; Gnanalingam, C; Gower, T; Harizaj, H; Hettiarachchi, G; Hollands, M; Jansz, S; Josiah, B; Kamara, M; Kidney, S; Kyere-Diabour, T; Lewiston, K; Miah, N; Millington, S; Mires, L; Mitchell, A; Mizzi, C; Naicker, K; Petrou, I; Phulpoto, MM; Ross-Parker, A; Ramadan, I; Roy, A; Ryan, A; Samuels, E; Sanctuary, T; Sharma, A; Singham, S; Sporrer, J; Ul Hassan, W; Vankayalapati, P; Velan, B; Smith, LV; Vyras, E; Wood, J; Zuhra, N; Clare, S; Ahmed, MC; Beuvink, Y; Blachford, K; Clamp, S; De,, JC; De, P; Fenton, M; Gammon, B; Hayes, A; Henry, L; Hussain, S; Joseph, S; Kinney, F; Knight, T; Kumar, R; Leong, W; Lim, T; Mahay, B; Nupa, Y; Orme, A; Osborne, W; Pilsworth, Z; Potter, S; Prew, S; Rajaiah, N; Rajasekaran, A; Senya, H; Shah, N; Shamim, N; Sivakumar, S; Smith, L; Thozthumparambil, P; Trudgill, N; Turner, A; Wagstaff, L; Willetts, S; Willis, H; Yan, M; Richardson, N; Alegria, A; Kapoor, R; Adegoke, K; Allen, L; Beranova, E; Boehmer, G; Crisp, N; Deery, J; Hansen, J; Elgohary, A; Elsefi, T; Hargreaves, C; Hazelton, T; Hulbert, R; Ionita, A; Knight, A; Linares, C; Loader, D; Matisa, E; McAndrew, J; Montasser, M; Moon, A; Oboh, C; Offord, P; Price, C; Rajasri, A; Rand, J; Schumacher, N; Stephensen, D; Stirrup, S; Tague, L; Tilbey, S; Turney, S; Vasu, V; Venditti, M; Weston, H; Woodward, Z; Kemp, T; Alexander, J; Al-Shamkhani, W; Bandla, N; Bland, A; Bodasing, N; Cadwgan, A; Chaudhary, MYN; Cheng, LY; Church, SR; Clark, F; Davies, M; Diwakar, L; Eaton, E; Evans, M; Farmer, A; Farook, F; Gellamucho, M; Glover, K; Haris, M; Humphries, J; Hussain, I; Khan, S; Korcierz, L; Lee, J; Machin, J; Marshall, J; McCreedy, H; Muddegowda, G; Mustapha, I; Nettleton, K; Noori, Z; Osman, W; Parker, H; Patel, N; Quinn, A; Ram, M; Remegoso, A; Scott, T; Sheikh, N; Swiftx, R; Thompson, C; Tomlinson, J; Turner, H; Walker, L; Weeratunga, J; White, C; White, J; Wu, P; Szakmany, T; Champanerkar, S; Griffiths, A; Ionescu, AA; Somashekar, C; Zalewska, K; Aitken, L; Baker, E; Barnett, D; Brouns, M; Cann, J; Cherian, S; Codd, R; Cutler, S; Davies, W; Dell, A; Edwards, M; Edwards, S; Fairbairn, S; Hawkins, N; Hodge, S; Hodkinson, G; Hughes, R; Ivenso, C; James, T; Jones, M; Jones, S; Lucey, A; MacCormac, J; Marshall, G; McKain, S; Nassa, H; Northfield, J; Palmer, S; Peter, L; Price, C; Pynn, M; Roynon-Reed, A; Shipp, L; Singh, J; Singh, M; Swarnkar, K; Torabi, P; Venkataramakrishnan, R; Wall, E; Waters, A; Wild, K; Winstanley, M; Wyness, K; Kushakovsky, V; Ramali, M; Alam, S; Bartholomew, S; Bataineh, A; Beeby, D; Bell, S; Broughton, N; Buckman, C; Calver, C; Campbell, J; Chabo, C; Chowdhury, M; Cooke, K; Deole, N; Driscoll, C; Elden, A; Eldew, H; Entwistle, N; Farnworth, F; Francis, R; Galloway, E; Garfield, M; Ghosh, A; Gray, G; Greenfield, P; Hadjiandreou, M; Hewer, H; Hossain, MS; Howard-Griffin, R; Islam, A; Jamieson, E; Jiao, Z; Johannessen, K; Lee, SH; Lewis, R; Lloyd, R; Mabelin, LA; Morris, D; Nallapareddy, S; Ooi, HC; Osagie, R; Parkinson, C; Patel, H; Prowse, H; Purewal, B; Ridley, P; Rivers, V; Rosier, J; Sharma, S; Sheik, A; Skelly, R; Smith, R; Sreenivasan, R; Taylor, A; Tovey, P; Turner, A; Turner, K; Vithian, K; Zhixin, J; Potton, E; Jain, N; Khadar, A; Morgan, P; Penny, J; Tatam, E; Abbasi, S; Acharya, D; Acosta, A; Ahmed, L; Ali, S; Alkhusheh, M; Amosun, V; Arter, A; Babi, M; Bacon, J; Bailey, K; Balachandran, N; Bandyopadhyam, S; Banks, L; Barla, J; Batty, T; Bax, S; Belgaumkar, A; Benison-Horner, G; Boles, A; Broomhead, N; Cetti, E; Chan, C; Chaudhry, I; Chudgar, D; Clark, J; Clueit, S; Collins, S; Combes, E; Conway, G; Curtis, O; Das, M; Daschel, M; Davies, S; Potton, E; Abbasi, S; Acharya, D; Acosta, A; Ahmed, L; Ali, S; Alkhusheh, M; Amosun, V; Arter, A; Babi, M; Bacon, J; Bailey, K; Balachandran, N; Bandyopadhyam, S; Banks, L; Barla, J; Batty, T; Bax, S; Belgaumkar, A; Benison-Horner, G; Boles, A; Broomhead, N; Cetti, E; Chan, C; Chaudhry, I; Chudgar, D; Clark, J; Clueit, S; Collins, S; Combes, E; Conway, G; Curtis, O; Das, M; Daschel, M; Davies, S; Day, A; Dhar, M; Diaz-Pratt, K; Dragan, C; Dube, H; Duraiswamy, V; Elias, J; Ellis, A; Ellis, TY; Emmanuel, J; Engden, A; Fahmay, Y; Field, B; Fishwick, K; Ganesh, U; Gilbert, C; Giokanini-Royal, T; Goudie, E; Griffith, S; Gurung, S; Habibi, R; Halevy, C; Haqiqi, A; Hartley, R; Hayman, A; Hives, J; Horsford, M; Hughes, S; Hui, C; Hussain, R; Iles, C; Jackson, L; James, A; Jayaram, D; Jessup-Dunton, E; Joefield, T; Khan, N; Kieffer, W; Knox, E; Kumar, V; Kumar, R; Kurmars, V; Lafferty, H; Lamb, F; Layug, R; Leitch, N; Lim, W; Limbu, U; Loveless, R; Mackenzie, M; Maghsoodi, N; Maher, S; Maljk, M; Man, I; McCarthy, N; Mearns, B; Mearns, C; Morgan-Jones, K; Mortem, G; Morton, G; Moya, B; Murphy, G; Mutton, S; Myers, A; Nasser, T; Navaratnam, J; Nazir, S; Nepal, S; Nimako, K; Nimako, L; O'Connor, C; Patel, A; Patel, K; Phongsathorn, V; Pillai, PA; Poole, M; Qureshi, N; Ranjan, S; Rehman, A; Samuels, T; Scott, E; Sekadde, G; Sharma, A; Sharp, G; Shotton, S; Simmons, O; Singh, P; Smith, S; Paranthamen, KS; Suresh, S; Thevarajah, K; Thomas, L; Timms, H; Tomasova, N; Tucker, S; Vara, S; Vaz, C; Weller, S; White, J; Wilde, M; Wilkinson, I; Williams, C; Win, M; Woosey, D; Wright, D; Roberts, M; Amsha, K; Cox, G; Downer, N; Hodgson, D; Hutchinson, J; Kalsoom, S; Molyneux, A; Noor, Z; Allsop, L; Brear, T; Buckley, P; Dunn, L; Gill, M; Goodwin, C; Heeley, C; Holmes, M; Holmes, R; Langthorne, E; Moulds, C; Nash, D; Rajeswary, J; Shelton, S; Slack, K; Smith, S; Valeria, B; Wynter, I; Yanney, M; Ynter, I; Azam, J; Chandler, KJ; Abdelfattah, M; Abung, A; Anderson, J; Antill, P; Appleby, S; Armtrong, P; Berriman, T; Bull, D; Clayton, O; Corlett, A; Crocombe, D; Davies, S; Elliott, K; Fahel, L; Ghosh, J; Gott, N; Greenwood, D; Holder, T; Inns, P; Lea, W; Lindsay, E; Mack, K; Marshall, N; McMeekin, S; Momoniat, T; Nikolaos, P; O'Kane, M; Patrick, G; Pearson, H; Ponnusamy, P; Poole, A; Price, N; Proudfoot, R; Purssord, G; Roche, S; Sefton, C; Shahi, S; Smith, D; Sohail, B; Thomas, R; Turnbull, A; Turner, L; Watchorn, HJ; Wiafe, E; Wilson, J; Yates, D; Bruce, MS; Baldwin, D; Clark, Z; Dale, M; Griffiths, D; Gunter, E; Horler, S; Joyce, T; Keltos, M; Kennard, S; Lakeman, N; Mallon, L; Miln, R; Nix, S; Orr, S; Pitts, S; Purandare, L; Rogers, L; Samways, J; Stride, E; Vamplew, L; Wallis, L; Willis, J; Blencowe, N; Singhal, P; Abraham, M; Al-Ramadhani, B; Archer, A; Aziz, G; Balcombe, A; Bateman, K; Baxter, M; Beacham, L; Belfield, K; Bell, N; Beresford, M; Bernatoniene, J; Bhojwani, D; Biggs, S; Blazeby, J; Bobruk, K; Brown, N; Buckley, L; Butler, P; Caws, C; Chakkarapani, E; Chatar, K; Chivima, B; de la Torre, CC; Cobain, K; Cotterill, D; Courtney, E; Cowman, S; Coy, K; Crosby, H; Curtis, K; Davis, P; Drewett, O; Dymond, H; Edgerley, K; Ekoi, M; Elokl, M; Evans, B; Farmery, T; Fineman, N; Finn, A; Gamble, L; Garty, F; Gibbison, B; Gourbault, L; Grant, D; Gregory, K; Griffin, M; Groome, R; Hamdollah-Zadeh, M; Hannington, A; Heywood, J; Hindmarsh, A; Holling, N; Houlihan, R; Hrycaiczuk, J; Hudson, H; Hurley, K; Jarvis, R; Jeffs, B; Jones, A; Jones, RE; King-Oakley, E; Kirkham, E; Kumar, R; Kurdy, M; Kyle, L; Lang, S; Leandro, L; Legge, H; Loro, F; Low, A; Martin, H; McCullagh, L; McMahon, G; Millett, L; Millington, K; Mok, J; Moon, JH; Morgan, L; Mulligan, S; O'Donovan, C; Payne, E; Penman, C; Pickard, J; Plumptre, C; Ramanan, A; Ramirez, J; Ratcliffe, S; Robinson, J; Roderick, M; Scattergood, S; Schadenberg, A; Sheppeard, R; Shioi, C; Simpson, D; Skorko, A; Squires, R; Stuttard, M; Sugden, P; Sundar, S; Swart, T; Swift, E; Thompson, K; Turner, K; Turner, S; Tyer, A; Vergnano, S; Vincent, R; Ward, R; Wilkinson, S; Williams, J; Williams, S; Willis, J; Winter, H; Woollen, L; Wright, R; Ibrahim, AY; Collini, P; Ang, A; Belcher, J; Chapman, L; Chin, K; Cohen, D; Cole, J; Colton, HE; Condliffe, R; Cribb, M; Curran, S; Darton, T; de Fonseka, D; de Silva, T; Dunn, A; Ferriman, E; Foster, RA; Greig, J; Hall, J; Haq, MU; Hardman, S; Headon, E; Holden, C; Hunt, L; Hurditch, E; Kibutu, F; Kitching, T; Lewis, L; Locke, T; Mair, L; May, P; Meiring, J; Middle, J; Middleton, JT; Morris, P; Newman, T; Passby, L; Payne, R; Rana, GF; Renshaw, S; Rothman, A; Sammut, D; Sherwin, S; Simpson, P; Sterrenburg, M; Stone, B; Surtees, M; Telfer, A; Thompson, R; Vethanayagam, N; West, R; Williams, T; Patel, K; Imray, C; Aldridge, N; Campbell, A; Evans, G; French, E; Grenfell, R; Hewins, S; Hewitt, D; Jones, J; Kumar, R; Mshengu, E; Quenby, S; Read, K; Satodia, P; Sear, E; Truslove, M; Kerry, A; Beale, A; Brooks, A; Browne, C; Butler, J; Callaghan, J; Chandrasekaran, B; Coombs, C; Davies, R; Davies, L; Elias, T; Fowler, E; Gowda, G; Gregory, J; Ipe, A; Jaffery, A; Jones, Q; Kyeremeh, L; Laing-Faiers, I; Langton, H; Lewis-Clarke, C; Mackinlay, C; Mappa, P; Maxwell, A; Mears, W; Mousley, E; Onyirioha, T; Pannell, L; Peglar, S; Pereira, A; Pointon, J; dos Reis, IPB; Price, E; Quayle, A; Qurratulain, Q; Small, S; Smith, H; Stratton, E; Tinkler, M; van der Meer, A; Wakefield, E; Waller, R; Walton, M; Watters, M; Whittam, L; Wiliams, T; Xia, Z; Yein, K; Zinyemba, V; Cupitt, J; Ahmed, N; Assaf, O; Barnett, A; Benham, L; Bradley, P; Bradshaw, Z; Brunton, M; Capstick, T; Caswell, M; Cunliffe, V; Downes, R; Latt, N; McDonald, R; Mulla, A; Mutema, E; Navin, J; Parker, A; Preston, S; Slawson, N; Stoddard, E; Traynor, S; Vasudevan, V; Ward, E; Warden, SA; Wilson, J; Zmierczak, A; Bari, S; Higham, A; Al-Jibury, M; Allison, K; Anu, V; Bartlett, C; Bhuiyan, S; Bishop, L; Burns, K; Davies, A; Fielding, A; Gorst, M; Hay, C; Keating, J; Khan, T; Mahmood, F; Mallinder, P; Peters, S; Power, D; Ritchie, J; Simpson, K; Spickett, H; Stokes, C; Thatcher, H; Varghese, A; Wan, T; Wood, F; Convery, R; Acheson, J; Brannigan, J; Cosgrove, D; McCullough, C; McFarland, D; McNulty, R; Sands, S; Thompson, O; Balasubramaniam, M; Subudhi, C; Acton, C; Ajmi, A; Ahmed, R; Ajmi, A; Al-Asadi, A; Amin, A; Bajandouh, A; Bhalme, M; Carrington, Z; Chadwick, J; Cocks, S; Dawe, C; Eusuf, A; Farzana, S; Hill, P; Holmes, R; Hughes, G; Hull, R; Ibrahim, K; Ijaz, M; Kalayi, RJ; Khurana, S; Latham, S; Lipscomb, K; Lomas, JP; Natarajan, N; Nethercott, D; Nicholas, P; Obeng, D; Priyash, V; Rhead, K; Saleh, M; Sharma, O; Shehata, Z; Shurmer, J; Sime, R; Singh, S; Smith, R; Tanton, E; Tewkesbury, D; Thet, P; Thornton, S; Wang, N; Watts, M; Webster, I; Easom, N; Adams, K; Baldwin, L; Barlow, G; Barton, R; Bexhell, H; Clark, D; Gunasekera, P; Harvey, A; Hayes, M; Ivan, M; James, A; Kassianides, X; Khan, S; Kolodziej, M; Lillie, P; Mathew, V; Mongolu, S; Muazzam, IA; O'Reilly, P; Perinpanathan, T; Philbey, C; Pickwell-Smith, B; Rollins, L; Samson, A; Sathyapalan, T; Sherris, L; Sivakumar, K; Taynton, T; Yates, H				Horby, P. W.; Roddick, A.; Spata, E.; Staplin, N.; Emberson, J.; Pessoa-Amorim, G.; Brightling, C.; Prudon, B.; Chadwick, D.; Ustianowski, A.; Ashish, A.; Todd, S.; Yates, B.; Buttery, R.; Scott, S.; Maseda, D.; Baillie, J. K.; Buch, M.; Chappell, L.; Day, J.; Faust, S. N.; Jaki, T.; Jeffery, K.; Juszczak, E.; Lim, W. S.; Montgomery, A.; Mumford, A.; Rowan, K.; Thwaites, G.; Mafham, M.; Haynes, R.; Landray, M. J.; Horby, P. W.; Landray, M. J.; Baillie, J. K.; Buch, M.; Chappell, L.; Day, J.; Faust, S. N.; Haynes, R.; Jaki, T.; Jeffery, K.; Juszczak, E.; Lim, W. S.; Mafham, M.; Montgomery, A.; Mumford, A.; Rowan, K.; Thwaites, G.; Sandercock, P.; Darbyshire, J.; DeMets, D.; Fowler, R.; Lalloo, D.; Roberts, I.; Wittes, J.; Horby, P.; Landray, M. J.; Haynes, R.; Fletcher, L.; Barton, J.; Basoglu, A.; Brown, R.; Brudlo, W.; Denis, E.; Howard, S.; McChlery, G.; Taylor, K.; Cui, G.; Goodenough, B.; King, A.; Lay, M.; Murray, D.; Stevens, W.; Wallendszus, K.; Welsh, R.; Crichton, C.; Davies, J.; Goldacre, R.; Harper, C.; Knight, F.; Latham-Mollart, J.; Mafham, M.; Nunn, M.; Salih, H.; Welch, J.; Campbell, M.; Pessoa-Amorim, G.; Peto, L.; Roddick, A.; Knott, C.; Wiles, J.; Bell, J. L.; Emberson, J.; Juszczak, E.; Linsell, L.; Spata, E.; Staplin, N.; Bagley, G.; Cameron, S.; Chamberlain, S.; Farrell, B.; Freeman, H.; Kennedy, A.; Whitehouse, A.; Wilkinson, S.; Wood, C.; Reith, C.; Davies, K.; Halls, H.; Holland, L.; Wilson, K.; Howie, L.; Lunn, M.; Rodgers, P.; Barnard, A.; Beety, J.; Birch, C.; Brend, M.; Chambers, E.; Chappell, L.; Crawshaw, S.; Drake, C.; Duckles-Leech, H.; Graham, J.; Harman, T.; Harper, H.; Lock, S.; Lomme, K.; McMillan, N.; Nickson, I.; Ohia, U.; OKell, E.; Poustie, V.; Sam, S.; Sharratt, P.; Sheffield, J.; Slade, H.; Hoff, W. Van't; Walker, S.; Williamson, J.; De Soyza, A.; Dimitri, P.; Faust, S. N.; Lemoine, N.; Minton, J.; Gilmour, K.; Pearson, K.; Armah, C.; Campbell, D.; Cate, H.; Priest, A.; Thomas, E.; Usher, R.; Johnson, G.; Logan, M.; Pratt, S.; Price, A.; Shirley, K.; Walton, E.; Williams, P.; Yelnoorkar, F.; Hanson, J.; Membrey, H.; Gill, L.; Oliver, A.; Das, S.; Murphy, S.; Sutu, M.; Collins, J.; Monaghan, H.; Unsworth, A.; Beddows, S.; Williams, K. Barker; Dowling, S.; Gibbons, K.; Pine, K.; Asghar, A.; Aubrey, P.; Jewell, D. Beaumont; Donaldson, K.; Skinner, T.; Luo, J.; Mguni, N.; Muzengi, N.; Pleass, R.; Wayman, E.; Coe, A.; Hicks, J.; Hough, M.; Levett, C.; Potter, A.; Taylor, J.; Dolman, M.; Gerdes, L.; Hall, C.; Lockett, T.; Wessex, D. Porter; Bartholomew, J.; Dowden, L.; Rook, C.; Walters, J.; Denton, E.; Tinkler, H.; Alexander, A.; Campbell, H.; Chapman, K.; Hall, A.; Rodgers, A.; Boyle, P.; Brookes, M.; Callens, C.; Duffy, H.; Green, C.; Hampshire, K.; Harrison, S.; Kirk, J.; Naz, M.; Porter, L.; Ryan, P.; Shenton, J.; Warmington, J.; Amezaga, M.; Dicks, P.; Goodwin, J.; Hodgson, H.; Jackson, S.; Odam, M.; Williamson, D.; Faust, S. N.; Bamford, A.; Bandi, S.; Bernatoniene, J.; Cathie, K.; Dmitri, P.; Drysdale, S.; Emonts, M.; Evans, J.; Finn, A.; Fleming, P.; Furness, J.; Gale, C.; Haynes, R.; Jones, C. E.; Juszczak, E.; Jyotish, D.; Kelly, D.; Murray, C.; Pathan, N.; Pollock, L.; Ramanan, A.; Riordan, A.; Roehr, C.; Wan, M.; Whittaker, E.; Chappell, L.; Hodson, K.; Knight, M.; Pavord, S.; Williamson, C.; Odam, M.; Black, P.; Gallagher, B.; MacInnes, L.; O'Brien, R.; Priestley, K.; Saunderson, A.; Bowman, L.; Chen, F.; Clarke, R.; Goonasekara, M.; Haynes, R.; Herrington, W.; Judge, P.; Mafham, M.; Ng, S.; Preiss, D.; Reith, C.; Sammons, E.; Zhu, D.; Pinches, H.; Bowker, P.; Byrne-Watts, V.; Chapman, G.; Coleman, G.; Gray, J.; Rees, A.; Landray, M. J.; Mafham, M.; Mather, N.; Stephenson, C.; Denwood, T.; Harrison, D.; Turner, G.; Bruce, J.; Arkley, C.; Rees, S.; Brightling, C.; Brunskill, N.; Wiselka, M.; Adenwalla, S.; Andreou, P.; Bakoulas, P.; Bandi, S.; Batham, S.; Beaver, T.; Bhandal, K.; Bourne, M.; Boyles, L.; Cannon, M.; Charalambou, A.; Cheung, C. Kay; Cotter, R.; Diver, S.; Dunphy, A.; Elneima, O.; Fawke, J.; Finch, J.; Gardiner-Hill, C.; Genato, G.; Graham-Brown, M.; Haines, C.; Hargadon, B.; Holdsworth, H.; Ibrahim, W.; Ingram, L.; Silva, J. Antonio Jesus; Kaul, K.; Joshi, M.; Kapoor, S.; Kim, J. Whang; Kuverji, A.; Kyriaki, K.; Lea, A.; Lee, T.; Lewszuk, A.; Lock, L.; Macconaill, K.; Major, R.; McAuley, H.; McCourt, P.; Kutten, D. Mullasseril; Palfreeman, A.; Parker, E.; Patel, K.; Patterson, M.; Phillips, R.; Plummer, L.; Russell, R.; Debbie, S.; Selvaskandan, H.; Southin, S. Michaela; Tsilimpari, K. Karali; Wiesender, C.; Yousuf, A.; Ustianowski, A.; Raw, J.; Tully, R.; Abdusamad, K.; Antonina, Z.; Ayaz, E.; Blackledge, B.; Bradley, P.; Bray, F.; Bruce, M.; Carty, C.; Charles, B.; Connolly, G.; Corbett, C.; Dermody, S.; Durrans, L.; Falconer, E.; Flaherty, J.; Fox, C.; Hadfield, D.; Harris, J.; Hoggett, L.; Horsley, A.; Hussain, S.; Irving, R.; Jacob, P.; Johnstone, D.; Joseph, R.; Melville, J. Julie; Kamath, P.; Khatun, T.; Lamb, T.; Law, H.; Lazo, M.; Lindergard, G.; Lokanathan, S.; Macfarlane, L.; Mathen, S.; McCullough, S.; McMaster, P.; McSorland, D.; Mishra, B.; Munt, S.; Neal, A.; Newport, R.; O'Connor, G.; O'Riordan, D.; Page, I.; Parambil, V.; Philbin, J.; Pinjala, M. Tejha; Rishton, C.; Riste, M.; Rothwell, J.; Sam, M.; Sarwar, Z.; Scarratt, L.; Sengupta, A.; Sharaf, H.; Prudon, B.; Jagannathan, V.; Adams, C.; Aung, N.; Barker, D.; Campbell, B.; Collins, V.; Deane, J.; Fenner, I.; Gowans, S.; Hartrey, W.; Nafei, M.; Poole, L.; Purvi, S.; Quigley, J.; Ramshaw, A.; Shepherd, L.; Skelton, J.; Srinivasan, R.; Taylor, R.; Walker, M.; Weetman, M.; Wetherall, B.; Wild, S.; Wilson, D.; Lim, W. S.; Ali, M.; Andrews, A.; Anderson, L.; Ashraf, S.; Ashton, D.; Babingto, G.; Bartlett, G.; Batra, D.; Bendall, L.; Benetti, N.; Brear, T.; Buck, A.; Bugg, G.; Butler, J.; Butler, J.; Cammack, R. F. D.; Cantliff, J.; Clark, L.; Connor, E.; Davies, P.; Dent, M.; Dobson, C.; Fatemi, M.; Fatemi, A.; Fleming, L.; Grundy, J.; Hallas, J.; Hodgen, L.; Hodgson, S.; Hodgkinson, S.; Howard, L.; Hutchinson, C.; Jackson, B.; Kaur, J.; Keddie-Gray, E.; Khurana, C.; Langley, M.; Looby, L.; Meredith, M.; Morris, L.; Navarra, H.; Nicol, R.; Oliver, J.; Peters, C.; Petrova, B.; Rose, Z.; Ryan, L.; Sampson, J.; Squires, G.; Squires, J.; Taylor, R.; Thomas, A.; Thornton, J.; Topham, K.; Warburton, S.; Wardle, S.; Waterfall, H.; Wei, S.; Wildsmith, T.; Wilson, L.; Chadwick, D.; Armstrong, S.; Athorne, D.; Branch, M.; Brolly, J.; Brown, S.; Cheaveau, J.; Chen, H. Min; Chua, Y.; Cunningham, N.; Dodds, J.; Dorgan, S.; Dunn, D.; Harper, P.; Harwood, H.; Hebbron, K.; Hunt, F.; Bhushan, A. Kala; Lambert, P.; Leaning, D.; Manders, T.; McCarron, B.; Miller-Biot, N.; Milne, C.; Mohammad, W.; Mollet, M.; Murad, A.; Owston, M.; Potts, J.; Proctor, C.; Rao, S.; Seelarbokus, M. A.; Singh, P.; Srirathan, V.; Swithenbank, L.; Thompson, L.; Wardy, H.; Wibli, L.; Widdrington, J.; Williams, J.; Winder, P.; Wroe, C.; Elmahi, E.; Zaman, M.; Abdul, B.; Abdulmumeen, A.; Abdulshukkoor, N.; Adnan, A.; Nazeer, M. H. Ahammed; Bazli, A.; Benesh, N.; Chin, W. Jie; Cunningham, N.; Daggett, H.; Davies, E.; Enyi, H.; Fawohunre, S.; Geoghegan, N.; Glover, J.; Hague, J. W.; Hall, K.; Hallett, C.; Haresh, K.; Hassan, W. Ul; Hewertson, J.; Hosea, J.; Htoon, N. Zaya; Idrees, M.; Igwe, C.; Imtiaz, H.; Irshad, M.; Ismail, A.; Jeffrey, R.; Jith, J.; Joshi, P.; Periyasami, R. Kaliannan; Khalid, A.; Khalid, M. Usman; Kodituwakku, R.; Lopez, P.; Mahmood, A.; Malanca, M.; Mapfunde, I. Tatenda; Maruthamuthu, V. Kumar; Masood, S.; Masood, S. S. M. E.; Matharu, M.; Merchant, A.; Merchant, F.; Naqvi, S.; Natarajan, R.; Natarajan, N.; Nawaz, K.; Ndefo, O.; Ogunkeye, O.; Paranamana, S.; Pugh, N.; Raj, A.; Rashid, K.; Rogers, M.; Saad, M.; Selvadurai, G.; Shah, A.; Shahzeb, M.; Shrestha, N.; Singh, A.; Smith, K.; Sohail, B.; Spinks, M.; Stockham, L.; Takyi, A.; Teoh, Y. He; Ullah, S.; Vayalaman, H.; Wafa, S. E. I.; Ward, T.; Watson, R.; White, D.; Melly, L. Ylquimiche; Zulaikha, R.; Green, C.; Whitehouse, T.; Ahmed, I.; Anderson, N.; Armstrong, C.; Bamford, A.; Bancroft, H.; Bates, M.; Begum, S.; Bellamy, M.; Bergin, C.; Bhandal, K.; Brandl-Salutz, E.; Buckingham, E.; Burke, E.; Carmody, M.; Cooper, L.; Daglish, J.; Dasgin, J.; Desai, A.; Dhani, S.; Dosanjh, D.; Ellis, H.; Gardiner, D.; Forster, E.; Grobovaite, E.; Hopkin, B.; Hull, D.; Hussain, Y.; Jones, J.; Khan, L.; Lenton, D.; Lewis, M.; Lovell, M.; Lowe, F.; Lynch, D.; McGhee, C.; McNeill, C.; Moore, F.; Nilsson, A.; Nunnick, J.; Prest, C.; Price, V.; Rhodes, J.; Sale, J.; Sangombe, M.; Smith, H.; Storey, I.; Thrasyvoulou, L.; Tsakiridou, K.; Walsh, D.; Welch, S.; Willis, H.; Wood, L.; Woodford, J.; Wooldridge, G.; Zullo, C.; Desai, P.; Appleyard, D.; Bromley, D.; Chambers, N.; Dale, S.; Gledhill, L.; Goddard, J.; Greig, J.; Haigh, A.; Hallas, K.; Hanson, K.; Holroyd, K.; Home, M.; Kelly, D.; Maharajh, A.; Matapure, L.; Mellor, S.; Merwaha, E.; Riley, H.; Robinson, M.; Sandhu, K.; Schwarz, K.; Shaw, L.; Terrett, L.; Usher, M.; Wilson, A.; Wood, T.; Felton, T.; Abbas, M.; Rasheed, A. Abdul; Abraham, T.; Aggarwal, S.; Akili, S.; Alexander, P. D. G.; Allanson, A.; Al-Sheklly, B.; Arora, D.; Avery, M.; Avram, C.; Aya, A.; Banda, J.; Banks, H.; Baptist, M.; Barrera, M.; Bazaz, R.; Behrouzi, R.; Benson, V.; Bentley, A.; Bhadi, A.; Biju, A.; Bikov, A.; Birchall, K.; Blane, S.; Bokhari, S.; Bradley, P.; Bradley-Potts, J.; Dean, K.; Dhillon, R.; Dolan, D.; Duggan, A.; Duran, B.; Durrington, H.; Eades, C.; Eatough, R.; Clark, R.; Clayton-Smith, J.; Conway, R.; Cook, E.; Cummings-Fosong, G.; Currie, S.; Dalgleish, H.; Davies, C.; Dean, K.; Dhillon, R.; Dolan, D.; Duggan, A.; Duran, B.; Durrington, H.; Eades, C.; Eatough, R.; Elyoussfi, S.; Evans, G.; Fairclough, A.; Faluyi, D.; Ferguson, S.; Fielding, J.; Fiouniz, S.; Fogarty, G.; Fowler, S.; Giannopoulou, S.; Gillott, R.; Gipson, A.; Glasgow, S.; Gorsuch, T.; Grana, G.; Gray, G.; Grayson, A.; Grey, G.; Griffin, B.; Hackney, P.; Hameed, B.; Hamid, I.; Handrean, S.; Henry, J.; Higgins, L.; Holt, L.; Horsley, A.; Howard, L.; Hughes, S.; Hulme, A.; Hulme, P.; Hyslop, M.; Ingham, J.; Ismail, O.; Jafar, A.; Jamal, S.; James, L.; John, A.; Johnstone, E.; Karunaratne, N.; Kausar, Z.; Kayappurathu, J. N.; Kelly, R.; Khan, A.; Khan, W.; Knight, S.; Kolakalurix, E.; Kolakaluri, E.; Kosmidis, C.; Kothandaraman, E.; Krizak, S.; Kyi, N. M.; Lalloo, F.; Logue, C.; Lord, R. W.; Macfarlane, L.; Madden, A.; Mahaveer, A.; Manderson, L.; Margaritopoulos, G.; Marsden, P.; Mathews, J.; McCarthy, E.; McGrath, B.; Mendonca, C.; Metryka, A.; Micallef, D.; Mishra, A.; Mistry, H.; Mitra, S.; Moss, S.; Muazzam, A.; Mudawi, D.; Murray, C.; Naguib, M.; Naveed, S.; Ninan, P.; Nirmalan, M.; Norton, R.; Odell, N.; Osborne, R.; Padden, G.; Palacios, A.; Panes, A.; Pantin, C. T.; Parker, B.; Peacock, L.; Peasley, A.; Pomery, F.; Power, N.; Pursell, M.; Ratcliffe, S.; Reilly, M.; Reynard, C.; Rice, E.; Rice, M.; Riley, P.; Rivera-Ortega, P.; Rogers, J.; Rogers, T.; Santosh, R.; Scott, A.; Sellers, K.; Sen, N.; Shanahan, T.; Shawcross, A.; Shibly, S.; Simpson, A.; Sivanadarajah, S.; Skehan, N.; Smith, C.; Smith, J.; Smith, L.; Soren, J.; Spiller, W.; Stratton, J.; Stubbs, A.; Swist-Szulik, K.; Tallon, B.; Thomas, S.; Thorpe, S.; Tohfa, M.; Tousis, R.; Trafford, M. T.; Turgut, T.; Varghese, M.; Varnier, G.; Venables, I.; Vinay, S.; Wang, R.; Ward, L.; Warner, C.; Watson, E.; Watterson, D.; Wentworth, L.; Whitehead, C.; Wilcock, D.; Williams, J. R.; Willis, E.; Woodhead, L.; Worton, S.; Xavier, B.; Rege, K.; Agbo, C.; Akindolie, O.; Al-Rabahi, A.; Ambrogetti, R.; Aung, K. Thu; Shah, A. Azman; Babs-Osibodu, A. Obaloluwa; Bahadori, K.; Bhayani, J.; Bond, T.; Boughton, H.; Brooks, S.; Butterworth-Cowin, N.; Buttery, R.; Carter, P.; Catana, A. Maria; Cave, L.; Choi, S.; Corogeanu, D.; Croysdill, R.; Davies, M.; de Souza, J.; Duff, N.; Dufour, L.; Ebigbola, O.; Eddings, C.; Faccenda, J.; Feroz, A.; Finch, L.; Freer, C.; Goodyear, P.; Gooentilleke, R.; Gosling, R.; Halford, W.; Havlik, S.; Hoskins, T.; Huson, C.; Ishak, M.; Javed, H.; Jones, T.; Kasianczuk, N.; Kaur, D.; Kerr, A.; Khan, A.; Koshy, G.; Eskenazia, A. Kozak; Lahane, S.; Lami, M. Kadhim Gulam; Marshall, J.; McDevitt, K.; Muru, N.; Mustafa, A. M. M.; Nazir, S.; Okpala, I.; Old, T.; Oleszkiewicz, G.; Orme, H.; O'Sullivan, S.; Paczko, P.; Pandey, A.; Patel, A.; Pathak, S.; Poon, S.; Rather, M. I.; Vattekkat, R. Renu; Rizvi, S. H. M.; Samyraju, M.; Sanyal, J.; Shah, S. H.; Smith, E.; Stacpoole, S.; Tan, B. Theng Tan; Temple, N.; Thazhatheyil, K.; Uddin, M. Saif; Veale, N.; Walter, D.; Ashish, A.; Cooper, J.; Heaton, D.; Hough, S.; Parkinson, V.; Robinson, E.; Taylor, T.; Tierney, C.; Verma, A.; Waddington, N.; Williams, C.; Zipitis, C.; Tiberi, S.; Aboaba, A.; Adeyeye, E.; Agwada-Akeru, J.; Ali, F. Runa; Allen, R.; Ardley, C.; Astin-Chamberlain, R.; Bacon, G.; Baillie, H.; Batha, R.; Bloom, B.; Bolton, M.; Borra, C.; Boyapati, G.; Buchanan, R.; Chan, C.; Chitsenga, C.; Cipriano, B.; Cofie, P. Foster; DeLuna, M.; Elia, S.; El-Shakankery, K.; Fikree, A.; Ghosh, A.; Goiriz, R.; Goldsmith, P.; Gouldbourne, M.; Grant, A.; Greenfield, L.; Grigoriadou, S.; Gritton, R.; Gunganah, K.; Hand, J.; Harwood, C.; Hemmila, U.; Higgins, J.; Hobden, D.; Howaniec, L.; Hsu, D.; Iliodromiti, S.; Issa, S.; Jones, P.; Juan, M.; Kassam, J.; Keith-Jopp, C.; Khan, M.; Khaw, C. Ryan; Kunst, H.; Lai, J.; Lee, I.; Lieberman, D.; Liebeschuetz, S.; Magavern, E.; Maniero, C.; Maitland, J.; Malcolm, H.; Marshall, H.; Matin, N.; May, P.; McDermott, R.; Menacho, K.; Millin, L.; Mohammed, A.; Moriarty, K.; Naeem, S.; Newman, T.; Fhogartaigh, C. Nic; Omar, M.; Pakozdi, A.; Parrott, M.; Pfeffer, P.; Pott, J.; Powell, J.; Ricketts, W.; Riddell, A.; Rughani, P.; Sahdev, N.; Sarodaya, V.; Selvarajah, B.; Skene, I.; Smallshaw, K. Denise; So, A.; Stevenson, D.; Suarez, C.; Swaine, T.; Thomas, S.; Thomas, A.; Thomson, J.; Thorn, N.; Tierney, C.; Ullah, S.; Vathenen, R.; Velauthar, L.; Ward, K.; Wiles, K.; Woodland, P.; Youssouf, S.; Zdanaviciene, A.; Fegan, C.; Balan, A.; Basker, B.; Bird, S.; Boult, Z.; Britten, V.; Broad, L.; Cendl, H.; Chakraborty, M.; Cole, J.; Edgar, M.; Evans, T.; Evans, J.; Evans, M.; Forton, J.; Frayling, S.; Greaves, F.; Harrhy, S.; Haynes, M.; Hill, H.; Hilton, Z.; Jones, L.; Jorgensen, S.; Kelly, A.; Knibbs, L.; Lau, D.; Maureen, E.; May, J.; McGough, E.; McQueen, A.; Milner, J.; Norman, R.; Nyland, K.; Oliver, C.; Paradowski, K.; Patal, M.; Rahilly, K.; Robinson, C.; Scourfield, S.; Starr, M.; Struik, S.; Thomas, E.; Thomas-Turner, R.; Williams, G.; Williams, J.; Williams, M.; Zaher, S.; Hine, P.; Todd, S.; Welters, I.; Wootton, D.; Ahmed, M.; Ahmed, R. A.; Al Balushi, A.; Barr, D.; Bennett, A.; Bond, H.; Burston, C.; Byrne, J.; Chambers, L.; Coey, D.; Cross, T.; Cruise, J.; Fenlon, K.; Gould, S.; Haigh, K.; Hall, C.; Harrison, M.; Hazenberg, P.; Hicks, S. R.; Hope, S.; Hunter, K.; Islim, A.; Iyer, S.; Jackson, A.; Jaime, F.; Keogan, L.; Knowles, K.; Krasauskas, K.; Lewis, J.; Lopez, P.; Lowe, C.; Mediana, A.; Middleton, M.; Nugent, M.; Pauls, L.; Pringle, S.; Quayle, I.; Raghunath, S.; Riley, M.; Sedano, J.; Shaw, D.; Smith, C.; Stevenson, S.; Stockdale, A.; Tangney, R.; Tempany, J.; Waugh, V.; Williams, K.; Yates, B.; Ashbrook-Raby, C.; Campbell, H.; Charlton, D.; Dodds, S.; Ferguson, V.; Hall, T.; Hamoodi, I.; Heslop, P.; Luke, J.; McLarty, N.; Patterson, L.; Pick, S.; Reynolds, J.; Robinson, S.; Tanney, C.; Taylor, L.; Winder, L.; Walker, C.; Scott, S.; Abouibrahim, M.; Ahmad, M.; Ahmed, S. Haris; Ajibode, A.; Alomari, L.; Asrar, A.; Austin, E.; Bamford, P.; Barclay, A.; Barker, L.; Barker-Williams, K.; Barnsley, W.; Batty, H.; Benton, I.; Billingham, S.; Brearey, S.; Brigham, S.; Brooker, V.; Burchett, C.; Burgess, M.; Cade, R.; Cameron, F.; Cannan, R.; Cawley, K.; Chavasse, N.; Cheng, Z.; Clarke, R.; Cole, E.; Cotton, C.; Davidson, A.; Doi, Y.; Dragos, C.; Ellerton, L. Nicola; Gamble, L.; Grant, M.; Grounds, J.; Hodgkins, H.; Irshad, M. Shoaib; Iyer, M.; Johari, A.; Jones, C.; Kearsley, N.; Lim, B.; Llanera, D. Kevin; Loh, S. Yin; London, E.; Martin, E.; Maskell, P.; McBurney, J.; McCarthy, M.; McEwen, R.; Meeks, E.; Metcalf-Cuenca, G.; Middleton, S.; Mihalca-Mason, L.; Nayyar, M.; Naz, F.; Okpo, E.; Parry, H. Claire; Pearson, S. Anthony; Phillips, D.; Pickering, C.; Ponnuswamy, A.; Prescott, V.; Prince, J.; Rahman, S. Ur; Scott, S.; Steele, C.; Thorne, C.; Tomlin, S.; Trussell, T.; Webster, T.; Zammit, L.; Zin, E. Thant; Grahamx, C.; Graham, C.; Abdelaziz, A.; Ali, O.; Atkinson, J.; Bell, G.; Brewer, C.; Clapham, M.; Gregory, J.; Hanif, S.; Harper, R.; Lane, M.; McSkeane, A.; Poultney, U.; Poulton, K.; Pritchard, S.; Shah, S.; Smit, C.; Tzavaras, P.; Vasadi, V.; Wilson, A.; Wilson, T.; Zehnde, D.; Shaw, D.; Tariq, S.; Ahmed, N.; Ali, S.; Allen, S.; Alzetani, M.; Ambrose, C.; Aneke, K.; Angel, T.; Aung, Z. Myo; Banerjee, R.; Baqai, T.; Batla, A.; Bergstrom, M.; Bhakta, S.; Bibi, N.; Chapman, T.; David, A.; Dirmantaite, L.; Edmondson, M.; Elfar, E.; Elgamal, M. Magdy; El-Sbahi, H.; Fishman, D.; Fornolles, C.; Forshall, T.; Francioni, A.; Gent, S.; George, N.; Ibrahim, A.; Ingram, A.; James, R.; Dawa, K. Kabiru; Khan, F.; Khan, M. Aamaz; Lee, S.; Lingam, C.; Luximon, C. Nisha; Marcus, N.; Masood, M.; Mejri, R.; Moharram, A.; Moss, C.; Naik, G.; Ng, A. Yong Kheng Cordero; Nicholls, L.; Nisar, M.; Parmar, V.; Raj, F. Prasanth; Puisa, V.; Quick, V.; Ramabhadran, B.; Reddy, A.; Riaz, N.; Rudran, B.; Sabaretnam, S.; Sagoo, H.; Sarma, S.; Savlani, K.; Shah, P.; Shaw, D.; Soo, S.; Sothirajah, P.; Southern, I.; Tate, M. Louise; Travill, C.; Uppal, V. Singh; Wakeford, W.; Brown, T.; Andrews, J.; Baker-Moffatt, M.; Bamgboye, A.; Barnes, D.; Baryschpolec, S.; Bell, L.; Borbone, J.; Broadway, M.; Brogan, F.; Bungue-Tuble, R.; Burrows, K.; Chauhan, A.; Chauhan, M.; Cowan, E.; Darbyshire, A.; Davey, M.; David, M.; Denham, J.; Downe, H.; Edwards, C.; Fox, L.; Garner, Z.; Giles, B.; Gribbin, A.; Harrington-Davies, Y.; Hawes, L.; Hicks, A.; Hossain, E.; Howe, S.; Jones, B.; Lameirinhas, C.; Longhurst, B.; Mamman, M.; McCready, S.; Minnis, C.; Moon, M.; Mouland, J.; Murray, L.; Rose, S.; Rupani, H.; Rutgers, M.; Scorrer, T.; Scott, K.; Thornton, R.; Tiller, A.; Turner, C.; Wands, M.; Watkins, L.; White, M.; Wiffen, L.; Winter, J.; Winn, S.; Wake, R.; Sadiq, S. Ahamed; Aldana, A.; Al-Hakim, B.; Agyapong, K. Ansu; Azzopardi, G.; Chicano, R.; Chukwulobelu, I.; Colbeck, N.; Cole, N.; Dogra, R.; Doherty, E.; Elradi, A.; Emberton, J.; Evans, T. J.; Ganapathy, R.; Haque, M.; Hayre, R.; Jain, S.; Jian, K.; Johnson, L.; Johnson, A.; Kotecha, J.; Kundu, A.; Langer, D.; Mashhoudi, Y.; Mathias, K.; Maxan, M. E.; Mellor, F.; Morgan, M.; Nafees, S.; Sai, V. Bharadwaj Palagiri; Phanish, M.; Rahimi, H. Rana; Ramanna, S.; Ratoff, J.; Rozewicz, S.; Samuel, T. D. L.; Shah, B.; Shahnazari, S.; Shail, R.; Sharif, A.; Somalanka, S.; Suckling, R.; Swift, P.; Tyagi, V.; Vilimiene, N.; Wells, C.; Maseda, D.; Ball, C.; Best, K.; Bridgwood, G.; Broadhurst, R.; Brockelsby, C.; Brockley, T.; Brown, J.; Bujazia, R.; Clarke, S.; Cremona, J.; Dixon, C.; Dowson, S.; Drogan, H.; Duncan, F.; Emmett, C.; Emms, M.; Farooq, H.; Fullerton, D.; Gabriel, C.; Hammersley, S.; Hum, R.; Jones, T.; Kay, S.; Kelly, E.; Kidd, M.; Lees, D.; Lowsby, R.; Matovu, E.; McIntyre, K.; Moulton, H.; Nourein, K.; Nytianandan, G.; O'Brian, M.; Pagett, K.; Ritchings, A.; Smith, S.; Taylor, J.; Thomas, K.; Turbitt, K.; Yasmin, S.; Spittle, N.; Weatherly, N.; Beavis, S.; Beghini, S.; Blundell, L.; Bradder, J.; Cort, J.; Cresswell, J.; Dale, K.; Foo, A.; Gardner, J.; Gascoyne, R.; Hall, E.; Kelly-Baxter, M.; Mackay, E.; Moxham, K.; Padmakumar, A.; Pritchard, K.; Salmon, J.; Smith, A.; Sorice, V.; Stevenson, L.; Whileman, A.; Wolodimeroff, E.; Meda, M.; Democratis, J.; Barnes, N.; Brooks, N.; Chapman, L.; da Rocha, J.; Dolman, R.; Edwards, A.; Foster, T.; Fowe, F.; Gaywood, E.; Gee, S.; Jaiswal, S.; Molloholli, M.; Raguro, A.; Regan, F.; Rowe-Leete, L.; Smith, C.; van de Venne, M.; Weerasinghe, T.; Jeffery, K.; Ainsworth, M.; Arnison-Newgass, C.; Bashyal, A.; Beer, S.; Bloss, A.; Buttress, D.; Byrne, W.; Capp, A.; Carter, P.; Cicconi, P.; Corrigan, R.; Coston, C.; Cowen, L.; Davidson, N.; Downs, L.; Edwards, J.; Evans, R.; Gardiner, S.; Georgiou, D.; Gillesen, A.; Harin, A.; Havinden-Williams, M.; Haynes, R.; Hird, C.; Hudak, A.; Hutton, P.; Irons, R.; Jastrzebska, P.; Johnston, S.; Kamfose, M.; Lewis, K.; Lockett, T.; del Rocio, F. Mendoza Maria; Garrido, J. Carlos Martinez; Masih, S.; Mentzer, A.; Morris, S.; O'Callaghan, C.; Oliver, Z.; Paulus, S.; Perez, E.; Periyasamy, L.; Peto, L.; Porter, D.; Prasath, S.; Purdue, C.; Ramasamy, M.; Roehr, C. C.; Rudenko, A.; Sanchez, V.; Sarfatti, A.; Segovia, M.; Sewdin, T.; Seymour, J.; Skinner, V.; Smith, L.; Diaz, A. Sobrino; Taylor-Siddons, M.; Thraves, H.; Tsang, C.; Vatish, M.; Warren, Y.; Wilcock, E.; Khan, B.; Ail, D.; Aldouri, R.; Awadzi, G.; Bassoy, B.; Bhalla, R.; Billings, J.; Bokhari, S.; Boniface, G.; Cernova, J.; Chen, T.; Chimbo, P.; Chitalia, N.; Bamfo, S. Danso; Depala, D.; Dhanoa, A.; Edmunds, T.; Fernandez, E.; Ferrari, T.; Fuller, B.; Gherman, A.; Heire, R.; Ilves, L.; Lacey, L.; Lawrence, E.; Lewis, M.; Maric, A.; Martin, W.; Min, Z.; Newman, C.; Nicholas, R.; Olufuwa, O.; Pieniazek, N.; Qadeer, T.; Rathore, S.; Sathianandan, S.; Scott, C.; Shonubi, A.; Siddique, S.; Sisson, G.; Soan, M.; Streit, D.; Stuart, C.; Szekely, M.; Umeojiako, W.; Urruela, S.; Warner, B.; Waterstone, M.; White, S.; Yip, K.; Zafar, A-M; Zaman, S.; West, R.; Abrams, J.; Baldwin, A.; Bannister, O.; Barker, J.; Beddall, H.; Blamey, H.; Chan, E.; Chaplin, J.; Chisnall, B.; Cleaver, C.; Crotty, S.; Dey, P.; Downs, L.; Kononen, M.; Kudsk-Iversen, S.; Kudzinskas, A.; Laurenson, M.; Mandeville, J.; McLure, S.; Morgan-Smith, E.; Ngumo, A.; Oxlade, R.; Parekh, A.; Rahman, M.; Robertson, C.; Shah, S.; Tebbutt, J.; Vella, N.; Veres, M.; Watson, A. J. R.; Wong, N.; Zammit-Mangion, M.; Zia, M.; Gray, A.; Baillie, K.; Adam, M.; Anand, A.; Anderson, R.; Baird, D.; Balaskas, T.; Balfour, J.; Black, P.; Blackstock, C.; Brady, S.; Campbell, R.; Carter, J.; Chapman, P.; Cheyne, C.; Christides, A.; Christmas, D.; Crisp, L.; Cryans, D.; Dear, J.; Dhaliwal, K.; Docherty, M.; R, Dodds; Donald, L.; Dummer, S.; Eddleston, M.; Fethers, N.; Foster, E.; Frake, R.; Gaughan, E.; D, Gilliland; Godson, E.; Grahamslaw, J.; Grant, A.; Grubb, N.; Hainey, S.; Harding, Z.; Harris, M.; Harvey, M.; Henshall, D.; Hobson, S.; Hunter, N.; Jaly, Y.; Jameson, J.; Japp, D.; Khin, H. Htet Ei; Kitto, L.; Krupej, S.; Langoya, C.; Lawrie, R.; Lloyd, A.; Lyell, B.; Lynch, D.; Macfarlane, J.; MacInnes, L.; MacRaild, A.; Marecka, M.; Marshall, A.; Martin, M.; McCann, C.; McCurrach, F.; Moatt, E.; Morley, W.; Morrissey, M.; Newby, D.; Din, K. Nizam Ud; O'Brien, R.; O'Sullivan, E.; Odam, M.; Peterson, A.; Phelan, P.; Pickering, G.; Quinn, T.; Robertson, N.; Rooney, L.; Rowan, N.; Salman, R.; Small, E.; Stefanowska, P.; Stevenson, A.; Stock, S.; Summers, A.; Teasdale, J.; Walker, I.; Walker, K.; Williams, A.; Wight, A.; Bailey, L.; Bokhari, S. Owais; Brownlee, S.; Bull, A.; Corless, J.; Denmade, C.; Ellard, N.; Farrell, A.; Hufton, A.; Jacob, R.; Jones, K. Elizabeth; Kerss, H.; McEntee, J.; Morris, N.; Myagerimath, R.; Newcombe, T.; Parsonage, M.; Peake, H.; Pearson, D.; Penfold, R.; Rath, S.; Saunders, R.; Sharp, A.; Spencer, B.; Suliman, A.; Sutton, S.; Tan, H.; Tarpey, D.; Thompson, L.; Thornton, T.; Twohey, E.; Wagstaff, D.; Wahbi, Z.; Williams, S.; Phull, M.; Umaipalan, A.; Ah-Chuen, J.; Ainsley, A.; Baijiu, G.; Basumatary, A.; Calderwood, C.; Dugh, P.; Dunne, K.; Greaves, P.; Hunt, K.; Islam, M.; Katsande, V.; Khan, M. R.; King, S.; Loverdou, A.; McGregor, A.; Misbahuddin, A.; Mohamed, A.; Nagesh, N.; Nicholls, D.; O'Brien, N.; Parker, L.; Pogreban, T.; Rosaro, L.; Salciute, E.; Sharma, M.; Smith, H.; Visentin, E.; Walshaw, L.; Saralaya, D.; Akhtar, N.; Beckett, V.; Brear, L.; Drew, V.; Eedle, J.; Hawes, N.; Kmachia, S.; Moss, S.; Oddie, S.; Paget, J.; Regan, K.; Ryan-Wakeling, D.; Shenoy, A.; Storton, K.; Swingler, R.; Syson, J.; Todd, J.; Wane, R.; Wilson, A.; Fuller, E.; MacNair, A.; Brown, C.; Burns, A.; Caroline, C.; Davidson, R.; Dickson, M.; Duncan, B.; Elkaram, N.; Emmerson, I.; Fairlie, L.; Hashimm, M.; Henderson, J.; Hinshaw, K.; Holden, J.; Hovvels, R.; Laybourne, S.; Madgwick, P.; Martin, K.; McKee, M.; Moore, J.; Mullen, N.; Murphy, P.; Palmer, L.; Parish, G.; Rangar, M.; Shahrul, R.; Smith, A.; Smith, L.; Smith, M.; Stidolph, B.; Terry, L.; Trotter, A.; Wakinshaw, F.; Walton, E.; Walton, M.; Frise, M.; Arimoto, R.; Black, S.; Camm, C.; Coles, H.; De Berker, H.; Fries, A.; Gabbitas, E.; Hasan, N.; Htet, Z.; Jacques, N.; Kashif, S.; Keating, L.; Leafe, S.; Milne, Z.; Mitchell, B.; Okeke, T.; Orchard, W.; Parmar, A.; Raffles, M.; Shields, N.; Thakker, M.; Thomas, M.; Wakefield, H.; Walden, A.; Moreno-Cuesta, J.; Rokadiya, S.; Govind, A.; Haldeos, A.; Leigh-Ellis, K.; van Someren, C.; Vincent, R.; Walker, L.; Thomas, K.; George, T.; Cannon, E.; Ikomi, A.; Jayasekera, L.; Kittridge, L.; Maloney, G.; Manoharan, B.; Mushabe, M.; Nicholson, A.; Pai, A.; Riches, J.; Samuel, J.; Setty, N.; Solesbury, A.; Southam, D.; Tisi, S.; Vertue, M.; Wadsworth, K.; Yung, B.; Limb, J.; Atkinson, V.; Birt, M.; Brown, E.; Cowton, A.; Craig, V.; Egginton, D.; Fernandes, D.; Ivy, A.; Jayachandran, D.; Jennings, J.; Kay, A.; Kent, M.; McAuliffe, S.; Naylor, S.; Nyamugunduru, G.; O'Brien, J.; Postlethwaite, K.; Potts, K.; Ranka, P.; Rogers, G.; Sen, S.; Temple, J.; Wadd, S.; Walters, H.; Yorke, J.; Whittington, A.; Adamus, M.; Barrett, J.; Cawa, F.; Chhabra, S.; Chita, S.; Dhillon, E.; Filson, S. Ann; Goodall, J.; Gravell, R.; Gupta-Wright, A.; Gurram, S.; Houston, H.; Hulston, G.; Isralls, S.; Kukadiya, C.; Lang, M.; MaeLow, J.; Macleod, C.; Milburn, J.; Muralidhara, K.; Nayar, B.; Ojo, O.; Papineni, P.; Parris, V.; Patel, M.; Quaid, S.; Sethi, J.; Sturdy, A.; Tyagi, B.; Vaccari, L. Cheyenne; van der Stelt, N.; Wallis, G.; Watson, E.; Sarkar, R.; Ahmed, I.; Ahmed, S.; Ambler, S.; Babatunde, F.; Banerjee, S.; Bhatia, N.; Brassington, L.; Brokke, F.; Bruce, D.; Cassimon, B.; Chauhan, R. Singh; Chengappa, A.; Divikar, N.; Donnelly, C.; Froneman, C.; Gnanalingam, C.; Gower, T.; Harizaj, H.; Hettiarachchi, G.; Hollands, M.; Jansz, S.; Josiah, B.; Kamara, M.; Kidney, S.; Kyere-Diabour, T.; Lewiston, K.; Miah, N.; Millington, S.; Mires, L.; Mitchell, A.; Mizzi, C.; Naicker, K.; Petrou, I.; Phulpoto, M. Mubeen; Ross-Parker, A.; Ramadan, I.; Roy, A.; Ryan, A.; Samuels, E.; Sanctuary, T.; Sharma, A.; Singham, S.; Sporrer, J.; Ul Hassan, W.; Vankayalapati, P.; Velan, B.; Smith, L. Vincent; Vyras, E.; Wood, J.; Zuhra, N.; Clare, S.; Ahmed, M. Cecilia; Beuvink, Y.; Blachford, K.; Clamp, S.; Colley, J.; De, P.; Fenton, M.; Gammon, B.; Hayes, A.; Henry, L.; Hussain, S.; Joseph, S.; Kinney, F.; Knight, T.; Kumar, R.; Leong, W.; Lim, T.; Mahay, B.; Nupa, Y.; Orme, A.; Osborne, W.; Pilsworth, Z.; Potter, S.; Prew, S.; Rajaiah, N.; Rajasekaran, A.; Senya, H.; Shah, N.; Shamim, N.; Sivakumar, S.; Smith, L.; Thozthumparambil, P.; Trudgill, N.; Turner, A.; Wagstaff, L.; Willetts, S.; Willis, H.; Yan, M.; Richardson, N.; Alegria, A.; Kapoor, R.; Adegoke, K.; Allen, L.; Beranova, E.; Boehmer, G.; Crisp, N.; Deery, J.; Hansen, J.; Elgohary, A.; Elsefi, T.; Hargreaves, C.; Hazelton, T.; Hulbert, R.; Ionita, A.; Knight, A.; Linares, C.; Loader, D.; Matisa, E.; McAndrew, J.; Montasser, M.; Moon, A.; Oboh, C.; Offord, P.; Price, C.; Rajasri, A.; Rand, J.; Schumacher, N.; Stephensen, D.; Stirrup, S.; Tague, L.; Tilbey, S.; Turney, S.; Vasu, V.; Venditti, M.; Weston, H.; Woodward, Z.; Kemp, T.; Alexander, J.; Al-Shamkhani, W.; Bandla, N.; Bland, A.; Bodasing, N.; Cadwgan, A.; Chaudhary, M. Yafaa Naveed; Cheng, L. Yin; Church, S. Rebecca; Clark, F.; Davies, M.; Diwakar, L.; Eaton, E.; Evans, M.; Farmer, A.; Farook, F.; Gellamucho, M.; Glover, K.; Haris, M.; Humphries, J.; Hussain, I.; Khan, S.; Korcierz, L.; Lee, J.; Machin, J.; Marshall, J.; McCreedy, H.; Muddegowda, G.; Mustapha, I.; Nettleton, K.; Noori, Z.; Osman, W.; Parker, H.; Patel, N.; Quinn, A.; Ram, M.; Remegoso, A.; Scott, T.; Sheikh, N.; Swiftx, R.; Thompson, C.; Tomlinson, J.; Turner, H.; Walker, L.; Weeratunga, J.; White, C.; White, J.; Wu, P.; Szakmany, T.; Champanerkar, S.; Griffiths, A.; Ionescu, A. Alina; Somashekar, C.; Zalewska, K.; Aitken, L.; Baker, E.; Barnett, D.; Brouns, M.; Cann, J.; Cherian, S.; Codd, R.; Cutler, S.; Davies, W.; Dell, A.; Edwards, M.; Edwards, S.; Fairbairn, S.; Hawkins, N.; Hodge, S.; Hodkinson, G.; Hughes, R.; Ivenso, C.; James, T.; Jones, M.; Jones, S.; Lucey, A.; MacCormac, J.; Marshall, G.; McKain, S.; Nassa, H.; Northfield, J.; Palmer, S.; Peter, L.; Price, C.; Pynn, M.; Roynon-Reed, A.; Shipp, L.; Singh, J.; Singh, M.; Swarnkar, K.; Torabi, P.; Venkataramakrishnan, R.; Wall, E.; Waters, A.; Wild, K.; Winstanley, M.; Wyness, K.; Kushakovsky, V.; Ramali, M.; Alam, S.; Bartholomew, S.; Bataineh, A.; Beeby, D.; Bell, S.; Broughton, N.; Buckman, C.; Calver, C.; Campbell, J.; Chabo, C.; Chowdhury, M.; Cooke, K.; Deole, N.; Driscoll, C.; Elden, A.; Eldew, H.; Entwistle, N.; Farnworth, F.; Francis, R.; Galloway, E.; Garfield, M.; Ghosh, A.; Gray, G.; Greenfield, P.; Hadjiandreou, M.; Hewer, H.; Hossain, M. S.; Howard-Griffin, R.; Islam, A.; Jamieson, E.; Jiao, Z.; Johannessen, K.; Lee, S. Han; Lewis, R.; Lloyd, R.; Mabelin, L. Andrew; Morris, D.; Nallapareddy, S.; Ooi, H. C.; Osagie, R.; Parkinson, C.; Patel, H.; Prowse, H.; Purewal, B.; Ridley, P.; Rivers, V.; Rosier, J.; Sharma, S.; Sheik, A.; Skelly, R.; Smith, R.; Sreenivasan, R.; Taylor, A.; Tovey, P.; Turner, A.; Turner, K.; Vithian, K.; Zhixin, J.; Potton, E.; Jain, N.; Khadar, A.; Morgan, P.; Penny, J.; Tatam, E.; Abbasi, S.; Acharya, D.; Acosta, A.; Ahmed, L.; Ali, S.; Alkhusheh, M.; Amosun, V.; Arter, A.; Babi, M.; Bacon, J.; Bailey, K.; Balachandran, N.; Bandyopadhyam, S.; Banks, L.; Barla, J.; Batty, T.; Bax, S.; Belgaumkar, A.; Benison-Horner, G.; Boles, A.; Broomhead, N.; Cetti, E.; Chan, C.; Chaudhry, I.; Chudgar, D.; Clark, J.; Clueit, S.; Collins, S.; Combes, E.; Conway, G.; Curtis, O.; Das, M.; Daschel, M.; Davies, S.; Potton, E.; Abbasi, S.; Acharya, D.; Acosta, A.; Ahmed, L.; Ali, S.; Alkhusheh, M.; Amosun, V.; Arter, A.; Babi, M.; Bacon, J.; Bailey, K.; Balachandran, N.; Bandyopadhyam, S.; Banks, L.; Barla, J.; Batty, T.; Bax, S.; Belgaumkar, A.; Benison-Horner, G.; Boles, A.; Broomhead, N.; Cetti, E.; Chan, C.; Chaudhry, I.; Chudgar, D.; Clark, J.; Clueit, S.; Collins, S.; Combes, E.; Conway, G.; Curtis, O.; Das, M.; Daschel, M.; Davies, S.; Day, A.; Dhar, M.; Diaz-Pratt, K.; Dragan, C.; Dube, H.; Duraiswamy, V.; Elias, J.; Ellis, A.; Ellis, T-Y; Emmanuel, J.; Engden, A.; Fahmay, Y.; Field, B.; Fishwick, K.; Ganesh, U.; Gilbert, C.; Giokanini-Royal, T.; Goudie, E.; Griffith, S.; Gurung, S.; Habibi, R.; Halevy, C.; Haqiqi, A.; Hartley, R.; Hayman, A.; Hives, J.; Horsford, M.; Hughes, S.; Hui, C.; Hussain, R.; Iles, C.; Jackson, L.; James, A.; Jayaram, D.; Jessup-Dunton, E.; Joefield, T.; Khan, N.; Kieffer, W.; Knox, E.; Kumar, V.; Kumar, R.; Kurmars, V.; Lafferty, H.; Lamb, F.; Layug, R.; Leitch, N.; Lim, W.; Limbu, U.; Loveless, R.; Mackenzie, M.; Maghsoodi, N.; Maher, S.; Maljk, M.; Man, I.; McCarthy, N.; Mearns, B.; Mearns, C.; Morgan-Jones, K.; Mortem, G.; Morton, G.; Moya, B.; Murphy, G.; Mutton, S.; Myers, A.; Nasser, T.; Navaratnam, J.; Nazir, S.; Nepal, S.; Nimako, K.; Nimako, L.; O'Connor, C.; Patel, A.; Patel, K.; Phongsathorn, V.; Pillai, P. A.; Poole, M.; Qureshi, N.; Ranjan, S.; Rehman, A.; Samuels, T.; Scott, E.; Sekadde, G.; Sharma, A.; Sharp, G.; Shotton, S.; Simmons, O.; Singh, P.; Smith, S.; Paranthamen, K. Sri; Suresh, S.; Thevarajah, K.; Thomas, L.; Timms, H.; Tomasova, N.; Tucker, S.; Vara, S.; Vaz, C.; Weller, S.; White, J.; Wilde, M.; Wilkinson, I.; Williams, C.; Win, M.; Woosey, D.; Wright, D.; Roberts, M.; Amsha, K.; Cox, G.; Downer, N.; Hodgson, D.; Hutchinson, J.; Kalsoom, S.; Molyneux, A.; Noor, Z.; Allsop, L.; Brear, T.; Buckley, P.; Dunn, L.; Gill, M.; Goodwin, C.; Heeley, C.; Holmes, M.; Holmes, R.; Langthorne, E.; Moulds, C.; Nash, D.; Rajeswary, J.; Shelton, S.; Slack, K.; Smith, S.; Valeria, B.; Wynter, I.; Yanney, M.; Ynter, I.; Azam, J.; Chandler, K. J.; Abdelfattah, M.; Abung, A.; Anderson, J.; Antill, P.; Appleby, S.; Armtrong, P.; Berriman, T.; Bull, D.; Clayton, O.; Corlett, A.; Crocombe, D.; Davies, S.; Elliott, K.; Fahel, L.; Ghosh, J.; Gott, N.; Greenwood, D.; Holder, T.; Inns, P.; Lea, W.; Lindsay, E.; Mack, K.; Marshall, N.; McMeekin, S.; Momoniat, T.; Nikolaos, P.; O'Kane, M.; Patrick, G.; Pearson, H.; Ponnusamy, P.; Poole, A.; Price, N.; Proudfoot, R.; Purssord, G.; Roche, S.; Sefton, C.; Shahi, S.; Smith, D.; Sohail, B.; Thomas, R.; Turnbull, A.; Turner, L.; Watchorn, H. J.; Wiafe, E.; Wilson, J.; Yates, D.; Bruce, M. Schuster; Baldwin, D.; Clark, Z.; Dale, M.; Griffiths, D.; Gunter, E.; Horler, S.; Joyce, T.; Keltos, M.; Kennard, S.; Lakeman, N.; Mallon, L.; Miln, R.; Nix, S.; Orr, S.; Pitts, S.; Purandare, L.; Rogers, L.; Samways, J.; Stride, E.; Vamplew, L.; Wallis, L.; Willis, J.; Blencowe, N.; Singhal, P.; Abraham, M.; Al-Ramadhani, B.; Archer, A.; Aziz, G.; Balcombe, A.; Bateman, K.; Baxter, M.; Beacham, L.; Belfield, K.; Bell, N.; Beresford, M.; Bernatoniene, J.; Bhojwani, D.; Biggs, S.; Blazeby, J.; Bobruk, K.; Brown, N.; Buckley, L.; Butler, P.; Caws, C.; Chakkarapani, E.; Chatar, K.; Chivima, B.; de la Torre, C. Clemente; Cobain, K.; Cotterill, D.; Courtney, E.; Cowman, S.; Coy, K.; Crosby, H.; Curtis, K.; Davis, P.; Drewett, O.; Dymond, H.; Edgerley, K.; Ekoi, M.; Elokl, M.; Evans, B.; Farmery, T.; Fineman, N.; Finn, A.; Gamble, L.; Garty, F.; Gibbison, B.; Gourbault, L.; Grant, D.; Gregory, K.; Griffin, M.; Groome, R.; Hamdollah-Zadeh, M.; Hannington, A.; Heywood, J.; Hindmarsh, A.; Holling, N.; Houlihan, R.; Hrycaiczuk, J.; Hudson, H.; Hurley, K.; Jarvis, R.; Jeffs, B.; Jones, A.; Jones, R. E.; King-Oakley, E.; Kirkham, E.; Kumar, R.; Kurdy, M.; Kyle, L.; Lang, S.; Leandro, L.; Legge, H.; Loro, F.; Low, A.; Martin, H.; McCullagh, L.; McMahon, G.; Millett, L.; Millington, K.; Mok, J.; Moon, J-H; Morgan, L.; Mulligan, S.; O'Donovan, C.; Payne, E.; Penman, C.; Pickard, J.; Plumptre, C.; Ramanan, A.; Ramirez, J.; Ratcliffe, S.; Robinson, J.; Roderick, M.; Scattergood, S.; Schadenberg, A.; Sheppeard, R.; Shioi, C.; Simpson, D.; Skorko, A.; Squires, R.; Stuttard, M.; Sugden, P.; Sundar, S.; Swart, T.; Swift, E.; Thompson, K.; Turner, K.; Turner, S.; Tyer, A.; Vergnano, S.; Vincent, R.; Ward, R.; Wilkinson, S.; Williams, J.; Williams, S.; Willis, J.; Winter, H.; Woollen, L.; Wright, R.; Ibrahim, A. Younes; Collini, P.; Ang, A.; Belcher, J.; Chapman, L.; Chin, K.; Cohen, D.; Cole, J.; Colton, H. E.; Condliffe, R.; Cribb, M.; Curran, S.; Darton, T.; de Fonseka, D.; de Silva, T.; Dunn, A.; Ferriman, E.; Foster, R. Anne; Greig, J.; Hall, J.; Haq, M. Ul; Hardman, S.; Headon, E.; Holden, C.; Hunt, L.; Hurditch, E.; Kibutu, F.; Kitching, T.; Lewis, L.; Locke, T.; Mair, L.; May, P.; Meiring, J.; Middle, J.; Middleton, J. T.; Morris, P.; Newman, T.; Passby, L.; Payne, R.; Rana, G. Farid; Renshaw, S.; Rothman, A.; Sammut, D.; Sherwin, S.; Simpson, P.; Sterrenburg, M.; Stone, B.; Surtees, M.; Telfer, A.; Thompson, R.; Vethanayagam, N.; West, R.; Williams, T.; Patel, K.; Imray, C.; Aldridge, N.; Campbell, A.; Evans, G.; French, E.; Grenfell, R.; Hewins, S.; Hewitt, D.; Jones, J.; Kumar, R.; Mshengu, E.; Quenby, S.; Read, K.; Satodia, P.; Sear, E.; Truslove, M.; Kerry, A.; Beale, A.; Brooks, A.; Browne, C.; Butler, J.; Callaghan, J.; Chandrasekaran, B.; Coombs, C.; Davies, R.; Davies, L.; Elias, T.; Fowler, E.; Gowda, G.; Gregory, J.; Ipe, A.; Jaffery, A.; Jones, Q.; Kyeremeh, L.; Laing-Faiers, I.; Langton, H.; Lewis-Clarke, C.; Mackinlay, C.; Mappa, P.; Maxwell, A.; Mears, W.; Mousley, E.; Onyirioha, T.; Pannell, L.; Peglar, S.; Pereira, A.; Pointon, J.; dos Reis, I. Ponte Bettencourt; Price, E.; Quayle, A.; Qurratulain, Q.; Small, S.; Smith, H.; Stratton, E.; Tinkler, M.; van der Meer, A.; Wakefield, E.; Waller, R.; Walton, M.; Watters, M.; Whittam, L.; Wiliams, T.; Xia, Z.; Yein, K.; Zinyemba, V.; Cupitt, J.; Ahmed, N.; Assaf, O.; Barnett, A.; Benham, L.; Bradley, P.; Bradshaw, Z.; Brunton, M.; Capstick, T.; Caswell, M.; Cunliffe, V.; Downes, R.; Latt, N.; McDonald, R.; Mulla, A.; Mutema, E.; Navin, J.; Parker, A.; Preston, S.; Slawson, N.; Stoddard, E.; Traynor, S.; Vasudevan, V.; Ward, E.; Warden, S. Andrew; Wilson, J.; Zmierczak, A.; Bari, S.; Higham, A.; Al-Jibury, M.; Allison, K.; Anu, V.; Bartlett, C.; Bhuiyan, S.; Bishop, L.; Burns, K.; Davies, A.; Fielding, A.; Gorst, M.; Hay, C.; Keating, J.; Khan, T.; Mahmood, F.; Mallinder, P.; Peters, S.; Power, D.; Ritchie, J.; Simpson, K.; Spickett, H.; Stokes, C.; Thatcher, H.; Varghese, A.; Wan, T.; Wood, F.; Convery, R.; Acheson, J.; Brannigan, J.; Cosgrove, D.; McCullough, C.; McFarland, D.; McNulty, R.; Sands, S.; Thompson, O.; Balasubramaniam, M.; Subudhi, C.; Acton, C.; Ajmi, A.; Ahmed, R.; Ajmi, A.; Al-Asadi, A.; Amin, A.; Bajandouh, A.; Bhalme, M.; Carrington, Z.; Chadwick, J.; Cocks, S.; Dawe, C.; Eusuf, A.; Farzana, S.; Hill, P.; Holmes, R.; Hughes, G.; Hull, R.; Ibrahim, K.; Ijaz, M.; Kalayi, R. J.; Khurana, S.; Latham, S.; Lipscomb, K.; Lomas, J. P.; Natarajan, N.; Nethercott, D.; Nicholas, P.; Obeng, D.; Priyash, V.; Rhead, K.; Saleh, M.; Sharma, O.; Shehata, Z.; Shurmer, J.; Sime, R.; Singh, S.; Smith, R.; Tanton, E.; Tewkesbury, D.; Thet, P.; Thornton, S.; Wang, N.; Watts, M.; Webster, I.; Easom, N.; Adams, K.; Baldwin, L.; Barlow, G.; Barton, R.; Bexhell, H.; Clark, D.; Gunasekera, P.; Harvey, A.; Hayes, M.; Ivan, M.; James, A.; Kassianides, X.; Khan, S.; Kolodziej, M.; Lillie, P.; Mathew, V.; Mongolu, S.; Muazzam, I. A.; O'Reilly, P.; Perinpanathan, T.; Philbey, C.; Pickwell-Smith, B.; Rollins, L.; Samson, A.; Sathyapalan, T.; Sherris, L.; Sivakumar, K.; Taynton, T.; Yates, H.		RECOVERY Collaborative Grp; Publ Heth England; Dept Hlth Social Care DHSC; DHSC Med Supply Contingency; NHS England; NHS Improvement; Movianto UK Ltd; Supply Chain Coordination Ltd	Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial	LANCET			English	Article								Background Azithromycin has been proposed as a treatment for COVID-19 on the basis of its immunomodulatory actions. We aimed to evaluate the safety and efficacy of azithromycin in patients admitted to hospital with COVID-19. Methods In this randomised, controlled, open-label, adaptive platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), several possible treatments were compared with usual care in patients admitted to hospital with COVID-19 in the UK. The trial is underway at 176 hospitals in the UK. Eligible and consenting patients were randomly allocated to either usual standard of care alone or usual standard of care plus azithromycin 500 mg once per day by mouth or intravenously for 10 days or until discharge (or allocation to one of the other RECOVERY treatment groups). Patients were assigned via web-based simple (unstratified) randomisation with allocation concealment and were twice as likely to be randomly assigned to usual care than to any of the active treatment groups. Participants and local study staff were not masked to the allocated treatment, but all others involved in the trial were masked to the outcome data during the trial. The primary outcome was 28-day all-cause mortality, assessed in the intention-to-treat population. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936. Findings Between April 7 and Nov 27, 2020, of 16 442 patients enrolled in the RECOVERY trial, 9433 (57%) were eligible and 7763 were included in the assessment of azithromycin. The mean age of these study participants was 65.3 years (SD 15.7) and approximately a third were women (2944 [38%] of 7763). 2582 patients were randomly allocated to receive azithromycin and 5181 patients were randomly allocated to usual care alone. Overall, 561 (22%) patients allocated to azithromycin and 1162 (22%) patients allocated to usual care died within 28 days (rate ratio 0.97, 95% CI 0.87-1.07; p=0.50). No significant difference was seen in duration of hospital stay (median 10 days [IQR 5 to >28] vs 11 days [5 to >28]) or the proportion of patients discharged from hospital alive within 28 days (rate ratio 1.04, 95% CI 0.98-1.10; p=0.19). Among those not on invasive mechanical ventilation at baseline, no significant difference was seen in the proportion meeting the composite endpoint of invasive mechanical ventilation or death (risk ratio 0.95, 95% CI 0.87-1.03; p=0.24). Interpretation In patients admitted to hospital with COVID-19, azithromycin did not improve survival or other prespecified clinical outcomes. Azithromycin use in patients admitted to hospital with COVID-19 should be restricted to patients in whom there is a clear antimicrobial indication. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.	[Horby, P.; Landray, M. J.; Haynes, R.; Fletcher, L.; Barton, J.; Basoglu, A.; Brown, R.; Brudlo, W.; Denis, E.; Howard, S.; McChlery, G.; Taylor, K.; Cui, G.; Goodenough, B.; King, A.; Lay, M.; Murray, D.; Stevens, W.; Wallendszus, K.; Welsh, R.; Crichton, C.; Davies, J.; Goldacre, R.; Harper, C.; Knight, F.; Latham-Mollart, J.; Mafham, M.; Nunn, M.; Salih, H.; Welch, J.; Campbell, M.; Pessoa-Amorim, G.; Peto, L.; Roddick, A.; Knott, C.; Wiles, J.; Bell, J. L.; Emberson, J.; Juszczak, E.; Linsell, L.; Spata, E.; Staplin, N.; Bagley, G.; Cameron, S.; Chamberlain, S.; Farrell, B.; Freeman, H.; Kennedy, A.; Whitehouse, A.; Wilkinson, S.; Wood, C.; Reith, C.; Davies, K.; Halls, H.; Holland, L.; Wilson, K.; Howie, L.; Lunn, M.; Rodgers, P.] RECOVERY Cent Coordinating Off, Oxford OX3 7LF, England; [Barnard, A.; Beety, J.; Birch, C.; Brend, M.; Chambers, E.; Chappell, L.; Crawshaw, S.; Drake, C.; Duckles-Leech, H.; Graham, J.; Harman, T.; Harper, H.; Lock, S.; Lomme, K.; McMillan, N.; Nickson, I.; Ohia, U.; OKell, E.; Poustie, V.; Sam, S.; Sharratt, P.; Sheffield, J.; Slade, H.; Hoff, W. Van't; Walker, S.; Williamson, J.; De Soyza, A.; Dimitri, P.; Faust, S. N.; Lemoine, N.; Minton, J.; Gilmour, K.; Pearson, K.; Armah, C.; Campbell, D.; Cate, H.; Priest, A.; Thomas, E.; Usher, R.; Johnson, G.; Logan, M.; Pratt, S.; Price, A.; Shirley, K.; Walton, E.; Williams, P.; Yelnoorkar, F.; Hanson, J.; Membrey, H.; Gill, L.; Oliver, A.; Das, S.; Murphy, S.; Sutu, M.; Collins, J.; Monaghan, H.; Unsworth, A.; Beddows, S.; Williams, K. Barker; Dowling, S.; Gibbons, K.; Pine, K.; Asghar, A.; Aubrey, P.; Jewell, D. Beaumont; Donaldson, K.; Skinner, T.; Luo, J.; Mguni, N.; Muzengi, N.; Pleass, R.; Wayman, E.; Coe, A.; Hicks, J.; Hough, M.; Levett, C.; Potter, A.; Taylor, J.; Dolman, M.; Gerdes, L.; Hall, C.; Lockett, T.; Wessex, D. Porter; Bartholomew, J.; Dowden, L.; Rook, C.; Walters, J.; Denton, E.; Tinkler, H.; Alexander, A.; Campbell, H.; Chapman, K.; Hall, A.; Rodgers, A.; Boyle, P.; Brookes, M.; Callens, C.; Duffy, H.; Green, C.; Hampshire, K.; Harrison, S.; Kirk, J.; Naz, M.; Porter, L.; Ryan, P.; Shenton, J.; Warmington, J.; Amezaga, M.; Dicks, P.; Goodwin, J.; Hodgson, H.; Jackson, S.; Odam, M.; Williamson, D.] Natl Inst Hlth Res Clin Res Network, London, England; [Faust, S. N.; Bamford, A.; Bandi, S.; Bernatoniene, J.; Cathie, K.; Dmitri, P.; Drysdale, S.; Emonts, M.; Evans, J.; Finn, A.; Fleming, P.; Furness, J.; Gale, C.; Haynes, R.; Jones, C. E.; Juszczak, E.; Jyotish, D.; Kelly, D.; Murray, C.; Pathan, N.; Pollock, L.; Ramanan, A.; Riordan, A.; Roehr, C.; Wan, M.; Whittaker, E.] Paediat working Grp, London, England; [Chappell, L.; Hodson, K.; Knight, M.; Pavord, S.; Williamson, C.] Obstetr working Grp, London, England; [Brightling, C.; Brunskill, N.; Wiselka, M.; Adenwalla, S.; Andreou, P.; Bakoulas, P.; Bandi, S.; Batham, S.; Beaver, T.; Bhandal, K.; Bourne, M.; Boyles, L.; Cannon, M.; Charalambou, A.; Cheung, C. Kay; Cotter, R.; Diver, S.; Dunphy, A.; Elneima, O.; Fawke, J.; Finch, J.; Gardiner-Hill, C.; Genato, G.; Graham-Brown, M.; Haines, C.; Hargadon, B.; Holdsworth, H.; Ibrahim, W.; Ingram, L.; Silva, J. Antonio Jesus; Kaul, K.; Joshi, M.; Kapoor, S.; Kim, J. Whang; Kuverji, A.; Kyriaki, K.; Lea, A.; Lee, T.; Lewszuk, A.; Lock, L.; Macconaill, K.; Major, R.; McAuley, H.; McCourt, P.; Kutten, D. Mullasseril; Palfreeman, A.; Parker, E.; Patel, K.; Patterson, M.; Phillips, R.; Plummer, L.; Russell, R.; Debbie, S.; Selvaskandan, H.; Southin, S. Michaela; Tsilimpari, K. Karali; Wiesender, C.; Yousuf, A.] Univ Hosp Leicester NHS Trust, Leicester, Leics, England; [Ustianowski, A.; Raw, J.; Tully, R.; Abdusamad, K.; Antonina, Z.; Ayaz, E.; Blackledge, B.; Bradley, P.; Bray, F.; Bruce, M.; Carty, C.; Charles, B.; Connolly, G.; Corbett, C.; Dermody, S.; Durrans, L.; Falconer, E.; Flaherty, J.; Fox, C.; Hadfield, D.; Harris, J.; Hoggett, L.; Horsley, A.; Hussain, S.; Irving, R.; Jacob, P.; Johnstone, D.; Joseph, R.; Melville, J. Julie; Kamath, P.; Khatun, T.; Lamb, T.; Law, H.; Lazo, M.; Lindergard, G.; Lokanathan, S.; Macfarlane, L.; Mathen, S.; McCullough, S.; McMaster, P.; McSorland, D.; Mishra, B.; Munt, S.; Neal, A.; Newport, R.; O'Connor, G.; O'Riordan, D.; Page, I.; Parambil, V.; Philbin, J.; Pinjala, M. Tejha; Rishton, C.; Riste, M.; Rothwell, J.; Sam, M.; Sarwar, Z.; Scarratt, L.; Sengupta, A.; Sharaf, H.] Pennine Acute Hosp NHS Trust, Manchester, Lancs, England; [Prudon, B.; Jagannathan, V.; Adams, C.; Aung, N.; Barker, D.; Campbell, B.; Collins, V.; Deane, J.; Fenner, I.; Gowans, S.; Hartrey, W.; Nafei, M.; Poole, L.; Purvi, S.; Quigley, J.; Ramshaw, A.; Shepherd, L.; Skelton, J.; Srinivasan, R.; Taylor, R.; Walker, M.; Weetman, M.; Wetherall, B.; Wild, S.; Wilson, D.] North Tees & Hartlepool NHS Fdn Trust, Stockton On Tees, England; [Lim, W. S.; Ali, M.; Andrews, A.; Anderson, L.; Ashraf, S.; Ashton, D.; Babingto, G.; Bartlett, G.; Batra, D.; Bendall, L.; Benetti, N.; Brear, T.; Buck, A.; Bugg, G.; Butler, J.; Cammack, R. F. D.; Cantliff, J.; Clark, L.; Connor, E.; Davies, P.; Dent, M.; Dobson, C.; Fatemi, M.; Fatemi, A.; Fleming, L.; Grundy, J.; Hallas, J.; Hodgen, L.; Hodgson, S.; Hodgkinson, S.; Howard, L.; Hutchinson, C.; Jackson, B.; Kaur, J.; Keddie-Gray, E.; Khurana, C.; Langley, M.; Looby, L.; Meredith, M.; Morris, L.; Navarra, H.; Nicol, R.; Oliver, J.; Peters, C.; Petrova, B.; Rose, Z.; Ryan, L.; Sampson, J.; Squires, G.; Squires, J.; Taylor, R.; Thomas, A.; Thornton, J.; Topham, K.; Warburton, S.; Wardle, S.; Waterfall, H.; Wei, S.; Wildsmith, T.; Wilson, L.] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Chadwick, D.; Armstrong, S.; Athorne, D.; Branch, M.; Brolly, J.; Brown, S.; Cheaveau, J.; Chen, H. Min; Chua, Y.; Cunningham, N.; Dodds, J.; Dorgan, S.; Dunn, D.; Harper, P.; Harwood, H.; Hebbron, K.; Hunt, F.; Bhushan, A. Kala; Lambert, P.; Leaning, D.; Manders, T.; McCarron, B.; Miller-Biot, N.; Milne, C.; Mohammad, W.; Mollet, M.; Murad, A.; Owston, M.; Potts, J.; Proctor, C.; Rao, S.; Seelarbokus, M. A.; Singh, P.; Srirathan, V.; Swithenbank, L.; Thompson, L.; Wardy, H.; Wibli, L.; Widdrington, J.; Williams, J.; Winder, P.; Wroe, C.] South Tees Hosp NHS Fdn Trust, Middlesbrough, Cleveland, England; [Elmahi, E.; Zaman, M.; Abdul, B.; Abdulmumeen, A.; Abdulshukkoor, N.; Adnan, A.; Nazeer, M. H. Ahammed; Bazli, A.; Benesh, N.; Chin, W. Jie; Cunningham, N.; Daggett, H.; Davies, E.; Enyi, H.; Fawohunre, S.; Geoghegan, N.; Glover, J.; Hague, J. W.; Hall, K.; Hallett, C.; Haresh, K.; Hassan, W. Ul; Hewertson, J.; Hosea, J.; Htoon, N. Zaya; Idrees, M.; Igwe, C.; Imtiaz, H.; Irshad, M.; Ismail, A.; Jeffrey, R.; Jith, J.; Joshi, P.; Periyasami, R. Kaliannan; Khalid, A.; Khalid, M. Usman; Kodituwakku, R.; Lopez, P.; Mahmood, A.; Malanca, M.; Mapfunde, I. Tatenda; Maruthamuthu, V. Kumar; Masood, S.; Masood, S. S. M. E.; Matharu, M.; Merchant, A.; Merchant, F.; Naqvi, S.; Natarajan, R.; Natarajan, N.; Nawaz, K.; Ndefo, O.; Ogunkeye, O.; Paranamana, S.; Pugh, N.; Raj, A.; Rashid, K.; Rogers, M.; Saad, M.; Selvadurai, G.; Shah, A.; Shahzeb, M.; Shrestha, N.; Singh, A.; Smith, K.; Sohail, B.; Spinks, M.; Stockham, L.; Takyi, A.; Teoh, Y. He; Ullah, S.; Vayalaman, H.; Wafa, S. E. I.; Ward, T.; Watson, R.; White, D.; Melly, L. Ylquimiche; Zulaikha, R.] Northampton Gen Hosp NHS Trust, Northampton, England; [Green, C.; Whitehouse, T.; Ahmed, I.; Anderson, N.; Armstrong, C.; Bamford, A.; Bancroft, H.; Bates, M.; Begum, S.; Bellamy, M.; Bergin, C.; Bhandal, K.; Brandl-Salutz, E.; Buckingham, E.; Burke, E.; Carmody, M.; Cooper, L.; Daglish, J.; Dasgin, J.; Desai, A.; Dhani, S.; Dosanjh, D.; Ellis, H.; Gardiner, D.; Forster, E.; Grobovaite, E.; Hopkin, B.; Hull, D.; Hussain, Y.; Jones, J.; Khan, L.; Lenton, D.; Lewis, M.; Lovell, M.; Lowe, F.; Lynch, D.; McGhee, C.; McNeill, C.; Moore, F.; Nilsson, A.; Nunnick, J.; Prest, C.; Price, V.; Rhodes, J.; Sale, J.; Sangombe, M.; Smith, H.; Storey, I.; Thrasyvoulou, L.; Tsakiridou, K.; Walsh, D.; Welch, S.; Willis, H.; Wood, L.; Woodford, J.; Wooldridge, G.; Zullo, C.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Desai, P.; Appleyard, D.; Bromley, D.; Chambers, N.; Dale, S.; Gledhill, L.; Goddard, J.; Greig, J.; Haigh, A.; Hallas, K.; Hanson, K.; Holroyd, K.; Home, M.; Kelly, D.; Maharajh, A.; Matapure, L.; Mellor, S.; Merwaha, E.; Riley, H.; Robinson, M.; Sandhu, K.; Schwarz, K.; Shaw, L.; Terrett, L.; Usher, M.; Wilson, A.; Wood, T.] Calderdale & Huddersfield NHS Fdn Trust, Huddersfield, W Yorkshire, England; [Felton, T.; Abbas, M.; Rasheed, A. Abdul; Abraham, T.; Aggarwal, S.; Akili, S.; Alexander, P. D. G.; Allanson, A.; Al-Sheklly, B.; Arora, D.; Avery, M.; Avram, C.; Aya, A.; Banda, J.; Banks, H.; Baptist, M.; Barrera, M.; Bazaz, R.; Behrouzi, R.; Benson, V.; Bentley, A.; Bhadi, A.; Biju, A.; Bikov, A.; Birchall, K.; Blane, S.; Bokhari, S.; Bradley, P.; Bradley-Potts, J.; Dean, K.; Dhillon, R.; Dolan, D.; Duggan, A.; Duran, B.; Durrington, H.; Eades, C.; Eatough, R.; Clark, R.; Clayton-Smith, J.; Conway, R.; Cook, E.; Cummings-Fosong, G.; Currie, S.; Dalgleish, H.; Davies, C.; Dean, K.; Dhillon, R.; Duggan, A.; Duran, B.; Durrington, H.; Eades, C.; Eatough, R.; Elyoussfi, S.; Evans, G.; Fairclough, A.; Faluyi, D.; Ferguson, S.; Fielding, J.; Fiouniz, S.; Fogarty, G.; Fowler, S.; Giannopoulou, S.; Gillott, R.; Gipson, A.; Glasgow, S.; Gorsuch, T.; Grana, G.; Gray, G.; Grayson, A.; Grey, G.; Griffin, B.; Hackney, P.; Hameed, B.; Hamid, I.; Handrean, S.; Henry, J.; Higgins, L.; Holt, L.; Horsley, A.; Howard, L.; Hughes, S.; Hulme, A.; Hulme, P.; Hyslop, M.; Ingham, J.; Ismail, O.; Jafar, A.; Jamal, S.; James, L.; John, A.; Johnstone, E.; Karunaratne, N.; Kausar, Z.; Kayappurathu, J. N.; Kelly, R.; Khan, A.; Khan, W.; Knight, S.; Kolakalurix, E.; Kolakaluri, E.; Kosmidis, C.; Kothandaraman, E.; Krizak, S.; Kyi, N. M.; Lalloo, F.; Logue, C.; Lord, R. W.; Macfarlane, L.; Madden, A.; Mahaveer, A.; Manderson, L.; Margaritopoulos, G.; Marsden, P.; Mathews, J.; McCarthy, E.; McGrath, B.; Mendonca, C.; Metryka, A.; Micallef, D.; Mishra, A.; Mistry, H.; Mitra, S.; Moss, S.; Muazzam, A.; Mudawi, D.; Murray, C.; Naguib, M.; Naveed, S.; Ninan, P.; Nirmalan, M.; Norton, R.; Odell, N.; Osborne, R.; Padden, G.; Palacios, A.; Panes, A.; Pantin, C. T.; Parker, B.; Peacock, L.; Peasley, A.; Pomery, F.; Power, N.; Pursell, M.; Ratcliffe, S.; Reilly, M.; Reynard, C.; Rice, E.; Rice, M.; Riley, P.; Rivera-Ortega, P.; Rogers, J.; Rogers, T.; Santosh, R.; Scott, A.; Sellers, K.; Sen, N.; Shanahan, T.; Shawcross, A.; Shibly, S.; Simpson, A.; Sivanadarajah, S.; Skehan, N.; Smith, C.; Smith, J.; Smith, L.; Soren, J.; Spiller, W.; Stratton, J.; Stubbs, A.; Swist-Szulik, K.; Tallon, B.; Thomas, S.; Thorpe, S.; Tohfa, M.; Tousis, R.; Trafford, M. T.; Turgut, T.; Varghese, M.; Varnier, G.; Venables, I.; Vinay, S.; Wang, R.; Ward, L.; Warner, C.; Watson, E.; Watterson, D.; Wentworth, L.; Whitehead, C.; Wilcock, D.; Williams, J. R.; Willis, E.; Woodhead, L.; Worton, S.; Xavier, B.] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England; [Rege, K.; Agbo, C.; Akindolie, O.; Al-Rabahi, A.; Ambrogetti, R.; Aung, K. Thu; Shah, A. Azman; Babs-Osibodu, A. Obaloluwa; Bahadori, K.; Bhayani, J.; Bond, T.; Boughton, H.; Brooks, S.; Butterworth-Cowin, N.; Buttery, R.; Carter, P.; Catana, A. Maria; Cave, L.; Choi, S.; Corogeanu, D.; Croysdill, R.; Davies, M.; de Souza, J.; Duff, N.; Dufour, L.; Ebigbola, O.; Eddings, C.; Faccenda, J.; Feroz, A.; Finch, L.; Freer, C.; Goodyear, P.; Gooentilleke, R.; Gosling, R.; Halford, W.; Havlik, S.; Hoskins, T.; Huson, C.; Ishak, M.; Javed, H.; Jones, T.; Kasianczuk, N.; Kaur, D.; Kerr, A.; Khan, A.; Koshy, G.; Eskenazia, A. Kozak; Lahane, S.; Lami, M. Kadhim Gulam; Marshall, J.; McDevitt, K.; Muru, N.; Mustafa, A. M. M.; Nazir, S.; Okpala, I.; Old, T.; Oleszkiewicz, G.; Orme, H.; O'Sullivan, S.; Paczko, P.; Pandey, A.; Patel, A.; Pathak, S.; Poon, S.; Rather, M. I.; Vattekkat, R. Renu; Rizvi, S. H. M.; Samyraju, M.; Sanyal, J.; Shah, S. H.; Smith, E.; Stacpoole, S.; Tan, B. Theng Tan; Temple, N.; Thazhatheyil, K.; Uddin, M. Saif; Veale, N.; Walter, D.] North West Anglia NHS Fdn Trust, Peterborough, Cambs, England; [Ashish, A.; Cooper, J.; Heaton, D.; Hough, S.; Parkinson, V.; Robinson, E.; Taylor, T.; Tierney, C.; Verma, A.; Waddington, N.; Williams, C.; Zipitis, C.] Wrightington Wigan & Leigh NHS Fdn Trust, Wigan, England; [Tiberi, S.; Aboaba, A.; Adeyeye, E.; Agwada-Akeru, J.; Ali, F. Runa; Allen, R.; Ardley, C.; Astin-Chamberlain, R.; Bacon, G.; Baillie, H.; Batha, R.; Bloom, B.; Bolton, M.; Borra, C.; Boyapati, G.; Buchanan, R.; Chan, C.; Chitsenga, C.; Cipriano, B.; Cofie, P. Foster; DeLuna, M.; Elia, S.; El-Shakankery, K.; Fikree, A.; Ghosh, A.; Goiriz, R.; Goldsmith, P.; Gouldbourne, M.; Grant, A.; Greenfield, L.; Grigoriadou, S.; Gritton, R.; Gunganah, K.; Hand, J.; Harwood, C.; Hemmila, U.; Higgins, J.; Hobden, D.; Howaniec, L.; Hsu, D.; Iliodromiti, S.; Issa, S.; Jones, P.; Juan, M.; Kassam, J.; Keith-Jopp, C.; Khan, M.; Khaw, C. Ryan; Kunst, H.; Lai, J.; Lee, I.; Lieberman, D.; Liebeschuetz, S.; Magavern, E.; Maniero, C.; Maitland, J.; Malcolm, H.; Marshall, H.; Matin, N.; May, P.; McDermott, R.; Menacho, K.; Millin, L.; Mohammed, A.; Moriarty, K.; Naeem, S.; Newman, T.; Fhogartaigh, C. Nic; Omar, M.; Pakozdi, A.; Parrott, M.; Pfeffer, P.; Pott, J.; Powell, J.; Ricketts, W.; Riddell, A.; Rughani, P.; Sahdev, N.; Sarodaya, V.; Selvarajah, B.; Skene, I.; Smallshaw, K. Denise; So, A.; Stevenson, D.; Suarez, C.; Swaine, T.; Thomas, S.; Thomas, A.; Thomson, J.; Thorn, N.; Tierney, C.; Ullah, S.; Vathenen, R.; Velauthar, L.; Ward, K.; Wiles, K.; Woodland, P.; Youssouf, S.; Zdanaviciene, A.] Barts Hlth NHS Trust, London, England; [Fegan, C.; Balan, A.; Basker, B.; Bird, S.; Boult, Z.; Britten, V.; Broad, L.; Cendl, H.; Chakraborty, M.; Cole, J.; Edgar, M.; Evans, T.; Evans, J.; Evans, M.; Forton, J.; Frayling, S.; Greaves, F.; Harrhy, S.; Haynes, M.; Hill, H.; Hilton, Z.; Jones, L.; Jorgensen, S.; Kelly, A.; Knibbs, L.; Lau, D.; Maureen, E.; May, J.; McGough, E.; McQueen, A.; Milner, J.; Norman, R.; Nyland, K.; Oliver, C.; Paradowski, K.; Patal, M.; Rahilly, K.; Robinson, C.; Scourfield, S.; Starr, M.; Struik, S.; Thomas, E.; Thomas-Turner, R.; Williams, G.; Williams, J.; Williams, M.; Zaher, S.] Cardiff & Vale Univ LHB, Cardiff, S Glam, Wales; [Hine, P.; Todd, S.; Welters, I.; Wootton, D.; Ahmed, M.; Ahmed, R. A.; Al Balushi, A.; Barr, D.; Bennett, A.; Bond, H.; Burston, C.; Byrne, J.; Chambers, L.; Coey, D.; Cross, T.; Cruise, J.; Fenlon, K.; Gould, S.; Haigh, K.; Hall, C.; Harrison, M.; Hazenberg, P.; Hicks, S. R.; Hope, S.; Hunter, K.; Islim, A.; Iyer, S.; Jackson, A.; Jaime, F.; Keogan, L.; Knowles, K.; Krasauskas, K.; Lewis, J.; Lopez, P.; Lowe, C.; Mediana, A.; Middleton, M.; Nugent, M.; Pauls, L.; Pringle, S.; Quayle, I.; Raghunath, S.; Riley, M.; Sedano, J.; Shaw, D.; Smith, C.; Stevenson, S.; Stockdale, A.; Tangney, R.; Tempany, J.; Waugh, V.; Williams, K.] Liverpool Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Yates, B.; Ashbrook-Raby, C.; Campbell, H.; Charlton, D.; Dodds, S.; Ferguson, V.; Hall, T.; Hamoodi, I.; Heslop, P.; Luke, J.; McLarty, N.; Patterson, L.; Pick, S.; Reynolds, J.; Robinson, S.; Tanney, C.; Taylor, L.; Winder, L.; Walker, C.] Northumbria Healthcare NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Scott, S.; Abouibrahim, M.; Ahmad, M.; Ahmed, S. Haris; Ajibode, A.; Alomari, L.; Asrar, A.; Austin, E.; Bamford, P.; Barclay, A.; Barker, L.; Barker-Williams, K.; Barnsley, W.; Batty, H.; Benton, I.; Billingham, S.; Brearey, S.; Brigham, S.; Brooker, V.; Burchett, C.; Burgess, M.; Cade, R.; Cameron, F.; Cannan, R.; Cawley, K.; Chavasse, N.; Cheng, Z.; Clarke, R.; Cole, E.; Cotton, C.; Davidson, A.; Doi, Y.; Dragos, C.; Ellerton, L. Nicola; Gamble, L.; Grant, M.; Grounds, J.; Hodgkins, H.; Irshad, M. Shoaib; Iyer, M.; Johari, A.; Jones, C.; Kearsley, N.; Lim, B.; Llanera, D. Kevin; Loh, S. Yin; London, E.; Martin, E.; Maskell, P.; McBurney, J.; McCarthy, M.; McEwen, R.; Meeks, E.; Metcalf-Cuenca, G.; Middleton, S.; Mihalca-Mason, L.; Nayyar, M.; Naz, F.; Okpo, E.; Parry, H. Claire; Pearson, S. Anthony; Phillips, D.; Pickering, C.; Ponnuswamy, A.; Prescott, V.; Prince, J.; Rahman, S. Ur; Steele, C.; Thorne, C.; Tomlin, S.; Trussell, T.; Webster, T.; Zammit, L.; Zin, E. Thant] Countess Chester Hosp NHS Fdn Trust, Chester, Cheshire, England; [Graham, C.; Abdelaziz, A.; Ali, O.; Atkinson, J.; Bell, G.; Brewer, C.; Clapham, M.; Gregory, J.; Hanif, S.; Harper, R.; Lane, M.; McSkeane, A.; Poultney, U.; Poulton, K.; Pritchard, S.; Shah, S.; Smit, C.; Tzavaras, P.; Vasadi, V.; Wilson, A.; Wilson, T.; Zehnde, D.] North Cumbria Integrated Care NHS Fdn Trust, Carlisle, England; [Shaw, D.; Tariq, S.; Ahmed, N.; Ali, S.; Allen, S.; Alzetani, M.; Ambrose, C.; Aneke, K.; Angel, T.; Aung, Z. Myo; Banerjee, R.; Baqai, T.; Batla, A.; Bergstrom, M.; Bhakta, S.; Bibi, N.; Chapman, T.; David, A.; Dirmantaite, L.; Edmondson, M.; Elfar, E.; Elgamal, M. Magdy; El-Sbahi, H.; Fishman, D.; Fornolles, C.; Forshall, T.; Francioni, A.; Gent, S.; George, N.; Ibrahim, A.; Ingram, A.; James, R.; Dawa, K. Kabiru; Khan, F.; Khan, M. Aamaz; Lee, S.; Lingam, C.; Luximon, C. Nisha; Marcus, N.; Masood, M.; Mejri, R.; Moharram, A.; Moss, C.; Naik, G.; Ng, A. Yong Kheng Cordero; Nicholls, L.; Nisar, M.; Parmar, V.; Raj, F. Prasanth; Puisa, V.; Quick, V.; Ramabhadran, B.; Reddy, A.; Riaz, N.; Rudran, B.; Sabaretnam, S.; Sagoo, H.; Sarma, S.; Savlani, K.; Shah, P.; Shaw, D.; Soo, S.; Sothirajah, P.; Southern, I.; Tate, M. Louise; Travill, C.; Uppal, V. Singh; Wakeford, W.] Luton & Dunstable Univ Hosp NHS Fdn Trust, Luton, Beds, England; [Brown, T.; Andrews, J.; Baker-Moffatt, M.; Bamgboye, A.; Barnes, D.; Baryschpolec, S.; Bell, L.; Borbone, J.; Broadway, M.; Brogan, F.; Bungue-Tuble, R.; Burrows, K.; Chauhan, A.; Chauhan, M.; Cowan, E.; Darbyshire, A.; Davey, M.; David, M.; Denham, J.; Downe, H.; Edwards, C.; Fox, L.; Garner, Z.; Giles, B.; Gribbin, A.; Harrington-Davies, Y.; Hawes, L.; Hicks, A.; Hossain, E.; Howe, S.; Jones, B.; Lameirinhas, C.; Longhurst, B.; Mamman, M.; McCready, S.; Minnis, C.; Moon, M.; Mouland, J.; Murray, L.; Rose, S.; Rupani, H.; Rutgers, M.; Scorrer, T.; Scott, K.; Thornton, R.; Tiller, A.; Turner, C.; Wands, M.; Watkins, L.; White, M.; Wiffen, L.; Winter, J.] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England; [Winn, S.; Wake, R.; Sadiq, S. Ahamed; Aldana, A.; Al-Hakim, B.; Agyapong, K. Ansu; Azzopardi, G.; Chicano, R.; Chukwulobelu, I.; Colbeck, N.; Cole, N.; Dogra, R.; Doherty, E.; Elradi, A.; Emberton, J.; Evans, T. J.; Ganapathy, R.; Haque, M.; Hayre, R.; Jain, S.; Jian, K.; Johnson, L.; Johnson, A.; Kotecha, J.; Kundu, A.; Langer, D.; Mashhoudi, Y.; Mathias, K.; Maxan, M. E.; Mellor, F.; Morgan, M.; Nafees, S.; Sai, V. Bharadwaj Palagiri; Phanish, M.; Rahimi, H. Rana; Ramanna, S.; Ratoff, J.; Rozewicz, S.; Samuel, T. D. L.; Shah, B.; Shahnazari, S.; Shail, R.; Sharif, A.; Somalanka, S.; Suckling, R.; Swift, P.; Tyagi, V.; Vilimiene, N.; Wells, C.] Epsom & St Helier Univ Hosp NHS Trust, Epsom, Surrey, England; [Maseda, D.; Ball, C.; Best, K.; Bridgwood, G.; Broadhurst, R.; Brockelsby, C.; Brockley, T.; Brown, J.; Bujazia, R.; Clarke, S.; Cremona, J.; Dixon, C.; Dowson, S.; Drogan, H.; Duncan, F.; Emmett, C.; Emms, M.; Farooq, H.; Fullerton, D.; Gabriel, C.; Hammersley, S.; Hum, R.; Jones, T.; Kay, S.; Kelly, E.; Kidd, M.; Lees, D.; Lowsby, R.; Matovu, E.; McIntyre, K.; Moulton, H.; Nourein, K.; Nytianandan, G.; O'Brian, M.; Pagett, K.; Ritchings, A.; Smith, S.; Taylor, J.; Thomas, K.; Turbitt, K.; Yasmin, S.] Mid Cheshire Hosp NHS Fdn Trust, Crewe, Cheshire, England; [Spittle, N.; Weatherly, N.; Beavis, S.; Beghini, S.; Blundell, L.; Bradder, J.; Cort, J.; Cresswell, J.; Dale, K.; Foo, A.; Gardner, J.; Gascoyne, R.; Hall, E.; Kelly-Baxter, M.; Mackay, E.; Moxham, K.; Padmakumar, A.; Pritchard, K.; Salmon, J.; Smith, A.; Sorice, V.; Stevenson, L.; Whileman, A.; Wolodimeroff, E.] Chesterfield Royal Hosp NHS Fdn Trust, Calow, England; [Meda, M.; Democratis, J.; Barnes, N.; Brooks, N.; Chapman, L.; da Rocha, J.; Dolman, R.; Edwards, A.; Foster, T.; Fowe, F.; Gaywood, E.; Gee, S.; Jaiswal, S.; Molloholli, M.; Raguro, A.; Regan, F.; Rowe-Leete, L.; Smith, C.; van de Venne, M.; Weerasinghe, T.] Univ Hosp Derby & Burton NHS Fdn Trust, Derby, England; [Jeffery, K.; Ainsworth, M.; Arnison-Newgass, C.; Bashyal, A.; Beer, S.; Bloss, A.; Buttress, D.; Byrne, W.; Capp, A.; Carter, P.; Cicconi, P.; Corrigan, R.; Coston, C.; Cowen, L.; Davidson, N.; Downs, L.; Edwards, J.; Evans, R.; Gardiner, S.; Georgiou, D.; Gillesen, A.; Harin, A.; Havinden-Williams, M.; Haynes, R.; Hird, C.; Hudak, A.; Hutton, P.; Irons, R.; Jastrzebska, P.; Johnston, S.; Kamfose, M.; Lewis, K.; Lockett, T.; del Rocio, F. Mendoza Maria; Garrido, J. Carlos Martinez; Masih, S.; Mentzer, A.; Morris, S.; O'Callaghan, C.; Oliver, Z.; Paulus, S.; Perez, E.; Periyasamy, L.; Peto, L.; Porter, D.; Prasath, S.; Purdue, C.; Ramasamy, M.; Roehr, C. C.; Rudenko, A.; Sanchez, V.; Sarfatti, A.; Segovia, M.; Sewdin, T.; Seymour, J.; Skinner, V.; Smith, L.; Diaz, A. Sobrino; Taylor-Siddons, M.; Thraves, H.; Tsang, C.; Vatish, M.; Warren, Y.; Wilcock, E.] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Khan, B.; Ail, D.; Aldouri, R.; Awadzi, G.; Bassoy, B.; Bhalla, R.; Billings, J.; Bokhari, S.; Boniface, G.; Cernova, J.; Chen, T.; Chimbo, P.; Chitalia, N.; Bamfo, S. Danso; Depala, D.; Dhanoa, A.; Edmunds, T.; Fernandez, E.; Ferrari, T.; Fuller, B.; Gherman, A.; Heire, R.; Ilves, L.; Lacey, L.; Lawrence, E.; Lewis, M.; Maric, A.; Martin, W.; Min, Z.; Newman, C.; Nicholas, R.; Olufuwa, O.; Pieniazek, N.; Qadeer, T.; Rathore, S.; Sathianandan, S.; Scott, C.; Shonubi, A.; Siddique, S.; Sisson, G.; Soan, M.; Streit, D.; Stuart, C.; Szekely, M.; Umeojiako, W.; Urruela, S.; Warner, B.; Waterstone, M.; White, S.; Yip, K.; Zafar, A-M; Zaman, S.] Dartford & Gravesham NHS Trust, Dartford, England; [West, R.; Abrams, J.; Baldwin, A.; Bannister, O.; Barker, J.; Beddall, H.; Blamey, H.; Chan, E.; Chaplin, J.; Chisnall, B.; Cleaver, C.; Crotty, S.; Dey, P.; Downs, L.; Kononen, M.; Kudsk-Iversen, S.; Kudzinskas, A.; Laurenson, M.; Mandeville, J.; McLure, S.; Morgan-Smith, E.; Ngumo, A.; Oxlade, R.; Parekh, A.; Rahman, M.; Robertson, C.; Shah, S.; Tebbutt, J.; Vella, N.; Veres, M.; Watson, A. J. R.; Wong, N.; Zammit-Mangion, M.; Zia, M.] Buckinghamshire Healthcare NHS Trust, Amersham, England; [Gray, A.; Baillie, K.; Adam, M.; Anand, A.; Anderson, R.; Baird, D.; Balaskas, T.; Balfour, J.; Black, P.; Blackstock, C.; Brady, S.; Campbell, R.; Carter, J.; Chapman, P.; Cheyne, C.; Christides, A.; Christmas, D.; Crisp, L.; Cryans, D.; Dear, J.; Dhaliwal, K.; Docherty, M.; R, Dodds; Donald, L.; Dummer, S.; Eddleston, M.; Fethers, N.; Foster, E.; Frake, R.; Gaughan, E.; D, Gilliland; Godson, E.; Grahamslaw, J.; Grant, A.; Grubb, N.; Hainey, S.; Harding, Z.; Harris, M.; Harvey, M.; Henshall, D.; Hobson, S.; Hunter, N.; Jaly, Y.; Jameson, J.; Japp, D.; Khin, H. Htet Ei; Kitto, L.; Krupej, S.; Langoya, C.; Lawrie, R.; Lloyd, A.; Lyell, B.; Lynch, D.; Macfarlane, J.; MacInnes, L.; MacRaild, A.; Marecka, M.; Marshall, A.; Martin, M.; McCann, C.; McCurrach, F.; Moatt, E.; Morley, W.; Morrissey, M.; Newby, D.; Din, K. Nizam Ud; O'Brien, R.; O'Sullivan, E.; Odam, M.; Peterson, A.; Phelan, P.; Pickering, G.; Quinn, T.; Robertson, N.; Rooney, L.; Rowan, N.; Salman, R.; Small, E.; Stefanowska, P.; Stevenson, A.; Stock, S.; Summers, A.; Teasdale, J.; Walker, I.; Walker, K.; Williams, A.] NHS Lothian Royal Infirm Edinburgh, Edinburgh, Midlothian, Scotland; [Wight, A.; Bailey, L.; Bokhari, S. Owais; Brownlee, S.; Bull, A.; Corless, J.; Denmade, C.; Ellard, N.; Farrell, A.; Hufton, A.; Jacob, R.; Jones, K. Elizabeth; Kerss, H.; McEntee, J.; Morris, N.; Myagerimath, R.; Newcombe, T.; Parsonage, M.; Peake, H.; Pearson, D.; Penfold, R.; Rath, S.; Saunders, R.; Sharp, A.; Spencer, B.; Suliman, A.; Sutton, S.; Tan, H.; Tarpey, D.; Thompson, L.; Thornton, T.; Twohey, E.; Wagstaff, D.; Wahbi, Z.; Williams, S.] Wirral Univ Teaching Hosp NHS Fdn Trust, Wirral, Merseyside, England; [Phull, M.; Umaipalan, A.; Ah-Chuen, J.; Ainsley, A.; Baijiu, G.; Basumatary, A.; Calderwood, C.; Dugh, P.; Dunne, K.; Greaves, P.; Hunt, K.; Islam, M.; Katsande, V.; Khan, M. R.; King, S.; Loverdou, A.; McGregor, A.; Misbahuddin, A.; Mohamed, A.; Nagesh, N.; Nicholls, D.; O'Brien, N.; Parker, L.; Pogreban, T.; Rosaro, L.; Salciute, E.; Sharma, M.; Smith, H.; Visentin, E.; Walshaw, L.] Barking Havering & Redbridge Univ Hosp NHS Trust, Romford, Essex, England; [Saralaya, D.; Akhtar, N.; Beckett, V.; Brear, L.; Drew, V.; Eedle, J.; Hawes, N.; Kmachia, S.; Moss, S.; Oddie, S.; Paget, J.; Regan, K.; Ryan-Wakeling, D.; Shenoy, A.; Storton, K.; Swingler, R.; Syson, J.; Todd, J.; Wane, R.; Wilson, A.] Bradford Teaching Hosp NHS Fdn Trust, Bradford, W Yorkshire, England; [Fuller, E.; MacNair, A.; Brown, C.; Burns, A.; Caroline, C.; Davidson, R.; Dickson, M.; Duncan, B.; Elkaram, N.; Emmerson, I.; Fairlie, L.; Hashimm, M.; Henderson, J.; Hinshaw, K.; Holden, J.; Hovvels, R.; Laybourne, S.; Madgwick, P.; Martin, K.; McKee, M.; Moore, J.; Mullen, N.; Murphy, P.; Palmer, L.; Parish, G.; Rangar, M.; Shahrul, R.; Smith, A.; Smith, L.; Smith, M.; Stidolph, B.; Terry, L.; Trotter, A.; Wakinshaw, F.; Walton, E.; Walton, M.] South Tyneside & Sunderland NHS Fdn Trust, Sunderland, Tyne & Wear, England; [Frise, M.; Arimoto, R.; Black, S.; Camm, C.; Coles, H.; De Berker, H.; Fries, A.; Gabbitas, E.; Hasan, N.; Htet, Z.; Jacques, N.; Kashif, S.; Keating, L.; Leafe, S.; Milne, Z.; Mitchell, B.; Okeke, T.; Orchard, W.; Parmar, A.; Raffles, M.; Shields, N.; Thakker, M.; Thomas, M.; Wakefield, H.; Walden, A.] Royal Berkshire NHS Fdn Trust, Reading, Berks, England; [Moreno-Cuesta, J.; Rokadiya, S.; Govind, A.; Haldeos, A.; Leigh-Ellis, K.; van Someren, C.; Vincent, R.; Walker, L.] North Middlesex Univ Hosp NHS Trust, London, England; [Thomas, K.; George, T.; Cannon, E.; Ikomi, A.; Jayasekera, L.; Kittridge, L.; Maloney, G.; Manoharan, B.; Mushabe, M.; Nicholson, A.; Pai, A.; Riches, J.; Samuel, J.; Setty, N.; Solesbury, A.; Southam, D.; Tisi, S.; Vertue, M.; Wadsworth, K.; Yung, B.] Basildon & Thurrock Univ Hosp NHS Fdn Trust, Basildon, England; [Limb, J.; Atkinson, V.; Birt, M.; Brown, E.; Cowton, A.; Craig, V.; Egginton, D.; Fernandes, D.; Ivy, A.; Jayachandran, D.; Jennings, J.; Kay, A.; Kent, M.; McAuliffe, S.; Naylor, S.; Nyamugunduru, G.; O'Brien, J.; Postlethwaite, K.; Potts, K.; Ranka, P.; Rogers, G.; Sen, S.; Temple, J.; Wadd, S.; Walters, H.; Yorke, J.] Cty Durham & Darlington NHS Fdn Trust, Darlington, Durham, England; [Whittington, A.; Adamus, M.; Barrett, J.; Cawa, F.; Chhabra, S.; Chita, S.; Dhillon, E.; Filson, S. Ann; Goodall, J.; Gravell, R.; Gupta-Wright, A.; Gurram, S.; Houston, H.; Hulston, G.; Isralls, S.; Kukadiya, C.; Lang, M.; MaeLow, J.; Macleod, C.; Milburn, J.; Muralidhara, K.; Nayar, B.; Ojo, O.; Papineni, P.; Parris, V.; Patel, M.; Quaid, S.; Sethi, J.; Sturdy, A.; Tyagi, B.; Vaccari, L. Cheyenne; van der Stelt, N.; Wallis, G.; Watson, E.] London North West Univ Healthcare NHS Trust, London, England; [Sarkar, R.; Ahmed, I.; Ahmed, S.; Ambler, S.; Babatunde, F.; Banerjee, S.; Bhatia, N.; Brassington, L.; Brokke, F.; Bruce, D.; Cassimon, B.; Chauhan, R. Singh; Chengappa, A.; Divikar, N.; Donnelly, C.; Froneman, C.; Gnanalingam, C.; Gower, T.; Harizaj, H.; Hettiarachchi, G.; Hollands, M.; Jansz, S.; Josiah, B.; Kamara, M.; Kidney, S.; Kyere-Diabour, T.; Lewiston, K.; Miah, N.; Millington, S.; Mires, L.; Mitchell, A.; Mizzi, C.; Naicker, K.; Petrou, I.; Phulpoto, M. Mubeen; Ross-Parker, A.; Ramadan, I.; Roy, A.; Ryan, A.; Samuels, E.; Sanctuary, T.; Sharma, A.; Singham, S.; Sporrer, J.; Ul Hassan, W.; Vankayalapati, P.; Velan, B.; Smith, L. Vincent; Vyras, E.; Wood, J.; Zuhra, N.] Medway NHS Fdn Trust, Gillingham, England; [Clare, S.; Ahmed, M. Cecilia; Beuvink, Y.; Blachford, K.; Clamp, S.; Colley, J.; De, P.; Fenton, M.; Gammon, B.; Hayes, A.; Henry, L.; Hussain, S.; Joseph, S.; Kinney, F.; Knight, T.; Kumar, R.; Leong, W.; Lim, T.; Mahay, B.; Nupa, Y.; Orme, A.; Osborne, W.; Pilsworth, Z.; Potter, S.; Prew, S.; Rajaiah, N.; Rajasekaran, A.; Senya, H.; Shah, N.; Shamim, N.; Sivakumar, S.; Smith, L.; Thozthumparambil, P.; Trudgill, N.; Turner, A.; Wagstaff, L.; Willetts, S.; Willis, H.; Yan, M.] Sandwell & West Birmingham Hosp NHS Trust, Birmingham, W Midlands, England; [Richardson, N.; Alegria, A.; Kapoor, R.; Adegoke, K.; Allen, L.; Beranova, E.; Boehmer, G.; Crisp, N.; Deery, J.; Hansen, J.; Elgohary, A.; Elsefi, T.; Hargreaves, C.; Hazelton, T.; Hulbert, R.; Ionita, A.; Knight, A.; Linares, C.; Loader, D.; Matisa, E.; McAndrew, J.; Montasser, M.; Moon, A.; Oboh, C.; Offord, P.; Price, C.; Rajasri, A.; Rand, J.; Schumacher, N.; Stephensen, D.; Stirrup, S.; Tague, L.; Tilbey, S.; Turney, S.; Vasu, V.; Venditti, M.; Weston, H.; Woodward, Z.] East Kent Hosp Univ NHS Fdn Trust, Canterbury, Kent, England; [Kemp, T.; Alexander, J.; Al-Shamkhani, W.; Bandla, N.; Bland, A.; Bodasing, N.; Cadwgan, A.; Chaudhary, M. Yafaa Naveed; Cheng, L. Yin; Church, S. Rebecca; Clark, F.; Davies, M.; Diwakar, L.; Eaton, E.; Evans, M.; Farmer, A.; Farook, F.; Gellamucho, M.; Glover, K.; Haris, M.; Humphries, J.; Hussain, I.; Khan, S.; Korcierz, L.; Lee, J.; Machin, J.; Marshall, J.; McCreedy, H.; Muddegowda, G.; Mustapha, I.; Nettleton, K.; Noori, Z.; Osman, W.; Parker, H.; Patel, N.; Quinn, A.; Ram, M.; Remegoso, A.; Scott, T.; Sheikh, N.; Swiftx, R.; Thompson, C.; Tomlinson, J.; Turner, H.; Walker, L.; Weeratunga, J.; White, C.; White, J.; Wu, P.] Univ Hosp North Midlands NHS Trust, Stoke On Trent, Staffs, England; [Szakmany, T.; Champanerkar, S.; Griffiths, A.; Ionescu, A. Alina; Somashekar, C.; Zalewska, K.; Aitken, L.; Baker, E.; Barnett, D.; Brouns, M.; Cann, J.; Cherian, S.; Codd, R.; Cutler, S.; Davies, W.; Dell, A.; Edwards, M.; Edwards, S.; Fairbairn, S.; Hawkins, N.; Hodge, S.; Hodkinson, G.; Hughes, R.; Ivenso, C.; James, T.; Jones, M.; Jones, S.; Lucey, A.; MacCormac, J.; Marshall, G.; McKain, S.; Nassa, H.; Northfield, J.; Palmer, S.; Peter, L.; Price, C.; Pynn, M.; Roynon-Reed, A.; Shipp, L.; Singh, J.; Singh, M.; Swarnkar, K.; Torabi, P.; Venkataramakrishnan, R.; Wall, E.; Waters, A.; Wild, K.; Winstanley, M.; Wyness, K.] Aneurin Bevan Univ LHB, Newport, Shrops, England; [Kushakovsky, V.; Ramali, M.; Alam, S.; Bartholomew, S.; Bataineh, A.; Beeby, D.; Bell, S.; Broughton, N.; Buckman, C.; Calver, C.; Campbell, J.; Chabo, C.; Chowdhury, M.; Cooke, K.; Deole, N.; Driscoll, C.; Elden, A.; Eldew, H.; Entwistle, N.; Farnworth, F.; Francis, R.; Galloway, E.; Garfield, M.; Ghosh, A.; Gray, G.; Greenfield, P.; Hadjiandreou, M.; Hewer, H.; Hossain, M. S.; Howard-Griffin, R.; Islam, A.; Jamieson, E.; Jiao, Z.; Johannessen, K.; Lee, S. Han; Lewis, R.; Lloyd, R.; Mabelin, L. Andrew; Morris, D.; Nallapareddy, S.; Ooi, H. C.; Osagie, R.; Parkinson, C.; Patel, H.; Prowse, H.; Purewal, B.; Ridley, P.; Rivers, V.; Rosier, J.; Sharma, S.; Sheik, A.; Skelly, R.; Smith, R.; Sreenivasan, R.; Taylor, A.; Tovey, P.; Turner, A.; Turner, K.; Vithian, K.; Zhixin, J.] East Suffolk & North Essex NHS Fdn Trust, Colchester, Essex, England; [Potton, E.; Jain, N.; Khadar, A.; Morgan, P.; Penny, J.; Tatam, E.; Abbasi, S.; Acharya, D.; Acosta, A.; Ahmed, L.; Ali, S.; Alkhusheh, M.; Arter, A.; Babi, M.; Bacon, J.; Bailey, K.; Balachandran, N.; Banks, L.; Barla, J.; Belgaumkar, A.; Benison-Horner, G.; Boles, A.; Broomhead, N.; Cetti, E.; Chan, C.; Chaudhry, I.; Chudgar, D.; Clark, J.; Clueit, S.; Combes, E.; Conway, G.; Curtis, O.; Das, M.; Daschel, M.; Potton, E.; Abbasi, S.; Acharya, D.; Ahmed, L.; Ali, S.; Alkhusheh, M.; Amosun, V.; Arter, A.; Babi, M.; Bacon, J.; Bailey, K.; Balachandran, N.; Bandyopadhyam, S.; Banks, L.; Barla, J.; Batty, T.; Bax, S.; Belgaumkar, A.; Benison-Horner, G.; Boles, A.; Broomhead, N.; Cetti, E.; Chan, C.; Chaudhry, I.; Chudgar, D.; Clark, J.; Clueit, S.; Collins, S.; Combes, E.; Conway, G.; Curtis, O.; Das, M.; Daschel, M.; Davies, S.; Day, A.; Dhar, M.; Diaz-Pratt, K.; Dragan, C.; Dube, H.; Duraiswamy, V.; Elias, J.; Ellis, A.; Ellis, T-Y; Emmanuel, J.; Engden, A.; Fahmay, Y.; Field, B.; Fishwick, K.; Ganesh, U.; Gilbert, C.; Giokanini-Royal, T.; Goudie, E.; Griffith, S.; Gurung, S.; Habibi, R.; Halevy, C.; Haqiqi, A.; Hartley, R.; Hayman, A.; Hives, J.; Horsford, M.; Hughes, S.; Hui, C.; Hussain, R.; Iles, C.; Jackson, L.; James, A.; Jayaram, D.; Jessup-Dunton, E.; Joefield, T.; Khan, N.; Kieffer, W.; Knox, E.; Kumar, V.; Kumar, R.; Kurmars, V.; Lafferty, H.; Lamb, F.; Layug, R.; Leitch, N.; Lim, W.; Limbu, U.; Loveless, R.; Mackenzie, M.; Maghsoodi, N.; Maher, S.; Maljk, M.; Man, I.; McCarthy, N.; Mearns, B.; Mearns, C.; Morgan-Jones, K.; Mortem, G.; Morton, G.; Moya, B.; Murphy, G.; Mutton, S.; Myers, A.; Nasser, T.; Navaratnam, J.; Nazir, S.; Nepal, S.; Nimako, K.; Nimako, L.; O'Connor, C.; Patel, A.; Patel, K.; Phongsathorn, V.; Pillai, P. A.; Poole, M.; Qureshi, N.; Ranjan, S.; Rehman, A.; Samuels, T.; Scott, E.; Sekadde, G.; Sharma, A.; Sharp, G.; Shotton, S.; Simmons, O.; Singh, P.; Smith, S.; Paranthamen, K. Sri; Suresh, S.; Thevarajah, K.; Thomas, L.; Timms, H.; Tomasova, N.; Tucker, S.; Vara, S.; Vaz, C.; Weller, S.; White, J.; Wilde, M.; Wilkinson, I.; Williams, C.; Win, M.; Woosey, D.; Wright, D.] Surrey & Sussex Healthcare NHS Trust, Surrey, England; [Roberts, M.; Amsha, K.; Cox, G.; Downer, N.; Hodgson, D.; Hutchinson, J.; Kalsoom, S.; Molyneux, A.; Noor, Z.; Allsop, L.; Brear, T.; Buckley, P.; Dunn, L.; Gill, M.; Goodwin, C.; Heeley, C.; Holmes, M.; Holmes, R.; Langthorne, E.; Moulds, C.; Nash, D.; Rajeswary, J.; Shelton, S.; Slack, K.; Smith, S.; Valeria, B.; Wynter, I.; Yanney, M.; Ynter, I.] Sherwood Forest Hosp NHS Fdn Trust, Sherwood, England; [Azam, J.; Chandler, K. J.; Abdelfattah, M.; Abung, A.; Anderson, J.; Antill, P.; Appleby, S.; Armtrong, P.; Berriman, T.; Bull, D.; Clayton, O.; Corlett, A.; Crocombe, D.; Davies, S.; Elliott, K.; Fahel, L.; Ghosh, J.; Gott, N.; Greenwood, D.; Holder, T.; Inns, P.; Lea, W.; Lindsay, E.; Mack, K.; Marshall, N.; McMeekin, S.; Momoniat, T.; Nikolaos, P.; O'Kane, M.; Patrick, G.; Pearson, H.; Ponnusamy, P.; Poole, A.; Price, N.; Proudfoot, R.; Purssord, G.; Roche, S.; Sefton, C.; Shahi, S.; Smith, D.; Sohail, B.; Thomas, R.; Turnbull, A.; Turner, L.; Watchorn, H. J.; Wiafe, E.; Wilson, J.; Yates, D.] York Teaching Hosp NHS Fdn Trust, York, N Yorkshire, England; [Bruce, M. Schuster; Baldwin, D.; Clark, Z.; Dale, M.; Griffiths, D.; Gunter, E.; Horler, S.; Joyce, T.; Keltos, M.; Kennard, S.; Lakeman, N.; Mallon, L.; Miln, R.; Nix, S.; Orr, S.; Pitts, S.; Purandare, L.; Rogers, L.; Samways, J.; Stride, E.; Vamplew, L.; Wallis, L.] Royal Bournemouth & Christchurch Hosp NHS Fdn Tru, Bournemouth, Dorset, England; [Willis, J.; Blencowe, N.; Singhal, P.; Abraham, M.; Al-Ramadhani, B.; Archer, A.; Aziz, G.; Balcombe, A.; Bateman, K.; Baxter, M.; Beacham, L.; Belfield, K.; Bell, N.; Beresford, M.; Bernatoniene, J.; Bhojwani, D.; Biggs, S.; Blazeby, J.; Bobruk, K.; Brown, N.; Buckley, L.; Butler, P.; Caws, C.; Chakkarapani, E.; Chatar, K.; Chivima, B.; de la Torre, C. Clemente; Cobain, K.; Cotterill, D.; Courtney, E.; Cowman, S.; Coy, K.; Crosby, H.; Curtis, K.; Davis, P.; Drewett, O.; Dymond, H.; Edgerley, K.; Ekoi, M.; Elokl, M.; Evans, B.; Farmery, T.; Fineman, N.; Finn, A.; Gamble, L.; Garty, F.; Gibbison, B.; Gourbault, L.; Grant, D.; Gregory, K.; Griffin, M.; Groome, R.; Hamdollah-Zadeh, M.; Hannington, A.; Heywood, J.; Hindmarsh, A.; Holling, N.; Houlihan, R.; Hrycaiczuk, J.; Hudson, H.; Hurley, K.; Jarvis, R.; Jeffs, B.; Jones, A.; Jones, R. E.; King-Oakley, E.; Kirkham, E.; Kumar, R.; Kurdy, M.; Kyle, L.; Lang, S.; Leandro, L.; Legge, H.; Loro, F.; Low, A.; Martin, H.; McCullagh, L.; McMahon, G.; Millett, L.; Millington, K.; Mok, J.; Moon, J-H; Morgan, L.; Mulligan, S.; O'Donovan, C.; Payne, E.; Penman, C.; Pickard, J.; Plumptre, C.; Ramanan, A.; Ramirez, J.; Ratcliffe, S.; Robinson, J.; Roderick, M.; Scattergood, S.; Schadenberg, A.; Sheppeard, R.; Shioi, C.; Simpson, D.; Skorko, A.; Squires, R.; Stuttard, M.; Sugden, P.; Sundar, S.; Swart, T.; Swift, E.; Thompson, K.; Turner, K.; Turner, S.; Tyer, A.; Vergnano, S.; Vincent, R.; Ward, R.; Wilkinson, S.; Williams, J.; Williams, S.; Winter, H.; Woollen, L.; Wright, R.; Ibrahim, A. Younes] Univ Hosp Bristol & Weston NHS Fdn Trust, Bristol, Avon, England; [Aggarwal, S.; Collini, P.; Ang, A.; Belcher, J.; Chapman, L.; Chin, K.; Cohen, D.; Cole, J.; Colton, H. E.; Condliffe, R.; Cribb, M.; Curran, S.; Darton, T.; de Fonseka, D.; de Silva, T.; Dunn, A.; Ferriman, E.; Foster, R. Anne; Greig, J.; Hall, J.; Haq, M. Ul; Hardman, S.; Headon, E.; Holden, C.; Hunt, L.; Hurditch, E.; Kibutu, F.; Kitching, T.; Lewis, L.; Locke, T.; Mair, L.; May, P.; Meiring, J.; Middle, J.; Middleton, J. T.; Morris, P.; Newman, T.; Passby, L.; Payne, R.; Rana, G. Farid; Renshaw, S.; Rothman, A.; Sammut, D.; Sherwin, S.; Simpson, P.; Sterrenburg, M.; Stone, B.; Surtees, M.; Telfer, A.; Thompson, R.; Vethanayagam, N.; West, R.; Williams, T.] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England; [Patel, K.; Imray, C.; Aldridge, N.; Campbell, A.; Evans, G.; French, E.; Grenfell, R.; Hewins, S.; Hewitt, D.; Jones, J.; Kumar, R.; Mshengu, E.; Quenby, S.; Read, K.; Satodia, P.; Sear, E.; Truslove, M.] Univ Hosp Coventry & Warwickshire NHS Trust, Coventry, W Midlands, England; [Kerry, A.; Beale, A.; Brooks, A.; Browne, C.; Butler, J.; Callaghan, J.; Chandrasekaran, B.; Coombs, C.; Davies, R.; Davies, L.; Elias, T.; Fowler, E.; Gowda, G.; Gregory, J.; Ipe, A.; Jaffery, A.; Jones, Q.; Kyeremeh, L.; Laing-Faiers, I.; Langton, H.; Lewis-Clarke, C.; Mackinlay, C.; Mappa, P.; Maxwell, A.; Mears, W.; Mousley, E.; Onyirioha, T.; Pannell, L.; Peglar, S.; Pereira, A.; Pointon, J.; dos Reis, I. Ponte Bettencourt; Price, E.; Quayle, A.; Qurratulain, Q.; Small, S.; Smith, H.; Stratton, E.; Tinkler, M.; van der Meer, A.; Wakefield, E.; Waller, R.; Walton, M.; Watters, M.; Whittam, L.; Wiliams, T.; Xia, Z.; Yein, K.; Zinyemba, V.] Great Western Hosp NHS Fdn Trust, Swindon, Wilts, England; [Cupitt, J.; Ahmed, N.; Assaf, O.; Barnett, A.; Benham, L.; Bradley, P.; Bradshaw, Z.; Brunton, M.; Capstick, T.; Caswell, M.; Cunliffe, V.; Downes, R.; Latt, N.; McDonald, R.; Mulla, A.; Mutema, E.; Navin, J.; Parker, A.; Preston, S.; Slawson, N.; Stoddard, E.; Traynor, S.; Vasudevan, V.; Ward, E.; Warden, S. Andrew; Wilson, J.; Zmierczak, A.] Blackpool Teaching Hosp NHS Fdn Trust, Blackpool, England; [Bari, S.; Higham, A.; Al-Jibury, M.; Allison, K.; Anu, V.; Bartlett, C.; Bhuiyan, S.; Bishop, L.; Burns, K.; Davies, A.; Fielding, A.; Gorst, M.; Hay, C.; Keating, J.; Khan, T.; Mahmood, F.; Mallinder, P.; Peters, S.; Power, D.; Ritchie, J.; Simpson, K.; Spickett, H.; Stokes, C.; Thatcher, H.; Varghese, A.; Wan, T.; Wood, F.] Univ Hosp Morecambe Bay NHS Fdn Trust, Kendal, England; [Convery, R.; Acheson, J.; Brannigan, J.; Cosgrove, D.; McCullough, C.; McFarland, D.; McNulty, R.; Sands, S.; Thompson, O.] Southern HSC Trust, Portadown, England; [Balasubramaniam, M.; Subudhi, C.; Acton, C.; Ajmi, A.; Ahmed, R.; Ajmi, A.; Al-Asadi, A.; Amin, A.; Bajandouh, A.; Bhalme, M.; Carrington, Z.; Chadwick, J.; Cocks, S.; Dawe, C.; Eusuf, A.; Farzana, S.; Hill, P.; Holmes, R.; Hughes, G.; Hull, R.; Ibrahim, K.; Ijaz, M.; Kalayi, R. J.; Khurana, S.; Latham, S.; Lipscomb, K.; Lomas, J. P.; Natarajan, N.; Nethercott, D.; Nicholas, P.; Obeng, D.; Priyash, V.; Rhead, K.; Saleh, M.; Sharma, O.; Shehata, Z.; Shurmer, J.; Sime, R.; Singh, S.; Smith, R.; Tanton, E.; Tewkesbury, D.; Thet, P.; Thornton, S.; Wang, N.; Watts, M.; Webster, I.] Bolton NHS Fdn Trust, Bolton, England; [Easom, N.; Adams, K.; Baldwin, L.; Barlow, G.; Barton, R.; Bexhell, H.; Clark, D.; Gunasekera, P.; Harvey, A.; Hayes, M.; Ivan, M.; James, A.; Kassianides, X.; Khan, S.; Kolodziej, M.; Lillie, P.; Mathew, V.; Mongolu, S.; Muazzam, I. A.; O'Reilly, P.; Perinpanathan, T.; Philbey, C.; Pickwell-Smith, B.; Rollins, L.; Samson, A.; Sathyapalan, T.; Sherris, L.; Sivakumar, K.; Taynton, T.; Yates, H.] Hull Univ Teaching Hosp NHS Trust, Kingston Upon Hull, N Humberside, England	University Hospitals of Leicester NHS Trust; University of Leicester; Nottingham University Hospital NHS Trust; University of Birmingham; Barts Health NHS Trust; Cardiff University; Portsmouth Hospitals NHS Trust; Oxford University Hospitals NHS Foundation Trust; Royal Berkshire Hospital; University of Sheffield; University of Warwick	Horby, PW; Landray, MJ (corresponding author), RECOVERY Cent Coordinating Off, Oxford OX3 7LF, England.	recoverytrial@ndph.ox.ac.uk; recoverytrial@ndph.ox.ac.uk	Satodia, Prakash/ABF-4151-2021; Tso, Simon/N-2422-2014; Baillie, Kenneth/AEK-6650-2022; Langer, Daniel/B-7307-2014; Evans, D Gareth/AAB-4308-2022; Baillie, John Kenneth/F-3124-2011; Ali, Omar/HHY-8838-2022; Darton, Thomas/H-2816-2017; Chaudhuri, Nazia/J-4517-2019; Chan, Xin Hui S/ABA-5004-2021; hodgson, luke/AAG-1477-2019; Rivera-Ortega, Pilar/X-7083-2019; Llewelyn, Martin/A-7194-2011; Bunclark, Katherine/GLN-3109-2022; Pessoa-Amorim, Guilherme/AAV-4151-2021; Shanahan, Thomas/AAP-3822-2020; Wu, Henry H.L./B-9400-2019; mcgrath, brendan a/D-7202-2013; Dosanjh, Davinder/ABD-8895-2021; Stockdale, Alexander/ADU-6666-2022; Skene, Imogen/D-6153-2018; Dhillon, Rubaid/GRF-0062-2022; Kassianides, Xenophon/AAQ-1838-2020; Ahmed, Naseer/C-8119-2019; Caplin, Ben/AAH-1641-2019; Fawke, Joe/ABA-9407-2021; Higgins, Julian PT/H-4008-2011; Gkrania-Klotsas, Effrossyni/AAT-8424-2021; chauhan, milan kumar/AAX-9583-2021; Diwakar, Lavanya/G-7425-2016; Tavoukjian, Vera/AAR-6922-2020; Gibbison, Ben/J-6611-2014; Kudsk-Iversen, Soren/Y-9391-2018; Payne, Brendan/I-1233-2016; Faust, Saul/J-9779-2014; Durrington, Hannah/B-4564-2016; moon, james/F-1031-2014	Satodia, Prakash/0000-0002-1796-5736; Tso, Simon/0000-0001-9221-7618; Baillie, Kenneth/0000-0001-5258-793X; Langer, Daniel/0000-0001-8738-9482; Evans, D Gareth/0000-0002-8482-5784; Baillie, John Kenneth/0000-0001-5258-793X; Darton, Thomas/0000-0003-2209-9956; Chaudhuri, Nazia/0000-0003-3325-6996; Chan, Xin Hui S/0000-0002-9941-6975; hodgson, luke/0000-0002-8278-9513; Rivera-Ortega, Pilar/0000-0002-7960-8822; Llewelyn, Martin/0000-0002-6811-1124; Bunclark, Katherine/0000-0002-8785-0715; Pessoa-Amorim, Guilherme/0000-0002-4050-6191; Shanahan, Thomas/0000-0001-5613-2545; Wu, Henry H.L./0000-0002-4561-0844; mcgrath, brendan a/0000-0003-3048-3480; Dosanjh, Davinder/0000-0002-9169-5607; Skene, Imogen/0000-0001-5215-2899; Ahmed, Naseer/0000-0002-0960-1123; Caplin, Ben/0000-0001-9544-164X; Fawke, Joe/0000-0002-5267-7107; Higgins, Julian PT/0000-0002-8323-2514; Gkrania-Klotsas, Effrossyni/0000-0002-0930-8330; chauhan, milan kumar/0000-0001-6120-2034; Diwakar, Lavanya/0000-0003-4369-6637; Tavoukjian, Vera/0000-0002-5479-688X; Patel, Manish/0000-0003-3012-7507; Esmail, Hanif/0000-0002-4278-9316; brightling, chris/0000-0002-9345-4903; Lowsby, Richard/0000-0001-9940-191X; Nigel, Brunskill/0000-0002-7109-7108; Major, Rupert/0000-0003-4920-623X; Bloom, Ben/0000-0002-3016-4925; Ricketts, William/0000-0002-0475-0744; Christides, Alexander/0000-0002-9476-9827; imray, chris/0000-0001-8451-4102; Gibbison, Ben/0000-0003-3635-6212; Emberson, Jonathan/0000-0001-7792-9422; Denis, Emmanuelle/0000-0001-8463-1341; Dey, Vishal/0000-0002-5108-4158; Torok, Mili Estee/0000-0001-9098-8590; Burden, Christy/0000-0001-6409-5238; Newman, Tom/0000-0002-7987-9948; Brannigan, Jamie/0000-0003-1697-403X; Shelley, Ben/0000-0001-6771-9659; Puxty, Kathryn/0000-0002-5742-6171; Vidler, Jennifer/0000-0003-2996-3014; Jha, Akhilesh/0000-0002-8413-7738; Colton, Hayley/0000-0002-3287-4103; Dimitri, Paul/0000-0001-7625-6713; Lim, Ivy/0000-0001-9848-8769; Hinshaw, Kim/0000-0003-0468-4326; Dark, Paul/0000-0003-3309-0164; Parker, Ben/0000-0001-7959-6529; Downey, Damian/0000-0002-6471-549X; Barker, Joseph/0000-0002-5483-9608; Haigh, Kathryn/0000-0003-1901-7315; Shah, Pallav/0000-0002-9052-4638; Chalmers, James/0000-0001-5514-7868; Grandjean, Louis/0000-0002-1457-8327; Hum, Ryan Malcolm/0000-0003-0801-6974; Spears, Mark/0000-0003-4381-5819; vatish, manu/0000-0002-6012-2574; Ramasamy, Maheshi Nirmala/0000-0002-2119-951X; Kametas, Nicholas/0000-0002-7992-6038; Horby, Peter/0000-0002-9822-1586; McKnight, Gerard/0000-0003-1546-7853; Cole, Joby/0000-0002-5258-5835; Islim, Abdurrahman/0000-0001-9621-043X; Ireland, Aidan Taeke/0000-0001-9513-2302; King, Scott/0000-0001-6821-9234; Lai, James/0000-0002-0436-3795; Linden, Dermot/0000-0003-0552-1115; Bhagani, Sanjay/0000-0003-2557-4337; Pfeffer, Paul/0000-0003-0369-2885; maskell, nick/0000-0002-1276-6500; Staplin, Natalie/0000-0003-4482-4418; Iliodromiti, Stamatina/0000-0001-6453-6654; Nadeem, Iftikhar/0000-0002-8644-925X; Landray, Martin/0000-0001-6646-827X; Adamali, Huzaifa/0000-0002-8230-175X; O'Sullivan, Eoin/0000-0002-7709-6595; Bibby, Anna/0000-0001-7386-7754; Stockdale, Alexander/0000-0002-5828-3328; Welters, Ingeborg/0000-0002-3408-8798; Welch, Hugh/0000-0001-6906-2718; Montgomery, Alan/0000-0003-0450-1606; Murray, Clare/0000-0002-8961-8055; Lillie, Patrick/0000-0002-4811-4774; Heyderman, Robert/0000-0003-4573-449X; Drysdale, Simon/0000-0002-6350-6557; Whittaker, Elizabeth/0000-0002-7944-8793; Toshner, Mark/0000-0002-3969-6143; Barnett-Vanes, Ashton/0000-0002-8088-1068; Crocombe, Dominic/0000-0002-1401-6930; Lord, Robert/0000-0001-9008-2502; Soiza, Roy/0000-0002-1397-4272; Willis, Joanna/0000-0003-3260-4311; Roddick, Alistair/0000-0002-4184-2541; mumford, andrew/0000-0002-5523-511X; Collini, Paul/0000-0001-6696-6826; Hormis, Anil/0000-0001-5510-7639; Sarodaya, Varun/0000-0003-4999-5144; Tridente, Ascanio/0000-0003-1500-447X; Elneima, Omer/0000-0003-2480-8840; Abu-Arafeh, Ahmad/0000-0003-2464-3871; Kudsk-Iversen, Soren/0000-0002-7112-3548; Hoggett, Lee/0000-0003-1135-6232; Campbell, Mark/0000-0002-9759-0232; Quenby, Siobhan/0000-0003-3221-5471; Payne, Brendan/0000-0002-3101-3512; Faust, Saul/0000-0003-3410-7642; Gibani, Malick/0000-0003-1781-0053; Ustianowski, Andrew/0000-0002-6134-7855; Rowan, Kathryn/0000-0001-8217-5602; Jhanji, Shaman/0000-0002-1116-628X; Mishra, Eleanor/0000-0002-5903-3005; Kelly, Dominic/0000-0002-6063-8896; Jajbhay, Danyal/0000-0002-3475-9651; Hawcutt, Dan/0000-0002-8120-6507; Daunt, Anna/0000-0001-6480-8867; Mentzer, Alexander/0000-0002-4502-2209; Cooper, Jamie/0000-0003-3812-7026; Dhaliwal, Kevin/0000-0002-3925-3174; Iftikhar, Hina/0000-0003-2138-1415; Leckie, Todd/0000-0003-4309-5225; Buch, Maya/0000-0002-8962-5642; Sahdev, Nikhil/0000-0003-2291-5044; Peters, Mark/0000-0003-3653-4808; Lim, Wei Shen/0000-0002-7694-3051; de Vere, Natasha/0000-0001-9593-6925; Cathie, Katrina/0000-0001-5074-0769; Pathan, Nazima/0000-0001-7656-9453; Yanney, Michael/0000-0002-2543-4425; , Prof Dr Muhammad Shahid Iqbal/0000-0003-0245-5976; Graham-Brown, Matthew/0000-0002-6197-180X; Durrington, Hannah/0000-0002-9990-9446; Pastika, Libor/0000-0001-6892-6553; Adams, Richard/0000-0003-3915-7243; Gregory, Katherine/0000-0002-0610-5386; Price, David/0000-0002-0562-7326; Gupta-Wright, Ankur/0000-0002-5150-2970; Taynton, Thomas/0000-0001-7771-9564; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Ahmed, Muhammad Shamsher/0000-0001-6163-8102; Harwood, Catherine/0000-0002-1375-0965; So, Beng/0000-0003-4356-532X; Fisk, Marie/0000-0002-1292-7642; Chapman, Laura/0000-0001-6174-9435; Blunden, Susara/0000-0003-2328-3755; Burton, Ben/0000-0001-9579-9078; Horsley, Alex/0000-0003-1828-0058; Rokadiya, Sakib/0000-0003-2955-4907; Spata, Enti/0000-0002-7207-2076; Behrouzi, Roya/0000-0002-1978-6539; Sarkar, Rahuldeb/0000-0002-4343-8526; Gorick, Hugh/0000-0003-3089-9830; Haynes, Richard/0000-0002-1179-0023; moon, james/0000-0001-8071-1491; Jethwa, Kishan/0000-0003-1715-9256; Smith, Christopher/0000-0001-7369-2034; de Silva, Thushan/0000-0002-6498-9212; Todd, Stacy/0000-0003-3215-9625; Forton, Julian/0000-0002-0580-0432; Mutch, Callum/0000-0001-9788-0179; Parmar, Chetan/0000-0002-1238-6524; Stewart, Grant D./0000-0003-3188-9140; Scott, Alex/0000-0001-6719-0417; Bancroft, Elizabeth/0000-0002-5482-5660; Hodson, Kenneth/0000-0003-3091-6952	UK Research and Innovation (Medical Research Council); National Institute of Health Research	UK Research and Innovation (Medical Research Council); National Institute of Health Research(National Institute for Health Research (NIHR))	UK Research and Innovation (Medical Research Council) and National Institute of Health Research.	Addy C, 2020, BMJ OPEN RESPIR RES, V7; Carsana L., 2020, LANCET INFECT DIS, V20, P1135, DOI [10.1016/S1473-3099(20)30434-5, DOI 10.1016/S1473-3099(20)30434-5, DOI 10.1016/S2665-9913(20)30127-2]; Cavalcanti AB, 2020, NEW ENGL J MED, V383, P2041, DOI 10.1056/NEJMoa2019014; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Echeverria-Esnal D, 2021, EXPERT REV ANTI-INFE, V19, P147, DOI 10.1080/14787210.2020.1813024; Furtado RHM, 2020, LANCET, V396, P959, DOI 10.1016/S0140-6736(20)31862-6; Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410; Ginsburg AS, 2020, LANCET GLOB HEALTH, V8, pE1453, DOI 10.1016/S2214-109X(20)30444-7; Hall M, 2020, ISARIC CLIN DAT REP, DOI [10.1101/2020.07.17.20155218, DOI 10.1101/2020.07.17.20155218]; Horby P, 2020, NEW ENGL J MED, V383, P2030, DOI 10.1056/NEJMoa2022926; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Horby PW, 2020, LANCET, V396, P1345, DOI 10.1016/S0140-6736(20)32013-4; Hui DS, 2018, ANTIVIR RES, V150, P202, DOI 10.1016/j.antiviral.2018.01.002; Hung IFN, 2017, CHEST, V151, P1069, DOI 10.1016/j.chest.2016.11.012; Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09; Lansbury L, 2020, J INFECTION, V81, P266, DOI 10.1016/j.jinf.2020.05.046; Lee N, 2017, ANTIVIR RES, V144, P48, DOI 10.1016/j.antiviral.2017.05.008; Lim WS, 2011, THORAX, V66, P548, DOI 10.1136/thoraxjnl-2011-200081; Oliver ME, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2163; Omrani, 2020, ECLINICALMEDICINE, V29; Rawson TM, 2020, CLIN INFECT DIS, V71, P2459, DOI 10.1093/cid/ciaa530; Sekhavati E, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106143; SERMO, 2020, SERMO REP JUR IS STI; Shinkai M, 2008, PHARMACOL THERAPEUT, V117, P393, DOI 10.1016/j.pharmthera.2007.11.001; Spagnolo P, 2013, EUR RESPIR J, V42, P239, DOI 10.1183/09031936.00136712; Sterne JAC, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04641-3; Sultana J, 2020, DRUG SAFETY, V43, P691, DOI 10.1007/s40264-020-00976-7; Touret F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70143-6; WHO, DAT ACC WATCH RES AW; Zimmermann P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00302	30	75	78	9	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2021	397	10274					605	612		10.1016/S0140-6736(21)00149-5	http://dx.doi.org/10.1016/S0140-6736(21)00149-5		FEB 2021	8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL2TN	33545096	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000620934000025
J	Iacobucci, G				Iacobucci, Gareth			Jeremy Hunt: I was too slow to boost the NHS workforce-the government must, and can, act now	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Department of Health and Social Care, 2020, ANN B EX CYGN REP AC; Department of Health and Social Care, EXP UND MED ED GOV R	2	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2021	372								n335	10.1136/bmj.n335	http://dx.doi.org/10.1136/bmj.n335			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC1VA	33568341				2022-12-28	WOS:000686320800002
J	Bumpus, NN				Bumpus, Namandje N.			For better drugs, diversify clinical trials	SCIENCE			English	Editorial Material							AFRICAN-AMERICAN		[Bumpus, Namandje N.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University	Bumpus, NN (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	nbumpus1@jhmi.edu			Merck; Genentech; Amgen	Merck(Merck & Company); Genentech(Roche HoldingGenentech); Amgen(Amgen)	The author has received consulting fees, honoraria,or funding from Amgen, Merck, and Genentech.	Guengerich FP, 2016, TRENDS PHARMACOL SCI, V37, P625, DOI 10.1016/j.tips.2016.05.006; Hernandez W, 2020, PHARMACOGENOMICS J, V20, P126, DOI 10.1038/s41397-019-0095-z; Johnson JA, 2017, CLIN PHARMACOL THER, V102, P397, DOI 10.1002/cpt.668; Johnson JA, 1997, J PHARM SCI, V86, P1328, DOI 10.1021/js9702168; Johnson Vanessa A, 2011, ABNF J, V22, P84; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Lamba JK, 2002, ADV DRUG DELIVER REV, V54, P1271, DOI 10.1016/S0169-409X(02)00066-2; Lee CR, 2002, PHARMACOGENETICS, V12, P251, DOI 10.1097/00008571-200204000-00010; Limdi NA, 2017, PHARMACOGENET GENOM, V27, P347, DOI 10.1097/FPC.0000000000000298; Loree JM, 2019, JAMA ONCOL, V5, DOI 10.1001/jamaoncol.2019.1870; Miller DR, 2008, HYPERTENSION, V51, P1624, DOI 10.1161/HYPERTENSIONAHA.108.110270; Perera MA, 2014, CLIN PHARMACOL THER, V95, P242, DOI 10.1038/clpt.2013.209; Ramamoorthy A, 2015, CLIN PHARMACOL THER, V97, P263, DOI 10.1002/cpt.61; Scherr CL, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00548; Taber DJ, 2017, TRANSPLANTATION, V101, P2931, DOI 10.1097/TP.0000000000001840	15	0	1	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		570	571		10.1126/science.abe2565	http://dx.doi.org/10.1126/science.abe2565			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QD7TF	33542124				2022-12-28	WOS:000615715300032
J	Perkel, JM				Perkel, Jeffrey M.			FIVE REASONS TO LOVE THE COMMAND LINE	NATURE			English	Editorial Material						Computational biology and bioinformatics; Computer science; Software; Information technology								Perkel, Jeffrey/0000-0001-5699-1008					0	0	0	2	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2021	590	7844					173	174		10.1038/d41586-021-00263-0	http://dx.doi.org/10.1038/d41586-021-00263-0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG6DC	33531705				2022-12-28	WOS:000617672800001
J	Halley, MC; Mangurian, C				Halley, Meghan C.; Mangurian, Christina			Caring for the Caregivers - Covid-19 Vaccination for Essential Members of the Health Care Team	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Halley, Meghan C.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Mangurian, Christina] Univ Calif San Francisco, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Halley, MC (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.			Halley, Meghan/0000-0002-5031-9840	NCATS NIH HHS [UL1 TR003142] Funding Source: Medline; NHGRI NIH HHS [U01 HG010218] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Antommaria AHM, 2021, J CLIN ETHIC, V32, P35; California Department of Developmental Services, 2021, COVID 19 VACC PHAS L; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.15585/mmwr.mm6932a1, 10.1101/2020.04.22.20076141v1]; Parmar J, 2020, HEALTH SOC CARE COMM, V28, P716, DOI 10.1111/hsc.12928	4	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2021	384	9								10.1056/NEJMpv2101339	http://dx.doi.org/10.1056/NEJMpv2101339			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QS8DS	33577149	Green Accepted, Bronze			2022-12-28	WOS:000626124800010
J	Cosby, RL; Judd, J; Zhang, RL; Zhong, A; Garry, N; Pritham, EJ; Feschotte, C				Cosby, Rachel L.; Judd, Julius; Zhang, Ruiling; Zhong, Alan; Garry, Nathaniel; Pritham, Ellen J.; Feschotte, Cedric			Recurrent evolution of vertebrate transcription factors by transposase capture	SCIENCE			English	Article							DNA-BINDING DOMAIN; READ ALIGNMENT; OFF-TARGET; ELEMENTS; GENOME; GENE; BAT; FINGER; PROTEINS; DATABASE	Genes with novel cellular functions may evolve through exon shuffling, which can assemble novel protein architectures. Here, we show that DNA transposons provide a recurrent supply of materials to assemble protein-coding genes through exon shuffling. We find that transposase domains have been captured-primarily via alternative splicing-to form fusion proteins at least 94 times independently over the course of similar to 350 million years of tetrapod evolution. We find an excess of transposase DNA binding domains fused to host regulatory domains, especially the Kruppel-associated box (KRAB) domain, and identify four independently evolved KRAB-transposase fusion proteins repressing gene expression in a sequence-specific fashion. The bat-specific KRABINER fusion protein binds its cognate transposons genome-wide and controls a network of genes and cis-regulatory elements. These results illustrate how a transcription factor and its binding sites can emerge.	[Cosby, Rachel L.; Judd, Julius; Zhang, Ruiling; Zhong, Alan; Garry, Nathaniel; Feschotte, Cedric] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Pritham, Ellen J.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA	Cornell University; Utah System of Higher Education; University of Utah	Feschotte, C (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	cf458@cornell.edu		Zhang, Ruiling/0000-0001-8523-1796; Judd, Julius/0000-0002-4602-0205; Pritham, Ellen/0000-0002-6548-8348	National Institutes of Health [R35GM122550];  [F31HG010820]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This work was supported by R35GM122550 from the National Institutes of Health to C.F. J.J. was supported by NHGRI fellowship F31HG010820. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; [Anonymous], 2020, JAJ256 JAJ256 PROSEQ, DOI [10.5281/zenodo.4019173, DOI 10.5281/ZENODO.4019173]; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Atkinson PW, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0054-2014; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Babu MM, 2006, NUCLEIC ACIDS RES, V34, P6505, DOI 10.1093/nar/gkl888; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Baiey AD, 2012, DNA REPAIR, V11, P488, DOI 10.1016/j.dnarep.2012.02.004; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Bao WD, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-3; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Breitling R, 2000, DEV GENES EVOL, V210, P644, DOI 10.1007/s004270000106; Bruno M, 2019, ANNU REV GENET, V53, P393, DOI 10.1146/annurev-genet-112618-043717; Busslinger, 2008, PAX GENES EVOLUTION; Castoe TA, 2013, P NATL ACAD SCI USA, V110, P20645, DOI 10.1073/pnas.1314475110; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; Conway JR, 2017, BIOINFORMATICS, V33, P2938, DOI 10.1093/bioinformatics/btx364; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; Core L. J., 2020, BIORXIV 2020 05 18 1; Cosby R., 2020, ZENODO, DOI [10.5281/zenodo.4060329, DOI 10.5281/ZENODO.4060329]; Deng C, 2010, P NATL ACAD SCI USA, V107, P21593, DOI 10.1073/pnas.1007883107; Dupeyron M, 2019, MOBILE DNA-UK, V10, DOI 10.1186/s13100-019-0153-8; Eckalbar WL, 2016, NAT GENET, V48, P528, DOI 10.1038/ng.3537; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Fuentes DR, 2018, ELIFE, V7, DOI 10.7554/eLife.35989; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Gomes NMV, 2011, AGING CELL, V10, P761, DOI 10.1111/j.1474-9726.2011.00718.x; Gray LT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002972; Gu B, 2018, SCIENCE, V359, P1050, DOI 10.1126/science.aao3136; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hayward A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059940; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helleboid PY, 2019, EMBO J, V38, DOI 10.15252/embj.2018101220; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Imbeault M, 2017, NATURE, V543, P550, DOI 10.1038/nature21683; Innan H, 2009, GENETICA, V137, P19, DOI 10.1007/s10709-009-9355-1; Judd J., 2020, 20200518102277 BIORX, P1, DOI DOI 10.1101/2020.05.18.102277; Kapitonov VV., 2007, REPBASE REPORTS, V7, P111; Kapusta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003470; Kojima KK, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-12; Kozmik Z, 2005, CURR OPIN GENET DEV, V15, P430, DOI 10.1016/j.gde.2005.05.001; Kumar S, 2017, MOL BIOL EVOL, V34, P1812, DOI 10.1093/molbev/msx116; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Long MY, 2013, ANNU REV GENET, V47, P307, DOI 10.1146/annurev-genet-111212-133301; Long MY, 1995, P NATL ACAD SCI USA, V92, P12495, DOI 10.1073/pnas.92.26.12495; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu SN, 2020, NUCLEIC ACIDS RES, V48, pD265, DOI 10.1093/nar/gkz991; Villanueva-Canas JL, 2017, GENOME BIOL EVOL, V9, P1886, DOI 10.1093/gbe/evx136; Lynch VJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-2; Lynch VJ, 2015, CELL REP, V10, P551, DOI 10.1016/j.celrep.2014.12.052; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mahat DB, 2016, NAT PROTOC, V11, P1455, DOI 10.1038/nprot.2016.086; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Mitros T, 2019, DEV BIOL, V452, P8, DOI 10.1016/j.ydbio.2019.03.015; Murphy KE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163555; Newman JC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000031; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Ohno S., 1970, P1; Oliveros JC, 2016, NUCLEIC ACIDS RES, V44, pW267, DOI 10.1093/nar/gkw407; Patthy L, 2003, GENETICA, V118, P217, DOI 10.1023/A:1024182432483; Pietrokovski S, 1997, MOL GEN GENET, V254, P689, DOI 10.1007/s004380050467; Pontis J, 2019, CELL STEM CELL, V24, P724, DOI 10.1016/j.stem.2019.03.012; Pritham EJ, 2007, P NATL ACAD SCI USA, V104, P1895, DOI 10.1073/pnas.0609601104; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ray DA, 2008, GENOME RES, V18, P717, DOI 10.1101/gr.071886.107; Richardson JM, 2006, EMBO J, V25, P1324, DOI 10.1038/sj.emboj.7601018; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; RUDDLE FH, 1994, ANNU REV GENET, V28, P423, DOI 10.1146/annurev.ge.28.120194.002231; Seim I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3212; Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116; Sotero-Caio CG, 2017, GENOME BIOL EVOL, V9, P161, DOI 10.1093/gbe/evw264; Stessman HAF, 2016, AM J HUM GENET, V98, P541, DOI 10.1016/j.ajhg.2016.02.004; Sundaram V, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0347; Tellier M, 2019, NUCLEIC ACIDS RES, V47, P122, DOI 10.1093/nar/gky937; Tie CHC, 2018, EMBO REP, V19, DOI 10.15252/embr.201745000; Tipney HJ, 2004, EUR J HUM GENET, V12, P551, DOI 10.1038/sj.ejhg.5201174; Trizzino M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4850-3; Van Oss SB, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008160; Wang Z, 2019, GENOME RES, V29, P293, DOI 10.1101/gr.238279.118; White J, 2016, GENOME MED, V8, DOI 10.1186/s13073-015-0253-0; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; Yang GJ, 2009, SCIENCE, V325, P1391, DOI 10.1126/science.1175688; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhang L, 2001, NUCLEIC ACIDS RES, V29, P3566, DOI 10.1093/nar/29.17.3566; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	100	47	47	7	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					797	+	eabc6405	10.1126/science.abc6405	http://dx.doi.org/10.1126/science.abc6405			61	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QJ4MB	33602827	Green Submitted, Green Accepted			2022-12-28	WOS:000619664700043
J	Doron, I; Leonardi, I; Li, XV; Fiers, WD; Semon, A; Bialt-DeCelie, M; Migaud, M; Gao, IH; Lin, WY; Kusakabe, T; Puel, A; Iliev, ID				Doron, Itai; Leonardi, Irina; Li, Xin, V; Fiers, William D.; Semon, Alexa; Bialt-DeCelie, Meghan; Migaud, Melanie; Gao, Iris H.; Lin, Woan-Yu; Kusakabe, Takato; Puel, Anne; Iliev, Iliyan D.			Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies	CELL			English	Article							CANDIDA-ALBICANS; CRYPTOCOCCUS-NEOFORMANS; COMMENSAL BACTERIA; DENDRITIC CELLS; INNATE IMMUNITY; RESPONSES; CARD9; PROTECTION; INFECTION; DEFENSE	Antibodies mediate natural and vaccine-induced immunity against viral and bacterial pathogens, whereas fungi represent a widespread kingdom of pathogenic species for which neither vaccine nor neutralizing antibody therapies are clinically available. Here, using a multi-kingdom antibody profiling (multiKAP) approach, we explore the human antibody repertoires against gut commensal fungi (mycobiota). We identify species preferentially targeted by systemic antibodies in humans, with Candida albicans being the major inducer of antifungal immunoglobulin G (IgG). Fungal colonization of the gut induces germinal center (GC)-dependent B cell expansion in extraintestinal lymphoid tissues and generates systemic antibodies that confer protection against disseminated C. albicans or C. auris infection. Antifungal IgG production depends on the innate immunity regulator CARD9 and CARD9(+)CX3CR1(+) macrophages. In individuals with invasive candidiasis, loss-of-function mutations in CARD9 are associated with impaired antifungal IgG responses. These results reveal an important role of gut commensal fungi in shaping the human antibody repertoire through CARD9-dependent induction of host-protective antifungal IgG.	[Doron, Itai; Leonardi, Irina; Li, Xin, V; Fiers, William D.; Semon, Alexa; Bialt-DeCelie, Meghan; Gao, Iris H.; Lin, Woan-Yu; Kusakabe, Takato; Iliev, Iliyan D.] Weill Cornell Med, Joan & Sanford I Weill Dept Med, Div Gastroenterol & Hepatol, New York, NY 10021 USA; [Doron, Itai; Leonardi, Irina; Li, Xin, V; Fiers, William D.; Semon, Alexa; Bialt-DeCelie, Meghan; Gao, Iris H.; Lin, Woan-Yu; Kusakabe, Takato; Iliev, Iliyan D.] Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA; [Migaud, Melanie; Puel, Anne] Necker Hosp Sick Children, INSERM, UMR 1163, Lab Human Genet Infect Dis, F-75015 Paris, France; [Iliev, Iliyan D.] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10065 USA; [Gao, Iris H.; Lin, Woan-Yu; Iliev, Iliyan D.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Weill Cornell Med, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA; [Migaud, Melanie; Puel, Anne] Univ Paris, Imagine Inst, F-75015 Paris, France	Cornell University; Cornell University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; UDICE-French Research Universities; Universite Paris Cite	Iliev, ID (corresponding author), Weill Cornell Med, Joan & Sanford I Weill Dept Med, Div Gastroenterol & Hepatol, New York, NY 10021 USA.; Iliev, ID (corresponding author), Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA.; Iliev, ID (corresponding author), Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10065 USA.; Iliev, ID (corresponding author), Cornell Univ, Weill Cornell Grad Sch Med Sci, Weill Cornell Med, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA.	iliev@med.cornell.edu	Li, Xin V./ABA-4321-2021; Puel, Anne/H-7305-2017	Li, Xin V./0000-0002-9444-8214; Puel, Anne/0000-0003-2603-0323; Semon, Alexa/0000-0002-0551-1446; Leonardi, Irina/0000-0002-0369-7371	National Institutes of Health [DK113136, DK121977, AI137157]; Leona M. and Harry B. Helmsley Charitable Trust; Crohn's and Colitis Foundation; Irma T. Hirschl Career Scientist Award; pilot project from the Center for Advanced Digestive Care (CADC); Jill Roberts Institute (JRI) for Research in IBD; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; Crohn's and Colitis Foundation; Irma T. Hirschl Career Scientist Award; pilot project from the Center for Advanced Digestive Care (CADC); Jill Roberts Institute (JRI) for Research in IBD; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases Award	We thank members of the Iliev laboratory for critical review of the manuscript. We thank Jean-Laurent Casanova of the Laboratory of Human Genetics of Infectious Diseases at Rockefeller University and Howard Hughes Medical Institute for help with the human genetics study of CARD9. We thank Jayanta Chaudhuri and Tobias Hohl for discussions and for providing a key reagent. We thank all contributing members of the JRI IBD Live Cell Bank Consortium and the Microbiome Core Laboratory of Weill Cornell Medicine. Support for sample acquisition through the JRI IBD Live Cell Bank is provided by the JRI, the Jill Roberts Center for IBD, Cure for IBD, the Rosanne H. Silbermann Foundation, and the Weill Cornell Medicine Division of Pediatric Gastroenterology and Nutrition. Research in the Iliev laboratory is supported by the National Institutes of Health (DK113136, DK121977, and AI137157), the Leona M. and Harry B. Helmsley Charitable Trust, the Crohn's and Colitis Foundation, the Irma T. Hirschl Career Scientist Award, pilot project funding from the Center for Advanced Digestive Care (CADC), the Jill Roberts Institute (JRI) for Research in IBD, and the Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases Award.	Ansaldo E, 2019, SCIENCE, V364, P1179, DOI 10.1126/science.aaw7479; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bacher P, 2019, CELL, V176, P1340, DOI 10.1016/j.cell.2019.01.041; Barbet G, 2018, IMMUNITY, V48, P584, DOI 10.1016/j.immuni.2018.02.015; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Cao ZF, 2015, IMMUNITY, V43, P715, DOI 10.1016/j.immuni.2015.10.005; Casadevall A, 2003, J EXP MED, V197, P1401, DOI 10.1084/jem.20030637; Casadevall A, 2012, CELL HOST MICROBE, V11, P447, DOI 10.1016/j.chom.2012.04.004; Chiani P, 2009, VACCINE, V27, P513, DOI 10.1016/j.vaccine.2008.11.030; Christmann BS, 2015, J ALLERGY CLIN IMMUN, V136, P1378, DOI 10.1016/j.jaci.2015.03.036; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Corvilain E, 2018, J CLIN IMMUNOL, V38, P656, DOI 10.1007/s10875-018-0539-2; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Doron I, 2019, FUNGAL GENET BIOL, V127, P45, DOI 10.1016/j.fgb.2019.03.001; Drummond RA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005293; Edwards JE, 2018, CLIN INFECT DIS, V66, P1928, DOI 10.1093/cid/ciy185; Eyre DW, 2018, NEW ENGL J MED, V379, P1322, DOI 10.1056/NEJMoa1714373; Fadlallah J, 2019, J ALLERGY CLIN IMMUN, V143, P1575, DOI 10.1016/j.jaci.2018.09.036; Fan D, 2015, NAT MED, V21, P808, DOI 10.1038/nm.3871; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Flores-Langarica A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02409; Garcia-Solache MA, 2010, MBIO, V1, DOI 10.1128/mBio.00061-10; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Huertas B, 2017, J PROTEOME RES, V16, P335, DOI 10.1021/acs.jproteome.6b00383; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Kim SG, 2019, NATURE, V572, P665, DOI 10.1038/s41586-019-1501-z; Kim YI, 2018, J IMMUNOL, V201, P1287, DOI 10.4049/jimmunol.1701459; Koch MA, 2016, CELL, V165, P827, DOI 10.1016/j.cell.2016.04.055; Koh AY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040035; Koscso B, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aax0062; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Lanternier F, 2015, J ALLERGY CLIN IMMUN, V135, P1558, DOI 10.1016/j.jaci.2014.12.1930; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Leonardi I, 2020, CELL HOST MICROBE, V27, P823, DOI 10.1016/j.chom.2020.03.006; Leonardi I, 2018, SCIENCE, V359, P232, DOI 10.1126/science.aao1503; Li X, 2018, CELL HOST MICROBE, V24, P847, DOI 10.1016/j.chom.2018.11.003; Li XV, 2019, IMMUNITY, V50, P1365, DOI 10.1016/j.immuni.2019.05.023; Limon JJ, 2019, CELL HOST MICROBE, V25, P377, DOI 10.1016/j.chom.2019.01.007; Lionakis MS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019638; Liu CM, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-56, 10.1186/1471-2180-12-255]; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Martinez LR, 2004, INFECT IMMUN, V72, P3674, DOI 10.1128/IAI.72.6.3674-3679.2004; McClelland EE, 2010, J CLIN INVEST, V120, P1355, DOI 10.1172/JCI38322; Montagnoli C, 2003, EUR J IMMUNOL, V33, P1193, DOI 10.1002/eji.200323790; Moreno-Sabater A, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00924-8; Nash AK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0373-4; Pachl J, 2006, CLIN INFECT DIS, V42, P1404, DOI 10.1086/503428; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; de Diego RP, 2015, J ALLERGY CLIN IMMUN, V136, P1139, DOI 10.1016/j.jaci.2015.06.031; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Rapaka RR, 2010, J EXP MED, V207, P2907, DOI 10.1084/jem.20100034; Richard ML, 2019, NAT REV GASTRO HEPAT, V16, P331, DOI 10.1038/s41575-019-0121-2; Riente L, 2004, J RHEUMATOL, V31, P920; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Roth S, 2013, TRENDS IMMUNOL, V34, P243, DOI 10.1016/j.it.2013.02.006; Rudkin FM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07738-1; SCHAEDLER RW, 1965, J EXP MED, V122, P59, DOI 10.1084/jem.122.1.59; Shao TY, 2019, CELL HOST MICROBE, V25, P404, DOI 10.1016/j.chom.2019.02.004; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Standaert-Vitse A, 2006, GASTROENTEROLOGY, V130, P1764, DOI 10.1053/j.gastro.2006.02.009; Standaert-Vitse A, 2009, AM J GASTROENTEROL, V104, P1745, DOI 10.1038/ajg.2009.225; Takaki H, 2018, MUCOSAL IMMUNOL, V11, P82, DOI 10.1038/mi.2017.48; Tang J, 2015, J IMMUNOL METHODS, V421, P112, DOI 10.1016/j.jim.2015.04.004; Teng F, 2016, IMMUNITY, V44, P875, DOI 10.1016/j.immuni.2016.03.013; Tso GHW, 2018, SCIENCE, V362, P589, DOI 10.1126/science.aat0537; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Witchley JN, 2019, CELL HOST MICROBE, V25, P432, DOI 10.1016/j.chom.2019.02.008; Wuthrich M, 2012, ANNU REV IMMUNOL, V30, P115, DOI 10.1146/annurev-immunol-020711-074958; Yang AM, 2017, J CLIN INVEST, V127, P2829, DOI 10.1172/JCI90562; Zeng MY, 2016, IMMUNITY, V44, P647, DOI 10.1016/j.immuni.2016.02.006; Zhai B, 2020, NAT MED, V26, P59, DOI 10.1038/s41591-019-0709-7	78	50	51	9	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					1017	+		10.1016/j.cell.2021.01.016	http://dx.doi.org/10.1016/j.cell.2021.01.016		FEB 2021	29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33548172	Green Accepted			2022-12-28	WOS:000629633400016
J	Torjesen, I				Torjesen, Ingrid			Covid-19 will become endemic but with decreased potency over time, scientists believe	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cele S, 2021, NATURE, V593, P142, DOI 10.1038/s41586-021-03471-w; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Hogan AB, 2020, 33 IMP COLL LOND, DOI [10.25561/82822, DOI 10.25561/82822]; Phillips N, 2021, NATURE, V590, P382, DOI 10.1038/d41586-021-00396-2	4	44	44	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2021	372								n494	10.1136/bmj.n494	http://dx.doi.org/10.1136/bmj.n494			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UD4NC	33602668	Bronze			2022-12-28	WOS:000687183600004
J	Torjesen, I				Torjesen, Ingrid			Covid-19: Sweden vows greater protection for academics as researcher quits after aggressive social media attack	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ludvigsson JF, 2021, NEW ENGL J MED, V384, P669, DOI 10.1056/NEJMc2026670; Paterlini M, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4508; Trysell K, LAKARTIDNINGENSE; World Health Organization, WHO COR DIS COVID 19	4	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2021	372								n489	10.1136/bmj.n489	http://dx.doi.org/10.1136/bmj.n489			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UD4NC	33602692	Bronze			2022-12-28	WOS:000687183600002
J	Chen, IC; Pant, S; Wu, QY; Cater, RJ; Sobti, M; Vandenberg, RJ; Stewart, AG; Tajkhorshid, E; Font, J; Ryan, RM				Chen, Ichia; Pant, Shashank; Wu, Qianyi; Cater, Rosemary J.; Sobti, Meghna; Vandenberg, Robert J.; Stewart, Alastair G.; Tajkhorshid, Emad; Font, Josep; Ryan, Renae M.			Glutamate transporters have a chloride channel with two hydrophobic gates	NATURE			English	Article							AMINO-ACID TRANSPORTER; CRYO-EM STRUCTURE; MOLECULAR-DYNAMICS; SUBSTRATE; BINDING; DOMAIN; MODEL; VISUALIZATION; CONDUCTANCES; MECHANISMS	Glutamate is the most abundant excitatory neurotransmitter in the central nervous system, and its precise control is vital to maintain normal brain function and to prevent excitotoxicity(1). The removal of extracellular glutamate is achieved by plasma-membrane-bound transporters, which couple glutamate transport to sodium, potassium and pH gradients using an elevator mechanism(2-5). Glutamate transporters also conduct chloride ions by means of a channel-like process that is thermodynamically uncoupled from transport(6-8). However, the molecular mechanisms that enable these dual-function transporters to carry out two seemingly contradictory roles are unknown. Here we report the cryo-electron microscopy structure of a glutamate transporter homologue in an open-channel state, which reveals an aqueous cavity that is formed during the glutamate transport cycle. The functional properties of this cavity, combined with molecular dynamics simulations, reveal it to be an aqueous-accessible chloride permeation pathway that is gated by two hydrophobic regions and is conserved across mammalian and archaeal glutamate transporters. Our findings provide insight into the mechanism by which glutamate transporters support their dual function, and add information that will assist in mapping the complete transport cycle shared by the solute carrier 1A transporter family.	[Chen, Ichia; Wu, Qianyi; Cater, Rosemary J.; Vandenberg, Robert J.; Font, Josep; Ryan, Renae M.] Univ Sydney, Sch Med Sci, Fac Med & Hlth, Transporter Biol Grp, Sydney, NSW, Australia; [Pant, Shashank; Tajkhorshid, Emad] Univ Illinois, NIH Ctr Macromol Modeling & Bioinformat, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Pant, Shashank; Tajkhorshid, Emad] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Pant, Shashank; Tajkhorshid, Emad] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA; [Sobti, Meghna; Stewart, Alastair G.] Victor Chang Cardiac Res Inst, Mol Struct & Computat Biol Div, Darlinghurst, NSW, Australia; [Sobti, Meghna; Stewart, Alastair G.] UNSW Sydney, St Vincents Clin Sch, Fac Med, Kensington, NSW, Australia; [Cater, Rosemary J.] Columbia Univ Irving Med Ctr, Dept Physiol & Cellular Biophys, New York, NY USA	University of Sydney; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; NewYork-Presbyterian Hospital	Font, J; Ryan, RM (corresponding author), Univ Sydney, Sch Med Sci, Fac Med & Hlth, Transporter Biol Grp, Sydney, NSW, Australia.; Tajkhorshid, E (corresponding author), Univ Illinois, NIH Ctr Macromol Modeling & Bioinformat, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.; Tajkhorshid, E (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.; Tajkhorshid, E (corresponding author), Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA.	emad@illinois.edu; josep.font@sydney.edu.au; renae.ryan@sydney.edu.au	Tajkhorshid, Emad/AAN-8323-2021; Pant, Shashank/ABA-8223-2021; Vandenberg, Robert/E-6018-2016	Pant, Shashank/0000-0002-8222-3616; Vandenberg, Robert/0000-0003-1523-4814; Stewart, Alastair/0000-0002-2070-6030; Tajkhorshid, Emad/0000-0001-8434-1010; Cater, Rosemary/0000-0003-4503-002X; Wu, Qianyi/0000-0003-4991-1692; Font Sadurni, Josep/0000-0001-5284-1344; Ryan, Renae/0000-0002-8680-4610; Chen, Ichia/0000-0002-1158-5484	Australian National Health and Medical Research Council [APP1164494, APP1159347]; National Institutes of Health [P41-GM104601, R01-GM067887]; Beckman Institute Graduate Fellowship; XSEDE [MCA06N060]; NSW Government; X. laevis colony at the University of Sydney	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Institute Graduate Fellowship; XSEDE; NSW Government; X. laevis colony at the University of Sydney	This work was supported by the Australian National Health and Medical Research Council Project Grant APP1164494 (to R.M.R., R.J.V. and J.F.) and Fellowship APP1159347 (to A.G.S.), by National Institutes of Health grants P41-GM104601 (to E.T.) and R01-GM067887 (to E.T.), a Research Training Program Scholarship (to I.C.) and a Beckman Institute Graduate Fellowship (to S.P.). Computational resources were provided by XSEDE (grant MCA06N060 to E.T.), NCSA Blue Waters (to E.T.) and Microsoft Azure (to E.T.). We acknowledge the use of the Victor Chang Cardiac Research Institute Innovation Centre, funded by the NSW Government; the Electron Microscope Unit at UNSW Sydney, funded in part by the NSW Government; the MX2 beamline at the Australian Synchrotron, part of ANSTO; and the Australian Cancer Research Foundation (ACRF) detector. We acknowledge the facilities and technical assistance of J. Bouwer and S. Brown from Cryo Electron Microscopy - Molecular Horizons, University of Wollongong; and W. Close from Microscopy Australia at the Australian Centre for Microscopy and Microanalysis, University of Sydney. We thank D. Chappell, X. Wang and O. Boudker for discussions; Z. Zhao for assistance with simulations; and C. Handford and those that support the X. laevis colony at the University of Sydney.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Akyuz N, 2015, NATURE, V518, P68, DOI 10.1038/nature14158; [Anonymous], 2018, PYMOL MOL GRAPHICS S; Aragao D, 2018, J SYNCHROTRON RADIAT, V25, P885, DOI 10.1107/S1600577518003120; Arkhipova V, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14834-8; Arkhipova V, 2019, ELIFE, V8, DOI 10.7554/eLife.45286; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; Basilio D, 2014, NAT STRUCT MOL BIOL, V21, P456, DOI 10.1038/nsmb.2814; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Canul-Tec JC, 2017, NATURE, V544, P446, DOI 10.1038/nature22064; Cater RJ, 2016, J GEN PHYSIOL, V148, P13, DOI 10.1085/jgp.201511556; Cater RJ, 2014, BIOPHYS J, V107, P621, DOI 10.1016/j.bpj.2014.05.046; Cheng MH, 2017, ELIFE, V6, DOI 10.7554/eLife.25850; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erkens GB, 2013, NATURE, V502, P119, DOI 10.1038/nature12538; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Galli A, 1996, P NATL ACAD SCI USA, V93, P8671, DOI 10.1073/pnas.93.16.8671; Garaeva AA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11363-x; Garaeva AA, 2018, NAT STRUCT MOL BIOL, V25, P515, DOI 10.1038/s41594-018-0076-y; Grossfield A., WHAM WEIGHTED HISTOG; Guskov A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13420; Hotzy J, 2013, J BIOL CHEM, V288, P36492, DOI 10.1074/jbc.M113.489385; Huang SW, 2007, BIOCHEMISTRY-US, V46, P9685, DOI 10.1021/bi700647f; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; IWADATE Y, 1982, J PHYS CHEM-US, V86, P5205, DOI 10.1021/j100223a028; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kastner J, 2011, WIRES COMPUT MOL SCI, V1, P932, DOI 10.1002/wcms.66; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Li J, 2013, P NATL ACAD SCI USA, V110, P7696, DOI 10.1073/pnas.1218986110; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Machtens JP, 2015, CELL, V160, P542, DOI 10.1016/j.cell.2014.12.035; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Matin TR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18811-z; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Oh S, 2018, ELIFE, V7, DOI 10.7554/eLife.37291; Parinejad N, 2016, J NEUROSCI, V36, P7640, DOI 10.1523/JNEUROSCI.0197-16.2016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poulsen MV, 2001, J PHYSIOL-LONDON, V534, P159, DOI 10.1111/j.1469-7793.2001.00159.x; Reyes N, 2013, NAT STRUCT MOL BIOL, V20, P634, DOI 10.1038/nsmb.2548; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Ruan Y, 2017, P NATL ACAD SCI USA, V114, P1584, DOI 10.1073/pnas.1616413114; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2016, NAT STRUCT MOL BIOL, V23, P187, DOI 10.1038/nsmb.3179; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scopelliti AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02444-w; Scopelliti AJ, 2014, J BIOL CHEM, V289, P17468, DOI 10.1074/jbc.M114.565242; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Shabaneh M, 2014, J BIOL CHEM, V289, P11175, DOI 10.1074/jbc.M114.550277; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Untiet V, 2017, GLIA, V65, P388, DOI 10.1002/glia.23098; Vandenberg RJ, 2008, CHANNELS, V2, P51, DOI 10.4161/chan.2.1.6047; Vandenberg RJ, 2013, PHYSIOL REV, V93, P1621, DOI 10.1152/physrev.00007.2013; Vandenberg RJ, 2011, BIOCHEM J, V439, P333, DOI 10.1042/BJ20110905; Verdon G, 2014, ELIFE, V3, DOI 10.7554/eLife.02283; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Veruki ML, 2006, NAT NEUROSCI, V9, P1388, DOI 10.1038/nn1793; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Walter JD, 2019, ELIFE, V8, DOI 10.7554/eLife.46986; Wang XY, 2020, ELIFE, V9, DOI 10.7554/eLife.58417; Wersinger E, 2006, J PHYSIOL-LONDON, V577, P221, DOI 10.1113/jphysiol.2006.118281; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Winter N, 2012, BRAIN, V135, P3416, DOI 10.1093/brain/aws255; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Yu XD, 2019, ELIFE, V8, DOI 10.7554/eLife.48120; Zerangue N, 1996, J BIOL CHEM, V271, P27991, DOI 10.1074/jbc.271.45.27991; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou WC, 2019, ELIFE, V8, DOI 10.7554/eLife.50576	87	20	20	6	41	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 11	2021	591	7849					327	+		10.1038/s41586-021-03240-9	http://dx.doi.org/10.1038/s41586-021-03240-9		FEB 2021	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8UA	33597752	Green Accepted, Green Submitted			2022-12-28	WOS:000618965700002
J	Dyer, C				Dyer, Clare			Mesh removal: skills accreditation planned for surgeons who work in new centres	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2020, BMJ-BRIT MED J, V371, DOI DOI 10.1136/BMJ.M4589; MAHASE E, 2020, BMJ-BRIT MED J, V370, DOI DOI 10.1136/BMJ.M2726	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2021	372								n452	10.1136/bmj.n452	http://dx.doi.org/10.1136/bmj.n452			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QI7RL	33589429				2022-12-28	WOS:000619180700002
J	Wise, J				Wise, Jacqui			Covid-19: Children less likely to report fever, persistent cough, or appetite loss, large UK study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Davis M, 2020, NEW LEFT REV, P7; World Health Organization, 2021, GLOB COVID 19 CLIN P	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2021	372								n408	10.1136/bmj.n408	http://dx.doi.org/10.1136/bmj.n408			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH9VF	33568385	Bronze			2022-12-28	WOS:000618622900002
J	Zhang, JZ; Wu, QQ; Johnson, CB; Pham, G; Kinder, JM; Olsson, A; Slaughter, A; May, M; Weinhaus, B; D'Alessandro, A; Engel, JD; Jiang, JX; Kofron, JM; Huang, LF; Prasath, VBS; Way, SS; Salomonis, N; Grimes, HL; Lucas, D				Zhang, Jizhou; Wu, Qingqing; Johnson, Courtney B.; Pham, Giang; Kinder, Jeremy M.; Olsson, Andre; Slaughter, Anastasiya; May, Margot; Weinhaus, Benjamin; D'Alessandro, Angelo; Engel, James Douglas; Jiang, Jean X.; Kofron, J. Matthew; Huang, L. Frank; Prasath, V. B. Surya; Way, Sing Sing; Salomonis, Nathan; Grimes, H. Leighton; Lucas, Daniel			In situ mapping identifies distinct vascular niches for myelopoiesis	NATURE			English	Article								In contrast to nearly all other tissues, the anatomy of cell differentiation in the bone marrow remains unknown. This is owing to a lack of strategies for examining myelopoiesis-the differentiation of myeloid progenitors into a large variety of innate immune cells-in situ in the bone marrow. Such strategies are required to understand differentiation and lineage-commitment decisions, and to define how spatial organizing cues inform tissue function. Here we develop approaches for imaging myelopoiesis in mice, and generate atlases showing the differentiation of granulocytes, monocytes and dendritic cells. The generation of granulocytes and dendritic cells-monocytes localizes to different blood-vessel structures known as sinusoids, and displays lineage-specific spatial and clonal architectures. Acute systemic infection with Listeria monocytogenes induces lineage-specific progenitor clusters to undergo increased self-renewal of progenitors, but the different lineages remain spatially separated. Monocyte-dendritic cell progenitors (MDPs) map with nonclassical monocytes and conventional dendritic cells; these localize to a subset of blood vessels expressing a major regulator of myelopoiesis, colony-stimulating factor 1 (CSF1, also known as M-CSF)(1). Specific deletion of Csf1 in endothelium disrupts the architecture around MDPs and their localization to sinusoids. Subsequently, there are fewer MDPs and their ability to differentiate is reduced, leading to a loss of nonclassical monocytes and dendritic cells during both homeostasis and infection. These data indicate that local cues produced by distinct blood vessels are responsible for the spatial organization of definitive blood cell differentiation. A combination of fluorescent antibodies is used to build visual maps of all myeloid cells in the bone marrow, providing new insight into how the bone marrow microenvironment regulates cell-fate decisions.	[Zhang, Jizhou; Wu, Qingqing; Johnson, Courtney B.; Slaughter, Anastasiya; May, Margot; Weinhaus, Benjamin; Huang, L. Frank; Grimes, H. Leighton; Lucas, Daniel] Cincinnati Childrens Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Pham, Giang; Kinder, Jeremy M.; Way, Sing Sing] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Ctr Inflammat & Tolerance, Cincinnati, OH 45229 USA; [Olsson, Andre; Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Olsson, Andre; Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Ctr Syst Immunol, Cincinnati, OH 45229 USA; [Slaughter, Anastasiya; Weinhaus, Benjamin] Univ Cincinnati, Coll Med, Immunol Grad Program, Cincinnati, OH USA; [D'Alessandro, Angelo] Univ Colorado Denver, Dept Biochem & Mol Genet, Anschutz Med Campus, Aurora, CO USA; [Engel, James Douglas] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA; [Kofron, J. Matthew] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Kofron, J. Matthew; Huang, L. Frank; Prasath, V. B. Surya; Way, Sing Sing; Salomonis, Nathan; Grimes, H. Leighton; Lucas, Daniel] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Huang, L. Frank] Cincinnati Childrens Med Ctr, Div Expt Hematol & Canc Biol, Brain Tumor Ctr, Cincinnati, OH USA; [Prasath, V. B. Surya; Salomonis, Nathan] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Michigan System; University of Michigan; University of Texas System; University of Texas Health San Antonio; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Lucas, D (corresponding author), Cincinnati Childrens Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.; Lucas, D (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA.	daniel.lucas@cchmc.org	Lucas, Daniel/ABB-6893-2021; Prasath, Surya/A-5243-2010; Wu, Qingqing/AFU-3222-2022; D'Alessandro, Angelo/AAA-4695-2019	Lucas, Daniel/0000-0002-0147-5425; Prasath, Surya/0000-0001-7163-7453; Wu, Qingqing/0000-0002-1566-1253; D'Alessandro, Angelo/0000-0002-2258-6490; May, Margot/0000-0002-2644-9098; Weinhaus, Benjamin/0000-0001-6250-3170; Slaughter, Anastasiya/0000-0003-4414-3639; Huang, L.Frank/0000-0002-0322-6078; Kofron, Matthew/0000-0001-6427-4148	National Heart Lung and Blood Institute [R01HL122661, R01HL136529]; National Institutes of Health (NIH)/National Center for Advancing Translational Sciences (NCATS) [U2CTR002818]; NIH/National Heart, Lung and Blood Institute (NHLBI) [U24HL148865]; NIH/National Institute of Allergy and Infectious Diseases (NIAID) [U01AI150748]; Cincinnati Pediatric Cell Atlas Center; Department of Defense (DoD) through a Peer Reviewed Cancer Research Program (PRCRP) award [W81XWH-20-1-0870, CA191188]; NIH [R01AI120202, R01AI124657, DP1AI131080, S10OD023410]; Howard Hughes Medical Institute (HHMI) Faculty Scholar's program; March of Dimes Ohio Collaborative for Prematurity Research; Burroughs Wellcome Fund Investigator in Pathogenesis Award; NIH/National Institute of Aging (NIA) [AG045040]; Welch Foundation [AQ-1507]; NIH Department of Health and Human Services (HHS) of the US [T32 AI118697/AI/NIAID]	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH)/National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH/National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cincinnati Pediatric Cell Atlas Center; Department of Defense (DoD) through a Peer Reviewed Cancer Research Program (PRCRP) award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI) Faculty Scholar's program; March of Dimes Ohio Collaborative for Prematurity Research; Burroughs Wellcome Fund Investigator in Pathogenesis Award; NIH/National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Welch Foundation(The Welch Foundation); NIH Department of Health and Human Services (HHS) of the US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Cancelas, M.-D. Filippi, D. Reynaud, D. Starczynowski and A. Hidalgo for feedback on the manuscript. We are grateful to L. G. Ng, I. Kwok and K. Leong for help in designing granulopoiesis experiments and reviewing the manuscript. We also thank the Confocal Imaging Core, the Research Flow Cytometry Core and the Veterinary Services at the University of Michigan and Cincinnati Children's Medical Center for experimental and technical assistance. This work was partially supported by the National Heart Lung and Blood Institute (grants R01HL122661 to H.L.G. and R01HL136529 to D.L.). V.B.S.P. is supported by National Institutes of Health (NIH)/National Center for Advancing Translational Sciences (NCATS) grant U2CTR002818, NIH/National Heart, Lung and Blood Institute (NHLBI) grant U24HL148865, and NIH/National Institute of Allergy and Infectious Diseases (NIAID) grant U01AI150748. N.S. is supported by the Cincinnati Pediatric Cell Atlas Center. L.F.H. is supported by the Department of Defense (DoD) through a Peer Reviewed Cancer Research Program (PRCRP) award, W81XWH-20-1-0870(#CA191188). S.S.W. is supported by the NIH through grants R01AI120202, R01AI124657 and DP1AI131080 and by the Howard Hughes Medical Institute (HHMI) Faculty Scholar's program, the March of Dimes Ohio Collaborative for Prematurity Research, and a Burroughs Wellcome Fund Investigator in Pathogenesis Award. J.X.J. is supported by NIH/National Institute of Aging (NIA) grant AG045040 and a Welch Foundation Grant, AQ-1507. A.S. is supported by grant T32 AI118697/AI/NIAID from the NIH Department of Health and Human Services (HHS) of the US. Data were generated using an SH800 cell sorter funded by NIH grant S10OD023410.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Baryawno N, 2019, CELL, V177, P1915, DOI 10.1016/j.cell.2019.04.040; Bowers E, 2018, NAT MED, V24, P95, DOI 10.1038/nm.4448; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Charbord P, 1996, BLOOD, V87, P4109, DOI 10.1182/blood.V87.10.4109.bloodjournal87104109; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Comazzetto S, 2019, CELL STEM CELL, V24, P477, DOI 10.1016/j.stem.2018.11.022; DePasquale EAK, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz789; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Evrard M, 2018, IMMUNITY, V48, P364, DOI 10.1016/j.immuni.2018.02.002; Gomes AC, 2016, IMMUNITY, V45, P1219, DOI 10.1016/j.immuni.2016.11.004; Harris SE, 2012, BONE, V50, P42, DOI 10.1016/j.bone.2011.09.038; Herault A, 2017, NATURE, V544, P53, DOI 10.1038/nature21693; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Kwok I, 2020, IMMUNITY, V53, P303, DOI 10.1016/j.immuni.2020.06.005; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; MOHANDAS N, 1978, BLOOD, V51, P633; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Muench DE, 2020, NATURE, V582, P109, DOI 10.1038/s41586-020-2227-7; Nestorowa S, 2016, BLOOD, V128, pE20, DOI 10.1182/blood-2016-05-716480; Olsson A, 2016, NATURE, V537, P698, DOI 10.1038/nature19348; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sapoznikov A, 2008, NAT IMMUNOL, V9, P388, DOI 10.1038/ni1571; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Stanley ER, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a021857; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Takaku T, 2010, BLOOD, V116, pE41, DOI 10.1182/blood-2010-02-268466; Thambyrajah R, 2016, NAT CELL BIOL, V18, P21, DOI 10.1038/ncb3276; Tikhonova AN, 2019, NATURE, V569, P222, DOI 10.1038/s41586-019-1104-8; Tusi BK, 2018, NATURE, V555, P54, DOI 10.1038/nature25741; Upadhaya S, 2018, J EXP MED, V215, P2815, DOI 10.1084/jem.20180136; Urbaniak G. C., RES RANDOMIZER VERSI; Venkatasubramanian M, 2020, BIOINFORMATICS, V36, P3773, DOI 10.1093/bioinformatics/btaa201; Wei QZ, 2018, IMMUNITY, V48, P632, DOI 10.1016/j.immuni.2018.03.024; WEISS L, 1965, J MORPHOL, V117, P467, DOI 10.1002/jmor.1051170308; WESTEN H, 1979, J EXP MED, V150, P919, DOI 10.1084/jem.150.4.919; Yanez A, 2017, IMMUNITY, V47, P890, DOI 10.1016/j.immuni.2017.10.021; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang JZ, 2019, J CLIN INVEST, V129, P2920, DOI 10.1172/JCI124829	45	33	33	6	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846					457	+		10.1038/s41586-021-03201-2	http://dx.doi.org/10.1038/s41586-021-03201-2		FEB 2021	32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QJ5CU	33568812	Green Accepted			2022-12-28	WOS:000616961600002
J	Mourad, MS				Mourad, Michelle S.			Donning and Doffing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay an internal medicine hospitalist explores what the new diagnosis of breast cancer means for her professional identity and considers how the COVID-19 pandemic facilitates the hiding of serious illness but also complicates disclosing the news to colleagues and friends.	[Mourad, Michelle S.] Univ Calif San Francisco, Div Hosp Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Mourad, MS (corresponding author), 505 Parnassus Ave,M-994,Box 0120, San Francisco, CA 94143 USA.	michelle.mourad@ucsf.edu							0	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2021	325	6					536	536		10.1001/jama.2020.26468	http://dx.doi.org/10.1001/jama.2020.26468			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG0MD	33560325				2022-12-28	WOS:000617279600014
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on . . . Contagion	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, GUARDIAN 1026; Grafton-Green P., 2021, MATT HANCOCK TELLS L; Manthorpe R., 2021, SKY NEWS	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2021	372								n350	10.1136/bmj.n350	http://dx.doi.org/10.1136/bmj.n350			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH2PI	33547037	Bronze			2022-12-28	WOS:000618119100022
J	Cooper, L				Cooper, Lisa			Rethink how we plan research to shrink COVID health disparities	NATURE			English	Editorial Material						SARS-CoV-2; Society; Health care; Medical research			[Cooper, Lisa] Johns Hopkins Sch Med, Med & Hlth Behav & Soc, Baltimore, MD 21205 USA; [Cooper, Lisa] Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Cooper, L (corresponding author), Johns Hopkins Sch Med, Med & Hlth Behav & Soc, Baltimore, MD 21205 USA.; Cooper, L (corresponding author), Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	lisa.cooper@jhmi.edu							0	2	2	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2021	590	7844					9	9		10.1038/d41586-021-00258-x	http://dx.doi.org/10.1038/d41586-021-00258-x			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG6CU	33531706				2022-12-28	WOS:000617672000001
J	[Anonymous]				[Anonymous]			Update to living systematic review on prediction models for diagnosis and prognosis of covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	Article													Verbakel, Jan/E-6758-2015	Verbakel, Jan/0000-0002-7166-7211					0	7	7	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2021	372								n236	10.1136/bmj.n236	http://dx.doi.org/10.1136/bmj.n236			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UD4MF	33536183	Green Published, Bronze			2022-12-28	WOS:000687181300001
J	Grubaugh, ND; Hodcroft, EB; Fauver, JR; Phelan, AL; Cevik, M				Grubaugh, Nathan D.; Hodcroft, Emma B.; Fauver, Joseph R.; Phelan, Alexandra L.; Cevik, Muge			Public health actions to control new SARS-CoV-2 variants Comment	CELL			English	Editorial Material								Recent reports suggest that some SARS-CoV-2 genetic variants, such as B.1.1.7, might be more transmissible and are quickly spreading around the world. As the emergence of more transmissible variants could exacerbate the pandemic, we provide public health guidance for increased surveillance and measures to reduce community transmission.	[Grubaugh, Nathan D.; Fauver, Joseph R.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA; [Grubaugh, Nathan D.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Grubaugh, Nathan D.] Yale Univ, Yale Inst Global Hlth, New Haven, CT USA; [Hodcroft, Emma B.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Phelan, Alexandra L.] Georgetown Univ, Ctr Global Hlth Sci & Secur, Washington, DC 20057 USA; [Phelan, Alexandra L.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA; [Cevik, Muge] Univ St Andrews, Sch Med, Div Infect & Global Hlth Res, St Andrews, Fife, Scotland	Yale University; Yale University; Yale University; University of Bern; Georgetown University; Georgetown University; University of St Andrews	Fauver, JR (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Hodcroft, EB (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.; Phelan, AL (corresponding author), Georgetown Univ, Ctr Global Hlth Sci & Secur, Washington, DC 20057 USA.; Phelan, AL (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA.	emma.hodcroft@ispm.unibe.ch; josephfauver@yale.edu; alexandra.phelan@georgetown.edu		Cevik, Muge/0000-0003-1133-3874	Emergent Ventures at the Mercatus Center at George Mason University; CDC [75D30120C09570]	Emergent Ventures at the Mercatus Center at George Mason University; CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	We thank Anderson Brito for help with the figure creation and all of the medical staff, public health officials, researchers, and essential employees for their service. N.D.G. is supported by Fast Grant from Emergent Ventures at the Mercatus Center at George Mason University and CDC Contract #75D30120C09570.	Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Davies Nicholas G, 2021, Science, V372, DOI 10.1126/science.abg3055; Devi S, 2020, LANCET, V395, P1331, DOI 10.1016/S0140-6736(20)30967-3; Greaney AJ, 2020, COMPREHENSIVE MAPPIN, DOI [10.1101/2020.12.31.425021, DOI 10.1101/2020.12.31.425021]; Grepin KA, 2020, EVIDENCE EFFECTIVENE, V2020, DOI [10.1101/2020.11.23.20236703, DOI 10.1101/2020.11.23.20236703]; Kemp S A, 2020, medRxiv, DOI 10.1101/2020.12.05.20241927; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kwai I., 2020, NY TIMES; Lauring AS, 2021, JAMA-J AM MED ASSOC, V325, P529, DOI 10.1001/jama.2020.27124; PHE, 2020, J NEUROL; Rourke M, 2020, SCIENCE, V368, P716, DOI 10.1126/science.abb9342; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; WHO, 2016, INT HLTH REG	14	72	72	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1127	1132		10.1016/j.cell.2021.01.044	http://dx.doi.org/10.1016/j.cell.2021.01.044		MAR 2021	6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33581746	Bronze, Green Published			2022-12-28	WOS:000629635700002
J	Lopatkin, AJ; Bening, SC; Manson, AL; Stokes, JM; Kohanski, MA; Badran, AH; Earl, AM; Cheney, NJ; Yang, JH; Collins, JJ				Lopatkin, Allison J.; Bening, Sarah C.; Manson, Abigail L.; Stokes, Jonathan M.; Kohanski, Michael A.; Badran, Ahmed H.; Earl, Ashlee M.; Cheney, Nicole J.; Yang, Jason H.; Collins, James J.			Clinically relevant mutations in core metabolic genes confer antibiotic resistance	SCIENCE			English	Article							ESCHERICHIA-COLI; DNA GYRASE; EVOLUTION; EXPRESSION; MECHANISMS; PERSISTENCE; ALIGNMENT; REVEALS; LEADS	Although metabolism plays an active role in antibiotic lethality, antibiotic resistance is generally associated with drug target modification, enzymatic inactivation, and/or transport rather than metabolic processes. Evolution experiments of Escherichia coli rely on growth-dependent selection, which may provide a limited view of the antibiotic resistance landscape. We sequenced and analyzed E. coli adapted to representative antibiotics at increasingly heightened metabolic states. This revealed various underappreciated noncanonical genes, such as those related to central carbon and energy metabolism, which are implicated in antibiotic resistance. These metabolic alterations lead to lower basal respiration, which prevents antibiotic-mediated induction of tricarboxylic acid cycle activity, thus avoiding metabolic toxicity and minimizing drug lethality. Several of the identified metabolism-specific mutations are overrepresented in the genomes of >3500 clinical E. coli pathogens, indicating clinical relevance.	[Lopatkin, Allison J.; Bening, Sarah C.; Stokes, Jonathan M.; Collins, James J.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lopatkin, Allison J.; Bening, Sarah C.; Stokes, Jonathan M.; Collins, James J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lopatkin, Allison J.; Bening, Sarah C.; Manson, Abigail L.; Stokes, Jonathan M.; Badran, Ahmed H.; Earl, Ashlee M.; Collins, James J.] Broad Inst MIT & Harvard, Infect Dis & Microbiome Program, Cambridge, MA 02142 USA; [Lopatkin, Allison J.; Stokes, Jonathan M.; Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Lopatkin, Allison J.] Barnard Coll, Dept Biol, New York, NY USA; [Lopatkin, Allison J.] Columbia Univ, Data Sci Inst, New York, NY USA; [Lopatkin, Allison J.] Columbia Univ, Ecol Evolut & Environm Biol, New York, NY USA; [Kohanski, Michael A.] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Div Rhinol, Philadelphia, PA 19104 USA; [Cheney, Nicole J.; Yang, Jason H.] Rutgers New Jersey Med Sch, Ruy V Lourenco Ctr Emerging & Re Emerging Pathoge, Newark, NJ USA; [Cheney, Nicole J.; Yang, Jason H.] Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ USA; [Collins, James J.] MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Collins, James J.] Harvard MIT Program Hlth Sci & Technol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Columbia University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Massachusetts Institute of Technology (MIT)	Collins, JJ (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), Broad Inst MIT & Harvard, Infect Dis & Microbiome Program, Cambridge, MA 02142 USA.; Collins, JJ (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Collins, JJ (corresponding author), MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), Harvard MIT Program Hlth Sci & Technol, Cambridge, MA 02139 USA.	jimjc@mit.edu	Yang, Jason H./AAB-2608-2019; Manson, Abigail/B-7132-2016	Yang, Jason H./0000-0003-0921-4657; Lopatkin, Allison/0000-0003-0018-9205; Manson, Abigail/0000-0002-3800-0714; Cheney, Nicole/0000-0003-3937-8310; Bening, Sarah/0000-0001-7449-3184; Earl, Ashlee/0000-0001-7857-9145	Defense Threat Reduction Agency [HDTRA1-15-1-0051]; National Institutes of Health [R00GM118907, R01AI146194]; National Institutes of Health Director's Early Independence Award [DP5-OD-024590]; National Science Foundation Graduate Research Fellowship Program [1122374]; Broad Institute of MIT and Harvard; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [U19AI110818]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Director's Early Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Broad Institute of MIT and Harvard; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Defense Threat Reduction Agency (HDTRA1-15-1-0051), the National Institutes of Health (R00GM118907, R01AI146194), the National Institutes of Health Director's Early Independence Award (DP5-OD-024590), the National Science Foundation Graduate Research Fellowship Program (1122374), the Broad Institute of MIT and Harvard, and a generous gift from Anita and Josh Bekenstein. This work has also been funded in part with funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under grant no. U19AI110818 to the Broad Institute.	Andersson DI, 2011, FEMS MICROBIOL REV, V35, P901, DOI 10.1111/j.1574-6976.2011.00289.x; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Cerqueira GC, 2017, P NATL ACAD SCI USA, V114, P1135, DOI 10.1073/pnas.1616248114; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Charusanti P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033727; Couce A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2698; de Evgrafov MR, 2015, MOL BIOL EVOL, V32, P1175, DOI 10.1093/molbev/msv006; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Dettman JR, 2012, MOL ECOL, V21, P2058, DOI 10.1111/j.1365-294X.2012.05484.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Espedido Bjorn A, 2012, Front Biosci (Schol Ed), V4, P900; Giedraitiene A, 2011, MEDICINA-LITHUANIA, V47, P137, DOI 10.3390/medicina47030019; Gompel N, 2009, DEV BIOL, V332, P36, DOI 10.1016/j.ydbio.2009.04.040; Jahn LJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00816; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Lang GI, 2014, GENOMICS, V104, P412, DOI 10.1016/j.ygeno.2014.09.011; Lang GI, 2011, GENETICS, V188, P647, DOI 10.1534/genetics.111.128942; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Leinonen T, 2012, EVOLUTION, V66, P3866, DOI 10.1111/j.1558-5646.2012.01724.x; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Levin-Reisman I, 2019, P NATL ACAD SCI USA, V116, P14734, DOI 10.1073/pnas.1906169116; Levin-Reisman I, 2017, SCIENCE, V355, P826, DOI 10.1126/science.aaj2191; Levin-Reisman I, 2014, JOVE-J VIS EXP, DOI 10.3791/51456; Levy SF, 2015, NATURE, V519, P181, DOI 10.1038/nature14279; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lopatkin, 2020, MATH MODEL CODE FOR, DOI [10.5281/zenodo.4323054, DOI 10.5281/ZENODO.4323054]; Lopatkin AJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01532-1; Lopatkin AJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.44, 10.1038/nmicrobiol.2016.44]; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; McElroy Kerensa, 2014, Microb Inform Exp, V4, P1, DOI 10.1186/2042-5783-4-1; Melnyk AH, 2015, EVOL APPL, V8, P273, DOI 10.1111/eva.12196; ORAM M, 1991, ANTIMICROB AGENTS CH, V35, P387, DOI 10.1128/AAC.35.2.387; Oz T, 2014, MOL BIOL EVOL, V31, P2387, DOI 10.1093/molbev/msu191; Pinto L, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00831; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodrigues JFM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000613; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Schenk MF, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-14; Stokes JM, 2019, CELL METAB, V30, P251, DOI 10.1016/j.cmet.2019.06.009; Suzuki S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6792; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; VILA J, 1994, ANTIMICROB AGENTS CH, V38, P2477, DOI 10.1128/AAC.38.10.2477; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; Wong A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002928; Woodford N, 2007, CLIN MICROBIOL INFEC, V13, P5, DOI 10.1111/j.1469-0691.2006.01492.x; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200; Yang JH, 2017, CURR OPIN MICROBIOL, V39, P73, DOI 10.1016/j.mib.2017.09.002; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1271, DOI 10.1128/AAC.34.6.1271; Zampieri M, 2017, CELL REP, V19, P1214, DOI 10.1016/j.celrep.2017.04.002; Zampieri M, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167028; Zhang DF, 2016, ANTIMICROB AGENTS CH, V60, P6600, DOI 10.1128/AAC.00664-16	58	68	69	85	254	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					799	+	eaba0862	10.1126/science.aba0862	http://dx.doi.org/10.1126/science.aba0862			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QJ4MB	33602825	Green Accepted, Green Submitted			2022-12-28	WOS:000619664700045
J	Blumenthal, D; Hamburg, M				Blumenthal, David; Hamburg, Margaret			US health and health care are a mess: now what? Comment	LANCET			English	Editorial Material									[Blumenthal, David] Commonwealth Fund, New York, NY USA; [Hamburg, Margaret] Nucl Threat Initiat, Washington, DC 20006 USA	Commonwealth Fund	Hamburg, M (corresponding author), Nucl Threat Initiat, Washington, DC 20006 USA.	margaretahamburg@gmail.com						Alonso-Zaldivar R., 2019, ASS PRESS; [Anonymous], 2020, HARVARD LAW REV, V133, P1049; CDC, 2021, COVID 19 FOR DEATHS; Jackson JL, 2020, TIME; Klein E., 2019, VOX             0729; Kliff S, 2019, VOX             0621; Luhby T., 2019, CNN; Obama B, 2016, JAMA-J AM MED ASSOC, V316, P525, DOI 10.1001/jama.2016.9797; Pew Research Center, 2020, AM VIEWS GOV LOW TRU; Woolhandler S, 2021, LANCET, V397, P705, DOI 10.1016/S0140-6736(20)32545-9	10	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					647	648		10.1016/S0140-6736(21)00318-4	http://dx.doi.org/10.1016/S0140-6736(21)00318-4		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL3PK	33581804	Bronze			2022-12-28	WOS:000620991800005
J	Colquitt, BM; Merullo, DP; Konopka, G; Roberts, TF; Brainard, MS				Colquitt, Bradley M.; Merullo, Devin P.; Konopka, Genevieve; Roberts, Todd F.; Brainard, Michael S.			Cellular transcriptomics reveals evolutionary identities of songbird vocal circuits	SCIENCE			English	Article							PROJECTION NEURONS; DEVELOPMENTAL ORIGIN; AVIAN TELENCEPHALON; BASAL GANGLIA; BRAIN-STEM; FOREBRAIN; NUCLEUS; MOTOR; MIGRATION; CELLS	Birds display advanced behaviors, including vocal learning and problem-solving, yet lack a layered neocortex, a structure associated with complex behavior in mammals. To determine whether these behavioral similarities result from shared or distinct neural circuits, we used single-cell RNA sequencing to characterize the neuronal repertoire of the songbird song motor pathway. Glutamatergic vocal neurons had considerable transcriptional similarity to neocortical projection neurons; however, they displayed regulatory gene expression patterns more closely related to neurons in the ventral pallium. Moreover, while gamma-aminobutyric acid-releasing neurons in this pathway appeared homologous to those in mammals and other amniotes, the most abundant avian class is largely absent in the neocortex. These data suggest that songbird vocal circuits and the mammalian neocortex have distinct developmental origins yet contain transcriptionally similar neurons.	[Colquitt, Bradley M.; Brainard, Michael S.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Colquitt, Bradley M.; Brainard, Michael S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Merullo, Devin P.; Konopka, Genevieve; Roberts, Todd F.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas	Brainard, MS (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Brainard, MS (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.; Konopka, G; Roberts, TF (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	genevieve.konopka@utsouthwestern.edu; todd.roberts@utsouthwestern.edu; michael.brainard@ucsf.edu	Colquitt, Bradley/AAR-7838-2021	Colquitt, Bradley/0000-0001-5819-7924; Merullo, Devin/0000-0003-2082-9492; Konopka, Genevieve/0000-0002-3363-7302; Roberts, Todd/0000-0002-0967-6598; Brainard, Michael/0000-0002-9425-9907	NINDS NIH [F32NS112557, F32NS098809, R01NS102488, R01NS108424, R01DC014364, UF1NS115821, R21DC016340]; Chan Zuckerberg Initiative; Silicon Valley Community Foundation [HCA-A-1704-01747]; NSF [IOS-1457206]; James S. McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition [220020467]; HHMI Investigator award	NINDS NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Chan Zuckerberg Initiative; Silicon Valley Community Foundation; NSF(National Science Foundation (NSF)); James S. McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition; HHMI Investigator award	Research reported in this publication was supported by the NINDS NIH under awards F32NS112557 to D. P. M.; F32NS098809 to B.M.C.; R01NS102488, R01NS108424, and R01DC014364 to T.F.R.; and UF1NS115821 and R21DC016340 to T.F. R. and G.K. Support was also provided by the Chan Zuckerberg Initiative, an advised fund of Silicon Valley Community Foundation (HCA-A-1704-01747) to G.K., NSF IOS-1457206 to T.F. R., the James S. McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition (Scholar Award 220020467) to G.K., and HHMI Investigator award to M.S.B. G.K. is a Jon Heighten Scholar in Autism Research at UTSW.	A.Kulkarni, 2020, bioRxiv, DOI 10.1101/2020.03.14.991042; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Alvarez MJ, 2016, NAT GENET, V48, P838, DOI 10.1038/ng.3593; ALVAREZBUYLLA A, 1990, SCIENCE, V249, P1444, DOI 10.1126/science.1698312; ALVAREZBUYLLA A, 1988, P NATL ACAD SCI USA, V85, P8722, DOI 10.1073/pnas.85.22.8722; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Bandler RC, 2017, CURR OPIN NEUROBIOL, V42, P17, DOI 10.1016/j.conb.2016.10.003; Belgard TG, 2013, P NATL ACAD SCI USA, V110, P13150, DOI 10.1073/pnas.1307444110; Bell ZW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37057-w; Bradleycolquitt, 2020, Zenodo, DOI 10.5281/ZENODO.4289038; Brainard MS, 2013, ANNU REV NEUROSCI, V36, P489, DOI 10.1146/annurev-neuro-060909-152826; Briscoe SD, 2019, CURR BIOL, V29, pR647, DOI 10.1016/j.cub.2019.05.026; Briscoe SD, 2018, SCIENCE, V362, P190, DOI 10.1126/science.aau3711; Burton SD, 2017, J NEUROPHYSIOL, V118, P2034, DOI 10.1152/jn.00109.2017; C. L.Pytte, 2020, bioRxiv, DOI 10.1101/2020.08.31.271783; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Campbell P, 2009, J COMP NEUROL, V512, P84, DOI 10.1002/cne.21881; Chen CC, 2013, J COMP NEUROL, V521, P3666, DOI 10.1002/cne.23406; Co M, 2020, WIRES DEV BIOL, V9, DOI 10.1002/wdev.375; Cobos I, 2001, DEV BIOL, V239, P46, DOI 10.1006/dbio.2001.0423; Cobos I, 2001, DEV BIOL, V239, P30, DOI 10.1006/dbio.2001.0422; Colquitt BM, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy008; Denisenko-Nehrbass NI, 2000, NEURON, V27, P359, DOI 10.1016/S0896-6273(00)00043-X; DEVOOGD TJ, 1981, J COMP NEUROL, V196, P309, DOI 10.1002/cne.901960209; Dugas-Ford J, 2012, P NATL ACAD SCI USA, V109, P16974, DOI 10.1073/pnas.1204773109; Egger R, 2020, CELL, V183, P537, DOI 10.1016/j.cell.2020.09.019; Faux C, 2012, NEUROSIGNALS, V20, P168, DOI 10.1159/000334489; Finn R, 2014, NEUROSCIENCE, V277, P552, DOI 10.1016/j.neuroscience.2014.07.029; Fu Y, 2015, ELIFE, V4, DOI 10.7554/eLife.05558; Goldberg JH, 2012, NAT NEUROSCI, V15, P620, DOI 10.1038/nn.3047; Grillner S, 2016, CURR BIOL, V26, pR1088, DOI 10.1016/j.cub.2016.06.041; Gschwend O, 2015, NAT NEUROSCI, V18, P1474, DOI 10.1038/nn.4089; Guan Zhonghui, 2016, Nat Neurosci, V19, P94, DOI 10.1038/nn.4189; Gunturkun O, 2016, TRENDS COGN SCI, V20, P291, DOI 10.1016/j.tics.2016.02.001; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; He LQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35108; Hegeman DJ, 2016, EUR J NEUROSCI, V43, P1239, DOI 10.1111/ejn.13196; Hu JS, 2017, DEVELOPMENT, V144, P3867, DOI 10.1242/dev.132852; Huerta-Cepas J, 2019, NUCLEIC ACIDS RES, V47, pD309, DOI 10.1093/nar/gky1085; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Jaffe PI, 2020, ELIFE, V9, DOI 10.7554/eLife.53288; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jarvis ED, 2019, SCIENCE, V366, P50, DOI 10.1126/science.aax0287; Jarvis ED, 2013, J COMP NEUROL, V521, P3614, DOI 10.1002/cne.23404; Karten HJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0060; KARTEN HJ, 1969, ANN NY ACAD SCI, V167, P164, DOI 10.1111/j.1749-6632.1969.tb20442.x; KARTEN HJ, 1991, BRAIN BEHAV EVOLUT, V38, P264, DOI 10.1159/000114393; Konopka G, 2016, CELL, V164, P1269, DOI 10.1016/j.cell.2016.02.039; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kosche G, 2015, J NEUROSCI, V35, P1217, DOI 10.1523/JNEUROSCI.4346-14.2015; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Laurent G, 2020, NAT REV NEUROSCI, V21, P395, DOI 10.1038/s41583-020-0323-1; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Lim DA, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018820; Lim L, 2018, NEURON, V100, P294, DOI 10.1016/j.neuron.2018.10.009; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; Lombardino AJ, 2005, P NATL ACAD SCI USA, V102, P8036, DOI 10.1073/pnas.0503239102; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Metin C, 2007, DEVELOPMENT, V134, P2815, DOI 10.1242/dev.02869; Miller MN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01914-5; Moerman T, 2019, BIOINFORMATICS, V35, P2159, DOI 10.1093/bioinformatics/bty916; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; Mu LF, 2012, J NEUROSCI, V32, P3067, DOI 10.1523/JNEUROSCI.4679-11.2012; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; NORDEEN KW, 1988, NATURE, V334, P149, DOI 10.1038/334149a0; Norimoto H, 2020, NATURE, V578, P413, DOI 10.1038/s41586-020-1993-6; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Obernier K, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.156059; Paolino A, 2018, CURR OPIN NEUROBIOL, V53, P57, DOI 10.1016/j.conb.2018.05.005; Pattabiraman K, 2014, NEURON, V82, P989, DOI 10.1016/j.neuron.2014.04.014; Pfenning AR, 2014, SCIENCE, V346, P1333, DOI 10.1126/science.1256846; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Puelles L., 2017, EVOLUTION NERVOUS SY, V2nd ed., P519, DOI [10.1016/B978-0-12-804042-3.00014-2, DOI 10.1016/B978-0-12-804042-3.00014-2]; Puelles L, 2019, J COMP NEUROL, V527, P1731, DOI 10.1002/cne.24650; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Reiner A, 2005, BRAIN RES BULL, V66, P317, DOI 10.1016/j.brainresbull.2005.05.007; Roberts TF, 2008, J NEUROSCI, V28, P3479, DOI 10.1523/JNEUROSCI.0177-08.2008; Roberts TF, 2017, NAT NEUROSCI, V20, P978, DOI 10.1038/nn.4563; Sanchez-Valpuesta M, 2019, P NATL ACAD SCI USA, V116, P22833, DOI 10.1073/pnas.1913575116; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scott BB, 2007, J COMP NEUROL, V502, P202, DOI 10.1002/cne.21296; Shea SD, 2010, J NEUROPHYSIOL, V103, P733, DOI 10.1152/jn.00803.2009; Sober SJ, 2008, J NEUROSCI, V28, P10370, DOI 10.1523/JNEUROSCI.2448-08.2008; Spiro JE, 1999, J NEUROPHYSIOL, V81, P3007, DOI 10.1152/jn.1999.81.6.3007; Stacho M, 2020, SCIENCE, V369, P1585, DOI 10.1126/science.abc5534; Striedter G. F., 2020, BRAINS TIME NATURAL; Striedter GF, 1997, BRAIN BEHAV EVOLUT, V49, P179, DOI 10.1159/000112991; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suzuki IK, 2012, DEV CELL, V22, P863, DOI 10.1016/j.devcel.2012.01.004; Tanaka M, 2018, NATURE, V563, P117, DOI 10.1038/s41586-018-0636-7; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Tosches MA, 2019, CURR OPIN NEUROBIOL, V56, P199, DOI 10.1016/j.conb.2019.04.009; Tosches MA, 2018, SCIENCE, V360, P881, DOI 10.1126/science.aar4237; Tschopp P, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2015.0475; Tucker ES, 2008, J NEUROSCI, V28, P9504, DOI 10.1523/JNEUROSCI.2341-08.2008; Tuorto F, 2003, EUR J NEUROSCI, V18, P3388, DOI 10.1111/j.1460-9568.2003.03059.x; Tyssowski KM, 2018, NEURON, V98, P530, DOI 10.1016/j.neuron.2018.04.001; Urban-Ciecko J, 2016, NAT REV NEUROSCI, V17, P401, DOI 10.1038/nrn.2016.53; VICARIO DS, 1993, NEUROREPORT, V4, P983, DOI 10.1097/00001756-199307000-00037; VICARIO DS, 1991, J COMP NEUROL, V309, P486, DOI 10.1002/cne.903090405; Waclaw RR, 2010, J NEUROSCI, V30, P6944, DOI 10.1523/JNEUROSCI.5772-09.2010; Waclaw RR, 2009, NEURON, V63, P451, DOI 10.1016/j.neuron.2009.07.015; Wagner G. P., 2014, HOMOLOGY GENES EVOLU; Wang XX, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.196; Whitney O, 2014, SCIENCE, V346, P1334, DOI 10.1126/science.1256780; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; Young Matthew D, 2020, Gigascience, V9, DOI 10.1093/gigascience/giaa151; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	118	41	41	10	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					695	+	eabd9704	10.1126/science.abd9704	http://dx.doi.org/10.1126/science.abd9704			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4IS	33574185	Green Accepted			2022-12-28	WOS:000617551600040
J	Tang, M; Chu, X; Hao, JH; Shen, B				Tang, Ming; Chu, Xu; Hao, Jihua; Shen, Bing			Orogenic quiescence in Earth's middle age	SCIENCE			English	Article							CARBON-ISOTOPE EXCURSION; BILLION YEARS; CRUSTAL THICKNESS; EVOLUTION; RISE; ATMOSPHERE; EMERGENCE; MANTLE; RECORD; OXYGENATION	Mountain belts modulate denudation flux and hydrologic processes and are thus fundamental to nutrient cycling on Earth's surface. We used europium anomalies in detrital zircons to track mountain-building processes over Earth's history. We show that the average thickness of active continental crust varied on billion-year time scales, with the thickest crust formed in the Archean and Phanerozoic. By contrast, the Proterozoic witnessed continuously decreasing crustal thickness, leaving the continents devoid of high mountains until the end of the eon. We link this gradually diminished orogenesis to the long-lived Nuna-Rodinia supercontinent, which altered the mantle thermal structure and weakened the continental lithosphere. This prolonged orogenic quiescence may have resulted in a persistent famine in the oceans and stalled life's evolution in Earth's middle age.	[Tang, Ming; Shen, Bing] Peking Univ, MOE Sch Earth & Space Sci, Key Lab Orogen Belt & Crustal Evolut, Beijing 100871, Peoples R China; [Chu, Xu] Univ Toronto, Dept Earth Sci, Toronto, ON M5S 3B1, Canada; [Hao, Jihua] Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Hao, Jihua] Univ Sci & Technol China, Sch Earth & Space Sci, CAS Key Lab Crust Mantle Mat & Environm, Hefei 230026, Anhui, Peoples R China	Peking University; University of Toronto; Rutgers State University New Brunswick; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Tang, M (corresponding author), Peking Univ, MOE Sch Earth & Space Sci, Key Lab Orogen Belt & Crustal Evolut, Beijing 100871, Peoples R China.	mingtang@pku.edu.cn	Tang, Ming/ABD-9218-2021; Hao, Jihua/HDO-7612-2022; Shen, Bing/D-5355-2009	Hao, Jihua/0000-0003-3657-050X; Shen, Bing/0000-0002-7955-0704; Tang, Ming/0000-0002-0474-2269	National Natural Science Foundation of China [41888101, 91755000, 42073026]; Beijing "Double-First Class" initiative grant [7101302526]; Peking University; NASA Astrobiology Institute grant [80NSSC18M0093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing "Double-First Class" initiative grant; Peking University(Peking University); NASA Astrobiology Institute grant	This work was supported by the National Natural Science Foundation of China (grants 41888101, 91755000, and 42073026). M.T. was supported by a Beijing "Double-First Class" initiative grant (7101302526) and a starting fund from Peking University. J.H. gratefully acknowledges a NASA Astrobiology Institute grant (80NSSC18M0093).	Bataille CP, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602183; Bradley DC, 2008, EARTH-SCI REV, V91, P1, DOI 10.1016/j.earscirev.2008.08.001; Brasier MD, 1998, GEOLOGY, V26, P555, DOI 10.1130/0091-7613(1998)026<0555:ABYOES>2.3.CO;2; Brown M, 2020, GEOLOGY, V48, P488, DOI 10.1130/G47417.1; Burnham AD, 2017, NAT GEOSCI, V10, P457, DOI [10.1038/ngeo2942, 10.1038/NGEO2942]; Cao WR, 2017, EARTH PLANET SC LETT, V461, P85, DOI 10.1016/j.epsl.2016.12.044; Cawood PA, 2020, GEOLOGY, V48, P525, DOI 10.1130/focus052020.1; Cawood PA, 2016, EARTH PLANET SC LETT, V449, P118, DOI 10.1016/j.epsl.2016.05.049; Cawood PA, 2014, GEOLOGY, V42, P503, DOI 10.1130/G35402.1; Collerson KD, 1999, SCIENCE, V283, P1519, DOI 10.1126/science.283.5407.1519; Coltice N, 2007, GEOLOGY, V35, P391, DOI 10.1130/G23240A.1; Crockford PW, 2019, CHEM GEOL, V513, P200, DOI 10.1016/j.chemgeo.2019.02.030; Crockford PW, 2018, NATURE, V559, P613, DOI 10.1038/s41586-018-0349-y; Dhuime B, 2015, NAT GEOSCI, V8, P552, DOI [10.1038/ngeo2466, 10.1038/NGEO2466]; Fakhraee M, 2019, NAT GEOSCI, V12, P375, DOI 10.1038/s41561-019-0351-5; Farner MJ, 2017, EARTH PLANET SC LETT, V470, P96, DOI 10.1016/j.epsl.2017.04.025; Greber ND, 2017, SCIENCE, V357, P1271, DOI 10.1126/science.aan8086; Hawkesworth CJ, 2010, J GEOL SOC LONDON, V167, P229, DOI 10.1144/0016-76492009-072; Herzberg C, 2010, EARTH PLANET SC LETT, V292, P79, DOI 10.1016/j.epsl.2010.01.022; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Hoskin PWO, 2003, REV MINERAL GEOCHEM, V53, P27, DOI 10.2113/0530027; Kipp MA, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4795; Korenaga J, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2015.0393; Krissansen-Totton J, 2015, AM J SCI, V315, P275, DOI 10.2475/04.2015.01; Kump LR, 2000, ANNU REV EARTH PL SC, V28, P611, DOI 10.1146/annurev.earth.28.1.611; Laakso TA, 2020, P NATL ACAD SCI USA, V117, P11961, DOI 10.1073/pnas.1916738117; Larsen IJ, 2014, GEOLOGY, V42, P527, DOI 10.1130/G35136.1; Lee C.T.A., 2014, TREATISE GEOCHEMISTR, V4, P423, DOI [10.1016/B978-0-08-095975-7.00314-4, DOI 10.1016/B978-0-08-095975-7.00314-4]; Lee CTA, 2018, INT GEOL REV, V60, P431, DOI 10.1080/00206814.2017.1340853; Lee CTA, 2016, NAT GEOSCI, V9, P417, DOI 10.1038/NGEO2707; Lee CTA, 2015, EARTH PLANET SC LETT, V425, P105, DOI 10.1016/j.epsl.2015.05.045; Lenardic A, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003663; Lenardic A., 2017, NAT GEOSCI, V10, P4, DOI [10.1038/ngeo2862, DOI 10.1038/NGEO2862]; Lenardic A, 2017, NAT GEOSCI, V10, P3, DOI 10.1038/ngeo2862; Liu C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02095-x; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Marshall CR, 2006, ANNU REV EARTH PL SC, V34, P355, DOI 10.1146/annurev.earth.33.031504.103001; Martin AP, 2013, EARTH-SCI REV, V127, P242, DOI 10.1016/j.earscirev.2013.10.006; Milliman J.D., 2013, RIVER DISCHARGE COAS; Parman SW, 2007, NATURE, V446, P900, DOI 10.1038/nature05691; Partin C., EARTH PLANET SC LETT, P284; Partin CA, 2013, EARTH PLANET SC LETT, V369, P284, DOI 10.1016/j.epsl.2013.03.031; Pearson D. G., 2014, TREAT GEOCHEM, V3, P255, DOI DOI 10.1016/B978-0-08-095975-7.00205-9; Planavsky NJ, 2014, NAT GEOSCI, V7, P855, DOI 10.1038/ngeo2307; Profeta L, 2015, SCI REP-UK, V5, DOI 10.1038/srep17786; Rivers T., 2012, TECTONIC STYLES CANA, P97; Rivers T, 2008, PRECAMBRIAN RES, V167, P237, DOI 10.1016/j.precamres.2008.08.005; Roberts NMW, 2013, GEOSCI FRONT, V4, P681, DOI 10.1016/j.gsf.2013.05.004; Rowley DB, 2013, J GEOL, V121, P445, DOI 10.1086/671392; Schroeder S, 2008, TERRA NOVA, V20, P108, DOI 10.1111/j.1365-3121.2008.00795.x; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Shields G.A., 2007, EEARTH, V2, P35, DOI DOI 10.5194/EE-2-35-2007; Silver PG, 2008, SCIENCE, V319, P85, DOI 10.1126/science.1148397; Tang M, 2021, GEOLOGY, V49, P76, DOI 10.1130/G47745.1; Tang M, 2020, GEOCHIM COSMOCHIM AC, V278, P6, DOI 10.1016/j.gca.2019.03.039; Tang M, 2016, SCIENCE, V351, P372, DOI 10.1126/science.aad5513; Viviroli D, 2003, MT RES DEV, V23, P32, DOI 10.1659/0276-4741(2003)023[0032:ATHSOT]2.0.CO;2; Wang HL, 2018, TECTONOPHYSICS, V746, P562, DOI 10.1016/j.tecto.2016.12.001; West AJ, 2005, EARTH PLANET SC LETT, V235, P211, DOI 10.1016/j.epsl.2005.03.020; Worndle S., [No title captured]; Zerkle AL, 2006, GEOBIOLOGY, V4, P285, DOI 10.1111/j.1472-4669.2006.00082.x; ZERKLE AL, 2006, GEOBIOLOGY, V4, P285; Zhao GC, 2002, EARTH-SCI REV, V59, P125, DOI 10.1016/S0012-8252(02)00073-9	63	40	47	31	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					728	+		10.1126/science.abf1876	http://dx.doi.org/10.1126/science.abf1876			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4IS	33574211				2022-12-28	WOS:000617551600047
J	Montis, R; Fusaro, L; Falqui, A; Hursthouse, MB; Tumanov, N; Coles, SJ; Threlfall, TL; Horton, PN; Sougrat, R; Lafontaine, A; Coquerel, G; Rae, AD				Montis, Riccardo; Fusaro, Luca; Falqui, Andrea; Hursthouse, Michael B.; Tumanov, Nikolay; Coles, Simon J.; Threlfall, Terry L.; Horton, Peter N.; Sougrat, Rachid; Lafontaine, Anais; Coquerel, Gerard; Rae, A. David			Complex structures arising from the self-assembly of a simple organic salt	NATURE			English	Article								Molecular self-assembly is the spontaneous association of simple molecules into larger and ordered structures(1). It is the basis of several natural processes, such as the formation of colloids, crystals, proteins, viruses and double-helical DNA(2). Molecular self-assembly has inspired strategies for the rational design of materials with specific chemical and physical properties(3), and is one of the most important concepts in supramolecular chemistry. Although molecular self-assembly has been extensively investigated, understanding the rules governing this phenomenon remains challenging. Here we report on a simple hydrochloride salt of fampridine that crystallizes as four different structures, two of which adopt unusual self-assemblies consisting of polyhedral clusters of chloride and pyridinium ions. These two structures represent Frank-Kasper (FK) phases of a small and rigid organic molecule. Although discovered in metal alloys(4,5) more than 60 years ago, FK phases have recently been observed in several classes of supramolecular soft matter(6-11) and in gold nanocrystal superlattices(12) and remain the object of recent discoveries(13). In these systems, atoms or spherical assemblies of molecules are packed to form polyhedra with coordination numbers 12, 14, 15 or 16. The two FK structures reported here crystallize from a dense liquid phase and show a complexity that is generally not observed in small rigid organic molecules. Investigation of the precursor dense liquid phase by cryogenic electron microscopy reveals the presence of spherical aggregates with sizes ranging between 1.5 and 4.6 nanometres. These structures, together with the experimental procedure used for their preparation, invite interesting speculation about their formation and open different perspectives for the design of organic crystalline materials. Frank-Kasper phases are observed in small organic molecules from the crystallization of fampridine hydrochloride into two distinct structures, indicating that complex self-assembled structures can arise from simple organic salts.	[Montis, Riccardo; Hursthouse, Michael B.; Coles, Simon J.; Threlfall, Terry L.; Horton, Peter N.] Univ Southampton, Sch Chem, Southampton, Hants, England; [Fusaro, Luca; Tumanov, Nikolay] Univ Namur, Namur Inst Struct Matter NISM, Namur, Belgium; [Falqui, Andrea] King Abdullah Univ Sci & TechnoL KAUST, Biol & Environm Sci & Engn BESE Div, NABLA Lab, Thuwal, Saudi Arabia; [Sougrat, Rachid] King Abdullah Univ Sci & Technol, KAUST Core Labs, Thuwal, Saudi Arabia; [Lafontaine, Anais; Coquerel, Gerard] Univ Rouen Normandie, Lab SMS, EA3233, Mont St Aignan, France; [Rae, A. David] Australian Natl Univ, Coll Phys Sci, Res Sch Chem, Canberra, ACT, Australia; [Montis, Riccardo] Univ Manchester, Dept Chem Engn & Analyt Sci, Manchester, Lancs, England; [Falqui, Andrea] Univ Milan, Dipartimento Fis Aldo Pontremoli, Milan, Italy	University of Southampton; University of Namur; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Australian National University; University of Manchester; University of Milan	Montis, R (corresponding author), Univ Southampton, Sch Chem, Southampton, Hants, England.; Montis, R (corresponding author), Univ Manchester, Dept Chem Engn & Analyt Sci, Manchester, Lancs, England.	riccardo.montis@gmail.com	Coles, Simon/A-1795-2009; Montis, Riccardo/AAU-6141-2021; Coles, Simon/AAI-7820-2020; Fusaro, Luca/J-6128-2013; Tumanov, Nikolay/O-5866-2015	Coles, Simon/0000-0001-8414-9272; Montis, Riccardo/0000-0001-5239-1849; Coles, Simon/0000-0001-8414-9272; Falqui, Andrea/0000-0002-1476-7742; Fusaro, Luca/0000-0001-5301-8034; Tumanov, Nikolay/0000-0001-6898-9036				Bonnett PE, 2003, CHEM COMMUN, P698, DOI 10.1039/b212062c; Deneau E, 2005, ORG PROCESS RES DEV, V9, P943, DOI 10.1021/op050107c; Ecija D, 2013, P NATL ACAD SCI USA, V110, P6678, DOI 10.1073/pnas.1222713110; FRANK FC, 1958, ACTA CRYSTALLOGR, V11, P184, DOI 10.1107/S0365110X58000487; FRANK FC, 1959, ACTA CRYSTALLOGR, V12, P483, DOI 10.1107/S0365110X59001499; Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271; Goodfellow BW, 2013, NANO LETT, V13, P5710, DOI 10.1021/nl403458q; Huang MJ, 2015, SCIENCE, V348, P424, DOI 10.1126/science.aaa2421; Hursthouse MB, 2014, CRYSTENGCOMM, V16, P2205, DOI 10.1039/c3ce42471e; Ilevbare GA, 2013, CRYST GROWTH DES, V13, P1497, DOI 10.1021/cg301679h; Kim SA, 2017, P NATL ACAD SCI USA, V114, P4072, DOI 10.1073/pnas.1701608114; Kukkonen E, 2019, CRYST GROWTH DES, V19, P2434, DOI 10.1021/acs.cgd.9b00119; Lee S, 2010, SCIENCE, V330, P349, DOI 10.1126/science.1195552; LEHN JM, 1988, ANGEW CHEM INT EDIT, V27, P89, DOI 10.1002/anie.198800891; LEHN JM, 1990, ANGEW CHEM INT EDIT, V29, P1304, DOI 10.1002/anie.199013041; Macksasitorn S, 2013, CRYSTENGCOMM, V15, P1698, DOI 10.1039/c2ce26107c; Montis R, 2012, CRYSTENGCOMM, V14, P7466, DOI 10.1039/c2ce26008e; Nguyen AH, 2013, J PHYS CHEM B, V117, P6330, DOI 10.1021/jp403503d; Pan WC, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1887168; Reddy A, 2018, P NATL ACAD SCI USA, V115, P10233, DOI 10.1073/pnas.1809655115; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sheldrick GM, 2015, ACTA CRYSTALLOGR A, V71, P3, DOI 10.1107/S2053273314026370; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Su ZB, 2019, NAT CHEM, V11, P899, DOI 10.1038/s41557-019-0330-x; TARATUTA VG, 1990, J PHYS CHEM-US, V94, P2140, DOI 10.1021/j100368a074; tenWolde PR, 1997, SCIENCE, V277, P1975, DOI 10.1126/science.277.5334.1975; Tsarfati Y, 2018, ACS CENTRAL SCI, V4, P1031, DOI 10.1021/acscentsci.8b00289; Ungar G, 2005, SOFT MATTER, V1, P95, DOI 10.1039/b502443a; Veesler S, 2006, ORG PROCESS RES DEV, V10, P841, DOI 10.1021/op060085+; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; Wiedenbeck E, 2019, ANGEW CHEM INT EDIT, V58, P19103, DOI 10.1002/anie.201910986; Zaccaro J, 2001, CRYST GROWTH DES, V1, P5, DOI 10.1021/cg0055171; Zhang JW, 2012, J AM CHEM SOC, V134, P7636, DOI 10.1021/ja301770v	33	18	18	24	127	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2021	590	7845								10.1038/s41586-021-03194-y	http://dx.doi.org/10.1038/s41586-021-03194-y			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG0TV	33568820	Green Accepted, Green Submitted			2022-12-28	WOS:000617300400017
J	Marteau, TM; Rutter, H; Marmot, M				Marteau, Theresa M.; Rutter, Harry; Marmot, Michael			Depression: EU approves expanded use of esketamine for rapid reduction of symptoms	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH; DETERMINANTS; POLICIES; ALCOHOL; AREAS; UK		[Marteau, Theresa M.] Univ Cambridge, Behav & Hlth Res Unit, Dept Publ Hlth & Primary Care, Cambridge, England; [Rutter, Harry] Univ Bath, Dept Social & Policy Sci, Bath, Avon, England; [Marmot, Michael] UCL, Inst Hlth Equ, London, England	University of Cambridge; University of Bath; University of London; University College London	Marteau, TM (corresponding author), Univ Cambridge, Behav & Hlth Res Unit, Dept Publ Hlth & Primary Care, Cambridge, England.	tm388@cam.ac.uk	Rutter, Harry/HCI-8765-2022					Alcock I, 2014, ENVIRON SCI TECHNOL, V48, P1247, DOI 10.1021/es403688w; [Anonymous], 2020, DEATHS INV COVID 19; Bambra Clare, 2020, J Epidemiol Community Health, V74, P964, DOI 10.1136/jech-2020-214401; Bloomberg MR, 2019, HLTH TAXES SAVE LIVE; Brown T, 2014, TOB CONTROL, V23, DOI 10.1136/tobaccocontrol-2013-051451; Burgoine T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1464; Burton R, 2017, LANCET, V389, P1558, DOI 10.1016/S0140-6736(16)32420-5; Chaiton MO, 2018, TOB CONTROL, V27, P163, DOI 10.1136/tobaccocontrol-2016-053490; Clemens T, 2020, TOB CONTROL, V29, P7, DOI 10.1136/tobaccocontrol-2018-054422; Codling S, 2020, ADDICTION, V115, P2280, DOI 10.1111/add.15042; Davies S., 2019, TIME SOLVE CHILDHOOD; Department of Health & Social Care, 2019, UK CHIEF MED OFF PHY; Goodair B, 2020, TOWNSCAPES ENGLANDS; Gregg P, 2006, LABOUR ECON, V13, P721, DOI 10.1016/j.labeco.2005.10.002; Hollands GJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1102; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Jones LE, 2019, CAN J ECON, V52, P1433, DOI 10.1111/caje.12409; Kickbusch I, 2016, LANCET GLOB HEALTH, V4, pE895, DOI 10.1016/S2214-109X(16)30217-0; Kriznik NM, 2018, J PUBLIC HEALTH-UK, V40, P764, DOI 10.1093/pubmed/fdy045; Kuipers MAG, 2018, TOB CONTROL, V27, P455, DOI 10.1136/tobaccocontrol-2017-053662; Macdonald L, 2018, HEALTH PLACE, V51, P224, DOI 10.1016/j.healthplace.2018.04.008; Mandall NA, 2005, BRIT DENT J, V199, P659, DOI 10.1038/sj.bdj.4812930; Marmot M, 2012, PUBLIC HEALTH, V126, pS4, DOI 10.1016/j.puhe.2012.05.014; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Marmot M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m693; Marteau TM, 2019, LANCET, V393, P2571, DOI 10.1016/S0140-6736(19)31510-7; Martin A, 2012, AM J PREV MED, V43, pE45, DOI 10.1016/j.amepre.2012.09.001; McGill R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1781-7; Nghiem N, 2013, AM J PUBLIC HEALTH, V103, P1954, DOI 10.2105/AJPH.2013.301337; O'Donnell A, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5274; OECD, 2020, BUILD BACK BETT SUST; Office for National Statistics, 2017, HLTH STAT LIF EXP NA; Pearce J, 2012, PROG HUM GEOG, V36, P3, DOI 10.1177/0309132511402710; Pechey R, 2019, APPETITE, V133, P286, DOI 10.1016/j.appet.2018.11.013; Pilling M, 2020, ADDICTION, V115, P1660, DOI 10.1111/add.14998; Pucher J, 2010, PREV MED, V50, pS106, DOI 10.1016/j.ypmed.2009.07.028; Reynolds JP, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.190522; Scarborough P, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003025; Scheelbeek PFD, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4786; Shortt NK, 2018, ANN AM ASSOC GEOGR, V108, P1210, DOI 10.1080/24694452.2018.1431105; Smith CE, 2020, TOB CONTROL; Smith R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040875; Steel N, 2018, LANCET, V392, P1647, DOI [10.1016/S0140-6736(18)32207-4, 10.1016/s0140-6736(18)32207-4]; Strully KW, 2010, AM SOCIOL REV, V75, P534, DOI 10.1177/0003122410374086; Tomlinson D, 2020, LIVING STANDARDS AUD; Twohig-Bennett C, 2018, ENVIRON RES, V166, P628, DOI 10.1016/j.envres.2018.06.030; Veinot TC, 2018, J AM MED INFORM ASSN, V25, P1080, DOI 10.1093/jamia/ocy052; WHO, 2017, BEST BUYS OTH REC IN	48	2	2	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2021	372								n398	10.1136/bmj.n398	http://dx.doi.org/10.1136/bmj.n398			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QH9VF	33568423				2022-12-28	WOS:000618622900003
J	Zhang, YX; Daday, C; Gu, RX; Cox, CD; Martinac, B; de Groot, BL; Walz, T				Zhang, Yixiao; Daday, Csaba; Gu, Ruo-Xu; Cox, Charles D.; Martinac, Boris; de Groot, Bert L.; Walz, Thomas			Visualization of the mechanosensitive ion channel MscS under membrane tension	NATURE			English	Article								Mechanosensitive channels sense mechanical forces in cell membranes and underlie many biological sensing processes(1-3). However, how exactly they sense mechanical force remains under investigation(4). The bacterial mechanosensitive channel of small conductance, MscS, is one of the most extensively studied mechanosensitive channels(4-8), but how it is regulated by membrane tension remains unclear, even though the structures are known for its open and closed states(9-11). Here we used cryo-electron microscopy to determine the structure of MscS in different membrane environments, including one that mimics a membrane under tension. We present the structures of MscS in the subconducting and desensitized states, and demonstrate that the conformation of MscS in a lipid bilayer in the open state is dynamic. Several associated lipids have distinct roles in MscS mechanosensation. Pore lipids are necessary to prevent ion conduction in the closed state. Gatekeeper lipids stabilize the closed conformation and dissociate with membrane tension, allowing the channel to open. Pocket lipids in a solvent-exposed pocket between subunits are pulled out under sustained tension, allowing the channel to transition to the subconducting state and then to the desensitized state. Our results provide a mechanistic underpinning and expand on the 'force-from-lipids' model for MscS mechanosensation(4,11). The authors report the structural characterization of the mechanically activated channel MscS in different membrane environments and show how the mechanosensation of MscS can be visualized.	[Zhang, Yixiao; Walz, Thomas] Rockefeller Univ, Lab Mol Electron Microscopy, 1230 York Ave, New York, NY 10021 USA; [Daday, Csaba; Gu, Ruo-Xu; de Groot, Bert L.] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, Gottingen, Germany; [Cox, Charles D.; Martinac, Boris] Univ New South Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Cox, Charles D.; Martinac, Boris] Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Sydney, NSW, Australia	Rockefeller University; Max Planck Society; University of New South Wales Sydney; Victor Chang Cardiac Research Institute	Walz, T (corresponding author), Rockefeller Univ, Lab Mol Electron Microscopy, 1230 York Ave, New York, NY 10021 USA.	twalz@rockefeller.edu	Cox, Charles D/GEC-3720-2022	Cox, Charles D/0000-0002-3802-6746; Walz, Thomas/0000-0003-2606-2835; Martinac, Boris/0000-0001-8422-7082; Zhang, Yixiao/0000-0003-1540-4334	German Research Foundation DFG [SFB 803]; Alexander von Humboldt foundation; National Health and Medical Research Council of Australia [APP1135974]; NSW Health EMCR Fellowship	German Research Foundation DFG(German Research Foundation (DFG)); Alexander von Humboldt foundation(Alexander von Humboldt Foundation); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NSW Health EMCR Fellowship	We thank D. Rees for critical reading of the manuscript, and M. Ebrahim, J. Sotiris and H. Ng at the Evelyn Gruss Lipper Cryo-EM Resource Center of The Rockefeller University for assistance with data collection. We acknowledge the German Research Foundation DFG (SFB 803, Project A03; to B.d.L.G. and C.D.) and the Alexander von Humboldt foundation (to R.-X.G.) for funding. B.M. is supported by a National Health and Medical Research Council of Australia Principal Research Fellowship (APP1135974). C.D.C. is supported by an NSW Health EMCR Fellowship.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akitake B, 2005, J GEN PHYSIOL, V125, P143, DOI 10.1085/jgp.200409198; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Bavi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11984; Belyy V, 2010, NAT STRUCT MOL BIOL, V17, P451, DOI 10.1038/nsmb.1775; Booth IR, 2014, CURR OPIN MICROBIOL, V18, P16, DOI 10.1016/j.mib.2014.01.005; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cheng AC, 2018, J STRUCT BIOL, V204, P270, DOI 10.1016/j.jsb.2018.07.015; Cox CD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3137; Cox CD, 2019, CELL REP, V29, P1, DOI 10.1016/j.celrep.2019.08.075; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DELCOUR AH, 1989, BIOPHYS J, V56, P631, DOI 10.1016/S0006-3495(89)82710-9; Edwards MD, 2008, BIOPHYS J, V94, P3003, DOI 10.1529/biophysj.107.123448; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Guo YSR, 2017, ELIFE, V6, DOI 10.7554/eLife.33660; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Kamaraju K, 2011, J GEN PHYSIOL, V138, P49, DOI 10.1085/jgp.201110606; Katta S, 2015, ANNU REV CELL DEV BI, V31, P347, DOI 10.1146/annurev-cellbio-100913-013426; Koprowski P, 1998, J MEMBRANE BIOL, V164, P253, DOI 10.1007/s002329900410; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Lai JY, 2013, PROTEIN SCI, V22, P502, DOI 10.1002/pro.2222; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Nomura T, 2012, P NATL ACAD SCI USA, V109, P8770, DOI 10.1073/pnas.1200051109; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pliotas C, 2015, NAT STRUCT MOL BIOL, V22, P991, DOI 10.1038/nsmb.3120; Pliotas C, 2012, P NATL ACAD SCI USA, V109, pE2675, DOI 10.1073/pnas.1202286109; Rasmussen T, 2019, J MOL BIOL, V431, P3081, DOI 10.1016/j.jmb.2019.07.006; Reddy AS, 2012, BBA-BIOMEMBRANES, V1818, P2271, DOI 10.1016/j.bbamem.2012.05.006; Reddy B, 2019, ELIFE, V8, DOI 10.7554/eLife.50486; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Roux B, 2008, BIOPHYS J, V95, P4205, DOI 10.1529/biophysj.108.136499; Saotome K, 2018, NATURE, V554, P481, DOI 10.1038/nature25453; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; Sukharev S, 2002, BIOPHYS J, V83, P290, DOI 10.1016/S0006-3495(02)75169-2; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Xue F, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183203; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zhang XZ, 2012, P NATL ACAD SCI USA, V109, P18180, DOI 10.1073/pnas.1207977109; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	62	32	33	9	50	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846					509	+		10.1038/s41586-021-03196-w	http://dx.doi.org/10.1038/s41586-021-03196-w		FEB 2021	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QJ5CU	33568813				2022-12-28	WOS:000616954000002
J	Duarte, CM; Chapuis, L; Collin, SP; Costa, DP; Devassy, RP; Eguiluz, VM; Erbe, C; Gordon, TAC; Halpern, BS; Harding, HR; Havlik, MN; Meekan, M; Merchant, ND; Miksis-Olds, JL; Parsons, M; Predragovic, M; Radford, AN; Radford, CA; Simpson, SD; Slabbekoorn, H; Staaterman, E; Van Opzeeland, IC; Winderen, J; Zhang, XL; Juanes, F				Duarte, Carlos M.; Chapuis, Lucille; Collin, Shaun P.; Costa, Daniel P.; Devassy, Reny P.; Eguiluz, Victor M.; Erbe, Christine; Gordon, Timothy A. C.; Halpern, Benjamin S.; Harding, Harry R.; Havlik, Michelle N.; Meekan, Mark; Merchant, Nathan D.; Miksis-Olds, Jennifer L.; Parsons, Miles; Predragovic, Milica; Radford, Andrew N.; Radford, Craig A.; Simpson, Stephen D.; Slabbekoorn, Hans; Staaterman, Erica; Van Opzeeland, Ilse C.; Winderen, Jana; Zhang, Xiangliang; Juanes, Francis			The soundscape of the Anthropocene ocean	SCIENCE			English	Review							UNDERWATER NOISE; ANTHROPOGENIC NOISE; CYNOSCION-NEBULOSUS; HARBOR PORPOISES; POGONIAS-CROMIS; SEISMIC SURVEYS; AMBIENT NOISE; VESSEL NOISE; CATCH RATES; BLACK DRUM	Oceans have become substantially noisier since the Industrial Revolution. Shipping, resource exploration, and infrastructure development have increased the anthrophony (sounds generated by human activities), whereas the biophony (sounds of biological origin) has been reduced by hunting, fishing, and habitat degradation. Climate change is affecting geophony (abiotic, natural sounds). Existing evidence shows that anthrophony affects marine animals at multiple levels, including their behavior, physiology, and, in extreme cases, survival. This should prompt management actions to deploy existing solutions to reduce noise levels in the ocean, thereby allowing marine animals to reestablish their use of ocean sound as a central ecological trait in a healthy ocean.	[Duarte, Carlos M.; Devassy, Reny P.; Havlik, Michelle N.; Predragovic, Milica] King Abdullah Univ Sci & Technol, Red Sea Res Ctr RSRC, Thuwal 23955, Saudi Arabia; [Duarte, Carlos M.; Devassy, Reny P.; Havlik, Michelle N.; Predragovic, Milica] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr CBRC, Thuwal 23955, Saudi Arabia; [Duarte, Carlos M.] Aarhus Univ, Arctic Res Ctr, Dept Biol, CF Mollers 8, DK-8000 Aarhus C, Denmark; [Chapuis, Lucille; Gordon, Timothy A. C.; Simpson, Stephen D.] Univ Exeter, Biosci, Prince Wales Rd, Exeter EX4 4PS, Devon, England; [Collin, Shaun P.] La Trobe Univ, Sch Life Sci, Bundoora, Vic 3086, Australia; [Costa, Daniel P.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95060 USA; [Eguiluz, Victor M.] Inst Fis Interdisciplinar & Sistemas Complejos IF, E-07122 Palma De Mallorca, Spain; [Erbe, Christine; Parsons, Miles] Curtin Univ, Ctr Marine Sci & Technol, Perth, WA 6102, Australia; [Gordon, Timothy A. C.; Meekan, Mark; Parsons, Miles] Australian Inst Marine Sci, Perth, WA 6009, Australia; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Harding, Harry R.; Radford, Andrew N.] Univ Bristol, Sch Biol Sci, 24 Tyndall Ave, Bristol BS8 1TQ, Avon, England; [Merchant, Nathan D.] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft NR33 0HT, Suffolk, England; [Miksis-Olds, Jennifer L.] Univ New Hampshire, Ctr Acoust Res & Educ, Durham, NH 03824 USA; [Radford, Craig A.] Univ Auckland, Inst Marine Sci, Leigh Marine Lab, POB 349, Warkworth 0941, New Zealand; [Slabbekoorn, Hans] Leiden Univ, Inst Biol, POB 9505, NL-2300 RA Leiden, Netherlands; [Staaterman, Erica] Waves, POB 126, Herndon, VA 20172 USA; [Van Opzeeland, Ilse C.] Alfred Wegener Inst Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany; [Winderen, Jana] Schweigaardsgate 80, N-0656 Oslo, Norway; [Zhang, Xiangliang] King Abdullah Univ Sci & Technol, Comp Elect & Math Sci & Engn Div, Thuwal 23955, Saudi Arabia; [Juanes, Francis] Univ Victoria, Dept Biol, Victoria, BC, Canada	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Aarhus University; University of Exeter; La Trobe University; University of California System; University of California Santa Cruz; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); Curtin University; Australian Institute of Marine Science; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Bristol; Centre for Environment Fisheries & Aquaculture Science; University System Of New Hampshire; University of New Hampshire; University of Auckland; Leiden University; Leiden University - Excl LUMC; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; King Abdullah University of Science & Technology; University of Victoria	Duarte, CM (corresponding author), King Abdullah Univ Sci & Technol, Red Sea Res Ctr RSRC, Thuwal 23955, Saudi Arabia.; Duarte, CM (corresponding author), King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr CBRC, Thuwal 23955, Saudi Arabia.	carlos.duarte@kaust.edu.sa	Erbe, Christine/AAA-3801-2021; Eguíluz, Víctor M./B-9655-2008; Duarte Quesada, Carlos Manuel/ABD-6208-2021; Lamont, Timothy A C/AAH-6029-2020; Chapuis, Lucille/A-6535-2010; Zhang, Xiangliang/AAG-2238-2021; Merchant, Nathan/B-7007-2015; Costa, Daniel/E-2616-2013; Duarte, Carlos M./A-7670-2013	Erbe, Christine/0000-0002-7884-9907; Eguíluz, Víctor M./0000-0003-1133-1289; Lamont, Timothy A C/0000-0002-0305-6603; Chapuis, Lucille/0000-0003-3001-983X; Zhang, Xiangliang/0000-0002-3574-5665; Merchant, Nathan/0000-0002-1090-0016; Harding, Harry/0000-0003-2511-3653; Costa, Daniel/0000-0002-0233-5782; Meekan, Mark/0000-0002-3067-9427; Juanes, Francis/0000-0001-7397-0014; Predragovic, Milica/0000-0001-6788-3264; Duarte, Carlos M./0000-0002-1213-1361	KAUST through the Tarek Ahmed Juffali Research Chair in Red Sea Ecology	KAUST through the Tarek Ahmed Juffali Research Chair in Red Sea Ecology	This research was funded by KAUST through the Tarek Ahmed Juffali Research Chair in Red Sea Ecology and baseline funding to C.M.D.	Aarts G, 2016, MAR ECOL PROG SER, V557, P261, DOI 10.3354/meps11829; Ahonen H, 2017, MAR POLLUT BULL, V123, P97, DOI 10.1016/j.marpolbul.2017.09.019; Au W.W.L., 2008, PRINCIPLES MARINE BI; Bates AE, 2020, BIOL CONSERV, V248, DOI 10.1016/j.biocon.2020.108665; Bejder L, 2009, MAR ECOL PROG SER, V395, P177, DOI 10.3354/meps07979; Bellmann M. A., 2014, INTERNOISE 2014 43 I, P1; Bertucci F, 2016, SCI REP-UK, V6, DOI 10.1038/srep33326; Blair HB, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0005; Boyd PW, 2011, NAT GEOSCI, V4, P273, DOI 10.1038/ngeo1150; Brondizio E, 2019, SUMMARY POLICYMAKERS; Butler J, 2017, ECOL INDIC, V77, P377, DOI 10.1016/j.ecolind.2017.02.041; Butler J, 2016, J EXP MAR BIOL ECOL, V479, P89, DOI 10.1016/j.jembe.2016.03.006; Carretta JV, 2011, MAR TECHNOL SOC J, V45, P7, DOI 10.4031/MTSJ.45.5.3; Carstensen J, 2006, MAR ECOL PROG SER, V321, P295, DOI 10.3354/meps321295; Casper BM, 2009, J FISH BIOL, V75, P2768, DOI 10.1111/j.1095-8649.2009.02477.x; Castellote M, 2016, ADV EXP MED BIOL, V875, P133, DOI 10.1007/978-1-4939-2981-8_16; Chapuis L, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.198184; Christian J. R., 2003, 144 ENV FUNDS FISH O; Christiansen B, 2020, MAR POLICY, V114, DOI 10.1016/j.marpol.2019.02.014; Clack JA, 2002, J NEUROBIOL, V53, P251, DOI 10.1002/neu.10129; Clark CW, 2004, J UNDERWATER ACOUST, V52, P13; Coffin A, 2004, SPR HDB AUD, V22, P55; Coquereau L, 2016, AQUAT BIOL, V25, P151, DOI 10.3354/ab00665; Cox K, 2018, GLOBAL CHANGE BIOL, V24, P3105, DOI 10.1111/gcb.14106; Davis GE, 2020, GLOBAL CHANGE BIOL, V26, P4812, DOI 10.1111/gcb.15191; Day R. D., 2016, 2012008 FRDC U TASM; Day RD, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1424; Day RD, 2017, P NATL ACAD SCI USA, V114, pE8537, DOI 10.1073/pnas.1700564114; Day RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep22723; Di Iorio L, 2012, J EXP MAR BIOL ECOL, V432, P9, DOI 10.1016/j.jembe.2012.07.010; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Duarte CM, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00063; Dunlop RA, 2008, MAR MAMMAL SCI, V24, P613, DOI 10.1111/j.1748-7692.2008.00208.x; Dziak RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123425; Elise S, 2019, ECOL INDIC, V107, DOI 10.1016/j.ecolind.2019.105623; Engas A, 1996, CAN J FISH AQUAT SCI, V53, P2238, DOI 10.1139/cjfas-53-10-2238; Erbe C, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00606; Erbe C, 2018, SPRINGER HANDB AUDIT, V66, P277, DOI 10.1007/978-1-4939-8574-6_10; Erbe C, 2018, MAR POLLUT BULL, V137, P656, DOI 10.1016/j.marpolbul.2018.10.064; Erbe C, 2017, J UNMANNED VEH SYST, V5, P92, DOI 10.1139/juvs-2016-0018; Erbe C, 2017, ACOUST AUST, V45, P179, DOI 10.1007/s40857-017-0101-z; Erbe C, 2017, J ACOUST SOC AM, V142, pEL281, DOI 10.1121/1.5003328; Erbe C, 2016, ACOUST AUST, V44, P333, DOI 10.1007/s40857-016-0062-7; Erbe C, 2016, MAR POLLUT BULL, V103, P15, DOI 10.1016/j.marpolbul.2015.12.007; Erbe C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089820; Erbe C, 2013, J ACOUST SOC AM, V133, pEL465, DOI 10.1121/1.4802183; Erbe C, 2013, J ACOUST SOC AM, V133, pEL326, DOI 10.1121/1.4795220; Erisman BE, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0656; Estabrook BJ, 2016, ENDANGER SPECIES RES, V30, P267, DOI 10.3354/esr00743; Fewtrell JL, 2012, MAR POLLUT BULL, V64, P984, DOI 10.1016/j.marpolbul.2012.02.009; Fields DM, 2019, ICES J MAR SCI, V76, P2033, DOI 10.1093/icesjms/fsz126; Forney KA, 2017, ENDANGER SPECIES RES, V32, P391, DOI 10.3354/esr00820; Garland EC, 2017, P NATL ACAD SCI USA, V114, P7822, DOI 10.1073/pnas.1621072114; Gassmann M, 2017, J ACOUST SOC AM, V142, P1563, DOI 10.1121/1.5001063; Gervaise C, 2012, J ACOUST SOC AM, V132, P76, DOI 10.1121/1.4728190; Correa JMG, 2019, OCEAN COAST MANAGE, V168, P22, DOI 10.1016/j.ocecoaman.2018.10.027; Gordon TAC, 2018, P NATL ACAD SCI USA, V115, P5193, DOI 10.1073/pnas.1719291115; Guerra A., 2004, ICES ANN SCI C VIG S; Halliday WD, 2018, MAR ECOL PROG SER, V603, P189, DOI 10.3354/meps12730; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Harding HR, 2019, BEHAV ECOL, V30, P1501, DOI 10.1093/beheco/arz114; Hawkins AD, 2015, REV FISH BIOL FISHER, V25, P39, DOI 10.1007/s11160-014-9369-3; Heide-Jorgensen MP, 2013, BIOL CONSERV, V158, P50, DOI 10.1016/j.biocon.2012.08.005; Hester KC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034913; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Holt DE, 2014, BEHAV ECOL, V25, P819, DOI 10.1093/beheco/aru028; Holt MM, 2009, J ACOUST SOC AM, V125, pEL27, DOI 10.1121/1.3040028; Hotchkin C, 2013, BIOL REV, V88, P809, DOI 10.1111/brv.12026; Howe BM, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00426; Ilyina T, 2010, NAT GEOSCI, V3, P18, DOI 10.1038/NGEO719; Ingeman KE, 2019, SCIENCE, V363, P363, DOI 10.1126/science.aav1004; IPCC, 2014, 2014 CLIM CHANG 2014; IPCC, 2014, CONTRIBUTION WORKING; IPCC (Intergovernmental Panel on Climate Change), 2019, CLIMATE CHANGE LAND; ISO, 2017, 184052017 ISO; Jerem P, 2021, CONSERV BIOL, V35, P115, DOI 10.1111/cobi.13510; Jolivet A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33829; Kastelein RA, 2015, J ACOUST SOC AM, V137, P556, DOI 10.1121/1.4906261; Kasumyan A.O., 2009, J ICHTHYOL, V49, P963, DOI [10.1134/S0032945209110010, DOI 10.1134/S0032945209110010]; Kennedy EV, 2010, J EXP MAR BIOL ECOL, V395, P85, DOI 10.1016/j.jembe.2010.08.017; Kight CR, 2011, ECOL LETT, V14, P1052, DOI 10.1111/j.1461-0248.2011.01664.x; Kunc HP, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0839; Ladich F., 2008, BIOACOUSTICS, V17, P34, DOI [10.1080/09524622.2008, DOI 10.1080/09524622.2008.9753755]; Ladich F, 2013, REV FISH BIOL FISHER, V23, P317, DOI 10.1007/s11160-012-9297-z; Leaper R., 2014, J OCEAN TECHNOL, V9, P50; Levin LA, 2015, NAT CLIM CHANGE, V5, P401, DOI 10.1038/nclimate2595; Lewandowski J, 2020, J ACOUST SOC AM, V147, P3160, DOI 10.1121/10.0001173; Lillis A, 2018, CORAL REEFS, V37, P597, DOI 10.1007/s00338-018-1684-z; Locascio JV, 2012, J FISH BIOL, V81, P1175, DOI 10.1111/j.1095-8649.2012.03376.x; Locascio JV, 2005, BIOL LETTERS, V1, P362, DOI 10.1098/rsbl.2005.0309; Lokkeborg S, 2012, CAN J FISH AQUAT SCI, V69, P1278, DOI 10.1139/F2012-059; Malakoff D, 2010, SCIENCE, V328, P1502, DOI 10.1126/science.328.5985.1502; Manley GA, 2004, SPR HDB AUD, V22, P1; Manley GA, 2000, P NATL ACAD SCI USA, V97, P11736, DOI 10.1073/pnas.97.22.11736; Mann DA, 1997, NATURE, V389, P341, DOI 10.1038/38636; Martin KJ, 2012, J EXP BIOL, V215, P3001, DOI 10.1242/jeb.066324; McCauley RD, 2003, J ACOUST SOC AM, V113, P638, DOI 10.1121/1.1527962; McCauley RD, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0195; MCCREERY CS, 1993, J ACOUST SOC AM, V93, P2639, DOI 10.1121/1.405838; McGeady R., 2016, P M ACOUSTICS ACOUST, V27, DOI [10.1121/2.0000281, DOI 10.1121/2.0000281]; Menze S, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160370; Merchant ND, 2020, MAR POLLUT BULL, V152, DOI 10.1016/j.marpolbul.2020.110951; Merchant ND, 2019, ENVIRON SCI POLICY, V92, P116, DOI 10.1016/j.envsci.2018.11.014; Miksis-Olds JL, 2016, J ACOUST SOC AM, V139, P501, DOI 10.1121/1.4938237; Miller I, 2013, MAR POLLUT BULL, V77, P63, DOI 10.1016/j.marpolbul.2013.10.031; Mitchell JD, 2018, REV FISH BIOL FISHER, V28, P715, DOI 10.1007/s11160-018-9528-z; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; MOK HK, 1983, B I ZOOL ACAD SINICA, V22, P157; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; Munk W, 2011, TELLUS A, V63, P190, DOI 10.1111/j.1600-0870.2010.00494.x; MYRBERG AA, 1972, J EXP BIOL, V57, P727; Nedelec SL, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0143; Nedelec SL, 2016, ENVIRON POLLUT, V216, P428, DOI 10.1016/j.envpol.2016.05.058; Newhall A.E., 2016, J ACOUST SOC AM, V139, P2181, DOI DOI 10.1121/1.4950483; Nikolopoulos A., LIFE11ENVSE841 BIAS; Nikolopoulos A., 2016, ENVSE841 BIAS LIFE11; Nystuen J., 2010, J ACOUST SOC AM, V127, P1728, DOI [10.1121/1.3383439, DOI 10.1121/1.3383439]; Organisation for Economic Co-operation and Development (OECD), 2016, OCEAN EC 2030; Organization for Economic Cooperation and Development (OECD), 2016, OC EC 2030, DOI DOI 10.1787/9789264251724-EN; Pangerc T, 2016, J ACOUST SOC AM, V140, P2913, DOI 10.1121/1.4964824; Parsons ECM, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00295; Parsons M. J. G., 2010, THESIS; Parsons MJG, 2020, J ACOUST SOC AM, V147, P3575, DOI 10.1121/10.0001264; Peng C, 2015, INT J ENV RES PUB HE, V12, P12304, DOI 10.3390/ijerph121012304; Pichegru L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16569-x; Pieretti N, 2017, ECOL INDIC, V83, P13, DOI 10.1016/j.ecolind.2017.07.011; Pijanowski BC, 2011, LANDSCAPE ECOL, V26, P1213, DOI 10.1007/s10980-011-9600-8; Pine MK, 2016, OCEAN COAST MANAGE, V127, P63, DOI 10.1016/j.ocecoaman.2016.04.007; Popper A. N. N., 2014, SPRINGER HDB AUDITOR, V50; Popper AN, 2005, J ACOUST SOC AM, V117, P3958, DOI 10.1121/1.1904386; POPPER AN, 1993, BRAIN BEHAV EVOLUT, V41, P14, DOI 10.1159/000113821; Popper AN, 2019, J FISH BIOL, V94, P692, DOI 10.1111/jfb.13948; Popper AN, 2009, INTEGR ZOOL, V4, P43, DOI 10.1111/j.1749-4877.2008.00134.x; Poulsen A.J., 2016, P M ACOUSTICS, V28, DOI [10.1111/j.1600-0870.2010.00494.x, DOI 10.1111/J.1600-0870.2010.00494.X]; Radford AN, 2014, BEHAV ECOL, V25, P1022, DOI [10.1093/beheco/aru029, 10.1093/beheco/art102]; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; Radford CA, 2008, OECOLOGIA, V156, P921, DOI 10.1007/s00442-008-1041-y; Reine KJ, 2014, J ACOUST SOC AM, V135, P3280, DOI 10.1121/1.4875712; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Rolland RM, 2012, P ROY SOC B-BIOL SCI, V279, P2363, DOI 10.1098/rspb.2011.2429; Rossi T, 2017, LANDSCAPE ECOL, V32, P239, DOI 10.1007/s10980-016-0439-x; Rowe S, 2006, T AM FISH SOC, V135, P529, DOI 10.1577/T04-061.1; Rutz C, 2020, NAT ECOL EVOL, V4, P1156, DOI 10.1038/s41559-020-1237-z; SAUCIER MH, 1993, ENVIRON BIOL FISH, V36, P257, DOI 10.1007/BF00001722; Schmidt H., 2016, PROC MEET ACOUST, V28, DOI [10.1121/2.0000552, DOI 10.1121/2.0000552]; Seger KD, 2019, MAR MAMMAL SCI, V35, P1099, DOI 10.1111/mms.12577; Sertlek HO, 2019, ENVIRON POLLUT, V247, P1143, DOI 10.1016/j.envpol.2019.01.119; Shannon G, 2016, BIOL REV, V91, P982, DOI 10.1111/brv.12207; Shapiro H. T., 2010, CLIMATE CHANGE ASSES; Simmonds J., 2005, FISHERIES ACOUSTICS; Simmonds M.P., 2014, J OCEAN TECHNOL, V9, P71; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Simpson SD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10544; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Slotte A, 2004, FISH RES, V67, P143, DOI 10.1016/j.fishres.2003.09.046; Sole M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37979; Staaterman E., 2017, J ACOUST SOC AM, V141, P3937, DOI DOI 10.1121/1.4988913; Staaterman E, 2014, MAR ECOL PROG SER, V508, P17, DOI 10.3354/meps10911; Sueur J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004065; Taylor B., 2004, SCI COMM 56 M INT WH; Thomas JA, 2004, ECHOLOCATION BATS DO; Thomson DJM, 2020, J ACOUST SOC AM, V147, P3390, DOI 10.1121/10.0001271; Thorson RF, 2002, J ACOUST SOC AM, V111, P2302, DOI 10.1121/1.1466865; Tixier P, 2015, ICES J MAR SCI, V72, P1673, DOI 10.1093/icesjms/fsu166; Tolstoy M., 2004, P 26 SEISM RES REV T, VII, P568; United Nations Convention on the Law of the Sea Preparatory Committee, 2019, REV DRAFT TEXT AGR U; Urick R.J, 1983, PRINCIPLES UNDERWATE; Van Opzeeland I, 2010, MAR ECOL PROG SER, V414, P267, DOI 10.3354/meps08683; Veirs S., 2018, PEERJPREPRINTS, P1, DOI [10.7287/peerj.preprints.26525, DOI 10.7287/PEERJ.PREPRINTS.26525V1]; Walsh EP, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0098; Weilgart L. S., 2007, INT J COMP PSYCHOL, V20; WENZ GM, 1962, J ACOUST SOC AM, V34, P1936, DOI 10.1121/1.1909155; Williams R, 2015, OCEAN COAST MANAGE, V115, P17, DOI 10.1016/j.ocecoaman.2015.05.021; Winn H.E., 1964, MARINE BIOACOUSTICS, P213; Winther J.-G., 2020, INTEGRATED OCEAN MAN; Zhang YF, 2015, INTEGR ZOOL, V10, P141, DOI 10.1111/1749-4877.12104	177	164	166	64	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		583	+	eaba4658	10.1126/science.aba4658	http://dx.doi.org/10.1126/science.aba4658			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QD7TF	33542110	Green Published			2022-12-28	WOS:000615715300040
J	Merkenschlager, J; Finkin, S; Ramos, V; Kraft, J; Cipolla, M; Nowosad, CR; Hartweger, H; Zhang, WZ; Olinares, PDB; Gazumyan, A; Oliveira, TY; Chait, BT; Nussenzweig, MC				Merkenschlager, Julia; Finkin, Shlomo; Ramos, Victor; Kraft, Julian; Cipolla, Melissa; Nowosad, Carla R.; Hartweger, Harald; Zhang, Wenzhu; Olinares, Paul Dominic B.; Gazumyan, Anna; Oliveira, Thiago Y.; Chait, Brian T.; Nussenzweig, Michel C.			Dynamic regulation of T-FH selection during the germinal centre reaction	NATURE			English	Article								The germinal centre is a dynamic microenvironment in which B cells that express high-affinity antibody variants produced by somatic hypermutation are selected for clonal expansion by limiting the numbers of T follicular helper cells(1,2). Although much is known about the mechanisms that control the selection of B cells in the germinal centre, far less is understood about the clonal behaviour of the T follicular helper cells that help to regulate this process. Here we report on the dynamic behaviour of T follicular helper cell clones during the germinal centre reaction. We find that, similar to germinal centre B cells, T follicular helper cells undergo antigen-dependent selection throughout the germinal centre reaction that results in differential proliferative expansion and contraction. Increasing the amount of antigen presented in the germinal centre leads to increased division of T follicular helper cells. Competition between T follicular helper cell clones is mediated by the affinity of T cell receptors for peptide-major-histocompatibility-complex ligands. T cells that preferentially expand in the germinal centre show increased expression of genes downstream of the T cell receptor, such as those required for metabolic reprogramming, cell division and cytokine production. These dynamic changes lead to marked remodelling of the functional T follicular helper cell repertoire during the germinal centre reaction.	[Merkenschlager, Julia; Finkin, Shlomo; Ramos, Victor; Kraft, Julian; Cipolla, Melissa; Hartweger, Harald; Gazumyan, Anna; Oliveira, Thiago Y.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA; [Nowosad, Carla R.] Rockefeller Univ, Lab Lymphocyte Dynam, 1230 York Ave, New York, NY 10021 USA; [Zhang, Wenzhu; Olinares, Paul Dominic B.; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, 1230 York Ave, New York, NY 10021 USA; [Gazumyan, Anna; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Merkenschlager, J (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	jmerkensch@rockefeller.edu	Oliveira, Thiago Y/HGA-3848-2022	Oliveira, Thiago Y/0000-0002-2654-0879; Finkin, Shlomo/0000-0003-4474-2658; merkenschlager, julia/0000-0001-6726-7939; Hartweger, Harald/0000-0002-1118-1818; Ramos, Victor/0000-0001-7353-3420	National Institutes of Health (NIH) [5R37 AI037526]; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVID) [1UM1AI144462-01]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVID)	We thank A. Miyawaki and T. Kurosaki for the Fucci mice, E. E. Kara and T. Hagglof for the generation and maintenance of Sell-CreERT2 ROSA-tdT reporter mice, H. Zebroski for the generation of the APLs and the NP-APL conjugates in house, T. Eisenreich for help with mouse colony management, and technical help, A. Escolano for advice, B. Zhang and C. Zhao at The Rockefeller University Genomics Resource Center for assistance with 10x genomics and high-throughput sequencing, K. Gordon and K. Chhosphel for assistance with cell sorting, and all members of the Nussenzweig laboratory for discussions. We thank G. Victora for discussions involving the photoactivation experiments. This work was supported by National Institutes of Health (NIH) grant 5R37 AI037526 and NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVID) 1UM1AI144462-01 to M.C.N. J.M. is an EMBO fellow. M.C.N. is an HHMI investigator.	Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; Cyster JG, 2019, CELL, V177, P524, DOI 10.1016/j.cell.2019.03.016; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Finkin S, 2019, IMMUNITY, V51, P324, DOI 10.1016/j.immuni.2019.06.013; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hu JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008891; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Lau AWY, 2020, CURR OPIN IMMUNOL, V63, P29, DOI 10.1016/j.coi.2019.11.001; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Merkenschlager J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10281; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pratama A, 2014, IMMUNOL CELL BIOL, V92, P40, DOI 10.1038/icb.2013.69; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004	36	26	26	2	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 18	2021	591	7850					458	+		10.1038/s41586-021-03187-x	http://dx.doi.org/10.1038/s41586-021-03187-x		FEB 2021	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY6JL	33536617	Green Accepted			2022-12-28	WOS:000614414900001
J	Wise, J				Wise, Jacqui			Covid-19: New data on Oxford AstraZeneca vaccine backs 12 week dosing interval	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Voysey M, SINGLE DOSE ADM INFL; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1	2	19	20	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2021	372								n326	10.1136/bmj.n326	http://dx.doi.org/10.1136/bmj.n326			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC1TD	33536232	Bronze			2022-12-28	WOS:000686315900009
J	Baker, MG; Wilson, N; Blakely, T				Baker, Michael G.; Wilson, Nick; Blakely, Tony			Elimination could be the optimal response strategy for covid-19 and other emerging pandemic diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFLUENZA		[Baker, Michael G.; Wilson, Nick] Univ Otago, Dept Publ Hlth, HEIRU, Wellington, New Zealand; [Wilson, Nick; Blakely, Tony] Univ Otago, Dept Publ Hlth, BODE Programme 3, Wellington, New Zealand; [Blakely, Tony] Univ Melbourne, Populat Intervent Unit, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia	University of Otago; University of Otago; University of Melbourne	Baker, MG (corresponding author), Univ Otago, Dept Publ Hlth, HEIRU, Wellington, New Zealand.	michael.baker@otago.ac.nz			Health Research Council of NZ [20/1066]	Health Research Council of NZ(Health Research Council of New Zealand)	We thank Amanda Kvalsvig, John Potter, the reviewers, and The BMJ's editorial staff for helpful comments on the manuscript. We acknowledge funding support from the Health Research Council of NZ (20/1066).	[Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2020, REP WHO CHIN JOINT M; Baker M, 2020, NEED ROBUST SCI DEFI; Baker MG, 2020, PREVENTABLE MEASLES; Baker MG, 2020, MED J AUSTRALIA, V213, P198, DOI 10.5694/mja2.50735; Baker MG, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMc2025203; Baker MG, 2020, NEW ZEAL MED J, V133, P10; Blakely T, 2020, MED J AUSTRALIA, V213, P349, DOI 10.5694/mja2.50786; Boyd M, 2020, AUST NZ J PUBL HEAL, V44, P89, DOI 10.1111/1753-6405.12991; Cowling BJ, 2020, LANCET PUBLIC HEALTH, V5, pE279, DOI 10.1016/S2468-2667(20)30090-6; Dinnes J, 2020, COCHRANE DB SYST REV, V8; Eades S, 2020, LANCET, V396, P237, DOI [10.1016/S0140-6736(20)31350-7, 10.1016/S0140-6736(20)31545-2]; Ferguson NM, 2020, IMPACT NONPHARMACEUT; Giesecke J, 2020, LANCET, V395, pE98, DOI 10.1016/S0140-6736(20)31035-7; GREENHALGH T, 2020, BMJ-BRIT MED J, V370, P9291, DOI DOI 10.1136/BMJ.M3026; Group of Eight Australia, 2020, COVID 19 ROADM REC R; Heywood AE, 2020, LANCET INFECT DIS, V20, P1005, DOI 10.1016/S1473-3099(20)30633-2; Huang QS, 2020, IMPACT COVID 19 NONP, DOI [10.1101/2020.11.11.20228692v1, DOI 10.1101/2020.11.11.20228692V1]; Kang J, 2020, AM J INFECT CONTROL, V48, P1080, DOI 10.1016/j.ajic.2020.06.003; Lu N, 2020, AM J INFECT CONTROL, V48, P851, DOI 10.1016/j.ajic.2020.04.021; Scudellari M, 2020, NATURE, V587, P536, DOI 10.1038/d41586-020-03284-3; Summers J, 2020, LANCET REG HEALTH-W, V4, DOI 10.1016/j.lanwpc.2020.100044; Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151; Wilson N, 2012, EMERG INFECT DIS, V18, P71, DOI 10.3201/eid1801.110035	24	69	72	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2020	371								m4907	10.1136/bmj.m4907	http://dx.doi.org/10.1136/bmj.m4907			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PI0ZX	33561814	Bronze			2022-12-28	WOS:000600829900002
J	Gibney, E				Gibney, Elizabeth			THE QUEST TO UNDERSTAND HOW THUNDERSTORMS CREATE GAMMA RAYS	NATURE			English	News Item						Space physics; Atmospheric science		Researchers in Japan are enlisting an army of citizens to explore how thunderstorms on Earth create extreme bursts of radiation usually associated with black holes and other cosmic objects.										Enoto T, 2017, NATURE, V551, P481, DOI 10.1038/nature24630; GUREVICH AV, 1992, PHYS LETT A, V165, P463, DOI 10.1016/0375-9601(92)90348-P; Tsuchiya H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.165002; Wada Y, 2019, COMMUN PHYS-UK, V2, DOI 10.1038/s42005-019-0168-y; Wilson CTR, 1925, P CAMB PHILOS SOC, V22, P534, DOI 10.1017/S0305004100003236; Yuasa T, 2020, PROG THEOR EXP PHYS, V2020, DOI 10.1093/ptep/ptaa115	6	1	1	2	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846					378	381		10.1038/d41586-021-00395-3	http://dx.doi.org/10.1038/d41586-021-00395-3			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WH0GR	33597766	Bronze			2022-12-28	WOS:000707368100001
J	Moore, W				Moore, Wendy			Elizabeth Blackwell: breaching the barriers for women in medicine	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					662	663		10.1016/S0140-6736(21)00260-9	http://dx.doi.org/10.1016/S0140-6736(21)00260-9		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL3PK	33545095				2022-12-28	WOS:000620991800015
J	Jaklevic, MC				Jaklevic, Mary Chris			Generic Glucagon Approved for Severe Hypoglycemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2021	325	7					613	613		10.1001/jama.2021.0383	http://dx.doi.org/10.1001/jama.2021.0383			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ3QZ	33591331				2022-12-28	WOS:000619608000006
J	Allada, R; Bass, J				Allada, Ravi; Bass, Joseph			Circadian Mechanisms in Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							REV-ERB-ALPHA; GENE-EXPRESSION; CELL-FUNCTION; CLOCK; RHYTHMS; SLEEP; TIME; LIGHT; CANCER; TRANSCRIPTION	Molecular insights into diurnal variations in human physiology and behavior are extending our understanding of a wide range of disease processes. Chronobiology is also providing testable hypotheses regarding the timing of treatments.	[Allada, Ravi] Northwestern Univ, Dept Neurobiol, Evanston, IL USA; [Bass, Joseph] Northwestern Univ, Dept Med, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Feinberg School of Medicine	Bass, J (corresponding author), Northwestern Univ, Dept Med, 303 E Super St,Lurie 7-107, Chicago, IL 60611 USA.	j-bass@northwestern.edu						Altman BJ, 2015, CELL METAB, V22, P1009, DOI 10.1016/j.cmet.2015.09.003; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bass J, 2016, SCIENCE, V354, P994, DOI 10.1126/science.aah4965; Braun R, 2018, P NATL ACAD SCI USA, V115, pE9247, DOI 10.1073/pnas.1800314115; BRIDGES AB, 1991, BLOOD COAGUL FIBRIN, V2, P447, DOI 10.1097/00001721-199106000-00007; Carr O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19888-9; Chang AM, 2015, P NATL ACAD SCI USA, V112, P1232, DOI 10.1073/pnas.1418490112; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; Duffy JF, 2011, P NATL ACAD SCI USA, V108, P15602, DOI 10.1073/pnas.1010666108; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Flourakis M, 2015, CELL, V162, P836, DOI 10.1016/j.cell.2015.07.036; Fultz NE, 2019, SCIENCE, V366, P628, DOI 10.1126/science.aax5440; Gaddameedhi S, 2011, P NATL ACAD SCI USA, V108, P18790, DOI 10.1073/pnas.1115249108; Gehring W, 2003, J MOL EVOL, V57, pS286, DOI 10.1007/s00239-003-0038-8; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Hablitz LM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18115-2; Hand LE, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-018-1770-1; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Izumo M, 2014, ELIFE, V3, DOI 10.7554/eLife.04617; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Jiddou MR, 2013, AM J CARDIOL, V111, P631, DOI 10.1016/j.amjcard.2012.11.010; Kemp DM, 2002, MOL CELL ENDOCRINOL, V191, P157, DOI 10.1016/S0303-7207(02)00064-3; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kriebs A, 2017, P NATL ACAD SCI USA, V114, P8776, DOI 10.1073/pnas.1704955114; Laing EE, 2017, ELIFE, V6, DOI 10.7554/eLife.20214; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; LeGates TA, 2012, NATURE, V491, P594, DOI 10.1038/nature11673; Leng Y, 2019, LANCET NEUROL, V18, P307, DOI 10.1016/S1474-4422(18)30461-7; Levi F, 1997, LANCET, V350, P681, DOI 10.1016/S0140-6736(97)03358-8; Li JZ, 2013, P NATL ACAD SCI USA, V110, P9950, DOI 10.1073/pnas.1305814110; Manfredini R, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030404; Martin-Olalla JM, 2020, CURR BIOL, V30, pR298, DOI 10.1016/j.cub.2020.03.007; McKee CA, 2020, CELL MOL LIFE SCI, V77, P1049, DOI 10.1007/s00018-019-03314-y; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Mersch PPA, 1999, J AFFECT DISORDERS, V53, P35, DOI 10.1016/S0165-0327(98)00097-4; Montaigne D, 2018, LANCET, V391, P59, DOI 10.1016/S0140-6736(17)32132-3; MULLER JE, 1987, J CARDIOVASC PHARM, V10, pS104, DOI 10.1097/00005344-198710011-00020; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Papagiannakopoulos T, 2016, CELL METAB, V24, P324, DOI 10.1016/j.cmet.2016.07.001; Patke A, 2020, NAT REV MOL CELL BIO, V21, P67, DOI 10.1038/s41580-019-0179-2; Patke A, 2017, CELL, V169, P203, DOI 10.1016/j.cell.2017.03.027; Paul JR, 2020, EUR J NEUROSCI, V51, P109, DOI 10.1111/ejn.14343; Peek CB, 2017, CELL METAB, V25, P86, DOI 10.1016/j.cmet.2016.09.010; Perelis M, 2015, SCIENCE, V350, DOI 10.1126/science.aac4250; Petrenko V, 2017, GENE DEV, V31, P383, DOI 10.1101/gad.290379.116; Poteser M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051611; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Salem AH, 2014, CLIN PHARMACOKINET, V53, P347, DOI 10.1007/s40262-013-0121-2; Scheer FAJL, 2014, BLOOD, V123, P590, DOI 10.1182/blood-2013-07-517060; Skene DJ, 2007, SLEEP MED, V8, P651, DOI 10.1016/j.sleep.2006.11.013; Taylor D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1888; Thosar SS, 2018, J CLIN INVEST, V128, P2157, DOI 10.1172/JCI80590; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; TWIDALE N, 1989, AM J CARDIOL, V64, P1204, DOI 10.1016/0002-9149(89)90881-3; VANCAUTER E, 1991, J CLIN INVEST, V88, P934, DOI 10.1172/JCI115396; Vitale J, 2015, CHRONOBIOL INT, V32, P385, DOI 10.3109/07420528.2014.983604; Wegrzyn LR, 2017, AM J EPIDEMIOL, V186, P532, DOI 10.1093/aje/kwx140; Wehrens SMT, 2017, CURR BIOL, V27, P1768, DOI 10.1016/j.cub.2017.04.059; Wilkinson MJ, 2020, CELL METAB, V31, P92, DOI 10.1016/j.cmet.2019.11.004; Xu FK, 2019, CELL REP, V27, P59, DOI 10.1016/j.celrep.2019.03.015; Yates NJ, 2016, REV NEUROSCIENCE, V27, P669, DOI 10.1515/revneuro-2016-0030; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zhang HX, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007927; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	75	110	112	29	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2021	384	6					550	561		10.1056/NEJMra1802337	http://dx.doi.org/10.1056/NEJMra1802337			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG5JQ	33567194	Green Accepted			2022-12-28	WOS:000617621800012
J	Chatterjee, S				Chatterjee, Soumya			Mechanic's Hands	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 37-year-old man presented with painful, thickened, and cracked skin on his fingertips, which was associated with weakness of the proximal hip and shoulder muscles. The dermatologic finding was consistent with "mechanic's hands," and a diagnosis of antisynthetase syndrome was made.	[Chatterjee, Soumya] Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Chatterjee, S (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.	chattes@ccf.org							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2021	384	6							e16	10.1056/NEJMicm2026773	http://dx.doi.org/10.1056/NEJMicm2026773			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QG5JQ	33567195				2022-12-28	WOS:000617621800001
J	Rimmer, A				Rimmer, Abi			Covid-19: Travellers to UK from "red list" countries will pay 1750 pound for 10 day hotel quarantine	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BBC, 2021, BBC; Department for Transport, 2020, COR COVID 19 TRAV BA	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2021	372								n412	10.1136/bmj.n412	http://dx.doi.org/10.1136/bmj.n412			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM2MY	33574058	Bronze			2022-12-28	WOS:000639500800007
J	Awodiya, A; Whelan, P; Pettit, J				Awodiya, Afolarin; Whelan, Paul; Pettit, John			How to make the most of your psychiatry placement	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Awodiya, Afolarin; Whelan, Paul] North East Wiltshire Community Mental Hlth Team, Salisbury, Wilts, England; [Pettit, John] Malmesbury Primary Care Ctr, Malmesbury, England		Awodiya, A (corresponding author), North East Wiltshire Community Mental Hlth Team, Salisbury, Wilts, England.	aa16875@bristol.ac.uk		Awodiya, Afolarin/0000-0002-1510-2558				Kjeldmand D, 2004, PATIENT EDUC COUNS, V55, P230, DOI 10.1016/j.pec.2003.09.009; Mind, 2020, MENT HLTH FUND PRIOR; Shapiro SL, 1998, J BEHAV MED, V21, P581, DOI 10.1023/A:1018700829825	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2021	372								n133	10.1136/bmj.n133	http://dx.doi.org/10.1136/bmj.n133			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QH9VF	33568392				2022-12-28	WOS:000618622900001
J	Narayan, KMV; Curran, JW; Foege, WH				Narayan, K. M. Venkat; Curran, James W.; Foege, William H.			The COVID-19 Pandemic as an Opportunity to Ensure a More Successful Future for Science and Public Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint suggests that the COVID-19 pandemic provides an opportunity to build trust in science and update federal agencies to improve public health and poses questions and offers recommendations for consideration.	[Narayan, K. M. Venkat; Curran, James W.; Foege, William H.] Emory Univ, Rollins Sch Publ Hlth Emory, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Narayan, KMV (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Room 730,1518 Clifton Rd NE, Atlanta, GA 30322 USA.; Narayan, KMV (corresponding author), Emory Univ, Sch Med, Room 730,1518 Clifton Rd NE, Atlanta, GA 30322 USA.	knaraya@emory.edu						[Anonymous], 1997, PREPARING 21 CENTURY; Nuzzo JB, 2020, JAMA-J AM MED ASSOC, V324, P1391, DOI 10.1001/jama.2020.17395; Rasmussen SA, 2020, JAMA-J AM MED ASSOC, V324, P1729, DOI 10.1001/jama.2020.19646; Sagan C., 1996, DEMON HAUNTED WORLD; Shah Soleil, 2020, JAMA Health Forum, V1, pe201139, DOI 10.1001/jamahealthforum.2020.1139; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598	6	11	11	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2021	325	6					525	526		10.1001/jama.2020.23479	http://dx.doi.org/10.1001/jama.2020.23479			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG0MD	33560328	Bronze			2022-12-28	WOS:000617279600009
J	Wise, J				Wise, Jacqui			Covid-19: The E484K mutation and the risks it poses	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Collier D, 2021, SARS COV 2 B 1 1 7 E, DOI [10.1101/2021.01.19.21249840v2, DOI 10.1101/2021.01.19.21249840V2]; Iacobucci G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n305; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n296	3	96	96	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2021	372								n359	10.1136/bmj.n359	http://dx.doi.org/10.1136/bmj.n359			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH2PI	33547053	Bronze			2022-12-28	WOS:000618119100014
J	Sacks, CA				Sacks, Chana A.			Ochronosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														MARCACCI, MAURILIO/0000-0002-7484-1246; Di Matteo, Berardo/0000-0002-9807-0271					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2021	384	5					461	461		10.1056/NEJMicm2025932	http://dx.doi.org/10.1056/NEJMicm2025932			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QX4QW	33535288				2022-12-28	WOS:000629333200014
J	Horn-Ghetko, D; Krist, DT; Prabu, JR; Baek, K; Mulder, MPC; Klugel, M; Scott, DC; Ovaa, H; Kleiger, G; Schulman, BA				Horn-Ghetko, Daniel; Krist, David T.; Prabu, J. Rajan; Baek, Kheewoong; Mulder, Monique P. C.; Kluegel, Maren; Scott, Daniel C.; Ovaa, Huib; Kleiger, Gary; Schulman, Brenda A.			Ubiquitin ligation to F-box protein targets by SCF-RBR E3-E3 super-assembly	NATURE			English	Article							ACTIVITY-BASED PROBES; RING E3 LIGASE; STRUCTURAL BASIS; COMPLEX REVEALS; CRYSTAL-STRUCTURE; MECHANISM; PARKIN; SUBSTRATE; NEDD8; ACTIVATION	E3 ligases are typically classified by hallmark domains such as RING and RBR, which are thought to specify unique catalytic mechanisms of ubiquitin transfer to recruited substrates(1,2). However, rather than functioning individually, many neddylated cullin-RING E3 ligases (CRLs) and RBR-type E3 ligases in the ARIH family-which together account for nearly half of all ubiquitin ligases in humans-form E3-E3 super-assemblies(3-7). Here, by studying CRLs in the SKP1-CUL1-F-box (SCF) family, we show how neddylated SCF ligases and ARIH1 (an RBR-type E3 ligase) co-evolved to ubiquitylate diverse substrates presented on various F-box proteins. We developed activity-based chemical probes that enabled cryo-electron microscopy visualization of steps in E3-E3 ubiquitylation, initiating with ubiquitin linked to the E2 enzyme UBE2L3, then transferred to the catalytic cysteine of ARIH1, and culminating in ubiquitin linkage to a substrate bound to the SCF E3 ligase. The E3-E3 mechanism places the ubiquitin-linked active site of ARIH1 adjacent to substrates bound to F-box proteins (for example, substrates with folded structures or limited length) that are incompatible with previously described conventional RING E3-only mechanisms. The versatile E3-E3 super-assembly may therefore underlie widespread ubiquitylation.	[Horn-Ghetko, Daniel; Krist, David T.; Prabu, J. Rajan; Baek, Kheewoong; Kluegel, Maren; Schulman, Brenda A.] Max Planck Inst Biochem, Dept Mol Machines & Signaling, Martinsried, Germany; [Mulder, Monique P. C.; Ovaa, Huib] Leiden Univ, Med Ctr, Dept Cell & Chem Biol, Oncode Inst,Chem Immunol, Leiden, Netherlands; [Scott, Daniel C.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kleiger, Gary] Univ Nevada, Dept Chem & Biochem, Las Vegas, NV 89154 USA; [Krist, David T.] Carle Illinois Coll Med, Champaign, IL USA	Max Planck Society; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; St Jude Children's Research Hospital; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Schulman, BA (corresponding author), Max Planck Inst Biochem, Dept Mol Machines & Signaling, Martinsried, Germany.; Schulman, BA (corresponding author), St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	schulman@biochem.mpg.de	Mulder, Monique Priscilla Catharina/AAA-4990-2022; ovaa, huib/M-2334-2016	Mulder, Monique Priscilla Catharina/0000-0001-5386-7132; Horn-Ghetko, Daniel/0000-0003-2290-2147; Prabu, Jesuraj Rajan/0000-0002-7726-9310; Schulman, Brenda/0000-0002-3083-1126; ovaa, huib/0000-0002-0068-054X	Max Planck Gesellschaft; ERC [H2020 789016-NEDD8Activate]; Leibniz Prize from the DFG [SCHU 3196/1-1]; NIH [R15GM117555-02]; ALSAC/St Jude	Max Planck Gesellschaft(Max Planck Society); ERC(European Research Council (ERC)European Commission); Leibniz Prize from the DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC/St Jude(American Lebanese Syrian Associated Charities (ALSAC))	This study is dedicated to the memory of Huib Ovaa, an exceptional and inspiring scientist, colleague, mentor and friend. We thank J. Kellermann, H. Stark, A. Chari, S. Kostrhon, S. von Gronau, J. Liwocha, L. Neumaier, S. Uebel, S. Pettera, C. M. P. Talavera Ormeno, P. J. M. Hekking, V. Sanchez and N. Purser for assistance and reagents; J. W. Harper and R. V. Farese Jr for helpful discussions and critical reading of the manuscript; and D. Bollschweiler and T. Schafer of the cryo-EM facility at Max Planck Institute of Biochemistry. This study was supported by the Max Planck Gesellschaft, the ERC (H2020 789016-NEDD8Activate) and Leibniz Prize from the DFG (SCHU 3196/1-1) to B.A.S., and NIH R15GM117555-02 to G.K. D.C.S. was supported by ALSAC/St Jude.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P814, DOI 10.1107/S2059798318009324; Baek K, 2020, NATURE, V578, P461, DOI 10.1038/s41586-020-2000-y; Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Bourne Y, 1996, CELL, V84, P863, DOI 10.1016/S0092-8674(00)81065-X; Chalker JM, 2011, CHEM SCI, V2, P1666, DOI 10.1039/c1sc00185j; Condos TEC, 2018, EMBO J, V37, DOI 10.15252/embj.2018100014; de Jong A, 2012, CHEMBIOCHEM, V13, P2251, DOI 10.1002/cbic.201200497; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dove KK, 2017, P NATL ACAD SCI USA, V114, pE6576, DOI 10.1073/pnas.1705060114; Dove KK, 2017, STRUCTURE, V25, P890, DOI 10.1016/j.str.2017.04.013; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Duda DM, 2012, MOL CELL, V47, P371, DOI 10.1016/j.molcel.2012.05.044; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gladkova C, 2018, NATURE, V559, P411, DOI 10.1038/s41586-018-0224-x; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hewings DS, 2017, FEBS J, V284, P1555, DOI 10.1111/febs.14039; Hill S, 2019, ELIFE, V8, DOI 10.7554/eLife.51163; Huttenhain R, 2019, CELL HOST MICROBE, V26, P86, DOI 10.1016/j.chom.2019.05.008; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; Kumar A, 2017, NAT STRUCT MOL BIOL, V24, P475, DOI 10.1038/nsmb.3400; Kumar A, 2015, EMBO J, V34, P2506, DOI 10.15252/embj.201592337; Lechtenberg BC, 2016, NATURE, V529, P546, DOI 10.1038/nature16511; Li GR, 2014, CHEM COMMUN, V50, P216, DOI 10.1039/c3cc47382a; Liu X, 2018, MOL CELL, V69, P773, DOI 10.1016/j.molcel.2018.01.038; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Mulder MPC, 2016, NAT CHEM BIOL, V12, P523, DOI 10.1038/nchembio.2084; Mulder MPC, 2014, CHEMBIOCHEM, V15, P946, DOI 10.1002/cbic.201402012; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Reitsma JM, 2017, CELL, V171, P1326, DOI 10.1016/j.cell.2017.10.016; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Rusnac DV, 2020, ADV EXP MED BIOL, V1217, P9, DOI 10.1007/978-981-15-1025-0_2; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sauve V, 2018, NAT STRUCT MOL BIOL, V25, P623, DOI 10.1038/s41594-018-0088-7; Scott DC, 2016, CELL, V166, P1198, DOI 10.1016/j.cell.2016.07.027; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Spratt DE, 2012, J BIOL CHEM, V287, P17374, DOI 10.1074/jbc.M112.353748; Stieglitz B, 2013, NATURE, V503, P422, DOI 10.1038/nature12638; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Wang KK, 2020, ADV EXP MED BIOL, V1217, P33, DOI 10.1007/978-981-15-1025-0_3; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Wu SD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2636; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964; Yuan LM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00272-6; Zemla A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2628; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	70	41	41	13	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847								10.1038/s41586-021-03197-9	http://dx.doi.org/10.1038/s41586-021-03197-9		FEB 2021	30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM2BL	33536622	hybrid, Green Published			2022-12-28	WOS:000614414900003
J	Kocher, RP				Kocher, Robert P.			Reducing Administrative Waste in the US Health Care System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kocher, Robert P.] USC Schaeffer Ctr, 635 DowneyWay,Verna & Peter Dauterive Hall, Los Angeles, CA 90089 USA		Kocher, RP (corresponding author), USC Schaeffer Ctr, 635 DowneyWay,Verna & Peter Dauterive Hall, Los Angeles, CA 90089 USA.	bkocher@venrock.com						Kocher B, 2019, PEOPLE COST EVEN MOR; Shrank WH, 2019, JAMA-J AM MED ASSOC, V322, P1501, DOI 10.1001/jama.2019.13978; Tseng P, 2018, JAMA-J AM MED ASSOC, V319, P691, DOI 10.1001/jama.2017.19148; Verma S, 2019, PATIENTS PAPERWORK; Wilensky G, 2018, JAMA-J AM MED ASSOC, V319, P2369, DOI 10.1001/jama.2018.6858	5	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2021	325	5					427	428		10.1001/jama.2020.24767	http://dx.doi.org/10.1001/jama.2020.24767			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QC6JP	33528543				2022-12-28	WOS:000614941900008
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Trust me, I'm the family doctor	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Ipsos MORI, 2020, IPS MORI VER IND 202	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2021	372								n293	10.1136/bmj.n293	http://dx.doi.org/10.1136/bmj.n293			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC1RG	33531334	Bronze			2022-12-28	WOS:000686311000001
J	Kadhum, M; Sinclair, P; Rolton, D				Kadhum, Murtaza; Sinclair, Pierre; Rolton, Daniel			A traumatic elbow injury	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUPRACONDYLAR HUMERUS		[Kadhum, Murtaza] Univ Oxford, Clin Acad Grad Sch, John Radcliffe Hosp, Oxford, England; [Sinclair, Pierre; Rolton, Daniel] Royal Berkshire Hosp, Dept Trauma & Orthopaed, Reading, Berks, England	University of Oxford; Royal Berkshire Hospital	Kadhum, M (corresponding author), Univ Oxford, Clin Acad Grad Sch, John Radcliffe Hosp, Oxford, England.	Murtaza.Kadhum@nhs.net						Alton TB, 2015, CLIN ORTHOP RELAT R, V473, P738, DOI 10.1007/s11999-014-4033-8; Kumar V, 2016, J CLIN DIAGN RES, V10, pRE1, DOI 10.7860/JCDR/2016/21647.8942	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2020	371								m4351	10.1136/bmj.m4351	http://dx.doi.org/10.1136/bmj.m4351			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PH2WY	33561813				2022-12-28	WOS:000600280900016
J	Kang, MJ; Perl, TM				Kang, Minji; Perl, Trish M.			Deja Vu: Coronaviruses and Transmission in Health Care Settings	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kang, Minji; Perl, Trish M.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Perl, Trish M.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Infect Dis & Geog Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Perl, TM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Infect Dis & Geog Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Trish.Perl@utsouthwestern.edu						Aitken C, 2001, CLIN MICROBIOL REV, V14, P528, DOI 10.1128/CMR.14.3.528-546.2001; Baystate Health, BAYSTATEMEDICAL CTR; Ellsworth M, 2020, AM J INFECT CONTROL, V48, P1285, DOI 10.1016/j.ajic.2020.06.179; Klompas M, 2021, ANN INTERN MED, V174, P794, DOI 10.7326/M20-7567; Krein SL, 2018, JAMA INTERN MED, V178, P1016, DOI 10.1001/jamainternmed.2018.1898; Mumma JM, 2019, CLIN INFECT DIS, V69, pS214, DOI 10.1093/cid/ciz614; Rhee C, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.20498	7	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN	2021	174	6					864	+		10.7326/M21-0526	http://dx.doi.org/10.7326/M21-0526			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SS5IR	33556269	Green Published			2022-12-28	WOS:000661788700030
J	Wilding, JPH; Batterham, RL; Calanna, S; Davies, M; Van Gaal, LF; Lingvay, I; McGowan, BM; Rosenstock, J; Tran, MTD; Wadden, TA; Wharton, S; Yokote, K; Zeuthen, N; Kushner, RF				Wilding, John P. H.; Batterham, Rachel L.; Calanna, Salvatore; Davies, Melanie; Van Gaal, Luc F.; Lingvay, Ildiko; McGowan, Barbara M.; Rosenstock, Julio; Tran, Marie T. D.; Wadden, Thomas A.; Wharton, Sean; Yokote, Koutaro; Zeuthen, Niels; Kushner, Robert F.		STEP 1 Study Grp	Once-Weekly Semaglutide in Adults with Overweight or Obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEIGHT-LOSS; BARIATRIC SURGERY; CARDIOVASCULAR RISK; INDIVIDUALS; CHALLENGES; GALLSTONES; OUTCOMES; TRIALS; MG	BACKGROUND Obesity is a global health challenge with few pharmacologic options. Whether adults with obesity can achieve weight loss with once-weekly semaglutide at a dose of 2.4 mg as an adjunct to lifestyle intervention has not been confirmed. METHODS In this double-blind trial, we enrolled 1961 adults with a body-mass index (the weight in kilograms divided by the square of the height in meters) of 30 or greater (>= 27 in persons with >= 1 weight-related coexisting condition), who did not have diabetes, and randomly assigned them, in a 2:1 ratio, to 68 weeks of treatment with once-weekly subcutaneous semaglutide (at a dose of 2.4 mg) or placebo, plus lifestyle intervention. The coprimary end points were the percentage change in body weight and weight reduction of at least 5%. The primary estimand (a precise description of the treatment effect reflecting the objective of the clinical trial) assessed effects regardless of treatment discontinuation or rescue interventions. RESULTS The mean change in body weight from baseline to week 68 was -14.9% in the semaglutide group as compared with -2.4% with placebo, for an estimated treatment difference of -12.4 percentage points (95% confidence interval [CI], -13.4 to -11.5; P<0.001). More participants in the semaglutide group than in the placebo group achieved weight reductions of 5% or more (1047 participants [86.4%] vs. 182 [31.5%]), 10% or more (838 [69.1%] vs. 69 [12.0%]), and 15% or more (612 [50.5%] vs. 28 [4.9%]) at week 68 (P<0.001 for all three comparisons of odds). The change in body weight from baseline to week 68 was -15.3 kg in the semaglutide group as compared with -2.6 kg in the placebo group (estimated treatment difference, -12.7 kg; 95% CI, -13.7 to -11.7). Participants who received semaglutide had a greater improvement with respect to cardiometabolic risk factors and a greater increase in participant-reported physical functioning from baseline than those who received placebo. Nausea and diarrhea were the most common adverse events with semaglutide; they were typically transient and mild-to-moderate in severity and subsided with time. More participants in the semaglutide group than in the placebo group discontinued treatment owing to gastrointestinal events (59 [4.5%] vs. 5 [0.8%]). CONCLUSIONS In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight.	[Wilding, John P. H.] Univ Liverpool, Inst Life Course & Med Sci, Dept Cardiovasc & Metab Med, Liverpool, Merseyside, England; [Batterham, Rachel L.] UCL, Div Med, Obes Res Ctr, London, England; [Batterham, Rachel L.] UCLH, Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Batterham, Rachel L.] Univ Coll London Hosp, Ctr Weight Management & Metab Surg, London, England; [McGowan, Barbara M.] Guys & St Thomas NHS Fdn Trust, Dept Endocrinol & Diabet, London, England; [Davies, Melanie] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England; [Davies, Melanie] NIHR Leicester Biomed Res Ctr, Leicester, Leics, England; [Calanna, Salvatore; Tran, Marie T. D.; Zeuthen, Niels] Novo Nordisk, Soborg, Denmark; [Van Gaal, Luc F.] Univ Antwerp, Univ Antwerp Hosp, Dept Endocrinol Diabetol & Metab, Antwerp, Belgium; [Lingvay, Ildiko] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med Endocrinol, Dallas, TX 75390 USA; [Lingvay, Ildiko] Univ Texas Southwestern Med Ctr Dallas, Dept Populat & Data Sci, Dallas, TX 75390 USA; [Rosenstock, Julio] Dallas Diabet Res Ctr Med City, Dallas, TX USA; [Wadden, Thomas A.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wharton, Sean] York Univ, Toronto, ON, Canada; [Wharton, Sean] McMaster Univ, Toronto, ON, Canada; [Wharton, Sean] Wharton Weight Management Clin, Toronto, ON, Canada; [Yokote, Koutaro] Chiba Univ, Grad Sch Med, Dept Endocrinol Hematol & Gerontol, Chiba, Japan; [Yokote, Koutaro] Chiba Univ Hosp, Dept Diabet Metab & Endocrinol, Chiba, Japan; [Kushner, Robert F.] Northwestern Univ, Div Endocrinol, Feinberg Sch Med, 645 N Michigan Ave,Suite 530, Chicago, IL 60611 USA	University of Liverpool; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of Leicester; University of Antwerp; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Diabetes & Endocrine Center; University of Pennsylvania; Pennsylvania Medicine; York University - Canada; McMaster University; Chiba University; Chiba University; Northwestern University; Feinberg School of Medicine	Kushner, RF (corresponding author), Northwestern Univ, Div Endocrinol, Feinberg Sch Med, 645 N Michigan Ave,Suite 530, Chicago, IL 60611 USA.	rkushner@northwestern.edu	Wilding, John/ABB-6443-2020	Wilding, John/0000-0003-2839-8404; McGowan, Barbara/0000-0003-2015-726X; Mohammedi, Kamel/0000-0001-6139-1197; Davies, Melanie/0000-0002-9987-9371; Batterham, Rachel/0000-0002-5477-8585	Novo Nordisk	Novo Nordisk(Novo Nordisk)	Supported by Novo Nordisk.; Dr. Wilding reports receiving advisory board fees, paid to his institution, from Astellas Pharma, grant support and fees for membership on a data and safety monitoring board, both paid to University of Liverpool, lecture fees, and travel support from AstraZeneca, advisory board fees, paid to his institution, and lecture fees from Boehringer Ingelheim, Napp, and Sanofi Pasteur, advisory board fees, paid to his institution, from Eli Lilly, Janssen Global Services, Rhythm, and Wilmington Healthcare, lecture fees from Mundipharma, grant support, advisory board fees, and fees for serving as an investigator, all paid to University of Liverpool, and lecture fees from Novo Nordisk, and advisory board fees from Takeda Medical Research Foundation; Dr. Batterham, receiving consulting fees from Boehringer Ingelheim, Pfizer, and ViiV Healthcare and consulting fees and lecture fees from Novo Nordisk; Dr. Calanna, being employed by Novo Nordisk; Dr. Davies, receiving grant support from AstraZeneca, lecture fees from AstraZeneca Pharma India, advisory board fees from BI-LLY Alliance, Lexicon Pharmaceuticals, and Sanofi, advisory board fees and lecture fees from Boehringer Ingelheim and Eli Lilly, lecture fees from Boehringer Ingelheim (China), Boehringer Ingelheim (Philippines), Boehringer Ingelheim Saudi Arabia Trading, Boehringer Ingelheim (Poland), Napp Pharmaceuticals, Sanofi Romania, and Sanofi (Japan), advisory board fees and lecture fees from Boehringer Ingelheim International, and grant support, lecture fees, and advisory board fees from Novo Nordisk; Dr. Van Gaal, receiving lecture fees from AstraZeneca and Boehringer Ingelheim and advisory board fees and lecture fees from Merck and Novo Nordisk; Dr. Lingvay, receiving advisory board fees and consulting fees from AstraZeneca, consulting fees from Bayer HealthCare Pharmaceuticals, Eli Lilly, Intarcia, Intercept Pharmaceuticals, Janssen Global Services, MannKind, Target Pharma, Valeritas, and Zealand Pharma, advisory board fees from Boehringer Ingelheim and Sanofi US Services, grant support, paid to UT Southwestern, from Merck, grant support, paid to his institution, from Mylan Pharmaceuticals and Pfizer, and grant support, paid to UT Southwestern, advisory board fees, consulting fees, and travel support from Novo Nordisk; Dr. McGowan, receiving educational fees from AstraZeneca, Merck, and Orexigen Therapeutics, lecture fees from Janssen Biotech, advisory board fees from Johnson & Johnson Health Care Systems, grant support, paid to Guys and St. Thomas' Hospital, consulting fees, and educational fees from Novo Nordisk, and owning stock in Reset Health Clinics; Dr. Rosenstock, receiving grant support, advisory board fees, and travel support from Applied Therapeutics, Intarcia, and Oramed, grant support and consulting fees from AstraZeneca, grant support, advisory board fees, lecture fees, and travel support from Boehringer Ingelheim, Novo Nordisk, and Sanofi US Services, grant support and advisory board fees from Eli Lilly, grant support from Genentech, GlaxoSmithKline, Janssen Biotech, Lexicon Pharmaceuticals, Novartis, Pfizer, and REMD Biotherapeutics, and advisory board fees from Zealand Pharma; Dr. Tran, being employed by and owning stock in Novo Nordisk; Dr. Wadden, receiving grant support, paid to the University of Pennsylvania, and advisory board fees from Novo Nordisk and advisory board fees from WW International; Dr. Wharton, receiving lecture fees from AstraZeneca and Bausch and Lomb and grant support, lecture fees, and advisory board fees from Novo Nordisk; Dr.; Yokote, receiving lecture fees from Amgen, Janssen Pharmaceuticals, Kyowa Hakko Kirin, Novartis Pharma, and Sanofi, grant support and lecture fees from Astellas Pharma, Daiichi Sankyo, Eli Lilly Japan, Merck Sharp and Dohme, Mitsubishi Tanabe Pharma, Nippon Boehringer Ingelheim, Novo Nordisk, Ono Pharmaceutical, Pfizer, Sumitomo Dainippon Pharma, Taisho Toyama Pharmaceutical, and Takeda Pharmaceutical, advisory board fees and lecture fees from AstraZeneca, grant support, lecture fees, and advisory board fees from Kowa Company and Novo Nordisk, and lecture fees and advisory board fees from Sanofi; Mr. Zeuthen, being employed by and owning stock in Novo Nordisk; and Dr. Kushner, receiving advisory board fees from Novo Nordisk and Weight Watchers. No other potential conflict of interest relevant to this article was reported.; We thank the trial participants and the trial site staff; Lisa von Huth Smith of Novo Nordisk, Denmark, for support with data presentation of participant-reported outcomes and critical review of an earlier draft of the manuscript; and Paul Barlass of Axis, a division of Spirit Medical Communications Group, for medical writing and editorial assistance with an earlier draft of the manuscript (funded by Novo Nordisk).	Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS89, DOI 10.2337/dc20-S008; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Aroda VR, 2019, DIABETES METAB, V45, P409, DOI 10.1016/j.diabet.2018.12.001; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Benraouane F, 2011, CURR OPIN CARDIOL, V26, P555, DOI 10.1097/HCO.0b013e32834b7fc4; Bessesen DH, 2018, LANCET DIABETES ENDO, V6, P237, DOI 10.1016/S2213-8587(17)30236-X; Bettge K, 2017, DIABETES OBES METAB, V19, P336, DOI 10.1111/dom.12824; Blundell J, 2017, DIABETES OBES METAB, V19, P1242, DOI 10.1111/dom.12932; Courcoulas AP, 2013, JAMA-J AM MED ASSOC, V310, P2416, DOI 10.1001/jama.2013.280928; Erlinger S, 2000, EUR J GASTROEN HEPAT, V12, P1347, DOI 10.1097/00042737-200012120-00015; Faillie JL, 2016, JAMA INTERN MED, V176, P1474, DOI 10.1001/jamainternmed.2016.1531; Food and Drug Administration, 2020, SAX LIR INJ PRESCR I; Food and Drug Administration, 2020, OZ SEM INJ PRESCR IN; Friedrichsen M, 2021, DIABETES OBES METAB, V23, P754, DOI 10.1111/dom.14280; Gabery S, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133429; Garvey WT, 2016, ENDOCR PRACT, V22, P1, DOI 10.4158/EP161365.GL; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Knudsen LB, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00155; Kolotkin RL, 2017, CLIN OBES, V7, P273, DOI 10.1111/cob.12203; Kushner RF, 2020, OBESITY, V28, P1050, DOI 10.1002/oby.22794; Lyseng-Williamson KA, 2019, CLIN DRUG INVEST, V39, P805, DOI 10.1007/s40261-019-00826-0; Maciejewski ML, 2016, JAMA SURG, V151, P1046, DOI 10.1001/jamasurg.2016.2317; Magkos F, 2016, CELL METAB, V23, P591, DOI 10.1016/j.cmet.2016.02.005; McCrimmon RJ, 2020, DIABETOLOGIA, V63, P473, DOI 10.1007/s00125-019-05065-8; Nauck MA, 2019, EUR J ENDOCRINOL, V181, pR211, DOI 10.1530/EJE-19-0566; Nauck MA, 2019, DIABETES CARE, V42, P1912, DOI 10.2337/dc19-0415; Neeland IJ, 2018, CIRCULATION, V137, P1391, DOI 10.1161/CIRCULATIONAHA.117.029617; O'Neil PM, 2018, LANCET, V392, P637, DOI 10.1016/S0140-6736(18)31773-2; Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P11, DOI 10.1056/NEJMoa1411892; Quesada BM, 2010, WORLD J GASTROENTERO, V16, P2075, DOI 10.3748/wjg.v16.i17.2075; Sanchis-Gomar F, 2020, MAYO CLIN PROC, V95, P1445, DOI 10.1016/j.mayocp.2020.05.006; Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI [10.1056/NEJMoa1401329, 10.1056/NEJMc1407393]; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Wharton S, INT J OBES; Wharton S, 2020, CAN MED ASSOC J, V192, pE875, DOI 10.1503/cmaj.191707; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Williamson DA, 2015, OBESITY, V23, P2319, DOI 10.1002/oby.21358; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; Yang JR, 2020, J MED VIROL, V92, P1681, DOI 10.1002/jmv.25940; Yumuk V, 2015, OBESITY FACTS, V8, P402, DOI 10.1159/000442721	41	462	463	28	98	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2021	384	11					989	1002		10.1056/NEJMoa2032183	http://dx.doi.org/10.1056/NEJMoa2032183			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QY5HJ	33567185	Green Published, Bronze			2022-12-28	WOS:000630070600012
J	Wang, K; Wang, J; Zhu, CL; Yang, LD; Ren, YD; Ruan, J; Fan, GY; Hu, J; Xu, WJ; Bi, XP; Zhu, YA; Song, Y; Chen, HT; Ma, TT; Zhao, RP; Jiang, HF; Zhang, B; Feng, CG; Yuan, Y; Gan, XN; Li, YX; Zeng, HH; Liu, Q; Zhang, YL; Shao, F; Hao, SJ; Zhang, H; Xu, X; Liu, X; Wang, DP; Zhu, M; Zhang, GJ; Zhao, WM; Qiu, Q; He, SP; Wang, W				Wang, Kun; Wang, Jun; Zhu, Chenglong; Yang, Liandong; Ren, Yandong; Ruan, Jue; Fan, Guangyi; Hu, Jiang; Xu, Wenjie; Bi, Xupeng; Zhu, Youan; Song, Yue; Chen, Huatao; Ma, Tiantian; Zhao, Ruoping; Jiang, Haifeng; Zhang, Bin; Feng, Chenguang; Yuan, Yuan; Gan, Xiaoni; Li, Yongxin; Zeng, Honghui; Liu, Qun; Zhang, Yaolei; Shao, Feng; Hao, Shijie; Zhang, He; Xu, Xun; Liu, Xin; Wang, Depeng; Zhu, Min; Zhang, Guojie; Zhao, Wenming; Qiu, Qiang; He, Shunping; Wang, Wen			African lungfish genome sheds light on the vertebrate water-to-land transition	CELL			English	Article							PHOSPHATE COTRANSPORTER SLC34A2; PULMONARY SURFACTANT; NEOCERATODUS-FORSTERI; PROVIDES INSIGHTS; YELLOW CATFISH; EVOLUTION; EXPRESSION; AMYGDALA; GENE; ALIGNMENT	Lungfishes are the closest extant relatives of tetrapods and preserve ancestral traits linked with the water-to-land transition. However, their huge genome sizes have hindered understanding of this key transition in evolution. Here, we report a 40-Gb chromosome-level assembly of the African lungfish (Protopterus annectens) genome, which is the largest genome assembly ever reported and has a contig and chromosome N50 of 1.60 Mb and 2.81 Gb, respectively. The large size of the lungfish genome is due mainly to retrotransposons. Genes with ultra-long length show similar expression levels to other genes, indicating that lungfishes have evolved high transcription efficacy to keep gene expression balanced. Together with transcriptomeand experimental data, we identified potential genes and regulatory elements related to such terrestrial adaptation traits as pulmonary surfactant, anxiolytic ability, pentadactyl limbs, and pharyngeal remodeling. Our results provide insights and key resources for understanding the evolutionary pathway leading from fishes to humans.	[Wang, Kun; Zhu, Chenglong; Ren, Yandong; Xu, Wenjie; Feng, Chenguang; Yuan, Yuan; Li, Yongxin; Qiu, Qiang] Northwestern Polytech Univ, Sch Ecol & Environm, Xian 710072, Peoples R China; [Wang, Jun] South China Agr Univ, Coll Marine Sci, Joint Lab Guangdong Prov & Hong Kong Reg Marine B, Guangzhou 510642, Peoples R China; [Wang, Jun] Hubei Univ Technol, Sch Civil Engn Architecture & Environm, Wuhan 430068, Peoples R China; [Zhu, Chenglong; Ren, Yandong; Zhao, Ruoping; Zhang, Guojie; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China; [Yang, Liandong; Jiang, Haifeng; Gan, Xiaoni; Zeng, Honghui; He, Shunping] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Peoples R China; [Ruan, Jue] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Guangdong Lab Lingnan Modern Agr, Genome Anal Lab,Minist Agr, Shenzhen 518120, Peoples R China; [Fan, Guangyi; Song, Yue; Liu, Qun; Zhang, Yaolei; Hao, Shijie; Zhang, He; Liu, Xin] BGI Qingdao, Qingdao 266555, Peoples R China; [Fan, Guangyi; Bi, Xupeng; Xu, Xun; Zhang, Guojie] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Hu, Jiang; Wang, Depeng] Grand Biosci, Beijing 102200, Peoples R China; [Zhu, Youan; Zhu, Min] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Chen, Huatao; Ma, Tiantian] Northwest A&F Univ, Coll Vet Med, Dept Clin Vet Med, Key Lab Anim Biotechnol,Minist Agr, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Bin; Zhao, Wenming] Chinese Acad Sci, Beijing Inst Genom, Beijing 100101, Peoples R China; [Zhang, Bin; Zhao, Wenming] China Natl Ctr Bioinformat, Beijing 100101, Peoples R China; [Shao, Feng] Southwest Univ, Sch Life Sci, Key Lab Freshwater Fish Reprod & Dev, Chongqing 400715, Peoples R China; [Zhang, Guojie; He, Shunping; Wang, Wen] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming 650223, Yunnan, Peoples R China; [Zhang, Guojie] Univ Copenhagen, Villum Ctr Biodivers Genom, Dept Biol, Sect Ecol & Evolut, Copenhagen, Denmark; [He, Shunping] Chinese Acad Sci, Inst Deep Sea Sci & Engn, Sanya 572000, Peoples R China; [Wang, Wen] Northwestern Polytech Univ, Xian 710072, Peoples R China	Northwestern Polytechnical University; South China Agricultural University; Hubei University of Technology; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Ministry of Agriculture & Rural Affairs; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Southwest University - China; Chinese Academy of Sciences; University of Copenhagen; Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS; Northwestern Polytechnical University	Qiu, Q (corresponding author), Northwestern Polytech Univ, Sch Ecol & Environm, Xian 710072, Peoples R China.; Wang, W (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China.; He, SP (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Peoples R China.; Zhao, WM (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Beijing 100101, Peoples R China.; Zhao, WM (corresponding author), China Natl Ctr Bioinformat, Beijing 100101, Peoples R China.; He, SP; Wang, W (corresponding author), Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming 650223, Yunnan, Peoples R China.; He, SP (corresponding author), Chinese Acad Sci, Inst Deep Sea Sci & Engn, Sanya 572000, Peoples R China.; Wang, W (corresponding author), Northwestern Polytech Univ, Xian 710072, Peoples R China.	zhaowm@big.ac.cn; qiuqiang@lzu.edu.cn; clad@ihb.ac.cn; wwang@mail.kiz.ac.cn	Chen, Huatao/H-3755-2011; Wang, Jun/AAN-4446-2021; Zhang, Guojie/J-7273-2019	Chen, Huatao/0000-0002-3800-5013; Wang, Jun/0000-0002-7574-9468; Zhang, Guojie/0000-0001-6860-1521; Zhang, Yaolei/0000-0003-2131-0254; Ruan, Jue/0000-0003-3713-3192	Strategic Priority Research Program of CAS [XDB13000000]; 1000 Talent Project of Shaanxi Province; Research Funds for Interdisciplinary Subject, NWPU [19SH030408]; State Key Laboratory of Freshwater Ecology and Biotechnology; Youth Innovation Promotion Association of the CAS; NSFC of China [41876179, 31972866]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2018); National Key Research and Development Program of China [2018YFD0900604]; Villum Foundation [25900]; Fish10k project; Frasergen Bioinformatics Co., Ltd.	Strategic Priority Research Program of CAS; 1000 Talent Project of Shaanxi Province; Research Funds for Interdisciplinary Subject, NWPU; State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences); Youth Innovation Promotion Association of the CAS; NSFC of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2018); National Key Research and Development Program of China; Villum Foundation(Villum Fonden); Fish10k project; Frasergen Bioinformatics Co., Ltd.	We are very grateful to Drs. Erwei Zuo and Zhifang Li for their great help in our functional analysis. This work was supported by the Strategic Priority Research Program of CAS (XDB13000000) to W.W., S. He, and W.Z.; the 1000 Talent Project of Shaanxi Province to Q.Q. and K.W.; Research Funds for Interdisciplinary Subject, NWPU (19SH030408) to Q.Q.; grants from the State Key Laboratory of Freshwater Ecology and Biotechnology, the Youth Innovation Promotion Association of the CAS, and the NSFC of China (41876179 and 31972866) to S. He and L.Y.; and Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2018) and the National Key Research and Development Program of China (2018YFD0900604) to J.W. G.Z. is supported by the Villum Foundation (grant no. 25900). We also thank the supports from Fish10k project and Frasergen Bioinformatics Co., Ltd.	Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Ashley-Ross MA, 2013, INTEGR COMP BIOL, V53, P192, DOI 10.1093/icb/ict048; Attarian SJ, 2018, PEDIATR RES, V84, P419, DOI 10.1038/pr.2018.30; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Babaev O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07762-1; Babaev O, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0063-8; Bei M, 2009, CURR OPIN GENET DEV, V19, P504, DOI 10.1016/j.gde.2009.09.002; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Benton MJ, 2015, PALAEONTOL ELECTRON, V18; Bi XP, 2021, CELL, V184, P1377, DOI 10.1016/j.cell.2021.01.046; Biscotti MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21571; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Braasch I, 2016, NAT GENET, V48, P427, DOI 10.1038/ng.3526; BRUCE LL, 1995, BRAIN BEHAV EVOLUT, V46, P224, DOI 10.1159/000113276; Bruno M, 2019, ANNU REV GENET, V53, P393, DOI 10.1146/annurev-genet-112618-043717; Butler A. B., 1996, COMP VERTEBRATE NEUR; Caley T, 2018, NATURE, V560, P76, DOI 10.1038/s41586-018-0309-6; Carlson MRJ, 2001, DEV BIOL, V229, P396, DOI 10.1006/dbio.2000.0104; Chalopin D, 2015, GENOME BIOL EVOL, V7, P567, DOI 10.1093/gbe/evv005; Chen P, 2017, FISH PHYSIOL BIOCHEM, V43, P229, DOI 10.1007/s10695-016-0282-7; Chen P, 2016, FISH PHYSIOL BIOCHEM, V42, P51, DOI 10.1007/s10695-015-0116-z; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Clack J. A., 2012, GAINING GROUND ORIGI; Clack JA, 2009, ANNU REV EARTH PL SC, V37, P163, DOI 10.1146/annurev.earth.36.031207.124146; Coates MI, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2418; Daniels CB, 2003, NEWS PHYSIOL SCI, V18, P151, DOI 10.1152/nips.01438.2003; Dannlowski U, 2011, NEUROPSYCHOPHARMACOL, V36, P1879, DOI 10.1038/npp.2011.73; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; DUBOULE D, 1999, MOL BIOL EVOL, V296, P19; Dudchenko O., 2018, JUICE BOX ASSEMBLY T, DOI [10.1101/254797, DOI 10.1101/254797]; Dudchenko O, 2017, SCIENCE, V356, P92, DOI 10.1126/science.aal3327; Dunbrack R, 2006, J FISH BIOL, V68, P443, DOI 10.1111/j.0022-1112.2006.00906.x; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Emms DM, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1832-y; Filogonio R, 2017, COMP BIOCHEM PHYS A, V207, P52, DOI 10.1016/j.cbpa.2016.12.030; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gisabella B, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.203; Gomez-Gil L, 2009, BIOPHYS J, V97, P2736, DOI 10.1016/j.bpj.2009.08.045; Gonzalez A, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00130; Gonzalez A, 2009, BRAIN BEHAV EVOLUT, V74, P43, DOI 10.1159/000229012; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graham A., 2019, EVOLUTION DEV FISHES; Haagsman HP, 2001, COMP BIOCHEM PHYS A, V129, P91, DOI 10.1016/S1095-6433(01)00308-7; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Harris R. S., 2007, THESIS PENNSYLVANIA, DOI 10.1016/j.brainres.2008.03.070; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hsia CCW, 2013, COMPR PHYSIOL, V3, P849, DOI 10.1002/cphy.c120003; Hu J, 2020, BIOINFORMATICS, V36, P2253, DOI 10.1093/bioinformatics/btz891; Imbeault M, 2017, NATURE, V543, P550, DOI 10.1038/nature21683; Izumi H, 2017, HUM GENOME VAR, V4, DOI 10.1038/hgv.2016.47; Johanson Z, 2007, J EXP ZOOL PART B, V308B, P757, DOI 10.1002/jez.b.21197; Jones BR, 2012, BIOINFORMATICS, V28, P2388, DOI 10.1093/bioinformatics/bts457; Joss J.E., 2011, BIOL LUNGFISHES; Joza S, 2012, AM J PATHOL, V181, P2003, DOI 10.1016/j.ajpath.2012.08.037; Jude E, 2014, FRONT EARTH SC-SWITZ, V2, DOI 10.3389/feart.2014.00018; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kherdjemil Y, 2016, NATURE, V539, P89, DOI 10.1038/nature19813; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leonenko Z, 2007, BIOPHYS J, V93, P674, DOI 10.1529/biophysj.107.106310; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIEM KF, 1988, AM ZOOL, V28, P739; Liu LA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-302; Liu ZJ, 2007, DEV BIOL, V305, P333, DOI 10.1016/j.ydbio.2007.02.014; Long JA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P700, DOI 10.1086/425183; Loong AM, 2008, J COMP PHYSIOL B, V178, P351, DOI 10.1007/s00360-007-0228-6; Lu J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2170; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Maximino C, 2013, J CHEM NEUROANAT, V48-49, P1, DOI 10.1016/j.jchemneu.2012.10.001; McLaughlin RN, 2017, J EXP BIOL, V220, P6, DOI 10.1242/jeb.148148; Medina G, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-32; Metcalfe CJ, 2012, MOL BIOL EVOL, V29, P3529, DOI 10.1093/molbev/mss159; Metscher BD, 2005, EVOL DEV, V7, P186, DOI 10.1111/j.1525-142X.2005.05021.x; Meyer A, 2021, NATURE, V590, DOI 10.1038/s41586-021-03198-8; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; NAKATANI Y, 2007, NUCLEIC ACIDS RES, V17, P1254; NORTHCUTT RG, 2009, GENOME RES, V73, P59; NOWOSHILOW S, 2018, BRAIN BEHAV EVOLUT, V554, P50; OKABE M, 2004, NATURE, V101, P17716; OKADA K, 2016, P NATL ACAD SCI USA, V143, P1800; ORGAN C, 2016, DEVELOPMENT, V15, P65; Orgeig S, 2001, COMP BIOCHEM PHYS A, V129, P75, DOI 10.1016/S1095-6433(01)00307-5; PERTEA M, 2015, COMP BIOCHEM PHYS A, V33, P290; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Qiao T, 2009, ACTA ZOOL-STOCKHOLM, V90, P236, DOI 10.1111/j.1463-6395.2008.00381.x; REINSCHEID RK, 2007, BIOINFORMATICS, V28, P830; RICE P, 2000, PEPTIDES, V16, P276; ROBINSON MD, 2010, TRENDS GENET, V11, pR25; ROGERS RL, 2018, GENOME BIOL, V35, P2913; ROLDAN N, 2016, MOL BIOL EVOL, V111, P1703; RUAN J, 2020, SYST BIOL, V17, P155; SANDERSON MJ, 2003, NAT METHODS, V19, P301; SANSOM JI, 2012, BIOINFORMATICS, V55, P243; SEPPEY M, 2019, PALAEONTOLOGY, V1962, P227; SHU W, 2007, METHOD MOL BIOL, V134, P1991; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Sirijovski N, 2005, J EXP ZOOL PART B, V304B, P40, DOI 10.1002/jez.b.21022; SMITH MD, 2015, J EXP ZOOL PART B, V32, P1342; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Streit F, 2014, STRESS, V17, P352, DOI 10.3109/10253890.2014.921903; SU D, 2001, STRESS, V236, P316; SUDA N, 2011, DEV BIOL, V90, P382; SUZUKI A, 1988, J DENT RES, V64, P119; Teoh J, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104632; THOMSON KS, 1972, NEUROBIOL DIS, V180, P363; TIERSCH TR, 1989, J EXP ZOOL, V118, P713; TIPPMANN HF, 2004, T AM FISH SOC, V5, P82; TOMOTSUNE D, 2000, BRIEF BIOINFORM, V98, P165; Vurture GW, 2017, BIOINFORMATICS, V33, P2202, DOI 10.1093/bioinformatics/btx153; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Wang YP, 2015, NAT GENET, V47, P625, DOI 10.1038/ng.3280; WARREN WC, 2017, NAT GENET, V7, P109; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WOO J, 2013, USE R, V201, P929; WU Y, 2008, J CELL BIOL, V135, P171; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; XU YL, 2004, DEVELOPMENT, V43, P487; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; ZERINA J, 2005, CELL TISSUE RES, V80, P303; ZHANG J, 2010, J COMPUT BIOL, V466, P234; Zhang Y., 2019, 602136 BIORXIV, DOI [10.1101/602136, DOI 10.1101/602136]; ZHANG Z, 2000, BIOL REV, V7, P203; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhu Min, 1995, Geobios Memoire Special (Villeurbanne), V19, P293; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855; 2014, METHODS MOL BIOL, V1079, P155	137	41	43	55	197	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1362	+		10.1016/j.cell.2021.01.047	http://dx.doi.org/10.1016/j.cell.2021.01.047		MAR 2021	33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33545087	Bronze			2022-12-28	WOS:000629635700021
J	Yu, H; Lin, T; Meng, XB; Du, HL; Zhang, JK; Liu, GF; Chen, MJ; Jing, YH; Kou, LQ; Li, XX; Gao, Q; Liang, Y; Liu, XD; Fan, ZL; Liang, YT; Cheng, ZK; Chen, MS; Tian, ZX; Wang, YH; Chu, CC; Zuo, JR; Wan, JM; Qian, Q; Han, B; Zuccolo, A; Wing, R; Gao, CX; Liang, CZ; Li, JY				Yu, Hong; Lin, Tao; Meng, Xiangbing; Du, Huilong; Zhang, Jingkun; Liu, Guifu; Chen, Mingjiang; Jing, Yanhui; Kou, Liquan; Li, Xiuxiu; Gao, Qiang; Liang, Yan; Liu, Xiangdong; Fan, Zhilan; Liang, Yuntao; Cheng, Zhukuan; Chen, Mingsheng; Tian, Zhixi; Wang, Yonghong; Chu, Chengcai; Zuo, Jianru; Wan, Jianmin; Qian, Qian; Han, Bin; Zuccolo, Andrea; Wing, Rod A.; Gao, Caixia; Liang, Chengzhi; Li, Jiayang			A route to de novo domestication of wild allotetraploid rice	CELL			English	Article							GENOME-WIDE PREDICTION; RAPID DIVERSIFICATION; NATURAL VARIATION; PHYLOGENETIC ANALYSIS; SEQUENCE-ANALYSIS; RESISTANCE GENE; READ ALIGNMENT; DRAFT SEQUENCE; CLIMATE-CHANGE; GRAIN-NUMBER	Cultivated rice varieties are all diploid, and polyploidization of rice has long been desired because of its advantages in genome buffering, vigorousness, and environmental robustness. However, a workable route remains elusive. Here, we describe a practical strategy, namely de novo domestication of wild allotetraploid rice. By screening allotetraploid wild rice inventory, we identified one genotype of Oryza alta (CCDD), polyploid rice 1 (PPR1), and established two important resources for its de novo domestication: (1) an efficient tissue culture, transformation, and genome editing system and (2) a high-quality genome assembly discriminated into two subgenomes of 12 chromosomes apiece. With these resources, we show that six agronomically important traits could be rapidly improved by editing O. alta homologs of the genes controlling these traits in diploid rice. Our results demonstrate the possibility that de novo domesticated allotetraploid rice can be developed into a new staple cereal to strengthen world food security.	[Yu, Hong; Lin, Tao; Meng, Xiangbing; Du, Huilong; Zhang, Jingkun; Liu, Guifu; Chen, Mingjiang; Jing, Yanhui; Kou, Liquan; Li, Xiuxiu; Gao, Qiang; Liang, Yan; Cheng, Zhukuan; Chen, Mingsheng; Wang, Yonghong; Chu, Chengcai; Zuo, Jianru; Liang, Chengzhi; Li, Jiayang] Chinese Acad Sci, Innovat Acad Seed Design, State Key Lab Plant Genom, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; [Yu, Hong; Lin, Tao; Meng, Xiangbing; Du, Huilong; Zhang, Jingkun; Liu, Guifu; Chen, Mingjiang; Jing, Yanhui; Kou, Liquan; Li, Xiuxiu; Gao, Qiang; Liang, Yan; Cheng, Zhukuan; Chen, Mingsheng; Wang, Yonghong; Chu, Chengcai; Zuo, Jianru; Liang, Chengzhi; Li, Jiayang] Chinese Acad Sci, Innovat Acad Seed Design, Natl Ctr Plant Gene Res, Beijing 100101, Peoples R China; [Du, Huilong; Zhang, Jingkun; Li, Xiuxiu; Cheng, Zhukuan; Chen, Mingsheng; Tian, Zhixi; Wang, Yonghong; Chu, Chengcai; Zuo, Jianru; Gao, Caixia; Liang, Chengzhi; Li, Jiayang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Liu, Xiangdong; Li, Jiayang] Guangdong Lab Lingnan Modern Agr, Guangzhou 510642, Peoples R China; [Liu, Xiangdong] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou 510642, Peoples R China; [Fan, Zhilan] Guangdong Acad Agr Sci, Rice Res Inst, Natl Field Genebank Wild Rice Guangzhou, Guangzhou 510640, Peoples R China; [Liang, Yuntao] Guangxi Acad Agr Sci, Rice Res Inst, Nanning 530007, Peoples R China; [Tian, Zhixi; Gao, Caixia] Chinese Acad Sci, Innovat Acad Seed Design, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China; [Wan, Jianmin] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China; [Qian, Qian] Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Peoples R China; [Han, Bin] Chinese Acad Sci, Natl Ctr Plant Gene Res, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai 200233, Peoples R China; [Han, Bin] Chinese Acad Sci, CAS Ctr Excellence Mol Plant Sci, Shanghai 200233, Peoples R China; [Zuccolo, Andrea; Wing, Rod A.] King Abdullah Univ Sci & Technol KAUST, Ctr Desert Agr, Biol & Environm Sci & Engn Div BESE, Thuwal 239556900, Saudi Arabia; [Zuccolo, Andrea] Scuola Super Sant Anna, Inst Life Sci, I-56127 Pisa, Italy; [Wing, Rod A.] Univ Arizona, Sch Plant Sci, Arizona Genom Inst, Tucson, AZ 85721 USA; [Lin, Tao] China Agr Univ, Coll Hort, Beijing 100193, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; South China Agricultural University; Guangdong Academy of Agricultural Sciences; Guangxi Academy of Agricultural Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; King Abdullah University of Science & Technology; Scuola Superiore Sant'Anna; University of Arizona; China Agricultural University	Yu, H; Liang, CZ; Li, JY (corresponding author), Chinese Acad Sci, Innovat Acad Seed Design, State Key Lab Plant Genom, Inst Genet & Dev Biol, Beijing 100101, Peoples R China.; Yu, H; Liang, CZ; Li, JY (corresponding author), Chinese Acad Sci, Innovat Acad Seed Design, Natl Ctr Plant Gene Res, Beijing 100101, Peoples R China.; Gao, CX; Liang, CZ; Li, JY (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Li, JY (corresponding author), Guangdong Lab Lingnan Modern Agr, Guangzhou 510642, Peoples R China.; Gao, CX (corresponding author), Chinese Acad Sci, Innovat Acad Seed Design, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China.	hyu@genetics.ac.cn; cxgao@genetics.ac.cn; cliang@genetics.ac.cn; jyli@genetics.ac.cn	Chu, Chengcai/AAF-6083-2019; Yu, Hong/H-2770-2012	Chu, Chengcai/0000-0001-8097-6115; Yu, Hong/0000-0002-1748-8693; Kou, Liquan/0000-0001-7613-5209; Lin, Tao/0000-0003-3647-0488; Zuccolo, Andrea/0000-0001-7574-0714; meng, xiangbing/0000-0001-7040-7138; Gao, Qiang/0000-0002-9323-1101; Wing, Rod/0000-0001-6633-6226	National Natural Science Foundation of China [31788103]; Chinese Academy of Sciences [XDA24030504, XDA24040201]; National Key Research and Development Program of China [2016YFD0101800]; National Transgenic Science and Technology Program of China [2019ZX08010-003, 2019ZX08010-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Research and Development Program of China; National Transgenic Science and Technology Program of China	We thank Prof. Yaoguang Liu (South China Agricultural University) for providing pYLCRISPR/Cas9P<INF>ubi</INF>-H vector. The research was supported by the National Natural Science Foundation of China (31788103), the Chinese Academy of Sciences (XDA24030504 and XDA24040201), the National Key Research and Development Program of China (2016YFD0101800), and the National Transgenic Science and Technology Program of China (2019ZX08010-003 and 2019ZX08010-001).	Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; Ammiraju JSS, 2010, BREEDING SCI, V60, P536, DOI 10.1270/jsbbs.60.536; Ammiraju JSS, 2010, PLANT J, V63, P430, DOI 10.1111/j.1365-313X.2010.04251.x; Ammiraju JSS, 2006, GENOME RES, V16, P140, DOI 10.1101/gr.3766306; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Atwell BJ, 2014, PLANT SCI, V215, P48, DOI 10.1016/j.plantsci.2013.10.007; Bailey-Serres J, 2019, NATURE, V575, P109, DOI 10.1038/s41586-019-1679-0; Bao Y, 2004, PLANT SYST EVOL, V249, P55, DOI 10.1007/s00606-004-0173-8; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cai DT, 2007, SCI CHINA SER C, V50, P356, DOI 10.1007/s11427-007-0049-6; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen JF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2596; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; DeHaan L, 2020, TRENDS PLANT SCI, V25, P525, DOI 10.1016/j.tplants.2020.02.004; Du HL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15324; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Eshed Y, 2019, SCIENCE, V366, P705, DOI 10.1126/science.aax0025; Falush D, 2003, GENETICS, V164, P1567; Fang Z, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.116, 10.1038/nplants.2016.116]; FARRIS JS, 1977, SYST ZOOL, V26, P77, DOI 10.2307/2412867; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gao H, 2014, P NATL ACAD SCI USA, V111, P16337, DOI 10.1073/pnas.1418204111; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; [郭韬 Guo Tao], 2019, [中国科学. 生命科学, Scientia Sinica Vitae], V49, P1185; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Hardigan MA, 2017, P NATL ACAD SCI USA, V114, pE9999, DOI 10.1073/pnas.1714380114; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Huang CL, 2008, GENETICS, V179, P1527, DOI 10.1534/genetics.108.089805; Huang G, 2020, NAT GENET, V52, P516, DOI 10.1038/s41588-020-0607-4; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Izawa T, 1996, TRENDS PLANT SCI, V1, P95, DOI 10.1016/S1360-1385(96)80041-0; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim J, 2015, PLANT PHYSIOL, V169, P1532, DOI 10.1104/pp.15.00976; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kyriakidou M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01660; Lacchini E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229782; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lemmon ZH, 2018, NAT PLANTS, V4, P766, DOI 10.1038/s41477-018-0259-x; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li PC, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3197-x; Li TD, 2018, NAT BIOTECHNOL, V36, P1160, DOI 10.1038/nbt.4273; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Lichman BR, 2020, CURR OPIN PLANT BIOL, V55, P74, DOI 10.1016/j.pbi.2020.03.005; Lin YJ, 2005, PLANT CELL REP, V23, P540, DOI 10.1007/s00299-004-0843-6; Long SP, 2015, CELL, V161, P56, DOI 10.1016/j.cell.2015.03.019; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu F, 2009, P NATL ACAD SCI USA, V106, P2071, DOI 10.1073/pnas.0812798106; Luo JH, 2013, PLANT CELL, V25, P3360, DOI 10.1105/tpc.113.113589; Luo JS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03088-0; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Ma Y, 2015, CELL, V160, P1209, DOI 10.1016/j.cell.2015.01.046; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meng XB, 2017, MOL PLANT, V10, P1238, DOI 10.1016/j.molp.2017.06.006; Menguer PK, 2017, GENET MOL BIOL, V40, P238, DOI [10.1590/1678-4685-gmb-2016-0093, 10.1590/1678-4685-GMB-2016-0093]; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Mohammed S, 2019, RICE SCI, V26, P133, DOI 10.1016/j.rsci.2019.04.001; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Ou SJ, 2018, PLANT PHYSIOL, V176, P1410, DOI 10.1104/pp.17.01310; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Prusty MR, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00417; Qian Q, 2016, NATL SCI REV, V3, P283, DOI 10.1093/nsr/nww006; Robertson R., 2009, INT FOOD POLICY RES, V21; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Seppey M, 2019, METHODS MOL BIOL, V1962, P227, DOI 10.1007/978-1-4939-9173-0_14; Shelton JM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1911-8; SHIMAMOTO K, 1989, NATURE, V338, P274, DOI 10.1038/338274a0; Shimizu-Sato S, 2020, RICE, V13, DOI 10.1186/s12284-020-00394-4; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Stein JC, 2018, NAT GENET, V50, P285, DOI 10.1038/s41588-018-0040-0; TAJIMA F, 1983, GENETICS, V105, P437; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, V25, p4.10.11, DOI 10.1002/0471250953.bi0410s25; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van De Peer Y, 2017, NAT REV GENET, V18, P411, DOI 10.1038/nrg.2017.26; Van Tassel DL, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00789; VanBuren R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14724-z; Vurture GW, 2017, BIOINFORMATICS, V33, P2202, DOI 10.1093/bioinformatics/btx153; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wang B, 2018, ANNU REV PLANT BIOL, V69, P437, DOI 10.1146/annurev-arplant-042817-040422; Wang J, 2018, SCIENCE, V361, P1026, DOI 10.1126/science.aat7675; Weng XY, 2014, PLANT PHYSIOL, V164, P735, DOI 10.1104/pp.113.231308; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Wing RA, 2018, NAT REV GENET, V19, P505, DOI 10.1038/s41576-018-0024-z; Wu JW, 2014, PLANT REPROD, V27, P181, DOI 10.1007/s00497-014-0250-2; Xie XR, 2017, MOL PLANT, V10, P1246, DOI 10.1016/j.molp.2017.06.004; Xu CM, 2014, MOL BIOL EVOL, V31, P1066, DOI 10.1093/molbev/msu085; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan WH, 2013, CELL RES, V23, P969, DOI 10.1038/cr.2013.43; Yang J, 2017, NAT PLANTS, V3, P696, DOI 10.1038/s41477-017-0002-z; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoon J, 2014, PLANT J, V79, P717, DOI 10.1111/tpj.12581; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zeng DL, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.31; Zhang JS, 2018, NAT GENET, V50, P1565, DOI 10.1038/s41588-018-0237-2; Zhang LS, 2019, PLANT CELL TISS ORG, V139, P577, DOI 10.1007/s11240-019-01701-8; Zhang QJ, 2014, P NATL ACAD SCI USA, V111, pE4954, DOI 10.1073/pnas.1418307111; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang Yi, 2016, Curr Protoc Plant Biol, V1, P235, DOI 10.1002/cppb.20004; Zhao Q, 2018, NAT GENET, V50, P279, DOI 10.1038/s41588-018-0041-z; Zheng Y, 2016, MOL PLANT, V9, P1667, DOI 10.1016/j.molp.2016.09.014; Zhou Y, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0438-2; Zhou YL, 2011, CROP PROT, V30, P637, DOI 10.1016/j.cropro.2010.12.002; Zong Y, 2018, NAT BIOTECHNOL, V36, P950, DOI 10.1038/nbt.4261; Zou XH, 2013, NEW PHYTOL, V198, P1155, DOI 10.1111/nph.12230; Zou XH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r49; Zsogon A, 2018, NAT BIOTECHNOL, V36, P1211, DOI 10.1038/nbt.4272; Zuccolo A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-152	137	115	130	63	267	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1156	+		10.1016/j.cell.2021.01.013	http://dx.doi.org/10.1016/j.cell.2021.01.013		MAR 2021	29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33539781	Bronze			2022-12-28	WOS:000629635700008
J	Ou, XY; Qin, X; Huang, BL; Zan, J; Wu, QX; Hong, ZZ; Xie, LL; Bian, HY; Yi, ZG; Chen, XF; Wu, YM; Song, XR; Li, J; Chen, QS; Yang, HH; Liu, XG				Ou, Xiangyu; Qin, Xian; Huang, Bolong; Zan, Jie; Wu, Qinxia; Hong, Zhongzhu; Xie, Lili; Bian, Hongyu; Yi, Zhigao; Chen, Xiaofeng; Wu, Yiming; Song, Xiaorong; Li, Juan; Chen, Qiushui; Yang, Huanghao; Liu, Xiaogang			High-resolution X-ray luminescence extension imaging	NATURE			English	Article							UP-CONVERSION; PERSISTENT LUMINESCENCE; EMISSION	Current X-ray imaging technologies involving flat-panel detectors have difficulty in imaging three-dimensional objects because fabrication of large-area, flexible, silicon-based photodetectors on highly curved surfaces remains a challenge(1-3). Here we demonstrate ultralong-lived X-ray trapping for flat-panel-free, high-resolution, three-dimensional imaging using a series of solution-processable, lanthanide-doped nanoscintillators. Corroborated by quantum mechanical simulations of defect formation and electronic structures, our experimental characterizations reveal that slow hopping of trapped electrons due to radiation-triggered anionic migration in host lattices can induce more than 30 days of persistent radioluminescence. We further demonstrate X-ray luminescence extension imaging with resolution greater than 20 line pairs per millimetre and optical memory longer than 15 days. These findings provide insight into mechanisms underlying X-ray energy conversion through enduring electron trapping and offer a paradigm to motivate future research in wearable X-ray detectors for patient-centred radiography and mammography, imaging-guided therapeutics, high-energy physics and deep learning in radiology. Using lanthanide-doped nanomaterials and flexible substrates, an approach that enables flat-panel-free, high-resolution, three-dimensional imaging is demonstrated and termed X-ray luminescence extension imaging.	[Ou, Xiangyu; Zan, Jie; Wu, Qinxia; Hong, Zhongzhu; Xie, Lili; Chen, Xiaofeng; Song, Xiaorong; Li, Juan; Chen, Qiushui; Yang, Huanghao; Liu, Xiaogang] Fuzhou Univ, MOE Key Lab Analyt Sci Food Safety & Biol, Fuzhou, Peoples R China; [Ou, Xiangyu; Zan, Jie; Wu, Qinxia; Hong, Zhongzhu; Xie, Lili; Chen, Xiaofeng; Song, Xiaorong; Li, Juan; Chen, Qiushui; Yang, Huanghao] Fuzhou Univ, State Key Lab Photocatalysis Energy & Environm, Coll Chem, Fuzhou, Peoples R China; [Qin, Xian; Bian, Hongyu; Yi, Zhigao; Wu, Yiming; Liu, Xiaogang] Natl Univ Singapore, Dept Chem, Singapore, Singapore; [Huang, Bolong] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Peoples R China; [Liu, Xiaogang] Joint Sch Natl Univ Singapore & Tianjin Univ, Fuzhou, Peoples R China; [Chen, Qiushui; Yang, Huanghao] Fujian Sci & Technol Innovat Lab Optoelect Inform, Fuzhou, Peoples R China; [Liu, Xiaogang] Natl Univ Singapore, Suzhou Res Inst, Ctr Funct Mat, Suzhou, Peoples R China; [Liu, Xiaogang] Natl Univ Singapore, Inst Hlth N1, Singapore, Singapore	Fuzhou University; Fuzhou University; National University of Singapore; Hong Kong Polytechnic University; TJU-NUS Joint Institute; National University of Singapore; National University of Singapore	Chen, QS; Yang, HH; Liu, XG (corresponding author), Fuzhou Univ, MOE Key Lab Analyt Sci Food Safety & Biol, Fuzhou, Peoples R China.; Chen, QS; Yang, HH (corresponding author), Fuzhou Univ, State Key Lab Photocatalysis Energy & Environm, Coll Chem, Fuzhou, Peoples R China.; Liu, XG (corresponding author), Natl Univ Singapore, Dept Chem, Singapore, Singapore.; Liu, XG (corresponding author), Joint Sch Natl Univ Singapore & Tianjin Univ, Fuzhou, Peoples R China.; Liu, XG (corresponding author), Natl Univ Singapore, Suzhou Res Inst, Ctr Funct Mat, Suzhou, Peoples R China.; Liu, XG (corresponding author), Natl Univ Singapore, Inst Hlth N1, Singapore, Singapore.	qchen@fzu.edu.cn; hhyang@fzu.edu.cn; chmlx@nus.edu.sg	LIU, XIAOGANG/A-8038-2011; Yi, Zhigao/I-6116-2015; Huang, Bolong/AAG-5165-2019; Song, Xiaorong/H-2147-2016	LIU, XIAOGANG/0000-0003-2517-5790; Yi, Zhigao/0000-0003-0853-2055; Huang, Bolong/0000-0002-2526-2002; Song, Xiaorong/0000-0001-5484-0978; Ou, Xiangyu/0000-0002-4093-6757; Wu, Yiming/0000-0002-1201-5053; Qin, Xian/0000-0001-8569-7721; Bian, Hongyu/0000-0002-0231-5466	National Key and Program of China [2018YFA0902600]; National Natural Science Foundation of China [21635002, 21771135, 21871071, 21771156]; Early Career Scheme fund from the Research Grant Council in Hong Kong [PolyU 253026/16P]; NUS NanoNash Programme [R143000B43114, NUHSRO/2020/002/NanoNash/LOA]; National Research Foundation, the Prime Minister's Office of Singapore under its NRF Investigatorship Programme [NRF-NRFI05-2019-0003]; Research Institute for Smart Energy of the Hong Kong Polytechnic University; Agency for Science, Technology and Research [A1883c0011, A1983c0038]	National Key and Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Early Career Scheme fund from the Research Grant Council in Hong Kong; NUS NanoNash Programme; National Research Foundation, the Prime Minister's Office of Singapore under its NRF Investigatorship Programme; Research Institute for Smart Energy of the Hong Kong Polytechnic University; Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR))	We thank L. Ma, Y. Huang, X. Wang and B. Hou for technical assistance. This work is supported by the National Key and Program of China (grant number 2018YFA0902600), the National Natural Science Foundation of China (grant numbers 21635002, 21771135, 21871071 and 21771156), the Early Career Scheme fund (grant number PolyU 253026/16P) from the Research Grant Council in Hong Kong, Research Institute for Smart Energy of the Hong Kong Polytechnic University, Agency for Science, Technology and Research (grant numbers A1883c0011 and A1983c0038), NUS NanoNash Programme (NUHSRO/2020/002/NanoNash/LOA and R143000B43114) and National Research Foundation, the Prime Minister's Office of Singapore under its NRF Investigatorship Programme (award number NRF-NRFI05-2019-0003).	All AH, 2019, ADV MATER, V31, DOI 10.1002/adma.201803474; Berger M.J., 2013, XCOM PHOTON CROSS SE; Blahuta S, 2013, OPT MATER, V35, P1865, DOI 10.1016/j.optmat.2013.03.030; Buechele P, 2015, NAT PHOTONICS, V9, P843, DOI [10.1038/NPHOTON.2015.216, 10.1038/nphoton.2015.216]; Bunzli JCG, 2010, CHEM REV, V110, P2729, DOI 10.1021/cr900362e; Capobianco JA, 2002, J PHYS CHEM B, V106, P1181, DOI 10.1021/jp0129582; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Chen QS, 2018, NATURE, V561, P88, DOI 10.1038/s41586-018-0451-1; Cooper DR, 2018, NANOSCALE, V10, P7821, DOI 10.1039/c8nr01262h; de Chermont QL, 2007, P NATL ACAD SCI USA, V104, P9266, DOI 10.1073/pnas.0702427104; Fernandez-Bravo A, 2018, NAT NANOTECHNOL, V13, P572, DOI 10.1038/s41565-018-0161-8; Heyd J, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2204597; Holler M, 2017, NATURE, V543, P402, DOI 10.1038/nature21698; Hsu CC, 2018, ACS APPL MATER INTER, V10, P7859, DOI 10.1021/acsami.8b00015; Huang BL, 2017, PHYS CHEM CHEM PHYS, V19, P12683, DOI 10.1039/c7cp01623a; Kang M, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.045105; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Li Y, 2016, CHEM SOC REV, V45, P2090, DOI 10.1039/c5cs00582e; Liu YJ, 2017, NATURE, V543, P229, DOI 10.1038/nature21366; Lu KD, 2018, NAT BIOMED ENG, V2, P600, DOI 10.1038/s41551-018-0203-4; Lushchik C.B., 1986, PHYS RADIAT EFFECT C, V13, P473, DOI [10.1016/B978-0-444-86946-3.50014-0, DOI 10.1016/B978-0-444-86946-3.50014-0]; Maldiney T, 2014, NAT MATER, V13, P418, DOI 10.1038/NMAT3908; Matsuzawa T, 1996, J ELECTROCHEM SOC, V143, P2670, DOI 10.1149/1.1837067; Nikl M, 2015, ADV OPT MATER, V3, P463, DOI 10.1002/adom.201400571; Pan ZW, 2012, NAT MATER, V11, P58, DOI [10.1038/nmat3173, 10.1038/NMAT3173]; Prigozhin MB, 2019, NAT NANOTECHNOL, V14, P420, DOI 10.1038/s41565-019-0395-0; RAPPE AM, 1990, PHYS REV B, V41, P1227, DOI 10.1103/PhysRevB.41.1227; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Shyichuk A, 2016, J LUMIN, V170, P560, DOI 10.1016/j.jlumin.2015.07.005; Song L, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201707496; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; Van den Eeckhout K, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.045126; Van der Heggen D, 2019, NANOMATERIALS-BASEL, V9, DOI 10.3390/nano9081127; Wang SH, 2018, NATURE, V555, P83, DOI 10.1038/nature25494; Wei HT, 2016, NAT PHOTONICS, V10, P333, DOI [10.1038/nphoton.2016.41, 10.1038/NPHOTON.2016.41]; Wei W, 2017, NAT PHOTONICS, V11, P315, DOI [10.1038/NPHOTON.2017.43, 10.1038/nphoton.2017.43]; Xue ZL, 2017, ACS APPL MATER INTER, V9, P22132, DOI 10.1021/acsami.7b03802; Yakunin S, 2015, NAT PHOTONICS, V9, P444, DOI [10.1038/nphoton.2015.82, 10.1038/NPHOTON.2015.82]; Yang YM, 2018, LIGHT-SCI APPL, V7, DOI 10.1038/s41377-018-0089-7	39	136	137	137	466	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846								10.1038/s41586-021-03251-6	http://dx.doi.org/10.1038/s41586-021-03251-6			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TY5YS	33597760	Green Accepted			2022-12-28	WOS:000683860300003
J	Dyer, C				Dyer, Clare			Urology surgeon faces GMC charges of inappropriate treatments for financial gain	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2019, BMJ-BRIT MED J, V367, DOI DOI 10.1136/BMJ.L6218	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2021	372								n472	10.1136/bmj.n472	http://dx.doi.org/10.1136/bmj.n472			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK7TO	33597127				2022-12-28	WOS:000620584600004
J	Mwananyanda, L; Gill, CJ; MacLeod, W; Kwenda, G; Pieciak, R; Mupila, Z; Lapidot, R; Mupeta, F; Forman, L; Ziko, L; Etter, L; Thea, D				Mwananyanda, Lawrence; Gill, Christopher J.; MacLeod, William; Kwenda, Geoffrey; Pieciak, Rachel; Mupila, Zachariah; Lapidot, Rotem; Mupeta, Francis; Forman, Leah; Ziko, Luunga; Etter, Lauren; Thea, Donald			Covid-19 deaths in Africa: prospective systematic postmortem surveillance study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVE To directly measure the fatal impact of coronavirus disease 2019 (covid-19) in an urban African population. DESIGN Prospective systematic postmortem surveillance study. SETTING Zambia's largest tertiary care referral hospital. PARTICIPANTS Deceased people of all ages at the University Teaching Hospital morgue in Lusaka, Zambia, enrolled within 48 hours of death. MAIN OUTCOME MEASURE Postmortem nasopharyngeal swabs were tested via reverse transcriptase quantitative polymerase chain reaction (PCR) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Deaths were stratified by covis-19 status, location, age, sex, and underlying risk factors. RESULTS 372 participants were enrolled between June and September 2020; PCR results were available for 364 (97.8%). SARS-CoV-2 was detected in 58/364 (15.9%) according to the recommended cycle threshold value of <40 and in 70/364 (19.2%) when expanded to any level of PCR detection. The median age at death among people with a positive test for SARS-CoV-2 was 48 (interquartile range 36-72) years, and 69% (n=48) were male. Most deaths in people with covid-19 (51/70; 73%) occurred in the community; none had been tested for SARS-CoV-2 before death. Among the 19/70 people who died in hospital, six were tested before death. Among the 52/70 people with data on symptoms, 44/52 had typical symptoms of covid-19 (cough, fever, shortness of breath), of whom only five were tested before death. Covid-19 was identified in seven children, only one of whom had been tested before death. The proportion of deaths with covid-19 increased with age, but 76% (n=53) of people who died were aged under 60 years. The five most common comorbidities among people who died with covid-19 were tuberculosis (22; 31%), hypertension (19; 27%), HIV/AIDS (16; 23%), alcohol misuse (12; 17%), and diabetes (9; 13%). CONCLUSIONS Contrary to expectations, deaths with covid-19 were common in Lusaka. Most occurred in the community, where testing capacity is lacking. However, few people who died at facilities were tested, despite presenting with typical symptoms of covid-19. Therefore, cases of covid-19 were under-reported because testing was rarely done not because covid-19 was rare. If these data are generalizable, the impact of covid-19 in Africa has been vastly underestimated.	[Mwananyanda, Lawrence; Gill, Christopher J.; MacLeod, William; Pieciak, Rachel; Lapidot, Rotem; Etter, Lauren; Thea, Donald] Boston Univ, Dept Global Hlth, Sch Publ Hlth, Boston, MA 02118 USA; [Mwananyanda, Lawrence] Right Care Zambia, Mansa, Zambia; [Kwenda, Geoffrey] Univ Zambia, Dept Biomed Sci, Lusaka, Zambia; [Mupila, Zachariah] Univ Teaching Hosp, ZPRIME Mol Lab, Lusaka, Zambia; [Mupeta, Francis; Ziko, Luunga] Univ Teaching Hosp, Div Internal Med, Infect Dis Sect, Lusaka, Zambia; [Forman, Leah] Boston Univ, Biostat & Epidemiol Data Analyt Ctr, Sch Publ Hlth, Boston, MA 02118 USA	Boston University; University of Zambia; University of Zambia; University of Zambia; Boston University	Gill, CJ (corresponding author), Boston Univ, Dept Global Hlth, Sch Publ Hlth, Boston, MA 02118 USA.	cgill@bu.edu		Ziko, Luunga/0000-0002-5450-8905; gill, christopher/0000-0003-3353-0617	Bill & Melinda Gates Foundation [OPP 1163027]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The ZPRIME study and the covid-19 expansion were made possible through the generous support of the Bill & Melinda Gates Foundation (OPP 1163027). The funders had no role in designing the study; in the collection and analysis of data; or in the decision to submit the article for publication. An earlier version of the manuscript was shared with the team at the Gates Foundation, and some of their comments were incorporated into the final version.	Africa Centers for Disease Control, 2020, COR DIS 2019 COVID 1; Akyala AI, 2020, PAN AFR MED J, V37, DOI 10.11604/pamj.2020.37.47.24200; American Academy of Pediatrics, 2020, CHILDR COVID 19 STAT; [Anonymous], 2020, LANCET, V395, P1669, DOI 10.1016/S0140-6736(20)31237-X; Bamgboye EL, 2020, J NATL MED ASSOC; Bell D, 2020, AM J TROP MED HYG, V103, P1191, DOI 10.4269/ajtmh.20-0546; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Chiappini E, 2020, PEDIAT ALLERG IMM-UK, V31, P92, DOI 10.1111/pai.13373; Ditekemena J, 2020, SCIENCE, V368, P445, DOI 10.1126/science.abc4859; Dube FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068097; El-Sadr WM, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2008193; Giacomelli A, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104931; Gupta S, 2020, CASE REP INFECT DIS, V2020, DOI 10.1155/2020/8823622; Karim SSA, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2014960; Lawal Y, 2021, INT J INFECT DIS, V102, P118, DOI 10.1016/j.ijid.2020.10.038; Mansourian M, 2021, ARCH PEDIAT; Mbow M, 2020, SCIENCE, V369, P624, DOI 10.1126/science.abd3902; National Institutes for Communicable Diseases (NICD), 2020, COVID 19 WEEKL EP BR; Nigerian Centers for Disease Control, 2020, COVID 19 NIG; Nordling L, 2020, SCIENCE, V369, P756, DOI 10.1126/science.369.6505.756; Nordling L, 2020, NATURE, V583, P672, DOI 10.1038/d41586-020-02216-5; Ogimi Chikara, 2020, medRxiv, DOI 10.1101/2020.10.17.20214510; Ozdemir O, 2020, MBIO, V11, DOI 10.1128/mBio.01832-20; Parker A, 2020, SAMJ S AFR MED J, V110, P982, DOI [10.7196/SAMJ.2020.v110i10.15067, 10.7196/samj.2020.v110i10.15067]; Rwema JOT, 2020, ANN INTERN MED, V173, P752, DOI 10.7326/M20-2628; Serina P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0528-8; Shrock E, 2020, SCIENCE, V370, P1058, DOI 10.1126/science.abd4250; The Central Intelligence Agency, 2020, WORLD FACT BOOK ZAMB; The COVID Tracking Project, 2020, TOT US; The World Bank, 2020, WORLD BANK ZAMB OV; Thompson KM, 2021, RISK ANAL, V41, P376, DOI 10.1111/risa.13614; Troeger C., 2020, JUST DEATHS DUE COVI; US Centers for Disease Control and Prevention, 2020, 3 US CTR DIS CONTR P; Van Horn KG, 2008, DIAGN MICR INFEC DIS, V62, P471, DOI 10.1016/j.diagmicrobio.2008.08.004; Velavan TP, 2020, LANCET INFECT DIS; Viglione G, 2020, NATURE, V585, P22, DOI 10.1038/d41586-020-02497-w; Viner RM, 2021, ARCH DIS CHILD, V106, P802, DOI 10.1136/archdischild-2020-320972; Were V, 2020, REVEALING EXTENT COV, DOI [10.1101/2020.09.02.20186817v1, DOI 10.1101/2020.09.02.20186817V1]; Yang GY, 2011, J VIROL METHODS, V171, P195, DOI 10.1016/j.jviromet.2010.10.024; Zambia Statistic's Agency (formerly the Central Statistical Office), 2018, ZAMB DEM HLTH SURV 2; Zhang JJ, 2020, LANCET INFECT DIS, V20, P793, DOI 10.1016/S1473-3099(20)30230-9	41	67	68	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2021	372								n334	10.1136/bmj.n334	http://dx.doi.org/10.1136/bmj.n334			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK7TO	33597166	Bronze, Green Published			2022-12-28	WOS:000620584600009
J	van der Valk, T; Pecnerova, P; Diez-del-Molino, D; Bergstrom, A; Oppenheimer, J; Hartmann, S; Xenikoudakis, G; Thomas, JA; Dehasque, M; Saglican, E; Fidan, FR; Barnes, I; Liu, SL; Somel, M; Heintzman, PD; Nikolskiy, P; Shapiro, B; Skoglund, P; Hofreiter, M; Lister, AM; Gotherstrom, A; Dalen, L				van der Valk, Tom; Pecnerova, Patricia; Diez-del-Molino, David; Bergstrom, Anders; Oppenheimer, Jonas; Hartmann, Stefanie; Xenikoudakis, Georgios; Thomas, Jessica A.; Dehasque, Marianne; Saglican, Ekin; Fidan, Fatma Rabia; Barnes, Ian; Liu, Shanlin; Somel, Mehmet; Heintzman, Peter D.; Nikolskiy, Pavel; Shapiro, Beth; Skoglund, Pontus; Hofreiter, Michael; Lister, Adrian M.; Gotherstrom, Anders; Dalen, Love			Million-year-old DNA sheds light on the genomic history of mammoths	NATURE			English	Article							WOOLLY MAMMOTH; ANCIENT DNA; SEQUENCE; EVOLUTION; ACCURATE; CONTAMINATION; MAMMUTHUS; INFERENCE; ADMIXTURE; ALIGNMENT	Temporal genomic data hold great potential for studying evolutionary processes such as speciation. However, sampling across speciation events would, in many cases, require genomic time series that stretch well back intothe Early Pleistocene subepoch. Although theoretical models suggest that DNA should survive on this timescale(1), the oldest genomic data recovered so far are from a horse specimen dated to 780-560 thousand years ago(2). Here we report the recovery of genome-wide data from three mammoth specimens dating to the Early and Middle Pleistocene subepochs, two of which are more than one million years old. We find that two distinct mammoth lineages were present in eastern Siberia during the Early Pleistocene. One of these lineages gave rise to the woolly mammoth and the other represents a previously unrecognized lineage that was ancestral to the first mammoths to colonize North America. Our analyses reveal that the Columbian mammoth of North America traces its ancestry to a Middle Pleistocene hybridization between these two lineages, with roughly equal admixture proportions. Finally, we show that the majority of protein-coding changes associated with cold adaptation in woolly mammoths were already present one million years ago. These findings highlight the potential of deep-time palaeogenomics to expand our understanding of speciation and long-term adaptive evolution.	[van der Valk, Tom; Diez-del-Molino, David; Dehasque, Marianne; Gotherstrom, Anders; Dalen, Love] Ctr Palaeogenet, Stockholm, Sweden; [van der Valk, Tom; Pecnerova, Patricia; Diez-del-Molino, David; Dehasque, Marianne; Dalen, Love] Swedish Museum Nat Hist, Dept Bioinformat & Genet, Stockholm, Sweden; [van der Valk, Tom] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Natl Bioinformat Infrastruct Sweden, Uppsala, Sweden; [Pecnerova, Patricia; Diez-del-Molino, David; Dehasque, Marianne; Dalen, Love] Stockholm Univ, Dept Zool, Stockholm, Sweden; [Pecnerova, Patricia] Univ Copenhagen, Sect Computat & RNA Biol, Dept Biol, Copenhagen, Denmark; [Bergstrom, Anders; Skoglund, Pontus] Francis Crick Inst, London, England; [Oppenheimer, Jonas] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Hartmann, Stefanie; Xenikoudakis, Georgios; Thomas, Jessica A.; Hofreiter, Michael] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Saglican, Ekin; Fidan, Fatma Rabia; Somel, Mehmet] Middle East Tech Univ, Dept Biol Sci, Ankara, Turkey; [Barnes, Ian; Lister, Adrian M.] Nat Hist Museum, Dept Earth Sci, London, England; [Liu, Shanlin] China Agr Univ, Coll Plant Protect, Beijing, Peoples R China; [Heintzman, Peter D.] UiT Arctic Univ Norway, Arctic Univ Museum Norway, Tromso, Norway; [Nikolskiy, Pavel] Russian Acad Sci, Geol Inst, Moscow, Russia; [Shapiro, Beth] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Shapiro, Beth] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Gotherstrom, Anders] Stockholm Univ, Dept Archaeol & Class Studies, Stockholm, Sweden	Swedish Museum of Natural History; Swedish Museum of Natural History; Uppsala University; Stockholm University; University of Copenhagen; Francis Crick Institute; University of California System; University of California Santa Cruz; University of Potsdam; Middle East Technical University; Natural History Museum London; China Agricultural University; UiT The Arctic University of Tromso; Geological Institute, Russian Academy of Sciences; Russian Academy of Sciences; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Stockholm University	van der Valk, T; Dalen, L (corresponding author), Ctr Palaeogenet, Stockholm, Sweden.; van der Valk, T; Dalen, L (corresponding author), Swedish Museum Nat Hist, Dept Bioinformat & Genet, Stockholm, Sweden.; van der Valk, T (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Natl Bioinformat Infrastruct Sweden, Uppsala, Sweden.; Dalen, L (corresponding author), Stockholm Univ, Dept Zool, Stockholm, Sweden.	tom.vandervalk@scilifelab.se; love.dalen@nrm.se	Dalén, Love/A-6686-2008; Liu, Shanlin/HGA-2841-2022; Fidan, Fatma Rabia/AET-4110-2022; Diez-del-Molino, David/ABC-3313-2020; Barnes, Ian C/B-8081-2008; Heintzman, Peter D./I-6768-2013; Fidan, Fatma Rabia/AFI-8689-2022; Liu, Shanlin/GNH-3256-2022; Nikolskiy, Pavel A/C-5041-2012	Dalén, Love/0000-0001-8270-7613; Liu, Shanlin/0000-0001-8118-8313; Diez-del-Molino, David/0000-0002-9701-5940; Barnes, Ian C/0000-0001-8322-6918; Heintzman, Peter D./0000-0002-6449-0219; Fidan, Fatma Rabia/0000-0001-5877-7945; Liu, Shanlin/0000-0001-8118-8313; Somel, Mehmet/0000-0002-3138-1307; Hartmann, Stefanine/0000-0002-3476-0169; Oppenheimer, Jonas/0000-0001-7973-6173; Bergstrom, Anders/0000-0002-4096-9268; Skoglund, Pontus/0000-0002-3021-5913; Dehasque, Marianne/0000-0002-4640-8306	Swedish Research Council [2012-3869, 2017-04647]; FORMAS [2018-01640]; Tryggers Foundation [CTS 17:109]; Knut and Alice Wallenberg Foundation (1,000 Ancient Genomes project); Francis Crick Institute from Cancer Research UK [FC001595]; UK Medical Research Council; Wellcome Trust [217223/Z/19/Z]; European Research Council [852558]; Vallee Foundation; NERC [NE/J010480/1]; ERC StG grant GeneFlow [310763]; US National Science Foundation [DEB-1754451]; RFBR [13-05-01128]; Science for Life Laboratory; Knut and Alice Wallenberg Foundation; National Genomics Infrastructure - Swedish Research Council; Uppsala Multidisciplinary Center for Advanced Computational Science; NERC [NE/J010480/2, NE/J009490/1] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); FORMAS(Swedish Research Council Formas); Tryggers Foundation; Knut and Alice Wallenberg Foundation (1,000 Ancient Genomes project); Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Vallee Foundation; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ERC StG grant GeneFlow; US National Science Foundation(National Science Foundation (NSF)); RFBR(Russian Foundation for Basic Research (RFBR)); Science for Life Laboratory; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); National Genomics Infrastructure - Swedish Research Council; Uppsala Multidisciplinary Center for Advanced Computational Science; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	T.v.d.V., P.P., D.D.-d.-M., M.D. and L.D. acknowledge support from the Swedish Research Council (2012-3869 and 2017-04647), FORMAS (2018-01640) and the Tryggers Foundation (CTS 17:109). A.G. is supported by the Knut and Alice Wallenberg Foundation (1,000 Ancient Genomes project). A.B. and P.S. were supported by the Francis Crick Institute (FC001595), which receives its core funding from Cancer Research UK, the UK Medical Research Council and the Wellcome Trust. P.S. was supported by the European Research Council (grant no. 852558), the Wellcome Trust (217223/Z/19/Z) and the Vallee Foundation. M.H., J.A.T., I.B., A.M.L. and G.X. were supported by NERC (grant no. NE/J010480/1) and the ERC StG grant GeneFlow (no. 310763). B.S. and J.O. were supported by the US National Science Foundation (DEB-1754451). P.N. was supported by RFBR (grant no. 13-05-01128). The authors also acknowledge support from Science for Life Laboratory, the Knut and Alice Wallenberg Foundation, the National Genomics Infrastructure funded by the Swedish Research Council, and Uppsala Multidisciplinary Center for Advanced Computational Science for assistance with massively parallel sequencing and access to the UPPMAX computational infrastructure. N. Clark at the Hunterian Museum provided access to the Scotland mammoth sample. Finally, we thank our late friend and colleague A. Sher, who defined and described the Olyorian sequence, collected large quantities of fossil vertebrate material (including all of the Early and Middle Pleistocene specimens studied here) and consistently promoted multidisciplinary studies on his finds.	Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; [Anonymous], 2013, PREPRINTS; Barnes I, 2007, CURR BIOL, V17, P1072, DOI 10.1016/j.cub.2007.05.035; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Chang D, 2017, SCI REP-UK, V7, DOI 10.1038/srep44585; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feuerborn TR, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-07229-y; Frith MC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-80; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Godfrey L.R., 2010, CENOZOIC MAMMALS AFR; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150; Leppala K, 2017, BIOINFORMATICS, V33, P1738, DOI 10.1093/bioinformatics/btx048; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister AM, 2015, SCIENCE, V350, P805, DOI 10.1126/science.aac5660; Lister AM, 2005, QUATERN INT, V126, P49, DOI 10.1016/j.quaint.2004.04.014; Lister AM, 2004, PHILOS T R SOC B, V359, P221, DOI 10.1098/rstb.2003.1436; Liu LQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10017-2; Lucas SG, 2017, QUATERN INT, V443, P2, DOI 10.1016/j.quaint.2016.12.017; Lynch VJ, 2015, CELL REP, V12, P217, DOI 10.1016/j.celrep.2015.06.027; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Meyer M, 2017, ELIFE, V6, DOI 10.7554/eLife.25413; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Palkopoulou E, 2018, P NATL ACAD SCI USA, V115, pE2566, DOI 10.1073/pnas.1720554115; Palkopoulou E, 2015, CURR BIOL, V25, P1395, DOI 10.1016/j.cub.2015.04.007; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pecnerova P, 2017, EVOL LETT, V1, P292, DOI 10.1002/evl3.33; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Repenning C. A, 1992, ALLOPHAIOMYS AGE OLY; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Skov L, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007641; Smit AF., 2018, REPEATMASKER; St John J., 2011, TOOL STRIPPING ADAPT; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	50	83	87	17	89	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 11	2021	591	7849					265	+		10.1038/s41586-021-03224-9	http://dx.doi.org/10.1038/s41586-021-03224-9		FEB 2021	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU6WY	33597750	Green Submitted, Green Accepted			2022-12-28	WOS:000618965700001
J	Iacobucci, G				Iacobucci, Gareth			Covid:19: Ethnic minority health staff are less likely to take up vaccine, early data show	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Martin CA, 2021, ASS DEMOGRAPHIC OCC, DOI [10.1101/2021.02.11.21251548v2, DOI 10.1101/2021.02.11.21251548V2]	1	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2021	372								n460	10.1136/bmj.n460	http://dx.doi.org/10.1136/bmj.n460			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RA8YP	33593814	Bronze			2022-12-28	WOS:000631706300009
J	Jaklevic, MC				Jaklevic, Mary Chris			More Scrutiny for Laparoscopic Power Morcellator Procedures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2021	325	7					613	613		10.1001/jama.2021.0923	http://dx.doi.org/10.1001/jama.2021.0923			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ3QZ	33591333				2022-12-28	WOS:000619608000007
J	Sudhakar, S; Abdosamadi, MK; Jachowski, TJ; Bugiel, M; Jannasch, A; Schaffer, E				Sudhakar, Swathi; Abdosamadi, Mohammad Kazem; Jachowski, Tobias Joerg; Bugiel, Michael; Jannasch, Anita; Schaeffer, Erik			Germanium nanospheres for ultraresolution picotensiometry of kinesin motors	SCIENCE			English	Article							OPTICAL TWEEZERS; 8-NM STEP; FORCE; NANOPARTICLES; MECHANICS; MOLECULES; TRACKING; TRAP; COORDINATION; OBJECTIVES	Kinesin motors are essential for the transport of cellular cargo along microtubules. How the motors step, detach, and cooperate with each other is still unclear. To dissect the molecular motion of kinesin-1, we developed germanium nanospheres as ultraresolution optical trapping probes. We found that single motors took 4-nanometer center-of-mass steps. Furthermore, kinesin-1 never detached from microtubules under hindering load conditions. Instead, it slipped on microtubules in microsecond-long, 8-nanometer steps and remained in this slip state before detaching or reengaging in directed motion. Unexpectedly, reengagement and thus rescue of directed motion was more frequent. Our observations broaden our knowledge on the mechanochemical cycle and slip state of kinesin. This state and rescue need to be accounted for to understand long-range transport by teams of motors.	[Sudhakar, Swathi; Abdosamadi, Mohammad Kazem; Jachowski, Tobias Joerg; Bugiel, Michael; Jannasch, Anita; Schaeffer, Erik] Eberhard Karls Univ Tubingen, Cellular Nanosci ZMBP, Auf Morgenstelle 32, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Schaffer, E (corresponding author), Eberhard Karls Univ Tubingen, Cellular Nanosci ZMBP, Auf Morgenstelle 32, D-72076 Tubingen, Germany.	erik.schaeffer@uni-tuebingen.de	Schäffer, Erik/A-4664-2010	Schäffer, Erik/0000-0001-7876-085X; Sudhakar, Swathi/0000-0003-3470-1713; Jannasch, Anita/0000-0002-5845-7869; , Swathi S/0000-0002-5926-6423	interdisciplinary "nanoBCP-Lab" - Carl Zeiss Foundation; German Research Foundation [Deutsche Forschungsgemeinschaft (DFG)] [JA 2589/1-1, CRC1011]; Institutional Strategy of the University of Tubingen (DFG) [ZUK 63]; Ph.D. Network "Novel Nanoparticles" of the University of Tubingen	interdisciplinary "nanoBCP-Lab" - Carl Zeiss Foundation; German Research Foundation [Deutsche Forschungsgemeinschaft (DFG)](German Research Foundation (DFG)); Institutional Strategy of the University of Tubingen (DFG); Ph.D. Network "Novel Nanoparticles" of the University of Tubingen	This work was supported by the interdisciplinary "nanoBCP-Lab" funded by the Carl Zeiss Foundation (Forschungsstrukturprogramm 2017), the German Research Foundation [Deutsche Forschungsgemeinschaft (DFG); JA 2589/1-1, CRC1011, project A04], the Institutional Strategy of the University of Tubingen (DFG, ZUK 63), and the Ph.D. Network "Novel Nanoparticles" of the University of Tubingen.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Bormuth V, 2008, OPT EXPRESS, V16, P13831, DOI 10.1364/OE.16.013831; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Brouwer I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9387; Bugiel M, 2015, BIOPHYS J, V108, P2019, DOI 10.1016/j.bpj.2015.03.022; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Chugh M, 2018, BIOPHYS J, V115, P375, DOI 10.1016/j.bpj.2018.06.012; CHUNG SH, 1991, J NEUROSCI METH, V40, P71, DOI 10.1016/0165-0270(91)90118-J; Coppin CM, 1996, P NATL ACAD SCI USA, V93, P1913, DOI 10.1073/pnas.93.5.1913; Coy DL, 1999, J BIOL CHEM, V274, P3667, DOI 10.1074/jbc.274.6.3667; Cross RA, 2016, BIOPOLYMERS, V105, P476, DOI 10.1002/bip.22862; Fan JY, 2010, SMALL, V6, P2080, DOI 10.1002/smll.201000543; Feng QZ, 2018, BIOPHYS J, V114, P400, DOI 10.1016/j.bpj.2017.11.016; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Gennerich A., 2017, OPTICAL TWEEZERS; Gittes F, 1998, METHOD CELL BIOL, V55, P129; Guo YJ, 2014, CHEM-ASIAN J, V9, P2272, DOI 10.1002/asia.201402227; Hancock WO, 2016, BIOPHYS J, V110, P1216, DOI 10.1016/j.bpj.2016.02.025; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Howard J., 2001, MECH MOTOR PROTEINS; Isojima H, 2016, NAT CHEM BIOL, V12, P290, DOI [10.1038/NCHEMBIO.2028, 10.1038/nchembio.2028]; Jachowski T. J, 2019, GITHUB; Jannasch A, 2013, BIOPHYS J, V104, P2456, DOI 10.1016/j.bpj.2013.02.040; Jannasch A, 2012, NAT PHOTONICS, V6, P469, DOI [10.1038/nphoton.2012.140, 10.1038/NPHOTON.2012.140]; Jannasch A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.228301; Kellogg EH, 2017, J MOL BIOL, V429, P633, DOI 10.1016/j.jmb.2017.01.001; Khataee H, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.188101; Kim TH, 2019, NANOTECHNOLOGY, V30, DOI 10.1088/1361-6528/ab0aa1; Krasnok A, 2018, ADV OPT MATER, V6, DOI 10.1002/adom.201701094; Kuznetsov AI, 2016, SCIENCE, V354, DOI 10.1126/science.aag2472; Ma L, 2017, ELIFE, V6, DOI 10.7554/eLife.30493.001; Mahamdeh M, 2011, OPT EXPRESS, V19, P11759, DOI 10.1364/OE.19.011759; Mahamdeh M, 2009, OPT EXPRESS, V17, P17190, DOI 10.1364/OE.17.017190; Mickolajczyk KJ, 2015, P NATL ACAD SCI USA, V112, pE7186, DOI 10.1073/pnas.1517638112; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Nieminen TA, 2007, J OPT A-PURE APPL OP, V9, pS196, DOI 10.1088/1464-4258/9/8/S12; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Peterman EJG, 2003, BIOPHYS J, V84, P1308, DOI 10.1016/S0006-3495(03)74946-7; Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z; Pyrpassopoulos S, 2020, BIOPHYS J, V118, P243, DOI 10.1016/j.bpj.2019.10.045; Ramaiya A, 2017, P NATL ACAD SCI USA, V114, P10894, DOI 10.1073/pnas.1706985114; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Santhosh PB, 2017, PHYS CHEM CHEM PHYS, V19, P18494, DOI 10.1039/c7cp03403b; Schaffer E, 2007, LANGMUIR, V23, P3654, DOI 10.1021/la0622368; Schiemann F., 2015, J BIOL METHODS, V2, P30, DOI DOI 10.14440/JBM.2015.79; Schimert KI, 2019, P NATL ACAD SCI USA, V116, P6152, DOI 10.1073/pnas.1817924116; Seol Y, 2006, OPT LETT, V31, P2429, DOI 10.1364/OL.31.002429; Simmert S, 2018, OPT EXPRESS, V26, P14499, DOI 10.1364/OE.26.014499; Smith DA, 1998, PHILOS T R SOC B, V353, P1969, DOI 10.1098/rstb.1998.0348; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Toleikis A, 2020, BIOPHYS J, V119, P1984, DOI 10.1016/j.bpj.2020.09.034; Tolic-Norrelykke SF, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2356852; Vaughn DD, 2013, CHEM SOC REV, V42, P2861, DOI 10.1039/c2cs35364d; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Wiggins PA, 2015, BIOPHYS J, V109, P346, DOI 10.1016/j.bpj.2015.05.038	65	26	26	7	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					692	+	eabd9944	10.1126/science.abd9944	http://dx.doi.org/10.1126/science.abd9944			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4IS	33574186	Green Submitted			2022-12-28	WOS:000617551600037
J	Wardlow, J				Wardlow, Julie			Speedy galaxy evolution	SCIENCE			English	Editorial Material							DISK GALAXY; COLD		[Wardlow, Julie] Univ Lancaster, Dept Phys, Lancaster LA1 4YB, England	Lancaster University	Wardlow, J (corresponding author), Univ Lancaster, Dept Phys, Lancaster LA1 4YB, England.	j.wardlow@lancaster.ac.uk	Wardlow, Julie/C-9903-2015	Wardlow, Julie/0000-0003-2376-8971	STFC [ST/P004784/2] Funding Source: UKRI	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Chen CC, 2017, ASTROPHYS J, V846, DOI 10.3847/1538-4357/aa863a; Hodge JA, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200556; Hodge JA, 2016, ASTROPHYS J, V833, DOI 10.3847/1538-4357/833/1/103; Lelli F, 2021, SCIENCE, V371, P713, DOI 10.1126/science.abc1893; Mandelker N, 2017, MON NOT R ASTRON SOC, V464, P635, DOI 10.1093/mnras/stw2358; Neeleman M, 2020, NATURE, V581, P269, DOI 10.1038/s41586-020-2276-y; Rivera GC, 2018, ASTROPHYS J, V863, DOI 10.3847/1538-4357/aacffa; Rizzo F, 2020, NATURE, V584, P201, DOI 10.1038/s41586-020-2572-6; Schaye J, 2015, MON NOT R ASTRON SOC, V446, P521, DOI 10.1093/mnras/stu2058; Schreiber NMF, 2020, ANNU REV ASTRON ASTR, V58, P661, DOI 10.1146/annurev-astro-032620-021910; Stott JP, 2016, MON NOT R ASTRON SOC, V457, P1888, DOI 10.1093/mnras/stw129; Wisnioski E, 2019, ASTROPHYS J, V886, DOI 10.3847/1538-4357/ab4db8; Wuyts S, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/96	13	0	0	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					674	675		10.1126/science.abg2907	http://dx.doi.org/10.1126/science.abg2907			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4IS	33574198	Green Submitted			2022-12-28	WOS:000617551600024
J	Dyer, O				Dyer, Owen			Covid-19: WHO says laboratory escape theory is "extremely unlikely" after mission to China	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2021	372								n428	10.1136/bmj.n428	http://dx.doi.org/10.1136/bmj.n428			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM2MY	33574118	Bronze			2022-12-28	WOS:000639500800010
J	Powell, K				Powell, Kendall			The broken promise that undermines human genome research	NATURE			English	News Item						Genomics; Databases; Research management		Data sharing was a core principle that led to the success of the Human Genome Project 20 years ago. Now scientists are struggling to keep information free. Data sharing was a core principle that led to the success of the Human Genome Project 20 years ago. Now scientists are struggling to keep information free.										Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Fernandes JD, 2020, NAT GENET, V52, P991, DOI 10.1038/s41588-020-0700-8; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mills MC, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0261-x	5	11	11	1	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2021	590	7845					198	201		10.1038/d41586-021-00331-5	http://dx.doi.org/10.1038/d41586-021-00331-5			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG0TV	33568833				2022-12-28	WOS:000617300400005
J	Marx, C				Marx, Clare			Outdated career ideals stifle medical women and hurt us all Combatting inequality of any kind is an essential part of delivering first class care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Marx, Clare] Gen Med Council, London, England		Marx, C (corresponding author), Gen Med Council, London, England.							[Anonymous], 2014, CLARE MARX BECAME GE	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2021	372								n353	10.1136/bmj.n353	http://dx.doi.org/10.1136/bmj.n353			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM1AV	33558217				2022-12-28	WOS:000639394000009
J	Xue, JJ; Wang, R; Chen, XH; Yao, CL; Jin, XY; Wang, KL; Huang, WC; Huang, TY; Zhao, YP; Zhai, YX; Meng, D; Tan, S; Liu, RZ; Wang, ZK; Zhu, CH; Zhu, K; Beard, MC; Yan, YF; Yang, Y				Xue, Jingjing; Wang, Rui; Chen, Xihan; Yao, Canglang; Jin, Xiaoyun; Wang, Kai-Li; Huang, Wenchao; Huang, Tianyi; Zhao, Yepin; Zhai, Yaxin; Meng, Dong; Tan, Shaun; Liu, Ruzhang; Wang, Zhao-Kui; Zhu, Chenhui; Zhu, Kai; Beard, Matthew C.; Yan, Yanfa; Yang, Yang			Reconfiguring the band-edge states of photovoltaic perovskites by conjugated organic cations	SCIENCE			English	Article							SOLAR-CELLS; EFFICIENCY	The band edges of metal-halide perovskites with a general chemical structure of ABX(3) (A, usually a monovalent organic cation; B, a divalent cation; and X, a halide anion) are constructed mainly of the orbitals from B and X sites. Hence, the structural and compositional varieties of the inorganic B-X framework are primarily responsible for regulating their electronic properties, whereas A-site cations are thought to only help stabilize the lattice and not to directly contribute to near-edge states. We report a pi-conjugation-induced extension of electronic states of A-site cations that affects perovskite frontier orbitals. The pi-conjugated pyrene-containing A-site cations electronically contribute to the surface band edges and influence the carrier dynamics, with a properly tailored intercalation distance between layers of the inorganic framework. The ethylammonium pyrene increased hole mobilities, improved power conversion efficiencies relative to that of a reference perovskite, and enhanced device stability.	[Xue, Jingjing; Wang, Rui; Huang, Tianyi; Zhao, Yepin; Meng, Dong; Tan, Shaun; Yang, Yang] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Xue, Jingjing; Wang, Rui; Huang, Tianyi; Zhao, Yepin; Meng, Dong; Tan, Shaun; Yang, Yang] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Chen, Xihan; Zhai, Yaxin; Zhu, Kai; Beard, Matthew C.] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Yao, Canglang; Yan, Yanfa] Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA; [Yao, Canglang; Yan, Yanfa] Univ Toledo, Ctr Photovolta Innovat & Commercializat, Toledo, OH 43606 USA; [Jin, Xiaoyun; Liu, Ruzhang] Yangzhou Univ, Sch Chem & Chem Engn, Yangzhou 225002, Jiangsu, Peoples R China; [Wang, Kai-Li; Wang, Zhao-Kui] Soochow Univ, Inst Funct Nano & Soft Mat FUNSOM, Jiangsu Key Lab Carbon Based Funct Mat & Devices, Suzhou 215123, Peoples R China; [Huang, Wenchao] Monash Univ, Dept Mat Sci & Engn, Clayton, Vic 3800, Australia; [Zhu, Chenhui] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Yangzhou University; Soochow University - China; Monash University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Yang, Y (corresponding author), Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA.; Yang, Y (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.; Beard, MC (corresponding author), Natl Renewable Energy Lab, Golden, CO 80401 USA.; Yan, YF (corresponding author), Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA.; Yan, YF (corresponding author), Univ Toledo, Ctr Photovolta Innovat & Commercializat, Toledo, OH 43606 USA.	matt.beard@nrel.gov; yanfa.yan@utoledo.edu; yangy@ucia.edu	Meng, Dong/R-2543-2016; Tan, Shaun/AAB-7841-2022; Chen, Xihan/M-9210-2016; Huang, Wenchao/D-9593-2013; Wang, Rui/U-9894-2019; Wang, Zhao-Kui/ABD-5942-2021; Lang, Ming/HIK-0758-2022; Xue, Jingjing/AAE-8517-2019; yang, yang/HGT-7999-2022; Zhu, Kai/AAF-1940-2019; yang, yang/GVT-5210-2022; Zhai, Yaxin/J-6870-2017; BEARD, MATTHEW/E-4270-2015	Meng, Dong/0000-0001-6776-0707; Tan, Shaun/0000-0002-0444-6777; Chen, Xihan/0000-0001-7907-2549; Huang, Wenchao/0000-0003-4992-1727; Wang, Zhao-Kui/0000-0003-1707-499X; Zhai, Yaxin/0000-0001-5862-1764; Huang, Tianyi/0000-0001-7153-6978; Wang, Rui/0000-0003-2185-0752; Xue, Jingjing/0000-0002-7861-8367; Wang, Kai-Li/0000-0002-8546-6824; Yan, Yanfa/0000-0003-3977-5789; BEARD, MATTHEW/0000-0002-2711-1355	U.S. Department of Energy's (DOE) Office of Energy Efficiency and Renewable Energy (EERE) under Solar Energy Technologies Office award [DE-EE0008751]; DOE Office of Basic Energy Sciences [DE-AC36-08GO28308]; Alliance for Sustainable Energy, LLC; National Renewable Energy Laboratory; National Energy Research Scientific Computing Center; Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundation of China [91733301]; Collaborative Innovation Center of Suzhou Nano Science and Technology	U.S. Department of Energy's (DOE) Office of Energy Efficiency and Renewable Energy (EERE) under Solar Energy Technologies Office award(United States Department of Energy (DOE)); DOE Office of Basic Energy Sciences(United States Department of Energy (DOE)); Alliance for Sustainable Energy, LLC; National Renewable Energy Laboratory(United States Department of Energy (DOE)); National Energy Research Scientific Computing Center; Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Center of Suzhou Nano Science and Technology	This material is based on work supported by the U.S. Department of Energy's (DOE) Office of Energy Efficiency and Renewable Energy (EERE) under Solar Energy Technologies Office award DE-EE0008751. Work performed at the National Renewable Energy Laboratory and University of Toledo was supported as part of the Center for Hybrid Organic Inorganic Semiconductors for Energy (CHOISE), an Energy Frontier Research Center funded by the DOE Office of Basic Energy Sciences, under contract DE-AC36-08GO28308, with Alliance for Sustainable Energy, LLC, the Manager and Operator of the National Renewable Energy Laboratory. The views expressed in the article do not necessarily represent the views of the DOE or the U.S. government. All theoretical works were performed on National Renewable Energy Laboratory's Eagle Computing System and National Energy Research Scientific Computing Center. The work at the Yangzhou University was financially supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions. Z.-K.W. acknowledges the Natural Science Foundation of China (91733301). This project was also supported by the Collaborative Innovation Center of Suzhou Nano Science and Technology. Part of the GIWAXS measurement was performed in beamline 7.3.3 at the Advanced Light Source, Lawrence Berkeley National Laboratory. The Australian Synchrotron, part of ANSTO, is also acknowledged for the GIWAXS characterizations.	Bi DQ, 2016, NAT ENERGY, V1, DOI [10.1038/NENERGY.2016.142, 10.1038/nenergy.2016.142]; Chen B, 2019, CHEM SOC REV, V48, P3842, DOI 10.1039/c8cs00853a; Chen XH, 2019, PHYS CHEM CHEM PHYS, V21, P16399, DOI 10.1039/c9cp02768h; Chu WB, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaw7453; de Paula P. A. J, 2006, **DROPPED REF**; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Gao Y, 2019, NAT CHEM, V11, P1151, DOI 10.1038/s41557-019-0354-2; Grancini G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15684; Grancini G, 2019, NAT REV MATER, V4, P4, DOI 10.1038/s41578-018-0065-0; Hutter J, 2014, WIRES COMPUT MOL SCI, V4, P15, DOI 10.1002/wcms.1159; Lee JW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05454-4; Lee JW, 2016, ACCOUNTS CHEM RES, V49, P311, DOI 10.1021/acs.accounts.5b00440; Manser JS, 2016, CHEM REV, V116, P12956, DOI 10.1021/acs.chemrev.6b00136; Min H, 2019, SCIENCE, V366, P749, DOI 10.1126/science.aay7044; Mizushima T, 2006, ORG BIOMOL CHEM, V4, P4336, DOI 10.1039/b609507k; Nie WY, 2015, SCIENCE, V347, P522, DOI 10.1126/science.aaa0472; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Saidaminov MI, 2020, NAT MATER, V19, P412, DOI 10.1038/s41563-019-0602-2; Saparov B, 2016, CHEM REV, V116, P4558, DOI 10.1021/acs.chemrev.5b00715; Sheldrick GM, 2015, ACTA CRYSTALLOGR A, V71, P3, DOI 10.1107/S2053273314026370; Shi D, 2015, SCIENCE, V347, P519, DOI 10.1126/science.aaa2725; Tong JH, 2019, SCIENCE, V364, P475, DOI 10.1126/science.aav7911; Tsai HH, 2016, NATURE, V536, P312, DOI 10.1038/nature18306; VandeVondele J, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2770708; Wang LG, 2019, SCIENCE, V363, P265, DOI 10.1126/science.aau5701; Wang R, 2019, SCIENCE, V366, P1509, DOI 10.1126/science.aay9698; Wang R, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201808843; Yang Y, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2016.207; Yin WJ, 2015, J MATER CHEM A, V3, P8926, DOI 10.1039/c4ta05033a; Yin WJ, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4864778; Zhai YX, 2020, ACS ENERGY LETT, V5, P47, DOI 10.1021/acsenergylett.9b02310; Zhang H, 2019, ADV MATER, V31, DOI 10.1002/adma.201805702	32	84	83	76	345	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		636	+		10.1126/science.abd4860	http://dx.doi.org/10.1126/science.abd4860			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QD7TF	33542138	Green Submitted			2022-12-28	WOS:000615715300055
J	Iacobucci, G				Iacobucci, Gareth			Progress "painfully slow" on air quality and other environmental issues, inquiry concludes	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Public Accounts Committee, ACH GOV LONG TERM	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2021	372								n318	10.1136/bmj.n318	http://dx.doi.org/10.1136/bmj.n318			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC1TD	33536164				2022-12-28	WOS:000686315900007
J	Colburn, JL				Colburn, Jessica L.			The In-between	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Colburn, Jessica L.] Johns Hopkins Univ, Sch Med, Dept Med, Div Geriatr Med & Gerontol, 4940 Eastern Ave, Baltimore, MD 21224 USA	Johns Hopkins University	Colburn, JL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Geriatr Med & Gerontol, 4940 Eastern Ave, Baltimore, MD 21224 USA.	jcolbur1@jhmi.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2021	325	5					435	436		10.1001/jama.2020.25885	http://dx.doi.org/10.1001/jama.2020.25885			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QC6JP	33528540				2022-12-28	WOS:000614941900012
J	Voelker, R				Voelker, Rebecca			Tighter Requirements to Ensure Safer Opioid Prescribing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2021	325	5					426	426		10.1001/jama.2021.0050	http://dx.doi.org/10.1001/jama.2021.0050			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QC6JP	33528521				2022-12-28	WOS:000614941900005
J	Escobar, GJ; Adams, AS; Liu, VX; Soltesz, L; Chen, YFI; Parodi, SM; Ray, GT; Myers, LC; Ramaprasad, CM; Dlott, R; Lee, C				Escobar, Gabriel J.; Adams, Alyce S.; Liu, Vincent X.; Soltesz, Lauren; Chen, Yi-Fen Irene; Parodi, Stephen M.; Ray, G. Thomas; Myers, Laura C.; Ramaprasad, Charulata M.; Dlott, Richard; Lee, Catherine			Racial Disparities in COVID-19 Testing and Outcomes Retrospective Cohort Study in an Integrated Health System	ANNALS OF INTERNAL MEDICINE			English	Article							HOSPITAL MORTALITY	Background: Racial disparities exist in outcomes after severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection. Objective: To evaluate the contribution of race/ethnicity in SARS-CoV-2 testing, infection, and outcomes. Design: Retrospective cohort study (1 February 2020 to 31 May 2020). Setting: Integrated health care delivery system in Northern California. Participants: Adult health plan members. Measurements: Age, sex, neighborhood deprivation index, comorbid conditions, acute physiology indices, and race/ethnicity; SARS-CoV-2 testing and incidence of positive test results; and hospitalization, illness severity, and mortality. Results: Among 3 481 716 eligible members, 42.0% were White, 6.4% African American, 19.9% Hispanic, and 18.6% Asian; 13.0% were of other or unknown race. Of eligible members, 91 212 (2.6%) were tested for SARS-CoV-2 infection and 3686 had positive results (overall incidence, 105.9 per 100 000 persons; by racial group, White, 55.1; African American, 123.1; Hispanic, 219.6; Asian, 111.7; other/unknown, 79.3). African American persons had the highest unadjusted testing and mortality rates, White persons had the lowest testing rates, and those with other or unknown race had the lowest mortality rates. Compared with White persons, adjusted testing rates among non-White persons were marginally higher, but infection rates were significantly higher; adjusted odds ratios [aORs] for African American persons, Hispanic persons, Asian persons, and persons of other/unknown race were 2.01 (95% CI, 1.75 to 2.31), 3.93 (CI, 3.59 to 4.30), 2.19 (CI, 1.98 to 2.42), and 1.57 (CI, 1.38 to 1.78), respectively. Geographic analyses showed that infections clustered in areas with higher proportions of nonWhite persons. Compared with White persons, adjusted hospitalization rates for African American persons, Hispanic persons, Asian persons, and persons of other/unknown race were 1.47 (CI, 1.03 to 2.09), 1.42 (CI, 1.11 to 1.82), 1.47 (CI, 1.13 to 1.92), and 1.03 (CI, 0.72 to 1.46), respectively. Adjusted analyses showed no racial differences in inpatient mortality or total mortality during the study period. For testing, comorbid conditions made the greatest relative contribution to model explanatory power (77.9%); race only accounted for 8.1%. Likelihood of infection was largely due to race (80.3%). For other outcomes, age was most important; race only contributed 4.5% for hospitalization, 12.8% for admission illness severity, 2.3% for in-hospital death, and 0.4% for any death. Limitation: The study involved an insured population in a highly integrated health system. Conclusion: Race was the most important predictor of SARS-CoV-2 infection. After infection, race was associated with increased hospitalization risk but not mortality.	[Escobar, Gabriel J.; Liu, Vincent X.; Soltesz, Lauren; Ray, G. Thomas; Myers, Laura C.; Lee, Catherine] Kaiser Permanente, Oakland, CA 94612 USA; [Adams, Alyce S.] Stanford Canc Inst, Stanford, CA USA; [Liu, Vincent X.] Kaiser Permanente Med Ctr, Santa Clara, CA USA; [Chen, Yi-Fen Irene; Parodi, Stephen M.] Permanente Med Grp Inc, 1950 Franklin St, Oakland, CA 94612 USA; [Myers, Laura C.] Kaiser Permanente Med Ctr, Walnut Creek, CA USA; [Ramaprasad, Charulata M.] Kaiser Permanente Med Ctr, San Jose, CA USA; [Dlott, Richard] Kaiser Permanente Med Ctr, Martinez, CA USA; [Escobar, Gabriel J.; Liu, Vincent X.; Soltesz, Lauren; Ray, G. Thomas; Myers, Laura C.; Lee, Catherine] Kaiser Permanente, Div Res, 2000 Broadway Ave, Oakland, CA 94612 USA; [Adams, Alyce S.] Kaiser Permanente Med Ctr, Intens Care Unit, 700 Lawrence Expressway, Santa Clara, CA 95051 USA; [Ramaprasad, Charulata M.] Kaiser Permanente Med Ctr, Adult Infect Dis, 270 Int Circle, San Jose, CA 95124 USA; [Dlott, Richard] Kaiser Permanente Med Ctr, Div Endocrinol, 200 Muir Rd, Martinez, CA 94553 USA	Kaiser Permanente; Stanford Cancer Institute; Kaiser Permanente; Permanente Medical Groups; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente	Escobar, GJ (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway Ave, Oakland, CA 94612 USA.	gabriel.escobar@kp.org	Chen, Yi/HIR-2608-2022	Adams, Alyce/0000-0002-0146-4996; Lee, Catherine/0000-0003-0008-9052	Permanente Medical Group, Inc.	Permanente Medical Group, Inc.	The Permanente Medical Group, Inc.	[Anonymous], J RACIAL ETHN HEALTH; [Anonymous], MED CARE; [Anonymous], HEALTH AFFAIR, DOI 10.1377/hlthaff.2020.00980; Artiga S, RACIAL DISPARITIES C; Assari S, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6010002; Azar KMJ, 2020, HEALTH AFFAIR, V39, P1253, DOI 10.1377/hlthaff.2020.00598; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Cohen MS, 2016, NEW ENGL J MED, V375, P830; Escobar GJ, 2008, MED CARE, V46, P232, DOI 10.1097/MLR.0b013e3181589bb6; Escobar GJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.16769; Escobar GJ, 2015, MED CARE, V53, P916, DOI 10.1097/MLR.0000000000000435; Escobar GJ, 2013, MED CARE, V51, P446, DOI 10.1097/MLR.0b013e3182881c8e; Escobar GJ, 2011, J HOSP MED, V6, P74, DOI 10.1002/jhm.817; Figueroa JF, 2020, HEALTH AFFAIR, V39, P1984, DOI 10.1377/hlthaff.2020.01040; Gross CP, 2020, J GEN INTERN MED, V35, P3097, DOI 10.1007/s11606-020-06081-w; Han J, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0056-6; Harrell FE, 2015, REGRESSION MODELING, P207; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Liberati A., 2009, J CLIN EPIDEMIOL, V62, P1; Messer LC, 2006, J URBAN HEALTH, V83, P1041, DOI 10.1007/s11524-006-9094-x; OkereaforA AllsopJ, 2008, PEDIATRICS, V121; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Phelan J. C., 2005, Journals of Gerontology. Series B, Psychological Sciences and Social Sciences, V60, pS27; Rubin-Miller, 2020, COVID 19 RACIAL DISP; United States Preventive Services Task Force, 2018, ANN INTERN MED; van Walraven C, 2010, J CLIN EPIDEMIOL, V63, P798, DOI 10.1016/j.jclinepi.2009.08.020; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Wadhera RK, 2020, JAMA-J AM MED ASSOC, V323, P2192, DOI 10.1001/jama.2020.7197; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; NEW ENGL J MED	31	78	78	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN	2021	174	6					786	+		10.7326/M20-6979	http://dx.doi.org/10.7326/M20-6979			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SS5IR	33556278	Green Published			2022-12-28	WOS:000661788700018
J	Bureau, C; Thabut, D; Jezequel, C; Archambeaud, I; D'Alteroche, L; Dharancy, S; Borentain, P; Oberti, F; Plessier, A; De Ledinghen, V; Ganne-Carrie, N; Carbonell, N; Rousseau, V; Sommet, A; Peron, JM; Vinel, JP				Bureau, Christophe; Thabut, Dominique; Jezequel, Caroline; Archambeaud, Isabelle; D'Alteroche, Louis; Dharancy, Sebastien; Borentain, Patrick; Oberti, Frederic; Plessier, Aurelie; De Ledinghen, Victor; Ganne-Carrie, Nathalie; Carbonell, Nicolas; Rousseau, Vanessa; Sommet, Agnes; Peron, Jean Marie; Vinel, Jean Pierre			The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt A Randomized Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article								Background: The efficacy of rifaximin in the secondary prevention of overt hepatic encephalopathy (HE) is well documented, but its effectiveness in preventing a first episode in patients after transjugular intrahepatic portosystemic shunt (TIPS) has not been established. Objective: To determine whether rifaximin prevents overt HE after TIPS compared with placebo. Design: Randomized, double-blind, multicenter, placebo-controlled trial. (ClinicalTrials.gov: NCT02016196) Participants: 197 patients with cirrhosis undergoing TIPS for intractable ascites or prevention of variceal rebleeding. Intervention: Patients were randomly assigned to receive rifaximin (600 mg twice daily) or placebo, beginning 14 days before TIPS and continuing for 168 days after the procedure. Measurements: The primary efficacy end point was incidence of overt HE within 168 days after the TIPS procedure. Results: An episode of overt HE occurred in 34% (95% CI, 25% to 44%) of patients in the rifaximin group (n = 93) and 53% (CI, 43% to 63%) in the placebo group (n = 93) during the postprocedure period (odds ratio, 0.48 [CI, 0.27 to 0.87]). Neither the incidence of adverse events nor transplant-free survival was significantly different between the 2 groups. Limitations: The study's conclusion applies mainly to patients with alcoholic cirrhosis, who made up the study population. The potential benefit of rifaximin 6 months after TIPS and beyond remains to be investigated. Conclusion: In patients with cirrhosis treated with TIPS, rifaximin was well tolerated and reduced the risk for overt HE. Rifaximin should therefore be considered for prophylaxis of post-TIPS HE.	[Bureau, Christophe] Univ Hosp Toulouse, Hepatol Unit, 1 Ave Jean Poulhes, F-31059 Toulouse, France; [Peron, Jean Marie; Vinel, Jean Pierre] Univ Hosp Toulouse, Toulouse, France; [Bureau, Christophe; Peron, Jean Marie; Vinel, Jean Pierre] Toulouse III Paul Sabatier Univ, 1 Ave Jean Poulhes, F-31059 Toulouse, France; [Thabut, Dominique] Grp Hosp Pitie Salpetriere, Paris, France; [Jezequel, Caroline] Ctr Invest Clin Rennes, Rennes, France; [Archambeaud, Isabelle] CHU Nantes, Nantes, France; [D'Alteroche, Louis] Trousseau Univ Hosp Tours, Tours, France; [Dharancy, Sebastien] CHU Lille, Lille, France; [Borentain, Patrick] CHU Timone, Serv Hepatogastroenterol, AP HM, 264 Rue St Pierre, F-13385 Marseille 05, France; [Oberti, Frederic] CHU Angers, Angers, France; [Plessier, Aurelie] Beaujon Hosp, Clichy, France; [De Ledinghen, Victor] CHU Bordeaux, Bordeaux, France; [Ganne-Carrie, Nathalie] Hop Univ Paris Seine St Denis, Bondy, France; [Ganne-Carrie, Nathalie] Univ Paris 13, Sorbonne Paris Cite, Paris, France; [Ganne-Carrie, Nathalie] INSERM, UMR 1162, Paris, France; [Carbonell, Nicolas] Hop St Antoine, 184 Rue Faubourg St Antoine, F-75012 Paris, France; [Rousseau, Vanessa; Sommet, Agnes] Toulouse Univ Hosp, Toulouse, France; [Thabut, Dominique] Sorbonne Univ, Site Pitie Salpetriere, AP HP, Serv Hepatogastroenterol, 83 Blvd Hop, F-75013 Paris, France; [Jezequel, Caroline] CHU Rennes, Hop Pontchaillou, Serv Malad Foie, 2 Rue Henri Le Guilloux, F-35033 Rennes 9, France; [Archambeaud, Isabelle] CHU Hotel Dieu, Serv Hepatogastroenterol & Cancerol Digest, 1 Pl Alexis Ricordeau, F-44093 Nantes 1, France; [D'Alteroche, Louis] Tours Univ, Dept Hepatol, Hop Trousseau, F-37044 Tours, France; [Dharancy, Sebastien] Hop Huriez, Serv Malad Appareil Digestif, Lille, France; [Oberti, Frederic] Univ Hosp, Liver Gastroenterol Dept, HIFIH Lab, Angers, France; [Plessier, Aurelie] Hop Beaujon, Dept Hepatol, 100 Blvd Gen Leclerc, F-92110 Clichy, France; [De Ledinghen, Victor] Hop Haut Leveque, Serv Hepatol & Transplantat Hepat, F-33600 Pessac, France; [Ganne-Carrie, Nathalie] Univ Sorbonne Paris Nord, Sorbonne Univ, Hop Avicenne, AP HP,INSERM,UMR S 1138,Equipe FunGeST,Ctr Rech C, F-75006 Paris, France; [Rousseau, Vanessa; Sommet, Agnes] Serv Pharmacol Med & Clin, 37 Allees Jules Guesde, F-31000 Toulouse, France; [Bureau, Christophe; Peron, Jean Marie; Vinel, Jean Pierre] Univ Hosp Toulouse Rangueil, 1 Ave Jean Poulhes, F-31059 Toulouse, France	CHU de Toulouse; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Nantes Universite; CHU de Nantes; CHU Tours; Universite de Lille - ISITE; CHU Lille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Rennes; Nantes Universite; CHU de Nantes; CHU Tours; Universite de Lille - ISITE; CHU Lille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; CHU de Toulouse	Bureau, C (corresponding author), Univ Hosp Toulouse, Hepatol Unit, 1 Ave Jean Poulhes, F-31059 Toulouse, France.; Bureau, C (corresponding author), Toulouse III Paul Sabatier Univ, 1 Ave Jean Poulhes, F-31059 Toulouse, France.	bureau.c@chu-toulouse.fr		borentain, patrick/0000-0003-0397-3070	French Public Health Ministry [PRHC 12 555 101]	French Public Health Ministry	By grant PRHC 12 555 101 from the French Public Health Ministry.	Bai M, 2014, WORLD J GASTROENTERO, V20, P2704, DOI 10.3748/wjg.v20.i10.2704; Bajaj JS, 2016, ALIMENT PHARM THER, V43, P11, DOI 10.1111/apt.13435; Bajaj JS, 2015, ALIMENT PHARM THER, V41, P39, DOI 10.1111/apt.12993; Bajaj JS, 2018, DIGEST LIVER DIS, V50, P741, DOI 10.1016/j.dld.2018.04.020; Bajaj JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060042; Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893; Bureau C, 2004, GASTROENTEROLOGY, V126, P469, DOI 10.1053/j.gastro.2003.11.016; Bureau C, 2017, GASTROENTEROLOGY, V152, P157, DOI 10.1053/j.gastro.2016.09.016; Butterworth RF, 2019, DRUGS, V79, P17, DOI 10.1007/s40265-018-1017-0; Garcia-Pagan JC, 2010, NEW ENGL J MED, V362, P2370, DOI 10.1056/NEJMoa0910102; CONN HO, 1977, GASTROENTEROLOGY, V72, P573; European Assoc Study Liver, 2018, J HEPATOL, V69, P406, DOI 10.1016/j.jhep.2018.03.024; Hernandez-Gea V, 2019, HEPATOLOGY, V69, P282, DOI 10.1002/hep.30182; Hudson M, 2019, EUR J GASTROEN HEPAT, V31, P434, DOI 10.1097/MEG.0000000000001311; Kalambokis GN, 2012, CLIN GASTROENTEROL H, V10, P815, DOI 10.1016/j.cgh.2012.02.025; Kang DJ, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.44; Kimer N, 2018, J GASTROEN HEPATOL, V33, P307, DOI 10.1111/jgh.13852; Kimer N, 2017, HEPATOLOGY, V65, P592, DOI 10.1002/hep.28898; Lv Y, 2019, LANCET GASTROENTEROL, V4, P587, DOI 10.1016/S2468-1253(19)30090-1; Montagnese S, 2019, DRUGS, V79, P11, DOI 10.1007/s40265-018-1019-y; Mullen KD, 2014, CLIN GASTROENTEROL H, V12, P1390, DOI 10.1016/j.cgh.2013.12.021; Neff G, 2018, PHARMACOECONOMICS, V36, P809, DOI 10.1007/s40273-018-0641-6; Riggio O, 2005, J HEPATOL, V42, P674, DOI 10.1016/j.jhep.2004.12.028; Salehi S, 2019, ALIMENT PHARM THER, V50, P435, DOI 10.1111/apt.15326; Sarwar S, 2019, PAK J MED SCI, V35, P1446, DOI 10.12669/pjms.35.5.549; Schepis F, 2018, CLIN GASTROENTEROL H, V16, P1153, DOI 10.1016/j.cgh.2018.01.029; TARAO K, 1990, GUT, V31, P702, DOI 10.1136/gut.31.6.702; Vilstrup H, 2014, HEPATOLOGY, V60, P715, DOI 10.1002/hep.27210; Wang QH, 2017, J HEPATOL, V67, P508, DOI 10.1016/j.jhep.2017.05.006; Wang ZF, 2019, DRUG DES DEV THER, V13, P1, DOI 10.2147/DDDT.S172324; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5; Zuo L, 2019, J VASC INTERV RADIOL, V30, P148, DOI 10.1016/j.jvir.2018.08.023	32	23	25	2	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					633	+		10.7326/M20-0202	http://dx.doi.org/10.7326/M20-0202			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33524293				2022-12-28	WOS:000652604800021
J	Powles, T; Rosenberg, JE; Sonpavde, GP; Loriot, Y; Duran, I; Lee, JL; Matsubara, N; Vulsteke, C; Castellano, D; Wu, CZ; Campbell, M; Matsangou, M; Petrylak, DP				Powles, Thomas; Rosenberg, Jonathan E.; Sonpavde, Guru P.; Loriot, Yohann; Duran, Ignacio; Lee, Jae-Lyun; Matsubara, Nobuaki; Vulsteke, Christof; Castellano, Daniel; Wu, Chunzhang; Campbell, Mary; Matsangou, Maria; Petrylak, Daniel P.			Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-II TRIAL; VINFLUNINE PLUS; SUPPORTIVE CARE; CELL CARCINOMA; DOCETAXEL; IMMUNOTHERAPY; PEMBROLIZUMAB; NECTIN-4; THERAPY; AGENT	Background Patients with advanced urothelial carcinoma have poor overall survival after platinum-containing chemotherapy and programmed cell death protein 1 (PD-1) or programmed death ligand 1 (PD-L1) inhibitor treatment. Methods We conducted a global, open-label, phase 3 trial of enfortumab vedotin for the treatment of patients with locally advanced or metastatic urothelial carcinoma who had previously received platinum-containing chemotherapy and had had disease progression during or after treatment with a PD-1 or PD-L1 inhibitor. Patients were randomly assigned in a 1:1 ratio to receive enfortumab vedotin (at a dose of 1.25 mg per kilogram of body weight on days 1, 8, and 15 of a 28-day cycle) or investigator-chosen chemotherapy (standard docetaxel, paclitaxel, or vinflunine), administered on day 1 of a 21-day cycle. The primary end point was overall survival. Results A total of 608 patients underwent randomization; 301 were assigned to receive enfortumab vedotin and 307 to receive chemotherapy. As of July 15, 2020, a total of 301 deaths had occurred (134 in the enfortumab vedotin group and 167 in the chemotherapy group). At the prespecified interim analysis, the median follow-up was 11.1 months. Overall survival was longer in the enfortumab vedotin group than in the chemotherapy group (median overall survival, 12.88 vs. 8.97 months; hazard ratio for death, 0.70; 95% confidence interval [CI], 0.56 to 0.89; P=0.001). Progression-free survival was also longer in the enfortumab vedotin group than in the chemotherapy group (median progression-free survival, 5.55 vs. 3.71 months; hazard ratio for progression or death, 0.62; 95% CI, 0.51 to 0.75; P<0.001). The incidence of treatment-related adverse events was similar in the two groups (93.9% in the enfortumab vedotin group and 91.8% in the chemotherapy group); the incidence of events of grade 3 or higher was also similar in the two groups (51.4% and 49.8%, respectively). Conclusions Enfortumab vedotin significantly prolonged survival as compared with standard chemotherapy in patients with locally advanced or metastatic urothelial carcinoma who had previously received platinum-based treatment and a PD-1 or PD-L1 inhibitor.	[Powles, Thomas] Queen Mary Univ London, Barts Canc Ctr, London, England; [Rosenberg, Jonathan E.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Sonpavde, Guru P.] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA; [Loriot, Yohann] Univ Paris Saclay, Gustave Roussy, Villejuif, France; [Duran, Ignacio] Hosp Univ Marques Valdecilla, Inst Invest Sanitaria Valdecilla, Cantabria, Spain; [Castellano, Daniel] Hosp Univ 12 Octubre, Madrid, Spain; [Lee, Jae-Lyun] Asan Med Ctr, Seoul, South Korea; [Lee, Jae-Lyun] Univ Ulsan, Coll Med, Seoul, South Korea; [Matsubara, Nobuaki] Natl Canc Ctr Hosp East, Chiba, Japan; [Vulsteke, Christof] Univ Antwerp, Integrated Canc Ctr Ghent, Ctr Oncol Res, Ghent, Belgium; [Wu, Chunzhang; Matsangou, Maria] Astellas Pharma, Northbrook, IL USA; [Campbell, Mary] Seagen, Bothell, WA USA; [Petrylak, Daniel P.] Yale Sch Med, Smilow Canc Ctr, New Haven, CT USA	University of London; Queen Mary University London; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario 12 de Octubre; University of Ulsan; National Cancer Center - Japan; University of Antwerp; Astellas Pharmaceuticals; Yale University	Powles, T (corresponding author), Yale Sch Med, Yale Canc Ctr, 333 Cedar St,POB 208032, New Haven, CT 06902 USA.	daniel.petrylak@yale.edu	Loriot, Yohann/W-5572-2019; Vulsteke, Christof/AAO-5115-2021	Vulsteke, Christof/0000-0002-4607-5660; Powles, Thomas/0000-0001-7760-4724	Astellas Pharma US; Seagen	Astellas Pharma US(Astellas Pharmaceuticals); Seagen	Supported by Astellas Pharma US and Seagen.; We thank Stephanie Phan, Pharm.D., Regina Switzer, Ph.D., and Elizabeth Hermans, Ph.D. (OPEN Health Medical Communications), for writing and editorial assistance with an earlier version of the manuscript (funded by Astellas Pharma US and Seagen).	[Anonymous], 2020, ASTELLAS SEATTLE GEN; Bambury RM, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00003; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Bellmunt J, 2014, ANN ONCOL, V25, P40, DOI 10.1093/annonc/mdu223; Bellmunt J, 2013, ANN ONCOL, V24, P1466, DOI 10.1093/annonc/mdt007; Bellmunt J, 2009, J CLIN ONCOL, V27, P4454, DOI 10.1200/JCO.2008.20.5534; Black Peter C, 2020, Can Urol Assoc J, V14, pE373, DOI 10.5489/cuaj.6458; Challita-Eid PM, 2016, CANCER RES, V76, P3003, DOI 10.1158/0008-5472.CAN-15-1313; Dreicer R, 2003, CANCER, V97, P2743, DOI 10.1002/cncr.11413; Fradet Y, 2019, ANN ONCOL, V30, P970, DOI 10.1093/annonc/mdz127; Kamat AM, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0271-0; Kersten K, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00516; McCaffrey JA, 1997, J CLIN ONCOL, V15, P1853, DOI 10.1200/JCO.1997.15.5.1853; Nadal R, 2019, CANCER TREAT REV, V76, P10, DOI 10.1016/j.ctrv.2019.04.002; National Comprehensive Cancer Network, 2020, BLADDER CANC VERSION; Petrylak DP, 2020, LANCET ONCOL, V21, P105, DOI 10.1016/S1470-2045(19)30668-0; Petrylak DP, 2017, LANCET, V390, P2266, DOI 10.1016/S0140-6736(17)32365-6; Powles T, 2020, NEW ENGL J MED, V383, P1218, DOI 10.1056/NEJMoa2002788; Powles T, 2018, LANCET, V391, P748, DOI 10.1016/S0140-6736(17)33297-X; Rosenberg J, 2020, J CLIN ONCOL, V38, P1041, DOI 10.1200/JCO.19.02044; Rosenberg JE, 2020, J CLIN ONCOL, V38; Rosenberg JE, 2019, J CLIN ONCOL, V37, P2592, DOI 10.1200/JCO.19.01140; Sridhar SS, 2020, JAMA ONCOL, V6, P1751, DOI 10.1001/jamaoncol.2020.3927; van Dijk N, 2019, EUR UROL, V75, P435, DOI 10.1016/j.eururo.2018.09.022; Vaughn DJ, 2002, J CLIN ONCOL, V20, P937, DOI 10.1200/JCO.20.4.937; Warren M., 2019, CAN UROL ASS J; Zhang Y, 2018, ONCOL LETT, V15, P8789, DOI 10.3892/ol.2018.8365; Zhang YJ, 2016, CANCER LETT, V375, P179, DOI 10.1016/j.canlet.2016.02.049; Zhu J, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0314-1	29	181	183	3	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2021	384	12					1125	1135		10.1056/NEJMoa2035807	http://dx.doi.org/10.1056/NEJMoa2035807			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RF4GG	33577729	Bronze, Green Accepted			2022-12-28	WOS:000634797200012
J	Slagstad, K				Slagstad, Ketil			The Political Nature of Sex - Transgender in the History of Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENDER		[Slagstad, Ketil] Univ Oslo, Inst Hlth & Soc, Fac Med, Oslo, Norway; [Slagstad, Ketil] Charite Univ Med Berlin, Inst Hist Med & Eth Med, Berlin, Germany	University of Oslo; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Slagstad, K (corresponding author), Univ Oslo, Inst Hlth & Soc, Fac Med, Oslo, Norway.; Slagstad, K (corresponding author), Charite Univ Med Berlin, Inst Hist Med & Eth Med, Berlin, Germany.			Slagstad, Ketil/0000-0002-6061-9900				American Medical Association, 2018, MED SPECTR GEN D 295; [Anonymous], 2018, NATURE, V563, P5; [Anonymous], TITLE ERROR; Benjamin H., 1966, TRANSSEXUAL PHENOMEN; DASTON L, 1995, GLQ-J LESBIAN GAY ST, V1, P419, DOI 10.1215/10642684-1-4-419; Daston Lorraine, 2019, AGAINST NATURE; Diamond M, 1997, ARCH PEDIAT ADOL MED, V151, P298, DOI 10.1001/archpedi.1997.02170400084015; Downing L., 2014, FUCKOLOGY CRITICAL E; Dreger Alice Domurat, 1998, HERMAPHRODITES MED I; Eder S, 2010, GEND HIST, V22, P692, DOI 10.1111/j.1468-0424.2010.01615.x; Endocrine Society, 2020, TRANSG HLTH END SOC; Germon J, 2009, GENDER: A GENEALOGY OF AN IDEA, P1, DOI 10.1057/9780230101814; Gill-Peterson J., 2018, HIST TRANSGENDER CHI; Groneberg M, 2005, DIOGENES, V52, P39, DOI 10.1177/0392192105059469; HAMBURGER C, 1953, JAMA-J AM MED ASSOC, V152, P391, DOI 10.1001/jama.1953.03690050015006; Herrn Rainer, 2005, SCHNITTMUSTER GESCHL; Hirschfeld M., 1923, INTERSEXUELLE KONSTI; Kloppel U., 2010, UNSOLVED HERMAPHRODI; Krafft-Ebing R., 1890, PSYCHOPATHIA SEXUALI; MONEY J, 1955, B JOHNS HOPKINS HOSP, V97, P301; MONEY J, 1955, B JOHNS HOPKINS HOSP, V97, P284; MONEY J, 1955, B JOHNS HOPKINS HOSP, V96, P253; MONEY J, 1956, B JOHNS HOPKINS HOSP, V98, P43; Oosterhuis Harry, 2000, STEPCHILDREN NATURE; Oudshoorn Nelly, 1994, NATURAL BODY ARCHEOL; Reiner WG, 2004, NEW ENGL J MED, V350, P333, DOI 10.1056/NEJMoa022236; Reis Elizabeth, 2009, BODIES DOUBT AM HIST; Repo J., 2016, BIOPOLITICS GENDER; Stoller RJ, 1968, SEX GENDER DEV MASCU; Stone S., 1991, BODY GUARDS CULTURAL; Stryker S., 2017, TRANSGENDER HIST ROO; Sutton Katie, 2019, SEX BODY MIND PSYCHO; ULRICHS KH, 1864, FORSCHUNGEN RATHSEL; Westphal C., 1870, ARCH PSYCHIAT NERVEN, V2, P73, DOI [10.1007/BF01796143, DOI 10.1007/BF01796143]	34	8	8	3	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2021	384	11					1070	1074		10.1056/NEJMms2029814	http://dx.doi.org/10.1056/NEJMms2029814			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QY5HJ	33534975	Green Published			2022-12-28	WOS:000630070600021
J	Agyepong, IA; Godt, S; Sombie, I; Binka, C; Okine, V; Ingabire, MG				Agyepong, Irene Akua; Godt, Sue; Sombie, Issiaka; Binka, Charity; Okine, Vicky; Ingabire, Marie-Gloriose			Strengthening capacities and resource allocation for co-production of health research in low and middle income countries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POLICY		[Agyepong, Irene Akua] Dodowa Hlth Res Ctr, Res & Dev Div, Ghana Hlth Serv, Dodowa, Ghana; [Agyepong, Irene Akua] Ghana Coll Phys & Surg, Accra, Ghana; [Sombie, Issiaka] West Africa Hlth Org, Bobo Dioulasso, Burkina Faso; [Binka, Charity] Women Media & Change WOMEC, Accra, Ghana; [Okine, Vicky] Alliance Reprod Hlth Rights, Accra, Ghana; [Ingabire, Marie-Gloriose] Int Dev Res Ctr, Ottawa, ON, Canada	Ghana Health Service	Agyepong, IA (corresponding author), Dodowa Hlth Res Ctr, Res & Dev Div, Ghana Hlth Serv, Dodowa, Ghana.; Agyepong, IA (corresponding author), Ghana Coll Phys & Surg, Accra, Ghana.	iagyepong@gcps.edu.gh		Agyepong, Irene Akua/0000-0002-0193-5882	International Development Research Centre	International Development Research Centre	The Consortium for Mothers, Children, Adolescents and Health Policy and Systems Strengthening and Women, Newborn, Children, and Adolescent Wellbeing projects are funded by International Development Research Centre grants. We thank Rachael Hinton at The BMJ for her editorial review of the various drafts of this manuscript.	Agyepong IA, 2008, HEALTH POLICY PLANN, V23, P150, DOI 10.1093/heapol/czn002; Agyepong IA, 2011, TROP MED INT HEALTH, V16, P105, DOI 10.1111/j.1365-3156.2010.02639.x; [Anonymous], CHILDREN ADOLESECENT; BINKA FN, 1995, STUD FAMILY PLANN, V26, P121, DOI 10.2307/2137832; Brown L., 2001, MEASURING CAPACITY B; Dangme West Health Insurance Scheme (Dangme Hewaminami Kpee), 2003, AN REP 2 INS YEAR 20; Dangme West Health Insurance Scheme (Dangme Hewaminami Kpee), 2002, ANN REP 1 INS YEAR 1; Davies R, 2020, REFLECTIVE QUESTIONS; de Sardan JPO, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0213-9; Defor S, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0215-7; Farr M, MAP RESOURCES COPROD; Ghana Health Service, 2014, RES DEV DIV; Gonzalez Block Miguel A, 2003, Health Res Policy Syst, V1, P1, DOI 10.1186/1478-4505-1-1; LaFond AK, 2002, INT J HEALTH PLAN M, V17, P3, DOI 10.1002/hpm.649; Mintzberg H., 1983, POWER ORG, DOI DOI 10.1177/017084068400500419; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Oliver K, 2019, HEALTH RES POLICY SY, V17, DOI 10.1186/s12961-019-0432-3; Pohl C, 2010, SCI PUBL POLICY, V37, P267, DOI 10.3152/030234210X496628; Potter C, 2004, HEALTH POLICY PLANN, V19, P336, DOI 10.1093/heapol/czh038; Tembo D, 2019, FRONT SOCIOL, V4, DOI 10.3389/fsoc.2019.00050; United Nations Development Programme, 2006, CAP DEV PRACT NOT; Vanyoro KP, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001523; VeneKlasen Lisa, 2007, NEW WEAVE POWER PEOP; Williams O, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-020-00558-0; Wyborn C, 2019, ANNU REV ENV RESOUR, V44, P319, DOI [10.1146/annurev-environ-101718-033103, 10.1146/annurev-environ-101718033103]	25	4	4	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2021	372								n166	10.1136/bmj.n166	http://dx.doi.org/10.1136/bmj.n166			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RA8YP	33593725	Green Published, hybrid			2022-12-28	WOS:000631706300018
J	Beran, D; Pesantes, MA; Berghusen, MC; Hennig, BJ; Jacobi, J; Lazo-Porras, M; Llanque, A; Placella, E; Robledo-Abad, C; Bayona, MT; Miranda, J				Beran, David; Pesantes, Maria Amalia; Berghusen, Maria Claudia; Hennig, Branwen J.; Jacobi, Johanna; Lazo-Porras, Maria; Llanque, Aymara; Placella, Enrichetta; Robledo-Abad, Carmenza; Bayona, Marta Tufet; Miranda, Jaime			Rethinking research processes to strengthen co- production in low and middle income countries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Beran, David; Lazo-Porras, Maria] Univ Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland; [Beran, David; Lazo-Porras, Maria] Geneva Univ Hosp, Geneva, Switzerland; [Pesantes, Maria Amalia; Lazo-Porras, Maria; Miranda, Jaime] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Hennig, Branwen J.] Wellcome Trust Res Labs, London, England; [Jacobi, Johanna] Univ Bern, Ctr Dev & Environm, Bern, Switzerland; [Jacobi, Johanna] Univ Bern, Inst Geog, Bern, Switzerland; [Llanque, Aymara] Univ Bern, Switzerland Ctr Dev & Environm, La Paz, Bolivia; [Placella, Enrichetta] Swiss Agcy Dev & Cooperat, Global Hlth Program, Bern, Switzerland; [Robledo-Abad, Carmenza] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland; [Bayona, Marta Tufet] UK Collaborat Dev Res, London, England; [Miranda, Jaime] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia	University of Geneva; University of Geneva; Universidad Peruana Cayetano Heredia; University of Bern; University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich; George Institute for Global Health; University of New South Wales Sydney; University of Sydney	Beran, D (corresponding author), Univ Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland.; Beran, D (corresponding author), Geneva Univ Hosp, Geneva, Switzerland.	david.beran@unige.ch		Hennig, Branwen J./0000-0003-4127-8386	Doris Duke Charitable Foundation	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	This article is part of a series produced in conjunction with the WHO and the Alliance for Health Policy Systems and Research with funding from the Doris Duke Charitable Foundation. The BMJ peer reviewed, edited, and made the decision to publish.	Beran D, 2019, LANCET GLOB HEALTH, V7, pE303, DOI 10.1016/S2214-109X(18)30529-1; Ciarli T, 2019, RES POLICY, V48, P949, DOI 10.1016/j.respol.2018.10.027; Clarke D, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014650; COHRED, 2020, RES FAIRN IN; DECIPHer, 2020, PUBL INV ALPHA CARD; Dodson J., 2017, BUILDING PARTNERSHIP; Gautier L, 2018, BMC MED ETHICS, V19, DOI 10.1186/s12910-018-0280-7; Hickey G, 2018, GUIDANE COOPRODUCING; Jacobi J, 2020, ENVIRON SCI POLICY, V103, P21, DOI 10.1016/j.envsci.2019.10.003; KFPE, 2012, GUID TRANSB RES PART; Lambert N, 2018, INT J MENT HEALTH NU, V27, P1273, DOI 10.1111/inm.12499; Lazo-Porras M, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2020.1754016; Lehmann U, 2015, HEALTH POLICY PLANN, V30, P957, DOI 10.1093/heapol/czu097; Litva A, 2002, SOC SCI MED, V54, P1825, DOI 10.1016/S0277-9536(01)00151-4; Madden M, 2016, RES INVOLV ENGAGEM, V2, P12, DOI 10.1186/s40900-016-0026-y; Mitton C, 2009, HEALTH POLICY, V91, P219, DOI 10.1016/j.healthpol.2009.01.005; National Institute for Health and Clinical Excellence, 2013, PAT PUBL INV POL; Needham C, COPRODUCTION EMERGIN; Oliver K, 2019, HEALTH RES POLICY SY, V17, DOI 10.1186/s12961-019-0432-3; Ritchie E., 2019, ODA RES DEV TOO MUCH; Russell J, 2019, PATIENT PUBLIC INVOL; Smith KE, 2017, SOC SCI MED, V189, P35, DOI 10.1016/j.socscimed.2017.07.014; Swiss National Science Foundation, 2020, SWISS PROGR RES GLOB; Tembo D, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n178; United Nations, 2017, NEW INN APPR SUPP IM; Universite de Montreal, 2020, COM PAT EXP	26	14	14	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2021	372								m4785	10.1136/bmj.m4785	http://dx.doi.org/10.1136/bmj.m4785			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RA8YP	33593804	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000631706300013
J	Marten, R; El-Jardali, F; Hafeez, A; Hanefeld, J; Leung, GM; Ghaffar, A				Marten, Robert; El-Jardali, Fadi; Hafeez, Assad; Hanefeld, Johanna; Leung, Gabriel M.; Ghaffar, Abdul			Co-producing the covid-19 response in Germany, Hong Kong, Lebanon, and Pakistan	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Marten, Robert; Ghaffar, Abdul] WHO, Alliance Hlth Policy & Syst Res, Geneva, Switzerland; [El-Jardali, Fadi] Amer Univ Beirut, Fac Hlth Sci, Knowledge Policy K2P Ctr, Beirut, Lebanon; [Hafeez, Assad] Hlth Serv Acad, Islamabad, Pakistan; [Hanefeld, Johanna] Robert Koch Inst, Berlin, Germany; [Hanefeld, Johanna] London Sch Hyg & Trop Med, London, England; [Leung, Gabriel M.] Univ Hong Kong, LKS Fac Med, Hong Kong, Peoples R China	World Health Organization; American University of Beirut; Health Services Academy; Robert Koch Institute; University of London; London School of Hygiene & Tropical Medicine; University of Hong Kong	Marten, R (corresponding author), WHO, Alliance Hlth Policy & Syst Res, Geneva, Switzerland.	martenr@who.int		Ghaffar, Abdul/0000-0002-8629-4526	Doris Duke Charitable Foundation	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	This article is part of a series produced in conjunction with the WHO and the Alliance for Health Policy Systems and Research with funding from the Doris Duke Charitable Foundation. The BMJ peer reviewed, edited, and made the decision to publish.	[Anonymous], 2020, LANCET INFECT DIS, V20, P629, DOI 10.1016/S1473-3099(20)30378-9; Filipe A, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001403; Immonen K., 2020, BMJ OPINION; Leung G., 2020, NY TIMES; Loewenson R, 2020, WE ARE SUBJECTS NOT; Matthews D., 2020, TIMES HIGHER ED; Michie S, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2982; Ni MY, 2020, LANCET, V395, P273, DOI 10.1016/S0140-6736(19)33160-5; Rajan D, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002655; Richards T, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2575; Torreele E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3209; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Yong E., 2021, ATLANTIC	13	16	16	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2021	372								n243	10.1136/bmj.n243	http://dx.doi.org/10.1136/bmj.n243			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RA8YP	33593791	Green Published, hybrid			2022-12-28	WOS:000631706300012
J	King, IL; Divangahi, M				King, Irah L.; Divangahi, Maziar			Training the metaorganism: the microbial counterpart	CELL			English	Editorial Material								Infection or immunization can reprogram innate immune cells generating memory responses with broad protection against subsequent infection, a process referred to as "trained immunity.'' A new study by Stacy and colleagues demonstrates that, following acute infection, the commensal microbiota can also be "trained'' to enhance colonization resistance against heterologous infection.	[King, Irah L.; Divangahi, Maziar] McGill Univ, Dept Microbiol & Immunol, Meakins Christie Labs, Montreal, PQ, Canada; [Divangahi, Maziar] McGill Univ, Ctr Hlth, McGill Int TB Ctr, Dept Med,Dept Pathol, Montreal, PQ, Canada	McGill University; McGill University	Divangahi, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Meakins Christie Labs, Montreal, PQ, Canada.; Divangahi, M (corresponding author), McGill Univ, Ctr Hlth, McGill Int TB Ctr, Dept Med,Dept Pathol, Montreal, PQ, Canada.	maziar.divangahi@mcgill.ca			Canadian Institutes of Health Research (CIHR); Kenneth Rainin Foundation; Bill and Melinda Gates Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Kenneth Rainin Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Both authors are supported by the Canadian Institutes of Health Research (CIHR). I.L.K. is supported by the Kenneth Rainin Foundation. M.D. is supported by the Bill and Melinda Gates Foundation.	Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; HUXTABLE RJ, 1986, TRENDS PHARMACOL SCI, V7, P481, DOI 10.1016/0165-6147(86)90433-5; Khan N, 2020, CELL, V183, P752, DOI 10.1016/j.cell.2020.09.062; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Podolsky SH, 2012, LANCET, V380, P1810, DOI 10.1016/S0140-6736(12)62018-2; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Stacy A, 2021, CELL, V184, P615, DOI 10.1016/j.cell.2020.12.011; Tso GHW, 2018, SCIENCE, V362, P589, DOI 10.1126/science.aat0537; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653	11	0	0	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2021	184	3					574	576		10.1016/j.cell.2021.01.009	http://dx.doi.org/10.1016/j.cell.2021.01.009		FEB 2021	3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX8ZJ	33545033	Green Accepted, Bronze			2022-12-28	WOS:000629631400004
J	Yu, J; Zhu, HT; Lape, R; Greiner, T; Du, J; Lu, W; Sivilotti, L; Gouaux, E				Yu, Jie; Zhu, Hongtao; Lape, Remigijus; Greiner, Timo; Du, Juan; Lu, Wei; Sivilotti, Lucia; Gouaux, Eric			Mechanism of gating and partial agonist action in the glycine receptor	CELL			English	Article							CRYO-EM STRUCTURE; X-RAY-STRUCTURE; ACETYLCHOLINE-RECEPTOR; MEMBRANE-PROTEINS; INTERMEDIATE STATES; DESENSITIZATION; LOOP; ACTIVATION; CHANNELS; CHLORIDE	Ligand-gated ion channels mediate signal transduction at chemical synapses and transition between resting, open, and desensitized states in response to neurotransmitter binding. Neurotransmitters that produce maximum open channel probabilities (Po) are full agonists, whereas those that yield lower than maximum Po are partial agonists. Cys-loop receptors are an important class of neurotransmitter receptors, yet a structure-based understanding of the mechanism of partial agonist action has proven elusive. Here, we study the glycine receptor with the full agonist glycine and the partial agonists taurine and gamma-amino butyric acid (GABA). We use electrophysiology to show how partial agonists populate agonist-bound, closed channel states and cryo-EM reconstructions to illuminate the structures of intermediate, pre-open states, providing insights into previously unseen conformational states along the receptor reaction pathway. We further correlate agonist-induced conformational changes to Po across members of the receptor family, providing a hypothetical mechanism for partial and full agonist action at Cys-loop receptors.	[Yu, Jie; Zhu, Hongtao; Du, Juan; Lu, Wei; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA; [Lape, Remigijus; Greiner, Timo; Sivilotti, Lucia] UCL, Dept Neurosci Physiol & Pharmacol, Med Sci Bldg,Gower St, London WC1E 6BT, England; [Du, Juan; Lu, Wei] Van Andel Inst, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; University of London; University College London; Van Andel Institute	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.; Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA.; Sivilotti, L (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Med Sci Bldg,Gower St, London WC1E 6BT, England.	l.sivilotti@ucl.ac.uk; gouauxe@ohsu.edu			MRC [MR/R009074/1]; NIH [R01 GM100400]	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Vaskalis for assistance with figures, F. Jalali-Yazdi for discussion and Polyscope for the SMA. Electron microscopy was performed at OHSU at the Multiscale Microscopy Core and at HHMI's Janelia Research Campus. This work was supported by MRC grant MR/R009074/1 to L.S. and NIH grant R01 GM100400 to E.G. E.G. is an investigator of the Howard Hughes Medical Institute.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Alvarez FJD, 2010, J AM CHEM SOC, V132, P9513, DOI 10.1021/ja104047c; Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; Autzen HE, 2019, CURR OPIN STRUC BIOL, V58, P259, DOI 10.1016/j.sbi.2019.05.022; Baenziger JE, 2015, BBA-BIOMEMBRANES, V1848, P1806, DOI 10.1016/j.bbamem.2015.03.010; Basak S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02997-4; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Breitinger HG, 2004, CHEM BIOL, V11, P1339, DOI 10.1016/j.chembiol.2004.07.008; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Cerdan AH, 2018, STRUCTURE, V26, P1555, DOI 10.1016/j.str.2018.07.019; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; Corradi J, 2014, J NEUROSCI, V34, P16865, DOI 10.1523/JNEUROSCI.1970-14.2014; Corradi J, 2009, BIOPHYS J, V97, P1335, DOI 10.1016/j.bpj.2009.06.018; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; Denisov IG, 2016, NAT STRUCT MOL BIOL, V23, P481, DOI 10.1038/nsmb.3195; Dorr JM, 2016, EUR BIOPHYS J BIOPHY, V45, P3, DOI 10.1007/s00249-015-1093-y; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fucile S, 1999, J PHYSIOL-LONDON, V517, P369, DOI 10.1111/j.1469-7793.1999.0369t.x; Gharpure A, 2019, NEURON, V104, P501, DOI 10.1016/j.neuron.2019.07.030; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; Gonzalez-Gutierrez G, 2017, J GEN PHYSIOL, V149, P1119, DOI 10.1085/jgp.201711803; Groot-Kormelink PJ, 2002, J NEUROSCI METH, V113, P207, DOI 10.1016/S0165-0270(01)00500-3; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; HEIDMANN T, 1980, EUR J BIOCHEM, V110, P35, DOI 10.1111/j.1432-1033.1980.tb04839.x; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Huang X, 2017, STRUCTURE, V25, P945, DOI 10.1016/j.str.2017.04.007; Huang X, 2017, NAT STRUCT MOL BIOL, V24, P108, DOI 10.1038/nsmb.3329; Huang X, 2015, NATURE, V526, P277, DOI 10.1038/nature14972; Jadey S, 2012, J GEN PHYSIOL, V140, P17, DOI 10.1085/jgp.201210801; Jakobi AJ, 2017, ELIFE, V6, DOI 10.7554/eLife.27131; Jamshad M, 2011, BIOCHEM SOC T, V39, P813, DOI 10.1042/BST0390813; Janzen D, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00322; Jayaram B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S7; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; Knowles TJ, 2009, J AM CHEM SOC, V131, P7484, DOI 10.1021/ja810046q; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Kumar A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17364-5; Lam Sum, 2007, Cardiol Rev, V15, P154, DOI 10.1097/01.crd.0000260270.12829.45; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lape R, 2012, J NEUROSCI, V32, P1336, DOI 10.1523/JNEUROSCI.4346-11.2012; Laverty D, 2019, NATURE, V565, P516, DOI 10.1038/s41586-018-0833-4; Lu T, 2008, NEURON, V57, P524, DOI 10.1016/j.neuron.2007.12.010; Lynch JW, 2001, J NEUROSCI, V21, P2589, DOI 10.1523/JNEUROSCI.21-08-02589.2001; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Masiulis S, 2019, NATURE, V566, pE8, DOI 10.1038/s41586-019-0929-5; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Mortensen M, 2004, J PHYSIOL-LONDON, V557, P389, DOI 10.1113/jphysiol.2003.054734; Mukhtasimova N, 2018, J GEN PHYSIOL, V150, P713, DOI 10.1085/jgp.201711881; Mukhtasimova N, 2016, J GEN PHYSIOL, V148, P43, DOI 10.1085/jgp.201611584; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; NELSON N, 1987, ANAL BIOCHEM, V165, P287, DOI 10.1016/0003-2697(87)90271-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phulera S, 2018, ELIFE, V7, DOI 10.7554/eLife.39383; Plested AJR, 2016, NAT STRUCT MOL BIOL, V23, P494, DOI 10.1038/nsmb.3214; Polovinkin L, 2018, NATURE, V563, P275, DOI 10.1038/s41586-018-0672-3; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; RUNDSTROM N, 1994, P NATL ACAD SCI USA, V91, P8950, DOI 10.1073/pnas.91.19.8950; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SCHMIEDEN V, 1992, EMBO J, V11, P2025, DOI 10.1002/j.1460-2075.1992.tb05259.x; SCHMIEDEN V, 1993, SCIENCE, V262, P256, DOI 10.1126/science.8211147; Schwartz RD, 1995, J NEUROSCI METH, V62, P185, DOI 10.1016/0165-0270(95)00075-5; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; STEPHENSON RP, 1956, BRIT J PHARM CHEMOTH, V11, P379, DOI 10.1111/j.1476-5381.1956.tb00006.x; Sunesen M, 2006, J BIOL CHEM, V281, P14875, DOI 10.1074/jbc.M511657200; Tripathy S, 2019, J GEN PHYSIOL, V151, P452, DOI 10.1085/jgp.201812212; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Walsh RM, 2018, NATURE, V557, P261, DOI 10.1038/s41586-018-0081-7; Zhang C, 2019, ULTRAMICROSCOPY, V203, P170, DOI 10.1016/j.ultramic.2018.11.016; Zhang JL, 2013, MOL NEUROBIOL, V48, P97, DOI 10.1007/s12035-013-8420-z; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	88	36	36	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					957	+		10.1016/j.cell.2021.01.026	http://dx.doi.org/10.1016/j.cell.2021.01.026		FEB 2021	33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33567265	Green Submitted, Green Accepted			2022-12-28	WOS:000629633400012
J	Horton, R				Horton, Richard			Offline: The path out of lockdown	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2021	397	10274					565	565						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2TN	33581809	Bronze			2022-12-28	WOS:000620934000008
J	Trujillo, CA; Rice, ES; Schaefer, NK; Chaim, IA; Wheeler, EC; Madrigal, AA; Buchanan, J; Preissl, S; Wang, A; Negraes, PD; Szeto, RA; Herai, RH; Huseynov, A; Ferraz, MSA; Borges, FS; Kihara, AH; Byrne, A; Marin, M; Vollmers, C; Brooks, AN; Lautz, JD; Semendeferi, K; Shapiro, B; Yeo, GW; Smith, SEP; Green, RE; Muotri, AR				Trujillo, Cleber A.; Rice, Edward S.; Schaefer, Nathan K.; Chaim, Isaac A.; Wheeler, Emily C.; Madrigal, Assael A.; Buchanan, Justin; Preissl, Sebastian; Wang, Allen; Negraes, Priscilla D.; Szeto, Ryan A.; Herai, Roberto H.; Huseynov, Alik; Ferraz, Mariana S. A.; Borges, Fernando S.; Kihara, Alexandre H.; Byrne, Ashley; Marin, Maximillian; Vollmers, Christopher; Brooks, Angela N.; Lautz, Jonathan D.; Semendeferi, Katerina; Shapiro, Beth; Yeo, Gene W.; Smith, Stephen E. P.; Green, Richard E.; Muotri, Alysson R.			Reintroduction of the archaic variant of NOVA1 in cortical organoids alters neurodevelopment	SCIENCE			English	Article							RNA-SEQ DATA; GENOME SEQUENCE; READ ALIGNMENT; NEANDERTHAL; GENE; PROTEINS; BINDING; NUMBER; MAP; DIVERSITY	The evolutionarily conserved splicing regulator neuro-oncological ventral antigen 1 (NOVA1) plays a key role in neural development and function. NOVA1 also includes a protein-coding difference between the modern human genome and Neanderthal and Denisovan genomes. To investigate the functional importance of an amino acid change in humans, we reintroduced the archaic allele into human induced pluripotent cells using genome editing and then followed their neural development through cortical organoids. This modification promoted slower development and higher surface complexity in cortical organoids with the archaic version of NOVA1. Moreover, levels of synaptic markers and synaptic protein coassociations correlated with altered electrophysiological properties in organoids expressing the archaic variant. Our results suggest that the human-specific substitution in NOVA1, which is exclusive to modern humans since divergence from Neanderthals, may have had functional consequences for our species' evolution.	[Trujillo, Cleber A.; Negraes, Priscilla D.; Szeto, Ryan A.; Muotri, Alysson R.] Univ Calif San Diego, Dept Pediat, Sch Med,Kavli Inst Brain & Mind, Ctr Acad Res & Training Anthropogeny CARTA, La Jolla, CA 92037 USA; [Trujillo, Cleber A.; Negraes, Priscilla D.; Szeto, Ryan A.; Muotri, Alysson R.] Univ Calif San Diego, Dept Cellular & Mol Med, Sch Med,Kavli Inst Brain & Mind, Ctr Acad Res & Training Anthropogeny CARTA, La Jolla, CA 92037 USA; [Rice, Edward S.; Schaefer, Nathan K.; Marin, Maximillian; Vollmers, Christopher; Brooks, Angela N.; Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Chaim, Isaac A.; Wheeler, Emily C.; Madrigal, Assael A.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Buchanan, Justin; Preissl, Sebastian; Wang, Allen; Yeo, Gene W.] Univ Calif San Diego, Ctr Epigen, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Herai, Roberto H.] Pontificia Univ Catolica Parana, Sch Med, Expt Multiuser Lab LEM, Grad Program Hlth Sci, BR-80215901 Curitiba, PR, Brazil; [Huseynov, Alik] Imperial Coll London, Natl Heart & Lung Inst, London SW3 6LY, England; [Ferraz, Mariana S. A.; Borges, Fernando S.; Kihara, Alexandre H.] Univ Fed ABC, Ctr Matemat Comp & Cognicao, Lab Neurogenet, BR-09606070 Sao Bernardo Do Campo, SP, Brazil; [Byrne, Ashley] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Lautz, Jonathan D.; Smith, Stephen E. P.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Lautz, Jonathan D.; Smith, Stephen E. P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Lautz, Jonathan D.; Smith, Stephen E. P.] Univ Washington, Grad Program Neurosci, Seattle, WA 98195 USA; [Semendeferi, Katerina] Univ Calif San Diego, Ctr Acad Res & Training Anthropogeny CARTA, Kavli Inst Brain & Mind, Dept Anthropol, La Jolla, CA 92037 USA; [Shapiro, Beth] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Shapiro, Beth] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Rice, Edward S.] Univ Nebraska, Dept Anim Sci, Lincoln, NE 68583 USA; [Rice, Edward S.] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Schaefer, Nathan K.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stern Cell, San Francisco, CA 94143 USA; [Marin, Maximillian] Harvard Med Sch, Dept Biomed Informat, Boston, MA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Santa Cruz; University of California System; University of California San Diego; University of California System; University of California San Diego; Pontificia Universidade Catolica do Parana; Imperial College London; University of California System; University of California Santa Cruz; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of Nebraska System; University of Nebraska Lincoln; University of Missouri System; University of Missouri Columbia; University of California System; University of California San Francisco; Harvard University; Harvard Medical School	Muotri, AR (corresponding author), Univ Calif San Diego, Dept Pediat, Sch Med,Kavli Inst Brain & Mind, Ctr Acad Res & Training Anthropogeny CARTA, La Jolla, CA 92037 USA.	muotri@ucsd.edu	Herai, Roberto/HII-2648-2022; Yeo, Gene/AAE-7676-2019; Kihara, Alexandre H/C-2458-2012; da Silva Borges, Fernando/AAG-7895-2021	Herai, Roberto/0000-0001-9885-2735; Yeo, Gene/0000-0002-0799-6037; Kihara, Alexandre H/0000-0002-4027-7261; da Silva Borges, Fernando/0000-0002-7647-2341; Green, Richard/0000-0003-0516-5827; Buchanan, Justin/0000-0001-5904-222X; Madrigal Anaya, Assael Alejandro/0000-0002-3311-5256; Sacrini Ayres Ferraz, Mariana/0000-0002-5574-2840; /0000-0003-1787-046X; Schaefer, Nathan/0000-0001-5881-7329; Preissl, Sebastian/0000-0001-8971-5616; Wheeler, Emily/0000-0003-0260-8530	Neanderthal Brain Foundation; NIH [MH113545, U19MH1073671, R01HG009889, R01HG004659, U19MH107367]; NARSAD Independent Investigator Grant; NSF [DEB-1754451, BCS-2034037]; Gordon and Betty Moore Foundation (GBMF) [3804]; UC San Diego School of Medicine; NIH/NIGMS [K12 GM068524]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Capes [001]; FAPESP [2019/17892-8, 2017/18977-1, 2019/15024-9]; CNPq [431000/2016-6, 312047/2017-7]; NIAAA [K01AA026911]; CDKL5 Program of Excellence (Loulou Foundation)	Neanderthal Brain Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Independent Investigator Grant(NARSAD); NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation (GBMF)(Gordon and Betty Moore Foundation); UC San Diego School of Medicine; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); CDKL5 Program of Excellence (Loulou Foundation)	This work was supported by the Neanderthal Brain Foundation; the NIH through U19MH1073671, part of the National Cooperative Reprogrammed Cell Research Groups (NCRCRG) to Study Mental Illness; and a NARSAD Independent Investigator Grant to A.R.M.; the NSF through DEB-1754451 to N.K.S., R.E.G., and B.S. and BCS-2034037 to R.E.G.; and a grant from the Gordon and Betty Moore Foundation (GBMF 3804). Work at the Center for Epigenomics was supported in part by the UC San Diego School of Medicine. I.A.C. is a San Diego IRACDA Fellow supported by award NIH/NIGMS K12 GM068524. A.H.K. was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Capes, Finance Code 001, FAPESP (#2019/17892-8), and CNPq (#431000/2016-6, #312047/2017-7). F.S.B. (#2017/18977-1) and M.S.A.F. (#2019/15024-9) were supported by FAPESP. Enhanced CLIP experiments and analysis were supported by NIH grants R01HG009889, R01HG004659, and U19MH107367 to G.W.Y. C.A.T. is partly funded by grants from K01AA026911 (NIAAA) and the CDKL5 Program of Excellence (Loulou Foundation). J.D.L. and S.E.P.S. were supported by NIH grant MH113545.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Boles NC, 2014, CELL REP, V6, P724, DOI 10.1016/j.celrep.2014.01.026; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; Brown EA, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0229-1; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; Byrne A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16027; Chiang C, 2015, NAT METHODS, V12, P966, DOI [10.1038/nmeth.3505, 10.1038/NMETH.3505]; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Davis LK, 2008, HUM GENET, V123, P371, DOI 10.1007/s00439-008-0484-x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Haapaniemi E, 2018, NAT MED, V24, P927, DOI 10.1038/s41591-018-0049-z; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heide M, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00113; Herai RH, 2019, GENE, V700, P176, DOI 10.1016/j.gene.2019.03.019; Hsieh CH, 2016, CELL STEM CELL, V19, P709, DOI 10.1016/j.stem.2016.08.002; Ihry RJ, 2018, NAT MED, V24, P939, DOI 10.1038/s41591-018-0050-6; Jelen N, 2007, PLOS GENET, V3, P1838, DOI 10.1371/journal.pgen.0030173; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Juric I, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006340; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Lacar B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11022; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lautz JD, 2018, J NEUROCHEM, V146, P540, DOI 10.1111/jnc.14466; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Li H., 2013, ALIGNING SEQUENCE RE; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin HH, 2010, STEM CELLS, V28, P1950, DOI 10.1002/stem.530; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Monteiro P, 2017, NAT REV NEUROSCI, V18, P147, DOI 10.1038/nrn.2016.183; NYGARD O, 1982, EMBO J, V1, P357, DOI 10.1002/j.1460-2075.1982.tb01174.x; Parikshak NN, 2016, NATURE, V540, P423, DOI 10.1038/nature20612; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Prufer K, 2018, BIOINFORMATICS, V34, P4165, DOI 10.1093/bioinformatics/bty507; Prufer K, 2017, SCIENCE, V358, P655, DOI 10.1126/science.aao1887; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Schaeffer SW, 2002, GENET RES, V80, P163, DOI 10.1017/S0016672302005955; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shimizu T, 2009, DEV GROWTH DIFFER, V51, P221, DOI 10.1111/j.1440-169X.2009.01088.x; Smith SEP, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad7279; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Su SL, 2012, J ORTHOP RES, V30, P9, DOI 10.1002/jor.21494; Szumlinski KK, 2006, CURR OPIN NEUROBIOL, V16, P251, DOI 10.1016/j.conb.2006.05.002; Teplova M, 2011, STRUCTURE, V19, P930, DOI 10.1016/j.str.2011.05.002; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Trujillo CA, 2019, CELL STEM CELL, V25, P558, DOI 10.1016/j.stem.2019.08.002; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Van Nostrand EL, 2020, NATURE, V583, P711, DOI 10.1038/s41586-020-2077-3; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Walkup WG, 2016, ELIFE, V5, DOI 10.7554/eLife.16813; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Xin Y, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12348; Zhang XC, 2016, CELL, V166, P1147, DOI 10.1016/j.cell.2016.07.025	77	35	36	5	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					694	+	eaax2537	10.1126/science.aax2537	http://dx.doi.org/10.1126/science.aax2537			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4IS	33574182	Green Accepted			2022-12-28	WOS:000617551600039
J	Guglielmi, G				Guglielmi, Giorgia			Rapid coronavirus tests: a guide for the perplexed	NATURE			English	News Item						SARS-CoV-2; Virology; Immunology		Scientists still debate whether millions of cheap, fast diagnostic kits will help control the pandemic. Here's why. Scientists still debate whether millions of cheap, fast diagnostic kits will help control the pandemic. Here's why.										Ferguson J, 2020, PREPRINT MEDRXIV, DOI [10.1101/2020.12.01.20237784, DOI 10.1101/2020.12.01.20237784]; Lindner A.K, 2021, PREPRINT MEDRXIV, DOI [10.1101/2021.01.06.20249009, DOI 10.1101/2021.01.06.20249009]; Pavelka M, 2020, PREPRINT; Peto T, 2021, PREPRINT MEDRXIV, DOI [10.1101/2021.01.13.21249563, DOI 10.1101/2021.01.13.21249563]; Pilarowski G, 2021, CLIN INFECT DIS, V73, pE3098, DOI 10.1093/cid/ciaa1890	5	45	46	1	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2021	590	7845					202	205		10.1038/d41586-021-00332-4	http://dx.doi.org/10.1038/d41586-021-00332-4			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2XL	33564189	Bronze			2022-12-28	WOS:000616762900015
J	Schwartzstein, RM; Medoff, BD; Sharma, A; Colson, YL; Gainor, J; Hariri, LP				Schwartzstein, Richard M.; Medoff, Benjamin D.; Sharma, Amita; Colson, Yolonda L.; Gainor, Justin; Hariri, Lida P.			Case 4-2021: A 70-Year-Old Woman with Dyspnea on Exertion and Abnormal Findings on Chest Imaging	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEUROENDOCRINE CELL HYPERPLASIA; BREATHLESSNESS; DIPNECH	A 70-year-old woman was evaluated because of increasing dyspnea on exertion and abnormal findings on chest imaging. Eleven years before this evaluation, mild mosaic attenuation at the lung bases was identified incidentally. Three years later, dyspnea on exertion developed and pulmonary function worsened. Diagnostic tests were performed.	[Schwartzstein, Richard M.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Medoff, Benjamin D.; Gainor, Justin] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sharma, Amita] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Colson, Yolonda L.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Hariri, Lida P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Medoff, Benjamin D.; Gainor, Justin] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Sharma, Amita] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Colson, Yolonda L.] Harvard Med Sch, Dept Surg, Boston, MA 02115 USA; [Hariri, Lida P.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Schwartzstein, RM (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.		Schwartzstein, Richard/AGO-8549-2022					AGUAYO SM, 1992, NEW ENGL J MED, V327, P1285, DOI 10.1056/NEJM199210293271806; Al-Toubah T, 2020, CHEST, V158, P401, DOI 10.1016/j.chest.2020.01.031; Aubry MC, 2007, CHEST, V131, P1635, DOI 10.1378/chest.06-2788; Chauhan A, 2015, LUNG, V193, P653, DOI 10.1007/s00408-015-9754-2; Davies SJ, 2007, THORAX, V62, P248, DOI 10.1136/thx.2006.063065; Gorshtein A, 2012, CANCER-AM CANCER SOC, V118, P612, DOI 10.1002/cncr.26200; Kligerman SJ, 2015, RADIOGRAPHICS, V35, P1360, DOI 10.1148/rg.2015140308; Koliakos E, 2017, AM J CASE REP, V18, P975, DOI 10.12659/AJCR.904468; Mahler DA, 1996, AM J RESP CRIT CARE, V154, P1357, DOI 10.1164/ajrccm.154.5.8912748; Moy ML, 1998, AM J RESP CRIT CARE, V158, P749, DOI 10.1164/ajrccm.158.3.9707088; Moy ML, 2000, AM J RESP CRIT CARE, V162, P451, DOI 10.1164/ajrccm.162.2.9907138; Myint ZW, 2018, LUNG, V196, P577, DOI 10.1007/s00408-018-0149-z; Nassar AA, 2011, AM J RESP CRIT CARE, V184, P8, DOI 10.1164/rccm.201010-1685PP; National Comprehensive Cancer Network, 2020, NCCN CLIN PRACT GUID; O'Donnell Denis E, 2007, Proc Am Thorac Soc, V4, P145, DOI 10.1513/pats.200611-159CC; Olson TP, 2010, CIRC-HEART FAIL, V3, P212, DOI 10.1161/CIRCHEARTFAILURE.109.879684; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Rossi G, 2016, EUR RESPIR J, V47, P1829, DOI 10.1183/13993003.01954-2015; SIMON PM, 1990, AM REV RESPIR DIS, V142, P1009, DOI 10.1164/ajrccm/142.5.1009; SIMON PM, 1989, AM REV RESPIR DIS, V140, P1021, DOI 10.1164/ajrccm/140.4.1021; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; Wirtschafter E, 2015, LUNG, V193, P659, DOI 10.1007/s00408-015-9755-1; Zhou HJ, 2014, J BRONCHOL INTERN PU, V21, P342, DOI 10.1097/LBR.0000000000000098	23	0	0	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2021	384	6					563	574		10.1056/NEJMcpc2027088	http://dx.doi.org/10.1056/NEJMcpc2027088			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG5JQ	33567196				2022-12-28	WOS:000617621800014
J	Maertens, JA; Rahav, G; Lee, DG; Ponce-de-Leon, A; Sanchez, ICR; Klimko, N; Sonet, A; Haider, S; Velez, JD; Raad, I; Koh, LP; Karthaus, M; Zhou, JY; Ben-Ami, R; Motyl, MR; Han, S; Grandhi, A; Waskin, H				Maertens, Johan A.; Rahav, Galia; Lee, Dong-Gun; Ponce-de-Leon, Alfredo; Ramirez Sanchez, Isabel Cristina; Klimko, Nikolay; Sonet, Anne; Haider, Shariq; Diego Velez, Juan; Raad, Issam; Koh, Liang-Piu; Karthaus, Meinolf; Zhou, Jianying; Ben-Ami, Ronen; Motyl, Mary R.; Han, Seongah; Grandhi, Anjana; Waskin, Hetty			Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial	LANCET			English	Article								Background Voriconazole has been recommended as primary treatment for patients with invasive aspergillosis. Intravenous and tablet formulations of posaconazole that have improved systemic absorption could be an effective alternative to voriconazole. We aimed to assess non-inferiority of posaconazole to voriconazole for the primary treatment of invasive aspergillosis. Methods We did a randomised, prospective, double-blind, double-dummy, controlled trial comparing posaconazole (intravenous or oral posaconazole 300 mg twice on day 1, followed by 300 mg once a day for days 2-84) with voriconazole (6 mg/kg intravenous or 300 mg oral twice on day 1 followed by 4 mg/kg intravenously or 200 mg orally twice a day for days 2-84) for 12 weeks or less in the primary treatment of invasive aspergillosis. Participants were from 91 study sites in 26 countries, were aged 13 years or older, weighed at least 40 kg, and met criteria for proven, probable, or possible fungal disease. Participants were randomly assigned (1:1) via a computer-generated randomisation schedule with stratification by risk status. The primary endpoint was cumulative all-cause mortality up until day 42 in the intention-to-treat (ITT) population (defined as randomly assigned participants who received >= 1 dose of study drug), with a 10% non-inferiority margin. The ITT population was also evaluated for safety. This study is registered with ClinicalTrials.gov, NCT01782131, and EudraCT, 2011-003938-14. Findings Between Oct 25, 2013, and Sept 10, 2019, of 653 individuals assessed for eligibility, 575 ITT participants were randomly assigned and received one or more doses of study drug (n=288 [50%] posaconazole, n=287 [50%] voriconazole). Mortality up until day 42 was 15% (44 of 288) in the posaconazole group and 21% (59 of 287) in the voriconazole group (treatment difference -5.3% [95% CI -11.6 to 1.0]; p<0.0001). Mortality up until day 42 in the full- analysis-set subpopulation (ITT participants with proven or probable invasive aspergillosis) supported this conclusion: 31 (19%) of 163 participants in the posaconazole group and 32 (19%) of 171 participants in the voriconazole group (treatment difference 0.3% [95% CI -8.2 to 8.8]). The most frequently reported treatmentrelated adverse events (incidence >3%) were increased aspartate aminotransferase (AST) or alanine aminotransferase (ALT), nausea, hypokalaemia, and vomiting in the posaconazole group and increased ALT, AST, or alkaline phosphatase, hallucination, increased gamma-glutamyltransferase peptidase, nausea, and blurred vision in the voriconazole group. The overall incidence of treatment-related adverse event rates in the ITT population was 30% for posaconazole and 40% for voriconazole (treatment difference - 10. 2% [95% CI -17 .9 to - 2.4]). Interpretation Posaconazole was non-inferior to voriconazole for all-cause mortality up until day 42 in participants with invasive aspergillosis. Posaconazole was well tolerated, and participants had fewer treatment-related adverse events than in the voriconazole group. This study supports the use of posaconazole as a first-line treatment for the condition.	[Maertens, Johan A.] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Leuven, Belgium; [Maertens, Johan A.] Univ Hosp Leuven, Dept Hematol, B-3000 Leuven, Belgium; [Rahav, Galia] Sheba Med Ctr, Ramat Gan, Israel; [Rahav, Galia] Tel Aviv Univ, Sackler Sch Med, Ramat Gan, Israel; [Lee, Dong-Gun] Catholic Univ Korea, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Ponce-de-Leon, Alfredo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Ramirez Sanchez, Isabel Cristina] Univ Antioquia, Hosp Pablo Tobon Uribe, Medellin, Colombia; [Klimko, Nikolay] North Western State Med Univ, Dept Clin Mycol Allergy & Immunol, St Petersburg, Russia; [Sonet, Anne] Catholic Univ Louvain, CHU UCL Namur, Yvoir, Belgium; [Haider, Shariq] McMaster Univ, Juravinski Hosp & Canc Ctr, Hamilton, ON, Canada; [Diego Velez, Juan] Fdn Valle Lili, Cali, Colombia; [Raad, Issam] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Koh, Liang-Piu] Natl Univ Hlth Syst, Natl Univ Canc Inst, Singapore, Singapore; [Karthaus, Meinolf] Klinikum Neuperlach, Munich, Germany; [Zhou, Jianying] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Resp Dis, Hangzhou, Peoples R China; [Ben-Ami, Ronen] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel; [Ben-Ami, Ronen] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Motyl, Mary R.] Merck & Co Inc, Dept Clin Microbiol, Kenilworth, NJ USA; [Han, Seongah] Merck & Co Inc, Dept Diabet NASH, Kenilworth, NJ USA; [Grandhi, Anjana] Merck & Co Inc, Dept Biostat, Kenilworth, NJ USA; [Waskin, Hetty] Merck & Co Inc, Dept Infect Dis, Kenilworth, NJ USA	KU Leuven; KU Leuven; University Hospital Leuven; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Catholic University of Korea; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad de Antioquia; North-Western State Medical University named after I.I. Mechnikov; Universite Catholique Louvain; McMaster University; Fundacion Valle del Lili; University of Texas System; UTMD Anderson Cancer Center; National University of Singapore; Munchen Klinik; Zhejiang University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Maertens, JA (corresponding author), Univ Hosp Leuven, Dept Hematol, B-3000 Leuven, Belgium.	johan.maertens@uzleuven.be	Lee, Dong-Gun/AGF-9891-2022	Lee, Dong-Gun/0000-0003-4655-0641; Ponce-de-Leon, Alfredo/0000-0003-2640-2916; Ben-Ami, Ronen/0000-0003-0628-0798	Merck Sharp Dohme	Merck Sharp Dohme(Merck & Company)	Merck Sharp & Dohme, a subsidiary of Merck & Co, Inc.	[Anonymous], 2013, NOXAFIL POSACONAZOLE; [Anonymous], 2019, NOXAFIL 40 MG ML ORA; Bruggemann RJM, 2008, THER DRUG MONIT, V30, P403, DOI 10.1097/FTD.0b013e31817b1a95; Cornely OA, 2007, NEW ENGL J MED, V356, P348, DOI 10.1056/NEJMoa061094; Cornely OA, 2017, J ANTIMICROB CHEMOTH, V72, P3406, DOI 10.1093/jac/dkx263; Cornely OA, 2016, J ANTIMICROB CHEMOTH, V71, P718, DOI 10.1093/jac/dkv380; Dmitrienko A., 2009, MULTIPLE TESTING PRO, V1; Eiden C, 2007, ANN PHARMACOTHER, V41, P755, DOI 10.1345/aph.1H671; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Maertens JA, 2016, LANCET, V387, P760, DOI 10.1016/S0140-6736(15)01159-9; Marr KA, 2015, ANN INTERN MED, V162, P81, DOI 10.7326/M13-2508; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Pasqualotto AC, 2010, EXPERT OPIN DRUG SAF, V9, P125, DOI 10.1517/14740330903485637; Patterson TF, 2016, CLIN INFECT DIS, V63, pE1, DOI 10.1093/cid/ciw326; Pfizer, 2019, VFEND VORICONOZOLE T; Segal BH, 2008, CLIN INFECT DIS, V47, P674, DOI 10.1086/590566; Tissot F, 2017, HAEMATOLOGICA, V102, P433, DOI 10.3324/haematol.2016.152900; Ullmann AJ, 2018, CLIN MICROBIOL INFEC, V24, pE1, DOI 10.1016/j.cmi.2018.01.002; Ullmann AJ, 2007, NEW ENGL J MED, V356, P335, DOI 10.1056/NEJMoa061098	19	45	47	5	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2021	397	10273					499	509						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QF1LZ	33549194				2022-12-28	WOS:000616661900025
J	Thornton, J				Thornton, Jacqui			Hopes for trachoma control in South Sudan	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2021	397	10273					461	461						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QF1LZ	33549180				2022-12-28	WOS:000616661900010
J	Zalc, A; Sinha, R; Gulati, GS; Wesche, DJ; Daszczuk, P; Swigut, T; Weissman, IL; Wysocka, J				Zalc, Antoine; Sinha, Rahul; Gulati, Gunsagar S.; Wesche, Daniel J.; Daszczuk, Patrycja; Swigut, Tomek; Weissman, Irving L.; Wysocka, Joanna			Reactivation of the pluripotency program precedes formation of the cranial neural crest	SCIENCE			English	Article							RNA-SEQ DATA; CHROMATIN; CELLS; OCT4; COMPETENCE; TRANSITION; EXPRESSION; SUGGESTS; FATE	During development, cells progress from a pluripotent state to a more restricted fate within a particular germ layer. However, cranial neural crest cells (CNCCs), a transient cell population that generates most of the craniofacial skeleton, have much broader differentiation potential than their ectodermal lineage of origin. Here, we identify a neuroepithelial precursor population characterized by expression of canonical pluripotency transcription factors that gives rise to CNCCs and is essential for craniofacial development. Pluripotency factor Oct4 is transiently reactivated in CNCCs and is required for the subsequent formation of ectomesenchyme. Furthermore, open chromatin landscapes of Oct4(+) CNCC precursors resemble those of epiblast stem cells, with additional features suggestive of priming for mesenchymal programs. We propose that CNCCs expand their developmental potential through a transient reacquisition of molecular signatures of pluripotency.	[Zalc, Antoine; Daszczuk, Patrycja; Swigut, Tomek; Wysocka, Joanna] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Sinha, Rahul; Gulati, Gunsagar S.; Wesche, Daniel J.; Weissman, Irving L.; Wysocka, Joanna] Stanford Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Wysocka, J (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA.; Wysocka, J (corresponding author), Stanford Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.; Wysocka, J (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.; Wysocka, J (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	wysocka@stanford.edu	Zalc, Antoine/GOH-1122-2022	Wesche, Daniel/0000-0003-0513-1571; Swigut, Tomek/0000-0002-7649-6781; Weissman, Irving/0000-0002-9077-7467; Zalc, Antoine/0000-0001-6077-0996; Daszczuk, Patrycja/0000-0001-9165-5800	Howard Hughes Medical Institute; National Institutes of Health [R35 GM131757]; Virginia and D.K. Ludwig Fund for Cancer Research; EMBO [ALTF 275-2015]; European Commission [LTFCOFUND2013, GA-2013-609409]; Marie Curie Actions; Polish National Science Center [ETIUDA 7 2019/32/T/NZ3/00370]; University of Warsaw Integrated Development Programme	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia and D.K. Ludwig Fund for Cancer Research; EMBO(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre); Marie Curie Actions(European Commission); Polish National Science Center; University of Warsaw Integrated Development Programme	This work was supported by the Howard Hughes Medical Institute, the National Institutes of Health (grant no. R35 GM131757), the Virginia and D.K. Ludwig Fund for Cancer Research (J.W.), EMBO (ALTF 275-2015), the European Commission (LTFCOFUND2013, GA-2013-609409), the Marie Curie Actions (A.Z.), the Polish National Science Center (ETIUDA 7 2019/32/T/NZ3/00370), and the University of Warsaw Integrated Development Programme (P.D.).	Aires R, 2016, DEV CELL, V38, P262, DOI 10.1016/j.devcel.2016.06.021; Aoto K, 2015, DEV BIOL, V402, P3, DOI 10.1016/j.ydbio.2015.02.022; Briggs JA, 2018, SCIENCE, V360, P980, DOI 10.1126/science.aar5780; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buitrago-Delgado E, 2015, SCIENCE, V348, P1332, DOI 10.1126/science.aaa3655; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Couly G, 2002, DEVELOPMENT, V129, P1061; Creuzet SE, 2009, P NATL ACAD SCI USA, V106, P15774, DOI 10.1073/pnas.0906072106; Debbache J, 2018, GENESIS, V56, DOI 10.1002/dvg.23105; DeVeale B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003957; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorighi KM, 2017, MOL CELL, V66, P568, DOI 10.1016/j.molcel.2017.04.018; Downs KM, 2008, DEV DYNAM, V237, P464, DOI 10.1002/dvdy.21438; Edri S, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.168187; Hagan N, 2012, MOL CELL NEUROSCI, V49, P217, DOI 10.1016/j.mcn.2011.11.008; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kobayashi D, 2002, DEVELOPMENT, V129, P83; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lignell A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01561-w; Ling ITC, 2019, NAT CELL BIOL, V21, P1504, DOI 10.1038/s41556-019-0428-9; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Metzis V, 2018, CELL, V175, P1105, DOI 10.1016/j.cell.2018.09.040; Minoux M, 2017, SCIENCE, V355, DOI 10.1126/science.aal2913; Mulas C, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.159103; Neijts R, 2016, GENE DEV, V30, P1937, DOI 10.1101/gad.285767.116; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pijuan-Sala B, 2020, NAT CELL BIOL, V22, DOI 10.1038/s41556-020-0489-9; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; ROWITCH DH, 1995, MECH DEVELOP, V52, P3, DOI 10.1016/0925-4773(95)00380-J; Scerbo P, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz1469; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Simandi Z, 2016, MOL CELL, V63, P647, DOI 10.1016/j.molcel.2016.06.039; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Soldatov R, 2019, SCIENCE, V364, P971, DOI 10.1126/science.aas9536; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theveneau E, 2012, WIRES DEV BIOL, V1, P435, DOI 10.1002/wdev.28; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Wang A, 2015, CELL STEM CELL, V16, P386, DOI 10.1016/j.stem.2015.02.013; Weston JA, 2004, DEV DYNAM, V229, P118, DOI 10.1002/dvdy.10478; Williams RM, 2019, DEV CELL, V51, P255, DOI 10.1016/j.devcel.2019.10.003; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Yang SH, 2019, CELL REP, V27, P3215, DOI 10.1016/j.celrep.2019.05.026; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	56	31	32	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		586	+	eabb4776	10.1126/science.abb4776	http://dx.doi.org/10.1126/science.abb4776			66	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QD7TF	33542111	Green Accepted, Green Published			2022-12-28	WOS:000615715300043
J	Swaminathan, S; Dehghan, M; Raj, JM; Thomas, T; Rangarajan, S; Jenkins, D; Mony, P; Mohan, V; Lear, SA; Avezum, A; Lopez-Jaramillo, P; Rosengren, A; Lanas, F; AlHabib, KF; Dans, A; Keskinler, MV; Puoane, T; Soman, B; Wei, L; Zatonska, K; Diaz, R; Ismail, N; Chifamba, J; Kelishadi, R; Yusufali, A; Khatib, R; Liu, XY; Bo, H; Iqbal, R; Yusuf, R; Yeates, K; Teo, K; Yusuf, S				Swaminathan, Sumathi; Dehghan, Mahshid; Raj, John Michael; Thomas, Tinku; Rangarajan, Sumathy; Jenkins, David; Mony, Prem; Mohan, Viswanathan; Lear, Scott A.; Avezum, Alvaro; Lopez-Jaramillo, Patricio; Rosengren, Annika; Lanas, Fernando; AlHabib, Khalid F.; Dans, Antonio; Keskinler, Mirac Vural; Puoane, Thandi; Soman, Biju; Wei, Li; Zatonska, Katarzyna; Diaz, Rafael; Ismail, Noorhassim; Chifamba, Jephat; Kelishadi, Roya; Yusufali, Afzalhussein; Khatib, Rasha; Liu Xiaoyun; Bo, Hu; Iqbal, Romaina; Yusuf, Rita; Yeates, Karen; Teo, Koon; Yusuf, Salim			Associations of cereal grains intake with cardiovascular disease and mortality across 21 countries in Prospective Urban and Rural Epidemiology study: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; DOSE-RESPONSE METAANALYSIS; ALL-CAUSE MORTALITY; WHOLE-GRAIN; FOOD-CONSUMPTION; RICE CONSUMPTION; CANCER-MORTALITY; REFINED-GRAIN; RISK; FRUIT	OBJECTIVE To evaluate the association between intakes of refined grains, whole grains, and white rice with cardiovascular disease, total mortality, blood lipids, and blood pressure in the Prospective Urban and Rural Epidemiology (PURE) study. DESIGN Prospective cohort study. SETTING PURE study in 21 countries. PARTICIPANTS 148 858 participants with median follow-up of 9.5 years. EXPOSURES Country specific validated food frequency questionnaires were used to assess intakes of refined grains, whole grains, and white rice. MAIN OUTCOME MEASURE Composite of mortality or major cardiovascular events (defined as death from cardiovascular causes, nonfatal myocardial infarction, stroke, or heart failure). Hazard ratios were estimated for associations of grain intakes with mortality, major cardiovascular events, and their composite by using multivariable Cox frailty models with random intercepts to account for clustering by centre. RESULTS Analyses were based on 137 130 participants after exclusion of those with baseline cardiovascular disease. During follow-up, 9.2% (n=12 668) of these participants had a composite outcome event. The highest category of intake of refined grains (>= 350 g/ day or about 7 servings/day) was associated with higher risk of total mortality (hazard ratio 1.27, 95% confidence interval 1.11 to 1.46; P for trend=0.004), major cardiovascular disease events (1.33, 1.16 to 1.52; P for trend<0.001), and their composite (1.28, 1.15 to 1.42; P for trend<0.001) compared with the lowest category of intake (<50 g/day). Higher intakes of refined grains were associated with higher systolic blood pressure. No significant associations were found between intakes of whole grains or white rice and health outcomes. CONCLUSION High intake of refined grains was associated with higher risk of mortality and major cardiovascular disease events. Globally, lower consumption of refined grains should be considered.	[Swaminathan, Sumathi; Mony, Prem] St Johns Res Inst, Bangalore, Karnataka, India; [Dehghan, Mahshid; Rangarajan, Sumathy; Teo, Koon; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst PHRI, Hamilton, ON, Canada; [Raj, John Michael; Thomas, Tinku] St Johns Med Coll, Bangalore, Karnataka, India; [Jenkins, David] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Jenkins, David] Univ Toronto, Dept Med, Fac Med, Toronto, ON, Canada; [Mohan, Viswanathan] Madras Diabet Res Fdn, Chennai, Tamil Nadu, India; [Mohan, Viswanathan] Dr Mohans Diabet Special Ctr, Chennai, Tamil Nadu, India; [Lear, Scott A.] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Avezum, Alvaro] Univ Santo Amaro UNISA, Int Res Ctr, Hosp Alemao Oswaldo Cruz, Sao Paulo, Brazil; [Lopez-Jaramillo, Patricio] Santander Univ UDES, Masira Res Inst, Sch Med, Santander, Colombia; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Rosengren, Annika] Univ Hosp, Sahlgrenska, Gothenburg, Sweden; [Lanas, Fernando] Univ La Frontera, Temuco, Chile; [AlHabib, Khalid F.] King Saud Univ, Coll Med, King Fahad Cardiac Ctr, Dept Cardiac Sci, Riyadh, Saudi Arabia; [Dans, Antonio] Univ Philippines, Sect Adult Med & Med Res Unit, Manila, Philippines; [Keskinler, Mirac Vural] Istanbul Medeniyet Univ, Dept Internal Med, Istanbul, Turkey; [Keskinler, Mirac Vural] Goztepe Training & Res Hosp, Istanbul, Turkey; [Puoane, Thandi] Univ Western Cape, Bellville, South Africa; [Soman, Biju] Hlth Act People, Thiruvananthapuram, Kerala, India; [Soman, Biju] Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Trivandrum, Kerala, India; [Wei, Li; Liu Xiaoyun; Bo, Hu] Chinese Acad Med Sci, Cardiovasc Inst & Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Zatonska, Katarzyna] Wroclaw Med Univ, Dept Social Med, Wroclaw, Poland; [Diaz, Rafael] Estudios Clinicos Latinoamer ECLA, Rosario, Santa Fe, Argentina; [Ismail, Noorhassim] Univ Kebangsaan Malaysia, Dept Community Hlth, Fac Med, Kuala Lumpur, Malaysia; [Chifamba, Jephat] Univ Zimbabwe, Dept Physiol, Coll Hlth Sci, Harare, Zimbabwe; [Kelishadi, Roya] Isfahan Univ Med Sci, Cardiovasc Res Inst, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; [Yusufali, Afzalhussein] Dubai Med Univ, Hatta Hosp, Dubai Hlth Author, Dubai, U Arab Emirates; [Khatib, Rasha] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Palestine; [Khatib, Rasha] Advocate Hlth Care, Advocate Res Inst, Downers Grove, IL USA; [Iqbal, Romaina] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Iqbal, Romaina] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Yusuf, Rita] Independent Univ, School Life Sci, Dhaka, Bangladesh; [Yeates, Karen] Queens Univ, Dept Med, Kingston, ON, Canada; [Yeates, Karen] York Univ, Coll Global Publ Hlth, New York, NY USA	St. John's National Academy of Health Sciences; St. John's Research Institute; McMaster University; Population Health Research Institute; St. John's National Academy of Health Sciences; St. John's Medical College; University of Toronto; University of Toronto; Madras Diabetes Research Foundation; Simon Fraser University; Universidade de Santo Amaro (UNISA); University of Gothenburg; Universidad de La Frontera; King Saud University; University of the Philippines System; University of the Philippines Manila; Istanbul Medeniyet University; Istanbul Goztepe Training and Research Hospital; University of the Western Cape; Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Wroclaw Medical University; Universiti Kebangsaan Malaysia; University of Zimbabwe; Isfahan University Medical Science; Birzeit University; Aga Khan University; Aga Khan University; Independent University Bangladesh (IUB); Queens University - Canada	Dehghan, M (corresponding author), McMaster Univ, Populat Hlth Res Inst PHRI, Hamilton, ON, Canada.	Mahshid.dehghan@phri.ca	Lanas, Fernando/AAE-8842-2022; Zatońska, Katarzyna/ABD-4236-2021; Mony, Prem K./GRF-4752-2022; Chifamba, Jephat/AHE-4535-2022; Swaminathan, Sumathi/AGI-7678-2022; Khatib, Rasha/GXV-8883-2022; Soman, Biju/AAS-9901-2021	Mony, Prem K./0000-0002-1399-0520; Chifamba, Jephat/0000-0001-8166-1182; Lanas, Fernando/0000-0003-3595-9759; Yusuf, Salim/0000-0003-4776-5601; Zatonska, Katarzyna/0000-0002-3772-5588; Dehghan, Mahshid/0000-0003-2149-847X; Soman, Biju/0000-0003-0748-0839	Heart and Stroke Foundation of Ontario; Population Health Research Institute; Hamilton Health Sciences Research Institute (HHSRI); Canadian Institutes of Health Research; Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit; Ontario Ministry of Health and Long term Care; AstraZeneca (Canada); Sanofi-Aventis (France and Canada); Boehringer Ingelheim (Germany and Canada); Servier; GlaxoSmithKline; Novartis; King Pharma; Farmers of Canada; National Dairy Council (US); Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de La Frontera [DI13-PE11]; Colombia: Colciencias [6566-04-18062, 6517-777-58228]; Malaysia: Ministry of Science, Technology and Innovation of Malaysia [100-IRDC/BIOTEK 16/6/21 [13/2007], 07-05-IFN-BPH 010]; Ministry of Higher Education of Malaysia [600-RMI/LRGS/5/3 [2/2011]]; Universiti Kebangsaan Malaysia [UKM-Hejim-Komuniti-15-2010]; Poland: Polish Ministry of Science and Higher Education [290/W-PURE/2008/0]; Swedish state; Swedish Heart and Lung Foundation; Swedish Research Council; Swedish Council for Health, Working Life and Welfare; King Gustaf V's and Queen Victoria Freemason's Foundation; AFA Insurance	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Population Health Research Institute; Hamilton Health Sciences Research Institute (HHSRI); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long term Care(Ministry of Health and Long-Term Care, Ontario); AstraZeneca (Canada)(AstraZeneca); Sanofi-Aventis (France and Canada); Boehringer Ingelheim (Germany and Canada)(Boehringer Ingelheim); Servier(Servier); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); King Pharma; Farmers of Canada; National Dairy Council (US); Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de La Frontera; Colombia: Colciencias; Malaysia: Ministry of Science, Technology and Innovation of Malaysia; Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia); Universiti Kebangsaan Malaysia; Poland: Polish Ministry of Science and Higher Education; Swedish state; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Health, Working Life and Welfare; King Gustaf V's and Queen Victoria Freemason's Foundation; AFA Insurance	SY is supported by the Marion W Burke endowed chair of the Heart and Stroke Foundation of Ontario. The PURE study is an investigator initiated study that is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute (HHSRI), the Canadian Institutes of Health Research, and the Heart and Stroke Foundation of Ontario, with support from the Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long term Care, and through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GlaxoSmithKline) and additional contributions from Novartis and King Pharma and from various national or local organisations in participating countries. These include Argentina: Fundacion ECLA (Estudios Clinicos Latino America); Bangladesh: Independent University, Bangladesh, and Mitra and Associates; Brazil: Unilever Health Institute, Brazil; Canada: unrestricted grant from Dairy Farmers of Canada and the National Dairy Council (US), Public Health Agency of Canada, and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de La Frontera (DI13-PE11); China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development; Colombia: Colciencias (grant 6566-04-18062 and grant 6517-777-58228); India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grant number: 100-IRDC/BIOTEK 16/6/21 [13/2007], and 07-05-IFN-BPH 010), Ministry of Higher Education of Malaysia (grant number: 600-RMI/LRGS/5/3 [2/2011]), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010); occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, International Development Research Centre, Canada; Philippines: Philippine Council for Health Research and Development; Poland: Polish Ministry of Science and Higher Education (grant number: 290/W-PURE/2008/0), Wroclaw Medical University; Saudi Arabia: Saudi Heart Association, Saudi Gastroenterology Association, Dr Mohammad Alfagih Hospital, the Deanship of Scientific Research at King Saud University, Riyadh, (research group number: RG-1436-013); South Africa: North-West University, Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, South Africa Sugar Association, Faculty of Community and Health Sciences; Sweden: grants from the Swedish state under the agreement concerning research and education of doctors, the Swedish Heart and Lung Foundation, the Swedish Research Council, the Swedish Council for Health, Working Life and Welfare, King Gustaf V's and Queen Victoria Freemason's Foundation, AFA Insurance; Turkey: Metabolic Syndrome Society, AstraZeneca, Sanofi Aventis; United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, Dubai Health Authority, Dubai. The external funders and sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; in the preparation, review, or approval of the manuscript; or in the decision to submit the manuscript for publication. Please refer to the supplementary material for a list of PURE project office staff, national coordinators, investigators, and key staff.	Adom KK, 2002, J AGR FOOD CHEM, V50, P6182, DOI 10.1021/jf0205099; Anand SS, 2015, J AM COLL CARDIOL, V66, P1590, DOI 10.1016/j.jacc.2015.07.050; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2716; Batis C, 2014, J EPIDEMIOL COMMUN H, V68, P773, DOI 10.1136/jech-2013-203560; Batis C, 2014, BRIT J NUTR, V111, P1441, DOI 10.1017/S0007114513003917; Bechthold A, 2019, CRIT REV FOOD SCI, V59, P1071, DOI 10.1080/10408398.2017.1392288; Belobrajdic DP, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-62; Benisi-Kohansal S, 2016, ADV NUTR, V7, P1052, DOI 10.3945/an.115.011635; Boers HM, 2015, BRIT J NUTR, V114, P1035, DOI 10.1017/S0007114515001841; Bots SH, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000298; Chen MT, 2017, INT J CLIN EXP MED, V10, P12749; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; Dehghan M, 2017, LANCET, V390, P2050, DOI [10.1016/s0140-6736(17)32252-3, 10.1016/S0140-6736(17)32252-3]; Develaraja Samir, 2016, J Nutrit Health Food Sci, V4, P1, DOI 10.15226/jnhfs.2016.00173; Eshak ES, 2011, J NUTR, V141, P595, DOI 10.3945/jn.110.132167; Farvid MS, 2016, BREAST CANCER RES TR, V159, P335, DOI 10.1007/s10549-016-3910-0; Gao Z., 2019, MED NOVEL TECHNOL DE, V4, P100025, DOI [10.1016/j.medntd.2019.100025, DOI 10.1016/J.MEDNTD.2019.100025]; Ho FK, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m688; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Huang T, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0294-7; JENKINS DJA, 1988, DIABETES CARE, V11, P149, DOI 10.2337/diacare.11.2.149; Johnsen NF, 2015, BRIT J NUTR, V114, P608, DOI 10.1017/S0007114515001701; Kaluza J, 2014, CIRC-HEART FAIL, V7, P552, DOI 10.1161/CIRCHEARTFAILURE.113.000921; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Kelly SAM, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005051.pub3; Krittanawong C, 2017, HEART ASIA, V9, DOI 10.1136/heartasia-2017-010909; Kyro C, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3046; Lafiandra D, 2014, J CEREAL SCI, V59, P312, DOI 10.1016/j.jcs.2014.01.001; Lear SA, 2017, LANCET, V390, P2643, DOI 10.1016/S0140-6736(17)31634-3; Li Bailing, 2016, Medicine (Baltimore), V95, pe4229, DOI 10.1097/MD.0000000000004229; Liu S, 2000, AM J CLIN NUTR, V72, P922; Liu SM, 2002, J AM COLL NUTR, V21, P298, DOI 10.1080/07315724.2002.10719227; Mellen PB, 2008, NUTR METAB CARDIOVAS, V18, P283, DOI 10.1016/j.numecd.2006.12.008; Miller V, 2017, LANCET, V390, P2037, DOI [10.1016/S0140-6736(17)32253-5, 10.1016/s0140-6736(17)32253-5]; Muraki I, 2015, AM J CLIN NUTR, V101, P164, DOI 10.3945/ajcn.114.087551; Reynolds A, 2019, LANCET, V393, P434, DOI 10.1016/S0140-6736(18)31809-9; Rosengren A, 2009, HEART, V95, P2014, DOI 10.1136/hrt.2009.182436; Rosengren A, 2019, LANCET GLOB HEALTH, V7, pE748, DOI 10.1016/S2214-109X(19)30045-2; Ross AB, 2015, AM J CLIN NUTR, V101, P903, DOI 10.3945/ajcn.114.098046; Saneei P, 2017, PUBLIC HEALTH NUTR, V20, P233, DOI [10.1017/S1368980016002172, 10.1017/s1368980016002172]; Schwingshackl L, 2017, AM J CLIN NUTR, V105, P1462, DOI 10.3945/ajcn.117.153148; Serra-Majem L, 2015, BRIT J NUTR, V113, pS29, DOI 10.1017/S0007114514003249; Shi ZM, 2020, EUR J CLIN NUTR, V74, P1725, DOI 10.1038/s41430-020-0668-6; Steffen LM, 2003, AM J CLIN NUTR, V78, P383, DOI 10.1093/ajcn/78.3.383; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Tong TYN, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4897; Wei HL, 2016, BRIT J NUTR, V116, P514, DOI 10.1017/S0007114516001975; Yu DX, 2013, AM J EPIDEMIOL, V178, P1542, DOI 10.1093/aje/kwt178; Zhang B, 2018, EUR J CLIN NUTR, V72, P57, DOI 10.1038/ejcn.2017.149; Zhong VTW, 2020, JAMA INTERN MED, V180, P503, DOI 10.1001/jamainternmed.2019.6969; Zong G, 2016, CIRCULATION, V133, P2370, DOI 10.1161/CIRCULATIONAHA.115.021101	52	27	29	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2021	372								m4948	10.1136/bmj.m4948	http://dx.doi.org/10.1136/bmj.m4948			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC1TD	33536317	Green Published, hybrid			2022-12-28	WOS:000686315900001
J	Monod, M; Blenkinsop, A; Xi, XY; Hebert, D; Bershan, S; Tietze, S; Baguelin, M; Bradley, VC; Chen, Y; Coupland, H; Filippi, S; Ish-Horowicz, J; McManus, M; Mellan, T; Gandy, A; Hutchinson, M; Unwin, HJT; van Elsland, SL; Vollmer, MAC; Weber, S; Zhu, H; Bezancon, A; Ferguson, NM; Mishra, S; Flaxman, S; Bhatt, S; Ratmann, O				Monod, Melodie; Blenkinsop, Alexandra; Xi, Xiaoyue; Hebert, Daniel; Bershan, Sivan; Tietze, Simon; Baguelin, Marc; Bradley, Valerie C.; Chen, Yu; Coupland, Helen; Filippi, Sarah; Ish-Horowicz, Jonathan; McManus, Martin; Mellan, Thomas; Gandy, Axel; Hutchinson, Michael; Unwin, H. Juliette T.; van Elsland, Sabine L.; Vollmer, Michaela A. C.; Weber, Sebastian; Zhu, Harrison; Bezancon, Anne; Ferguson, Neil M.; Mishra, Swapnil; Flaxman, Seth; Bhatt, Samir; Ratmann, Oliver		Imperial Coll COVID-19 Response Te	Age groups that sustain resurging COVID-19 epidemics in the United States	SCIENCE			English	Article							TRANSMISSION; CONTACTS	After initial declines, in mid-2020 a resurgence in transmission of novel coronavirus disease (COVID-19) occurred in the United States and Europe. As efforts to control COVID-19 disease are reintensified, understanding the age demographics driving transmission and how these affect the loosening of interventions is crucial. We analyze aggregated, age-specific mobility trends from more than 10 million individuals in the United States and link these mechanistically to age-specific COVID-19 mortality data. We estimate that as of October 2020, individuals aged 20 to 49 are the only age groups sustaining resurgent SARS-CoV-2 transmission with reproduction numbers well above one and that at least 65 of 100 COVID-19 infections originate from individuals aged 20 to 49 in the United States. Targeting interventions-including transmission-blocking vaccines-to adults aged 20 to 49 is an important consideration in halting resurgent epidemics and preventing COVID-19-attributable deaths.	[Monod, Melodie; Blenkinsop, Alexandra; Xi, Xiaoyue; Chen, Yu; Filippi, Sarah; Ish-Horowicz, Jonathan; McManus, Martin; Gandy, Axel; Zhu, Harrison; Flaxman, Seth; Ratmann, Oliver] Imperial Coll London, Dept Math, London, England; [Hebert, Daniel] Foursquare Inc, New York, NY USA; [Bershan, Sivan; Tietze, Simon; Bezancon, Anne] Emodo, San Francisco, CA USA; [Baguelin, Marc; Coupland, Helen; Mellan, Thomas; Unwin, H. Juliette T.; van Elsland, Sabine L.; Vollmer, Michaela A. C.; Ferguson, Neil M.; Mishra, Swapnil; Bhatt, Samir] Imperial Coll London, MRC Ctr Global Infect Dis Anal, Sch Publ Hlth, London, England; [Baguelin, Marc; Coupland, Helen; Mellan, Thomas; Unwin, H. Juliette T.; van Elsland, Sabine L.; Vollmer, Michaela A. C.; Ferguson, Neil M.; Mishra, Swapnil; Bhatt, Samir] Imperial Coll London, Abdul Latif Jameel Inst Dis & Emergency Analyt J, Sch Publ Hlth, London, England; [Bradley, Valerie C.; Hutchinson, Michael] Univ Oxford, Dept Stat, Oxford, England; [Weber, Sebastian] Novartis Pharma AG, Basel, Switzerland; [Bhatt, Samir] Univ Copenhagen, Dept Publ Hlth, Sect Epidemiol, Copenhagen, Denmark	Imperial College London; Imperial College London; Imperial College London; University of Oxford; Novartis; University of Copenhagen	Flaxman, S; Ratmann, O (corresponding author), Imperial Coll London, Dept Math, London, England.; Bhatt, S (corresponding author), Imperial Coll London, MRC Ctr Global Infect Dis Anal, Sch Publ Hlth, London, England.; Bhatt, S (corresponding author), Imperial Coll London, Abdul Latif Jameel Inst Dis & Emergency Analyt J, Sch Publ Hlth, London, England.; Bhatt, S (corresponding author), Univ Copenhagen, Dept Publ Hlth, Sect Epidemiol, Copenhagen, Denmark.	s.flaxman@imperial.ac.uk; s.bhatt@imperial.ac.uk; oliver.ratmann@imperial.ac.uk	Cucunuba, Zulma M/X-5670-2019; Blenkinsop, Alexandra/ABG-5805-2021	Cucunuba, Zulma M/0000-0002-8165-3198; Blenkinsop, Alexandra/0000-0002-2328-8671; Filippi, Sarah/0000-0001-8652-358X; Ratmann, Oliver/0000-0001-8667-4118; Jauneikaite, Elita/0000-0002-7075-6896; Mishra, Swapnil/0000-0002-8759-5902; Gaythorpe, Katy/0000-0003-3734-9081; Monod, Melodie/0000-0001-6448-2051; Okell, Lucy/0000-0001-7202-6873; Mellan, Thomas/0000-0003-4185-9930; Unwin, Juliette/0000-0002-9120-4003; Coupland, Helen/0000-0003-3581-1404	NIHR HPRU in Modelling and Health Economics; Imperial College London; LSHTM [NIHR200908]; Imperial College Research Computing Service; Imperial College COVID-19 Response Fund; Bill AMP; Melinda Gates Foundation; EPSRC, through the EPSRC Centre for Doctoral Training in Modern Statistics and Statistical Machine Learning at Imperial and Oxford; MRC Centre for Global Infectious Disease Analysis - UK Medical Research Council (MRC) [MR/R015600/1]; UK Foreign, Commonwealth, and Development Office (FCDO), under the MRC-FCDO; European Union; PHE; MRC [MC_PC_19012, MR/R015600/1] Funding Source: UKRI	NIHR HPRU in Modelling and Health Economics; Imperial College London(General Electric); LSHTM; Imperial College Research Computing Service; Imperial College COVID-19 Response Fund; Bill AMP; Melinda Gates Foundation(CGIAR); EPSRC, through the EPSRC Centre for Doctoral Training in Modern Statistics and Statistical Machine Learning at Imperial and Oxford(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC Centre for Global Infectious Disease Analysis - UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Foreign, Commonwealth, and Development Office (FCDO), under the MRC-FCDO; European Union(European Commission); PHE; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the NIHR HPRU in Modelling and Health Economics, a partnership between PHE, Imperial College London and LSHTM (grant code NIHR200908), and the Imperial College Research Computing Service. We acknowledge funding from the Imperial College COVID-19 Response Fund; the Bill & Melinda Gates Foundation; the EPSRC, through the EPSRC Centre for Doctoral Training in Modern Statistics and Statistical Machine Learning at Imperial and Oxford; and the MRC Centre for Global Infectious Disease Analysis (reference MR/R015600/1), jointly funded by the UK Medical Research Council (MRC) and the UK Foreign, Commonwealth, and Development Office (FCDO), under the MRC-FCDO Concordat agreement and that is also part of the EDCTP2 program supported by the European Union. We thank Microsoft and Amazon for providing cloud computing services. The views expressed are those of the authors and not necessarily those of the United Kingdom (UK) Department of Health and Social Care, the National Health Service, the National Institute for Health Research (NIHR), or Public Health England (PHE)	Aiello AE, 2016, EPIDEMICS-NETH, V15, P38, DOI 10.1016/j.epidem.2016.01.001; Ainslie Kylie E C, 2020, Wellcome Open Res, V5, P81, DOI 10.12688/wellcomeopenres.15843.1; Alabama Public Health, 2020, DEMOGRAPHICS DEATHS; Alaska Department of Health and Social Services Coronavirus Response, 2020, DEMOGRAPHIC DISTRIBU; Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; Arizona Department of Health Services, 2020, COVID 19 DEATHS; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Boehmer TK, 2020, MMWR-MORBID MORTAL W, V69, P1404, DOI 10.15585/mmwr.mm6939e1; California Department of Public Health, 2020, STATEWIDE CASE STATS; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Centers for Disease Control and Prevention, 2020, COMMERCIAL LAB SEROP; Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Colorado Department of Public Health & Environment, 2020, DPHE COVID19 STATE L; Connecticut Open Data, 2020, COVID 19 CASES DEATH; Cook, 2020, PROJECTING CONTACT M, DOI [10.1101/2020.07.22.20159772, DOI 10.1101/2020.07.22.20159772]; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Delaware Environmental Public Health Tracking Network, 2020, DEMOGRAPHIC BREAKDOW; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Education Week, 2020, MAP CORONAVIRUS SCH; European Center for Disease Prevention and Control, CORONAVIRUS DIS 2019; European Center for Disease Prevention and Control,, 2020, CORONAVIRUS DIS 2019; European Centre for Disease Prevention and Control, 2020, COVID 19 CHILDREN RO; Feehan D. M., 2020, QUANTIFYING POPULATI, DOI [10.1101/2020.04.13.20064014, DOI 10.1101/2020.04.13.20064014]; Fisher KA, 2020, MMWR-MORBID MORTAL W, V69, P1258, DOI 10.15585/mmwr.mm6936a5; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Florida Division of Emergency Management,, 2020, CORONAVIRUS CHARACTE; Foursquare Inc, 2020, PILGRIM SDK; Friedman Joseph, 2020, medRxiv, DOI 10.1101/2020.07.13.20151233; Gelman A., 2013, BAYESIAN DATA ANAL, DOI [10.1201/b16018, DOI 10.1201/B16018]; Georgia Department of Public Health, 2020, DEATHS GEORGIA; Goldstein E, 2021, J INFECT DIS, V223, P362, DOI [10.1093/infdis/jiaa691, 10.1101/2020.07.19.20157362]; Google LLC, 2020, COVID 19 COMMUNITY M; Government of the District of Columbia, 2020, CORONAVIRUS DATASSSS; Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310; Hale T., 2021, VARIATION GOVT RESPO; Havers FP, 2020, JAMA INTERN MED, V180, P1576, DOI 10.1001/jamainternmed.2020.4130; Hoang T, 2019, EPIDEMIOLOGY, V30, P723, DOI 10.1097/EDE.0000000000001047; Holmdahl I, 2020, NEW ENGL J MED, V383, P303, DOI 10.1056/NEJMp2016822; Idaho Division of Public Health, 2020, COVID 19 DEMOGRAPHIC; Illinois Department of Public Health, 2020, AGE DEMOGRAPHICS; Imperial College London COVID-19 Response Team, 2020, COVID 19 AGE SPECIFI; Indiana State Department of Health, 2020, STATEWIDE DEMOGRAPHI; Iowa Department of Public Health, 2020, DEATHS AGE GROUP; Iyer Anita S, 2020, medRxiv, DOI 10.1101/2020.07.18.20155374; Jarvis CI, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01597-8; Jing QL, 2020, LANCET INFECT DIS, V20, P1141, DOI 10.1016/S1473-3099(20)30471-0; Kansas Department of Health and Environment, 2020, DEATH SUMMARY; Kentucky Department for Public Health, 2020, DEATHS AGE GROUP; L. L. C. Google, 2020, COVID 19 COMMUNITY M; Lavezzo E, 2020, NATURE, V584, P425, DOI 10.1038/s41586-020-2488-1; Levin AT, 2020, EUR J EPIDEMIOL, V35, P1123, DOI 10.1007/s10654-020-00698-1; Levinson M, 2020, NEW ENGL J MED, V383, P981, DOI 10.1056/NEJMms2024920; Liu YN, 2021, J CANCER EDUC, V36, P1014, DOI 10.1007/s13187-019-01682-4; Louisiana Department of Health, 2020, CASES DEATHS AGE; Maine Center for Disease Control & Prevention, 2020, MAINE COVID 19 SUMMA; Maryland Department of Health, 2020, CASES DEATHS DATA BR; Massachusetts Department of Public Health, 2020, DEATHS DEATH RATE AG; McAloon, 2020, INCUBATION PERIOD CO, DOI [10.1101 / 2020.04. 24.20073957, DOI 10.1101/2020.04.24.20073957, 10.1101/2020.04.24.20073957]; Messner W, 2020, PUBLIC HEALTH, V187, P15, DOI 10.1016/j.puhe.2020.07.035; Michigan Department of Health and Human Services, 2020, DATA REQUESTED DEP H; Michigan Department of Health and Human Services, 2020, DEATHS DEMOGRAPHIC C; Miller A. C., 2020, MEDRXIV, DOI DOI 10.1101/2020.05.07.20094441; Minnesota Department of Health, 2020, AGE GROUP DATA TABLE; Mishra, 2021, IMPERIALCOLLEGELONDO, DOI [10.5281 / ZENODO.4461896, DOI 10.5281/ZENODO.4461896]; Mississippi State Department of Health, 2020, COVID 19 CASES DEATH; Missouri Department of Health and Senior Services, 2020, DEATHS AGE RANGE; Mistry, 2020, ARXIV; Monod, 2021, IMPERIALCOLLEGELONDO, DOI [10.5281/ZENODO.4461896, DOI 10.5281/ZENODO.4461896]; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; National Centre for Education Statistics,, 2020, COMMON CORE DATA AME; New Hampshire Department of Health and Human Services, 2020, LAB CONFIRMED COVID; New Jersey Department of Health, 2020, DEATHS AGE GROUP; New Mexico Department of Health, 2020, UPDATED NEW MEXICO C; New York City Department of Health, 2020, CORONAVIRUS DATA; New York City Department of Health, 2020, NYC COVID 19 DEATHS; North Carolina Department of Health and Human Services, 2020, DEMOGRAPHIC DATA; North Dakota Department of Health, 2020, CASES AGE GROUP; Nouvellet, 2020, REPORT 26 REDUCTION, DOI [10.25561/79643, DOI 10.25561/79643]; Oklahoma State Department of Health, 2020, TOTAL DEATHS AGE GRO; Oregon Health Authority COVID-19, 2020, OREGONS COVID 19 CAS; Pei S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd6370; Pennsylvania State Department of Health, 2020, AGE DISTRIBUTION DEA; Potter GE, 2012, ANN APPL STAT, V6, P1, DOI 10.1214/11-AOAS505; Reiner RC, 2021, NAT MED, V27, P94, DOI 10.1038/s41591-020-1132-9; Rhode Island Department of Health, 2020, COVID 19 RHODE ISLAN; Rosenberg ES, 2020, ANN EPIDEMIOL, V48, P23, DOI 10.1016/j.annepidem.2020.06.004; Rossen LM, 2020, MMWR-MORBID MORTAL W, V69, P1522, DOI [10.1101/2020.06.06.20120857v1.full.pdf, 10.15585/mmwr.mm6942e2]; Schulien I, 2021, NAT MED, V27, P78, DOI 10.1038/s41591-020-01143-2; Smieszek T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-136; South Carolina Department of Health and Environmental Control, 2020, REPORTED COVID 19 DE; State of Hawaii Department of Health, 2020, WHAT ARE AGES GENDER; State of Nevada Department of Health and Human Services, 2020, RESULTS FILTER DEMOG; Tennessee Department of Health, 2020, CASE COUNTS 10 YEAR; Texas Department of State Health Services, 2020, AGE CONFIRMED FATALI; United States Census Bureau, 2018, AGE SEX AM COMMUNITY; United States Census Bureau, 2010, STATE AREA MEASUREME; Unwin H., 2020, REPORT 23 STATE LEVE, DOI [10.25561/79231, DOI 10.25561/79231]; Utah Department of Health, 2020, TOTAL DEATHS AGE; Van de Kassteele J, 2017, CONTACT PATTERNS; van de Kassteele J, 2017, ANN APPL STAT, V11, P320, DOI 10.1214/16-AOAS1006; Verity R, 2020, ESTIMATES SEVERITY C, DOI DOI 10.1101/2020.03.09.20033357; Vermont Department of Health, 2020, VERMONT COVID 19 DEA; Viner RM, 2020, SUSCEPTIBILITY TRANS, DOI [10.1101/2020.05.20.20108126, DOI 10.1101/2020.05.20.20108126]; Virginia Department of Health, 2020, CUMULATIVE TOTAL NUM; Vogel, 2020, SCH RISK CALCULATION; Volz E., 2021, MEDRXIV, DOI [10.1101/2020.12.30.20249034, DOI 10.1101/2020.12.30.20249034]; Waksman A., 2018, PHONES LAMBDAS JOY S; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Washington State Department of Health, 2020, DEATHS AGE GROUP; Waterfield T, 2021, ARCH DIS CHILD, V106, P680, DOI 10.1136/archdischild-2020-320558; Wikipedia, 2019, NEW YORK CITY; Wisconsin Department of Health Services, 2020, COVID 19 HIST DATA S; Wutzler, 2019, LOGNORM FUNCTIONS LO; Wyoming Department of Health, 2020, COVID 19 MAP STAT; YouGov PLC, 2020, PERSONAL MEASURES TA; Zhang JJ, 2020, LANCET INFECT DIS, V20, P793, DOI 10.1016/S1473-3099(20)30230-9; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344; LANCET PUBLIC HEALTH	121	119	121	5	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2021	371	6536					1336	+	eabe8372	10.1126/science.abe8372	http://dx.doi.org/10.1126/science.abe8372			132	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH2GI	33531384	Green Published, Green Submitted			2022-12-28	WOS:000636043400032
J	Rahbani, JF; Roesler, A; Hussain, MF; Samborska, B; Dykstra, CB; Tsai, L; Jedrychowski, MP; Vergnes, L; Reue, K; Spiegelman, BM; Kazak, L				Rahbani, Janane F.; Roesler, Anna; Hussain, Mohammed F.; Samborska, Bozena; Dykstra, Christien B.; Tsai, Linus; Jedrychowski, Mark P.; Vergnes, Laurent; Reue, Karen; Spiegelman, Bruce M.; Kazak, Lawrence			Creatine kinase B controls futile creatine cycling in thermogenic fat	NATURE			English	Article							BROWN; MITOCHONDRIAL; OBESITY; BEIGE; ABLATION; MUSCLE; BRITE	Obesity increases the risk of mortality because of metabolic sequelae such as type 2 diabetes and cardiovascular disease(1). Thermogenesis by adipocytes can counteract obesity and metabolic diseases(2,3). In thermogenic fat, creatine liberates a molar excess of mitochondrial ADP-purportedly via a phosphorylation cycle(4)-to drive thermogenic respiration. However, the proteins that control this futile creatine cycle are unknown. Here we show that creatine kinase B (CKB) is indispensable for thermogenesis resulting from the futile creatine cycle, during which it traffics to mitochondria using an internal mitochondrial targeting sequence. CKB is powerfully induced by thermogenic stimuli in both mouse and human adipocytes. Adipocyte-selective inactivation of Ckb in mice diminishes thermogenic capacity, increases predisposition to obesity, and disrupts glucose homeostasis. CKB is therefore a key effector of the futile creatine cycle. Upon induction by thermogenic stimuli, creatine kinase B traffics to mitochondria to trigger the futile creatine cycle in thermogenic fat.	[Rahbani, Janane F.; Roesler, Anna; Hussain, Mohammed F.; Samborska, Bozena; Dykstra, Christien B.; Kazak, Lawrence] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Rahbani, Janane F.; Roesler, Anna; Hussain, Mohammed F.; Samborska, Bozena; Dykstra, Christien B.; Kazak, Lawrence] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Tsai, Linus] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02115 USA; [Jedrychowski, Mark P.; Spiegelman, Bruce M.] Harvard Med Sch, Dept Cell Biol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Vergnes, Laurent; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	McGill University; McGill University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kazak, L (corresponding author), McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada.; Kazak, L (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	Lawrence.kazak@mcgill.ca		Tsai, Linus/0000-0002-0134-6949; Rahbani, Janane/0000-0003-4598-4683	Canadian Institutes of Health Research grant [PJT-159529]; Canadian Foundation for Innovation John R. Evans Leaders Fund [37919]; Canderel fellowship; Canderel studentship; Dr John R. and Clara M. Fraser Memorial Trust; Terry Fox Foundation; Quebec Breast Cancer Foundation; McGill University; Charlotte and Leo Karassik fellowship	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation John R. Evans Leaders Fund; Canderel fellowship; Canderel studentship; Dr John R. and Clara M. Fraser Memorial Trust; Terry Fox Foundation; Quebec Breast Cancer Foundation; McGill University; Charlotte and Leo Karassik fellowship	We thank P. Seale for discussions; the McGill Goodman Cancer Research Centre (GCRC) Metabolomics core facility for technical assistance; the Histology Core Facility at the McGill/GCRC for assistance with embedding and processing tissue samples; and all members of the Kazak laboratory for critical reading of the manuscript. This work was supported by a Canadian Institutes of Health Research grant (PJT-159529) and the Canadian Foundation for Innovation John R. Evans Leaders Fund (37919) (to L.K.); by Canderel and Charlotte and Leo Karassik fellowships (to J.F.R.); and by a Canderel studentship (to M.F.H.). The GCRC metabolomics core facility is funded by the Dr John R. and Clara M. Fraser Memorial Trust; the Terry Fox Foundation; the Quebec Breast Cancer Foundation and McGill University. L.K. is a Canada Research Chair in Adipocyte Biology.	Backes S, 2018, J CELL BIOL, V217, P1369, DOI 10.1083/jcb.201708044; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Betz MJ, 2018, NAT REV ENDOCRINOL, V14, P77, DOI 10.1038/nrendo.2017.132; Carpentier AC, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00447; Challa TD, 2020, CELL REP, V30, P3424, DOI 10.1016/j.celrep.2020.02.055; Corrigan JK, 2020, ELIFE, V9, DOI 10.7554/eLife.53560; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; EPPENBERGER HM, 1967, J BIOL CHEM, V242, P204; FURTER R, 1993, BIOCHEMISTRY-US, V32, P7022, DOI 10.1021/bi00078a030; Guo JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015961; Guo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000511; Hornemann T, 2000, BBA-PROTEIN STRUCT M, V1480, P365, DOI 10.1016/S0167-4838(00)00098-4; Kazak L, 2019, NAT METAB, V1, P360, DOI 10.1038/s42255-019-0035-x; Kazak L, 2017, CELL METAB, V26, P660, DOI 10.1016/j.cmet.2017.08.009; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Kazak L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062340; Kazak L, 2013, NUCLEIC ACIDS RES, V41, P2354, DOI 10.1093/nar/gks1347; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Lowe MTJ, 2013, J CEREBR BLOOD F MET, V33, P1295, DOI 10.1038/jcbfm.2013.84; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Min SY, 2019, P NATL ACAD SCI USA, V116, P17970, DOI 10.1073/pnas.1906512116; Perna MK, 2016, AMINO ACIDS, V48, P2057, DOI 10.1007/s00726-016-2291-3; Roh HC, 2018, CELL METAB, V27, P1121, DOI 10.1016/j.cmet.2018.03.005; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Vergnes L, 2016, J CLIN ENDOCR METAB, V101, P4440, DOI 10.1210/jc.2016-2670; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Ward ZJ, 2019, NEW ENGL J MED, V381, P2440, DOI 10.1056/NEJMsa1909301; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107	29	35	35	9	45	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846								10.1038/s41586-021-03221-y	http://dx.doi.org/10.1038/s41586-021-03221-y			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TY5ZN	33597756	Green Submitted, Green Accepted			2022-12-28	WOS:000683862400001
J	Redman, S; Greenhalgh, T; Adedokun, L; Staniszewska, S; Denegri, S				Redman, S.; Greenhalgh, T.; Adedokun, L.; Staniszewska, S.; Denegri, S.		Co-production Knowledge C	Co-production of knowledge: the future	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Redman, S.] Sax Inst, Sydney, NSW, Australia; [Greenhalgh, T.] Univ Oxford, Oxford, England; [Adedokun, L.] Doris Duke Charitable Fdn, New York, NY USA; [Staniszewska, S.] Univ Warwick, Warwick Res Nursing, Warwick Med Sch, Warwick, England; [Denegri, S.] Acad Med Sci, London, England	University of Sydney; University of Oxford; University of Warwick	Redman, S (corresponding author), Sax Inst, Sydney, NSW, Australia.		Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088	NIHR ARC West Midlands; NIHR HPRU Gastrointestinal Infections; NIHR HPRU Genomics and Enabling Data	NIHR ARC West Midlands; NIHR HPRU Gastrointestinal Infections; NIHR HPRU Genomics and Enabling Data	We have read and understood BMJ policy on declaration of interests and have no relevant interests to declare. SS is part funded by NIHR ARC West Midlands, the NIHR HPRU Gastrointestinal Infections, and the NIHR HPRU Genomics and Enabling Data, and SD is a member of the Allies Group of the Co-Production Collective.	Agyepong IA, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n166; [Anonymous], ACC PROGR SELF SUST; Beran D, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4785; George A, 2021, BMJ OPINION; Gilson L, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4650; Greenhalgh T, 2019, HEALTH EXPECT, V22, P785, DOI 10.1111/hex.12888; Greenhalgh T, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0467-4; Hansen P, 2021, BMJ OPINION; INVOLVE, 2019, COPR ACT NUMB ON; Kumanan R., 2021, BMJ OPINION; Moore G, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0411-0; Mouffe Chantal, 2013, AGONISTICTHINKING, V1st; Oliver K, 2019, HEALTH RES POLICY SY, V17, DOI 10.1186/s12961-019-0432-3; Sherriff SL, 2019, EVID POLICY, V15, P371, DOI 10.1332/174426419X15524681005401; Tangcharoensathien V, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4669; Tembo D, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n178; Turk E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4752; Williamson A, 2019, IMPLEMENT SCI S2, V14, P69, DOI [10.1186/s13012-019-0911-515, DOI 10.1186/S13012-019-0911-515]; Williamson A, 2019, HEALTH RES POLICY SY, V17, DOI 10.1186/s12961-018-0408-8; World Health Organization, 2004, WORLD REP KNOWL BETT	20	38	38	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2021	372								n434	10.1136/bmj.n434	http://dx.doi.org/10.1136/bmj.n434			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RA8YP	33593753	hybrid, Green Published			2022-12-28	WOS:000631706300006
J	Weedon, MN; Jackson, L; Harrison, JW; Ruth, KS; Tyrrell, J; Hattersley, AT; Wright, CF				Weedon, M. N.; Jackson, L.; Harrison, J. W.; Ruth, K. S.; Tyrrell, J.; Hattersley, A. T.; Wright, C. F.			Use of SNP chips to detect rare pathogenic variants: retrospective, population based diagnostic evaluation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENOME	OBJECTIVE To determine whether the sensitivity and specificity of SNP chips are adequate for detecting rare pathogenic variants in a clinically unselected population. DESIGN Retrospective, population based diagnostic evaluation. PARTICIPANTS 49 908 people recruited to the UK Biobank with SNP chip and next generation sequencing data, and an additional 21 people who purchased consumer genetic tests and shared their data online via the Personal Genome Project. MAIN OUTCOME MEASURES Genotyping (that is, identification of the correct DNA base at a specific genomic location) using SNP chips versus sequencing, with results split by frequency of that genotype in the population. Rare pathogenic variants in the BRCA1 and BRCA2 genes were selected as an exemplar for detailed analysis of clinically actionable variants in the UK Biobank, and BRCA related cancers (breast, ovarian, prostate, and pancreatic) were assessed in participants through use of cancer registry data. RESULTS Overall, genotyping using SNP chips performed well compared with sequencing; sensitivity, specificity, positive predictive value, and negative predictive value were all above 99% for 108 574 common variants directly genotyped on the SNP chips and sequenced in the UK Biobank. However, the likelihood of a true positive result decreased dramatically with decreasing variant frequency; for variants that are very rare in the population, with a frequency below 0.001% in UK Biobank, the positive predictive value was very low and only 16% of 4757 heterozygous genotypes from the SNP chips were confirmed with sequencing data. Results were similar for SNP chip data from the Personal Genome Project, and 20/21 individuals analysed had at least one false positive rare pathogenic variant that had been incorrectly genotyped. For pathogenic variants in the BRCA1 and BRCA2 genes, which are individually very rare, the overall performance metrics for the SNP chips versus sequencing in the UK Biobank were: sensitivity 34.6%, specificity 98.3%, positive predictive value 4.2%, and negative predictive value 99.9%. Rates of BRCA related cancers in UK Biobank participants with a positive SNP chip result were similar to those for age matched controls (odds ratio 1.31, 95% confidence interval 0.99 to 1.71) because the vast majority of variants were false positives, whereas sequence positive participants had a significantly increased risk (odds ratio 4.05, 2.72 to 6.03). CONCLUSIONS SNP chips are extremely unreliable for genotyping very rare pathogenic variants and should not be used to guide health decisions without validation.	[Weedon, M. N.; Jackson, L.; Harrison, J. W.; Ruth, K. S.; Tyrrell, J.; Hattersley, A. T.; Wright, C. F.] Univ Exeter, Coll Med & Hlth, Royal Devon & Exeter Hosp, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England	University of Exeter	Wright, CF (corresponding author), Univ Exeter, Coll Med & Hlth, Royal Devon & Exeter Hosp, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England.	caroline.wright@exeter.ac.uk		Wright, Caroline/0000-0003-2958-5076; Harrison, James/0000-0002-8314-9411	Wellcome Trust [098395]; UK Biobank Resource [49847]	Wellcome Trust(Wellcome TrustEuropean Commission); UK Biobank Resource	This research has been conducted using the UK Biobank Resource under Application Number 49847, using the University of Exeter High-Performance Computing (HPC) facility. ATH is a Wellcome Trust Senior Investigator (098395) and an NIHR senior investigator. The funders had no influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. Ethical approval: The UK Biobank has received ethics approval from the National Health Service National Research Ethics Service (ref 11/NW/0382).	AlHilli MM, 2019, J MINIM INVAS GYN, V26, P253, DOI 10.1016/j.jmig.2018.09.767; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Ball MP, 2014, GENOME MED, V6, DOI 10.1186/gm527; Border R, 2019, AM J PSYCHIAT, V176, P376, DOI 10.1176/appi.ajp.2018.18070881; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chen R, 2016, NAT BIOTECHNOL, V34, P531, DOI 10.1038/nbt.3514; Chin ELH, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-6; Clark MM, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0053-8; Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799; Ellard S, 2015, EUR J HUM GENET, V23, P401, DOI 10.1038/ejhg.2014.120; Esplin ED, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.SABCS18-P4-03-06; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; Horton R, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5688; Kapoor RR, 2013, EUR J ENDOCRINOL, V168, P557, DOI 10.1530/EJE-12-0673; Kellog G, 2019, IMPLICATIONS FDA APP; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Ludwig KK, 2016, AM J SURG, V212, P660, DOI 10.1016/j.amjsurg.2016.06.010; Mattocks CJ, 2010, EUR J HUM GENET, V18, P1276, DOI 10.1038/ejhg.2010.101; MIT Technology Review, 2019, MORE 26 MILLION PEOP; Moscarello T, 2019, GENET MED, V21, P539, DOI 10.1038/s41436-018-0097-2; Nelson SC, 2019, AM J HUM GENET, V105, P122, DOI 10.1016/j.ajhg.2019.05.014; Price AL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1684; Schleit J, 2019, GENET MED, V21, P510, DOI 10.1038/s41436-018-0071-z; Smart A, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-016-0240-3; Tandy-Connor S, 2018, GENET MED, V20, P1515, DOI 10.1038/gim.2018.38; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; van de Putte R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217477; van der Wouden CH, 2016, ANN INTERN MED, V164, P513, DOI 10.7326/M15-0995; Van Hout CV, 2020, NATURE, V586, P749, DOI 10.1038/s41586-020-2853-0; Vasen HFA, 2007, J MED GENET, V44, P353, DOI 10.1136/jmg.2007.048991; Visscher PM, 2019, GENETICS, V211, P1125, DOI 10.1534/genetics.118.301594; Whiffin N, 2017, GENET MED, V19, P1151, DOI 10.1038/gim.2017.26; Wright CF, 2019, AM J HUM GENET, V104, P275, DOI 10.1016/j.ajhg.2018.12.015; Wuttke TV, 2007, NEUROLOGY, V69, P2045, DOI 10.1212/01.wnl.0000275523.95103.36	37	16	16	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2021	372								n214	10.1136/bmj.n214	http://dx.doi.org/10.1136/bmj.n214			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RA8YP	33589468	Green Published, hybrid			2022-12-28	WOS:000631706300010
J	Rimmer, A				Rimmer, Abi			Covid-19: Healthcare staff must be given time to recuperate from pandemic, say leaders	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2021	372								n420	10.1136/bmj.n420	http://dx.doi.org/10.1136/bmj.n420			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM2MY	33574038	Bronze			2022-12-28	WOS:000639500800009
J	Brooks, JT; Butler, JC				Brooks, John T.; Butler, Jay C.			Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This JAMA Insights CDC review summarizes accumulating evidence that mask wearing reduces spread of SARS-CoV-2 infection and that universal mandatory mask wearing policies reduce infections and deaths and emphasizes face masks are one component of pandemic control measures, including physical distancing and handwashing, pending natural or vaccine-induced population immunity.	[Brooks, John T.; Butler, Jay C.] Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Brooks, JT (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, 1600 Clifton Rd NE,Mailstop D-21, Atlanta, GA 30333 USA.	zud4@cdc.gov		Brooks, John/0000-0002-2399-3389				Bundgaard H, 2021, ANN INTERN MED, V174, P335, DOI 10.7326/M20-6817; Doung-ngern P, 2020, EMERG INFECT DIS, V26, P2607, DOI 10.3201/eid2611.203003; JOHANSSON MA, 2021, JAMA NETW OPEN, V4, DOI [10.1001/jamanetworkopen.2020.35057, DOI 10.1001/JAMANETWORKOPEN.2020.35057]; Lindsley WG, 2021, AEROSOL SCI TECH, V55, P449, DOI 10.1080/02786826.2020.1862409; Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818; Payne DC, 2020, MMWR-MORBID MORTAL W, V69, P714, DOI [10.15585/mmwr.mm6923e4, 10.15585/mmwr.mm6923e4externalicon]; Ruba AL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243708; Samannan R, 2021, ANN AM THORAC SOC, V18, P539, DOI 10.1513/AnnalsATS.202007-812RL; Ueki H, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00637-20; Wang Y, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002794	10	118	121	4	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2021	325	10					998	999		10.1001/jama.2021.1505	http://dx.doi.org/10.1001/jama.2021.1505		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV3UE	33566056	Bronze, Green Accepted			2022-12-28	WOS:000617178800002
J	Deng, SZ; Chen, HJ				Deng, Shaozhi; Chen, Huanjun			Ultrafast generation of optical hyperbolicity	SCIENCE			English	Editorial Material							POLARITONS		[Deng, Shaozhi; Chen, Huanjun] Sun Yat Sen Univ, Sch Elect & Informat Technol, Guangdong Prov Key Lab Display Mat & Technol, State Key Lab Optoelect Mat & Technol, Guangzhou 510275, Peoples R China	Sun Yat Sen University	Deng, SZ (corresponding author), Sun Yat Sen Univ, Sch Elect & Informat Technol, Guangdong Prov Key Lab Display Mat & Technol, State Key Lab Optoelect Mat & Technol, Guangzhou 510275, Peoples R China.	stsdsz@mail.sysu.edu.cn			National Key R&D Program of China [2019YFA0210201, 2019YFA0210203]; National Natural Science Foundation of China [91963205]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	S.D. and H.C. thank the National Key R&D Program of China (nos.2019YFA0210201 and 2019YFA0210203) and the National Natural Science Foundation of China (no. 91963205).	Basov DN, 2016, SCIENCE, V354, DOI 10.1126/science.aag1992; Dai S, 2014, SCIENCE, V343, P1125, DOI 10.1126/science.1246833; Korzeb K, 2015, OPT EXPRESS, V23, P25406, DOI 10.1364/OE.23.025406; Low T, 2017, NAT MATER, V16, P182, DOI [10.1038/NMAT4792, 10.1038/nmat4792]; Ma WL, 2018, NATURE, V562, P557, DOI 10.1038/s41586-018-0618-9; Poddubny A, 2013, NAT PHOTONICS, V7, P948, DOI [10.1038/NPHOTON.2013.243, 10.1038/nphoton.2013.243]; Shen Y, 2019, ACS NANO, V13, P1977, DOI 10.1021/acsnano.8b08444; Sternbach A.J., 2020, SCIENCE, V371, P617; Taboada-Gutierrez J, 2020, NAT MATER, V19, P964, DOI 10.1038/s41563-020-0665-0; Tielrooij KJ, 2018, NAT NANOTECHNOL, V13, P41, DOI 10.1038/s41565-017-0008-8; Wang C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15001-9; Zheng ZB, 2018, ADV MATER, V30, DOI 10.1002/adma.201705318	12	0	0	3	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		572	573		10.1126/science.abf7933	http://dx.doi.org/10.1126/science.abf7933			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QD7TF	33542125				2022-12-28	WOS:000615715300033
J	O'Dowd, A				O'Dowd, Adrian			Covid-19: Black people over 80 in England are half as likely as white people to have been vaccinated	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Morton CE, 2021, TRENDS REGIONAL VARI, DOI [10.1101/2021.01.25.21250356, DOI 10.1101/2021.01.25.21250356]	1	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2021	372								n357	10.1136/bmj.n357	http://dx.doi.org/10.1136/bmj.n357			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH2PI	33547172	Bronze			2022-12-28	WOS:000618119100005
J	Rimmer, A				Rimmer, Abi			Covid-19: Drop the hero narrative and support doctors' mental health, says charity	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mental Health at Work, OUR FRONTL; Mental Health at Work, SUPP MENT HLTH NHS S	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2021	372								n337	10.1136/bmj.n337	http://dx.doi.org/10.1136/bmj.n337			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QH2NH	33541858	Bronze			2022-12-28	WOS:000618113700001
J	Wu, C; Dai, RP				Wu, Chan; Dai, Rongping			Central Retinal Artery and Vein Occlusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wu, Chan; Dai, Rongping] Peking Union Med Coll Hosp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Wu, C (corresponding author), Peking Union Med Coll Hosp, Beijing, Peoples R China.								0	0	0	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2021	384	5								10.1056/NEJMicm2026957	http://dx.doi.org/10.1056/NEJMicm2026957			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QX4QW	33534977				2022-12-28	WOS:000629333200001
J	Hofman, MS; Emmett, L; Sandhu, S; Iravani, A; Joshua, AM; Goh, JC; Pattison, DA; Tan, TH; Kirkwood, ID; Ng, S; Francis, RJ; Gedye, C; Rutherford, NK; Weickhardt, A; Scott, AM; Lee, ST; Kwan, EM; Azad, AA; Ramdave, S; Redfern, AD; Macdonald, W; Guminski, A; Hsiao, E; Chua, W; Lin, P; Zhang, AY; McJannett, MM; Stockler, MR; Violet, JA; Williams, SG; Martin, AJ; Davis, ID				Hofman, Michael S.; Emmett, Louise; Sandhu, Shahneen; Iravani, Amir; Joshua, Anthony M.; Goh, Jeffrey C.; Pattison, David A.; Tan, Thean Hsiang; Kirkwood, Ian D.; Ng, Siobhan; Francis, Roslyn J.; Gedye, Craig; Rutherford, Natalie K.; Weickhardt, Andrew; Scott, Andrew M.; Lee, Sze-Ting; Kwan, Edmond M.; Azad, Arun A.; Ramdave, Shakher; Redfern, Andrew D.; Macdonald, William; Guminski, Alex; Hsiao, Edward; Chua, Wei; Lin, Peter; Zhang, Alison Y.; McJannett, Margaret M.; Stockler, Martin R.; Violet, John A.; Williams, Scott G.; Martin, Andrew J.; Davis, Ian D.		TheraP Trial Investigators; Australian New Zealand Urogenital	[Lu-177]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial	LANCET			English	Article								Background Lutetium-177 [Lu-177]Lu-PSMA-617 is a radiolabelled small molecule that delivers beta radiation to cells expressing prostate-specific membrane antigen (PSMA), with activity and safety in patients with metastatic castration-resistant prostate cancer. We aimed to compare [Lu-177]Lu-PSMA-617 with cabazitaxel in patients with metastatic castration-resistant prostate cancer. Methods We did this multicentre, unblinded, randomised phase 2 trial at 11 centres in Australia. We recruited men with metastatic castration-resistant prostate cancer for whom cabazitaxel was considered the next appropriate standard treatment. Participants were required to have adequate renal, haematological, and liver function, and an Eastern Cooperative Oncology Group performance status of 0-2. Previous treatment with androgen receptor-directed therapy was allowed. Men underwent gallium-68 [Ga-68]Ga-PSMA-11 and 2-flourine-18[F-18]fluoro-2-deoxy-D-glucose (FDG) PET-CT scans. PET eligibility criteria for the trial were PSMA-positive disease, and no sites of metastatic disease with discordant FDG-positive and PSMA-negative findings. Men were randomly assigned (1:1) to [Lu-177] Lu-PSMA-617 (6.0-8-5 GBq intravenously every 6 weeks for up to six cycles) or cabazitaxel (20 mg/m(2) intravenously every 3 weeks for up to ten cycles). The primary endpoint was prostate-specific antigen (PSA) response defined by a reduction of at least 50% from baseline. This trial is registered with ClinicalTrials.gov, NCT03392428. Findings Between Feb 6,2018, and Sept 3,2019, we screened 291 men, of whom 200 were eligible on PET imaging. Study treatment was received by 98 (99%) of 99 men randomly assigned to [Lu-177]Lu-PSMA-617 versus 85 (84%) of 101 randomly assigned to cabazitaxel. PSA responses were more frequent among men in the [Lu-177]Lu-PSMA-617 group than in the cabazitaxel group (65 vs 37 PSA responses; 66% vs 37% by intention to treat; difference 29% (95% CI 16-42; p<0.0001; and 66% vs 44% by treatment received; difference 23% [9-37]; p=0.0016). Grade 3-4 adverse events occurred in 32 (33%) of 98 men in the [Lu-177]Lu-PSMA-617 group versus 45 (53%) of 85 men in the cabazitaxel group. No deaths were attributed to [Lu-177]Lu-PSMA-617. Interpretation [Lu-177]Lu-PSMA-617 compared with cabazitaxel in men with metastatic castration-resistant prostate cancer led to a higher PSA response and fewer grade 3 or 4 adverse events. [Lu-177]Lu-PSMA-617 is a new effective class of therapy and a potential alternative to cabazitaxel. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Hofman, Michael S.; Sandhu, Shahneen; Iravani, Amir; Azad, Arun A.; Violet, John A.; Williams, Scott G.] Peter MacCallum Canc Ctr, Prostate Canc Theranost & Imaging Ctr Excellence, Mol Imaging & Therapeut Nucl Med, Melbourne, Vic, Australia; [Hofman, Michael S.; Sandhu, Shahneen; Azad, Arun A.; Violet, John A.; Williams, Scott G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Scott, Andrew M.; Lee, Sze-Ting] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Emmett, Louise] St Vincents Hosp, Dept Theranost & Nucl Med, Sydney, NSW, Australia; [Joshua, Anthony M.] St Vincents Hosp, Dept Med Oncol, Kinghorn Canc Ctr, Sydney, NSW, Australia; [Emmett, Louise; Lin, Peter] UNSW Sydney, Fac Med, Sydney, NSW, Australia; [Iravani, Amir] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Pattison, David A.] Royal Brisbane & Womens Hosp, Dept Nucl Med & Specialised PET Serv, Brisbane, Qld, Australia; [Goh, Jeffrey C.] Royal Brisbane & Womens Hosp, Dept Med Oncol, Brisbane, Qld, Australia; [Pattison, David A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Tan, Thean Hsiang; Kirkwood, Ian D.] Royal Adelaide Hosp, Dept Oncol, Adelaide, SA, Australia; [Kirkwood, Ian D.] Royal Adelaide Hosp, Dept Nucl Med & PET, Adelaide, SA, Australia; [Tan, Thean Hsiang; Kirkwood, Ian D.] Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA, Australia; [Ng, Siobhan] Sir Charles Gairdner Hosp, Dept Oncol, Perth, WA, Australia; [Francis, Roslyn J.] Sir Charles Gairdner Hosp, Dept Nucl Med, Perth, WA, Australia; [Ng, Siobhan; Francis, Roslyn J.; Redfern, Andrew D.] Univ Western Australia, Sch Med, Perth, WA, Australia; [Gedye, Craig] Calvary Mater Newcastle, Dept Med Oncol, Waratah, NSW, Australia; [Rutherford, Natalie K.] Hunter New England Hlth, Dept Nucl Med, Newcastle, NSW, Australia; [Gedye, Craig; Rutherford, Natalie K.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia; [Weickhardt, Andrew] Austin Hlth, Olivia Newton John Canc & Wellness Ctr, Melbourne, Vic, Australia; [Scott, Andrew M.; Lee, Sze-Ting] Austin Hlth, Dept Mol Imaging & Therapy, Melbourne, Vic, Australia; [Weickhardt, Andrew; Scott, Andrew M.; Lee, Sze-Ting] La Trobe Univ, Sch Canc Med, Melbourne, Vic, Australia; [Scott, Andrew M.; Lee, Sze-Ting] Olivia Newton John Canc Res Inst, Melbourne, Vic, Australia; [Kwan, Edmond M.] Monash Hlth, Dept Med Oncol, Melbourne, Vic, Australia; [Ramdave, Shakher] Monash Hlth, Monash Hlth Imaging, Melbourne, Vic, Australia; [Redfern, Andrew D.] Fiona Stanley Hosp, Dept Med Oncol, Perth, WA, Australia; [Macdonald, William] Fiona Stanley Hosp, Dept Nucl Med, Perth, WA, Australia; [Guminski, Alex] Royal North Shore Hosp, Dept Med Oncol, Sydney, NSW, Australia; [Hsiao, Edward] Royal North Shore Hosp, Dept Nucl Med & PET, Sydney, NSW, Australia; [Guminski, Alex; Zhang, Alison Y.; Stockler, Martin R.; Martin, Andrew J.] Univ Sydney, NHMRC Clin Trials Ctr, Northern Clin Sch, Sydney, NSW, Australia; [Chua, Wei] Liverpool Hosp, Dept Med Oncol, Sydney, NSW, Australia; [Lin, Peter] Liverpool Hosp, Dept Nucl Med & PET, Sydney, NSW, Australia; [McJannett, Margaret M.] Australian & New Zealand Urogenital & Prostate Ca, Sydney, NSW, Australia; [Zhang, Alison Y.] Macquarie Univ Hosp, Dept Med Oncol, Sydney, NSW, Australia; [Zhang, Alison Y.; Stockler, Martin R.] Chris OBrien Lifehouse, Dept Med Oncol, Sydney, NSW, Australia; [Davis, Ian D.] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic, Australia; [Davis, Ian D.] Eastern Hlth, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; St Vincents Hospital Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; Washington University (WUSTL); Royal Brisbane & Women's Hospital; Royal Brisbane & Women's Hospital; University of Queensland; Royal Adelaide Hospital; Royal Adelaide Hospital; University of Adelaide; University of Western Australia; University of Western Australia; University of Western Australia; Calvary Mater Newcastle Hospital; University of Newcastle; Florey Institute of Neuroscience & Mental Health; La Trobe University; Olivia Newton-John Cancer Research Institute; Florey Institute of Neuroscience & Mental Health; La Trobe University; La Trobe University; Olivia Newton-John Cancer Research Institute; Royal North Shore Hospital; Royal North Shore Hospital; University of Sydney; Liverpool Hospital; Liverpool Hospital; Macquarie University; University of Sydney; Monash University	Hofman, MS (corresponding author), Peter MacCallum Canc Ctr, Prostate Canc Theranost & Imaging Ctr Excellence, Mol Imaging & Therapeut Nucl Med, Melbourne, Vic, Australia.	michael.hofman@petermac.org	Pattison, David/C-7266-2017; Iravani, Amir/AAH-5355-2019	Pattison, David/0000-0001-9718-5598; Iravani, Amir/0000-0002-1273-5835; Martin, Andrew/0000-0001-5804-2295; Redfern, Andrew/0000-0001-6728-8713; Zhang, Alison/0000-0002-1902-6863; Francis, Roslyn/0000-0002-6256-1351; Emmett, Louise/0000-0002-4895-7384	Prostate Cancer Foundation of Australia; Endocyte (a Novartis company); Australian Nuclear Science and Technology Organization; Movember; Distinguished Gentleman's Ride, It's a Bloke Thing; CAN4CANCER	Prostate Cancer Foundation of Australia; Endocyte (a Novartis company); Australian Nuclear Science and Technology Organization; Movember; Distinguished Gentleman's Ride, It's a Bloke Thing; CAN4CANCER	Prostate Cancer Foundation of Australia, Endocyte (a Novartis company), Australian Nuclear Science and Technology Organization, Movember, The Distinguished Gentleman's Ride, It's a Bloke Thing, and CAN4CANCER.	Bailey DL, 2018, J NUCL MED, V59, P636, DOI 10.2967/jnumed.117.202861; Chauvie S, 2014, CLIN TRIALS, V11, P355, DOI 10.1177/1740774514525690; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; de Wit R, 2019, NEW ENGL J MED, V381, P2506, DOI 10.1056/NEJMoa1911206; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Emmett L, 2019, CLIN GENITOURIN CANC, V17, P15, DOI 10.1016/j.clgc.2018.09.014; Gillessena S, 2020, EUR UROL, V77, P508, DOI 10.1016/j.eururo.2020.01.012; Heck MM, 2019, EUR UROL, V75, P920, DOI 10.1016/j.eururo.2018.11.016; Hofman MS, 2019, BJU INT, V124, P5, DOI 10.1111/bju.14876; Hofman MS, 2018, LANCET ONCOL, V19, P825, DOI 10.1016/S1470-2045(18)30198-0; Kratochwil C, 2016, J NUCL MED, V57, P1170, DOI 10.2967/jnumed.115.171397; Rahbar K, 2016, J NUCL MED, V57, P1334, DOI 10.2967/jnumed.116.173757; Scher HI, 2016, J CLIN ONCOL, V34, P1402, DOI 10.1200/JCO.2015.64.2702; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Thang SP, 2019, EUR UROL ONCOL, V2, P670, DOI 10.1016/j.euo.2018.11.007; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Violet J, 2020, J NUCL MED, V61, P857, DOI 10.2967/jnumed.119.236414	18	253	257	21	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					797	804		10.1016/S0140-6736(21)00237-3	http://dx.doi.org/10.1016/S0140-6736(21)00237-3		FEB 2021	8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QP6DN	33581798				2022-12-28	WOS:000623925500030
J	Rimmer, A				Rimmer, Abi			Respiratory workforce is in a state of constant crisis, doctors warn	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Taskforce for Lung Health, 3 PEOPL LUNG COND FE	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2021	372								n497	10.1136/bmj.n497	http://dx.doi.org/10.1136/bmj.n497			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UD4NC	33602675				2022-12-28	WOS:000687183600005
J	Rosenberg, ES				Rosenberg, Eric S.			Case 5-2021: A 68-Year-Old Man with Delirium and Renal Insufficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article																		Gornik HL, 2008, CIRCULATION, V117, P3039, DOI 10.1161/CIRCULATIONAHA.107.760686; Lee CJ, 2017, ANN VASC SURG, V39, DOI 10.1016/j.avsg.2016.05.120; Liu YQ, 2019, J ONCOL, V2019, DOI 10.1155/2019/6230409; Parent ME, 2018, CLIN RHEUMATOL, V37, P2297, DOI 10.1007/s10067-018-4136-9; Asin MAPJ, 2014, MEDICINE, V93, P236, DOI 10.1097/MD.0000000000000119; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573	7	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2021	384	7					651	662		10.1056/NEJMcpc1913474	http://dx.doi.org/10.1056/NEJMcpc1913474			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2HH	33596360				2022-12-28	WOS:000620900000013
J	Tan, X; Letendre, JH; Collins, JJ; Wong, WW				Tan, Xiao; Letendre, Justin H.; Collins, James J.; Wong, Wilson W.			Synthetic biology in the clinic: engineering vaccines, diagnostics, and therapeutics	CELL			English	Review								Synthetic biology is a design-driven discipline centered on engineering novel biological functions through the discovery, characterization, and repurposing of molecular parts. Several synthetic biological solutions to critical biomedical problems are on the verge of widespread adoption and demonstrate the burgeoning maturation of the field. Here, we highlight applications of synthetic biology in vaccine development, molecular diagnostics, and cell-based therapeutics, emphasizing technologies approved for clinical use or in active clinical trials. We conclude by drawing attention to recent innovations in synthetic biology that are likely to have a significant impact on future applications in biomedicine.	[Tan, Xiao; Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Tan, Xiao] Massachusetts Gen Hosp, Div Gastroenterol, 55 Fruit St, Boston, MA 02114 USA; [Tan, Xiao] Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA; [Tan, Xiao; Collins, James J.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Letendre, Justin H.; Wong, Wilson W.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Letendre, Justin H.; Wong, Wilson W.] Boston Univ, Biol Design Ctr, Boston, MA 02215 USA; [Collins, James J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Collins, James J.] MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Collins, James J.] Harvard MIT Program Hlth Sci & Technol, Cambridge, MA 02139 USA; [Collins, James J.] Broad Inst MIT & Harvard, Cambridge, MA 02139 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Boston University; Boston University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Collins, JJ (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Collins, JJ (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Wong, WW (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.; Wong, WW (corresponding author), Boston Univ, Biol Design Ctr, Boston, MA 02215 USA.; Collins, JJ (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), Harvard MIT Program Hlth Sci & Technol, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02139 USA.	jimjc@mit.edu; wilwong@bu.edu			American Gastroenterological Association Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease; NIH [5F31HL149334, 1R56EB027729-01A1, 1R01GM129011-01, R01EB029483, 1DP2CA186574]; Paul G. Allen Frontiers Group; Wyss Institute; Boston University Ignition Award; NSF [1522074]; NSF CAREER [162457]; NSF BBSRC [1614642]	American Gastroenterological Association Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul G. Allen Frontiers Group; Wyss Institute; Boston University Ignition Award; NSF(National Science Foundation (NSF)); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	X.T. is supported by an American Gastroenterological Association Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease and the Wyss Institute. J.H.L. acknowledges funding from NIH 5F31HL149334. J.J.C. acknowledges funding from the Paul G. Allen Frontiers Group and the Wyss Institute. W.W.W. acknowledges funding from the Boston University Ignition Award, NIH (1DP2CA186574, 1R56EB027729-01A1, 1R01GM129011-01, R01EB029483), NSF Expedition in Computing (1522074), NSF CAREER (162457), and NSF BBSRC (1614642).	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Ackerman CM, 2020, NATURE, V582, P277, DOI 10.1038/s41586-020-2279-8; Alleman MM, 2020, MMWR-MORBID MORTAL W, V69, P489, DOI 10.15585/mmwr.mm6916a1; Alley EC, 2019, NAT METHODS, V16, P1315, DOI 10.1038/s41592-019-0598-1; Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Andries O, 2015, J CONTROL RELEASE, V217, P337, DOI 10.1016/j.jconrel.2015.08.051; Angenent-Mari NM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18677-1; Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Athey J, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1793-7; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Badran AH, 2015, CURR OPIN CHEM BIOL, V24, P1, DOI 10.1016/j.cbpa.2014.09.040; Balsells E, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010407; Barnes KG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17994-9; Basu P, 2018, INT J GYNECOL CANCER, V28, P764, DOI 10.1097/IGC.0000000000001235; Becerra CR, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.2536; Beissert T, 2020, MOL THER, V28, P119, DOI 10.1016/j.ymthe.2019.09.009; Benn CS, 2020, LANCET INFECT DIS, V20, pE274, DOI 10.1016/S1473-3099(19)30742-X; Bielamowicz K, 2018, NEURO-ONCOLOGY, V20, P506, DOI 10.1093/neuonc/nox182; Bonifant CL, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.11; Boyiadzis MM, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0460-5; Bradley AJ, 1999, BBA-BIOMEMBRANES, V1418, P19, DOI 10.1016/S0005-2736(99)00013-9; Brito LA, 2015, ADV GENET, V89, P179, DOI 10.1016/bs.adgen.2014.10.005; Broughton JP, 2020, NAT BIOTECHNOL, V38, P870, DOI 10.1038/s41587-020-0513-4; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006; Cao JX, 2020, CYTOTHERAPY, V22, P214, DOI 10.1016/j.jcyt.2020.01.015; Carding Simon, 2015, Microbial Ecology in Health and Disease, V26, P26191, DOI 10.3402/mehd.v26.26191; Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245; Cho JH, 2018, CELL, V173, P1426, DOI 10.1016/j.cell.2018.03.038; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Codagenix, 2020, CODAGENIX ANNOUNCES; Cogent Biosciences, 2020, UN THER PROV UPD ITS; Cogent Biosciences, 2019, UN THER ANN REG UPD; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Corbett KS, 2019, MBIO, V10, DOI 10.1128/mBio.02810-18; CureVac, 2020, CUREVACS COVID 19 VA; Deguine Jacques, 2014, F1000Prime Rep, V6, P97, DOI 10.12703/P6-97; Devarkar SC, 2016, P NATL ACAD SCI USA, V113, P596, DOI 10.1073/pnas.1515152113; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Didovyk A, 2017, ACS SYNTH BIOL, V6, P2198, DOI 10.1021/acssynbio.7b00253; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Eitzinger S, 2020, NUCLEIC ACIDS RES, V48, P4698, DOI 10.1093/nar/gkaa219; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Fan RLY, 2015, J VIROL, V89, P10762, DOI 10.1128/JVI.01443-15; Feaster M, 2020, EMERG INFECT DIS, V26, P2416, DOI 10.3201/eid2610.202694; Fedorov VD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006597; Fletcher JR, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00089-18; Ford C., 2019, OPEN FORUM INFECT DI, V6, pS547; Foster AE, 2017, MOL THER, V25, P2176, DOI 10.1016/j.ymthe.2017.06.014; Fuchs R.T., 2019, CAS12A TRANSCLEAVAGE, DOI [10.1101/600890, DOI 10.1101/600890]; Fuller DH, 2020, NEW ENGL J MED, V382, P2469, DOI 10.1056/NEJMcibr2009737; Furukawa Nathan W, 2020, Emerg Infect Dis, V26, DOI 10.3201/eid2607.201595; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Grada Z, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.32; Grawe A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210940; Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002; Gudbjartsson DF, 2020, NEW ENGL J MED, V383, P1724, DOI 10.1056/NEJMoa2026116; Guntas G, 2015, P NATL ACAD SCI USA, V112, P112, DOI 10.1073/pnas.1417910112; Gussow AB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17652-0; Gust J, 2019, ANN NEUROL, V86, P42, DOI 10.1002/ana.25502; HERWEIJER H, 1995, HUM GENE THER, V6, P1161, DOI 10.1089/hum.1995.6.9-1161; Hong F, 2020, CELL, V180, P1018, DOI 10.1016/j.cell.2020.02.011; Hsiao V, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156663; Humphreys IR, 2018, IMMUNOLOGY, V153, P1, DOI 10.1111/imm.12829; Hyatt D, 2012, BIOINFORMATICS, V28, P2223, DOI 10.1093/bioinformatics/bts429; Isabella VM, 2018, NAT BIOTECHNOL, V36, P857, DOI 10.1038/nbt.4222; Ishino Y, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00580-17; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Jackson NAC, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-0159-8; Joung J, 2020, NEW ENGL J MED, V383, P1492, DOI 10.1056/NEJMc2026172; Jung JK, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0571-7; Jurburg SD, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00271; Kaminski MM, 2020, NAT BIOMED ENG, V4, P601, DOI 10.1038/s41551-020-0546-5; Kanekiyo M, 2019, J INFECT DIS, V219, pS88, DOI 10.1093/infdis/jiy745; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kariko K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr695; Kowalski PS, 2019, MOL THER, V27, P710, DOI 10.1016/j.ymthe.2019.02.012; Kudo K, 2014, CANCER RES, V74, P93, DOI 10.1158/0008-5472.CAN-13-1365; Kuida K, 2000, INT J BIOCHEM CELL B, V32, P121, DOI 10.1016/S1357-2725(99)00024-2; Kumar M, 2019, NAT MICROBIOL, V4, P1253, DOI 10.1038/s41564-019-0491-9; Kunjapur AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06798-7; Lanitis E, 2013, CANCER IMMUNOL RES, V1, P43, DOI 10.1158/2326-6066.CIR-13-0008; Le Nouen C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01250; Le Nouen C, 2014, P NATL ACAD SCI USA, V111, P13169, DOI 10.1073/pnas.1411290111; Lee JW, 2018, NAT CHEM BIOL, V14, P530, DOI 10.1038/s41589-018-0056-x; Lee RA, 2020, P NATL ACAD SCI USA, V117, P25722, DOI 10.1073/pnas.2010196117; Leitman EM, 2016, J INFECT DIS, V214, P379, DOI 10.1093/infdis/jiw093; Leslie HH, 2017, B WORLD HEALTH ORGAN, V95, P738, DOI 10.2471/BLT.17.191916; Li L, 2016, EXPERT REV VACCINES, V15, P313, DOI 10.1586/14760584.2016.1124762; Li LX, 2019, ACS SYNTH BIOL, V8, P2228, DOI 10.1021/acssynbio.9b00209; Li SY, 2018, CELL RES, V28, P491, DOI 10.1038/s41422-018-0022-x; Lillacci G, 2018, NUCLEIC ACIDS RES, V46, P9855, DOI 10.1093/nar/gky795; Linderman SL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005806; Lohmueller JJ, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1368604; Lopez-Sagaseta J, 2016, COMPUT STRUCT BIOTEC, V14, P58, DOI 10.1016/j.csbj.2015.11.001; Magnusdottir S, 2018, CURR OPIN BIOTECH, V51, P90, DOI 10.1016/j.copbio.2017.12.005; Majzner RG, 2018, CANCER DISCOV, V8, P1219, DOI 10.1158/2159-8290.CD-18-0442; Makarova KS, 2020, NAT REV MICROBIOL, V18, P67, DOI 10.1038/s41579-019-0299-x; Mannix RJ, 2008, NAT NANOTECHNOL, V3, P36, DOI 10.1038/nnano.2007.418; Mauger DM, 2019, P NATL ACAD SCI USA, V116, P24075, DOI 10.1073/pnas.1908052116; McNerney MP, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax4473; Mimee M, 2018, SCIENCE, V360, P915, DOI 10.1126/science.aas9315; Moderna, 2020, MOD ANN LONG SHELF L; Moderna, 2020, OBSERVER BLIND PLACE; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; Mueller S, 2010, NAT BIOTECHNOL, V28, P723, DOI 10.1038/nbt.1636; Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4; Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836; Nielsen AAK, 2016, SCIENCE, V352, DOI 10.1126/science.aac7341; Onodi F, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00517; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Padilha VA, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa062; Pan YJ, 2018, P NATL ACAD SCI USA, V115, P992, DOI 10.1073/pnas.1714900115; Pardee K, 2016, CELL, V167, P248, DOI 10.1016/j.cell.2016.09.013; Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059; Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004; Pardi N, 2020, CURR OPIN IMMUNOL, V65, P14, DOI 10.1016/j.coi.2020.01.008; Parker KR, 2020, CELL, V183, P126, DOI 10.1016/j.cell.2020.08.022; Pedrolli DB, 2019, TRENDS BIOTECHNOL, V37, P100, DOI 10.1016/j.tibtech.2018.09.005; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Polack FP, 2003, NAT MED, V9, P1209, DOI 10.1038/nm918; Radivojevic T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18008-4; Raj D, 2019, GUT, V68, P1052, DOI 10.1136/gutjnl-2018-316595; Ramaswamy S, 2017, P NATL ACAD SCI USA, V114, pE1941, DOI 10.1073/pnas.1619653114; RAUH LW, 1965, AM J DIS CHILD, V109, P232, DOI 10.1001/archpedi.1965.02090020234007; Reed AD, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00039-20; Reichmuth AM, 2016, THER DELIV, V7, P319, DOI 10.4155/tde-2016-0006; Richardson SM, 2017, SCIENCE, V355, P1040, DOI 10.1126/science.aaf4557; Rodgers DT, 2016, P NATL ACAD SCI USA, V113, pE459, DOI 10.1073/pnas.1524155113; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Ruella M, 2016, J CLIN INVEST, V126, P3814, DOI 10.1172/JCI87366; Salehi ASM, 2017, ANAL CHEM, V89, P3395, DOI 10.1021/acs.analchem.6b04034; Saxena P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11247; Schirrmacher V, 2019, INT J ONCOL, V54, P407, DOI 10.3892/ijo.2018.4661; Schlub TE, 2018, MOL BIOL EVOL, V35, P2572, DOI 10.1093/molbev/msy155; Schmidts A, 2019, BLOOD ADV, V3, P3248, DOI 10.1182/bloodadvances.2019000703; Schukur L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4964; SCHWARZ AJF, 1962, AM J DIS CHILD, V103, P386, DOI 10.1001/archpedi.1962.02080020398042; Sedlmayer F, 2018, NAT BIOMED ENG, V2, P399, DOI 10.1038/s41551-018-0215-0; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Seres Therapeutics, 2020, SER THER ANN POS TOP; Shah NN, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.2510; Shaw J, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-119779; Shen SH, 2015, P NATL ACAD SCI USA, V112, P4749, DOI 10.1073/pnas.1502864112; Silverman AD, 2020, NAT REV GENET, V21, P151, DOI 10.1038/s41576-019-0186-3; Slomovic S, 2015, P NATL ACAD SCI USA, V112, P14429, DOI 10.1073/pnas.1508521112; Smith TRF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16505-0; Soleimany AP, 2020, TRENDS MOL MED, V26, P450, DOI 10.1016/j.molmed.2020.01.013; Stanton BZ, 2018, SCIENCE, V359, DOI 10.1126/science.aao5902; Straathof KC, 2005, BLOOD, V105, P4247, DOI 10.1182/blood-2004-11-4564; Sukumaran S, 2018, CANCER DISCOV, V8, P972, DOI 10.1158/2159-8290.CD-17-1298; Synlogic, 2019, SYNL BRIDG STUD DAT; Takahashi MK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05864-4; Tam J, 2020, P NATL ACAD SCI USA, V117, P6792, DOI 10.1073/pnas.1916965117; Tamada K, 2012, CLIN CANCER RES, V18, P6436, DOI 10.1158/1078-0432.CCR-12-1449; Tebas P, 2019, J INFECT DIS, V220, P400, DOI 10.1093/infdis/jiz132; Thavarajah W, 2020, NPJ CLEAN WATER, V3, DOI 10.1038/s41545-020-0064-8; The Scripps Research Institute, 2020, CALIBRS SWITCH CAR T; Thess A, 2015, MOL THER, V23, P1456, DOI 10.1038/mt.2015.103; Toda S, 2018, SCIENCE, V361, P156, DOI 10.1126/science.aat0271; Tong A, 2020, GATES VETS ADJUVANT; Duyen TTM, 2017, J BIOSCI BIOENG, V123, P96, DOI 10.1016/j.jbiosc.2016.07.015; Tulloch F, 2014, ELIFE, V3, DOI 10.7554/eLife.04531; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Valeri JA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18676-2; Viaud S, 2018, P NATL ACAD SCI USA, V115, pE10898, DOI 10.1073/pnas.1810060115; Vogel AB, 2018, MOL THER, V26, P446, DOI 10.1016/j.ymthe.2017.11.017; Volk MJ, 2020, ACS SYNTH BIOL, V9, P1514, DOI 10.1021/acssynbio.0c00129; von Niessen AGO, 2019, MOL THER, V27, P824, DOI 10.1016/j.ymthe.2018.12.011; Voss S, 2015, CURR OPIN CHEM BIOL, V28, P194, DOI 10.1016/j.cbpa.2015.09.003; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; Wang J, 2020, RNA BIOL, V17, P13, DOI 10.1080/15476286.2019.1669406; Wang XM, 2020, BLOOD ADV, V4, P1950, DOI 10.1182/bloodadvances.2020001510; Wang Z, 2004, GENE THER, V11, P711, DOI 10.1038/sj.gt.3302213; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Weber W, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp014; Wei TY, 2016, CELL CHEM BIOL, V23, P1056, DOI 10.1016/j.chembiol.2016.07.016; Weinberg BH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12800-7; Weinberg BH, 2017, NAT BIOTECHNOL, V35, P453, DOI 10.1038/nbt.3805; Wessels HH, 2020, NAT BIOTECHNOL, V38, P722, DOI 10.1038/s41587-020-0456-9; Wolff Jon A., 1992, Human Molecular Genetics, V1, P363, DOI 10.1093/hmg/1.6.363; Wu CY, 2015, SCIENCE, V350, DOI 10.1126/science.aab4077; Yang KK, 2019, NAT METHODS, V16, P687, DOI 10.1038/s41592-019-0496-6; Ye HF, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0005; Zah E, 2016, CANCER IMMUNOL RES, V4, P498, DOI 10.1158/2326-6066.CIR-15-0231; ZHOU XZ, 1995, P NATL ACAD SCI USA, V92, P3009, DOI 10.1073/pnas.92.7.3009; Zou YP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235216; Zuniga A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18455-z	195	23	26	18	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					881	898		10.1016/j.cell.2021.01.017	http://dx.doi.org/10.1016/j.cell.2021.01.017		FEB 2021	18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33571426	Green Accepted, Green Submitted			2022-12-28	WOS:000629633400007
J	Tembo, D; Hickey, G; Montenegro, C; Chandler, D; Nelson, E; Porter, K; Dikomitis, L; Chambers, M; Chimbari, M; Mumba, N; Beresford, P; Ekiikina, PO; Musesengwa, R; Staniszewska, S; Coldham, T; Rennard, U				Tembo, Doreen; Hickey, Gary; Montenegro, Cristian; Chandler, David; Nelson, Erica; Porter, Katie; Dikomitis, Lisa; Chambers, Mary; Chimbari, Moses; Mumba, Noni; Beresford, Peter; Ekiikina, Peter O.; Musesengwa, Rosemary; Staniszewska, Sophie; Coldham, Tina; Rennard, Una			Effective engagement and involvement with community stakeholders in the co-production of global health research	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PUBLIC INVOLVEMENT; PATIENT; PARTICIPATION; ETHICS		[Tembo, Doreen; Hickey, Gary; Porter, Katie] Univ Southampton, Fac Med, Wessex Inst, Southampton, Hants, England; [Hickey, Gary] Univ Brighton, Sch Hlth Sci, Brighton, E Sussex, England; [Montenegro, Cristian] Pontificia Univ Catolica Chile, Sch Nursing, Santiago, Chile; [Chandler, David] Psoriasis & Psoriat Arthrit Alliance, St Albans, Herts, England; [Nelson, Erica] London Sch Hyg & Trop Med, London, England; [Dikomitis, Lisa] Keele Univ, Sch Med, Keele, Staffs, England; [Chambers, Mary] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Chambers, Mary] Univ Oxford, Nuffield Dept Med, Ho Chi Minh City, Vietnam; [Chimbari, Moses] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Durban, South Africa; [Mumba, Noni] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, KEMRI Wellcome Trust Res Programme, Nairobi, Kenya; [Beresford, Peter] Univ Essex, Sch Hlth & Social Care, Colchester, Essex, England; [Ekiikina, Peter O.] Fdn Open Dev, Tororo, Uganda; [Musesengwa, Rosemary] Univ Oxford, Dept Psychiat, Oxford, England; [Staniszewska, Sophie] Univ Warwick, Div Hlth Sci, Warwick Med Sch, Coventry, W Midlands, England; [Coldham, Tina] Natl Inst Hlth Res, Ctr Engagement & Disseminat, London, England; [Coldham, Tina] Natl Inst Hlth Res, Sch Social Care Res, London, England	University of Southampton; University of Brighton; Pontificia Universidad Catolica de Chile; University of London; London School of Hygiene & Tropical Medicine; Keele University; University of Oxford; University of Oxford; University of Kwazulu Natal; University of Essex; University of Oxford; University of Warwick	Tembo, D (corresponding author), Univ Southampton, Fac Med, Wessex Inst, Southampton, Hants, England.	d.tembo@soton.ac.uk	Montenegro, Cristian/AAH-8016-2021	Montenegro, Cristian/0000-0001-9291-267X; Dikomitis, Professor Lisa/0000-0002-5752-3270; Beresford, Peter/0000-0001-6052-033X; /0000-0001-9161-4814; Tembo, Doreen/0000-0002-8615-3563	Doris Duke Charitable Foundation	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	This article is part of a series produced in conjunction with the WHO and the Alliance for Health Policy Systems and Research with funding from the Doris Duke Charitable Foundation. The BMJ peer reviewed, edited, and made the decision to publish.	Abimbola S, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-002068; Adhikari B., 2019, GLOBAL BIOETHICS, V31, P1, DOI DOI 10.1080/11287462.201; [Anonymous], NO MORE THROW AWAY P; ARNSTEIN SR, 1969, J AM I PLANNERS, V35, P216, DOI 10.1080/01944366908977225; AVAC, 2011, UNAIDS GOOD PART PRA; Bernheim RG, 2016, EMERGENCY ETHICS PUB, DOI [10.1093/med/9780190270742.001.0001/med-9780190270742-chapter-5, DOI 10.1093/MED/9780190270742.001.0001/MED-9780190270742-CHAPTER-5]; Brett J, 2014, HEALTH EXPECT, V17, P637, DOI 10.1111/j.1369-7625.2012.00795.x; Campbell C, 2009, J HEALTH MANAG, V11, P315, DOI 10.1177/097206340901100204; Carr S., 2016, POSITION PAPER ARE M; Chimbari MJ, 2017, ACTA TROP, V175, P9, DOI 10.1016/j.actatropica.2016.09.028; Clark T, 2008, SOCIOLOGY, V42, P953, DOI 10.1177/0038038508094573; Cornish F, 2012, HEALTH PLACE, V18, P468, DOI 10.1016/j.healthplace.2011.08.018; Crocker JC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4738; Domecq JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-89; Farr M, 2020, MAP RESOURCES COPROD; Fredriksson M, 2017, SOCIOL HEALTH ILL, V39, P95, DOI 10.1111/1467-9566.12483; Gbadegesin S, 2006, BIOETHICS, V20, P248, DOI 10.1111/j.1467-8519.2006.00501.x; Gibbs L, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5621609; Glasziou P, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4645; Green G, 2020, PUBLIC PARTICIPATION, DOI [10.3389/978-2-88963-298-5, DOI 10.3389/978-2-88963-298-5]; Greenhalgh T, 2019, HEALTH EXPECT, V22, P785, DOI 10.1111/hex.12888; Hickey G., 2018, NIHR INVOLV; Hickey G, 2018, HEALTH EXPECT, V21, P693, DOI 10.1111/hex.12821; Huang J, 2017, TRANSL BEHAV MED, V7, P773, DOI 10.1007/s13142-017-0487-z; INVOLVE, 2012, BRIEF NOT RES INV PU; Jagosh J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1949-1; Jaiswal J, 2020, AIDS BEHAV, V24, P2776, DOI 10.1007/s10461-020-02925-y; Lignou S, 2019, AM J BIOETHICS, V19, P49, DOI 10.1080/15265161.2019.1619877; Maiter S, 2008, ACTION RES-LONDON, V6, P305, DOI 10.1177/1476750307083720; Marsh V, 2008, SOC SCI MED, V67, P721, DOI 10.1016/j.socscimed.2008.02.007; Michener L, 2012, ACAD MED, V87, P285, DOI 10.1097/ACM.0b013e3182441680; Musesengwa R, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-017-0236-3; Nelson E., 2019, RESOURCE GUIDE COMMU; O'Mara-Eves A, 2013, NIHR JOURNALS LIB; Owen D, 2016, STATE PLAY PUBLIC EN; Powell KM, 2003, COLL COMPOS COMMUN, V54, P394, DOI 10.2307/3594171; Pratt B, 2018, DEV WORLD BIOETH, V18, P76, DOI 10.1111/dewb.12136; Ramsbottom A, 2018, J COMMUN HEALTH, V43, P412, DOI 10.1007/s10900-017-0415-7; Shaping Our Lives, 2020, NAT NETW SERV US DIS; Shucksmith MO, 2016, INTERACTION CAN ACAD; Slutsky J, 2016, J HEALTH ORGAN MANAG, V30, P751, DOI 10.1108/JHOM-03-2016-0037; Staley Kristina, 2019, Res Involv Engagem, V5, P14, DOI 10.1186/s40900-019-0147-1; Staley Kristina, 2015, Res Involv Engagem, V1, P6, DOI 10.1186/s40900-015-0008-5; Street J, 2020, INT J TECHNOL ASSESS, V36, P87, DOI 10.1017/S0266462320000094; Sultana F, 2007, ACME, V6, P374; Tembo D, 2019, FRONT SOCIOL, V4, DOI 10.3389/fsoc.2019.00050; Terama E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168533; Tindana PO, 2007, PLOS MED, V4, P1451, DOI 10.1371/journal.pmed.0040273; UK Research and Innovation Science and Technology Facilities Council, 2020, SCI FI COM GIV VOIC; UNICEF, 2020, MIN QUAL STAND IND C; Vasquez EE, 2019, GLOB PUBLIC HEALTH, V14, P777, DOI 10.1080/17441692.2019.1601752; Wilson P., 2015, HLTH SERVICES DELIVE, V3, P1; Wright K., 2020, COVID 19 RES GLOBAL	53	40	40	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2021	372								n178	10.1136/bmj.n178	http://dx.doi.org/10.1136/bmj.n178			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RA8YP	33593805	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000631706300019
J	Mahase, E				Mahase, Elisabeth			Covid-19: Are cloth masks still effective? And other questions answered	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		[Anonymous], 2021, FRANCE24; [Anonymous], 2020, WHICH; Centers for Disease Control & Prevention, 2021, IMPR YOUR MASK PROT; Fauci, 2021, TODAY; MAHASE E, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1422; Murphy J., 2021, EVENING STANDARD; O'Kelly E, 2021, WELL FACE MASKS PROT, DOI [10.1101/2021.01.27.21250645v1, DOI 10.1101/2021.01.27.21250645V1]; Rebeiro PF, 2021, CLIN INFECT DIS; SAGE, 2020, APPL PHYS DIST FABR; Sodha S., 2021, OBSERVER; World Health Organization, 2021, COR DIS COV 19 MASKS	11	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2021	372								n432	10.1136/bmj.n432	http://dx.doi.org/10.1136/bmj.n432			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QI7RL	33589420	Bronze			2022-12-28	WOS:000619180700003
J	Lane, R				Lane, Richard			Ndidiamaka Amutah-Onukagha: advancing maternal health justice	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2021	397	10274					571	571						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2TN	33581814				2022-12-28	WOS:000620934000013
J	Shimabukuro, TT; Cole, M; Su, JR				Shimabukuro, Tom T.; Cole, Matthew; Su, John R.			Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRACTICES INTERIM RECOMMENDATION; UNITED-STATES; ADVISORY-COMMITTEE	This JAMA Insights review provides clinical details of anaphylactic reactions reported to and verified by the CDC in the first month of use of the Pfizer-BioNTech and Moderna COVID-19 vaccines in the US, December 14, 2020-January 18, 2021.	[Shimabukuro, Tom T.; Su, John R.] Ctr Dis Control & Prevent, Immunizat Safety Off, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Rd, Atlanta, GA 30329 USA; [Cole, Matthew] Ctr Dis Control & Prevent, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Shimabukuro, TT (corresponding author), Ctr Dis Control & Prevent, Immunizat Safety Off, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Rd, Atlanta, GA 30329 USA.	tshimabukuro@cdc.gov						CDC, COVID 19 VACC INT CL; CDC, 2020, COVID 19 VACC INT CO; McNeil MM, 2018, J ALLERGY CLIN IMMUN, V141, P463, DOI 10.1016/j.jaci.2017.12.971; Oliver SE, 2021, MMWR-MORBID MORTAL W, V69, P1653, DOI 10.15585/mmwr.mm695152e1; Oliver SE, 2020, MMWR-MORBID MORTAL W, V69, P1922, DOI 10.15585/mmwr.mm6950e2; Rossen LM, 2020, MMWR-MORBID MORTAL W, V69, P1522, DOI [10.1101/2020.06.06.20120857v1.full.pdf, 10.15585/mmwr.mm6942e2]; Ruggeberg JU, 2007, VACCINE, V25, P5675, DOI 10.1016/j.vaccine.2007.02.064; Shimabukuro T, 2021, MMWR-MORBID MORTAL W, V70, P125, DOI [10.15585/mmwr.mm7004e1externalicon, 10.15585/mmwr.mm7004e1, 10.1111/ajt.16517]; Shimabukuro T, 2021, JAMA-J AM MED ASSOC, V325, P780, DOI 10.1001/jama.2021.0600; Shimabukuro TT, 2015, VACCINE, V33, P4398, DOI 10.1016/j.vaccine.2015.07.035	10	198	199	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2021	325	11					1101	1102		10.1001/jama.2021.1967	http://dx.doi.org/10.1001/jama.2021.1967		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QZ1BV	33576785	Bronze, Green Accepted			2022-12-28	WOS:000617177600001
J	Olson, RM				Olson, Rose M.			Learning How to Die - Lessons from the Irish Wake	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Over years of rigorous medical training, from cold cadaver labs to physically demanding, gruesome codes, it gets easier to stop giving love so freely, to cover a dying person's face, to put on your mask. Yet there are moments in medicine that crack our thick exteriors.	[Olson, Rose M.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Olson, RM (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.								0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2021	384	6					494	495		10.1056/NEJMp2030773	http://dx.doi.org/10.1056/NEJMp2030773			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QG5JQ	33567481				2022-12-28	WOS:000617621800006
J	Zhang, WJ; Davis, BD; Chen, SS; Martinez, JSM; Plummer, JT; Vail, E				Zhang, Wenjuan; Davis, Brian D.; Chen, Stephanie S.; Sincuir Martinez, Jorge M.; Plummer, Jasmine T.; Vail, Eric			Emergence of a Novel SARS-CoV-2 Variant in Southern California	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This research describes findings of sequencing and phylogenetic analyses of SARS-CoV-2 isolates from symptomatic patients cared for at Cedar-Sinai Medical Center in November-December 2020 during a regional surge in cases and hospitalizations.	[Zhang, Wenjuan; Sincuir Martinez, Jorge M.; Vail, Eric] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Davis, Brian D.; Chen, Stephanie S.; Plummer, Jasmine T.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center	Plummer, JT (corresponding author), Cedars Sinai Med Ctr, 8700 Beverly Blvd,SSB365, Los Angeles, CA 90048 USA.	jasmine.plummer@cshs.org	Vail, Eric/AAU-4908-2020; Plummer, Jasmine/AAN-7768-2021	Vail, Eric/0000-0002-6578-178X; Zhang, Wenjuan/0000-0001-5391-7064	Department of Biomedical Sciences, Cedars-Sinai Medical Center	Department of Biomedical Sciences, Cedars-Sinai Medical Center	This project was funded by an internal grant to Dr Plummer provided by the Department of Biomedical Sciences, Cedars-Sinai Medical Center.	Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Lauring AS, 2021, JAMA-J AM MED ASSOC, V325, P529, DOI 10.1001/jama.2020.27124; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Tang JLW, 2021, J INFECTION, V82, pE27, DOI 10.1016/j.jinf.2020.12.024; Zhang WJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.24191	6	183	186	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2021	325	13					1324	1326		10.1001/jama.2021.1612	http://dx.doi.org/10.1001/jama.2021.1612		FEB 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RK4TM	33571356	Bronze, Green Accepted			2022-12-28	WOS:000617177800001
J	Sillesen, AS; Vogg, O; Pihl, C; Raja, AA; Sundberg, K; Vedel, C; Zingenberg, H; Jorgensen, FS; Vejlstrup, N; Iversen, K; Bundgaard, H				Sillesen, Anne-Sophie; Vogg, Ottilia; Pihl, Christian; Raja, Anna Axelsson; Sundberg, Karin; Vedel, Cathrine; Zingenberg, Helle; Jorgensen, Finn Stener; Vejlstrup, Niels; Iversen, Kasper; Bundgaard, Henning			Prevalence of Bicuspid Aortic Valve and Associated Aortopathy in Newborns in Copenhagen, Denmark	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PEDIATRIC ECHOCARDIOGRAM; AMERICAN-SOCIETY; PERFORMANCE; DILATATION; DIFFERENCE; MORPHOLOGY; INSIGHTS; CHILDREN; DISEASE	Importance The prevalence and characteristics of bicuspid aortic valve (BAV) are mainly reported from selected cohorts. BAV is associated with aortopathy, but it is unclear if it represents a fetal developmental defect or is secondary to abnormal valve dynamics. Objective To determine the prevalence of BAV and BAV subtypes and to describe the associated aortopathy in a large, population-based cohort of newborns. Design, Setting, and Participants The Copenhagen Baby Heart Study was a cross-sectional, population-based study open to all newborns born in Copenhagen between April 1, 2016, and October 31, 2018. Newborns with BAV were matched 1:2 to newborns with a tricuspid aortic valve (non-BAV group) on sex, singleton/twin pregnancy, gestational age, weight, and age at time of examination. Exposures Transthoracic echocardiography within 60 days after birth. Main Outcomes and Measures Primary outcome was BAV prevalence and types, ie, number of raphes and spatial orientation of raphes or cusps (no raphes), according to the classification system of Sievers and Schmidtke (classified as type 0, 1, or 2, with numbers indicating the number of raphes). Secondary outcome was valve function and BAV-associated aortopathy, defined as aortic diameter z score of 3 or greater or coarctation. Results In total, 25 556 newborns (51.7% male; mean age, 12 [SD, 8] days) underwent echocardiography. BAV was diagnosed in 196 newborns (prevalence, 0.77% [95% CI, 0.67%-0.88%]), with male-female ratio 2.1:1. BAV was classified as type 0 in 17 newborns (8.7% [95% CI, 5.5%-13.5%]), type 1 in 178 (90.8% [95% CI, 86.0%-94.1%]) (147 [75.0% {95% CI, 68.5%-80.5%}] right-left coronary raphe, 27 [13.8% {95% CI, 9.6%-19.3%}] right coronary-noncoronary raphe, 4 [2.0% {95% CI, 0.8%-5.1%}] left coronary-noncoronary raphe), and type 2 in 1 (0.5% [95% CI, 0.1%-2.8%]). Aortic regurgitation was more prevalent in newborns with BAV (n = 29 [14.7%]) than in those without BAV (1.3%) (absolute % difference, 13.4% [95% CI, 7.8%-18.9%]; P < .001). Newborns with BAV had higher flow velocities across the valve (0.67 [95% CI, 0.65-0.69] m/s vs 0.61 [95% CI, 0.60-0.62] m/s; mean difference, 0.06 m/s [95% CI, 0-0.1]) and larger aortic root and tubular ascending aortic diameters than those without BAV (10.7 [95% CI, 10.7-10.9] mm vs 10.3 [95% CI, 10.2-10.4] mm; mean difference, 0.43 mm [95% CI, 0.2-0.6 mm] and 9.8 [95% CI, 9.6-10.0] mm vs 9.4 [95% CI, 9.3-9.5] mm; mean difference, 0.46 mm [95% CI, 0.30-0.70], respectively) (P < .001 for all). Aortopathy was seen in 65 newborns (33.2%) with BAV (62 with aortic z score >= 3; 3 with coarctation). Conclusions and Relevance Among newborns in Copenhagen, the prevalence of BAV was 0.77%. Aortopathy was common in newborns with BAV, suggesting that it also represents a fetal malformation. Question What is the prevalence of bicuspid aortic valve among newborns and what is the extent of associated disease of the aorta? Findings This cross-sectional study included 25 556 newborns in Denmark between 2016 and 2018 who underwent transthoracic echocardiography. The prevalence of bicuspid aortic valve was 0.77%; of these, aortopathy was present in 33%. Meaning Among newborns in Copenhagen, the prevalence of bicuspid aortic valve was 0.77% and associated aortic disease was common, suggesting that it was a fetal malformation. This population epidemiology study describes the prevalence of bicuspid aortic valve (BAV) and BAV subtypes, and of accompanying enlarged aortic diameter or coarctation, in Danish newborns born in Copenhagen 2016-2018.	[Sillesen, Anne-Sophie; Raja, Anna Axelsson; Vejlstrup, Niels; Bundgaard, Henning] Copenhagen Univ Hosp, Heart Ctr, Dept Cardiol, Rigshosp, Copenhagen, Denmark; [Sillesen, Anne-Sophie; Vogg, Ottilia; Pihl, Christian; Raja, Anna Axelsson; Iversen, Kasper] Copenhagen Univ Hosp Herlev, Dept Cardiol, Copenhagen, Denmark; [Sillesen, Anne-Sophie; Vogg, Ottilia; Pihl, Christian; Raja, Anna Axelsson; Sundberg, Karin; Vedel, Cathrine; Zingenberg, Helle; Jorgensen, Finn Stener; Vejlstrup, Niels; Iversen, Kasper; Bundgaard, Henning] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Vogg, Ottilia] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Sundberg, Karin; Vedel, Cathrine] Copenhagen Univ Hosp, Ctr Fetal Med & Pregnancy, Dept Obstet, Rigshosp, Copenhagen, Denmark; [Zingenberg, Helle] Copenhagen Univ Hosp Herlev, Ctr Fetal Med, Dept Obstet & Gynecol, Copenhagen, Denmark; [Jorgensen, Finn Stener] Copenhagen Univ Hosp Hvidovre, Dept Obstet & Gynecol, Fetal Med Unit, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Statens Serum Institut; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Sillesen, AS (corresponding author), Copenhagen Univ Hosp Herlev, Dept Cardiol, Borgmester Ib Juuls Vej 1, DK-2730 Herlev, Denmark.	anne-sophie.sillesen@regionh.dk	Iversen, Kasper/GSD-6427-2022; Sillesen, Anne-Sophie/N-4277-2017; Bundgaard, Henning/AAA-4381-2020	Sillesen, Anne-Sophie/0000-0001-7993-1016; Bundgaard, Henning/0000-0002-0563-7049; Jorgensen, Finn Stener/0000-0002-1592-5407; Vedel, Cathrine/0000-0001-7475-513X; Axelsson Raja, Anna/0000-0001-8665-3309; Vogg, R Ottilia B/0000-0001-6982-5105				Andreassi MG, 2016, CURR OPIN CARDIOL, V31, P585, DOI 10.1097/HCO.0000000000000328; Basso C, 2004, AM J CARDIOL, V93, P661, DOI 10.1016/j.amjcard.2003.11.031; Chan KL, 1999, CAN J CARDIOL, V15, P48; Chandra S, 2012, JACC-CARDIOVASC IMAG, V5, P981, DOI 10.1016/j.jcmg.2012.07.008; DATTA BN, 1988, JPN HEART J, V29, P661; Gelpi G, 2018, INT J CARDIOL, V250, P120, DOI 10.1016/j.ijcard.2017.09.168; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Jijeh AMZ, 2018, ANN PEDIAT CARDIOL, V11, P143, DOI 10.4103/apc.APC_171_17; Kong WKF, 2017, JAMA CARDIOL, V2, P285, DOI 10.1001/jamacardio.2016.5228; Lai WW, 2006, J AM SOC ECHOCARDIOG, V19, P1413, DOI 10.1016/j.echo.2006.09.001; LARSON EW, 1984, AM J CARDIOL, V53, P849, DOI 10.1016/0002-9149(84)90418-1; Lopez L, 2021, J AM SOC ECHOCARDIOG, V34, P185, DOI 10.1016/j.echo.2020.09.019; Lopez L, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.117.006979; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; Losenno KL, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/145202; Mahle WT, 2010, J PEDIATR-US, V157, P445, DOI 10.1016/j.jpeds.2010.03.004; Martinez-Micaelo N, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1176-x; Masri A, 2017, HEART, V103, P40, DOI 10.1136/heartjnl-2016-309630; Merkx R, 2017, AM J CARDIOL, V120, P131, DOI 10.1016/j.amjcard.2017.03.245; Michelena HI, 2008, CIRCULATION, V117, P2776, DOI 10.1161/CIRCULATIONAHA.107.740878; Michelena HI, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004211; Morosin M, 2017, J CARDIOVASC MED, V18, P74, DOI 10.2459/JCM.0000000000000430; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nishimura RA, 2014, J THORAC CARDIOV SUR, V148, pE1, DOI 10.1016/j.jtcvs.2014.05.014; Pauperio HM, 1999, CARDIOL YOUNG, V9, P488, DOI 10.1017/S1047951100005400; Prakash SK, 2014, J AM COLL CARDIOL, V64, P832, DOI 10.1016/j.jacc.2014.04.073; ROBERTS WC, 1970, AM J CARDIOL, V26, P72, DOI 10.1016/0002-9149(70)90761-7; Robicsek F, 2004, ANN THORAC SURG, V77, P177, DOI 10.1016/S0003-4975(03)01249-9; Ruzmetov M, 2015, ANN THORAC SURG, V99, P2101, DOI 10.1016/j.athoracsur.2015.02.036; Sievers HH, 2007, J THORAC CARDIOV SUR, V133, P1226, DOI 10.1016/j.jtcvs.2007.01.039; Sievers HH, 2016, EUR J CARDIO-THORAC, V49, P439, DOI 10.1093/ejcts/ezv087; Sillesen AS, 2019, J AM SOC ECHOCARDIOG, V32, P895, DOI 10.1016/j.echo.2019.02.015; Sillesen AS, 2019, EUR J EPIDEMIOL, V34, P79, DOI 10.1007/s10654-018-0448-y; Siu SC, 2010, J AM COLL CARDIOL, V55, P2789, DOI 10.1016/j.jacc.2009.12.068; Tutar E, 2005, AM HEART J, V150, P513, DOI 10.1016/j.ahj.2004.10.036; Tzemos N, 2008, JAMA-J AM MED ASSOC, V300, P1317, DOI 10.1001/jama.300.11.1317; Verma S, 2014, NEW ENGL J MED, V370, P1920, DOI 10.1056/NEJMra1207059; Wauchope GM, 1928, Q J MED, V21, P383, DOI 10.1093/qjmed/os-21.83.383	38	28	27	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2021	325	6					561	567		10.1001/jama.2020.27205	http://dx.doi.org/10.1001/jama.2020.27205			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG0MD	33560321	Bronze, Green Published			2022-12-28	WOS:000617279600019
J	Adhikari, EH; Spong, CY				Adhikari, Emily H.; Spong, Catherine Y.			COVID-19 Vaccination in Pregnant and Lactating Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses the need for shared decision-making when counseling pregnant and nursing women about the unstudied benefits and risks COVID-19 vaccination, calling for rigorously designed studies with real-time, proactive data collection to establish evidence as quickly as possible about coronavirus vaccine safety in mothers and their infants.	[Adhikari, Emily H.; Spong, Catherine Y.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Adhikari, Emily H.; Spong, Catherine Y.] Parkland Hlth & Hosp Syst, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Spong, CY (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Catherine.Spong@utsouthwestern.edu						Academy of Breastfeeding Medicine, COSN COVID 19 VACC L; Adhikari EH, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.29256; Atyeo C, 2020, CELL; Independent, 2021, INDEPENDENT; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Smith DD, 2020, AM J PERINAT, V37, P792, DOI 10.1055/s-0040-1712103; Spong CY, 2018, JAMA-J AM MED ASSOC, V319, P337, DOI 10.1001/jama.2017.19138; Steinhoff MC, 2017, LANCET INFECT DIS, V17, P981, DOI 10.1016/S1473-3099(17)30252-9; Winter K, 2017, CLIN INFECT DIS, V64, P3, DOI 10.1093/cid/ciw634	10	57	57	2	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2021	325	11					1039	1040		10.1001/jama.2021.1658	http://dx.doi.org/10.1001/jama.2021.1658		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QZ1BV	33555297	Bronze			2022-12-28	WOS:000617177400003
J	Iacobucci, G				Iacobucci, Gareth			Government to reverse Lansley reforms in major NHS shake up	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, BMJ BRIT MED J; [Anonymous], 2021, EDITORIAL FRIDAY 5 F; Iacobucci G, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l990	3	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2021	372								n377	10.1136/bmj.n377	http://dx.doi.org/10.1136/bmj.n377			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM1AV	33558216				2022-12-28	WOS:000639394000011
J	Liu, S; Shankar, S; Marchetti, MC; Wu, YL				Liu, Song; Shankar, Suraj; Marchetti, M. Cristina; Wu, Yilin			Viscoelastic control of spatiotemporal order in bacterial active matter	NATURE			English	Article							TOPOLOGICAL DEFECTS; COLLECTIVE DYNAMICS; DILUTE; DNA	Active matter consists of units that generate mechanical work by consuming energy(1). Examples include living systems (such as assemblies of bacteria(2-5) and biological tissues(6,7)), biopolymers driven by molecular motors(8-11) and suspensions of synthetic self-propelled particles(12-14). A central goal is to understand and control the self-organization of active assemblies in space and time. Most active systems exhibit either spatial order mediated by interactions that coordinate the spatial structure and the motion of active agents(12,14,15) or the temporal synchronization of individual oscillatory dynamics(2). The simultaneous control of spatial and temporal organization is more challenging and generally requires complex interactions, such as reaction-diffusion hierarchies(16) or genetically engineered cellular circuits(2). Here we report a simple technique to simultaneously control the spatial and temporal self-organization of bacterial active matter. We confine dense active suspensions of Escherichia coli cells and manipulate a single macroscopic parameter-namely, the viscoelasticity of the suspending fluid- through the addition of purified genomic DNA. This reveals self-driven spatial and temporal organization in the form of a millimetre-scale rotating vortex with periodically oscillating global chirality of tunable frequency, reminiscent of a torsional pendulum. By combining experiments with an active-matter model, we explain this behaviour in terms of the interplay between active forcing and viscoelastic stress relaxation. Our findings provide insight into the influence of bacterial motile behaviour in complex fluids, which may be of interest in health- and ecology-related research, and demonstrate experimentally that rheological properties can be harnessed to control active-matter flows(17,18). We envisage that our millimetre-scale, tunable, self-oscillating bacterial vortex may be coupled to actuation systems to act a 'clock generator' capable of providing timing signals for rhythmic locomotion of soft robots and for programmed microfluidic pumping(19), for example, by triggering the action of a shift register in soft-robotic logic devices(20). Introducing viscoelasticity by addition of DNA into the fluid surrounding a suspension of Escherichia coli produces a giant oscillating vortex with a period controllable through the DNA concentration.	[Liu, Song; Wu, Yilin] Chinese Univ Hong Kong, Dept Phys, Hong Kong, Peoples R China; [Liu, Song; Wu, Yilin] Chinese Univ Hong Kong, Shenzhen Res Inst, Hong Kong, Peoples R China; [Shankar, Suraj] Syracuse Univ, Dept Phys, Syracuse, NY USA; [Shankar, Suraj] Syracuse Univ, Soft & Living Matter Program, Syracuse, NY USA; [Shankar, Suraj] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Shankar, Suraj] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Marchetti, M. Cristina] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	Chinese University of Hong Kong; Chinese University of Hong Kong; Syracuse University; Syracuse University; University of California System; University of California Santa Barbara; Harvard University; University of California System; University of California Santa Barbara	Wu, YL (corresponding author), Chinese Univ Hong Kong, Dept Phys, Hong Kong, Peoples R China.; Wu, YL (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Hong Kong, Peoples R China.	ylwu@cuhk.edu.hk	Wu, Yilin/C-3526-2013	Wu, Yilin/0000-0002-0392-2137; Marchetti, M Cristina/0000-0003-3583-4999; Shankar, Suraj/0000-0002-4615-975X	National Natural Science Foundation of China (NSFC) [31971182]; Research Grants Council of Hong Kong SAR (RGC) [14303918]; US National Science Foundation [DMR-1609208]; KITP [PHY-1748958]; Harvard Society of Fellows; Research Grants Council of Hong Kong SAR (CUHK Direct Grants)	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Research Grants Council of Hong Kong SAR (RGC); US National Science Foundation(National Science Foundation (NSF)); KITP; Harvard Society of Fellows; Research Grants Council of Hong Kong SAR (CUHK Direct Grants)	We thank Y. Li and W. Zuo for building the image acquisition and microscope stage temperature control systems, H. C. Berg (Harvard University) for providing the bacterial strains, A. Mukherjee and C. M. Schroeder (UIUC) for providing the pAM06-tet plasmid, and L. Xu (CUHK) for assistance with bulk rheology measurement. We thank E. S.C. Ching (CUHK), K. Xia (CUHK) and T. Ngai (CUHK) for discussions and comments. This work was supported by the National Natural Science Foundation of China (NSFC no. 31971182, to Y.W.), the Research Grants Council of Hong Kong SAR (RGC Ref. No. 14303918 and CUHK Direct Grants; to Y.W.), the US National Science Foundation Grant DMR-1609208 (to M.C.M and S.S) and KITP under grant no. PHY-1748958. S.S. is supported by the Harvard Society of Fellows. M.C.M and S.S thank the KITP for hospitality in the course of this work.	Benzi R, 2018, ANNU REV CONDEN MA P, V9, P163, DOI 10.1146/annurev-conmatphys-033117-053913; Bozorgi Y, 2014, J NON-NEWTON FLUID, V214, P69, DOI 10.1016/j.jnnfm.2014.09.016; Bricard A, 2013, NATURE, V503, P95, DOI 10.1038/nature12673; BROCHARD F, 1979, J POLYM SCI POL PHYS, V17, P1367, DOI 10.1002/pol.1979.180170808; Chen C, 2017, NATURE, V542, P210, DOI 10.1038/nature20817; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Doostmohammadi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05666-8; Ginoux JM, 2012, CHAOS, V22, DOI 10.1063/1.3670008; Giomi L, 2012, NONLINEARITY, V25, P2245, DOI 10.1088/0951-7715/25/8/2245; Giomi L, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.218101; Hemingway EJ, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.032702; Hemingway EJ, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.098302; Huber L, 2018, SCIENCE, V361, P255, DOI 10.1126/science.aao5434; Karig D, 2018, P NATL ACAD SCI USA, V115, P6572, DOI 10.1073/pnas.1720770115; Kawaguchi K, 2017, NATURE, V545, P327, DOI 10.1038/nature22321; Keber FC, 2014, SCIENCE, V345, P1135, DOI 10.1126/science.1254784; Kundukad B, 2010, BIOPHYS J, V99, P1906, DOI 10.1016/j.bpj.2010.07.013; Li GJ, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.118001; Liu YG, 2009, J RHEOL, V53, P1069, DOI 10.1122/1.3160734; Lopez HM, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.028301; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282; Mukherjee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064753; Murray J.D., 2007, INTRODUCTION, V17, DOI [10.1007/b98868.pdf%2520http://www.ulb.tu-darmstadt.de/tocs/127987207.pdf, DOI 10.1007/B98868.PDF%2520HTTP://WWW.ULB.TU-DARMSTADT.DE/TOCS/127987207.PDF]; Palacci J, 2013, SCIENCE, V339, P936, DOI 10.1126/science.1230020; Preston DJ, 2019, P NATL ACAD SCI USA, V116, P7750, DOI 10.1073/pnas.1820672116; Prost J, 2015, NAT PHYS, V11, P111, DOI [10.1038/nphys3224, 10.1038/NPHYS3224]; Saw TB, 2017, NATURE, V544, P212, DOI 10.1038/nature21718; Simha RA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.058101; Sokolov A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158102; Sokolov A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248109; Vicker MG, 2002, EXP CELL RES, V275, P54, DOI 10.1006/excr.2001.5466; Warner M., 2007, LIQUID CRYSTAL ELAST; Wehner M, 2016, NATURE, V536, P451, DOI 10.1038/nature19100; Wensink HH, 2012, P NATL ACAD SCI USA, V109, P14308, DOI 10.1073/pnas.1202032109; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wioland H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.268102; Woodhouse FG, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.168105; Wu KT, 2017, SCIENCE, V355, DOI 10.1126/science.aal1979; Yan J, 2016, NAT MATER, V15, P1095, DOI [10.1038/NMAT4696, 10.1038/nmat4696]; Zhu XY, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3009249	41	34	34	15	112	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2021	590	7844					80	+		10.1038/s41586-020-03168-6	http://dx.doi.org/10.1038/s41586-020-03168-6			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TY5HF	33536650	Green Accepted			2022-12-28	WOS:000683814700001
J	Mahase, E				Mahase, Elisabeth			Covid-19: Israel sees new infections plummet following vaccinations	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BBC, 2021, BBC; Chodick G, 2021, EFFECTIVENESS 1 DOES, DOI [10.1101/2021.01.27.21250612v1, DOI 10.1101/2021.01.27.21250612V1]; Hunter PR, 2021, ESTIMATING EFFECTIVE	3	8	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2021	372								n338	10.1136/bmj.n338	http://dx.doi.org/10.1136/bmj.n338			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH2NH	33541863	Bronze			2022-12-28	WOS:000618113700007
J	Alderwick, H; Dunn, P; Gardner, T; Mays, N; Dixon, J				Alderwick, Hugh; Dunn, Phoebe; Gardner, Tim; Mays, Nicholas; Dixon, Jennifer			Will a new NHS structure in England help recovery from the pandemic?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PARTNERSHIPS; IMPACT; HEALTH		[Alderwick, Hugh; Dunn, Phoebe; Gardner, Tim; Dixon, Jennifer] Hlth Fdn, London, England; [Mays, Nicholas] London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine	Alderwick, H (corresponding author), Hlth Fdn, London, England.	hugh.alderwick@health.org.uk		Alderwick, Hugh/0000-0002-9362-2567				Alderwick H, 2016, SUSTAINABILITY TRANS; Alderwick H, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4468; Alderwick H, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1670; Alderwick H, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l84; Allen P, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-011745; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; Baxter S, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3161-3; Berwick D, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a838; Bourquin P., 2020, LIVING STANDARDS POV; Braithwaite J, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2014; Briggs ADM., 2020, INTEGR HEALTHC J, V2; Checkland K, 2018, UNDERSTANDING NEW CO; Damery S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011952; Department of Health, 2019, NHS LONG TERM PLAN; Dunn P, 2020, COVID19 POLICY TRACK; Dunn P, 2020, ADULT SOCIAL CARE CO, DOI 10.37829/HF-2020-P06; Edwards N., 2010, TRIUMPH HOPE EXPERIE; Exworthy M, 2016, DISMANTLING NHS EVAL, DOI [10.1332/policypress/9781447330226.001.0001, DOI 10.1332/POLICYPRESS/9781447330226.001.0001]; Fisher B, 2019, UNDERSTANDING PRIMAR; Fitzpatrick S., 2020, DESTITUTION UK; Fulop N, 2002, BRIT MED J, V325, P246, DOI 10.1136/bmj.325.7358.246; Gardner T., 2020, ELECTIVE CARE ENGLAN; Greer SL, 2020, MILBANK Q, V98, P975, DOI 10.1111/1468-0009.12471; Ham C, 2015, NHS COALITION GOVT 1; Hayes SL, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007825.pub5; Health Foundation, 2020, SPEND REV LEAV NHS E; Health Foundation, NHS REORG ACT 1972; Health Foundation, NAT HLTH SERV REF HL; House of Commons Health Select Committee, 2018, 7 REP SESS 2017 19; Le Grand J, 1998, LEARNING NHS INTERNA; Lorne C, 2019, INTEGRATED CARE SYST; Mackie Sue, 2016, Br J Community Nurs, V21, P82, DOI 10.12968/bjcn.2016.21.2.82; Majeed A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4654; Marmot M, 2020, BUILD BACK BETTER CO; Mays N, UNDERSTANDING NEW LA; Ndumbe-Eyoh S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1056; NHS England, COVID 19 HOSP ACT; NHS England, 2019, NHS IMPR NHSS REC GO; NHS England, 2020, INT CAR SYST; NHS England NHS Improvement., 2020, INT CAR NEXT STEPS B; NHS England NHS Improvement., 2020, DEV PAYM SYST 2021 2; Perkins N, 2010, POLICY POLIT, V38, P101, DOI 10.1332/030557309X458425; Robinson R, 1993, EVALUATING NHS REFOR; Shembavnekar N., 2020, GOING COVID 19 HLTH; Smith J, 2010, NEXT COMMISSIONING E; Smith J, 2011, UNDERSTANDING NEW LA; Smith J, 2004, REV EFFECTIVENESS PR; Smith JA, 2020, EARLY EVIDENCE DEV P, DOI [10.3310/hsdr-tr-129678, DOI 10.3310/HSDR-TR-129678]; Smith KE, 2009, J PUBLIC HEALTH-UK, V31, P210, DOI 10.1093/pubmed/fdp002; Thorlby R, 2020, SPENDING REV 2020 PR; Towe VL, 2016, HEALTH AFFAIR, V35, P1964, DOI 10.1377/hlthaff.2016.0604; Winters S, 2016, INT J INTEGR CARE, V16, DOI 10.5334/ijic.2460	52	17	17	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2021	372								n248	10.1136/bmj.n248	http://dx.doi.org/10.1136/bmj.n248			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC1TD	33536236	Bronze, Green Submitted			2022-12-28	WOS:000686315900004
J	Yuan, G; Flores, NM; Hausmann, S; Lofgren, SM; Kharchenko, V; Angulo-Ibanez, M; Sengupta, D; Lu, XY; Czaban, I; Azhibek, D; Vicent, S; Fischle, W; Jaremko, M; Fang, B; Wistuba, II; Chua, KF; Roth, JA; Minna, JD; Shao, NY; Jaremko, L; Mazur, PK; Gozani, O				Yuan, Gang; Flores, Natasha M.; Hausmann, Simone; Lofgren, Shane M.; Kharchenko, Vladlena; Angulo-Ibanez, Maria; Sengupta, Deepanwita; Lu, Xiaoyin; Czaban, Iwona; Azhibek, Dulat; Vicent, Silvestre; Fischle, Wolfgang; Jaremko, Mariusz; Fang, Bingliang; Wistuba, Ignacio I.; Chua, Katrin F.; Roth, Jack A.; Minna, John D.; Shao, Ning-Yi; Jaremko, Lukasz; Mazur, Pawel K.; Gozani, Or			Elevated NSD3 histone methylation activity drives squamous cell lung cancer	NATURE			English	Article							CHEMICAL-SHIFT; GENOME-WIDE; ONCOGENE; RECOGNITION; RECOMBINANT; INHIBITION; EXPRESSION; CARCINOMA; PROTEINS; PROGRAM	Amplification of chromosomal region 8p11-12 is a common genetic alteration that has been implicated in the aetiology of lung squamous cell carcinoma (LUSC)(1-3). The FGFR1 gene is the main candidate driver of tumorigenesis within this region(4). However, clinical trials evaluating FGFR1 inhibition as a targeted therapy have been unsuccessful(5). Here we identify the histone H3 lysine 36 (H3K36) methyltransferase NSD3, the gene for which is located in the 8p11-12 amplicon, as a key regulator of LUSC tumorigenesis. In contrast to other 8p11-12 candidate LUSC drivers, increased expression of NSD3 correlated strongly with its gene amplification. Ablation of NSD3, but not of FGFR1, attenuated tumour growth and extended survival in a mouse model of LUSC. We identify an LUSC-associated variant NSD3(T1232A) that shows increased catalytic activity for dimethylation of H3K36 (H3K36me2) in vitro and in vivo. Structural dynamic analyses revealed that the T1232A substitution elicited localized mobility changes throughout the catalytic domain of NSD3 to relieve auto-inhibition and to increase accessibility of the H3 substrate. Expression of NSD3(T1232A) in vivo accelerated tumorigenesis and decreased overall survival in mouse models of LUSC. Pathological generation of H3K36me2 by NSD3(T1232A) reprograms the chromatin landscape to promote oncogenic gene expression signatures. Furthermore, NSD3, in a manner dependent on its catalytic activity, promoted transformation in human tracheobronchial cells and growth of xenografted human LUSC cell lines with amplification of 8p11-12. Depletion of NSD3 in patient-derived xenografts from primary LUSCs containing NSD3 amplification or the NSD3(T1232A)-encoding variant attenuated neoplastic growth in mice. Finally, NSD3-regulated LUSC-derived xenografts were hypersensitive to bromodomain inhibition. Thus, our work identifies NSD3 as a principal 8p11-12 amplicon-associated oncogenic driver in LUSC, and suggests that NSD3-dependency renders LUSC therapeutically vulnerable to bromodomain inhibition.	[Yuan, Gang; Sengupta, Deepanwita; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Flores, Natasha M.; Hausmann, Simone; Lofgren, Shane M.; Lu, Xiaoyin; Mazur, Pawel K.] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Kharchenko, Vladlena; Czaban, Iwona; Azhibek, Dulat; Fischle, Wolfgang; Jaremko, Mariusz; Jaremko, Lukasz] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia; [Angulo-Ibanez, Maria; Chua, Katrin F.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Angulo-Ibanez, Maria; Chua, Katrin F.] Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA USA; [Vicent, Silvestre] Univ Navarra, Ctr Appl Med Res, Pamplona, Spain; [Fang, Bingliang; Roth, Jack A.] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Minna, John D.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Minna, John D.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Minna, John D.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Shao, Ning-Yi] Univ Macau, Fac Hlth Sci, Macau, Peoples R China	Stanford University; University of Texas System; UTMD Anderson Cancer Center; King Abdullah University of Science & Technology; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Navarra; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Macau	Gozani, O (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Mazur, PK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.; Jaremko, L (corresponding author), King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia.; Shao, NY (corresponding author), Univ Macau, Fac Hlth Sci, Macau, Peoples R China.	nshao@um.edu.mo; lukasz.jaremko@kaust.edu.sa; pkmazur@mdanderson.org; ogozani@stanford.edu	Jaremko, Lukasz/GQB-5017-2022; Jaremko, Lukasz/A-3101-2009; Lu, Xiaoyin/AAO-5561-2021; Mazur, Pawel K./AAU-6343-2021; Sengupta, Deepanwita/X-9126-2019; Vicent, Silvestre/K-4261-2017	Jaremko, Lukasz/0000-0001-7684-9359; Lu, Xiaoyin/0000-0002-9244-325X; Mazur, Pawel K./0000-0002-5820-8344; Sengupta, Deepanwita/0000-0001-5406-4497; Azhibek, Dulat/0000-0002-6627-3285; Czaban, Iwona/0000-0002-8038-1573; Gozani, Or/0000-0002-1365-4463; Vicent, Silvestre/0000-0002-9457-6881; Jaremko, Mariusz/0000-0002-0787-702X	NIH [R01 GM079641, R35 GM139569, R01AG050997, R00 CA197816, 1U54CA224065]; VA Merit Award; KAUST; P. Neuroendocrine Tumor Research Foundation; AACR; DOD PRCRP Career Development Award [CA181486]; Career Enhancement Grant -The University of Texas NIH SPORE in Lung Cancer [P50CA070907]; Andrew Sabin Family Foundation Scientist and CPRIT Scholar in Cancer Research [RR160078]; American Cancer Society -Joe & Jessie Crump Foundation Fellowship [PF-20-108-01-DMC]; CPRIT Research Training Grant [RP170067]; Deutsche Forschungsgemeinschaft Fellowship [HA8434/1-1];  [SRG2019-00177-FHS];  [FDCT0038/2020/AFJ]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); KAUST(King Abdullah University of Science & Technology); P. Neuroendocrine Tumor Research Foundation; AACR; DOD PRCRP Career Development Award; Career Enhancement Grant -The University of Texas NIH SPORE in Lung Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Andrew Sabin Family Foundation Scientist and CPRIT Scholar in Cancer Research; American Cancer Society -Joe & Jessie Crump Foundation Fellowship; CPRIT Research Training Grant; Deutsche Forschungsgemeinschaft Fellowship(German Research Foundation (DFG)); ; 	We thank members of the Gozani and Mazur laboratories for critical reading of the manuscript, and M. Lin for the AkaLuc vector. This work was supported in part by grants from the NIH to O.G. (R01 GM079641 and R35 GM139569), K.F.C. (R01AG050997) and P.K.M. (R00 CA197816), 1U54CA224065 to B.F. and J.A.R., VA Merit Award to K.F.C., intramural funds from KAUST to W.F., L.J. and M.J., the P. Neuroendocrine Tumor Research Foundation, AACR, DOD PRCRP Career Development Award (CA181486), Career Enhancement Grant -The University of Texas NIH SPORE in Lung Cancer (P50CA070907), and the Andrew Sabin Family Foundation Scientist and CPRIT Scholar in Cancer Research (RR160078) to P.K.M. N.-Y.S. was supported by SRG2019-00177-FHS and FDCT0038/2020/AFJ, N.M.F. by the American Cancer Society -Joe & Jessie Crump Foundation Fellowship (PF-20-108-01-DMC), X.L. by a CPRIT Research Training Grant (RP170067) and S.H. by a Deutsche Forschungsgemeinschaft Fellowship (HA8434/1-1).	Adams JR, 2011, CANCER RES, V71, P2706, DOI 10.1158/0008-5472.CAN-10-0738; Balsara BR, 1997, CANCER RES, V57, P2116; BALWIERZ W, 1987, Folia Haematologica (Leipzig), V114, P789; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bradbury RH, 2016, J MED CHEM, V59, P7801, DOI 10.1021/acs.jmedchem.6b00070; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheema MS, 2017, METHODS MOL BIOL, V1528, P75, DOI 10.1007/978-1-4939-6630-1_6; Chen SD, 2015, MOL CELL, V60, P319, DOI 10.1016/j.molcel.2015.08.019; Chu V, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0234-4; Cochran AG, 2019, NAT REV DRUG DISCOV, V18, P609, DOI 10.1038/s41573-019-0030-7; Edelman BL, 2018, METHODS MOL BIOL, V1809, P59, DOI 10.1007/978-1-4939-8570-8_5; Ferone G, 2016, CANCER CELL, V30, P519, DOI 10.1016/j.ccell.2016.09.001; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Fushiki H, 2009, CANCER SCI, V100, P1544, DOI 10.1111/j.1349-7006.2009.01199.x; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Graham SE, 2016, PROTEIN SCI, V25, P1021, DOI 10.1002/pro.2912; Hainer Sarah J, 2019, Curr Protoc Mol Biol, V126, pe85, DOI 10.1002/cpmb.85; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hoch RV, 2006, DEVELOPMENT, V133, P663, DOI 10.1242/dev.02242; Husmann D, 2019, NAT STRUCT MOL BIOL, V26, P880, DOI 10.1038/s41594-019-0298-7; Iwano S, 2018, SCIENCE, V359, P935, DOI 10.1126/science.aaq1067; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lakomek NA, 2012, J BIOMOL NMR, V53, P209, DOI 10.1007/s10858-012-9626-5; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li Y, 2017, BIOMOL NMR ASSIGN, V11, P225, DOI 10.1007/s12104-017-9753-8; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lim SH, 2016, CANCER-AM CANCER SOC, V122, P3024, DOI 10.1002/cncr.30135; Lin KH, 2020, NAT GENET, V52, P408, DOI 10.1038/s41588-020-0590-9; Liu S, 2019, CELL, V176, P491, DOI 10.1016/j.cell.2018.11.038; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METH MOL B, V119, P1; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; Morrison MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197082; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Rooney C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149628; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Shen C, 2015, MOL CELL, V60, P847, DOI 10.1016/j.molcel.2015.10.033; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shen Y, 2015, METHODS MOL BIOL, V1260, P17, DOI 10.1007/978-1-4939-2239-0_2; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shultz Leonard D, 2014, Cold Spring Harb Protoc, V2014, P737, DOI 10.1101/pdb.prot078089; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Su YC, 2020, NAT METHODS, V17, P852, DOI 10.1038/s41592-020-0889-6; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tisi D, 2016, ACS CHEM BIOL, V11, P3093, DOI 10.1021/acschembio.6b00308; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Travis WD, 2020, CLIN CHEST MED, V41, P67, DOI 10.1016/j.ccm.2019.11.001; Turner-Ivey B, 2017, BREAST CANCER RES TR, V164, P349, DOI 10.1007/s10549-017-4258-9; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wang ZT, 2020, CANCER CELL, V37, P834, DOI 10.1016/j.ccell.2020.04.014; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Yang S, 2016, GENE DEV, V30, P1611, DOI 10.1101/gad.284323.116; Yang ZQ, 2010, CANCER RES, V70, P8487, DOI 10.1158/0008-5472.CAN-10-1013; Zhang Q, 2016, STRUCTURE, V24, P1201, DOI 10.1016/j.str.2016.04.019; Zhang Y N, 2017, J HEALTHC ENG, V2017, P2017, DOI DOI 10.1016/J.PA; Zhu Q, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1802-4	70	32	33	16	73	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846					504	+		10.1038/s41586-020-03170-y	http://dx.doi.org/10.1038/s41586-020-03170-y		FEB 2021	33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS8NV	33536620	Green Submitted, Green Accepted			2022-12-28	WOS:000614414900009
J	Zhou, SS; Bhukya, H; Malet, N; Harrison, PJ; Rea, D; Belousoff, MJ; Venugopal, H; Sydor, PK; Styles, KM; Song, LJ; Cryle, MJ; Alkhalaf, LM; Flp, V; Challis, GL; Corre, C				Zhou, Shanshan; Bhukya, Hussain; Malet, Nicolas; Harrison, Peter J.; Rea, Dean; Belousoff, Matthew J.; Venugopal, Hariprasad; Sydor, Paulina K.; Styles, Kathryn M.; Song, Lijiang; Cryle, Max J.; Alkhalaf, Lona M.; Fulop, Vilmos; Challis, Gregory L.; Corre, Christophe			Molecular basis for control of antibiotic production by a bacterial hormone	NATURE			English	Article								Actinobacteria produce numerous antibiotics and other specialized metabolites that have important applications in medicine and agriculture(1). Diffusible hormones frequently control the production of such metabolites by binding TetR family transcriptional repressors (TFTRs), but the molecular basis for this remains unclear(2). The production of methylenomycin antibiotics in Streptomyces coelicolor A3(2) is initiated by the binding of 2-alkyl-4-hydroxymethylfuran-3-carboxylic acid (AHFCA) hormones to the TFTR MmfR(3). Here we report the X-ray crystal structure of an MmfR-AHFCA complex, establishing the structural basis for hormone recognition. We also elucidate the mechanism for DNA release upon hormone binding through the single-particle cryo-electron microscopy structure of an MmfR-operator complex. DNA binding and release assays with MmfR mutants and synthetic AHFCA analogues define the role of individual amino acid residues and hormone functional groups in ligand recognition and DNA release. These findings will facilitate the exploitation of actinobacterial hormones and their associated TFTRs in synthetic biology and in the discovery of new antibiotics.	[Zhou, Shanshan; Malet, Nicolas; Harrison, Peter J.; Sydor, Paulina K.; Song, Lijiang; Alkhalaf, Lona M.; Challis, Gregory L.; Corre, Christophe] Univ Warwick, Dept Chem, Coventry, W Midlands, England; [Rea, Dean; Styles, Kathryn M.; Fulop, Vilmos; Corre, Christophe] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [Challis, Gregory L.; Corre, Christophe] Univ Warwick, Warwick Integrat Synthet Biol Ctr, Coventry, W Midlands, England; [Bhukya, Hussain; Cryle, Max J.; Challis, Gregory L.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Belousoff, Matthew J.] Monash Univ, Dept Microbiol, Infect & Immun Program, Clayton, Vic, Australia; [Venugopal, Hariprasad] Monash Univ, Ramaciotti Ctr Electron Microscopy, Clayton, Vic, Australia; [Cryle, Max J.; Challis, Gregory L.] Monash Univ, ARC Ctr Excellence Innovat Peptide & Prot Sci, Clayton, Vic, Australia	University of Warwick; University of Warwick; University of Warwick; Monash University; Monash University; Monash University; Monash University	Challis, GL; Corre, C (corresponding author), Univ Warwick, Dept Chem, Coventry, W Midlands, England.; Corre, C (corresponding author), Univ Warwick, Sch Life Sci, Coventry, W Midlands, England.; Challis, GL; Corre, C (corresponding author), Univ Warwick, Warwick Integrat Synthet Biol Ctr, Coventry, W Midlands, England.; Challis, GL (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Challis, GL (corresponding author), Monash Univ, ARC Ctr Excellence Innovat Peptide & Prot Sci, Clayton, Vic, Australia.	G.L.Challis@warwick.ac.uk; C.Corre@warwick.ac.uk	Corre, Christophe/J-2896-2013; Belousoff, Matthew/N-4066-2017	Corre, Christophe/0000-0002-4292-9315; Zhou, Shanshan/0000-0003-4466-803X; Belousoff, Matthew/0000-0002-3229-474X; Challis, Gregory/0000-0001-5976-3545; Harrison, Peter/0000-0001-5167-0547; Bhukya, Hussain/0000-0002-5225-1579	University Research Fellowship from The Royal Society [UF090255]; UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M022765/1]; BBSRC [BB/M017982/1]; MonashWarwick Alliance; University of Warwick (Chancellor's International Scholarship); University of Warwick (Warwick Collaborative Postgraduate Research Scholarship); University of Warwick (Institute of Advanced Study Postdoctoral Research Fellowship); ARC Centre of Excellence in Advanced Molecular Imaging; BBSRC [BB/M022765/1] Funding Source: UKRI	University Research Fellowship from The Royal Society(Royal Society of London); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MonashWarwick Alliance; University of Warwick (Chancellor's International Scholarship); University of Warwick (Warwick Collaborative Postgraduate Research Scholarship); University of Warwick (Institute of Advanced Study Postdoctoral Research Fellowship); ARC Centre of Excellence in Advanced Molecular Imaging(Australian Research Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	C.C. acknowledges support of this work by a University Research Fellowship from The Royal Society (UF090255) and by grant BB/M022765/1 from the UK Biotechnology and Biological Sciences Research Council (BBSRC). This work was also supported by BBSRC grant BB/M017982/1 (to G.L.C. and C.C.). G.L.C. is grateful to the MonashWarwick Alliance (postdoctoral fellowship to H.B.), the University of Warwick (Chancellor's International Scholarship to S.Z., Warwick Collaborative Postgraduate Research Scholarship to N.M. and Institute of Advanced Study Postdoctoral Research Fellowship to P.K.S.) and the ARC Centre of Excellence in Advanced Molecular Imaging for support of this work. Crystallographic data were collected at beam lines IO3, IO4 and I24 at Diamond Light Source, UK and we acknowledge the support of the beam line scientists. We thank C. J. Lupton for assisting with instrument set-up for the fluorescence anisotropy measurements and I. Prokes for assistance with acquiring the NMR data.	Arakawa K, 2012, CHEMBIOCHEM, V13, P1447, DOI 10.1002/cbic.201200149; Barka EA, 2016, MICROBIOL MOL BIOL R, V80, P1, DOI 10.1128/MMBR.00019-15; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bhukya H, 2014, NUCLEIC ACIDS RES, V42, P10122, DOI 10.1093/nar/gku587; Corre C, 2008, P NATL ACAD SCI USA, V105, P17510, DOI 10.1073/pnas.0805530105; Cuthbertson L, 2013, MICROBIOL MOL BIOL R, V77, P440, DOI 10.1128/MMBR.00018-13; Flardh K, 2009, NAT REV MICROBIOL, V7, P36, DOI 10.1038/nrmicro1968; HINRICHS W, 1994, SCIENCE, V264, P418, DOI 10.1126/science.8153629; Horinouchi S, 2007, P JPN ACAD B-PHYS, V83, P277, DOI [10.2183/pjab.83.277, 10.2183/pjab/83.277]; Kapoor I, 2020, ELIFE, V9, DOI 10.7554/eLife.57824; Kitani S, 2011, P NATL ACAD SCI USA, V108, P16410, DOI 10.1073/pnas.1113908108; Le TBK, 2011, NUCLEIC ACIDS RES, V39, P9433, DOI 10.1093/nar/gkr640; Natsume R, 2004, J MOL BIOL, V336, P409, DOI 10.1016/j.jmb.2003.12.040; O'Rourke S, 2009, MOL MICROBIOL, V71, P763, DOI 10.1111/j.1365-2958.2008.06560.x; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Takano E, 2005, MOL MICROBIOL, V56, P465, DOI 10.1111/j.1365-2958.2005.04543.x; van der Heul HU, 2018, NAT PROD REP, V35, P575, DOI 10.1039/c8np00012c; Willey JM, 2011, CHEM REV, V111, P174, DOI 10.1021/cr1000404	21	4	6	7	73	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846					463	+		10.1038/s41586-021-03195-x	http://dx.doi.org/10.1038/s41586-021-03195-x		FEB 2021	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QJ5CU	33536618	Green Submitted			2022-12-28	WOS:000614414900004
J	Khatana, SAM; Venkataramani, AS; Nathan, AS; Dayoub, EJ; Eberly, LA; Kazi, DS; Yeh, RBW; Mitra, N; Subramanian, SV; Groeneveld, PW				Khatana, Sameed Ahmed M.; Venkataramani, Atheendar S.; Nathan, Ashwin S.; Dayoub, Elias J.; Eberly, Lauren A.; Kazi, Dhruv S.; Yeh, Robert W.; Mitra, Nandita; Subramanian, S. V.; Groeneveld, Peter W.			Association Between County-Level Change in Economic Prosperity and Change in Cardiovascular Mortality Among Middle-aged US Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Importance After a decline in cardiovascular mortality for nonelderly US adults, recent stagnation has occurred alongside rising income inequality. Whether this is associated with underlying economic trends is unclear. Objective To assess the association between changes in economic prosperity and trends in cardiovascular mortality in middle-aged US adults. Design, Setting, and Participants Retrospective analysis of the association between change in 7 markers of economic prosperity in 3123 US counties and county-level cardiovascular mortality among 40- to 64-year-old adults (102 660 852 individuals in 2010). Exposures Mean rank for change in 7 markers of economic prosperity between 2 time periods (baseline: 2007-2011 and follow-up: 2012-2016). A higher mean rank indicates a greater relative increase or lower relative decrease in prosperity (range, 5 to 92; mean [SD], 50 [14]). Main Outcomes and Measures Mean annual percentage change (APC) in age-adjusted cardiovascular mortality rates. Generalized linear mixed-effects models were used to estimate the additional APC associated with a change in prosperity. Results Among 102 660 852 residents aged 40 to 64 years living in these counties in 2010 (51% women), 979 228 cardiovascular deaths occurred between 2010 and 2017. Age-adjusted cardiovascular mortality rates did not change significantly between 2010 and 2017 in counties in the lowest tertile for change in economic prosperity (mean [SD], 114.1 [47.9] to 116.1 [52.7] deaths per 100 000 individuals; APC, 0.2% [95% CI, -0.3% to 0.7%]). Mortality decreased significantly in the intermediate tertile (mean [SD], 104.7 [38.8] to 101.9 [41.5] deaths per 100 000 individuals; APC, -0.4% [95% CI, -0.8% to -0.1%]) and highest tertile for change in prosperity (100.0 [37.9] to 95.1 [39.1] deaths per 100 000 individuals; APC, -0.5% [95% CI, -0.9% to -0.1%]). After accounting for baseline prosperity and demographic and health care-related variables, a 10-point higher mean rank for change in economic prosperity was associated with 0.4% (95% CI, 0.2% to 0.6%) additional decrease in mortality per year. Conclusions and Relevance In this retrospective study of US county-level mortality data from 2010 to 2017, a relative increase in county-level economic prosperity was significantly associated with a small relative decrease in cardiovascular mortality among middle-aged adults. Individual-level inferences are limited by the ecological nature of the study. Question Are changes in county-level economic prosperity associated with changes in cardiovascular mortality among middle-aged adults (aged 40-64 years) in the US? Findings In this retrospective analysis of county-level mortality data from 3123 US counties from 2010 to 2017, every 10-point greater change in economic prosperity from baseline to follow-up (range, 5 to 92) was significantly associated with a 0.4% lower cardiovascular mortality rate per year among middle-aged adults. Meaning In US counties from 2010 to 2017, a relative increase in economic prosperity was associated with a small relative decrease in cardiovascular mortality among middle-aged adults. This population epidemiology study estimates the association between changes in county-level economic prosperity and changes in cardiovascular mortality in US adults aged 40 to 64 years between 2007-2011 and 2012-2016.	[Khatana, Sameed Ahmed M.; Nathan, Ashwin S.; Eberly, Lauren A.] Univ Penn, Perelman Sch Med, Div Cardiovasc Med, 3400 Civic Ctr Blvd, Philadelphia, PA 19104 USA; [Khatana, Sameed Ahmed M.; Nathan, Ashwin S.; Dayoub, Elias J.; Eberly, Lauren A.; Groeneveld, Peter W.] Univ Penn, Penn Cardiovasc Outcomes, Qual & Evaluat Res Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Khatana, Sameed Ahmed M.; Venkataramani, Atheendar S.; Nathan, Ashwin S.; Dayoub, Elias J.; Eberly, Lauren A.; Mitra, Nandita; Groeneveld, Peter W.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Venkataramani, Atheendar S.] Univ Penn, Perelman Sch Med, Dept Med Ethics & Hlth Policy, Philadelphia, PA 19104 USA; [Kazi, Dhruv S.; Yeh, Robert W.] Beth Israel Deaconess Med Ctr, Richard & Susan Smith Ctr Outcomes Res Cardiol, Boston, MA 02215 USA; [Kazi, Dhruv S.; Yeh, Robert W.] Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; [Kazi, Dhruv S.; Yeh, Robert W.] Harvard Med Sch, Boston, MA 02115 USA; [Mitra, Nandita] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Subramanian, S. V.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Groeneveld, Peter W.] Univ Penn, Perelman Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA; [Groeneveld, Peter W.] Michael J Crescenz Vet Affairs Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center	Khatana, SAM (corresponding author), Univ Penn, Perelman Sch Med, Div Cardiovasc Med, 3400 Civic Ctr Blvd, Philadelphia, PA 19104 USA.	sameed.khatana@pennmedicine.upenn.edu	Khatana, Sameed/AAC-3151-2020	Groeneveld, Peter/0000-0002-7374-4292				Arias Elizabeth, 2016, Vital Health Stat 2, P1; Arroyo-Johnson C, 2016, GASTROENTEROL CLIN N, V45, P571, DOI 10.1016/j.gtc.2016.07.012; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Chen YX, 2019, JAMA CARDIOL, V4, P1230, DOI 10.1001/jamacardio.2019.3891; Cross SH, 2020, JAMA-J AM MED ASSOC, V323, P1852, DOI 10.1001/jama.2020.2047; Curtin Sally C, 2019, Natl Vital Stat Rep, V68, P1; Durfey SNM, 2019, HEALTH SERV RES, V54, P206, DOI 10.1111/1475-6773.13092; Economic Innovation Group, DISTR COMM IND METH; Foreman KJ, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0082-4; Gallo WT, 2004, AM J IND MED, V45, P408, DOI 10.1002/ajim.20004; Havranek EP, 2015, CIRCULATION, V132, P873, DOI 10.1161/CIR.0000000000000228; Kaiser Family Foundation, STAT HLTH FACTS POV; Kawachi I, 1997, BMJ-BRIT MED J, V314, P1037, DOI 10.1136/bmj.314.7086.1037; Lee S, 2004, ANN EPIDEMIOL, V14, P24, DOI 10.1016/S1047-2797(03)00074-7; Lopez-De Fede A, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0378-9; National Center for Health Statistics, 2018, DET MORT ALL COUNT 2; National Interagency Coordination Center (NICC), 2020, NAT DIAB STAT REP WE; Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413; Semega J., 2019, CURRENT POPULATION R; Shanahan L, 2019, AM J PUBLIC HEALTH, V109, P854, DOI 10.2105/AJPH.2019.305016; Sidney S, 2016, JAMA CARDIOL, V1, P594, DOI 10.1001/jamacardio.2016.1326; Stein EM, 2017, AM J PUBLIC HEALTH, V107, P1541, DOI [10.2105/AJPH.2017.303941, 10.2105/ajph.2017.303941]; Tawakol A, 2019, J AM COLL CARDIOL, V73, P3243, DOI 10.1016/j.jacc.2019.04.042; United States Department of Agriculture Economic Research Service, 2019, RURAL EMPLOYMENT UNE; Vaughan AS, 2017, ANN EPIDEMIOL, V27, P796, DOI 10.1016/j.annepidem.2017.10.012; Wang SY, 2019, JAMA CARDIOL, V4, P1203, DOI 10.1001/jamacardio.2019.3788	26	14	13	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2021	325	5					445	453		10.1001/jama.2020.26141	http://dx.doi.org/10.1001/jama.2020.26141			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QC6JP	33528535	Bronze, Green Published			2022-12-28	WOS:000614941900017
J	Park, JM; Cao, Y; Watanabe, K; Taniguchi, T; Jarillo-Herrero, P				Park, Jeong Min; Cao, Yuan; Watanabe, Kenji; Taniguchi, Takashi; Jarillo-Herrero, Pablo			Tunable strongly coupled superconductivity in magic-angle twisted trilayer graphene	NATURE			English	Article							CORRELATED STATES; TRANSITIONS; INSULATOR; CASCADE; BANDS; MOTT	Moire superlattices(1,2) have recently emerged as a platform upon which correlated physics and superconductivity can be studied with unprecedented tunability(3-6). Although correlated effects have been observed in several other moire system(7-17), magic-angle twisted bilayergraphene remains the only one in which robust superconductivity has been reproducibly measured(4-6). Here we realize a moire superconductor in magic-angle twisted trilayer graphene (MATTG)(18), which has better tunability of its electronic structure and superconducting properties than magic-angle twisted bilayer graphene. Measurements ofthe Hall effect and quantum oscillations as a function of density and electric field enable us to determine the tunable phase boundaries of the system in the normal metallic state. Zero-magnetic-field resistivity measurements reveal that the existence of superconductivity is intimately connected to the broken-symmetry phase that emerges from two carriers per moire unit cell. We find that the superconducting phase is suppressed and bounded at the Van Hove singularities that partially surround the broken-symmetry phase, which is difficult to reconcile with weak-coupling Bardeen-Cooper-Schrieffer theory. Moreover, the extensive in situ tunability of our system allows us to reach the ultrastrong-coupling regime, characterized by a Ginzburg-Landau coherence length that reaches the average inter-particle distance, and very large T-BKT/F, values, in excess of 0.1 (where T-BKT and T-F are the Berezinskii-Kosterlitz-Thouless transition and Fermi temperatures, respectively). These observations suggest that MATTG can be electrically tuned close to the crossover to a two-dimensional Bose-Einstein condensate. Our results establish a family of tunable moire superconductors that have the potential to revolutionize our fundamental understanding of and the applications for strongly coupled superconductivity.	[Park, Jeong Min; Cao, Yuan; Jarillo-Herrero, Pablo] MIT, Dept Phys, Cambridge, MA 02139 USA; [Watanabe, Kenji] Natl Inst Mat Sci, Res Ctr Funct Mat, Tsukuba, Ibaraki, Japan; [Taniguchi, Takashi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki, Japan	Massachusetts Institute of Technology (MIT); National Institute for Materials Science; National Institute for Materials Science	Cao, Y; Jarillo-Herrero, P (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	caoyuan@mit.edu; pjarillo@mit.edu	Watanabe, Kenji/ABB-2135-2021; Jarillo-Herrero, Pablo/E-3755-2013	Watanabe, Kenji/0000-0003-3701-8119; Jarillo-Herrero, Pablo/0000-0001-8217-8213; Park, Jeong Min/0000-0001-8905-3640; /0000-0002-9000-4501	US Department of Energy (DOE), Office of Basic Energy Sciences (BES), Division of Materials Sciences and Engineering [DE-SC0001819]; National Science Foundation [DMR-0819762]; STC Center for Integrated Quantum Materials (NSF) [DMR-1231319]; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF9643]; Fundacion Ramon Areces; US DOE Office of Science, BES [DE-SC0019300]; Elemental Strategy Initiative; MEXT, Japan [JPMXP0112101001]; JSPS KAKENHI [JP20H00354]; CREST, JST [JPMJCR15F3]; NSF [ECS-0335765]	US Department of Energy (DOE), Office of Basic Energy Sciences (BES), Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); STC Center for Integrated Quantum Materials (NSF); Gordon and Betty Moore Foundation's EPiQS Initiative; Fundacion Ramon Areces; US DOE Office of Science, BES(United States Department of Energy (DOE)); Elemental Strategy Initiative; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); NSF(National Science Foundation (NSF))	We thank S. Todadri, A. Vishwanath, S. Kivelson, M. Randeria, S. Ilani, L. Fu and A. Georges for discussions. This work has been primarily supported by the US Department of Energy (DOE), Office of Basic Energy Sciences (BES), Division of Materials Sciences and Engineering under award DE-SC0001819 (J.M.P.). Help with transport measurements and data analysis were supported by the National Science Foundation (DMR-1809802), and the STC Center for Integrated Quantum Materials (NSF grant number DMR-1231319; Y.C.). P.J.-H. acknowledges support from the Gordon and Betty Moore Foundation's EPiQS Initiative through grant GBMF9643. P.J.-H. acknowledges partial support by the Fundacion Ramon Areces. The development of new nanofabrication and characterization techniques enabling this work has been supported by the US DOE Office of Science, BES, under award DE-SC0019300. K.W. and T.T. acknowledge support from the Elemental Strategy Initiative conducted by the MEXT, Japan, grant number JPMXP0112101001, JSPS KAKENHI grant numbers JP20H00354 and the CREST (JPMJCR15F3), JST. This work made use of the Materials Research Science and Engineering Center Shared Experimental Facilities supported by the National Science Foundation (DMR-0819762) and of Harvard's Center for Nanoscale Systems, supported by the NSF (ECS-0335765).	Bistritzer R, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.035440; Bistritzer R, 2011, P NATL ACAD SCI USA, V108, P12233, DOI 10.1073/pnas.1108174108; Burg GW, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.197702; Cao Y, 2020, NATURE, V583, pE27, DOI 10.1038/s41586-020-2393-7; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Carr S, 2020, NANO LETT, V20, P3030, DOI 10.1021/acs.nanolett.9b04979; Chen GR, 2020, NATURE, V581, pE3, DOI 10.1038/s41586-020-2237-5; Chen GR, 2019, NATURE, V572, P215, DOI 10.1038/s41586-019-1393-y; Chen GR, 2019, NAT PHYS, V15, P237, DOI 10.1038/s41567-018-0387-2; Chen SW, 2021, NAT PHYS, V17, P374, DOI 10.1038/s41567-020-01062-6; DESSAU DS, 1993, PHYS REV LETT, V71, P2781, DOI 10.1103/PhysRevLett.71.2781; Giamarchi T, 2001, LECT NOTES PHYS, V595, P314; Hazra T, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.031049; He MH, 2021, NAT PHYS, V17, P26, DOI 10.1038/s41567-020-1030-6; Khalaf E., 2020, PREPRINT; Khalaf E, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.085109; Lei C., 2020, PREPRINT; Liu XM, 2020, NATURE, V583, P221, DOI 10.1038/s41586-020-2458-7; Lopez-Bezanilla A, 2020, PHYS REV RES, V2, DOI 10.1103/PhysRevResearch.2.033357; Lu XB, 2019, NATURE, V574, P653, DOI 10.1038/s41586-019-1695-0; MacDonald A. H., 2020, PREPRINT; Mora C, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.026402; Munoz RC, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165408; Nakagawa Y, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.064512; NELSON DR, 1977, PHYS REV LETT, V39, P1201, DOI 10.1103/PhysRevLett.39.1201; Oliveira GNP, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.224418; Park J., 2020, PREPRINT; Polshyn H, 2020, NATURE, V588, P66, DOI 10.1038/s41586-020-2963-8; Regan EC, 2020, NATURE, V579, P359, DOI 10.1038/s41586-020-2092-4; Serlin M, 2020, SCIENCE, V367, P900, DOI 10.1126/science.aay5533; Sharpe AL, 2019, SCIENCE, V365, P605, DOI 10.1126/science.aaw3780; Shen C, 2020, NAT PHYS, V16, P520, DOI 10.1038/s41567-020-0825-9; Shi Y., 2020, PREPRINT; Shoenberg D., 1984, MAGNETIC OSCILLATION; Tang YH, 2020, NATURE, V579, P353, DOI 10.1038/s41586-020-2085-3; Tsai K.-T, 2019, PREPRINT; Wang L, 2020, NAT MATER, V19, P861, DOI 10.1038/s41563-020-0708-6; Wang ZQ, 2017, J PHYS-CONDENS MAT, V29, DOI 10.1088/1361-648X/aa5f26; Yankowitz M, 2019, SCIENCE, V363, P1059, DOI 10.1126/science.aav1910; Yokoya T, 1996, PHYS REV LETT, V76, P3009, DOI 10.1103/PhysRevLett.76.3009; Zhang YH, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.125104; Zondiner U, 2020, NATURE, V582, P203, DOI 10.1038/s41586-020-2373-y	48	231	235	100	465	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2021	590	7845								10.1038/s41586-021-03192-0	http://dx.doi.org/10.1038/s41586-021-03192-0		FEB 2021	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG0TV	33526935	Green Submitted			2022-12-28	WOS:000613628300002
J	Gewin, V				Gewin, Virginia			HOW TO FORGE A PRODUCTIVE SCIENCE-ART COLLABORATION	NATURE			English	Editorial Material								Researchers and artists reflect on partnerships that have invigorated their careers and deepened the public understanding of science											0	3	3	1	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846					515	518		10.1038/d41586-021-00397-1	http://dx.doi.org/10.1038/d41586-021-00397-1			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TY6AA	33597767				2022-12-28	WOS:000683863700001
J	Gilson, L; Barasa, E; Brady, L; Kagwanja, N; Nxumalo, N; Nzinga, J; Molyneux, S; Tsofa, B				Gilson, Lucy; Barasa, Edwine; Brady, Leanne; Kagwanja, Nancy; Nxumalo, Nonhlanhla; Nzinga, Jacinta; Molyneux, Sassy; Tsofa, Benjamin			Collective sensemaking for action: researchers and decision makers working collaboratively to strengthen health systems	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POLICY		[Gilson, Lucy] Univ Cape Town, Sch Publ Hlth & Family Med, Hlth Policy & Syst Div, Cape Town, South Africa; [Gilson, Lucy; Brady, Leanne] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Barasa, Edwine] KEMRI Wellcome Trust Res Programme, Hlth Econ Res Unit, Nairobi, Kenya; [Barasa, Edwine; Molyneux, Sassy] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England; [Brady, Leanne] Western Cape Govt, Dept Hlth, Emergency Med Serv, Cape Town, South Africa; [Kagwanja, Nancy; Molyneux, Sassy; Tsofa, Benjamin] KEMRI Wellcome Trust Res Programme, Hlth Syst Res Grp, Kilifi, Kenya; [Nxumalo, Nonhlanhla] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Ctr Hlth Policy, Johannesburg, South Africa	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Witwatersrand	Gilson, L (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Hlth Policy & Syst Div, Cape Town, South Africa.; Gilson, L (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England.	lucy.gilson@uct.ac.za	Molyneux, Catherine/HGB-8464-2022	Molyneux, Catherine/0000-0001-9522-416X; Barasa, Edwine/0000-0001-5793-7177	Doris Duke Charitable Foundation	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	This article is part of a series produced in conjunction with the WHO and the Alliance for Health Policy Systems and Research with funding from the Doris Duke Charitable Foundation. The BMJ peer reviewed, edited, and made the decision to publish.	Akhnif E, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0176-x; Alliance for Health Policy and Systems Research, 2020, WHAT IS HLTH POL SYS; Barasa E, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-020-00552-6; Beckett K, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0375-0; Best A, 2010, EVID POLICY, V6, P145, DOI 10.1332/174426410X502284; Brady L, 2019, HUM RESOUR HEALTH, V17, DOI 10.1186/s12960-019-0373-5; Gachau S, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000468; Gilson L, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000224; Irimu G, 2018, ARCH DIS CHILD, V103, P1013, DOI 10.1136/archdischild-2017-314348; Jordan ME, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-15; Kagwanja N, 2020, HEALTH POLICY PLANN, V35, P522, DOI 10.1093/heapol/czaa002; Koon AD, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-019-0522-2; Langley J, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3397-y; Liverani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077404; McGivern G, 2017, SOC SCI MED, V195, P115, DOI 10.1016/j.socscimed.2017.11.031; Mills A, 2012, HEALTH POLICY PLANN, V27, P1, DOI 10.1093/heapol/czr006; Molyneux S, 2016, DEV WORLD BIOETH, V16, P168, DOI 10.1111/dewb.12130; Oliver K, 2019, HEALTH RES POLICY SY, V17, DOI 10.1186/s12961-019-0432-3; Olivera Betran J., 2017, Apunts. Educacio Fisica i Esports, P9; Vindrola-Padros C, 2019, BMJ QUAL SAF, V28, P67, DOI 10.1136/bmjqs-2017-007127; Western Cape HPSR Journal Club team, 2020, INT J HLTH POL MANAG, DOI [10.34172/ijhpm.2020.128, DOI 10.34172/IJHPM.2020.128]; Whitty C, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-S1-S1; Writers' Community Action Network, 2020, ROAR MAGAZINE   0605	23	11	11	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2021	372								m4650	10.1136/bmj.m4650	http://dx.doi.org/10.1136/bmj.m4650			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RA8YP	33593963	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000631706300014
J	Kuehn, BM				Kuehn, Bridget M.			Global Partnership Aims to Improve Infant HIV Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2021	325	7					612	612		10.1001/jama.2021.0844	http://dx.doi.org/10.1001/jama.2021.0844			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ3QZ	33591356				2022-12-28	WOS:000619608000004
J	Tangcharoensathien, V; Sirilak, S; Sritara, P; Patcharanarumol, W; Lekagul, A; Isaranuwatchai, W; Wittayapipopsakul, W; Chandrasiri, O				Tangcharoensathien, Viroj; Sirilak, Supakit; Sritara, Piyamitr; Patcharanarumol, Walaiporn; Lekagul, Angkana; Isaranuwatchai, Wanrudee; Wittayapipopsakul, Woranan; Chandrasiri, Orana			Co-production of evidence for policies in Thailand: from concept to action	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIALYSIS; COVERAGE		[Tangcharoensathien, Viroj; Patcharanarumol, Walaiporn; Lekagul, Angkana; Wittayapipopsakul, Woranan; Chandrasiri, Orana] Minist Publ Hlth, Int Hlth Policy Programme, Nonthaburi, Thailand; [Sirilak, Supakit] Minist Publ Hlth, Off Permanent Secretary, Bangkok, Thailand; [Sritara, Piyamitr] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok, Thailand; [Patcharanarumol, Walaiporn] Minist Publ Hlth, Global Hlth Div, Nonthaburi, Thailand; [Isaranuwatchai, Wanrudee] Minist Publ Hlth, Hlth Intervent & Technol Assessment Programme, Nonthaburi, Thailand; [Isaranuwatchai, Wanrudee] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Mahidol University; Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; University of Toronto	Tangcharoensathien, V (corresponding author), Minist Publ Hlth, Int Hlth Policy Programme, Nonthaburi, Thailand.	Tangcharoensathienviroj@ihpp.thaigov.net						Chuengsaman P, 2017, SEMIN NEPHROL, V37, P287, DOI 10.1016/j.semnephrol.2017.02.008; Chuengsatiansup K., 2008, DELIBERATIVE ACTION; Elwyn G, 2020, BMJ QUAL SAF, V29, P711, DOI 10.1136/bmjqs-2019-009830; Fung A, 2006, PUBLIC ADMIN REV, V66, P66, DOI 10.1111/j.1540-6210.2006.00667.x; Gyawali B, 2018, JAMA ONCOL, V4, P623, DOI 10.1001/jamaoncol.2017.5697; Kanchanachitra C, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000383; Kasemsup V, 2006, VALUE HEALTH, V9, pA385, DOI 10.1016/S1098-3015(10)63770-9; Meyfroidt G, 2020, ETHICAL PRINCIPLES P; National Health Security Office, HIST REN FAIL FUND; Nephrology Society of Thailand, 2008, REP THAIL REN REPL T; New York State Department of Health, 2015, VENT ALL GUID; Norstrom AV, 2020, NAT SUSTAIN, V3, P182, DOI 10.1038/s41893-019-0448-2; Office of the Council of State, 2007, CONST KINGD THAIL; Petkham M, 2020, J NURS HLTH CARE, V38, P138; Pitayarangsarit S., 2005, THESIS SCH HYGIENE T; Pitayarangsarit S, 2009, B WORLD HEALTH ORGAN, V87, P72, DOI 10.2471/BLT.07.044479; Prakongsai P, 2009, J INT DEV, V21, P291, DOI 10.1002/jid.1553; Rajan D, 2017, TRIANGLE MOVES MOUNT; Rycroft-Malone J, 2016, INT J HEALTH POLICY, V5, P221, DOI 10.15171/ijhpm.2016.08; Tantivess S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f462; Teerawattananon Y, 2007, VALUE HEALTH, V10, P61, DOI 10.1111/j.1524-4733.2006.00145.x; Towse A, 2004, BRIT MED J, V328, P103, DOI 10.1136/bmj.328.7431.103; Wasi P., 2000, HUMAN RESOURCES HLTH, V4, P106	23	10	10	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2021	372								m4669	10.1136/bmj.m4669	http://dx.doi.org/10.1136/bmj.m4669			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RA8YP	33593790	hybrid, Green Published			2022-12-28	WOS:000631706300005
J	Sharfstein, JM; Goodman, JL; Borio, L				Sharfstein, Joshua M.; Goodman, Jesse L.; Borio, Luciana			The US Regulatory System and COVID-19 Vaccines The Importance of a Strong and Capable FDA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint examines the important role of the Food and Druf Administration (FDA) in facilitating the rapid development of coronavirus disease 2019 (COVID-19) vaccines.	[Sharfstein, Joshua M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, 615 N Wolfe St,Room W1033D, Baltimore, MD 21205 USA; [Goodman, Jesse L.] Georgetown Univ, Med & Infect Dis, Washington, DC USA; [Borio, Luciana] In Q Tel, Arlington Cty, VA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Georgetown University	Sharfstein, JM (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, 615 N Wolfe St,Room W1033D, Baltimore, MD 21205 USA.	joshua.sharfstein@jhu.edu						Bauchner H, 2020, JAMA-J AM MED ASSOC, V324, P1296, DOI 10.1001/jama.2020.18860; Davis, 2021, GUARDIAN        0128; McClellan M., 2020, WALL STR J; Moutinho S., 2021, 3 TIMES CHARM BRAZIL; Pearson S, 2021, WALL STR J; Shah A, 2020, JAMA-J AM MED ASSOC, V324, P931, DOI 10.1001/jama.2020.15725; US Food and Drug Administration, 2020, DEV LIC VACC PREV CO; US Food and Drug Administration, 2020, EM AUTH VACC PREV CO	8	7	7	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2021	325	12					1153	1154		10.1001/jama.2021.1961	http://dx.doi.org/10.1001/jama.2021.1961		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ7PB	33587124	Bronze			2022-12-28	WOS:000619613200001
J	Ferry, G				Ferry, Georgina			Rebecca Lee Crumpler: first Black woman physician in the USA	LANCET			English	Editorial Material												mgf@georginaferry.com							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2021	397	10274					572	572						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2TN	33581815				2022-12-28	WOS:000620934000014
J	Siva, N				Siva, Nayanah			New global initiative to tackle Alzheimer's disease	LANCET			English	Editorial Material																			0	8	8	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2021	397	10274					568	569						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2TN	33581812				2022-12-28	WOS:000620934000011
J	Carter, JM; Goldman, GT; Rosenberg, AA; Reed, G; Desikan, A; MacKinney, T				Carter, Jacob M.; Goldman, Gretchen T.; Rosenberg, Andrew A.; Reed, Genna; Desikan, Anita; MacKinney, Taryn			Strengthen scientific integrity under the Biden administration	SCIENCE			English	Editorial Material									[Carter, Jacob M.; Goldman, Gretchen T.; Rosenberg, Andrew A.; Reed, Genna; Desikan, Anita; MacKinney, Taryn] Union Concerned Scientists, Washington, DC 20006 USA		Carter, JM (corresponding author), Union Concerned Scientists, Washington, DC 20006 USA.	jcarter@ucsusa.org		Reed, Genna/0000-0002-9602-1193				Allen T., 2020, INDEPENDENT ASSESSME; Berman E., 2018, J SCI POLICY GOVERNA, V13, P1; Brym M., 2020, 20P0173 EPA OFF INSP; Desikan A., 2020, LET SCI SPEAK CDC EX; Frederickson L., 2019, SHEEP CLOSET EROSION; Goldman GT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231929; Goldman GT, 2019, NATURE, V570, P417, DOI 10.1038/d41586-019-01961-6; Goldman GT, 2017, SCIENCE, V355, P696, DOI 10.1126/science.aam5733; Gowen Annie, 2020, WASHINGTON POST; Holdren J. P., 2010, MEMORANDUM HEADS EXE; Kelly M. L., 2021, ENV LAW REV, V51, P1; MacKinney T., 2020, STRENGTHENING SCI IN; Reed G., 2018, ABANDONING SCI ADVIC; Union of Concerned Scientists, 2017, ATT SCI; WhiteHouse, 2021, FACT SHEET PRES BID	15	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					668	671		10.1126/science.abg0533	http://dx.doi.org/10.1126/science.abg0533			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4IS	33574196				2022-12-28	WOS:000617551600022
J	Gao, JH; Jiang, SH; Zhang, HR; Huang, YH; Guan, DK; Xu, YD; Guan, SK; Bendersky, LA; Davydov, AV; Wu, Y; Zhu, HH; Wang, YD; Lu, ZP; Rainforth, WM				Gao, Junheng; Jiang, Suihe; Zhang, Huairuo; Huang, Yuhe; Guan, Dikai; Xu, Yidong; Guan, Shaokang; Bendersky, Leonid A.; Davydov, Albert, V; Wu, Yuan; Zhu, Huihui; Wang, Yandong; Lu, Zhaoping; Rainforth, W. Mark			Facile route to bulk ultrafine-grain steels for high strength and ductility	NATURE			English	Article								Steels with sub-micrometre grain sizes usually possess high toughness and strength, which makes them promising for lightweighting technologies and energy-saving strategies. So far, the industrial fabrication of ultrafine-grained (UFG) alloys, which generally relies on the manipulation of diffusional phase transformation, has been limited to steels with austenite-to-ferrite transformation(1-3). Moreover, the limited work hardening and uniform elongation of these UFG steels(1,4,5) hinder their widespread application. Here we report the facile mass production of UFG structures in a typical Fe-22Mn-0.6C twinning-induced plasticity steel by minor Cu alloying and manipulation of the recrystallization process through the intragranular nanoprecipitation (within 30 seconds) of a coherent disordered Cu-rich phase. The rapid and copious nanoprecipitation not only prevents the growth of the freshly recrystallized sub-micrometre grains but also enhances the thermal stability of the obtained UFG structure through the Zener pinning mechanism(6). Moreover, owing to their full coherency and disordered nature, the precipitates exhibit weak interactions with dislocations under loading. This approach enables the preparation of a fully recrystallized UFG structure with a grain size of 800 +/- 400 nanometres without the introduction of detrimental lattice defects such as brittle particles and segregated boundaries. Compared with the steel to which no Cu was added, the yield strength of the UFG structure was doubled to around 710 megapascals, with a uniform ductility of 45 per cent and a tensile strength of around 2,000 megapascals. This grain-refinement concept should be extendable to other alloy systems, and the manufacturing processes can be readily applied to existing industrial production lines. Bulk ultrafine-grained steel is prepared by an approach that involves the rapid production of coherent, disordered nanoprecipitates, which restrict grain growth but do not interfere with twinning or dislocation motion, resulting in high strength and ductility.	[Gao, Junheng; Huang, Yuhe; Guan, Dikai; Xu, Yidong; Rainforth, W. Mark] Univ Sheffield, Dept Mat Sci & Engn, Sheffield, S Yorkshire, England; [Jiang, Suihe; Wu, Yuan; Zhu, Huihui; Wang, Yandong; Lu, Zhaoping] Univ Sci & Technol Beijing, Beijing Adv Innovat Ctr Mat Genome Engn, State Key Lab Adv Met & Mat, Beijing, Peoples R China; [Zhang, Huairuo] Theiss Res Inc, La Jolla, CA 92037 USA; [Zhang, Huairuo; Bendersky, Leonid A.; Davydov, Albert, V] NIST, Mat Sci & Engn Div, Gaithersburg, MD 20899 USA; [Guan, Shaokang] Zhengzhou Univ, Sch Mat Sci & Engn, Zhengzhou, Peoples R China	University of Sheffield; University of Science & Technology Beijing; National Institute of Standards & Technology (NIST) - USA; Zhengzhou University	Rainforth, WM (corresponding author), Univ Sheffield, Dept Mat Sci & Engn, Sheffield, S Yorkshire, England.; Jiang, SH; Lu, ZP (corresponding author), Univ Sci & Technol Beijing, Beijing Adv Innovat Ctr Mat Genome Engn, State Key Lab Adv Met & Mat, Beijing, Peoples R China.; Zhang, HR (corresponding author), Theiss Res Inc, La Jolla, CA 92037 USA.; Zhang, HR (corresponding author), NIST, Mat Sci & Engn Div, Gaithersburg, MD 20899 USA.	jiangsh@ustb.edu.cn; huairuo.zhang@nist.gov; luzp@ustb.edu.cn; m.rainforth@sheffield.ac.uk	wang, yandong/G-9404-2013; Wu, Yuan/C-4025-2015; Xu, Yidong/AAO-4735-2021	wang, yandong/0000-0002-4758-4352; Wu, Yuan/0000-0001-7857-0247; Xu, Yidong/0000-0002-1687-0698	Medical Research Council [MR/T019123/1] Funding Source: Medline; Intramural NIST DOC [9999-NIST] Funding Source: Medline; EPSRC [EP/S019367/1, EP/P02470X/1, EP/L025213/1] Funding Source: UKRI; UKRI [MR/T019123/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Intramural NIST DOC; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UKRI		Arlazarov A, 2013, ISIJ INT, V53, P1076, DOI 10.2355/isijinternational.53.1076; Bai JW, 2013, MAT SCI ENG A-STRUCT, V584, P57, DOI 10.1016/j.msea.2013.06.082; Blavette D, 1999, SCIENCE, V286, P2317, DOI 10.1126/science.286.5448.2317; Blavette D, 1996, ACTA MATER, V44, P4995, DOI 10.1016/S1359-6454(96)00087-0; Bouaziz O, 2008, SCRIPTA MATER, V58, P484, DOI 10.1016/j.scriptamat.2007.10.050; Bouaziz O, 2013, STEEL RES INT, V84, P937, DOI 10.1002/srin.201200288; Caul M, 1996, SCRIPTA MATER, V35, P831, DOI 10.1016/1359-6462(96)00234-5; Chan HL, 2010, ACTA MATER, V58, P5086, DOI 10.1016/j.actamat.2010.05.044; Chen Z, 2016, INT J PLASTICITY, V83, P178, DOI 10.1016/j.ijplas.2016.04.009; Chookajorn T, 2012, SCIENCE, V337, P951, DOI 10.1126/science.1224737; De Cooman BC, 2018, ACTA MATER, V142, P283, DOI 10.1016/j.actamat.2017.06.046; De Moor E, 2011, ISIJ INT, V51, P137, DOI 10.2355/isijinternational.51.137; Dini G, 2010, MATER LETT, V64, P15, DOI 10.1016/j.matlet.2009.09.057; Fan DN, 1997, ACTA MATER, V45, P3297, DOI 10.1016/S1359-6454(97)00022-0; Funakawa Y, 2004, ISIJ INT, V44, P1945, DOI 10.2355/isijinternational.44.1945; Gault B, 2009, J APPL PHYS, V105, DOI 10.1063/1.3068197; Grassel O, 2000, INT J PLASTICITY, V16, P1391, DOI 10.1016/S0749-6419(00)00015-2; Gu XL, 2019, MAT SCI ENG A-STRUCT, V754, P318, DOI 10.1016/j.msea.2019.03.070; Gwon H, 2017, MAT SCI ENG A-STRUCT, V696, P416, DOI 10.1016/j.msea.2017.04.083; Haase C, 2017, ACTA MATER, V122, P332, DOI 10.1016/j.actamat.2016.10.006; Hasegawa H, 1999, MAT SCI ENG A-STRUCT, V265, P188, DOI 10.1016/S0921-5093(98)01136-8; Howe AA, 2000, MATER SCI TECH SER, V16, P1264, DOI 10.1179/026708300101507488; Huang JN, 2019, MAT SCI ENG A-STRUCT, V764, DOI 10.1016/j.msea.2019.138231; Humphreys F.J., 2004, RECRYSTALLIZATION RE, DOI 10.1016/B978-0-08-044164-1.X5000-2; Jiang SH, 2017, NATURE, V544, P460, DOI 10.1038/nature22032; Kim SH, 2015, NATURE, V518, P77, DOI 10.1038/nature14144; Kim YW, 2014, MAT SCI ENG A-STRUCT, V605, P244, DOI 10.1016/j.msea.2014.03.054; Liang ZY, 2016, SCRIPTA MATER, V112, P28, DOI 10.1016/j.scriptamat.2015.09.003; Moody MP, 2009, ULTRAMICROSCOPY, V109, P815, DOI 10.1016/j.ultramic.2009.03.016; Murr L.E., 1975, INTERFACIAL PHENOMEN; NES E, 1985, ACTA METALL MATER, V33, P11, DOI 10.1016/0001-6160(85)90214-7; Ohmori A, 2004, ISIJ INT, V44, P1063, DOI 10.2355/isijinternational.44.1063; Park KT, 2000, MAT SCI ENG A-STRUCT, V293, P165, DOI 10.1016/S0921-5093(00)01220-X; Rahman KM, 2015, ACTA MATER, V89, P247, DOI 10.1016/j.actamat.2015.02.008; Sohn SS, 2019, ADV MATER, V31, DOI 10.1002/adma.201807142; Song R, 2006, MAT SCI ENG A-STRUCT, V441, P1, DOI 10.1016/j.msea.2006.08.095; Song R, 2005, ACTA MATER, V53, P4881, DOI 10.1016/j.actamat.2005.07.009; Straska J, 2014, MATER CHARACT, V94, P69, DOI 10.1016/j.matchar.2014.05.013; Takeuchi A, 2005, MATER TRANS, V46, P2817, DOI 10.2320/matertrans.46.2817; Tian YZ, 2017, MATER CHARACT, V126, P74, DOI 10.1016/j.matchar.2016.12.026; Ungar T, 1998, ACTA MATER, V46, P3693, DOI 10.1016/S1359-6454(98)00001-9; Ungar T, 1999, J APPL CRYSTALLOGR, V32, P992, DOI 10.1107/S0021889899009334; Xi T, 2016, MAT SCI ENG A-STRUCT, V675, P243, DOI 10.1016/j.msea.2016.08.058; Yao MJ, 2017, ACTA MATER, V140, P258, DOI 10.1016/j.actamat.2017.08.049; Zhang J.S., 2010, HIGH TEMPERATURE DEF; Zhang M, 2006, MAT SCI ENG A-STRUCT, V438, P296, DOI 10.1016/j.msea.2006.01.128; Zhao JL, 2012, J IRON STEEL RES INT, V19, P57, DOI 10.1016/S1006-706X(12)60088-0; Zhou P, 2016, ACTA MATER, V111, P96, DOI 10.1016/j.actamat.2016.03.057	48	42	42	69	295	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2021	590	7845								10.1038/s41586-021-03246-3	http://dx.doi.org/10.1038/s41586-021-03246-3			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG0TV	33568822	Green Accepted			2022-12-28	WOS:000617300400015
J	Buckland, R; Abernethy, MK				Buckland, Rosalyn; Abernethy, Michael K.			Death by Massive Hemorrhage in Robert Frost's "Out, Out-" A Plea to the Immediate Responder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Buckland, Rosalyn] Queen Mary Univ, Med Humanities, Mile End Rd, London E1 4NS, England; [Abernethy, Michael K.] Univ Wisconsin, Sch Publ Hlth & Med, Emergency Med, Madison, WI USA	University of London; Queen Mary University London; University of Wisconsin System; University of Wisconsin Madison	Buckland, R (corresponding author), Queen Mary Univ, Med Humanities, Mile End Rd, London E1 4NS, England.	ha17341@qmul.ac.uk		Buckland, Rosalyn/0000-0002-2069-798X				[Anonymous], 1910, LITTLETON COURIER, P567; Frost R, 2001, POETRY R FROST, P136; Gray R, 2012, HISTORY OF AMERICAN LITERATURE, 2ND EDITION, P308; Newman L., 2000, R FROST PEOPLE PLACE, P96; Rotella G, 2012, LIT IMAGIN, V14, P88, DOI 10.1093/litimag/imr087	5	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2021	325	6					515	516		10.1001/jama.2020.24787	http://dx.doi.org/10.1001/jama.2020.24787			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG0MD	33560303				2022-12-28	WOS:000617279600001
J	Lane, R				Lane, Richard			Profile Tahmeed Ahmed: new leader of icddr,b	LANCET			English	Biographical-Item																		AHMED T, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2021	397	10273					463	463						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QF1LZ	33549182				2022-12-28	WOS:000616661900012
J	Naseer, N; Strelau, K				Naseer, Nawar; Strelau, Katherine			Tracing contacts, finding ourselves	SCIENCE			English	Editorial Material									[Naseer, Nawar; Strelau, Katherine] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Naseer, N (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.								0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		646	646		10.1126/science.371.6529.646	http://dx.doi.org/10.1126/science.371.6529.646			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QD7TF	33542139				2022-12-28	WOS:000615715300056
J	Shen, T; Lambert, TH				Shen, Tao; Lambert, Tristan H.			Electrophotocatalytic diamination of vicinal C-H bonds	SCIENCE			English	Article							PHOTOCHEMISTRY; SUBSTITUTION; INHIBITORS; AMINATION; ACYLATION; OLEFINS; REMOTE; POTENT; ACID	The conversion of unactivated carbon-hydrogen (C-H) bonds to carbon-nitrogen (C-N) bonds is a highly valued transformation. Existing strategies typically accomplish such reactions at only a single C-H site because the first derivatization diminishes the reactivity of surrounding C-H bonds. Here, we show that alkylated arenes can undergo vicinal C-H diamination reactions to form 1,2-diamine derivatives through an electrophotocatalytic strategy, using acetonitrile as both solvent and nitrogen source. The reaction is catalyzed by a trisaminocyclopropenium (TAC) ion, which undergoes anodic oxidation to furnish a stable radical dication while the cathodic reaction reduces protons to molecular hydrogen. Irradiation of the TAC radical dication (wavelength of maximum absorption of 450 to 550 nanometers) with a white-light compact fluorescent light generates a strongly oxidizing photoexcited intermediate. Depending on the electrolyte used, either 3,4-dihydroimidazole or aziridine products are obtained.	[Shen, Tao; Lambert, Tristan H.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA	Cornell University	Lambert, TH (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA.	tristan.lambert@cornell.edu		Lambert, Tristan/0000-0002-7720-3290; Shen, Tao/0000-0002-2028-152X	National Institutes of Health [R35 GM127135]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the National Institutes of Health under R35 GM127135.	[Anonymous], PRICES ARE FOLLOWING; Baskakis C, 2008, J MED CHEM, V51, P8027, DOI 10.1021/jm800649q; BECKER JY, 1975, J AM CHEM SOC, V97, P853, DOI 10.1021/ja00837a027; BECKER JY, 1974, J AM CHEM SOC, V96, P4718, DOI 10.1021/ja00821a083; BONNER WA, 1964, J ORG CHEM, V29, P430, DOI 10.1021/jo01025a045; Cahiez G, 2007, ANGEW CHEM INT EDIT, V46, P4364, DOI 10.1002/anie.200700742; Clark JR, 2018, NAT CHEM, V10, P583, DOI 10.1038/s41557-018-0020-0; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; deLijser HJP, 1997, J ORG CHEM, V62, P8432, DOI 10.1021/jo971197p; Duhamel T, 2019, ACS CATAL, V9, P7741, DOI 10.1021/acscatal.9b01566; Fuerstner C., 2012, PCT Int. Appl, Patent No. [WO/2012/028644, 2012028644]; Guandalini L, 2015, BIOORG MED CHEM LETT, V25, P1700, DOI 10.1016/j.bmcl.2015.03.009; Hashimoto Y, 2002, BIOORGAN MED CHEM, V10, P461, DOI 10.1016/S0968-0896(01)00308-X; He ZQ, 2018, J AM CHEM SOC, V140, P2693, DOI 10.1021/jacs.8b00380; Hille UE, 2011, ACS MED CHEM LETT, V2, P2, DOI 10.1021/ml100071J; Huang H, 2020, J AM CHEM SOC, V142, P1698, DOI 10.1021/jacs.9b11472; Huang H, 2020, ANGEW CHEM INT EDIT, V59, P658, DOI 10.1002/anie.201909983; Huang H, 2019, ANGEW CHEM INT EDIT, V58, P13318, DOI 10.1002/anie.201906381; Hynes J. T., 2007, HYDROGEN TRANSFER RE; Kiyokawa K, 2016, CHEM COMMUN, V52, P13082, DOI 10.1039/c6cc07164c; Krishnegowda G, 2011, BIOORGAN MED CHEM, V19, P6006, DOI 10.1016/j.bmc.2011.08.044; Lopez-Perez A, 2009, ORG LETT, V11, P5514, DOI 10.1021/ol902335c; Lund BW, 2005, J MED CHEM, V48, P7517, DOI 10.1021/jm050891r; Metallinos C, 1999, ORG LETT, V1, P1183, DOI 10.1021/ol990846b; Michaudel Q, 2012, J AM CHEM SOC, V134, P2547, DOI 10.1021/ja212020b; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; MOUTET JC, 1982, J CHEM SOC CHEM COMM, P654, DOI 10.1039/c39820000654; Park Y, 2017, CHEM REV, V117, P9247, DOI 10.1021/acs.chemrev.6b00644; Pascal Jr R. A., 1991, J ORG CHEM, V56, P6954; Prusinowski AF, 2020, J AM CHEM SOC, V142, P5429, DOI 10.1021/jacs.0c01318; Reddy AGK, 2016, J ORG CHEM, V81, P12212, DOI 10.1021/acs.joc.6b02015; Richter MF, 2017, NATURE, V545, P299, DOI 10.1038/nature22308; RITTER JJ, 1948, J AM CHEM SOC, V70, P4048, DOI 10.1021/ja01192a023; RITTER JJ, 1948, J AM CHEM SOC, V70, P4045, DOI 10.1021/ja01192a022; Roth HG, 2016, SYNLETT, V27, P714, DOI 10.1055/s-0035-1561297; Sato N, 2009, BIOORG MED CHEM LETT, V19, P1670, DOI 10.1016/j.bmcl.2009.01.101; SCHEFFOLD R, 1983, J AM CHEM SOC, V105, P7200, DOI 10.1021/ja00362a047; SHASTIN AV, 1984, ZH ORG KHIM+, V20, P1357; Steinig AG, 1999, J ORG CHEM, V64, P2406, DOI 10.1021/jo982222+; Vidal Juan B., 2003, PCT Int. Appl., Patent No. [WO/2003/000694, 2003000694]; Wang F, 2019, ANGEW CHEM INT EDIT, V58, P6385, DOI 10.1002/anie.201813960; Wen YH, 2009, ORG LETT, V11, P2365, DOI 10.1021/ol900808z; Yan H, 2019, ANGEW CHEM INT EDIT, V58, P4592, DOI 10.1002/anie.201814488; Zhang L, 2019, NAT CATAL, V2, P366, DOI 10.1038/s41929-019-0231-9; Zhang W, 2020, ANGEW CHEM INT EDIT, V59, P409, DOI 10.1002/anie.201910300	45	60	60	20	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		620	+		10.1126/science.abf2798	http://dx.doi.org/10.1126/science.abf2798			296	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QD7TF	33542135	Green Accepted			2022-12-28	WOS:000615715300052
J	Xu, YF; Li, XY; Gao, JH; Wang, J; Ma, GY; Wen, XD; Yang, Y; Li, YW; Ding, MY				Xu, Yanfei; Li, Xiangyang; Gao, Junhu; Wang, Jie; Ma, Guangyuan; Wen, Xiaodong; Yang, Yong; Li, Yongwang; Ding, Mingyue			A hydrophobic FeMn@Si catalyst increases olefins from syngas by suppressing C1 by-products	SCIENCE			English	Article							FISCHER-TROPSCH SYNTHESIS; IRON CATALYSTS; SELECTIVE CONVERSION; CO HYDROGENATION; LIGHT OLEFINS; SYNTHESIS GAS; ACTIVE PHASE; WATER; OXIDE; PARTICLES	Although considerable efforts have been made in the selective conversion of syngas [carbon monoxide (CO) and hydrogen] to olefins through Fischer-Tropsch synthesis (FTS), similar to 50% of the converted CO is transformed into the undesired one-carbon molecule (C1) by-products [carbon dioxide (CO2) and methane (CH4)]. In this study, a core-shell FeMn@Si catalyst with excellent hydrophobicity was designed to hinder the formation of CO2 and CH4. The hydrophobic shell protected the iron carbide core from oxidation by water generated during FTS and shortened the retention of water on the catalyst surface, restraining the side reactions related to water. Furthermore, the electron transfer from manganese to iron atoms boosted olefin production and inhibited CH4 formation. The multifunctional catalyst could suppress the total selectivity of CO2 and CH4 to less than 22.5% with an olefin yield of up to 36.6% at a CO conversion of 56.1%.	[Xu, Yanfei; Wang, Jie; Ma, Guangyuan; Ding, Mingyue] Wuhan Univ, Sch Power & Mech Engn, Wuhan 430072, Peoples R China; [Li, Xiangyang; Gao, Junhu; Wen, Xiaodong; Yang, Yong; Li, Yongwang] Synfuels China Co Ltd, Beijing 101407, Peoples R China; [Wen, Xiaodong; Yang, Yong; Li, Yongwang] Chinese Acad Sci, Inst Coal Chem, State Key Lab Coal Convers, Taiyuan 030001, Peoples R China	Wuhan University; Chinese Academy of Sciences; Institute of Coal Chemistry, CAS	Ding, MY (corresponding author), Wuhan Univ, Sch Power & Mech Engn, Wuhan 430072, Peoples R China.	dingmy@whu.edu.cn		Xu, Yanfei/0000-0002-7060-7532	National Natural Science Foundation of China [51861145102, 21978225]; National Key Research and Development Plan of China [2018YFE0125200]; Guangdong Provincial Science and Technology Project [2019A050510031]; Science and Technology program of Shenzhen [JCYJ20180302153928437]; Fundamental Research Fund for the Central Universities [2042019kf0221]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan of China; Guangdong Provincial Science and Technology Project; Science and Technology program of Shenzhen; Fundamental Research Fund for the Central Universities	This work was supported by the National Natural Science Foundation of China (51861145102 and 21978225), National Key Research and Development Plan of China (2018YFE0125200), Guangdong Provincial Science and Technology Project (2019A050510031), Science and Technology program of Shenzhen (JCYJ20180302153928437), and Fundamental Research Fund for the Central Universities (2042019kf0221).	Bao J, 2019, ACS CATAL, V9, P3026, DOI 10.1021/acscatal.8b03924; Bukur DB, 2016, CATAL TODAY, V275, P66, DOI 10.1016/j.cattod.2015.11.005; Chen XQ, 2015, CHEM COMMUN, V51, P217, DOI [10.1039/c4cc06600f, 10.3778/j.issn.1002-8331.1401-0315]; Cheng K, 2016, ANGEW CHEM INT EDIT, V55, P4725, DOI 10.1002/anie.201601208; Cheng Y, 2017, APPL CATAL B-ENVIRON, V204, P475, DOI 10.1016/j.apcatb.2016.11.058; de Smit E, 2008, CHEM SOC REV, V37, P2758, DOI 10.1039/b805427d; Ding MY, 2015, APPL ENERG, V160, P982, DOI 10.1016/j.apenergy.2014.12.042; Galvis HMT, 2013, ACS CATAL, V3, P2130, DOI 10.1021/cs4003436; Galvis HMT, 2012, SCIENCE, V335, P835, DOI 10.1126/science.1215614; Jiao F, 2016, SCIENCE, V351, P1065, DOI 10.1126/science.aaf1835; Jin Z, 2020, SCIENCE, V367, P193, DOI 10.1126/science.aaw1108; Jin Z, 2018, ACS CATAL, V8, P5250, DOI 10.1021/acscatal.8b00732; Krishnamoorthy S, 2002, CATAL LETT, V80, P77, DOI 10.1023/A:1015382811877; Li SZ, 2002, J CATAL, V206, P202, DOI 10.1006/jcat.2001.3506; Li YS, 2012, J MAGN MAGN MATER, V324, P1543, DOI 10.1016/j.jmmm.2011.11.065; Li YX, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17042-6; Liu JH, 2018, IND ENG CHEM RES, V57, P9120, DOI 10.1021/acs.iecr.8b02017; Liu Y, 2015, ACS CATAL, V5, P3905, DOI 10.1021/acscatal.5b00492; Lu JZ, 2014, ACS CATAL, V4, P613, DOI 10.1021/cs400931z; Ojeda M, 2010, J CATAL, V272, P287, DOI 10.1016/j.jcat.2010.04.012; Pirola C, 2009, CATAL COMMUN, V10, P823, DOI 10.1016/j.catcom.2008.12.006; Rodulfo-Baechler SM, 2004, MATER LETT, V58, P2447, DOI 10.1016/j.matlet.2004.02.032; Rytter E, 2018, CATAL TODAY, V299, P20, DOI 10.1016/j.cattod.2017.04.031; Santos VP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7451; SATTERFIELD CN, 1986, IND ENG CHEM PROD RD, V25, P407, DOI 10.1021/i300023a007; Shi LH, 2007, CHINESE J CATAL, V28, P999, DOI 10.1016/S1872-2067(07)60084-9; van der Laan GP, 2000, APPL CATAL A-GEN, V193, P39, DOI 10.1016/S0926-860X(99)00412-3; Wang J, 2018, ACS APPL MATER INTER, V10, P43578, DOI 10.1021/acsami.8b11820; Wang P, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau2947; Wang WY, 2020, APPL CATAL B-ENVIRON, V276, DOI 10.1016/j.apcatb.2020.119142; Xie JX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08019-7; Xu YF, 2018, FUEL, V228, P1, DOI 10.1016/j.fuel.2018.04.151; Yu XF, 2018, APPL CATAL B-ENVIRON, V232, P420, DOI 10.1016/j.apcatb.2018.03.048; Zhai P, 2016, ANGEW CHEM INT EDIT, V55, P9902, DOI 10.1002/anie.201603556; Zhang QH, 2010, CHEMCATCHEM, V2, P1030, DOI 10.1002/cctc.201000071; Zhong LS, 2016, NATURE, V538, P84, DOI 10.1038/nature19786; Zhou W, 2019, CHEM SOC REV, V48, P3193, DOI 10.1039/c8cs00502h; Zhu YF, 2017, ACS CATAL, V7, P2800, DOI 10.1021/acscatal.7b00221; Zhuo O, 2019, CHEM SCI, V10, P6083, DOI 10.1039/c9sc01210a	39	81	87	124	566	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		610	+		10.1126/science.abb3649	http://dx.doi.org/10.1126/science.abb3649			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QD7TF	33542132				2022-12-28	WOS:000615715300049
J	Ahmed, R; Omidian, Z; Giwa, A; Donner, T; Jie, CF; Hamad, ARA				Ahmed, Rizwan; Omidian, Zahra; Giwa, Adebola; Donner, Thomas; Jie, Chunfa; Hamad, Abdel Rahim A.			A reply to "TCR plus /BCR plus dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes''	CELL			English	Editorial Material								We have recently identified a novel lymphocyte that is a dual expresser (DE) of TCR alpha beta and BCR. DEs in T1D patients are predominated by a public BCR clonotype (clone-x) that encodes a potent autoantigen that cross-activates insulin-reactive T cells. Betts and colleagues were able to detect DEs but alleged to not detect high DE frequency, clone-x, or similar clones in T1D patients. Unfortunately, the authors did not follow our methods and when they did, their flow cytometric data at two sites were conflicting. Moreover, contrary to their claim, we identified clones similar to clone-x in their data along with clones bearing the core motif (DTAMVYYFDYW). Additionally, their report of no increased usage of clone-x VH/DH genes by bulk B cells confirms rather than challenges our results. Finally, the authors failed to provide data verifying purity of their sorted DEs, making it difficult to draw reliable conclusion of their repertoire analysis. This Matters Arising Response paper addresses the Japp et al. (2021) Matters Arising paper, published concurrently in Cell.	[Ahmed, Rizwan; Omidian, Zahra; Giwa, Adebola; Hamad, Abdel Rahim A.] Johns Hopkins Univ, Sch Med, Dept Pathol, 720 Rutland Ave,Ross 664G, Baltimore, MD 21205 USA; [Giwa, Adebola; Donner, Thomas; Hamad, Abdel Rahim A.] Johns Hopkins Univ, Sch Med, Dept Med, 720 Rutland Ave,Ross 664G, Baltimore, MD 21205 USA; [Jie, Chunfa] Des Moines Univ, Dept Biochem & Nutr, 3200 Grand Ave,Ryan Hall 230, Des Moines, IA 50266 USA	Johns Hopkins University; Johns Hopkins University	Hamad, ARA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, 720 Rutland Ave,Ross 664G, Baltimore, MD 21205 USA.; Hamad, ARA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 720 Rutland Ave,Ross 664G, Baltimore, MD 21205 USA.	ahamad@jhmi.edu		, Chunfa/0000-0003-4838-5168				Ahmed R, 2019, CELL, V177, P1583, DOI 10.1016/j.cell.2019.05.007; Brusko T, 2007, CELL BIOCHEM BIOPHYS, V48, P165, DOI 10.1007/s12013-007-0018-5; Brusko T, 2007, DIABETES, V56, P604, DOI 10.2337/db06-1248; DeWitt WS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160853; Japp AS, 2021, CELL, V184, P827, DOI 10.1016/j.cell.2020.11.035; Seay HR, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88242; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3	7	0	0	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2021	184	3					840	843		10.1016/j.cell.2020.11.036	http://dx.doi.org/10.1016/j.cell.2020.11.036		FEB 2021	4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX8ZJ	33545037	Bronze, Green Accepted			2022-12-28	WOS:000629631400021
J	Torjesen, I				Torjesen, Ingrid			Covid-19: How the UK is using lateral flow tests in the pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												ingrid_torjesen@hotmail.com						[Anonymous], 2021, OBSERVATIONAL STUDY; Cabinet Office Department of Health and Social Care, COMM TEST PROGR AR; Crozier A, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n208; Department for Transport, 2020, COR COV 19 TEST REL; Department of Health and Social Care, 2021, MOR EMPL SIGN RAP TE; Department of Health and Social Care, 2020, PIL FAM MEMB GET REG; Department of Health and Social Care, 2021, 1 WAV LAT FLOW TEST; Ferguson J, 2020, VALIDATION TESTING D, DOI [10.1101/2020/12/01/20237784, DOI 10.1101/2020/12/01/20237784]; Halliday J., 2021, GUARDIAN; Liverpool Covid-19 Community Testing Pilot, 2020, INT EV REP; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n238; NHS, 2021, LAT FLOW ANT TEST FA; Science Media Centre, 2021, EXP REACT PREPR LOOK; Tidman Z., 2021, INDEPENDENT; World Health Organization, 2020, SARS COV 2 ANT DET R	15	30	30	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2021	372								n287	10.1136/bmj.n287	http://dx.doi.org/10.1136/bmj.n287			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH2NH	33541908	Bronze			2022-12-28	WOS:000618113700005
J	Boix, CA; James, BT; Park, YP; Meuleman, W; Kellis, M				Boix, Carles A.; James, Benjamin T.; Park, Yongjin P.; Meuleman, Wouter; Kellis, Manolis			Regulatory genomic circuitry of human disease loci by integrative epigenomics	NATURE			English	Article							WIDE ASSOCIATION; PARTITIONING HERITABILITY; SYSTEMATIC ANNOTATION; CHROMATIN STATES; DISCOVERY; EXPRESSION; VARIANTS; HEART	Annotating the molecular basis of human disease remains an unsolved challenge, as 93% of disease loci are non-coding and gene-regulatory annotations are highly incomplete(1-3). Here we present EpiMap, a compendium comprising 10,000 epigenomic maps across 800 samples, which we used to define chromatin states, high-resolution enhancers, enhancer modules, upstream regulators and downstream target genes. We used this resource to annotate 30,000 genetic loci that were associated with 540 traits(4), predicting trait-relevant tissues, putative causal nucleotide variants in enriched tissue enhancers and candidate tissue-specific target genes for each. We partitioned multifactorial traits into tissue-specific contributing factors with distinct functional enrichments and disease comorbidity patterns, and revealed both single-factor monotropic and multifactor pleiotropic loci. Top-scoring loci frequently had multiple predicted driver variants, converging through multiple enhancers with a common target gene, multiple genes in common tissues, or multiple genes and multiple tissues, indicating extensive pleiotropy. Our results demonstrate the importance of dense, rich, high-resolution epigenomic annotations for the investigation of complex traits.	[Boix, Carles A.; James, Benjamin T.; Park, Yongjin P.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Boix, Carles A.; James, Benjamin T.; Park, Yongjin P.; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Boix, Carles A.] MIT, Computat & Syst Biol Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Park, Yongjin P.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Meuleman, Wouter] Altius Inst Biomed Sci, Seattle, WA USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of British Columbia	Kellis, M (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Kellis, M (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	manoli@mit.edu		James, Benjamin/0000-0002-6228-055X; Boix, Carles/0000-0001-9212-856X	US National Institutes of Health [HG008155, HG009446, HG009088, HG007234, HG007610, GM113708, MH109978, MH119509, AG058002]; National Institutes of Health training grant [GM087237]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the ENCODE, Roadmap and GGR consortia for generating high-quality public datasets and rapidly disseminating their results to the broader community; D. Li and T. Wang, and I. Gabdank and J. S. Strattan for making our observed and imputed genome-wide tracks and chromatin-state annotations available through the WashU Epigenome Browser and the ENCODE portal, respectively; J. Ernst for advice, guidance and for developing the ChromImpute methodology and code base; P. Kheradpour for help with the motif enrichment analysis software; L. D. Ward for discussions on interactive visualizations of our predictions and HaploReg; C. Epstein, J. Schreiber, W. Noble, Z. Weng, M. Gerstein, ENCODE, Roadmap, GENCODE and GTEx consortia for feedback on early versions of this work; and I. Jungreis, X. Wang, L. Hou, L. Agudelo, S. Mohammadi, M. Wolf, A. Shi, K. Nguyen, M. Kousi, S. Kuosmanen, E. Schmauch and A. Amirabad for feedback on the work and the resource. This work was supported by the US National Institutes of Health grants HG008155, HG009446, HG009088, HG007234, HG007610, GM113708, MH109978, MH119509 and AG058002 (to M.K.) and the National Institutes of Health training grant GM087237 (to C.A.B.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becker JS, 2016, TRENDS GENET, V32, P29, DOI 10.1016/j.tig.2015.11.001; Blackshear PJ, 2003, DEVELOPMENT, V130, P4539, DOI 10.1242/dev.00661; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Busnelli M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44503; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Chang W, 2021, SHINY WEB APPL FRAME; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fulco CP, 2019, NAT GENET, V51, P1664, DOI 10.1038/s41588-019-0538-0; Gallagher MD, 2018, AM J HUM GENET, V102, P717, DOI 10.1016/j.ajhg.2018.04.002; Genomics of Gene Regulation, GENOME GOV; Goes FS, 2015, AM J MED GENET B, V168, P649, DOI 10.1002/ajmg.b.32349; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Henstridge CM, 2019, NAT REV NEUROSCI, V20, P94, DOI 10.1038/s41583-018-0113-1; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/nmeth.1937, 10.1038/NMETH.1937]; Jacquemin P, 1997, J BIOL CHEM, V272, P12928, DOI 10.1074/jbc.272.20.12928; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Karimzadeh M, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky677; Katz JP, 2002, DEVELOPMENT, V129, P2619; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Kulakovskiy IV, 2018, NUCLEIC ACIDS RES, V46, pD252, DOI 10.1093/nar/gkx1106; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lappegard KT, 2014, MOL IMMUNOL, V61, P126, DOI 10.1016/j.molimm.2014.06.036; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; Li DF, 2019, NUCLEIC ACIDS RES, V47, pW158, DOI 10.1093/nar/gkz348; Liu YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1308-x; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Melville J., 2018, UMAP UNIFORM MANIFO; Meuleman W, 2020, NATURE, V584, P244, DOI 10.1038/s41586-020-2559-3; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Moore JE, 2020, NATURE, V583, P699, DOI 10.1038/s41586-020-2493-4; Moore JE, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-019-1924-8; Moyerbrailean GA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005875; Olson JM, 2001, DEV BIOL, V234, P174, DOI 10.1006/dbio.2001.0245; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Stunnenberg HG, 2016, CELL, V167, P1145, DOI 10.1016/j.cell.2016.11.007; Tanaka T, 2006, J PATHOL, V208, P662, DOI 10.1002/path.1928; van der Harst P, 2018, CIRC RES, V122, P433, DOI [10.1161/CIRCRESAHA.117.312086, 10.1161/circresaha.117.312086]; Vierstra J, 2020, NATURE, V583, P729, DOI 10.1038/s41586-020-2528-x; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Winkler TW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005378; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	64	63	65	4	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2021	590	7845								10.1038/s41586-020-03145-z	http://dx.doi.org/10.1038/s41586-020-03145-z		FEB 2021	28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG0TV	33536621	Green Published, hybrid			2022-12-28	WOS:000614414900005
J	Limb, M				Limb, Matthew			Deaths from alcohol hit record high during 2020, show figures	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		ONS, 2021, Q ALC SPEC DEATHS EN	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2021	372								n317	10.1136/bmj.n317	http://dx.doi.org/10.1136/bmj.n317			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC1TD	33536233				2022-12-28	WOS:000686315900006
J	Ham, C				Ham, Chris			The UK's poor record on covid-19 is a failure of policy learning	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ham, Chris] Kings Fund, London, England		Ham, C (corresponding author), Kings Fund, London, England.	C.Ham@kingsfund.org.uk							0	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2021	372								n284	10.1136/bmj.n284	http://dx.doi.org/10.1136/bmj.n284			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QE0LS	33526426	Bronze			2022-12-28	WOS:000615899800001
J	Jones, I; Roy, P				Jones, Ian; Roy, Polly			Sputnik V COVID-19 vaccine candidate appears safe and effective Comment	LANCET			English	Editorial Material									[Jones, Ian] Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England; [Roy, Polly] London Sch Hyg & Trop Med, Dept Infect Biol, London, England	University of Reading; University of London; London School of Hygiene & Tropical Medicine	Jones, I (corresponding author), Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England.	i.m.jones@reading.ac.uk		Roy, Polly/0000-0001-6535-6911				Almuqrin A, 2020, RES SQUARE, DOI [10.21203/rs.3.rs-94837/v1, DOI 10.21203/RS.3.RS-94837/V1, 10.21203/ rs.3.rs-94837/v1]; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; Cohen J., 2020, SCIENCE, DOI [10.1126/ science.abf6791, DOI 10.1126/SCIENCE.ABF6791]; Dolzhikova IV, 2017, HUM VACC IMMUNOTHER, V13, P613, DOI 10.1080/21645515.2016.1238535; Douoguih M., 2020, SAFETY IMMUNOGENICIT, DOI [10.1101/ 2020.09.23.20199604, DOI 10.1101/2020.09.23.20199604]; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8; Logunov DY, 2020, LANCET, V396, P887, DOI 10.1016/S0140-6736(20)31866-3; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Zhu FC, 2020, LANCET, V396, P479, DOI 10.1016/S0140-6736(20)31605-6	11	130	139	2	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					642	643		10.1016/S0140-6736(21)00191-4	http://dx.doi.org/10.1016/S0140-6736(21)00191-4		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL3PK	33545098	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000620991800002
J	Wise, J				Wise, Jacqui			Covid-19: Infections in England fall by two thirds since January	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Riley S, 2021, REACT 1 ROUND 9 INTE	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2021	372								n491	10.1136/bmj.n491	http://dx.doi.org/10.1136/bmj.n491			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UD4NC	33602726	Bronze			2022-12-28	WOS:000687183600003
J	Walensky, RP; Walke, HT; Fauci, AS				Walensky, Rochelle P.; Walke, Henry T.; Fauci, Anthony S.			SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint from directors at the CDC and NIH describes measures that federal agencies are taking to rapidly characterize emerging coronavirus variants and monitor their implications for national pandemic response and control, including assessment of ongoing effectiveness of current diagnostics, therapeutics, and vaccines.	[Walensky, Rochelle P.; Walke, Henry T.] Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30333 USA; [Fauci, Anthony S.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Walke, HT (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30333 USA.	hfw3@cdc.gov						Faria N., 2021, GENOMIC CHARACTERISA, DOI 10.1093/cid/ciaa1864; Firestone MJ, 2021, MMWR-MORBID MORTAL W, V70, P278, DOI 10.15585/mmwr.mm7008e1; Galloway SE, 2021, MMWR-MORBID MORTAL W, V70, P95, DOI [10.15585/mmwr.mm7003e2externalicon, 10.15585/mmwr.mm7003e2]; Horby P., SAGE M REP JAN 21; Mwenda M, 2021, MMWR-MORBID MORTAL W, V70, P280, DOI [10.15585/mmwr.mm7008e2, 10.15585/mmwr.mm7008e2externalicon]; Washington Nicole L, 2021, medRxiv, DOI 10.1101/2021.02.06.21251159; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; World Health Organization, 2021, COVID 19 VACC PROGR	9	155	159	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2021	325	11					1037	1038		10.1001/jama.2021.2294	http://dx.doi.org/10.1001/jama.2021.2294		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QZ1BV	33595644	Bronze, Green Accepted			2022-12-28	WOS:000619613600002
J	Yadav, K; Lewis, RJ				Yadav, Kabir; Lewis, Roger J.			Immortal Time Bias in Observational Studies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This JAMA Guide to Statistics and Medicine explains immortal time bias, an error in estimating the association between an exposure and an outcome that results from misclassification or exclusion of time intervals; explains how this misclassification or exclusion can occur; and presents approaches to minimize or avoid immortal time bias.	[Yadav, Kabir; Lewis, Roger J.] Harbor UCLA Med Ctr, Dept Emergency Med, 1000 W Carson St,Bldg D9, Torrance, CA 90509 USA; [Yadav, Kabir; Lewis, Roger J.] Lundquist Inst, Torrance, CA USA; [Yadav, Kabir; Lewis, Roger J.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Lewis, Roger J.] Berry Consultants LLC, Austin, TX USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Yadav, K (corresponding author), Harbor UCLA Med Ctr, Dept Emergency Med, 1000 W Carson St,Bldg D9, Torrance, CA 90509 USA.	kabir@emedharbor.edu		Yadav, Kabir/0000-0002-1092-9935				Hernan MA, 2016, J CLIN EPIDEMIOL, V79, P70, DOI 10.1016/j.jclinepi.2016.04.014; Honigberg MC, 2019, JAMA-J AM MED ASSOC, V322, P2411, DOI 10.1001/jama.2019.19191; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324	4	47	47	3	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2021	325	7					686	687		10.1001/jama.2020.9151	http://dx.doi.org/10.1001/jama.2020.9151			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ3QZ	33591334				2022-12-28	WOS:000619608000020
J	Lelli, F; Di Teodoro, EM; Fraternali, F; Man, AWS; Zhang, ZY; De Breuck, C; Davis, TA; Maiolino, R				Lelli, Federico; Di Teodoro, Enrico M.; Fraternali, Filippo; Man, Allison W. S.; Zhang, Zhi-Yu; De Breuck, Carlos; Davis, Timothy A.; Maiolino, Roberto			A massive stellar bulge in a regularly rotating galaxy 1.2 billion years after the Big Bang	SCIENCE			English	Article								Cosmological models predict that galaxies forming in the early Universe experience a chaotic phase of gas accretion and star formation, followed by gas ejection due to feedback processes. Galaxy bulges may assemble later via mergers or internal evolution. Here we present submillimeter observations (with spatial resolution of 700 parsecs) of ALESS 073.1, a starburst galaxy at redshift z. 5 when the Universe was 1.2 billion years old. This galaxy's cold gas forms a regularly rotating disk with negligible noncircular motions. The galaxy rotation curve requires the presence of a central bulge in addition to a star-forming disk. We conclude that massive bulges and regularly rotating disks can form more rapidly in the early Universe than predicted by models of galaxy formation.	[Lelli, Federico; Davis, Timothy A.] Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3AA, Wales; [Lelli, Federico] Ist Nazl Astrofis, Arcetri Astrophys Observ, I-50125 Florence, Italy; [Di Teodoro, Enrico M.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Fraternali, Filippo] Univ Groningen, Kapteyn Astron Inst, NL-9700 AV Groningen, Netherlands; [Man, Allison W. S.] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Zhang, Zhi-Yu] Nanjing Univ, Sch Astron & Space Sci, Nanjing 210023, Peoples R China; [De Breuck, Carlos] European Southern Observ, D-85748 Garching, Germany; [Maiolino, Roberto] Univ Cambridge, Kavli Inst Cosmol, Cambridge CB3 0HA, England; [Maiolino, Roberto] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	Cardiff University; Istituto Nazionale Astrofisica (INAF); Johns Hopkins University; University of Groningen; University of Toronto; Nanjing University; European Southern Observatory; University of Cambridge; University of Cambridge	Lelli, F (corresponding author), Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3AA, Wales.; Lelli, F (corresponding author), Ist Nazl Astrofis, Arcetri Astrophys Observ, I-50125 Florence, Italy.	federico.lelli@inaf.it	Di Teodoro, Enrico/AAV-4065-2020; Fraternali, Filippo/F-6647-2014	Di Teodoro, Enrico/0000-0003-4019-0673; Zhang, Zhiyu/0000-0002-7299-2876; Lelli, Federico/0000-0002-9024-9883; Man, Allison/0000-0003-2475-124X; Davis, Timothy/0000-0003-4932-9379; Fraternali, Filippo/0000-0002-0447-3230; De Breuck, Carlos/0000-0002-6637-3315; Maiolino, Roberto/0000-0002-4985-3819	ESO fellowship; U.S. National Science Foundation [1616177]; Friedrich Wilhelm Bessel Research Award Programme of the Alexander von Humboldt Foundation; Dunlap Fellowship at the Dunlap Institute for Astronomy Astrophysics; University of Toronto; ERC [695671]; Science and Technology Facilities Council (STFC); STFC [ST/M001172/1, ST/S00033X/1, ST/L004496/2, ST/L004496/1] Funding Source: UKRI	ESO fellowship; U.S. National Science Foundation(National Science Foundation (NSF)); Friedrich Wilhelm Bessel Research Award Programme of the Alexander von Humboldt Foundation; Dunlap Fellowship at the Dunlap Institute for Astronomy Astrophysics; University of Toronto(University of Toronto); ERC(European Research Council (ERC)European Commission); Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)Science and Technology Development Fund (STDF)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	F.L. was supported by an ESO fellowship during the initial stages of this project. E.M.D.T. was supported by the U.S. National Science Foundation under grant 1616177. F.F. acknowledges support from the Friedrich Wilhelm Bessel Research Award Programme of the Alexander von Humboldt Foundation. A.W.S.M. is supported by a Dunlap Fellowship at the Dunlap Institute for Astronomy & Astrophysics, funded through an endowment established by the David Dunlap family and the University of Toronto. R.M. acknowledges ERC Advanced Grant 695671 "QUENCH" and support from the Science and Technology Facilities Council (STFC).	Aghanim N, 2020, ASTRON ASTROPHYS, V641, DOI 10.1051/0004-6361/201833910; ATHANASSOULA E, 1978, ASTRON ASTROPHYS, V69, P395; Banados E, 2019, ASTROPHYS J LETT, V881, DOI 10.3847/2041-8213/ab3659; CASERTANO S, 1983, MON NOT R ASTRON SOC, V203, P735, DOI 10.1093/mnras/203.3.735; CASERTANO S, 1991, ASTRON J, V101, P1231, DOI 10.1086/115759; Coppin KEK, 2010, MON NOT R ASTRON SOC, V407, pL103, DOI 10.1111/j.1745-3933.2010.00914.x; Coppin KEK, 2009, MON NOT R ASTRON SOC, V395, P1905, DOI 10.1111/j.1365-2966.2009.14700.x; Davis TA, 2016, MON NOT R ASTRON SOC, V455, P214, DOI 10.1093/mnras/stv2313; Davis TA, 2013, NATURE, V494, P328, DOI 10.1038/nature11819; De Breuck C, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201116868; De Breuck C, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201323331; de Vaucouleurs G., 1948, ANN DAP, V11, P247; Dekel A, 2006, MON NOT R ASTRON SOC, V368, P2, DOI 10.1111/j.1365-2966.2006.10145.x; Di Teodoro EM, 2016, ASTRON ASTROPHYS, V594, DOI 10.1051/0004-6361/201628315; Di Teodoro EM, 2015, MON NOT R ASTRON SOC, V451, P3021, DOI 10.1093/mnras/stv1213; Dutton AA, 2014, MON NOT R ASTRON SOC, V441, P3359, DOI 10.1093/mnras/stu742; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Fraternali F, 2001, ASTROPHYS J, V562, pL47, DOI 10.1086/338102; Gall C, 2011, ASTRON ASTROPHYS REV, V19, P1, DOI 10.1007/s00159-011-0043-7; Genzel R, 2017, NATURE, V543, P397, DOI 10.1038/nature21685; Gilli R, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322892; Gilli R, 2011, ASTROPHYS J LETT, V730, DOI 10.1088/2041-8205/730/2/L28; Gullberg B, 2018, ASTROPHYS J, V859, DOI 10.3847/1538-4357/aabe8c; Guo Q, 2010, MON NOT R ASTRON SOC, V404, P1111, DOI 10.1111/j.1365-2966.2010.16341.x; Hodge JA, 2019, ASTROPHYS J, V876, DOI 10.3847/1538-4357/ab1846; Hodge JA, 2016, ASTROPHYS J, V833, DOI 10.3847/1538-4357/833/1/103; Ishibashi W, 2014, MON NOT R ASTRON SOC, V441, P1474, DOI 10.1093/mnras/stu672; Jones GC, 2017, ASTROPHYS J, V850, DOI 10.3847/1538-4357/aa8df2; KENT SM, 1986, ASTRON J, V91, P1301, DOI 10.1086/114106; Koekemoer AM, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/36; Kormendy J, 2004, ANNU REV ASTRON ASTR, V42, P603, DOI 10.1146/annurev.astro.42.053102.134024; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; Lang P, 2019, ASTROPHYS J, V879, DOI 10.3847/1538-4357/ab1f77; Legrand L, 2019, MON NOT R ASTRON SOC, V486, P5468, DOI 10.1093/mnras/stz1198; Lehnert MD, 2009, ASTROPHYS J, V699, P1660, DOI 10.1088/0004-637X/699/2/1660; Lelli F, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219457; Lelli F, 2012, ASTRON ASTROPHYS, V537, DOI 10.1051/0004-6361/201117867; Lelli F, 2018, MON NOT R ASTRON SOC, V479, P5440, DOI 10.1093/mnras/sty1795; Lelli F, 2016, ASTRON J, V152, DOI 10.3847/0004-6256/152/6/157; Lelli F, 2014, MON NOT R ASTRON SOC, V445, P1694, DOI 10.1093/mnras/stu1804; Maiolino R, 2017, NATURE, V544, P202, DOI 10.1038/nature21677; McMullin JP, 2007, ASTR SOC P, V376, P127; MILGROM M, 1983, ASTROPHYS J, V270, P365, DOI 10.1086/161130; Navarro JF, 1996, ASTROPHYS J, V462, P563, DOI 10.1086/177173; Noordermeer E, 2007, MON NOT R ASTRON SOC, V376, P1513, DOI 10.1111/j.1365-2966.2007.11533.x; Noordermeer E, 2008, MON NOT R ASTRON SOC, V385, P1359, DOI 10.1111/j.1365-2966.2008.12837.x; Peng CY, 2010, ASTRON J, V139, P2097, DOI 10.1088/0004-6256/139/6/2097; Pensabene A, 2020, ASTRON ASTROPHYS, V637, DOI 10.1051/0004-6361/201936634; Pezzulli G, 2015, MON NOT R ASTRON SOC, V451, P2324, DOI 10.1093/mnras/stv1077; Sancisi R, 2008, ASTRON ASTROPHYS REV, V15, P189, DOI [10.1007/s00159-008-0010-0, 10.1007/S00159-008-0010-0]; Sellwood JA, 1999, ASTR SOC P, V182, P351; Simpson JM, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/125; Skordis C., 2020, ARXIV200700082ASTPHC; Stark DP, 2007, ASTROPHYS J, V659, P84, DOI 10.1086/511325; Sweet SM, 2019, MON NOT R ASTRON SOC, V485, P5700, DOI 10.1093/mnras/stz750; Tacconi LJ, 2008, ASTROPHYS J, V680, P246, DOI 10.1086/587168; Tak H, 2018, MON NOT R ASTRON SOC, V481, P277, DOI 10.1093/mnras/sty2326; THOMASSON M, 1989, ASTRON ASTROPHYS, V211, P25; Trachternach C, 2008, ASTRON J, V136, P2720, DOI 10.1088/0004-6256/136/6/2720; Ubler H, 2019, ASTROPHYS J, V880, DOI 10.3847/1538-4357/ab27cc; Vale A, 2004, MON NOT R ASTRON SOC, V353, P189, DOI 10.1111/j.1365-2966.2004.08059.x; van der Kruit PC, 2011, ANNU REV ASTRON ASTR, V49, P301, DOI 10.1146/annurev-astro-083109-153241; Venemans BP, 2019, ASTROPHYS J LETT, V874, DOI 10.3847/2041-8213/ab11cc; Vogelaar MGR, 2001, ASTR SOC P, V238, P358; Vogelsberger M, 2014, NATURE, V509, P177, DOI 10.1038/nature13316; Wardlow JL, 2011, MON NOT R ASTRON SOC, V415, P1479, DOI 10.1111/j.1365-2966.2011.18795.x; Wiklind T, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/111; Wisnioski E, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/209	70	23	23	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					713	+		10.1126/science.abc1893	http://dx.doi.org/10.1126/science.abc1893			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4IS	33574209	Green Published, Green Submitted			2022-12-28	WOS:000617551600044
J	Kuehn, BM				Kuehn, Bridget M.			Accelerated Overdose Deaths Linked With COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	21	21	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2021	325	6					523	523		10.1001/jama.2021.0074	http://dx.doi.org/10.1001/jama.2021.0074			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG0MD	33560330	Bronze			2022-12-28	WOS:000617279600007
J	Dyer, O				Dyer, Owen			McKinsey agrees to pay $574m to US states to settle opioid claims	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2021	372								n360	10.1136/bmj.n360	http://dx.doi.org/10.1136/bmj.n360			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM1AV	33558222				2022-12-28	WOS:000639394000003
J	Xie, JX				Xie, Jingxiu			Designing the right protection	SCIENCE			English	Editorial Material							CONVERSION		[Xie, Jingxiu] Univ Groningen, Engn & Technol Inst Groning, Green Chem React Engn, Nijenborgh 4, NL-9747 AG Groningen, Netherlands	University of Groningen	Xie, JX (corresponding author), Univ Groningen, Engn & Technol Inst Groning, Green Chem React Engn, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	jingxiu.xie@rug.nl		Xie, Jingxiu/0000-0001-7383-9016				Cheng K., 2016, ANGEW CHEM INT EDIT, V128, P4803, DOI DOI 10.1002/ange.201601208; Galvis HMT, 2012, SCIENCE, V335, P835, DOI 10.1126/science.1215614; Hepburn C, 2019, NATURE, V575, P87, DOI 10.1038/s41586-019-1681-6; Jiao F, 2016, SCIENCE, V351, P1065, DOI 10.1126/science.aaf1835; Liu B, 2019, NAT ENERGY, V4, P700, DOI 10.1038/s41560-019-0430-2; Lyu S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20068-5; Olsbye U, 2015, CHEM SOC REV, V44, P7155, DOI 10.1039/c5cs00304k; Wang P, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau2947; Xie JX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08019-7; Xu YF, 2021, SCIENCE, V371, P610, DOI 10.1126/science.abb3649; Yarulina I, 2018, NAT CATAL, V1, P398, DOI 10.1038/s41929-018-0078-5	11	2	2	5	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		577	577		10.1126/science.abg1750	http://dx.doi.org/10.1126/science.abg1750			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QD7TF	33542129	Green Published			2022-12-28	WOS:000615715300037
J	Chan, V; Gherardini, PF; Krummel, MF; Fragiadakis, GK				Chan, Vincent; Gherardini, Pier Federico; Krummel, Matthew F.; Fragiadakis, Gabriela K.			A "data sharing trust'' model for rapid, collaborative science Comment	CELL			English	Editorial Material								Complex datasets provide opportunities for discoveries beyond their initial scope. Effective and rapid data sharing andmanagement practices are crucial to realize this potential; however, they are harder to implement than post-publication access. Here, we introduce the concept of a "data sharing trust'' tomaximize the value of large datasets.	[Chan, Vincent] Univ Calif San Francisco, Dept Microbiol & Immunol, 513 Parnassus Ave, San Francisco, CA 94143 USA; [Chan, Vincent; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, 513 Parnassus Ave, San Francisco, CA 94143 USA; [Chan, Vincent; Krummel, Matthew F.; Fragiadakis, Gabriela K.] Univ Calif San Francisco, Dept Microbiol & Immunol, ImmunoX Initiat, 513 Parnassus Ave, San Francisco, CA 94143 USA; [Fragiadakis, Gabriela K.] Univ Calif San Francisco, UCSF CoLabs, 513 Parnassus Ave, San Francisco, CA 94143 USA; [Fragiadakis, Gabriela K.] Univ Calif San Francisco, Dept Med, Div Rheumatol, 513 Parnassus Ave, San Francisco, CA 94143 USA; [Gherardini, Pier Federico] Parker Inst Canc Immunotherapy, 1 Letterman Dr,Suite D3500, San Francisco, CA 94129 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, 513 Parnassus Ave, San Francisco, CA 94143 USA.; Krummel, MF; Fragiadakis, GK (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, ImmunoX Initiat, 513 Parnassus Ave, San Francisco, CA 94143 USA.; Fragiadakis, GK (corresponding author), Univ Calif San Francisco, UCSF CoLabs, 513 Parnassus Ave, San Francisco, CA 94143 USA.; Fragiadakis, GK (corresponding author), Univ Calif San Francisco, Dept Med, Div Rheumatol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu; gabriela.fragiadakis@ucsf.edu						[Anonymous], 2020, INT COMMITTEE MED J; Bierer BE, 2017, NEW ENGL J MED, V376, P1684, DOI 10.1056/NEJMsb1616595; Olfson M, 2017, JAMA PSYCHIAT, V74, P5, DOI 10.1001/jamapsychiatry.2016.2610; Sim I, 2020, SCIENCE, V367, P1308, DOI 10.1126/science.aba4456; Toronto Int Data Release Workshop, 2009, NATURE, V461, P168, DOI 10.1038/461168a	5	1	1	3	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2021	184	3					566	570		10.1016/j.cell.2021.01.006	http://dx.doi.org/10.1016/j.cell.2021.01.006		FEB 2021	5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX8ZJ	33545032	Bronze			2022-12-28	WOS:000629631400002
J	Krist, AH; Davidson, KW; Mangione, CM; Barry, MJ; Cabana, M; Caughey, AB; Donahue, K; Doubeni, CA; Epling, JW; Kubik, M; Ogedegbe, G; Pbert, L; Silverstein, M; Simon, MA; Tseng, CW; Wong, JB				Krist, Alex H.; Davidson, Karina W.; Mangione, Carol M.; Barry, Michael J.; Cabana, Michael; Caughey, Aaron B.; Donahue, Katrina; Doubeni, Chyke A.; Epling, John W., Jr.; Kubik, Martha; Ogedegbe, Gbenga; Pbert, Lori; Silverstein, Michael; Simon, Melissa A.; Tseng, Chien-Wen; Wong, John B.		US Preventive Services Task Force	Screening for Asymptomatic Carotid Artery Stenosis US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CARDIOVASCULAR-DISEASE; ENDARTERECTOMY; POPULATION; GUIDELINES	This 2021 US Preventive Services Task Force Recommendation Statement recommends against screening for asymptomatic carotid artery stenosis in the general adult population (D recommendation). Importance Carotid artery stenosis is atherosclerotic disease that affects extracranial carotid arteries. Asymptomatic carotid artery stenosis refers to stenosis in persons without a history of ischemic stroke, transient ischemic attack, or other neurologic symptoms referable to the carotid arteries. The prevalence of asymptomatic carotid artery stenosis is low in the general population but increases with age. Objective To determine if its 2014 recommendation should be reaffirmed, the US Preventive Services Task Force (USPSTF) commissioned a reaffirmation evidence review. The reaffirmation update focused on the targeted key questions on the potential benefits and harms of screening and interventions, including revascularization procedures designed to improve carotid artery blood flow, in persons with asymptomatic carotid artery stenosis. Population This recommendation statement applies to adults without a history of transient ischemic attack, stroke, or other neurologic signs or symptoms referable to the carotid arteries. Evidence Assessment The USPSTF found no new substantial evidence that could change its recommendation and therefore concludes with moderate certainty that the harms of screening for asymptomatic carotid artery stenosis outweigh the benefits. Recommendation The USPSTF recommends against screening for asymptomatic carotid artery stenosis in the general adult population. (D recommendation)	[Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, 830 E Main St,One Capitol Sq,Sixth Floor, Richmond, VA 23219 USA; [Davidson, Karina W.] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA 02115 USA; [Cabana, Michael] Univ Calif San Francisco, San Francisco, CA USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Donahue, Katrina; Doubeni, Chyke A.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Doubeni, Chyke A.] Mayo Clin, Rochester, MN USA; [Epling, John W., Jr.] Virginia Tech, Caril Sch Med, Roanoke, VA USA; [Kubik, Martha] George Mason Univ, Fairfax, VA 22030 USA; [Ogedegbe, Gbenga] NYU, New York, NY USA; [Pbert, Lori; Silverstein, Michael] Univ Massachusetts, Sch Med, Worcester, MA USA; [Simon, Melissa A.] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa A.] Northwestern Univ, Evanston, IL USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Wong, John B.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Virginia Commonwealth University; Northwell Health; University of California System; University of California Los Angeles; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Oregon Health & Science University; University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic; Virginia Polytechnic Institute & State University; George Mason University; New York University; University of Massachusetts System; University of Massachusetts Worcester; Boston University; Northwestern University; University of Hawaii System; Pacific Health Research & Education Institute; Tufts University	Krist, AH (corresponding author), Virginia Commonwealth Univ, 830 E Main St,One Capitol Sq,Sixth Floor, Richmond, VA 23219 USA.	chair@uspstf.net	Epling, John W/J-1097-2019; Davidson, Karina/GWC-0996-2022	Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X; Wong, John/0000-0003-4203-9010				Abbott AL, 2020, J VASC SURG, V71, P257, DOI 10.1016/j.jvs.2019.04.490; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P1997, DOI 10.1001/jama.2016.15450; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Brott TG, 2011, J AM COLL CARDIOL, V57, P1002, DOI 10.1016/j.jacc.2010.11.005; Centers for Disease Control and Prevention, 2020, LEAD CAUS DEATH; de Weerd M, 2010, STROKE, V41, P1294, DOI 10.1161/STROKEAHA.110.581058; Grossman DC, 2017, JAMA-J AM MED ASSOC, V318, P167, DOI 10.1001/jama.2017.7171; Guirguis-Blake JM, 2021, JAMA-J AM MED ASSOC, V325, P487, DOI 10.1001/jama.2020.20364; Guirguis-Blake JM, 2020, AHRQ PUBLICATION; Hopkins LN, 2010, J STROKE CEREBROVASC, V19, P153, DOI 10.1016/j.jstrokecerebrovasdis.2010.01.001; Jonas DE, 2014, AHRQ PUBLICATION, V14-EHC029-EF; Kolos I, 2015, J VASC SURG, V62, P914, DOI 10.1016/j.jvs.2015.05.005; Krist AH, 2021, JAMA-J AM MED ASSOC, V325, P265, DOI 10.1001/jama.2020.25019; LeFevre ML, 2014, ANN INTERN MED, V161, P356, DOI 10.7326/M14-1333; Lichtman JH, 2017, JAMA-J AM MED ASSOC, V318, P1035, DOI 10.1001/jama.2017.12882; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Nejim B, 2019, J VASC SURG, V69, P1490, DOI 10.1016/j.jvs.2018.07.062; Owens DK, 2019, JAMA-J AM MED ASSOC, V322, P2211, DOI 10.1001/jama.2019.18928; Reiff T, 2020, INT J STROKE, V15, P638, DOI 10.1177/1747493019833017; Ricotta JJ, 2011, J VASC SURG, V54, pE1, DOI 10.1016/j.jvs.2011.07.031; Siu AL, 2015, ANN INTERN MED, V163, P778, DOI 10.7326/M15-2223; U.S. Preventive Services Task Force, 2020, PROC MAN; 2020, JAMA-J AM MED ASSOC, V324, P2069, DOI DOI 10.1001/jama.2020.21749	23	30	29	5	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2021	325	5					476	481		10.1001/jama.2020.26988	http://dx.doi.org/10.1001/jama.2020.26988			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QC6JP	33528542	Bronze			2022-12-28	WOS:000614941900020
J	Voelker, R				Voelker, Rebecca			Dedicated Device Permits Less Invasive Pancreatic Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2021	325	5					426	426		10.1001/jama.2021.0170	http://dx.doi.org/10.1001/jama.2021.0170			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QC6JP	33528523				2022-12-28	WOS:000614941900006
J	Salisch, NC; Stephenson, KE; Williams, K; Cox, F; van der Fits, L; Heerwegh, D; Truyers, C; Habets, MN; Kanjilal, DG; Larocca, RA; Abbink, P; Liu, JY; Peter, L; Fierro, C; De la Barrera, RA; Modjarrad, K; Zahn, RC; Hendriks, J; Cahill, CP; Leyssen, M; Douoguih, M; van Hoof, J; Schuitemaker, H; Barouch, DH				Salisch, Nadine C.; Stephenson, Kathryn E.; Williams, Kristi; Cox, Freek; van der Fits, Leslie; Heerwegh, Dirk; Truyers, Carla; Habets, Marrit N.; Kanjilal, Diane G.; Larocca, Rafael A.; Abbink, Peter; Liu, Jinyan; Peter, Lauren; Fierro, Carlos; De la Barrera, Rafael A.; Modjarrad, Kayvon; Zahn, Roland C.; Hendriks, Jenny; Cahill, Conor P.; Leyssen, Maarten; Douoguih, Macaya; van Hoof, Johan; Schuitemaker, Hanneke; Barouch, Dan H.			A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine	ANNALS OF INTERNAL MEDICINE			English	Article							DNA VACCINE; IMMUNOGENICITY; SAFETY; ANTIBODIES; TOLERABILITY; MULTICENTER; PROTECTION; CHALLENGE; INFECTION; RESPONSES	Background: Zika virus (ZIKV) may cause severe congenital disease after maternal-fetal transmission. No vaccine is currently available. Objective: To assess the safety and immunogenicity of Ad26.ZIKV.001, a prophylactic ZIKV vaccine candidate. Design: Phase 1 randomized, double-blind, placebo-controlled clinical study. (ClinicalTrials.gov: NCT03356561) Setting: United States. Participants: 100 healthy adult volunteers. Intervention: Ad26.ZIKV.001, an adenovirus serotype 26 vector encoding ZIKV M-Env, administered in 1- or 2-dose regimens of 5 x 10(10) or 1 x 10(11) viral particles (vp), or placebo. Measurements: Local and systemic adverse events; neutralization titers by microneutralization assay (MN50) and T-cell responses by interferon-g enzyme-linked immunospot and intracellular cytokine staining; and protectivity of vaccine-induced antibodies in a subset of participants through transfer in an exploratory mouse ZIKV challenge model. Results: All regimens were well tolerated, with no safety concerns identified. In both 2-dose regimens, ZIKV neutralizing titers peaked 14 days after the second vaccination, with geometric mean MN50 titers (GMTs) of 1065.6 (95% CI, 494.9 to 2294.5) for 5 x 10(10) vp and 956.6 (595.8 to 1535.8) for 1 x 10(11) vp. Titers persisted for at least 1 year at a GMT of 68.7 (CI, 26.4-178.9) for 5 x 10(10) vp and 87.0 (CI, 29.3 to 258.6) for 1 x 10(11) vp. A 1-dose regimen of 1 x 10(11) vp Ad26.ZIKV.001 induced seroconversion in all participants 56 days after the first vaccination (GMT, 103.4 [CI, 52.7 to 202.9]), with titers persisting for at least 1 year (GMT, 90.2 [CI, 38.4 to 212.2]). Env-specific cellular responses were induced. Protection against ZIKV challenge was observed after antibody transfer from participants into mice, and MN50 titers correlated with protection in this model. Limitation: The study was conducted in a nonendemic area, so it did not assess safety and immunogenicity in a flavivirus-exposed population. Conclusion: The safety and immunogenicity profile makes Ad26.ZIKV.001 a promising candidate for further development if the need reemerges.	[Salisch, Nadine C.; Cox, Freek; van der Fits, Leslie; Habets, Marrit N.; Zahn, Roland C.; Hendriks, Jenny; Cahill, Conor P.; Leyssen, Maarten; Douoguih, Macaya; van Hoof, Johan; Schuitemaker, Hanneke] Janssen Vaccines & Prevent, Newtonweg 1, NL-2333 CP Leiden, Netherlands; [Stephenson, Kathryn E.; Kanjilal, Diane G.; Larocca, Rafael A.; Abbink, Peter; Liu, Jinyan; Peter, Lauren; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Williams, Kristi] Janssen Res & Dev, Spring House, PA USA; [Heerwegh, Dirk; Truyers, Carla] Janssen Res & Dev, Beerse, Belgium; [Fierro, Carlos] Johnson Cty Clin Trials, Lenexa, KS USA; [De la Barrera, Rafael A.; Modjarrad, Kayvon] Walter Reed Army Inst Res, Silver Spring, MD USA; [Barouch, Dan H.] 330 Brookline Ave, Boston, MA 02215 USA; [Stephenson, Kathryn E.; Kanjilal, Diane G.; Liu, Jinyan; Peter, Lauren] 3 Blackfan Circle, Boston, MA 02115 USA; [Heerwegh, Dirk; Truyers, Carla] Janssen Pharmaceut Co, Tumhoutseweg 30,Bldg 106,6th Floor, B-2340 Beerse, Belgium; [Larocca, Rafael A.] 1 Bresciani Lane, West Bridgewater, MA 02379 USA; [Abbink, Peter] 31 North Bend St, Lynn, MA 01904 USA; [De la Barrera, Rafael A.] Walter Reed Army Inst Res, 6720A Rockledge Dr, Bethesda, MD 20817 USA; [Modjarrad, Kayvon] 4109 Jones Bridge Rd, Chevy Chase, MD 20815 USA; [Cahill, Conor P.] Univercells Vaccines, Rue Maitrise 11, B-1400 Nivelles, Belgium	Harvard University; Beth Israel Deaconess Medical Center; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Johnson & Johnson; Janssen Pharmaceuticals; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Salisch, NC (corresponding author), Janssen Vaccines & Prevent, Newtonweg 1, NL-2333 CP Leiden, Netherlands.; Barouch, DH (corresponding author), 330 Brookline Ave, Boston, MA 02215 USA.	nsalisch@its.jnj.com; dbarouch@bidmc.harvard.edu	Cahill, Conor/CAF-4415-2022; Zahn, Roland/ABE-8779-2021	Cahill, Conor/0000-0001-7108-1168; Stephenson, Kathryn/0000-0002-3440-4105	Janssen Vaccines and Infectious Diseases	Janssen Vaccines and Infectious Diseases	Janssen Vaccines and Infectious Diseases.	Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7; Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163; Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Anywaine Z, 2019, J INFECT DIS, V220, P46, DOI 10.1093/infdis/jiz070; Barouch DH, 2018, LANCET, V392, P232, DOI [10.1016/s0140-6736(18)31364-3, 10.1016/S0140-6736(18)31364-3]; Barouch DH, 2013, J INFECT DIS, V207, P248, DOI 10.1093/infdis/jis671; Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189; Bullard BL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35755-z; Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332; Cox F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202820; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420; Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7; Grubaugh ND, 2019, TRENDS MICROBIOL, V27, P381, DOI 10.1016/j.tim.2019.02.004; Hassert M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01678; Kaiser R, 2000, INFECTION, V28, P78, DOI 10.1007/s150100050051; Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Milligan ID, 2016, JAMA-J AM MED ASSOC, V315, P1610, DOI 10.1001/jama.2016.4218; Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115; Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9; Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533; Mulkey SB, 2020, JAMA PEDIATR, V174, P269, DOI 10.1001/jamapediatrics.2019.5204; Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511; Mutua G, 2019, J INFECT DIS, V220, P57, DOI 10.1093/infdis/jiz071; Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010; Pan American Health Organization, REV FUND VACC PRIC 2; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Salisch NC, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0150-4; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Stephenson KE, 2020, LANCET INFECT DIS, V20, P1061, DOI 10.1016/S1473-3099(20)30085-2; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Tebas P, 2017, NEW ENGL J MED, DOI [10.1056/NEJMoa1708120, DOI 10.1056/NEJMOA1708120]; Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11; Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x; Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416; Zahn R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044115; Zimmermann P, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00084-18	41	20	21	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					585	+		10.7326/M20-5306	http://dx.doi.org/10.7326/M20-5306			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33587687				2022-12-28	WOS:000652604800016
J	Hao, ZY; Zimmerman, AM; Ledwith, P; Khalaf, E; Najafabadi, DH; Watanabe, K; Taniguchi, T; Vishwanath, A; Kim, P				Hao, Zeyu; Zimmerman, A. M.; Ledwith, Patrick; Khalaf, Eslam; Najafabadi, Danial Haie; Watanabe, Kenji; Taniguchi, Takashi; Vishwanath, Ashvin; Kim, Philip			Electric field-tunable superconductivity in alternating-twist magic-angle trilayer graphene	SCIENCE			English	Article								Engineering moire superlattices by twisting layers in van der Waals (vdW) heterostructures has uncovered a wide array of quantum phenomena. We constructed a vdW heterostructure that consists of three graphene layers stacked with alternating twist angles +/- theta. At the average twist angle theta similar to 1.56 degrees, a theoretically predicted "magic angle" for the formation of flat electron bands, we observed displacement field-tunable superconductivity with a maximum critical temperature of 2.1 kelvin. By tuning the doping level and displacement field, we found that superconducting regimes occur in conjunction with flavor polarization of moire bands and are bounded by a van Hove singularity (vHS) at high displacement fields. Our findings display inconsistencies with a weak coupling description, suggesting that the observed moire superconductivity has an unconventional nature.	[Hao, Zeyu; Zimmerman, A. M.; Ledwith, Patrick; Khalaf, Eslam; Najafabadi, Danial Haie; Vishwanath, Ashvin; Kim, Philip] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Watanabe, Kenji] Natl Inst Mat Sci, Res Ctr Funct Mat, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Taniguchi, Takashi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan	Harvard University; National Institute for Materials Science; National Institute for Materials Science	Kim, P (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	pkim@physics.harvard.edu	Watanabe, Kenji/ABB-2135-2021; Kim, Philip/N-1886-2013	Watanabe, Kenji/0000-0003-3701-8119; Kim, Philip/0000-0002-8255-0086; Zimmerman, Andrew/0000-0001-6249-1210; Hao, Zeyu/0000-0001-5361-8259; Khalaf, Eslam/0000-0001-9298-1245; Ledwith, Patrick/0000-0001-7694-6554; Vishwanath, Ashvin/0000-0002-6306-2263	NSF [DMR-1922172]; U.S. Department of Defense (DOD) Vannevar Bush Faculty Fellowship [N00014-18-1-2877]; ARO MURI [W911NF-14-1-0247]; Simons Investigator award; Simons Collaboration on Ultra-Quantum Matter - Simons Foundation [651440]; DOD through the National Defense Science and Engineering Graduate Fellowship (NDSEG) Program; Elemental Strategy Initiative by the MEXT, Japan [JPMXP0112101001]; JSPS KAKENHI [JP20H00354]; CREST, JST [JPMJCR15F3]	NSF(National Science Foundation (NSF)); U.S. Department of Defense (DOD) Vannevar Bush Faculty Fellowship(United States Department of Defense); ARO MURI(MURI); Simons Investigator award; Simons Collaboration on Ultra-Quantum Matter - Simons Foundation; DOD through the National Defense Science and Engineering Graduate Fellowship (NDSEG) Program; Elemental Strategy Initiative by the MEXT, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	The major experimental work is supported by NSF (DMR-1922172). P.K. acknowledges support from the U.S. Department of Defense (DOD) Vannevar Bush Faculty Fellowship N00014-18-1-2877. Z.H. is supported by ARO MURI (W911NF-14-1-0247). A.V. and E.K. were supported by a Simons Investigator award (to A.V.) and by the Simons Collaboration on Ultra-Quantum Matter, which is a grant from the Simons Foundation (651440, to A.V.). P.L. was supported by the DOD through the National Defense Science and Engineering Graduate Fellowship (NDSEG) Program. K.W. and T.T. acknowledge support from the Elemental Strategy Initiative conducted by the MEXT, Japan, grant JPMXP0112101001, JSPS KAKENHI grant JP20H00354, and the CREST(JPMJCR15F3), JST.	An LH, 2020, NANOSCALE HORIZ, V5, P1309, DOI 10.1039/d0nh00248h; Andrei E. Y, 2020, ARXIV200703735CONDMA; [Anonymous], MAT METHODS ARE AVIA; Balents L, 2020, NAT PHYS, V16, P725, DOI 10.1038/s41567-020-0906-9; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Bistritzer R, 2011, P NATL ACAD SCI USA, V108, P12233, DOI 10.1073/pnas.1108174108; Bussmann-Holder A, 2017, J SUPERCOND NOV MAGN, V30, P151, DOI 10.1007/s10948-016-3947-7; Cao Y, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.116804; Cao Y, 2020, ARXIV200404148CONDMA; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Carr S, 2020, NANO LETT, V20, P3030, DOI 10.1021/acs.nanolett.9b04979; Chen GR, 2019, NATURE, V572, P215, DOI 10.1038/s41586-019-1393-y; Chen SW, 2021, NAT PHYS, V17, P374, DOI 10.1038/s41567-020-01062-6; dos Santos JMBL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.256802; Hao Z., 2021, **DROPPED REF**, DOI [10.7910/DVN/OB9CNK, DOI 10.7910/DVN/OB9CNK]; He MH, 2021, NAT PHYS, V17, P26, DOI 10.1038/s41567-020-1030-6; HEBARD AF, 1983, PHYS REV LETT, V50, P1603, DOI 10.1103/PhysRevLett.50.1603; Henriksen EA, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.011004; Hwang EH, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205418; Khalaf E, 2020, ARXIV200400638CONDNA; Khalaf E, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.085109; Kuroki K, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.212509; Liu X, 2020, ARXIV200311072CONDMA; Liu XM, 2020, NATURE, V583, P221, DOI 10.1038/s41586-020-2458-7; Lopez-Bezanilla A, 2020, PHYS REV RES, V2, DOI 10.1103/PhysRevResearch.2.033357; Lu XB, 2019, NATURE, V574, P653, DOI 10.1038/s41586-019-1695-0; Matsumoto K, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.014516; NELSON DR, 1977, PHYS REV LETT, V39, P1201, DOI 10.1103/PhysRevLett.39.1201; Nuckolls KP, 2020, NATURE, V588, P610, DOI 10.1038/s41586-020-3028-8; Park J. M., 2020, ARXIV200812296 CONDM; Park J. M., 2020, ARXIV200812296 COND; Polshyn H, 2020, NATURE, V588, P66, DOI 10.1038/s41586-020-2963-8; Regan EC, 2020, NATURE, V579, P359, DOI 10.1038/s41586-020-2092-4; Saito Y, 2020, ARXIV200810830COND; Saito Y, 2020, NAT PHYS, V16, P926, DOI 10.1038/s41567-020-0928-3; Serlin M, 2020, SCIENCE, V367, P900, DOI 10.1126/science.aay5533; Sharpe AL, 2019, SCIENCE, V365, P605, DOI 10.1126/science.aaw3780; Stepanov P, 2020, NATURE, V583, P375, DOI 10.1038/s41586-020-2459-6; Morell ES, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.121407; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; Tsai K.-T, 2019, **DROPPED REF**; Xing Y, 2015, SCIENCE, V350, P542, DOI 10.1126/science.aaa7154; Xu Y, 2020, NATURE, V587, P214, DOI 10.1038/s41586-020-2868-6; Yankowitz M, 2019, SCIENCE, V363, P1059, DOI 10.1126/science.aav1910; Zondiner U, 2020, NATURE, V582, P203, DOI 10.1038/s41586-020-2373-y	52	135	135	32	215	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2021	371	6534					1133	+		10.1126/science.abg0399	http://dx.doi.org/10.1126/science.abg0399			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY5RG	33542148	Green Submitted			2022-12-28	WOS:000630096400029
J	Xiao, P; Yan, W; Gou, L; Zhong, YN; Kong, LL; Wu, C; Wen, X; Yuan, Y; Cao, S; Qu, CX; Yang, X; Yang, CC; Xia, AJ; Hu, ZQ; Zhang, QQ; He, YH; Zhang, DL; Zhang, C; Hou, GH; Liu, HX; Zhu, LZ; Fu, P; Yang, SY; Rosenbaum, DM; Sun, JP; Du, Y; Zhang, L; Yu, X; Shao, ZH				Xiao, Peng; Yan, Wei; Gou, Lu; Zhong, Ya-Ni; Kong, Liangliang; Wu, Chao; Wen, Xin; Yuan, Yuan; Cao, Sheng; Qu, Changxiu; Yang, Xin; Yang, Chuan-Cheng; Xia, Anjie; Hu, Zhenquan; Zhang, Qianqian; He, Yong-Hao; Zhang, Dao-Lai; Zhang, Chao; Hou, Gui-Hua; Liu, Huanxiang; Zhu, Lizhe; Fu, Ping; Yang, Shengyong; Rosenbaum, Daniel M.; Sun, Jin-Peng; Du, Yang; Zhang, Lei; Yu, Xiao; Shao, Zhenhua			Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes	CELL			English	Article							MOLECULAR-DYNAMICS; FORCE-FIELD; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; ACCURATE DOCKING; BETA-ARRESTIN; RECEPTOR; GLIDE; MODEL; GUI	Dopamine receptors, includingD1- and D2-like receptors, are important therapeutic targets in a variety of neurological syndromes, as well as cardiovascular and kidney diseases. Here, we present five cryoelectron microscopy (cryo-EM) structures of the dopamine D1 receptor (DRD1) coupled to Gs heterotrimer in complex with three catechol-based agonists, a non-catechol agonist, and a positive allosteric modulator for endogenous dopamine. These structures revealed that a polar interaction network is essential for catecholamine-like agonist recognition, whereas specific motifs in the extended binding pocket were responsible for discriminating D1-from D2-like receptors. Moreover, allosteric binding at a distinct inner surface pocket improved the activity of DRD1 by stabilizing endogenous dopamine interaction at the orthosteric site. DRD1-Gs interface revealed key features that serve as determinants for G protein coupling. Together, our study provides a structural understanding of the ligand recognition, allosteric regulation, and G protein coupling mechanisms of DRD1.	[Xiao, Peng; Yan, Wei; Wu, Chao; Yuan, Yuan; Yang, Xin; Xia, Anjie; Fu, Ping; Yang, Shengyong; Shao, Zhenhua] Sichuan Univ, West China Hosp, Div Nephrol, Chengdu 610041, Sichuan, Peoples R China; [Xiao, Peng; Yan, Wei; Wu, Chao; Yuan, Yuan; Yang, Xin; Xia, Anjie; Fu, Ping; Yang, Shengyong; Shao, Zhenhua] Sichuan Univ, West China Hosp, Kidney Res Inst, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Xiao, Peng; Yan, Wei; Wu, Chao; Yuan, Yuan; Yang, Xin; Xia, Anjie; Fu, Ping; Yang, Shengyong; Shao, Zhenhua] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu 610041, Sichuan, Peoples R China; [Xiao, Peng; Zhong, Ya-Ni; Wen, Xin; Qu, Changxiu; Yang, Chuan-Cheng; He, Yong-Hao; Sun, Jin-Peng; Yu, Xiao] Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Key Lab Expt Teratol,Minist Educ, Jinan 250012, Shandong, Peoples R China; [Xiao, Peng; Zhong, Ya-Ni; Wen, Xin; Qu, Changxiu; Yang, Chuan-Cheng; He, Yong-Hao; Sun, Jin-Peng] Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Dept Biochem & Mol Biol, Jinan 250012, Shandong, Peoples R China; [Gou, Lu; Zhang, Lei] Xi An Jiao Tong Univ, Sch Phys, MOE Key Lab Nonequilibrium Synth & Modulat Conden, Xian 710049, Peoples R China; [Yu, Xiao] Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Dept Physiol, Jinan 250012, Shandong, Peoples R China; [Kong, Liangliang] Chinese Acad Sci, Shanghai Adv Res Inst, Zhangjiang Lab, Natl Facil Prot Sci Shanghai, Shanghai 201204, Peoples R China; [Sun, Jin-Peng] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Key Lab Mol Cardiovasc Sci,Minist Educ, Beijing 100191, Peoples R China; [Cao, Sheng; Du, Yang] Chinese Univ Hong Kong, Sch Life & Hlth Sci, Kobilka Inst Innovat Drug Discovery, Shenzhen 518172, Guangdong, Peoples R China; [Rosenbaum, Daniel M.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Zhang, Chao; Hou, Gui-Hua] Shandong Univ, Cheeloo Coll Med, Biomed Isotope Res Ctr, Sch Basic Med Sci, Jinan 250012, Shandong, Peoples R China; [Hu, Zhenquan; Zhu, Lizhe] Chinese Univ Hong Kong, Warshel Inst Computat Biol, Shenzhen 518172, Guangdong, Peoples R China; [Zhang, Qianqian; Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [He, Yong-Hao; Zhang, Dao-Lai] Binzhou Med Univ, Sch Pharm, Yantai 264003, Shandong, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Shandong University; Shandong University; Xi'an Jiaotong University; Shandong University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; Peking University; Chinese University of Hong Kong, Shenzhen; University of Texas System; University of Texas Southwestern Medical Center Dallas; Shandong University; Chinese University of Hong Kong, Shenzhen; Lanzhou University; Binzhou Medical University	Shao, ZH (corresponding author), Sichuan Univ, West China Hosp, Div Nephrol, Chengdu 610041, Sichuan, Peoples R China.; Shao, ZH (corresponding author), Sichuan Univ, West China Hosp, Kidney Res Inst, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China.; Shao, ZH (corresponding author), Sichuan Univ, West China Hosp, Canc Ctr, Chengdu 610041, Sichuan, Peoples R China.; Sun, JP; Yu, X (corresponding author), Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Key Lab Expt Teratol,Minist Educ, Jinan 250012, Shandong, Peoples R China.; Sun, JP (corresponding author), Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Dept Biochem & Mol Biol, Jinan 250012, Shandong, Peoples R China.; Zhang, L (corresponding author), Xi An Jiao Tong Univ, Sch Phys, MOE Key Lab Nonequilibrium Synth & Modulat Conden, Xian 710049, Peoples R China.; Yu, X (corresponding author), Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Dept Physiol, Jinan 250012, Shandong, Peoples R China.; Sun, JP (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Key Lab Mol Cardiovasc Sci,Minist Educ, Beijing 100191, Peoples R China.; Du, Y (corresponding author), Chinese Univ Hong Kong, Sch Life & Hlth Sci, Kobilka Inst Innovat Drug Discovery, Shenzhen 518172, Guangdong, Peoples R China.	sunjinpeng@sdu.edu.cn; yangdu@cuhk.edu.cn; zhangleio@mail.xjtu.edu.cn; yuxiao@sdu.edu.cn; zhenhuashao@scu.edu.cn	Zhang, Qianqian/GXA-0841-2022; Zhang, Lei/G-6427-2012; Xia, Anjie/HIK-3659-2022	Zhang, Qianqian/0000-0002-4422-4968; Zhang, Lei/0000-0002-4880-824X; Xia, Anjie/0000-0002-2695-3024; Zhu, Lizhe/0000-0001-8252-7807; Shao, Zhenhua/0000-0001-7204-801X; Liu, Huanxiang/0000-0002-9284-3667; Xiao, Peng/0000-0002-9809-3481	Science and Technology Department of Sichuan Province [2020YJ0208]; National Key R&D Program of China [2019YFA0508800]; National Science Fund for Excellent Young Scholars [81822008, 11922410]; National Science Fund for Distinguished Young Scholars [81825022]; National Natural Science Foundation of China [31972916, 31971195]; Shandong University Youth Interdisciplinary Science Innovation Group [2020QNQT002]; National Institutes of Health [R35GM136387]	Science and Technology Department of Sichuan Province; National Key R&D Program of China; National Science Fund for Excellent Young Scholars; National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong University Youth Interdisciplinary Science Innovation Group; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Cryo-EM data were collected at the cryo-EM facility of the National Center for Protein Science in Shanghai. We thank Sichuan University West China Cryo-EM Center and Duyu High Performance Computing Center and the Instrumental Analysis Center of Xi'an Jiaotong University for cryo-EM sample preparation. We thank Professor Yajun Wang, Dr. Jiannan Zhang, and Can Lu from the College of Life Sciences Sichuan University for their help on cAMP measurement. This study was supported by the Science and Technology Department of Sichuan Province (2020YJ0208 to Z.S.), the National Key R&D Program of China (2019YFA0508800 to Z.S. and P.X.), the National Science Fund for Excellent Young Scholars (81822008 to Xiao Yu and 11922410 to Lei Zhang), the National Science Fund for Distinguished Young Scholars (81825022 to J.-P.S.), the National Natural Science Foundation of China (31972916 to Z.S. and 31971195 to P.X.), Shandong University Youth Interdisciplinary Science Innovation Group (2020QNQT002 to Xiao Yu), and the National Institutes of Health (R35GM136387 to D.M.R.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Betz R., 2018, **DATA OBJECT**, DOI [10.5281/zenodo.836914, DOI 10.5281/ZENODO.836914]; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Conroy JL, 2015, ACS CHEM NEUROSCI, V6, P681, DOI 10.1021/acschemneuro.5b00020; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; Fowler JC, 2012, MOL PHARMACOL, V81, P820, DOI 10.1124/mol.111.075457; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gray DL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02776-7; Gurrell R, 2018, CLIN DRUG INVEST, V38, P509, DOI 10.1007/s40261-018-0632-6; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hall A, 2019, J MED CHEM, V62, P128, DOI 10.1021/acs.jmedchem.8b01767; Hao JL, 2019, J MED CHEM, V62, P8711, DOI 10.1021/acs.jmedchem.9b01234; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; Kumar KK, 2019, CELL, V176, P448, DOI 10.1016/j.cell.2018.11.040; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Liu Heng, 2021, CELL, V184; MANSOUR A, 1992, EUR J PHARM-MOLEC PH, V227, P205, DOI 10.1016/0922-4106(92)90129-J; Masureel M, 2018, NAT CHEM BIOL, V14, P1059, DOI 10.1038/s41589-018-0145-x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; NICHOLS AJ, 1990, AM J HYPERTENS, V3, pS116, DOI 10.1093/ajh/3.6.116S; Noce A, 2019, CURR PHARM BIOTECHNO, V20, P366, DOI 10.2174/1389201020666190417124711; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Roh SH, 2017, P NATL ACAD SCI USA, V114, P8259, DOI 10.1073/pnas.1704725114; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schultz W, 2016, NAT REV NEUROSCI, V17, P183, DOI 10.1038/nrn.2015.26; Spano P F, 1978, Adv Biochem Psychopharmacol, V19, P155; Sun JP, 2003, J BIOL CHEM, V278, P12406, DOI 10.1074/jbc.M212491200; Thal DM, 2018, NATURE, V559, P45, DOI 10.1038/s41586-018-0259-z; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wang PY, 2019, ACS MED CHEM LETT, V10, P792, DOI 10.1021/acsmedchemlett.9b00050; Wang S, 2018, NATURE, V555, P269, DOI 10.1038/nature25758; Wang S, 2017, SCIENCE, V358, P381, DOI 10.1126/science.aan5468; Wang XS, 2018, MOL PHARMACOL, V94, P1232, DOI 10.1124/mol.118.112649; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wu C, 2019, GEN COMP ENDOCR, V281, P91, DOI 10.1016/j.ygcen.2019.05.013; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yang F, 2020, NATURE, V587, P499, DOI 10.1038/s41586-020-2569-1; Yang F, 2018, NAT CHEM BIOL, V14, P876, DOI 10.1038/s41589-018-0115-3; Yin J, 2020, NATURE, V584, P125, DOI 10.1038/s41586-020-2379-5; Zhang J, 2009, MED RES REV, V29, P272, DOI 10.1002/med.20130; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou P, 2009, J CHEM INF MODEL, V49, P2344, DOI 10.1021/ci9002393; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	58	34	35	16	105	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					943	+		10.1016/j.cell.2021.01.028	http://dx.doi.org/10.1016/j.cell.2021.01.028		FEB 2021	32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33571432				2022-12-28	WOS:000629633400011
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: How are you, doctor?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2021	372								n447	10.1136/bmj.n447	http://dx.doi.org/10.1136/bmj.n447			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RA8YP	33593747	Bronze			2022-12-28	WOS:000631706300008
J	Eke, O; Otugo, O; Isom, J				Eke, Onyinyechi; Otugo, Onyeka; Isom, Jessica			Black women in medicine-rising above invisibility	LANCET			English	Editorial Material									[Eke, Onyinyechi] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Otugo, Onyeka] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Isom, Jessica] Codman Sq Hlth Ctr, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Eke, O (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA.	oeke@mgh.harvard.edu							0	4	4	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2021	397	10274					573	575						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2TN	33581816				2022-12-28	WOS:000620934000015
J	Roychowdhury, S; Ghosh, T; Arora, R; Samanta, M; Xie, L; Singh, NK; Soni, A; He, JQ; Waghmare, UV; Biswas, K				Roychowdhury, Subhajit; Ghosh, Tanmoy; Arora, Raagya; Samanta, Manisha; Xie, Lin; Singh, Niraj Kumar; Soni, Ajay; He, Jiaqing; Waghmare, Umesh, V; Biswas, Kanishka			Enhanced atomic ordering leads to high thermoelectric performance in AgSbTe2	SCIENCE			English	Article								High thermoelectric performance is generally achieved through either electronic structure modulations or phonon scattering enhancements, which often counteract each other. A leap in performance requires innovative strategies that simultaneously optimize electronic and phonon transports. We demonstrate high thermoelectric performance with a near room-temperature figure of merit, ZT similar to 1.5, and a maximum ZT similar to 2.6 at 573 kelvin, by optimizing atomic disorder in cadmium-doped polycrystalline silver antimony telluride (AgSbTe2). Cadmium doping in AgSbTe2 enhances cationic ordering, which simultaneously improves electronic properties by tuning disorder-induced localization of electronic states and reduces lattice thermal conductivity through spontaneous formation of nanoscale (similar to 2 to 4 nanometers) superstructures and coupling of soft vibrations localized within similar to 1 nanometer around cadmium sites with local strain modulation. The strategy is applicable to most other thermoelectric materials that exhibit inherent atomic disorder.	[Roychowdhury, Subhajit; Ghosh, Tanmoy; Samanta, Manisha; Biswas, Kanishka] Jawaharlal Nehru Ctr Adv Sci Res JNCASR, New Chem Unit, Jakkur PO, Bangalore 560064, Karnataka, India; [Arora, Raagya; Waghmare, Umesh, V] JNCASR, Theoret Sci Unit, Jakkur PO, Bangalore 560064, Karnataka, India; [Xie, Lin; He, Jiaqing] Southern Univ Sci & Technol, Dept Phys, Shenzhen 518055, Peoples R China; [Singh, Niraj Kumar; Soni, Ajay] Indian Inst Technol Mandi, Sch Basic Sci, Mandi 175075, Himachal Prades, India; [Waghmare, Umesh, V; Biswas, Kanishka] JNCASR, Sch Adv Mat, Jakkur PO, Bangalore 560064, Karnataka, India; [Waghmare, Umesh, V; Biswas, Kanishka] JNCASR, Int Ctr Mat Sci, Jakkur PO, Bangalore 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Southern University of Science & Technology; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Mandi; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Biswas, K (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res JNCASR, New Chem Unit, Jakkur PO, Bangalore 560064, Karnataka, India.; Biswas, K (corresponding author), JNCASR, Sch Adv Mat, Jakkur PO, Bangalore 560064, Karnataka, India.; Biswas, K (corresponding author), JNCASR, Int Ctr Mat Sci, Jakkur PO, Bangalore 560064, Karnataka, India.	kanishka@jncasr.ac.in	Singh, Niraj/GQP-2645-2022; Ghosh, Tanmoy/AAX-1138-2021; He, Jiaqing/A-2245-2010	Ghosh, Tanmoy/0000-0002-4078-7093; He, Jiaqing/0000-0003-3954-6003; Soni, Ajay/0000-0002-8926-0225; Singh, Niraj Kumar/0000-0003-2608-4022; Waghmare, Umesh/0000-0002-9378-155X; Arora, Raagya/0000-0001-9871-0120; ROYCHOWDHURY, SUBHAJIT/0000-0002-1808-9432	Swarnajayanti Fellowship, Science and Engineering Research Board (SERB) [SB/SJF/2019-20/06]; Department of Science and Technology (DST), India [DST/SJF/CSA-02/2018-19]; Sheik Saqr Fellowship, SSL, ICMS; JNCASR, India; CSIR, India; UGC, India; National Natural Science Foundation of China [11934007]; Science and Technology Innovation Committee Foundation of Shenzhen [KQTD2016022619565991]; IKST, Sheikh Saqr Fellowship; J. C. Bose National Fellowship of the DST, India	Swarnajayanti Fellowship, Science and Engineering Research Board (SERB); Department of Science and Technology (DST), India(Department of Science & Technology (India)); Sheik Saqr Fellowship, SSL, ICMS; JNCASR, India; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); UGC, India(University Grants Commission, India); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Committee Foundation of Shenzhen; IKST, Sheikh Saqr Fellowship; J. C. Bose National Fellowship of the DST, India	K.B. acknowledges generous funding support from Swarnajayanti Fellowship, Science and Engineering Research Board (SERB) (SB/SJF/2019-20/06), Department of Science and Technology (DST) (DST/SJF/CSA-02/2018-19), India; Sheik Saqr Fellowship, SSL, ICMS, and JNCASR, India. S.R. and M.S. acknowledge CSIR and UGC, India, for research fellowship, respectively. J.H. acknowledges support from the National Natural Science Foundation of China (11934007) and the Science and Technology Innovation Committee Foundation of Shenzhen (KQTD2016022619565991). U.V.W. acknowledges support from IKST, Sheikh Saqr Fellowship, and J. C. Bose National Fellowship of the DST, India.	Agne MT, 2018, ENERG ENVIRON SCI, V11, P609, DOI 10.1039/c7ee03256k; Altshuler B. L., 1985, Electron-electron interactions in disordered systems, P1; ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; [Anonymous], J AM CHEM SOC, V139, P9382, DOI [10.1021/jacs.7b05143, DOI 10.1021/JACS.7B05143]; Armstrong R. W., 1960, J APPL PHYS, V31, P1954; Banik A, 2019, ENERG ENVIRON SCI, V12, P589, DOI 10.1039/c8ee03162b; Barabash SV, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.075212; Barabash SV, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.155704; BERGMANN G, 1984, PHYS REP, V107, P1, DOI 10.1016/0370-1573(84)90103-0; Biswas K, 2012, NATURE, V489, P414, DOI 10.1038/nature11439; Chang C, 2018, SCIENCE, V360, P778, DOI 10.1126/science.aaq1479; Chetty R, 2019, J MATER CHEM C, V7, P5184, DOI [10.1039/c9tc00B6Bc, 10.1039/c9tc00868c]; Deng RG, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar5606; Du BL, 2010, CHEM MATER, V22, P5521, DOI 10.1021/cm101503y; ENDERBY JE, 1994, PHYS REV B, V49, P5062, DOI 10.1103/PhysRevB.49.5062; Fukuyama H., 1985, Electron-electron interactions in disordered systems, P155; He J, 2017, SCIENCE, V357, DOI 10.1126/science.aak9997; Heremans JP, 2008, SCIENCE, V321, P554, DOI 10.1126/science.1159725; Hoang K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.156403; Hong M, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201702333; Hsu KF, 2004, SCIENCE, V303, P818, DOI 10.1126/science.1092963; Hu XK, 2015, J ALLOY COMPD, V649, P1060, DOI 10.1016/j.jallcom.2015.07.197; Hua XL, 1997, PHYS REV B, V55, P16103, DOI 10.1103/PhysRevB.55.16103; Jana MK, 2018, ACS ENERGY LETT, V3, P1315, DOI 10.1021/acsenergylett.8b00435; Jood P, 2018, JOULE, V2, P1339, DOI 10.1016/j.joule.2018.04.025; Jovovic V, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.245204; Kim SI, 2015, SCIENCE, V348, P109, DOI 10.1126/science.aaa4166; Kunioka H, 2017, APPL PHYS EXPRESS, V10, DOI 10.7567/APEX.10.095801; Lee MH, 2019, ACS NANO, V13, P3806, DOI 10.1021/acsnano.8b08579; LEE PA, 1985, REV MOD PHYS, V57, P287, DOI 10.1103/RevModPhys.57.287; Li J, 2018, JOULE, V2, P976, DOI 10.1016/j.joule.2018.02.016; Lin SQ, 2017, JOULE, V1, P816, DOI 10.1016/j.joule.2017.09.006; Liu HL, 2012, NAT MATER, V11, P422, DOI [10.1038/NMAT3273, 10.1038/nmat3273]; Ma J, 2013, NAT NANOTECHNOL, V8, P445, DOI [10.1038/nnano.2013.95, 10.1038/NNANO.2013.95]; Ma J., PHONON SCATTERING RA; Mahan GD, 1996, P NATL ACAD SCI USA, V93, P7436, DOI 10.1073/pnas.93.15.7436; Mao J, 2019, SCIENCE, V365, P495, DOI 10.1126/science.aax7792; MCHUGH JP, 1961, J APPL PHYS, V32, P1785, DOI 10.1063/1.1728441; Morelli DT, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.035901; MOTT N, 1978, PHYS TODAY, V31, P42, DOI 10.1063/1.2994815; Mukhopadhyay S, 2018, SCIENCE, V360, P1455, DOI 10.1126/science.aar8072; Pei YZ, 2011, NATURE, V473, P66, DOI 10.1038/nature09996; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; Quarez E, 2005, J AM CHEM SOC, V127, P9177, DOI 10.1021/ja051653o; Rosi F D, 1960, ELECTRON ENG, V79, P450, DOI DOI 10.1109/EE.1960.6432651; Roychowdhury S, 2018, CHEM MATER, V30, P5799, DOI 10.1021/acs.chemmater.8b02676; Roychowdhury S, 2018, ANGEW CHEM INT EDIT, V57, P4043, DOI 10.1002/anie.201801491; Roychowdhury S, 2017, ACS ENERGY LETT, V2, P349, DOI 10.1021/acsenergylett.6b00639; Samanta M, 2017, J AM CHEM SOC, V139, P9382, DOI 10.1021/jacs.7b05143; Semeghini G, 2015, NAT PHYS, V11, P554, DOI 10.1038/NPHYS3339; Sharma PA, 2010, J APPL PHYS, V107, DOI 10.1063/1.3446094; Shi X, 2011, J AM CHEM SOC, V133, P7837, DOI 10.1021/ja111199y; Snyder GJ, 2017, ENERG ENVIRON SCI, V10, P2280, DOI 10.1039/c7ee02007d; Snyder GJ, 2004, NAT MATER, V3, P458, DOI 10.1038/nmat1154; Sugar JD, 2011, J MATER SCI, V46, P1668, DOI 10.1007/s10853-010-4984-4; Sugar JD, 2009, J ALLOY COMPD, V478, P75, DOI 10.1016/j.jallcom.2008.11.054; Tan GJ, 2016, CHEM REV, V116, P12123, DOI 10.1021/acs.chemrev.6b00255; Tiang ZT, 2019, ACS NANO, V13, P3750, DOI 10.1021/acsnano.9b02399; Villagonzalo C, 1999, EUR PHYS J B, V12, P179, DOI 10.1007/s100510050994; Wang H, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3029774; Wang SY, 2015, CHEM MATER, V27, P1071, DOI 10.1021/cm504398d; Wojciechowski KT, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.184202; Yamamoto K, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.155201; Ye LH, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.245203; Zhao HZ, 2014, NANO ENERGY, V7, P97, DOI 10.1016/j.nanoen.2014.04.012; Zhao LD, 2016, SCIENCE, V351, P141, DOI 10.1126/science.aad3749; Zhao LD, 2014, NATURE, V508, P373, DOI 10.1038/nature13184; Zhao LD, 2014, ENERG ENVIRON SCI, V7, P251, DOI 10.1039/c3ee43099e	72	158	159	98	471	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					722	+		10.1126/science.abb3517	http://dx.doi.org/10.1126/science.abb3517			48	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4IS	33574210				2022-12-28	WOS:000617551600046
J	Blauvelt, A; Kempers, S; Lain, E; Schlesinger, T; Tyring, S; Forman, S; Ablon, G; Martin, G; Wang, H; Cutler, DL; Fang, JE; Kwan, MFR				Blauvelt, Andrew; Kempers, Steven; Lain, Edward; Schlesinger, Todd; Tyring, Stephen; Forman, Seth; Ablon, Glynis; Martin, George; Wang, Hui; Cutler, David L.; Fang, Jane; Kwan, Min-Fun R.		Phase 3 Tirbanibulin For Actinic	Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FLUOROURACIL CREAM; 2.5-PERCENT; 5-PERCENT; OUTCOMES	Background The tubulin polymerization and Src kinase signaling inhibitor tirbanibulin is being investigated as a topical treatment for actinic keratosis, a precursor of squamous-cell carcinoma. Methods In two identically designed double-blind trials, we randomly assigned, in a 1:1 ratio, adults with actinic keratoses on the face or scalp to receive either topical tirbanibulin or vehicle (placebo) ointment. The ointment was applied by the patients to a 25-cm(2) contiguous area containing four to eight lesions once daily for 5 consecutive days. The primary outcome was the percentage of patients with a complete (100%) reduction in the number of lesions in the application area at day 57. The secondary outcome was the percentage of patients with a partial (>= 75%) reduction in the number of lesions within the application area at day 57. The incidence of recurrence was evaluated at 1 year. Local reactions were scored with the use of 4-point scale (ranging from 0 [absent] to 3 [severe]). Results A total of 702 patients were enrolled in the two trials (351 patients per trial). Complete clearance in trial 1 occurred in 44% of the patients (77 of 175) in the tirbanibulin group and in 5% of those (8 of 176) in the vehicle group (difference, 40 percentage points; 95% confidence interval [CI], 32 to 47; P<0.001); in trial 2, the percentages were 54% (97 of 178 patients) and 13% (22 of 173), respectively (difference, 42 percentage points; 95% CI, 33 to 51; P<0.001). The percentages of patients with partial clearance were significantly higher in the tirbanibulin groups than in the vehicle groups. At 1 year, the estimated percentage of patients with recurrent lesions was 47% among patients who had had a complete response to tirbanibulin. The most common local reactions to tirbanibulin were erythema in 91% of the patients and flaking or scaling in 82%. Adverse events with tirbanibulin were application-site pain in 10% of the patients and pruritus in 9%, all of which resolved. Conclusions In two identically designed trials, tirbanibulin 1% ointment applied once daily for 5 days was superior to vehicle for the treatment of actinic keratosis at 2 months but was associated with transient local reactions and recurrence of lesions at 1 year. Trials comparing tirbanibulin with conventional treatments and that have longer follow-up are needed to determine the effects of tirbanibulin therapy on actinic keratosis. (Funded by Athenex; ClinicalTrials.gov numbers, and .) The tubulin polymerization and Src kinase inhibitor tirbanibulin was superior to placebo ointment in clearing actinic keratoses on the face and scalp at 2 months. As is typical of the disorder, lesions recurred in 47% of patients at 1 year. Adverse events were related to local irritation.	[Blauvelt, Andrew] Oregon Med Res Ctr, Portland, OR USA; [Kempers, Steven] Minnesota Clin Study Ctr, New Brighton, England; [Lain, Edward] Austin Inst Clin Res, Pflugerville, TX USA; [Tyring, Stephen] Univ Texas Hlth Sci Ctr Houston, Dept Dermatol, Houston, TX 77030 USA; [Tyring, Stephen] Univ Texas Hlth Sci Ctr Houston, Ctr Clin Studies, Houston, TX 77030 USA; [Schlesinger, Todd] Clin Res Ctr Carolinas, Charleston, SC USA; [Forman, Seth] ForCare Clin Res, Tampa, FL USA; [Ablon, Glynis] Ablon Skin Inst Res Ctr, Manhattan Beach, CA USA; [Martin, George] Dr George Martin Dermatol Associates, Kihei, HI USA; [Wang, Hui; Cutler, David L.; Fang, Jane; Kwan, Min-Fun R.] Athenex, 1001 Main St,Suite 600, Buffalo, NY 14203 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Fang, JE (corresponding author), Athenex, 1001 Main St,Suite 600, Buffalo, NY 14203 USA.	jfang@athenex.com			Athenex	Athenex	Funded by Athenex; ClinicalTrials.gov numbers, NCT03285477 and NCT03285490.	3M Health Care, 2010, ALDARA IMIQUIMOD PRE; Almirall, 2019, SOL DICL SOD PRESCR; American Academy of Dermatology, 2019, ACT KER; Balcere A, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55040092; Cramer P, 2020, EXPERT OPIN EMERG DR, V25, P49, DOI 10.1080/14728214.2020.1730810; Del Rosso James Q, 2014, J Clin Aesthet Dermatol, V7, pS2; Dirschka T, 2019, J EUR ACAD DERMATOL, V33, P288, DOI 10.1111/jdv.15185; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Food and Drug Administration, 2016, DRAFT GUID ING MEB; Glogau RG, 2000, J AM ACAD DERMATOL, V42, pS23, DOI 10.1067/mjd.2000.103339; Goldenberg G, 2017, J EUR ACAD DERMATOL, V31, P12, DOI 10.1111/jdv.14152; Gollnick H, 2020, J EUR ACAD DERMATOL, V34, P82, DOI 10.1111/jdv.15868; Ibrahim Sherrif F, 2009, J Clin Aesthet Dermatol, V2, P43; Kempers S, 2020, J DRUGS DERMATOL, V19, P1093, DOI 10.36849/JDD.2020.5576; Khanna R, 2017, CLIN COSMET INV DERM, V10, P179, DOI 10.2147/CCID.S121323; Krawtchenko N, 2007, BRIT J DERMATOL, V157, P34, DOI 10.1111/j.1365-2133.2007.08271.x; Lebwohl M, 2012, NEW ENGL J MED, V366, P1010, DOI 10.1056/NEJMoa1111170; Lewin Group, 2005, BURD SKIN DIS; MARKS R, 1988, LANCET, V1, P795, DOI 10.1016/s0140-6736(88)91658-3; Memon AA, 2000, BRIT J DERMATOL, V142, P1154, DOI 10.1046/j.1365-2133.2000.03541.x; Pomerantz H, 2015, JAMA DERMATOL, V151, P952, DOI 10.1001/jamadermatol.2015.0502; Reynolds KA, 2020, JAMA DERMATOL, V156, P326, DOI 10.1001/jamadermatol.2019.4212; Richard MA, 2018, J EUR ACAD DERMATOL, V32, P339, DOI 10.1111/jdv.14753; Rivers JK, 2002, BRIT J DERMATOL, V146, P94, DOI 10.1046/j.1365-2133.2002.04561.x; Rosen R, 2014, DERMATOLOGY THER, V4, P207, DOI 10.1007/s13555-014-0059-9; Skov T, 2018, DERMATOLOGY THER, V8, P425, DOI 10.1007/s13555-018-0247-0; Smolinski MP, 2018, J MED CHEM, V61, P4704, DOI 10.1021/acs.jmedchem.8b00164; Swanson N, 2010, J AM ACAD DERMATOL, V62, P582, DOI 10.1016/j.jaad.2009.07.004; Valeant Pharmaceuticals North America, 2019, EF FLUOR PRESCR INF; Weiss J, 2002, CUTIS, V70, P22; Werner RN, 2013, BRIT J DERMATOL, V169, P502, DOI 10.1111/bjd.12420; Yavel R, 2020, ANN M EUR ASS DERM V	32	39	40	3	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2021	384	6					512	520		10.1056/NEJMoa2024040	http://dx.doi.org/10.1056/NEJMoa2024040			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG5JQ	33567191	Bronze			2022-12-28	WOS:000617621800008
J	McConville, JF; Woodruff, JN				McConville, John F.; Woodruff, James N.			A Shared Evaluation Platform for Medical Training	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The debate about changing the scoring system for the USMLE Step 1 exam is both a manifestation of dysfunction in the medical education pathway and an opportunity to address this dysfunction.	[McConville, John F.] Univ Chicago, Internal Med Residency Training Program, Chicago, IL 60637 USA; [Woodruff, James N.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	McConville, JF (corresponding author), Univ Chicago, Internal Med Residency Training Program, Chicago, IL 60637 USA.							Holmboe ES, 2020, ACAD MED, V95, P97, DOI 10.1097/ACM.0000000000002899; Santen SA, 2015, AM J MED, V128, P790, DOI 10.1016/j.amjmed.2015.02.001; Stohl Hindi E, 2010, J Grad Med Educ, V2, P322, DOI 10.4300/JGME-D-09-00101.1; Webster-Wright A, 2009, REV EDUC RES, V79, P702, DOI 10.3102/0034654308330970; Woodruff JN, 2021, MED EDUC, V55, P12, DOI 10.1111/medu.14377	5	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2021	384	6					491	493		10.1056/NEJMp2031317	http://dx.doi.org/10.1056/NEJMp2031317			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QG5JQ	33567480				2022-12-28	WOS:000617621800005
J	Kuehn, BM				Kuehn, Bridget M.			Updated Recommendations for Gonorrhea Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2021	325	6					523	523		10.1001/jama.2021.0241	http://dx.doi.org/10.1001/jama.2021.0241			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG0MD	33560331				2022-12-28	WOS:000617279600008
J	Samarasekera, U				Samarasekera, Udani			Relocated Rohingya face uncertain health-care provision	LANCET			English	Editorial Material																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2021	397	10273					460	460						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QF1LZ	33549179				2022-12-28	WOS:000616661900009
J	Alizon, S				Alizon, Samuel			Superspreading genomes	SCIENCE			English	Editorial Material							HETEROGENEITY; TRANSMISSION		[Alizon, Samuel] Inst Rech & Dev 224, UMR CNRS 5290, Malad Infect & Vecteurs Ecol Genet Evolut & Contr, Montpellier, France	Universite de Montpellier	Alizon, S (corresponding author), Inst Rech & Dev 224, UMR CNRS 5290, Malad Infect & Vecteurs Ecol Genet Evolut & Contr, Montpellier, France.	samuel.alizon@cnrs.fr		Alizon, Samuel/0000-0002-0779-9543	Institut pour la Recherche et le Developpement; Region Occitanie; CNRS	Institut pour la Recherche et le Developpement; Region Occitanie(Region Occitanie); CNRS(Centre National de la Recherche Scientifique (CNRS))	thank CNRS, Institut pour la Recherche et le Developpement, and Region Occitanie for financial support and T. Kamiya,M. T. Sofonea, M. van Baalen,and the Experimental and Theoretical Evolution team for discussion.	Britton T, 2020, SCIENCE, V369, P846, DOI 10.1126/science.abc6810; Du XJ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan5325; Freed NE, 2020, BIOL METHODS PROTOC, V5, DOI 10.1093/biomethods/bpaa014; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Kennedy DA, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3001000; Kucharski AJ, 2015, EUROSURVEILLANCE, V20, P14, DOI 10.2807/1560-7917.ES2015.20.25.21167; Lau MSY, 2017, P NATL ACAD SCI USA, V114, P2337, DOI 10.1073/pnas.1614595114; Lemieux JE, 2021, SCIENCE, V371, P588, DOI 10.1126/science.abe3261; Li LM, 2017, MOL BIOL EVOL, V34, P2982, DOI 10.1093/molbev/msx195; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Stadler Tanja, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.02bc6d927ecee7bbd33532ec8ba6a25f; Volz EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002947; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Yates A, 2006, P ROY SOC B-BIOL SCI, V273, P3075, DOI 10.1098/rspb.2006.3681	14	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		574	575		10.1126/science.abg0100	http://dx.doi.org/10.1126/science.abg0100			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QD7TF	33542127	Green Submitted			2022-12-28	WOS:000615715300035
J	Perry, JJ; Sivilotti, MLA; Emond, M; Stiell, IG; Stotts, G; Lee, J; Worster, A; Morris, J; Cheung, KW; Jin, AY; Oczkowski, WJ; Sahlas, DJ; Murray, HE; Mackey, A; Verreault, S; Camden, MC; Yip, S; Teal, P; Gladstone, DJ; Boulos, MI; Chagnon, N; Shouldice, E; Atzema, C; Slaoui, T; Teitlebaum, J; Abdulaziz, K; Nemnom, MJ; Wells, GA; Sharma, M				Perry, Jeffrey J.; Sivilotti, Marco L. A.; Emond, Marcel; Stiell, Ian G.; Stotts, Grant; Lee, Jacques; Worster, Andrew; Morris, Judy; Cheung, Ka Wai; Jin, Albert Y.; Oczkowski, Wieslaw J.; Sahlas, Demetrios J.; Murray, Heather E.; Mackey, Ariane; Verreault, Steve; Camden, Marie-Christine; Yip, Samuel; Teal, Philip; Gladstone, David J.; Boulos, Mark I.; Chagnon, Nicolas; Shouldice, Elizabeth; Atzema, Clare; Slaoui, Tarik; Teitlebaum, Jeanne; Abdulaziz, Kasim; Nemnom, Marie-Joe; Wells, George A.; Sharma, Mukul			Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVE To validate the previously derived Canadian TIA Score to stratify subsequent stroke risk in a new cohort of emergency department patients with transient ischaemic attack. DESIGN Prospective cohort study. SETTING 13 Canadian emergency departments over five years. PARTICIPANTS 7607 consecutively enrolled adult patients attending the emergency department with transient ischaemic attack or minor stroke. MAIN OUTCOME MEASURES The primary outcome was subsequent stroke or carotid endarterectomy/carotid artery stenting within seven days. The secondary outcome was subsequent stroke within seven days (with or without carotid endarterectomy/carotid artery stenting). Telephone follow-up used the validated Questionnaire for Verifying Stroke Free Status at seven and 90 days. All outcomes were adjudicated by panels of three stroke experts, blinded to the index emergency department visit. RESULTS Of the 7607 patients, 108 (1.4%) had a subsequent stroke within seven days, 83 (1.1%) had carotid endarterectomy/carotid artery stenting within seven days, and nine had both. The Canadian TIA Score stratified the risk of stroke, carotid endarterectomy/carotid artery stenting, or both within seven days as low (risk =0.5%; interval likelihood ratio 0.20, 95% confidence interval 0.09 to 0.44), medium (risk 2.3%; interval likelihood ratio 0.94, 0.85 to 1.04), and high (risk 5.9% interval likelihood ratio 2.56, 2.02 to 3.25) more accurately (area under the curve 0.70, 95% confidence interval 0.66 to 0.73) than did the ABCD2 (0.60, 0.55 to 0.64) or ABCD2i (0.64, 0.59 to 0.68). Results were similar for subsequent stroke regardless of carotid endarterectomy/carotid artery stenting within seven days. CONCLUSION The Canadian TIA Score stratifies patients' seven day risk for stroke, with or without carotid endarterectomy/carotid artery stenting, and is now ready for clinical use. Incorporating this validated risk estimate into management plans should improve early decision making at the index emergency visit regarding benefits of hospital admission, timing of investigations, and prioritisation of specialist referral.	[Perry, Jeffrey J.; Stiell, Ian G.] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada; [Perry, Jeffrey J.; Stiell, Ian G.; Abdulaziz, Kasim; Nemnom, Marie-Joe; Wells, George A.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Sivilotti, Marco L. A.; Sahlas, Demetrios J.; Sharma, Mukul] Queens Univ, Dept Emergency Med, Kingston, ON, Canada; [Emond, Marcel; Murray, Heather E.] CHU Quebec, Hop Enfant Jesus, Quebec City, PQ, Canada; [Emond, Marcel; Mackey, Ariane; Verreault, Steve; Camden, Marie-Christine] Univ Laval, Div Emergency Med, Quebec City, PQ, Canada; [Stotts, Grant] Univ Ottawa, Div Neurol, Dept Med, Ottawa, ON, Canada; [Lee, Jacques] Mt Sinai Hosp, Schwartz Reisman Emergency Med Inst, Toronto, ON, Canada; [Lee, Jacques] Sunnybrook Hlth Sci Ctr, Dept Emergency Med, Toronto, ON, Canada; [Worster, Andrew; Atzema, Clare] McMaster Univ, Hamilton, ON, Canada; [Morris, Judy] Univ Montreal, Hop Sacre Coeur Montreal, Montreal, PQ, Canada; [Cheung, Ka Wai; Slaoui, Tarik; Teitlebaum, Jeanne] Univ British Columbia, Vancouver, BC, Canada; [Jin, Albert Y.] Queens Univ, Div Neurol, Kingston, ON, Canada; [Oczkowski, Wieslaw J.] McMaster Univ, Div Neurol, Hamilton, ON, Canada; [Mackey, Ariane; Verreault, Steve; Camden, Marie-Christine] Laval Univ, Div Neurol, Quebec City, PQ, Canada; [Yip, Samuel; Teal, Philip] Univ British Columbia, Div Neurol, Vancouver, BC, Canada; [Gladstone, David J.; Boulos, Mark I.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada; [Gladstone, David J.; Boulos, Mark I.] Sunnybrook Hlth Sci Ctr, Dept Med, Div Neurol, Toronto, ON, Canada; [Gladstone, David J.; Boulos, Mark I.] Univ Toronto, Toronto, ON, Canada; [Chagnon, Nicolas] Montfort Hosp, Dept Emergency Med, Ottawa, ON, Canada; [Chagnon, Nicolas; Shouldice, Elizabeth] Univ Ottawa, Ottawa, ON, Canada; [Shouldice, Elizabeth] Queensway Carleton Hosp, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Queens University - Canada; Laval University; Laval University; University of Ottawa; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; Universite de Montreal; University of British Columbia; Queens University - Canada; McMaster University; Laval University; University of British Columbia; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Ottawa; University of Ottawa	Perry, JJ (corresponding author), Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada.; Perry, JJ (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.	jperry@ohri.ca	Abdulaziz, Kasim E/GZA-8875-2022; Murray, Heather/GQY-8016-2022; Lee, Jacques/CAF-4380-2022	Abdulaziz, Kasim E/0000-0002-6072-0822; Lee, Jacques/0000-0002-9143-6285; Boulos, Mark/0000-0002-9547-1889; Nemnom, Marie-Joe/0000-0002-0102-1984	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The study was funded by the Canadian Institutes of Health Research. The funder had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. Researchers are independent from funders, and all authors, external and internal, had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.	Amarenco P, 2016, NEW ENGL J MED, V374, P1533, DOI 10.1056/NEJMoa1412981; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Boulanger JM, 2018, INT J STROKE, V13, P949, DOI 10.1177/1747493018786616; Camargo CA, 2003, ACAD EMERG MED, V10, P432, DOI [10.1197/aemj.10.5.432, DOI 10.1197/AEMJ.10.5.432]; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Giles MF, 2010, STROKE, V41, P1907, DOI 10.1161/STROKEAHA.110.578971; Giles MF, 2010, STROKE, V41, P667, DOI 10.1161/STROKEAHA.109.571174; Gladstone DJ, 2004, CAN MED ASSOC J, V170, P1099, DOI 10.1503/cmaj.1031349; Goldstein LB, 2000, ARCH INTERN MED, V160, P2941, DOI 10.1001/archinte.160.19.2941; Hill MD, 2004, NEUROLOGY, V62, P2015, DOI 10.1212/01.WNL.0000129482.70315.2F; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2005, STROKE, V36, P724, DOI 10.1161/str.36.4.724; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Jones WJ, 2001, STROKE, V32, P2232, DOI 10.1161/hs1001.096191; Kleindorfer D, 2005, STROKE, V36, P720, DOI 10.1161/01.STR.0000158917.59233.b7; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Lovett JK, 2003, STROKE, V34, pE138, DOI 10.1161/01.STR.0000080935.01264.91; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Meschia JF, 2000, STROKE, V31, P1076, DOI 10.1161/01.STR.31.5.1076; Mikulik R, 2019, JAMA NEUROL, V76, P1439, DOI 10.1001/jamaneurol.2019.3063; Perry JJ, 2016, CAN J EMERG MED, V18, P10, DOI 10.1017/cem.2015.57; Perry JJ, 2015, J STROKE CEREBROVASC, V24, P2514, DOI 10.1016/j.jstrokecerebrovasdis.2015.06.034; Perry JJ, 2014, STROKE, V45, P92, DOI 10.1161/STROKEAHA.113.003085; Perry JJ, 2011, CAN MED ASSOC J, V183, P1137, DOI 10.1503/cmaj.101668; Perry JJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5204; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Sheehan OC, 2010, STROKE, V41, P844, DOI 10.1161/STROKEAHA.109.571844; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Wein T, 2018, INT J STROKE, V13, P420, DOI 10.1177/1747493017743062; Wu CM, 2007, ARCH INTERN MED, V167, P2417, DOI 10.1001/archinte.167.22.2417	32	11	11	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2021	372								n49	10.1136/bmj.n49	http://dx.doi.org/10.1136/bmj.n49			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH2NH	33541890	hybrid, Green Published			2022-12-28	WOS:000618113700010
J	Rodriguez, F; Harrington, RA				Rodriguez, Fatima; Harrington, Robert A.			Management of Antithrombotic Therapy after Acute Coronary Syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE MYOCARDIAL-INFARCTION; DUAL-ANTIPLATELET THERAPY; 2013 ACCF/AHA GUIDELINE; ASSOCIATION TASK-FORCE; VITAMIN-K ANTAGONISTS; ST-SEGMENT ELEVATION; ATRIAL-FIBRILLATION; TRIPLE THERAPY; CARDIOVASCULAR EVENTS; STENT IMPLANTATION	Antithrombotic therapy is a central component of treatment after acute coronary syndromes. The focus is on antiplatelet therapy, but balancing the benefit with the bleeding risk is still controversial. Clinical research and recommended approaches to management are reviewed.	[Rodriguez, Fatima; Harrington, Robert A.] Stanford Univ, Dept Med, Div Cardiovasc Med, Palo Alto, CA 94304 USA; [Rodriguez, Fatima; Harrington, Robert A.] Stanford Univ, Stanford Cardiovasc Inst, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Harrington, RA (corresponding author), Stanford Univ, Dept Med, 300 Pasteur Dr,S102,MC 5110, Stanford, CA 94305 USA.	robert.harrington@stanford.edu						Alexander JH, 2020, CIRCULATION, V141, P1618, DOI 10.1161/CIRCULATIONAHA.120.046534; Alexander JH, 2011, NEW ENGL J MED, V365, P699, DOI 10.1056/NEJMoa1105819; Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; Andreotti F, 2006, EUR HEART J, V27, P519, DOI 10.1093/eurheartj/ehi485; [Anonymous], 2020, Circulation, V141, pe33, DOI 10.1161/CIR.0000000000000746; [Anonymous], 2016, CIRC-HEART FAIL, V9, pS173; Bergmeijer TO, 2017, CARDIOLOGY, V138, P164, DOI 10.1159/000475705; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454; Capodanno D, 2019, J AM COLL CARDIOL, V74, P83, DOI 10.1016/j.jacc.2019.05.016; Collet J.P, 2020, EUR HEART J; Costa F, 2017, LANCET, V389, P1025, DOI 10.1016/S0140-6736(17)30397-5; Crea F, 2017, CIRCULATION, V136, P1155, DOI 10.1161/CIRCULATIONAHA.117.029870; Crenshaw BS, 1997, J AM COLL CARDIOL, V30, P406, DOI 10.1016/S0735-1097(97)00194-0; De Servi S, 2011, CURR OPIN CARDIOL, V26, pS15, DOI 10.1097/01.hco.0000409963.12964.7d; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Eikelboom JW, 2017, NEW ENGL J MED, V377, P1319, DOI 10.1056/NEJMoa1709118; Furtado RHM, 2020, EUR HEART J, V41, P1625, DOI 10.1093/eurheartj/ehz821; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; GOLDBERG RJ, 1990, AM HEART J, V119, P996, DOI 10.1016/S0002-8703(05)80227-3; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hess CN, 2015, J AM COLL CARDIOL, V66, P777, DOI 10.1016/j.jacc.2015.06.027; Hess CN, 2015, J AM COLL CARDIOL, V66, P616, DOI 10.1016/j.jacc.2015.05.062; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011; Karazniewicz-Lada M, 2012, EXPERT OPIN PHARMACO, V13, P663, DOI 10.1517/14656566.2012.666524; Kereiakes DJ, 2016, J AM COLL CARDIOL, V67, P2492, DOI 10.1016/j.jacc.2016.03.485; Khan SU, 2020, ANN INTERN MED, V172, P474, DOI 10.7326/M19-3763; Kim BK, 2020, JAMA-J AM MED ASSOC, V323, P2407, DOI 10.1001/jama.2020.7580; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Lopes RD, 2019, NEW ENGL J MED, V380, P1509, DOI 10.1056/NEJMoa1817083; Marquis-Gravel G, 2020, JAMA CARDIOL, V5, P598, DOI 10.1001/jamacardio.2020.0116; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mehran R, 2019, NEW ENGL J MED, V381, P2032, DOI 10.1056/NEJMoa1908419; O'Donoghue ML, 2020, CIRCULATION, V142, P538, DOI 10.1161/CIRCULATIONAHA.120.046251; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Pare G, 2010, NEW ENGL J MED, V363, P1704, DOI 10.1056/NEJMoa1008410; Piccolo R, 2017, ANN INTERN MED, V167, P17, DOI 10.7326/M16-2389; Rathore SS, 2000, CIRCULATION, V101, P969, DOI 10.1161/01.CIR.101.9.969; Rodriguez F, 2016, J AM COLL CARDIOL, V68, P313, DOI 10.1016/j.jacc.2016.03.599; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Sarafoff N, 2013, J AM COLL CARDIOL, V61, P2060, DOI 10.1016/j.jacc.2013.02.036; Schupke S, 2019, NEW ENGL J MED, V381, P1524, DOI 10.1056/NEJMoa1908973; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Tahhan AS, 2020, JAMA CARDIOL, V5, P714, DOI 10.1001/jamacardio.2020.0359; Tomaniak M, 2019, JAMA CARDIOL, V4, P1092, DOI 10.1001/jamacardio.2019.3355; Vranckx P, 2019, LANCET, V394, P1335, DOI 10.1016/S0140-6736(19)31872-0; Vranckx P, 2018, LANCET, V392, P940, DOI 10.1016/S0140-6736(18)31858-0; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wang TY, 2019, JAMA-J AM MED ASSOC, V321, P44, DOI 10.1001/jama.2018.19791; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2013, LANCET, V382, P605, DOI 10.1016/S0140-6736(13)61451-8; Yasuda S, 2019, NEW ENGL J MED, V381, P1103, DOI 10.1056/NEJMoa1904143; Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775; Yeh RW, 2015, J AM COLL CARDIOL, V65, P2211, DOI 10.1016/j.jacc.2015.03.003; Yusuf S, 2001, NEW ENGL J MED, V345, P494; 2019, BRAIN STIMUL MAR, V12, pe0075	61	33	33	2	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2021	384	5					452	460		10.1056/NEJMra1607714	http://dx.doi.org/10.1056/NEJMra1607714			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QX4QW	33534976	Green Accepted			2022-12-28	WOS:000629333200013
J	Moreno-De-Luca, A; Millan, F; Pesacreta, DR; Elloumi, HZ; Oetjens, MT; Teigen, C; Wain, KE; Scuffins, J; Myers, SM; Torene, RI; Gainullin, VG; Arvai, K; Kirchner, HL; Ledbetter, DH; Retterer, K; Martin, CL				Moreno-De-Luca, Andres; Millan, Francisca; Pesacreta, Denis R.; Elloumi, Houda Z.; Oetjens, Matthew T.; Teigen, Claire; Wain, Karen E.; Scuffins, Julie; Myers, Scott M.; Torene, Rebecca I.; Gainullin, Vladimir G.; Arvai, Kevin; Kirchner, H. Lester; Ledbetter, David H.; Retterer, Kyle; Martin, Christa L.			Molecular Diagnostic Yield of Exome Sequencing in Patients With Cerebral Palsy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Question What is the molecular diagnostic yield of exome sequencing (prevalence of pathogenic and likely pathogenic variants) among patients with cerebral palsy? Findings In this cross-sectional study that included 2 independent cohorts of 1526 patients with cerebral palsy, the molecular diagnostic yield of exome sequencing was 32.7% in a cohort that predominantly consisted of pediatric patients and 10.5% in a cohort that predominantly consisted of adult patients. Meaning This study identified pathogenic and likely pathogenic variants among some patients with cerebral palsy, although further research is needed to understand the clinical implications of these findings. Importance Cerebral palsy is a common neurodevelopmental disorder affecting movement and posture that often co-occurs with other neurodevelopmental disorders. Individual cases of cerebral palsy are often attributed to birth asphyxia; however, recent studies indicate that asphyxia accounts for less than 10% of cerebral palsy cases. Objective To determine the molecular diagnostic yield of exome sequencing (prevalence of pathogenic and likely pathogenic variants) in individuals with cerebral palsy. Design, Setting, and Participants A retrospective cohort study of patients with cerebral palsy that included a clinical laboratory referral cohort with data accrued between 2012 and 2018 and a health care-based cohort with data accrued between 2007 and 2017. Exposures Exome sequencing with copy number variant detection. Main Outcomes and Measures The primary outcome was the molecular diagnostic yield of exome sequencing. Results Among 1345 patients from the clinical laboratory referral cohort, the median age was 8.8 years (interquartile range, 4.4-14.7 years; range, 0.1-66 years) and 601 (45%) were female. Among 181 patients in the health care-based cohort, the median age was 41.9 years (interquartile range, 28.0-59.6 years; range, 4.8-89 years) and 96 (53%) were female. The molecular diagnostic yield of exome sequencing was 32.7% (95% CI, 30.2%-35.2%) in the clinical laboratory referral cohort and 10.5% (95% CI, 6.0%-15.0%) in the health care-based cohort. The molecular diagnostic yield ranged from 11.2% (95% CI, 6.4%-16.2%) for patients without intellectual disability, epilepsy, or autism spectrum disorder to 32.9% (95% CI, 25.7%-40.1%) for patients with all 3 comorbidities. Pathogenic and likely pathogenic variants were identified in 229 genes (29.5% of 1526 patients); 86 genes were mutated in 2 or more patients (20.1% of 1526 patients) and 10 genes with mutations were independently identified in both cohorts (2.9% of 1526 patients). Conclusions and Relevance Among 2 cohorts of patients with cerebral palsy who underwent exome sequencing, the prevalence of pathogenic and likely pathogenic variants was 32.7% in a cohort that predominantly consisted of pediatric patients and 10.5% in a cohort that predominantly consisted of adult patients. Further research is needed to understand the clinical implications of these findings. This cross-sectional study describes the prevalence of pathogenic and likely pathogenic variants detected on exome sequencing of children and adults with cerebral palsy referred for genetic testing.	[Moreno-De-Luca, Andres; Pesacreta, Denis R.; Oetjens, Matthew T.; Wain, Karen E.; Myers, Scott M.; Ledbetter, David H.; Martin, Christa L.] Geisinger, Autism & Dev Med Inst, 120 Hamm Dr,Ste 202,MC 60-36, Danville, PA 17837 USA; [Moreno-De-Luca, Andres; Wain, Karen E.; Ledbetter, David H.; Martin, Christa L.] Geisinger, Genom Med Inst, Danville, PA USA; [Moreno-De-Luca, Andres] Geisinger, Dept Radiol, Danville, PA USA; [Moreno-De-Luca, Andres] Geisinger, Diagnost Med Inst, Danville, PA USA; [Millan, Francisca; Elloumi, Houda Z.; Teigen, Claire; Scuffins, Julie; Torene, Rebecca I.; Gainullin, Vladimir G.; Arvai, Kevin; Retterer, Kyle] GeneDx, Gaithersburg, MD USA; [Kirchner, H. Lester] Geisinger, Dept Populat Hlth Sci, Danville, PA USA		Moreno-De-Luca, A (corresponding author), Geisinger, Autism & Dev Med Inst, 120 Hamm Dr,Ste 202,MC 60-36, Danville, PA 17837 USA.	amorenodeluca@geisinger.edu	Myers, Scott/AAE-6398-2019; De Luca, Andres Moreno/AAB-3570-2021	De Luca, Andres Moreno/0000-0002-2732-4043				Bromham N, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l806; Carey DJ, 2016, GENET MED, V18, P906, DOI 10.1038/gim.2015.187; Corbett MA, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0073-4; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Ebrahimi-Fakhari D, 2020, BRAIN, V143, P2929, DOI 10.1093/brain/awz307; Ellenberg JH, 2013, DEV MED CHILD NEUROL, V55, P210, DOI 10.1111/dmcn.12016; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Finucane BM, 2020, CURR OPIN GENET DEV, V65, P47, DOI 10.1016/j.gde.2020.05.001; Friedman J., 2015, GENEREVIEWS; Gonzalez-Mantilla AJ, 2016, JAMA PSYCHIAT, V73, P275, DOI 10.1001/jamapsychiatry.2015.2692; Granild-Jensen JB, 2015, DEV MED CHILD NEUROL, V57, P931, DOI 10.1111/dmcn.12760; Hebebrand M, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1020-x; Jin SC, 2020, NAT GENET, V52, P1046, DOI 10.1038/s41588-020-0695-1; Kharbanda M, 2017, EUR J MED GENET, V60, P130, DOI 10.1016/j.ejmg.2016.11.008; Klebe S, 2012, EUR J HUM GENET, V20, P645, DOI 10.1038/ejhg.2011.261; Korzeniewski SJ, 2018, NAT REV NEUROL, V14, P528, DOI 10.1038/s41582-018-0043-6; Lee JR, 2015, HUM MUTAT, V36, P69, DOI 10.1002/humu.22709; MacLennan AH, 2019, J CHILD NEUROL, V34, P472, DOI 10.1177/0883073819840449; Maenner MJ, 2016, ANN EPIDEMIOL, V26, P222, DOI 10.1016/j.annepidem.2016.01.001; Malaquias MJ, 2019, NEUROL SCI, V40, P2213, DOI 10.1007/s10072-019-03964-7; McMichael G, 2015, MOL PSYCHIATR, V20, P176, DOI 10.1038/mp.2014.189; McMichael G, 2014, EUR J HUM GENET, V22, P40, DOI 10.1038/ejhg.2013.93; Moreno-De-Luca A, 2013, LANCET NEUROL, V12, P423, DOI 10.1016/S1474-4422(13)70011-5; Moreno-De-Luca A, 2012, LANCET NEUROL, V11, P283, DOI 10.1016/S1474-4422(11)70287-3; Moreno-De-Luca A, 2011, J MED GENET, V48, P141, DOI 10.1136/jmg.2010.082263; Novak I, 2017, JAMA PEDIATR, V171, P897, DOI 10.1001/jamapediatrics.2017.1689; Oskoui M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8949; Rainier S, 2006, ARCH NEUROL-CHICAGO, V63, P445, DOI 10.1001/archneur.63.3.445; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Fernandez IS, 2019, NEUROLOGY, V92, pE418, DOI 10.1212/WNL.0000000000006850; Schirinzi T, 2019, PARKINSONISM RELAT D, V61, P19, DOI 10.1016/j.parkreldis.2018.11.019; Segel R, 2015, NEUROLOGY, V84, P1660, DOI 10.1212/WNL.0000000000001494; Smithers-Sheedy H, 2014, DEV MED CHILD NEUROL, V56, P323, DOI 10.1111/dmcn.12262; Srivastava S, 2019, GENET MED, V21, P2413, DOI 10.1038/s41436-019-0554-6; Srivastava S, 2014, ANN NEUROL, V76, P473, DOI 10.1002/ana.24251; Takezawa Y, 2018, ANN CLIN TRANSL NEUR, V5, P538, DOI 10.1002/acn3.551; Zarrei M, 2018, GENET MED, V20, P172, DOI 10.1038/gim.2017.83; Zouvelou V, 2019, EUR J PAEDIATR NEURO, V23, P427, DOI 10.1016/j.ejpn.2019.02.001	40	24	24	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2021	325	5					467	475		10.1001/jama.2020.26148	http://dx.doi.org/10.1001/jama.2020.26148			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QC6JP	33528536	Green Published, Bronze			2022-12-28	WOS:000614941900019
J	Eaton, L				Eaton, Lynn			Covid-19: WHO warns against "vaccine nationalism" or face further virus mutations	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Association of the British Pharmaceutical Industry, 2019, GOV ANN RESTR EXP SO	1	32	33	2	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2021	372								n292	10.1136/bmj.n292	http://dx.doi.org/10.1136/bmj.n292			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QE0LS	33526414	Bronze			2022-12-28	WOS:000615899800004
J	Murai, IH; Fernandes, AL; Sales, LP; Pinto, AJ; Goessler, KF; Duran, CSC; Silva, CBR; Franco, AS; Macedo, MB; Dalmolin, HHH; Baggio, J; Balbi, GGM; Reis, BZ; Antonangelo, L; Caparbo, VF; Gualano, B; Pereira, RMR				Murai, Igor H.; Fernandes, Alan L.; Sales, Lucas P.; Pinto, Ana J.; Goessler, Karla F.; Duran, Camila S. C.; Silva, Carla B. R.; Franco, Andre S.; Macedo, Marina B.; Dalmolin, Henrique H. H.; Baggio, Janaina; Balbi, Guilherme G. M.; Reis, Bruna Z.; Antonangelo, Leila; Caparbo, Valeria F.; Gualano, Bruno; Pereira, Rosa M. R.			Effect of a Single High Dose of Vitamin D-3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19 A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							D SUPPLEMENTATION	IMPORTANCE The efficacy of vitamin D-3 supplementation in coronavirus disease 2019 (COVID-19) remains unclear. OBJECTIVE To investigate the effect of a single high dose of vitamin D-3 on hospital length of stay in patients with COVID-19. DESIGN, SETTING, AND PARTICIPANTS This was a multicenter, double-blind, randomized, placebo-controlled trial conducted in 2 sites in Sao Paulo, Brazil. The study included 240 hospitalized patients with COVID-19 who were moderately to severely ill at the time of enrollment from June 2, 2020, to August 27, 2020. The final follow-up was on October 7, 2020. INTERVENTIONS Patients were randomly assigned to receive a single oral dose of 200 000 IU of vitamin D-3 (n = 120) or placebo (n = 120). MAIN OUTCOMES AND MEASURES The primary outcome was length of stay, defined as the time from the date of randomization to hospital discharge. Prespecified secondary outcomes included mortality during hospitalization; the number of patients admitted to the intensive care unit; the number of patients who required mechanical ventilation and the duration of mechanical ventilation; and serum levels of 25-hydroxyvitamin D, total calcium, creatinine, and C-reactive protein. RESULTS Of 240 randomized patients, 237 were included in the primary analysis (mean [SD] age, 56.2 [14.4] years; 104 [43.9%] women; mean [SD] baseline 25-hydroxyvitamin D level, 20.9 [9.2] ng/mL). Median (interquartile range) length of stay was not significantly different between the vitamin D-3 (7.0 [4.0-10.0] days) and placebo groups (7.0 [5.0-13.0] days) (log-rank P = .59; unadjusted hazard ratio for hospital discharge, 1.07 [95% CI, 0.82-1.39]; P = .62). The difference between the vitamin D-3 group and the placebo group was not significant for in-hospital mortality (7.6% vs 5.1%; difference, 2.5% [95% CI, -4.1% to 9.2%]; P = .43), admission to the intensive care unit (16.0% vs 21.2%; difference, -5.2% [95% CI, -15.1% to 4.7%]; P = .30), or need for mechanical ventilation (7.6% vs 14.4%; difference, -6.8% [95% CI, -15.1% to 1.2%]; P = .09). Mean serum levels of 25-hydroxyvitamin D significantly increased after a single dose of vitamin D-3 vs placebo (44.4 ng/mL vs 19.8 ng/mL; difference, 24.1 ng/mL [95% CI, 19.5-28.7]; P < .001). There were no adverse events, but an episode of vomiting was associated with the intervention. CONCLUSIONS AND RELEVANCE Among hospitalized patients with COVID-19, a single high dose of vitamin D-3, compared with placebo, did not significantly reduce hospital length of stay. The findings do not support the use of a high dose of vitamin D-3 for treatment of moderate to severe COVID-19.	[Murai, Igor H.; Fernandes, Alan L.; Sales, Lucas P.; Duran, Camila S. C.; Silva, Carla B. R.; Franco, Andre S.; Macedo, Marina B.; Dalmolin, Henrique H. H.; Baggio, Janaina; Balbi, Guilherme G. M.; Reis, Bruna Z.; Caparbo, Valeria F.; Pereira, Rosa M. R.] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Rheumatol Div, Sao Paulo, Brazil; [Pinto, Ana J.; Goessler, Karla F.; Gualano, Bruno] Univ Sao Paulo, Fac Med, Appl Physiol & Nutr Res Grp, Sao Paulo, Brazil; [Antonangelo, Leila] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Clin Pathol Div, Sao Paulo, Brazil; [Gualano, Bruno] Univ Sao Paulo, Food Res Ctr, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Pereira, RMR (corresponding author), Univ Sao Paulo, Fac Med FMUSP, Rheumatol Div, 3 Andar,Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.	rosamariarp@yahoo.com	Gualano, Bruno/ABA-9571-2020; Antonangelo, Leila/H-9998-2012; Fernandes, Alan Lins/R-7248-2019; Caparbo, Valéria/ABF-1198-2021; Sales, Lucas Peixoto/AAV-2301-2020; Pereira, Rosa M R/C-5192-2012; Pinto, Ana Jessica/E-9869-2018; Pinto, Ana Jessica/Y-6637-2019; Macêdo, Marina Barguil/AID-8278-2022; Reis, Bruna Zavarize/F-3102-2014	Gualano, Bruno/0000-0001-7100-8681; Antonangelo, Leila/0000-0002-8634-5100; Fernandes, Alan Lins/0000-0002-6786-3922; Sales, Lucas Peixoto/0000-0003-2439-2240; Pereira, Rosa M R/0000-0002-3723-5028; Pinto, Ana Jessica/0000-0002-1363-7233; Pinto, Ana Jessica/0000-0002-1363-7233; Macêdo, Marina Barguil/0000-0002-8927-5566; Reis, Bruna Zavarize/0000-0001-8726-8699; de Falco Caparbo, Valeria/0000-0002-6606-8628; Franco, Andre/0000-0002-6526-0140	FAPESP [20/05752-4, 19/24782-4, 20/11102-2, 16/00006-7, 17/13552-2, 15/26937-4, 19/18039-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [305556/2017-7]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by FAPESP (grants 20/05752-4; 19/24782-4; 20/11102-2; 16/00006-7; 17/13552-2; 15/26937-4; 19/18039-7) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (305556/2017-7).	Aglipay M, 2017, JAMA-J AM MED ASSOC, V318, P245, DOI 10.1001/jama.2017.8708; Aibana O, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002907; Annweiler G, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113377; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Bacchetti P, 2008, BIOMETRICS, V64, P577, DOI [10.1111/j.1541-0420.2008.01004.x, 10.1111/j.1541-0420.2008.01004_1.x]; Bacchetti P, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-17; Bilezikian JP, 2020, EUR J ENDOCRINOL, V183, pR133, DOI 10.1530/EJE-20-0665; Campbell GR, 2012, AUTOPHAGY, V8, P1523, DOI 10.4161/auto.21154; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Carpagnano GE, 2021, J ENDOCRINOL INVEST, V44, P765, DOI 10.1007/s40618-020-01370-x; Franco AS, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000007024, 10.1097/md.0000000000007024]; Hernandez Jose L., 2021, Journal of Clinical Endocrinology & Metabolism, V106, pE1343, DOI 10.1210/clinem/dgaa733; Ilie PC, 2020, AGING CLIN EXP RES, V32, P1195, DOI 10.1007/s40520-020-01570-8; Kaufman HW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239252; Kearns MD, 2014, ENDOCR PRACT, V20, P341, DOI 10.4158/EP13265.RA; Laplana M, 2018, GENE, V678, P384, DOI 10.1016/j.gene.2018.08.017; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martineau AR, 2020, LANCET DIABETES ENDO, V8, P735, DOI 10.1016/S2213-8587(20)30268-0; Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583; Meltzer DO, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19722; Mitchell F, 2020, LANCET DIABETES ENDO, V8, P570, DOI 10.1016/S2213-8587(20)30183-2; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002	23	236	242	17	56	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2021	325	11					1053	1060		10.1001/jama.2020.26848	http://dx.doi.org/10.1001/jama.2020.26848		FEB 2021	8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QZ1BV	33595634	Green Published, Bronze			2022-12-28	WOS:000619613600003
J	Chow, MR; Ayiotis, AI; Schoo, DP; Gimmon, Y; Lane, KE; Morris, BJ; Rahman, MA; Valentin, NS; Boutros, PJ; Bowditch, SP; Ward, BK; Sun, DQ; Guajardo, CT; Schubert, MC; Carey, JP; Della Santina, CC				Chow, M. R.; Ayiotis, A. I.; Schoo, D. P.; Gimmon, Y.; Lane, K. E.; Morris, B. J.; Rahman, M. A.; Valentin, N. S.; Boutros, P. J.; Bowditch, S. P.; Ward, B. K.; Sun, D. Q.; Guajardo, C. Trevino; Schubert, M. C.; Carey, J. P.; Della Santina, C. C.			Posture, Gait, Quality of Life, and Hearing with a Vestibular Implant	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NORMATIVE DATA; DISORDERS ACTIVITIES; HEALTH; BALANCE; REHABILITATION; RELIABILITY; IMPACT; ADULTS; INDEX	Background Bilateral vestibular hypofunction is associated with chronic disequilibrium, postural instability, and unsteady gait owing to failure of vestibular reflexes that stabilize the eyes, head, and body. A vestibular implant may be effective in alleviating symptoms. Methods Persons who had had ototoxic (7 participants) or idiopathic (1 participant) bilateral vestibular hypofunction for 2 to 23 years underwent unilateral implantation of a prosthesis that electrically stimulates the three semicircular canal branches of the vestibular nerve. Clinical outcomes included the score on the Bruininks-Oseretsky Test of Motor Proficiency balance subtest (range, 0 to 36, with higher scores indicating better balance), time to failure on the modified Romberg test (range, 0 to 30 seconds), score on the Dynamic Gait Index (range, 0 to 24, with higher scores indicating better gait performance), time needed to complete the Timed Up and Go test, gait speed, pure-tone auditory detection thresholds, speech discrimination scores, and quality of life. We compared participants' results at baseline (before implantation) with those at 6 months (8 participants) and at 1 year (6 participants) with the device set in its usual treatment mode (varying stimulus pulse rate and amplitude to represent rotational head motion) and in a placebo mode (holding pulse rate and amplitude constant). Results The median scores at baseline and at 6 months on the Bruininks-Oseretsky test were 17.5 and 21.0, respectively (median within-participant difference, 5.5 points; 95% confidence interval [CI], 0 to 10.0); the median times on the modified Romberg test were 3.6 seconds and 8.3 seconds (difference, 5.1; 95% CI, 1.5 to 27.6); the median scores on the Dynamic Gait Index were 12.5 and 22.5 (difference, 10.5 points; 95% CI, 1.5 to 12.0); the median times on the Timed Up and Go test were 11.0 seconds and 8.7 seconds (difference, 2.3; 95% CI, -1.7 to 5.0); and the median speeds on the gait-speed test were 1.03 m per second and 1.10 m per second (difference, 0.13; 95% CI, -0.25 to 0.30). Placebo-mode testing confirmed that improvements were due to treatment-mode stimulation. Among the 6 participants who were also assessed at 1 year, the median within-participant changes from baseline to 1 year were generally consistent with results at 6 months. Implantation caused ipsilateral hearing loss, with the air-conducted pure-tone average detection threshold at 6 months increasing by 3 to 16 dB in 5 participants and by 74 to 104 dB in 3 participants. Changes in participant-reported disability and quality of life paralleled changes in posture and gait. Conclusions Six months and 1 year after unilateral implantation of a vestibular prosthesis for bilateral vestibular hypofunction, measures of posture, gait, and quality of life were generally in the direction of improvement from baseline, but hearing was reduced in the ear with the implant in all but 1 participant. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, .) Eight adults with severe vestibular hypofunction underwent implantation of a device that stimulates the semicircular canal branches with continuous information about the angular motion of the head. At 6 months and 1 year, most tests of posture, gait, and quality of life showed improvement. There was hearing loss in the ear with the implant in seven participants.	[Chow, M. R.; Ayiotis, A. I.; Schoo, D. P.; Gimmon, Y.; Lane, K. E.; Morris, B. J.; Boutros, P. J.; Bowditch, S. P.; Ward, B. K.; Sun, D. Q.; Guajardo, C. Trevino; Schubert, M. C.; Carey, J. P.; Della Santina, C. C.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Chow, M. R.; Ayiotis, A. I.; Morris, B. J.; Boutros, P. J.; Della Santina, C. C.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Rahman, M. A.; Valentin, N. S.; Della Santina, C. C.] Labyrinth Devices, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Della Santina, CC (corresponding author), 720 Rutland Ave,Ross Bldg,Rm 826, Baltimore, MD 21205 USA.	cds@jhmi.ed		Ayiotis, Andrianna/0000-0002-5497-7197; Chow, Margaret/0000-0002-4335-0903; Gimmon, Yoav/0000-0001-5979-3269; Morris, Brian/0000-0002-8119-6177	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by the National Institutes of Health and others	Agrawal Y, 2011, OTOL NEUROTOL, V32, P1309, DOI 10.1097/MAO.0b013e31822e5bee; [Anonymous], 1952, NEW ENGL J MED, V246, P458; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Ara R, 2009, VALUE HEALTH, V12, P346, DOI 10.1111/j.1524-4733.2008.00428.x; Bischoff HA, 2003, AGE AGEING, V32, P315, DOI 10.1093/ageing/32.3.315; Brach JS, 2008, ARCH PHYS MED REHAB, V89, P2293, DOI 10.1016/j.apmr.2008.06.010; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Bruininks RH, 2005, BRUININKS OSERETSKY; CAMPBELL MJ, 1988, BRIT MED J, V296, P1454, DOI 10.1136/bmj.296.6634.1454; Barros CGC, 2010, NEUROSCI LETT, V476, P123, DOI 10.1016/j.neulet.2010.04.012; CDC, 2017, TIM GO TUG; Cohen HS, 2014, J VESTIBUL RES-EQUIL, V24, P33, DOI 10.3233/VES-130475; Cohen HS, 2000, ARCH OTOLARYNGOL, V126, P881, DOI 10.1001/archotol.126.7.881; Cohen HS, 2000, LARYNGOSCOPE, V110, P1204, DOI 10.1097/00005537-200007000-00026; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Fryback DG, 2007, MED CARE, V45, P1162, DOI 10.1097/MLR.0b013e31814848f1; Guinand N, 2015, ORL J OTO-RHINO-LARY, V77, P227, DOI 10.1159/000433554; Guyot JP, 2019, CURR OPIN NEUROL, V32, P145, DOI 10.1097/WCO.0000000000000639; Herman T, 2009, GAIT POSTURE, V29, P237, DOI 10.1016/j.gaitpost.2008.08.013; Honegger F, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-115; Horsman John, 2003, Health Qual Life Outcomes, V1, P54, DOI 10.1186/1477-7525-1-54; Ibrahim A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185641; Iversen MM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28592-7; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437; Lins L, 2016, SAGE OPEN MED, V4, DOI 10.1177/2050312116671725; Merfeld DM, 2012, CURR OPIN OTOLARYNGO, V20, P386, DOI 10.1097/MOO.0b013e328357630f; Nguyen KD, 2010, OTOL NEUROTOL, V31, P793, DOI 10.1097/MAO.0b013e3181e3d60e; PETERSON GE, 1962, J SPEECH HEAR DISORD, V27, P62, DOI 10.1044/jshd.2701.62; Rubinstein JT, 2020, OTOL NEUROTOL, V41, P68, DOI 10.1097/MAO.0000000000002463; Shumaway-Cook A, 1995, MOTOR CONTROL THEORY; Sienko KH, 2017, J VESTIBUL RES-EQUIL, V27, P63, DOI 10.3233/VES-170606; Sluydts M, 2020, AUDIOL NEURO-OTOL, V25, P6, DOI 10.1159/000502407; Spahr AJ, 2012, EAR HEARING, V33, P112, DOI 10.1097/AUD.0b013e31822c2549; Strupp M, 2017, J VESTIBUL RES-EQUIL, V27, P177, DOI 10.3233/VES-170619; Sun DQ, 2014, JAMA OTOLARYNGOL, V140, P527, DOI 10.1001/jamaoto.2014.490; Vereeck L, 2008, INT J AUDIOL, V47, P67, DOI 10.1080/14992020701689688; Ward BK, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00177; Ward BK, 2013, JAMA OTOLARYNGOL, V139, P803, DOI 10.1001/jamaoto.2013.3913; Wright A, 2012, J MAN MANIP THER, V20, P160, DOI 10.1179/2042618612Y.0000000001	40	18	21	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2021	384	6					521	532		10.1056/NEJMoa2020457	http://dx.doi.org/10.1056/NEJMoa2020457			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG5JQ	33567192	Green Accepted, Bronze			2022-12-28	WOS:000617621800009
J	Day, M				Day, Michael			Covid-19: More young children are being infected in Israel and Italy, emerging data suggest	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Independent SAGE, 2021, 34 IND SAGE	1	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2021	372								n383	10.1136/bmj.n383	http://dx.doi.org/10.1136/bmj.n383			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RG0MZ	33563602	Bronze			2022-12-28	WOS:000635231900010
J	Ducrocq, G; Gonzalez-Juanatey, JR; Puymirat, E; Lemesle, G; Cachanado, M; Durand-Zaleski, I; Arnaiz, JA; Martinez-Selles, M; Silvain, J; Ariza-Sole, A; Ferrari, E; Calvo, G; Danchin, N; Avendano-Sola, C; Frenkiel, J; Rousseau, A; Vicaut, E; Simon, T; Steg, PG				Ducrocq, Gregory; Gonzalez-Juanatey, Jose R.; Puymirat, Etienne; Lemesle, Gilles; Cachanado, Marine; Durand-Zaleski, Isabelle; Albert Arnaiz, Joan; Martinez-Selles, Manuel; Silvain, Johanne; Ariza-Sole, Albert; Ferrari, Emile; Calvo, Gonzalo; Danchin, Nicolas; Avendano-Sola, Cristina; Frenkiel, Jerome; Rousseau, Alexandra; Vicaut, Eric; Simon, Tabassome; Steg, Philippe Gabriel		REALITY Investigators	Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia The REALITY Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								This noninferiority trial compares the effects of a restrictive (hemoglobin <= 8 g/dL) vs liberal (hemoglobin <= 10 g/dL) transfusion strategy on 30-day cardiovascular events among adults with acute myocardial infarction (AMI) and anemia (hemoglobin 7-10 g/dL). Question Is a restrictive strategy of blood transfusion noninferior to a liberal strategy among patients with acute myocardial infarction and anemia? Findings In this randomized clinical trial that included 668 patients with acute myocardial infarction and hemoglobin level between 7 and 10 g/dL who were treated with a restrictive transfusion strategy (triggered by hemoglobin <= 8 g/dL) vs a liberal strategy (triggered by hemoglobin <= 10 g/dL), the composite outcome (all-cause death, stroke, recurrent myocardial infarction, or emergency revascularization) at 30 days occurred in 11% vs 14% of patients, a difference that met the noninferiority criterion of relative risk less than 1.25. Meaning A restrictive transfusion strategy compared with a liberal strategy resulted in a noninferior rate of major cardiovascular events among patients with acute myocardial infarction and anemia, but the CI included what may be a clinically important harm. Importance The optimal transfusion strategy in patients with acute myocardial infarction and anemia is unclear. Objective To determine whether a restrictive transfusion strategy would be clinically noninferior to a liberal strategy. Design, Setting, and Participants Open-label, noninferiority, randomized trial conducted in 35 hospitals in France and Spain including 668 patients with myocardial infarction and hemoglobin level between 7 and 10 g/dL. Enrollment could be considered at any time during the index admission for myocardial infarction. The first participant was enrolled in March 2016 and the last was enrolled in September 2019. The final 30-day follow-up was accrued in November 2019. Interventions Patients were randomly assigned to undergo a restrictive (transfusion triggered by hemoglobin <= 8; n = 342) or a liberal (transfusion triggered by hemoglobin <= 10 g/dL; n = 324) transfusion strategy. Main Outcomes and Measures The primary clinical outcome was major adverse cardiovascular events (MACE; composite of all-cause death, stroke, recurrent myocardial infarction, or emergency revascularization prompted by ischemia) at 30 days. Noninferiority required that the upper bound of the 1-sided 97.5% CI for the relative risk of the primary outcome be less than 1.25. The secondary outcomes included the individual components of the primary outcome. Results Among 668 patients who were randomized, 666 patients (median [interquartile range] age, 77 [69-84] years; 281 [42.2%] women) completed the 30-day follow-up, including 342 in the restrictive transfusion group (122 [35.7%] received transfusion; 342 total units of packed red blood cells transfused) and 324 in the liberal transfusion group (323 [99.7%] received transfusion; 758 total units transfused). At 30 days, MACE occurred in 36 patients (11.0% [95% CI, 7.5%-14.6%]) in the restrictive group and in 45 patients (14.0% [95% CI, 10.0%-17.9%]) in the liberal group (difference, -3.0% [95% CI, -8.4% to 2.4%]). The relative risk of the primary outcome was 0.79 (1-sided 97.5% CI, 0.00-1.19), meeting the prespecified noninferiority criterion. In the restrictive vs liberal group, all-cause death occurred in 5.6% vs 7.7% of patients, recurrent myocardial infarction occurred in 2.1% vs 3.1%, emergency revascularization prompted by ischemia occurred in 1.5% vs 1.9%, and nonfatal ischemic stroke occurred in 0.6% of patients in both groups. Conclusions and Relevance Among patients with acute myocardial infarction and anemia, a restrictive compared with a liberal transfusion strategy resulted in a noninferior rate of MACE after 30 days. However, the CI included what may be a clinically important harm.	[Ducrocq, Gregory; Steg, Philippe Gabriel] Univ Paris, INSERM, French Alliance Cardiovasc Trials FACT, AP HP,U1148, Paris, France; [Gonzalez-Juanatey, Jose R.] Univ Santiago de Compostela, Univ Hosp, Cardiol Dept, IDIS,CIBERCV, Santiago De Compostela, Spain; [Puymirat, Etienne; Danchin, Nicolas] Univ Paris, French Alliance Cardiovasc Trials FACT, Hop Europeen Georges Pompidou, AP HP, Paris, France; [Lemesle, Gilles] Univ Lille, CHU Lille, Fac Med Lille, Inst Pasteur Lille,Inserm,U1011,Inst Coeur Poumon, Lille, France; [Lemesle, Gilles] French Alliance Cardiovasc Trials FACT, Paris, France; [Cachanado, Marine; Rousseau, Alexandra; Simon, Tabassome] Hop St Antoine, AP HP, Dept Clin Pharmacol, Paris, France; [Cachanado, Marine; Rousseau, Alexandra; Simon, Tabassome] Hop St Antoine, AP HP, Clin Res Platform East Paris URC CRC CRB, Paris, France; [Durand-Zaleski, Isabelle; Frenkiel, Jerome] Hop Hotel Dieu, AP HP, Hlth Econ Res Unit, INSERM,UMR CRESS 1153, Paris, France; [Albert Arnaiz, Joan; Martinez-Selles, Manuel] Hosp Clin Barcelona, Clin Pharmacol Dept, Clin Trials Unit, Barcelona, Spain; [Albert Arnaiz, Joan; Martinez-Selles, Manuel] Univ Complutense, Univ Europea, Hosp Univ Gregorio Maranon, CIBERCV,Serv Cardiol, Madrid, Spain; [Silvain, Johanne] Sorbonne Univ, Inst Cardiol, Hop Pitie Salpetriere, AP HP,ACTION Study Grp,INSERM,UMRS1166, Paris, France; [Ariza-Sole, Albert] Univ Hosp Bellvitge, Heart Dis Inst, Barcelona, Spain; [Ferrari, Emile] Univ Cote dAzur, Serv Cardiol, CHU Nice, Hop Pasteur 1, Nice, France; [Calvo, Gonzalo] Univ Barcelona, Hosp Clin Barcelona, Area Medicament, Barcelona, Spain; [Avendano-Sola, Cristina] Hosp Univ Puerta Hierro Majadahonda, Clin Pharmacol Serv, Madrid, Spain; [Vicaut, Eric] Univ Paris Diderot, Fernand Widal Hosp, AP HP, Sorbonne Paris Cite,Dept Biostat, Paris, France; [Simon, Tabassome] Sorbonne Univ, Dept Clin Pharmacol, French Alliance Cardiovasc Trials FACT, Hop St Antoine,AP HP,Clin Res Platform URCEST CRB, Paris, France; [Steg, Philippe Gabriel] Imperial Coll, Royal Brompton Hosp, London, England	Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Universidade de Santiago de Compostela; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Complutense University of Madrid; European University of Madrid; General University Gregorio Maranon Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; University of Barcelona; Hospital Clinic de Barcelona; Hospital Puerta de Hierro-Majadahonda; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Imperial College London; Royal Brompton Hospital	Steg, PG (corresponding author), Hop Bichat Claude Bernard, AP HP, 46 Rue Henri Huchard, F-75018 Paris, France.	gabriel.steg@aphp.fr	Puymirat, Etienne/AAP-8895-2021; Garcia-Garcia, Cosme/E-2406-2016	Garcia-Garcia, Cosme/0000-0001-6330-1677; Puymirat, Etienne/0000-0002-0533-9682; FERRARI, Emile/0000-0002-8233-6039; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388; Avendano Sola, Cristina/0000-0001-5437-7215				Alexander KP, 2008, AM HEART J, V155, P1047, DOI 10.1016/j.ahj.2008.01.009; [Anonymous], 2016, NON CLIN TRIALS EST; [Anonymous], 1998, STAT PRINC CLIN TRIA; Carson JL, 2013, AM HEART J, V165, P964, DOI 10.1016/j.ahj.2013.03.001; Carson JL, 2013, JAMA-J AM MED ASSOC, V309, P83, DOI 10.1001/jama.2012.50429; Chatterjee S, 2013, JAMA INTERN MED, V173, P132, DOI 10.1001/2013.jamainternmed.1001; Cooper HA, 2011, AM J CARDIOL, V108, P1108, DOI 10.1016/j.amjcard.2011.06.014; Docherty AB, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1351; Ducrocq G, 2021, CLIN CARDIOL, V44, P143, DOI 10.1002/clc.23453; Ducrocq G, 2015, AM HEART J, V170, P726, DOI 10.1016/j.ahj.2015.07.004; Farhan S, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004908; Hahn JY, 2018, LANCET, V391, P1274, DOI 10.1016/S0140-6736(18)30493-8; Hanssen M, 2012, HEART, V98, P699, DOI 10.1136/heartjnl-2012-301700; Jabre P, 2018, JAMA-J AM MED ASSOC, V319, P779, DOI 10.1001/jama.2018.0156; Kedhi E, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k3793; Kim HS, 2020, LANCET, V396, P1079, DOI 10.1016/S0140-6736(20)31791-8; Mazer CD, 2018, NEW ENGL J MED, V379, P1224, DOI 10.1056/NEJMoa1808561; Mulla SM, 2012, JAMA-J AM MED ASSOC, V308, P2605, DOI 10.1001/2012.jama.11235; Murphy GJ, 2015, NEW ENGL J MED, V372, P997, DOI 10.1056/NEJMoa1403612; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Pocock SJ, 2015, J AM COLL CARDIOL, V66, P2886, DOI 10.1016/j.jacc.2015.10.051; Puymirat E, 2012, JAMA-J AM MED ASSOC, V308, P998, DOI 10.1001/2012.jama.11348; Rao SV, 2014, J AM COLL CARDIOL, V63, P1297, DOI 10.1016/j.jacc.2013.11.028; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Silvain J, 2014, J AM COLL CARDIOL, V63, P1289, DOI 10.1016/j.jacc.2013.11.029; Silvain J, 2010, EUR HEART J, V31, P2816, DOI 10.1093/eurheartj/ehq209; Steg PG, 2017, EUR HEART J, V38, P1044, DOI 10.1093/eurheartj/ehx110; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Watanabe H, 2019, JAMA-J AM MED ASSOC, V321, P2414, DOI 10.1001/jama.2019.8145; Williamson LM, 2013, LANCET, V381, P1866, DOI 10.1016/S0140-6736(13)60631-5; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615; Yeh RW, 2014, J AM COLL CARDIOL, V64, P820, DOI 10.1016/j.jacc.2014.05.041	34	59	60	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2021	325	6					552	560		10.1001/jama.2021.0135	http://dx.doi.org/10.1001/jama.2021.0135			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG0MD	33560322	Green Published, Bronze			2022-12-28	WOS:000617279600018
J	Mathew, R				Mathew, Rammya			Rammya Mathew: Is home working bad for our health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rammya.mathew@nhs.net							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2021	372								n333	10.1136/bmj.n333	http://dx.doi.org/10.1136/bmj.n333			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RG0MZ	33563592	Bronze			2022-12-28	WOS:000635231900001
J	Jones, H				Jones, Helen			Taking the helm during a pandemic: dermatologist Tanya Bleiker Consultant dermatologist Tanya Bleiker talks to Helen Jones about how she has developed her career by seizing every opportunity that has come her way	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2021	372								n336	10.1136/bmj.n336	http://dx.doi.org/10.1136/bmj.n336			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM1AV	33558214	Bronze			2022-12-28	WOS:000639394000010
J	Davar, D; Dzutsev, AK; McCulloch, JA; Rodrigues, RR; Chauvin, JM; Morrison, RM; Deblasio, RN; Menna, C; Ding, QQ; Pagliano, O; Zidi, B; Zhang, SW; Badger, JH; Vetizou, M; Cole, AM; Fernandes, MR; Prescott, S; Costa, RGF; Balaji, AK; Morgun, A; Vujkovic-Cvijin, I; Wang, H; Borhani, AA; Schwartz, MB; Dubner, HM; Ernst, SJ; Rose, A; Najjar, YG; Belkaid, Y; Kirkwood, JM; Trinchieri, G; Zarour, HM				Davar, Diwakar; Dzutsev, Amiran K.; McCulloch, John A.; Rodrigues, Richard R.; Chauvin, Joe-Marc; Morrison, Robert M.; Deblasio, Richelle N.; Menna, Carmine; Ding, Quanquan; Pagliano, Ornella; Zidi, Bochra; Zhang, Shuowen; Badger, Jonathan H.; Vetizou, Marie; Cole, Alicia M.; Fernandes, Miriam R.; Prescott, Stephanie; Costa, Raquel G. F.; Balaji, Ascharya K.; Morgun, Andrey; Vujkovic-Cvijin, Ivan; Wang, Hong; Borhani, Amir A.; Schwartz, Marc B.; Dubner, Howard M.; Ernst, Scarlett J.; Rose, Amy; Najjar, Yana G.; Belkaid, Yasmine; Kirkwood, John M.; Trinchieri, Giorgio; Zarour, Hassane M.			Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients	SCIENCE			English	Article							CD8(+) T-CELLS; NATURAL-KILLER; GUT MICROBIOTA; EFFICACY; PEMBROLIZUMAB; SUPPRESSION; NIVOLUMAB; REVEAL	Anti-programmed cell death protein 1 (PD-1) therapy provides long-term clinical benefits to patients with advanced melanoma. The composition of the gut microbiota correlates with anti-PD-1 efficacy in preclinical models and cancer patients. To investigate whether resistance to anti-PD-1 can be overcome by changing the gut microbiota, this clinical trial evaluated the safety and efficacy of responder-derived fecal microbiota transplantation (FMT) together with anti-PD-1 in patients with PD-1-refractory melanoma. This combination was well tolerated, provided clinical benefit in 6 of 15 patients, and induced rapid and durable microbiota perturbation. Responders exhibited increased abundance of taxa that were previously shown to be associated with response to anti-PD-1, increased CD8(+) T cell activation, and decreased frequency of interleukin-8-expressing myeloid cells. Responders had distinct proteomic and metabolomic signatures, and transkingdom network analyses confirmed that the gut microbiome regulated these changes. Collectively, our findings show that FMT and anti-PD-1 changed the gut microbiome and reprogrammed the tumor microenvironment to overcome resistance to anti-PD-1 in a subset of PD-1 advanced melanoma.	[Davar, Diwakar; Chauvin, Joe-Marc; Morrison, Robert M.; Deblasio, Richelle N.; Menna, Carmine; Ding, Quanquan; Pagliano, Ornella; Zidi, Bochra; Zhang, Shuowen; Ernst, Scarlett J.; Rose, Amy; Najjar, Yana G.; Kirkwood, John M.; Zarour, Hassane M.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15213 USA; [Davar, Diwakar; Chauvin, Joe-Marc; Morrison, Robert M.; Deblasio, Richelle N.; Menna, Carmine; Ding, Quanquan; Pagliano, Ornella; Zidi, Bochra; Zhang, Shuowen; Ernst, Scarlett J.; Rose, Amy; Najjar, Yana G.; Kirkwood, John M.; Zarour, Hassane M.] Univ Pittsburgh, UPMC Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Dzutsev, Amiran K.; McCulloch, John A.; Rodrigues, Richard R.; Badger, Jonathan H.; Vetizou, Marie; Cole, Alicia M.; Fernandes, Miriam R.; Prescott, Stephanie; Costa, Raquel G. F.; Balaji, Ascharya K.; Trinchieri, Giorgio] NCI, Lab Integrat Canc Immunol, Ctr Canc Res, Bethesda, MD 20892 USA; [Rodrigues, Richard R.] Frederick Natl Lab Canc Res, Basic Sci Program, Genet & Microbiome Core, Frederick, MD 21702 USA; [Morgun, Andrey] Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA; [Vujkovic-Cvijin, Ivan; Belkaid, Yasmine] NIAID, Lab Immune Syst Biol, NIH, Bethesda, MD 20892 USA; [Wang, Hong] Univ Pittsburgh, UPMC Hillman Canc Ctr, Biostat Facil, Pittsburgh, PA 15213 USA; [Borhani, Amir A.] Univ Pittsburgh, Dept Radiol, Div Abdominal Imaging, Pittsburgh, PA 15213 USA; [Schwartz, Marc B.; Dubner, Howard M.] Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA; [Zarour, Hassane M.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15213 USA; [Zhang, Shuowen] Tsinghua Univ, Sch Med, 1 Tsinghua Yuan, Beijing 100084, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oregon State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tsinghua University	Zarour, HM (corresponding author), Univ Pittsburgh, UPMC Hillman Canc Ctr, Pittsburgh, PA 15213 USA.; Trinchieri, G (corresponding author), NCI, Lab Integrat Canc Immunol, Ctr Canc Res, Bethesda, MD 20892 USA.; Zarour, HM (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15213 USA.	trinchig@mail.nih.gov; zarourhm@upmc.edu	Fernandes, Miriam Rodriguez/AAB-5493-2022; Davar, Diwakar/AAL-9592-2021; zidi, Bochra/GQZ-1473-2022	Kirkwood, John/0000-0002-3570-4476; Wang, Hong/0000-0003-0477-2908; Cole, Alicia/0000-0002-7792-2543; Davar, Diwakar/0000-0002-7846-8055; Prescott, Stephanie/0000-0002-0469-5255; Morrison, Robert/0000-0002-8421-8183; Rodrigues, Richard/0000-0003-3985-3003; Vujkovic-Cvijin, Ivan/0000-0002-8611-4900; Balaji, Ascharya/0000-0003-1382-5864; Chauvin, Joe-Marc/0000-0002-5294-8632; McCulloch, John/0000-0001-7107-6561	Merck MSD; Melanoma Breakthrough Foundation Breakthrough Consortium; National Cancer Institute (NCI) of the National Institutes of Health (NIH) [R01 CA228181, R01 CA222203]; James W. and Frances G. McGlothlin Chair in Melanoma Immunotherapy Research; UPMC Hillman Cancer Center Microbiome Shared Facility; NIH NCI Comprehensive Cancer Center Support CORE grant [P30 CA047904]; University of Pittsburgh Center for Research Computing and Unified Flow Cytometry Core of the University of Pittsburgh's Department of Immunology; Intramural Research Program of the NIH, NIAID, and NCI Center for Cancer Research	Merck MSD(Merck & Company); Melanoma Breakthrough Foundation Breakthrough Consortium; National Cancer Institute (NCI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); James W. and Frances G. McGlothlin Chair in Melanoma Immunotherapy Research; UPMC Hillman Cancer Center Microbiome Shared Facility; NIH NCI Comprehensive Cancer Center Support CORE grant; University of Pittsburgh Center for Research Computing and Unified Flow Cytometry Core of the University of Pittsburgh's Department of Immunology; Intramural Research Program of the NIH, NIAID, and NCI Center for Cancer Research	The clinical trial (NCT03341143) was supported by a research contract from Merck MSD to D.D. D.D. is supported by the Melanoma Breakthrough Foundation Breakthrough Consortium. H.M.Z. is supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) (award numbers R01 CA228181 and R01 CA222203) and the James W. and Frances G. McGlothlin Chair in Melanoma Immunotherapy Research. Work of the UPMC Hillman Cancer Center Microbiome Shared Facility and Cytometry Facility is supported by the NIH NCI Comprehensive Cancer Center Support CORE grant (P30 CA047904). This research was supported in part by the University of Pittsburgh Center for Research Computing and Unified Flow Cytometry Core of the University of Pittsburgh's Department of Immunology through the resources provided. This work was supported in part by the Intramural Research Program of the NIH, NIAID, and NCI Center for Cancer Research.	Alshetaiwi H, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay6017; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Danilo M, 2018, CELL REP, V22, P2107, DOI 10.1016/j.celrep.2018.01.072; Dzutsev A, 2015, EUR J IMMUNOL, V45, P17, DOI 10.1002/eji.201444972; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Finlay BB, 2020, NAT REV IMMUNOL, V20, P522, DOI 10.1038/s41577-020-0374-6; Frankel AE, 2017, NEOPLASIA, V19, P848, DOI 10.1016/j.neo.2017.08.004; Gokyavuz B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39553-z; Goldszmid RS, 2015, CANCER IMMUNOL RES, V3, P103, DOI 10.1158/2326-6066.CIR-14-0225; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Guia S, 2008, BLOOD, V111, P5008, DOI 10.1182/blood-2007-11-122259; Hasumi K, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26381; Kamphorst AO, 2017, P NATL ACAD SCI USA, V114, P4993, DOI 10.1073/pnas.1705327114; Kluger HM, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000398; Koblish HK, 1998, J EXP MED, V188, P1603, DOI 10.1084/jem.188.9.1603; Krieg C, 2018, NAT MED, V24, P144, DOI 10.1038/nm.4466; Kunert A, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0608-y; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin J, 2015, JAMA ONCOL, V1, P433, DOI 10.1001/jamaoncol.2015.1184; Martinez-Guryn K, 2018, CELL HOST MICROBE, V23, P458, DOI 10.1016/j.chom.2018.03.011; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; Menni C, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-10382-2, 10.1038/s41598-017-13722-4]; Nowicka Malgorzata, 2017, F1000Res, V6, P748, DOI 10.12688/f1000research.11622.3; Ohkawa T, 2001, IMMUNOLOGY, V103, P281, DOI 10.1046/j.1365-2567.2001.01248.x; Peters BA, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0672-4; Pinato DJ, 2019, JAMA ONCOL, V5, P1774, DOI 10.1001/jamaoncol.2019.2785; Pittet MJ, 2000, J IMMUNOL, V164, P1148, DOI 10.4049/jimmunol.164.3.1148; Ribas A, 2018, LANCET ONCOL, V19, pE219, DOI 10.1016/S1470-2045(18)30202-X; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; Ribas A, 2016, CANCER IMMUNOL RES, V4, P194, DOI 10.1158/2326-6066.CIR-15-0210; Robert C, 2019, LANCET ONCOL, V20, P1239, DOI 10.1016/S1470-2045(19)30388-2; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Rodrigues RR, 2018, METHODS MOL BIOL, V1849, P227, DOI 10.1007/978-1-4939-8728-3_15; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Sanmamed MF, 2017, ANN ONCOL, V28, P1988, DOI 10.1093/annonc/mdx190; Schalper KA, 2020, NAT MED, V26, P688, DOI 10.1038/s41591-020-0856-x; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Terme M, 2011, CANCER RES, V71, P5393, DOI 10.1158/0008-5472.CAN-11-0993; Vernocchi P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01144; Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0; Yambartsev A, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0155-0; Zarour HM, 2016, CLIN CANCER RES, V22, P1856, DOI 10.1158/1078-0432.CCR-15-1849; Zeng MY, 2016, IMMUNITY, V44, P647, DOI 10.1016/j.immuni.2016.02.006	51	301	310	56	225	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		595	+		10.1126/science.abf3363	http://dx.doi.org/10.1126/science.abf3363			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QD7TF	33542131	Green Accepted			2022-12-28	WOS:000615715300047
J	Powell, J				Powell, Jessica			The rise of the green general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jessicapowell.freelance@googlemail.com						NHS England, 2020, NHS BEC WORLDS 1 NAT	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2021	372								m4827	10.1136/bmj.m4827	http://dx.doi.org/10.1136/bmj.m4827			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QE0PW	33531339				2022-12-28	WOS:000615910600006
J	Uscher-Pines, L; Sousa, J; Jones, M; Whaley, C; Perrone, C; McCullough, C; Ober, AJ				Uscher-Pines, Lori; Sousa, Jessica; Jones, Maggie; Whaley, Christopher; Perrone, Christopher; McCullough, Colleen; Ober, Allison J.			Telehealth Use Among Safety-Net Organizations in California During the COVID-19 Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Uscher-Pines, Lori; Sousa, Jessica; Whaley, Christopher; McCullough, Colleen; Ober, Allison J.] RAND Corp, 1200 S Hayes St, Arlington, VA 22202 USA; [Jones, Maggie] Kaiser PermanenteWashington Hlth Res Inst, Ctr Community Hlth & Evaluat, Seattle, WA USA; [Perrone, Christopher] Calif Hlth Care Fdn, Oakland, CA USA	RAND Corporation	Uscher-Pines, L (corresponding author), RAND Corp, 1200 S Hayes St, Arlington, VA 22202 USA.	luscherp@rand.org	Sousa, Jessica/AAN-6572-2021	Sousa, Jessica/0000-0003-1714-4441	California Health Care Foundation [G-31038]	California Health Care Foundation	This work was supported by grant G-31038 from the California Health Care Foundation.	California Department of Health Care Services, TEL DEF; Centers for Medicare & Medicaid Services, TEL; Centers for Medicare & Medicaid Services, PROP POL PAYM QUAL P; Health Resources and Services Administration, UN DAT SYST RES; Health Resources Services Administration, 2019 NAT HLTH CTR DA 2019 NAT HLTH CTR DA; Verma S, EARLY IMPACT CMS EXP	6	49	49	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2021	325	11					1106	1107		10.1001/jama.2021.0282	http://dx.doi.org/10.1001/jama.2021.0282		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QZ1BV	33528494	Bronze, Green Published			2022-12-28	WOS:000614934700001
J	Voelker, R				Voelker, Rebecca			Adjuvant Therapy Approved for NSCLC	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2021	325	5					426	426		10.1001/jama.2021.0168	http://dx.doi.org/10.1001/jama.2021.0168			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QC6JP	33528522				2022-12-28	WOS:000614941900007
J	Thiruganasambandamoorthy, V; Sivilotti, MLA				Thiruganasambandamoorthy, Venkatesh; Sivilotti, Marco L. A.			Inpatient Notes: Identifying High-Risk Patients With Syncope-What Hospitalists Need to Know	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Thiruganasambandamoorthy, Venkatesh] Univ Ottawa, Ottawa, ON, Canada; [Thiruganasambandamoorthy, Venkatesh] Ottawa Hosp, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Sivilotti, Marco L. A.] Queens Univ, Kingston, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Queens University - Canada	Thiruganasambandamoorthy, V (corresponding author), Ottawa Hosp Res Inst, 1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.	vthirug@ohri.ca		Thiruganasambandamoorthy, Venkatesh/0000-0003-4373-3688				Brignole M, 2018, EUR HEART J, V39, P1883, DOI 10.1093/eurheartj/ehy037; Thiruganasambandamoorthy V, 2020, ANN INTERN MED, V172, P648, DOI 10.7326/M19-3515; Thiruganasambandamoorthy V, 2020, JAMA INTERN MED, V180, P737, DOI 10.1001/jamainternmed.2020.0288; Thiruganasambandamoorthy V, 2019, CIRCULATION, V139, P1396, DOI 10.1161/CIRCULATIONAHA.118.036088; Viau JA, 2019, ACAD EMERG MED, V26, P479, DOI 10.1111/acem.13568	5	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2021	174	2					HO2	HO3		10.7326/M20-8081	http://dx.doi.org/10.7326/M20-8081			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ2CK	33587884				2022-12-28	WOS:000619497100001
J	Klompas, M; Baker, MA; Rhee, C; Tucker, R; Fiumara, K; Griesbach, D; Bennett-Rizzo, C; Salmasian, H; Wang, R; Wheeler, N; Gallagher, GR; Lang, AS; Fink, T; Baez, S; Smole, S; Madoff, L; Goralnick, E; Resnick, A; Pearson, M; Britton, K; Sinclair, J; Morris, CA				Klompas, Michael; Baker, Meghan A.; Rhee, Chanu; Tucker, Robert; Fiumara, Karen; Griesbach, Diane; Bennett-Rizzo, Carin; Salmasian, Hojjat; Wang, Rui; Wheeler, Noah; Gallagher, Glen R.; Lang, Andrew S.; Fink, Timelia; Baez, Stephanie; Smole, Sandra; Madoff, Larry; Goralnick, Eric; Resnick, Andrew; Pearson, Madelyn; Britton, Kathryn; Sinclair, Julia; Morris, Charles A.			A SARS-CoV-2 Cluster in an Acute Care Hospital	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE RESPIRATORY SYNDROME; TRANSMISSION; INFECTION; COVID-19	Background: Little is known about clusters of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in acute care hospitals. Objective: To describe the detection, mitigation, and analysis of a large cluster of SARS-CoV-2 infections in an acute care hospital with mature infection control policies. Design: Descriptive study. Setting: Brigham and Women's Hospital, Boston, Massachusetts. Participants: Patients and staff with cluster-related SARSCoV-2 infections. Intervention: Close contacts of infected patients and staff were identified and tested every 3 days, patients on affected units were preemptively isolated and repeatedly tested, affected units were cleaned, room ventilation was measured, and specimens were sent for whole-genome sequencing. A case-control study was done to compare clinical interactions, personal protective equipment use, and breakroom and workroom practices in SARS-CoV-2-positive versus negative staff. Measurements: Description of the cluster, mitigation activities, and risk factor analysis. Results: Fourteen patients and 38 staff members were included in the cluster per whole-genome sequencing and epidemiologic associations. The index case was a symptomatic patient in whom isolation was discontinued after 2 negative results on nasopharyngeal polymerase chain reaction testing. The patient subsequently infected multiple roommates and staff, who then infected others. Seven of 52 (13%) secondary infections were detected only on second or subsequent tests. Eight of 9 (89%) patients who shared rooms with potentially contagious patients became infected. Potential contributing factors included high viral loads, nebulization, and positive pressure in the index patient's room. Risk factors for transmission to staff included presence during nebulization, caring for patients with dyspnea or cough, lack of eye protection, at least 15 minutes of exposure to case patients, and interactions with SARS-CoV-2-positive staff in clinical areas. Whole-genome sequencing confirmed that 2 staff members were infected despite wearing surgical masks and eye protection. Limitation: Findings may not be generalizable. Conclusion: SARS-CoV-2 clusters can occur in hospitals despite robust infection control policies. Insights from this cluster may inform additional measures to protect patients and staff.	[Klompas, Michael; Baker, Meghan A.; Rhee, Chanu] Harvard Med Sch, Harvard Pilgrim Hlth Care Inst, Boston, MA 02115 USA; [Klompas, Michael; Baker, Meghan A.; Rhee, Chanu; Tucker, Robert; Fiumara, Karen; Griesbach, Diane; Bennett-Rizzo, Carin; Salmasian, Hojjat; Wheeler, Noah; Gallagher, Glen R.; Lang, Andrew S.; Fink, Timelia; Baez, Stephanie; Smole, Sandra; Madoff, Larry; Goralnick, Eric; Resnick, Andrew; Pearson, Madelyn; Britton, Kathryn; Sinclair, Julia; Morris, Charles A.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Wang, Rui] Harvard Med Sch, Boston, MA 02115 USA; [Wang, Rui] Harvard Pilgrim Hlth Care Inst, 401 Pk Dr,Suite 401 East, Boston, MA 02115 USA; [Gallagher, Glen R.; Lang, Andrew S.; Fink, Timelia; Baez, Stephanie; Smole, Sandra; Madoff, Larry] Massachusetts Dept Publ Hlth, Boston, MA USA; [Wang, Rui] Harvard Med Sch, Dept Populat Med, 401 Pk Dr,Suite 401 East, Boston, MA 02215 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Massachusetts Department of Public Health; Harvard University; Harvard Medical School	Klompas, M (corresponding author), Harvard Pilgrim Hlth Care Inst, 401 Pk Dr,Suite 401 East, Boston, MA 02115 USA.; Klompas, M (corresponding author), Harvard Med Sch, Dept Populat Med, 401 Pk Dr,Suite 401 East, Boston, MA 02215 USA.	mklompas@bwh.harvard.edu; rui_wang@harvardpilgrim.org	Wang, Rui/X-1699-2019; Rhee, Chanu/AAO-8368-2020	Wang, Rui/0000-0001-5007-193X; Lang, Andrew/0000-0002-9368-1751				Adam DC, 2020, NAT MED, V26, P1714, DOI 10.1038/s41591-020-1092-0; Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; [Anonymous], JAMA INTERN MED; [Anonymous], PLOS ONE; Arkin, 2019, SCIENCE, DOI [10.1126/science.364.6438.320, 10.1126/science.abe9728]; Basile K, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1579, DOI 10.1093/CID/CIAA1579]; Centers for Disease Control and Prevention, 2020, CLIN INFECT DIS; Cheng VCC, 2020, AM J INFECT CONTROL, V48, P890, DOI 10.1016/j.ajic.2020.05.018; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Clapp PW, 2021, JAMA INTERN MED, V181, P463, DOI 10.1001/jamainternmed.2020.8168; Cummings DAT, 2021, CLIN INFECT DIS, V73, pE4428, DOI 10.1093/cid/ciaa900; Dimcheff DE, 2021, INFECT CONT HOSP EP, V42, P392, DOI 10.1017/ice.2020.1220; Greve FV, 2018, CRIT CARE MED, V46, P29, DOI 10.1097/CCM.0000000000002752; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Heinzerling A, 2020, MMWR-MORBID MORTAL W, V69, P472, DOI 10.15585/mmwr.mm6915e5; Jones AM, 2003, THORAX, V58, P525, DOI 10.1136/thorax.58.6.525; Klompas M, 2021, JAMA SURG, V156, P113, DOI 10.1001/jamasurg.2020.6643; Kobayashi T, 2021, CLIN INFECT DIS, V73, pE3116, DOI 10.1093/cid/ciaa1630; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Loeb M, 2004, EMERG INFECT DIS, V10, P251, DOI 10.3201/eid1002.030838; Mohammadi Abbas, 2020, medRxiv, DOI 10.1101/2020.05.14.20102038; Rhee C, 2020, CLIN INFECT DIS, DOI [10 .1093/cid/ciaa126, DOI 10.1093/CID/CIAA126]; Rhee C., 2020, CLIN INFECT DIS, V72, P1467, DOI [10.1093/cid/ciaa1249, DOI 10.1093/CID/CIAA1249]; Rickman HM, 2021, CLIN INFECT DIS, V72, P690, DOI 10.1093/cid/ciaa816; Salvatore PP, 2021, CLIN INFECT DIS, V72, pE761, DOI 10.1093/cid/ciaa1469; Sickbert-Bennett EE, 2020, JAMA INTERN MED, V180, P1607, DOI 10.1001/jamainternmed.2020.4221; Ueki H, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00637-20; Wilcoxon F., 1945, BIOMETRICS, V1, P80; World Medical Association, 2013, JAMA-J AM MED ASSOC; Yu ITS, 2005, CLIN INFECT DIS, V40, P1237, DOI 10.1086/428735; Zeng WB, 2020, JAMA OPHTHALMOL, V138, P1196, DOI 10.1001/jamaophthalmol.2020.3906; JAMA NETW OPEN	32	75	75	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN	2021	174	6					794	+		10.7326/M20-7567	http://dx.doi.org/10.7326/M20-7567			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SS5IR	33556277	Green Published			2022-12-28	WOS:000661788700019
J	van der Kooij, MK; Suijkerbuijk, KPM; Aarts, MJB; van den Berkmortel, FWPJ; Blank, CU; Boers-Sonderen, MJ; van Breeschoten, J; van den Eertwegh, AJM; de Groot, JWB; Haanen, JBAG; Hospers, GAP; Piersma, D; van Rijn, RS; Ten Tije, AJ; van der Veldt, AAM; Vreugdenhil, G; van Zeijl, MCT; Wouters, MWJM; Dekkers, OM; Kapiteijn, E				van der Kooij, Monique K.; Suijkerbuijk, Karijn P. M.; Aarts, Maureen J. B.; van den Berkmortel, Franchette W. P. J.; Blank, Christian U.; Boers-Sonderen, Marye J.; van Breeschoten, Jesper; van den Eertwegh, Alfonsus J. M.; de Groot, Jan Willem B.; Haanen, John B. A. G.; Hospers, Geke A. P.; Piersma, Djura; van Rijn, Rozemarijn S.; Ten Tije, Albert J.; van der Veldt, Astrid A. M.; Vreugdenhil, Gerard; van Zeijl, Michiel C. T.; Wouters, Michel W. J. M.; Dekkers, Olaf M.; Kapiteijn, Ellen			Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CHOICE CHEMOTHERAPY; METASTATIC MELANOMA; IPILIMUMAB; NIVOLUMAB; SURVIVAL; CANCER; IMMUNOTHERAPY; THERAPY; PEMBROLIZUMAB	Background: Because immune checkpoint inhibition (ICI) can cause immune-related adverse events (irAEs) mimicking immunologic diseases, patients with preexisting autoimmune disease (AID) have been excluded from clinical trials. Objective: To evaluate the safety and efficacy of ICI in patients with advanced melanoma with and without AID. Design: Nationwide cohort study. Setting: The Netherlands. Patients: 4367 patients with advanced melanoma enrolled in the Dutch Melanoma Treatment Registry (DMTR) between July 2013 and July 2018 and followed through February 2019. Measurements: Patient, clinical, and treatment characteristics; irAEs of grade 3 or higher; treatment response; and survival. Results: A total of 415 patients (9.5%) had AID, categorized as rheumatologic AID (n = 227), endocrine AID (n = 143), inflammatory bowel disease (IBD) (n = 55), or "other" (n = 8). Of these, 228 patients (55%) were treated with ICI (vs. 2546 [58%] without AID); 87 were treated with anti-cytotoxic T lymphocyte-associated protein 4 (CTLA-4), 187 with anti-programmed cell death 1 (PD-1), and 34 with the combination. The incidences of irAEs of grade 3 or higher in patients with AID were 30% (95% CI, 21% to 41%) with anti-CTLA-4, 17% (CI, 12% to 23%) with anti-PD-1, and 44% (CI, 27% to 62%) with combination therapy; for patients without AID, the incidences were 30% (CI, 27% to 33%) (n = 916), 13% (CI, 12% to 15%) (n = 1540), and 48% (CI, 43% to 53%) (n = 388), respectively. Patients with AID more often discontinued anti-PD-1 treatment because of toxicity than patients without AID (17% [CI, 12% to 23%] vs. 9% [CI, 8% to 11%]). Patients with IBD were more prone to anti-PD-1-induced colitis (6/31 = 19% [CI, 7% to 37%]) than patients with other AIDs (3% [CI, 0% to 6%]) and patients without AID (2% [CI, 2% to 3%]). The objective response rate was similar in patients with versus without AID who were treated with anti-CTLA-4 (10% [CI, 5% to 19%] vs. 16% [CI, 14% to 19%]), anti-PD-1 (40% [CI, 33% to 47%] vs. 44% [CI, 41% to 46%]), or the combination (39% [CI, 20% to 59%] vs. 43% [CI, 38% to 49%]). Survival did not differ between patients with and those without AID (median, 13 months [CI, 10 to 16 months] vs. 14 months [CI, 13 to 15 months]). Limitation: Information was limited on AID severity and immunosuppressive treatment. Conclusion: Response to ICI with anti-CTLA-4, anti-PD-1, or their combination for advanced melanoma and overall incidence of any irAEs of grade 3 or higher were similar in patients with and without preexisting AID. However, severe colitis and toxicity requiring early discontinuation of treatment occurred more frequently among patients with preexisting IBD, warranting close follow-up.	[van der Kooij, Monique K.; Kapiteijn, Ellen] Leiden Univ, Med Ctr, Dept Med Oncol, Albinusdreef 2,POB 9600, NL-2300 RC Leiden, Netherlands; [Dekkers, Olaf M.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Albinusdreef 2,POB 9600, NL-2300 RC Leiden, Netherlands; [Suijkerbuijk, Karijn P. M.] Univ Med Ctr Utrecht, Dept Med Oncol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands; [Aarts, Maureen J. B.] Maastricht Univ, Med Ctr, Dept Med Oncol, P Debyelaan 25, NL-6202 AZ Maastricht, Netherlands; [van den Berkmortel, Franchette W. P. J.] Zuyderland Med Ctr, Dept Med Oncol, NL-6130 MB Sittard Geleen, Netherlands; [Blank, Christian U.; Haanen, John B. A. G.] Netherlands Canc Inst, Antoni van Leeuwenhoek Hosp, Dept Med Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Boers-Sonderen, Marye J.] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, Grootepl Zuid 10, NL-6500 HB Nijmegen, Netherlands; [van Breeschoten, Jesper; van Zeijl, Michiel C. T.; Wouters, Michel W. J. M.] Dutch Inst Clin Auditing, Rijnsburgerweg 10, NL-2333 AA Leiden, Netherlands; [van Breeschoten, Jesper; van den Eertwegh, Alfonsus J. M.] Vrije Univ Amsterdam, Amsterdam Univ, Canc Ctr Amsterdam, Med Ctr, Amsterdam, Netherlands; [de Groot, Jan Willem B.] Isala, Isala Oncol Ctr, NL-8000 GK Zwolle, Netherlands; [Hospers, Geke A. P.] Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [Piersma, Djura] Med Spectrum Twente, Dept Med Oncol, Koningspl 1, NL-7512 KZ Enschede, Netherlands; [van Rijn, Rozemarijn S.] Med Ctr Leeuwarden, Dept Med Oncol, Henri Dunantweg 2, NL-8934 AD Leeuwarden, Netherlands; [Ten Tije, Albert J.] Amphia Ziekenhuis, Dept Med Oncol, Langendijk 175, NL-4819 EV Breda, Netherlands; [van der Veldt, Astrid A. M.] Erasmus MC, Canc Inst, Dept Med Oncol, Dr Molewaterpl 40, NL-3000 CA Rotterdam, Netherlands; [Vreugdenhil, Gerard] Maxima Med Ctr, Dept Med Oncol, Run 4600, NL-5500 MB Veldhoven, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Maastricht University; Maastricht University Medical Centre (MUMC); Netherlands Cancer Institute; Radboud University Nijmegen; University of Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; Medical Spectrum Twente; Medical Center Leeuwarden; Amphia Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Maxima Medical Center	Kapiteijn, E (corresponding author), Leiden Univ, Med Ctr, Dept Med Oncol, Albinusdreef 2,POB 9600, NL-2300 RC Leiden, Netherlands.	h.w.kapiteijn@lumc.nl	Haanen, John/AAD-8534-2022; van den Berkmortel, Franchette/AAB-6784-2022; Haanen, John/AAD-8578-2022	Haanen, John/0000-0001-5884-7704; Kapiteijn, Ellen/0000-0002-4814-6426	Netherlands Organization for Health Research and Development [836002002]; Bristol-Myers Squibb; Novartis; Roche Nederland; Merck Sharp Dohme; Pierre Fabre via the Dutch Institute	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Bristol-Myers Squibb(Bristol-Myers Squibb); Novartis(Novartis); Roche Nederland; Merck Sharp Dohme(Merck & Company); Pierre Fabre via the Dutch Institute	The DMTR was funded by grant 836002002 from The Netherlands Organization for Health Research and Development. From its foundation, the DMTR has been sponsored by Bristol-Myers Squibb, Novartis, Roche Nederland, Merck Sharp & Dohme, and Pierre Fabre via the Dutch Institute for Clinical Auditing.	Abdel-Wahab N, 2018, ANN INTERN MED, V169, P133, DOI 10.7326/L18-0209; Abdel-Wahab N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160221; Abu-Sbeih H, 2020, J CLIN ONCOL, V38, P576, DOI 10.1200/JCO.19.01674; Calabrese LH, 2018, ANN INTERN MED, V168, P149, DOI 10.7326/M17-3079; Carlino MS, 2018, EUR J CANCER, V101, P236, DOI 10.1016/j.ejca.2018.06.034; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Danlos FX, 2018, EUR J CANCER, V91, P21, DOI 10.1016/j.ejca.2017.12.008; de Glas NA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv366; Donia Marco, 2019, Oncotarget, V10, P4513, DOI 10.18632/oncotarget.27077; Donia M, 2017, SEMIN IMMUNOPATHOL, V39, P333, DOI 10.1007/s00281-016-0595-8; Donia M, 2017, EUR J CANCER, V74, P89, DOI 10.1016/j.ejca.2016.12.017; Hamid O, 2019, ANN ONCOL, V30, P582, DOI 10.1093/annonc/mdz011; Hamid O, 2017, EUR J CANCER, V86, P37, DOI 10.1016/j.ejca.2017.07.022; Jochems A, 2017, EUR J CANCER, V72, P156, DOI 10.1016/j.ejca.2016.11.021; Johnson DB, 2016, JAMA ONCOL, V2, P234, DOI 10.1001/jamaoncol.2015.4368; Larkin J, 2019, NEW ENGL J MED, V381, P1535, DOI 10.1056/NEJMoa1910836; Larkin J, 2018, J CLIN ONCOL, V36, P383, DOI 10.1200/JCO.2016.71.8023; Leonardi GC, 2018, J CLIN ONCOL, V36, P1905, DOI 10.1200/JCO.2017.77.0305; Magee DE, 2020, ANN ONCOL, V31, P50, DOI 10.1016/j.annonc.2019.10.008; Menzies AM, 2017, ANN ONCOL, V28, P368, DOI 10.1093/annonc/mdw443; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Schwartz LH, 2016, EUR J CANCER, V62, P132, DOI 10.1016/j.ejca.2016.03.081; Verheijden RJ, 2020, CLIN CANCER RES, V26, P2268, DOI 10.1158/1078-0432.CCR-19-3322; Wang DY, 2018, JAMA ONCOL, V4, P1721, DOI 10.1001/jamaoncol.2018.3923; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Wolchok JD, 2017, NEW ENGL J MED, V377, P2503; Zhao B, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0421-z	27	16	15	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					641	+		10.7326/M20-3419	http://dx.doi.org/10.7326/M20-3419			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33587686	Green Published, Green Submitted			2022-12-28	WOS:000652604800022
J	Chou, R; Dana, T; Selph, S; Totten, A; Buckley, DI; Fu, RW				Chou, Roger; Dana, Tracy; Selph, Shelley; Totten, AnnetteM.; Buckley, David I.; Fu, Rongwei			Update Alert 7: Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers	ANNALS OF INTERNAL MEDICINE			English	Letter							SARS-COV-2 SEROPREVALENCE		[Chou, Roger; Dana, Tracy; Selph, Shelley; Totten, AnnetteM.; Buckley, David I.; Fu, Rongwei] Pacific Northwest Evidence Based Practice Ctr, Portland, OR USA; [Chou, Roger; Dana, Tracy; Selph, Shelley; Totten, AnnetteM.] Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA; [Buckley, David I.; Fu, Rongwei] Oregon Hlth & Sci Univ Portland State Univ, Sch Publ Hlth, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Portland State University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu		Totten, Annette/0000-0002-9100-8678	World Health Organization	World Health Organization(World Health Organization)	The original review was funded by the World Health Organization. The World Health Organization staff developed the key questions and scope for the original review but did not have any role in the selection, assessment, or synthesis of evidence for this update.	Abdelmoniem R, 2021, J CLIN VIROL, V134, DOI 10.1016/j.jcv.2020.104710; Akinbami LJ, 2020, EMERG INFECT DIS, V26, P2863, DOI 10.3201/eid2612.203764; Algado-Selles N, 2020, AM J PREV MED, V59, pE221, DOI 10.1016/j.amepre.2020.07.014; Banerjee Abhra, 2020, J Assoc Physicians India, V68, P55; Barrett ES, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05587-2; Calcagno A, 2021, EMERG INFECT DIS, V27, P303, DOI 10.3201/eid2701.203027; Chou R, 2021, ANN INTERN MED, V174, pW18, DOI 10.7326/L20-1323; Chou R, 2020, ANN INTERN MED, V173, pW154, DOI 10.7326/L20-1227; Chou R, 2020, ANN INTERN MED, V173, pW143, DOI 10.7326/L20-1134; Chou R, 2020, ANN INTERN MED, V173, pW123, DOI 10.7326/L20-1005; Chou R, 2020, ANN INTERN MED, V173, pW46, DOI 10.7326/L20-0768; Chou R, 2020, ANN INTERN MED, V173, pW77, DOI 10.7326/M20-4806; Chou R, 2020, ANN INTERN MED, V173, P120, DOI 10.7326/M20-1632; Colaneri M, 2021, J PUBLIC HEALTH-UK, V43, P26, DOI 10.1093/pubmed/fdaa195; Goenka Mahesh, 2020, J Assoc Physicians India, V68, P14; Gras-Valenti Paula, 2021, Enferm Infecc Microbiol Clin, V39, P319, DOI 10.1016/j.eimc.2020.09.015; Jones CR, 2021, J INFECTION, V82, pE24, DOI 10.1016/j.jinf.2020.11.036; Krastinova E, 2021, OCCUP ENVIRON MED, V78, P479, DOI 10.1136/oemed-2020-106866; Perez-Garcia F, 2021, INFECT CONT HOSP EP, V42, P803, DOI 10.1017/ice.2020.1303; Rashid M, 2020, INT GEOSCI REMOTE SE, P1, DOI 10.1109/IGARSS39084.2020.9323927; Schmitz D, 2021, EUR J EMERG MED, V28, P202, DOI 10.1097/MEJ.0000000000000766; Shields A, 2020, THORAX, V75, P1089, DOI 10.1136/thoraxjnl-2020-215414; Sims MD, 2021, CLIN INFECT DIS, V73, pS154, DOI 10.1093/cid/ciaa1684; Wang Xuan, 2020, Sleep Med X, V2, P100028, DOI 10.1016/j.sleepx.2020.100028; Yogo N, 2021, INFECT CONT HOSP EP, V42, P1260, DOI 10.1017/ice.2020.1370	25	8	8	2	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2021	174	4					W45	W46		10.7326/L21-0034	http://dx.doi.org/10.7326/L21-0034			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RU1WZ	33556273	Green Published			2022-12-28	WOS:000644942400001
J	de Vries, RD; Schmitz, KS; Bovier, FT; Predella, C; Khao, J; Noack, D; Haagmans, BL; Herfst, S; Stearns, KN; Drew-Bear, J; Biswas, S; Rockx, B; McGill, G; Dorrello, NV; Gellman, SH; Alabi, CA; de Swart, RL; Moscona, A; Porotto, M				de Vries, Rory D.; Schmitz, Katharina S.; Bovier, Francesca T.; Predella, Camilla; Khao, Jonathan; Noack, Danny; Haagmans, Bart L.; Herfst, Sander; Stearns, Kyle N.; Drew-Bear, Jennifer; Biswas, Sudipta; Rockx, Barry; McGill, Gael; Dorrello, N. Valerio; Gellman, Samuel H.; Alabi, Christopher A.; de Swart, Rik L.; Moscona, Anne; Porotto, Matteo			Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets	SCIENCE			English	Article								Containment of the COVID-19 pandemic requires reducing viral transmission. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is initiated by membrane fusion between the viral and host cell membranes, which is mediated by the viral spike protein. We have designed lipopeptide fusion inhibitors that block this critical first step of infection and, on the basis of in vitro efficacy and in vivo biodistribution, selected a dimeric form for evaluation in an animal model. Daily intranasal administration to ferrets completely prevented SARS-CoV- 2 direct-contact transmission during 24-hour cohousing with infected animals, under stringent conditions that resulted in infection of 100% of untreated animals. These lipopeptides are highly stable and thus may readily translate into safe and effective intranasal prophylaxis to reduce transmission of SARS-CoV-2.	[de Vries, Rory D.; Schmitz, Katharina S.; Noack, Danny; Haagmans, Bart L.; Herfst, Sander; Rockx, Barry; de Swart, Rik L.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Bovier, Francesca T.; Predella, Camilla; Stearns, Kyle N.; Drew-Bear, Jennifer; Dorrello, N. Valerio; Moscona, Anne; Porotto, Matteo] Columbia Univ, Dept Pediat, Vagelos Coll Phys & Surg, New York, NY 10027 USA; [Bovier, Francesca T.; Stearns, Kyle N.; Drew-Bear, Jennifer; Moscona, Anne; Porotto, Matteo] Columbia Univ, Ctr Host Pathogen Interact, Vagelos Coll Phys & Surg, New York, NY 10027 USA; [Bovier, Francesca T.; Porotto, Matteo] Univ Campania Luigi Vanvitelli, Dept Expt Med, Caserta, Italy; [Predella, Camilla] Politecn Milan, Dept Biomed Engn, Milan, Italy; [Khao, Jonathan; McGill, Gael] Digizyme Inc, Brookline, MA USA; [Stearns, Kyle N.; Moscona, Anne] Columbia Univ, Dept Physiol & Cellular Biophys, Vagelos Coll Phys & Surg, New York, NY 10027 USA; [Biswas, Sudipta; Alabi, Christopher A.] Cornell Univ, Robert Frederick Smith Sch Chem & Biomol Engn, Ithaca, NY 14850 USA; [McGill, Gael] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Ctr Mol & Cellular Dynam, Boston, MA 02115 USA; [Gellman, Samuel H.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Moscona, Anne] Columbia Univ, Dept Microbiol & Immunol, Vagelos Coll Phys & Surg, New York, NY 10027 USA	Erasmus University Rotterdam; Erasmus MC; Columbia University; Columbia University; Universita della Campania Vanvitelli; Polytechnic University of Milan; Columbia University; Cornell University; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Columbia University	de Swart, RL (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.; Moscona, A; Porotto, M (corresponding author), Columbia Univ, Dept Pediat, Vagelos Coll Phys & Surg, New York, NY 10027 USA.; Moscona, A; Porotto, M (corresponding author), Columbia Univ, Ctr Host Pathogen Interact, Vagelos Coll Phys & Surg, New York, NY 10027 USA.; Porotto, M (corresponding author), Univ Campania Luigi Vanvitelli, Dept Expt Med, Caserta, Italy.; Moscona, A (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, Vagelos Coll Phys & Surg, New York, NY 10027 USA.; Alabi, CA (corresponding author), Cornell Univ, Robert Frederick Smith Sch Chem & Biomol Engn, Ithaca, NY 14850 USA.; Moscona, A (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Vagelos Coll Phys & Surg, New York, NY 10027 USA.	caa238@cornell.edu; r.deswart@erasmusmc.nl; am939@cumc.columbia.edu; mp3509@cumc.columbia.edu	de Vries, Rory D/L-2264-2015; Biswas, Sudipta/AAN-3538-2021; Haagmans, Bart/E-9791-2015; De Swart, Rik/E-6508-2011	de Vries, Rory D/0000-0003-2817-0127; Haagmans, Bart/0000-0001-6221-2015; Predella, Camilla/0000-0003-3699-0256; POROTTO, Matteo/0000-0003-3866-9220; Khao, Jonathan/0000-0001-9424-7925; Bovier, Francesca T./0000-0003-3446-9619; Schmitz, Katharina S./0000-0002-8537-0646; Stearns, Kyle/0000-0002-5166-7927; De Swart, Rik/0000-0003-3599-8969; Noack, Danny/0000-0003-1845-7511	National Institutes of Health [AI146980, AI121349, NS091263, AI114736, HHSN272201400008C]; Sharon Golub Fund at Columbia University Irving Medical Center (CUIMC); Children's Health Innovation Nucleation Fund of the Pediatrics Department at CUIMC; Harrington Discovery Institute COVID-19 Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sharon Golub Fund at Columbia University Irving Medical Center (CUIMC); Children's Health Innovation Nucleation Fund of the Pediatrics Department at CUIMC; Harrington Discovery Institute COVID-19 Award	This work was supported by funding from the National Institutes of Health (AI146980, AI121349, and NS091263 to M.P.; AI114736 to A.M.; and HHSN272201400008C to S.H.), the Sharon Golub Fund at Columbia University Irving Medical Center (CUIMC), the Children's Health Innovation Nucleation Fund of the Pediatrics Department at CUIMC, and a Harrington Discovery Institute COVID-19 Award to A.M. A. M. is the inaugural Sherie L. Morrison Professor of Immunology.	Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]; Cao LX, 2020, SCIENCE, V370, P426, DOI 10.1126/science.abd9909; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Cox RM, 2021, NAT MICROBIOL, V6, P11, DOI 10.1038/s41564-020-00835-2; Figueira TN, 2018, BIOCONJUGATE CHEM, V29, P3362, DOI 10.1021/acs.bioconjchem.8b00527; Figueira TN, 2017, J VIROL, V91, DOI 10.1128/JVI.01554-16; Figueira TN, 2018, ACS NANO, V12, P9855, DOI 10.1021/acsnano.8b01422; Hakansson-McReynolds S, 2006, J BIOL CHEM, V281, P11965, DOI 10.1074/jbc.M601174200; Halgren TA, 1996, ABSTR PAP AM CHEM S, V212, P2; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2020, NATURE, V585, P588, DOI 10.1038/s41586-020-2575-3; Kim YI, 2020, CELL HOST MICROBE, V27, P704, DOI 10.1016/j.chom.2020.03.023; Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a; Mathieu C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43610; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Mykytyn AZ, 2021, ELIFE, V10, DOI 10.7554/eLife.64508; Outlaw VK, 2020, MBIO, V11, DOI 10.1128/mBio.01935-20; Pessi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036833; Porotto M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001168; Richard M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17367-2; Schoof M, 2020, SCIENCE, V370, P1473, DOI 10.1126/science.abe3255; van Doornum GJJ, 2007, J MED VIROL, V79, P1868, DOI 10.1002/jmv.21031; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; Wang XL, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113843; Wu Kai, 2021, bioRxiv, DOI 10.1101/2021.01.25.427948; Xia S, 2020, CELL RES, V30, P343, DOI 10.1038/s41422-020-0305-x; Xia S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4580; Zhang LZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19808-4; Zhu YM, 2020, J VIROL, V94, DOI 10.1128/JVI.00635-20	33	84	86	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2021	371	6536					1379	+		10.1126/science.abf4896	http://dx.doi.org/10.1126/science.abf4896			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH2GI	33597220	Green Submitted, Green Published			2022-12-28	WOS:000636043400053
J	Sachs, JD; Karim, SA; Aknin, L; Allen, J; Brosbol, K; Barron, GC; Daszak, P; Espinosa, MF; Gaspar, V; Gaviria, A; Haines, A; Hotez, PJ; Koundouri, P; Larrain, BF; Lee, JK; Pate, M; Polman, P; Ramos, G; Reddy, KS; Serageldin, I; Shah, R; Thwaites, J; Vike-Freiberga, V; Wang, C; Were, MK; Xue, L; Zhu, M; Bottazzi, ME; Colombo, F; Laryea-Adjei, G; Ben Amor, Y; Caman, OK; Lafortune, G; Torres, E; Ethridge, I; Bartels, J				Sachs, Jeffrey D.; Karim, Salim Abdool; Aknin, Lara; Allen, Joseph; Brosbol, Kirsten; Cuevas Barron, Gabriela; Daszak, Peter; Fernanda Espinosa, Maria; Gaspar, Vitor; Gaviria, Alejandro; Haines, Andy; Hotez, Peter J.; Koundouri, Phoebe; Larrain, Felipe B.; Lee, Jong-Koo; Pate, Muhammad; Polman, Paul; Ramos, Gabriela; Reddy, K. Srinath; Serageldin, Ismail; Shah, Rajiv; Thwaites, John; Vike-Freiberga, Vaira; Wang, Chen; Were, Miriam Khamadi; Xue, Lan; Zhu, Min; Bottazzi, Maria Elena; Colombo, Francesca; Laryea-Adjei, George; Ben Amor, Yanis; Caman, Ozge Karadag; Lafortune, Guillaume; Torres, Emma; Ethridge, Ismini; Bartels, Juliana		Lancet COVID-19 Commission	Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission	LANCET			English	Editorial Material									[Sachs, Jeffrey D.] Columbia Univ, New York, NY 10027 USA; [Karim, Salim Abdool] Columbia Univ, Mailman Sch Publ Hlth, Global Hlth Epidemiol, New York, NY 10027 USA; [Aknin, Lara] Simon Fraser Univ, Burnaby, BC, Canada; [Allen, Joseph] Harvard TH Chan Sch Publ Hlth, Exposure Assessment Sci, Boston, MA USA; [Brosbol, Kirsten] Parliamentarians Global Goals, Frederiksberg, Denmark; [Cuevas Barron, Gabriela] Mexican Congress, Parliament, Mexico City, DF, Mexico; [Daszak, Peter] EcoHealth Alliance, New York, NY USA; [Fernanda Espinosa, Maria] Gen Assembly & former Minister Foreign Affairs &, Quito, Ecuador; [Gaspar, Vitor] IMF, Fiscal Affairs Dept, Washington, DC USA; [Gaviria, Alejandro] Univ Los Andes, Bogota, Colombia; [Gaviria, Alejandro] Minister Hlth, Bogota, Colombia; [Haines, Andy] London Sch Hyg & Trop Med, Environm Change & Publ Hlth, London, England; [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Houston, TX 77030 USA; [Koundouri, Phoebe] Athens Univ Econ & Business, Sch Econ, Athens, Greece; [Koundouri, Phoebe] European Assoc Environm & Resource Economists, Thessaloniki, Greece; [Larrain, Felipe B.] Pontificia Univ Catolica Chile, Econ, Santiago, Chile; [Larrain, Felipe B.] Minist Finance, Santiago, Chile; [Lee, Jong-Koo] Seoul Natl Univ, Seoul, South Korea; [Lee, Jong-Koo] Korea Ctr Dis Control & Prevent, Seoul, South Korea; [Pate, Muhammad] Harvard TH Chan Sch Publ Hlth, Publ Hlth & Leadership, Boston, MA USA; [Polman, Paul] Imagine One, London, England; [Polman, Paul] Unilever, London, England; [Ramos, Gabriela] UNESCO, Gen Social & Human Sci, Paris, France; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India; [Serageldin, Ismail] Bibliotheca Alexandrina, Alexandria, Egypt; [Shah, Rajiv] Rockefeller Fdn, New York, NY USA; [Thwaites, John] Monash Sustainable Dev Inst, Clayton, Vic, Australia; [Wang, Chen] Chinese Acad Med Sci, Peking Union Med Coll, Beijing, Peoples R China; [Wang, Chen] Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China; [Were, Miriam Khamadi] Champ AIDS Free Generat, Nairobi, Kenya; [Xue, Lan] Tsinghua Univ, Schwarzman Coll, Beijing, Peoples R China; [Zhu, Min] IMF, Washington, DC USA; [Zhu, Min] Bank China, New York, NY USA; [Bottazzi, Maria Elena] Baylor Coll Med, Natl Sch Trop Med, Houston, TX 77030 USA; [Colombo, Francesca] Org Econ Cooperat & Dev, Hlth Div, Paris, France; [Laryea-Adjei, George] UNICEF, Accra, Ghana; [Ben Amor, Yanis] Columbia Univ, Global Hlth & Microbiol Sci, New York, NY 10027 USA; [Ben Amor, Yanis; Caman, Ozge Karadag] Columbia Univ, Ctr Sustainable Dev, New York, NY 10027 USA; [Lafortune, Guillaume] United Nations Sustainable Dev Solut Network, Paris, France; [Torres, Emma] United Nations Sustainable Dev Solut Network, Amer, New York, NY USA; [Torres, Emma] United Nations Sustainable Dev Solut Network, New York Off, New York, NY USA; [Ethridge, Ismini] Columbia Univ, Ctr Sustainable Dev, New York, NY 10027 USA; [Bartels, Juliana] Columbia Univ, Ctr Sustainable Dev, New York, NY 10027 USA	Columbia University; Columbia University; Simon Fraser University; Harvard University; Harvard T.H. Chan School of Public Health; International Monetary Fund; Universidad de los Andes (Colombia); University of London; London School of Hygiene & Tropical Medicine; Baylor College of Medicine; Athens University of Economics & Business; Pontificia Universidad Catolica de Chile; Seoul National University (SNU); Korea Centers for Disease Control & Prevention (KCDC); Harvard University; Harvard T.H. Chan School of Public Health; Public Health Foundation of India; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; International Monetary Fund; Baylor College of Medicine; Organisation for Economic Co-operation & Development (OECD); Columbia University; Columbia University; Columbia University; Columbia University	Sachs, JD (corresponding author), Columbia Univ, New York, NY 10027 USA.	sachs@columbia.edu	Gaspar, Vítor/AAB-3045-2022; Reddy, K. Srinath/B-2820-2011; wang, chen/GWM-9481-2022; Koundouri, Phoebe/AAI-2160-2021; Abdool Karim, Salim/N-5947-2013; Karadag, Ozge/A-2024-2011	Reddy, K. Srinath/0000-0002-8545-7039; Koundouri, Phoebe/0000-0001-5979-6128; Wang, Chen/0000-0001-7857-5435; Abdool Karim, Salim/0000-0002-4986-2133; Were, Miriam/0000-0001-5811-9424; Haines, Andy/0000-0002-8053-4605; Karadag, Ozge/0000-0003-1372-1555				Battersby B, 2020, IMF BLOG 0520; Callaway E, 2021, NATURE, V590, P17, DOI 10.1038/d41586-021-00268-9; Callaway E, 2021, NATURE, V589, P500, DOI 10.1038/d41586-021-00121-z; Callaway E, 2021, NATURE, V589, P177, DOI 10.1038/d41586-021-00031-0; Centers for Disease Control and Prevention, 2021, EM SARS COV 2 VAR; Chand M, 2021, PUBLIC HLTH ENGLAND; Council for Trade-Related Aspects of Intellectual Property Rights, 2020, WAIV CERT PROV THETR; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Davies Nicholas G, 2021, Science, V372, DOI 10.1126/science.abg3055; Eurasia Group, 2020, END COVID 19 PAND NE; European Centre for Disease Prevention and Control, 2020, RISK REL SPREAD NEW; Franceschi VB, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-021-07708-w; Gurara Daniel., 2020, IMF BLOG 0827; International Monetary Fund, 2020, DEBT SERV REL CAT CO; International Monetary Fund, 2021, WORLD EC OUTL OCT 20; Mahase E, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4944; Mwai P., 2021, BBC; PAHO WHO, 2021, OCC VAR SARS COV 2 A; Ritchie H, 2021, STAT RES CORONAVIRUS; Ritchie H, 2021, CORONAVIRUS COVID 19; Studdert DM, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2024274; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; WHO, 2020, WHAT IS ACT ACC; World Health Organization, 2020, COV ANN ADD DEALS AC; World Health Organization, 2020, DIS OUTBREAK NE 0208; Zhang WJ, 2021, JAMA-J AM MED ASSOC, V325, P1324, DOI 10.1001/jama.2021.1612	26	16	16	9	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2021	397	10278					947	950		10.1016/S0140-6736(21)00388-3	http://dx.doi.org/10.1016/S0140-6736(21)00388-3		MAR 2021	5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QV2NT	33587888	Bronze, Green Published			2022-12-28	WOS:000627814200006
J	Hawkins, MB; Henke, K; Harris, MP				Hawkins, M. Brent; Henke, Katrin; Harris, Matthew P.			Latent developmental potential to form limb-like skeletal structures in zebrafish	CELL			English	Article								Changes in appendage structure underlie key transitions in vertebrate evolution. Addition of skeletal elements along the proximal-distal axis facilitated critical transformations, including the fin-to-limb transition that permitted generation of diverse modes of locomotion. Here, we identify zebrafish mutants that form supernumerary long bones in their pectoral fins. These new bones integrate into musculature, form joints, and articulate with neighboring elements. This phenotype is caused by activating mutations in previously unrecognized regulators of appendage patterning, vav2 and waslb, that function in a common pathway. This pathway is required for appendage development across vertebrates, and loss of Wasl in mice causes defects similar to those seen in murine Hox mutants. Concordantly, formation of supernumerary bones requires Hox11 function, and mutations in the vav2/wasl pathway drive enhanced expression of hoxa11b, indicating developmental homology with the forearm. Our findings reveal a latent, limb-like pattern ability in fins that is activated by simple genetic perturbation.	[Hawkins, M. Brent; Henke, Katrin; Harris, Matthew P.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Hawkins, M. Brent; Henke, Katrin; Harris, Matthew P.] Boston Childrens Hosp, Dept Orthoped Res, Boston, MA 02115 USA; [Hawkins, M. Brent] Harvard Univ, Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Hawkins, M. Brent] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard University	Harris, MP (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Harris, MP (corresponding author), Boston Childrens Hosp, Dept Orthoped Res, Boston, MA 02115 USA.	harris@genetics.med.harvard.edu	Henke, Katrin/W-5033-2019	Henke, Katrin/0000-0002-1282-3616; Harris, Matthew/0000-0002-7201-4693; Hawkins, Michael/0000-0002-5164-2893	NSF DDIG [DEB-1600920]; Children's Orthopedic Research Foundation	NSF DDIG(National Science Foundation (NSF)); Children's Orthopedic Research Foundation	We thank J. Lopes and M. Warman (Boston Children's Hospital, BCH) for assistance in mouse husbandry, N. Shubin (University of Chicago, UC) for providing hox13 zebrafish mutants, S. Snapper (BCH) for sharing the Wasl conditional mouse, S. Mackem (National Institutes of Health) for sharing the Hoxb6-Cre line, and O. Pourquie and J. Rao (Harvard Medical School and Brigham and Women's Hospital) for providing the T-Cre line. We also thank Drs. R. Dahn, S. Donoughe, and J. Hanken for their comments on early drafts of the manuscript. This study was supported by NSF DDIG DEB-1600920 to M.B.H. and the Children's Orthopedic Research Foundation.	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Ahn D, 2008, DEV BIOL, V322, P220, DOI 10.1016/j.ydbio.2008.06.032; Arratia Gloria, 1999, P265; Askary A, 2016, ELIFE, V5, DOI 10.7554/eLife.16415; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Betancur-R R, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0958-3; Boulet AM, 2004, DEVELOPMENT, V131, P299, DOI 10.1242/dev.00936; Bowen ME, 2012, GENETICS, V190, P1017, DOI 10.1534/genetics.111.136069; Bustelo Xose R, 2014, Small GTPases, V5, P9, DOI 10.4161/21541248.2014.973757; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Carlier MF, 1999, CHEM BIOL, V6, pR235, DOI 10.1016/S1074-5521(99)80107-0; COATES MI, 1994, DEVELOPMENT, P169; Cotta-de-Almeida V, 2007, P NATL ACAD SCI USA, V104, P15424, DOI 10.1073/pnas.0706881104; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; Davis MC, 2004, J MORPHOL, V262, P608, DOI 10.1002/jmor.10264; Dewit J, 2011, J EXP ZOOL PART B, V316B, P584, DOI 10.1002/jez.b.21433; Diogo R., 2018, MUSCLES CHORDATES DE, p664 PP; Duboule D, 1991, CURR OPIN GENET DEV, V1, P211, DOI 10.1016/S0959-437X(05)80072-3; Ferrai C, 2009, MOL BIOL CELL, V20, P3543, DOI 10.1091/mbc.E09-02-0114; Freitas R, 2012, DEV CELL, V23, P1219, DOI 10.1016/j.devcel.2012.10.015; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gegenbaur C., 1865, UNTERSUCHUNGEN VERGL, V2; Gegenbaur C., 1878, ELEMENTS COMP ANATOM; Grandel H, 2003, THEOR BIOSCI, V122, P288, DOI 10.1007/s12064-003-0058-3; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; HAACK H, 1993, DEV BIOL, V157, P410, DOI 10.1006/dbio.1993.1145; Haffter P, 1996, DEV GENES EVOL, V206, P260, DOI 10.1007/s004270050051; Haines RW, 1942, BIOL REV CAMB PHILOS, V17, P267, DOI 10.1111/j.1469-185X.1942.tb00440.x; Hall B. K., 2015, BONES CARTILAGE DEV; Hammond-Weinberger DR, 2020, JOVE-J VIS EXP, DOI 10.3791/60575; Henke K, 2017, GENETICS, V207, P609, DOI 10.1534/genetics.117.300187; Heronimus C., 1911, ANAT ANZEIGER, V34, P193; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; JESSEN H L, 1972, Fossils and Strata, P1; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Khan IM, 2007, CURR TOP DEV BIOL, V79, P1, DOI 10.1016/S0070-2153(06)79001-9; Kherdjemil Y, 2016, NATURE, V539, P89, DOI 10.1038/nature19813; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kuroda J, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.580520; Labun K, 2019, NUCLEIC ACIDS RES, V47, pW171, DOI 10.1093/nar/gkz365; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lalonde RL, 2016, DEV BIOL, V417, P91, DOI 10.1016/j.ydbio.2016.05.019; Lalonde RL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192500; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Lowe LA, 2000, GENESIS, V26, P118, DOI 10.1002/(SICI)1526-968X(200002)26:2<118::AID-GENE5>3.0.CO;2-S; Lufkin Thomas, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4823; Martin WM, 2009, DEV DYNAM, V238, P3126, DOI 10.1002/dvdy.22164; Masselink W, 2016, NATURE, V535, P542, DOI 10.1038/nature18953; Masuya H, 2007, HUM MOL GENET, V16, P2366, DOI 10.1093/hmg/ddm195; Metscher BD, 2005, EVOL DEV, V7, P186, DOI 10.1111/j.1525-142X.2005.05021.x; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nakamura T, 2016, NATURE, V537, P225, DOI 10.1038/nature19322; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Owen Richard., 1849, NATURE LIMBS DISCOUR; Panza P, 2015, DEVELOPMENT, V142, P1879, DOI 10.1242/dev.118943; Pardo JD, 2017, NATURE, V546, P642, DOI 10.1038/nature22966; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Pineault KM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11100-4; R Core Team, 2020, R LANG ENV STAT COMP; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; SMALL KM, 1993, GENE DEV, V7, P2318, DOI 10.1101/gad.7.12a.2318; Smith A, 2008, DEV DYNAM, V237, P417, DOI 10.1002/dvdy.21417; Snapper SB, 1999, ANNU REV IMMUNOL, V17, P905, DOI 10.1146/annurev.immunol.17.1.905; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Sordino P, 1996, MECH DEVELOP, V59, P165, DOI 10.1016/0925-4773(96)00587-4; Starks E.C., 1930, PRIMARY SHOULDER GIR, V6; Suetsugu S, 2003, J BIOL CHEM, V278, P42515, DOI 10.1074/jbc.M302177200; Summerbell D., 1991, DEV PATTERNING VERTE; Swinehart IT, 2013, DEVELOPMENT, V140, P4574, DOI 10.1242/dev.096693; Thisse C, 2005, ZFIN DIRECT DATA SUB; Tschopp P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000398; Tulenko FJ, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2780; Tulenko FJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22720; vanEeden FJM, 1996, DEVELOPMENT, V123, P255; WINTERBOTTOM R, 1974, P ACAD NAT SCI PHILA, V125, P225; Woltering JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001773; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Yano T, 2012, DEVELOPMENT, V139, P2916, DOI 10.1242/dev.075572; YOKOUCHI Y, 1991, NATURE, V353, P443, DOI 10.1038/353443a0; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zhu M, 2009, BIOL LETTERS, V5, P372, DOI 10.1098/rsbl.2008.0784	92	15	15	8	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					899	+		10.1016/j.cell.2021.01.003	http://dx.doi.org/10.1016/j.cell.2021.01.003		FEB 2021	26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33545089	Green Submitted			2022-12-28	WOS:000629633400008
J	Zhuang, YW; Xu, PY; Mao, CY; Wang, L; Krumm, B; Zhou, XE; Huang, SJ; Liu, H; Cheng, X; Huang, XP; Shen, DD; Xu, TH; Liu, YF; Wang, Y; Guo, J; Jiang, Y; Jiang, HL; Melcher, K; Roth, BL; Zhang, Y; Zhang, C; Xu, HE				Zhuang, Youwen; Xu, Peiyu; Mao, Chunyou; Wang, Lei; Krumm, Brian; Zhou, X. Edward; Huang, Sijie; Liu, Heng; Cheng, Xi; Huang, Xi-Ping; Shen, Dan-Dan; Xu, Tinghai; Liu, Yong-Feng; Wang, Yue; Guo, Jia; Jiang, Yi; Jiang, Hualiang; Melcher, Karsten; Roth, Bryan L.; Zhang, Yan; Zhang, Cheng; Xu, H. Eric			Structural insights into the human D1 and D2 dopamine receptor signaling complexes	CELL			English	Article							AGONISTS; STABILIZATION; PHARMACOLOGY; SELECTIVITY; VALIDATION; REWARD; DRUGS	The D1- and D2-dopamine receptors (D1R and D2R), which signal through G(s) and G(i), respectively, represent the principal stimulatory and inhibitory dopamine receptors in the central nervous system. D1R and D2R also represent the main therapeutic targets for Parkinson's disease, schizophrenia, and many other neuropsychiatric disorders, and insight into their signaling is essential for understanding both therapeutic and side effects of dopaminergic drugs. Here, we report four cryoelectron microscopy (cryo-EM) structures of D1R-G(s) and D2R-G(i) signaling complexes with selective and non-selective dopamine agonists, including two currently used anti-Parkinson's disease drugs, apomorphine and bromocriptine. These structures, together with mutagenesis studies, reveal the conserved binding mode of dopamine agonists, the unique pocket topology underlying ligand selectivity, the conformational changes in receptor activation, and potential structural determinants for G protein-coupling selectivity. These results provide both a molecular understanding of dopamine signaling and multiple structural templates for drug design targeting the dopaminergic system.	[Zhuang, Youwen; Xu, Peiyu; Huang, Sijie; Cheng, Xi; Wang, Yue; Guo, Jia; Jiang, Yi; Jiang, Hualiang; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Zhuang, Youwen; Xu, Peiyu; Huang, Sijie; Wang, Yue; Guo, Jia; Jiang, Yi; Xu, H. Eric] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Xu, Peiyu; Mao, Chunyou; Shen, Dan-Dan; Zhang, Yan] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Biophys, Sch Med, Hangzhou 310058, Peoples R China; [Xu, Peiyu; Mao, Chunyou; Shen, Dan-Dan; Zhang, Yan] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Pathol, Sch Med, Hangzhou 310058, Peoples R China; [Mao, Chunyou; Shen, Dan-Dan; Zhang, Yan] Zhejiang Univ, Zhejiang Lab Syst & Precison Med, Med Ctr, Hangzhou 311121, Peoples R China; [Mao, Chunyou; Shen, Dan-Dan; Zhang, Yan] Zhejiang Univ, MOE Frontier Sci Ctr Brain Res & Brain Machine In, Sch Med, Hangzhou 310058, Peoples R China; [Wang, Lei; Liu, Heng; Zhang, Cheng] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Krumm, Brian; Huang, Xi-Ping; Liu, Yong-Feng; Roth, Bryan L.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Zhou, X. Edward; Xu, Tinghai; Melcher, Karsten] Van Andel Res Inst, Ctr Canc & Cell Biol, Program Struct Biol, Grand Rapids, MI USA; [Huang, Sijie; Xu, H. Eric] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Cheng, Xi; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Zhang, Yan] Zhejiang Prov Key Lab Immun & Inflammatory Dis, Hangzhou 310058, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; Van Andel Institute; ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Xu, HE (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China.; Xu, HE (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Zhang, Y (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Biophys, Sch Med, Hangzhou 310058, Peoples R China.; Zhang, Y (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Pathol, Sch Med, Hangzhou 310058, Peoples R China.; Zhang, Y (corresponding author), Zhejiang Univ, Zhejiang Lab Syst & Precison Med, Med Ctr, Hangzhou 311121, Peoples R China.; Zhang, Y (corresponding author), Zhejiang Univ, MOE Frontier Sci Ctr Brain Res & Brain Machine In, Sch Med, Hangzhou 310058, Peoples R China.; Zhang, C (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA.; Roth, BL (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.; Xu, HE (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.; Zhang, Y (corresponding author), Zhejiang Prov Key Lab Immun & Inflammatory Dis, Hangzhou 310058, Peoples R China.	bryan_roth@med.unc.edu; zhang_yan@zju.edu.cn; chengzh@pitt.edu; eric.xu@simm.ac.cn	Melcher, Karsten/AAZ-3861-2020; Liu, Yongfeng/ABA-8335-2021; Xu, H. Eric/ABD-7487-2021; Wang, Lei/AAA-1917-2020; Liu, Yongfeng/ABG-1361-2020; Zhang, Yan/V-8007-2019; Roth, Bryan L/F-3928-2010	Melcher, Karsten/0000-0002-9125-4027; Liu, Yongfeng/0000-0003-3583-8092; Wang, Lei/0000-0002-3024-8627; Liu, Yongfeng/0000-0002-8649-7892; Zhang, Yan/0000-0003-2189-0244; Cheng, Xi/0000-0003-3081-3750; Xu, Peiyu/0000-0003-3590-4037; Zhuang, Youwen/0000-0002-1380-8047; Mao, Chunyou/0000-0001-5349-8592; Xu, H. Eric/0000-0002-6829-8144; Xu, Tinghai/0000-0003-2239-1420	National Key R&D Programs of China [2018YFA0507002, 2019YFA0508800]; Shanghai Municipal Science and Technology Major Projects [2019SHZDZX02]; CAS Strategic Priority Research Program [XDB37030103]; National Natural Science Foundation of China [81922071, 31770796]; Zhejiang Province Natural Science Fund for Excellent Young Scholars [LR19H310001]; Fundamental Research Funds for the Central Universities [2019XZZX001-01-06]; Science and Technology Commission of Shanghai Municipality [20431900100]; Jack Ma Foundation [2020-CMKYGG-05]; National Science and Technology Major Projects [2018ZX09711002-002-002]; NIMH (Psychoactive Drug Screening Program) [RO1MH112205]; NIH [R35GM128641]	National Key R&D Programs of China; Shanghai Municipal Science and Technology Major Projects; CAS Strategic Priority Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Natural Science Fund for Excellent Young Scholars; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Jack Ma Foundation; National Science and Technology Major Projects; NIMH (Psychoactive Drug Screening Program)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The cryo-EM data were collected at the Center of Cryo-Electron Microscopy, Zhejiang University, and at the Center of Cryo-Electron Microscopy, Shanghai Institute of Materia Medica. This work was partially supported by the National Key R&D Programs of China (2018YFA0507002 to H.E.X., 2019YFA0508800 to Y. Zhang), Shanghai Municipal Science and Technology Major Projects (2019SHZDZX02 to H.E.X.), CAS Strategic Priority Research Program (XDB37030103 to H.E.X.), the National Natural Science Foundation of China (81922071 to Y. Zhang), Zhejiang Province Natural Science Fund for Excellent Young Scholars (LR19H310001 to Y. Zhang), the Fundamental Research Funds for the Central Universities (2019XZZX001-01-06 to Y. Zhang), the Science and Technology Commission of Shanghai Municipality (20431900100 to H.J.), the Jack Ma Foundation (2020-CMKYGG-05 to H.J.), the National Natural Science Foundation of China (31770796 to Y.J.), the National Science and Technology Major Projects (2018ZX09711002-002-002 to Y.J.), NIMH (Psychoactive Drug Screening Program to X.-P.H., L.Y., and B.L.R. and RO1MH112205 to B.K. and B.L.R.), and NIH (R35GM128641 to C.Z.).	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANDERSEN PH, 1990, EUR J PHARM-MOLEC PH, V188, P335, DOI 10.1016/0922-4106(90)90194-3; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Beninger RJ, 1998, NEUROSCI BIOBEHAV R, V22, P335, DOI 10.1016/S0149-7634(97)00019-5; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Butini S, 2016, PROG NEUROBIOL, V142, P68, DOI 10.1016/j.pneurobio.2016.03.011; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Conroy JL, 2015, ACS CHEM NEUROSCI, V6, P681, DOI 10.1021/acschemneuro.5b00020; DEKEYSER J, 1995, PROG NEURO-PSYCHOPH, V19, P1147, DOI 10.1016/0278-5846(95)00232-4; Di Chiara G, 1978, Adv Pharmacol Chemother, V15, P87, DOI 10.1016/S1054-3589(08)60482-2; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan Luyu, 2020, Nat Commun, V11, P1074, DOI 10.1038/s41467-020-14884-y; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; Hall A, 2019, J MED CHEM, V62, P128, DOI 10.1021/acs.jmedchem.8b01767; Heymann JB, 2018, PROTEIN SCI, V27, P159, DOI 10.1002/pro.3293; Kang YY, 2018, NATURE, V558, P553, DOI 10.1038/s41586-018-0215-y; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Kostrzewa RM, 2018, J PHARMACOL EXP THER, V366, P519, DOI 10.1124/jpet.118.247981; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Lanau F, 1997, J NEUROCHEM, V68, P804; Lee SM, 2014, NEUROPHARMACOLOGY, V86, P145, DOI 10.1016/j.neuropharm.2014.05.042; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Liang YL, 2018, ACS PHARMACOL TRANSL, V1, P12, DOI 10.1021/acsptsci.8b00017; Liu P, 2016, ACTA PHARMACOL SIN, V37, P1259, DOI 10.1038/aps.2016.69; Liu W, 2013, SCIENCE, V342, P1521, DOI 10.1126/science.1244142; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Masureel M, 2018, NAT CHEM BIOL, V14, P1059, DOI 10.1038/s41589-018-0145-x; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; Neumeyer JL, 2003, EUR J PHARMACOL, V474, P137, DOI 10.1016/S0014-2999(03)02008-9; PARKES JD, 1976, J NEUROL NEUROSUR PS, V39, P184, DOI 10.1136/jnnp.39.2.184; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reichmann H, 2006, J NEUROL, V253, P36, DOI 10.1007/s00415-006-4009-z; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Sanchez-Garcia R., 2020, DEEPEMHANCER DEEP LE, DOI [10.1101/2020.06.12, DOI 10.1101/2020.06.12]; Sanchez-Soto Marta, 2016, Mol Pharmacol, V89, P457, DOI 10.1124/mol.115.101808; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Vass M, 2019, J MED CHEM, V62, P3784, DOI 10.1021/acs.jmedchem.8b00836; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Volkow ND, 2015, CELL, V162, P712, DOI 10.1016/j.cell.2015.07.046; Wang S, 2018, NATURE, V555, P269, DOI 10.1038/nature25758; Wang S, 2017, SCIENCE, V358, P381, DOI 10.1126/science.aan5468; Xiao P., 2021, CELL, V184; Xing CR, 2020, CELL, V180, P645, DOI 10.1016/j.cell.2020.01.007; Yin J, 2020, NATURE, V584, P125, DOI 10.1038/s41586-020-2379-5; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhuang YW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14728-9; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	61	48	49	17	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					931	+		10.1016/j.cell.2021.01.027	http://dx.doi.org/10.1016/j.cell.2021.01.027		FEB 2021	30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33571431	Green Accepted			2022-12-28	WOS:000629633400010
J	Wise, J				Wise, Jacqui			Covid-19: Extra 1.7 million people in England are asked to shield	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ayoubkhani D., 2021, UPDATED ESTIMATES CO; Clift AK, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3731; Department of Health and Social Care, 2021, GUID SHIELD PROT PEO	3	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2021	372								n467	10.1136/bmj.n467	http://dx.doi.org/10.1136/bmj.n467			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK7TO	33597119	Bronze			2022-12-28	WOS:000620584600002
J	Lu, Y; Kwaan, MR; Lin, AY				Lu, Yang; Kwaan, Mary R.; Lin, Anne Y.			Diagnosis and Treatment of Anal Fissures in 2021	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MANAGEMENT; GUIDELINE	This JAMA Insights Clinical Update reviews the diagnosis and management of anal fissures, including use of supportive, topical, injection, and surgical treatment options.	[Lu, Yang] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Kwaan, Mary R.; Lin, Anne Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Div Colorectal Surg, 10833 Le Conte Ave,72-227 CHS, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lin, AY (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Div Colorectal Surg, 10833 Le Conte Ave,72-227 CHS, Los Angeles, CA 90095 USA.	aylin@mednet.ucla.edu						Boland PA, 2020, INT J COLORECTAL DIS, V35, P1807, DOI 10.1007/s00384-020-03699-4; Ebinger SM, 2017, J GASTROENTEROL, V52, P663, DOI 10.1007/s00535-017-1335-0; Idrees JJ, 2019, DIS COLON RECTUM, V62, P867, DOI 10.1097/DCR.0000000000001315; Jenkins JT, 2008, COLORECTAL DIS, V10, P280, DOI 10.1111/j.1463-1318.2007.01335.x; Madalinski Mariusz H, 2011, World J Gastrointest Pharmacol Ther, V2, P9, DOI 10.4292/wjgpt.v2.i2.9; Mapel DW, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-129; Nelson RL, 2017, TECH COLOPROCTOL, V21, P605, DOI 10.1007/s10151-017-1664-2; Nelson RL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003431.pub3; Stewart DB, 2017, DIS COLON RECTUM, V60, P7, DOI 10.1097/DCR.0000000000000735; Wald A, 2014, AM J GASTROENTEROL, V109, P1141, DOI 10.1038/ajg.2014.190	10	2	2	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2021	325	7					688	689		10.1001/jama.2020.16705	http://dx.doi.org/10.1001/jama.2020.16705			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ3QZ	33591336				2022-12-28	WOS:000619608000021
J	Goff, PA				Goff, Phillip Atiba			Asking the right questions about race and policing	SCIENCE			English	Editorial Material							BIAS		[Goff, Phillip Atiba] Yale Univ, Dept African Amer Studies, New Haven, CT 06520 USA; [Goff, Phillip Atiba] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Goff, Phillip Atiba] Ctr Policing Equ, Los Angeles, CA 90067 USA	Yale University; Yale University	Goff, PA (corresponding author), Yale Univ, Dept African Amer Studies, New Haven, CT 06520 USA.; Goff, PA (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.; Goff, PA (corresponding author), Ctr Policing Equ, Los Angeles, CA 90067 USA.	phillip.goff@yale.edu						Asher J., 2020, NEW YORK TIMES; Ba BA, 2021, SCIENCE, V371, P696, DOI 10.1126/science.abd8694; Clarke R. V. G., 1980, EFFECTIVENESS POLICI, P1; Crabtree S., 2020, GALLUP; Davis AY., 2011, ABOLITION DEMOCRACY; Du Bois W. E.B., 2017, BLACK RECONSTRUCTION; Goff P.A., 2016, SCI JUSTICE RACE ARR; Goff PA, 2012, SOC ISS POLICY REV, V6, P177, DOI 10.1111/j.1751-2409.2011.01039.x; Gramlich J, 2020, WHAT DATA SAYS DOESN; National Academies of Sciences, 2018, ENG MED PROACT POL E; National Research Council, 2004, FAIRNESS EFFECTIVENE; Sim JJ, 2013, PERS SOC PSYCHOL B, V39, P291, DOI 10.1177/0146167212473157; Sullivan Sean, 2020, WASHINGTON POST; Wood G, 2020, P NATL ACAD SCI USA, V117, P9815, DOI 10.1073/pnas.1920671117	14	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					677	678		10.1126/science.abf4518	http://dx.doi.org/10.1126/science.abf4518			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4IS	33574200				2022-12-28	WOS:000617551600026
J	Gertler, JM; Baker, B; Li, JL; Shirol, S; Koch, J; Wang, C				Gertler, Jeffrey M.; Baker, Brian; Li, Juliang; Shirol, Shruti; Koch, Jens; Wang, Chen			Protecting a bosonic qubit with autonomous quantum error correction	NATURE			English	Article								To build a universal quantum computer from fragile physical qubits, effective implementation of quantum error correction (QEC)(1) is an essential requirement and a central challenge. Existing demonstrations of QEC are based on an active schedule of error-syndrome measurements and adaptive recovery operations(2,3,4,5,6,7) that are hardware intensive and prone to introducing and propagating errors. In principle, QEC can be realized autonomously and continuously by tailoring dissipation within the quantum system(1,8,9,10,11,12,13,14), but so far it has remained challenging to achieve the specific form of dissipation required to counter the most prominent errors in a physical platform. Here we encode a logical qubit in Schrodinger cat-like multiphoton states(15) of a superconducting cavity, and demonstrate a corrective dissipation process that stabilizes an error-syndrome operator: the photon number parity. Implemented with continuous-wave control fields only, this passive protocol protects the quantum information by autonomously correcting single-photon-loss errors and boosts the coherence time of the bosonic qubit by over a factor of two. Notably, QEC is realized in a modest hardware setup with neither high-fidelity readout nor fast digital feedback, in contrast to the technological sophistication required for prior QEC demonstrations. Compatible with additional phase-stabilization and fault-tolerant techniques(16,17,18), our experiment suggests quantum dissipation engineering as a resource-efficient alternative or supplement to active QEC in future quantum computing architectures. A logical qubit encoded in multi-photon states of a superconducting cavity is protected with autonomous correction of certain quantum errors by tailoring the dissipation it is exposed to.	[Gertler, Jeffrey M.; Li, Juliang; Shirol, Shruti; Wang, Chen] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Baker, Brian; Koch, Jens] Northwestern Univ, Dept Phys & Astron, Evanston, IL USA	University of Massachusetts System; University of Massachusetts Amherst; Northwestern University	Wang, C (corresponding author), Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA.	wangc@umass.edu	Koch, Jens/G-6789-2011; Koch, Jens/GVT-0089-2022	Koch, Jens/0000-0002-5047-631X; Koch, Jens/0000-0002-5047-631X; Wang, Chen/0000-0003-4488-7056				Ahn C, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.042301; Albert VV, 2019, QUANTUM SCI TECHNOL, V4, DOI 10.1088/2058-9565/ab1e69; Andersen CK, 2020, NAT PHYS, V16, P875, DOI 10.1038/s41567-020-0920-y; Atalaya J, 2020, CONTINUOUS QUANTUM E; Axline C., 2016, APPL PHYS LETT, V109, P042601; Barreiro JT, 2011, NATURE, V470, P486, DOI 10.1038/nature09801; Brown BJ, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.045005; Brune M, 1996, PHYS REV LETT, V77, P4887, DOI 10.1103/PhysRevLett.77.4887; CAHILL KE, 1969, PHYS REV, V177, P1882, DOI 10.1103/PhysRev.177.1882; Chuang IL, 1997, PHYS REV A, V56, P1114, DOI 10.1103/PhysRevA.56.1114; Cohen J, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.060503; Cramer J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11526; Doucot B, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/7/072001; Glaser SJ, 2015, EUR PHYS J D, V69, DOI 10.1140/epjd/e2015-60464-1; Gollub C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.073002; Grimm A, 2020, NATURE, V584, P205, DOI 10.1038/s41586-020-2587-z; Grimsmo AL, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.011058; Gyenis A, 2019, EXPT REALIZATION INT; Heeres RW, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00045-1; Hu L, 2019, NAT PHYS, V15, P503, DOI 10.1038/s41567-018-0414-3; Kapit E, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.150501; Kelly J, 2015, NATURE, V519, P66, DOI 10.1038/nature14270; Kerckhoff J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.040502; Kienzler D, 2015, SCIENCE, V347, P53, DOI 10.1126/science.1261033; Kirchmair G, 2013, NATURE, V495, P205, DOI 10.1038/nature11902; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Krauter H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.080503; Leghtas Z, 2015, SCIENCE, V347, P853, DOI 10.1126/science.aaa2085; Leghtas Z, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.120501; Lescanne R, 2020, NAT PHYS, V16, P509, DOI 10.1038/s41567-020-0824-x; Lihm JM, 2018, PHYS REV A, V98, DOI 10.1103/PhysRevA.98.012317; Ma WL, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.110503; Ma Y, 2020, NAT PHYS, V16, P827, DOI 10.1038/s41567-020-0893-x; Macklin C, 2015, SCIENCE, V350, P307, DOI 10.1126/science.aaa8525; Mundhada SO, 2019, PHYS REV APPL, V12, DOI 10.1103/PhysRevApplied.12.054051; Nigg SE, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.240502; Ofek N, 2016, NATURE, V536, P441, DOI 10.1038/nature18949; Peterer MJ, 2015, PHYS REV LETT, V114, P240501; Pinotsi D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093603; Poyatos JF, 1996, PHYS REV LETT, V77, P4728, DOI 10.1103/PhysRevLett.77.4728; Reagor M, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.014506; Reinhold P, 2020, NAT PHYS, V16, P822, DOI 10.1038/s41567-020-0931-8; Reiter F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01895-5; Sarovar M, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.012306; Schindler P, 2011, SCIENCE, V332, P1059, DOI 10.1126/science.1203329; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Serniak K, 2019, PHYS REV APPL, V12, DOI 10.1103/PhysRevApplied.12.014052; Sun L, 2014, NATURE, V511, P444, DOI 10.1038/nature13436; Susskind L., 1964, PHYSICS LONG ISLAND, V1, P49; Terhal BM, 2020, QUANTUM SCI TECHNOL, V5, DOI 10.1088/2058-9565/ab98a5; Vlastakis B, 2013, SCIENCE, V342, P607, DOI 10.1126/science.1243289; Wang C, 2016, SCIENCE, V352, P1087, DOI 10.1126/science.aaf2941; Werschnik J, 2007, J PHYS B-AT MOL OPT, V40, pR175, DOI 10.1088/0953-4075/40/18/R01	59	33	33	6	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2021	590	7845								10.1038/s41586-021-03257-0	http://dx.doi.org/10.1038/s41586-021-03257-0			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG0TV	33568826	Green Submitted			2022-12-28	WOS:000617300400012
J	Bateman, BT; Hernandez-Diaz, S; Straub, L; Zhu, YM; Gray, KJ; Desai, RJ; Mogun, H; Gautam, N; Huybrechts, KF				Bateman, Brian T.; Hernandez-Diaz, Sonia; Straub, Loreen; Zhu, Yanmin; Gray, Kathryn J.; Desai, Rishi J.; Mogun, Helen; Gautam, Nileesa; Huybrechts, Krista F.			Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIDEPRESSANT USE; PREGNANCY; RISK; ADJUSTMENT; MEDICAID; WOMEN; VALIDATION; EXPOSURE; CLAIMS; CARE	OBJECTIVE To evaluate the risk of first trimester exposure to prescription opioids for major congenital malformations, previously reported to be associated with such exposure. DESIGN Population based cohort study. SETTING Nationwide sample of publicly and commercially insured pregnant women linked to their liveborn infants, nested in the Medicaid Analytic eXtract (MAX, 2000-14) and the MarketScan Research Database (MarketScan, 2003-15). PARTICIPANTS 1 602 580 publicly insured (MAX) and 1 177 676 commercially insured (MarketScan) pregnant women with eligibility from at least three months before pregnancy to one month after delivery; infants with eligibility for at least three months after birth. INTERVENTIONS Use of prescription opioids was ascertained by requiring two or more dispensations of any opioid during the first trimester. MAIN OUTCOMES MEASURES Major malformations overall, cardiac malformations overall, ventricular septal defect, secund um atrial septal defect/patent foramen ovale, neural tube defect, clubfoot, and oral cleft, defined based on validated algorithms. Propensity score stratification was used to adjust for potential confounders and/or proxies for confounders. Estimates from each database were combined using meta-analysis. RESULTS 70 447 (4.4%) of 1 602 580 publicly insured and 12 454 (1.1%) of 1 177 676 commercially insured pregnant women had two or more dispensations of an opioid during the first trimester. Absolute risk of malformations overall was 41.0 (95% confidence interval 39.5 to 42.5) per 1000 pregnancies exposed to opioids versus 32.0 (31.7 to 32.3) per 1000 unexposed pregnancies in the MAX cohort, and 42.6 (39.0 to 46.1) and 37.3 (37.0 to 37.7) per 1000, respectively, in the MarketScan cohort. Pooled unadjusted relative risk estimates were raised for all outcomes but shifted substantially toward the null after adjustment; for malformations overall (relative risk 1.06, 95% confidence interval 1.02 to 1.10), cardiovascular malformations (1.09, 1.00 to 1.18), ventricular septal defect (1.07, 0.95 to 1.21), atrial septal defect/patent foramen ovale (1.04, 0.88 to 1.24), neural tube defect (0.82, 0.53 to 1.27), and clubfoot (1.06, 0.88 to 1.28). The relative risk for oral clefts remained raised after adjustment (1.21, 0.98 to 1.50), with a higher risk of cleft palate (1.62, 1.23 to 2.14). CONCLUSIONS Prescription opioids used in early pregnancy are not associated with a substantial increase in risk for most of the malformation types considered, although a small increase in the risk of oral clefts associated with their use is possible.	[Bateman, Brian T.; Straub, Loreen; Zhu, Yanmin; Desai, Rishi J.; Mogun, Helen; Gautam, Nileesa; Huybrechts, Krista F.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA; [Bateman, Brian T.; Straub, Loreen; Zhu, Yanmin; Desai, Rishi J.; Mogun, Helen; Gautam, Nileesa; Huybrechts, Krista F.] Harvard Med Sch, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA; [Bateman, Brian T.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA; [Hernandez-Diaz, Sonia; Huybrechts, Krista F.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Gray, Kathryn J.] Brigham & Womens Hosp, Dept Obstet & Gynecol, Div Maternal Fetal Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Bateman, BT (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.; Bateman, BT (corresponding author), Harvard Med Sch, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.; Bateman, BT (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	bbateman@bwh.harvard.edu	Desai, Rishi/AAH-8988-2021		National Institute on Drug Abuse [R01-DA044293]	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grant R01-DA044293 from the National Institute on Drug Abuse. The funding source had no role in the study design; in the collection, analysis, and interpretation of the data; in the writing of the report; and in the decision to submit the article for publication.	Ailes EC, 2015, MMWR-MORBID MORTAL W, V64, pCOVER1; [Anonymous], 2013, OBSTET GYNECOL, V122, P957, DOI 10.1097/AOG.0b013e3182a603bb; Bateman BT, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1035; Bateman BT, 2014, ANESTHESIOLOGY, V120, P1216, DOI 10.1097/ALN.0000000000000172; Broussard CS, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.039; Casagrande D, 2015, J AM ACAD ORTHOP SUR, V23, P539, DOI 10.5435/JAAOS-D-14-00248; Centers for Disease Control and Prevention, 2020, OP US PREGN; Daw JR, 2012, CLIN THER, V34, P239, DOI 10.1016/j.clinthera.2011.11.025; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desai RJ, 2017, EPIDEMIOLOGY, V28, P249, DOI 10.1097/EDE.0000000000000595; Desai RJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2102; Desai RJ, 2014, OBSTET GYNECOL, V123, P997, DOI 10.1097/AOG.0000000000000208; Engeland A, 2018, PHARMACOEPIDEM DR S, V27, P995, DOI 10.1002/pds.4577; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Gallagher BK, 2016, MMWR-MORBID MORTAL W, V65, P415, DOI 10.15585/mmwr.mm6516a2; Handal M, 2011, EUR J CLIN PHARMACOL, V67, P953, DOI 10.1007/s00228-011-1030-7; Huybrechts KF, 2020, JAMA-J AM MED ASSOC, V323, P372, DOI 10.1001/jama.2019.18587; Huybrechts KF, 2018, JAMA-J AM MED ASSOC, V320, P2429, DOI 10.1001/jama.2018.18307; Huybrechts KF, 2016, JAMA PSYCHIAT, V73, P938, DOI 10.1001/jamapsychiatry.2016.1520; Huybrechts KF, 2015, JAMA-J AM MED ASSOC, V313, P2142, DOI 10.1001/jama.2015.5605; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; Irvine L, 2010, DRUG SAFETY, V33, P593, DOI 10.2165/11532330-000000000-00000; Lind JN, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4131; Metcalfe A, 2015, BJOG-INT J OBSTET GY, V122, P1748, DOI 10.1111/1471-0528.13254; Miller AM, 2019, WOMEN BIRTH, V32, pE272, DOI 10.1016/j.wombi.2018.06.013; Palmsten K, 2015, OBSTET GYNECOL, V126, P465, DOI 10.1097/AOG.0000000000000982; Palmsten K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067405; Patorno E, 2017, NEW ENGL J MED, V376, P2245, DOI 10.1056/NEJMoa1612222; Rough K, 2019, PHARMACOEPIDEM DR S, V28, P62, DOI 10.1002/pds.4443; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Sujan AC, 2019, PLOS MED, V16, DOI [10.1371/journal.pmed.1002980, 10.1371/journal.pmed.1002980.r001, 10.1371/journal.pmed.1002980.r002, 10.1371/journal.pmed.1002980.r003, 10.1371/journal.pmed.1002980.r004]; Svensson E, 2014, EPIDEMIOLOGY, V25, P866, DOI 10.1097/EDE.0000000000000163; Tudor CG, 2013, MEMORANDUM MED D; Zagon IS, 1999, BRAIN RES, V839, P313, DOI 10.1016/S0006-8993(99)01753-9	35	11	13	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2021	372								n102	10.1136/bmj.n102	http://dx.doi.org/10.1136/bmj.n102			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH9VF	33568363	Green Published, hybrid			2022-12-28	WOS:000618622900006
J	Dusetzina, SB				Dusetzina, Stacie B.			Cancer Care Under the Biden Administration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint evaluates Biden's health care proposals to help reduce the cost burden on patients with cancer should they be enacted legislatively.	[Dusetzina, Stacie B.] Vanderbilt Univ, Sch Med, Dept Hlth Policy, 2525 W End Ave,Ste 1203, Nashville, TN 37212 USA; [Dusetzina, Stacie B.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Dusetzina, SB (corresponding author), Vanderbilt Univ, Sch Med, Dept Hlth Policy, 2525 W End Ave,Ste 1203, Nashville, TN 37212 USA.	s.dusetzina@vanderbilt.edu						[Anonymous], HLTH CARE; Centers for Disease Control and Prevention, HLTH EC COSTS CHRONI; Cha A., 2020, REASONS BEING UNINSU; Dusetzina SB, 2019, JAMA-J AM MED ASSOC, V321, P2025, DOI 10.1001/jama.2019.4492; GARFIELD R, 2020, COVERAGE GAP UNINSUR; Keith, 2020, HLTH AFFAIRS BLOG, DOI 10.1377/hblog20201030.291472/full/; Ladanie A, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.24406; Mariotto AB, 2020, CANCER EPIDEM BIOMAR, V29, P1304, DOI 10.1158/1055-9965.EPI-19-1534; National Cancer Institute, CANC STAT	9	1	1	3	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2021	325	6					527	528		10.1001/jama.2020.25424	http://dx.doi.org/10.1001/jama.2020.25424			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG0MD	33560329				2022-12-28	WOS:000617279600010
J	Stokel-Walker, C				Stokel-Walker, Chris			Covid-19: Why test and trace will fail without support for self-isolation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stokel@gmail.com						Pagel C., 2021, BMJ OPINION; Yeung Jessie, 2021, THE CNN	2	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2021	372								n327	10.1136/bmj.n327	http://dx.doi.org/10.1136/bmj.n327			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC1TT	33558221	Bronze			2022-12-28	WOS:000686317500001
J	Ahmad, K; Vashista, G				Ahmad, Kashif; Vashista, Girish			A wrist injury	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISLOCATIONS		[Ahmad, Kashif] Liverpool Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Vashista, Girish] Doncaster Royal Infirm, Doncaster, England		Ahmad, K (corresponding author), Liverpool Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England.	K.Ahmad@doctors.org.uk		Ahmad, Kashif/0000-0003-0784-150X				Goodman AD, 2019, ORTHOPEDICS, V42, pE1, DOI 10.3928/01477447-20181102-05; Karadsheh M., 2020, LUNATE DISLOCATION P; MAYFIELD JK, 1980, J HAND SURG-AM, V5, P226, DOI 10.1016/S0363-5023(80)80007-4; Muppavarapu RC, 2015, HAND CLIN, V31, P399, DOI 10.1016/j.hcl.2015.04.002; Newberry Jennifer A, 2012, Perm J, V16, P70; Perron AD, 2001, AM J EMERG MED, V19, P157, DOI 10.1053/ajem.2001.21306; Stanbury SJ, 2011, J AM ACAD ORTHOP SUR, V19, P554, DOI 10.5435/00124635-201109000-00006	7	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2021	372								n101	10.1136/bmj.n101	http://dx.doi.org/10.1136/bmj.n101			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH2PI	33547054				2022-12-28	WOS:000618119100021
J	Sternbach, AJ; Chae, SH; Latini, S; Rikhter, AA; Shao, Y; Li, B; Rhodes, D; Kim, B; Schuck, PJ; Xu, X; Zhu, XY; Averitt, RD; Hone, J; Fogler, MM; Rubio, A; Basov, DN				Sternbach, A. J.; Chae, S. H.; Latini, S.; Rikhter, A. A.; Shao, Y.; Li, B.; Rhodes, D.; Kim, B.; Schuck, P. J.; Xu, X.; Zhu, X-Y; Averitt, R. D.; Hone, J.; Fogler, M. M.; Rubio, A.; Basov, D. N.			Programmable hyperbolic polaritons in van der Waals semiconductors	SCIENCE			English	Article								Collective electronic modes or lattice vibrations usually prohibit propagation of electromagnetic radiation through the bulk of common materials over a frequency range associated with these oscillations. However, this textbook tenet does not necessarily apply to layered crystals. Highly anisotropic materials often display nonintuitive optical properties and can permit propagation of subdiffractional waveguide modes, with hyperbolic dispersion, throughout their bulk. Here, we report on the observation of optically induced electronic hyperbolicity in the layered transition metal dichalcogenide tungsten diselenide (WSe2). We used photoexcitation to inject electron-hole pairs in WSe2 and then visualized, by transient nanoimaging, the hyperbolic rays that traveled along conical trajectories inside of the crystal. We establish here the signatures of programmable hyperbolic electrodynamics and assess the role of quantum transitions of excitons within the Rydberg series in the observed polaritonic response.	[Sternbach, A. J.; Shao, Y.; Basov, D. N.] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Chae, S. H.; Li, B.; Rhodes, D.; Kim, B.; Schuck, P. J.; Hone, J.] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Latini, S.; Rubio, A.] Max Planck Inst Struct & Dynam Matter, D-22761 Hamburg, Germany; [Rikhter, A. A.; Averitt, R. D.; Fogler, M. M.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Xu, X.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Zhu, X-Y] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Rubio, A.] Flatiron Inst, Ctr Computat Quantum Phys CCQ, New York, NY 10010 USA; [Rhodes, D.] Univ Wisconsin, Mat Sci & Engn, Madison, WI 53706 USA	Columbia University; Columbia University; Max Planck Society; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; Columbia University; University of Wisconsin System; University of Wisconsin Madison	Sternbach, AJ (corresponding author), Columbia Univ, Dept Phys, New York, NY 10027 USA.	as5049@columbia.edu	Rubio, Angel/A-5507-2008; Averitt, Richard/AAX-4178-2021; Chae, Sang Hoon/AAN-1534-2020; Hone, James C/E-1879-2011; Li, Baichang/AAY-1969-2021	Rubio, Angel/0000-0003-2060-3151; Hone, James C/0000-0002-8084-3301; Li, Baichang/0000-0002-2345-6735; Latini, Dr. Simone/0000-0001-9553-5259; Chae, Sang Hoon/0000-0002-9612-5371; Rikhter, Andrey/0000-0002-1602-9452; Schuck, Peter James/0000-0001-9244-2671; Sternbach, Aaron/0000-0002-9464-889X	Programmable Quantum Materials, an Energy Frontier Research Center - U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) [DE-SC0019443]; Moore Investigator in Quantum Materials EPIQS [9455]; Vannevar Bush Faculty Fellowship [N00014-19-1-2630]; European Research Council [ERC-2015-AdG694097]; Cluster of Excellence "Advanced Imaging of Matter" (AIM); Flatiron Institute, a division of the Simons Foundation; Alexander von Humboldt foundation; National Research Foundation of Korea through the Global Research Laboratory (GRL) program [2016K1A1A2912707]; NSF MRSEC Program through Columbia in the Center for PrecisionAssembled Quantum Materials [DMR-2011738]	Programmable Quantum Materials, an Energy Frontier Research Center - U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES)(United States Department of Energy (DOE)); Moore Investigator in Quantum Materials EPIQS; Vannevar Bush Faculty Fellowship; European Research Council(European Research Council (ERC)European Commission); Cluster of Excellence "Advanced Imaging of Matter" (AIM); Flatiron Institute, a division of the Simons Foundation; Alexander von Humboldt foundation(Alexander von Humboldt Foundation); National Research Foundation of Korea through the Global Research Laboratory (GRL) program; NSF MRSEC Program through Columbia in the Center for PrecisionAssembled Quantum Materials	This work is supported as part of Programmable Quantum Materials, an Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES), under award no. DE-SC0019443. D.N.B. is a Moore Investigator in Quantum Materials EPIQS no. 9455. The development of pump-probe nanoscale optics at Columbia is supported by Vannevar Bush Faculty Fellowship no. N00014-19-1-2630. We acknowledge support from the European Research Council (ERC-2015-AdG694097) and the Cluster of Excellence "Advanced Imaging of Matter" (AIM). Support by the Flatiron Institute, a division of the Simons Foundation, is acknowledged. S.L. acknowledges support from the Alexander von Humboldt foundation. S.H.C. and J.H. were supported by the National Research Foundation of Korea through the Global Research Laboratory (GRL) program (2016K1A1A2912707). Synthesis of WSe2 was supported by the NSF MRSEC Program through Columbia in the Center for PrecisionAssembled Quantum Materials (DMR-2011738). We acknowledge workshops and conferences at the Max Planck Institute -New York City Center for Non-Equilibrium Quantum Phenomena for providing forum for discussions.	Andersen K, 2015, NANO LETT, V15, P4616, DOI 10.1021/acs.nanolett.5b01251; Andrade X, 2015, PHYS CHEM CHEM PHYS, V17, P31371, DOI 10.1039/c5cp00351b; Basov DN, 2021, NANOPHOTONICS-BERLIN, V10, P549, DOI 10.1515/nanoph-2020-0449; Caldwell JD, 2019, NAT REV MATER, V4, P552, DOI 10.1038/s41578-019-0124-1; Chaudhary K, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7171; Chen MY, 2020, NAT MATER, V19, P1372, DOI 10.1038/s41563-020-0781-x; Chernikov A, 2015, NAT PHOTONICS, V9, P466, DOI 10.1038/NPHOTON.2015.104; Chui ST, 2019, J PHYS-CONDENS MAT, V31, DOI 10.1088/1361-648X/ab0fb3; Dai S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7963; Dai S, 2014, SCIENCE, V343, P1125, DOI 10.1126/science.1246833; Duan JH, 2020, NANO LETT, V20, P5323, DOI 10.1021/acs.nanolett.0c01673; Edelberg D, 2019, NANO LETT, V19, P4371, DOI 10.1021/acs.nanolett.9b00985; Eisele M, 2014, NAT PHOTONICS, V8, P841, DOI [10.1038/nphoton.2014.225, 10.1038/NPHOTON.2014.225]; Epstein I, 2020, 2D MATER, V7, DOI 10.1088/2053-1583/ab8dd4; FISHER RK, 1970, PHYS LETT A, VA 31, P235, DOI 10.1016/0375-9601(70)90946-1; Follan TG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06858-y; Hoffman AJ, 2009, J APPL PHYS, V105, DOI 10.1063/1.3124087; Hu F, 2017, NAT PHOTONICS, V11, P356, DOI [10.1038/nphoton.2017.65, 10.1038/NPHOTON.2017.65]; Hu GW, 2020, NATURE, V582, P209, DOI 10.1038/s41586-020-2359-9; Hu GW, 2020, NANO LETT, V20, P3217, DOI 10.1021/acs.nanolett.9b05319; Huber MA, 2017, NAT NANOTECHNOL, V12, P207, DOI [10.1038/NNANO.2016.261, 10.1038/nnano.2016.261]; Jacob Z, 2010, APPL PHYS B-LASERS O, V100, P215, DOI 10.1007/s00340-010-4096-5; Krishnamoorthy HNS, 2012, SCIENCE, V336, P205, DOI 10.1126/science.1219171; Latini S, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.245123; Li PN, 2018, SCIENCE, V359, P892, DOI 10.1126/science.aaq1704; Li PN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8507; Low T, 2017, NAT MATER, V16, P182, DOI [10.1038/NMAT4792, 10.1038/nmat4792]; Ma WL, 2018, NATURE, V562, P557, DOI 10.1038/s41586-018-0618-9; McLeod AS, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085136; Merkl P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16069-z; Mrejen M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat9618; Novoselov KS, 2016, SCIENCE, V353, DOI 10.1126/science.aac9439; Park KD, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav5931; Pedersen TG, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/7/073043; Poellmann C, 2015, NAT MATER, V14, P889, DOI [10.1038/nmat4356, 10.1038/NMAT4356]; Ruta FL, 2020, NANO LETT, V20, P7933, DOI 10.1021/acs.nanolett.0c02671; Sternbach AJ, 2017, OPT EXPRESS, V25, P28589, DOI 10.1364/OE.25.028589; Sternbach AJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17335-w; Taboada-Gutierrez J, 2020, NAT MATER, V19, P964, DOI 10.1038/s41563-020-0665-0; Wagner M, 2014, NANO LETT, V14, P894, DOI 10.1021/nl4042577; Wang G, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.021001; Wang J, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0145; Zheng Z., 2018, ADV MAT, V30; Zheng ZB, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav8690; Zheng ZB, 2018, ADV MATER, V30, DOI 10.1002/adma.201705318	45	29	29	12	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		617	+		10.1126/science.abe9163	http://dx.doi.org/10.1126/science.abe9163			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QD7TF	33542134				2022-12-28	WOS:000615715300051
J	Jia, YX; Wen, JJ; Qureshi, R; Ehrhardt, S; Celentano, DD; Wei, X; Rosman, L; Wen, YM; Robinson, KA				Jia, Yuanxi; Wen, Jiajun; Qureshi, Riaz; Ehrhardt, Stephan; Celentano, David D.; Wei, Xin; Rosman, Lori; Wen, Yumeng; Robinson, Karen A.			Effect of redundant clinical trials from mainland China evaluating statins in patients with coronary artery disease: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SYSTEMATIC REVIEWS; RANDOMIZED-TRIALS; EQUIPOISE; CITATION; ETHICS; END	OBJECTIVE To identify redundant clinical trials evaluating statin treatment in patients with coronary artery disease from mainland China, and to estimate the number of extra major adverse cardiac events (MACEs) experienced by participants not treated with statins in those trials. DESIGN Cross sectional study. SETTING 2577 randomized clinical trials comparing statin treatment with placebo or no treatment in patients with coronary artery disease from mainland China, searched from bibliographic databases to December 2019. PARTICIPANTS 250 810 patients with any type of coronary artery disease who were enrolled in the 2577 randomized clinical trials. MAIN OUTCOME MEASURES Redundant clinical trials were defined as randomized clinical trials that initiated or continued recruiting after 2008 (ie, one year after statin treatment was strongly recommended by clinical practice guidelines). The primary outcome is the number of extra MACEs that were attributable to the deprivation of statins among patients in the control groups of redundant clinical trials-that is, the number of extra MACEs that could have been prevented if patients were given statins. Cumulative meta-analyses were also conducted to establish the time points when statins were shown to have a statistically significant effect on coronary artery disease. RESULTS 2045 redundant clinical trials were identified published between 2008 and 2019, comprising 101 486 patients in the control groups not treated with statins for 24 638 person years. 3470 (95% confidence interval 3230 to 3619) extra MACEs were reported, including 559 (95% confidence interval 506 to 612) deaths, 973 (95% confidence interval 897 to 1052) patients with new or recurrent myocardial infarction, 161 (132 to 190) patients with stroke, 83 (58 to 105) patients requiring revascularization, 398 (352 to 448) patients with heart failure, 1197 (1110 to 1282) patients with recurrent or deteriorated angina pectoris, and 99 (95% confidence interval 69 to 129) unspecified MACEs. CONCLUSIONS Of more than 2000 redundant clinical trials on statins in patients with coronary artery disease identified from mainland China, an extra 3000 MACEs, including nearly 600 deaths, were experienced by participants not treated with statins in these trials. The scale of redundancy necessitates urgent reform to protect patients.	[Jia, Yuanxi; Robinson, Karen A.] Johns Hopkins Univ, Sch Med, Dept Med, 1830 East Monument St,Suite 8068, Baltimore, MD 21287 USA; [Wen, Jiajun; Qureshi, Riaz; Ehrhardt, Stephan; Celentano, David D.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Wei, Xin] Virginia Commonwealth Univ, Dept Cardiol, Richmond, VA USA; [Rosman, Lori] Johns Hopkins Univ, Welch Med Lib, Baltimore, MD USA; [Wen, Yumeng] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Virginia Commonwealth University; Johns Hopkins University; Johns Hopkins University	Robinson, KA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 1830 East Monument St,Suite 8068, Baltimore, MD 21287 USA.	krobin@jhmi.edu	Wen, Yumeng/AAS-4616-2020	Wen, Yumeng/0000-0002-1392-6369; Jia, Yuanxi/0000-0002-5098-1746; Robinson, Karen/0000-0003-1021-7820				Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P195; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P295; Borgerson K, 2014, KENNEDY INST ETHIC J, V24, P385, DOI 10.1353/ken.2014.0029; China State Food and Drug Administration, 2003, GOOD CLIN PRACT; Clark J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h210; Clarke M, 2007, J ROY SOC MED, V100, P187, DOI 10.1258/jrsm.100.4.187; Clarke M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102670; Cohen JF, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0017-3; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; Fergusson D, 2005, CLIN TRIALS, V2, P218, DOI 10.1191/1740774505cn085oa; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Garattini S, 2003, BMJ-BRIT MED J, V326, P1199, DOI 10.1136/bmj.326.7400.1199; Grady C, 2015, CHEST, V148, P1148, DOI 10.1378/chest.15-0706; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Habre C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5219; Homji RSM, 2011, QJM-INT J MED, V104, P469, DOI 10.1093/qjmed/hcr027; Ioannidis JPA, 2016, MILBANK Q, V94, P485, DOI 10.1111/1468-0009.12210; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Jia YX, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.5894; Kip KE, 2008, J AM COLL CARDIOL, V51, P701, DOI 10.1016/j.jacc.2007.10.034; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Lund H, 2021, J CLIN EPIDEMIOL, V129, P158, DOI 10.1016/j.jclinepi.2020.07.019; PEDERSEN TR, 1994, LANCET, V344, P1383; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Qiu J, 2010, NATURE, V463, P142, DOI 10.1038/463142a; Rao Y., 2010, CHINAS RES CULTURE; Robinson KA, 2021, J CLIN EPIDEMIOL, V129, P151, DOI 10.1016/j.jclinepi.2020.07.020; Robinson KA, 2011, ANN INTERN MED, V154, P50, DOI 10.7326/0003-4819-154-1-201101040-00007; Sawin VI, 2016, J CLIN EPIDEMIOL, V69, P174, DOI 10.1016/j.jclinepi.2015.03.026; Schulz KF, 2002, LANCET, V359, P696, DOI 10.1016/S0140-6736(02)07816-9; Tollefson J, 2018, NATURE, V553, P390, DOI 10.1038/d41586-018-00927-4; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; US Department of Health and Human Services. National commission for the protection of human subjects of biomedical and behavioral research, 1979, BELM REP ETH PRINC G, P45; Vale N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006870.pub3; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wu TX, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-46; Yuan HF, 2013, LANCET, V381, pE4, DOI 10.1016/S0140-6736(13)60174-9	37	2	2	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2021	372								n48	10.1136/bmj.n48	http://dx.doi.org/10.1136/bmj.n48			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QE0PW	33531350	Green Published, hybrid			2022-12-28	WOS:000615910600007
J	Shepherd, A				Shepherd, Alison			THE BIG PICTURE China races to contain covid outbreak	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2021	372								n307	10.1136/bmj.n307	http://dx.doi.org/10.1136/bmj.n307			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UD4LK	33531341	Bronze			2022-12-28	WOS:000687179200003
J	Udomkarnjananun, S; Puapatanakul, P; Praditpornsilpa, K				Udomkarnjananun, Suwasin; Puapatanakul, Pongpratch; Praditpornsilpa, Kearkiat			Relapsing polychondritis associated with pauci-immune crescentic glomerulonephritis	LANCET			English	Editorial Material									[Udomkarnjananun, Suwasin; Puapatanakul, Pongpratch; Praditpornsilpa, Kearkiat] Chulalongkorn Univ, Fac Med, Dept Med, Div Nephrol, Bangkok, Thailand; [Udomkarnjananun, Suwasin; Puapatanakul, Pongpratch; Praditpornsilpa, Kearkiat] King Chulalongkorn Mem Hosp, Bangkok 10330, Thailand	Chulalongkorn University; Chulalongkorn University	Udomkarnjananun, S (corresponding author), King Chulalongkorn Mem Hosp, Bangkok 10330, Thailand.	suwasin.u@gmail.com	Udomkarnjananun, Suwasin/AAV-2650-2021; Praditpronsilpa, Kearkiat/AFT-5058-2022	Udomkarnjananun, Suwasin/0000-0003-4087-9032; 					0	0	0	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2020	396	10259					E63	E63						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OF2SS	33543713				2022-12-28	WOS:000581064900005
J	Kerlikowske, K; Bibbins-Domingo, K				Kerlikowske, Karla; Bibbins-Domingo, Kirsten			Toward Risk-Based Breast Cancer Screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DENSE BREASTS; BENEFITS; WOMEN		[Kerlikowske, Karla; Bibbins-Domingo, Kirsten] Univ Calif San Francisco, 550 16th St,2nd Floor, San Francisco, CA 94158 USA; [Kerlikowske, Karla] Univ Calif San Francisco, VAMC 111A1,4150 Clement St, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, 550 16th St,2nd Floor, San Francisco, CA 94158 USA.	kirsten.bibbins-domingo@ucsf.edu		Kerlikowske, Karla/0000-0001-8793-8779				Engmann NJ, 2017, JAMA ONCOL, V3, P1228, DOI 10.1001/jamaoncol.2016.6326; Kerlikowske K, 2015, ANN INTERN MED, V162, P673, DOI 10.7326/M14-1465; Mandelblatt JS, 2016, ANN INTERN MED, V164, P215, DOI 10.7326/M15-1536; Melnikow J, 2016, ANN INTERN MED, V164, P268, DOI 10.7326/M15-1789; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Shih YCT, 2021, ANN INTERN MED, V174, P602, DOI 10.7326/M20-2912; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Trentham-Dietz A, 2016, ANN INTERN MED, V165, P700, DOI 10.7326/M16-0476; Vilaprinyo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086858	9	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					710	+		10.7326/M21-0398	http://dx.doi.org/10.7326/M21-0398			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33556272				2022-12-28	WOS:000652604800037
J	Fontanet, A; Autran, B; Lina, B; Kieny, MP; Karim, SSA; Sridhar, D				Fontanet, Arnaud; Autran, Brigitte; Lina, Bruno; Kieny, Marie Paule; Karim, Salim S. Abdool; Sridhar, Devi			SARS-CoV-2 variants and ending the COVID-19 pandemic	LANCET			English	Editorial Material									[Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, F-75015 Paris, France; [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, PACRI Unit, Paris, France; [Autran, Brigitte] Sorbonne Univ, Paris, France; [Autran, Brigitte] CIMI Paris Ctr Rech Immun Malad Infect, UMR S Inserm UPMC 1135, Paris, France; [Lina, Bruno] Hosp Civils Lyon, CNR Virus Infect Resp, Inst Agents Infect, Lyon, France; [Lina, Bruno] UCBL, Ecole Normale Super Lyon, Ctr Int Rech Infectiol, Virpath,Univ Lyon,Inserm U1111,CNRS UMR5308, Lyon, France; [Kieny, Marie Paule] INSERM, Paris, France; [Karim, Salim S. Abdool] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Karim, Salim S. Abdool] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Sridhar, Devi] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh Med Sch, Edinburgh, Midlothian, Scotland	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; heSam Universite; Conservatoire National Arts & Metiers (CNAM); UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Columbia University; University of Edinburgh	Fontanet, A (corresponding author), Inst Pasteur, Emerging Dis Epidemiol Unit, F-75015 Paris, France.; Fontanet, A (corresponding author), Conservatoire Natl Arts & Metiers, PACRI Unit, Paris, France.	fontanet@pasteur.fr	; Abdool Karim, Salim/N-5947-2013	, arnaud/0000-0002-5239-6110; Abdool Karim, Salim/0000-0002-4986-2133				[Anonymous], 2021, AFR UN SEC 400 MILL; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Cohen J., 2021, SCIENCE, DOI [10.1126/science.abg7115, DOI 10.1126/SCIENCE.ABG7115]; Cohen J., 2021, SCIENCE, DOI [10.1126/science.abg9559, DOI 10.1126/SCIENCE.ABG9559]; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Emary KRW, 2021, SSRN, DOI 10.2139/ssrn.3779160; Faria NR, 2021, VIROLOGICAL; Gu HJ, 2020, SCIENCE, V369, P1603, DOI 10.1126/science.abc4730; Hsiao M., 2020, NICD COVID 19 SPEC P, V18, P1; Johnson Johnson, 2021, JOHNS JOHNS ANN SING; Lipsitch M, 2020, SCIENCE, V370, P763, DOI 10.1126/science.abe5938; Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Mullard Asher, 2020, Nature, DOI 10.1038/d41586-020-03370-6; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Tegally H., 2020, NATURE, DOI [DOI 10.1038/S41586-021-03402-9, 10.1101/2020.12.21.20248640]; Wadman M, 2021, SCIENCE, V12; Wang Zijun, 2021, Nature, V592, P616, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]	19	269	272	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2021	397	10278					952	954		10.1016/S0140-6736(21)00370-6	http://dx.doi.org/10.1016/S0140-6736(21)00370-6		MAR 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QV2NT	33581803	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000627814200008
J	Woolhandler, S; Himmelstein, DU; Ahmed, S; Bailey, Z; Bassett, MT; Bird, M; Bor, J; Bor, D; Carrasquillo, O; Chowkwanyun, M; Dickman, SL; Fisher, S; Gaffney, A; Galea, S; Gottfried, RN; Grumbach, K; Guyatt, G; Hansen, H; Landrigan, PJ; Lighty, M; McKee, M; McCormick, D; McGregor, A; Mirza, R; Morris, JE; Mukherjee, JS; Nestle, M; Prine, L; Saadi, A; Schiff, D; Shapiro, M; Tesema, L; Venkataramani, A				Woolhandler, Steffie; Himmelstein, David U.; Ahmed, Sameer; Bailey, Zinzi; Bassett, Mary T.; Bird, Michael; Bor, Jacob; Bor, David; Carrasquillo, Olveen; Chowkwanyun, Merlin; Dickman, Samuel L.; Fisher, Samantha; Gaffney, Adam; Galea, Sandro; Gottfried, Richard N.; Grumbach, Kevin; Guyatt, Gordon; Hansen, Helena; Landrigan, Philip J.; Lighty, Michael; McKee, Martin; McCormick, Danny; McGregor, Alecia; Mirza, Reza; Morris, Juliana E.; Mukherjee, Joia S.; Nestle, Marion; Prine, Linda; Saadi, Altaf; Schiff, Davida; Shapiro, Martin; Tesema, Lello; Venkataramani, Atheendar			Public policy and health in the Trump era	LANCET			English	Review							NUTRITION ASSISTANCE PROGRAM; QUALITY-OF-CARE; OPIOID USE DISORDER; UNITED-STATES; LIFE EXPECTANCY; INCOME INEQUALITY; PROFIT STATUS; FOR-PROFIT; MORTALITY; ABORTION		[Woolhandler, Steffie; Himmelstein, David U.] CUNY Hunter Coll, Sch Urban Publ Hlth, New York, NY 10035 USA; [Woolhandler, Steffie; Himmelstein, David U.; Bor, David; Gaffney, Adam; McCormick, Danny] Cambridge Hlth Alliance, Cambridge, England; [Woolhandler, Steffie; Himmelstein, David U.; Bor, David; Gaffney, Adam; McCormick, Danny; Morris, Juliana E.; Mukherjee, Joia S.; Saadi, Altaf; Schiff, Davida] Harvard Med Sch, Boston, MA 02115 USA; [Ahmed, Sameer] Harvard Law Sch, Harvard Immigrat & Refugee Clin Program, Boston, MA USA; [Bassett, Mary T.] Harvard Univ, Francois Xavier Bagnoud Ctr Hlth & Human Rights, Boston, MA 02115 USA; [Bailey, Zinzi] Univ Miami, Miller Sch Med, Div Med Oncol, Miami, FL 33136 USA; [Carrasquillo, Olveen] Univ Miami, Miller Sch Med, Div Gen Internal Med, Miami, FL 33136 USA; [Bor, Jacob; Galea, Sandro] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Chowkwanyun, Merlin] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Dickman, Samuel L.] Planned Parenthood South Texas, San Antonio, TX USA; [Fisher, Samantha; Landrigan, Philip J.] Boston Coll, Program Global Publ Hlth & Common Good, Chestnut Hill, MA 02167 USA; [Lighty, Michael] Natl Nurses United, Oakland, CA USA; [Gottfried, Richard N.] NewYork State Assembly, Comm Hlth, Albany, NY USA; [Grumbach, Kevin] Univ Calif San Francisco, Dept Family andCommun Med, San Francisco, CA 94143 USA; [Guyatt, Gordon] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Guyatt, Gordon] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Hansen, Helena] Univ Calif Los Angeles, David Geffen Sch Med, Res Theme Translat Social Sci & Hlth Equ, Los Angeles, CA 90095 USA; [Nestle, Marion] NYU, Dept Nutr & Food Studies, New York, NY USA; [McKee, Martin] London Sch Hyg &Trop Med, Dept Hlth Serv Res & Policy, London, England; [McGregor, Alecia] Tufts Univ, Dept Community Hlth, Medford, MA 02155 USA; [Mirza, Reza] Univ Toronto, Dept Med, Toronto, ON, Canada; [Morris, Juliana E.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Morris, Juliana E.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Saadi, Altaf] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Mukherjee, Joia S.] Partners Hlth, Boston, MA USA; [Mukherjee, Joia S.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Prine, Linda] Mt Sinai Sch Med, Dept Family & Community Med, New York, NY USA; [Schiff, Davida] MassGen Hosp Children, Div Gen Acad Pediat, Boston, MA USA; [Shapiro, Martin] WeillCornell Med Coll, Dept Med, New York, NY USA; [Tesema, Lello] Los Angeles Cty, Dept Publ Hlth, Los Angeles, CA USA; [Venkataramani, Atheendar] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA	City University of New York (CUNY) System; Hunter College (CUNY); Harvard University; Harvard Medical School; Harvard University; Harvard University; University of Miami; University of Miami; Boston University; Columbia University; Boston College; University of California System; University of California San Francisco; McMaster University; McMaster University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York University; University of London; London School of Hygiene & Tropical Medicine; Tufts University; University of Toronto; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Los Angeles County Department of Public Health; University of Pennsylvania; Pennsylvania Medicine	Himmelstein, DU (corresponding author), CUNY Hunter Coll, Sch Urban Publ Hlth, New York, NY 10035 USA.	dhimmels@hunter.cuny.edu	Galea, Sandro/GLR-6066-2022; Grumbach, Kevin/L-9222-2016		Doris Duke Charitable Foundation; Open Society Foundations	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Open Society Foundations	The Commission was supported by grants from the Doris Duke Charitable Foundation and the Open Society Foundations, which covered costs of some members' travel and lodging for Commission meetings, and some data purchases. Commissioners were not compensated for their participation. Additional support came from in-kind contributions by the Boston University School of Public Health and the Roosevelt House Public Policy Institute at Hunter College of the City University of New York, which hosted Commission meetings. Some staff members of the Open Society Foundations attended some in-person Commission meetings as observers but played no role in drafting the report or recommendations. Jaime R Torres and Antonio I Fernandez (both from Latinos for Healthcare Equity) provided general advice and data for the Puerto Rico panel. Prof Alfredo Morabia (Barry Commoner Center for Health and the Environment, Queens College City, University of New York, NY, USA) was the senior adviser to the Commission. Mark Almberg (an independent consultant) served as the Commission's fact checker and editorial adviser.	Acevedo N., 2020, WHY ARE MIGRANT CHIL; AHPRA & National Boards, 2021, AUSTR HLTH PRACT REG; Alexander M., 2012, NEW JIM CROW MASS IN; Alexander MJ, 2018, EPIDEMIOLOGY, V29, P707, DOI [10.1097/EDE.0000000000000858, 10.1097/ede.0000000000000858]; American Civil Liberties Union, 2018, FAM SEP NUMB; American Hospital Association, 2019, 2019 AHA HOSP STAT; American Immigration Council, 2018, END IMM ENF PRIOR UN; American Medical Association,, 2020, ISS BRIEF REP INCR O; [Anonymous], 2018, NRA; [Anonymous], 2019, GBD RES TOOL; [Anonymous], 2018, THISISOURLANE MEDICA; [Anonymous], FY 2019 PRES BUDG; [Anonymous], 2017, AM J KIDNEY DIS, V69, pA4, DOI [DOI 10.1053/j.ajkd.2017.01.036, 10.1053/j.ajkd.2017.01.036, DOI 10.1053/J.AJKD.2017.01.036]; [Anonymous], 2018, HEALTHCARE LAW BLOG; [Anonymous], 2020, BBC NEWS; [Anonymous], 2020, GUARDIAN 1026; Armour S., 2020, PLAN REVAMP MEDICAID; Association of American Medical Colleges, 2016, DIV MED ED ADD DET T; Association of American Medical Colleges, 2019, DIV MED FACTS FIG; Association of American Medical Colleges, 2015, ALT COURS BLACK MAL; Association of American Medical Colleges, 2018, UPD LOOK EC DIV US M; Ault A, 2018, CLIN JOIN THRONGS MA; Autor David, 2017, IMPORTING POLITICAL; Autor David, 2017, WORK DISAPPEARS MANU; Balko R., 2019, TRUMP ADM GAVE FEDER; Bassett MT, 2016, AM J PUBLIC HEALTH, V106, P1741, DOI 10.2105/AJPH.2016.303412; Baum D., 2016, LEGALISE IT ALL WIN; Beaulieu ND, 2020, NEW ENGL J MED, V382, P51, DOI 10.1056/NEJMsa1901383; Beckfield J, 2016, SOC SCI MED, V171, P30, DOI 10.1016/j.socscimed.2016.10.017; Bedard P., 2019, MULVANEY CHEERS MORE; Bendavid E, 2011, B WORLD HEALTH ORGAN, V89, P873, DOI 10.2471/BLT.11.091660; Berchick ER., 2019, HLTH INSURANCE COVER; Berchick ER, 2019, HLTH INSURANCE COVER; Berkowitz D., 2020, MANY SAY OSHA NOT PR; Beyrer C, 2016, LANCET, V388, P1033, DOI 10.1016/S0140-6736(16)30829-7; Bialik K., 2018, ICE ARRESTS WENT 201; Biggs MA, 2017, JAMA PSYCHIAT, V74, P169, DOI 10.1001/jamapsychiatry.2016.3478; Billings KC, 2019, SCH MEALS PROGRAMS O; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Bird ME, 2002, AM J PUBLIC HEALTH, V92, P1391, DOI 10.2105/AJPH.92.9.1391; Bor J, 2018, LANCET, V392, P302, DOI [10.1016/S0140-6736(18)31130-9, 10.1016/s0140-6736(18)31130-9]; Bor J, 2017, AM J PUBLIC HEALTH, V107, P1560, DOI [10.2105/AJPH.2017.303945, 10.2105/ajph.2017.303945]; Bor J, 2017, LANCET, V389, P1475, DOI 10.1016/S0140-6736(17)30571-8; Bowen EA, 2019, INT J DRUG POLICY, V74, P90, DOI 10.1016/j.drugpo.2019.09.014; Boyd RW, 2020, LANCET, V395, P105; Boyd RW, 2019, LANCET, V393, P2484, DOI 10.1016/S0140-6736(19)31353-4; Braswell K, 2013, MOYNIHAN REPORT REVI; Braun Lundy, 2015, Can J Respir Ther, V51, P99; Braveman P, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/00333549141291S206; Burns K., 2020, RACIST HIST TRUMPS W, DOI [1274754/racist-history-trump-when-the-looting-starts-the-shooting-starts, DOI 1274754/RACIST-HISTORY-TRUMP-WHEN-THE-LOOTING-STARTS-THE-SHOOTING-STARTS]; Butkus R, 2014, ANN INTERN MED, V160, P858, DOI 10.7326/M14-0216; Cabin W, 2014, HEALTH AFFAIR, V33, P1460, DOI 10.1377/hlthaff.2014.0307; Cai C, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003013; Carcasson M, 2006, RHETOR PUBLIC AFF, V9, P655; Carson EA, 2020, PRISONERS 2018; Case A, 2017, BROOKINGS PAP ECO AC, P397; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Center for American Progress, 2019, STAT TRUMP ADM FIN R; Center for Science and Democracy at the Union of Concerned Scientists, 2020, PRES REC 2020 BLUEPR; Center for Systems Science and Engineering John Hopkins University, 2020, COVID 19 DAT REP; Center for the Study of the Presidency and Congress, 2012, SNAP HLTH FRESH APPR; Centers for Disease Control and Prevention, 2020, PROVISIONAL DRUG OVE; Centers for Disease Control and Prevention, 2018, EST FOODB ILL FIND; Centers for Disease Control and Prevention, 2020, COVID 19 HOSP DEATH; Centers for Medicare & Medicaid Services, 2019, HLTH DAT NZ 2019; Chadha N, 2020, ABOLITION BIOL RACE; Charles D, 2015, J URBAN HEALTH, V92, P1007, DOI 10.1007/s11524-015-9993-9; CHASNOFF IJ, 1985, NEW ENGL J MED, V313, P666, DOI 10.1056/NEJM198509123131105; Chernew M, 2020, MEDICARE PAYMENT ADV; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Chu DM, 2019, OBSTET GYNECOL, V133, P117, DOI 10.1097/AOG.0000000000003023; Clarke Rachel, 2020, Lancet, V395, P180, DOI 10.1016/S0140-6736(19)33164-2; Clyburn JE., 2020, LETT HONORABLE SONNY; Cohen RA, 2020, HLTH INSURANCE COVER; Coleman-Jensen A, 2020, EC RES SERV US DEP A; Collins Sara R., 2017, WELL DOES INSURANCE; Collins Sara R., 2020, US HLTH INSURANCE CO; Collins SR., 2019, HLTH INSURANCE COVER; Comondore VR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2732; Congressional Budget Office, 2019, FED SUBS HLTH INS CO; Cooper Z, 2019, SURPRISE OUT OF NETW; Council of Economic Advisers, 2014, METH APP METH US CON; Crowley R, 2020, ANN INTERN MED, V172, pS7, DOI 10.7326/M19-2415; Cutler D, 2018, JAMA-J AM MED ASSOC, V319, P2261, DOI 10.1001/jama.2018.7351; Daniel Roxanne., 2020, YOU ASKED WHAT DATA; Davidson K, 2020, TRUMP ADM WEIGHS TIG; Davis K, 1978, HLTH WAR POVERTY 10; Depersio G., 2019, ORIGINS P RICAN DEBT; Deshazo RD, 2018, AM J MED, V131, P595, DOI 10.1016/j.amjmed.2017.12.045; Devereaux PJ, 2004, CAN MED ASSOC J, V170, P1817, DOI 10.1503/cmaj.1040722; Dewey-Mattia D, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6710a1; Diamond D, 2020, BLOCK GRANTS NO MORE; Dickerson C., 2019, YOUNGEST CHILD SEPAR; Dickman S, 2021, INT J HEALTH SERV, V51, P371, DOI 10.1177/0020731420980682; Dickman SL, 2016, HEALTH AFFAIR, V35, P1189, DOI 10.1377/hlthaff.2015.1024; Dillon L, 2018, AM J PUBLIC HEALTH, V108, pS89, DOI 10.2105/AJPH.2018.304360; Dittmer J., 2009, GOOD DOCTORS MED COM; Dorn S, 2020, AM COVERAGE CRISIS D; Douglas Leah., 2020, FOOD ENV REPORTING N; Dow W, 2019, CAN EC POLICIES REDU; Dwyer-Lindgren L, 2017, JAMA INTERN MED, V177, P1003, DOI 10.1001/jamainternmed.2017.0918; Edwards F, 2019, P NATL ACAD SCI USA, V116, P16793, DOI 10.1073/pnas.1821204116; Elk M., 2019, PRIVATE EQUITYS LATE; Elo IT, 2019, POPUL DEV REV, V45, P549, DOI 10.1111/padr.12249; Eshaq AM, 2017, LANCET, V389, P31, DOI 10.1016/S0140-6736(16)32592-2; Eskenazi B, 2019, JAMA PEDIATR, V173, P744, DOI 10.1001/jamapediatrics.2019.1475; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Faherty LJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.14078; Federspiel F, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6227-6; Feinberg A, TRUMP EFFECT 2016 CA; Fetzer T, 2019, AM ECON REV, V109, P3849, DOI 10.1257/aer.20181164; Fleming PJ, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7290-3; Food and Nutrition Service US Department of Agriculture, 2019, REV CAT EL SUPPL NUT; Food and Nutrition Service US Department of Agriculture., 2019, SUPPL NUTR ASS PROGR; Food and Nutrition Service US Department of Agriculture., 2020, SNAP DAT TABL; Food and Nutrition Service US Department of Agriculture., 2020, SUPPL NUTR ASS PROGR; Foster DG, 2018, AM J PUBLIC HEALTH, V108, P407, DOI [10.2105/AJPH.2017.304247, 10.2105/ajph.2017.304247]; Fox L., 2018, SUPPLEMENTAL POVERTY, VP60-265; Frank Joseph W, 2014, Health Justice, V2, P6; Friedman L., 2020, CORONAVIRUS DOESNT S; Fung E., 2019, D TRUMP HAS BEEN VER; Furr-Holden D, 2021, ADDICTION, V116, P677, DOI 10.1111/add.15233; Gaffney A, 2020, HEALTH AFFAIR, V39, P33, DOI 10.1377/hlthaff.2019.00481; Gaffney A, 2017, LANCET, V389, P1442, DOI 10.1016/S0140-6736(17)30786-9; Galea S, 2019, WELL WHAT WE NEED TA; Galofre-Vila G, 2017, AUSTERITY RISE NAZI; Galvani AP, 2020, LANCET, V395, P1692, DOI 10.1016/S0140-6736(20)30857-6; Galvani AP, 2020, LANCET, V395, P524, DOI 10.1016/S0140-6736(19)33019-3; GARFIELD R, 2020, COVERAGE GAP UNINSUR; Garrett L., 2018, TRUMP IS COMA PUBLIC; Gemmill A, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7084; Gerdts C, 2016, AM J PUBLIC HEALTH, V106, P857, DOI 10.2105/AJPH.2016.303134; Geruso M, 2020, J POLIT ECON, V128, P984, DOI 10.1086/704756; Gibbons-Neff T., 2020, 160 NATIONS BAN THES; Gladden RM, 2016, MMWR-MORBID MORTAL W, V65, P837, DOI 10.15585/mmwr.mm6533a2; Goldman N., 2020, REDUCTIONS 2020 US L, DOI [10.1101/2020.07.12.20148387v2, DOI 10.1101/2020.07.12.20148387V2]; Goodridge J, 2019, PRISON LABOUR US INV; Gordon S, 2019, VA IS PRIVATISING VE; Gostin LO, 2018, US ELEVATES CORPORAT, DOI [10.1377/hblog20180830.186562/full/, DOI 10.1377/HBLOG20180830.186562/FULL]; Gourevitch MN., 2019, LARGE LIFE EXPECTANC; Goyal V, 2020, CONTRACEPTION, V102, P109, DOI 10.1016/j.contraception.2020.04.008; Gramer R, 2020, TRUMP SEEKS HALVE US; GROFMAN B, 1991, LEGIS STUD QUART, V16, P111, DOI 10.2307/439970; Grumbach K, 2008, HEALTH AFFAIR, V27, P413, DOI 10.1377/hlthaff.27.2.413; Guttenplan DD, 2020, ITS TIME DISARM POLI; Guttmacher Institute, 2022, STATE FACTS ABORTION; Guttmacher Institute, 2020, STAT POL AB; Haight SC, 2018, MMWR-MORBID MORTAL W, V67, P845, DOI 10.15585/mmwr.mm6731a1; Hales Craig M, 2020, NCHS Data Brief, P1; Hales Craig M, 2017, NCHS Data Brief, P1; Hamel L., 2020, KFF 0130; Hanna-Attisha M, 2016, AM J PUBLIC HEALTH, V106, P283, DOI 10.2105/AJPH.2015.303003; Hansen HB, 2013, J BEHAV HEALTH SER R, V40, P367, DOI 10.1007/s11414-013-9341-3; Harrington C., 2018, NURSING FACILITIES S; Hartocollis A., 2017, NEW YORK TIMES; Hatcher W, 2020, J PUBLIC HEALTH-UK, V42, pE482, DOI 10.1093/pubmed/fdz176; Herman Bob, 2020, AXIOS 0305; Hillmer MP, 2005, MED CARE RES REV, V62, P139, DOI 10.1177/1077558704273769; Himmelstein DU, 2020, ANN INTERN MED, V172, P134, DOI 10.7326/M19-2818; Himmelstein DU, 2019, AM J PUBLIC HEALTH, V109, P431, DOI 10.2105/AJPH.2018.304901; Himmelstein DU, 2018, LANCET, V392, P993, DOI 10.1016/S0140-6736(18)32171-8; Himmelstein G, 2020, INT J HEALTH SERV, V50, P363, DOI 10.1177/0020731420937632; Himmelstein KEW, 2019, AM J PUBLIC HEALTH, V109, P198, DOI 10.2105/AJPH.2018.304801; Ho J, 2010, INT DIFFERENCES MORT; Hsia RY, 2011, JAMA-J AM MED ASSOC, V305, P1978, DOI 10.1001/jama.2011.620; Human Mortality Database, 2018, DAT AV; Hung PY, 2017, HEALTH AFFAIR, V36, P1663, DOI 10.1377/hlthaff.2017.0338; Interlandi J., 2019, WHY DOESNT US HAVE U; International Panel of Experts on Sustainable Food Systems, 2020, COVID 19 CRIS FOOD S; Jacobson G, 2019, FINANCIAL PERFORMANC; Jarlenski M, 2017, OBSTET GYNECOL, V129, P786, DOI 10.1097/AOG.0000000000001982; Johnson DB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2015.3918; Jones DS, 2006, AM J PUBLIC HEALTH, V96, P2122, DOI 10.2105/AJPH.2004.054262; Jones KM, 2015, ECON DEV CULT CHANGE, V64, P31, DOI 10.1086/682981; Jones RK, 2019, SELF MANAGED ABORTIO, DOI [10.1377/hblog20191105.113811/full/, DOI 10.1377/HBLOG20191105.113811/FULL]; Joseph A, 2019, NATL TRIBAL BUDGET F; JOst TS, 2019, FUT ASS HLTH PLANS; Kaiser Family Foundation, 2020, WHITHOUS REL FY21 BU; Kaiser J, 2004, SCIENCE, V304, P662; Katz MH, 2018, JAMA-J AM MED ASSOC, V320, P2075, DOI 10.1001/jama.2018.16391; Keith-Jennings B, 2019, AM J PUBLIC HEALTH, V109, P1636, DOI 10.2105/AJPH.2019.305325; Keynes JM., 1920, EC CONSEQUENCES PEAC, P211; Khatri UG, 2020, J ADDICT MED, V14, pE6, DOI 10.1097/ADM.0000000000000684; Khomani N., 2017, METOO HASHTAG BECAME; Kim D, 2016, PREV MED, V84, P62, DOI 10.1016/j.ypmed.2015.11.013; Kim DD, 2016, VALUE HEALTH, V19, P602, DOI 10.1016/j.jval.2016.02.008; Kim Grace, 2019, AMA J Ethics, V21, pE8, DOI 10.1001/amajethics.2019.8; Kim JW, 2020, J HEALTH POLIT POLIC, V45, P177, DOI 10.1215/03616878-8004850; King A, 2020, LANCET, V396, P96, DOI 10.1016/S0140-6736(20)31489-6; King M.L, 1964, WHY WE CANT WAIT; Kochanek Kenneth D, 2019, Natl Vital Stat Rep, V68, P1; Koltai J, 2020, AM J PUBLIC HEALTH, V110, P401, DOI 10.2105/AJPH.2019.305488; Kormann C., 2018, SCOTT PRUITTS CRUSAD; Kozhimannil KB, 2019, ADDICT BEHAV, V90, P272, DOI 10.1016/j.addbeh.2018.11.019; Krieger N., 2020, UNEQUAL TOLL COVID 1; Krieger N, 2008, PLOS MED, V5, P227, DOI 10.1371/journal.pmed.0050046; Krieger N, 2013, AM J PUBLIC HEALTH, V103, P2234, DOI 10.2105/AJPH.2013.301350; Krogstad J.M., 2022, FACTTANK; Krogstad JM, 2019, KEY FACTS REFUGEES U; Kuziemko I, 2018, AM ECON REV, V108, P2830, DOI 10.1257/aer.20161413; Lagisetty PA, 2019, JAMA PSYCHIAT, V76, P979, DOI 10.1001/jamapsychiatry.2019.0876; Lakoff G, 2010, ENVIRON COMMUN, V4, P70, DOI 10.1080/17524030903529749; Landrigan PJ, 2019, NEW ENGL J MED, V381, P598, DOI 10.1056/NEJMp1906207; Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0; Largent EA, 2018, PUBLIC HEALTH REP, V133, P715, DOI 10.1177/0033354918795891; Larochelle MR, 2018, ANN INTERN MED, V169, P137, DOI 10.7326/M17-3107; Larsen K, 2017, TAKING STOCK 2017 AD; Latner M, 2019, OUR UNHEALTHY DEMOCR; Ledger K., 1998, HOPKINS MED NEWS, DOI [11033731/http://www.hopkinsmedicine.org/hmn/w98/sea.html, DOI 11033731/HTTP://WWW.HOPKINSMEDICINE.ORG/HMN/W98/SEA.HTML]; Leider JP, 2018, AM J PREV MED, V54, P334, DOI 10.1016/j.amepre.2017.10.026; Leung J, 2019, MMWR-MORBID MORTAL W, V68, P749, DOI 10.15585/mmwr.mm6834a4; Lew-Williams B., 2018, CHINESE MUST GO VIOL; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Linton JM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2017-0483; Lippold KM, 2019, MMWR-MORBID MORTAL W, V68, P967, DOI 10.15585/mmwr.mm6843a3; Lopez G, 2017, OBAMA IS 1 PRESIDENT, DOI [14189862/obama-mass-incarceration-prison, DOI 14189862/OBAMA-MASS-INCARCERATION-PRISON]; Lowey N., 2019, NEW DISASTER RELIEF; Maclean N., 2017, DEMOCRACY CHAINS DEE; Marmot M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m693; Martinez AD, 2018, SSM-POPUL HLTH, V5, P188, DOI 10.1016/j.ssmph.2018.06.003; Mazurenko O, 2018, HEALTH AFFAIR, V37, P944, DOI 10.1377/hlthaff.2017.1491; McGregor AJ, 2020, J PREV INTERV COMMUN, V48, P7, DOI 10.1080/10852352.2019.1617520; McKee M, 2006, INT J EPIDEMIOL, V35, P1398, DOI 10.1093/ije/dyl237; McNeilJnr DG, 2019, GILEAD WILL DONATE T; Medicaid and CHIP Payment and Access Commission (MACPAC), 2019, MED WAIV TRACK APPR; Medicare Payment Advisory Commission, 2019, REP C MED PAYM POL; Melnick GA, 2016, INQUIRY-J HEALTH CAR, V53, DOI 10.1177/0046958016651555; Merling M, 2017, MORE TROUBLE AHEAD P; Metzl Jonathan M., 2019, DYING WHITENESS POLI; Michaels D, 2020, WHAT TRUMP COULD RIG; Miller A.M., 2017, NEONATAL ABSTINENCE; Miller M, 2017, REPUBLICANS NEXT HLT; Miller M, 2018, MEDICARE ADVANTAGE P; Miller S, 2019, MEDICAID MORTALITY N; Mitchell A., 1996, 2 CLINTON AIDES RESI; Montez JK, 2020, MILBANK Q, V98, P668, DOI 10.1111/1468-0009.12469; Morgan RO, 1997, NEW ENGL J MED, V337, P169, DOI 10.1056/NEJM199707173370306; Moynihan D, 2020, TRUMPS CHINESE VIRUS; Muennig PA, 2018, AM J PUBLIC HEALTH, V108, P1626, DOI 10.2105/AJPH.2018.304585; Mullan F, 2010, ANN INTERN MED, V152, P804, DOI 10.7326/0003-4819-152-12-201006150-00009; Murray CJL, 2020, LANCET, V396, P1223, DOI 10.1016/S0140-6736(20)30752-2; Nation Health Commission, 2020, CHIN HLTH STAT YB 20; National Centers for Environmental Information National Oceanic and Atmospheric Administration., 2019, BILL DOLL WEATH CLIM; National Science Board National Science Foundation, 2020, NSB20202 NAT SCI FDN; Natl Res Council, 2014, GROWTH OF INCARCERATION IN THE UNITED STATES: EXPLORING CAUSES AND CONSEQUENCES, P1; Nestle M, 2019, AM J PUBLIC HEALTH, V109, P1631, DOI 10.2105/AJPH.2019.305361; Netherland J, 2017, BIOSOCIETIES, V12, P217, DOI 10.1057/biosoc.2015.46; Nohria N., 2010, HDB LEADERSHIP THEOR; Nolte E, 2012, HEALTH AFFAIR, V31, P2114, DOI 10.1377/hlthaff.2011.0851; Nosrati E, 2019, LANCET PUBLIC HEALTH, V4, pE326, DOI 10.1016/S2468-2667(19)30104-5; Nosrati E, 2018, INT J EPIDEMIOL, V47, P720, DOI 10.1093/ije/dyx243; Novak NL, 2017, INT J EPIDEMIOL, V46, P839, DOI 10.1093/ije/dyw346; Occupational Safety and Health Administration US Department of Labor., 2018, WORKPL INJ ILLN FAT; Oxfam, 2019, DRUG CO REAP BILL NE; Patterson EJ, 2015, SOC SCI RES, V53, P325, DOI 10.1016/j.ssresearch.2015.06.011; Pelech D., 2018, C BUDGET OFFICE WORK; Perreira KM, 2019, ANNU REV PUBL HEALTH, V40, P147, DOI 10.1146/annurev-publhealth-040218-044115; Petersen EE, 2019, MMWR-MORBID MORTAL W, V68, P762, DOI 10.15585/mmwr.mm6835a3; Peterson AM., 2020, COMMONPLACE CONTROVE; Physicians for Human Rights, 2019, UNS UNS INH PHR MED; Pierce JR, 2020, AM ECON REV INSIGHTS, V2, P47, DOI 10.1257/aeri.20180396; Piketty T., 2014, CAPITAL SIGLO 21; Piller C, 2019, SCIENCE, V365, P12, DOI 10.1126/science.365.6448.12; Piven F. F., 1977, POOR PEOPLES MOVEMEN; Pollitt K., 1997, ABORTION AM HIST; Pomeranz JL, 2019, AM J PUBLIC HEALTH, V109, P1659, DOI 10.2105/AJPH.2019.305350; Popovich N, 2019, TRUMP ADM IS REVERSI; Preston SH, 2018, P NATL ACAD SCI USA, V115, P957, DOI 10.1073/pnas.1716802115; Prison Policy Initiative, 2020, STAT FED PRIS WAG PO; Quadagno JS., 1994, COLOUR WELFARE RACIS; Rahman M, 2015, HEALTH AFFAIR, V34, P1675, DOI 10.1377/hlthaff.2015.0272; Reagan LJ., 1998, ABORTION WAS CRIME W; Redd Steve, 2018, RESP S REDD CTR DIS; Redden E, 2019, DEEP CUTS P RICCO; Reinarman C, 1997, CRACK AM DEMON DRUGS; Reinhart E, 2020, HEALTH AFFAIR, V39, P1412, DOI 10.1377/hlthaff.2020.00652; Reuters staff, 2020, TRUMP SAID HE KNEW V; Richey W., 1995, US FIGHTS SPAINS REF; Roberts Dorothy E., 2011, MINNESOTA J LAW SCI, V12, P15; Rodgers J., 2019, FEDS BLOCKED DENYING; Rosenberg E., 2019, TRUMP IS MOST EXCITE; Ross LJ, 2001, AM J HLTH STUDIES, V7, P79; Saadi A, 2020, HEALTH HUM RIGHTS, V22, P187; Saadi A, 2019, LANCET, V393, P2299, DOI 10.1016/S0140-6736(19)30351-4; Saadi A, 2017, JAMA-J AM MED ASSOC, V318, P2079, DOI 10.1001/jama.2017.15714; Saloner B, 2020, JAMA-J AM MED ASSOC, V324, P602, DOI 10.1001/jama.2020.12528; Saloner B, 2018, PUBLIC HEALTH REP, V133, p24S, DOI 10.1177/0033354918793627; Schaaf M, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001786; Schempf AH, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.055; Schubel J., 2019, STATES EXPERIENCES C; Schwartz MB, 2015, CHILD OBES, V11, P242, DOI 10.1089/chi.2015.0019; Sehgal AR, 2021, ANN INTERN MED, V174, P127, DOI 10.7326/M20-4331; Seita A, 2018, LANCET, V391, P294, DOI 10.1016/S0140-6736(18)30113-2; Sharpe Tanya Telfair, 2005, 8 BALL SEX CRACK COC; Sherwood J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6008-2; Sigmon SC, 2013, JAMA PSYCHIAT, V70, P1347, DOI 10.1001/jamapsychiatry.2013.2216; Sinclair Upton., 1906, JUNGLE; Smith D., 2018, ANTIOBAMA TRUMPS DRI; Sobel L., 2020, STATE ACTION LIMIT A; Sommers BD, 2019, NEW ENGL J MED, V381, P1073, DOI 10.1056/NEJMsr1901772; Staley E, 2004, HUNGER AM DEFINITION; Starrs AM, 2017, LANCET, V389, P485, DOI 10.1016/S0140-6736(17)30270-2; Steele J, 2018, THERE IS COST TRUMP; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Sun LH, 2017, NEARLY 700 VACANCIES; Tack DM, 2019, MMWR-MORBID MORTAL W, V68, P369, DOI 10.15585/mmwr.mm6816a2; Tackett M., 2019, TRUMP FULFILLS HIS P; Taibbi M., 2020, BIG PHARMAS COVID 19; Tan S, 2019, JAMA DERMATOL, V155, P1013, DOI 10.1001/jamadermatol.2019.1634; Taylor M., 2019, CLIMATE CRISIS 6 MIL; Time staff, 2015, HERES D TRUMPS PRESI; Torres SA, 2018, AM PSYCHOL, V73, P843, DOI 10.1037/amp0000184; True Fit, 2018, STAT RET FOOTW APP S; Trust for America's Health, 2020, STAT OB 2020 BETT PO; Trust for America's Health, 2019, IMP CHRON UND AM PUB; U.S. Food and Drug Administration, 2019, RES PRIOR; UA Office of Management and Budget, 2020, BUDG US GOV BUDG AM; United States Department of Health and Human Services Health Resources and Services Administration National Center for Health Workforce Analysis, 2017, SEX RAC ETHN DIV US; US Bureau of Justice Statistics, 2016, KEY STAT PRIS; US Census Bureau, 2019, 2018 POP EST AG SEX; US Census Bureau, 2020, AM COMM SURV TABL HL; US Citizenship and Immigration Services, 2018, GUID PROC REAS CRED; US Congressional Budget Office, 2017, EFF TERM PAYM COST S; US Congressional Budget Office, 2020, CBO AN COST PROP SIN; US Department of Agriculture, 2019, AE62 REV CAT EL SNAP; US Department of Agriculture, 2019, REG REF GLANC PROP R; US Department of Agriculture, 2020, FNS RESP COVID 19; US Department of Health and Human Services, 2019, HHS ANN FIN CONSC PR; US Department of Health and Human Services, 2018, HHS IS EX ITS MISS C; US Environmental Protection Agency, 2019, DRAFT SCOP DOC HIGH; US Food & Drug Administation, 2020, FSMA RUL GUID IND; US General Accounting Office, 1987, ALL MISC INT MED CTR; US Government, 2010, LETS MOV ACH; US Government Accountability Office, 2017, FOOD SAF NAT STRAT N; US Government Accountability Office, 2019, FOOD SAF HIGH RISK I; US National Center for Health Statistics, HLTH US 2018 TABL 4; US National Institute of Mental Health, 2018, T NIH BAB BRAIN COGN; USDA-AMS, 2020, USDA FARM FAM FOOD B; Venkataramani AS, 2020, JAMA INTERN MED, V180, P254, DOI 10.1001/jamainternmed.2019.5686; Venkataramani AS, 2017, LANCET PUBLIC HEALTH, V2, pE175, DOI 10.1016/S2468-2667(17)30047-6; Venkataramani AS, 2016, AM J PUBLIC HEALTH, V106, P478, DOI 10.2105/AJPH.2015.302941; Wachterman MW, 2011, JAMA-J AM MED ASSOC, V305, P472, DOI 10.1001/jama.2011.70; Wagner J, 2018, TRUMP IMMIGRATION IS; Warne D, 2014, AM J PUBLIC HEALTH, V104, pS263, DOI 10.2105/AJPH.2013.301682; Weisbrot Mark, 2019, EC SANCTIONS COLLECT; White House, 2017, EXECUTIVE ORDER PROT; White K, 2019, OBSTET GYNECOL, V133, P771, DOI 10.1097/AOG.0000000000003183; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1; Wildeman C, 2017, LANCET, V389, P1464, DOI 10.1016/S0140-6736(17)30259-3; Wilson WJ, 1997, POLIT SCI QUART, V111, P567; Wintour P, 2018, THERES NO OTHER WORD; Woolf SH, 2013, US HLTH INT PERSPECT; Woolf SH, 2019, JAMA-J AM MED ASSOC, V322, P1996, DOI 10.1001/jama.2019.16932; Woolhandler S, 2020, ANN INTERN MED, V173, P63, DOI 10.7326/M20-1491; Woolhandler S, 2017, ANN INTERN MED, V167, P424, DOI 10.7326/M17-1403; Xu J., 2020, MORTALITY US 2018; Zeng Z., 2020, 253044 NCJ BUR JUST; Zhang HB, 2017, ADV CLIM CHANG RES, V8, P220, DOI 10.1016/j.accre.2017.09.002; Zuckerman B, 2002, JAMA-J AM MED ASSOC, V287, P1990, DOI 10.1001/jama.287.15.1990	359	43	43	8	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					705	753		10.1016/S0140-6736(20)32545-9	http://dx.doi.org/10.1016/S0140-6736(20)32545-9		FEB 2021	49	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL3PK	33581802				2022-12-28	WOS:000620991800033
J	Zappasodi, R; Serganova, I; Cohen, IJ; Maeda, M; Shindo, M; Senbabaoglu, Y; Watson, MJ; Leftin, A; Maniyar, R; Verma, S; Lubin, M; Ko, M; Mane, MM; Zhong, H; Liu, CL; Ghosh, A; Abu-Akeel, M; Ackerstaff, E; Koutcher, JA; Ho, PC; Delgoffe, GM; Blasberg, R; Wolchok, JD; Merghoub, T				Zappasodi, Roberta; Serganova, Inna; Cohen, Ivan J.; Maeda, Masatomo; Shindo, Masahiro; Senbabaoglu, Yasin; Watson, McLane J.; Leftin, Avigdor; Maniyar, Rachana; Verma, Svena; Lubin, Matthew; Ko, Myat; Mane, Mayuresh M.; Zhong, Hong; Liu, Cailian; Ghosh, Arnab; Abu-Akeel, Mohsen; Ackerstaff, Ellen; Koutcher, Jason A.; Ho, Ping-Chih; Delgoffe, Greg M.; Blasberg, Ronald; Wolchok, Jedd D.; Merghoub, Taha			CTLA-4 blockade drives loss of T-reg stability in glycolysis-low tumours	NATURE			English	Article								Limiting metabolic competition in the tumour microenvironment may increase the effectiveness of immunotherapy. Owing to its crucial role in the glucose metabolism of activated T cells, CD28 signalling has been proposed as a metabolic biosensor of T cells(1). By contrast, the engagement of CTLA-4 has been shown to downregulate T cell glycolysis(1). Here we investigate the effect of CTLA-4 blockade on the metabolic fitness of intra-tumour T cells in relation to the glycolytic capacity of tumour cells. We found that CTLA-4 blockade promotes metabolic fitness and the infiltration of immune cells, especially in glycolysis-low tumours. Accordingly, treatment with anti-CTLA-4 antibodies improved the therapeutic outcomes of mice bearing glycolysis-defective tumours. Notably, tumour-specific CD8(+) T cell responses correlated with phenotypic and functional destabilization of tumour-infiltrating regulatory T (T-reg) cells towards IFN gamma- and TNF-producing cells in glycolysis-defective tumours. By mimicking the highly and poorly glycolytic tumour microenvironments in vitro, we show that the effect of CTLA-4 blockade on the destabilization of T-reg cells is dependent on T-reg cell glycolysis and CD28 signalling. These findings indicate that decreasing tumour competition for glucose may facilitate the therapeutic activity of CTLA-4 blockade, thus supporting its combination with inhibitors of tumour glycolysis. Moreover, these results reveal a mechanism by which anti-CTLA-4 treatment interferes with T-reg cell function in the presence of glucose.	[Zappasodi, Roberta; Senbabaoglu, Yasin; Maniyar, Rachana; Verma, Svena; Zhong, Hong; Liu, Cailian; Ghosh, Arnab; Abu-Akeel, Mohsen; Wolchok, Jedd D.; Merghoub, Taha] MSK, Ludwig Collaborat & Swim Amer Lab, New York, NY USA; [Zappasodi, Roberta; Wolchok, Jedd D.; Merghoub, Taha] MSK, Parker Inst Canc Immunotherapy, New York, NY USA; [Zappasodi, Roberta; Serganova, Inna; Koutcher, Jason A.; Wolchok, Jedd D.; Merghoub, Taha] Weill Cornell Med, New York, NY USA; [Serganova, Inna; Cohen, Ivan J.; Maeda, Masatomo; Shindo, Masahiro; Lubin, Matthew; Ko, Myat; Mane, Mayuresh M.; Blasberg, Ronald] MSK, Dept Neurol, New York, NY USA; [Cohen, Ivan J.] MSK, Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY USA; [Watson, McLane J.; Delgoffe, Greg M.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Leftin, Avigdor; Ackerstaff, Ellen; Koutcher, Jason A.] MSK, Dept Med Phys, New York, NY USA; [Verma, Svena] Weill Cornell Med, Weill Cornell Grad Sch Med Sci, New York, NY USA; [Koutcher, Jason A.; Blasberg, Ronald] MSK, Mol Pharmacol Program, New York, NY USA; [Koutcher, Jason A.; Wolchok, Jedd D.; Merghoub, Taha] MSK, Dept Med, New York, NY USA; [Ho, Ping-Chih] Univ Lausanne, Dept Oncol, Lausanne, Switzerland; [Ho, Ping-Chih] Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland; [Wolchok, Jedd D.; Merghoub, Taha] MSK, Human Oncol & Pathogenesis Program, New York, NY USA; [Senbabaoglu, Yasin] Genentech Inc, Dept Oncol Bioinformat, San Francisco, CA USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; Memorial Sloan Kettering Cancer Center; Roche Holding; Genentech	Zappasodi, R; Wolchok, JD; Merghoub, T (corresponding author), MSK, Ludwig Collaborat & Swim Amer Lab, New York, NY USA.; Zappasodi, R; Wolchok, JD; Merghoub, T (corresponding author), MSK, Parker Inst Canc Immunotherapy, New York, NY USA.; Zappasodi, R; Wolchok, JD; Merghoub, T (corresponding author), Weill Cornell Med, New York, NY USA.; Wolchok, JD; Merghoub, T (corresponding author), MSK, Dept Med, New York, NY USA.; Wolchok, JD; Merghoub, T (corresponding author), MSK, Human Oncol & Pathogenesis Program, New York, NY USA.	roz4002@med.cornell.edu; wolchokj@mskcc.org; merghout@mskcc.org	Delgoffe, Greg M./HCH-2805-2022; Merghoub, Taha/ABD-8362-2021; Ackerstaff, Ellen/B-9420-2008	Delgoffe, Greg M./0000-0002-2957-8135; Ackerstaff, Ellen/0000-0003-4454-7481; Maniyar, Rachana/0000-0002-4135-6375; Verma, Svena/0000-0001-5504-6012; Ho, Ping-Chih/0000-0003-3078-3774	NIH/NCI [R01 CA215136-01A1, R50 CA221810]; Cancer Center Support Grant [P30 CA008748]; Swim Across America; Ludwig Institute for Cancer Research; Parker Institute for Cancer Immunotherapy; Breast Cancer Research Foundation; SNSF [31003A_182470]; European Research Council Staring Grant [802773-MitoGuide];  [T32CA082084];  [F31AI149971];  [DP2AI136598];  [R21AI135367]	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant; Swim Across America; Ludwig Institute for Cancer Research; Parker Institute for Cancer Immunotherapy; Breast Cancer Research Foundation; SNSF(Swiss National Science Foundation (SNSF)); European Research Council Staring Grant; ; ; ; 	We thank the Flow Cytometry and Integrated Genomics Operation Cores at MSK for technical assistance. We thank A. Rudensky for the constructive discussions for the revisions of this manuscript. This research was funded in part through the NIH/NCI R01 CA215136-01A1 and Cancer Center Support Grant P30 CA008748, the Swim Across America, Ludwig Institute for Cancer Research, Parker Institute for Cancer Immunotherapy and Breast Cancer Research Foundation. R.Z. was supported by the Parker Institute for Cancer Immunotherapy scholar and bridge scholar awards. I.S. was supported by R50 CA221810 (NIH/NCI) grant. M.J.W. was supported by T32CA082084 and F31AI149971. P.-C.H. was supported by the SNSF project grants (31003A_182470) and European Research Council Staring Grant (802773-MitoGuide). G.M.D. was supported by DP2AI136598 and R21AI135367.	Boudreau A, 2016, NAT CHEM BIOL, V12, P779, DOI 10.1038/nchembio.2143; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Geltink RIK, 2017, CELL, V171, P385, DOI 10.1016/j.cell.2017.08.018; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He NH, 2017, P NATL ACAD SCI USA, V114, P12542, DOI 10.1073/pnas.1715363114; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Luengo A, 2017, CELL CHEM BIOL, V24, P1161, DOI 10.1016/j.chembiol.2017.08.028; Martinez AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22480-w; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Nathanson T, 2017, CANCER IMMUNOL RES, V5, P84, DOI 10.1158/2326-6066.CIR-16-0019; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Ottensmeier CH, 2016, CANCER RES, V76, P4136, DOI 10.1158/0008-5472.CAN-15-3121; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Rizwan A, 2013, CLIN CANCER RES, V19, P5158, DOI 10.1158/1078-0432.CCR-12-3300; Scrimieri F, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26889; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Serganova I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203965; Serganova I, 2011, CLIN CANCER RES, V17, P6250, DOI 10.1158/1078-0432.CCR-11-0397; Simoes RV, 2015, NEOPLASIA, V17, P671, DOI 10.1016/j.neo.2015.08.005; Singer K, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00605; Singer K, 2011, INT J CANCER, V128, P2085, DOI 10.1002/ijc.25543; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; Wang HP, 2020, NAT IMMUNOL, V21, P298, DOI 10.1038/s41590-019-0589-5; Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yeung C, 2019, CANCER RES, V79, P5060, DOI 10.1158/0008-5472.CAN-19-0217; Zappasodi R, 2018, CANCER CELL, V33, P1017, DOI 10.1016/j.ccell.2018.05.009	40	88	90	33	124	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 25	2021	591	7851					652	+		10.1038/s41586-021-03326-4	http://dx.doi.org/10.1038/s41586-021-03326-4		FEB 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB5UT	33588426	Green Accepted			2022-12-28	WOS:000627285900001
J	Langley, RE; Gilbert, DC; Duong, T; Clarke, NW; Nankivell, M; Rosen, SD; Mangar, S; Macnair, A; Sundaram, SK; Laniado, ME; Dixit, S; Madaan, S; Manetta, C; Pope, A; Scrase, CD; Mckay, S; Muazzam, IA; Collins, GN; Worlding, J; Williams, ST; Paez, E; Robinson, A; McFarlane, J; Deighan, JV; Marshall, J; Forcat, S; Weiss, M; Kockelbergh, R; Alhasso, A; Kynaston, H; Parmar, M				Langley, Ruth E.; Gilbert, Duncan C.; Duong, Trinh; Clarke, Noel W.; Nankivell, Matthew; Rosen, Stuart D.; Mangar, Stephen; Macnair, Archie; Sundaram, Subramanian Kanaga; Laniado, Marc E.; Dixit, Sanjay; Madaan, Sanjeev; Manetta, Caroline; Pope, Alvan; Scrase, Christopher D.; Mckay, Stephen; Muazzam, Iqtedar A.; Collins, Gerald N.; Worlding, Jane; Williams, Simon T.; Paez, Edgar; Robinson, Angus; McFarlane, Jonathan; Deighan, John, V; Marshall, John; Forcat, Silvia; Weiss, Melanie; Kockelbergh, Roger; Alhasso, Abdulla; Kynaston, Howard; Parmar, Mahesh			Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme	LANCET			English	Article							DEPRIVATION THERAPY; PARENTERAL ESTROGEN; AGONISTS; RISK; MEN; REPLACEMENT; MORBIDITY; MORTALITY	Background Androgen suppression is a central component of prostate cancer management but causes substantial long-term toxicity. Transdermal administration of oestradiol (tE2) circumvents first-pass hepatic metabolism and, therefore, should avoid the cardiovascular toxicity seen with oral oestrogen and the oestrogen-depletion effects seen with luteinising hormone releasing hormone agonists (LHRHa). We present long-term cardiovascular follow-up data from the Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. Methods PATCH is a seamless phase 2/3, randomised, multicentre trial programme at 52 study sites in the UK. Men with locally advanced or metastatic prostate cancer were randomly allocated (1:2 from August, 2007 then 1:1 from February, 2011) to either LHRHa according to local practice or tE2 patches (four 100 mu g patches per 24 h, changed twice weekly, reducing to three patches twice weekly if castrate at 4 weeks [defined as testosterone <= 1.7 nmol/L]). Randomisation was done using a computer-based minimisation algorithm and was stratified by several factors, including disease stage, age, smoking status, and family history of cardiac disease. The primary outcome of this analysis was cardiovascular morbidity and mortality. Cardiovascular events, including heart failure, acute coronary syndrome, thromboembolic stroke, and other thromboembolic events, were confirmed using predefined criteria and source data. Sudden or unexpected deaths were attributed to a cardiovascular category if a confirmatory post-mortem report was available and as other relevant events if no post-mortem report was available. PATCH is registered with the ISRCTN registry, ISRCTN70406718; the study is ongoing and adaptive. Findings Between Aug 14, 2007, and July 30, 2019, 1694 men were randomly allocated either LHRHa (n=790) or tE2 patches (n=904). Overall, median follow-up was 3.9 (IQR 2.4-7.0) years. Respective castration rates at 1 month and 3 months were 65% and 93% among patients assigned LHRHa and 83% and 93% among those allocated tE2. 157 events from 145 men met predefined cardiovascular criteria, with a further ten sudden deaths with no postmortem report (total 167 events in 153 men). 26 (2%) of 1694 patients had fatal cardiovascular events, 15 (2%) of 790 assigned LHRHa and 11 (1%) of 904 allocated tE2. The time to first cardiovascular event did not differ between treatments (hazard ratio 1.11, 95% CI 0.80-1.53; p=0.54 [including sudden deaths without post-mortem report]; 1.20, 0.86-1.68; p=0.29 [confirmed group only]). 30 (34%) of 89 cardiovascular events in patients assigned tE2 occurred more than 3 months after tE2 was stopped or changed to LHRHa. The most frequent adverse events were gynaecomastia (all grades), with 279 (38%) events in 730 patients who received LHRHa versus 690 (86%) in 807 patients who received tE2 (p<0.0001) and hot flushes (all grades) in 628 (86%) of those who received LHRHa versus 280 (35%) who received tE2 (p<0.0001). Interpretation Long-term data comparing tE2 patches with LHRHa show no evidence of a difference between treatments in cardiovascular mortality or morbidity. Oestrogens administered transdermally should be reconsidered for androgen suppression in the management of prostate cancer. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Langley, Ruth E.; Gilbert, Duncan C.; Duong, Trinh; Nankivell, Matthew; Macnair, Archie; Deighan, John, V; Marshall, John; Forcat, Silvia; Weiss, Melanie; Parmar, Mahesh] Univ Coll London UCL, Med Res Council MRC, Clin Trials Units, London, England; [Clarke, Noel W.] Christie & Salford Royal Hosp, Manchester, Lancs, England; [Rosen, Stuart D.] Imperial Coll, Natl Heart & Lung Inst, London, England; [Mangar, Stephen] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, London, England; [Sundaram, Subramanian Kanaga] Mid Yorkshire NHS Trust, Wakefield, England; [Laniado, Marc E.] Wexha Pk Hosp, Frimley Hlth Fdn Trust, Slough, Berks, England; [Dixit, Sanjay] Scunthorpe Gen Hosp, Scunthorpe, England; [Madaan, Sanjeev] Dartford & Gravesham NHS Trust, Dept Urol & Nephrol, Dartford, England; [Manetta, Caroline] Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Pope, Alvan] Hillingdon Hosp NHS Fdn Trust & Imperial Coll Hea, London, England; [Scrase, Christopher D.] East Suffolk North Essex NHS Fdn Trust, Ipswich Hosp, Ipswich, Suffolk, England; [Mckay, Stephen] Forth Valley Royal Hosp, Larbert, Scotland; [Mckay, Stephen; Alhasso, Abdulla] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Muazzam, Iqtedar A.] Hull Univ Teaching Hosp NHS Trust, Castle Hill Hosp, Cottingham, England; [Collins, Gerald N.] East Cheshire NHS Trust, Macclesfield Dist Gen Hosp, Macclesfield, Cheshire, England; [Worlding, Jane] Univ Hosp Coventry, Coventry, W Midlands, England; [Williams, Simon T.] Royal Derby Hosp, Derby, England; [Paez, Edgar] Freeman Rd Hosp, Newcastle Urol, Newcastle Upon Tyne, Tyne & Wear, England; [Robinson, Angus] Sussex Canc Ctr, Brighton, E Sussex, England; [McFarlane, Jonathan] Bath NHS Fdn Trust, Royal United Hosp, Bath, Avon, England; [Kockelbergh, Roger] Univ Hosp Leicester, Dept Urol, Leicester, Leics, England; [Kynaston, Howard] Cardiff Univ, Div Canc & Genet, Med Sch, Cardiff, Wales	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; Christie NHS Foundation Trust; Christie Hospital; Salford Royal NHS Foundation Trust; Salford Royal Hospital; Imperial College London; Imperial College London; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; Ipswich Hospital NHS Trust; Ipswich Hospital; Beatson Oncology Centre; University of Hull; University of Warwick; University of Nottingham; Newcastle Freeman Hospital; Newcastle University - UK; University Hospitals of Leicester NHS Trust; University of Leicester; Cardiff University	Langley, RE (corresponding author), MRC Clin Trials Unit UCL, London WC1V 6LJ, England.	ruth.langley@ucl.ac.uk		Scrase, Christopher/0000-0001-8328-7454; Madaan, Sanjeev/0000-0003-4220-5613; Gilbert, Duncan/0000-0003-1859-7012	Cancer Research UK; Medical Research Council Clinical Trials Unit at University College London; MRC [MC_UU_12023/28] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council Clinical Trials Unit at University College London(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Cancer Research UK, and Medical Research Council Clinical Trials Unit at University College London.	Albertsen PC, 2014, EUR UROL, V65, P565, DOI 10.1016/j.eururo.2013.10.032; Alibhai SMH, 2015, CANCER-AM CANCER SOC, V121, P2350, DOI 10.1002/cncr.29355; Benedict C, 2014, J SEX MED, V11, P2571, DOI 10.1111/jsm.12645; Bourke L, 2013, BRIT J CANCER, V108, P9, DOI 10.1038/bjc.2012.523; BYAR DP, 1973, CANCER, V32, P1126, DOI 10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO;2-C; Canonico M, 2008, BMJ-BRIT MED J, V336, P1227, DOI 10.1136/bmj.39555.441944.BE; FINKELSTEIN JS, 1991, J CLIN ENDOCR METAB, V73, P621, DOI 10.1210/jcem-73-3-621; Gilbert DC, 2018, BJU INT, V121, P680, DOI 10.1111/bju.14153; Gilbert DC, 2017, BJU INT, V119, P667, DOI 10.1111/bju.13687; Gonzalez BD, 2015, J UROLOGY, V194, P690, DOI 10.1016/j.juro.2015.03.026; Hayes FJ, 2000, J CLIN ENDOCR METAB, V85, P3027, DOI 10.1210/jc.85.9.3027; Hedlund PO, 2000, UROLOGY, V55, P328, DOI 10.1016/S0090-4295(99)00580-4; Langley RE, 2008, BJU INT, V102, P442, DOI 10.1111/j.1464-410X.2008.07583.x; Langley RE, 2016, EUR UROL, V69, P1016, DOI 10.1016/j.eururo.2015.11.030; Langley RE, 2013, LANCET ONCOL, V14, P306, DOI 10.1016/S1470-2045(13)70025-1; Nguyen PL, 2011, JAMA-J AM MED ASSOC, V306, P2359, DOI 10.1001/jama.2011.1745; Norman G, 2008, BRIT J CANCER, V98, P697, DOI 10.1038/sj.bjc.6604230; O'Farrell S, 2015, J CLIN ONCOL, V33, P1243, DOI 10.1200/JCO.2014.59.1792; Ott J, 2010, FERTIL STERIL, V93, P1267, DOI 10.1016/j.fertnstert.2008.12.017; Parker C, 2020, ANN ONCOL, V31, P1119, DOI 10.1016/j.annonc.2020.06.011; Purnell JQ, 2006, J LIPID RES, V47, P349, DOI 10.1194/jlr.M500276-JLR200; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; Shore ND, 2020, NEW ENGL J MED, V382, P2187, DOI 10.1056/NEJMoa2004325; Smith MR, 2002, J CLIN ENDOCR METAB, V87, P599, DOI 10.1210/jc.87.2.599; vanKesteren PJM, 1997, CLIN ENDOCRINOL, V47, P337, DOI 10.1046/j.1365-2265.1997.2601068.x; VONSCHOULTZ B, 1989, PROSTATE, V14, P389, DOI 10.1002/pros.2990140410; WALSH BW, 1991, NEW ENGL J MED, V325, P1196, DOI 10.1056/NEJM199110243251702; Wilcox C, 2012, ONCOLOGY-BASEL, V82, P56, DOI 10.1159/000334999	29	8	8	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2021	397	10274					581	591						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL2TN	33581820	Green Submitted, Green Accepted			2022-12-28	WOS:000620934000023
J	Wise, J				Wise, Jacqui			Covid-19: Arthritis drug tocilizumab reduces deaths in hospitalised patients, study shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0; Wise J, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4530	2	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2021	372								n433	10.1136/bmj.n433	http://dx.doi.org/10.1136/bmj.n433			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM2MY	33574097	Bronze			2022-12-28	WOS:000639500800013
J	Andersson, NW; Olsen, RH; Andersen, JT				Andersson, Niklas Worm; Olsen, Rasmus Huan; Andersen, Jon Traerup			Association between use of macrolides in pregnancy and risk of major birth defects: nationwide, register based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVE To examine the association between the use of macrolide antibiotics in pregnancy and the risk of major birth defects. DESIGN Nationwide, register based cohort study. SETTING Denmark, 1997-2016. PARTICIPANTS Of 1 192 539 live birth pregnancies, pregnancies during which macrolides had been used (13 019) were compared with those during which penicillin (that is, phenoxymethylpenicillin) had been used (matched in a 1:1 ratio on propensity scores). Other comparative groups were pregnancies when macrolides had been used recently but before pregnancy (matched 1:1) and pregnancies where no antibiotics had been used (matched 1:4). MAIN OUTCOME MEASURES Association with an outcome of any major birth defect and specific subgroups of birth defects were assessed by relative risk ratios and absolute risk differences. RESULTS In matched comparisons, 457 infants were born with major birth defects to women who had used macrolides during pregnancy (35.1 per 1000 pregnancies) compared with 481 infants (37.0 per 1000 pregnancies) to women who had used penicillin (relative risk ratio 0.95; 95% confidence interval 0.84 to 1.08), corresponding to an absolute risk difference of -1.8 (95% confidence interval -6.4 to 2.7) per 1000 pregnancies. The risk of major birth defects was not significantly increased for women who had used macrolides during pregnancy compared with those who had used macrolides recently but before becoming pregnant (relative risk ratio 1.00 (95% confidence interval 0.88 to 1.14); absolute risk difference -0.1 (95% confidence interval -4.8 to 4.7) per 1000 pregnancies) or compared with women who did not use any antibiotics (1.05 (0.95 to 1.17); 1.8 (-1.7 to 5.3) per 1000 pregnancies). For all three comparative group analyses and in the analyses of use of individual macrolides, no significant increased risk of specific subgroups of birth defects associated with the use of macrolides was found. CONCLUSIONS In this nationwide cohort study, the use of macrolide antibiotics in pregnancy was not associated with an increased risk of major birth defects. Analyses of the associated risk of 12 specific subgroups of birth defects with the use of macrolides in pregnancy were not significant.	[Andersson, Niklas Worm; Olsen, Rasmus Huan; Andersen, Jon Traerup] Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Clin Pharmacol, Copenhagen NV, Denmark; [Andersson, Niklas Worm] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; [Andersen, Jon Traerup] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; Statens Serum Institut; University of Copenhagen	Andersson, NW (corresponding author), Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Clin Pharmacol, Copenhagen NV, Denmark.; Andersson, NW (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark.	nwandersson@gmail.com	Andersson, Niklas Worm/AAA-6988-2022; Olsen, Rasmus Huan/G-2249-2010	Andersson, Niklas Worm/0000-0001-7622-6303; Olsen, Rasmus Huan/0000-0001-8114-365X				Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Brookhart MA, 2013, CIRC-CARDIOVASC QUAL, V6, P604, DOI 10.1161/CIRCOUTCOMES.113.000359; Cooper WO, 2009, PAEDIATR PERINAT EP, V23, P18, DOI 10.1111/j.1365-3016.2008.00978.x; Czeizel AE, 1999, REPROD TOXICOL, V13, P531, DOI 10.1016/S0890-6238(99)00046-5; Damkier P, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.06.050; de Jonge L, 2014, PHARMACOEPIDEM DR S, V23, P60, DOI 10.1002/pds.3492; Dinur AB, 2013, ANTIMICROB AGENTS CH, V57, P3307, DOI 10.1128/AAC.01691-12; Eck LK, 2017, OBSTET GYNECOL, V129, P707, DOI [10.1097/AOG.0000000000001936, 10.1097/aog.0000000000001936]; Einarson A, 1998, AM J PERINAT, V15, P523, DOI 10.1055/s-2007-994053; Engeland A, 2018, PHARMACOEPIDEM DR S, V27, P995, DOI 10.1002/pds.4577; EUROCAT, INSTRUCTIONS REGISTR; Fan H, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m331; Fan H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212212; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Huybrechts KF, 2018, JAMA-J AM MED ASSOC, V320, P2429, DOI 10.1001/jama.2018.18307; Kallen BAJ, 2005, REPROD TOXICOL, V20, P209, DOI 10.1016/j.reprotox.2005.01.010; Kallen B, 2014, EUR J CLIN PHARMACOL, V70, P355, DOI 10.1007/s00228-013-1624-3; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knudsen LB, 1998, DAN MED BULL, V45, P320; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; Muanda FT, 2017, BRIT J CLIN PHARMACO, V83, P2557, DOI 10.1111/bcp.13364; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Petersen I, 2010, J ANTIMICROB CHEMOTH, V65, P2238, DOI 10.1093/jac/dkq307; Romoren M, 2012, BRIT J CLIN PHARMACO, V74, P1053, DOI 10.1111/j.1365-2125.2012.04286.x; Sadler TW, 2011, LANGMANS MED EMBRYOL; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Ventura M, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5545-z	30	4	4	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2021	372								n107	10.1136/bmj.n107	http://dx.doi.org/10.1136/bmj.n107			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH9VF	33568349	hybrid, Green Published			2022-12-28	WOS:000618622900008
J	Pulla, P				Pulla, Priyanka			Covid-19: Government wasted millions on poor quality PPE, spending watchdog finds	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												emailpriyanka@gmail.com			Thakur Family Foundation	Thakur Family Foundation	I have read and understood the BMJ policy on declaration of interests and declare: reporting for this article was funded by a grant from the Thakur Family Foundation, which did not influence the contents of the article.	Agarwal A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3939; [Anonymous], 2021, **NON-TRADITIONAL**; Carabelli AM, 2020, PERSISTENT SARS COV; Hermine O, 2021, JAMA INTERN MED, V181, P32, DOI 10.1001/jamainternmed.2020.6820; Indian Council of Medical Research, 2020, EV BAS ADV ADDR IN U; Kumar S, 20239574 MEDRXIV, DOI [10.1101/2020.12.01.20239574v1, DOI 10.1101/2020.12.01.20239574V1]; Libster R, 2021, NEW ENGL J MED, V384, P610, DOI 10.1056/NEJMoa2033700; Rosas I., 2020, TOCILIZUMAB HOSPITAL, DOI [10.1101/2020.08.27.20183442, DOI 10.1101/2020.08.27.20183442]; Salvarani C, 2021, JAMA INTERN MED, V181, P24, DOI 10.1001/jamainternmed.2020.6615; Simonovich VA, 2020, N ENGL J MED; Stone JH, 2020, NEW ENGL J MED, V383, P2333, DOI 10.1056/NEJMoa2028836; The REMAP-CAP Investigators, INT 6 REC ANT CRIT I, DOI [10.1101/2021.01.07.21249390v2, DOI 10.1101/2021.01.07.21249390V2]	12	3	3	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2021	372								n399	10.1136/bmj.n399	http://dx.doi.org/10.1136/bmj.n399			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH9VF	33568391	Bronze			2022-12-28	WOS:000618622900005
J	Yamey, G				Yamey, Gavin			Changing behaviour: an essential component of tackling health inequalities	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VACCINE		[Yamey, Gavin] Duke Univ, Duke Global Hlth Inst, Ctr Policy Impact Global Hlth, Durham, NC 27708 USA	Duke University	Yamey, G (corresponding author), Duke Univ, Duke Global Hlth Inst, Ctr Policy Impact Global Hlth, Durham, NC 27708 USA.	gavin.yamey@duke.edu	Rutter, Harry/HCI-8765-2022; Marmot, Michael/Y-3920-2019	Rutter, Harry/0000-0002-9322-0656; Marmot, Michael/0000-0002-2431-6419				Bandara Shashika, 2020, F1000Res, V9, P416, DOI 10.12688/f1000research.24015.1; Branswell H., 2020, STAT NEWS; Byanyima W, 2021, GLOBAL VACCINE APART; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Gupta R, 2020, SCIENCE, V370, P913, DOI 10.1126/science.abe0773; Pollet J, 2021, ADV DRUG DELIVER REV, V170, P71, DOI 10.1016/j.addr.2021.01.001; Summers LH, 2015, HUFFINGTON POST; Tait DR, 2019, NEW ENGL J MED, V381, P2429, DOI 10.1056/NEJMoa1909953; van Riel D, 2020, NAT MATER, V19, P810, DOI 10.1038/s41563-020-0746-0; World Health Organization, COVID 19 VACC LANDSC; Yamey G, 2020, DEV AGGREGATOR MECH	11	28	29	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2021	372								n332	10.1136/bmj.n332	http://dx.doi.org/10.1136/bmj.n332			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH9VF	33568384	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000618622900004
J	Berwick, DM; Beckman, AL; Gondi, S				Berwick, Donald M.; Beckman, Adam L.; Gondi, Suhas			The Triple Aim Applied to Correctional Health Systems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint characterizes correctional health care as a separate health system in the US responsible for the lives of 2 million citizens, but largely neglected by the quality improvement movement, and discusses ways to improve care, outcomes, and health care value for incarcerated individuals and populations.	[Berwick, Donald M.] Inst Healthcare Improvement IHI, Boston, MA USA; [Berwick, Donald M.; Beckman, Adam L.; Gondi, Suhas] Harvard Med Sch, Boston, MA 02115 USA	Institute for Healthcare Improvement; Harvard University; Harvard Medical School	Berwick, DM (corresponding author), Inst Healthcare Improvement, 53 State St,19th Floor, Boston, MA 02109 USA.	donberwick@gmail.com						Ahalt C, 2015, ANN INTERN MED, V162, P345, DOI 10.7326/M14-2161; Green TC, 2018, JAMA PSYCHIAT, V75, P405, DOI 10.1001/jamapsychiatry.2017.4614; Hawks L, 2020, J GEN INTERN MED, DOI 10.1007/s11606-020-06057-w; Olson Marin G, 2020, JAMA Health Forum, V1, pe200885, DOI 10.1001/jamahealthforum.2020.0885; PEW Charitable Trusts, PRIS HLTH CAR COSTS; Prison Policy Initiative, CRIM JUST RESP COR P; Saloner B, 2020, JAMA-J AM MED ASSOC, V324, P602, DOI 10.1001/jama.2020.12528; Substance Abuse and Mental Health Services Administration (SAMHSA), US MED ASS TREATM OP; Thanthong-Knight S., 2018, WASHINGTON POST; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	10	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2021	325	10					935	936		10.1001/jama.2021.0263	http://dx.doi.org/10.1001/jama.2021.0263		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV3UE	33555303				2022-12-28	WOS:000617177400002
J	Nabavi, N				Nabavi, Nikki			Increase in medical school applicants will not equal more doctors, says BMA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2019, BMJ BRIT MED J; Rimmer A, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2781; Rimmer A, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1328; UCAS, 2020, ENTR PROV LEV END CY	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2021	372								n369	10.1136/bmj.n369	http://dx.doi.org/10.1136/bmj.n369			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM1AV	33558266				2022-12-28	WOS:000639394000008
J	Spencer, NJ; Fryer, AA; Farmer, AD; Duff, CJ				Spencer, Nathaniel J.; Fryer, Anthony A.; Farmer, Adam D.; Duff, Christopher J.			Blood test monitoring of immunomodulatory therapy in inflammatory disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BOWEL-DISEASE; DERMATOLOGISTS GUIDELINES; BRITISH ASSOCIATION; NATIONAL GUIDANCE; PREVALENCE; MANAGEMENT; METHOTREXATE; ARTHRITIS; RISK; SAFE		[Spencer, Nathaniel J.; Fryer, Anthony A.; Duff, Christopher J.] Univ Hosp North Midlands NHS Trust, Dept Clin Biochem, Stoke On Trent, Staffs, England; [Fryer, Anthony A.; Farmer, Adam D.; Duff, Christopher J.] Keele Univ, Sch Med, Stoke On Trent, Staffs, England; [Farmer, Adam D.] Univ Hosp North Midlands NHS Trust, Dept Gastroenterol, Stoke On Trent, Staffs, England	Keele University	Duff, CJ (corresponding author), Univ Hosp North Midlands NHS Trust, Dept Clin Biochem, Stoke On Trent, Staffs, England.; Duff, CJ (corresponding author), Keele Univ, Sch Med, Stoke On Trent, Staffs, England.	chris.duff@uhnm.nhs.uk		Fryer, Anthony/0000-0001-8678-0404				British Association of Dermatologists, 2020, SAF PRESCR MON PROT; British Society for Rheumatology, 2020, COVID 19 GUID; British Society of Gastroenterology, 2020, BSG EXP CONS ADV MAN; British Society of Paediatric Gastroenterology, 2008, HEP NUTR GUID; Curtis JR, 2010, ANN RHEUM DIS, V69, P43, DOI 10.1136/ard.2008.101378; Driskell OJ, 2012, CLIN CHEM, V58, P906, DOI 10.1373/clinchem.2011.176487; Fryer AA, 2013, J CLIN PATHOL, V66, P62, DOI 10.1136/jclinpath-2011-200524; Gisbert JP, 2008, AM J GASTROENTEROL, V103, P1783, DOI 10.1111/j.1572-0241.2008.01848.x; Gisbert JP, 2007, AM J GASTROENTEROL, V102, P1518, DOI 10.1111/j.1572-0241.2007.01187.x; Lamb CA, 2019, GUT, V68, pS1, DOI 10.1136/gutjnl-2019-318484; Ledingham J, 2017, RHEUMATOLOGY, V56, P865, DOI 10.1093/rheumatology/kew479; Lichtenstein GR, 2018, AM J GASTROENTEROL, V113, P481, DOI 10.1038/ajg.2018.27; Ludlow Helen, 2009, Nurs Times, V105, P26; Matheny ME, 2008, J AM MED INFORM ASSN, V15, P424, DOI 10.1197/jamia.M2602; McMillan B, 2016, BRIT J GEN PRACT, V66, P631, DOI 10.3399/bjgp16X688297; Meggitt SJ, 2011, BRIT J DERMATOL, V165, P711, DOI 10.1111/j.1365-2133.2011.10575.x; National Institute for Health and Care Excellence, 2020, COVID 19 RAP GUID AR; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Rahier JF, 2014, J CROHNS COLITIS, V8, P443, DOI 10.1016/j.crohns.2013.12.013; Scargill JJ, 2017, EXP CLIN ENDOCR DIAB, V125, P625, DOI 10.1055/s-0043-103018; Springate DA, 2017, BRIT J DERMATOL, V176, P650, DOI 10.1111/bjd.15021; Symmons D, 2002, RHEUMATOLOGY, V41, P793, DOI 10.1093/rheumatology/41.7.793; Visser K, 2009, CLIN EXP RHEUMATOL, V27, P1017; Warren RB, 2016, BRIT J DERMATOL, V175, P23, DOI 10.1111/bjd.14816	24	3	3	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2021	372								n159	10.1136/bmj.n159	http://dx.doi.org/10.1136/bmj.n159			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM1AV	33558310	Green Accepted			2022-12-28	WOS:000639394000007
J	Japp, AS; Meng, WZ; Rosenfeld, AM; Perry, DJ; Thirawatananond, P; Bacher, RL; Liu, CY; Gardner, JS; Atkinson, MA; Kaestner, KH; Brusko, TM; Naji, A; Prak, ETL; Betts, MR				Japp, Alberto Sada; Meng, Wenzhao; Rosenfeld, Aaron M.; Perry, Daniel J.; Thirawatananond, Puchong; Bacher, Rhonda L.; Liu, Chengyang; Gardner, Jay S.; Atkinson, Mark A.; Kaestner, Klaus H.; Brusko, Todd M.; Naji, Ali; Prak, Eline T. Luning; Betts, Michael R.		HPAP Consortium	TCR+/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes	CELL			English	Article							T-CELLS; B-CELLS; REPERTOIRE; COMMITMENT; GENERATION; CONVERSION; TOOL	Ahmed and colleagues recently described a novel hybrid lymphocyte expressing both a B and T cell receptor, termed double expresser (DE) cells. DE cells in blood of type 1 diabetes (T1D) subjects were present at increased numbers and enriched for a public B cell clonotype. Here, we attempted to reproduce these findings. While we could identify DE cells by flow cytometry, we found no association between DE cell frequency and T1D status. We were unable to identify the reported public B cell clone, or any similar clone, in bulk B cells or sorted DE cells from T1D subjects or controls. We also did not observe increased usage of the public clone VH or DH genes in B cells or in sorted DE cells. Taken together, our findings suggest that DE cells and their alleged public clonotype are not enriched in T1D. This Matters Arising paper is in response to Ahmed et al. (2019), published in Cell. See also the response by Ahmed et al. (2021), published in this issue.	[Japp, Alberto Sada; Gardner, Jay S.; Betts, Michael R.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Japp, Alberto Sada; Meng, Wenzhao; Rosenfeld, Aaron M.; Liu, Chengyang; Gardner, Jay S.; Naji, Ali; Prak, Eline T. Luning; Betts, Michael R.] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Meng, Wenzhao; Rosenfeld, Aaron M.; Prak, Eline T. Luning] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Perry, Daniel J.; Thirawatananond, Puchong; Atkinson, Mark A.; Brusko, Todd M.] Univ Florida, Coll Med, Diabet Inst, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Bacher, Rhonda L.] Univ Florida, Coll Med, Dept Biostat, Gainesville, FL 32610 USA; [Liu, Chengyang; Naji, Ali] Univ Penn, Perelman Sch Med, Dept Surg, Philadelphia, PA 19104 USA; [HPAP Consortium] Perelman Sch Med, Human Pancreas Anal Program, Philadelphia, PA 19104 USA; [Kaestner, Klaus H.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Kaestner, Klaus H.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Betts, MR (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.; Prak, ETL; Betts, MR (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA.; Prak, ETL (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	luning@pennmedicine.upenn.edu; betts@pennmedicine.upenn.edu	Bacher, Rhonda/AAM-5912-2021	Bacher, Rhonda/0000-0001-5787-476X; Brusko, Todd/0000-0003-2878-9296	NIH [UC4 DK112217, P30-CA016520, P01 AI42288]; Human Islet Research Network (HIRN); Network for Pancreatic Organ donors with Diabetes (nPOD) [RRID: SCR_014641]; Juvenile Diabetes Research Foundation (JDRF) [nPOD: 5-SRA-2018-557-Q-R]; Leona M. & Harry B. Helmsley Charitable Trust [2018PG-T1D053]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Islet Research Network (HIRN); Network for Pancreatic Organ donors with Diabetes (nPOD); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Leona M. & Harry B. Helmsley Charitable Trust	Funding was provided by NIH grants UC4 DK112217 (to A.N., K.H.K., and M.R.B.), P30-CA016520 (to E.T.L.P.), and P01 AI42288 (to T.M.B. and M.A.A.) and the Human Islet Research Network (HIRN). This research was performed with the support of the Network for Pancreatic Organ donors with Diabetes (nPOD; RRID: SCR_014641), a collaborative type 1 diabetes research project sponsored by the Juvenile Diabetes Research Foundation (JDRF) (nPOD: 5-SRA-2018-557-Q-R), and The Leona M. & Harry B. Helmsley Charitable Trust (grant 2018PG-T1D053). We thank S. Chamala and M. Kamoun for HLA immunogenetics expertise and I. Kusmartseva, E. Walters, and K. McGrail for help with sample shipping, management and metadata. We further thank D. Farber, M. Shlomchik, M. Kamoun, and M. Cancro for helpful discussions.	Ahmed R, 2019, CELL, V177, P1583, DOI 10.1016/j.cell.2019.05.007; Allman D, 1999, J EXP MED, V189, P735, DOI 10.1084/jem.189.4.735; Atkinson MA, 2015, DIABETES CARE, V38, P979, DOI 10.2337/dc15-0144; Battaglia M, 2020, DIABETES CARE, V43, P5, DOI 10.2337/dc19-0880; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Bueno C, 2016, LEUKEMIA, V30, P674, DOI 10.1038/leu.2015.294; Burel JG, 2020, CYTOM PART A, V97, P1127, DOI 10.1002/cyto.a.24027; Caserta S, 2008, CANCER RES, V68, P3010, DOI 10.1158/0008-5472.CAN-07-5796; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; CUMANO A, 1986, EMBO J, V5, P2459, DOI 10.1002/j.1460-2075.1986.tb04522.x; DeWitt WS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160853; Efron B., 1986, STAT SCI, V1, P54, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gidoni M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08489-3; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; Herold KC, 2019, NEW ENGL J MED, V381, P603, DOI 10.1056/NEJMoa1902226; Herold KC, 2013, NAT REV IMMUNOL, V13, P243, DOI 10.1038/nri3422; Ikawa T, 2016, GENE DEV, V30, P2475, DOI 10.1101/gad.290593.116; ISENBERG D, 1993, BRIT J RHEUMATOL, V32, P876; Jedema I, 2011, HAEMATOL-HEMATOL J, V96, P1204, DOI 10.3324/haematol.2010.039099; Kaestner KH, 2019, DIABETES, V68, P1394, DOI 10.2337/db19-0058; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LEVENSHT.VI, 1965, DOKL AKAD NAUK SSSR+, V163, P845; Lun ATL, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1662-y; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Meng WZ, 2017, NAT BIOTECHNOL, V35, P879, DOI 10.1038/nbt.3942; Mi XL, 2018, AM J HEMATOL, V93, P1358, DOI 10.1002/ajh.25256; Miho E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09278-8; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Olson BJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02533; Opie EL, 1901, J EXP MED, V5, P397, DOI 10.1084/jem.5.4.397; Perry DJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22574-5; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Pugh-Bernard AE, 2001, J CLIN INVEST, V108, P1061, DOI 10.1172/JCI12462; Quigley MF, 2010, P NATL ACAD SCI USA, V107, P19414, DOI 10.1073/pnas.1010586107; Rosenfeld AM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02107; Rosenfeld AM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01472; Rothenberg EV, 2011, J IMMUNOL, V186, P6649, DOI 10.4049/jimmunol.1003703; Rubelt F, 2017, NAT IMMUNOL, V18, P1274, DOI 10.1038/ni.3873; Seay HR, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88242; Sosenko JM, 2013, DIABETES CARE, V36, P2615, DOI 10.2337/dc13-0425; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; THOMAS JW, 1993, J IMMUNOL, V150, P1375; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vander Heiden JA, 2014, BIOINFORMATICS, V30, P1930, DOI 10.1093/bioinformatics/btu138; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhang BC, 2015, J IMMUNOL METHODS, V427, P105, DOI 10.1016/j.jim.2015.10.009	56	3	3	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2021	184	3					827	+		10.1016/j.cell.2020.11.035	http://dx.doi.org/10.1016/j.cell.2020.11.035		FEB 2021	27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX8ZJ	33545036	Green Accepted, Bronze			2022-12-28	WOS:000629631400020
J	Alonso-Curbelo, D; Ho, YJ; Burdziak, C; Maag, JLV; Morris, JP; Chandwani, R; Chen, HA; Tsanov, KM; Barriga, FM; Luan, W; Tasdemir, N; Livshits, G; Azizi, E; Chun, J; Wilkinson, JE; Mazutis, L; Leach, SD; Koche, R; Pe'er, D; Lowe, SW				Alonso-Curbelo, Direna; Ho, Yu-Jui; Burdziak, Cassandra; Maag, Jesper L. V.; Morris, John P.; Chandwani, Rohit; Chen, Hsuan-An; Tsanov, Kaloyan M.; Barriga, Francisco M.; Luan, Wei; Tasdemir, Nilgun; Livshits, Geulah; Azizi, Elham; Chun, Jaeyoung; Wilkinson, John E.; Mazutis, Linas; Leach, Steven D.; Koche, Richard; Pe'er, Dana; Lowe, Scott W.			A gene-environment-induced epigenetic program initiates tumorigenesis	NATURE			English	Article							PANCREATIC-CANCER PROGRESSION; ONCOGENIC KRAS; CELL IDENTITY; TRANSCRIPTION FACTORS; SUPER-ENHANCERS; TUMOR; DIFFERENTIATION; INHIBITION; GENERATION; EXPRESSION	Tissue damage increases the risk of cancer through poorly understood mechanisms(1). In mouse models of pancreatic cancer, pancreatitis associated with tissue injury collaborates with activating mutations in the Kras oncogene to markedly accelerate the formation of early neoplastic lesions and, ultimately, adenocarcinoma(2,3). Here, by integrating genomics, single-cell chromatin assays and spatiotemporally controlled functional perturbations in autochthonous mouse models, we show that the combination of Kras mutation and tissue damage promotes a unique chromatin state in the pancreatic epithelium that distinguishes neoplastic transformation from normal regeneration and is selected for throughout malignant evolution. This cancer-associated epigenetic state emerges within 48 hours of pancreatic injury, and involves an 'acinar-to-neoplasia' chromatin switch that contributes to the early dysregulation of genes that define human pancreatic cancer. Among the factors that are most rapidly activated after tissue damage in the pre-malignant pancreatic epithelium is the alarmin cytokine interleukin 33, which recapitulates the effects of injury in cooperating with mutant Kras to unleash the epigenetic remodelling program of early neoplasia and neoplastic transformation. Collectively, our study demonstrates how gene-environment interactions can rapidly produce gene-regulatory programs that dictate early neoplastic commitment, and provides a molecular framework for understanding the interplay between genetic and environmental cues in the initiation of cancer.	[Alonso-Curbelo, Direna; Ho, Yu-Jui; Morris, John P.; Chen, Hsuan-An; Tsanov, Kaloyan M.; Barriga, Francisco M.; Luan, Wei; Tasdemir, Nilgun; Livshits, Geulah; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Burdziak, Cassandra; Azizi, Elham; Chun, Jaeyoung; Mazutis, Linas; Pe'er, Dana] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Burdziak, Cassandra] Weill Cornell Med, Triinst Training Program Computat Biol & Med, New York, NY USA; [Maag, Jesper L. V.; Koche, Richard] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, 1275 York Ave, New York, NY 10021 USA; [Chandwani, Rohit; Leach, Steven D.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Chandwani, Rohit] Weill Cornell Med Coll, Dept Surg, New York, NY USA; [Chandwani, Rohit] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Chen, Hsuan-An] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10021 USA; [Chun, Jaeyoung; Mazutis, Linas] Mem Sloan Kettering Canc Ctr, Alan & Sandra Gerry Metastasis & Tumor Ecosyst Ct, 1275 York Ave, New York, NY 10021 USA; [Wilkinson, John E.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Leach, Steven D.] Dartmouth Norris Cotton Canc Ctr, Hanover, NH USA; [Leach, Steven D.] Mem Sloan Kettering Canc Ctr, David M Rubenstein Ctr Pancreat Canc Res, 1275 York Ave, New York, NY 10021 USA; [Lowe, Scott W.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; Norris Cotton Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.; Lowe, SW (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	lowes@mskcc.org	Mazutis, Linas/A-5408-2012; Tsanov, Kaloyan M/J-6852-2012; Alonso Curbelo, Direna/AFT-1035-2022	Mazutis, Linas/0000-0002-5552-6427; Alonso Curbelo, Direna/0000-0001-6674-3059; Azizi, Elham/0000-0001-5059-6971; Ho, Yu-jui/0000-0002-7540-024X; Barriga, Francisco/0000-0002-0996-7707; Chen, Hsuan-An/0000-0002-8979-3670	NCI Cancer Center Support Grant (CCSG) [P30 CA08748]; Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; Spanish Fundacion Ramon Areces Postdoctoral Fellowship; La Caixa Postdoctoral Junior Leader Fellowship [LCF/BQ/PI20/11760006]; NIH F31 grant [F31CA246901]; American Cancer Society Postdoctoral Fellowship [126337-PF-14-066-01-TBE]; Pancreatic Cancer Action Network-AACR Pathway to Leadership Award; Jane Coffin Childs Memorial Fund for Medical Research; MSKCC's Translational Research Oncology Training Fellowship [5T32CA160001-08]; NIH K99 grant [K99CA237736, F99CA245797, K99CA230195]; NIH F32 grant [1F32CA177072-01]; American Cancer Society Fellowship [PF-13-037-01-DMC]; MSKCC's David Rubenstein Center for Pancreatic Research Pilot Project; Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center; Lustgarten Foundation Research Investigator Award; Agilent Thought Leader Program; NIH [P01CA13106, R01CA204228, P30CA023108, U54CA209975]	NCI Cancer Center Support Grant (CCSG)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; Spanish Fundacion Ramon Areces Postdoctoral Fellowship; La Caixa Postdoctoral Junior Leader Fellowship; NIH F31 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Postdoctoral Fellowship(American Cancer Society); Pancreatic Cancer Action Network-AACR Pathway to Leadership Award; Jane Coffin Childs Memorial Fund for Medical Research; MSKCC's Translational Research Oncology Training Fellowship; NIH K99 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH F32 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Fellowship(American Cancer Society); MSKCC's David Rubenstein Center for Pancreatic Research Pilot Project; Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center; Lustgarten Foundation Research Investigator Award; Agilent Thought Leader Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Chalarca, S. Ackermann, J. Simon, A. Wuest and the MSKCC animal facility for technical support with animal colonies; S. Yang, S. Young, Z. Zhao and A. Kahn for assistance with the generation of ES-cell-derived mouse models; J. Valdes, S. Dhara, T. Baslan, S. Tian and A. Osterhoudt for support with profiling experiments; I. Masilionis and O. Chaduhary for support with scATAC-seq experiments; V. Lavallee for his input and discussion on scATAC-seq data analysis; R. Garner and the MSKCC Flow Cytometry Core facility staff for assistance with cell sorting; and J. Reyes and other members of the Lowe laboratory for advice and discussions. We also acknowledge the MSKCC Integrated Genomics Operation Core, funded by the NCI Cancer Center Support Grant (CCSG, P30 CA08748), Cycle for Survival, and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology. D.A.-C. was supported by the Spanish Fundacion Ramon Areces Postdoctoral Fellowship and is recipient of the La Caixa Postdoctoral Junior Leader Fellowship (LCF/BQ/PI20/11760006); C.B. is supported by an NIH F31 grant (F31CA246901); J.P.M. was supported by an American Cancer Society Postdoctoral Fellowship (126337-PF-14-066-01-TBE); R.C. is supported by the Pancreatic Cancer Action Network-AACR Pathway to Leadership Award; H.-A.C. is supported by a NIH F99 Grant (F99CA245797); K.M.T. is supported by the Jane Coffin Childs Memorial Fund for Medical Research; F.M.B. is supported by MSKCC's Translational Research Oncology Training Fellowship (5T32CA160001-08); N.T. is supported by an NIH K99 grant (K99CA237736); G.L. was supported by an NIH F32 grant (1F32CA177072-01) and American Cancer Society Fellowship (PF-13-037-01-DMC); and E.A. is supported by a NIH K99 grant (K99CA230195). This work was also supported by MSKCC's David Rubenstein Center for Pancreatic Research Pilot Project (to S.W.L.) and The Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (to S.W.L./D.P.); the Lustgarten Foundation Research Investigator Award (to S.W.L.); the Agilent Thought Leader Program (to S.W.L.); and the NIH grants P01CA13106 (to S.W.L.), R01CA204228 and P30CA023108 (to S.D.L.) and U54CA209975 (to D.P.). S.W.L. is an investigator in the Howard Hughes Medical Institute and the Geoffrey Beene Chair for Cancer Biology.	Arda HE, 2018, CELL SYST, V7, P310, DOI 10.1016/j.cels.2018.07.007; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bian B, 2017, EMBO MOL MED, V9, P482, DOI 10.15252/emmm.201606975; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Carriere C, 2009, BIOCHEM BIOPH RES CO, V382, P561, DOI 10.1016/j.bbrc.2009.03.068; Cebola I, 2015, NAT CELL BIOL, V17, P615, DOI 10.1038/ncb3160; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cobo I, 2018, NATURE, V554, P533, DOI 10.1038/nature25751; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Danese A., 2019, EPISCANPY INTEGRATED, DOI [10.1101/648097, DOI 10.1101/648097]; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; DelGiorno KE, 2014, GASTROENTEROLOGY, V146, P233, DOI 10.1053/j.gastro.2013.08.053; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Diaferia GR, 2016, EMBO J, V35, P595, DOI 10.15252/embj.201592404; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dow LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095236; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Dumartin L, 2017, ONCOGENE, V36, P3094, DOI 10.1038/onc.2016.459; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Giroux V, 2017, NAT REV CANCER, V17, P594, DOI 10.1038/nrc.2017.68; Gopinathan A, 2015, DIS MODEL MECH, V8, P1185, DOI 10.1242/dmm.021055; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heiser PW, 2008, GASTROENTEROLOGY, V135, P1288, DOI 10.1053/j.gastro.2008.06.089; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hoang CQ, 2016, MOL CELL BIOL, V36, P3033, DOI 10.1128/MCB.00358-16; Holmstrom SR, 2011, GENE DEV, V25, P1674, DOI 10.1101/gad.16860911; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jiang M, 2016, MOL CELL BIOL, V36, P2945, DOI 10.1128/MCB.00370-16; Kalisz M, 2020, EMBO J, V39, DOI 10.15252/embj.2019102808; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Krah NM, 2015, ELIFE, V4, DOI 10.7554/eLife.07125; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li A, 2019, CELL REP, V29, P2998, DOI 10.1016/j.celrep.2019.10.120; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Livshits G, 2018, ELIFE, V7, DOI 10.7554/eLife.35216; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Maintainer B. P., 2015, TXDB DMELANOGASTER U; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753; McInnes L., 2018, UMAP UNIFORM MANIFOL, DOI DOI 10.21105/JOSS.00861; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Moral JA, 2020, NATURE, V579, P130, DOI 10.1038/s41586-020-2015-4; Morris JP, 2019, NATURE, V573, P595, DOI 10.1038/s41586-019-1577-5; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; O'Rourke KP, 2017, NAT BIOTECHNOL, V35, P577, DOI 10.1038/nbt.3837; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Pronier E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122703; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roe JS, 2017, CELL, V170, P875, DOI 10.1016/j.cell.2017.07.007; Saborowski M, 2014, GENE DEV, V28, P85, DOI 10.1101/gad.232082.113; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; Sherman MH, 2018, ANNU REV CELL DEV BI, V34, P333, DOI 10.1146/annurev-cellbio-100617-062855; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Stanger BZ, 2013, GASTROENTEROLOGY, V144, P1170, DOI 10.1053/j.gastro.2013.01.074; Storz P, 2017, NAT REV GASTRO HEPAT, V14, P296, DOI 10.1038/nrgastro.2017.12; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tasdemir N, 2016, CANCER DISCOV, V6, P612, DOI 10.1158/2159-8290.CD-16-0217; Truty MJ, 2009, J BIOL CHEM, V284, P6291, DOI 10.1074/jbc.M807791200; Vallejo A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14294; von Figura G, 2014, GUT, V63, P656, DOI 10.1136/gutjnl-2012-304287; Wei DY, 2016, CANCER CELL, V29, P324, DOI 10.1016/j.ccell.2016.02.005; Whittle MC, 2015, CELL, V161, P1345, DOI 10.1016/j.cell.2015.04.048; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wollny D, 2016, DEV CELL, V39, P289, DOI 10.1016/j.devcel.2016.10.002; Yang SH, 2016, CANCER RES, V76, P3838, DOI 10.1158/0008-5472.CAN-15-2841; Yevshin I, 2019, NUCLEIC ACIDS RES, V47, pD100, DOI 10.1093/nar/gky1128; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZD, 2020, CANCER CELL, V37, P584, DOI 10.1016/j.ccell.2020.03.001; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	89	51	52	4	55	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847								10.1038/s41586-020-03147-x	http://dx.doi.org/10.1038/s41586-020-03147-x		FEB 2021	37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM2BL	33536616	Green Accepted			2022-12-28	WOS:000614414900008
J	Wachterman, MW; Sommers, BD				Wachterman, Melissa W.; Sommers, Benjamin D.			Dying Poor in the US - Disparities in End-of-Life Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Wachterman, Melissa W.] VA Boston Healthcare Syst, 150 South Huntington Ave, Boston, MA 02130 USA; [Wachterman, Melissa W.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Sommers, Benjamin D.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Sommers, Benjamin D.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Wachterman, MW (corresponding author), VA Boston Healthcare Syst, 150 South Huntington Ave, Boston, MA 02130 USA.	melissa.wachterman@alumni.tufts.edu							0	7	7	3	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2021	325	5					423	424		10.1001/jama.2020.26162	http://dx.doi.org/10.1001/jama.2020.26162			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QC6JP	33528526	Bronze			2022-12-28	WOS:000614941900003
J	Haussler, M; Eck, M; Rothauer, D; Mecking, S				Haeussler, Manuel; Eck, Marcel; Rothauer, Dario; Mecking, Stefan			Closed-loop recycling of polyethylene-like materials	NATURE			English	Article							CHAIN; POLYOLEFINS; ACIDS; OILS	Plastics are key components of almost any technology today. Although their production consumes substantial feedstock resources, plastics are largely disposed of after their service life. In terms of a circular economy(1-8), reuse of post-consumer sorted polymers ('mechanical recycling') is hampered by deterioration of materials performance(9,10). Chemical recycling(1,11) via depolymerization to monomer offers an alternative that retains high-performance properties. The linear hydrocarbon chains of polyethylene(12) enable crystalline packing and provide excellent materials properties(13). Their inert nature hinders chemical recycling, however, necessitating temperatures above 600 degrees Celsius and recovering ethylene with a yield of less than 10 per cent(3,11,14). Here we show that renewable polycarbonates and polyesters with a low density of in-chain functional groups as break points in a polyethylene chain can be recycled chemically by solvolysis with a recovery rate of more than 96 per cent. At the same time, the break points do not disturb the crystalline polyethylene structure, and the desirable materials properties (like those of high-density polyethylene) are fully retained upon recycling. Processing can be performed by common injection moulding and the materials are well-suited for additive manufacturing, such as 3D printing. Selective removal from model polymer waste streams is possible. In our approach, the initial polymers result from polycondensation of long-chain building blocks, derived by state-of-the-art catalytic schemes from common plant oil feedstocks, or microalgae oils(15). This allows closed-loop recycling of polyethylene-like materials. Polycarbonates and polyesters with materials properties like those of high-density polyethylene can be recycled chemically by depolymerization to their constituent monomers, re-polymerization yielding material with uncompromised processing and materials properties.	[Haeussler, Manuel; Eck, Marcel; Rothauer, Dario; Mecking, Stefan] Univ Konstanz, Dept Chem, Chem Mat Sci, Constance, Germany	University of Konstanz	Mecking, S (corresponding author), Univ Konstanz, Dept Chem, Chem Mat Sci, Constance, Germany.	stefan.mecking@uni-konstanz.de	Rothauer, Dario/GQA-8969-2022; Mecking, Stefan/E-6991-2012	Rothauer, Dario/0000-0002-2661-0486; Mecking, Stefan/0000-0002-6618-6659; Haeussler, Manuel/0000-0002-8864-5940; Eck, Marcel/0000-0003-1121-1906	ERC [832480]	ERC(European Research Council (ERC)European Commission)	We thank M. Schnitte and L. Bolk for GPC and DSC measurements. Support of our studies of degradable polyethylenes by the ERC (Advanced Grant DEEPCAT, number 832480) is gratefully acknowledged.	AlAbbad M, 2017, CHEM PHYS LETT, V684, P390, DOI 10.1016/j.cplett.2017.07.020; Biermann U, 2011, ANGEW CHEM INT EDIT, V50, P3854, DOI 10.1002/anie.201002767; Capello C, 2007, GREEN CHEM, V9, P927, DOI 10.1039/b617536h; Chikkali S, 2012, ANGEW CHEM INT EDIT, V51, P5802, DOI 10.1002/anie.201107645; Coates GW, 2020, NAT REV MATER, V5, P501, DOI 10.1038/s41578-020-0190-4; De Hoe GX, 2018, J AM CHEM SOC, V140, P963, DOI 10.1021/jacs.7b10173; Eagan JM, 2017, SCIENCE, V355, P814, DOI 10.1126/science.aah5744; Ellen MacArthur Foundation, 2016, NEW PLASTICS EC RETH; FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008; Hees T, 2019, MACROMOL RAPID COMM, V40, DOI 10.1002/marc.201800608; Hess SK, 2018, EUR J LIPID SCI TECH, V120, DOI 10.1002/ejlt.201700152; Huf S, 2011, EUR J LIPID SCI TECH, V113, P548, DOI 10.1002/ejlt.201000112; Jeremic D., 2014, ULLMANNS ENCY IND CH, P1, DOI [10.1002/14356007.a21_487.pub3, DOI 10.1002/14356007.A21_487.PUB3]; Kaminsky W, 2016, MACROMOL SYMP, V360, P10, DOI 10.1002/masy.201500127; Lopez G, 2017, RENEW SUST ENERG REV, V73, P346, DOI 10.1016/j.rser.2017.01.142; Mutlu H, 2013, RSC ADV, V3, P4927, DOI 10.1039/c3ra40330k; Ortmann P, 2014, GREEN CHEM, V16, P1816, DOI 10.1039/c3gc42592d; Otera J., 2010, ESTERIFICATION METHO; Ragaert K, 2017, WASTE MANAGE, V69, P24, DOI 10.1016/j.wasman.2017.07.044; Rahimi A, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0046; SANCHEZ IC, 1975, MACROMOLECULES, V8, P638, DOI 10.1021/ma60047a012; Schirmeister CG, 2019, ADDIT MANUF, V28, P152, DOI 10.1016/j.addma.2019.05.003; Stempfle F, 2016, CHEM REV, V116, P4597, DOI 10.1021/acs.chemrev.5b00705; Stempfle F, 2011, MACROMOLECULES, V44, P4159, DOI 10.1021/ma200627e; Strobl G., 2007, PHYS POLYM; Sturzel M, 2016, CHEM REV, V116, P1398, DOI 10.1021/acs.chemrev.5b00310; Sun JJ, 2017, RSC ADV, V7, P12550, DOI 10.1039/c7ra01317e; Technology-manufacturing, 2013, EL REN SCI EL REN SCI; Vollmer I, 2020, ANGEW CHEM INT EDIT, V59, P15402, DOI 10.1002/anie.201915651; Witt T, 2017, ANGEW CHEM INT EDIT, V56, P7589, DOI 10.1002/anie.201702796; Zhang XY, 2018, CHEM REV, V118, P839, DOI 10.1021/acs.chemrev.7b00329; Zhu YQ, 2016, NATURE, V540, P354, DOI 10.1038/nature21001	32	122	125	103	431	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846								10.1038/s41586-020-03149-9	http://dx.doi.org/10.1038/s41586-020-03149-9			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TY5YS	33597754	Green Submitted			2022-12-28	WOS:000683860300005
J	Pal, SK; Tangen, C; Thompson, IM; Balzer-Haas, N; George, DJ; Heng, DYC; Shuch, B; Stein, M; Tretiakova, M; Humphrey, P; Adeniran, A; Narayan, V; Bjarnason, GA; Vaishampayan, U; Alva, A; Zhang, T; Cole, S; Plets, M; Wright, J; Lara, PN				Pal, Sumanta K.; Tangen, Catherine; Thompson, Ian M., Jr.; Balzer-Haas, Naomi; George, Daniel J.; Heng, Daniel Y. C.; Shuch, Brian; Stein, Mark; Tretiakova, Maria; Humphrey, Peter; Adeniran, Adebowale; Narayan, Vivek; Bjarnason, Georg A.; Vaishampayan, Ulka; Alva, Ajjai; Zhang, Tian; Cole, Scott; Plets, Melissa; Wright, John; Lara, Primo N., Jr.			A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial	LANCET			English	Article							1ST-LINE TREATMENT; C-MET; INHIBITOR; CLASSIFICATION; EXPRESSION; BIOMARKER; TYPE-1; TARGET	Background MET (also known as hepatocyte growth factor receptor) signalling is a key driver of papillary renal cell carcinoma (PRCC). Given that no optimal therapy for metastatic PRCC exists, we aimed to compare an existing standard of care, sunitinib, with the MET kinase inhibitors cabozantinib, crizotinib, and savolitinib for treatment of patients with PRCC. Methods We did a randomised, open-label, phase 2 trial done in 65 centres in the USA and Canada. Eligible patients were aged 18 years or older with metastatic PRCC who had received up to one previous therapy (excluding vascular endothelial growth factor-directed and MET-directed agents). Patients were randomly assigned to receive sunitinib, cabozantinib, crizotinib, or savolitinib, with stratification by receipt of previous therapy and PRCC subtype. All drug doses were administered orally: sunitinib 50 mg, 4 weeks on and 2 weeks off (dose reductions to 37.5 mg and 25 mg allowed); cabozantinib 60 mg daily (reductions to 40 mg and 20 mg allowed); crizotinib 250 mg twice daily (reductions to 200 mg twice daily and 250 mg once daily allowed); and savolitinib 600 mg daily (reductions to 400 mg and 200 mg allowed). Progression-free survival (PFS) was the primary endpoint. Analyses were done in an intention-to-treat population, with patients who did not receive protocol therapy excluded from safety analyses. This trial is registered with ClinicalTrials.gov, NCT02761057. Findings Between April 5, 2016, and Dec 15, 2019, 152 patients were randomly assigned to one of four study groups. Five patients were identified as ineligible post-randomisation and were excluded from these analyses, resulting in 147 eligible patients. Assignment to the savolitinib (29 patients) and crizotinib (28 patients) groups was halted after a prespecified futility analysis; planned accrual was completed for both sunitinib (46 patients) and cabozantinib (44 patients) groups. PFS was longer in patients in the cabozantinib group (median 9.0 months, 95% CI 6-12) than in the sunitinib group (5.6 months, 3-7; hazard ratio for progression or death 0.60, 0.37-0.97, one-sided p=0.019). Response rate for cabozantinib was 23% versus 4% for sunitinib (two-sided p=0.010). Savolitinib and crizotinib did not improve PFS compared with sunitinib. Grade 3 or 4 adverse events occurred in 31 (69%) of 45 patients receiving sunitinib, 32 (74%) of 43 receiving cabozantinib, ten (37%) of 27 receiving crizotinib, and 11 (39%) of 28 receiving savolitinib; one grade 5 thromboembolic event was recorded in the cabozantinib group. Interpretation Cabozantinib treatment resulted in significantly longer PFS compared with sunitinib in patients with metastatic PRCC. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Pal, Sumanta K.] City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA; [Tangen, Catherine; Plets, Melissa] SWOG Stat & Data Management Ctr, Seattle, WA USA; [Tangen, Catherine; Plets, Melissa] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Thompson, Ian M., Jr.] CHRISTUS Santa Rosa Med Ctr Hosp, San Antonio, TX USA; [Balzer-Haas, Naomi; Narayan, Vivek] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [George, Daniel J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Heng, Daniel Y. C.] Tom Baker Canc Clin, Calgary, AB, Canada; [Shuch, Brian] Univ Calif Los Angeles, Inst Urol Oncol, Los Angeles, CA USA; [Stein, Mark] Columbia Univ, Dept Med, New York, NY USA; [Tretiakova, Maria] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Humphrey, Peter; Adeniran, Adebowale] Yale Univ, Dept Pathol, New Haven, CT USA; [Bjarnason, Georg A.] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; [Vaishampayan, Ulka] Wayne State Univ, Dept Med, Detroit, MI 48202 USA; [Vaishampayan, Ulka; Alva, Ajjai] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Zhang, Tian] Duke Canc Res Inst, Alliance Clin Trials Oncol, Durham, NC USA; [Cole, Scott] NRG Oncol, Oklahoma Canc Specialists & Res Inst, Tulsa, OK USA; [Wright, John] NCI, Canc Therapy Evaluat Program, Invest Drug Branch, Bethesda, MD 20892 USA; [Lara, Primo N., Jr.] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA	City of Hope; Southwest Oncology Group; Fred Hutchinson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Duke University; Tom Baker Cancer Clinic; University of Calgary; University of California System; University of California Los Angeles; Columbia University; University of Washington; University of Washington Seattle; Yale University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Wayne State University; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Davis	Pal, SK (corresponding author), City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA.	spal@coh.org	Bjarnason, Georg Arnold/Q-5302-2016	Bjarnason, Georg Arnold/0000-0001-6903-5357	National Institutes of Health; National Cancer Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health and National Cancer Institute.	Albiges L, 2014, CLIN CANCER RES, V20, P3411, DOI 10.1158/1078-0432.CCR-13-2173; Armstrong AJ, 2016, LANCET ONCOL, V17, P378, DOI 10.1016/S1470-2045(15)00515-X; Changa NM, 2019, LANCET ONCOL, V20, P581, DOI 10.1016/S1470-2045(18)30907-0; Choueiri TK, 2020, ANN ONCOL, V31, pS1159, DOI 10.1016/j.annonc.2020.08.2257; Choueiri TK, 2020, JAMA ONCOL, V6, P1247, DOI 10.1001/jamaoncol.2020.2218; Choueiri TK, 2017, J CLIN ONCOL, V35, P2893, DOI 10.1200/JCO.2017.72.2967; Choueiri TK, 2013, J CLIN ONCOL, V31, P181, DOI 10.1200/JCO.2012.43.3383; Gavine PR, 2015, MOL ONCOL, V9, P323, DOI 10.1016/j.molonc.2014.08.015; Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917; McDermott DF, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.7_suppl.546; McGregor BA, 2020, ANN ONCOL, V31, pS558, DOI 10.1016/j.annonc.2020.08.781; Moch H, 2016, EUR UROL, V70, P93, DOI 10.1016/j.eururo.2016.02.029; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; National Comprehensive Cancer Network, 2021, NCCN GUID KIDN CANC; Pal SK, 2018, EUR UROL, V73, P71, DOI 10.1016/j.eururo.2017.05.033; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Ravaud A, 2015, ANN ONCOL, V26, P1123, DOI 10.1093/annonc/mdv149; Schoffski P, 2017, EUR J CANCER, V87, P147, DOI 10.1016/j.ejca.2017.10.014; Song SH, 2014, INT J CLIN EXP PATHO, V7, P7681; Srigley JR, 2013, AM J SURG PATHOL, V37, P1469, DOI 10.1097/PAS.0b013e318299f2d1; Rodriguez CS, 2020, J CLIN ONCOL, V38; Tannir NM, 2016, EUR UROL, V69, P866, DOI 10.1016/j.eururo.2015.10.049; Tannir NM, 2012, EUR UROL, V62, P1013, DOI 10.1016/j.eururo.2012.06.043; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264; Yu H, 2015, BRIT J CANCER, V113, P616, DOI 10.1038/bjc.2015.237; Zhang Tian, 2017, Am Soc Clin Oncol Educ Book, V37, P337, DOI 10.14694/EDBK_175572; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	27	63	63	3	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					695	703		10.1016/S0140-6736(21)00152-5	http://dx.doi.org/10.1016/S0140-6736(21)00152-5		FEB 2021	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL3PK	33592176	Green Accepted			2022-12-28	WOS:000620991800031
J	Kang, W; Lee, CC; Jasniewski, AJ; Ribbe, MW; Hu, YL				Kang, Wonchull; Lee, Chi Chung; jasniewski, Andrew J.; Ribbe, Markus W.; Hu, Yilin			Response to Comment on "Structural evidence for a dynamic metallocofactor during N-2 reduction by Monitrogenase"	SCIENCE			English	Editorial Material								Peters et al. comment on our report of the dynamic structure of the nitrogenase metallocofactor during N-2 reduction. Their claim that their independent structural refinement and consideration of biochemical data contradict our finding is incorrect and is strongly refuted by our biochemical and structural data that collectively and conclusively point to the binding of dinitrogen species to the nitrogenase cofactor.	[Kang, Wonchull; Lee, Chi Chung; jasniewski, Andrew J.; Ribbe, Markus W.; Hu, Yilin] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Ribbe, Markus W.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Ribbe, MW; Hu, YL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.; Ribbe, MW (corresponding author), Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA.	mribbe@uci.edu; yilinh@uci.edu		Jasniewski, Andrew/0000-0001-7614-0796; Lee, Chi Chung/0000-0002-5266-6686				Benediktsson B, 2018, CHEM COMMUN, V54, P7310, DOI 10.1039/c8cc03793k; Cao LL, 2020, J BIOL INORG CHEM, V25, P847, DOI 10.1007/s00775-020-01813-z; Kang W, 2020, SCIENCE, V368, P1381, DOI 10.1126/science.aaz6748; Owens CP, 2016, J AM CHEM SOC, V138, P10124, DOI 10.1021/jacs.6b06783; Peters J. W., 2020, SCIENCE, V371; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Rutledge HL, 2020, CHEM REV, V120, P5158, DOI 10.1021/acs.chemrev.9b00663; Sippel D, 2018, SCIENCE, V359, P1484, DOI 10.1126/science.aar2765; Tanifuji K, 2020, CHEM REV, V120, P5194, DOI 10.1021/acs.chemrev.9b00544	9	13	13	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530								10.1126/science.abe5856	http://dx.doi.org/10.1126/science.abe5856			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SM4GH	33574184				2022-12-28	WOS:000657565600001
J	Bergstrom, A; Stringer, C; Hajdinjak, M; Scerri, EML; Skoglund, P				Bergstrom, Anders; Stringer, Chris; Hajdinjak, Mateja; Scerri, Eleanor M. L.; Skoglund, Pontus			Origins of modern human ancestry	NATURE			English	Review							COVERAGE NEANDERTHAL GENOME; ANATOMICALLY MODERN HUMANS; MODERN HUMAN DISPERSALS; EVOLUTIONARY HISTORY; LATE PLEISTOCENE; DENISOVAN DNA; AFRICAN POPULATIONS; SEPARATION HISTORY; MITOCHONDRIAL-DNA; GENETIC DIVERSITY	New finds in the palaeoanthropological and genomic records have changed our view of the origins of modern human ancestry. Here we review our current understanding of how the ancestry of modern humans around the globe can be traced into the deep past, and which ancestors it passes through during our journey back in time. We identify three key phases that are surrounded by major questions, and which will be at the frontiers of future research. The most recent phase comprises the worldwide expansion of modern humans between 40 and 60 thousand years ago (ka) and their last known contacts with archaic groups such as Neanderthals and Denisovans. The second phase is associated with a broadly construed African origin of modern human diversity between 60 and 300 ka. The oldest phase comprises the complex separation of modern human ancestors from archaic human groups from 0.3 to 1 million years ago. We argue that no specific point in time can currently be identified at which modern human ancestry was confined to a limited birthplace, and that patterns of the first appearance of anatomical or behavioural traits that are used to define Homo sapiens are consistent with a range of evolutionary histories. A Review describes the three key phases that define the origins of modern human ancestry, and highlights the importance of analysing both palaeoanthropological and genomic records to further improve our understanding of our evolutionary history.	[Bergstrom, Anders; Hajdinjak, Mateja; Skoglund, Pontus] Francis Crick Inst, Ancient Genom Lab, London, England; [Stringer, Chris] Nat Hist Museum, Dept Earth Sci, London, England; [Scerri, Eleanor M. L.] Max Planck Inst Sci Human Hist, Pan African Evolut Res Grp, Jena, Germany; [Scerri, Eleanor M. L.] Univ Malta, Dept Class & Archaeol, Msida, Malta; [Scerri, Eleanor M. L.] Univ Cologne, Inst Prehist Archaeol, Cologne, Germany	Francis Crick Institute; Natural History Museum London; University of Malta; University of Cologne	Skoglund, P (corresponding author), Francis Crick Inst, Ancient Genom Lab, London, England.; Stringer, C (corresponding author), Nat Hist Museum, Dept Earth Sci, London, England.	c.stringer@nhm.ac.uk; pontus.skoglund@crick.ac.uk	Scerri, Eleanor/AHC-6769-2022	Scerri, Eleanor/0000-0002-7468-9977; Skoglund, Pontus/0000-0002-3021-5913; Bergstrom, Anders/0000-0002-4096-9268; Stringer, Chris/0000-0002-9183-7337; Hajdinjak, Mateja/0000-0002-4064-0331				Anton SC, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0236; Arnold LJ, 2014, J HUM EVOL, V67, P85, DOI 10.1016/j.jhevol.2013.12.001; Athreya S, 2017, AM J PHYS ANTHROPOL, V164, P679, DOI 10.1002/ajpa.23305; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Berger L., 2020, AFRICARXIV PREPR, DOI [10.31730/osf.io/eqs7d, DOI 10.31730/OSF.IO/EQS7D]; Bergstrom A, 2020, SCIENCE, V367, P1339, DOI 10.1126/science.aay5012; Breeze PS, 2016, QUATERNARY SCI REV, V144, P155, DOI 10.1016/j.quascirev.2016.05.012; Broushaki F, 2016, SCIENCE, V353, P499, DOI 10.1126/science.aaf7943; Brown S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23559; Browning SR, 2018, CELL, V173, P53, DOI 10.1016/j.cell.2018.02.031; Bruner E, 2020, J ANTHROPOL SCI, V98, P89, DOI [10.4436/jass.98014, 10.4436/JASS.98014]; Cai YJ, 2017, QUATERN INT, V434, P84, DOI 10.1016/j.quaint.2015.12.088; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Chen FH, 2019, NATURE, V569, P409, DOI 10.1038/s41586-019-1139-x; Chen L, 2020, CELL, V180, P677, DOI 10.1016/j.cell.2020.01.012; Clarkson C, 2017, NATURE, V547, P306, DOI 10.1038/nature22968; Cole C.B., 2020, ANCIENT ADMIXTURE AF, DOI [10.1101/2020.06.01.127555, DOI 10.1101/2020.06.01.127555]; Crevecoeur I, 2016, J HUM EVOL, V96, P35, DOI 10.1016/j.jhevol.2016.04.003; Currat M, 2011, P NATL ACAD SCI USA, V108, P15129, DOI 10.1073/pnas.1107450108; DeGiorgio M, 2009, P NATL ACAD SCI USA, V106, P16057, DOI 10.1073/pnas.0903341106; Deshpande O, 2009, P ROY SOC B-BIOL SCI, V276, P291, DOI 10.1098/rspb.2008.0750; Durvasula A, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax5097; Fan SH, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1679-2; Ferring R, 2011, P NATL ACAD SCI USA, V108, P10432, DOI 10.1073/pnas.1106638108; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Galway-Witham J, 2019, J QUATERNARY SCI, V34, P355, DOI 10.1002/jqs.3137; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Groucutt HS, 2018, NAT ECOL EVOL, V2, P800, DOI 10.1038/s41559-018-0518-2; Groucutt HS, 2015, EVOL ANTHROPOL, V24, P149, DOI 10.1002/evan.21455; Grun R, 2005, J HUM EVOL, V49, P316, DOI 10.1016/j.jhevol.2005.04.006; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Haber M, 2019, GENETICS, V212, P1421, DOI 10.1534/genetics.119.302368; Hajdinjak M, 2018, NATURE, V555, P652, DOI 10.1038/nature26151; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Hammond AS, 2018, J HUM EVOL, V123, P109, DOI 10.1016/j.jhevol.2018.06.010; Harding RM, 2004, CURR OPIN GENET DEV, V14, P667, DOI 10.1016/j.gde.2004.08.010; Harris K, 2016, GENETICS, V203, P881, DOI 10.1534/genetics.116.186890; Harvati K, 2019, NATURE, V571, P500, DOI 10.1038/s41586-019-1376-z; Harvati K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024024; Henn BM, 2018, CURR OPIN GENET DEV, V53, P148, DOI 10.1016/j.gde.2018.10.003; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Hershkovitz I, 2018, SCIENCE, V359, P456, DOI 10.1126/science.aap8369; Higham T, 2011, NATURE, V479, P521, DOI 10.1038/nature10484; Hsieh P, 2016, GENOME RES, V26, P291, DOI 10.1101/gr.196634.115; Hubisz MJ, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008895; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Hublin JJ, 2017, NATURE, V546, P289, DOI 10.1038/nature22336; Isaac GL., 1975, AUSTRALOPITHECINES, P875; Jacobs GS, 2019, CELL, V177, P1010, DOI 10.1016/j.cell.2019.02.035; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Juric I, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006340; Kamm J, 2020, J AM STAT ASSOC, V115, P1472, DOI 10.1080/01621459.2019.1635482; Karmin M, 2015, GENOME RES, V25, P459, DOI 10.1101/gr.186684.114; Kim BY, 2015, AM J HUM GENET, V96, P454, DOI 10.1016/j.ajhg.2014.12.029; Kingdon J., 1993, SELF MADE MAN HIS UN; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Kuhlwilm M, 2016, NATURE, V530, P429, DOI 10.1038/nature16544; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; Lacruz RS, 2019, NAT ECOL EVOL, V3, P726, DOI 10.1038/s41559-019-0865-7; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Lazaridis I, 2018, BIORXIV, P1, DOI [10.1101/423079(, DOI 10.1101/423079]; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lipson M, 2020, NATURE, V577, P665, DOI 10.1038/s41586-020-1929-1; Lipson M, 2017, MOL BIOL EVOL, V34, P889, DOI 10.1093/molbev/msw293; Liu W, 2015, NATURE, V526, P696, DOI 10.1038/nature15696; Llorente MG, 2015, SCIENCE, V350, P820, DOI 10.1126/science.aad2879; Lopez M, 2018, NAT ECOL EVOL, V2, P721, DOI 10.1038/s41559-018-0496-4; Mafessoni F, 2020, P NATL ACAD SCI USA, V117, P15132, DOI 10.1073/pnas.2004944117; Malaspinas AS, 2016, NATURE, V538, P207, DOI 10.1038/nature18299; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Martinon-Torres M, 2019, J HUM EVOL, V127, P93, DOI 10.1016/j.jhevol.2018.12.001; Mendez FL, 2013, AM J HUM GENET, V92, P454, DOI 10.1016/j.ajhg.2013.02.002; Meyer M, 2016, NATURE, V531, P504, DOI 10.1038/nature17405; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mondal M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08089-7; Mondal M, 2016, NAT GENET, V48, P1066, DOI 10.1038/ng.3621; Moorjani P, 2016, P NATL ACAD SCI USA, V113, P5652, DOI 10.1073/pnas.1514696113; Mounier A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11213-w; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Pagani L, 2016, NATURE, V538, P238, DOI 10.1038/nature19792; Patin E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000448; Pearson OM, 2008, EVOL ANTHROPOL, V17, P38, DOI 10.1002/evan.20155; Petr M, 2020, SCIENCE, V369, P1653, DOI 10.1126/science.abb6460; Petr M, 2019, P NATL ACAD SCI USA, V116, P1639, DOI 10.1073/pnas.1814338116; Pickrell JK, 2014, TRENDS GENET, V30, P377, DOI 10.1016/j.tig.2014.07.007; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; Pinhasi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117301; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Posth C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16046; Posth C, 2016, CURR BIOL, V26, P827, DOI 10.1016/j.cub.2016.01.037; Poznik GD, 2016, NAT GENET, V48, P593, DOI 10.1038/ng.3559; Prufer K, 2017, SCIENCE, V358, P655, DOI 10.1126/science.aao1887; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Qin PF, 2015, MOL BIOL EVOL, V32, P2665, DOI 10.1093/molbev/msv141; Ragsdale AP, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008204; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reich D, 2018, WHO WE ARE WE GOT HE; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reyes-Centeno H, 2014, P NATL ACAD SCI USA, V111, P7248, DOI 10.1073/pnas.1323666111; Rogers AR, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay5483; Rosenberg KR, 2006, P NATL ACAD SCI USA, V103, P3552, DOI 10.1073/pnas.0508681103; Sanchez-Quinto F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047765; Sankararaman S, 2016, CURR BIOL, V26, P1241, DOI 10.1016/j.cub.2016.03.037; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Scerri EML, 2019, NAT ECOL EVOL, V3, P1370, DOI 10.1038/s41559-019-0992-1; Scerri EML, 2018, TRENDS ECOL EVOL, V33, P582, DOI 10.1016/j.tree.2018.05.005; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Schumer M, 2018, SCIENCE, V360, P656, DOI 10.1126/science.aar3684; Seguin-Orlando A, 2014, SCIENCE, V346, P1113, DOI 10.1126/science.aaa0114; Sehlebusch CM, 2017, SCIENCE, V358, P652, DOI 10.1126/science.aao6266; Shackelford L, 2018, QUATERN INT, V466, P93, DOI 10.1016/j.quaint.2016.12.002; Sikora M, 2019, NATURE, V570, P182, DOI 10.1038/s41586-019-1279-z; Sikora M, 2017, SCIENCE, V358, P659, DOI 10.1126/science.aao1807; Skoglund P, 2018, ANNU REV GENOM HUM G, V19, P381, DOI 10.1146/annurev-genom-083117-021749; Skoglund P, 2018, NAT GENET, V50, P632, DOI 10.1038/s41588-018-0097-9; Skoglund P, 2017, CELL, V171, P59, DOI 10.1016/j.cell.2017.08.049; Skoglund P, 2016, NATURE, V538, P510, DOI 10.1038/nature19844; Skoglund P, 2014, SCIENCE, V344, P747, DOI 10.1126/science.1253448; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Skov L, 2020, NATURE, V582, P78, DOI 10.1038/s41586-020-2225-9; Slon V, 2018, NATURE, V561, P113, DOI 10.1038/s41586-018-0455-x; Slon V, 2017, SCIENCE, V356, P605, DOI 10.1126/science.aam9695; Song SY, 2017, GENETICS, V205, P385, DOI 10.1534/genetics.116.192963; Speidel L, 2019, NAT GENET, V51, P1321, DOI 10.1038/s41588-019-0484-x; Stojanowski CM, 2014, J HUM EVOL, V75, P80, DOI 10.1016/j.jhevol.2014.02.018; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Stringer C, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0237; Tassi F, 2015, INVESTIG GENET, V6, DOI 10.1186/s13323-015-0030-2; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; Tucci S, 2018, SCIENCE, V361, P511, DOI 10.1126/science.aar8486; Valladas H, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P69; van de Loosdrecht M, 2018, SCIENCE, V360, P548, DOI 10.1126/science.aar8380; Veeramah KR, 2012, MOL BIOL EVOL, V29, P617, DOI 10.1093/molbev/msr212; Verdu P, 2009, CURR BIOL, V19, P312, DOI 10.1016/j.cub.2008.12.049; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; Vernot B, 2015, AM J HUM GENET, V96, P448, DOI 10.1016/j.ajhg.2015.01.006; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Villanea FA, 2019, NAT ECOL EVOL, V3, P39, DOI 10.1038/s41559-018-0735-8; Wall JD, 2019, NATURE, V576, P106, DOI 10.1038/s41586-019-1793-z; Wall JD, 2019, AM J HUM GENET, V105, P1254, DOI 10.1016/j.ajhg.2019.11.005; Wall JD, 2017, AM J HUM GENET, V100, P766, DOI 10.1016/j.ajhg.2017.04.002; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Wang K, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008552; Wang SG, 2013, GENOME BIOL EVOL, V5, P2075, DOI 10.1093/gbe/evt160; Welker F, 2020, NATURE, V580, P235, DOI 10.1038/s41586-020-2153-8; Westaway KE, 2017, NATURE, V548, P322, DOI 10.1038/nature23452; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Wu XJ, 2019, P NATL ACAD SCI USA, V116, P9820, DOI 10.1073/pnas.1902396116; Yang MA, 2017, CURR BIOL, V27, P3202, DOI 10.1016/j.cub.2017.09.030; Yang MA, 2012, MOL BIOL EVOL, V29, P2987, DOI 10.1093/molbev/mss117; Zanolli C, 2013, CR PALEVOL, V12, P293, DOI 10.1016/j.crpv.2013.06.004; Zhang DJ, 2020, SCIENCE, V370, P584, DOI 10.1126/science.abb6320	169	56	60	34	148	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2021	590	7845					229	237		10.1038/s41586-021-03244-5	http://dx.doi.org/10.1038/s41586-021-03244-5			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG0TV	33568824				2022-12-28	WOS:000617300400011
J	Mueller, S; Winzer, EB; Duvinage, A; Gevaert, AB; Edelmann, F; Haller, B; Pieske-Kraigher, E; Beckers, P; Bobenko, A; Hommel, J; Van de Heyning, CM; Esefeld, K; von Korn, P; Christle, JW; Haykowsky, MJ; Linke, A; Wisloff, U; Adams, V; Pieske, B; van Craenenbroeck, EM; Halle, M				Mueller, Stephan; Winzer, Ephraim B.; Duvinage, Andre; Gevaert, Andreas B.; Edelmann, Frank; Haller, Bernhard; Pieske-Kraigher, Elisabeth; Beckers, Paul; Bobenko, Anna; Hommel, Jennifer; Van de Heyning, Caroline M.; Esefeld, Katrin; von Korn, Pia; Christle, Jeffrey W.; Haykowsky, Mark J.; Linke, Axel; Wisloff, Ulrik; Adams, Volker; Pieske, Burkert; van Craenenbroeck, Emeline M.; Halle, Martin		OptimEx-Clin Study Grp	Effect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity Advice on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								This randomized trial compares the effects of high-intensity interval training, moderate continuous training, and guideline-based physical activity on change in peak oxygen consumption (V?o2) in patients with heart failure with preserved ejection fraction (HFpEF). Question Is there a difference in change in peak oxygen consumption (V?o(2)) among patients with heart failure with preserved ejection fraction (HFpEF) treated with differing modes of exercise? Findings This randomized clinical trial included 180 patients with HFpEF assigned to high-intensity interval training, moderate continuous training, or a control of guideline-based physical activity advice. At 3 months, the changes in peak V?o(2) were 1.1, 1.6, and -0.6 mL/kg/min, respectively. There was no statistically significant difference between high-intensity interval and moderate continuous training, and neither group met the a priori-defined minimal clinically important difference of 2.5 mL/kg/min compared with the guideline control. Meaning These findings do not support either high-intensity interval training or moderate continuous training compared with guideline-based physical activity for patients with HFpEF. Importance Endurance exercise is effective in improving peak oxygen consumption (peak V?o(2)) in patients with heart failure with preserved ejection fraction (HFpEF). However, it remains unknown whether differing modes of exercise have different effects. Objective To determine whether high-intensity interval training, moderate continuous training, and guideline-based advice on physical activity have different effects on change in peak V?o(2) in patients with HFpEF. Design, Setting, and Participants Randomized clinical trial at 5 sites (Berlin, Leipzig, and Munich, Germany; Antwerp, Belgium; and Trondheim, Norway) from July 2014 to September 2018. From 532 screened patients, 180 sedentary patients with chronic, stable HFpEF were enrolled. Outcomes were analyzed by core laboratories blinded to treatment groups; however, the patients and staff conducting the evaluations were not blinded. Interventions Patients were randomly assigned (1:1:1; n = 60 per group) to high-intensity interval training (3 x 38 minutes/week), moderate continuous training (5 x 40 minutes/week), or guideline control (1-time advice on physical activity according to guidelines) for 12 months (3 months in clinic followed by 9 months telemedically supervised home-based exercise). Main Outcomes and Measures Primary end point was change in peak V?o(2) after 3 months, with the minimal clinically important difference set at 2.5 mL/kg/min. Secondary end points included changes in metrics of cardiorespiratory fitness, diastolic function, and natriuretic peptides after 3 and 12 months. Results Among 180 patients who were randomized (mean age, 70 years; 120 women [67%]), 166 (92%) and 154 (86%) completed evaluation at 3 and 12 months, respectively. Change in peak V?o(2) over 3 months for high-intensity interval training vs guideline control was 1.1 vs -0.6 mL/kg/min (difference, 1.5 [95% CI, 0.4 to 2.7]); for moderate continuous training vs guideline control, 1.6 vs -0.6 mL/kg/min (difference, 2.0 [95% CI, 0.9 to 3.1]); and for high-intensity interval training vs moderate continuous training, 1.1 vs 1.6 mL/kg/min (difference, -0.4 [95% CI, -1.4 to 0.6]). No comparisons were statistically significant after 12 months. There were no significant changes in diastolic function or natriuretic peptides. Acute coronary syndrome was recorded in 4 high-intensity interval training patients (7%), 3 moderate continuous training patients (5%), and 5 guideline control patients (8%). Conclusions and Relevance Among patients with HFpEF, there was no statistically significant difference in change in peak V?o(2) at 3 months between those assigned to high-intensity interval vs moderate continuous training, and neither group met the prespecified minimal clinically important difference compared with the guideline control. These findings do not support either high-intensity interval training or moderate continuous training compared with guideline-based physical activity for patients with HFpEF.	[Mueller, Stephan; Duvinage, Andre; Esefeld, Katrin; von Korn, Pia; Christle, Jeffrey W.; Halle, Martin] Tech Univ Munich, Univ Hosp Klinikum Rechts Isar, Dept Prevent & Sports Med, Munich, Germany; [Mueller, Stephan; Duvinage, Andre; Esefeld, Katrin; von Korn, Pia; Christle, Jeffrey W.] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Winzer, Ephraim B.; Hommel, Jennifer; Linke, Axel; Adams, Volker] Tech Univ Dresden, Heart Ctr Dresden, Dept Internal Med & Cardiol, Univ Hosp, Dresden, Germany; [Gevaert, Andreas B.; Beckers, Paul; Van de Heyning, Caroline M.; van Craenenbroeck, Emeline M.] Univ Antwerp, GENCOR Dept, Res Grp Cardiovasc Dis, Antwerp, Belgium; [Gevaert, Andreas B.; Beckers, Paul; Van de Heyning, Caroline M.; van Craenenbroeck, Emeline M.] Antwerp Univ Hosp, Dept Cardiol, Edegem, Belgium; [Edelmann, Frank; Pieske-Kraigher, Elisabeth; Bobenko, Anna; Pieske, Burkert] Charite Univ Med Berlin, Dept Internal Med & Cardiol, Campus Virchow Klinikum, Berlin, Germany; [Edelmann, Frank; Pieske-Kraigher, Elisabeth; Bobenko, Anna; Pieske, Burkert] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Haller, Bernhard] Tech Univ Munich, Inst Med Informat Stat & Epidemiol, Munich, Germany; [Christle, Jeffrey W.] Stanford Univ, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Haykowsky, Mark J.] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [Wisloff, Ulrik] Norwegian Univ Sci & Technol, Cardiac Exercise Res Grp, Dept Circulat & Med Imaging, Trondheim, Norway	Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Antwerp; University of Antwerp; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Technical University of Munich; Stanford University; University of Alberta; Norwegian University of Science & Technology (NTNU)	Halle, M (corresponding author), Tech Univ Munich, Dept Prevent & Sports Med, Accredited Ctr Sports Cardiol EAPC, Sch Med,Univ Hosp Klinikum Rechts Isar, Georg Brauchle Ring 56, D-80992 Munich, Germany.	martin.halle@mri.tum.de	Van Craenenbroeck, Emeline/AAG-4540-2020; Haller, Bernhard/I-1943-2019; Van De Heyning, Caroline M./H-6320-2016; Winzer, Ephraim/GYQ-8644-2022; Gevaert, Andreas B./B-2484-2017; Mueller, Stephan/AAM-9760-2021; Pieske, Burkert/M-8089-2016	Van Craenenbroeck, Emeline/0000-0001-7686-2668; Haller, Bernhard/0000-0002-9723-393X; Van De Heyning, Caroline M./0000-0002-4661-4732; Gevaert, Andreas B./0000-0002-1338-4133; Mueller, Stephan/0000-0003-4890-3981; von Korn, Pia/0000-0003-4528-2681; Haykowsky, Mark/0000-0002-7217-2747; Pieske, Burkert/0000-0002-6466-5306; Edelmann, Frank/0000-0003-4401-5936				Alves AJ, 2012, MED SCI SPORT EXER, V44, P776, DOI 10.1249/MSS.0b013e31823cd16a; Angadi SS, 2015, J APPL PHYSIOL, V119, P753, DOI 10.1152/japplphysiol.00518.2014; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bobenko A, 2018, ESC HEART FAIL, V5, P53, DOI 10.1002/ehf2.12227; Bonsu KO, 2018, HEART FAIL REV, V23, P147, DOI 10.1007/s10741-018-9679-y; Bowen TS, 2015, EUR J HEART FAIL, V17, P263, DOI 10.1002/ejhf.239; Chang PP, 2014, AM J CARDIOL, V113, P504, DOI 10.1016/j.amjcard.2013.10.032; da Silveira AD, 2020, EUR J PREV CARDIOL, V27, P1733, DOI 10.1177/2047487319901206; Edelmann F, 2013, JAMA-J AM MED ASSOC, V309, P781, DOI 10.1001/jama.2013.905; Edelmann F, 2011, J AM COLL CARDIOL, V58, P1780, DOI 10.1016/j.jacc.2011.06.054; Ellingsen O, 2017, CIRCULATION, V135, P839, DOI 10.1161/CIRCULATIONAHA.116.022924; Fleg JL, 2015, CIRC-HEART FAIL, V8, P209, DOI 10.1161/CIRCHEARTFAILURE.113.001420; Fujimoto N, 2012, AM HEART J, V164, P869, DOI 10.1016/j.ahj.2012.06.028; Fukuta H, 2019, HEART FAIL REV, V24, P535, DOI 10.1007/s10741-019-09774-5; Gary RA, 2004, HEART LUNG, V33, P210, DOI 10.1016/j.hrtlng.2004.01.004; Gevaert AB, 2019, EUR J HEART FAIL, V21, P125, DOI 10.1002/ejhf.1339; Guazzi M, 2016, CIRCULATION, V133, pE694, DOI 10.1161/CIR.0000000000000406; Haykowsky MJ, 2012, J AM COLL CARDIOL, V60, P120, DOI 10.1016/j.jacc.2012.02.055; Ho JE, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.003116; Kitzman DW, 2016, JAMA-J AM MED ASSOC, V315, P36, DOI 10.1001/jama.2015.17346; Kitzman DW, 2013, J AM COLL CARDIOL, V62, P584, DOI 10.1016/j.jacc.2013.04.033; Kitzman DW, 2010, CIRC-HEART FAIL, V3, P659, DOI 10.1161/CIRCHEARTFAILURE.110.958785; Kitzman DW, 2002, JAMA-J AM MED ASSOC, V288, P2144, DOI 10.1001/jama.288.17.2144; Mezzani A, 2009, EUR J CARDIOV PREV R, V16, P249, DOI 10.1097/HJR.0b013e32832914c8; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Pandey A, 2017, J AM COLL CARDIOL, V69, P1129, DOI 10.1016/j.jacc.2016.11.081; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Schmederer Z, 2018, INT J CARDIOL, V273, P147, DOI 10.1016/j.ijcard.2018.08.087; Solomon SD, 2019, NEW ENGL J MED, V381, P1609, DOI 10.1056/NEJMoa1908655; Spertus J, 2005, AM HEART J, V150, P707, DOI 10.1016/j.ahj.2004.12.010; Suchy C, 2014, EUR J PREV CARDIOL, V21, P18, DOI 10.1177/2047487314552764; Tucker WJ, 2018, HEART LUNG CIRC, V27, P9, DOI 10.1016/j.hlc.2017.07.002; Tucker Wesley J, 2016, Card Fail Rev, V2, P95, DOI 10.15420/cfr.2016:16:2; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Yelland LN, 2015, CLIN TRIALS, V12, P418, DOI 10.1177/1740774515588097	37	69	71	24	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2021	325	6					542	551		10.1001/jama.2020.26812	http://dx.doi.org/10.1001/jama.2020.26812			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG0MD	33560320	Bronze, Green Published			2022-12-28	WOS:000617279600017
J	Gerberding, JL; Haynes, BF				Gerberding, Julie L.; Haynes, Barton F.			Vaccine Innovations - Past and Future	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gerberding, Julie L.] Merck, Kenilworth, NJ 07033 USA; [Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC USA	Merck & Company; Duke University	Gerberding, JL (corresponding author), Merck, Kenilworth, NJ 07033 USA.							Carroll D, 2018, SCIENCE, V359, P872, DOI 10.1126/science.aap7463; Greene SA, 2019, MMWR-MORBID MORTAL W, V68, P458, DOI 10.15585/mmwr.mm6820a3; Lee LA, 2013, VACCINE, V31, pB61, DOI 10.1016/j.vaccine.2012.11.035; Plotkin SA, 2017, PLOTKINS VACCINES, P1; Usdin S., 2020, WHO MAPPING OUT COVI	5	9	10	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2021	384	5					393	396		10.1056/NEJMp2029466	http://dx.doi.org/10.1056/NEJMp2029466			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QX4QW	33535287	Bronze			2022-12-28	WOS:000629333200006
J	Leeming, J; Brown, P				Leeming, Jack; Brown, Patrick			Meet the food pioneer whose meat replacements are rocking the gravy boat	NATURE			English	Editorial Material						Careers; Lab life; Industry		Pat Brown explains how he's slicing into the market with plant-based steaks that are eco-friendly and good to eat. Pat Brown explains how he's slicing into the market with plant-based steaks that are eco-friendly and good to eat.	[Brown, Patrick] Impossible Foods, Redwood City, CA USA										0	1	1	6	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2021	590	7844					176	176		10.1038/d41586-021-00264-z	http://dx.doi.org/10.1038/d41586-021-00264-z			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA9GL	33526940	Bronze			2022-12-28	WOS:000613750500006
J	Russell, WA				Russell, W. Alton			Estimating the Effect of Discontinuing Universal Screening of Donated Blood for Zika Virus in the 50 US States	ANNALS OF INTERNAL MEDICINE			English	Letter									[Russell, W. Alton] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Russell, WA (corresponding author), Stanford Univ, Dept Management Sci & Engn, 475 Via Ortega, Stanford, CA 94305 USA.	altonr@stanford.edu		Russell, W Alton/0000-0003-1780-4470	Stanford Interdisciplinary Graduate Fellowship	Stanford Interdisciplinary Graduate Fellowship	Mr. Russell was funded by a Stanford Interdisciplinary Graduate Fellowship.	Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Diseases, 2021, ZIK VIR STAT MAPS; Kobres PY, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007451; Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246; Russell WA, 2019, ANN INTERN MED, V170, P164, DOI 10.7326/M18-2238; Russell WA., 2021, **DATA OBJECT**, DOI [10.5281/zenodo.4068495, DOI 10.5281/ZENODO.4068495]; U.S. Food and Drug Administration Center for Biologics Evaluation and Research., 120 M BLOOD PROD ADV	6	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					728	+		10.7326/M20-6879	http://dx.doi.org/10.7326/M20-6879			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33587688				2022-12-28	WOS:000652604800043
J	Wang, QK; Gao, HB; Clark, KM; Mugisha, CS; Davis, K; Tang, JP; Harlan, GH; DeSelm, CJ; Presti, RM; Kutluay, SB; Shan, L				Wang, Qiankun; Gao, Hongbo; Clark, Kolin M.; Mugisha, Christian Shema; Davis, Keanu; Tang, Jack P.; Harlan, Gray H.; DeSelm, Carl J.; Presti, Rachel M.; Kutluay, Sebla B.; Shan, Liang			CARD8 is an inflammasome sensor for HIV-1 protease activity	SCIENCE			English	Article								HIV-1 has high mutation rates and exists as mutant swarms within the host. Rapid evolution of HIV-1 allows the virus to outpace the host immune system, leading to viral persistence. Approaches to targeting immutable components are needed to clear HIV-1 infection. Here, we report that the caspase recruitment domain-containing protein 8 (CARD8) inflammasome senses HIV-1 protease activity. HIV-1 can evade CARD8 sensing because its protease remains inactive in infected cells before viral budding. Premature intracellular activation of the viral protease triggered CARD8 inflammasome-mediated pyroptosis of HIV-1-infected cells. This strategy led to the clearance of latent HIV-1 in patient CD4(+) T cells after viral reactivation. Thus, our study identifies CARD8 as an inflammasome sensor of HIV-1, which holds promise as a strategy for the clearance of persistent HIV-1 infection.	[Wang, Qiankun; Gao, Hongbo; Clark, Kolin M.; Harlan, Gray H.; Presti, Rachel M.; Shan, Liang] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; [Mugisha, Christian Shema; Davis, Keanu; Kutluay, Sebla B.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Tang, Jack P.; DeSelm, Carl J.] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA; [DeSelm, Carl J.; Shan, Liang] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Shan, L (corresponding author), Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA.; Shan, L (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.	liang.shan@wustl.edu	Gao, Hongbo/AHE-9262-2022; Shan, Liang/ABB-9210-2021	Clark, Kolin/0000-0003-3025-125X; Presti, Rachel/0000-0002-5469-0727; Wang, Qiankun/0000-0002-4390-4785; Shema Mugisha, Christian/0000-0002-0517-7986; Harlan, Gray/0000-0002-5235-2644; Tang, Jack Pengfei/0000-0003-4479-9638	NIH [R00AI125065, AI150470, 5DP5OD026427]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants R00AI125065 (to L.S.), AI150470 (to S.B.K.), and 5DP5OD026427 (to C.J.D.).	Ball DP, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000664; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Bauernfried S, 2021, SCIENCE, V371, P482, DOI 10.1126/science.abd0811; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chavarria-Smith J, 2015, IMMUNOL REV, V265, P22, DOI 10.1111/imr.12283; Chui AJ, 2019, SCIENCE, V364, P82, DOI 10.1126/science.aau1208; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Clayton KL, 2018, NAT IMMUNOL, V19, P475, DOI 10.1038/s41590-018-0085-3; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; ERICKSONVIITANEN S, 1989, AIDS RES HUM RETROV, V5, P577, DOI 10.1089/aid.1989.5.577; Fagerberg L., [No title captured]; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Figueiredo A, 2006, PLOS PATHOG, V2, P1051, DOI 10.1371/journal.ppat.0020119; Finger JN, 2012, J BIOL CHEM, V287, P25030, DOI 10.1074/jbc.M112.378323; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Frew BC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002659; Ganor Y, 2019, NAT MICROBIOL, V4, P633, DOI 10.1038/s41564-018-0335-z; Huang SH, 2018, J CLIN INVEST, V128, P876, DOI [10.1172/JCI97555, 10.1172/jci97555]; Jochmans D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-89; Johnson DC, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02865-4; Johnson DC, 2018, NAT MED, V24, P1151, DOI 10.1038/s41591-018-0082-y; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Linder A, 2020, EMBO J, V39, DOI 10.15252/embj.2020105071; Mochizuki H, 1998, J VIROL, V72, P8873, DOI 10.1128/JVI.72.11.8873-8883.1998; PARK JS, 1991, J VIROL, V65, P5111, DOI 10.1128/JVI.65.9.5111-5117.1991; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Potempa M, 2018, J MOL BIOL, V430, P5182, DOI 10.1016/j.jmb.2018.10.022; Potempa M, 2015, J MOL BIOL, V427, P2360, DOI 10.1016/j.jmb.2015.05.007; Preston BD, 1996, TRENDS MICROBIOL, V4, P16, DOI 10.1016/0966-842X(96)81500-9; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Robinson KS, 2020, SCIENCE, V370, P1182, DOI 10.1126/science.aay2002; Sandstrom A, 2019, SCIENCE, V364, P42, DOI 10.1126/science.aau1330; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Siliciano Janet D, 2005, Methods Mol Biol, V304, P3; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Trinite B, 2019, RETROVIROLOGY, V16, DOI 10.1186/s12977-019-0479-9; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wickliffe KE, 2008, CELL MICROBIOL, V10, P1352, DOI 10.1111/j.1462-5822.2008.01131.x; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Zerbato JM, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01736-16	46	30	32	6	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2021	371	6535					1224	+	eabe1707	10.1126/science.abe1707	http://dx.doi.org/10.1126/science.abe1707			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RE3JJ	33542150	Green Accepted			2022-12-28	WOS:000634054600035
J	Al-Hendy, A; Lukes, AS; Poindexter, AN; Venturella, R; Villarroel, C; Critchley, HOD; Li, YL; McKain, L; Ferreira, JCA; Langenberg, AGM; Wagman, RB; Stewart, EA				Al-Hendy, Ayman; Lukes, Andrea S.; Poindexter, Alfred N., III; Venturella, Roberta; Villarroel, Claudio; Critchley, Hilary O. D.; Li, Yulan; McKain, Laura; Ferreira, Juan C. Arjona; Langenberg, Andria G. M.; Wagman, Rachel B.; Stewart, Elizabeth A.			Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OVARIAN CONSERVATION; WOMEN; HORMONE; EPIDEMIOLOGY; ANTAGONIST; MANAGEMENT; ELAGOLIX; MYOMAS; SAFETY	BACKGROUND Uterine fibroids are a common cause of heavy menstrual bleeding and pain. Treatment with the combination of relugolix (an oral gonadotropin-releasing hormone-receptor antagonist), estradiol, and norethindrone acetate, administered once daily, may have efficacy in women with uterine fibroids and heavy bleeding while avoiding hypoestrogenic effects. METHODS We conducted two replicate international, double-blind, 24-week, phase 3 trials involving women with fibroid-associated heavy menstrual bleeding. Participants were randomly assigned in a 1:1:1 ratio to receive once-daily placebo, relugolix combination therapy (40 mg of relugolix, 1 mg of estradiol, and 0.5 mg of norethindrone acetate), or delayed relugolix combination therapy (40 mg of relugolix monotherapy, followed by relugolix combination therapy, each for 12 weeks). The primary efficacy end point in each trial was the percentage of participants with a response (volume of menstrual blood loss <80 ml and a >= 50% reduction in volume from baseline) in the relugolix combination therapy group, as compared with the placebo group. Key secondary end points were amenorrhea, volume of menstrual blood loss, distress from bleeding and pelvic discomfort, anemia, pain, fibroid volume, and uterine volume. Safety and bone mineral density were assessed. RESULTS A total of 388 women in trial L1 and 382 in trial L2 underwent randomization. A total of 73% of the participants in the relugolix combination therapy group in trial L1 and 71% of those in trial L2 had a response (primary end point), as compared with 19% and 15%, respectively, of those in the placebo groups (P<0.001 for both comparisons). Both relugolix combination therapy groups had significant improvements, as compared with the placebo groups, in six of seven key secondary end points, including measures of menstrual blood loss (including amenorrhea), pain, distress from bleeding and pelvic discomfort, anemia, and uterine volume, but not fibroid volume. The incidence of adverse events was similar with relugolix combination therapy and placebo. Bone mineral density was similar with relugolix combination therapy and placebo but decreased with relugolix monotherapy. CONCLUSIONS Once-daily relugolix combination therapy resulted in a significant reduction in menstrual bleeding, as compared with placebo, and preserved bone mineral density in women with uterine fibroids.	[Al-Hendy, Ayman] Univ Chicago, Dept Obstet & Gynecol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Lukes, Andrea S.] Carolina Womens Res & Wellness Ctr, Durham, NC USA; [Poindexter, Alfred N., III] Adv Hlth, Houston, TX USA; [Venturella, Roberta] Magna Graecia Univ Catanzaro, Unit Obstet & Gynecol, Dept Clin & Expt Med, Catanzaro, Italy; [Villarroel, Claudio] Univ Chile, Fac Med, Inst Mother & Child Res, Santiago, Chile; [Critchley, Hilary O. D.] Univ Edinburgh, Medi Res Council Ctr Repro Duct Hlth, Edinburgh, Midlothian, Scotland; [Li, Yulan; McKain, Laura; Ferreira, Juan C. Arjona; Langenberg, Andria G. M.; Wagman, Rachel B.] Myovant Sci, Brisbane, CA USA; [Stewart, Elizabeth A.] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN USA; [Stewart, Elizabeth A.] Mayo Clin, Alix Sch Med, Rochester, MN USA	University of Chicago; Magna Graecia University of Catanzaro; Universidad de Chile; University of Edinburgh; Mayo Clinic; Mayo Clinic	Al-Hendy, A (corresponding author), Univ Chicago, Dept Obstet & Gynecol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	aalhendy@bsd.uchicago.edu	Venturella, Roberta/K-3414-2016; Li, yu/HHZ-5236-2022; CRITCHLEY, HILARY OD/C-7575-2013; li, yu/HGL-9518-2022	Venturella, Roberta/0000-0003-1359-770X; CRITCHLEY, HILARY/0000-0003-1913-4044	Myovant Sciences	Myovant Sciences	Supported by Myovant Sciences.	Al-Hendy A, 2017, SEMIN REPROD MED, V35, P473, DOI 10.1055/s-0037-1607264; [Anonymous], 2021, ULIPRISTAL ACETATE U; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Borah BJ, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.017; Bulun SE, 2013, NEW ENGL J MED, V369, P1344, DOI 10.1056/NEJMra1209993; Cardozo ER, 2012, AM J OBSTET GYNECOL, V206, DOI [10.1016/j.ajog.2011.12.002, 10.1016/j.ajog.2012.08.020]; David M, 2016, EUR J OBSTET GYN R B, V199, P137, DOI 10.1016/j.ejogrb.2016.02.026; Donnez J, 2016, HUM REPROD UPDATE, V22, P665, DOI 10.1093/humupd/dmw023; Food and Drug Administration, 2020, OR EL ESTR NOR INDR; Foth D, 2017, ARCH GYNECOL OBSTET, V295, P415, DOI 10.1007/s00404-016-4239-y; FRIEDMAN AJ, 1990, AM J OBSTET GYNECOL, V163, P1114, DOI 10.1016/0002-9378(90)90667-V; HALLBERG L, 1966, ACTA OBSTET GYN SCAN, V45, P320, DOI 10.3109/00016346609158455; Hartmann KE, 2017, AHRQ PUBLICATION, V17, DOI [10.23970/AHRQEPCCER195, DOI 10.23970/AHRQEPCCER195]; HIGHAM JM, 1990, BRIT J OBSTET GYNAEC, V97, P734, DOI 10.1111/j.1471-0528.1990.tb16249.x; Khan KN, 2010, HUM REPROD, V25, P2878, DOI 10.1093/humrep/deq240; Laughlin-Tommaso SK, 2018, OBSTET GYNECOL, V132, P961, DOI 10.1097/AOG.0000000000002785; Laughlin-Tommaso SK, 2018, MENOPAUSE, V25, P483, DOI 10.1097/GME.0000000000001043; Lewis TD, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2414609; Li J, 2019, FERTIL STERIL, V112, pE344, DOI 10.1016/j.fertnstert.2019.07.991; Lukes A, 2017, HUM REPROD, V32, P267; Miwa K, 2011, J MED CHEM, V54, P4998, DOI 10.1021/jm200216q; Monleon J, 2018, EUR J OBSTET GYN R B, V226, P59, DOI 10.1016/j.ejogrb.2018.05.026; Munro MG, 2018, INT J GYNECOL OBSTET, V143, P393, DOI 10.1002/ijgo.12666; Nelson AL, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.04.023; Ng J, 2017, J CLIN ENDOCR METAB, V102, P1683, DOI 10.1210/jc.2016-3845; Osuga Y, 2019, FERTIL STERIL, V112, P922, DOI 10.1016/j.fertnstert.2019.07.013; Osuga Y, 2019, OBSTET GYNECOL, V133, P423, DOI 10.1097/AOG.0000000000003141; Parker WH, 2013, OBSTET GYNECOL, V121, P709, DOI 10.1097/AOG.0b013e3182864350; Perez-Lopez FR, 2014, MATURITAS, V79, P106, DOI 10.1016/j.maturitas.2014.06.002; Sabry M, 2012, REPROD SCI, V19, P339, DOI 10.1177/1933719111432867; Schlaff WD, 2020, NEW ENGL J MED, V382, P328, DOI 10.1056/NEJMoa1904351; Soliman AM, 2017, CURR MED RES OPIN, V33, P1971, DOI 10.1080/03007995.2017.1372107; Stewart E, 2015, NAT REV DIS PRIMERS, V372, P1646, DOI DOI 10.1038/nrdp.2016.43; Stewart EA, 2015, NEW ENGL J MED, V372, P1646, DOI [10.1056/NEJMcp1411029, 10.1038/nrdp.2016.43]; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; Wise LA, 2016, CLIN OBSTET GYNECOL, V59, P2, DOI 10.1097/GRF.0000000000000164; Yao X, 2017, BJOG-INT J OBSTET GY, V124, P322, DOI 10.1111/1471-0528.14383	37	37	41	7	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2021	384	7					630	642		10.1056/NEJMoa2008283	http://dx.doi.org/10.1056/NEJMoa2008283			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL2HH	33596357	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000620900000010
J	Kuehn, BM				Kuehn, Bridget M.			High-Income Countries Have Secured the Bulk of COVID-19 Vaccines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2021	325	7					612	612		10.1001/jama.2021.0189	http://dx.doi.org/10.1001/jama.2021.0189			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ3QZ	33591354	Bronze			2022-12-28	WOS:000619608000002
J	Sezer, A; Kilickap, S; Gumus, M; Bondarenko, I; Ozguroglu, M; Gogishvili, M; Turk, HM; Cicin, I; Bentsion, D; Gladkov, O; Clingan, P; Sriuranpong, V; Rizvi, N; Gao, B; Li, SY; Lee, S; McGuire, K; Chen, CI; Makharadze, T; Paydas, S; Nechaeva, M; Seebach, F; Weinreich, DM; Yancopoulos, GD; Gullo, G; Lowy, I; Rietschel, P				Sezer, Ahmet; Kilickap, Saadettin; Gumus, Mahmut; Bondarenko, Igor; Ozguroglu, Mustafa; Gogishvili, Miranda; Turk, Haci M.; Cicin, Irfan; Bentsion, Dmitry; Gladkov, Oleg; Clingan, Philip; Sriuranpong, Virote; Rizvi, Naiyer; Gao, Bo; Li, Siyu; Lee, Sue; McGuire, Kristina; Chen, Chieh-, I; Makharadze, Tamta; Paydas, Semra; Nechaeva, Marina; Seebach, Frank; Weinreich, David M.; Yancopoulos, George D.; Gullo, Giuseppe; Lowy, Israel; Rietschel, Petra			Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial	LANCET			English	Article								Background We aimed to examine cemiplimab, a programmed cell death 1 inhibitor, in the first-line treatment of advanced non-small-cell lung cancer with programmed cell death ligand 1 (PD-L1) of at least 50%. Methods In EMPOWER-Lung 1, a multicentre, open-label, global, phase 3 study, eligible patients recruited in 138 clinics from 24 countries (aged >= 18 years with histologically or cytologically confirmed advanced non-small-cell lung cancer, an Eastern Cooperative Oncology Group performance status of 0-1; never-smokers were ineligible) were randomly assigned (1:1) to cemiplimab 350 mg every 3 weeks or platinum-doublet chemotherapy. Crossover from chemotherapy to cemiplimab was allowed following disease progression. Primary endpoints were overall survival and progression-free survival per masked independent review committee. Primary endpoints were assessed in the intention-to-treat population and in a prespecified PD-L1 of at least 50% population (per US Food and Drug Administration request to the sponsor), which consisted of patients with PD-L1 of at least 50% per 22C3 assay done according to instructions for use. Adverse events were assessed in all patients who received at least one dose of the assigned treatment. This study is registered with ClinicalTrials.gov, NCT03088540 and is ongoing. Findings Between June 27, 2017 and Feb 27, 2020, 710 patients were randomly assigned (intention-to-treat population). In the PD-L1 of at least 50% population, which consisted of 563 patients, median overall survival was not reached (95% CI 17.9-not evaluable) with cemiplimab (n=283) versus 14.2 months (11.2-17.5) with chemotherapy (n=280; hazard ratio [HR] 0.57 [0.42-0.77]; p=0.0002). Median progression-free survival was 8.2 months (6.1-8.8) with cemiplimab versus 5.7 months (4.5-6.2) with chemotherapy (HR 0.54 [0.43-0.68]; p<0.0001). Significant improvements in overall survival and progression-free survival were also observed with cemiplimab in the intention-to-treat population despite a high crossover rate (74%). Grade 3-4 treatment-emergent adverse events occurred in 98 (28%) of 355 patients treated with cemiplimab and 135 (39%) of 342 patients treated with chemotherapy. Interpretation Cemiplimab monotherapy significantly improved overall survival and progression-free survival compared with chemotherapy in patients with advanced non-small-cell lung cancer with PD-L1 of at least 50%, providing a potential new treatment option for this patient population. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Sezer, Ahmet] Baskent Univ, Dept Med Oncol, Dadaloglu Mh 39 SK, Adana, Turkey; [Kilickap, Saadettin] Hacettepe Univ, Dept Med Oncol, Canc Inst, Ankara, Turkey; [Gumus, Mahmut] Istanbul Medeniyet Univ, Sch Med, Dept Med Oncol, Istanbul, Turkey; [Bondarenko, Igor] Dnipropetrovsk Med Acad, Dept Oncol & Med Radiol, Dnipro, Ukraine; [Ozguroglu, Mustafa] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Istanbul, Turkey; [Gogishvili, Miranda] Univ Clin, High Technol Med Ctr, Tbilisi, Georgia; [Turk, Haci M.] Bezmialem Vakif Univ, Med Fac, Dept Med Oncol, Istanbul, Turkey; [Cicin, Irfan] Trakya Univ, Dept Med Oncol, Edirne, Turkey; [Bentsion, Dmitry] Sverdlovsk Reg Oncol Ctr, Radiotherapy Dept, Ekaterinburg, Russia; [Gladkov, Oleg] LLC EVIMED, Chelyabinsk, Russia; [Clingan, Philip] Univ Wollongong, Wollongong Hosp, Southern Med Day Care Ctr, Illawarra Canc Ctr, Wollongong, NSW, Australia; [Clingan, Philip] Univ Wollongong, Wollongong Hosp, Illawarra Hlth & Med Res Inst, Illawarra Canc Ctr, Wollongong, NSW, Australia; [Sriuranpong, Virote] Chulalongkorn Univ, Fac Med, Dept Med, Div Med Oncol, Bangkok, Thailand; [Sriuranpong, Virote] King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Rizvi, Naiyer] Columbia Univ, Div Hematol Oncol, Med Ctr, New York, NY USA; [Gao, Bo; Li, Siyu; Lee, Sue; Chen, Chieh-, I] Regeneron Pharmaceut, Basking Ridge, NJ USA; [Makharadze, Tamta] High Technol Hosp Medctr, Batumi, Georgia; [Paydas, Semra] Cukurova Univ, Fac Med, Dept Med Oncol, Adana, Turkey; [Nechaeva, Marina] Arkhangelsk Clin Oncol Ctr, Arkhangelsk, Russia; [McGuire, Kristina; Seebach, Frank; Weinreich, David M.; Yancopoulos, George D.; Gullo, Giuseppe; Lowy, Israel; Rietschel, Petra] Regeneron Pharmaceut, New York, NY USA	Baskent University; Hacettepe University; Istanbul Medeniyet University; Dnipro State Medical University; Istanbul University - Cerrahpasa; Bezmialem Vakif University; Trakya University; University of Wollongong; Wollongong Hospital; University of Wollongong; Wollongong Hospital; Chulalongkorn University; Chulalongkorn University; Columbia University; Cukurova University; Regeneron	Sezer, A (corresponding author), Baskent Univ, Dept Med Oncol, Dadaloglu Mh 39 SK, Adana, Turkey.	drasezer@hotmail.com.tr	Kilickap, Saadettin/AAP-3732-2021; MUSTAFA, ÖZGÜROĞLU/A-8234-2016; SEZER, AHMET/AAD-2667-2020; Paydas, Semra/F-3132-2018; Bondarenko, Igor/W-9412-2019; Bondarenko, Igor N/GQP-1497-2022	Kilickap, Saadettin/0000-0003-1637-7390; MUSTAFA, ÖZGÜROĞLU/0000-0002-8417-8628; SEZER, AHMET/0000-0002-6445-1439; Paydas, Semra/0000-0003-4642-3693; Bondarenko, Igor/0000-0002-7071-2471; Bondarenko, Igor N/0000-0002-7071-2471	Regeneron Pharmaceuticals; Sanofi	Regeneron Pharmaceuticals(Regeneron); Sanofi	Regeneron Pharmaceuticals and Sanofi.	Burova E, 2017, MOL CANCER THER, V16, P861, DOI 10.1158/1535-7163.MCT-16-0665; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ernani V, 2018, J THORAC DIS, V10, pS412, DOI 10.21037/jtd.2017.12.94; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Gridelli C, 2018, NAT REV CLIN ONCOL, V15, P593, DOI 10.1038/s41571-018-0070-7; Hanna NH, 2020, J CLIN ONCOL, V38, P1608, DOI 10.1200/JCO.19.03022; Herbst RS, 2020, NEW ENGL J MED, V383, P1328, DOI 10.1056/NEJMoa1917346; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Hirsch FR, 2017, J THORAC ONCOL, V12, P208, DOI 10.1016/j.jtho.2016.11.2228; Macdonald LE, 2014, P NATL ACAD SCI USA, V111, P5147, DOI 10.1073/pnas.1323896111; Migden MR, 2018, NEW ENGL J MED, V379, P341, DOI 10.1056/NEJMoa1805131; Migden MR, 2020, LANCET ONCOL, V21, P294, DOI 10.1016/S1470-2045(19)30728-4; Mok TSK, 2019, LANCET, V393, P1819, DOI 10.1016/S0140-6736(18)32409-7; Murphy AJ, 2014, P NATL ACAD SCI USA, V111, P5153, DOI 10.1073/pnas.1324022111; National Comprehensive Cancer Network,, NCCN CLIN PRACTICE G; Olmedo Garcia ME, 2019, P AM SOC CLIN ONCOL, V37; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Papadopoulos KP, 2020, CLIN CANCER RES, V26, P1025, DOI 10.1158/1078-0432.CCR-19-2609; Pilkington G, 2015, THORAX, V70, P359, DOI 10.1136/thoraxjnl-2014-205914; Reck M, 2019, J CLIN ONCOL, V37, P537, DOI 10.1200/JCO.18.00149; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rimm DL, 2017, JAMA ONCOL, V3, P1051, DOI 10.1001/jamaoncol.2017.0013; Rischin D, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000775; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Scagliotti GV, 2014, LUNG CANCER, V85, P408, DOI 10.1016/j.lungcan.2014.07.005; Socinski MA, 2018, NEW ENGL J MED, V378, P2288, DOI 10.1056/NEJMoa1716948; Ulas Arife, 2015, Asian Pac J Cancer Prev, V16, P815; West H, 2019, LANCET ONCOL, V20, P924, DOI 10.1016/S1470-2045(19)30167-6	30	181	186	13	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2021	397	10274					592	604						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL2TN	33581821				2022-12-28	WOS:000620934000024
J	Page, K; Melia, MT; Veenhuis, RT; Winter, M; Rousseau, KE; Massaccesi, G; Osburn, WO; Forman, M; Thomas, E; Thornton, K; Wagner, K; Vassilev, V; Lin, L; Lum, PJ; Giudice, LC; Stein, E; Asher, A; Chang, SJ; Gorman, R; Ghany, MG; Liang, TJ; Wierzbicki, MR; Scarselli, E; Nicosia, A; Folgori, A; Capone, S; Cox, AL				Page, Kimberly; Melia, Michael T.; Veenhuis, Rebecca T.; Winter, Matthew; Rousseau, Kimberly E.; Massaccesi, Guido; Osburn, William O.; Forman, Michael; Thomas, Elaine; Thornton, Karla; Wagner, Katherine; Vassilev, Ventzislav; Lin, Lan; Lum, Paula J.; Giudice, Linda C.; Stein, Ellen; Asher, Alice; Chang, Soju; Gorman, Richard; Ghany, Marc G.; Liang, T. Jake; Wierzbicki, Michael R.; Scarselli, Elisa; Nicosia, Alfredo; Folgori, Antonella; Capone, Stefania; Cox, Andrea L.			Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C VIRUS-INFECTION; T-CELL RESPONSES; SPONTANEOUS CLEARANCE; FEMALE SEX; DRUG-USERS; HEPATITIS; IMMUNOGENICITY; PEOPLE; IL28B	Background A safe and effective vaccine to prevent chronic hepatitis C virus (HCV) infection is a critical component of efforts to eliminate the disease. Methods In this phase 1-2 randomized, double-blind, placebo-controlled trial, we evaluated a recombinant chimpanzee adenovirus 3 vector priming vaccination followed by a recombinant modified vaccinia Ankara boost; both vaccines encode HCV nonstructural proteins. Adults who were considered to be at risk for HCV infection on the basis of a history of recent injection drug use were randomly assigned (in a 1:1 ratio) to receive vaccine or placebo on days 0 and 56. Vaccine-related serious adverse events, severe local or systemic adverse events, and laboratory adverse events were the primary safety end points. The primary efficacy end point was chronic HCV infection, defined as persistent viremia for 6 months. Results A total of 548 participants underwent randomization, with 274 assigned to each group. There was no significant difference in the incidence of chronic HCV infection between the groups. In the per-protocol population, chronic HCV infection developed in 14 participants in each group (hazard ratio [vaccine vs. placebo], 1.53; 95% confidence interval [CI], 0.66 to 3.55; vaccine efficacy, -53%; 95% CI, -255 to 34). In the modified intention-to-treat population, chronic HCV infection developed in 19 participants in the vaccine group and 17 in placebo group (hazard ratio, 1.66; 95% CI, 0.79 to 3.50; vaccine efficacy, -66%; 95% CI, -250 to 21). The geometric mean peak HCV RNA level after infection differed between the vaccine group and the placebo group (152.51x10(3) IU per milliliter and 1804.93x10(3) IU per milliliter, respectively). T-cell responses to HCV were detected in 78% of the participants in the vaccine group. The percentages of participants with serious adverse events were similar in the two groups. Conclusions In this trial, the HCV vaccine regimen did not cause serious adverse events, produced HCV-specific T-cell responses, and lowered the peak HCV RNA level, but it did not prevent chronic HCV infection. (Funded by the National Institute of Allergy and Infectious Diseases; ClinicalTrials.gov number, .) In this trial, the safety and efficacy of a recombinant chimpanzee adenovirus 3 vector priming vaccination and a recombinant modified vaccinia Ankara boost was assessed in adults who were at risk for HCV infection because of injection drug use. The vaccine did not cause serious adverse events and did elicit HCV-specific T-cell responses, but it did not prevent chronic HCV infection.	[Page, Kimberly; Thomas, Elaine; Thornton, Karla; Wagner, Katherine] Univ New Mexico, Albuquerque, NM 87131 USA; [Melia, Michael T.; Veenhuis, Rebecca T.; Winter, Matthew; Rousseau, Kimberly E.; Massaccesi, Guido; Osburn, William O.; Forman, Michael; Cox, Andrea L.] Johns Hopkins Univ, Baltimore, MD USA; [Chang, Soju; Gorman, Richard] NIAID, Div Microbiol & Infect Dis, Rockville, MD USA; [Wierzbicki, Michael R.] Emmes Co, Rockville, MD USA; [Ghany, Marc G.; Liang, T. Jake] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Vassilev, Ventzislav; Lin, Lan] GSK Vaccines, Rixensart, Belgium; [Lum, Paula J.; Giudice, Linda C.; Stein, Ellen; Asher, Alice] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Asher, Alice] Ctr Dis Control & Prevent, Off Policy Planning & Partnerships, Atlanta, GA USA; [Scarselli, Elisa; Folgori, Antonella; Capone, Stefania] ReiThera, Rome, Italy; [Nicosia, Alfredo] CEINGE, Naples, Italy	University of New Mexico; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); GlaxoSmithKline; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; CEINGE Biotecnologie Avanzate	Cox, AL (corresponding author), Johns Hopkins Univ, Sch Med, 551 Rangos Bldg,855 N Wolfe St, Baltimore, MD 21205 USA.	acox@jhmi.edu	Ghany, Marc/AAU-4238-2021	Ghany, Marc/0000-0003-2837-0188; Massaccesi, Guido/0000-0002-4528-0937; Rousseau, Kimberly/0000-0003-3097-0289; Scarselli, Elisa/0000-0002-5393-6713	National Institute of Allergy and Infectious Diseases	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institute of Allergy and Infectious Diseases	Asher AK, 2016, SUBST USE MISUSE, V51, P1218, DOI 10.3109/10826084.2016.1161054; Baral S, 2007, LANCET INFECT DIS, V7, P667, DOI 10.1016/S1473-3099(07)70237-2; Bartenschlager R, 2018, VIRUS RES, V248, P53, DOI 10.1016/j.virusres.2018.02.016; CHOO QL, 1994, P NATL ACAD SCI USA, V91, P1294, DOI 10.1073/pnas.91.4.1294; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Erickson AL, 2001, IMMUNITY, V15, P883, DOI 10.1016/S1074-7613(01)00245-X; Esmaeili A, 2018, CLIN INFECT DIS, V66, P20, DOI 10.1093/cid/cix768; Flanagan KL, 2017, ANNU REV CELL DEV BI, V33, P577, DOI 10.1146/annurev-cellbio-100616-060718; Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202; Glynn SA, 2005, TRANSFUSION, V45, P994, DOI 10.1111/j.1537-2995.2005.04390.x; Grebely J, 2014, HEPATOLOGY, V59, P109, DOI 10.1002/hep.26639; Hajarizadeh B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122232; Hartnell F, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03175; Hill AM, 2017, J VIRUS ERAD, V3, P117; Jefferies M, 2018, WORLD J CLIN CASES, V6, P589, DOI 10.12998/wjcc.v6.i13.589; Kelly C, 2015, EUR J IMMUNOL, V45, P309, DOI 10.1002/eji.201444686; Kinchen VJ, 2018, TRENDS MICROBIOL, V26, P854, DOI 10.1016/j.tim.2018.04.002; Larrey D, 2013, DRUG-INDUCED LIVER DISEASE, 3RD EDITION, P443, DOI 10.1016/B978-0-12-387817-5.00025-X; Maticic M, 2020, CLIN MICROBIOL INFEC, V26, P818, DOI 10.1016/j.cmi.2020.01.014; McElrath MJ, 2000, AIDS RES HUM RETROV, V16, P907, DOI 10.1089/08892220050042846; Mehta SH, 2008, J COMMUN HEALTH, V33, P126, DOI 10.1007/s10900-007-9083-3; Morris MD, 2019, DRUG ALCOHOL DEPEN, V198, P133, DOI 10.1016/j.drugalcdep.2019.02.008; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Page K, 2018, AM J PUBLIC HEALTH, V108, P156, DOI 10.2105/AJPH.2017.304201; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Park SH, 2013, NAT MED, V19, P1638, DOI 10.1038/nm.3408; Pine SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018526; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Roingeard P, 2020, HEPATOLOGY, V71, P1845, DOI 10.1002/hep.31182; Ryerson AB, 2020, MMWR-MORBID MORTAL W, V69, P399, DOI 10.15585/mmwr.mm6914a2; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; WHO, 2017, GLOB HEP REP	33	50	50	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2021	384	6					541	549		10.1056/NEJMoa2023345	http://dx.doi.org/10.1056/NEJMoa2023345			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QG5JQ	33567193	Green Accepted, Bronze			2022-12-28	WOS:000617621800011
J	Montzka, SA; Dutton, GS; Portmann, RW; Chipperfield, MP; Davis, S; Feng, WH; Manning, AJ; Ray, E; Rigby, M; Hall, BD; Siso, C; Nance, JD; Krummel, PB; Mhle, J; Young, D; O'Doherty, S; Salameh, PK; Harth, CM; Prinn, RG; Weiss, RF; Elkins, JW; Walter-Terrinoni, H; Theodoridi, C				Montzka, Stephen A.; Dutton, Geoffrey S.; Portmann, Robert W.; Chipperfield, Martyn P.; Davis, Sean; Feng, Wuhu; Manning, Alistair J.; Ray, Eric; Rigby, Matthew; Hall, Bradley D.; Siso, Carolina; Nance, J. David; Krummel, Paul B.; Muhle, Jens; Young, Dickon; O'Doherty, Simon; Salameh, Peter K.; Harth, Christina M.; Prinn, Ronald G.; Weiss, Ray F.; Elkins, James W.; Walter-Terrinoni, Helen; Theodoridi, Christina			A decline in global CFC-11 emissions during 2018-2019	NATURE			English	Article								The atmospheric concentration of trichlorofluoromethane (CFC-11) has been in decline since the production of ozone-depleting substances was phased out under the Montreal Protocol(1,2). Since 2013, the concentration decline of CFC-11 slowed unexpectedly owing to increasing emissions, probably from unreported production, which, if sustained, would delay the recovery of the stratospheric ozone layer(1-12). Here we report an accelerated decline in the global mean CFC-11 concentration during 2019 and 2020, derived from atmospheric concentration measurements at remote sites around the world. We find that global CFC-11 emissions decreased by 18 +/- 6 gigagrams per year (26 +/- 9 per cent; one standard deviation) from 2018 to 2019, to a 2019 value (52 +/- 10 gigagrams per year) that is similar to the 2008-2012 mean. The decline in global emissions suggests a substantial decrease in unreported CFC-11 production. If the sharp decline in unexpected global emissions and unreported production is sustained, any associated future ozone depletion is likely to be limited, despite an increase in the CFC-11 bank (the amount of CFC-11 produced, but not yet emitted) by 90 to 725 gigagrams by the beginning of 2020. Atmospheric concentration measurements at remote sites around the world reveal an accelerated decline in the global mean CFC-11 concentration during 2018 and 2019, reversing recent trends and building confidence in the timely recovery of the stratospheric ozone layer.	[Montzka, Stephen A.; Hall, Bradley D.; Siso, Carolina; Nance, J. David; Elkins, James W.] NOAA, Global Monitoring Lab, Boulder, CO 80305 USA; [Dutton, Geoffrey S.; Ray, Eric; Siso, Carolina; Nance, J. David] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO USA; [Dutton, Geoffrey S.; Portmann, Robert W.; Davis, Sean; Ray, Eric] NOAA, Chem Sci Lab, Boulder, CO USA; [Chipperfield, Martyn P.; Feng, Wuhu] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Chipperfield, Martyn P.] Univ Leeds, Natl Ctr Earth Observat, Leeds, W Yorkshire, England; [Feng, Wuhu] Univ Leeds, Natl Ctr Atmospher Sci, Leeds, W Yorkshire, England; [Manning, Alistair J.] Hadley Ctr, Met Off, Exeter, Devon, England; [Rigby, Matthew; Young, Dickon; O'Doherty, Simon] Univ Bristol, Sch Chem, Bristol, Avon, England; [Krummel, Paul B.] CSIRO Oceans & Atmosphere, Climate Sci Ctr, Aspendale, Vic, Australia; [Muhle, Jens; Salameh, Peter K.; Harth, Christina M.; Weiss, Ray F.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Prinn, Ronald G.] MIT, Ctr Global Change Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Walter-Terrinoni, Helen] Air Conditioning Heating & Refrigerat Inst, Arlington, VA USA; [Theodoridi, Christina] Nat Resources Def Council, Washington, DC USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA; University of Leeds; University of Leeds; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Atmospheric Science; University of Leeds; Met Office - UK; Hadley Centre; University of Bristol; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of California System; University of California San Diego; Scripps Institution of Oceanography; Massachusetts Institute of Technology (MIT)	Montzka, SA (corresponding author), NOAA, Global Monitoring Lab, Boulder, CO 80305 USA.	stephen.a.montzka@noaa.gov	Chipperfield, Martyn/H-6359-2013; Ray, Eric/D-5941-2013; Davis, Sean/C-9570-2011; Portmann, Robert W/C-4903-2009; montzka, stephen/V-6162-2019; Krummel, Paul B/A-4293-2013; Young, Dickon/AFO-7065-2022	Chipperfield, Martyn/0000-0002-6803-4149; Ray, Eric/0000-0001-8727-9849; Davis, Sean/0000-0001-9276-6158; Portmann, Robert W/0000-0002-0279-6087; montzka, stephen/0000-0002-9396-0400; Krummel, Paul B/0000-0002-4884-3678; Young, Dickon/0000-0002-6723-3138	National Aeronautics and Space Administration (NASA, USA) [NAG5-12669, NNX07AE89G, NNX11AF17G, NNX16AC98G, NAG5-4023, NNX07AE87G, NNX07AF09G, NNX11AF15G, NNX11AF16G, NNX16AC97G, NNX16AC96G]; Department for Business, Energy AMP; Industrial Strategy (BEIS, UK); Commonwealth Scientific and Industrial Research Organisation (CSIRO, Australia); Bureau of Meteorology (BoM, Australia); National Science Foundation; Office of Science (BER) of the US Department of Energy; NERC SISLAC project [NE/R001782/1]; NOAA Climate Program Office's AC4 programme; Met Office Hadley Centre Climate Programme - UK's Department for Business, Energy and Industrial Strategy; Met Office Hadley Centre Climate Programme - UK's Department for Environment, Food and Rural Affairs; National Oceanic and Atmospheric Administration (NOAA, USA); NERC [NE/R001782/1] Funding Source: UKRI	National Aeronautics and Space Administration (NASA, USA)(National Aeronautics & Space Administration (NASA)); Department for Business, Energy AMP; Industrial Strategy (BEIS, UK); Commonwealth Scientific and Industrial Research Organisation (CSIRO, Australia); Bureau of Meteorology (BoM, Australia); National Science Foundation(National Science Foundation (NSF)); Office of Science (BER) of the US Department of Energy(United States Department of Energy (DOE)); NERC SISLAC project; NOAA Climate Program Office's AC4 programme; Met Office Hadley Centre Climate Programme - UK's Department for Business, Energy and Industrial Strategy; Met Office Hadley Centre Climate Programme - UK's Department for Environment, Food and Rural Affairs; National Oceanic and Atmospheric Administration (NOAA, USA); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	For sample flask collection and on-site instrument operation, maintenance, and troubleshooting we are grateful to station personnel from NOAA and AGAGE. The operation of AGAGE stations was supported by the National Aeronautics and Space Administration (NASA, USA) (grants NAG5-12669, NNX07AE89G, NNX11AF17G and NNX16AC98G to the Massachusetts Institute of Technology; grants NAG5-4023, NNX07AE87G, NNX07AF09G, NNX11AF15G, NNX11AF16G, NNX16AC97G and NNX16AC96G to the Scripps Institution of Oceanography), the Department for Business, Energy & Industrial Strategy (BEIS, UK), the National Oceanic and Atmospheric Administration (NOAA, USA), and the Commonwealth Scientific and Industrial Research Organisation (CSIRO, Australia), Bureau of Meteorology (BoM, Australia). We also are indebted to personnel from cooperative institutions involved with flasks sampling in Australia (BoM/CSIRO), Canada (Environment and Climate Change Canada), Ireland (University of Bristol), Israel (Weizmann Inst.), Republic of Korea (Korean Meteorological Administration), the USA (University of Colorado, Harvard University, University of Wisconsin, Scripps Institution of Oceanography), and for logistics support from the US NSF at Summit Greenland, Palmer Antarctica, and South Pole Antarctica Stations. We thank R. Wang for algorithms for extracting background mole fractions from those influenced by recent emission input, and for calculating correlations between CFC-11 data from the American Samoa and Barbados stations and ENSO, and M. Lickley for discussions and results from Bayesian banks analysis. The Community Earth System Modeling project is supported by the National Science Foundation and the Office of Science (BER) of the US Department of Energy. We acknowledge the NOAA Research and Development High Performance Computing Program for computing and storage resources. The TOMCAT modelling work was supported by the NERC SISLAC project (NE/R001782/1) and simulations were performed on the UK Archer and Leeds Arc HPC machines. This work was funded in part by the NOAA Climate Program Office's AC4 programme. Support was also received from The Met Office Hadley Centre Climate Programme, funded by the UK's Department for Business, Energy and Industrial Strategy and Department for Environment, Food and Rural Affairs.	Adcock KE, 2020, ENVIRON SCI TECHNOL, V54, P3814, DOI 10.1021/acs.est.9b06433; [Anonymous], 2019, SPARC; Bonisch H, 2011, ATMOS CHEM PHYS, V11, P3937, DOI 10.5194/acp-11-3937-2011; Chen YH, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005542; Chipperfield MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8233; Chipperfield MP, 2016, ATMOS CHEM PHYS, V16, P15741, DOI 10.5194/acp-16-15741-2016; Dameris M, 2019, ATMOS CHEM PHYS, V19, P13759, DOI 10.5194/acp-19-13759-2019; Davis NA, 2020, GEOSCI MODEL DEV, V13, P717, DOI 10.5194/gmd-13-717-2020; DLUGOKENCKY EJ, 1994, J GEOPHYS RES-ATMOS, V99, P17021, DOI 10.1029/94JD01245; Engel A., 2018, 58 WMO, P1; Environmental Investigation Agency (EIA), 2018, BLOWING IT ILL PROD; Fleming EL, 2020, J GEOPHYS RES-ATMOS, V125, DOI 10.1029/2019JD031849; Harris N. R. P, 2014, 55 WORLD MET ORG, P1; Hersbach H, 2020, Q J ROY METEOR SOC, V146, P1999, DOI 10.1002/qj.3803; Jones A, 2007, NATO-CHAL M, V17, P580; Ko M. K., 2013, 6 SPARC; Kuijpers L, 2004, REP TEAP CHILL TASK; Laube JC, 2020, ATMOS CHEM PHYS, V20, P9771, DOI 10.5194/acp-20-9771-2020; Li ZF, 2016, ATMOS ENVIRON, V132, P77, DOI 10.1016/j.atmosenv.2016.02.038; Liang Q, 2017, J GEOPHYS RES-ATMOS, V122, P11914, DOI 10.1002/2017JD026926; Lickley M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15162-7; Lin YJ, 2019, ENVIRON SCI TECH LET, V6, P114, DOI 10.1021/acs.estlett.9b00022; Liu F, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc2992; Marsh DR, 2013, J CLIMATE, V26, P7372, DOI 10.1175/JCLI-D-12-00558.1; Montzka S. A, 2003, 47 WORLD MET ORG, P1; Montzka S. A., 2011, 52 WORLD MET ORG GLO; Montzka SA, 2018, NATURE, V557, P413, DOI 10.1038/s41586-018-0106-2; O'Doherty S, 2001, J GEOPHYS RES-ATMOS, V106, P20429, DOI 10.1029/2000JD900792; Park S, 2021, NATURE, V590, P433, DOI 10.1038/s41586-021-03277-w; Pons J., 2019, DEC 30 3 TEAP TASK F, V3; Prinn RG, 2000, J GEOPHYS RES-ATMOS, V105, P17751, DOI 10.1029/2000JD900141; Prinn RG, 2018, EARTH SYST SCI DATA, V10, P985, DOI 10.5194/essd-10-985-2018; Randel WJ, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006744; Ray EA, 2020, NAT GEOSCI, V13, P22, DOI 10.1038/s41561-019-0507-3; Rigby M, 2019, NATURE, V569, P546, DOI 10.1038/s41586-019-1193-4; Rosenlof KH, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009109; United Nations Environmental Programme (UNEP), 2019, UNEPOZLPRO3011; United Nations Environmental Programme (UNEP), 2019, 31 M PART MONTR PROT; Vollmer MK, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038659	39	33	33	15	68	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846					428	+		10.1038/s41586-021-03260-5	http://dx.doi.org/10.1038/s41586-021-03260-5		FEB 2021	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QJ5CU	33568809	Bronze, Green Submitted			2022-12-28	WOS:000616961600003
J	Mahase, E				Mahase, Elisabeth			Covid-19: South Africa pauses use of Oxford vaccine after study casts doubt on efficacy against variant	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n296; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n86; Mancini DP, 2021, FINANCIAL TIME 0207	3	16	16	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2021	372								n372	10.1136/bmj.n372	http://dx.doi.org/10.1136/bmj.n372			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM1AV	33558207	Bronze			2022-12-28	WOS:000639394000012
J	Gordon, KB; Foley, P; Krueger, JG; Pinter, A; Reich, K; Vender, R; Vanvoorden, V; Madden, C; White, K; Cioffi, C; Blauvelt, A				Gordon, Kenneth B.; Foley, Peter; Krueger, James G.; Pinter, Andreas; Reich, Kristian; Vender, Ronald; Vanvoorden, Veerle; Madden, Cynthia; White, Katy; Cioffi, Christopher; Blauvelt, Andrew			Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial	LANCET			English	Article								Background Bimekizumab is a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)-17F in addition to IL-17A. This study investigated the efficacy and safety of bimekizumab in patients with moderate to severe plaque psoriasis, the effects of treatment withdrawal, and two maintenance dosing schedules over 56 weeks. Methods BE READY was a phase 3, multicentre, randomised, double-blind, placebo-controlled trial done at 77 sites (hospitals, clinics, private doctor's practices, and dedicated clinical research centres) in nine countries across Asia, Australia, Europe, and North America. Adult patients aged 18 years or older with moderate to severe plaque psoriasis were stratified by region and previous biologic exposure, and randomly assigned (4:1) to receive bimekizumab 320 mg every 4 weeks or placebo every 4 weeks by use of interactive response technology. Coprimary endpoints were the proportion of patients achieving 90% or greater improvement from baseline in the Psoriasis Area Severity Index (PASI90) and the proportion of patients achieving a score of 0 (clear) or 1 (almost clear) on the five-point Investigator's Global Assessment (IGA) scale at week 16 (non-responder imputation). Bimekizumab-treated patients achieving PASI90 at week 16 were re-allocated (1:1:1) to receive bimekizumab 320 mg every 4 weeks, every 8 weeks, or placebo for weeks 16-56. Efficacy analyses were done in the intention-to-treat population; the safety analysis set comprised all patients who received at least one dose of study treatment. This trial is registered with ClinicalTrials.gov (NCT03410992), and is now completed. Findings Between Feb 5, 2018, and Jan 7, 2020, 435 patients were randomly assigned to receive either bimekizumab 320 mg every 4 weeks (n=349) or placebo every 4 weeks (n=86). Coprimary endpoints were met: at week 16, 317 (91%) of 349 patients receiving bimekizumab 320 mg every 4 weeks achieved PASI90, compared with one (1%) of 86 patients receiving placebo (risk difference 89.8 [95% CI 86.1-93.4]; p<0.0001); and 323 (93%) of 349 patients receiving bimekizumab 320 mg every 4 weeks achieved an IGA score of 0 or 1 versus one (1%) of 86 patients receiving placebo (risk difference 91.5 [95% CI 88.0-94.9]; p<0.0001). Responses were maintained through to week 56 with bimekizumab 320 mg every 8 weeks and every 4 weeks. Treatment-emergent adverse events in the initial treatment period (up to week 16) were reported in 213 (61%) of 349 patients receiving bimekizumab 320 mg every 4 weeks and 35 (41%) of 86 patients receiving placebo every 4 weeks. From week 16 to week 56, treatment-emergent adverse events were reported in 78 (74%) of 106 patients receiving bimekizumab 320 mg every 4 weeks, 77 (77%) of 100 patients receiving bimekizumab 320 mg every 8 weeks, and 72 (69%) of 105 patients receiving placebo. Interpretation Bimekizumab showed high levels of response, which were durable over 56 weeks, with both maintenance dosing schedules (every 4 weeks and every 8 weeks). Moreover, bimekizumab was well tolerated, with no unexpected safety findings. Data presented here further support the therapeutic value of bimekizumab and inhibition of IL-17F in addition to IL-17A for patients with moderate to severe plaque psoriasis.	[Gordon, Kenneth B.] Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA; [Foley, Peter] Skin Hlth Inst, Carlton, Vic, Australia; [Foley, Peter] Univ Melbourne, Parkville, Vic, Australia; [Krueger, James G.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Pinter, Andreas] Univ Hosp Frankfurt Main, Dept Dermatol, Frankfurt, Germany; [Reich, Kristian] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Ctr Translat Res Inflammatory Skin Dis, Hamburg, Germany; [Vender, Ronald] McMaster Univ, Div Dermatol, Hamilton, ON, Canada; [Vanvoorden, Veerle] UCB Pharma, Brussels, Belgium; [Madden, Cynthia; Cioffi, Christopher] UCB Pharma, Raleigh, NC USA; [White, Katy] UCB Pharma, Slough, Berks, England; [Blauvelt, Andrew] Oregon Med Res Ctr, Portland, OR USA	Medical College of Wisconsin; University of Melbourne; Rockefeller University; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; McMaster University; UCB Pharma SA; UCB Pharma SA; UCB Pharma SA	Gordon, KB (corresponding author), Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA.	kegordon@mcw.edu			UCB Pharma	UCB Pharma(UCB Pharma SA)	UCB Pharma.	Adams R, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01894; Bhoi P, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015872; Blauvelt A, 2020, BRIT J DERMATOL, V182, P1348, DOI 10.1111/bjd.18851; Blauvelt A, 2017, J EUR ACAD DERMATOL, V31, P1004, DOI 10.1111/jdv.14163; Blauvelt A, 2020, J AM ACAD DERMATOL, V83, P1367, DOI 10.1016/j.jaad.2020.05.105; Blauvelt A, 2020, JAMA DERMATOL, V156, P649, DOI 10.1001/jamadermatol.2020.0723; Blauvelt A, 2018, CLIN REV ALLERG IMMU, V55, P379, DOI 10.1007/s12016-018-8702-3; Blauvelt A, 2017, J AM ACAD DERMATOL, V76, P60, DOI 10.1016/j.jaad.2016.08.008; Bonafede M, 2013, J DERMATOL TREAT, V24, P369, DOI 10.3109/09546634.2012.755255; Brezinski EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033486; Chan TC, 2018, THER ADV CHRONIC DIS, V9, P111, DOI 10.1177/2040622318759282; Coleman CI, 2012, J MANAGE CARE PHARM, V18, P527, DOI 10.18553/jmcp.2012.18.7.527; Farahnik B, 2016, DERMATOLOGY THER, V6, P111, DOI 10.1007/s13555-016-0121-x; Frieder J, 2018, THER ADV CHRONIC DIS, V9, P5, DOI 10.1177/2040622317738910; Gisondi P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112427; Glatt S, 2018, ANN RHEUM DIS, V77, P523, DOI 10.1136/annrheumdis-2017-212127; Glatt S, 2017, BRIT J CLIN PHARMACO, V83, P991, DOI 10.1111/bcp.13185; Gordon KB, 2019, J INVEST DERMATOL, V139, P2437, DOI 10.1016/j.jid.2019.05.016; Gottlieb AB, 2020, DERMATOLOGY THER, V10, P1255, DOI 10.1007/s13555-020-00434-3; Johnston A, 2013, J IMMUNOL, V190, P2252, DOI 10.4049/jimmunol.1201505; Liu YW, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/6519465; Mease PJ, 2020, ANN RHEUM DIS, V79, P123, DOI 10.1136/annrheumdis-2019-215386; Papp KA, 2018, J AM ACAD DERMATOL, V79, P277, DOI 10.1016/j.jaad.2018.03.037; Pariser D, 2018, DERMATOLOGY THER, V8, P17, DOI 10.1007/s13555-017-0211-4; Patel DD, 2013, ANN RHEUM DIS, V72, P116, DOI 10.1136/annrheumdis-2012-202371; Reich K, 2021, LANCET, V397, P487, DOI 10.1016/S0140-6736(21)00125-2; Reich K, 2019, LANCET, V394, P831, DOI 10.1016/S0140-6736(19)31773-8; Sbidian E, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011535.pub3; Warren RB, 2021, BRIT J DERMATOL, V184, P50, DOI 10.1111/bjd.19341; Warren RB, 2015, J INVEST DERMATOL, V135, P2632, DOI 10.1038/jid.2015.208	30	56	56	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2021	397	10273					475	486						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QF1LZ	33549192				2022-12-28	WOS:000616661900023
J	Carter, KP; Shield, KM; Smith, KF; Jones, ZR; Wacker, JN; Arnedo-Sanchez, L; Mattox, TM; Moreau, LM; Knope, KE; Kozimor, SA; Booth, CH; Abergel, RJ				Carter, Korey P.; Shield, Katherine M.; Smith, Kurt F.; Jones, Zachary R.; Wacker, Jennifer N.; Arnedo-Sanchez, Leticia; Mattox, Tracy M.; Moreau, Liane M.; Knope, Karah E.; Kozimor, Stosh A.; Booth, Corwin H.; Abergel, Rebecca J.			Structural and spectroscopic characterization of an einsteinium complex	NATURE			English	Article							STABILITY-CONSTANTS; LUMINESCENCE; SPECTRA	The transplutonium elements (atomic numbers 95-103) are a group of metals that lie at the edge of the periodic table. As a result, the patterns and trends used to predict and control the physics and chemistry for transition metals, main-group elements and lanthanides are less applicable to transplutonium elements. Furthermore, understanding the properties of these heavy elements has been restricted by their scarcity and radioactivity. This is especially true for einsteinium (Es), the heaviest element on the periodic table that can currently be generated in quantities sufficient to enable classical macroscale studies(1). Here we characterize a coordination complex of einsteinium, using less than 200 nanograms of Es-254 (with half-life of 275.7(5) days), with an organic hydroxypyridinone-based chelating ligand. X-ray absorption spectroscopic and structural studies are used to determine the energy of the L-3-edge and a bond distance of einsteinium. Photophysical measurements show antenna sensitization of Es-III luminescence; they also reveal a hypsochromic shift on metal complexation, which had not previously been observed in lower-atomic-number actinide elements. These findings are indicative of an intermediate spin-orbit coupling scheme in which j-j coupling (whereby single-electron orbital angular momentum and spin are first coupled to form a total angular momentum, j) prevails over Russell-Saunders coupling. Together with previous actinide complexation studies(2), our results highlight the need to continue studying the unusual behaviour of the actinide elements, especially those that are scarce and short-lived. An einsteinium coordination complex is synthesized and spectroscopically characterized using less than 200 nanograms of einsteinium, enabling examination of its structure and measurement of an einsteinium bond distance.	[Carter, Korey P.; Shield, Katherine M.; Smith, Kurt F.; Arnedo-Sanchez, Leticia; Moreau, Liane M.; Booth, Corwin H.; Abergel, Rebecca J.] Lawrence Berkeley Natl Lab, Chem Sci Div, Berkeley, CA 94720 USA; [Shield, Katherine M.; Abergel, Rebecca J.] Univ Calif Berkeley, Dept Nucl Engn, Berkeley, CA 94720 USA; [Jones, Zachary R.; Wacker, Jennifer N.; Kozimor, Stosh A.] Los Alamos Natl Lab, Los Alamos, NM 87544 USA; [Wacker, Jennifer N.; Knope, Karah E.] Georgetown Univ, Dept Chem, Washington, DC 20057 USA; [Mattox, Tracy M.] Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Los Alamos National Laboratory; Georgetown University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Booth, CH; Abergel, RJ (corresponding author), Lawrence Berkeley Natl Lab, Chem Sci Div, Berkeley, CA 94720 USA.; Abergel, RJ (corresponding author), Univ Calif Berkeley, Dept Nucl Engn, Berkeley, CA 94720 USA.; Kozimor, SA (corresponding author), Los Alamos Natl Lab, Los Alamos, NM 87544 USA.	stosh@lanl.gov; chbooth@lbl.gov; abergel@berkeley.edu		Mattox, Tracy/0000-0002-6520-830X; Moreau, Liane/0000-0003-4381-8753; Carter, Korey/0000-0003-4191-0740	DOE, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division at Lawrence Berkeley National Laboratory [DE-AC02-05CH1123]; DOE, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division at Los Alamos National Laboratory (LANL); NNSA of the DOE [89233218CNA000001]; DOE Integrated University Program graduate research fellowship; Glenn T. Seaborg Institute at LANL; DOE, Office of Science, Office of Basic Energy Sciences, Early Career Research Program [DE-SC0019190]; DOE, Office of Science, Office of Workforce Development for Teachers and Scientists, Office of Science Graduate Student Research (SCGSR) program [DE-SC0014664]; DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-05CH1123, DE-AC02-76SF00515]	DOE, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division at Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); DOE, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division at Los Alamos National Laboratory (LANL); NNSA of the DOE; DOE Integrated University Program graduate research fellowship(United States Department of Energy (DOE)); Glenn T. Seaborg Institute at LANL; DOE, Office of Science, Office of Basic Energy Sciences, Early Career Research Program(United States Department of Energy (DOE)); DOE, Office of Science, Office of Workforce Development for Teachers and Scientists, Office of Science Graduate Student Research (SCGSR) program(United States Department of Energy (DOE)); DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	<SUP>254</SUP>Es was supplied by the Isotope Program within the US Department of Energy (DOE), Office of Science, Office of Nuclear Physics. We thank N. Edelstein for discussions, M. Fox for. spectrometer calibration, and N. Singh, B. Fairchild, S. Hays and R. Davis for assistance in planning and implementing experiments at the Stanford Synchrotron Radiation Lightsource (SSRL) and at the Molecular Foundry. This work was supported by the DOE, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division at Lawrence Berkeley National Laboratory, under contract number DE-AC02-05CH1123, and at Los Alamos National Laboratory (LANL), an affirmative-action/equal-opportunity employer, managed by Triad National Security, LLC, for the NNSA of the DOE (contract number 89233218CNA000001). K.M.S. acknowledges support from a DOE Integrated University Program graduate research fellowship. Z.R.J. was supported by the Glenn T. Seaborg Institute at LANL. K.E.K. and J.N.W. were supported by the DOE, Office of Science, Office of Basic Energy Sciences, Early Career Research Program under award DE-SC0019190. J.N.W. was also supported by the DOE, Office of Science, Office of Workforce Development for Teachers and Scientists, Office of Science Graduate Student Research (SCGSR) program, which is administered by the Oak Ridge Institute for Science and Education (ORISE) and managed by ORAU (contract number DE-SC0014664) for the DOE. Use of the SSRL, SLAC National Accelerator Laboratory, is supported by the DOE, Office of Science, Office of Basic Energy Sciences under contract number DE-AC02-76SF00515. Near-infrared luminescence spectra were collected at the Molecular Foundry, a User Facility supported by the DOE, Office of Science, Office of Basic Energy Sciences under contract number DE-AC02-05CH1123.	Barbanel' YA, 1997, RADIOCHIM ACTA, V78, P91; BEARDEN JA, 1967, REV MOD PHYS, V39, P125, DOI 10.1103/RevModPhys.39.125; BEITZ JV, 1983, J LESS-COMMON MET, V93, P331, DOI 10.1016/0022-5088(83)90178-9; Booth CH, 2009, J PHYS CONF SER, V190, DOI 10.1088/1742-6596/190/1/012028; CARNALL WT, 1973, J CHEM PHYS, V59, P1785, DOI 10.1063/1.1680264; CHOPPIN GR, 1956, J INORG NUCL CHEM, V2, P66, DOI 10.1016/0022-1902(56)80105-X; Daumann LJ, 2015, J AM CHEM SOC, V137, P2816, DOI 10.1021/ja5116524; Edelstein NM, 2006, COORDIN CHEM REV, V250, P948, DOI 10.1016/j.ccr.2006.02.004; FELLOWS RL, 1975, INORG NUCL CHEM LETT, V11, P737, DOI 10.1016/0020-1650(75)80090-0; FERGUSON DE, 1963, NUCL SCI ENG, V17, P435, DOI 10.13182/NSE63-A17394; GUTMACHER RG, 1967, J OPT SOC AM, V57, P1389, DOI 10.1364/JOSA.57.001389; Haire R. G., 2011, CHEM ACTINIDE TRANSA, P1577; HAIRE RG, 1973, J INORG NUCL CHEM, V35, P489, DOI 10.1016/0022-1902(73)80561-5; HARMON HD, 1972, INORG NUCL CHEM LETT, V8, P57, DOI 10.1016/0020-1650(72)80084-9; HARMON HD, 1972, J INORG NUCL CHEM, V34, P1381, DOI 10.1016/0022-1902(72)80339-7; HORWITZ EP, 1969, J INORG NUCL CHEM, V31, P1149, DOI 10.1016/0022-1902(69)80164-8; HULET EK, 1983, RADIOCHIM ACTA, V32, P7; Kelley MP, 2018, CHEM COMMUN, V54, P10578, DOI 10.1039/c8cc05230a; Kelley MP, 2018, INORG CHEM, V57, P5352, DOI 10.1021/acs.inorgchem.8b00345; Lundberg D, 2016, COORDIN CHEM REV, V318, P131, DOI 10.1016/j.ccr.2016.04.003; MCDOWELL WJ, 1972, J INORG NUCL CHEM, V34, P2837, DOI 10.1016/0022-1902(72)80590-6; Meierfrankenfeld D, 2011, ATOM DATA NUCL DATA, V97, P134, DOI 10.1016/j.adt.2010.11.001; Moore KT, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.196404; Nugent LJ, 1970, CHEM PHYS LETT, V7, P179, DOI 10.1016/0009-2614(70)80280-9; Peterson JR, 1998, J ALLOY COMPD, V271, P876, DOI 10.1016/S0925-8388(98)00238-2; PYYKKO P, 1988, CHEM REV, V88, P563, DOI 10.1021/cr00085a006; Sturzbecher-Hoehne M, 2016, DALTON T, V45, P9912, DOI 10.1039/c6dt00328a; THOMPSON SG, 1954, J AM CHEM SOC, V76, P6229, DOI 10.1021/ja01653a004	28	14	14	10	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2021	590	7844					85	+		10.1038/s41586-020-03179-3	http://dx.doi.org/10.1038/s41586-020-03179-3			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TY5HF	33536647	Green Published			2022-12-28	WOS:000683814700002
J	Mohanan, M; Malani, A; Krishnan, K; Acharya, A				Mohanan, Manoj; Malani, Anup; Krishnan, Kaushik; Acharya, Anu			Prevalence of SARS-CoV-2 in Karnataka, India	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Mohanan, Manoj] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Malani, Anup] Univ Chicago, Sch Law, Chicago, IL 60637 USA; [Krishnan, Kaushik] Ctr Monitoring Indian Econ, Mumbai, Maharashtra, India; [Acharya, Anu] Mapmygenome, Hyderabad, Telangana, India	Duke University; University of Chicago	Malani, A (corresponding author), Univ Chicago, 1111 E 60th St, Chicago, IL 60622 USA.	amalani@uchicago.edu		Mohanan, Manoj/0000-0001-7028-6479	IDFC Foundation (Mumbai, India)	IDFC Foundation (Mumbai, India)	This study was funded by an Action Covid-19 Team grant awarded to IDFC Foundation (Mumbai, India).	Chaudhuri S, 2020, J CLIN VIROL, V131, DOI 10.1016/j.jcv.2020.104609; Public Health England, RAP ASS BIOM ARG SAR; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Vyas M, CONSUMER PYRAMIDS HO; Waghmare R, 2021, EUR J OBSTET GYN R B, V256, P503, DOI 10.1016/j.ejogrb.2020.09.030	5	18	18	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2021	325	10					1001	1003		10.1001/jama.2021.0332	http://dx.doi.org/10.1001/jama.2021.0332		FEB 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV3UE	33538774	Green Published, Bronze			2022-12-28	WOS:000614935100002
J	Willyard, C				Willyard, Cassandra			HOW GUT BACTERIA ALTER THE BRAIN	NATURE			English	News Item																		al-Haddad BJS, 2019, JAMA PSYCHIAT, V76, P594, DOI 10.1001/jamapsychiatry.2019.0029; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Blacher E, 2019, NATURE, V572, P474, DOI 10.1038/s41586-019-1443-5; Careaga M, 2017, BIOL PSYCHIAT, V81, P391, DOI 10.1016/j.biopsych.2016.10.020; Chen SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep34477; de la Rubia JE, 2019, AMYOTROPH LAT SCL FR, V20, P115, DOI 10.1080/21678421.2018.1536152; Friedland RP, 2015, J ALZHEIMERS DIS, V45, P349, DOI 10.3233/JAD-142841; Kim S, 2017, NATURE, V549, P528, DOI 10.1038/nature23910; Kim S, 2019, NEURON, V103, P627, DOI 10.1016/j.neuron.2019.05.035; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Sampson TR, 2020, ELIFE, V9, DOI 10.7554/eLife.53111; Sgritta M, 2019, NEURON, V101, P246, DOI 10.1016/j.neuron.2018.11.018; Svensson E, 2015, ANN NEUROL, V78, P522, DOI 10.1002/ana.24448; Yim YS, 2017, NATURE, V549, P482, DOI 10.1038/nature23909	14	29	31	8	52	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2021	590	7844					22	25		10.1038/d41586-021-00260-3	http://dx.doi.org/10.1038/d41586-021-00260-3			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS3JL	33536656				2022-12-28	WOS:000750576500001
J	Biswas, S; Mandal, G; Payne, KK; Anadon, CM; Gatenbee, CD; Chaurio, RA; Costich, TL; Moran, C; Harro, CM; Rigolizzo, KE; Mine, JA; Trillo-Tinoco, J; Sasamoto, N; Terry, KL; Marchion, D; Buras, A; Wenham, RM; Yu, XQ; Townsend, MK; Tworoger, SS; Rodriguez, PC; Anderson, AR; Conejo-Garcia, JR				Biswas, Subir; Mandal, Gunjan; Payne, Kyle K.; Anadon, Carmen M.; Gatenbee, Chandler D.; Chaurio, Ricardo A.; Costich, Tara Lee; Moran, Carlos; Harro, Carly M.; Rigolizzo, Kristen E.; Mine, Jessica A.; Trillo-Tinoco, Jimena; Sasamoto, Naoko; Terry, Kathryn L.; Marchion, Douglas; Buras, Andrea; Wenham, Robert M.; Yu, Xiaoqing; Townsend, Mary K.; Tworoger, Shelley S.; Rodriguez, Paulo C.; Anderson, Alexander R.; Conejo-Garcia, Jose R.			IgA transcytosis and antigen recognition govern ovarian cancer immunity	NATURE			English	Article							TERTIARY LYMPHOID STRUCTURES; T-CELLS; B-CELLS; IMMUNOTHERAPY; SURVIVAL; PROGNOSIS; RESPONSES	Most ovarian cancers are infiltrated by prognostically relevant activated T cells(1-3), yet exhibit low response rates to immune checkpoint inhibitors(4). Memory B cell and plasma cell infiltrates have previously been associated with better outcomes in ovarian cancer(5,6), but the nature and functional relevance of these responses are controversial. Here, using 3 independent cohorts that in total comprise 534 patients with high-grade serous ovarian cancer, we show that robust, protective humoral responses are dominated by the production of polyclonal IgA, which binds to polymeric IgA receptors that are universally expressed on ovarian cancer cells. Notably, tumour B-cell-derived IgA redirects myeloid cells against extracellular oncogenic drivers, which causes tumour cell death. In addition, IgA transcytosis through malignant epithelial cells elicits transcriptional changes that antagonize the RAS pathway and sensitize tumour cells to cytolytic killing by T cells, which also contributes to hindering malignant progression. Thus, tumour-antigen-specific and -antigen-independent IgA responses antagonize the growth of ovarian cancer by governing coordinated tumour cell, T cell and B cell responses. These findings provide a platform for identifying targets that are spontaneously recognized by intratumoural B-cell-derived antibodies, and suggest that immunotherapies that augment B cell responses may be more effective than approaches that focus on T cells, particularly for malignancies that are resistant to checkpoint inhibitors.	[Biswas, Subir; Mandal, Gunjan; Payne, Kyle K.; Anadon, Carmen M.; Chaurio, Ricardo A.; Costich, Tara Lee; Harro, Carly M.; Rigolizzo, Kristen E.; Mine, Jessica A.; Trillo-Tinoco, Jimena; Rodriguez, Paulo C.; Conejo-Garcia, Jose R.] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Gatenbee, Chandler D.; Anderson, Alexander R.] H Lee Moffitt Canc Ctr & Res Inst, Dept Math Oncol, Tampa, FL USA; [Moran, Carlos] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL USA; [Sasamoto, Naoko; Terry, Kathryn L.; Marchion, Douglas] Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, 75 Francis St, Boston, MA 02115 USA; [Sasamoto, Naoko; Terry, Kathryn L.; Marchion, Douglas] Harvard Med Sch, Boston, MA 02115 USA; [Buras, Andrea; Wenham, Robert M.] H Lee Moffitt Canc Ctr & Res Inst, Dept Gynecol Oncol, Tampa, FL USA; [Yu, Xiaoqing] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA; [Townsend, Mary K.; Tworoger, Shelley S.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Tworoger, Shelley S.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Harvard University; Harvard T.H. Chan School of Public Health	Conejo-Garcia, JR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA.	Jose.Conejo-Garcia@moffitt.org	Conejo-Garcia, Jose R/V-1897-2019; BISWAS, SUBIR/AAZ-6856-2021; Anderson, Alexander R.A./A-2713-2011; Rodríguez, Paulo/HDM-9539-2022	Conejo-Garcia, Jose R/0000-0001-6431-4074; BISWAS, SUBIR/0000-0003-2428-6288; Anderson, Alexander R.A./0000-0002-2536-4383; Rigolizzo, Kristen/0000-0003-0222-0683; Rodriguez, Paulo/0000-0001-7480-6566; Harro, Carly/0000-0002-0683-217X; Anadon Galindo, Carmen Maria/0000-0002-8851-4545; Mine, Jessica/0000-0003-4664-8286; Buras, Andrea L/0000-0001-9735-2798; Gatenbee, Chandler/0000-0002-9730-5964; Trillo-Tinoco, Jimena/0000-0002-1240-9650; Payne, Kyle/0000-0002-6531-9835	Cancer Center Support Grant (CCSG) [P30-CA076292]; American Cancer Society Postdoctoral Fellowship; National Institutes of Health [UM1 CA186107, UM1 CA176726, P01 CA087969, R01 CA054419, R35 CA197605]; Analytic Microscopy Core, CLIA Tissue Imaging Laboratory;  [R01CA157664];  [R01CA124515];  [R01CA178687];  [R01CA211913];  [U01CA232758];  [R01CA184185];  [T32CA009140]	Cancer Center Support Grant (CCSG); American Cancer Society Postdoctoral Fellowship(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Analytic Microscopy Core, CLIA Tissue Imaging Laboratory; ; ; ; ; ; ; 	Support for shared resources was provided by a Cancer Center Support Grant (CCSG) P30-CA076292 to H. Lee Moffitt Cancer Center. We thank the Analytic Microscopy Core, CLIA Tissue Imaging Laboratory, Molecular Genomics, Proteomics, Flow Cytometry and Biostatistics and Bioinformatics Shared Resources for support; and J. Cleveland for his critical review of this manuscript. This study was supported by R01CA157664, R01CA124515, R01CA178687, R01CA211913 and U01CA232758 to JRCG; R01CA184185 to P.C.R. K.K.P. was supported by T32CA009140 and The American Cancer Society Postdoctoral Fellowship. We thank the participants and staff of the NHS, NHSII and NECC for their contributions to the collection of tissues from the NHS, NHSII and NECC, which were supported by National Institutes of Health Award Numbers UM1 CA186107, UM1 CA176726, P01 CA087969, R01 CA054419, and R35 CA197605; we also acknowledge the following cancer registries: AL, AZ, AR, CA, CO, CT, DE, FL, GA, ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, VA, WA and WY.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bao Y, 2016, AM J PUBLIC HEALTH, V106, P1573, DOI 10.2105/AJPH.2016.303338; Boland JL, 2019, GYNECOL ONCOL, V152, P251, DOI 10.1016/j.ygyno.2018.11.025; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; CARDONE M, 1995, FEBS LETT, V376, P74, DOI 10.1016/0014-5793(95)01251-8; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; Kroeger DR, 2016, CLIN CANCER RES, V22, P3005, DOI 10.1158/1078-0432.CCR-15-2762; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Montfort A, 2017, CLIN CANCER RES, V23, P250, DOI 10.1158/1078-0432.CCR-16-0081; Mysona D, 2019, GYNECOL ONCOL, V152, P574, DOI 10.1016/j.ygyno.2018.12.015; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Payne KK, 2020, SCIENCE, V369, P942, DOI 10.1126/science.aay2767; Perales-Puchalt A, 2017, CLIN CANCER RES, V23, P441, DOI 10.1158/1078-0432.CCR-16-0492; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Rasoulouniriana D, 2019, J CLIN INVEST, V129, P4151, DOI 10.1172/JCI127590; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Romanska HM, 2011, J PATHOL, V223, P4, DOI 10.1002/path.2779; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Sautes-Fridman C, 2019, NAT REV CANCER, V19, P307, DOI 10.1038/s41568-019-0144-6; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vitonis AF, 2011, OBSTET GYNECOL, V117, P1042, DOI 10.1097/AOG.0b013e318212fcb7; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	31	45	45	12	54	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 18	2021	591	7850					464	+		10.1038/s41586-020-03144-0	http://dx.doi.org/10.1038/s41586-020-03144-0		FEB 2021	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY6JL	33536615	Green Published, hybrid			2022-12-28	WOS:000614414900007
J	Dyer, O				Dyer, Owen			US pathologist who deceived drug testers and misdiagnosed patients is sentenced to 20 years	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2021	372								n306	10.1136/bmj.n306	http://dx.doi.org/10.1136/bmj.n306			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UD4LK	33531340				2022-12-28	WOS:000687179200002
J	[Anonymous]				[Anonymous]			Current Comment (Reprinted from JAMA, vol 76, pg 383-385, 1921)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1921, JAMA, V76, P383	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2021	325	5					496	496		10.1001/jama.2020.17774	http://dx.doi.org/10.1001/jama.2020.17774			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QC6JP	33528527				2022-12-28	WOS:000614941900031
J	Bi, XP; Wang, K; Yang, LD; Pan, HL; Jiang, HF; Wei, QW; Fang, MQ; Yu, H; Zhu, CL; Cai, YR; He, YM; Gan, XN; Zeng, HH; Yu, DQ; Zhu, YA; Jiang, HF; Qiu, Q; Yang, HM; Zhang, YE; Wang, W; Zhu, M; He, SP; Zhang, GJ				Bi, Xupeng; Wang, Kun; Yang, Liandong; Pan, Hailin; Jiang, Haifeng; Wei, Qiwei; Fang, Miaoquan; Yu, Hao; Zhu, Chenglong; Cai, Yiran; He, Yuming; Gan, Xiaoni; Zeng, Honghui; Yu, Daqi; Zhu, Youan; Jiang, Huifeng; Qiu, Qiang; Yang, Huanming; Zhang, Yong E.; Wang, Wen; Zhu, Min; He, Shunping; Zhang, Guojie			Tracing the genetic footprints of vertebrate landing in non-teleost ray-finned fishes	CELL			English	Article							COMPARATIVE GENOME ANALYSIS; ACIPENSER-NACCARII HEART; CONUS ARTERIOSUS; PHYLOGENETIC ANALYSIS; LIMB TRANSITION; PECTORAL FIN; EVOLUTION; ORIGIN; LUNG; SEQUENCE	Rich fossil evidence suggests that many traits and functions related to terrestrial evolution were present long before the ancestor of lobe- and ray-finned fishes. Here, we present genome sequences of the bichir, paddlefish, bowfin, and alligator gar, covering all major early divergent lineages of ray-finned fishes. Our analyses show that these species exhibit many mosaic genomic features of lobe- and ray-finned fishes. In particular, many regulatory elements for limb development are present in these fishes, supporting the hypothesis that the relevant ancestral regulation networks emerged before the origin of tetrapods. Transcriptome analyses confirm the homology between the lung and swim bladder and reveal the presence of functional lung-related genes in early ray-finned fishes. Furthermore, we functionally validate the essential role of a jawed vertebrate highly conserved element for cardiovascular development. Our results imply the ancestors of jawed vertebrates already had the potential gene networks for cardio-respiratory systems supporting air breathing.	[Bi, Xupeng; Yang, Liandong; Jiang, Haifeng; Gan, Xiaoni; Zeng, Honghui; He, Shunping] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Peoples R China; [Bi, Xupeng; Pan, Hailin; Fang, Miaoquan; Yu, Hao; Cai, Yiran; He, Yuming; Yang, Huanming; Zhang, Guojie] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Wang, Kun; Zhu, Chenglong; Qiu, Qiang; Wang, Wen] Northwestern Polytech Univ, Sch Ecol & Environm, Xian 710072, Peoples R China; [Wei, Qiwei] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Key Lab Freshwater Biodivers Conservat, Minist Agr & Rural Affairs, Wuhan, Peoples R China; [Yu, Daqi; Zhang, Yong E.] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing 100101, Peoples R China; [Yu, Daqi; Zhang, Yong E.] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China; [Yu, Daqi; Zhang, Yong E.] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhu, Youan; Zhu, Min] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, 142 Xi Zhi Men Wai St, Beijing 100044, Peoples R China; [Zhu, Youan; Zhu, Min] CAS Ctr Excellence Life & Paleoenvironm, Beijing 100044, Peoples R China; [Jiang, Huifeng] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou, Peoples R China; [Yang, Huanming] BGI Shenzhen, Guangdong Prov Academician Workstn BGI Synthet Ge, Shenzhen 518120, Peoples R China; [Zhang, Yong E.; Wang, Wen; He, Shunping; Zhang, Guojie] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, 32 Jiaochang Donglu, Kunming 650223, Yunnan, Peoples R China; [Wang, Wen; Zhang, Guojie] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China; [Zhu, Min] Univ Chinese Acad Sci, Coll Earth & Planetary Sci, Beijing 100049, Peoples R China; [He, Shunping] Chinese Acad Sci, Inst Deep Sea Sci & Engn, Sanya 572000, Peoples R China; [Zhang, Guojie] Univ Copenhagen, Villum Ctr Biodivers Genom, Dept Biol, Sect Ecol & Evolut, Copenhagen, Denmark	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Beijing Genomics Institute (BGI); Northwestern Polytechnical University; Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS; University of Copenhagen	He, SP (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Peoples R China.; Zhang, GJ (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.; Wang, W (corresponding author), Northwestern Polytech Univ, Sch Ecol & Environm, Xian 710072, Peoples R China.; Zhu, M (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, 142 Xi Zhi Men Wai St, Beijing 100044, Peoples R China.; Zhu, M (corresponding author), CAS Ctr Excellence Life & Paleoenvironm, Beijing 100044, Peoples R China.; Wang, W; He, SP; Zhang, GJ (corresponding author), Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, 32 Jiaochang Donglu, Kunming 650223, Yunnan, Peoples R China.; Wang, W; Zhang, GJ (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China.; Zhu, M (corresponding author), Univ Chinese Acad Sci, Coll Earth & Planetary Sci, Beijing 100049, Peoples R China.; He, SP (corresponding author), Chinese Acad Sci, Inst Deep Sea Sci & Engn, Sanya 572000, Peoples R China.; Zhang, GJ (corresponding author), Univ Copenhagen, Villum Ctr Biodivers Genom, Dept Biol, Sect Ecol & Evolut, Copenhagen, Denmark.	wwang@mail.kiz.ac.cn; zhumin@ivpp.ac.cn; clad@ihb.ac.cn; guojie.zhang@bio.ku.dk	Zhang, Guojie/J-7273-2019; yu, hao/HIK-0596-2022	Zhang, Guojie/0000-0001-6860-1521; Wang, Kun/0000-0001-6059-6529; Bi, Xupeng/0000-0002-2642-2856; Cai, Yiran/0000-0002-5851-013X; Zhang, Yong E./0000-0003-3770-2383; Pan, Hailin/0000-0001-6785-9862	Fish10K project; Wuhan Frasergen Bioinformatics Co., Ltd.; State Key Laboratory of Freshwater Ecology and Biotechnology, Institute of Hydrobiology, Chinese Academy of Sciences; National Natural Science Foundation of China [41876179, 31972866]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB13000000, XDB31020000]; Villum Investigator grant from The Villum Foundation [25900]; Guangdong Provincial Academician Workstation of BGI Synthetic Genomics [2017B090904014]; Youth Innovation Promotion Association, Chinese Academy of Sciences	Fish10K project; Wuhan Frasergen Bioinformatics Co., Ltd.; State Key Laboratory of Freshwater Ecology and Biotechnology, Institute of Hydrobiology, Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Villum Investigator grant from The Villum Foundation; Guangdong Provincial Academician Workstation of BGI Synthetic Genomics; Youth Innovation Promotion Association, Chinese Academy of Sciences	We thank Qiwu Xu, Guangyi Fan, and Xiaoli Chen for Hi-C library construction and sequencing, and also thank the support from the Fish10K project and Wuhan Frasergen Bioinformatics Co., Ltd. We thank Tom Gilbert for the helpful suggestions. This research was supported by grants from the State Key Laboratory of Freshwater Ecology and Biotechnology, Institute of Hydrobiology, Chinese Academy of Sciences and from the National Natural Science Foundation of China (41876179 and 31972866) to S.H. and funded by the Strategic Priority Research Program of the Chinese Academy of Sciences grants (no. XDB13000000 and no. XDB31020000) and a Villum Investigator grant (no. 25900) from The Villum Foundation to G.Z. It was also supported by the Guangdong Provincial Academician Workstation of BGI Synthetic Genomics (no. 2017B090904014) to H. Yang and Youth Innovation Promotion Association, Chinese Academy of Sciences to L.Y. (http://www.yicas.cn).	Aizawa S., 2009, GENUS POLYPTERUS BIC, V2009; Allen J.A, 1876, AM BISONS LIVING EXT, V10; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Anagnostopoulou P, 2012, J CLIN INVEST, V122, P3629, DOI 10.1172/JCI60429; Andreev PS, 2015, PALAEONTOLOGY, V58, P691, DOI 10.1111/pala.12167; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Arora R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002866; Askary A, 2016, ELIFE, V5, DOI 10.7554/eLife.16415; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Braasch I, 2016, NAT GENET, V48, P427, DOI 10.1038/ng.3526; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Carroll Robert L., 2007, P185; Chauve C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000234; Chen YX, 2017, GIGASCIENCE, V7, DOI 10.1093/gigascience/gix120; Clack JA, 2009, ANNU REV EARTH PL SC, V37, P163, DOI 10.1146/annurev.earth.36.031207.124146; Coates MI, 2017, NATURE, V541, P208, DOI 10.1038/nature20806; Cope E.D., 1878, DESCRIPTIONS NEW EXT; Cuervo R, 2012, P NATL ACAD SCI USA, V109, P3838, DOI 10.1073/pnas.1006619109; Darwin C., 1877, ORIGIN SPECIES; Davis MC, 2004, J MORPHOL, V262, P608, DOI 10.1002/jmor.10264; DENISON ROBERT H., 1941, JOUR PALEONTOL, V15, P553; Du K, 2020, NAT ECOL EVOL, V4, P841, DOI 10.1038/s41559-020-1166-x; Dudchenko O, 2017, SCIENCE, V356, P92, DOI 10.1126/science.aal3327; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans BJ, 2008, FRONT BIOSCI-LANDMRK, V13, P4687, DOI 10.2741/3033; Farmer CG, 1999, ANNU REV PHYSIOL, V61, P573, DOI 10.1146/annurev.physiol.61.1.573; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Friedman M, 2015, PALAEONTOLOGY, V58, P213, DOI 10.1111/pala.12150; Gao Y, 2011, DEV BIOL, V352, P83, DOI 10.1016/j.ydbio.2011.01.018; Gardiner BG, 2005, ZOOL J LINN SOC-LOND, V144, P511, DOI 10.1111/j.1096-3642.2005.00181.x; Gibert JM, 2017, DEV GENES EVOL, V227, P297, DOI 10.1007/s00427-017-0589-0; Giles S, 2017, NATURE, V549, P265, DOI 10.1038/nature23654; Giles S, 2015, PALAEONTOLOGY, V58, P849, DOI 10.1111/pala.12182; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Goujet D, 2011, CR PALEVOL, V10, P323, DOI 10.1016/j.crpv.2011.03.008; Graham JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4022; Grande L, 2002, J VERTEBR PALEONTOL, V22, P209, DOI 10.1671/0272-4634(2002)022[0209:PLAWPP]2.0.CO;2; Han X, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.176198; Hara Y, 2018, NAT ECOL EVOL, V2, P1761, DOI 10.1038/s41559-018-0673-5; Haro E, 2017, DEVELOPMENT, V144, P2009, DOI 10.1242/dev.146332; Harris R. S., 2007, THESIS PENNSYLVANIA, DOI 10.1016/j.brainres.2008.03.070; Harter Till S., 2017, Fish Physiology, V36B, P1; HINCHLIFFE JR, 1994, DEVELOPMENT, P163; Hong TM, 2007, CLIN CANCER RES, V13, P4759, DOI 10.1158/1078-0432.CCR-07-0001; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Icardo JM, 2002, ANAT REC, V268, P388, DOI 10.1002/ar.10170; Icardo JM, 2002, ANAT RECORD, V267, P17, DOI 10.1002/ar.10080; Icardo JM, 2006, ANAT REC PART A, V288A, P900, DOI 10.1002/ar.a.20361; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Ishimatsu Atsushi, 2012, Aqua-Bioscience Monographs, V5, P1; Jiang Y, 2017, NAT GENET, V49, P1239, DOI 10.1038/ng.3906; Katoh M, 2013, BRIT J CANCER, V109, P299, DOI 10.1038/bjc.2013.281; Kikugawa K, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-3; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kuratani S, 2018, ZOOL LETT, V4, DOI 10.1186/s40851-017-0083-6; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P700, DOI 10.1086/425183; Longo S, 2013, J MORPHOL, V274, P687, DOI 10.1002/jmor.20128; Lorenzale M, 2018, BIOL REV, V93, P1604, DOI 10.1111/brv.12411; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Maisey JG, 2005, B AM MUS NAT HIST, P1; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Maldanis L, 2016, ELIFE, V5, DOI 10.7554/eLife.14698; Matsui A, 2010, MOL BIOL EVOL, V27, P1192, DOI 10.1093/molbev/msq003; Mesbah K, 2008, CIRC RES, V103, P743, DOI 10.1161/CIRCRESAHA.108.172858; Mirarab S, 2014, BIOINFORMATICS, V30, pI541, DOI 10.1093/bioinformatics/btu462; Miyake T, 2016, ANAT REC, V299, P1203, DOI 10.1002/ar.23392; Molnar JL, 2017, J ANAT, V230, P532, DOI 10.1111/joa.12573; Morris SC, 2008, J PALEONTOL, V82, P424, DOI 10.1666/06-130.1; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Muschick M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-116; Neyt C, 2000, NATURE, V408, P82, DOI 10.1038/35040549; Niimura Y, 2009, GENOME BIOL EVOL, V1, P34, DOI 10.1093/gbe/evp003; Noack K, 1996, GENETICS, V144, P1165; Olsen P.E., 1991, Journal of Vertebrate Paleontology, V11, P269; Perry SF, 2001, COMP BIOCHEM PHYS A, V129, P37, DOI 10.1016/S1095-6433(01)00304-X; Perry SF, 2004, RESP PHYSIOL NEUROBI, V144, P125, DOI 10.1016/j.resp.2004.06.018; Qu QM, 2015, NATURE, V526, P108, DOI 10.1038/nature15259; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Rabosky DL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2958; Ruan J, 2020, NAT METHODS, V17, P155, DOI 10.1038/s41592-019-0669-3; Sacerdot C, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1559-1; Sagai T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14300; Sallan LC, 2014, BIOL REV, V89, P950, DOI 10.1111/brv.12086; SATCHELL GH, 1967, J EXP BIOL, V46, P373; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Silva L, 2017, ANNU REV ANIM BIOSCI, V5, P353, DOI 10.1146/annurev-animal-022516-022801; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Soltis P.S., 2012, POLYPLOIDY GENOME EV, V665; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Stensio E.A, 1927, DOWNTONIAN DEVONIAN, V1; Sudarto, 2010, MAR BIOL, V157, P2253, DOI 10.1007/s00227-010-1492-7; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tanaka M, 2016, DEV BIOL, V413, P1, DOI 10.1016/j.ydbio.2016.03.007; Tatsumi N, 2016, SCI REP-UK, V6, DOI 10.1038/srep30580; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaidya R, 2017, PEDIATR RES, V82, P863, DOI 10.1038/pr.2017.160; Vaser R, 2017, GENOME RES, V27, P737, DOI 10.1101/gr.214270.116; Venkatesh B, 2001, P NATL ACAD SCI USA, V98, P11382, DOI 10.1073/pnas.201415598; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wagner GR, 2001, J EXP ZOOL, V291, P226, DOI 10.1002/jez.1100; West-Eberhard Mary Jane, 2003, pi; Wolff J, 2018, NUCLEIC ACIDS RES, V46, pW11, DOI 10.1093/nar/gky504; Woltering JM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc3510; Xu GH, 2018, PEERJ, V6, DOI 10.7717/peerj.6054; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YOUNG G C, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V167, P10; Yuan ZH, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4516-1; Zaccone G, 2009, ACTA HISTOCHEM, V111, P217, DOI 10.1016/j.acthis.2008.11.013; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; Zhu M, 2009, BIOL LETTERS, V5, P372, DOI 10.1098/rsbl.2008.0784; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855	126	24	27	30	126	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1377	+		10.1016/j.cell.2021.01.046	http://dx.doi.org/10.1016/j.cell.2021.01.046		MAR 2021	29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33545088	Bronze			2022-12-28	WOS:000629635700022
J	Brouwer, PJM; Brinkkemper, M; Maisonnasse, P; Dereuddre-Bosquet, N; Grobben, M; Claireaux, M; de Gast, M; Marlin, R; Chesnais, V; Diry, S; Allen, JD; Watanabe, Y; Giezen, JM; Kerster, G; Turner, HL; van der Straten, K; van der Linden, CA; Aldon, Y; Naninck, T; Bontjer, I; Burger, JA; Poniman, M; Mykytyn, AZ; Okba, NMA; Schermer, EE; van Breemen, MJ; Ravichandran, R; Caniels, TG; van Schooten, J; Kahlaoui, N; Contreras, V; Lemaitre, J; Chapon, C; Fang, RHT; Villaudy, J; Sliepen, K; van der Velden, YU; Haagmans, BL; de Bree, GJ; Ginoux, E; Ward, AB; Crispin, M; King, NP; van der Werf, S; van Gils, MJ; Le Grand, R; Sanders, RW				Brouwer, Philip J. M.; Brinkkemper, Mitch; Maisonnasse, Pauline; Dereuddre-Bosquet, Nathalie; Grobben, Marloes; Claireaux, Mathieu; de Gast, Marlon; Marlin, Romain; Chesnais, Virginie; Diry, Segolene; Allen, Joel D.; Watanabe, Yasunori; Giezen, Julia M.; Kerster, Gius; Turner, Hannah L.; van der Straten, Karlijn; van der Linden, Cynthia A.; Aldon, Yoann; Naninck, Thibaut; Bontjer, Ilja; Burger, Judith A.; Poniman, Meliawati; Mykytyn, Anna Z.; Okba, Nisreen M. A.; Schermer, Edith E.; van Breemen, Marielle J.; Ravichandran, Rashmi; Caniels, Tom G.; van Schooten, Jelle; Kahlaoui, Nidhal; Contreras, Vanessa; Lemaitre, Julien; Chapon, Catherine; Fang, Raphael Ho Tsong; Villaudy, Julien; Sliepen, Kwinten; van der Velden, Yme U.; Haagmans, Bart L.; de Bree, Godelieve J.; Ginoux, Eric; Ward, Andrew B.; Crispin, Max; King, Neil P.; van der Werf, Sylvie; van Gils, Marit J.; Le Grand, Roger; Sanders, Rogier W.			Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection	CELL			English	Article							NEUTRALIZING ANTIBODY-RESPONSES; HIV-1 ENVELOPE TRIMERS; IMMUNOGENICITY	The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is continuing to disrupt personal lives, global healthcare systems, and economies. Hence, there is an urgent need for a vaccine that prevents viral infection, transmission, and disease. Here, we present a two-component protein-based nanoparticle vaccine that displays multiple copies of the SARS-CoV-2 spike protein. Immunization studies show that this vaccine induces potent neutralizing antibody responses in mice, rabbits, and cynomolgus macaques. The vaccine-induced immunity protects macaques against a high-dose challenge, resulting in strongly reduced viral infection and replication in the upper and lower airways. These nanoparticles are a promising vaccine candidate to curtail the SARS-CoV-2 pandemic.	[Brouwer, Philip J. M.; Brinkkemper, Mitch; Grobben, Marloes; Claireaux, Mathieu; de Gast, Marlon; Giezen, Julia M.; Kerster, Gius; van der Straten, Karlijn; van der Linden, Cynthia A.; Aldon, Yoann; Bontjer, Ilja; Burger, Judith A.; Poniman, Meliawati; Schermer, Edith E.; van Breemen, Marielle J.; Caniels, Tom G.; van Schooten, Jelle; Sliepen, Kwinten; van der Velden, Yme U.; van Gils, Marit J.; Sanders, Rogier W.] Univ Amsterdam, Amsterdam Infect & Immun Inst, Dept Med Microbiol, Amsterdam UMC, NL-1105 AZ Amsterdam, Netherlands; [Maisonnasse, Pauline; Dereuddre-Bosquet, Nathalie; Marlin, Romain; Naninck, Thibaut; Kahlaoui, Nidhal; Contreras, Vanessa; Lemaitre, Julien; Chapon, Catherine; Fang, Raphael Ho Tsong; Le Grand, Roger] Univ Paris Saclay, Ctr Immunol Viral Autoimmune Hematol & Bacterial, CEA, INSERM, Fontenay Aux Roses, France; [Chesnais, Virginie; Diry, Segolene; Ginoux, Eric] Life & Soft, F-92350 Le Plessis Robinson, France; [Allen, Joel D.; Watanabe, Yasunori; Crispin, Max] Univ Southampton, Sch Biol Sci, Southampton SO17 1BJ, Hants, England; [Watanabe, Yasunori] Univ Oxford, Oxford Glycobiol Inst, Dept Biochem, Oxford OX1 3QU, England; [Turner, Hannah L.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Mykytyn, Anna Z.; Okba, Nisreen M. A.; Haagmans, Bart L.] Erasmus MC, Dept Virosci, NL-3015 GD Rotterdam, Netherlands; [Ravichandran, Rashmi; King, Neil P.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Ravichandran, Rashmi; King, Neil P.] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Villaudy, Julien] AIMM Therapeut BV, NL-1105 BA Amsterdam, Netherlands; [van der Werf, Sylvie] Univ Paris, CNRS UMR 3569, Inst Pasteur, Mol Genet RNA Viruses,Dept Virol, Paris, France; [van der Werf, Sylvie] Inst Pasteur, Natl Reference Ctr Resp Viruses, Paris, France; [de Bree, Godelieve J.] Univ Amsterdam, Amsterdam Inst Infect & Immun, Dept Internal Med, Amsterdam UMC, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Southampton; University of Oxford; Scripps Research Institute; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Amsterdam	Sanders, RW (corresponding author), Univ Amsterdam, Amsterdam Infect & Immun Inst, Dept Med Microbiol, Amsterdam UMC, NL-1105 AZ Amsterdam, Netherlands.; Le Grand, R (corresponding author), Univ Paris Saclay, Ctr Immunol Viral Autoimmune Hematol & Bacterial, CEA, INSERM, Fontenay Aux Roses, France.	roger.le-grand@cea.fr; r.w.sanders@amsterdamumc.nl	Naninck, Thibaut/AAY-1322-2021; Ward, Andrew/ABD-7728-2021; Haagmans, Bart/E-9791-2015; Crispin, Max/AAG-4098-2020; Okba, Nisreen MA/K-9984-2017; van Gils, Marit J./H-4791-2019	Ward, Andrew/0000-0001-7153-3769; Haagmans, Bart/0000-0001-6221-2015; Crispin, Max/0000-0002-1072-2694; Okba, Nisreen MA/0000-0002-2394-1079; van Gils, Marit J./0000-0003-3422-8161; Allen, Joel/0000-0003-2547-968X; Caniels, Tom/0000-0001-9580-157X; Chesnais, Virginie/0000-0002-6730-9761; Maisonnasse, Pauline/0000-0002-0555-207X; de Gast, Marlon/0000-0003-3976-8183; Grobben, Marloes/0000-0002-1559-9592; Lemaitre, Julien/0000-0001-6239-0110	Netherlands Organisation for Scientific Research (NWO) Vici grant; Bill & Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery (CAVD) grants [OPP1111923, OPP1132237, INV-002022, INV-008352/OPP1153692, OPP1196345/INV-008813, OPP1170236]; Fondation Dormeur, Vaduz; Health-Holland PPS-allowance [LSHM20040]; University of Southampton Coronavirus Response Fund; Netherlands Organisation for Health Research and Development ZONMW; AMC Fellowship from Amsterdam UMC; COVID-19 grant from the Amsterdam Institute for Infection and Immunity; University of Amsterdam Proof of Concept fund [200421]; Programme Investissements d'Avenir [ANR-11-INBS-0008]; REACTing; ANR (AM-CoV-Path); European Infrastructure TRANSVAC2 [730964]	Netherlands Organisation for Scientific Research (NWO) Vici grant(Netherlands Organization for Scientific Research (NWO)); Bill & Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery (CAVD) grants; Fondation Dormeur, Vaduz; Health-Holland PPS-allowance; University of Southampton Coronavirus Response Fund; Netherlands Organisation for Health Research and Development ZONMW(Netherlands Organization for Health Research and Development); AMC Fellowship from Amsterdam UMC; COVID-19 grant from the Amsterdam Institute for Infection and Immunity; University of Amsterdam Proof of Concept fund; Programme Investissements d'Avenir(French National Research Agency (ANR)); REACTing; ANR (AM-CoV-Path)(French National Research Agency (ANR)); European Infrastructure TRANSVAC2	We thank B. Delache, S. Langlois, J. Demilly, N. Dhooge, P. Le Calvez, M. Potier, F. Relouzat, J.M. Robert, T. Prot, and C. Dodan for the non-human primate experiments; L. Bossevot, M. Leonec, L. Moenne-Loccoz, and J. Morin for the qRT-PCR and ELISpot assays and preparation of reagents; B. Fert for her help with the CT scans; M. Barendji, J. Dinh, and E. Guyon for the non-human primate sample processing; S. Keyser for the transports organization; N. Dimant and B. Targat for their help with the experimental studies in the context of COVID-19-induced constraints; F. Ducancel and Y. Gorin for their help with the logistics and safety management; and I. Mangeot for her help with resource management. Ramos B cells were obtained from Drs. L. Wu and V.N. KewalRaman through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH. We thank A. McGuire for kindly sharing the pRRL.EuB29 lentiviral vector to transduce Ramos B cells. We thank P. Bieniasz for kindly sharing the pHIV-1NL43DENV-NanoLuc and SARS-CoV-2-SD19 plasmids and the 293T/ACE2 cell line. We thank H. Nijhuis for sample transportation. We thank A. Chung for sharing knowledge on the Luminex assay protocol and B. Wines and M. Hogarth for sharing the FcgR dimers. We thank Antoine Nougairede for sharing the plasmid used for the sgRNA assay standardization. Finally, we thank Dietmar Katinger and Philipp Mundsperger for providing the squalene emulsion and MPLA liposome adjuvants. Animal images in Figures 3 and 4 were created with BioRender.com. This work was supported by a Netherlands Organisation for Scientific Research (NWO) Vici grant (to R.W.S.); the Bill & Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery (CAVD) grants OPP1111923, OPP1132237, and INV-002022 (to R.W.S. and/or N.P.K.), INV-008352/OPP1153692 and OPP1196345/INV-008813 (to M.C.), and OPP1170236 (to A.B.W.); the Fondation Dormeur, Vaduz (R.W.S. and to M.J.v.G.) and Health-Holland PPS-allowance LSHM20040 (to M.J.v.G.); the University of Southampton Coronavirus Response Fund (M.C.); and the Netherlands Organisation for Health Research and Development ZONMW (B.L.H). M.J.v.G. is a recipient of an AMC Fellowship from Amsterdam UMC and a COVID-19 grant from the Amsterdam Institute for Infection and Immunity. R.W.S. and M.J.v.G. are recipients of support from the University of Amsterdam Proof of Concept fund (contract 200421) as managed by Innovation Exchange Amsterdam (IXA). The Infectious Disease Models and Innovative Therapies (IDMIT) research infrastructure is supported by the Programme Investissements d'Avenir, managed by the National Research Agency (ANR) under reference ANR-11-INBS-0008. The Fondation Bettencourt Schueller and the Region Ile-de-France contributed to the implementation of IDMIT's facilities and imaging technologies. The non-human primate study received financial support from REACTing, the ANR (AM-CoV-Path), and the European Infrastructure TRANSVAC2 (730964). The funders had no role in study design, data collection, data analysis, data interpretation, or data reporting.	Addetia Amin, 2020, medRxiv, DOI 10.1101/2020.08.13.20173161; Amanat Fatima, 2020, bioRxiv, DOI 10.1101/2020.09.16.300970; Antanasijevic A, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008665; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Bale JB, 2016, SCIENCE, V353, P389, DOI 10.1126/science.aaf8818; Boyoglu-Barnum S., 2020, ELICITATION BROADLY, DOI [10.1101/2020.05.30.125179, DOI 10.1101/2020.05.30.125179]; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Brouwer PJM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12080-1; Bruun TUJ, 2018, ACS NANO, V12, P8855, DOI 10.1021/acsnano.8b02805; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Corbett KS, 2020, NEW ENGL J MED, V383, P1544, DOI 10.1056/NEJMoa2024671; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Edge P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12493-y; Feng LQ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18077-5; GAEBLER C, 2021, NATURE; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Gee P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14957-y; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Guebre-Xabier M, 2020, VACCINE, V38, P7892, DOI 10.1016/j.vaccine.2020.10.064; Hassan AO, 2020, CELL, V183, P169, DOI 10.1016/j.cell.2020.08.026; He LL, 2021, SCI ADV, V7, DOI [10.1126/sciadv.abf1591, 10.1101/2020.09.14.296715]; Heit A, 2017, J EXP MED, V214, P2139, DOI 10.1084/jem.20161794; Hsieh Ching-Lin, 2020, bioRxiv, DOI [10.1126/science.abd0826, 10.1101/2020.05.30.125484]; Juraszek J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20321-x; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Kelly HG, 2019, EXPERT REV VACCINES, V18, P269, DOI 10.1080/14760584.2019.1578216; Klasse P.J., 2020, IMMUNOGENICITY CLIN; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Krarup A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9143; Lal H, 2018, VACCINE, V36, P148, DOI 10.1016/j.vaccine.2017.11.019; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lescure FX, 2020, LANCET INFECT DIS, V20, P697, DOI 10.1016/S1473-3099(20)30200-0; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Liang JG, 2020, S TRIMER COVID 19 SU, DOI [10.1101/2020.09.24.311027., DOI 10.1101/2020.09.24.311027, 10.1101/2020.09.24.311027]; Ma XC, 2020, IMMUNITY, V53, P1315, DOI 10.1016/j.immuni.2020.11.015; Maisonnasse P, 2020, NATURE, V585, P584, DOI 10.1038/s41586-020-2558-4; Marcandalli J, 2019, CELL, V176, P1420, DOI 10.1016/j.cell.2019.01.046; McGuire AT, 2014, SCIENCE, V346, P1380, DOI 10.1126/science.1259206; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Moyer TJ, 2016, J CLIN INVEST, V126, P799, DOI 10.1172/JCI81083; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370; Patel A., 2020, INTRADERMAL DELIVERE, DOI 10.1101/2020.07.28.225649v1; Potter CS, 1999, ULTRAMICROSCOPY, V77, P153, DOI 10.1016/S0304-3991(99)00043-1; Powell AE, 2021, ACS CENTRAL SCI, V7, P183, DOI 10.1021/acscentsci.0c01405; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Schmidt Fabian, 2020, J Exp Med, V217, DOI [10.1101/2020.06.08.140871, 10.1084/jem.20201181]; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4; Sliepen K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10262-5; Sliepen K, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0210-4; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; ter Brake O, 2006, MOL THER, V14, P883, DOI 10.1016/j.ymthe.2006.07.007; Tian JH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20653-8; Tokatlian T, 2019, SCIENCE, V363, P649, DOI 10.1126/science.aat9120; Tyson John R, 2020, bioRxiv, DOI 10.1101/2020.09.04.283077; van Doremalen N, 2020, NATURE, V586, P578, DOI [10.1038/s41586-020-2608-y, 10.1101/2020.05.13.093195]; Vella LA, 2019, J CLIN INVEST, V129, P3185, DOI 10.1172/JCI125628; Veneziano R, 2020, NAT NANOTECHNOL, V15, P716, DOI 10.1038/s41565-020-0719-0; Walls Alexandra C, 2020, Cell, V183, P1367, DOI [10.1101/2020.08.11.247395, 10.1016/j.cell.2020.10.043]; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang H, 2020, CELL, V182, P713, DOI 10.1016/j.cell.2020.06.008; Watanabe Y, 2020, SCIENCE, V369, P330, DOI 10.1126/science.abb9983; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Yao HP, 2020, CELL, V183, P730, DOI 10.1016/j.cell.2020.09.018; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; COMPUT STRUCT BIOTEC	74	70	71	5	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1188	+		10.1016/j.cell.2021.01.035	http://dx.doi.org/10.1016/j.cell.2021.01.035		MAR 2021	32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33577765	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000629635700010
J	Blakney, AK; McKay, PF				Blakney, Anna K.; McKay, Paul F.			Next-generation COVID-19 vaccines: here come the proteins Comment	LANCET			English	Editorial Material									[Blakney, Anna K.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6S 0K3, Canada; [McKay, Paul F.] Imperial Coll London, Dept Infect Dis, London, England	University of British Columbia; Imperial College London	Blakney, AK (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V6S 0K3, Canada.	anna.blakney@msl.ubc.ca	Blakney, Anna/GWC-0911-2022	Blakney, Anna/0000-0002-5812-9689				Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; CEPI, 2021, CENTR LABS NETW; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Liu HP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09518-1; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Richmond P, 2021, LANCET, V397, P682, DOI 10.1016/S0140-6736(21)00241-5; Stoesser N, 2020, LANCET INFECT DIS, V20, P1390, DOI 10.1016/S1473-3099(20)30634-4; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Watterson D, 2020, RES SQUARE	12	9	9	4	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					643	645		10.1016/S0140-6736(21)00258-0	http://dx.doi.org/10.1016/S0140-6736(21)00258-0		FEB 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL3PK	33524312	Green Published, Bronze			2022-12-28	WOS:000620991800003
J	Burton, DR; Topol, EJ				Burton, Dennis R.; Topol, Eric J.			Variant-proof vaccines - invest now for the next pandemic	NATURE			English	Editorial Material						Public health; Medical research; Virology; Epidemiology		COVID's evolution signals the importance of rational vaccine design based on broadly neutralizing antibodies. COVID's evolution signals the importance of rational vaccine design based on broadly neutralizing antibodies.	[Burton, Dennis R.] Scripps Res Inst, Immunol & Microbiol, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Steering Comm, Cambridge, MA 02139 USA; [Topol, Eric J.] Scripps Res Translat Inst, La Jolla, CA USA; [Topol, Eric J.] Scripps Res Inst, Mol Med, La Jolla, CA 92037 USA	Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Scripps Research Institute	Burton, DR (corresponding author), Scripps Res Inst, Immunol & Microbiol, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Ragon Inst MGH MIT & Harvard, Steering Comm, Cambridge, MA 02139 USA.	burton@scripps.edu; etopol@scripps.edu						Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Rappazzo CG, 2021, SCIENCE, V371, P823, DOI 10.1126/science.abf4830; Rees-Spear C, 2021, PREPRINT BIORXIV, DOI [10.1101/2021.01.15.426849, DOI 10.1101/2021.01.15.426849]; Sok D, 2018, NAT IMMUNOL, V19, P1179, DOI 10.1038/s41590-018-0235-7; Wang C, 2020, PREPRINT BIORXIV, DOI [10.1101/2020.10.20.346916, DOI 10.1101/2020.10.20.346916]; Wang P, 2021, PREPRINT BIORXIV, DOI [10.1101/2021.01.25.428137, DOI 10.1101/2021.01.25.428137]; Wang Z, 2021, PREPRINT BIORXIV, DOI [10.1101/2021.01.15.426911, DOI 10.1101/2021.01.15.426911]; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; West BR, 2019, NAT STRUCT MOL BIOL, V26, P204, DOI 10.1038/s41594-019-0191-4; Wibmer CK, 2021, PREPRINT BIORXIV, DOI [10.1101/2021.01.18.427166, DOI 10.1101/2021.01.18.427166]; Yang H, 2019, ABSTRACT O0814 29 EU	12	16	16	0	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846					386	388		10.1038/d41586-021-00340-4	http://dx.doi.org/10.1038/d41586-021-00340-4			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG3VU	33558746				2022-12-28	WOS:000617518000001
J	Ivanova, M				Ivanova, Maria			At 50, the UN Environment Programme must lead again	NATURE			English	Editorial Material						Environmental sciences; Institutions			[Ivanova, Maria] Univ Massachusetts, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston	Ivanova, M (corresponding author), Univ Massachusetts, Boston, MA 02125 USA.	maria.ivanova@umb.edu	Ivanova, Mariia/ACC-9004-2022	Ivanova, Mariia/0000-0002-7636-1000					0	1	1	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846					365	365		10.1038/d41586-021-00393-5	http://dx.doi.org/10.1038/d41586-021-00393-5			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QJ5CU	33594287				2022-12-28	WOS:000619709400007
J	Liu, B; Lin, YH; Yan, JC; Yao, JC; Liu, D; Ma, WW; Wang, JB; Liu, WL; Wang, CS; Zhang, L; Qi, H				Liu, Bo; Lin, Yihan; Yan, Jiacong; Yao, Jiacheng; Liu, Dan; Ma, Weiwei; Wang, Jianbin; Liu, Wanli; Wang, Chengshuo; Zhang, Luo; Qi, Hai			Affinity-coupled CCL22 promotes positive selection in germinal centres	NATURE			English	Article								Antibody affinity maturation depends on positive selection in germinal centres (GCs) of rare B cell clones that acquire higher-affinity B cell receptors via somatic hypermutation, present more antigen to follicular helper T (T-FH) cells and, consequently, receive more contact-dependent T cell help(1). As these GC B cells and T-FH cells do not maintain long-lasting contacts in the chaotic GC environment(2-4), it is unclear how sufficient T cell help is cumulatively focused onto those rare clones. Here we show that, upon stimulation of CD40, GC B cells upregulate the chemokine CCL22 and to a lesser extent CCL17. By engaging the chemokine receptor CCR4 on T-FH cells, CCL22 and CCL17 can attract multiple helper cells from a distance, thus increasing the chance of productive help. During a GC response, B cells that acquire higher antigen-binding affinities express higher levels of CCL22, which in turn 'highlight' these high-affinity GC B cells. Acute increase or blockade of T-FH cells helps to rapidly increase or decrease CCL22 expression by GC B cells, respectively. Therefore, a chemokine-based intercellular reaction circuit links the amount of T cell help that individual B cells have received recently to their subsequent ability to attract more help. When CCL22 and CCL17 are ablated in B cells, GCs form but B cells are not affinity-matured efficiently. When competing with wild-type B cells in the same reaction, B cells lacking CCL22 and CCL17 receive less T cell help to maintain GC participation or develop into bone-marrow plasma cells. By uncovering a chemokine-mediated mechanism that highlights affinity-improved B cells for preferential help from T-FH cells, our study reveals a principle of spatiotemporal orchestration of GC positive selection.	[Liu, Bo; Lin, Yihan; Yan, Jiacong; Yao, Jiacheng; Liu, Dan; Ma, Weiwei; Liu, Wanli; Qi, Hai] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China; [Liu, Bo; Lin, Yihan; Yan, Jiacong; Liu, Dan; Ma, Weiwei; Qi, Hai] Tsinghua Univ, Inst Immunol, Lab Dynam Immunobiol, Beijing, Peoples R China; [Liu, Bo; Lin, Yihan; Yan, Jiacong; Liu, Dan; Ma, Weiwei; Qi, Hai] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing, Peoples R China; [Yao, Jiacheng; Wang, Jianbin; Liu, Wanli; Qi, Hai] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China; [Liu, Wanli; Qi, Hai] Tsinghua Univ, Beijing Key Lab Immunol Res Chron Dis, Beijing, Peoples R China; [Wang, Chengshuo; Zhang, Luo] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Qi, Hai] Tsinghua Univ, Beijing Frontier Res Ctr Biol Struct, Beijing, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Capital Medical University; Tsinghua University	Qi, H (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Inst Immunol, Lab Dynam Immunobiol, Beijing, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Beijing Key Lab Immunol Res Chron Dis, Beijing, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Beijing Frontier Res Ctr Biol Struct, Beijing, Peoples R China.	qihai@tsinghua.edu.cn		Yan, Jiacong/0000-0002-2429-036X; Qi, Hai/0000-0001-5475-3989; Zhang, Luo/0000-0002-0910-9884	National Key R&D Program of China (Ministry of Science and Technology) [2018YFE0200300]; National Natural Science Foundation of China [81621002, 31830023, 81761128019]; Tsinghua-Peking Center for Life Sciences; Beijing Municipal Science & Technology Commission; Beijing Frontier Research Center for Biological Structure	National Key R&D Program of China (Ministry of Science and Technology); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Center for Life Sciences; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Beijing Frontier Research Center for Biological Structure	We thank M. Nussenzweig for providing the B1-8<SUP>hi</SUP> mice. The work was funded in part by the National Key R&D Program of China (Ministry of Science and Technology, 2018YFE0200300 to H.Q.), National Natural Science Foundation of China (grant 81621002, 31830023, 81761128019 to H.Q.), the Tsinghua-Peking Center for Life Sciences, the Beijing Municipal Science & Technology Commission, and the Beijing Frontier Research Center for Biological Structure.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Holmes AB, 2020, J EXP MED, V217, DOI 10.1084/jem.20200483; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Mayer CT, 2017, SCIENCE, V358, DOI 10.1126/science.aao2602; Rapp M, 2019, J EXP MED, V216, P1170, DOI 10.1084/jem.20170277; Rodriguez EA, 2017, TRENDS BIOCHEM SCI, V42, P111, DOI 10.1016/j.tibs.2016.09.010; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Shi JW, 2018, IMMUNITY, V49, P264, DOI 10.1016/j.immuni.2018.06.012; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wang YF, 2017, NAT IMMUNOL, V18, P921, DOI 10.1038/ni.3788	19	12	12	6	36	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 1	2021	592	7852								10.1038/s41586-021-03239-2	http://dx.doi.org/10.1038/s41586-021-03239-2		FEB 2021	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TS6IE	33597749				2022-12-28	WOS:000618965700005
J	Perak, AM; Lancki, N; Kuang, A; Labarthe, DR; Allen, NB; Shah, SH; Lowe, LP; Grobman, WA; Lawrence, JM; Lloyd-Jones, DM; Lowe, WL; Scholtens, DM				Perak, Amanda M.; Lancki, Nicola; Kuang, Alan; Labarthe, Darwin R.; Allen, Norrina B.; Shah, Svati H.; Lowe, Lynn P.; Grobman, William A.; Lawrence, Jean M.; Lloyd-Jones, Donald M.; Lowe, William L., Jr.; Scholtens, Denise M.		Hapo Follow-Up Study Cooperative R	Associations of Maternal Cardiovascular Health in Pregnancy With Offspring Cardiovascular Health in Early Adolescence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Key PointsQuestionIs maternal cardiovascular health during pregnancy (characterized by the combination of 5 metrics: body mass index, blood pressure, total cholesterol level, glucose level, and smoking) associated with offspring cardiovascular health during early adolescence (characterized by the combination of 4 metrics: body mass index, blood pressure, total cholesterol level, and glucose level)? FindingsIn this multinational cohort study of 2302 mother-child dyads, poorer maternal cardiovascular health at a mean of 28 weeks' gestation was significantly associated with higher risks for poorer offspring cardiovascular health at ages 10 to 14 years (adjusted relative risk for association between >= 2 poor [vs all ideal] maternal metrics and >= 2 poor [vs all ideal] offspring metrics, 7.82). MeaningMaternal cardiovascular health during pregnancy was significantly associated with offspring cardiovascular health during early adolescence. ImportancePregnancy may be a key window to optimize cardiovascular health (CVH) for the mother and influence lifelong CVH for her child. ObjectiveTo examine associations between maternal gestational CVH and offspring CVH. Design, Setting, and ParticipantsThis cohort study used data from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study (examinations: July 2000-April 2006) and HAPO Follow-Up Study (examinations: February 2013-December 2016). The analyses included 2302 mother-child dyads, comprising 48% of HAPO Follow-Up Study participants, in an ancillary CVH study. Participants were from 9 field centers across the United States, Barbados, United Kingdom, China, Thailand, and Canada. ExposuresMaternal gestational CVH at a target of 28 weeks' gestation, based on 5 metrics: body mass index, blood pressure, total cholesterol level, glucose level, and smoking. Each metric was categorized as ideal, intermediate, or poor using pregnancy guidelines. Total CVH was categorized as follows: all ideal metrics, 1 or more intermediate (but 0 poor) metrics, 1 poor metric, or 2 or more poor metrics. Main Outcomes and MeasuresOffspring CVH at ages 10 to 14 years, based on 4 metrics: body mass index, blood pressure, total cholesterol level, and glucose level. Total CVH was categorized as for mothers. ResultsAmong 2302 dyads, the mean (SD) ages were 29.6 (2.7) years for pregnant mothers and 11.3 (1.1) years for children. During pregnancy, the mean (SD) maternal CVH score was 8.6 (1.4) out of 10. Among pregnant mothers, the prevalence of all ideal metrics was 32.8% (95% CI, 30.6%-35.1%), 31.7% (95% CI, 29.4%-34.0%) for 1 or more intermediate metrics, 29.5% (95% CI, 27.2%-31.7%) for 1 poor metric, and 6.0% (95% CI, 3.8%-8.3%) for 2 or more poor metrics. Among children of mothers with all ideal metrics, the prevalence of all ideal metrics was 42.2% (95% CI, 38.4%-46.2%), 36.7% (95% CI, 32.9%-40.7%) for 1 or more intermediate metrics, 18.4% (95% CI, 14.6%-22.4%) for 1 poor metric, and 2.6% (95% CI, 0%-6.6%) for 2 or more poor metrics. Among children of mothers with 2 or more poor metrics, the prevalence of all ideal metrics was 30.7% (95% CI, 22.0%-40.4%), 28.3% (95% CI, 19.7%-38.1%) for 1 or more intermediate metrics, 30.7% (95% CI, 22.0%-40.4%) for 1 poor metric, and 10.2% (95% CI, 1.6%-20.0%) for 2 or more poor metrics. The adjusted relative risks associated with 1 or more intermediate, 1 poor, and 2 or more poor (vs all ideal) metrics, respectively, in mothers during pregnancy were 1.17 (95% CI, 0.96-1.42), 1.66 (95% CI, 1.39-1.99), and 2.02 (95% CI, 1.55-2.64) for offspring to have 1 poor (vs all ideal) metrics, and the relative risks were 2.15 (95% CI, 1.23-3.75), 3.32 (95% CI,1.96-5.62), and 7.82 (95% CI, 4.12-14.85) for offspring to have 2 or more poor (vs all ideal) metrics. Additional adjustment for categorical birth factors (eg, preeclampsia) did not fully explain these significant associations (eg, relative risk for association between 2 or more poor metrics among mothers during pregnancy and 2 or more poor metrics among offspring after adjustment for an extended set of birth factors, 6.23 [95% CI, 3.03-12.82]). Conclusions and RelevanceIn this multinational cohort, better maternal CVH at 28 weeks' gestation was significantly associated with better offspring CVH at ages 10 to 14 years. This international cohort study examines associations between the cardiovascular (CV) health of pregnant women (defined by 5 CV risk factors) and CV health of their offspring at ages 10 to 14 years.	[Perak, Amanda M.; Lancki, Nicola; Kuang, Alan; Labarthe, Darwin R.; Allen, Norrina B.; Lowe, Lynn P.; Grobman, William A.; Lloyd-Jones, Donald M.; Lowe, William L., Jr.; Scholtens, Denise M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Perak, Amanda M.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Shah, Svati H.] Duke Univ, Med Ctr, Durham, NC USA; [Lawrence, Jean M.] Kaiser Permanente Southern Calif, Pasadena, CA USA; [Lawrence, Jean M.] NIDDK, Div Diabet Endocrinol & Metab Dis, Bethesda, MD 20892 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Duke University; Kaiser Permanente; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Perak, AM (corresponding author), Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, 680 N Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA.	amarma@luriechildrens.org		Marma, Amanda/0000-0003-1025-0997; Lloyd-Jones, Donald/0000-0003-0847-6110	NCATS NIH HHS [UL1 TR002548, UL1 TR001422] Funding Source: Medline; NHLBI NIH HHS [K23 HL145101, L30 HL134048] Funding Source: Medline; NICHD NIH HHS [R01 HD034242, R01 HD034243] Funding Source: Medline; NIDDK NIH HHS [R01 DK095963, R01 DK117491, U01 DK094830] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; Allen NB, 2017, CIRCULATION, V135, P1693, DOI 10.1161/CIRCULATIONAHA.116.026252; Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS14, DOI 10.2337/dc20-S002; Andraweera PH, 2019, J PEDIATR-US, V208, P104, DOI 10.1016/j.jpeds.2018.12.008; [Anonymous], 2019, Obstet Gynecol, V133, P1, DOI 10.1097/AOG.0000000000003018; [Anonymous], 2017, Obstet Gynecol, V130, P1, DOI 10.1097/AOG.0000000000002348; Brown HL, 2018, CIRCULATION, V137, pE843, DOI 10.1161/CIR.0000000000000582; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Contreras M, 2002, INT J GYNECOL OBSTET, V78, P69; Daniels SR, 2019, J PEDIATR-US, V209, P240, DOI 10.1016/j.jpeds.2019.01.042; Daraki V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126327; de Nigris F, 2018, JAMA CARDIOL, V3, P1184, DOI 10.1001/jamacardio.2018.3546; Flynn JT, 2018, PEDIATRICS, V142, DOI [10.1542/peds.2018-1739, 10.1542/peds.2017-1904]; Godfrey KM, 2017, LANCET DIABETES ENDO, V5, P53, DOI 10.1016/S2213-8587(16)30107-3; Hammad IA, 2020, AM J OBSTET GYNECOL, V222, DOI 10.1016/j.ajog.2019.07.024; Knop MR, 2018, J AM HEART ASSOC, V7, DOI [10.1161/JAHA.118.008870, 10.1161/jaha.118.008870]; Laitinen TT, 2012, CIRCULATION, V125, P1971, DOI 10.1161/CIRCULATIONAHA.111.073585; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lowe WL, 2018, JAMA-J AM MED ASSOC, V320, P1005, DOI 10.1001/jama.2018.11628; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; National Heart Lung and Blood Institute, 2012, EXP PAN INT GUID CAR; Nesbitt GS, 2006, CLIN TRIALS, V3, P397, DOI 10.1177/174077450607695; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Paauw ND, 2017, ACTA PHYSIOL, V219, P241, DOI 10.1111/apha.12702; Palinski W, 2014, CIRCULATION, V129, P2066, DOI 10.1161/CIRCULATIONAHA.113.001805; Perak AM., 2020, AM J OBSTET GYNECOL, DOI [10.1161/circ.141.suppl_1.33, DOI 10.1161/CIRC.141.SUPPL_1.33]; Perak AM, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015123; R Core Team, R LANGUAGE ENV STAT; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; Singh GK, 2019, J OBES, V2019, DOI 10.1155/2019/2419263; van Elten TM, 2019, J DEV ORIG HLTH DIS, V10, P286, DOI 10.1017/S204017441800082X; van Sloten TT, 2018, JAMA-J AM MED ASSOC, V320, P1793, DOI 10.1001/jama.2018.16975; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Yu YF, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6398	37	28	28	3	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2021	325	7					658	668		10.1001/jama.2021.0247	http://dx.doi.org/10.1001/jama.2021.0247			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ3QZ	33591345	Green Published, Bronze			2022-12-28	WOS:000619608000018
J	Gates, AJ; Gysi, DM; Kellis, M; Barabasi, AL				Gates, Alexander J.; Gysi, Deisy Morselli; Kellis, Manolis; Barabasi, Albert-Laszlo			A wealth of discovery built on the Human Genome Project - by the numbers	NATURE			English	Editorial Material						Genetics; Medical research; Drug discovery; Biotechnology		A new analysis traces the story of the draft genome's impact on genomics since 2001, linking its effects on publications, drug approvals and understanding of disease. A new analysis traces the story of the draft genome's impact on genomics since 2001, linking its effects on publications, drug approvals and understanding of disease.	[Gates, Alexander J.; Gysi, Deisy Morselli; Barabasi, Albert-Laszlo] Northeastern Univ, Network Sci Inst, Boston, MA 02115 USA; [Gysi, Deisy Morselli; Barabasi, Albert-Laszlo] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Gysi, Deisy Morselli] MIT, Comp Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Barabasi, Albert-Laszlo] Northeastern Univ, Network Sci, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Cent European Univ, Dept Network & Data Sci, Budapest, Hungary	Northeastern University; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Northeastern University; Central European University	Barabasi, AL (corresponding author), Northeastern Univ, Network Sci Inst, Boston, MA 02115 USA.; Barabasi, AL (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Barabasi, AL (corresponding author), Northeastern Univ, Network Sci, Boston, MA 02115 USA.; Barabasi, AL (corresponding author), Cent European Univ, Dept Network & Data Sci, Budapest, Hungary.	a.barabasi@northeastern.edu	Gysi, Deisy Morselli/ABC-2056-2020; Gates, Alexander/O-9825-2017	Gysi, Deisy Morselli/0000-0002-5771-8182; Gates, Alexander/0000-0003-0099-7480				Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P325; Bianconi G, 2001, EUROPHYS LETT, V54, P436, DOI 10.1209/epl/i2001-00260-6; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gysi D.M., 2020, PREPRINT; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lencz T, 2007, MOL PSYCHIATR, V12, P572, DOI 10.1038/sj.mp.4001983; Portin P, 2017, GENETICS, V205, P1353, DOI 10.1534/genetics.116.196956; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338	15	23	24	9	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2021	590	7845					212	215		10.1038/d41586-021-00314-6	http://dx.doi.org/10.1038/d41586-021-00314-6			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG0NG	33568828				2022-12-28	WOS:000617282500001
J	Wonkam, A				Wonkam, Ambroise			Sequence three million genomes across Africa	NATURE			English	Editorial Material						Genomics; Research management	SCHIZOPHRENIA; PROTEIN	Capture the full scope of variation to improve health care, equity and medical research globally. Capture the full scope of variation to improve health care, equity and medical research globally.	[Wonkam, Ambroise] Univ Cape Town, Fac Hlth Sci, Med Genet, Rondebosch, South Africa; [Wonkam, Ambroise] Univ Cape Town, Fac Hlth Sci, Res, Rondebosch, South Africa; [Wonkam, Ambroise] African Soc Human Genet, Cape Town, South Africa	University of Cape Town; University of Cape Town	Wonkam, A (corresponding author), Univ Cape Town, Fac Hlth Sci, Med Genet, Rondebosch, South Africa.; Wonkam, A (corresponding author), Univ Cape Town, Fac Hlth Sci, Res, Rondebosch, South Africa.; Wonkam, A (corresponding author), African Soc Human Genet, Cape Town, South Africa.	ambroise.wonkam@uct.ac.za	Wonkam, Ambroise/AFU-6901-2022		NHGRI NIH HHS [U54 HG009790] Funding Source: Medline; NHLBI NIH HHS [U24 HL135600] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adedokun BO, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31026; Choudhury A, 2020, NATURE, V586, P741, DOI 10.1038/s41586-020-2859-7; Curtis D, 2018, PSYCHIAT GENET, V28, P85, DOI 10.1097/YPG.0000000000000206; Geard A, 2017, BRIT J HAEMATOL, V178, P629, DOI 10.1111/bjh.14724; Genovese G, 2016, NAT NEUROSCI, V19, P1433, DOI 10.1038/nn.4402; Green ED, 2020, NATURE, V586, P683, DOI 10.1038/s41586-020-2817-4; Gulsuner S, 2020, SCIENCE, V367, P569, DOI 10.1126/science.aay8833; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Schulze KV, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13433-6; Sherman RM, 2019, NAT GENET, V51, P30, DOI 10.1038/s41588-018-0273-y; Sirugo G, 2019, CELL, V177, P26, DOI 10.1016/j.cell.2019.02.048; Swart M, 2013, PHARMACOGENET GENOM, V23, P415, DOI 10.1097/FPC.0b013e328363176f; Wonkam A, 2020, HUM MOL GENET, V29, P3729, DOI 10.1093/hmg/ddaa225; Wonkam A, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.152	15	17	17	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2021	590	7845					209	211		10.1038/d41586-021-00313-7	http://dx.doi.org/10.1038/d41586-021-00313-7			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG0TV	33568829				2022-12-28	WOS:000617300400006
J	Allou, L; Balzano, S; Magg, A; Quinodoz, M; Royer-Bertrand, B; Schopflin, R; Chan, WL; Speck-Martins, CE; Carvalho, DR; Farage, L; Lourenco, CM; Albuquerque, R; Rajagopal, S; Nampoothiri, S; Campos-Xavier, B; Chiesa, C; Niel-Butschi, F; Wittler, L; Timmermann, B; Spielmann, M; Robson, MI; Ringel, A; Heinrich, V; Cova, G; Andrey, G; Prada-Medina, CA; Pescini-Gobert, R; Unger, S; Bonafe, L; Grote, P; Rivolta, C; Mundlos, S; Superti-Furga, A				Allou, Lila; Balzano, Sara; Magg, Andreas; Quinodoz, Mathieu; Royer-Bertrand, Beryl; Schopflin, Robert; Chan, Wing-Lee; Speck-Martins, Carlos E.; Carvalho, Daniel Rocha; Farage, Luciano; Lourenco, Charles Marques; Albuquerque, Regina; Rajagopal, Srilakshmi; Nampoothiri, Sheela; Campos-Xavier, Belinda; Chiesa, Carole; Niel-Buetschi, Florence; Wittler, Lars; Timmermann, Bernd; Spielmann, Malte; Robson, Michael I.; Ringel, Alessa; Heinrich, Verena; Cova, Giulia; Andrey, Guillaume; Prada-Medina, Cesar A.; Pescini-Gobert, Rosanna; Unger, Sheila; Bonafe, Luisa; Grote, Phillip; Rivolta, Carlo; Mundlos, Stefan; Superti-Furga, Andrea			Non-coding deletions identify Maenli lncRNA as a limb-specific En1 regulator	NATURE			English	Article							GENE-EXPRESSION; READ ALIGNMENT; CHROMATIN; RNA; SUSCEPTIBILITY; TRANSCRIPTION; GENERATION; DISTINCT; CANCER; CELLS	Long non-coding RNAs (IncRNAs) can be important components in gene-regulatory networks(1), but the exact nature and extent of their involvement in human Mendelian disease is largely unknown. Here we show that genetic ablation of a lncRNA locus on human chromosome 2 causes a severe congenital limb malformation. We identified homozygous 27-63-kilobase deletions located 300 kilobases upstream of the engrailed-1 gene (EN1) in patients with a complex limb malformation featuring mesomelic shortening, syndactyly and ventralnails (dorsal dimelia). Re-engineering of the human deletions in mice resulted in a complete loss of En1 expression in the limb and a double dorsal-limb phenotype that recapitulates the human disease phenotype. Genome-widetranscriptome analysis in the developing mouse limb revealed a four-exon-longnon-codingtranscript with in the deleted region, which we named Maenli. Functional dissection of the Maenli locus showed that its transcriptional activity is required for limb-specificEn1 activation in cis, thereby fine-tuningthe gene-regulatory networks controlling dorso-ventral polarity in the developing limb bud. Its loss results in the En1-related dorsal ventral limb phenotype, a subset of the full En1-associated phenotype. Our findings demonstrate that mutations involving lncRNA loci can result in human Mendelian disease.	[Allou, Lila; Magg, Andreas; Schopflin, Robert; Spielmann, Malte; Robson, Michael I.; Ringel, Alessa; Cova, Giulia; Andrey, Guillaume; Prada-Medina, Cesar A.; Mundlos, Stefan] Max Planck Inst Mol Genet, RG Dev & Dis, Berlin, Germany; [Allou, Lila; Magg, Andreas; Schopflin, Robert; Chan, Wing-Lee; Spielmann, Malte; Cova, Giulia; Mundlos, Stefan] Charite Univ Med Berlin, Inst Med & Human Genet, Berlin, Germany; [Balzano, Sara; Quinodoz, Mathieu; Pescini-Gobert, Rosanna; Rivolta, Carlo] Univ Lausanne, Dept Computat Biol, Med Genet Unit, Lausanne, Switzerland; [Balzano, Sara; Royer-Bertrand, Beryl; Chiesa, Carole; Niel-Buetschi, Florence; Unger, Sheila; Bonafe, Luisa; Superti-Furga, Andrea] Lausanne Univ Hosp CHUV, Div Genet Med, Lausanne, Switzerland; [Balzano, Sara; Royer-Bertrand, Beryl; Chiesa, Carole; Niel-Buetschi, Florence; Unger, Sheila; Bonafe, Luisa; Superti-Furga, Andrea] Univ Lausanne, Lausanne, Switzerland; [Magg, Andreas; Chan, Wing-Lee; Mundlos, Stefan] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Quinodoz, Mathieu] Inst Mol & Clin Ophthalmol Basel IOB, Basel, Switzerland; [Quinodoz, Mathieu; Rivolta, Carlo] Univ Basel, Dept Ophthalmol, Basel, Switzerland; [Speck-Martins, Carlos E.; Carvalho, Daniel Rocha] SARAH Network Rehabil Hosp, Genet Unit, Brasilia, DF, Brazil; [Farage, Luciano] Inst Cardiol Dist Fed, Brasilia, DF, Brazil; [Lourenco, Charles Marques] Ctr Univ Estacio, Fac Med, Ribeirao Preto, Brazil; [Albuquerque, Regina] Fac Estadual Med Sao Jose Rio Preto FAMERP, Sao Jose Do Rio Preto, Brazil; [Rajagopal, Srilakshmi] Tamil Nadu Dr MGR Med Univ, Dept Med Genet, Chennai, Tamil Nadu, India; [Nampoothiri, Sheela] Amrita Inst Med Sci & Res Ctr, Dept Pediat Genet, Cochin, Kerala, India; [Wittler, Lars] Max Planck Inst Mol Genet, Dept Dev Genet, Berlin, Germany; [Timmermann, Bernd] Max Planck Inst Mol Genet, Sequencing Core Facil, Berlin, Germany; [Spielmann, Malte] Univ Lubeck, Inst Humangenet Lubeck, Lubeck, Germany; [Heinrich, Verena] Max Planck Inst Mol Genet, Dept Computat Mol Biol, Berlin, Germany; [Andrey, Guillaume] Univ Geneva, Dept Genet Med & Dev & iGE3, Fac Med, Geneva, Switzerland; [Grote, Phillip] Goethe Univ, Ctr Mol Med, Inst Cardiovasc Regenerat, Frankfurt, Germany; [Rivolta, Carlo] Univ Leicester, Dept Genet & Genome Biol, Leicester, Leics, England	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Basel; Universidade de Sao Paulo; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; Max Planck Society; Max Planck Society; University of Lubeck; Max Planck Society; University of Geneva; Goethe University Frankfurt; University of Leicester	Mundlos, S (corresponding author), Max Planck Inst Mol Genet, RG Dev & Dis, Berlin, Germany.; Mundlos, S (corresponding author), Charite Univ Med Berlin, Inst Med & Human Genet, Berlin, Germany.; Mundlos, S (corresponding author), Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.	mundlos@molgen.mpg.de	Nampoothiri, Sheela/AAQ-4854-2021; Andrey, Guillaume/AAL-4397-2020	Nampoothiri, Sheela/0000-0002-9575-0722; Robson, Michael/0000-0003-1126-3538; Rivolta, Carlo/0000-0002-0733-9950; Mundlos, Stefan/0000-0002-9788-3166; Cova, Giulia/0000-0001-6489-8807; Pescini Gobert, Rosanna/0000-0002-2434-7530; Magg, Andreas/0000-0003-4032-0175; Campos-Xavier, Belinda/0000-0002-6271-0724	Deutsche Forschungsgemeinschaft (DFG) [MU 880/16-1, MU 880/14-3]; Fondation Guillaume-Gentil (Lausanne); Faculte de Biologie et Medecine of the University of Lausanne; Swiss National Science Foundation [176097]; FOXG1 Foundation [P.S.7905]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fondation Guillaume-Gentil (Lausanne); Faculte de Biologie et Medecine of the University of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); FOXG1 Foundation	This work was supported by grants MU 880/16-1 and MU 880/14-3 from the Deutsche Forschungsgemeinschaft (DFG) to S.M., by grants from the Fondation Guillaume-Gentil (Lausanne) and the Faculte de Biologie et Medecine of the University of Lausanne to A.S.-F., and by the Swiss National Science Foundation grant no. 176097 to C.R. L.A. was supported by the FOXG1 Foundation (grant P.S.7905). We thank K. Macura, C. Franke, N. Engemann, C. Hillgardt, V. Desiniotis, N. Brieske, S. Haas and K. Kraft in Berlin for technical and/or scientific support.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Andrey G, 2017, GENOME RES, V27, P223, DOI 10.1101/gr.213066.116; Artus J, 2011, METHODS MOL BIOL, V693, P37, DOI 10.1007/978-1-60761-974-1_3; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Castellanos-Rubio A, 2016, SCIENCE, V352, P91, DOI 10.1126/science.aad0467; Cho SW, 2018, CELL, V173, P1398, DOI 10.1016/j.cell.2018.03.068; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Gagnon KT, 2014, NAT PROTOC, V9, P2045, DOI 10.1038/nprot.2014.135; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hon CC, 2017, NATURE, V543, P199, DOI 10.1038/nature21374; Huettl RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118505; Ibrahim DM, 2013, GENOME RES, V23, P2091, DOI 10.1101/gr.157610.113; Ishii N, 2006, J HUM GENET, V51, P1087, DOI 10.1007/s10038-006-0070-9; Isoda T, 2017, CELL, V171, P103, DOI 10.1016/j.cell.2017.09.001; Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Kraft K, 2019, NAT CELL BIOL, V21, P305, DOI 10.1038/s41556-019-0273-x; Kraft K, 2015, CELL REP, V10, P833, DOI 10.1016/j.celrep.2015.01.016; Kragesteen BK, 2018, NAT GENET, V50, P1463, DOI 10.1038/s41588-018-0221-x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liska F, 2010, FOLIA BIOL-PRAGUE, V56, P58; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Maass PG, 2012, J CLIN INVEST, V122, P3990, DOI 10.1172/JCI65508; Naslavsky MS, 2017, HUM MUTAT, V38, P751, DOI 10.1002/humu.23220; Paliou C, 2019, P NATL ACAD SCI USA, V116, P12390, DOI 10.1073/pnas.1900672116; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Royer-Bertrand B, 2015, SCI REP-UK, V5, DOI 10.1038/srep17154; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; van Dijk M, 2012, J CLIN INVEST, V122, P4003, DOI 10.1172/JCI65171; Vian L, 2018, CELL, V175, P292, DOI 10.1016/j.cell.2018.09.002; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wingett Steven, 2015, F1000Res, V4, P1310, DOI 10.12688/f1000research.7334.1; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; WURST W, 1994, DEVELOPMENT, V120, P2065; Xiang JF, 2014, CELL RES, V24, P513, DOI 10.1038/cr.2014.35	51	26	26	8	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 1	2021	592	7852					93	+		10.1038/s41586-021-03208-9	http://dx.doi.org/10.1038/s41586-021-03208-9		FEB 2021	33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YU2FD	33568816	Green Published			2022-12-28	WOS:000616961600004
J	Bianchi, DW; Kaeser, L; Cernich, AN				Bianchi, Diana W.; Kaeser, Lisa; Cernich, Alison N.			Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint from the National Institute of Child Health and Human Development emphasizes the need to use existing data sources and develop partnerships, infrastructure, and ethical and regulatory standards to generate data about the safety and efficacy of COVID-19 vaccination in pregnant individuals.	[Bianchi, Diana W.; Kaeser, Lisa; Cernich, Alison N.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bianchi, DW (corresponding author), 31 Ctr Dr,Room 2A03, Bethesda, MD 20892 USA.	diana.bianchi@nih.gov						[Anonymous], 2020, VACCINES RELATED BIO; CDC, ENS SAF COVID 19 VAC; Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2020, TASK FORC RES SPEC P; Health Resources & Services Administration, COUNT INJ COMP PROGR; Ke AB, 2014, ANNU REV PHARMACOL, V54, P53, DOI 10.1146/annurev-pharmtox-011613-140009; Metz TD, 2021, AM J OBSTET GYNECOL, V224, pS722	7	40	40	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2021	325	11					1041	1042		10.1001/jama.2021.1865	http://dx.doi.org/10.1001/jama.2021.1865		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QZ1BV	33566088	Bronze			2022-12-28	WOS:000617178800005
J	Oliver, D				Oliver, David			David Oliver: Mistruths and misunderstandings about covid-19 death numbers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Abbasi K, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4487; [Anonymous], 2021, BBC NEWS 0112; Ayoubkhani D., 2021, MEDRXIV, DOI [10.1101/2021.01.15.21249885., 10.1101/2021.01.15.21249885]; Duncan P, GUARDIAN 0122; King's Fund, 2020, DEATHS COV 19 COR; Nuffield Trust, 2021, MEAS MORT COV 19 Q A; Office for National Statistics, 2021, COR COV 19 ROUND; Office for National Statistics HM Passport Office, 2020, GUID DOCT COMPL MED; Oliver D, 2021, BMJ OPINION; Oliver D, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3035; Spiegelhalter D., POLITICO 0128; The Health Foundation, 2020, NHS TEST TRAC JOURN; Watson J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1808; Xie Y, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4677	14	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2021	372								n352	10.1136/bmj.n352	http://dx.doi.org/10.1136/bmj.n352			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC1VA	33568449	Bronze			2022-12-28	WOS:000686320800003
J	Hunger, D				Hunger, David			Quantum logic at a distance	SCIENCE			English	Editorial Material							ENTANGLEMENT; NETWORK		[Hunger, David] Karlsruhe Inst Technol KIT, Inst Quantum Mat & Technol, Phys Inst, Wolfgang Gaede Str 1, D-76131 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Hunger, D (corresponding author), Karlsruhe Inst Technol KIT, Inst Quantum Mat & Technol, Phys Inst, Wolfgang Gaede Str 1, D-76131 Karlsruhe, Germany.	david.hunger@kit.edu	Hunger, David/A-7673-2012	Hunger, David/0000-0001-6156-6145				Cohen I, 2018, PHYS REV A, V98, DOI 10.1103/PhysRevA.98.030302; Daiss S, 2021, SCIENCE, V371, P614, DOI 10.1126/science.abe3150; Duan LM, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.032333; Humphreys PC, 2018, NATURE, V558, P268, DOI 10.1038/s41586-018-0200-5; Kalb N, 2017, SCIENCE, V356, P928, DOI 10.1126/science.aan0070; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Nickerson NH, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041041; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Roch N, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.170501; Wehner S, 2018, SCIENCE, V362, DOI 10.1126/science.aam9288	11	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		576	576		10.1126/science.abg1536	http://dx.doi.org/10.1126/science.abg1536			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QD7TF	33542128				2022-12-28	WOS:000615715300036
J	Riddell, EA; Iknayan, KJ; Hargrove, L; Tremor, S; Patton, JL; Ramirez, R; Wolf, BO; Beissinger, SR				Riddell, E. A.; Iknayan, K. J.; Hargrove, L.; Tremor, S.; Patton, J. L.; Ramirez, R.; Wolf, B. O.; Beissinger, S. R.			Exposure to climate change drives stability or collapse of desert mammal and bird communities	SCIENCE			English	Article							EVAPORATIVE WATER-LOSS; SPECIES RICHNESS; OCCUPANCY MODELS; HEAT TOLERANCE; ANIMAL COATS; TEMPERATURE; THERMOREGULATION; SELECTION; MICROHABITAT; ENVIRONMENT	High exposure to warming from climate change is expected to threaten biodiversity by pushing many species toward extinction. Such exposure is often assessed for all taxa at a location from climate projections, yet species have diverse strategies for buffering against temperature extremes. We compared changes in species occupancy and site-level richness of small mammal and bird communities in protected areas of the Mojave Desert using surveys spanning a century. Small mammal communities remained remarkably stable, whereas birds declined markedly in response to warming and drying. Simulations of heat flux identified different exposure to warming for birds and mammals, which we attribute to microhabitat use. Estimates from climate projections are unlikely to accurately reflect species' exposure without accounting for the effects of microhabitat buffering on heat flux.	[Riddell, E. A.; Patton, J. L.; Beissinger, S. R.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Riddell, E. A.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50010 USA; [Iknayan, K. J.; Beissinger, S. R.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Iknayan, K. J.] San Francisco Estuary Inst, Richmond, CA 94804 USA; [Hargrove, L.; Tremor, S.] San Diego Nat Hist Museum, Dept Birds & Mammals, San Diego, CA 92101 USA; [Ramirez, R.; Wolf, B. O.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of California System; University of California Berkeley; Iowa State University; University of California System; University of California Berkeley; University of New Mexico	Beissinger, SR (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.; Beissinger, SR (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	beis@berkeley.edu	Hargrove, Lori/GWR-2243-2022	Beissinger, Steven/0000-0003-1323-2727; Ramirez, Richard/0000-0003-0057-826X; Hargrove, Lori/0000-0001-7400-4280; Patton, James/0000-0002-8709-7196; Tremor, Scott/0000-0001-8647-2444	NSF [DEB-1457742, DEB-1457521, DEB-1457524, DEB-1911334]	NSF(National Science Foundation (NSF))	Supported by NSF grants DEB-1457742, -1457521, -1457524, and -1911334. Any opinions, findings, and conclusions or recommendation expressed in this material are those of the authors and do not necessarily reflect the views of NSF.	Albright TP, 2017, P NATL ACAD SCI USA, V114, P2283, DOI 10.1073/pnas.1613625114; BAKKEN GS, 1981, J THERM BIOL, V6, P23, DOI 10.1016/0306-4565(81)90038-3; Broms KM, 2016, ECOLOGY, V97, P1759, DOI 10.1890/15-1471.1; Brooks M. L., 2000, FIR C 2000 1 NAT C F, P7; Brown JH, 2000, AM NAT, V156, P314, DOI 10.1086/303385; BUFFENSTEIN R, 1984, J THERM BIOL, V9, P235, DOI 10.1016/0306-4565(84)90002-0; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; Campbell G.S., 1998, INTRO ENV BIOPHYSICS, Vsecond, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; CENA K, 1973, PHYS MED BIOL, V18, P432, DOI 10.1088/0031-9155/18/3/008; CENA K, 1975, PROC R SOC SER B-BIO, V188, P395, DOI 10.1098/rspb.1975.0027; CHAPPELL MA, 1980, J MAMMAL, V61, P278, DOI 10.2307/1380049; CHAPPELL MA, 1981, PHYSIOL ZOOL, V54, P215, DOI 10.1086/physzool.54.2.30155822; Conradie SR, 2019, P NATL ACAD SCI USA, V116, P14065, DOI 10.1073/pnas.1821312116; Cooke RSC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10284-z; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Devarajan K, 2020, ECOGRAPHY, V43, P1612, DOI 10.1111/ecog.04957; Dorazio RM, 2010, ECOLOGY, V91, P2466, DOI 10.1890/09-1033.1; du Plessis KL, 2012, GLOBAL CHANGE BIOL, V18, P3063, DOI 10.1111/j.1365-2486.2012.02778.x; Faurby S, 2018, ECOLOGY, V99, P2626, DOI 10.1002/ecy.2443; Fitzpatrick MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136677; Flint L.E., 2013, ECOL PROCESS, V2, P1, DOI [DOI 10.1186/2192-1709-2-25, 10.1186/2192-1709-2-25]; Furnas BJ, 2018, CONDOR, V120, P188, DOI 10.1650/CONDOR-17-165.1; Gates D. M., 1980, BIOPHYSICAL ECOLOGY; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Grinnell Joseph, 1910, Popular Science Monthly, V77; Guillera-Arroita G, 2019, ECOL EVOL, V9, P780, DOI 10.1002/ece3.4821; HAINSWOR.FR, 1968, AM J PHYSIOL, V214, P979, DOI 10.1152/ajplegacy.1968.214.5.979; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HELDMAIER G, 1990, THERMORECEPTION AND TEMPERATURE REGULATION, P235; Iknayan KJ, 2020, GLOBAL CHANGE BIOL, V26, P3268, DOI 10.1111/gcb.15030; Iknayan KJ, 2018, P NATL ACAD SCI USA, V115, P8597, DOI 10.1073/pnas.1805123115; Iknayan KJ, 2014, TRENDS ECOL EVOL, V29, P97, DOI 10.1016/j.tree.2013.10.012; Jarzyna MA, 2016, TRENDS ECOL EVOL, V31, P527, DOI 10.1016/j.tree.2016.04.002; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kearney MR, 2017, ECOGRAPHY, V40, P664, DOI 10.1111/ecog.02360; Kelt DA, 2011, J MAMMAL, V92, P1158, DOI 10.1644/10-MAMM-S-238.1; Levy O, 2016, AM NAT, V188, P205, DOI 10.1086/687246; Link WA, 2016, ECOLOGY, V97, P1746, DOI 10.1890/15-1286.1; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; MacKenzie D.I., 2018, OCCUPANCY ESTIMATION, V2nd, DOI DOI 10.1016/B978-0-12-407197-1.00015-6; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacLean SA, 2017, GLOBAL CHANGE BIOL, V23, P4094, DOI 10.1111/gcb.13736; McKechnie AE, 2019, PHYSIOLOGY, V34, P302, DOI 10.1152/physiol.00011.2019; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; MITCHELL JW, 1976, BIOPHYS J, V16, P561, DOI 10.1016/S0006-3495(76)85711-6; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Murray IW, 2012, CAN J ZOOL, V90, P1171, DOI 10.1139/Z2012-084; NAGY KA, 1994, AUST J ZOOL, V42, P55, DOI 10.1071/ZO9940055; Plummer M., 2017, JAGS US MAN VERS 4 3; Porter WP, 2009, P NATL ACAD SCI USA, V106, P19666, DOI 10.1073/pnas.0907321106; Randall J.M., 2010, MOJAVE DESERT ECOREG; Reid F., 2006, PETERSON FIELD GUIDE, V4th; Richmond OMW, 2010, ECOL APPL, V20, P2036, DOI 10.1890/09-0470.1; RICKLEFS RE, 1968, ECOLOGY, V49, P227, DOI 10.2307/1934451; Riddell E. A., 2020, ZENODO; Riddell E.A., 2020, **DATA OBJECT**, DOI [10.5281/zenodo.4421498, DOI 10.5281/ZENODO.4421498]; Riddell EA, 2019, P NATL ACAD SCI USA, V116, P21609, DOI 10.1073/pnas.1908791116; Rota CT, 2016, METHODS ECOL EVOL, V7, P1164, DOI 10.1111/2041-210X.12587; Rota CT, 2009, J APPL ECOL, V46, P1173, DOI 10.1111/j.1365-2664.2009.01734.x; Rowe KC, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1857; Rowe RJ, 2010, GLOBAL CHANGE BIOL, V16, P2930, DOI 10.1111/j.1365-2486.2009.02150.x; Scheffers BR, 2014, GLOBAL CHANGE BIOL, V20, P495, DOI 10.1111/gcb.12439; SCHMIDTNIELSEN B, 1950, ECOLOGY, V31, P75, DOI 10.2307/1931362; SCHMIDTNIELSEN B, 1951, J CELL COMPAR PHYSL, V38, P165, DOI 10.1002/jcp.1030380204; SEALANDER JA, 1951, AM MIDL NAT, V46, P257, DOI 10.2307/2421980; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Smith EK, 2017, J EXP BIOL, V220, P3290, DOI 10.1242/jeb.161141; Smith FA, 2014, J MAMMAL, V95, P1128, DOI 10.1644/13-MAMM-S-070; Socolar JB, 2017, P NATL ACAD SCI USA, V114, P12976, DOI 10.1073/pnas.1705897114; Tattersall GJ, 2017, BIOL REV, V92, P1630, DOI 10.1111/brv.12299; Team RC., 2022, LANG ENV STAT COMP; Tingley MW, 2020, METHODS ECOL EVOL, V11, P633, DOI 10.1111/2041-210X.13378; Tingley MW, 2013, ECOLOGY, V94, P598, DOI 10.1890/12-0928.1; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Trisos CH, 2020, NATURE, V580, P496, DOI 10.1038/s41586-020-2189-9; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; van de Ven TMFN, 2019, OECOLOGIA, V191, P205, DOI 10.1007/s00442-019-04486-x; WALSBERG GE, 1993, ORNIS SCAND, V24, P174, DOI 10.2307/3676733; WALSBERG GE, 1978, J COMP PHYSIOL, V126, P211, DOI 10.1007/BF00688930; WALSBERG GE, 1988, J THERM BIOL, V13, P89, DOI 10.1016/0306-4565(88)90018-6; Warren R, 2018, SCIENCE, V360, P791, DOI 10.1126/science.aar3646; Wieczorek J, 2004, INT J GEOGR INF SCI, V18, P745, DOI 10.1080/13658810412331280211; Williams Stephen E, 2008, PLoS Biol, V6, P2621, DOI 10.1371/journal.pbio.0060325; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Wolf BO, 1996, CONDOR, V98, P424, DOI 10.2307/1369162; Wolf BO, 1996, J EXP BIOL, V199, P451; Zipkin EF, 2012, ECOL APPL, V22, P1962, DOI 10.1890/11-1936.1; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	91	39	39	42	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		633	+		10.1126/science.abd4605	http://dx.doi.org/10.1126/science.abd4605			65	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QD7TF	33542137				2022-12-28	WOS:000615715300054
J	Bielecki, P; Riesenfeld, SJ; Hutter, JC; Triglia, ET; Kowalczyk, MS; Ricardo-Gonzalez, RR; Lian, M; Vesely, MCA; Kroehling, L; Xu, H; Slyper, M; Muus, C; Ludwig, LS; Christian, E; Tao, LM; Kedaigle, AJ; Steach, HR; York, AG; Skadow, MH; Yaghoubi, P; Dionne, D; Jarret, A; McGee, HM; Porter, CBM; Licona-Limon, P; Bailis, W; Jackson, R; Gagliani, N; Gasteiger, G; Locksley, RM; Regev, A; Flavell, RA				Bielecki, Piotr; Riesenfeld, Samantha J.; Hutter, Jan-Christian; Triglia, Elena Torlai; Kowalczyk, Monika S.; Ricardo-Gonzalez, Roberto R.; Lian, Mi; Vesely, Maria C. Amezcua; Kroehling, Lina; Xu, Hao; Slyper, Michal; Muus, Christoph; Ludwig, Leif S.; Christian, Elena; Tao, Liming; Kedaigle, Amanda J.; Steach, Holly R.; York, Autumn G.; Skadow, Mathias H.; Yaghoubi, Parastou; Dionne, Danielle; Jarret, Abigail; McGee, Heather M.; Porter, Caroline B. M.; Licona-Limon, Paula; Bailis, Will; Jackson, Ruaidhri; Gagliani, Nicola; Gasteiger, Georg; Locksley, Richard M.; Regev, Aviv; Flavell, Richard A.			Skin-resident innate lymphoid cells converge on a pathogenic effector state	NATURE			English	Article							DELTA T-CELLS; REGULATORY NETWORK; TRANSCRIPTION; INFLAMMATION; DIFFERENTIATION; ACCESSIBILITY; DEFICIENCY; PROGENITOR; ADAPTATION; EXPRESSION	Tissue-resident innate lymphoid cells (ILCs) help sustain barrier function and respond to local signals. ILCs are traditionally classified as ILC1, ILC2 or ILC3 on the basis of their expression of specific transcription factors and cytokines(1). In the skin, disease-specific production of ILC3-associated cytokines interleukin (IL)-17 and IL-22 in response to IL-23 signalling contributes to dermal inflammation in psoriasis. However, it is not known whether this response is initiated by pre-committed ILCs or by cell-state transitions. Here we show that the induction of psoriasis in mice by IL-23 or imiquimod reconfigures a spectrum of skin ILCs, which converge on a pathogenic ILC3-like state. Tissue-resident ILCs were necessary and sufficient, in the absence of circulatory ILCs, to drive pathology. Single-cell RNA-sequencing (scRNA-seq) profiles of skin ILCs along a time course of psoriatic inflammation formed a dense transcriptional continuum-even at steady state-reflecting fluid ILC states, including a naive or quiescent-like state and an ILC2 effector state. Upon disease induction, the continuum shifted rapidly to span a mixed, ILC3-like subset also expressing cytokines characteristic of ILC2s, which we inferred as arising through multiple trajectories. We confirmed the transition potential of quiescent-like and ILC2 states using in vitro experiments, single-cell assay for transposase-accessible chromatin using sequencing (scATAC-seq) and in vivo fate mapping. Our results highlight the range and flexibility of skin ILC responses, suggesting that immune activities primed in healthy tissues dynamically adapt to provocations and, left unchecked, drive pathological remodelling.	[Bielecki, Piotr; Vesely, Maria C. Amezcua; Kroehling, Lina; Xu, Hao; Steach, Holly R.; York, Autumn G.; Skadow, Mathias H.; Yaghoubi, Parastou; Jarret, Abigail; McGee, Heather M.; Licona-Limon, Paula; Bailis, Will; Jackson, Ruaidhri; Gagliani, Nicola; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Riesenfeld, Samantha J.; Hutter, Jan-Christian; Triglia, Elena Torlai; Kowalczyk, Monika S.; Slyper, Michal; Muus, Christoph; Ludwig, Leif S.; Christian, Elena; Tao, Liming; Kedaigle, Amanda J.; Dionne, Danielle; Porter, Caroline B. M.; Regev, Aviv] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [Riesenfeld, Samantha J.] Univ Chicago, Pritzker Sch Mol Engn, Chicago, IL 60637 USA; [Riesenfeld, Samantha J.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Ricardo-Gonzalez, Roberto R.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA USA; [Ricardo-Gonzalez, Roberto R.; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, Sandler Asthma Res Ctr, San Francisco, CA 94143 USA; [Lian, Mi; Gasteiger, Georg] Julius Maximilians Univ Wurzburg, Wurzburg Inst Syst Immunol, Max Planck Res Grp, Wurzburg, Germany; [Lian, Mi] Univ Freiburg, Fac Biol, Freiburg, Germany; [Vesely, Maria C. Amezcua; Locksley, Richard M.; Regev, Aviv; Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Muus, Christoph] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [McGee, Heather M.] Salk Inst Biol Sci, NOMIS Ctr Immunobiol & Microbial Pathogenesis, La Jolla, CA USA; [Licona-Limon, Paula] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City, DF, Mexico; [Bailis, Will] Childrens Hosp Philadelphia, Div Protect Immun, Philadelphia, PA 19104 USA; [Bailis, Will] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Gagliani, Nicola] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Gagliani, Nicola] Univ Med Ctr Hamburg Eppendorf, Dept Med, Hamburg, Germany; [Gagliani, Nicola] Karolinska Inst & Univ Hosp, Dept Med, Immunol & Allergy Unit, Stockholm, Sweden; [Regev, Aviv] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Bielecki, Piotr] Celsius Therapeut, Cambridge, MA 02139 USA; [Regev, Aviv] Genentech Inc, San Francisco, CA 94080 USA	Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Chicago; University of Chicago; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Max Planck Society; University of Wurzburg; University of Freiburg; Howard Hughes Medical Institute; Harvard University; Salk Institute; Universidad Nacional Autonoma de Mexico; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Karolinska Institutet; Karolinska University Hospital; Massachusetts Institute of Technology (MIT); Roche Holding; Genentech	Bielecki, P; Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Riesenfeld, SJ; Regev, A (corresponding author), Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA.; Riesenfeld, SJ (corresponding author), Univ Chicago, Pritzker Sch Mol Engn, Chicago, IL 60637 USA.; Riesenfeld, SJ (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Regev, A; Flavell, RA (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Regev, A (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Bielecki, P (corresponding author), Celsius Therapeut, Cambridge, MA 02139 USA.; Regev, A (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	piotr.stanislaw.bielecki@gmail.com; sriesenfeld@uchicago.edu; aregev@broadinstitute.org; richard.flavell@yale.edu	Ludwig, Leif S./A-1913-2015; TAO, Li/HIR-4254-2022; Triglia, Elena Torlai/AAS-5807-2020; Kedaigle, Amanda/AAA-8171-2022	Ludwig, Leif S./0000-0002-2916-2164; Triglia, Elena Torlai/0000-0002-6059-0116; Kedaigle, Amanda/0000-0001-6156-5046; Gasteiger, Georg/0000-0001-6986-127X; Steach, Holly/0000-0003-0018-3129; Riesenfeld, Samantha/0000-0001-9144-021X; AMEZCUA VESELY, MARIA CAROLINA/0000-0001-9631-1249; McGee, Heather/0000-0003-3761-5087; Gagliani, Nicola/0000-0001-8514-1395	AbbVie [YAP-013-2015]; NIH [AI026918]; Klarman Cell Observatory; HHMI; NIH/NIAMS [K08 AR075880]; Robert Wood Johnson Foundation; Amos Medical Faculty Development Program [74257]; DFG priority program 1937-Innate lymphoid cells [GA2129/2-1]; ERC [759176]	AbbVie(AbbVie); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Cell Observatory; HHMI(Howard Hughes Medical Institute); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Amos Medical Faculty Development Program; DFG priority program 1937-Innate lymphoid cells(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	We thank L. Gaffney and A. Hupalowska for help with figures and illustrations; J. Alderman, C. Lieber, C. Hughes, L. Evangelisti, E. Hughes-Picard, G. Lyon, and E. Menet for help in facilitating this work; and P.S. Pillai for comments and discussion on the manuscript. This work was supported in part by grants (YAP-013-2015) provided by AbbVie (R.A.F.), NIH AI026918 (R.M.L.), by the Klarman Cell Observatory (A.R.) and HHMI (A.R., R.A.F. and R.M.L.), NIH/NIAMS K08 AR075880 Robert Wood Johnson Foundation, Amos Medical Faculty Development Program (grant no. 74257) (R.R.R.-G.). DFG priority program 1937-Innate lymphoid cells (GA2129/2-1) and ERC (759176-TissueLymphoContexts) (G.G.).	Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Bernink JH, 2019, NAT IMMUNOL, V20, P992, DOI 10.1038/s41590-019-0423-0; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2004, ADV NEUR IN, V16, P17; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Califano D, 2015, IMMUNITY, V43, P354, DOI 10.1016/j.immuni.2015.07.005; Cao ZX, 2010, BLOOD, V116, P4404, DOI 10.1182/blood-2010-05-285353; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Erosheva, 2006, LATENT CLASS REPRESE; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Farrell JA, 2018, SCIENCE, V360, P979, DOI 10.1126/science.aar3131; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Galloway A, 2016, SCIENCE, V352, P453, DOI 10.1126/science.aad5978; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Ghaedi M, 2020, J EXP MED, V217, DOI 10.1084/jem.20182293; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Kobayashi T, 2019, CELL, V176, P982, DOI 10.1016/j.cell.2018.12.031; Laurenti E, 2018, NATURE, V553, P418, DOI 10.1038/nature25022; Li B, 2020, NAT METHODS, V17, P793, DOI 10.1038/s41592-020-0905-x; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Li Z., 2016, NAT COMMUN, V7; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Price AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039750; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Pritchard JK, 2000, GENETICS, V155, P945; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Schiebinger G, 2019, CELL, V176, DOI 10.1016/j.cell.2019.02.026; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Stuart T., MULTIMODAL SINGLE CE, DOI 10.1101/2020.11.09.373613; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; SZABO P, 2019, NAT, V10; Taddy M., 2012, P 15 INT C ART INT S, V22, P1184; Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2351, DOI 10.1038/jid.2014.146; Tusi BK, 2018, NATURE, V555, P54, DOI 10.1038/nature25741; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Villanova F, 2014, J INVEST DERMATOL, V134, P984, DOI 10.1038/jid.2013.477; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wallrapp A, 2019, IMMUNITY, V51, P709, DOI 10.1016/j.immuni.2019.09.005; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wang S, 2017, CELL, V171, P201, DOI 10.1016/j.cell.2017.07.027; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Yu Y, 2016, NATURE, V539, P102, DOI 10.1038/nature20105; Zeis P, 2020, IMMUNITY, V53, P775, DOI 10.1016/j.immuni.2020.09.002	70	46	46	10	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 1	2021	592	7852					128	+		10.1038/s41586-021-03188-w	http://dx.doi.org/10.1038/s41586-021-03188-w		FEB 2021	32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YT1AI	33536623	Green Accepted, Green Submitted			2022-12-28	WOS:000614414900002
J	Herzer, KR; Pronovost, PJ				Herzer, Kurt R.; Pronovost, Peter J.			Ensuring Quality in the Era of Virtual Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Herzer, Kurt R.] Johns Hopkins Sch Med, Baltimore, MD USA; [Pronovost, Peter J.] Case Western Reserve Univ, Sch Med, Univ Hosp, Cleveland, OH USA	Johns Hopkins University; Johns Hopkins Medicine; Case Western Reserve University; University Hospitals of Cleveland	Pronovost, PJ (corresponding author), Case Western Reserve Univ, Univ Hosp Hlth Syst, Cleveland, OH 44106 USA.	peter.pronovost@uhhospitals.org						Alexander GC, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.21476; [Anonymous], 2019, 2018 NAT HEALTHC QUA; Bashshur RL, 2016, TELEMED E-HEALTH, V22, P342, DOI 10.1089/tmj.2016.0045; FAIR Health, 2020, MONTHL TEL REG TRACK; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Koonin LM, 2020, MMWR-MORBID MORTAL W, V69, P1595, DOI 10.15585/mmwr.mm6943a3; Muntner P, 2020, JAMA-J AM MED ASSOC, V324, P1190, DOI 10.1001/jama.2020.14545; Velasquez D, 2020, HLTH AFFAIRS BLOG	8	27	26	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2021	325	5					429	430		10.1001/jama.2020.24955	http://dx.doi.org/10.1001/jama.2020.24955			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QC6JP	33528544				2022-12-28	WOS:000614941900009
J	Dyer, C				Dyer, Clare			Homeless man should have double leg amputation to save his life, says judge	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2021	372								n300	10.1136/bmj.n300	http://dx.doi.org/10.1136/bmj.n300			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QE0LS	33526447				2022-12-28	WOS:000615899800002
J	Chahroudi, A; Permar, S				Chahroudi, Ann; Permar, Sallie			Will We Have the Tools to Address a Reemergent Zika Virus Epidemic?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chahroudi, Ann] Emory Univ, Sch Med, Atlanta, GA USA; [Chahroudi, Ann] Childrens Healthcare Atlanta, Atlanta, GA USA; [Permar, Sallie] NewYork Presbyterian Weill Cornell Med Sch, New York, NY USA; [Permar, Sallie] Weill Cornell Med Sch, 525 East 68th St, New York, NY 10021 USA; [Chahroudi, Ann] Hlth Sci Res Bldg,1760 Haygood Dr, Atlanta, GA 30322 USA	Emory University; Children's Healthcare of Atlanta (CHOA); Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Permar, S (corresponding author), Weill Cornell Med Sch, 525 East 68th St, New York, NY 10021 USA.	sap4017@med.cornell.edu						Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Castanha PMS, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12121371; Lebov JF, 2018, PEDIATR NEUROL, V85, P16, DOI 10.1016/j.pediatrneurol.2018.03.001; Marchant A, 2017, LANCET INFECT DIS, V17, pE197, DOI 10.1016/S1473-3099(17)30229-3; Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982; Raper J, 2021, TROP MED INFECT DIS, V6, DOI 10.3390/tropicalmed6010010; Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7; Russell WA, 2021, ANN INTERN MED, V174, P728, DOI 10.7326/M20-6879; Sadoff J, 2021, NEW ENGL J MED, V384, P1824, DOI 10.1056/NEJMoa2034201; Salisch NC, 2021, ANN INTERN MED, V174, P585, DOI 10.7326/M20-5306	10	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					708	+		10.7326/M21-0397	http://dx.doi.org/10.7326/M21-0397			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33587689				2022-12-28	WOS:000652604800036
J	Shih, YCT; Dong, WL; Xu, Y; Etzioni, R; Shen, Y				Shih, Ya-Chen Tina; Dong, Wenli; Xu, Ying; Etzioni, Ruth; Shen, Yu			Incorporating Baseline Breast Density When Screening Women at Average Risk for Breast Cancer A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							ADJUVANT CHEMOTHERAPY; DIGITAL MAMMOGRAPHY; STAGE-II; FILM MAMMOGRAPHY; STRATEGIES; BENEFITS; HEALTH; IMPACT; TIME	Background: Breast density classification is largely determined by mammography, making the timing of the first screening mammogram clinically important. Objective: To evaluate the cost-effectiveness of breast cancer screening strategies that are stratified by breast density. Design: Microsimulation model to generate the natural history of breast cancer for women with and those without dense breasts and assessment of the cost-effectiveness of strategies tailored to breast density and nontailored strategies. Data Sources: Model parameters from the literature; statistical modeling; and analysis of Surveillance, Epidemiology, and End Results-Medicare data. Target Population: Women aged 40 years or older. Time Horizon: Lifetime. Perspective: Societal. Intervention: No screening; biennial or triennial mammography from age 50 to 75 years; annual mammography from age 50 to 75 years for women with dense breasts at age 50 years and biennial or triennial mammography from age 50 to 75 years for those without dense breasts at age 50 years; and annual mammography at age 40 to 75 years for women with dense breasts at age 40 years and biennial or triennial mammography at age 50 to 75 years for those without dense breasts at age 40 years. Outcome Measures: Lifetime costs and quality-adjusted life-years (QALYs), discounted at 3% annually. Results of Base-Case Analysis: Baseline screening at age 40 years followed by annual screening at age 40 to 75 years for women with dense breasts and biennial screening at age 50 to 75 years for women without dense breasts was effective and cost-effective, yielding an incremental cost-effectiveness ratio of $36 200 per QALY versus the biennial strategy at age 50 to 75 years. Results of Sensitivity Analysis: At a societal willingness-to-pay threshold of $100 000 per QALY, the probability that the density-stratified strategy at age 40 years was optimal was 56% compared with 6 other strategies. Limitation: Findings may not be generalizable outside the United States. Conclusion: The study findings advocate for breast density-stratified screening with baseline mammography at age 40 years.	[Shih, Ya-Chen Tina; Xu, Ying] Univ Texas MD Anderson Canc Ctr, Sect Canc Econ & Policy, Dept Hlth Serv Res, Unit 1444,1400 Pressler St, Houston, TX 77030 USA; [Dong, Wenli; Shen, Yu] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Unit 1411,POB 301402, Houston, TX 77030 USA; [Etzioni, Ruth] Fred Hutchinson Canc Ctr, Program Biostat, 1100 Fairview Ave North,M2-B230,POB 19024, Seattle, WA 98109 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Fred Hutchinson Cancer Center	Shih, YCT (corresponding author), Univ Texas MD Anderson Canc Ctr, Sect Canc Econ & Policy, Dept Hlth Serv Res, Unit 1444,1400 Pressler St, Houston, TX 77030 USA.	yashih@mdanderson.org		Xu, Ying/0000-0002-9454-4337; Shih, Ya-Chen Tina/0000-0001-7290-3864; Shen, Yu/0000-0002-3899-7868	National Cancer Institute [R01CA 207216, R01CA225646, CCSG P30 CA016672]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute (R01CA 207216, R01CA225646, and CCSG P30 CA016672).	Ahern CH, 2014, BRIT J CANCER, V111, P1542, DOI 10.1038/bjc.2014.458; Ahern CH, 2009, CANCER EPIDEM BIOMAR, V18, P718, DOI 10.1158/1055-9965.EPI-08-0918; American College of Surgeons, NCDB PUBL BENCHM REP; Assi V, 2015, INT J CANCER, V136, P2378, DOI 10.1002/ijc.29275; Azam S, 2019, JNCI CANCER SPECT, V3, DOI 10.1093/jncics/pkz004; Centers for Medicare & Medicaid Services, 2020, MED DRUG AV SAL PR B; Centers for Medicare & Medicaid Services, 2020, PHYS FEE SCHEDULE; Dahabreh IJ, 2008, ONCOLOGIST, V13, P620, DOI 10.1634/theoncologist.2008-0001; Darabi H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3110; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; Duffy SW, 2008, AM J EPIDEMIOL, V168, P98, DOI 10.1093/aje/kwn120; Duffy SW, 2018, EUR J CANCER, V88, P48, DOI 10.1016/j.ejca.2017.10.022; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Houssami N, 2018, BREAST, V42, P102, DOI 10.1016/j.breast.2018.09.001; Keating NL, 2019, JAMA-J AM MED ASSOC, V321, P2275, DOI 10.1001/jama.2019.5919; Kwon JS, 2017, J NATL COMPR CANC NE, V15, P1015, DOI 10.6004/jnccn.2017.0136; Lee CI, 2015, RADIOLOGY, V274, P772, DOI 10.1148/radiol.14141237; Mandelblatt JS, 2016, ANN INTERN MED, V164, P215, DOI 10.7326/M15-1536; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Mandelblatt JS, 2015, COLLABORATIVE MODELI; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Mariotto Angela B, 2006, J Natl Cancer Inst Monogr, P7, DOI 10.1093/jncimonographs/lgj003; Mavaddat N, 2019, AM J HUM GENET, V104, P21, DOI 10.1016/j.ajhg.2018.11.002; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; National Cancer Institute, 2020, CANC QUER SYST PROB; Pashayan N, 2018, JAMA ONCOL, V4, P1504, DOI 10.1001/jamaoncol.2018.1901; PEER PGM, 1993, CANCER, V71, P3547, DOI 10.1002/1097-0142(19930601)71:11<3547::AID-CNCR2820711114>3.0.CO;2-C; Perloff M, 1996, J CLIN ONCOL, V14, P1589, DOI 10.1200/JCO.1996.14.5.1589; Plevritis SK, 2006, JAMA-J AM MED ASSOC, V295, P2374, DOI 10.1001/jama.295.20.2374; Public Health England, 2020, GUID BREAST CANC SCR; Ries L., 2005, SEER CANC STAT REV 1; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Shen Y, 2006, PROBABILITY, STATISTICS AND MODELLING IN PUBLIC HEALTH, P405, DOI 10.1007/0-387-26023-4_27; Shen Y, 2005, CANCER EPIDEM BIOMAR, V14, P529, DOI 10.1158/1055-9965.EPI-04-0499; Shen Y, 2001, J CLIN ONCOL, V19, P3490, DOI 10.1200/JCO.2001.19.15.3490; Shih YCT, 2020, JNCI-J NATL CANCER I, V112, P553, DOI 10.1093/jnci/djz185; Shih YCT, 2019, VALUE HEALTH, V22, P185, DOI 10.1016/j.jval.2018.07.880; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Souza FH, 2013, BREAST, V22, P217, DOI 10.1016/j.breast.2013.02.013; Sprague BL, 2017, RADIOLOGY, V283, P59, DOI 10.1148/radiol.2017161519; Sprague BL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju255; Stout NK, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju092; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004; Trentham-Dietz A, 2016, ANN INTERN MED, V165, P700, DOI 10.7326/M16-0476; U.S. Bureau of Labor Statistics, EC NEWS REL TABL 3 M; U.S. Cancer Statistics Working Group Centers for Disease Control and Prevention, 2020, US CANC STAT DAT VIS; Vilaprinyo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086858; Vinnicombe S, 2009, RADIOLOGY, V251, P347, DOI 10.1148/radiol.2512081235; Warren JL, 2002, MED CARE, V40, P3; Welch HG, 2016, NEW ENGL J MED, V375, P1438, DOI 10.1056/NEJMoa1600249; WOLFE JN, 1976, AM J ROENTGENOL, V126, P1130, DOI 10.2214/ajr.126.6.1130; WOOD WC, 1994, NEW ENGL J MED, V330, P1253, DOI 10.1056/NEJM199405053301801; WOOD WC, 1985, WORLD J SURG, V9, P714, DOI 10.1007/BF01655185; Yabroff K. Robin, 2013, Journal of the National Cancer Institute Monographs, P62, DOI 10.1093/jncimonographs/lgt001	55	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					602	+		10.7326/m20-2912	http://dx.doi.org/10.7326/m20-2912			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33556275	Green Accepted			2022-12-28	WOS:000652604800018
J	Gadelha, AC; Ohlberg, DAA; Rabelo, C; Neto, EGS; Vasconcelos, TL; Campos, JL; Lemos, JS; Ornelas, V; Miranda, D; Nadas, R; Santana, FC; Watanabe, K; Taniguchi, T; van Troeye, B; Lamparski, M; Meunier, V; Nguyen, VH; Paszko, D; Charlier, JC; Campos, LC; Cancado, LG; Medeiros-Ribeiro, G; Jorio, A				Gadelha, Andreij C.; Ohlberg, Douglas A. A.; Rabelo, Cassiano; Neto, Eliel G. S.; Vasconcelos, Thiago L.; Campos, Joao L.; Lemos, Jessica S.; Ornelas, Vinicius; Miranda, Daniel; Nadas, Rafael; Santana, Fabiano C.; Watanabe, Kenji; Taniguchi, Takashi; van Troeye, Benoit; Lamparski, Michael; Meunier, Vincent; Nguyen, Viet-Hung; Paszko, Dawid; Charlier, Jean-Christophe; Campos, Leonardo C.; Cancado, Luiz G.; Medeiros-Ribeiro, Gilberto; Jorio, Ado			Localization of lattice dynamics in low-angle twisted bilayer graphene	NATURE			English	Article							RAMAN-SPECTROSCOPY; SCATTERING	Twisted bilayer graphene is created by slightly rotating the two crystal networks in bilayer graphene with respect to each other. For small twist angles, the material undergoes a self-organized lattice reconstruction, leading to the formation of a periodically repeated domain(1-3). The resulting superlattice modulates the vibrational(3,4) and electronic(5,6) structures within the material, leading to changes in the behaviour of electron-phonon coupling(7,8) and to the observation of strong correlations and superconductivity(9). However, accessing these modulations and understanding the related effects are challenging, because the modulations are too small for experimental techniques to accurately resolve the relevant energy levels and too large for theoretical models to properly describe the localized effects. Here we report hyperspectral optical images, generated by a nano-Raman spectroscope(10), of the crystal superlattice in reconstructed (low-angle) twisted bilayer graphene. Observations of the crystallographic structure with visible light are made possible by the nano-Raman technique, which reveals the localization of lattice dynamics, with the presence of strain solitons and topological points(1) causing detectable spectral variations. The results are rationalized by an atomistic model that enables evaluation of the local density of the electronic and vibrational states of the superlattice. This evaluation highlights the relevance of solitons and topological points for the vibrational and electronic properties of the structures, particularly for small twist angles. Our results are an important step towards understanding phonon-related effects at atomic and nanometric scales, such as Jahn-Teller effects(11) and electronic Cooper pairing(12-14), and may help to improve device characterization(15) in the context of the rapidly developing field of twistronics(16). Nano-Raman spectroscopy reveals localization of some vibrational modes in reconstructed twisted bilayer graphene and provides qualitative insights into how electron-phonon coupling affects the vibrational and electronic properties of the material.	[Gadelha, Andreij C.; Ohlberg, Douglas A. A.; Campos, Joao L.; Lemos, Jessica S.; Ornelas, Vinicius; Miranda, Daniel; Nadas, Rafael; Santana, Fabiano C.; Campos, Leonardo C.; Cancado, Luiz G.; Jorio, Ado] Univ Fed Minas Gerais, Phys Dept, Belo Horizonte, MG, Brazil; [Rabelo, Cassiano; Jorio, Ado] Univ Fed Minas Gerais, Elect Engn Grad Program, Belo Horizonte, MG, Brazil; [Neto, Eliel G. S.] Univ Fed Bahia, Phys Inst, Campus Univ Ondina, Salvador, BA, Brazil; [Vasconcelos, Thiago L.] Inmetro, Div Metrol Mat, Duque De Caxias, RJ, Brazil; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Ibaraki, Japan; [van Troeye, Benoit; Lamparski, Michael; Meunier, Vincent] Jonsson Rowland Sci Ctr, Dept Phys Appl Phys & Astron, Troy, NY 12180 USA; [Nguyen, Viet-Hung; Paszko, Dawid; Charlier, Jean-Christophe] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, Louvain La Neuve, Belgium; [Medeiros-Ribeiro, Gilberto] Univ Fed Minas Gerais, Comp Sci Dept, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal da Bahia; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); National Institute for Materials Science; Universite Catholique Louvain; Universidade Federal de Minas Gerais	Jorio, A (corresponding author), Univ Fed Minas Gerais, Phys Dept, Belo Horizonte, MG, Brazil.; Jorio, A (corresponding author), Univ Fed Minas Gerais, Elect Engn Grad Program, Belo Horizonte, MG, Brazil.; Meunier, V (corresponding author), Jonsson Rowland Sci Ctr, Dept Phys Appl Phys & Astron, Troy, NY 12180 USA.	meuniv@rpi.edu; adojorio@fisica.ufmg.br	Jorio, Ado/F-2141-2010; ribeiro, gilberto medeiros/E-1835-2012; Meunier, Vincent/F-9391-2010; Campos, JOÃO LUIZ E/J-1262-2012; Nguyen, Viet Hung/F-6189-2010	Jorio, Ado/0000-0002-5978-2735; ribeiro, gilberto medeiros/0000-0001-5309-2488; Meunier, Vincent/0000-0002-7013-179X; Campos, JOÃO LUIZ E/0000-0002-8071-0525; Nguyen, Viet Hung/0000-0001-6729-3520; Ohlberg, Douglas/0000-0003-1634-0264; Rabelo, Cassiano/0000-0003-0488-2242; Vasconcelos, Thiago/0000-0003-0195-444X; Battistella Nadas, Rafael/0000-0001-6165-5981; Miranda, Daniel/0000-0002-9784-3340; Lemos, Jessica/0000-0002-9493-9240; Silva Neto, Eliel/0000-0002-4658-3243; Gadelha, Andreij C/0000-0002-6350-7680; Ornelas, Vinicius/0000-0002-3636-7272	CNPq [302775/2018-8]; CAPES [88881.198744/2018-01]; FAPEMIG, Brazil; Federation Wallonie-Bruxelles through the ARC on 3D nano-architecturing of 2D crystals [16/21-077]; European Union's Horizon 2020 Research Project and Innovation Program -Graphene Flagship Core3 [881603]; Flag-Era JTC project 'MECHANIC' [R.50.07.18]; Flag-Era JTC project 'TATTOOS' [R.8010.19]; Belgium FNRS [T.1077.15, T.0051.18]; Francqui-Stichting Foundation; NY State Empire State Development's Division of Science, Technology and Innovation (NYSTAR); CNPq (INCT/Nanomaterials de Carbono); CAPES (RELAII)	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Federation Wallonie-Bruxelles through the ARC on 3D nano-architecturing of 2D crystals; European Union's Horizon 2020 Research Project and Innovation Program -Graphene Flagship Core3; Flag-Era JTC project 'MECHANIC'; Flag-Era JTC project 'TATTOOS'; Belgium FNRS(Fonds de la Recherche Scientifique - FNRS); Francqui-Stichting Foundation; NY State Empire State Development's Division of Science, Technology and Innovation (NYSTAR); CNPq (INCT/Nanomaterials de Carbono)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CAPES (RELAII)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CNPq (302775/2018-8 and INCT/Nanomaterials de Carbono), CAPES (RELAII and 88881.198744/2018-01) and FAPEMIG, Brazil. V.-H.N. and J.-C.C. acknowledge financial support from the Federation Wallonie-Bruxelles through the ARC on 3D nano-architecturing of 2D crystals (16/21-077), from the European Union's Horizon 2020 Research Project and Innovation Program -Graphene Flagship Core3 (881603), from the Flag-Era JTC projects 'MECHANIC' (R.50.07.18) and 'TATTOOS' (R.8010.19), from the Belgium FNRS through the research projects T.1077.15 and T.0051.18, and from the Francqui-Stichting Foundation. V.M. and M.L. acknowledge support from NY State Empire State Development's Division of Science, Technology and Innovation (NYSTAR).	Alden JS, 2013, P NATL ACAD SCI USA, V110, P11256, DOI 10.1073/pnas.1309394110; Angeli M, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.041010; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Charlier JC, 2008, TOP APPL PHYS, V111, P673, DOI 10.1007/978-3-540-72865-8_21; Cocemasov AI, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.035428; Das A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.155417; Dresselhaus MS, 2010, NANO LETT, V10, P751, DOI 10.1021/nl904286r; Efthimiopoulos I, 2020, J PHYS CHEM C, V124, P4835, DOI 10.1021/acs.jpcc.9b10875; Eliel GSN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03479-3; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Ferrari AC, 2013, NAT NANOTECHNOL, V8, P235, DOI 10.1038/nnano.2013.46; Gargiulo F, 2018, 2D MATER, V5, DOI 10.1088/2053-1583/aa9640; Jiang LL, 2016, NAT MATER, V15, P840, DOI [10.1038/nmat4653, 10.1038/NMAT4653]; Jorio A, 2013, SOLID STATE COMMUN, V175, P3, DOI 10.1016/j.ssc.2013.08.008; Kim K, 2016, NANO LETT, V16, P1989, DOI 10.1021/acs.nanolett.5b05263; Lamparski M, 2020, 2D MATER, V7, DOI 10.1088/2053-1583/ab7874; Lazzeri M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155426; Lazzeri M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266407; Lee JE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2022; Liang LB, 2017, NANOSCALE, V9, P15340, DOI 10.1039/c7nr05839j; Lin XQ, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.195432; Mele EJ, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.161405; Miranda H, 2020, PHYS REV RES, V2, DOI 10.1103/PhysRevResearch.2.023408; Miranda H, 2020, PHYS STATUS SOLIDI-R, V14, DOI 10.1002/pssr.202000212; Neumann C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9429; Pisana S, 2007, NAT MATER, V6, P198, DOI 10.1038/nmat1846; Piscanec S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.185503; Pizzocchero F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11894; Rabelo C., 2019, P 4 INT S INSTR SYST, P1; Ribeiro HB, 2015, CARBON, V90, P138, DOI 10.1016/j.carbon.2015.04.005; Serlin M, 2020, SCIENCE, V367, P900, DOI 10.1126/science.aay5533; Shao F, 2019, ANAL BIOANAL CHEM, V411, P37, DOI 10.1007/s00216-018-1392-0; Sharpe AL, 2019, SCIENCE, V365, P605, DOI 10.1126/science.aaw3780; Sunku SS, 2018, SCIENCE, V362, P1153, DOI 10.1126/science.aau5144; Thomsen C, 2000, PHYS REV LETT, V85, P5214, DOI 10.1103/PhysRevLett.85.5214; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; Uri A, 2020, NATURE, V581, P47, DOI 10.1038/s41586-020-2255-3; Vasconcelos TL, 2018, ADV OPT MATER, V6, DOI 10.1002/adom.201800528; Woods CR, 2014, NAT PHYS, V10, P451, DOI [10.1038/NPHYS2954, 10.1038/nphys2954]; Yoo H, 2019, NAT MATER, V18, P448, DOI 10.1038/s41563-019-0346-z; YOSHIMORI A, 1956, J PHYS SOC JPN, V11, P352, DOI 10.1143/JPSJ.11.352; Zabel J, 2012, NANO LETT, V12, P617, DOI 10.1021/nl203359n	46	67	68	46	180	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846								10.1038/s41586-021-03252-5	http://dx.doi.org/10.1038/s41586-021-03252-5			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TY5YS	33597759				2022-12-28	WOS:000683860300002
J	Mantia, C; Choudhury, AD				Mantia, Charlene; Choudhury, Atish D.			Transdermal oestrogen for advanced prostate cancer	LANCET			English	Editorial Material							ANDROGEN DEPRIVATION THERAPY; HORMONE AGONISTS; CARDIOVASCULAR-DISEASE; OUTCOMES; ESTRADIOL; IMPACT		[Mantia, Charlene; Choudhury, Atish D.] Dana Farber Canc Inst, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute	Choudhury, AD (corresponding author), Dana Farber Canc Inst, Boston, MA 02215 USA.	atish_choudhury@dfci.harvard.edu		Choudhury, Atish/0000-0001-9344-6631				Abufaraj M, 2021, EUR UROL, V79, P44, DOI 10.1016/j.eururo.2020.06.002; Alibhai SMH, 2009, J CLIN ONCOL, V27, P3452, DOI 10.1200/JCO.2008.20.0923; Byar D P, 1988, NCI Monogr, P165; FINKELSTEIN JS, 1991, J CLIN ENDOCR METAB, V73, P621, DOI 10.1210/jcem-73-3-621; Gilbert DC, 2017, BJU INT, V119, P667, DOI 10.1111/bju.13687; Hayes FJ, 2000, J CLIN ENDOCR METAB, V85, P3027, DOI 10.1210/jc.85.9.3027; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Langley RE, 2021, LANCET, V397, P581, DOI 10.1016/S0140-6736(21)00100-8; Langley RE, 2016, EUR UROL, V69, P1016, DOI 10.1016/j.eururo.2015.11.030; Langley RE, 2013, LANCET ONCOL, V14, P306, DOI 10.1016/S1470-2045(13)70025-1; Shore ND, 2020, NEW ENGL J MED, V382, P2187, DOI 10.1056/NEJMoa2004325; VONSCHOULTZ B, 1989, PROSTATE, V14, P389, DOI 10.1002/pros.2990140410	12	1	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2021	397	10274					556	557						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2TN	33581806				2022-12-28	WOS:000620934000003
J	Tosches, MA				Tosches, Maria Antonietta			Different origins for similar brain circuits	SCIENCE			English	Editorial Material							EVOLUTION		[Tosches, Maria Antonietta] Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA	Columbia University	Tosches, MA (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	mt3353@columbia.edu						Arendt D, 2016, NAT REV GENET, V17, P744, DOI 10.1038/nrg.2016.127; Briscoe SD, 2018, SCIENCE, V362, P190, DOI 10.1126/science.aau3711; BRUCE LL, 1995, BRAIN BEHAV EVOLUT, V46, P224, DOI 10.1159/000113276; Calabrese A, 2015, P NATL ACAD SCI USA, V112, P3517, DOI 10.1073/pnas.1408545112; Colquitt BM, 2021, SCIENCE, V371, P695, DOI 10.1126/science.abd9704; Karten HJ, 2013, CURR BIOL, V23, pR12, DOI 10.1016/j.cub.2012.11.013; Puelles L., 2017, EVOLUTION NERVOUS SY, V2nd ed., P519, DOI [10.1016/B978-0-12-804042-3.00014-2, DOI 10.1016/B978-0-12-804042-3.00014-2]; Tosches MA, 2018, SCIENCE, V360, P881, DOI 10.1126/science.aar4237; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	9	5	5	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					676	677		10.1126/science.abf9551	http://dx.doi.org/10.1126/science.abf9551			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4IS	33574199				2022-12-28	WOS:000617551600025
J	Backes, KM; Palken, DA; Al Kenany, S; Brubaker, BM; Cahn, SB; Droster, A; Hilton, GC; Ghosh, S; Jackson, H; Lamoreaux, SK; Leder, AF; Lehnert, KW; Lewis, SM; Malnou, M; Maruyama, RH; Rapidis, NM; Simanovskaia, M; Singh, S; Speller, DH; Urdinaran, I; Vale, LR; van Assendelft, EC; van Bibber, K; Wang, H				Backes, K. M.; Palken, D. A.; Al Kenany, S.; Brubaker, B. M.; Cahn, S. B.; Droster, A.; Hilton, Gene C.; Ghosh, Sumita; Jackson, H.; Lamoreaux, S. K.; Leder, A. F.; Lehnert, K. W.; Lewis, S. M.; Malnou, M.; Maruyama, R. H.; Rapidis, N. M.; Simanovskaia, M.; Singh, Sukhman; Speller, D. H.; Urdinaran, I; Vale, Leila R.; van Assendelft, E. C.; van Bibber, K.; Wang, H.			A quantum enhanced search for dark matter axions	NATURE			English	Article								A quantum enhanced search for dark matter that uses vacuum squeezing to overcome the quantum noise limit finds no evidence of dark matter axions in a well motivated mass range. The manipulation of quantum states of light(1) holds the potential to enhance searches for fundamental physics. Only recently has the maturation of quantum squeezing technology coincided with the emergence of fundamental physics searches that are limited by quantum uncertainty(2,3). In particular, the quantum chromodynamics axion provides a possible solution to two of the greatest outstanding problems in fundamental physics: the strong-CP (charge-parity) problem of quantum chromodynamics(4) and the unknown nature of dark matter(5-7). In dark matter axion searches, quantum uncertainty manifests as a fundamental noise source, limiting the measurement of the quadrature observables used for detection. Few dark matter searches have approached this limit(3,8), and until now none has exceeded it. Here we use vacuum squeezing to circumvent the quantum limit in a search for dark matter. By preparing a microwave-frequency electromagnetic field in a squeezed state and near-noiselessly reading out only the squeezed quadrature(9), we double the search rate for axions over a mass range favoured by some recent theoretical projections(10,11). We find no evidence of dark matter within the axion rest energy windows of 16.96-17.12 and 17.14-17.28 microelectronvolts. Breaking through the quantum limit invites an era of fundamental physics searches in which noise reduction techniques yield unbounded benefit compared with the diminishing returns of approaching the quantum limit.	[Backes, K. M.; Cahn, S. B.; Ghosh, Sumita; Lamoreaux, S. K.; Maruyama, R. H.; Singh, Sukhman; Speller, D. H.; van Assendelft, E. C.; Wang, H.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Palken, D. A.; Brubaker, B. M.; Lehnert, K. W.; Malnou, M.] NIST, JILA, Boulder, CO USA; [Palken, D. A.; Brubaker, B. M.; Lehnert, K. W.; Malnou, M.] Univ Colorado, Boulder, CO 80309 USA; [Palken, D. A.; Brubaker, B. M.; Lehnert, K. W.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Al Kenany, S.; Droster, A.; Jackson, H.; Leder, A. F.; Lewis, S. M.; Rapidis, N. M.; Simanovskaia, M.; Urdinaran, I; van Bibber, K.] Univ Calif Berkeley, Dept Nucl Engn, Berkeley, CA 94720 USA; [Hilton, Gene C.; Lehnert, K. W.; Malnou, M.; Vale, Leila R.] NIST, Boulder, CO USA	Yale University; National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of California System; University of California Berkeley; National Institute of Standards & Technology (NIST) - USA	Backes, KM (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06520 USA.	kelly.backes@yale.edu		Rapidis, Nicholas M./0000-0002-4119-8565; Palken, Daniel/0000-0003-1688-6531; Ghosh, Sumita/0000-0003-3502-0063	National Science Foundation [PHY-1701396, PHY-1607223, PHY-1734006, PHY-1914199, PHY-2011357]; Heising-Simons Foundation [2016-044]	National Science Foundation(National Science Foundation (NSF)); Heising-Simons Foundation	We acknowledge support from the National Science Foundation under grant numbers PHY-1701396, PHY-1607223, PHY-1734006, PHY-1914199 and PHY-2011357 and the Heising-Simons Foundation under grants 2016-044 and 2016-044. We thank K. Thatcher and C. Schwadron for work on the design and fabrication of the SSR mechanical components, F. Vietmeyer for work on the room-temperature electronics and S. Burrows for graphical design work. We thank V. Bernardo and the J. W. Gibbs Professional Shop as well as C. Miller and D. Johnson for assistance with fabricating the system's mechanical components. We thank M. Buehler of Low-T Solutions for cryogenics advice. Finally, we thank the Wright laboratory for housing the experiment and providing computing and facilities support.	ABBOTT LF, 1983, PHYS LETT B, V120, P133, DOI 10.1016/0370-2693(83)90638-X; Ade PAR, 2016, ASTRON ASTROPHYS, V594, DOI 10.1051/0004-6361/201525830; Al Kenany S, 2017, NUCL INSTRUM METH A, V854, P11, DOI 10.1016/j.nima.2017.02.012; Arvanitaki A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.161801; Bertone G, 2018, NATURE, V562, P51, DOI 10.1038/s41586-018-0542-z; Braine T, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.101303; Braunstein SL, 2005, REV MOD PHYS, V77, P513, DOI 10.1103/RevModPhys.77.513; Brubaker BM, 2017, PHYS REV D, V96, DOI 10.1103/PhysRevD.96.123008; Brubaker BM, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.061302; Burkhart L.D, 2020, ERROR DETECTED STATE; Buschmann M, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.161103; CAVES CM, 1982, PHYS REV D, V26, P1817, DOI 10.1103/PhysRevD.26.1817; CAVES CM, 1980, REV MOD PHYS, V52, P341, DOI 10.1103/RevModPhys.52.341; Di Luzio L, 2020, PHYS REP, V870, P1, DOI 10.1016/j.physrep.2020.06.002; DINE M, 1983, PHYS LETT B, V120, P137, DOI 10.1016/0370-2693(83)90639-1; DINE M, 1981, PHYS LETT B, V104, P199, DOI 10.1016/0370-2693(81)90590-6; Garcon A, 2018, QUANTUM SCI TECHNOL, V3, DOI 10.1088/2058-9565/aa9861; Gorghetto M, 2018, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2018)151; KIM JE, 1979, PHYS REV LETT, V43, P103, DOI 10.1103/PhysRevLett.43.103; Klaer VB, 2017, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2017/11/049; Majorovits B., 2019, Journal of Physics: Conference Series, V1342, DOI 10.1088/1742-6596/1342/1/012098; Malnou M, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021023; Malnou M, 2018, PHYS REV APPL, V9, DOI 10.1103/PhysRevApplied.9.044023; Ouellet JL, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.121802; Palken D, 2020, THESIS U COLORADO BO; Palken DA, 2020, PHYS REV D, V101, DOI 10.1103/PhysRevD.101.123011; PECCEI RD, 1977, PHYS REV LETT, V38, P1440, DOI 10.1103/PhysRevLett.38.1440; PRESKILL J, 1983, PHYS LETT B, V120, P127, DOI 10.1016/0370-2693(83)90637-8; PRIMAKOFF H, 1951, PHYS REV, V81, P899, DOI 10.1103/PhysRev.81.899; Rapidis NM, 2019, REV SCI INSTRUM, V90, DOI 10.1063/1.5055246; SHIFMAN MA, 1980, NUCL PHYS B, V166, P493, DOI 10.1016/0550-3213(80)90209-6; SIKIVIE P, 1983, PHYS REV LETT, V51, P1415, DOI 10.1103/PhysRevLett.51.1415; SLUSHER RE, 1985, PHYS REV LETT, V55, P2409, DOI 10.1103/PhysRevLett.55.2409; Tanabashi M, 2018, PHYS REV D, V98, DOI 10.1103/PhysRevD.98.030001; Tse M, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.231107; Yamamoto T, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2964182; ZHITNITSKII AP, 1980, SOV J NUCL PHYS+, V31, P260; Zhong L, 2018, PHYS REV D, V97, DOI 10.1103/PhysRevD.97.092001	39	89	89	5	28	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2021	590	7845								10.1038/s41586-021-03226-7	http://dx.doi.org/10.1038/s41586-021-03226-7			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG0NG	33568823	Green Submitted			2022-12-28	WOS:000617282500002
J	Goverman, JM				Goverman, Joan M.			Regulatory T Cells in Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Regulatory T cells suppress inflammation and are defective in autoimmune diseases. A recent study provides new insight into how these cells become dysregulated in multiple sclerosis and points to a potential strategy for restoring their function.	[Goverman, Joan M.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Goverman, JM (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.							Pacella I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01889; Pompura SL., 2020, J CLIN INVEST; Procaccini C, 2016, IMMUNITY, V44, P712, DOI 10.1016/j.immuni.2016.02.022	3	5	5	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2021	384	6					578	580		10.1056/NEJMcibr2033544	http://dx.doi.org/10.1056/NEJMcibr2033544			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QG5JQ	33567197				2022-12-28	WOS:000617621800016
J	Mahase, E				Mahase, Elisabeth			NHS reorganisation must not be rushed through during pandemic, leaders warn	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health and Social Care, 2021, WORK TOG IMPR HLTH S; Iacobucci G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n377	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2021	372								n431	10.1136/bmj.n431	http://dx.doi.org/10.1136/bmj.n431			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM2MY	33574096				2022-12-28	WOS:000639500800012
J	Rogers, C; Piggott, AY; Thomson, DJ; Wiser, RF; Opris, IE; Fortune, SA; Compston, AJ; Gondarenko, A; Meng, FF; Chen, X; Reed, GT; Nicolaescu, R				Rogers, Christopher; Piggott, Alexander Y.; Thomson, David J.; Wiser, Robert F.; Opris, Ion E.; Fortune, Steven A.; Compston, Andrew J.; Gondarenko, Alexander; Meng, Fanfan; Chen, Xia; Reed, Graham T.; Nicolaescu, Remus			A universal 3D imaging sensor on a silicon photonics platform	NATURE			English	Article								A compact, high-performance silicon photonics-based light detection and ranging system for three-dimensional imaging is developed that should be amenable to low-cost mass manufacturing Accurate three-dimensional (3D) imaging is essential for machines to map and interact with the physical world(1,2). Although numerous 3D imaging technologies exist, each addressing niche applications with varying degrees of success, none has achieved the breadth of applicability and impact that digital image sensors have in the two-dimensional imaging world(3-10). A large-scale two-dimensional array of coherent detector pixels operating as a light detection and ranging system could serve as a universal 3D imaging platform. Such a system would offer high depth accuracy and immunity to interference from sunlight, as well as the ability to measure the velocity of moving objects directly(11). Owing to difficulties in providing electrical and photonic connections to every pixel, previous systems have been restricted to fewer than 20 pixels(12-15). Here we demonstrate the operation of a large-scale coherent detector array, consisting of 512 pixels, in a 3D imaging system. Leveraging recent advances in the monolithic integration of photonic and electronic circuits, a dense array of optical heterodyne detectors is combined with an integrated electronic readout architecture, enabling straightforward scaling to arbitrarily large arrays. Two-axis solid-state beam steering eliminates any trade-off between field of view and range. Operating at the quantum noise limit(16,17), our system achieves an accuracy of 3.1 millimetres at a distance of 75 metres when using only 4 milliwatts of light, an order of magnitude more accurate than existing solid-state systems at such ranges. Future reductions of pixel size using state-of-the-art components could yield resolutions in excess of 20 megapixels for arrays the size of a consumer camera sensor. This result paves the way for the development and proliferation of low-cost, compact and high-performance 3D imaging cameras that could be used in applications from robotics and autonomous navigation to augmented reality and healthcare.	[Rogers, Christopher; Piggott, Alexander Y.; Wiser, Robert F.; Fortune, Steven A.; Compston, Andrew J.; Gondarenko, Alexander; Nicolaescu, Remus] Pointcloud Inc, San Francisco, CA 94107 USA; [Thomson, David J.; Meng, Fanfan; Chen, Xia; Reed, Graham T.] Univ Southampton, Optoelect Res Ctr, Southampton, Hants, England; [Opris, Ion E.] Opris Consulting, San Jose, CA USA	University of Southampton	Nicolaescu, R (corresponding author), Pointcloud Inc, San Francisco, CA 94107 USA.	remus.nicolaescu@point.cloud			EPSRC [EP/N013247/1, EP/L021129/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Aflatouni F, 2015, OPT EXPRESS, V23, P5117, DOI 10.1364/OE.23.005117; Ahmed MG, 2019, IEEE J SOLID-ST CIRC, V54, P834, DOI 10.1109/JSSC.2018.2882265; Behroozpour B, 2017, IEEE COMMUN MAG, V55, P135, DOI 10.1109/MCOM.2017.1700030; CHEN HS, 1968, J PHYS D APPL PHYS, V1, P1191, DOI 10.1088/0022-3727/1/9/312; COLLETT MJ, 1987, J MOD OPTIC, V34, P881, DOI 10.1080/09500348714550811; Corti A, 2016, ROBOT AUTON SYST, V75, P584, DOI 10.1016/j.robot.2015.09.024; El Gamal A, 2005, IEEE CIRCUITS DEVICE, V21, P6, DOI 10.1109/MCD.2005.1438751; Giewont K, 2019, IEEE J SEL TOP QUANT, V25, DOI 10.1109/JSTQE.2019.2908790; GRIFFITHS HD, 1990, ELECTRON COMMUN ENG, V2, P185, DOI 10.1049/ecej:19900043; Hu K, 2017, IEEE SENS J, V17, P5547, DOI 10.1109/JSEN.2017.2724064; Hutchings SW, 2019, IEEE J SOLID-ST CIRC, V54, P2947, DOI 10.1109/JSSC.2019.2939083; Inoue D, 2019, OPT EXPRESS, V27, P2499, DOI 10.1364/OE.27.002499; Kasturi A., 2016, P SPIE, V9832, P206; Kidd J., 2017, THESIS U NEW HAMPSHI; Li C, 2019, OPT EXPRESS, V27, P32970, DOI 10.1364/OE.27.032970; Lichti DD, 2007, ISPRS J PHOTOGRAMM, V61, P307, DOI 10.1016/j.isprsjprs.2006.10.004; Martin A, 2018, J LIGHTWAVE TECHNOL, V36, P4640, DOI 10.1109/JLT.2018.2840223; McManamon PF, 2017, OPT ENG, V56, DOI 10.1117/1.OE.56.3.031223; McManamon PF, 2012, OPT ENG, V51, DOI 10.1117/1.OE.51.6.060901; Mendez-Astudillo M, 2019, OPT EXPRESS, V27, P899, DOI 10.1364/OE.27.000899; Miller S. A., 2018; Mohan SS, 2000, IEEE J SOLID-ST CIRC, V35, P346, DOI 10.1109/4.826816; Piggott AY, 2020, ACS PHOTONICS, V7, P569, DOI 10.1021/acsphotonics.9b01540; Poulton CV, 2017, OPT LETT, V42, P4091, DOI 10.1364/OL.42.004091; Poulton CV, 2019, IEEE J SEL TOP QUANT, V25, DOI 10.1109/JSTQE.2019.2908555; Razavi B., 2019, IEEE SOLID STATE CIR, V11, P10; RAZAVI B, 2000, IEEE INT SOL STAT CI, P162, DOI DOI 10.1109/ISSCC.2000.839732; Rebolj D, 2017, AUTOMAT CONSTR, V84, P323, DOI 10.1016/j.autcon.2017.09.021; Riemensberger J, 2020, NATURE, V581, P164, DOI 10.1038/s41586-020-2239-3; Romanova A, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8101073; Rong HS, 2005, NATURE, V433, P292, DOI 10.1038/nature03273; Rubin MA, 2007, OPT LETT, V32, P1369, DOI 10.1364/OL.32.001369; Salvi J, 2004, PATTERN RECOGN, V37, P827, DOI 10.1016/j.patcog.2003.10.002; Samani A, 2019, J LIGHTWAVE TECHNOL, V37, P2989, DOI 10.1109/JLT.2019.2908655; Shahdoost S, 2016, ANALOG INTEGR CIRC S, V86, P233, DOI 10.1007/s10470-015-0669-x; Shen YC, 2017, NAT PHOTONICS, V11, P441, DOI [10.1038/NPHOTON.2017.93, 10.1038/nphoton.2017.93]; Sheng Z, 2012, IEEE PHOTONICS J, V4, P2272, DOI 10.1109/JPHOT.2012.2230320; Sorianello V, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2987999; Stann BL, 2004, P SOC PHOTO-OPT INS, V5412, P264, DOI 10.1117/12.542549; STOVE AG, 1992, IEE PROC-F, V139, P343, DOI 10.1049/ip-f-2.1992.0048; Sun J, 2013, NATURE, V493, P195, DOI 10.1038/nature11727; Thurn K, 2013, IEEE MTT S INT MICR, DOI 10.1109/MWSYM.2013.6697654; Tsang HK, 2002, APPL PHYS LETT, V80, P416, DOI 10.1063/1.1435801; Urmson C, 2008, J FIELD ROBOT, V25, P425, DOI 10.1002/rob.20255; Wang J, 2015, J INTELL ROBOT SYST, V79, P417, DOI 10.1007/s10846-014-0116-8; WANG JY, 1982, APPL OPTICS, V21, P464, DOI 10.1364/AO.21.000464; Wang Q, 2019, ADV ENG INFORM, V39, P306, DOI 10.1016/j.aei.2019.02.007; Winkler V, 2007, EUROP RADAR CONF, P165; Ximenes AR, 2019, IEEE J SOLID-ST CIRC, V54, P3203, DOI 10.1109/JSSC.2019.2938412	50	60	61	37	142	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2021	590	7845								10.1038/s41586-021-03259-y	http://dx.doi.org/10.1038/s41586-021-03259-y			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG0TV	33568821	Green Submitted			2022-12-28	WOS:000617300400014
J	Hoijman, E; Hakkinen, HM; Tolosa-Ramon, Q; Jimenez-Delgado, S; Wyatt, C; Miret-Cuesta, M; Irimia, M; Callan-Jones, A; Wieser, S; Ruprecht, V				Hoijman, Esteban; Hakkinen, Hanna-Maria; Tolosa-Ramon, Queralt; Jimenez-Delgado, Senda; Wyatt, Chris; Miret-Cuesta, Marta; Irimia, Manuel; Callan-Jones, Andrew; Wieser, Stefan; Ruprecht, Verena			Cooperative epithelial phagocytosis enables error correction in the early embryo	NATURE			English	Article							APOPTOTIC CELLS; CLEARANCE; SURFACE; DEATH	Errors in early embryogenesis are a cause of sporadic cell death and developmental failure(1,2). Phagocytic activity has a central role in scavenging apoptotic cells in differentiated tissues(3-6). However, how apoptotic cells are cleared in the blastula embryo in the absence of specialized immune cells remains unknown. Here we show that the surface epithelium of zebrafish and mouse embryos, which is the first tissue formed during vertebrate development, performs efficient phagocytic clearance of apoptotic cells through phosphatidylserine-mediated target recognition. Quantitative four-dimensional in vivo imaging analyses reveal a collective epithelial clearance mechanism that is based on mechanical cooperation by two types of Rac1-dependent basal epithelial protrusions. The first type of protrusion, phagocytic cups, mediates apoptotic target uptake. The second, a previously undescribed type of fast and extended actin-based protrusion that we call 'epithelial arms', promotes the rapid dispersal of apoptotic targets through Arp2/3-dependent mechanical pushing. On the basis of experimental data and modelling, we show that mechanical load-sharing enables the long-range cooperative uptake of apoptotic cells by multiple epithelial cells. This optimizes the efficiency of tissue clearance by extending the limited spatial exploration range and local uptake capacity of non-motile epithelial cells. Our findings show that epithelial tissue clearance facilitates error correction that is relevant to the developmental robustness and survival of the embryo, revealing the presence of an innate immune function in the earliest stages of embryonic development. Mechanical load-sharing enables the long-range cooperative uptake of apoptotic cells by multiple epithelial cells; and clearance of these apoptotic cells facilitates error correction, which is necessary for developmental robustness and survival of the embryo.	[Hoijman, Esteban; Hakkinen, Hanna-Maria; Tolosa-Ramon, Queralt; Jimenez-Delgado, Senda; Wyatt, Chris; Miret-Cuesta, Marta; Irimia, Manuel; Ruprecht, Verena] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Barcelona, Spain; [Irimia, Manuel; Ruprecht, Verena] Univ Pompeu Fabra UPF, Barcelona, Spain; [Irimia, Manuel] ICREA, Barcelona, Spain; [Callan-Jones, Andrew] Univ Paris, CNRS, UMR 7057, Lab Matiere & Syst Complexes, Paris, France; [Wieser, Stefan] Barcelona Inst Sci & Technol, Inst Ciencies Foton ICFO, Casterdefels, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO)	Hoijman, E; Ruprecht, V (corresponding author), Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Barcelona, Spain.; Ruprecht, V (corresponding author), Univ Pompeu Fabra UPF, Barcelona, Spain.; Wieser, S (corresponding author), Barcelona Inst Sci & Technol, Inst Ciencies Foton ICFO, Casterdefels, Spain.	hoijman@gmail.com; stefan.wieser@icfo.eu; verena.ruprecht@crg.eu	Ruprecht, Verena/H-7563-2017	Ruprecht, Verena/0000-0003-4088-8633; Hoijman, Esteban/0000-0003-1927-1989; Miret Cuesta, Marta/0000-0002-1083-5904; Irimia, Manuel/0000-0002-2179-2567; Wieser, Stefan/0000-0002-2670-2217; Tolosa Ramon, Queralt/0000-0002-3086-6097	The Ministerio de Ciencia, Innovacion y Universidades and Fondo Social Europeo (FSE) [PRE2018-084393]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [ERC-StG-LS2-63759]; Spanish Ministry of Economy and Competitiveness [BFU2014-55076-P]; Government of Spain (MINECO's Plan Nacional) [PGC2018-098532-A-I00]; Fundacio Cellex; Fundacio Mir-Puig; Generalitat de Catalunya (CERCA, AGAUR); Spanish Ministry of Science and Innovation; Centro de Excelencia Severo Ochoa; MINECO's Plan Nacional [BFU2017-86296-P]; Generalitat de Catalunya (CERCA); CRG Core Facilities for Genomics, Biomolecular Screening and Protein Technologies, Flow Cytometry and Advanced Light Microscopy; Government of Spain (Severo Ochoa) [CEX2019-000910-S]	The Ministerio de Ciencia, Innovacion y Universidades and Fondo Social Europeo (FSE); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); Spanish Ministry of Economy and Competitiveness(Spanish Government); Government of Spain (MINECO's Plan Nacional); Fundacio Cellex(Foundation CELLEX); Fundacio Mir-Puig; Generalitat de Catalunya (CERCA, AGAUR); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Centro de Excelencia Severo Ochoa; MINECO's Plan Nacional; Generalitat de Catalunya (CERCA); CRG Core Facilities for Genomics, Biomolecular Screening and Protein Technologies, Flow Cytometry and Advanced Light Microscopy; Government of Spain (Severo Ochoa)	We thank T. Graf, B. Lehner and V. Malhotra for discussions and reading of the manuscript. Q.T.-R. acknowledges a grant funded by 'The Ministerio de Ciencia, Innovacion y Universidades and Fondo Social Europeo (FSE)' (PRE2018-084393). M.I. acknowledges funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (ERC-StG-LS2-63759) and the Spanish Ministry of Economy and Competitiveness (BFU2014-55076-P). S.W. acknowledges support from the Government of Spain (MINECO's Plan Nacional (PGC2018-098532-A-I00), Severo Ochoa (CEX2019-000910-S)), Fundacio Cellex, Fundacio Mir-Puig and Generalitat de Catalunya (CERCA, AGAUR). V.R. acknowledges support from the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, MINECO's Plan Nacional (BFU2017-86296-P), Generalitat de Catalunya (CERCA) and support from the CRG Core Facilities for Genomics, Biomolecular Screening and Protein Technologies, Flow Cytometry and Advanced Light Microscopy.	Akhtar N, 2016, DEV CELL, V38, P522, DOI 10.1016/j.devcel.2016.08.005; Akieda Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12609-4; Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253; Arienti S, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00891; Armitage EL, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02875-2; Artus J, 2013, STEM CELLS, V31, P1932, DOI 10.1002/stem.1442; Bolton H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11165; Claveria C, 2013, NATURE, V500, P39, DOI 10.1038/nature12389; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Doran AC, 2020, NAT REV IMMUNOL, V20, P254, DOI 10.1038/s41577-019-0240-6; Elliott MR, 2016, DEV CELL, V38, P147, DOI 10.1016/j.devcel.2016.06.029; Ellis SJ, 2019, NATURE, V569, P497, DOI 10.1038/s41586-019-1199-y; Evans IR, 2013, CELL DEATH DIFFER, V20, P709, DOI 10.1038/cdd.2012.166; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fazeli G, 2018, CELL REP, V23, P2070, DOI 10.1016/j.celrep.2018.04.043; Furniss KL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003832; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Greco E, 2015, NEW ENGL J MED, V373, P2089, DOI 10.1056/NEJMc1500421; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Jaumouille V, 2019, NAT CELL BIOL, V21, P1357, DOI 10.1038/s41556-019-0414-2; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lee CS, 2016, IMMUNITY, V44, P807, DOI 10.1016/j.immuni.2016.02.005; Lim JJ, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00191; Nakanishi N, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-26; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Palchaudhuri R, 2015, CELL REP, V13, P2027, DOI 10.1016/j.celrep.2015.10.042; Park H, 2009, MOL BIOL CELL, V20, P4500, DOI 10.1091/mbc.E09-03-0230; Patel PC, 2008, MOL BIOL CELL, V19, P4628, DOI 10.1091/mbc.E08-02-0223; Penberthy KK, 2018, TRENDS CELL BIOL, V28, P317, DOI 10.1016/j.tcb.2018.01.004; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.08.009, 10.1016/j.cell.2016.03.023]; Rasmussen JP, 2015, J NEUROSCI, V35, P559, DOI 10.1523/JNEUROSCI.3613-14.2015; Schlam D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9623; Schneider I, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000173; Serizier SB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01642; Shinoda H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061548; Silva JRMC, 2000, DEV COMP IMMUNOL, V24, P733, DOI 10.1016/S0145-305X(00)00028-8; van Ham TJ, 2012, CURR BIOL, V22, P830, DOI 10.1016/j.cub.2012.03.027; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Voelz K, 2015, DIS MODEL MECH, V8, P1375, DOI 10.1242/dmm.019992; Vorselen D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13804-z; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Wood W, 2000, DEVELOPMENT, V127, P5245; Yamaguchi Y, 2011, J CELL BIOL, V195, P1047, DOI 10.1083/jcb.201104057; Zent CS, 2017, FEBS J, V284, P1021, DOI 10.1111/febs.13961; Zhong JX, 2014, CELL DEATH DIFFER, V21, P1013, DOI 10.1038/cdd.2014.22; Zhu YL, 2019, CELL, V179, P74, DOI 10.1016/j.cell.2019.08.001	50	14	14	7	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847								10.1038/s41586-021-03200-3	http://dx.doi.org/10.1038/s41586-021-03200-3		FEB 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM2BL	33568811	Green Accepted, Green Submitted			2022-12-28	WOS:000616954000003
J	Tan, IB; Tan, CV; Hsu, LY; Dan, YY; Aw, A; Cook, AR; Lee, VJ				Tan, Iain Beehuat; Tan, Clive; Hsu, Li Yang; Dan, Yock Young; Aw, Andrew; Cook, Alex R.; Lee, Vernon J.			Prevalence and Outcomes of SARS-CoV-2 Infection Among Migrant Workers in Singapore	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study examines the prevalence and outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among migrant workers in Singapore.	[Tan, Iain Beehuat] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore; [Tan, Iain Beehuat; Tan, Clive; Hsu, Li Yang; Dan, Yock Young; Lee, Vernon J.] Minist Hlth, Singapore, Singapore; [Tan, Iain Beehuat; Tan, Clive] Singapore Armed Forces Headquarters, Headquarters Med Corps, Singapore, Singapore; [Tan, Iain Beehuat; Hsu, Li Yang; Cook, Alex R.; Lee, Vernon J.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Dan, Yock Young] Natl Univ Singapore, Dept Med, Singapore, Singapore; [Aw, Andrew] Tan Tock Seng Hosp, Dent Serv, Singapore, Singapore	National Cancer Centre Singapore (NCCS); Ministry of Health-Singapore; National University of Singapore; National University of Singapore; Tan Tock Seng Hospital	Lee, VJ (corresponding author), Minist Hlth Singapore, Communicable Dis Div, Coll Med Bldg,16 Coll Rd, Singapore 169854, Singapore.	vernon_lee@moh.gov.sg	Tan, Clive/ABA-6220-2021	Tan, Clive/0000-0001-9573-2068	National Medical Research Council	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Drs I. B. Tan and Cook received research support from the National Medical Research Council.	Bastos ML, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2516; European Centre for Disease Prevention and Control, COVID 19 SURV REP; R Core Team, R LANG ENV STAT COMP; Sloane PD, 2020, J AM MED DIR ASSOC, V21, P958, DOI 10.1016/j.jamda.2020.04.020; World Health Organization, WHO COR DIS COVID 19; Yi HS, 2021, J TRAVEL MED, V28, DOI 10.1093/jtm/taaa159	6	18	18	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2021	325	6					584	585		10.1001/jama.2020.24071	http://dx.doi.org/10.1001/jama.2020.24071			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG0MD	33560312	Bronze, Green Published			2022-12-28	WOS:000617279600023
J	Wahl, A; Gralinski, LE; Johnson, CE; Yao, WB; Kovarova, M; Dinnon, KH; Liu, HW; Madden, VJ; Krzystek, HM; De, C; White, KK; Gully, K; Schafer, A; Zaman, T; Leist, SR; Grant, PO; Bluemling, GR; Kolykhalov, AA; Natchus, MG; Askin, FB; Painter, G; Browne, EP; Jones, CD; Pickles, RJ; Baric, RS; Garcia, JV				Wahl, Angela; Gralinski, Lisa E.; Johnson, Claire E.; Yao, Wenbo; Kovarova, Martina; Dinnon, Kenneth H., III; Liu, Hongwei; Madden, Victoria J.; Krzystek, Halina M.; De, Chandrav; White, Kristen K.; Gully, Kendra; Schafer, Alexandra; Zaman, Tanzila; Leist, Sarah R.; Grant, Paul O.; Bluemling, Gregory R.; Kolykhalov, Alexander A.; Natchus, Michael G.; Askin, Frederic B.; Painter, George; Browne, Edward P.; Jones, Corbin D.; Pickles, Raymond J.; Baric, Ralph S.; Garcia, J. Victor			SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801	NATURE			English	Article							REVERSE GENETICS; SARS; KNOWLEDGE; COVID-19; CDNA	All coronaviruses known to have recently emerged as human pathogens probably originatedin bats(1). Here we use a single experimental platform based on immunodeficient mice implanted with human lung tissue (hereafter, human lung-only mice (LoM)) to demonstrate the efficient in vivo replication of severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as two endogenous SARS-like bat coronaviruses that show potential for emergence as human pathogens. Virus replication in this model occurs in bona fide human lung tissue and does not require any type of adaptation of the virus or the host. Our results indicate that bats contain endogenous coronaviruses that are capable of direct transmission to humans. Our detailed analysis of in vivo infection with SARS-CoV-2 in human lung tissue from LoM showed a predominant infection of human lung epithelial cells, including type-2 pneumocytes that are present in alveoli and ciliated airway cells. Acute infection with SARS-CoV-2 was highly cytopathic and induced a robust and sustained type-I interferon and inflammatory cytokine and chemokine response. Finally, we evaluated a therapeutic and pre-exposure prophylaxis strategy for SARS-CoV-2 infection. Our results show that therapeutic and prophylactic administration of EIDD-2801-an oral broad-spectrum antiviral agent that is currently in phase II/III clinical trials-markedly inhibited SARS-CoV-2 replication in vivo, and thus has considerable potential for the prevention and treatment of COVID-19.	[Wahl, Angela; Johnson, Claire E.; Yao, Wenbo; Kovarova, Martina; De, Chandrav; Garcia, J. Victor] Univ North Carolina Chapel Hill, Int Ctr Adv Translat Sci, Chapel Hill, NC 27599 USA; [Wahl, Angela; Johnson, Claire E.; Yao, Wenbo; Kovarova, Martina; De, Chandrav; Browne, Edward P.; Garcia, J. Victor] Univ North Carolina Chapel Hill, Div Infect Dis, Dept Med, Chapel Hill, NC 27599 USA; [Wahl, Angela; Johnson, Claire E.; Yao, Wenbo; Kovarova, Martina; De, Chandrav; Browne, Edward P.; Garcia, J. Victor] Univ North Carolina Chapel Hill, Ctr AIDS Res, Chapel Hill, NC 27599 USA; [Gralinski, Lisa E.; Dinnon, Kenneth H., III; Gully, Kendra; Schafer, Alexandra; Leist, Sarah R.; Baric, Ralph S.] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA; [Dinnon, Kenneth H., III; Browne, Edward P.; Pickles, Raymond J.; Baric, Ralph S.] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Liu, Hongwei; Krzystek, Halina M.; Zaman, Tanzila; Grant, Paul O.; Jones, Corbin D.] Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC USA; [Liu, Hongwei; Krzystek, Halina M.; Zaman, Tanzila; Grant, Paul O.; Jones, Corbin D.] Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC USA; [Madden, Victoria J.; White, Kristen K.] Univ North Carolina Chapel Hill, Microscopy Serv Lab, Chapel Hill, NC USA; [Bluemling, Gregory R.; Kolykhalov, Alexander A.; Painter, George] Emory Univ, Emory Inst Drug Dev EIDD, Atlanta, GA 30322 USA; [Bluemling, Gregory R.; Kolykhalov, Alexander A.; Natchus, Michael G.; Painter, George] Emory DRIVE, Drug Innovat Ventures, Atlanta, GA USA; [Askin, Frederic B.] Univ North Carolina Chapel Hill, Dept Pathol, Chapel Hill, NC USA; [Painter, George] Emory Univ, Dept Pharmacol & Chem Biol, Atlanta, GA 30322 USA; [Browne, Edward P.] Univ North Carolina Chapel Hill, UNC HIV Cure Ctr, Chapel Hill, NC USA; [Pickles, Raymond J.] Univ North Carolina Chapel, Marsico Lung Inst, Chapel Hill, NC USA; [Baric, Ralph S.] Univ North Carolina Chapel Hill, Rapid Emerging Antiviral Drug Discovery Initiat, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Emory University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Emory University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Garcia, JV (corresponding author), Univ North Carolina Chapel Hill, Int Ctr Adv Translat Sci, Chapel Hill, NC 27599 USA.; Garcia, JV (corresponding author), Univ North Carolina Chapel Hill, Div Infect Dis, Dept Med, Chapel Hill, NC 27599 USA.; Garcia, JV (corresponding author), Univ North Carolina Chapel Hill, Ctr AIDS Res, Chapel Hill, NC 27599 USA.	victor_garcia@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; , Pathology Services Core/CEZ-2246-2022	Dinnon, Kenneth/0000-0002-8942-1551; Madden, Victoria/0000-0002-7909-7743; Kovarova, Martina/0000-0001-7152-1709	National Institutes of Health [R21AI113736, U19AI100625, R01 AI108197, R01AI123010, R01AI111899, R01AI140799, R01MH108179]; North Carolina Policy Collaboratory at the University of North Carolina at Chapel Hill; North Carolina Coronavirus Relief Fund; Cancer Center Support Grant [P30 CA016086]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina Policy Collaboratory at the University of North Carolina at Chapel Hill; North Carolina Coronavirus Relief Fund; Cancer Center Support Grant	We thank current and past members of the laboratory of J.V.G. for technical assistance; technicians at the UNC Animal Histopathology and Laboratory Medicine Core and Division of Comparative Medicine; the UNC School of Medicine Bioinformatics and Analytics Research Collaborative (BARC) for providing technical support; and K. Mollan and B. Shook-Sa of the UNC CFAR Biostatistics Core for providing statistical support. This work was supported by funding from National Institutes of Health grants R21AI113736 (R.J.P.), U19AI100625 and R01 AI108197 (R.S.B.), Fast Grants (L.E.G.), R01AI123010 (A.W.), R01AI111899 (J.V.G.), R01AI140799 (J.V.G.) and R01MH108179 (J.V.G.). This project was also supported by the North Carolina Policy Collaboratory at the University of North Carolina at Chapel Hill with funding from the North Carolina Coronavirus Relief Fund established and appropriated by the North Carolina General Assembly. The Microscopy Services Laboratory, Department of Pathology and Laboratory Medicine, is supported in part by P30 CA016086 Cancer Center Support Grant to the UNC Lineberger Comprehensive Cancer Center.	Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5; Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849; Cockrell AS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.226; Cox RM, 2021, NAT MICROBIOL, V6, P11, DOI 10.1038/s41564-020-00835-2; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; Dinnon Kenneth H, 2020, bioRxiv, DOI 10.1101/2020.05.06.081497; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Franks Teri J, 2008, Proc Am Thorac Soc, V5, P763, DOI 10.1513/pats.200803-025HR; Gralinski LE, 2018, MBIO, V9, DOI 10.1128/mBio.01753-18; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; Jiang RD, 2020, CELL, V182, P50, DOI 10.1016/j.cell.2020.05.027; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Kim PS, 2020, JAMA-J AM MED ASSOC, V324, P2149, DOI 10.1001/jama.2020.22813; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; MENACHERY V, 2017, MSPHERE, V2; Menachery VD, 2016, P NATL ACAD SCI USA, V113, P3048, DOI 10.1073/pnas.1517719113; Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985; Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134; Merck Sharp & Dohme Corp, 2020, EFFICACY SAFETY MOLN; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Regeneron Pharmaceuticals Inc, 2020, REGENERONS COVID 19; Rockx Barry, 2020, Science, V368, P1012, DOI 10.1126/science.abb7314; Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110; Sheahan TP, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb5883; SIMIONESCU N, 1976, J CELL BIOL, V70, P608, DOI 10.1083/jcb.70.3.608; Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227; Spiegel M, 2005, J VIROL, V79, P2079, DOI 10.1128/JVI.79.4.2079-2086.2005; Sticher ZM, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01719-19; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010; TOOTS M, 2019, SCI, V11; VERHEIDEN A, 2020, J VIROL, V94; Wahl A, 2019, NAT BIOTECHNOL, V37, P1163, DOI 10.1038/s41587-019-0225-9; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Zhang HL, 2020, ANN INTERN MED, V172, P629, DOI 10.7326/M20-0533; Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	52	151	153	18	79	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 18	2021	591	7850					451	+		10.1038/s41586-021-03312-w	http://dx.doi.org/10.1038/s41586-021-03312-w		FEB 2021	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY6JL	33561864	Green Published, Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000627311500001
J	Burki, T				Burki, Talha			Understanding variants of SARS-CoV-2	LANCET			English	Editorial Material																			0	105	109	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2021	397	10273					462	462						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QF1LZ	33549181	Green Published, Bronze			2022-12-28	WOS:000616661900011
J	Reich, K; Papp, KA; Blauvelt, A; Langley, RG; Armstrong, A; Warren, RB; Gordon, KB; Merola, JF; Okubo, Y; Madden, C; Wang, M; Cioffi, C; Vanvoorden, V; Lebwohl, M				Reich, Kristian; Papp, Kim A.; Blauvelt, Andrew; Langley, Richard G.; Armstrong, April; Warren, Richard B.; Gordon, Kenneth B.; Merola, Joseph F.; Okubo, Yukari; Madden, Cynthia; Wang, Maggie; Cioffi, Christopher; Vanvoorden, Veerle; Lebwohl, Mark			Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial	LANCET			English	Article								Background There is an unmet need for a treatment for psoriasis that results in complete skin clearance with a reliably quick response. Bimekizumab is a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)-17F in addition to IL-17A. We aimed to compare the efficacy and safety of bimekizumab with placebo and ustekinumab in patients with moderate to severe plaque psoriasis over 52 weeks. Methods BE VIVID was a multicentre, randomised, double-blind, active comparator and placebo controlled phase 3 trial done across 105 sites (clinics, hospitals, research units, and private practices) in 11 countries in Asia, Australia, Europe, and North America. Adults aged 18 years or older with moderate to severe plaque psoriasis (Psoriasis Area and Severity Index [PASI] score >= 12, >= 10% body surface area affected by psoriasis, and Investigator's Global Assessment [IGA] score =3 on a five point scale) were included. Randomisation was stratified by geographical region and previous exposure to biologics; patients, investigators, and sponsors were masked to treatment assignment. Patients were randomly assigned (4:2:1) using an interactive response technology to bimekizumab 320 mg every 4 weeks, ustekinumab 45 mg or 90 mg (baseline weight-dependent dosing) at weeks 0 and 4, then every 12 weeks, or placebo every 4 weeks. At week 16, patients receiving placebo switched to bimekizumab 320 mg every 4 weeks. All study treatments were administered as two subcutaneous injections. Coprimary endpoints were the proportion of patients with 90% improvement in the PASI (PASI90) and the proportion of patients with an IGA response of clear or almost clear (score 0 or 1) at week 16 (non-responder imputation). Efficacy analyses included the intention-to-treat population; safety analysis included patients who received at least one dose of study treatment. This trial was registered at ClinicalTrials.gov, NCT03370133 (completed). Findings Between Dec 6, 2017, and Dec 13, 2019, 735 patients were screened and 567 were enrolled and randomly assigned (bimekizumab 320 mg every 4 weeks n=321, ustekinumab 45 mg or 90 mg every 12 weeks n=163, placebo n=83). At week 16, 273 (85%) of 321 patients in the bimekizumab group had PASI90 versus 81 (50%) of 163 in the ustekinumab group (risk difference 35 [95% CI 27-43]; p<0.0001) and four (5%) of 83 in the placebo group (risk difference 80 [74-86]; p<0.0001). At week 16, 270 (84%) patients in the bimekizumab group had an IGA response versus 87 (53%) in the ustekinumab group (risk difference 30 [95% CI 22-39]; p<0.0001) and four (5%) in the placebo group (risk difference 79 [73-85]; p<0.0001). Over 52 weeks, serious treatment-emergent adverse events were reported in 24 (6%) of 395 patients in the bimekizumab group (including those who switched from placebo at week 16) and 13 (8%) of 163 in the ustekinumab group. Interpretation Bimekizumab was more efficacious than ustekinumab and placebo in the treatment of moderate to severe plaque psoriasis. The bimekizumab safety profile was consistent with that observed in previous studies.	[Reich, Kristian] Univ Med Ctr Hamburg Eppendorf, Ctr Translat Res Inflammatory Skin Dis, Inst Hlth Serv Res Dermatol & Nursing, D-20246 Hamburg, Germany; [Papp, Kim A.] Prob Med Res & K Papp Clin Res, Waterloo, ON, Canada; [Blauvelt, Andrew] Oregon Med Res Ctr, Portland, OR USA; [Langley, Richard G.] Dalhousie Univ, Div Clin Dermatol & Cutaneous Sci, Halifax, NS, Canada; [Armstrong, April] USC, Keck Sch Med, Dermatol, Los Angeles, CA USA; [Warren, Richard B.] Univ Manchester, Manchester NIHR Biomed Res Ctr, Salford Royal NHS Fdn Trust, Dermatol Ctr, Manchester, Lancs, England; [Gordon, Kenneth B.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Merola, Joseph F.] Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA; [Merola, Joseph F.] Harvard Med Sch, Boston, MA 02115 USA; [Okubo, Yukari] Tokyo Med Univ, Dept Dermatol, Tokyo, Japan; [Madden, Cynthia; Wang, Maggie; Cioffi, Christopher] UCB Pharma, Raleigh, NC USA; [Vanvoorden, Veerle] UCB Pharma, Brussels, Belgium; [Lebwohl, Mark] Icahn Sch Med, New York, NY USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Dalhousie University; University of Southern California; University of Southern California Keck Hospital; Salford Royal NHS Foundation Trust; University of Manchester; Medical College of Wisconsin; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Tokyo Medical University; UCB Pharma SA; UCB Pharma SA; Icahn School of Medicine at Mount Sinai	Reich, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Translat Res Inflammatory Skin Dis, Inst Hlth Serv Res Dermatol & Nursing, D-20246 Hamburg, Germany.	k.reich@uke.de	OKUBO, YUKARI/AEX-3889-2022; OKUBO, YUKARI/AAG-7997-2022; Warren, Richard/G-4929-2015	Warren, Richard/0000-0002-2918-6481	UCB Pharma	UCB Pharma(UCB Pharma SA)	UCB Pharma.	Adams R, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01894; Blauvelt A, 2020, J AM ACAD DERMATOL, V83, P1367, DOI 10.1016/j.jaad.2020.05.105; Blauvelt A, 2018, CLIN REV ALLERG IMMU, V55, P379, DOI 10.1007/s12016-018-8702-3; Blauvelt A, 2015, J INVEST DERMATOL, V135, P1946, DOI 10.1038/jid.2015.144; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; European Medicines Agency, 2020, UST SUMM PROD CHAR; Glatt S, 2018, ANN RHEUM DIS, V77, P523, DOI 10.1136/annrheumdis-2017-212127; Glatt S, 2017, BRIT J CLIN PHARMACO, V83, P991, DOI 10.1111/bcp.13185; Gordon KB, 2016, NEW ENGL J MED, V375, P345, DOI 10.1056/NEJMoa1512711; Gordon KB, 2021, LANCET, V397, P475, DOI 10.1016/S0140-6736(21)00126-4; Gottlieb AB, 2020, DERMATOLOGY THER, V10, P1255, DOI 10.1007/s13555-020-00434-3; Griffiths CEM, 2015, LANCET, V386, P541, DOI 10.1016/S0140-6736(15)60125-8; Johnston A, 2013, J IMMUNOL, V190, P2252, DOI 10.4049/jimmunol.1201505; Kimball AB, 2005, AM J CLIN DERMATOL, V6, P383, DOI 10.2165/00128071-200506060-00005; Kolbinger F, 2017, J ALLERGY CLIN IMMUN, V139, P923, DOI 10.1016/j.jaci.2016.06.038; Kornmehl H, 2020, DERMATOLOGY, V28, P1; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Lebwohl M, 2015, NEW ENGL J MED, V373, P1318, DOI 10.1056/NEJMoa1503824; Papp KA, 2018, J AM ACAD DERMATOL, V79, P277, DOI 10.1016/j.jaad.2018.03.037; Reich K, 2017, J AM ACAD DERMATOL, V76, P441, DOI 10.1016/j.jaad.2016.10.027; Ritchlin CT, 2020, LANCET, V395, P427, DOI 10.1016/S0140-6736(19)33161-7; de Oliveira MDSP, 2015, AN BRAS DERMATOL, V90, P9, DOI 10.1590/abd1806-4841.20153038; Sbidian E, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011535.pub3; Schreiber S, 2019, ANN RHEUM DIS, V78, P473, DOI 10.1136/annrheumdis-2018-214273; Strober B, 2016, J AM ACAD DERMATOL, V75, P77, DOI 10.1016/j.jaad.2016.03.026; Thaci D, 2015, J AM ACAD DERMATOL, V73, P400, DOI 10.1016/j.jaad.2015.05.013; US Food and Drug Administration, 2016, GUID IND; US Food and Drug Administration, 2020, UST PRESCR INF; Warren RB, 2015, J INVEST DERMATOL, V135, P2632, DOI 10.1038/jid.2015.208; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799	30	58	60	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2021	397	10273					487	498						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QF1LZ	33549193				2022-12-28	WOS:000616661900024
J	Feinmann, J				Feinmann, Jane			Why aren't covid-19 vaccines being manufactured in standard prefilled syringes?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com						[Anonymous], 1912, DAILY TELEGRAPH; [Anonymous], 2017, NEWS NIH         SEP; Elsom J., 2021, DAILY MAIL; Hart C., 2021, SUPPLY MANAGEMENT; Royal Pharmaceutical Society, 2018, PROF GUID SAF SEC HA; Subramanian S., 2020, BLOOMBERG; US International Development Finance Corporation, 2020, DFC APPR 590 MILL LO	7	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2021	372								n263	10.1136/bmj.n263	http://dx.doi.org/10.1136/bmj.n263			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QE0PP	33536182	Bronze			2022-12-28	WOS:000615909900002
J	Mathewson, ND; Ashenberg, O; Tirosh, I; Gritsch, S; Perez, EM; Marx, S; Jerby-Arnon, L; Chanoch-Myers, R; Hara, T; Richman, AR; Ito, Y; Pyrdol, J; Friedrich, M; Schumann, K; Poitras, MJ; Gokhale, PC; Castro, LNG; Shore, ME; Hebert, CM; Shaw, B; Cahill, HL; Drummond, M; Zhang, WB; Olawoyin, O; Wakimoto, H; Rozenblatt-Rosen, O; Brastianos, PK; Liu, XS; Jones, PS; Cahill, DP; Frosch, MP; Louis, DN; Freeman, GJ; Ligon, KL; Marson, A; Chiocca, EA; Reardon, DA; Regev, A; Suva, ML; Wucherpfennig, KW				Mathewson, Nathan D.; Ashenberg, Orr; Tirosh, Itay; Gritsch, Simon; Perez, Elizabeth M.; Marx, Sascha; Jerby-Arnon, Livnat; Chanoch-Myers, Rony; Hara, Toshiro; Richman, Alyssa R.; Ito, Yoshinaga; Pyrdol, Jason; Friedrich, Mirco; Schumann, Kathrin; Poitras, Michael J.; Gokhale, Prafulla C.; Castro, L. Nicolas Gonzalez; Shore, Marni E.; Hebert, Christine M.; Shaw, Brian; Cahill, Heather L.; Drummond, Matthew; Zhang, Wubing; Olawoyin, Olamide; Wakimoto, Hiroaki; Rozenblatt-Rosen, Orit; Brastianos, Priscilla K.; Liu, X. Shirley; Jones, Pamela S.; Cahill, Daniel P.; Frosch, Matthew P.; Louis, David N.; Freeman, Gordon J.; Ligon, Keith L.; Marson, Alexander; Chiocca, E. Antonio; Reardon, David A.; Regev, Aviv; Suva, Mario L.; Wucherpfennig, Kai W.			Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis	CELL			English	Article								T cells are critical effectors of cancer immunotherapies, but little is known about their gene expression programs in diffuse gliomas. Here, we leverage single-cell RNA sequencing (RNA-seq) to chart the gene expression and clonal landscape of tumor-infiltrating T cells across 31 patients with isocitrate dehydrogenase (IDH) wild-type glioblastoma and IDH mutant glioma. We identify potential effectors of anti-tumor immunity in subsets of T cells that co-express cytotoxic programs and several natural killer (NK) cell genes. Analysis of clonally expanded tumor-infiltrating T cells further identifies the NK gene KLRB1 (encoding CD161) as a candidate inhibitory receptor. Accordingly, genetic inactivation of KLRB1 or antibody-mediated CD161 blockade enhances T cell-mediated killing of glioma cells in vitro and their anti-tumor function in vivo. KLRB1 and its associated transcriptional program are also expressed by substantial T cell populations in other human cancers. Our work provides an atlas of T cells in gliomas and highlights CD161 and other NK cell receptors as immunotherapy targets.	[Mathewson, Nathan D.; Marx, Sascha; Ito, Yoshinaga; Pyrdol, Jason; Friedrich, Mirco; Olawoyin, Olamide; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Mathewson, Nathan D.; Marx, Sascha; Ito, Yoshinaga; Wucherpfennig, Kai W.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Mathewson, Nathan D.; Castro, L. Nicolas Gonzalez; Wucherpfennig, Kai W.] Brigham & Womens Hosp, Div Neurol, Boston, MA 02115 USA; [Mathewson, Nathan D.; Ashenberg, Orr; Gritsch, Simon; Perez, Elizabeth M.; Jerby-Arnon, Livnat; Hara, Toshiro; Richman, Alyssa R.; Castro, L. Nicolas Gonzalez; Shore, Marni E.; Hebert, Christine M.; Rozenblatt-Rosen, Orit; Regev, Aviv; Suva, Mario L.; Wucherpfennig, Kai W.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ashenberg, Orr; Gritsch, Simon; Perez, Elizabeth M.; Jerby-Arnon, Livnat; Hara, Toshiro; Richman, Alyssa R.; Castro, L. Nicolas Gonzalez; Shore, Marni E.; Hebert, Christine M.; Rozenblatt-Rosen, Orit; Regev, Aviv; Suva, Mario L.] Broad Inst Harvard & MIT, Klarman Cell Observ, Cambridge, MA 02142 USA; [Tirosh, Itay; Chanoch-Myers, Rony] Weizmann Inst Sci, Dept Mol Cell Biol, IL-761001 Rehovot, Israel; [Gritsch, Simon; Perez, Elizabeth M.; Hara, Toshiro; Richman, Alyssa R.; Castro, L. Nicolas Gonzalez; Shore, Marni E.; Hebert, Christine M.; Cahill, Heather L.; Drummond, Matthew; Frosch, Matthew P.; Louis, David N.; Suva, Mario L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Gritsch, Simon; Perez, Elizabeth M.; Hara, Toshiro; Richman, Alyssa R.; Castro, L. Nicolas Gonzalez; Shore, Marni E.; Hebert, Christine M.; Cahill, Heather L.; Drummond, Matthew; Frosch, Matthew P.; Louis, David N.; Suva, Mario L.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Perez, Elizabeth M.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Jerby-Arnon, Livnat] Stanford Univ, Dept Genet, Sch Med, Stanford, CA USA; [Jerby-Arnon, Livnat] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Schumann, Kathrin; Marson, Alexander] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Schumann, Kathrin] Tech Univ Munchen TUM, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Poitras, Michael J.; Gokhale, Prafulla C.] Dana Farber Canc Inst, Expt Therapeut Core, Boston, MA 02115 USA; [Poitras, Michael J.; Gokhale, Prafulla C.] Dana Farber Canc Inst, Belfer Ctr Appl Canc Sci, Boston, MA 02115 USA; [Castro, L. Nicolas Gonzalez; Freeman, Gordon J.; Reardon, David A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Shaw, Brian; Brastianos, Priscilla K.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Div Hematol Oncol,Canc Ctr, Boston, MA 02114 USA; [Shaw, Brian; Brastianos, Priscilla K.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Div Hematol Oncol,Canc Ctr, Boston, MA 02114 USA; [Shaw, Brian; Brastianos, Priscilla K.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Div Neurooncol,Canc Ctr, Boston, MA 02114 USA; [Shaw, Brian; Brastianos, Priscilla K.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Div Neurooncol,Canc Ctr, Boston, MA 02114 USA; [Zhang, Wubing; Liu, X. Shirley] Harvard TH Chan Sch Publ Hlth, Dana Farber Canc Inst, Dept Data Sci, Boston, MA USA; [Wakimoto, Hiroaki; Jones, Pamela S.; Cahill, Daniel P.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Wakimoto, Hiroaki; Jones, Pamela S.; Cahill, Daniel P.] Harvard Med Sch, Boston, MA 02114 USA; [Rozenblatt-Rosen, Orit; Regev, Aviv] Genentech Inc, San Francisco, CA 94080 USA; [Ligon, Keith L.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Marson, Alexander] Gladstone Inst, San Francisco, CA 94158 USA; [Marson, Alexander] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Chiocca, E. Antonio] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA; [Reardon, David A.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Regev, Aviv] MIT, Koch Inst Integrat Canc Res, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Weizmann Institute of Science; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Stanford University; University of California System; University of California San Francisco; Technical University of Munich; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Roche Holding; Genentech; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Wucherpfennig, KW (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA.; Wucherpfennig, KW (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.; Wucherpfennig, KW (corresponding author), Brigham & Womens Hosp, Div Neurol, Boston, MA 02115 USA.; Regev, A; Suva, ML; Wucherpfennig, KW (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Regev, A; Suva, ML (corresponding author), Broad Inst Harvard & MIT, Klarman Cell Observ, Cambridge, MA 02142 USA.; Suva, ML (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Suva, ML (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA.; Regev, A (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.; Reardon, DA (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Regev, A (corresponding author), MIT, Koch Inst Integrat Canc Res, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	david_reardon@dfci.harvard.edu; aregev@broadinstitute.org; suva.mario@mgh.harvard.edu; kai_wucherpfennig@dfci.harvard.edu	Schumann, Kathrin/HHZ-8041-2022; Cahill, Heather L/GSN-2298-2022; Frosch, Matthew P/ABD-7456-2021; Rozenblatt-Rosen, Orit/HDN-4182-2022	Frosch, Matthew P/0000-0002-3940-9861; Perez, Elizabeth/0000-0002-6198-8329; Wakimoto, Hiroaki/0000-0001-8225-241X; Mathewson, Nathan/0000-0002-8895-2609; Friedrich, Mirco/0000-0002-6401-3623; Chanoch-Myers, Rony/0000-0002-8197-5795; Zhang, Wubing/0000-0003-2233-299X	Ben and Catherine Ivy Foundation; Bridge Project; Koch Institute for Integrative Cancer Research at MIT; DanaFarber/Harvard Cancer Center; NIH [R01CA227821, P50CA165962]; Ambrose Monell Foundation; MGH Research Scholars; Sontag Foundation; Zuckerman STEM Leadership Program; Human Frontier Science Program; Mexican Friends New Generation; Benoziyo Endowment Fund for the Advancement of Science; Parker Institute for Cancer Immunotherapy (PICI); American Cancer Society [PF-17-042-01-LIB]; NIH education loan repayment program - NCI [L30 CA231679-01]; Deutsche Forschungsgemeinschaft (DFG) [GR 5252/1-1]; Burroughs Wellcome Fund; Cancer Research Institute (CRI) Lloyd J. Old STAR award; Innovative Genomics Institute (IGI); Howard Hughes Medical Institute; Klarman Cell Observatory, NCI [1U24CA180922, R33CA202820, P30-CA14051]; National Cancer Institute; Ludwig Center at MIT; National Science Foundation Graduate Research Fellowship [DGE1745303]; Burroughs Wellcome Fund (BWF); Wendy Schmidt postdoctoral program; K12 award [CA090354]; Loglio Foundation; Japan Society for the Promotion of Science, SENSHIN Medical Research Foundation; Kanae Foundation for the Promotion of Medical Science	Ben and Catherine Ivy Foundation; Bridge Project; Koch Institute for Integrative Cancer Research at MIT; DanaFarber/Harvard Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ambrose Monell Foundation; MGH Research Scholars; Sontag Foundation; Zuckerman STEM Leadership Program; Human Frontier Science Program(Human Frontier Science Program); Mexican Friends New Generation; Benoziyo Endowment Fund for the Advancement of Science; Parker Institute for Cancer Immunotherapy (PICI); American Cancer Society(American Cancer Society); NIH education loan repayment program - NCI; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cancer Research Institute (CRI) Lloyd J. Old STAR award; Innovative Genomics Institute (IGI); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Klarman Cell Observatory, NCI; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ludwig Center at MIT; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Burroughs Wellcome Fund (BWF)(Burroughs Wellcome Fund); Wendy Schmidt postdoctoral program; K12 award; Loglio Foundation; Japan Society for the Promotion of Science, SENSHIN Medical Research Foundation; Kanae Foundation for the Promotion of Medical Science	We thank Ania Hupalowska for help with graphics and Dr. John Sampson (Duke University) for generously providing cells from the D270 PDX model. This work was supported by a grant from the Ben and Catherine Ivy Foundation (to D.A.R., M.L.S., and K.W.W.) and the Bridge Project, a partnership between the Koch Institute for Integrative Cancer Research at MIT and the DanaFarber/Harvard Cancer Center (to K.W.W., M.L.S., and A.R.R.). The work was supported by the NIH (R01 CA238039 to K.W.W., P01 CA236749 to K.W.W., M.L.S., D.A.R., and E.A.C., R01 CA234018 to K.W.W. and X.S.L., and R37CA245523 to M.L.S.), a gift from the Ambrose Monell Foundation (to K.W.W.), the MGH Research Scholars (to M.L.S.), the Sontag Foundation (to M.L.S.), the Zuckerman STEM Leadership Program (to I.T.), the Human Frontier Science Program (to I.T.), the Mexican Friends New Generation (to I.T.), and the Benoziyo Endowment Fund for the Advancement of Science (to I.T.). K.W.W. is a member of the Parker Institute for Cancer Immunotherapy (PICI). N.D.M. was supported by a postdoctoral fellowship from the American Cancer Society (PF-17-042-01-LIB) and the NIH education loan repayment program funded by the NCI (L30 CA231679-01). S.M. was supported by a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft (DFG, MA-8489/1-1). A.M. is an investigator at the Chan Zuckerberg Biohub, holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund and the Cancer Research Institute (CRI) Lloyd J. Old STAR award, has received funding from the Innovative Genomics Institute (IGI), and is a member of the Parker Institute for Cancer Immunotherapy (PICI). A.R. was supported by funds from the Howard Hughes Medical Institute, the Klarman Cell Observatory, NCI (1U24CA180922 and R33CA202820), by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute, and the Ludwig Center at MIT. E.M.P. is supported by the National Science Foundation Graduate Research Fellowship (DGE1745303). S.G. was supported by a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft (DFG, GR 5252/1-1). L.J.-A. is a Chan Zuckerberg Biohub investigator and holds a Career Award at the Scientific Interface from Burroughs Wellcome Fund (BWF). L.J.-A. was a fellow of the Eric and Wendy Schmidt postdoctoral program and a CRI Irvington Fellow supported by the CRI. L.N.G.C. was supported by a K12 award (CA090354). D.P.C. was supported by NIH (R01CA227821 and P50CA165962), the Tawingo Fund, and Loglio Foundation. T.H. was supported by Grant-in-Aid for JSPS Fellows from the Japan Society for the Promotion of Science, SENSHIN Medical Research Foundation, and Kanae Foundation for the Promotion of Medical Science.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Bunse L, 2018, NAT MED, V24, P1192, DOI 10.1038/s41591-018-0095-6; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Chongsathidkiet P, 2018, NAT MED, V24, P1459, DOI 10.1038/s41591-018-0135-2; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Fergusson JR, 2016, MUCOSAL IMMUNOL, V9, P401, DOI 10.1038/mi.2015.69; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Filley AC, 2017, ONCOTARGET, V8, P91779, DOI 10.18632/oncotarget.21586; Friebel E, 2020, CELL, V181, P1626, DOI 10.1016/j.cell.2020.04.055; Gao J, 2017, CANCER SCI, V108, P1934, DOI 10.1111/cas.13324; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Gedeon PC, 2018, CLIN CANCER RES, V24, P3611, DOI 10.1158/1078-0432.CCR-17-0126; Germain C, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1026503; Germain C, 2011, J BIOL CHEM, V286, P37964, DOI 10.1074/jbc.M111.285312; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grossman SA, 2011, CLIN CANCER RES, V17, P5473, DOI 10.1158/1078-0432.CCR-11-0774; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Gustafson MP, 2010, NEURO-ONCOLOGY, V12, P631, DOI 10.1093/neuonc/noq001; Higuchi F, 2018, MOL CANCER THER, V17, P2551, DOI 10.1158/1535-7163.MCT-18-0177; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Kaplanski G, 2018, IMMUNOL REV, V281, P138, DOI 10.1111/imr.12616; Keller AN, 2017, CURR OPIN IMMUNOL, V46, P66, DOI 10.1016/j.coi.2017.04.002; Keskin DB, 2019, NATURE, V565, P234, DOI 10.1038/s41586-018-0792-9; Klemm F, 2020, CELL, V181, P1643, DOI 10.1016/j.cell.2020.05.007; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Bourhis L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003681; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Llibre A, 2016, J IMMUNOL, V196, P2085, DOI 10.4049/jimmunol.1502462; Luoma AM, 2020, CELL, V182, P655, DOI 10.1016/j.cell.2020.06.001; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028; Miao HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094281; Mori L, 2016, ANNU REV IMMUNOL, V34, P479, DOI 10.1146/annurev-immunol-032414-112008; Neftel C, 2019, CELL, V178, P835, DOI 10.1016/j.cell.2019.06.024; Nigim F, 2015, J NEUROPATH EXP NEUR, V74, P710, DOI 10.1097/NEN.0000000000000210; Omuro A., 2019, Neuro-On- col, V19, pIII21; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Rapoport AP, 2015, NAT MED, V21, P914, DOI 10.1038/nm.3910; Reardon DA, 2020, JAMA ONCOL, V6, P1003, DOI 10.1001/jamaoncol.2020.1024; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Roth P, 2007, CANCER RES, V67, P3540, DOI 10.1158/0008-5472.CAN-06-4783; Roth TL, 2018, NATURE, V559, P405, DOI 10.1038/s41586-018-0326-5; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Schirmer L, 2013, JAMA NEUROL, V70, P345, DOI 10.1001/2013.jamaneurol.409; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Smolders J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07053-9; Stubbington MJT, 2016, NAT METHODS, V13, P329, DOI [10.1038/NMETH.3800, 10.1038/nmeth.3800]; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478; Woroniecka K, 2018, CLIN CANCER RES, V24, P4175, DOI 10.1158/1078-0432.CCR-17-1846; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zhang LJ, 2018, CLIN CANCER RES, V24, P5381, DOI 10.1158/1078-0432.CCR-17-3855; Zhang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050561; Zhao YB, 2005, J IMMUNOL, V174, P4415, DOI 10.4049/jimmunol.174.7.4415; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035	65	89	90	37	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1281	+		10.1016/j.cell.2021.01.022	http://dx.doi.org/10.1016/j.cell.2021.01.022		MAR 2021	44	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33592174	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000629635700016
J	Best, J				Best, Jo			Wearable technology: covid-19 and the rise of remote clinical monitoring	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jo.best@journalist.com						[Anonymous], 2020, HOSP TIMES; Apple, 2019, ECG APP IRR HEART RH; Imperial College London, 2020, WEAR SENS TRIALL REM; Laranjo L, 2021, BRIT J SPORT MED, V55, DOI 10.1136/bjsports-2020-102892; Microsoft, 2019, DOCT AR US TECHN HEL; NHS, 2019, TOP REV; NHS, 2019, DIG DIAB PREV ROLL O; Norfolk and Norwich University Hospitals NHS Foundation Trust, 2020, WEAR DEV RES HELP OR; Stanford Medicine, 2019, APPL HEART STUD DEM; Surrey and Borders Partnership NHS Foundation Trust, 2018, DEN STUD ENT NEXT PH; The Engineer, 2017, UK WEAR HEALTHC STAR; UK Government, 2017, MOB APPL WRISTB TECH; Weenk M, 2020, J MED INTERNET RES, V22, DOI 10.2196/15471	13	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2021	372								n413	10.1136/bmj.n413	http://dx.doi.org/10.1136/bmj.n413			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK7SF	33602670	Bronze			2022-12-28	WOS:000620581100005
J	Mahase, E				Mahase, Elisabeth			Doctors reject claim that US "no longer has a prescription opioid driven epidemic"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		American Medical Association, 2020, ISSS BRIEF REP INCR; Ballantyne JC, 2021, BMJ	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2021	372								n448	10.1136/bmj.n448	http://dx.doi.org/10.1136/bmj.n448			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK7TO	33597126				2022-12-28	WOS:000620584600013
J	Mills, MC; Sivela, J				Mills, Melinda C.; Sivela, Jonas			Should spreading anti-vaccine misinformation be criminalised?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HESITANCY		[Mills, Melinda C.] Univ Oxford, Oxford, England; [Mills, Melinda C.] Univ Oxford Nuffield Coll, Oxford, England; [Sivela, Jonas] Finnish Inst Hlth & Welf THL, Helsinki, Finland	University of Oxford; University of Oxford	Mills, MC (corresponding author), Univ Oxford, Oxford, England.; Mills, MC (corresponding author), Univ Oxford Nuffield Coll, Oxford, England.; Sivela, J (corresponding author), Finnish Inst Hlth & Welf THL, Helsinki, Finland.	melinda.mills@nuffield.ox.ac.uk; jonas.sivela@thl.fi			Leverhulme Trust; Leverhulme Centre for Demographic Science [ERC-2018-ADG-835079]; ESRC (Economic and Social Research Council)/UKRI (UK Research and Innovation); NWO (Dutch Research Council); Social Science and Research Council of Canada; European Commission; Academy of Finland	Leverhulme Trust(Leverhulme Trust); Leverhulme Centre for Demographic Science; ESRC (Economic and Social Research Council)/UKRI (UK Research and Innovation)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NWO (Dutch Research Council); Social Science and Research Council of Canada; European Commission(European CommissionEuropean Commission Joint Research Centre); Academy of Finland(Academy of Finland)	MCM currently receives research funding from the Leverhulme Trust, Leverhulme Centre for Demographic Science and ERC-2018-ADG-835079 and has received research funding from the ESRC (Economic and Social Research Council)/UKRI (UK Research and Innovation), the NWO (Dutch Research Council), the Social Science and Research Council of Canada, and the European Commission.; JS has received research funding from the European Commission (2018, 2020) and the Academy of Finland (2020). He is a member of the Scientific Committee of the annual Vaccine Acceptance Meeting organised by Fondation Merieux. Travel and accommodation expenses related to these meetings have been paid for by Fondation Merieux (2018, 2019). JS is also an unpaid member of the advisory board for Sabin Vaccine Institute's Vaccine Acceptance Research Network.	Abeysinghe S., 2015, PLOS CURR; Amnesty International, 2020, RUSS FED FAK NEWS BI; Bamberg Michael., 2004, CONSIDERING COUNTER, P351, DOI [DOI 10.1075/SIN.4.43BAM, 10.1075/sin.4.43bam]; Basch CH, 2017, CHILD CARE HLTH DEV, V43, P499, DOI 10.1111/cch.12442; Berman JM, 2020, ANTIVAXXERS CHALLENG, DOI [10.7551/mitpress/12242.001.0001, DOI 10.7551/MITPRESS/12242.001.0001]; Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657; Godlee, 2011, BRIT MED J, V342, pd22, DOI [10.1136/bmj.d22, DOI 10.1136/BMJ.D22]; Ibrahim A, 2020, J WILDLIFE BIODIVERS, V4, P1, DOI 10.22120/jwb.2020.123579.1127; Jennings W, 2021, MEDRXIV PREPRINT, DOI [10.1101/2021.01.26.21250246v1, DOI 10.1101/2021.01.26.21250246V1]; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Massey PM, 2016, J HEALTH COMMUN, V21, P118, DOI 10.1080/10810730.2015.1058444; Mills M., 2020, COVID 19 VACCINE DEP; Mills MC, 2021, ECLINICALMEDICINE, V31, DOI 10.1016/j.eclinm.2020.100674; Poland GA, 2011, NEW ENGL J MED, V364, P97, DOI 10.1056/NEJMp1010594; Salmon DA, 2015, VACCINE, V33, pD66, DOI 10.1016/j.vaccine.2015.09.035; Schaeffer K., 2020, NEARLY THREE TEN AME; Verger P, 2015, EBIOMEDICINE, V2, P891, DOI 10.1016/j.ebiom.2015.06.018; Williamson E, 2018, NY TIMES; Wolfe RM, 2002, BMJ-BRIT MED J, V325, P430, DOI 10.1136/bmj.325.7361.430; World Health Organization, 2019, 10 THREATS GLOB HLTH; Wynne B, 2010, NATURE, V466, P441, DOI 10.1038/466441a	22	6	6	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2021	372								n272	10.1136/bmj.n272	http://dx.doi.org/10.1136/bmj.n272			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK7TO	33597153	Bronze			2022-12-28	WOS:000620584600005
J	Sharma, D; Zagore, LL; Brister, MM; Ye, X; Crespo-Hernandez, CE; Licatalosi, DD; Jankowsky, E				Sharma, Deepak; Zagore, Leah L.; Brister, Matthew M.; Ye, Xuan; Crespo-Hernandez, Carlos E.; Licatalosi, Donny D.; Jankowsky, Eckhard			The kinetic landscape of an RNA-binding protein in cells	NATURE			English	Article							SINGLE-NUCLEOTIDE RESOLUTION; CROSS-LINKING; HITS-CLIP; NUCLEIC-ACIDS; IN-VIVO; RECOGNITION; NETWORK; MODELS	Gene expression in higher eukaryotic cells orchestrates interactions between thousands of RNA-binding proteins (RBPs) and tens of thousands of RNAs1. The kinetics by which RBPs bind to and dissociate from their RNA sites are critical for the coordination of cellular RNA-protein interactions(2). However, these kinetic parameters have not been experimentally measured in cells. Here we show that time-resolved RNA-protein cross-linking with a pulsed femtosecond ultraviolet laser, followed by immunoprecipitation and high-throughput sequencing, allows the determination of binding and dissociation kinetics of the RBP DAZL for thousands of individual RNA-binding sites in cells. This kinetic cross-linking and immunoprecipitation (KIN-CLIP) approach reveals that DAZL resides at individual binding sites for time periods of only seconds or shorter, whereas the binding sites remain DAZL-free for markedly longer. The data also indicate that DAZL binds to many RNAs in clusters of multiple proximal sites. The effect of DAZL on mRNA levels and ribosome association correlates with the cumulative probability of DAZL binding in these clusters. Integrating kinetic data with mRNA features quantitatively connects DAZL-RNA binding to DAZL function. Our results show how kinetic parameters for RNA-protein interactions can be measured in cells, and how these data link RBP-RNA binding to the cellular function of RBPs.	[Sharma, Deepak; Zagore, Leah L.; Ye, Xuan; Licatalosi, Donny D.; Jankowsky, Eckhard] Case Western Reserve Univ, Sch Med, Ctr RNA Sci & Therapeut, Cleveland, OH 44106 USA; [Sharma, Deepak; Zagore, Leah L.; Ye, Xuan; Licatalosi, Donny D.; Jankowsky, Eckhard] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Brister, Matthew M.; Crespo-Hernandez, Carlos E.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Jankowsky, Eckhard] Case Western Reserve Univ, Dept Phys, Cleveland, OH 44106 USA; [Jankowsky, Eckhard] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Licatalosi, DD; Jankowsky, E (corresponding author), Case Western Reserve Univ, Sch Med, Ctr RNA Sci & Therapeut, Cleveland, OH 44106 USA.; Licatalosi, DD; Jankowsky, E (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.; Jankowsky, E (corresponding author), Case Western Reserve Univ, Dept Phys, Cleveland, OH 44106 USA.; Jankowsky, E (corresponding author), Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	ddl33@case.edu; exj13@case.edu	Brister, Matthew/AAU-2178-2021; Sharma, Deepak/GPT-1692-2022; Crespo-Hernández, Carlos E./A-9915-2008	Brister, Matthew/0000-0002-1563-6496; Crespo-Hernández, Carlos E./0000-0002-3594-0890; Ye, Xuan/0000-0002-3157-7537; Jankowsky, Eckhard/0000-0001-7677-7412; Sharma, Deepak/0000-0001-8436-1759	RBFOXmut(RRM); NIH [GM118088, GM107331]; NSF [CHE-1800052]	RBFOXmut(RRM); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	We thank G. Varani for providing purified RBFOX(RRM) and RBFOXmut(RRM); A. Komar for the design of the codon-optimized DAZL construct; and W. Huang for assistance with the fluorescence polarization experiments. This work was supported by the NIH (GM118088 to E.J. and GM107331 to D.D.L.) and the NSF (CHE-1800052 to C.E.C.-H.).	Aken BL, 2017, NUCLEIC ACIDS RES, V45, pD635, DOI 10.1093/nar/gkw1104; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Biggs D., 1991, J APPL STAT, V18, P49, DOI [DOI 10.1080/02664769100000005, 10.1080/02664769100000005]; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Brister MM, 2019, J PHYS CHEM LETT, V10, P2156, DOI 10.1021/acs.jpclett.9b00492; Brister MM, 2015, J PHYS CHEM LETT, V6, P4404, DOI 10.1021/acs.jpclett.5b01901; BUDOWSKY EI, 1986, EUR J BIOCHEM, V159, P95, DOI 10.1111/j.1432-1033.1986.tb09837.x; Cao J, 2014, BIOMETRICS, V70, P84, DOI 10.1111/biom.12122; Chen Y, 2016, NAT CHEM BIOL, V12, P717, DOI 10.1038/nchembio.2128; Corley M, 2020, MOL CELL, V78, P9, DOI 10.1016/j.molcel.2020.03.011; Dua D., 2019, UCI MACHINE LEARNING; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkz1031, 10.1093/nar/gkx1132]; Fabregat A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1559-2; Fox J., 2019, R COMPANION APPL REG, VThird; Fu XF, 2015, INT J BIOL SCI, V11, P1226, DOI 10.7150/ijbs.11536; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Gleitsman KR, 2017, RNA, V23, P1745, DOI 10.1261/rna.062026.117; GOODMAN LA, 1979, J AM STAT ASSOC, V74, P537, DOI 10.2307/2286971; Haberman N, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1130-x; HOCKENSMITH JW, 1986, J BIOL CHEM, V261, P3512; HOFMANN MC, 1992, EXP CELL RES, V201, P417, DOI 10.1016/0014-4827(92)90291-F; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Itri F, 2016, CELL MOL LIFE SCI, V73, P637, DOI 10.1007/s00018-015-2015-y; Jarmoskaite I, 2019, MOL CELL, V74, P966, DOI 10.1016/j.molcel.2019.04.012; Jenkins HT, 2011, P NATL ACAD SCI USA, V108, P18266, DOI 10.1073/pnas.1105211108; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Kass GV, 1980, J R STAT SOC C-APPL, P119; Kerr G, 2008, COMPUT BIOL MED, V38, P283, DOI 10.1016/j.compbiomed.2007.11.001; Krijthe J.H., 2015, RTSNE T DISTRIBUTED; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leschinski C., 2019, VIGNETTE MONTECARLO; Licatalosi DD, 2020, WIRES RNA, V11, DOI 10.1002/wrna.1565; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; MAGIDSON J, 1982, J MARKETING RES, V19, P461, DOI 10.2307/3151720; Moore MJ, 2014, NAT PROTOC, V9, P263, DOI 10.1038/nprot.2014.012; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Paschotta R., 2008, ENCY LASER PHYS TECH; PASHEV IG, 1991, TRENDS BIOCHEM SCI, V16, P323, DOI 10.1016/0968-0004(91)90133-G; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reynolds N, 2005, HUM MOL GENET, V14, P3899, DOI 10.1093/hmg/ddi414; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Russmann C, 1997, NUCLEIC ACIDS RES, V25, P2478, DOI 10.1093/nar/25.12.2478; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/rep.0.1260589; Schindler D., 2019, RANDOMIZER RANDOMIZA; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Steube A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01251-7; Strober W., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima03bs21, DOI 10.1002/0471142735.IMA03BS111]; Sutandy FXR, 2018, GENOME RES, V28, P699, DOI 10.1101/gr.229757.117; Thompson H W, 1999, Nutr Neurosci, V2, P43, DOI 10.1080/1028415X.1999.11747262; Ule J, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032243; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Van Nostrand EL, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01982-9; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; Yang CR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15209-9; Zagore LL, 2018, CELL REP, V25, P1225, DOI 10.1016/j.celrep.2018.10.012; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873	59	21	21	6	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					152	+		10.1038/s41586-021-03222-x	http://dx.doi.org/10.1038/s41586-021-03222-x		FEB 2021	29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT9QO	33568810	Green Accepted, Green Submitted			2022-12-28	WOS:000616961600005
J	He, XC; Tham, YJ; Dada, L; Wang, MY; Finkenzeller, H; Stolzenburg, D; Iyer, S; Simon, M; Kurten, A; Shen, JL; Rorup, B; Rissanen, M; Schobesberger, S; Baalbaki, R; Wang, DS; Koenig, TK; Jokinen, T; Sarnela, N; Beck, LJ; Almeida, J; Amanatidis, S; Amorim, A; Ataei, F; Baccarini, A; Bertozzi, B; Bianchi, F; Brilke, S; Caudillo, L; Chen, DX; Chiu, R; Chu, BW; Dias, A; Ding, AJ; Dommen, J; Duplissy, J; El Haddad, I; Carracedo, LG; Granzin, M; Hansel, A; Heinritzi, M; Hofbauer, V; Junninen, H; Kangasluoma, J; Kemppainen, D; Kim, C; Kong, WM; Krechmer, JE; Kvashin, A; Laitinen, T; Lamkaddam, H; Lee, CP; Lehtipalo, K; Leiminger, M; Li, ZJ; Makhmutov, V; Manninen, HE; Marie, G; Marten, R; Mathot, S; Mauldin, RL; Mentler, B; Mohler, O; Muller, T; Nie, W; Onnela, A; Petaja, T; Pfeifer, J; Philippov, M; Ranjithkumar, A; Saiz-Lopez, A; Salma, I; Scholz, W; Schuchmann, S; Schulze, B; Steiner, G; Stozhkov, Y; Tauber, C; Tome, A; Thakur, RC; Vaisanen, O; Vazquez-Pufleau, M; Wagner, AC; Wang, YH; Weber, SK; Winkler, PM; Wu, YS; Xiao, M; Yan, C; Ye, Q; Ylisirnio, A; Zauner-Wieczorek, M; Zha, QZ; Zhou, PT; Flagan, RC; Curtius, J; Baltensperger, U; Kulmala, M; Kerminen, VM; Kurten, T; Donahue, NM; Volkamer, R; Kirkby, J; Worsnop, DR; Sipila, M				He, Xu-Cheng; Tham, Yee Jun; Dada, Lubna; Wang, Mingyi; Finkenzeller, Henning; Stolzenburg, Dominik; Iyer, Siddharth; Simon, Mario; Kuerten, Andreas; Shen, Jiali; Roerup, Birte; Rissanen, Matti; Schobesberger, Siegfried; Baalbaki, Rima; Wang, Dongyu S.; Koenig, Theodore K.; Jokinen, Tuija; Sarnela, Nina; Beck, Lisa J.; Almeida, Joao; Amanatidis, Stavros; Amorim, Antonio; Ataei, Farnoush; Baccarini, Andrea; Bertozzi, Barbara; Bianchi, Federico; Brilke, Sophia; Caudillo, Lucia; Chen, Dexian; Chiu, Randall; Chu, Biwu; Dias, Antonio; Ding, Aijun; Dommen, Josef; Duplissy, Jonathan; El Haddad, Imad; Carracedo, Loic Gonzalez; Granzin, Manuel; Hansel, Armin; Heinritzi, Martin; Hofbauer, Victoria; Junninen, Heikki; Kangasluoma, Juha; Kemppainen, Deniz; Kim, Changhyuk; Kong, Weimeng; Krechmer, Jordan E.; Kvashin, Aleksander; Laitinen, Totti; Lamkaddam, Houssni; Lee, Chuan Ping; Lehtipalo, Katrianne; Leiminger, Markus; Li, Zijun; Makhmutov, Vladimir; Manninen, Hanna E.; Marie, Guillaume; Marten, Ruby; Mathot, Serge; Mauldin, Roy L.; Mentler, Bernhard; Moehler, Ottmar; Mueller, Tatjana; Nie, Wei; Onnela, Antti; Petaja, Tuukka; Pfeifer, Joschka; Philippov, Maxim; Ranjithkumar, Ananth; Saiz-Lopez, Alfonso; Salma, Imre; Scholz, Wiebke; Schuchmann, Simone; Schulze, Benjamin; Steiner, Gerhard; Stozhkov, Yuri; Tauber, Christian; Tome, Antonio; Thakur, Roseline C.; Vaisanen, Olli; Vazquez-Pufleau, Miguel; Wagner, Andrea C.; Wang, Yonghong; Weber, Stefan K.; Winkler, Paul M.; Wu, Yusheng; Xiao, Mao; Yan, Chao; Ye, Qing; Ylisirnio, Arttu; Zauner-Wieczorek, Marcel; Zha, Qiaozhi; Zhou, Putian; Flagan, Richard C.; Curtius, Joachim; Baltensperger, Urs; Kulmala, Markku; Kerminen, Veli-Matti; Kurten, Theo; Donahue, Neil M.; Volkamer, Rainer; Kirkby, Jasper; Worsnop, Douglas R.; Sipila, Mikko			Role of iodine oxoacids in atmospheric aerosol nucleation	SCIENCE			English	Article								Iodic acid (HIO3) is known to form aerosol particles in coastal marine regions, but predicted nucleation and growth rates are lacking. Using the CERN CLOUD (Cosmics Leaving Outdoor Droplets) chamber, we find that the nucleation rates of HIO3 particles are rapid, even exceeding sulfuric acid-ammonia rates under similar conditions. We also find that ion-induced nucleation involves IO3- and the sequential addition of HIO3 and that it proceeds at the kinetic limit below +10 degrees C. In contrast, neutral nucleation involves the repeated sequential addition of iodous acid (HIO2) followed by HIO3, showing that HIO2 plays a key stabilizing role. Freshly formed particles are composed almost entirely of HIO3, which drives rapid particle growth at the kinetic limit. Our measurements indicate that iodine oxoacid particle formation can compete with sulfuric acid in pristine regions of the atmosphere.	[He, Xu-Cheng; Tham, Yee Jun; Dada, Lubna; Stolzenburg, Dominik; Shen, Jiali; Roerup, Birte; Baalbaki, Rima; Jokinen, Tuija; Sarnela, Nina; Beck, Lisa J.; Bianchi, Federico; Chu, Biwu; Duplissy, Jonathan; Junninen, Heikki; Kangasluoma, Juha; Kemppainen, Deniz; Laitinen, Totti; Lehtipalo, Katrianne; Petaja, Tuukka; Thakur, Roseline C.; Wang, Yonghong; Wu, Yusheng; Yan, Chao; Zha, Qiaozhi; Zhou, Putian; Kulmala, Markku; Kerminen, Veli-Matti; Worsnop, Douglas R.; Sipila, Mikko] Univ Helsinki, Fac Sci, Inst Atmospher & Earth Syst Res Phys, Helsinki 00014, Finland; [Wang, Mingyi; Chen, Dexian; Hofbauer, Victoria; Ye, Qing; Donahue, Neil M.] Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA; [Finkenzeller, Henning; Koenig, Theodore K.; Chiu, Randall; Wagner, Andrea C.; Volkamer, Rainer] Univ Colorado, Dept Chem, Boulder, CO 80309 USA; [Finkenzeller, Henning; Koenig, Theodore K.; Chiu, Randall; Wagner, Andrea C.; Volkamer, Rainer] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Stolzenburg, Dominik; Brilke, Sophia; Carracedo, Loic Gonzalez; Tauber, Christian; Vazquez-Pufleau, Miguel; Winkler, Paul M.] Univ Vienna, Fac Phys, A-1090 Vienna, Austria; [Iyer, Siddharth; Rissanen, Matti] Tampere Univ, Fac Engn & Nat Sci, Phys Unit, Aerosol Phys Lab, Tampere 33014, Finland; [Simon, Mario; Kuerten, Andreas; Caudillo, Lucia; Granzin, Manuel; Heinritzi, Martin; Marie, Guillaume; Mueller, Tatjana; Wagner, Andrea C.; Zauner-Wieczorek, Marcel; Curtius, Joachim; Kirkby, Jasper] Goethe Univ Frankfurt, Inst Atmospher & Environm Sci, D-60438 Frankfurt, Germany; [Schobesberger, Siegfried; Li, Zijun; Vaisanen, Olli; Ylisirnio, Arttu] Univ Eastern Finland, Dept Appl Phys, Kuopio 70211, Finland; [Wang, Dongyu S.; Baccarini, Andrea; Dommen, Josef; El Haddad, Imad; Lamkaddam, Houssni; Lee, Chuan Ping; Marten, Ruby; Xiao, Mao; Baltensperger, Urs] Paul Scherrer Inst, Lab Atmospher Chem, CH-5232 Villigen, Switzerland; [Almeida, Joao; Manninen, Hanna E.; Mathot, Serge; Onnela, Antti; Pfeifer, Joschka; Weber, Stefan K.; Kirkby, Jasper] CERN, European Org Nucl Res, CH-1211 Geneva 23, Switzerland; [Amanatidis, Stavros; Kim, Changhyuk; Kong, Weimeng; Schulze, Benjamin; Flagan, Richard C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Amorim, Antonio; Dias, Antonio] Univ Lisbon, CENTRA, P-1749016 Lisbon, Portugal; [Amorim, Antonio; Dias, Antonio] Univ Lisbon, Fac Ciencias, P-1749016 Lisbon, Portugal; [Ataei, Farnoush] Leibniz Inst Tropospher Res, D-04318 Leipzig, Germany; [Bertozzi, Barbara; Moehler, Ottmar] Karlsruhe Inst Technol, Inst Meteorol & Climate Res, D-76344 Eggenstein Leopoldshafen, Germany; [Ding, Aijun; Nie, Wei; Kulmala, Markku] Nanjing Univ, Sch Atmospher Sci, Joint Int Res Lab Atmospher & Earth Syst Sci, Nanjing 210023, Peoples R China; [Ding, Aijun; Nie, Wei] Jiangsu Prov Collaborat Innovat Ctr Climate Chang, Nanjing 210023, Peoples R China; [Duplissy, Jonathan; Kulmala, Markku] Univ Helsinki, Helsinki Inst Phys, Helsinki 00014, Finland; [Hansel, Armin; Leiminger, Markus; Mentler, Bernhard; Scholz, Wiebke; Steiner, Gerhard] Univ Innsbruck, Inst Ion Phys & Appl Phys, A-6020 Innsbruck, Austria; [Hansel, Armin; Leiminger, Markus; Scholz, Wiebke] Ionicon Analyt GesmbH, A-6020 Innsbruck, Austria; [Junninen, Heikki] Univ Tartu, Inst Phys, EE-50411 Tartu, Estonia; [Kim, Changhyuk] Pusan Natl Univ, Sch Civil & Environm Engn, Busan 46241, South Korea; [Krechmer, Jordan E.; Worsnop, Douglas R.] Aerodyne Res Inc, Billerica, MA 01821 USA; [Kvashin, Aleksander; Makhmutov, Vladimir; Philippov, Maxim; Stozhkov, Yuri] Russian Acad Sci, PN Lebedev Phys Inst, Moscow 119991, Russia; [Lehtipalo, Katrianne] Finnish Meteorol Inst, Helsinki 00560, Finland; [Mauldin, Roy L.] Univ Colorado, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA; [Ranjithkumar, Ananth] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Saiz-Lopez, Alfonso] CSIC, Inst Phys Chem Rocasolano, Dept Atmospher Chem & Climate, Madrid 28006, Spain; [Salma, Imre] Eotvos Lorand Univ, Inst Chem, H-1117 Budapest, Hungary; [Schuchmann, Simone] Johannes Gutenberg Univ Mainz, Inst Phys, D-55128 Mainz, Germany; [Tome, Antonio] Univ Beira Interior, Inst Infante Dom Luiz, P-6201001 Covilha, Portugal; [Kulmala, Markku] Beijing Univ Chem Technol, Beijing Adv Innovat Ctr Soft Matter Sci & Engn, Aerosol & Haze Lab, Beijing 100029, Peoples R China; [Kurten, Theo] Univ Helsinki, Dept Chem, Helsinki 00014, Finland; [Donahue, Neil M.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; [Donahue, Neil M.] Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA; [Donahue, Neil M.] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA	University of Helsinki; Carnegie Mellon University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Vienna; Tampere University; Goethe University Frankfurt; University of Eastern Finland; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; European Organization for Nuclear Research (CERN); California Institute of Technology; Universidade de Lisboa; Universidade de Lisboa; Leibniz Institut fur Tropospharenforschung (TROPOS); Helmholtz Association; Karlsruhe Institute of Technology; Nanjing University; Helsinki Institute of Physics; University of Helsinki; University of Innsbruck; University of Tartu; University of Tartu Institute of Physics; Pusan National University; Aerodyne Research; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; Finnish Meteorological Institute; University of Colorado System; University of Colorado Boulder; University of Leeds; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Eotvos Lorand University; Hungarian Academy of Sciences; Johannes Gutenberg University of Mainz; Universidade da Beira Interior; Beijing University of Chemical Technology; University of Helsinki; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	He, XC; Sipila, M (corresponding author), Univ Helsinki, Fac Sci, Inst Atmospher & Earth Syst Res Phys, Helsinki 00014, Finland.; Kirkby, J (corresponding author), Goethe Univ Frankfurt, Inst Atmospher & Environm Sci, D-60438 Frankfurt, Germany.; Kirkby, J (corresponding author), CERN, European Org Nucl Res, CH-1211 Geneva 23, Switzerland.	xucheng.he@helsinki.fi; jasper.kirkby@cern.ch; mikko.sipila@helsinki.fi	Kürten, Andreas/O-3851-2019; Wang, Yonghong/AAA-5402-2022; Dada, Lubna/X-7559-2018; Petäjä, Tuukka/A-8009-2008; Krechmer, Jordan E/C-9153-2016; Tome, Antonio R/A-5681-2013; Makhmutov, Vladimir/N-2086-2015; Simon, Mario/AGI-2749-2022; Kirkby, Jasper/A-4973-2012; Saiz-Lopez, Alfonso/B-3759-2015; Wagner, Andrea Christine/AGH-3531-2022; Kurtén, Theo C/G-2120-2012; Donahue, Neil M/A-2329-2008; Sipilä, Mikko/G-3024-2010; Kangasluoma, Juha/AAY-7941-2021; kangasluoma, juha/W-7450-2019; Kvashnin, Aleksandr N/M-8673-2015; Studies, Center for Atmospheric Particle/AAR-6731-2020; Kong, Weimeng/AAK-3328-2020; Thakur, Roseline/AHC-1408-2022; Wang, Mingyi/GLS-1610-2022; Duplissy, Jonathan/A-1723-2010; Curtius, Joachim/A-2681-2011; Ding, Aijun/D-1610-2009; Stozhkov, Yuri/M-7433-2015; Philippov, Maxim/M-9717-2015; Nie, Wei/L-2179-2015; Wang, Dongyu/AAD-3415-2020; Amorim, Antonio/C-8460-2013; Yan, Chao/ABA-5642-2020; Chu, Biwu/AAC-2615-2019; Schobesberger, Siegfried/L-4454-2014; Hansel, Armin/F-3915-2010; Chu, Biwu/GQR-1691-2022; Philippov, Maxim/ABG-1859-2021; Yuri, Stozhkov/ABG-7096-2021; Haddad, Imad El/B-8073-2011; Möhler, Ottmar/J-9426-2012; Tham, Yee Jun/AFP-5568-2022; /AAU-5680-2021; Tham, Yee Jun/AFO-0101-2022; Baalbaki, Rima/B-9124-2019; Bianchi, Federico/G-8428-2012; He, Xu-Cheng/AGF-2263-2022; baccarini, andrea/R-7251-2018; Jokinen, Tuija/B-3365-2014; Junninen, Heikki/C-2157-2014; Iyer, Siddharth/C-8283-2017; VOLKAMER, RAINER/B-8925-2016	Kürten, Andreas/0000-0002-8955-4450; Wang, Yonghong/0000-0003-2498-9143; Dada, Lubna/0000-0003-1105-9043; Petäjä, Tuukka/0000-0002-1881-9044; Krechmer, Jordan E/0000-0003-3642-0659; Tome, Antonio R/0000-0001-9144-7120; Makhmutov, Vladimir/0000-0002-2242-1055; Kirkby, Jasper/0000-0003-2341-9069; Saiz-Lopez, Alfonso/0000-0002-0060-1581; Wagner, Andrea Christine/0000-0003-3159-9434; Kurtén, Theo C/0000-0002-6416-4931; Donahue, Neil M/0000-0003-3054-2364; Sipilä, Mikko/0000-0002-8594-7003; Kangasluoma, Juha/0000-0002-1639-1187; Kvashnin, Aleksandr N/0000-0001-7218-6738; Kong, Weimeng/0000-0002-9432-2857; Thakur, Roseline/0000-0002-3238-4171; Wang, Mingyi/0000-0001-5782-2513; Duplissy, Jonathan/0000-0001-8819-0264; Curtius, Joachim/0000-0003-3153-4630; Ding, Aijun/0000-0003-4481-5386; Stozhkov, Yuri/0000-0003-1917-0328; Philippov, Maxim/0000-0003-4302-0020; Wang, Dongyu/0000-0001-7549-1578; Amorim, Antonio/0000-0003-0638-2321; Yan, Chao/0000-0002-5735-9597; Schobesberger, Siegfried/0000-0002-5777-4897; Hansel, Armin/0000-0002-1062-2394; Chu, Biwu/0000-0002-7548-5669; Haddad, Imad El/0000-0002-2461-7238; Möhler, Ottmar/0000-0002-7551-9814; /0000-0002-7416-306X; Baalbaki, Rima/0000-0002-4480-2107; Bianchi, Federico/0000-0003-2996-3604; He, Xu-Cheng/0000-0002-7416-306X; baccarini, andrea/0000-0003-4614-247X; Jokinen, Tuija/0000-0002-1280-1396; Finkenzeller, Henning/0000-0002-8349-3714; Rissanen, Matti/0000-0003-0463-8098; Vaisanen, Olli/0000-0001-5674-7013; Zhou, Putian/0000-0003-0803-7337; Bertozzi, Barbara/0000-0003-2571-6585; Junninen, Heikki/0000-0001-7178-9430; Beck, Lisa J./0000-0003-3700-5895; Iyer, Siddharth/0000-0001-5989-609X; Lehtipalo, Katrianne/0000-0002-1660-2706; Stolzenburg, Dominik/0000-0003-1014-1360; Rorup, Birte/0000-0001-8755-9453; Zha, Qiaozhi/0000-0001-6301-7086; Tauber, Christian/0000-0003-1453-1067; Simon, Mario/0000-0002-4900-7460; VOLKAMER, RAINER/0000-0002-0899-1369; Sarnela, Nina/0000-0003-1874-3235	European Organization for Nuclear Research (CERN); Academy of Finland [316114, 307331, 310682, 266388, 3282290, 306853, 296628, 229574, 333397, 326948, 1325656]; European Research Council [692891, 616075, 764991, 316662, 742206, 714621]; EC Seventh Framework Programme; EU [764991, 316662]; Austrian Science Fund (FWF) [J3951-N36, P27295-N20]; Swiss National Science Foundation [20FI20_159851, 200021_169090, 200020_172602, 20FI20_172622]; U.S. National Science Foundation [AGS1447056, AGS1439551, AGS1801574, AGS1620530, AGS1801897, AGS153128, AGS1649147, AGS1801280, AGS1602086, AGS1801329, 665779]; German Federal Ministry of Education and Research [CLOUD-16 (01LK1601A)]; Portuguese Foundation for Science and Technology [CERN/FIS-COM/0014/2017]; Academy of Finland Centre of Excellence in Atmospheric Sciences [272041]; European Regional Development Fund [MOBTT42]; Jiangsu Collaborative Innovation Center for Climate Change; Yangtze River Delta Atmosphere and Earth System Science National Observation and Research Station; Estonian Research Council [PRG714]; Hungarian National Research, Development and Innovation Office [K116788, K132254]; NASA Graduate Fellowship [NASA-NNX16AP36H, 654109]	European Organization for Nuclear Research (CERN); Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission); EC Seventh Framework Programme(European Commission); EU(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. National Science Foundation(National Science Foundation (NSF)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Academy of Finland Centre of Excellence in Atmospheric Sciences; European Regional Development Fund(European Commission); Jiangsu Collaborative Innovation Center for Climate Change; Yangtze River Delta Atmosphere and Earth System Science National Observation and Research Station; Estonian Research Council(Estonian Research Council); Hungarian National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); NASA Graduate Fellowship	We thank the European Organization for Nuclear Research (CERN) for supporting CLOUD with important technical and financial resources and for providing a particle beam from the CERN Proton Synchrotron. This research has received support from the Academy of Finland (projects 316114, 307331, 310682, 266388, 3282290, 306853, 296628, 229574, 333397, 326948, and 1325656); the European Research Council (projects 692891, 616075, 764991, 316662, 742206, and 714621); CSC -Finnish IT center; the EC Seventh Framework Programme and the EU H2020 programme Marie Sklodowska Curie ITN "CLOUD-TRAIN" (316662) and "CLOUD-MOTION" (764991); Austrian Science Fund (FWF) (J3951-N36 and P27295-N20); the Swiss National Science Foundation (20FI20_159851, 200021_169090, 200020_172602, and 20FI20_172622); the U.S. National Science Foundation (grants AGS1447056, AGS1439551, AGS1801574, AGS1620530, AGS1801897, AGS153128, AGS1649147, AGS1801280, AGS1602086, and AGS1801329); MSCA H2020 COFUND-FP-CERN2014 fellowship (665779); German Federal Ministry of Education and Research: CLOUD-16 (01LK1601A); Portuguese Foundation for Science and Technology (CERN/FIS-COM/0014/2017); Academy of Finland Centre of Excellence in Atmospheric Sciences (grant 272041); European Regional Development Fund (project MOBTT42); Jiangsu Collaborative Innovation Center for Climate Change; Yangtze River Delta Atmosphere and Earth System Science National Observation and Research Station; Estonian Research Council (project PRG714); Hungarian National Research, Development and Innovation Office (K116788 and K132254); NASA Graduate Fellowship (NASA-NNX16AP36H); and ACTRIS 2TNA H2020 OCTAVE (654109). We are also grateful for all the people who have contributed to the field measurements around the world.	Allan JD, 2015, ATMOS CHEM PHYS, V15, P5599, DOI 10.5194/acp-15-5599-2015; Almeida J, 2013, NATURE, V502, P359, DOI 10.1038/nature12663; Baccarini A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18551-0; Bosch H, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003078; Carpenter LJ, 2013, NAT GEOSCI, V6, P108, DOI [10.1038/ngeo1687, 10.1038/NGEO1687]; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Cuevas CA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03756-1; Dawson ML, 2012, P NATL ACAD SCI USA, V109, P18719, DOI 10.1073/pnas.1211878109; Deng CJ, 2020, ENVIRON SCI TECHNOL, V54, P8547, DOI 10.1021/acs.est.0c00808; Dix B, 2013, P NATL ACAD SCI USA, V110, P2035, DOI 10.1073/pnas.1212386110; Drougas E, 2005, J PHYS CHEM A, V109, P3887, DOI 10.1021/jp044197j; Dunne EM, 2016, SCIENCE, V354, P1119, DOI 10.1126/science.aaf2649; Duplissy J, 2016, J GEOPHYS RES-ATMOS, V121, P1752, DOI 10.1002/2015JD023539; Feller D, 1996, J COMPUT CHEM, V17, P1571, DOI 10.1002/(SICI)1096-987X(199610)17:13<1571::AID-JCC9>3.0.CO;2-P; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Gettelman A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004190; Martin JCG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18252-8; Gordon H, 2017, J GEOPHYS RES-ATMOS, V122, P8739, DOI 10.1002/2017JD026844; Hari P, 2005, BOREAL ENVIRON RES, V10, P315; Hartmann DL, 2001, J CLIMATE, V14, P4495, DOI 10.1175/1520-0442(2001)014<4495:TCATEB>2.0.CO;2; He X.-C., 2021, **DROPPED REF**, DOI [10.5281/zenodo.4299441, DOI 10.5281/ZENODO.4299441]; He X.-C., 2021, AEROSOL SCI TECHNOL, V55, P231; He XC, 2021, AEROSOL SCI TECH, V55, P231, DOI 10.1080/02786826.2020.1839013; Hoffmann T, 2001, GEOPHYS RES LETT, V28, P1949, DOI 10.1029/2000GL012399; Huang RJ, 2010, ATMOS CHEM PHYS, V10, P4823, DOI 10.5194/acp-10-4823-2010; Hussein T, 2008, TELLUS B, V60, P509, DOI 10.1111/j.1600-0889.2008.00365.x; Hyttinen N, 2018, J PHYS CHEM A, V122, P269, DOI 10.1021/acs.jpca.7b10015; Jokinen T, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat9744; Jokinen T, 2012, ATMOS CHEM PHYS, V12, P4117, DOI 10.5194/acp-12-4117-2012; Junninen H, 2010, ATMOS MEAS TECH, V3, P1039, DOI 10.5194/amt-3-1039-2010; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; Khanniche S, 2016, CHEM PHYS LETT, V662, P114, DOI 10.1016/j.cplett.2016.09.023; Khanniche S, 2016, COMPUT THEOR CHEM, V1094, P98, DOI 10.1016/j.comptc.2016.09.010; Kirkby J, 2016, NATURE, V533, P521, DOI 10.1038/nature17953; Kirkby J, 2011, NATURE, V476, P429, DOI 10.1038/nature10343; Koenig TK, 2020, P NATL ACAD SCI USA, V117, P1860, DOI 10.1073/pnas.1916828117; KREIDENWEIS SM, 1988, ATMOS ENVIRON, V22, P283, DOI 10.1016/0004-6981(88)90034-0; Kuang C, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009253; Kurten A, 2019, ATMOS CHEM PHYS, V19, P5033, DOI 10.5194/acp-19-5033-2019; Kurten A, 2018, ATMOS CHEM PHYS, V18, P845, DOI 10.5194/acp-18-845-2018; Kurten A, 2014, P NATL ACAD SCI USA, V111, P15019, DOI 10.1073/pnas.1404853111; Kulmala M, 2013, SCIENCE, V339, P943, DOI 10.1126/science.1227385; Kummerlowe G, 2005, INT J MASS SPECTROM, V244, P84, DOI 10.1016/j.ijms.2005.03.012; Legrand M, 2018, P NATL ACAD SCI USA, V115, P12136, DOI 10.1073/pnas.1809867115; Lehtipalo K, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau5363; Lehtipalo K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11594; Lehtipalo K, 2014, BOREAL ENVIRON RES, V19, P215; Lopez-Hilfiker FD, 2014, ATMOS MEAS TECH, V7, P983, DOI 10.5194/amt-7-983-2014; Mahajan AS, 2010, ATMOS CHEM PHYS, V10, P4611, DOI 10.5194/acp-10-4611-2010; Manninen HE, 2016, ATMOS MEAS TECH, V9, P3577, DOI 10.5194/amt-9-3577-2016; McMurry PH, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005901; Meehl GA, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1981; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; O'Dowd CD, 2002, NATURE, V417, P632, DOI 10.1038/nature00775; Passananti M, 2019, CHEM COMMUN, V55, P5946, DOI 10.1039/c9cc02896j; Plane JMC, 2006, J PHYS CHEM A, V110, P93, DOI 10.1021/jp055364y; Prados-Roman C, 2015, ATMOS CHEM PHYS, V15, P583, DOI 10.5194/acp-15-583-2015; Pundt I, 1998, J ATMOS CHEM, V30, P173, DOI 10.1023/A:1006071612477; Riplinger C, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4773581; Saiz-Lopez A, 2004, ATMOS CHEM PHYS, V4, P1443, DOI 10.5194/acp-4-1443-2004; Saiz-Lopez A, 2015, GEOPHYS RES LETT, V42, P6852, DOI 10.1002/2015GL064796; Sherwen TM, 2016, GEOPHYS RES LETT, V43, P10012, DOI 10.1002/2016GL070062; Sipila M, 2016, NATURE, V537, P532, DOI 10.1038/nature19314; Sive BC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030528; Stolzenburg D, 2020, ATMOS CHEM PHYS, V20, P7359, DOI 10.5194/acp-20-7359-2020; Stolzenburg D, 2017, ATMOS MEAS TECH, V10, P1639, DOI 10.5194/amt-10-1639-2017; Stozhkov YI, 2009, ADV SPACE RES, V44, P1124, DOI 10.1016/j.asr.2008.10.038; SU T, 1973, J CHEM PHYS, V58, P3027, DOI 10.1063/1.1679615; Thalman R, 2013, PHYS CHEM CHEM PHYS, V15, P15371, DOI 10.1039/c3cp50968k; Trostl J, 2015, J AEROSOL SCI, V87, P75, DOI 10.1016/j.jaerosci.2015.04.001; Vanhanen J, 2011, AEROSOL SCI TECH, V45, P533, DOI 10.1080/02786826.2010.547889; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Volkamer R, 2015, ATMOS MEAS TECH, V8, P2121, DOI 10.5194/amt-8-2121-2015; Wang H, 2020, NATURE, V585, P187, DOI 10.1038/d41586-020-02381-7; Wang SY, 2015, P NATL ACAD SCI USA, V112, P9281, DOI 10.1073/pnas.1505142112; Washenfelder RA, 2008, ATMOS CHEM PHYS, V8, P7779, DOI 10.5194/acp-8-7779-2008; Williamson CJ, 2019, NATURE, V574, P399, DOI 10.1038/s41586-019-1638-9; Yu H, 2019, ATMOS CHEM PHYS, V19, P4025, DOI 10.5194/acp-19-4025-2019; Zhang J, 2016, PHYS CHEM CHEM PHYS, V18, P3003, DOI 10.1039/c5cp06313b; Zhang J, 2015, PHYS CHEM CHEM PHYS, V17, P24173, DOI 10.1039/c5cp04060d; Zhao X, 2019, ENVIRON SCI TECHNOL, V53, P8706, DOI 10.1021/acs.est.9b01160; Zhou Y, 2020, ATMOS CHEM PHYS, V20, P1201, DOI 10.5194/acp-20-1201-2020	82	47	47	27	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2021	371	6529			SI		589	+		10.1126/science.abe0298	http://dx.doi.org/10.1126/science.abe0298			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QD7TF	33542130	Green Submitted, Green Accepted			2022-12-28	WOS:000615715300046
J	Kraus, F; Roy, K; Pucadyil, TJ; Ryan, MT				Kraus, Felix; Roy, Krishnendu; Pucadyil, Thomas J.; Ryan, Michael T.			Function and regulation of the divisome for mitochondrial fission	NATURE			English	Review							DYNAMIN-RELATED PROTEIN-1; REAL-TIME ANALYSIS; CRYSTAL-STRUCTURE; MEMBRANE FISSION; INDUCED TRANSFORMATION; DRP1 RECRUITMENT; MFF; MID51; MID49; FUSION	Mitochondria form dynamic networks in the cell that are balanced by the flux of iterative fusion and fission events of the organelles. It is now appreciated that mitochondrial fission also represents an end-point event in a signalling axis that allows cells to sense and respond to external cues. The fission process is orchestrated by membrane-associated adaptors, influenced by organellar and cytoskeletal interactions and ultimately executed by the dynamin-like GTPase DRP1. Here we invoke the framework of the 'mitochondrial divisome', which is conceptually and operationally similar to the bacterial cell-division machinery. We review the functional and regulatory aspects of the mitochondrial divisome and, within this framework, parse the core from the accessory machinery. In so doing, we transition from a phenomenological to a mechanistic understanding of the fission process. The functional and regulatory aspects of the 'mitochondrial divisome' are separated into core and accessory machinery, thus providing a mechanistic understanding of the process of mitochondrial fission.	[Kraus, Felix; Ryan, Michael T.] Monash Univ, Monash Biomed Discovery Inst, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Roy, Krishnendu; Pucadyil, Thomas J.] Indian Inst Sci Educ & Res, Pune, Maharashtra, India; [Kraus, Felix] Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA 02115 USA	Monash University; Indian Institute of Science Education & Research (IISER) Pune; Harvard University; Harvard Medical School	Ryan, MT (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Dept Biochem & Mol Biol, Melbourne, Vic, Australia.; Pucadyil, TJ (corresponding author), Indian Inst Sci Educ & Res, Pune, Maharashtra, India.	pucadyila@iiserpune.ac.in; michael.ryan@monash.edu	; Ryan, Michael/C-6673-2011	Roy, Krishnendu/0000-0003-2731-2525; Ryan, Michael/0000-0003-2586-8829; Pucadyil, Thomas/0000-0002-2907-9889; Kraus, Felix/0000-0002-3757-541X	Council for Scientific and Industrial Research; Department of Science and Technology-SERB; Howard Hughes Medical Institute (HHMI); Australian Research Council; National Health and Medical Research Council	Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology-SERB; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	We thank members of the Pucadyil and Ryan laboratories for comments on the manuscript. K.R. thanks the Council for Scientific and Industrial Research for a graduate fellowship. Work in the Pucadyil laboratory is supported by funds from the Department of Science and Technology-SERB and the Howard Hughes Medical Institute (HHMI). T.J.P. is an International Scholar of the HHMI. M.T.R. acknowledges support from the Australian Research Council and the National Health and Medical Research Council.	Abrisch RG, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201911122; Ackema KB, 2014, EMBO J, V33, P2659, DOI 10.15252/embj.201489039; Adachi Y, 2016, MOL CELL, V63, P1034, DOI 10.1016/j.molcel.2016.08.013; Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Antonny B, 2016, EMBO J, V35, P2270, DOI 10.15252/embj.201694613; Arimura S, 2018, PLANT PHYSIOL, V176, P152, DOI 10.1104/pp.17.01025; Bartsakoulia M, 2018, HUM MOL GENET, V27, P1186, DOI 10.1093/hmg/ddy033; Basu K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179397; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Bohuszewicz O, 2018, NAT STRUCT MOL BIOL, V25, P722, DOI 10.1038/s41594-018-0097-6; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106; Bustillo-Zabalbeitia I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102738; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chakrabarti R, 2018, J CELL BIOL, V217, P251, DOI 10.1083/jcb.201709111; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chen Le, 2011, Congest Heart Fail, V17, P257; Chen ZL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11337-z; Cherok E, 2017, MOL BIOL CELL, V28, P396, DOI 10.1091/mbc.E16-04-0208; Cho B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15754; Civenni G, 2019, CELL METAB, V30, P303, DOI 10.1016/j.cmet.2019.05.004; Clinton RW, 2016, J BIOL CHEM, V291, P478, DOI 10.1074/jbc.M115.680025; Costello JL, 2017, J CELL SCI, V130, P1675, DOI 10.1242/jcs.200204; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Dar S, 2017, NAT PROTOC, V12, P390, DOI 10.1038/nprot.2016.173; Dar S, 2015, NAT CELL BIOL, V17, P1588, DOI 10.1038/ncb3254; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Elgass KD, 2015, J CELL SCI, V128, P2795, DOI 10.1242/jcs.169136; Faelber K, 2019, NATURE, V571, P429, DOI 10.1038/s41586-019-1372-3; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Favaro G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10226-9; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Fonseca TB, 2019, NATURE, V570, pE34, DOI 10.1038/s41586-019-1296-y; Ford MGJ, 2019, TRAFFIC, V20, P717, DOI 10.1111/tra.12676; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Fox CA, 2019, BBA-BIOMEMBRANES, V1861, P1030, DOI 10.1016/j.bbamem.2019.03.005; Francy CA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11008-3; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Gao S, 2011, IMMUNITY, V35, P514, DOI 10.1016/j.immuni.2011.07.012; Giacomello M, 2016, CELL DEATH DIFFER, V23, P1417, DOI 10.1038/cdd.2016.52; Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7; Gomes LC, 2013, BBA-MOL CELL RES, V1833, P205, DOI 10.1016/j.bbamcr.2012.02.012; Haeusser DP, 2016, NAT REV MICROBIOL, V14, P305, DOI 10.1038/nrmicro.2016.26; Hammerschmidt P, 2019, CELL, V177, P1536, DOI 10.1016/j.cell.2019.05.008; Hatch AL, 2016, MOL BIOL CELL, V27, P3109, DOI 10.1091/mbc.E16-03-0193; Helle SCJ, 2017, ELIFE, V6, DOI 10.7554/eLife.30292; Hennings TG, 2018, ENDOCRINOLOGY, V159, P3245, DOI 10.1210/en.2018-00445; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Horn A, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201909154; Humphries BA, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-020-01301-x; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Itoh K, 2018, J BIOL CHEM, V293, P11809, DOI 10.1074/jbc.RA117.001253; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kalia R, 2018, NATURE, V558, P401, DOI 10.1038/s41586-018-0211-2; Kamerkar SC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07543-w; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Kim YM, 2018, CELL REP, V23, P3565, DOI 10.1016/j.celrep.2018.05.054; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Koch J, 2016, J MED GENET, V53, P270, DOI 10.1136/jmedgenet-2015-103500; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Kong L, 2018, NATURE, V560, P258, DOI 10.1038/s41586-018-0378-6; Korobova F, 2014, CURR BIOL, V24, P409, DOI 10.1016/j.cub.2013.12.032; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Kraus F, 2017, J CELL SCI, V130, P2953, DOI 10.1242/jcs.199562; Kuroiwa T, 2006, BBA-MOL CELL RES, V1763, P510, DOI 10.1016/j.bbamcr.2006.03.007; Lackner LL, 2009, SCIENCE, V325, P874, DOI 10.1126/science.1176921; Lee JE, 2016, NATURE, V540, P139, DOI 10.1038/nature20555; Lewis MR, 1915, AM J ANAT, V17, P339, DOI 10.1002/aja.1000170304; Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549; Lewis TL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07416-2; Li SA, 2015, J CELL BIOL, V208, P109, DOI 10.1083/jcb.201404050; Lieber T, 2019, NATURE, V570, P380, DOI 10.1038/s41586-019-1213-4; Liu R, 2015, MOL BIOL CELL, V26, P4466, DOI 10.1091/mbc.E15-08-0591; Loson OC, 2015, PROTEIN SCI, V24, P386, DOI 10.1002/pro.2629; Loson OC, 2014, STRUCTURE, V22, P367, DOI 10.1016/j.str.2014.01.001; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Lu B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29001-9; Ma J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210461; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Macdonald PJ, 2016, J BIOL CHEM, V291, P493, DOI 10.1074/jbc.M115.680181; Manor U, 2015, ELIFE, V4, DOI 10.7554/eLife.08828; McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047; Melatti C, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007512; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Moore AS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12886; Morita M, 2017, MOL CELL, V67, P922, DOI 10.1016/j.molcel.2017.08.013; Nagashima S, 2020, SCIENCE, V367, P1366, DOI 10.1126/science.aax6089; Nagdas S, 2019, CELL REP, V28, P1845, DOI 10.1016/j.celrep.2019.07.031; Nguyen TN, 2016, TRENDS CELL BIOL, V26, P733, DOI 10.1016/j.tcb.2016.05.008; Nishida K, 2004, J HISTOCHEM CYTOCHEM, V52, P843, DOI 10.1369/jhc.4C6315.2004; Nishimura A, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat5185; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Osellame LD, 2016, J CELL SCI, V129, P2170, DOI 10.1242/jcs.185165; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Otera H, 2016, J CELL BIOL, V212, P531, DOI 10.1083/jcb.201508099; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2013, J BIOL CHEM, V288, P27584, DOI 10.1074/jbc.M113.479873; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Pfluger PT, 2015, CELL METAB, V22, P838, DOI 10.1016/j.cmet.2015.08.022; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Prieto J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11124; Prudent J, 2015, MOL CELL, V59, P941, DOI 10.1016/j.molcel.2015.08.001; Purkanti R, 2015, P NATL ACAD SCI USA, V112, P2800, DOI 10.1073/pnas.1407163112; Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x; Rana A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00525-4; Reubold TF, 2015, NATURE, V525, P404, DOI 10.1038/nature14880; Richter V, 2014, J CELL BIOL, V204, P477, DOI 10.1083/jcb.201311014; Rosenbloom AB, 2014, P NATL ACAD SCI USA, V111, P13093, DOI 10.1073/pnas.1320044111; Rowlett VW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0028; Sabouny R, 2020, TRENDS BIOCHEM SCI, V45, P564, DOI 10.1016/j.tibs.2020.03.009; Samangouei Parisa, 2018, Cond Med, V1, P239; Schmitt K, 2018, CELL METAB, V27, P657, DOI 10.1016/j.cmet.2018.01.011; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Shen QF, 2014, MOL BIOL CELL, V25, P145, DOI 10.1091/mbc.E13-09-0525; Sheng ZH, 2017, TRENDS CELL BIOL, V27, P403, DOI 10.1016/j.tcb.2017.01.005; Shields LY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.94; Simula L, 2018, CELL REP, V25, P3059, DOI 10.1016/j.celrep.2018.11.018; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1; Stepanyants N, 2015, MOL BIOL CELL, V26, P3104, DOI 10.1091/mbc.E15-06-0330; Stephan T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48838-2; Strack S, 2012, J BIOL CHEM, V287, P10990, DOI 10.1074/jbc.M112.342105; Tian L, 2017, J MOL MED, V95, P381, DOI 10.1007/s00109-017-1522-8; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Udagawa O, 2020, J BIOCHEM, V167, P257, DOI 10.1093/jb/mvz093; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; Verrigni D, 2019, HUM MUTAT, V40, P601, DOI 10.1002/humu.23729; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wang LX, 2015, DIABETOLOGIA, V58, P2371, DOI 10.1007/s00125-015-3704-7; Wang Y, 2017, CELL, V171, P331, DOI 10.1016/j.cell.2017.08.041; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Wong YC, 2018, NATURE, V554, P382, DOI 10.1038/nature25486; Xian HX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10096-1; Xie Q, 2015, NAT NEUROSCI, V18, P501, DOI 10.1038/nn.3960; Xu S, 2016, MOL BIOL CELL, V27, P349, DOI 10.1091/mbc.E15-09-0678; Yamada T, 2018, CELL METAB, V28, P588, DOI 10.1016/j.cmet.2018.06.014; Yang CS, 2019, NAT CELL BIOL, V21, P603, DOI 10.1038/s41556-019-0313-6; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu B., 2020, NAT COMMUN, V11; Zhang DY, 2020, ELIFE, V9, DOI 10.7554/eLife.50294; Zhang ZZ, 2016, FASEB J, V30, P466, DOI 10.1096/fj.15-274258; Zhou H, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005328	157	64	65	20	71	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2021	590	7844					57	66		10.1038/s41586-021-03214-x	http://dx.doi.org/10.1038/s41586-021-03214-x			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TY5GY	33536648				2022-12-28	WOS:000683814000001
J	Weill, A; Nguyen, P; Labidi, M; Cadier, B; Passeri, T; Duranteau, L; Bernat, AL; Yoldjian, I; Fontanel, S; Froelich, S; Coste, J				Weill, Alain; Nguyen, Pierre; Labidi, Moujahed; Cadier, Benjamin; Passeri, Thibault; Duranteau, Lise; Bernat, Anne-Laure; Yoldjian, Isabelle; Fontanel, Sylvie; Froelich, Sebastien; Coste, Joel			Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CENTRAL-NERVOUS-SYSTEM; PROGESTERONE-RECEPTORS; ESTROGEN-RECEPTORS; CHILDHOOD-CANCER; BRAIN-TUMORS; DISCONTINUATION; ASSOCIATION; REGRESSION; RADIATION; GROWTH	OBJECTIVE To assess the risk of meningioma associated with use of high dose cyproterone acetate, a progestogen indicated for clinical hyperandrogenism. DESIGN Observational cohort study. SETTING Data from SNDS, the French administrative healthcare database, between 2007 and 2015. PARTICIPANTS 253 777 girls and women aged 7-70 years living in France who started cyproterone acetate between 2007 and 2014. Participants had at least one reimbursement for high dose cyproterone acetate and no history of meningioma or benign brain tumour, or long term disease status. Participants were considered to be exposed when they had received a cumulative dose of at least 3 g during the first six months (139 222 participants) and very slightly exposed (control group) when they had received a cumulative dose of less than 3 g (114 555 participants). 10 876 transgender participants (male to female) were included in an additional analysis. MAIN OUTCOME MEASURE Surgery (resection or decompression) or radiotherapy for one or more intracranial meningiomas. RESULTS Overall, 69 meningiomas in the exposed group (during 289 544 person years of follow-up) and 20 meningiomas in the control group (during 439 949 person years of follow-up) were treated by surgery or radiotherapy. The incidence of meningioma in the two groups was 23.8 and 4.5 per 100 000 person years, respectively (crude relative risk 5.2, 95% confidence interval 3.2 to 8.6; adjusted hazard ratio 6.6, 95% confidence interval 4.0 to 11.1). The adjusted hazard ratio for a cumulative dose of cyproterone acetate of more than 60 g was 21.7 (10.8 to 43.5). After discontinuation of cyproterone acetate for one year, the risk of meningioma in the exposed group was 1.8-fold higher (1.0 to 3.2) than in the control group. In a complementary analysis, 463 women with meningioma were observed among 123 997 already using cyproterone acetate in 2006 (risk of 383 per 100 000 person years in the group with the highest exposure in terms of cumulative dose). Meningiomas located in the anterior skull base and middle skull base, particularly the medial third of the middle skull base, involving the spheno-orbital region, appeared to be specific to cyproterone acetate. An additional analysis of transgender participants showed a high risk of meningioma (three per 14 460 person years; 20.7 per 100 000 person years). CONCLUSIONS A strong dose-effect relation was observed between use of cyproterone acetate and risk of intracranial meningiomas. A noticeable reduction in risk was observed after discontinuation of treatment.	[Weill, Alain; Cadier, Benjamin; Coste, Joel] French Natl Hlth Insurance, Dept Publ Hlth Studies, Paris, France; [Weill, Alain; Nguyen, Pierre] EPI PHARE Sci Interest Grp, 42 Bd Liberat, F-93200 St Denis, France; [Nguyen, Pierre; Yoldjian, Isabelle] French Natl Agcy Safety Medicines & Hlth Prod ANS, St Denis, France; [Labidi, Moujahed; Passeri, Thibault; Bernat, Anne-Laure; Froelich, Sebastien] Univ Paris, Lariboisiere Hosp, Dept Neurosurg, AP HP, Paris, France; [Duranteau, Lise] Univ Paris Saclay, Bicetre Hosp, AP HP, Ctr Rare Dis Genital De,Gynaecol Unit & Reference, Le Kremlin Bicetre, France; [Fontanel, Sylvie] Grand Est Reg Hlth Author, Nancy, France; [Coste, Joel] Cochin Hosp, AP HP, Biostat & Epidemiol Unit, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Weill, A (corresponding author), French Natl Hlth Insurance, Dept Publ Hlth Studies, Paris, France.; Weill, A (corresponding author), EPI PHARE Sci Interest Grp, 42 Bd Liberat, F-93200 St Denis, France.	alain.weill@assurance-maladie.fr		nguyen, pierre/0000-0001-9066-9100; Weill, Alain/0000-0001-8687-9092; Labidi, Moujahed/0000-0002-7496-8327	French National Health Insurance Fund (CNAM); Health Product Epidemiology Scientific Interest Group (ANSM-CNAM EPI-PHARE SIG); French National Health Insurance Fund	French National Health Insurance Fund (CNAM); Health Product Epidemiology Scientific Interest Group (ANSM-CNAM EPI-PHARE SIG); French National Health Insurance Fund	This research was funded by the French National Health Insurance Fund (CNAM) and the Health Product Epidemiology Scientific Interest Group (ANSM-CNAM EPI-PHARE SIG). AW, JC, and BC are employees of French National Health Insurance Fund, PN is an employee of the French National Agency for Medicines and Health Products Safety. The present paper represents the opinions of the authors and does not necessarily reflect the position of their employers.	Agence nationale de securite du medicament et des produits de sante (ANSM), 2019, SOURC OCTAVE; Alderman Christopher P, 2016, Consult Pharm, V31, P500, DOI 10.4140/TCP.n.2016.500; ANSM, 2012, RES CAR PROD ANSM MI; ANSM, 2018, MEN CYPR AC TEMP SPE; Basson M, 2016, GUT, V65, P1664, DOI 10.1136/gutjnl-2015-309690; Benson VS, 2008, BRIT J CANCER, V99, P185, DOI 10.1038/sj.bjc.6604445; Benson VS, 2015, INT J CANCER, V136, P2369, DOI 10.1002/ijc.29274; Bergoglio MT, 2013, ENDOCRINOL NUTR, V60, P264, DOI 10.1016/j.endonu.2012.07.004; Bernat AL, 2018, J OPHTHAL VIS RES, V13, P355, DOI 10.4103/jovr.jovr_21_17; Bernat AL, 2015, ACTA NEUROCHIR, V157, P1741, DOI 10.1007/s00701-015-2532-3; Bezin J, 2017, PHARMACOEPIDEM DR S, V26, P954, DOI 10.1002/pds.4233; Blitshteyn S, 2008, J CLIN ONCOL, V26, P279, DOI 10.1200/JCO.2007.14.2133; Blotiere PO, 2019, NEUROLOGY, V93, pE167, DOI 10.1212/WNL.0000000000007696; Botella C, 2015, NEUROCHIRURGIE, V61, P339, DOI 10.1016/j.neuchi.2015.05.002; BOUILLOT P, 1994, J NEUROSURG, V81, P765, DOI 10.3171/jns.1994.81.5.0765; Braganza MZ, 2012, NEURO-ONCOLOGY, V14, P1316, DOI 10.1093/neuonc/nos208; Cea-Soriano L, 2012, CANCER EPIDEMIOL, V36, P198, DOI 10.1016/j.canep.2011.08.003; Cebula H, 2010, ACTA NEUROCHIR, V152, P1955, DOI 10.1007/s00701-010-0787-2; Chakravarthy V, 2018, WORLD NEUROSURG, V114, pE1261, DOI 10.1016/j.wneu.2018.03.187; Champagne PO, 2019, ACTA NEUROCHIR, V161, P589, DOI 10.1007/s00701-018-03782-4; Champeaux-Depond C, 2020, CLIN NEUROL NEUROSUR, V198, DOI 10.1016/j.clineuro.2020.106236; Coste J, 2017, PHARMACOEPIDEM DR S, V26, P600, DOI 10.1002/pds.4190; Custer BS, 2002, CANCER, V94, P1626, DOI 10.1002/cncr.10410; DONNELL MS, 1979, J NEUROSURG, V50, P499, DOI 10.3171/jns.1979.50.4.0499; European Medicines Agency, 2020, M HIGHL PHARM RISK A; Froelich S., 2008, END 10 EUR C END, P158; Gazzeri R, 2007, NEW ENGL J MED, V357, P2411, DOI 10.1056/NEJMc071938; Gil M, 2011, BRIT J CLIN PHARMACO, V72, P965, DOI 10.1111/j.1365-2125.2011.04031.x; Giral P, 2019, EUR HEART J, V40, P3516, DOI 10.1093/eurheartj/ehz458; GOFFIN J, 1986, CLIN NEUROL NEUROSUR, V88, P169, DOI 10.1016/S0303-8467(86)80024-5; Goldbrunner R, 2016, LANCET ONCOL, V17, pE383, DOI 10.1016/S1470-2045(16)30321-7; Goncalves AMG, 2010, AM J NEURORADIOL, V31, P1504, DOI 10.3174/ajnr.A1978; Grave C, 2020, NEUROLOGY, V94, pE2168, DOI 10.1212/WNL.0000000000009180; Gurcay Ahmet Gurhan, 2018, Asian J Neurosurg, V13, P86, DOI 10.4103/1793-5482.181115; Hansson CM, 2007, BMC GENOMICS, V8, P1, DOI 10.1186/1471-2164-8-16; HAS, 2012, COMM TRANSP AV 19 DE; HAS, 2016, COMM TRANSP AV 22 JU, DOI CIP: 34009 323 510 0 8) Androcur 100 mg, comprime secable B/60 (CIP: 34009 340 417 5 4); Hemminki K, 2009, LANCET ONCOL, V10, P481, DOI 10.1016/S1470-2045(09)70076-2; Hijiya N, 2007, JAMA-J AM MED ASSOC, V297, P1207, DOI 10.1001/jama.297.11.1207; HMA, 2009, PHVWP REP CYPR AC RI; Hortobagyi T, 2017, OPEN MED-WARSAW, V12, DOI 10.1515/med-2017-0029; Kerschbaumer J, 2016, J NEUROSURG, V124, P137, DOI 10.3171/2014.12.JNS142112; Kubo M, 2001, JPN J CLIN ONCOL, V31, P510, DOI 10.1093/jjco/hye109; Lee E, 2006, INT J CANCER, V119, P1152, DOI 10.1002/ijc.21950; Lemaitre M, 2017, JAMA-J AM MED ASSOC, V318, P1679, DOI 10.1001/jama.2017.16071; MAIURI F, 1986, SURG NEUROL, V26, P435, DOI 10.1016/0090-3019(86)90255-7; Malmer B, 2003, INT J CANCER, V106, P260, DOI 10.1002/ijc.11213; Maura G, 2015, CIRCULATION, V132, P1252, DOI 10.1161/CIRCULATIONAHA.115.015710; Meyer A, 2019, ANN INTERN MED, V170, P99, DOI 10.7326/M18-1512; Moulis G, 2015, REV MED INTERNE, V36, P411, DOI 10.1016/j.revmed.2014.11.009; Neglia JP, 2006, J NATL CANCER I, V98, P1528, DOI 10.1093/jnci/djj411; Omulecka A, 2006, FOLIA NEUROPATHOL, V44, P111; Passeri T, 2019, ACTA NEUROCHIR, V161, P761, DOI 10.1007/s00701-019-03848-x; Peyre M, 2018, ANN ONCOL, V29, P681, DOI 10.1093/annonc/mdx763; POISSON M, 1980, REV NEUROL-FRANCE, V136, P193; Preston DL, 2002, JNCI-J NATL CANCER I, V94, P1555, DOI 10.1093/jnci/94.20.1555; PRESTONMARTIN S, 1990, NEUROEPIDEMIOLOGY, V9, P106, DOI 10.1159/000110757; Razavi HB., 2014, SOJ NEUROL, V1, P1, DOI [DOI 10.15226/2374-6858/1/2/00109, 10.15226/2374-6858/1/2/00109]; RON E, 1988, NEW ENGL J MED, V319, P1033, DOI 10.1056/NEJM198810203191601; RYAN P, 1992, ORAL ONCOL, V28B, P91; Sadetzki S, 2005, CANCER EPIDEM BIOMAR, V14, P969, DOI 10.1158/1055-9965.EPI-04-0366; Sadetzki S, 2002, J NEUROSURG, V97, P1078, DOI 10.3171/jns.2002.97.5.1078; Shimizu J, 2008, NEUROL MED-CHIR, V48, P227, DOI 10.2176/nmc.48.227; Swerdlow AJ, 2019, J CLIN ENDOCR METAB, V104, P658, DOI 10.1210/jc.2018-01133; Sys Celine, 2015, GMS Ophthalmol Cases, V5, pDoc05, DOI 10.3205/oc000027; Taylor AJ, 2010, J CLIN ONCOL, V28, P5287, DOI 10.1200/JCO.2009.27.0090; Tuppin P, 2017, REV EPIDEMIOL SANTE, V65, pS149, DOI 10.1016/j.respe.2017.05.004; Ulgen E, 2019, WORLD NEUROSURG, V123, pE520, DOI 10.1016/j.wneu.2018.11.201; van der Vossen S, 2014, J REHABIL MED, V46, P430, DOI 10.2340/16501977-1795; Weill A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2002; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3; Wigertz A, 2008, CANCER EPIDEM BIOMAR, V17, P2663, DOI 10.1158/1055-9965.EPI-08-0406; Wigertz A, 2006, AM J EPIDEMIOL, V164, P629, DOI 10.1093/aje/kwj254; Zairi F, 2017, J NEUROSURG SCI, V61, P98	74	32	32	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2021	372								n37	10.1136/bmj.n37	http://dx.doi.org/10.1136/bmj.n37			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC1TD	33536184	hybrid			2022-12-28	WOS:000686315900010
J	Rushton, J; Huntington, B; Gilbert, W; Herrero, M; Torgerson, PR; Shaw, APM; Bruce, M; Marsh, TL; Pendell, DL; Bernardo, TM; Stacey, D; Grace, D; Watkins, K; Bondad-Reantaso, M; Devleesschauwer, B; Pigott, DM; Stone, M; Mesenhowski, S				Rushton, J.; Huntington, B.; Gilbert, W.; Herrero, M.; Torgerson, P. R.; Shaw, A. P. M.; Bruce, M.; Marsh, T. L.; Pendell, D. L.; Bernardo, T. M.; Stacey, D.; Grace, D.; Watkins, K.; Bondad-Reantaso, M.; Devleesschauwer, B.; Pigott, D. M.; Stone, M.; Mesenhowski, S.			Roll-out of the Global Burden of Animal Diseases programme	LANCET			English	Editorial Material							LIVESTOCK		[Rushton, J.; Huntington, B.; Gilbert, W.; Shaw, A. P. M.] Univ Liverpool, Inst Infection Veterinary & Ecol Sci, Dept Livestock & One Hlth, Liverpool L3 5RF, Merseyside, England; [Huntington, B.] Pengwern Anim Hlth Ltd, Wallasey Village, England; [Herrero, M.] CSIRO Agr & Food, St Lucia, Qld, Australia; [Torgerson, P. R.] Univ Zurich, Vetsuisse Fac, Epidemiol Sect, Zurich, Switzerland; [Shaw, A. P. M.] AP Consultants, Andover, MA USA; [Bruce, M.] Murdoch Univ, Sch Vet Med, Ctr Anim Prod & Hlth, Murdoch, WA, Australia; [Marsh, T. L.] Washington State Univ, Sch Econ Sci, Paul G Allen Sch Global Anim Hlth, Allen Ctr, Pullman, WA 99164 USA; [Pendell, D. L.] Kansas State Univ, Dept Agr Econ, Manhattan, KS 66506 USA; [Bernardo, T. M.] Univ Guelph, Dept Populat Med, Ontario Vet Coll, Guelph, ON, Canada; [Stacey, D.] Univ Guelph, Sch Comp Sci, Guelph, ON, Canada; [Grace, D.] Univ Greenwich, Nat Resources Inst, Fac Sci & Engn, Food & Markets Dept, Chatham, Kent, England; [Grace, D.] Int Livestock Res Inst, Nairobi, Kenya; [Watkins, K.] FoodFirst LLC, Indianapolis, IN USA; [Bondad-Reantaso, M.] Food & Agr Org United Nations, Div Fisheries, Rome, Italy; [Devleesschauwer, B.] Dept Epidemiol & Publ Hlth, Brussels, Belgium; [Bondad-Reantaso, M.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Stone, M.] OIE World Org Anim Hlth, Paris, France; [Mesenhowski, S.] Bill & Melinda Gates Fdn, Seattle, WA USA	University of Liverpool; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Zurich; Murdoch University; Washington State University; Kansas State University; University of Guelph; University of Guelph; University of Greenwich; CGIAR; International Livestock Research Institute (ILRI); Food & Agriculture Organization of the United Nations (FAO); Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Bill & Melinda Gates Foundation	Rushton, J (corresponding author), Univ Liverpool, Inst Infection Veterinary & Ecol Sci, Dept Livestock & One Hlth, Liverpool L3 5RF, Merseyside, England.	j.rushton@liverpool.ac.uk	Torgerson, Paul/M-4447-2013	Torgerson, Paul/0000-0003-4277-9983	BBSRC [BB/R021279/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Livestock Environment and Development Initiative Food and Agriculture Organization of the United Nations, 2006, LIV ENV DEV IN; Mehrabi Z, 2020, NAT FOOD, V1, P160, DOI 10.1038/s43016-020-0042-9; Murray CJL, 2020, LANCET, V396, P1223, DOI 10.1016/S0140-6736(20)30752-2; OIE, 2020, OIE ANN REP ANT AG I; OIE, 2016, RES AD WORLD ASS DEL; Rothman-Ostrow P, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.556788; Rushton J, 2018, LANCET, V392, P538, DOI 10.1016/S0140-6736(18)31472-7; Woolhouse M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0083	10	8	8	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2021	397	10279					1045	1046		10.1016/S0140-6736(21)00189-6	http://dx.doi.org/10.1016/S0140-6736(21)00189-6		MAR 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QZ0AN	33549170				2022-12-28	WOS:000630397800008
J	Penninx, BWJH; Pine, DS; Holmes, EA; Reif, A				Penninx, Brenda W. J. H.; Pine, Daniel S.; Holmes, Emily A.; Reif, Andreas			Anxiety disorders	LANCET			English	Review							CROSS-NATIONAL EPIDEMIOLOGY; COGNITIVE-BEHAVIORAL THERAPY; MENTAL-DISORDERS; 2-YEAR COURSE; CLINICAL-OUTCOMES; PANIC DISORDER; HEALTH; METAANALYSIS; DEPRESSION; ONSET	Anxiety disorders form the most common group of mental disorders and generally start before or in early adulthood. Core features include excessive fear and anxiety or avoidance of perceived threats that are persistent and impairing. Anxiety disorders involve dysfunction in brain circuits that respond to danger. Risk for anxiety disorders is influenced by genetic factors, environmental factors, and their epigenetic relations. Anxiety disorders are often comorbid with one another and with other mental disorders, especially depression, as well as with somatic disorders. Such comorbidity generally signifies more severe symptoms, greater clinical burden, and greater treatment difficulty. Reducing the large burden of disease from anxiety disorders in individuals and worldwide can be best achieved by timely, accurate disease detection and adequate treatment administration, scaling up of treatments when needed. Evidence-based psychotherapy (particularly cognitive behavioural therapy) and psychoactive medications (particularly serotonergic compounds) are both effective, facilitating patients' choices in therapeutic decisions. Although promising, no enduring preventive measures are available, and, along with frequent therapy resistance, clinical needs remain unaddressed. Ongoing research efforts tackle these problems, and future efforts should seek individualised, more effective approaches for treatment with precision medicine.	[Penninx, Brenda W. J. H.] Vrije Univ, Amsterdam Univ Med Ctr, Dept Psychiat, NL-1081 HL Amsterdam, Netherlands; [Penninx, Brenda W. J. H.] GGZ InGeest, Amsterdam, Netherlands; [Pine, Daniel S.] NIMH, Emot & Dev Branch, Bethesda, MD 20892 USA; [Holmes, Emily A.] Uppsala Univ, Dept Psychol, Uppsala, Sweden; [Reif, Andreas] Goethe Univ, Univ Hosp Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany	Vrije Universiteit Amsterdam; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Uppsala University; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Penninx, BWJH (corresponding author), Vrije Univ, Amsterdam Univ Med Ctr, Dept Psychiat, NL-1081 HL Amsterdam, Netherlands.	b.penninx@amsterdamumc.nl						Ambrosini PJ, 2000, J AM ACAD CHILD PSY, V39, P49, DOI 10.1097/00004583-200001000-00016; Anacker C, 2017, NAT REV NEUROSCI, V18, P335, DOI 10.1038/nrn.2017.45; Bandelow B, 2015, DIALOGUES CLIN NEURO, V17, P327; Bandelow B, 2015, INT CLIN PSYCHOPHARM, V30, P183, DOI 10.1097/YIC.0000000000000078; Barlow DH, 2017, JAMA PSYCHIAT, V74, P875, DOI 10.1001/jamapsychiatry.2017.2164; Batelaan NM, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3927; Batelaan NM, 2016, BRIT J PSYCHIAT, V208, P223, DOI 10.1192/bjp.bp.114.156554; Batelaan NM, 2012, J CLIN PSYCHIAT, V73, P1195, DOI 10.4088/JCP.12m07743; Baxter AJ, 2013, PSYCHOL MED, V43, P897, DOI 10.1017/S003329171200147X; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bighelli I, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010676.pub2; Boedhoe PSW, 2018, AM J PSYCHIAT, V175, P453, DOI 10.1176/appi.ajp.2017.17050485; Bouchard S, 2017, BRIT J PSYCHIAT, V210, P276, DOI 10.1192/bjp.bp.116.184234; Brady LS, 2019, EXPERT OPIN DRUG DIS, V14, P1213, DOI 10.1080/17460441.2019.1666102; Breilmann J, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010677.pub2; Brenes GA, 2015, JAMA PSYCHIAT, V72, P1012, DOI 10.1001/jamapsychiatry.2015.1154; Brown LA, 2015, PSYCHOL MED, V45, P647, DOI 10.1017/S0033291714002062; Caldwell DM, 2019, LANCET PSYCHIAT, V6, P1011, DOI 10.1016/S2215-0366(19)30403-1; Caspi A, 2018, AM J PSYCHIAT, V175, P831, DOI 10.1176/appi.ajp.2018.17121383; Chawner SJRA, 2019, LANCET PSYCHIAT, V6, P493, DOI 10.1016/S2215-0366(19)30123-3; Christensen H, 2016, LANCET PSYCHIAT, V3, P333, DOI 10.1016/S2215-0366(15)00536-2; Cirillo P, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1284; Copeland WE, 2014, J AM ACAD CHILD PSY, V53, P21, DOI 10.1016/j.jaac.2013.09.017; Costello H, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027925; Craske MG, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0025; Creswell C, 2017, LANCET PSYCHIAT, V4, P529, DOI 10.1016/S2215-0366(17)30149-9; Cuijpers P, 2016, WORLD PSYCHIATRY, V15, P245, DOI 10.1002/wps.20346; Cuijpers P, 2014, WORLD PSYCHIATRY, V13, P56, DOI 10.1002/wps.20089; Curtiss J, 2017, EXPERT OPIN PHARMACO, V18, P243, DOI 10.1080/14656566.2017.1285907; de Jonge P, 2016, DEPRESS ANXIETY, V33, P1155, DOI 10.1002/da.22572; de Quervain D, 2017, NAT REV NEUROSCI, V18, P7, DOI 10.1038/nrn.2016.155; de Vries YA, 2018, DEPRESS ANXIETY, V35, P515, DOI 10.1002/da.22737; Deady M, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1473-1; Deane KHO, 2021, BRIT J PSYCHIAT, V218, P135, DOI 10.1192/bjp.2019.234; Deckert J, 2017, MOL PSYCHIATR, V22, P1431, DOI 10.1038/mp.2017.2; Duits P, 2015, DEPRESS ANXIETY, V32, P239, DOI 10.1002/da.22353; Einarson A, 2010, DEPRESS ANXIETY, V27, P35, DOI 10.1002/da.20598; Eisner MD, 2010, THORAX, V65, P229, DOI 10.1136/thx.2009.126201; Fonzo GA, 2017, DIALOGUES CLIN NEURO, V19, P169; Forstner AJ, 2021, MOL PSYCHIATR, V26, P4179, DOI 10.1038/s41380-019-0590-2; Fox AS, 2014, AM J PSYCHIAT, V171, P1162, DOI 10.1176/appi.ajp.2014.14040449; Freeman D, 2018, LANCET PSYCHIAT, V5, P625, DOI 10.1016/S2215-0366(18)30226-8; Garfin DR, 2020, HEALTH PSYCHOL, V39, P355, DOI 10.1037/hea0000875; Generoso MB, 2017, INT CLIN PSYCHOPHARM, V32, P49, DOI 10.1097/YIC.0000000000000147; Gingnell M, 2016, BRIT J PSYCHIAT, V209, P229, DOI 10.1192/bjp.bp.115.175794; Ginsburg GS, 2015, AM J PSYCHIAT, V172, P1207, DOI 10.1176/appi.ajp.2015.14091178; Glue P, 2020, J PSYCHOPHARMACOL, V34, P267, DOI 10.1177/0269881119874457; Gomez AF, 2018, EXPERT OPIN PHARMACO, V19, P883, DOI 10.1080/14656566.2018.1472767; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hendriks SM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0946-y; Hendriks SM, 2013, ACTA PSYCHIAT SCAND, V128, P212, DOI 10.1111/acps.12024; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Holmes EA, 2018, LANCET PSYCHIAT, V5, P237, DOI 10.1016/S2215-0366(17)30513-8; Howe AS, 2016, MOL PSYCHIATR, V21, P665, DOI 10.1038/mp.2015.138; Iancu SC, 2014, PSYCHOL MED, V44, P593, DOI 10.1017/S0033291713001050; James AC, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004690.pub3, 10.1002/14651858.CD004690.pub4]; Janiri D., 2019, JAMA PSYCHIAT, P1, DOI DOI 10.1001/jamapsychiatry.2019.3351; Ji JLL, 2019, CNS SPECTRUMS, V24, P114, DOI 10.1017/S1092852918001487; Joyal M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214998; Joyce S, 2016, PSYCHOL MED, V46, P683, DOI 10.1017/S0033291715002408; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Kindt M, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0033; Kircanski K, 2018, JAMA PSYCHIAT, V75, P631, DOI 10.1001/jamapsychiatry.2018.0468; Lamers F, 2011, J CLIN PSYCHIAT, V72, P341, DOI 10.4088/JCP.10m06176blu; Lawrence PJ, 2019, J AM ACAD CHILD PSY, V58, P46, DOI 10.1016/j.jaac.2018.07.898; Lebowitz ER, 2020, J AM ACAD CHILD PSY, V59, P362, DOI 10.1016/j.jaac.2019.02.014; LeDoux J, 2018, NAT REV NEUROSCI, V19, P269, DOI 10.1038/nrn.2018.22; Levey DF, 2020, AM J PSYCHIAT, V177, P223, DOI 10.1176/appi.ajp.2019.19030256; Lewis-Fernandez R, 2016, PSYCHOL MED, V46, P1987, DOI 10.1017/S0033291716000763; Locher C, 2017, JAMA PSYCHIAT, V74, P1011, DOI 10.1001/jamapsychiatry.2017.2432; Maneeton N, 2016, DRUG DES DEV THER, V10, P259, DOI 10.2147/DDDT.S89485; Marin MF, 2020, JAMA PSYCHIAT, V77, P618, DOI 10.1001/jamapsychiatry.2019.4833; Marwood L, 2018, NEUROSCI BIOBEHAV R, V95, P61, DOI 10.1016/j.neubiorev.2018.09.022; Mataix-Cols D, 2017, JAMA PSYCHIAT, V74, P501, DOI 10.1001/jamapsychiatry.2016.3955; Mayo-Wilson E, 2014, LANCET PSYCHIAT, V1, P368, DOI 10.1016/S2215-0366(14)70329-3; McClellan J, 2017, J AM ACAD CHILD PSY, V56, P1008, DOI 10.1016/j.jaac.2017.09.431; McTeague LM, 2012, DEPRESS ANXIETY, V29, P264, DOI 10.1002/da.21891; Meier SM, 2019, JAMA PSYCHIAT, V76, P924, DOI 10.1001/jamapsychiatry.2019.1119; Meier SM, 2019, CURR PSYCHIAT REP, V21, DOI 10.1007/s11920-019-1002-7; Meier SM, 2016, BRIT J PSYCHIAT, V209, P216, DOI 10.1192/bjp.bp.115.171975; Meier SM, 2015, LANCET PSYCHIAT, V2, P515, DOI 10.1016/S2215-0366(15)00092-9; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Mkrtchian A, 2017, BIOL PSYCHIAT, V82, P532, DOI 10.1016/j.biopsych.2017.01.017; Momen NC, 2020, NEW ENGL J MED, V382, P1721, DOI 10.1056/NEJMoa1915784; Monfils MH, 2018, LANCET PSYCHIAT, V5, P1032, DOI 10.1016/S2215-0366(18)30270-0; Moreno-Peral P, 2017, JAMA PSYCHIAT, V74, P1021, DOI 10.1001/jamapsychiatry.2017.2509; Moser JS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00466; Nagel M, 2018, NAT GENET, V50, P920, DOI 10.1038/s41588-018-0151-7; National Institute of Health and Care Excellence, 2014, ANXIETY DISORDERS; Olthuis JV, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011565; Ormel J, 2015, PSYCHOL MED, V45, P345, DOI 10.1017/S0033291714001469; Otowa T, 2016, MOL PSYCHIATR, V21, P1391, DOI 10.1038/mp.2015.197; Otte C, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.65; Pasion R, 2019, NEUROSCI BIOBEHAV R, V103, P133, DOI 10.1016/j.neubiorev.2019.06.013; Patterson B, 2016, DEPRESS ANXIETY, V33, P728, DOI 10.1002/da.22525; Penninx BWJH, 2011, J AFFECT DISORDERS, V133, P76, DOI 10.1016/j.jad.2011.03.027; Pergamin-Hight L, 2015, CLIN PSYCHOL REV, V35, P10, DOI 10.1016/j.cpr.2014.10.005; Pine DS, 2015, ANNU REV PSYCHOL, V66, P459, DOI 10.1146/annurev-psych-010814-015038; Pitman A, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1415; Pittig A, 2018, NEUROSCI BIOBEHAV R, V88, P117, DOI 10.1016/j.neubiorev.2018.03.015; Pittig A, 2016, CURR OPIN PSYCHIATR, V29, P39, DOI 10.1097/YCO.0000000000000220; Plaisier I, 2010, J AFFECT DISORDERS, V125, P198, DOI 10.1016/j.jad.2010.01.072; Plummer F, 2016, GEN HOSP PSYCHIAT, V39, P24, DOI 10.1016/j.genhosppsych.2015.11.005; Purves KL, 2020, MOL PSYCHIATR, V25, P3292, DOI 10.1038/s41380-019-0559-1; Rebar AL, 2015, HEALTH PSYCHOL REV, V9, P366, DOI 10.1080/17437199.2015.1022901; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Rith-Najarian LR, 2019, J AFFECT DISORDERS, V257, P568, DOI 10.1016/j.jad.2019.06.035; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Roest AM, 2019, DEPRESS ANXIETY, V36, P499, DOI 10.1002/da.22885; Ruscio AM, 2017, JAMA PSYCHIAT, V74, P465, DOI 10.1001/jamapsychiatry.2017.0056; Schartner C, 2017, EUR NEUROPSYCHOPHARM, V27, P360, DOI 10.1016/j.euroneuro.2017.01.005; Schmaal L, 2017, MOL PSYCHIATR, V22, P900, DOI 10.1038/mp.2016.60; Schmaal L, 2015, BIOL PSYCHIAT, V77, DOI 10.1038/mp.2015.69; Scholten WD, 2016, J AFFECT DISORDERS, V195, P185, DOI 10.1016/j.jad.2016.02.025; Silove DM, 2016, J AFFECT DISORDERS, V205, P292, DOI 10.1016/j.jad.2016.07.052; Slee A, 2019, LANCET, V393, P768, DOI 10.1016/S0140-6736(18)31793-8; Smaardijk VR, 2020, INT J CARDIOL, V302, P21, DOI 10.1016/j.ijcard.2019.12.014; Soeter M, 2015, BIOL PSYCHIAT, V78, P880, DOI 10.1016/j.biopsych.2015.04.006; Spinhoven P, 2016, J ANXIETY DISORD, V44, P92, DOI 10.1016/j.janxdis.2016.10.011; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Spoorthy MS, 2019, WORLD J PSYCHIATR, V9, P7, DOI 10.5498/wjp.v9.i1.7; Stein DJ, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0889-2; Stockings EA, 2016, PSYCHOL MED, V46, P11, DOI 10.1017/S0033291715001725; Taylor JH, 2018, NEUROPSYCHOPHARMACOL, V43, P325, DOI 10.1038/npp.2017.194; VANZUUREN FJ, 1988, BRIT J PSYCHIAT, V153, P659, DOI 10.1192/bjp.153.5.659; Vogelzangs N, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.92; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Wardenaar KJ, 2017, PSYCHOL MED, V47, P1744, DOI [10.1017/S0033291717000174, 10.1017/s0033291717000174]; White LK, 2017, AM J PSYCHIAT, V174, P775, DOI 10.1176/appi.ajp.2017.16070847; Windle E, 2020, JAMA PSYCHIAT, V77, P294, DOI 10.1001/jamapsychiatry.2019.3750; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wu Y, 2018, PSYCHIAT RES-NEUROIM, V282, P82, DOI 10.1016/j.pscychresns.2018.09.009; Ziegler C, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.41; Ziegler C, 2015, NEUROPSYCHOPHARMACOL, V40, P1528, DOI 10.1038/npp.2015.2; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	135	57	59	40	88	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2021	397	10277					914	927		10.1016/S0140-6736(21)00359-7	http://dx.doi.org/10.1016/S0140-6736(21)00359-7		MAR 2021	14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QT5BR	33581801	Green Accepted			2022-12-28	WOS:000626603400030
J	Vorobieva, AA; White, P; Liang, BY; Horne, JE; Bera, AK; Chow, CM; Gerben, S; Marx, S; Kang, A; Stiving, AQ; Harvey, SR; Marx, DC; Khan, GN; Fleming, KG; Wysocki, VH; Brockwell, DJ; Tamm, LK; Radford, SE; Baker, D				Vorobieva, Anastassia A.; White, Paul; Liang, Binyong; Horne, Jim E.; Bera, Asim K.; Chow, Cameron M.; Gerben, Stacey; Marx, Sinduja; Kang, Alex; Stiving, Alyssa Q.; Harvey, Sophie R.; Marx, Dagan C.; Khan, G. Nasir; Fleming, Karen G.; Wysocki, Vicki H.; Brockwell, David J.; Tamm, Lukas K.; Radford, Sheena E.; Baker, David			De novo design of transmembrane beta barrels	SCIENCE			English	Article							MEMBRANE-PROTEIN OMPA; THERMODYNAMIC STABILITY; SELF-ASSOCIATION; AROMATIC RESCUE; LIPID-BILAYERS; TORSION ANGLES; SHEET BARRELS; SEQUENCE; PRINCIPLES; PEPTIDES	Transmembrane beta-barrel proteins (TMBs) are of great interest for single-molecule analytical technologies because they can spontaneously fold and insert into membranes and form stable pores, but the range of pore properties that can be achieved by repurposing natural TMBs is limited. We leverage the power of de novo computational design coupled with a "hypothesis, design, and test" approach to determine TMB design principles, notably, the importance of negative design to slow beta-sheet assembly. We design new eight-stranded TMBs, with no homology to known TMBs, that insert and fold reversibly into synthetic lipid membranes and have nuclear magnetic resonance and x-ray crystal structures very similar to the computational models. These advances should enable the custom design of pores for a wide range of applications.	[Vorobieva, Anastassia A.; Bera, Asim K.; Chow, Cameron M.; Gerben, Stacey; Kang, Alex; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Vorobieva, Anastassia A.; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [White, Paul; Horne, Jim E.; Khan, G. Nasir; Brockwell, David J.; Radford, Sheena E.] Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Liang, Binyong; Tamm, Lukas K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA; [Liang, Binyong; Tamm, Lukas K.] Univ Virginia, Ctr Membrane & Cell Physiol, Charlottesville, VA 22903 USA; [Bera, Asim K.; Chow, Cameron M.; Kang, Alex; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Marx, Sinduja] Univ Washington, Dept Mol Engn & Sci, Seattle, WA 98195 USA; [Stiving, Alyssa Q.; Harvey, Sophie R.; Wysocki, Vicki H.] Ohio State Univ, Dept Chem & Biochem, Resource Nat Mass Spectrometry Guided Struct Biol, Columbus, OH 43210 USA; [Marx, Dagan C.; Fleming, Karen G.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA; [Vorobieva, Anastassia A.] VIB VUB Ctr Struct Biol, VIB, Brussels, Belgium; [Horne, Jim E.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Stiving, Alyssa Q.] Merck & Co Inc, Analyt Res & Dev, 770 Sumneytown Pike, West Point, PA USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Leeds; University of Virginia; University of Virginia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University System of Ohio; Ohio State University; Johns Hopkins University; Flanders Institute for Biotechnology (VIB); University of Oxford; Merck & Company	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.	dabaker@uw.edu		Harvey, Sophie/0000-0003-0763-8173; Marx, Dagan/0000-0003-0149-3778; Horne, Jim/0000-0001-5260-2634; Chow, Cameron/0000-0001-5351-6412; Marx, Sinduja/0000-0002-6126-6019; Gerben, Stacey/0000-0003-0313-6248; Vorobieva, Anastassia/0000-0001-5554-1398; White, Paul/0000-0001-7536-4552	HHMI; Fulbright Belgium and Luxembourg; BBSRC [BB/M011151/1]; MRC [MR/P018491/1]; NIH [R01 GM051329, P01 GM072694, R01 GM079440, T32 GM008403, P30GM124165, S10OD021527]; Open Philanthropy Project Improving Protein Design Fund; Air Force Office of Scientific Research [FA9550-18-1-0297]; Nordstrom Barrier Institute for Protein Design Directors Fund; Wellcome Trust [094232/Z/10/Z]; NIH P41 grant [GM128577]; DOE [DE-AC02-06CH11357]	HHMI(Howard Hughes Medical Institute); Fulbright Belgium and Luxembourg; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Open Philanthropy Project Improving Protein Design Fund; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Nordstrom Barrier Institute for Protein Design Directors Fund; Wellcome Trust(Wellcome TrustEuropean Commission); NIH P41 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE))	We acknowledge funding from HHMI (D.B. and A. A. V.), Fulbright Belgium and Luxembourg (A.A.V.), BBSRC (BB/M011151/1 to J.E.H.), MRC (MR/P018491/1 to P.W. and G.N.K.), NIH grants R01 GM051329 and P01 GM072694 for the NMR work (L.K.T.), R01 GM079440 (K.G.F.), T32 GM008403 (K.G.F.), and The Open Philanthropy Project Improving Protein Design Fund (D.B. and C.M.C.), Air Force Office of Scientific Research (FA9550-18-1-0297 to D.B. and C.M.C.), The Nordstrom Barrier Institute for Protein Design Directors Fund (D.B. and S.M.), and Eric and Wendy Schmidt by recommendation of the Schmidt Futures program (D.B. and S.G.). The CD instrument in Leeds was funded by the Wellcome Trust (094232/Z/10/Z). The native mass spectrometry studies were supported by a NIH P41 grant (GM128577 to V.H. W.). Northeastern Collaborative Access Team beamline was supported by NIH grants P30GM124165 and S10OD021527, and DOE contract DE-AC02-06CH11357.	Adams P.D., 2012, INT TABLES CRYSTALLO, P539, DOI 10.1107/97809553602060000865; Jimenez MA, 2014, METHODS MOL BIOL, V1216, P15, DOI 10.1007/978-1-4939-1486-9_2; Bishop CR, 2001, J MOL BIOL, V309, P975, DOI 10.1006/jmbi.2001.4715; Blandl T, 2003, PROTEIN SCI, V12, P237, DOI 10.1110/ps.0228603; Boyken SE, 2016, SCIENCE, V352, P680, DOI 10.1126/science.aad8865; Burgess NK, 2008, J BIOL CHEM, V283, P26748, DOI 10.1074/jbc.M802754200; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; Chaturvedi D, 2017, BBA-BIOMEMBRANES, V1859, P2467, DOI 10.1016/j.bbamem.2017.09.020; Chen PY, 2001, PROTEIN SCI, V10, P1794, DOI 10.1110/ps.49001; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Craveur P, 2013, PROTEIN SCI, V22, P1366, DOI 10.1002/pro.2324; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Danoff EJ, 2017, BIOCHEMISTRY-US, V56, P47, DOI 10.1021/acs.biochem.6b00809; Danoff EJ, 2011, BIOPHYS CHEM, V159, P194, DOI 10.1016/j.bpc.2011.06.013; deAlba E, 1996, FOLD DES, V1, P133, DOI 10.1016/S1359-0278(96)00022-3; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dou JY, 2018, NATURE, V561, P485, DOI 10.1038/s41586-018-0509-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fioroni M., 2013, BARREL CHANNEL PROTE; Fioroni M., 2013, FBARREL CHANNEL PROT; Fleishman SJ, 2012, CELL, V149, P262, DOI 10.1016/j.cell.2012.03.016; Flower DR, 1996, BIOCHEM J, V318, P1; Franklin MW, 2018, J MOL BIOL, V430, P3251, DOI 10.1016/j.jmb.2018.06.013; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fujiwara K, 2014, PROTEINS, V82, P1484, DOI 10.1002/prot.24518; Goddard T. D., SPARKY 3; Greene LH, 2001, PROTEIN SCI, V10, P2301, DOI 10.1110/ps.22901; Gront D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023294; Guan XY, 2005, CHEMBIOCHEM, V6, P1875, DOI 10.1002/cbic.200500064; Haque F, 2012, ACS NANO, V6, P3251, DOI 10.1021/nn3001615; HEMMINGSEN JM, 1994, PROTEIN SCI, V3, P1927, DOI 10.1002/pro.5560031104; Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101; Hong HD, 2007, J AM CHEM SOC, V129, P8320, DOI 10.1021/ja068849o; Horne JE, 2020, J BIOL CHEM, V295, P10340, DOI 10.1074/jbc.REV120.011473; Huysmans GHM, 2010, P NATL ACAD SCI USA, V107, P4099, DOI 10.1073/pnas.0911904107; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Jackups R, 2005, J MOL BIOL, V354, P979, DOI 10.1016/j.jmb.2005.09.094; Jackups R, 2006, J MOL BIOL, V363, P611, DOI 10.1016/j.jmb.2006.07.095; Joh NH, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0214; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kallberg M, 2014, METHODS MOL BIOL, V1137, P17, DOI 10.1007/978-1-4939-0366-5_2; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Kleinschmidt J. H., 2003, METHOD MOL BIOL, V2019, P145; Kleinschmidt JH, 2002, J MOL BIOL, V324, P319, DOI 10.1016/S0022-2836(02)01071-9; Kleinschmidt JH, 1999, BIOCHEMISTRY-US, V38, P5006, DOI 10.1021/bi982465w; Kleinschmidt JH, 1996, BIOCHEMISTRY-US, V35, P12993, DOI 10.1021/bi961478b; Kleinschmidt JH, 2015, BBA-BIOMEMBRANES, V1848, P1927, DOI 10.1016/j.bbamem.2015.05.004; Koebnik R, 1999, J BACTERIOL, V181, P3688, DOI 10.1128/JB.181.12.3688-3694.1999; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Langan RA, 2019, NATURE, V572, P205, DOI 10.1038/s41586-019-1432-8; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Leyton DL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5239; Lin YR, 2015, P NATL ACAD SCI USA, V112, pE5478, DOI 10.1073/pnas.1509508112; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Lu PL, 2018, SCIENCE, V359, P1042, DOI 10.1126/science.aaq1739; Marcos E, 2018, NAT STRUCT MOL BIOL, V25, P1028, DOI 10.1038/s41594-018-0141-6; Marcos E, 2017, SCIENCE, V355, P201, DOI 10.1126/science.aah7389; Marty MT, 2015, ANAL CHEM, V87, P4370, DOI 10.1021/acs.analchem.5b00140; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCLACHLAN AD, 1979, J MOL BIOL, V128, P49, DOI 10.1016/0022-2836(79)90308-5; Merkel JS, 1998, FOLD DES, V3, P449, DOI 10.1016/S1359-0278(98)00062-5; Michalik M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182016; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Misra R., 2012, ISRN MOL BIOL, V2012, DOI DOI 10.5402/2012/708203; Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110; Moon CP, 2011, J MOL BIOL, V413, P484, DOI 10.1016/j.jmb.2011.08.041; Moon CP, 2011, P NATL ACAD SCI USA, V108, P10174, DOI 10.1073/pnas.1103979108; MURZIN AG, 1994, J MOL BIOL, V236, P1382, DOI 10.1016/0022-2836(94)90065-5; MURZIN AG, 1994, J MOL BIOL, V236, P1369, DOI 10.1016/0022-2836(94)90064-7; Ng AH, 2019, NATURE, V572, P265, DOI 10.1038/s41586-019-1425-7; Ohnishi S, 2001, BBA-BIOMEMBRANES, V1515, P159, DOI 10.1016/S0005-2736(01)00410-2; Park H, 2016, J CHEM THEORY COMPUT, V12, P6201, DOI 10.1021/acs.jctc.6b00819; Pocanschi CL, 2006, BIOPHYS J, V91, pL75, DOI 10.1529/biophysj.106.091439; Popot JL, 2014, ARCH BIOCHEM BIOPHYS, V564, P314, DOI 10.1016/j.abb.2014.06.029; Requiao RD, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005549; Ricci D. P., 2019, ECOSALPLUS, V8, DOI [10.1128/ecosalplus.ESP-0035-2018, DOI 10.1128/ECOSALPLUS.ESP-0035-2018]; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; Schiffrin B, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0464-5; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Silva DA, 2019, NATURE, V565, P186, DOI 10.1038/s41586-018-0830-7; Stapleton JA, 2015, P NATL ACAD SCI USA, V112, P9632, DOI 10.1073/pnas.1501836112; Stein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063090; SURREY T, 1992, P NATL ACAD SCI USA, V89, P7457, DOI 10.1073/pnas.89.16.7457; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; Tan AE, 2010, MACROMOL BIOSCI, V10, P763, DOI 10.1002/mabi.200900479; Tu YM, 2020, NAT MATER, V19, P347, DOI 10.1038/s41563-019-0577-z; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; Vorobieva A, 2020, VOROBIEVA TRANSMEMBR, DOI [10.5281/zenodo.4068108, DOI 10.5281/ZENODO.4068108]; Walsh I, 2014, NUCLEIC ACIDS RES, V42, pW301, DOI 10.1093/nar/gku399; Wang H, 2013, BBA-PROTEINS PROTEOM, V1834, P127, DOI 10.1016/j.bbapap.2012.09.002; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wimley WC, 2002, PROTEIN SCI, V11, P301, DOI 10.1110/ps.29402; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	99	31	32	9	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					801	+	eabc8182	10.1126/science.abc8182	http://dx.doi.org/10.1126/science.abc8182			88	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QJ4MB	33602829	Green Accepted, Green Submitted			2022-12-28	WOS:000619664700047
J	Baraniuk, C				Baraniuk, Chris			Covid-19: How the UK vaccine rollout delivered success, so far	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												chrisbaraniuk@gmail.com						[Anonymous], 2020, PFIZER 1202; [Anonymous], 2021, SKY NEWS; Boffey D, 2021, GUARDIAN; Bolzen S, 2021, LA REPUBBLICA; Dickinson K., 2021, CHRONICLE LIVE; Gardner B, 2021, TELEGRAPH; Guerrera A, 2021, LA REPUBBLICA; Lem P., 2021, RES PROFESSIONA 0127; Manthorpe R., 2021, SKY NEWS; Sharma A, 2020, VACC MAN INN CTR OP; Triggle N., 2021, BBC NEWS; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n326	12	36	36	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2021	372								n421	10.1136/bmj.n421	http://dx.doi.org/10.1136/bmj.n421			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK7SF	33602672	Bronze			2022-12-28	WOS:000620581100003
J	Ma, S; Dubin, AE; Zhang, YX; Mousavi, SAR; Wang, Y; Coombs, AM; Loud, M; Andolfo, I; Patapoutian, A				Ma, Shang; Dubin, Adrienne E.; Zhang, Yunxiao; Mousavi, Seyed Ali Reza; Wang, Yu; Coombs, Adam M.; Loud, Meaghan; Andolfo, Immacolata; Patapoutian, Ardem			A role of PIEZO1 in iron metabolism in mice and humans	CELL			English	Article							ACTIVATED ION-CHANNEL; OF-FUNCTION MUTATIONS; MOUSE MODEL; MACROPHAGES; OVERLOAD; HEPCIDIN; GENE; HEMOCHROMATOSIS; ERYTHROFERRONE; TRAFFICKING	Iron overload causes progressive organ damage and is associated with arthritis, liver damage, and heart failure. Elevated iron levels are present in 1%-5% of individuals; however, iron overload is undermonitored and underdiagnosed. Genetic factors affecting iron homeostasis are emerging. Individuals with hereditary xerocytosis, a rare disorder with gain-of-function (GOF) mutations in mechanosensitive PIEZO1 ion channel, develop age-onset iron overload. We show that constitutive or macrophage expression of a GOF Piezo1 allele in mice disrupts levels of the iron regulator hepcidin and causes iron overload. We further show that PIEZO1 is a key regulator of macrophage phagocytic activity and subsequent erythrocyte turnover. Strikingly, we find that E756del, a mild GOF PIEZO1 allele present in one-third of individuals of African descent, is strongly associated with increased plasma iron. Our study links macrophage mechanotransduction to iron metabolism and identifies a genetic risk factor for increased iron levels in African Americans.	[Ma, Shang; Dubin, Adrienne E.; Zhang, Yunxiao; Mousavi, Seyed Ali Reza; Wang, Yu; Coombs, Adam M.; Loud, Meaghan; Patapoutian, Ardem] Scripps Res, Howard Hughes Med Inst, Dept Neurosci, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Andolfo, Immacolata] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, CEINGE Biotecnol Avanzate, Naples, Italy	Howard Hughes Medical Institute; Scripps Research Institute; CEINGE Biotecnologie Avanzate; University of Naples Federico II	Patapoutian, A (corresponding author), Scripps Res, Howard Hughes Med Inst, Dept Neurosci, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	ardem@scripps.edu	Andolfo, Immacolata/K-7381-2016	Andolfo, Immacolata/0000-0003-0493-812X; Mousavi, Seyed Ali Reza/0000-0002-2948-1771; Zhang, Yunxiao/0000-0003-2145-4151; Coombs, Adam/0000-0001-5690-0364	NIH [R35 NS105067, R01 DE022358]; Calibr-GHDDI Gates postdoctoral fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Calibr-GHDDI Gates postdoctoral fellowship	We thank Adrienne Dubin, Tomas Ganz, Rose Hill, and Kara Marshall for critical reading of the manuscript. We thank Roberto Aiolfi from Ruggeri lab at The Scripps Research Institute (TSRI) for sharing ProCyte equipment. We also thank Achille Iolascon and Roberta Russo for discussions on experimental design. This work was supported by NIH grants R35 NS105067 and R01 DE022358 to A.P. S.M. was supported by a Calibr-GHDDI Gates postdoctoral fellowship. A.P. is an investigator of the Howard Hughes Medical Institute.	Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Albuisson J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2899; Andolfo I, 2020, AM J HEMATOL, V95, P188, DOI 10.1002/ajh.25683; Andrews NC, 2020, MOLECULAR HEMATOLOGY, 4TH EDITION, P161; Aykut B, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb5168; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Benyamin B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5926; Bowman CL, 2007, TOXICON, V49, P249, DOI 10.1016/j.toxicon.2006.09.030; Brissot P, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.16; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Cahalan SM, 2015, ELIFE, V4, DOI 10.7554/eLife.07370; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cook-Mills JM, 2004, BIOCHEM J, V378, P539, DOI 10.1042/BJ20030794; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Crayne CB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00119; Culemann S, 2019, NATURE, V572, P670, DOI 10.1038/s41586-019-1471-1; DABBAGH AJ, 1993, ANN RHEUM DIS, V52, P67, DOI 10.1136/ard.52.1.67; Dholakia U, 2015, COMPARATIVE MED, V65, P196; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Ganz T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011668; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Gomme PT, 2005, DRUG DISCOV TODAY, V10, P267, DOI 10.1016/S1359-6446(04)03333-1; Gronski MA, 2009, CELL DEATH DIFFER, V16, P1323, DOI 10.1038/cdd.2009.55; Gujja P, 2010, J AM COLL CARDIOL, V56, P1001, DOI 10.1016/j.jacc.2010.03.083; Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997; Heinrich AC, 2004, BLOOD, V104, P659, DOI 10.1182/blood-2003-05-1442; Hershko C, 2010, ANN NY ACAD SCI, V1202, P1, DOI 10.1111/j.1749-6632.2010.05544.x; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Ilboudo Y, 2018, AM J HEMATOL, V93, pE362, DOI 10.1002/ajh.25245; Jain N, 2019, ANNU REV BIOMED ENG, V21, P267, DOI 10.1146/annurev-bioeng-062117-121224; Jensen PD, 2004, BRIT J HAEMATOL, V124, P697, DOI 10.1111/j.1365-2141.2004.04838.x; Kautz L, 2015, BLOOD, V126, P2031, DOI 10.1182/blood-2015-07-658419; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Knovich MA, 2009, BLOOD REV, V23, P95, DOI 10.1016/j.blre.2008.08.001; Korolnek T, 2015, BLOOD, V125, P2893, DOI 10.1182/blood-2014-12-567776; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Ma S, 2018, CELL, V173, P443, DOI 10.1016/j.cell.2018.02.047; Mao Yingyu, 2015, Small GTPases, V6, P89, DOI 10.4161/21541248.2014.989785; Masters TA, 2013, P NATL ACAD SCI USA, V110, P11875, DOI 10.1073/pnas.1301766110; Milic S, 2016, MED SCI MONITOR, V22, P2144, DOI 10.12659/MSM.896494; Mobarra Naser, 2016, Int J Hematol Oncol Stem Cell Res, V10, P239; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; Murthy SE, 2018, ELIFE, V7, DOI 10.7554/eLife.41844; Nguetse CN, 2020, P NATL ACAD SCI USA, V117, P9074, DOI 10.1073/pnas.1919843117; Nunes P, 2010, J LEUKOCYTE BIOL, V88, P57, DOI 10.1189/jlb.0110028; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; PARMLEY RT, 1978, J HISTOCHEM CYTOCHEM, V26, P729, DOI 10.1177/26.9.712049; Pasricha SR, 2016, ANNU REV NUTR, V36, P417, DOI 10.1146/annurev-nutr-071715-050731; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Picard V, 2019, HAEMATOLOGICA, V104, P1554, DOI 10.3324/haematol.2018.205328; Pilling LC, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5222; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Romac JMJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04194-9; Rooks H, 2019, HAEMATOLOGICA, V104, pE91, DOI 10.3324/haematol.2018.202697; Roy CN, 1999, J BIOL CHEM, V274, P9022, DOI 10.1074/jbc.274.13.9022; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Solis AG, 2019, NATURE, V573, P69, DOI 10.1038/s41586-019-1485-8; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Sun WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.47454; Taher AT, 2017, HEMATOL-AM SOC HEMAT, P265, DOI 10.1182/asheducation-2017.1.265; Tam V, 2019, NAT REV GENET, V20, P467, DOI 10.1038/s41576-019-0127-1; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253; Zeng WZ, 2018, SCIENCE, V362, P464, DOI 10.1126/science.aau6324; Zhang ZZ, 2011, BLOOD, V118, P1912, DOI 10.1182/blood-2011-01-330324	73	31	33	7	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					969	+		10.1016/j.cell.2021.01.024	http://dx.doi.org/10.1016/j.cell.2021.01.024		FEB 2021	27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33571427	Bronze, Green Accepted			2022-12-28	WOS:000629633400013
J	Park, J; Lim, JM; Jung, I; Heo, SJ; Park, J; Chang, Y; Kim, HK; Jung, D; Yu, JH; Min, S; Yoon, S; Cho, SR; Park, T; Kim, HH				Park, Jihye; Lim, Jung Min; Jung, Inkyung; Heo, Seok-Jae; Park, Jinman; Chang, Yoojin; Kim, Hui Kwon; Jung, Dongmin; Yu, Ji Hea; Min, Seonwoo; Yoon, Sungroh; Cho, Sung-Rae; Park, Taeyoung; Kim, Hyongbum Henry			Recording of elapsed time and temporal information about biological events using Cas9	CELL			English	Article								DNA has not been utilized to record temporal information, although DNA has been used to record biological information and to compute mathematical problems. Here, we found that indel generation by Cas9 and guide RNA can occur at steady rates, in contrast to typical dynamic biological reactions, and the accumulated indel frequency can be a function of time. By measuring indel frequencies, we developed a method for recording and measuring absolute time periods over hours to weeks in mammalian cells. These time-recordings were conducted in several cell types, with different promoters and delivery vectors for Cas9, and in both cultured cells and cells of living mice. As applications, we recorded the duration of chemical exposure and the lengths of elapsed time since the onset of biological events (e.g., heat exposure and inflammation). We propose that our systems could serve as synthetic "DNA clocks.''	[Park, Jihye; Lim, Jung Min; Park, Jinman; Chang, Yoojin; Kim, Hui Kwon; Jung, Dongmin; Kim, Hyongbum Henry] Yonsei Univ, Dept Pharmacol, Coll Med, Seoul 03722, South Korea; [Park, Jihye; Park, Jinman; Chang, Yoojin; Kim, Hui Kwon; Cho, Sung-Rae; Kim, Hyongbum Henry] Yonsei Univ, Brain Korea 21 Plus Project Med Sci, Coll Med, Seoul 03722, South Korea; [Jung, Inkyung; Heo, Seok-Jae] Yonsei Univ, Dept Biomed Syst Informat, Coll Med, Div Biostat, Seoul 03722, South Korea; [Jung, Inkyung; Heo, Seok-Jae] Yonsei Univ, Grad Sch, Dept Biostat & Comp, Seoul 03722, South Korea; [Yu, Ji Hea; Cho, Sung-Rae] Yonsei Univ, Coll Med, Dept & Res Inst Rehabil Med, Seoul 03722, South Korea; [Min, Seonwoo; Yoon, Sungroh] Seoul Natl Univ, Elect & Comp Engn, Seoul 00826, South Korea; [Yoon, Sungroh] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul 00826, South Korea; [Yoon, Sungroh] Seoul Natl Univ, Interdisciplinary Program Artificial Intelligence, Seoul 00826, South Korea; [Park, Taeyoung] Yonsei Univ, Dept Appl Stat, Seoul 03722, South Korea; [Park, Taeyoung] Yonsei Univ, Dept Stat & Data Sci, Seoul 03722, South Korea; [Kim, Hyongbum Henry] Inst Basic Sci IBS, Ctr Nanomed, Seoul, South Korea; [Kim, Hyongbum Henry] Yonsei Univ, Adv Sci Inst, Grad Program Nano Biomed Engn NanoBME, Seoul, South Korea; [Kim, Hyongbum Henry] Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul 03722, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University; Institute for Basic Science - Korea (IBS); Yonsei University; Yonsei University; Yonsei University Health System	Kim, HH (corresponding author), Yonsei Univ, Dept Pharmacol, Coll Med, Seoul 03722, South Korea.; Kim, HH (corresponding author), Yonsei Univ, Brain Korea 21 Plus Project Med Sci, Coll Med, Seoul 03722, South Korea.; Kim, HH (corresponding author), Yonsei Univ, Adv Sci Inst, Grad Program Nano Biomed Engn NanoBME, Seoul, South Korea.; Kim, HH (corresponding author), Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul 03722, South Korea.	hkim1@yuhs.ac	Kim, Hyongbum Henry/D-5804-2019; Lim, Jung Min/ABF-4448-2021; Lim, Jung Min/AAT-8819-2021	Kim, Hyongbum Henry/0000-0002-4693-738X; Lim, Jung Min/0000-0002-0223-5933; Lim, Jung Min/0000-0002-0223-5933; Jung, Inkyung/0000-0003-3780-3213; Heo, Seok-Jae/0000-0002-8764-7995; Kim, Hui Kwon/0000-0003-0694-9244; Min, Seonwoo/0000-0002-3278-0211; Park, Jihye/0000-0001-8728-6301; Cho, Sung-Rae/0000-0003-1429-2684; CHANG, YOO JIN/0000-0001-5421-3771	Samsung Research Funding & Incubation Center of Samsung Electronics [SRFC-MA1701-06]	Samsung Research Funding & Incubation Center of Samsung Electronics(Samsung)	We are grateful to Bukweon Kim (Department of Computational Science and Engineering, Yonsei University) and Sungchul Lee (Department of Mathematics, Yonsei University) for their assistance with computational analyses. We thank Minyoung Lee for proofreading. This work was supported by the Samsung Research Funding & Incubation Center of Samsung Electronics under project number SRFC-MA1701-06.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen F, 2019, NAT BIOTECHNOL, V37, P64, DOI 10.1038/nbt.4317; [Anonymous], 1904, RADIO ACTIVITY; Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; ARNOLD JR, 1949, SCIENCE, V110, P678, DOI 10.1126/science.110.2869.678; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Boltwood BB, 1907, AM J SCI, V23, P77; Brinkman EK, 2018, MOL CELL, V70, P801, DOI 10.1016/j.molcel.2018.04.016; Chen W, 2019, NUCLEIC ACIDS RES, V47, P7989, DOI 10.1093/nar/gkz487; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Du D, 2017, NAT METHODS, V14, P577, DOI [10.1038/NMETH.4286, 10.1038/nmeth.4286]; Farzadfard F, 2019, MOL CELL, V75, P769, DOI 10.1016/j.molcel.2019.07.011; Farzadfard F, 2018, SCIENCE, V361, P870, DOI 10.1126/science.aat9249; Farzadfard F, 2014, SCIENCE, V346, P825, DOI 10.1126/science.1256272; Fridman R, 2012, NAT PROTOC, V7, P1138, DOI 10.1038/nprot.2012.053; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Gompertz B., 1825, PHILOS T R SOC LOND, V115, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; Gong SZ, 2018, CELL REP, V22, P359, DOI 10.1016/j.celrep.2017.12.041; Hart T, 2017, G3-GENES GENOM GENET, V7, P2719, DOI 10.1534/g3.117.041277; Hsiao V, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156663; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones SK, 2021, NAT BIOTECHNOL, V39, P84, DOI 10.1038/s41587-020-0646-5; Kalhor R, 2018, SCIENCE, V361, P893, DOI 10.1126/science.aat9804; Kalhor R, 2017, NAT METHODS, V14, P195, DOI [10.1038/nmeth.4108, 10.1038/NMETH.4108]; Kim E, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800278; Kim HK, 2017, NAT METHODS, V14, P153, DOI [10.1038/NMETH.4104, 10.1038/nmeth.4104]; Kim HK, 2020, NAT BIOMED ENG, V4, P111, DOI 10.1038/s41551-019-0505-1; Kim HK, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax9249; Kim HK, 2018, NAT BIOTECHNOL, V36, P239, DOI 10.1038/nbt.4061; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim N, 2020, NAT BIOTECHNOL, V38, P1328, DOI 10.1038/s41587-020-0537-9; Knott GJ, 2019, NAT STRUCT MOL BIOL, V26, P315, DOI 10.1038/s41594-019-0208-z; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lin B., 2015, RADIOMETRIC DATING; Liu MD, 2015, NAT BIOTECHNOL, V33, P198, DOI 10.1038/nbt.3062; Liu MS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17411-1; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lundberg SM, 2020, NAT MACH INTELL, V2, P56, DOI 10.1038/s42256-019-0138-9; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Ortner V, 2015, CELL STRESS CHAPERON, V20, P277, DOI 10.1007/s12192-014-0540-5; Perli SD, 2016, SCIENCE, V353, DOI 10.1126/science.aag0511; Pinkney JNM, 2012, P NATL ACAD SCI USA, V109, P20871, DOI 10.1073/pnas.1211922109; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Raper AT, 2018, J AM CHEM SOC, V140, P2971, DOI 10.1021/jacs.7b13047; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roquet N, 2016, SCIENCE, V353, P363, DOI 10.1126/science.aad8559; Rose JC, 2018, ACS CHEM BIOL, V13, P438, DOI 10.1021/acschembio.7b00652; Rose JC, 2017, NAT METHODS, V14, P891, DOI [10.1038/nmeth.4368, 10.1038/NMETH.4368]; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmidt F, 2018, NATURE, V562, P380, DOI 10.1038/s41586-018-0569-1; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen JP, 2017, NAT METHODS, V14, P573, DOI 10.1038/nmeth.4225; Shen MW, 2018, NATURE, V563, P646, DOI 10.1038/s41586-018-0686-x; Sheth RU, 2017, SCIENCE, V358, P1457, DOI 10.1126/science.aao0958; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Singh D, 2018, P NATL ACAD SCI USA, V115, P5444, DOI 10.1073/pnas.1718686115; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Strohkendl I, 2018, MOL CELL, V71, P816, DOI 10.1016/j.molcel.2018.06.043; Tang WX, 2018, SCIENCE, V360, DOI 10.1126/science.aap8992; Urbinati F, 2009, MOL THER, V17, P1527, DOI 10.1038/mt.2009.89; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Wang DQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12281-8; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Weinstein JA, 2019, CELL, V178, P229, DOI 10.1016/j.cell.2019.05.019; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yourik P, 2019, RNA, V25, P35, DOI 10.1261/rna.067355.118; Yuen G, 2017, NUCLEIC ACIDS RES, V45, P12039, DOI 10.1093/nar/gkx843	82	9	9	8	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					1047	+		10.1016/j.cell.2021.01.014	http://dx.doi.org/10.1016/j.cell.2021.01.014		FEB 2021	40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33539780				2022-12-28	WOS:000629633400018
J	Richmond, P; Hatchuel, L; Dong, M; Ma, B; Hu, B; Smolenov, I; Li, P; Liang, P; Han, HH; Liang, JS; Clemens, R				Richmond, Peter; Hatchuel, Lara; Dong, Min; Ma, Brenda; Hu, Branda; Smolenov, Igor; Li, Ping; Liang, Peng; Han, Htay Htay; Liang, Joshua; Clemens, Ralf			Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial	LANCET			English	Article							HYPONATREMIA; MECHANISMS	Background As part of the accelerated development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we report a dose-finding and adjuvant justification study of SCB-2019, a protein subunit vaccine candidate containing a stabilised trimeric form of the spike (S)-protein (S-Trimer) combined with two different adjuvants. Methods Our study is a phase 1, randomised, double-blind placebo-controlled trial at a specialised clinical trials centre in Australia. We enrolled healthy adult volunteers in two age groups: younger adults (aged 18-54 years) and older adults (aged 55-75 years). Participants were randomly allocated either vaccine or placebo using a list prepared by the study funder. Participants were to receive two doses of SCB-2019 (either 3 mu g, 9 mu g, or 30 mu g) or a placebo (0.9% NaCl) 21 days apart. SCB-2019 either had no adjuvant (S-Trimer protein alone) or was adjuvanted with AS03 or CpG/Alum. The assigned treatment was administered in opaque syringes to maintain masking of assignments. Reactogenicity was assessed for 7 days after each vaccination. Humoral responses were measured as SCB-2019 binding IgG antibodies and ACE2-competitive blocking IgG antibodies by ELISA and as neutralising antibodies by wild-type SARS-CoV-2 microneutralisation assay. Cellular responses to pooled S-protein peptides were measured by flow-cytometric intracellular cytokine staining. This trial is registered with ClinicalTrials.gov, NCT04405908; this is an interim analysis and the study is continuing. Findings Between June 19 and Sept 23, 2020, 151 volunteers were enrolled; three people withdrew, two for personal reasons and one with an unrelated serious adverse event (pituitary adenoma). 148 participants had at least 4 weeks of follow-up after dose two and were included in this analysis (database lock, Oct 23, 2020). Vaccination was well tolerated, with two grade 3 solicited adverse events (pain in 9 mu g AS03-adjuvanted and 9 mu g CpG/Alum-adjuvanted groups). Most local adverse events were mild injection-site pain, and local events were more frequent with SCB-2019 formulations containing AS03 adjuvant (44-69%) than with those containing CpG/Alum adjuvant (6-44%) or no adjuvant (3-13%). Systemic adverse events were more frequent in younger adults (38%) than in older adults (17%) after the first dose but increased to similar levels in both age groups after the second dose (30% in older and 34% in younger adults). SCB-2019 with no adjuvant elicited minimal immune responses (three seroconversions by day 50), but SCB-2019 with fixed doses of either AS03 or CpG/Alum adjuvants induced high titres and seroconversion rates of binding and neutralising antibodies in both younger and older adults (anti-SCB-2019 IgG antibody geometric mean titres at day 36 were 1567-4452 with AS03 and 174-2440 with CpG/Alum). Titres in all AS03 dose groups and the CpG/Alum 30 mu g group were higher than were those recorded in a panel of convalescent serum samples from patients with COVID-19. Both adjuvanted SCB-2019 formulations elicited T-helper-1-biased CD4(+) T-cell responses. Interpretation The SCB-2019 vaccine, comprising S-Trimer protein formulated with either AS03 or CpG/Alum adjuvants, elicited robust humoral and cellular immune responses against SARS-CoV-2, with high viral neutralising activity. Both adjuvanted vaccine formulations were well tolerated and are suitable for further clinical development. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Richmond, Peter] Univ Western Australia, Div Paediat, Wesfarmers Ctr Vaccines & Infect Dis, Telethon Kids Inst & Perth Childrens Hosp, Perth, WA, Australia; [Hatchuel, Lara; Dong, Min; Ma, Brenda; Hu, Branda; Smolenov, Igor; Li, Ping; Liang, Peng] Linear Clin Res, Perth, WA, Australia; [Clemens, Ralf] Global Res Infect Dis, BR-22261070 Rio De Janeiro, Brazil	University of Western Australia; Wesfarmers Limited	Clemens, R (corresponding author), Global Res Infect Dis, BR-22261070 Rio De Janeiro, Brazil.	clemens.ralf@outlook.com	Smolenov, Igor/N-8950-2015; Richmond, Peter C/G-3379-2012	Smolenov, Igor/0000-0002-7075-9827; Richmond, Peter C/0000-0001-7562-7228	Clover Biopharmaceuticals; Coalition for Epidemic Preparedness Innovations	Clover Biopharmaceuticals; Coalition for Epidemic Preparedness Innovations	Clover Biopharmaceuticals and the Coalition for Epidemic Preparedness Innovations.	Barry M, 2007, EXPERT OPIN BIOL TH, V7, P1731, DOI 10.1517/14712598.7.11.1731; Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011; Bopeththa BVKM, 2019, J MED CASE REP, V13, DOI 10.1186/s13256-019-2000-4; Cohet C., 2019, VACCINE, V37, P3003; European Medicines Agency, 2016, ASSESSMENT REPORT PA; Florindo HF, 2020, NAT NANOTECHNOL, V15, P630, DOI 10.1038/s41565-020-0732-3; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Halperin SA, 2012, VACCINE, V30, P2556, DOI 10.1016/j.vaccine.2012.01.087; Huang Y, 2020, ACTA PHARMACOL SIN, V41, P1141, DOI 10.1038/s41401-020-0485-4; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Johns Hopkins University of Medicine, 2021, COVID 19 DASHBOARD C; Keech C, 2020, NEW ENGL J MED, V383, P2320, DOI 10.1056/NEJMoa2026920; Langley JM, 2011, J INFECT DIS, V203, P1729, DOI 10.1093/infdis/jir172; Liang JG, 2020, S TRIMER COVID 19 SU, DOI [10.1101/2020.09.24.311027., DOI 10.1101/2020.09.24.311027, 10.1101/2020.09.24.311027]; Liu HP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09518-1; Luo G, 2018, P NATL ACAD SCI USA, V115, pE12323, DOI 10.1073/pnas.1818150116; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Poland GA, 2020, LANCET, V396, P1595, DOI 10.1016/S0140-6736(20)32137-1; Rajput R., 2017, Acta Medica Bulgarica, V44, P46, DOI 10.1515/amb-2017-0008; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shi ST, 2019, VACCINE, V37, P3167, DOI 10.1016/j.vaccine.2019.04.055; Tan E, 2021, CHEST, V159, P524, DOI 10.1016/j.chest.2020.10.014; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; WHO, 2021, DRAFT LANDSCAPE COVI; Zogheri A, 2006, J ENDOCRINOL INVEST, V29, P750, DOI 10.1007/BF03344188	29	141	152	4	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					682	694		10.1016/S0140-6736(21)00241-5	http://dx.doi.org/10.1016/S0140-6736(21)00241-5		FEB 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL3PK	33524311	Bronze, Green Published			2022-12-28	WOS:000620991800030
J	Sacks, CA				Sacks, Chana A.			Bone Marrow Necrosis in Acute Monoblastic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Terao, Toshiki/0000-0002-6728-3346					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2021	384	7					650	650		10.1056/NEJMicm2026508	http://dx.doi.org/10.1056/NEJMicm2026508			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2HH	33596359				2022-12-28	WOS:000620900000012
J	Tuyisenge, G; Goldenberg, SM				Tuyisenge, Germaine; Goldenberg, Shira M.			COVID-19, structural racism, and migrant health in Canada Comment	LANCET			English	Editorial Material									[Tuyisenge, Germaine; Goldenberg, Shira M.] Ctr Gender & Sexual Hlth Equ, Vancouver, BC V6Z 1Y6, Canada; [Tuyisenge, Germaine; Goldenberg, Shira M.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada	Simon Fraser University	Goldenberg, SM (corresponding author), Ctr Gender & Sexual Hlth Equ, Vancouver, BC V6Z 1Y6, Canada.; Goldenberg, SM (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada.	dr.goldenberg@cgshe.ubc.ca	Goldenberg, Shira/C-9627-2009	Goldenberg, Shira/0000-0003-1633-9749; Tuyisenge, Germaine/0000-0002-1777-8930				Abbas M, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0403-4; Ahmed S, 2016, J IMMIGR MINOR HEALT, V18, P1522, DOI 10.1007/s10903-015-0276-z; Guadagno L., 2020, MIGRATION RES SERIES, V60, P1; Guttmann A., 2020, COVID 19 IMMIGRANTS; Hayman N, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000104; Lenard PT, 2012, LEGISLATED INEQUALITY: TEMPORARY LABOUR MIGRATION IN CANADA, P1; Orcutt M, 2020, LANCET, V395, P1482, DOI 10.1016/S0140-6736(20)30971-5; Orrenius PM, 2013, ELGAR ORIG REF, P214; Strauss K, 2017, GEOFORUM, V78, P199, DOI 10.1016/j.geoforum.2016.01.008; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598	10	20	20	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					650	652		10.1016/S0140-6736(21)00215-4	http://dx.doi.org/10.1016/S0140-6736(21)00215-4		FEB 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL3PK	33539727	Green Accepted, Bronze			2022-12-28	WOS:000620991800007
J	Wang, Q; Zheng, JN; Xu, JM; Zhong, YS				Wang, Qiang; Zheng, Ji-Na; Xu, Jian-Min; Zhong, Yun-Shi			An irregular ulcer in the rectum	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wang, Qiang; Zheng, Ji-Na] Fudan Univ, Zhongshan Hosp, Dept Dermatol, Shanghai, Peoples R China; [Xu, Jian-Min; Zhong, Yun-Shi] Fudan Univ, Zhongshan Hosp, Dept Surg, Shanghai, Peoples R China	Fudan University; Fudan University	Wang, Q (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Dermatol, Shanghai, Peoples R China.	wangqiang7766@163.com	Zhong, Yun/HCH-6868-2022					Febbraro I, 2008, DIGEST LIVER DIS, V40, P579, DOI 10.1016/j.dld.2007.09.004; Bensusan IG, 2014, ENDOSCOPY, V46, pE533, DOI 10.1055/s-0034-1377638; Hook EW, 2017, LANCET, V389, P1550, DOI 10.1016/S0140-6736(16)32411-4; Lopez-Alvarez M, 2018, REV ESP ENFERM DIG, V110, P597, DOI 10.17235/reed.2018.5592/2018; National Institute for Health and Care Excellence, 2019, CLIN KNOWL SUMM SYPH; Peeling RW, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.73	6	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2021	372								n316	10.1136/bmj.n316	http://dx.doi.org/10.1136/bmj.n316			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK7SF	33602665				2022-12-28	WOS:000620581100004
J	Messier, SP; Mihalko, SL; Beavers, DP; Nicklas, BJ; DeVita, P; Carr, JJ; Hunter, DJ; Lyles, M; Guermazi, A; Bennell, KL; Loeser, RF				Messier, Stephen P.; Mihalko, Shannon L.; Beavers, Daniel P.; Nicklas, Barbara J.; DeVita, Paul; Carr, J. Jeffery; Hunter, David J.; Lyles, Mary; Guermazi, Ali; Bennell, Kim L.; Loeser, Richard F.			Effect of High-Intensity Strength Training on Knee Pain and Knee Joint Compressive Forces Among Adults With Knee Osteoarthritis: The START Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OLDER-ADULTS; WEIGHT-LOSS; RESISTANCE; EXERCISE; PROGRESSION; ARTHRITIS; HIP; IMPROVEMENT; DISABILITY; OVERWEIGHT	Key PointsQuestionIs high-intensity strength training more effective than low-intensity strength training and attention control for the outcomes of knee pain and knee joint compressive forces in participants with knee osteoarthritis? FindingsIn this randomized clinical trial involving 377 participants with knee osteoarthritis, high-intensity strength training, compared with low-intensity strength training and an attention control, did not significantly improve knee pain or knee joint compressive forces at 18 months. MeaningThese findings do not support the use of high-intensity strength training over low-intensity strength training or attention control in adults with knee osteoarthritis. ImportanceThigh muscle weakness is associated with knee discomfort and osteoarthritis disease progression. Little is known about the efficacy of high-intensity strength training in patients with knee osteoarthritis or whether it may worsen knee symptoms. ObjectiveTo determine whether high-intensity strength training reduces knee pain and knee joint compressive forces more than low-intensity strength training and more than attention control in patients with knee osteoarthritis. Design, Setting, and ParticipantsAssessor-blinded randomized clinical trial conducted at a university research center in North Carolina that included 377 community-dwelling adults (>= 50 years) with body mass index (BMI) ranging from 20 to 45 and with knee pain and radiographic knee osteoarthritis. Enrollment occurred between July 2012 and February 2016, and follow-up was completed September 2017. InterventionsParticipants were randomized to high-intensity strength training (n=127), low-intensity strength training (n=126), or attention control (n=124). Main Outcomes and MeasuresPrimary outcomes at the 18-month follow-up were Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) knee pain (0 best-20 worst; minimally clinically important difference [MCID, 2]) and knee joint compressive force, defined as the maximal tibiofemoral contact force exerted along the long axis of the tibia during walking (MCID, unknown). ResultsAmong 377 randomized participants (mean age, 65 years; 151 women [40%]), 320 (85%) completed the trial. Mean adjusted (sex, baseline BMI, baseline outcome values) WOMAC pain scores at the 18-month follow-up were not statistically significantly different between the high-intensity group and the control group (5.1 vs 4.9; adjusted difference, 0.2; 95% CI, -0.6 to 1.1; P=.61) or between the high-intensity and low-intensity groups (5.1 vs 4.4; adjusted difference, 0.7; 95% CI, -0.1 to 1.6; P=.08). Mean knee joint compressive forces were not statistically significantly different between the high-intensity group and the control group (2453 N vs 2512 N; adjusted difference, -58; 95% CI, -282 to 165 N; P=.61), or between the high-intensity and low-intensity groups (2453 N vs 2475 N; adjusted difference, -21; 95% CI, -235 to 193 N; P=.85). There were 87 nonserious adverse events (high-intensity, 53; low-intensity, 30; control, 4) and 13 serious adverse events unrelated to the study (high-intensity, 5; low-intensity, 3; control, 5). Conclusions and RelevanceAmong patients with knee osteoarthritis, high-intensity strength training compared with low-intensity strength training or an attention control did not significantly reduce knee pain or knee joint compressive forces at 18 months. The findings do not support the use of high-intensity strength training over low-intensity strength training or an attention control in adults with knee osteoarthritis. Trial RegistrationClinicalTrials.gov Identifier: NCT01489462 This randomized trial compares the effects of high- vs low-intensity strength training vs control on 18-mo knee pain and knee joint compressive force among adults with knee pain and radiographic evidence of osteoarthritis.	[Messier, Stephen P.] Wake Forest Univ, Dept Hlth & Exercise Sci, JB Snow Biomech Lab, Winston Salem, NC 27109 USA; [Messier, Stephen P.; Nicklas, Barbara J.; Lyles, Mary] Wake Forest Sch Med, Sect Gerontol & Geriatr Med, Winston Salem, NC 27101 USA; [Mihalko, Shannon L.; Nicklas, Barbara J.] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27109 USA; [Beavers, Daniel P.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27101 USA; [DeVita, Paul] East Carolina Univ, Dept Kinesiol, Greenville, NC 27858 USA; [Carr, J. Jeffery] Vanderbilt Univ, Dept Radiol & Radiol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Hunter, David J.] Univ Sydney, Royal North Shore Hosp, Rheumatol Dept, Sydney, NSW, Australia; [Hunter, David J.] Univ Sydney, Inst Bone & Joint Res, Kolling Inst, Sydney, NSW, Australia; [Guermazi, Ali] Boston Univ, Dept Radiol, VA Boston Healthcare Syst, Sch Med, Boston, MA 02215 USA; [Bennell, Kim L.] Univ Melbourne, Dept Physiotherapy, Parkville, Vic, Australia; [Loeser, Richard F.] Univ N Carolina, Div Rheumatol Allergy & Immunol, Sch Med, Chapel Hill, NC 27515 USA; [Loeser, Richard F.] Univ N Carolina, Thurston Arthrit Res Ctr, Sch Med, Chapel Hill, NC 27515 USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; University of North Carolina; East Carolina University; Vanderbilt University; Royal North Shore Hospital; University of Sydney; University of Sydney; Kolling Institute of Medical Research; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of Melbourne; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Messier, SP (corresponding author), Wake Forest Univ, JB Snow Biornechan Lab, Dept Hlth & Exercise Sci, Worrell Profess Ctr, 1834 Wake Forest Rd, Winston Salem, NC 27109 USA.	messier@wfu.edu	Carr, John/A-1938-2012	Carr, John/0000-0002-4398-8237				Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Baker KR, 2001, J RHEUMATOL, V28, P1655; Bandura A., 1997, SELF EFFICACY EXERCI; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bliddal H, 2011, ANN RHEUM DIS, V70, P1798, DOI 10.1136/ard.2010.142018; Dougados M, 2000, OSTEOARTHR CARTILAGE, V8, P395, DOI 10.1053/joca.2000.0361; Englund M, 2018, ANN RHEUM DIS, V77, P159, DOI 10.1136/annrheumdis-2017-211664; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; FELSON DT, 1995, ARTHRITIS RHEUM-US, V38, P1500, DOI 10.1002/art.1780381017; Ferenczi MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085739; Griffin TM, 2005, EXERC SPORT SCI REV, V33, P195, DOI 10.1097/00003677-200510000-00008; Griffiths G, 1993, INFLAMMOPHARMACOLOGY, V2, P85, DOI DOI 10.1007/BF02663745; Hall M, 2018, OSTEOARTHR CARTILAGE, V26, P495, DOI 10.1016/j.joca.2018.01.018; Hurley MV, 1998, BRIT J RHEUMATOL, V37, P1181; Jan MH, 2008, PHYS THER, V88, P427, DOI 10.2522/ptj.20060300; Kapstad H, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-55; King LK, 2008, MED SCI SPORT EXER, V40, P1376, DOI 10.1249/MSS.0b013e31816f1c4a; Kolasinski SL, 2020, ARTHRITIS RHEUMATOL, V72, P220, DOI [10.1002/art.41142, 10.1002/acr.24131]; Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1097/00005768-200202000-00027; Mazzuca SA, 2008, OSTEOARTHR CARTILAGE, V16, P1555, DOI 10.1016/j.joca.2008.04.010; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Messier SP, 2013, JAMA-J AM MED ASSOC, V310, P1263, DOI 10.1001/jama.2013.277669; Messier SP, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-208; Mikesky AE, 2006, ARTHRIT RHEUM-ARTHR, V55, P690, DOI 10.1002/art.22245; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Naylor JM, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1249-7; Neogi T, 2013, OSTEOARTHR CARTILAGE, V21, P1145, DOI 10.1016/j.joca.2013.03.018; Otterness IG, 1998, ARTHRITIS RHEUM-US, V41, P2068, DOI 10.1002/1529-0131(199811)41:11<2068::AID-ART23>3.0.CO;2-L; Pham T, 2004, OSTEOARTHR CARTILAGE, V12, P389, DOI 10.1016/j.joca.2004.02.001; Sharma L, 2003, ANN INTERN MED, V138, P613, DOI 10.7326/0003-4819-138-8-200304150-00006; Sharma L, 2000, ARTHRITIS RHEUM, V43, P568, DOI 10.1002/1529-0131(200003)43:3<568::AID-ANR13>3.0.CO;2-E; Singh NA, 1997, J GERONTOL A-BIOL, V52, pM27, DOI 10.1093/gerona/52A.1.M27; Siviero P, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2593-1; Tuttle AH, 2015, PAIN, V156, P2616, DOI 10.1097/j.pain.0000000000000333; Van Den Hoogen BM, 1998, BRIT J RHEUMATOL, V37, P671; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wilson DR, 2008, RHEUM DIS CLIN N AM, V34, P605, DOI 10.1016/j.rdc.2008.05.002	38	20	21	12	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2021	325	7					646	657		10.1001/jama.2021.0411	http://dx.doi.org/10.1001/jama.2021.0411			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ3QZ	33591346	Green Published, Bronze			2022-12-28	WOS:000619608000017
J	Turk, E; Durrance-Bagale, A; Han, E; Bell, S; Rajan, S; Lota, MMM; Ochu, C; Porras, ML; Mishra, P; Frumence, G; Mckee, M; Legido-Quigley, H				Turk, Eva; Durrance-Bagale, Anna; Han, Emeline; Bell, Sadie; Rajan, Selina; Lota, Maria Margarita M.; Ochu, Chinwe; Porras, Maria Lazo; Mishra, Pallavi; Frumence, Gasto; Mckee, Martin; Legido-Quigley, Helena			International experiences with co-production and people centredness offer lessons for covid-19 responses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; IMPLEMENTATION; PARTICIPATION; INVOLVEMENT; KNOWLEDGE; SERVICES		[Turk, Eva] Univ South Eastern Norway, Sci Ctr Hlth & Technol, Drammen, Norway; [Turk, Eva] Univ Maribor, Fac Med, Maribor, Slovenia; [Durrance-Bagale, Anna; Bell, Sadie; Rajan, Selina; Mckee, Martin; Legido-Quigley, Helena] London Sch Hyg & Trop Med, London, England; [Han, Emeline; Legido-Quigley, Helena] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Lota, Maria Margarita M.] Natl Univ Hlth Syst, Singapore, Singapore; [Ochu, Chinwe] Univ Philippines, SEAMEO TROPMED Reg Ctr PUBL Hlth, Hosp Adm Environm & Occupat Hlth, Coll Publ Hlth,Dept Med Microbiol, Manila, Philippines; [Ochu, Chinwe] Nigeria Ctr Dis Control, Prevent Programmes & Knowledge Management, Abuja, Nigeria; [Porras, Maria Lazo] Univ Peruana Cayetano Heredia, Lima, Peru; [Mishra, Pallavi] Ctr Chron Dis Control, New Delhi, India; [Frumence, Gasto] Muhimbili Univ Hlth & Allied Sci, Dept Dev Studies, Sch Publ Hlth & Social Sci, Dar Es Salaam, Tanzania	University College of Southeast Norway; University of Maribor; University of London; London School of Hygiene & Tropical Medicine; National University of Singapore; National University of Singapore; University of the Philippines System; University of the Philippines Manila; Universidad Peruana Cayetano Heredia; Muhimbili University of Health & Allied Sciences	Mckee, M (corresponding author), London Sch Hyg & Trop Med, London, England.	Martin.mckee@lshtm.ac.uk		Durrance-Bagale, Anna/0000-0001-6674-1862	Doris Duke Charitable Foundation	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	This article is part of a series produced in conjunction with the WHO and the Alliance for Health Policy Systems and Research with funding from the Doris Duke Charitable Foundation. The BMJ peer reviewed, edited, and made the decision to publish.	[Anonymous], 2006, COMMUNITY ENGAGEMENT; Balane MA, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002661; Barr Victoria J, 2003, Hosp Q, V7, P73; Batalden M, 2016, BMJ QUAL SAF, V25, P509, DOI 10.1136/bmjqs-2015-004315; Beresford Peter., 2019, POLICY PRACTICE REV, V3, P41, DOI [10.3389/fsoc.2018.00041, DOI 10.3389/FSOC.2018.00041]; Coldham T., 2018, MEET CO PRO MAESTRO; Coulter A., 2013, DELIVERING BETTER SE, P1; Frumence G, 2014, GLOB PUBLIC HEALTH, V9, P1125, DOI 10.1080/17441692.2014.953563; George AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141091; Gilmore B, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003188; Haldane V, 2020, HEALTH POLICY, V124, P419, DOI 10.1016/j.healthpol.2019.11.012; Hickey G., 2018, NIHR INVOLV; Hutchinson E, 2019, INT J HEALTH POLICY, V8, P191, DOI 10.15171/ijhpm.2018.123; Kirchhoff CJ, 2013, ANNU REV ENV RESOUR, V38, P393, DOI 10.1146/annurev-environ-022112-112828; Kleintjes S, 2010, INT REV PSYCHIATR, V22, P568, DOI 10.3109/09540261.2010.536153; Kothari A, 2017, INT J HEALTH POLICY, V6, P299, DOI 10.15171/ijhpm.2017.15; Langley J, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3397-y; Lazo-Porras M, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2020.1754016; Legido-Quigley H, 2018, RESILIENT PEOPLE CTR; Liu HM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025127; McCormack B., 2017, PERSON CTR PRACTICE, V2, DOI [10.1002/9781119099635, DOI 10.1002/9781119099635]; O'Mara-Eves A., 2013, PUBLIC HLTH RES, V1, P1, DOI [10.3310/phr01040, DOI 10.3310/PHR01040]; Ochu CL, 2021, HEALTH SECUR, V19, P223, DOI 10.1089/hs.2020.0151; Oliver K, 2019, HEALTH RES POLICY SY, V17, DOI 10.1186/s12961-019-0432-3; Rasmussen E, 2014, PERSON CTR CARE COCR; Realpe A., 2010, WHAT IS COPRODUCTION; Richards P., 2016, EBOLA PEOPLES SCI HE; Richards P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224511; Rifkin SB., 2000, PARTICIPATORY APPROA; Roux DJ, 2006, ECOL SOC, V11; Rutter D, 2004, SOC SCI MED, V58, P1973, DOI 10.1016/S0277-9536(03)00401-5; Sheahan Margo, 2007, Aust New Zealand Health Policy, V4, P5, DOI 10.1186/1743-8462-4-5; Vennik FD, 2016, INT REV ADM SCI, V82, P150, DOI 10.1177/0020852315570553; Vincent K, 2018, CLIM SERV, V12, P48, DOI 10.1016/j.cliser.2018.11.001; Wagner E H, 1998, Eff Clin Pract, V1, P2; Wallerstein N, 2006, CPH WHO REG EUR, P37; Wilkinson A, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0305	37	27	27	3	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2021	372								m4752	10.1136/bmj.m4752	http://dx.doi.org/10.1136/bmj.m4752			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RA8YP	33593813	Green Published			2022-12-28	WOS:000631706300016
J	Watson, MJ; Vignali, PDA; Mullett, SJ; Overacre-Delgoffe, AE; Peralta, RM; Grebinoski, S; Menk, AV; Rittenhouse, NL; DePeaux, K; Whetstone, RD; Vignali, DAA; Hand, TW; Poholek, AC; Morrison, BM; Rothstein, JD; Wendell, SG; Delgoffe, GM				Watson, McLane J.; Vignali, Paolo D. A.; Mullett, Steven J.; Overacre-Delgoffe, Abigail E.; Peralta, Ronal M.; Grebinoski, Stephanie; Menk, Ashley V.; Rittenhouse, Natalie L.; DePeaux, Kristin; Whetstone, Ryan D.; Vignali, Dario A. A.; Hand, Timothy W.; Poholek, Amanda C.; Morrison, Brett M.; Rothstein, Jeffrey D.; Wendell, Stacy G.; Delgoffe, Greg M.			Metabolic support of tumour-infiltrating regulatory T cells by lactic acid	NATURE			English	Article							TRANSPORTER; LACTATE; GLUCOSE; CANCER; PHOSPHOENOLPYRUVATE; INHIBITOR; STABILITY; LIVER; FOXP3	Regulatory T (T-reg) cells, although vital for immune homeostasis, also represent a major barrier to anti-cancer immunity, as the tumour microenvironment (TME) promotes the recruitment, differentiation and activity of these cells(1,2). Tumour cells show deregulated metabolism, leading to a metabolite-depleted, hypoxic and acidic TME3, which places infiltrating effector T cells in competition with the tumour for metabolites and impairs their function(4-6). At the same time, T-reg cells maintain a strong suppression of effector T cells within the TME7,8. As previous studies suggested that T-reg cells possess a distinct metabolic profile from effector T cells(9-11), we hypothesized that the altered metabolic landscape of the TME and increased activity of intratumoral T-reg cells are linked. Here we show that T-reg cells display broad heterogeneity in their metabolism of glucose within normal and transformed tissues, and can engage an alternative metabolic pathway to maintain suppressive function and proliferation. Glucose uptake correlates with poorer suppressive function and long-term instability, and high-glucose conditions impair the function and stability of T-reg cells in vitro. T-reg cells instead upregulate pathways involved in the metabolism of the glycolytic by-product lactic acid. T-reg cells withstand high-lactate conditions, and treatment with lactate prevents the destabilizing effects of high-glucose conditions, generating intermediates necessary for proliferation. Deletion of MCT1-a lactate transporter-in T-reg cells reveals that lactate uptake is dispensable for the function of peripheral T-reg cells but required intratumorally, resulting in slowed tumour growth and an increased response to immunotherapy. Thus, T-reg cells are metabolically flexible: they can use 'alternative' metabolites in the TME to maintain their suppressive identity. Further, our results suggest that tumours avoid destruction by not only depriving effector T cells of nutrients, but also metabolically supporting regulatory populations.	[Watson, McLane J.; Vignali, Paolo D. A.; Overacre-Delgoffe, Abigail E.; Peralta, Ronal M.; Grebinoski, Stephanie; DePeaux, Kristin; Whetstone, Ryan D.; Vignali, Dario A. A.; Delgoffe, Greg M.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Watson, McLane J.; Vignali, Paolo D. A.; Peralta, Ronal M.; Menk, Ashley V.; DePeaux, Kristin; Whetstone, Ryan D.; Vignali, Dario A. A.; Delgoffe, Greg M.] UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA USA; [Watson, McLane J.; Vignali, Paolo D. A.; Peralta, Ronal M.; Grebinoski, Stephanie; DePeaux, Kristin] Univ Pittsburgh, Sch Med, Grad Program Microbiol & Immunol, Pittsburgh, PA USA; [Mullett, Steven J.; Wendell, Stacy G.] Univ Pittsburgh, Hlth Sci Metabol & Lipid Core, Pittsburgh, PA USA; [Overacre-Delgoffe, Abigail E.; Rittenhouse, Natalie L.; Hand, Timothy W.; Poholek, Amanda C.] UPMC Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA; [Vignali, Dario A. A.; Hand, Timothy W.; Delgoffe, Greg M.] UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA USA; [Morrison, Brett M.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Wendell, Stacy G.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Wendell, Stacy G.] Univ Pittsburgh, Dept Clin Translat Sci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Delgoffe, GM (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA.; Delgoffe, GM (corresponding author), UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA USA.; Delgoffe, GM (corresponding author), UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA USA.	gdelgoffe@pitt.edu	Hand, Timothy W/AAH-1216-2021; Grebinoski, Stephanie/AGX-9855-2022; Delgoffe, Greg M./HCH-2805-2022	Hand, Timothy W/0000-0002-2684-9462; Grebinoski, Stephanie/0000-0002-3562-3190; Delgoffe, Greg M./0000-0002-2957-8135; DePeaux, Kristin/0000-0001-8460-727X; Watson, McLane/0000-0001-5778-7690; Peralta, Ronal/0000-0002-2863-0157				Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; CONSOLI A, 1990, AM J PHYSIOL, V259, pE677, DOI 10.1152/ajpendo.1990.259.5.E677; D'Alise AM, 2011, P NATL ACAD SCI USA, V108, P8737, DOI 10.1073/pnas.1105364108; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Gerriets VA, 2016, NAT IMMUNOL, V17, P1459, DOI 10.1038/ni.3577; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Jackson VN, 1996, J BIOL CHEM, V271, P861, DOI 10.1074/jbc.271.2.861; Jha MK, 2020, GLIA, V68, P161, DOI 10.1002/glia.23710; Jung YS, 2015, HEAD NECK-J SCI SPEC, V37, P327, DOI 10.1002/hed.23608; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Lowther DE, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85935; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Menk AV, 2018, CELL REP, V22, P1509, DOI 10.1016/j.celrep.2018.01.040; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Najjar YG, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124989; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; Overacre-Delgoffe AE, 2017, CELL, V169, P1130, DOI 10.1016/j.cell.2017.05.005; Priyadharshini B, 2018, J IMMUNOL, V201, P2215, DOI 10.4049/jimmunol.1800311; Procaccini C, 2016, IMMUNITY, V44, P406, DOI 10.1016/j.immuni.2016.01.028; Proia P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091450; ROBINSON BH, 1975, FEBS LETT, V58, P12, DOI 10.1016/0014-5793(75)80214-6; Romero-Garcia S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00052; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Sinclair L.V., 2020, IMMUNOMETABOLISM, V2; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Wang D, 2018, CELL REP, V23, P3262, DOI 10.1016/j.celrep.2018.05.050; Wang HP, 2017, TRENDS CANCER, V3, P583, DOI 10.1016/j.trecan.2017.06.005; Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z; Xia LY, 2019, CELL METAB, V29, P103, DOI 10.1016/j.cmet.2018.09.020; Xu H, 2016, BIOCHEM BIOPH RES CO, V474, P240, DOI 10.1016/j.bbrc.2016.03.133	43	183	193	51	242	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 25	2021	591	7851					645	+		10.1038/s41586-020-03045-2	http://dx.doi.org/10.1038/s41586-020-03045-2		FEB 2021	15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB5UT	33589820	Green Accepted			2022-12-28	WOS:000618152300001
J	Lambrechts, RA; Uyttenboogaart, M; Drost, G				Lambrechts, Roald A.; Uyttenboogaart, Maarten; Drost, Gea			A vertebral artery halo sign indicates giant cell arteritis affecting the posterior circulation of the brain	LANCET			English	Editorial Material									[Lambrechts, Roald A.; Uyttenboogaart, Maarten; Drost, Gea] Univ Med Ctr Groningen, Dept Neurol, NL-9713 GZ Groningen, Netherlands	University of Groningen	Lambrechts, RA (corresponding author), Univ Med Ctr Groningen, Dept Neurol, NL-9713 GZ Groningen, Netherlands.	r.a.lambrechts@umcg.nl		Drost, Gea/0000-0002-3546-4548					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2021	397	10274					E6	E6						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2TN	33581822	Green Published			2022-12-28	WOS:000620934000001
J	Horton, R				Horton, Richard			Offline: COVID-19 and the convergence of nations	LANCET			English	Editorial Material												richard.horton@lancet.com							0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2021	397	10273					458	458						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QF1LZ	33549177	Green Published, Bronze			2022-12-28	WOS:000616661900007
J	Hwang, JP; Ferrajoli, A; Lok, AS				Hwang, Jessica P.; Ferrajoli, Alessandra; Lok, Anna S.			Hepatitis B reactivation after chemoimmunotherapy: screen before treatment	LANCET			English	Editorial Material									[Hwang, Jessica P.] Univ Texas MD Anderson Canc Ctr, Dept Gen Internal Med, Houston, TX 77030 USA; [Ferrajoli, Alessandra] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Lok, Anna S.] Univ Michigan, Dept Internal Med, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Michigan System; University of Michigan	Lok, AS (corresponding author), Univ Michigan, Dept Internal Med, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA.	aslok@umich.edu		Hwang, Jessica/0000-0002-5896-4182	NIDDK NIH HHS [P30 DK034933, U01 DK082863] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))			0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2021	397	10273					510	510						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QF1LZ	33549195	Green Accepted			2022-12-28	WOS:000616661900026
J	Torjesen, I				Torjesen, Ingrid			Covid-19: Risk of aerosol transmission to staff outside of intensive care is likely to be higher than predicted	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Hamilton F, AEROSOL EMISSION RES, V2021, DOI [10.1101/2021.01.29.21250552v1, DOI 10.1101/2021.01.29.21250552V1]; Martin CA, 2020, J PUBLIC HLTH OXF; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n30	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2021	372								n354	10.1136/bmj.n354	http://dx.doi.org/10.1136/bmj.n354			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH2PI	33547056	Bronze			2022-12-28	WOS:000618119100019
J	Jani, H; Lin, JC; Chen, JH; Harrison, J; Maccherozzi, F; Schad, J; Prakash, S; Eom, CB; Ariando, A; Venkatesan, T; Radaelli, PG				Jani, Hariom; Lin, Jheng-Cyuan; Chen, Jiahao; Harrison, Jack; Maccherozzi, Francesco; Schad, Jonathon; Prakash, Saurav; Eom, Chang-Beom; Ariando, A.; Venkatesan, T.; Radaelli, Paolo G.			Antiferromagnetic half-skyrmions and bimerons at room temperature	NATURE			English	Article								In the quest for post-CMOS (complementary metal-oxide-semiconductor) technologies, driven by the need for improved efficiency and performance, topologically protected ferromagnetic 'whirls' such as skyrmions(1-8) and their anti-particles have shown great promise as solitonic information carriers in racetrack memory-in-logic or neuromorphic devices(1,9-11). However, the presence of dipolar fields in ferromagnets, which restricts the formation of ultrasmall topological textures(3,6,8,9,12), and the deleterious skyrmion Hall effect, when skyrmions are driven by spin torques(9,10,12), have thus far inhibited their practical implementation. Antiferromagnetic analogues, which are predicted to demonstrate relativistic dynamics, fast deflection-free motion and size scaling, have recently become the subject of intense focus(9,13-19), but they have yet to be experimentally demonstrated in natural antiferromagnetic systems. Here we realize a family of topological antiferromagnetic spin textures in alpha-Fe2O3-an Earth-abundant oxide insulator-capped with a platinum overlayer. By exploiting a first-order analogue of the Kibble-Zurek mechanism(20,21), we stabilize exotic merons and antimerons (half-skyrmions)(8) and their pairs (bimerons)(16,22), which can be erased by magnetic fields and regenerated by temperature cycling. These structures have characteristic sizes of the order of 100 nanometres and can be chemically controlled via precise tuning of the exchange and anisotropy, with pathways through which further scaling may be achieved. Driven by current-based spin torques from the heavy-metal overlayer, some of these antiferromagnetic textures could emerge as prime candidates for low-energy antiferromagnetic spintronics at room temperature(1,9-11,23).	[Jani, Hariom; Prakash, Saurav; Ariando, A.] Natl Univ Singapore, Dept Phys, Singapore, Singapore; [Lin, Jheng-Cyuan; Chen, Jiahao; Harrison, Jack; Radaelli, Paolo G.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford, England; [Maccherozzi, Francesco] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot, Oxon, England; [Schad, Jonathon; Eom, Chang-Beom] Univ Wisconsin Madison, Dept Mat Sci & Engn, Madison, WI USA; [Ariando, A.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Venkatesan, T.] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore, Singapore	National University of Singapore; University of Oxford; Diamond Light Source; University of Wisconsin System; University of Wisconsin Madison; National University of Singapore; National University of Singapore	Jani, H (corresponding author), Natl Univ Singapore, Dept Phys, Singapore, Singapore.; Radaelli, PG (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford, England.; Venkatesan, T (corresponding author), Natl Univ Singapore, Dept Elect & Comp Engn, Singapore, Singapore.	hariom.k.jani@u.nus.edu; venky@nus.edu.sg; paolo.radaelli@physics.ox.ac.uk	Jani, Hariom/AAV-4468-2021; , Ariando/F-8953-2012; Radaelli, Paolo G/C-2952-2011	Jani, Hariom/0000-0003-4902-5180; , Ariando/0000-0002-0598-426X; Radaelli, Paolo G/0000-0002-6717-035X; Venkatesan, Thirumalai/0000-0001-9683-4584; Harrison, Jack/0000-0003-4787-1869; Prakash, Saurav/0000-0002-1334-5767	EPSRC [EP/M2020517/1]; National Research Foundation (NRF) [NRF2015NRF-CRP001-015]; Agency for Science, Technology and Research (A*STAR) under its Advanced Manufacturing and Engineering (AME) Individual Research Grant (IRG) [A1983c0034]; Chinese Scholarship Council (CSC); National University of Defense Technology (NUDT); Army Research Office [W911NF-17-1-0462]; Vannevar Bush Faculty Fellowship by ONR [N00014-20-1-2844]	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Research Foundation (NRF); Agency for Science, Technology and Research (A*STAR) under its Advanced Manufacturing and Engineering (AME) Individual Research Grant (IRG); Chinese Scholarship Council (CSC)(China Scholarship Council); National University of Defense Technology (NUDT); Army Research Office; Vannevar Bush Faculty Fellowship by ONR	We thank S. Parameswaran for discussions, F. P. Chmiel for guidance with data reduction, and R. D. Johnson for assistance with experiments. We acknowledge the Diamond Light Source for time on Beam Line I06 under proposals MM23857 and S120317. The work done at the University of Oxford (H.J., J.-C.L., J.C., J.H. and P.G.R.) is funded by EPSRC grant no. EP/M2020517/1 (Quantum Materials Platform Grant). The work at the National University of Singapore (H.J., S.P., A.A. and T.V.) is supported by the National Research Foundation (NRF) under the Competitive Research Program (NRF2015NRF-CRP001-015) and we also acknowledge SSLS for time on Beam Line XDD, which is under NRF. A.A. thanks the Agency for Science, Technology and Research (A*STAR) under its Advanced Manufacturing and Engineering (AME) Individual Research Grant (IRG) (A1983c0034) for financial support. J.C. acknowledges a full scholarship from the Chinese Scholarship Council (CSC) and support from the National University of Defense Technology (NUDT). The work at University of Wisconsin-Madison (J.S. and C.B.E.) is supported by the Army Research Office through grant W911NF-17-1-0462. C.B.E. acknowledges a Vannevar Bush Faculty Fellowship, funded by ONR (N00014-20-1-2844).	Arenholz E, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.094407; Back C, 2020, J PHYS D APPL PHYS, V53, DOI 10.1088/1361-6463/ab8418; Baltz V, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.015005; Barker J, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.147203; Bessarab PF, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.140411; BESSER PJ, 1967, PHYS REV, V153, P632, DOI 10.1103/PhysRev.153.632; Boulle O, 2016, NAT NANOTECHNOL, V11, P449, DOI 10.1038/nnano.2015.315; Buttner F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22242-8; Caretta L, 2018, NAT NANOTECHNOL, V13, P1154, DOI 10.1038/s41565-018-0255-3; Cheng Y, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.027202; Chmiel FP, 2018, NAT MATER, V17, P581, DOI 10.1038/s41563-018-0101-x; COEY JMD, 1971, J PHYS PART C SOLID, V4, P2386, DOI 10.1088/0022-3719/4/15/025; Dohi T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13182-6; Galkina EG, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.184413; Gobel B, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.060407; Grollier J, 2020, NAT ELECTRON, V3, P360, DOI 10.1038/s41928-019-0360-9; Hanneken C, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/5/055009; Juge R, 2019, PHYS REV APPL, V12, DOI 10.1103/PhysRevApplied.12.044007; Juge R, 2018, J MAGN MAGN MATER, V455, P3, DOI 10.1016/j.jmmm.2017.10.030; Kampfrath T, 2011, NAT PHOTONICS, V5, P31, DOI [10.1038/nphoton.2010.259, 10.1038/NPHOTON.2010.259]; Kharkov YA, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.207201; Khoshlahni R, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.054423; KIBBLE TWB, 1976, J PHYS A-MATH GEN, V9, P1387, DOI 10.1088/0305-4470/9/8/029; Kimel AV, 2004, NATURE, V429, P850, DOI 10.1038/nature02659; KUIPER P, 1993, PHYS REV LETT, V70, P1549, DOI 10.1103/PhysRevLett.70.1549; Kurumaji T, 2019, SCIENCE, V365, P914, DOI 10.1126/science.aau0968; Lebrun R, 2018, NATURE, V561, P222, DOI 10.1038/s41586-018-0490-7; Legrand W, 2020, NAT MATER, V19, P34, DOI 10.1038/s41563-019-0468-3; Leonov AO, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.014423; Li XG, 2020, NPJ COMPUT MATER, V6, DOI 10.1038/s41524-020-00435-y; Liang X., 2019, PREPRINT; Litzius K, 2017, NAT PHYS, V13, P170, DOI [10.1038/nphys4000, 10.1038/NPHYS4000]; Luning J, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.214433; Luo ZC, 2020, NATURE, V579, P214, DOI 10.1038/s41586-020-2061-y; Moreau-Luchaire C, 2016, NAT NANOTECHNOL, V11, P444, DOI 10.1038/nnano.2015.313; Nayak AK, 2017, NATURE, V548, P561, DOI 10.1038/nature23466; Park S, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/27007; Price NW, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.177601; Radaelli PG, 2020, PHYS REV B, V101, DOI 10.1103/PhysRevB.101.144420; Shen LC, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.037202; Shiino T, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.087203; Soumyanarayanan A, 2017, NAT MATER, V16, P898, DOI [10.1038/NMAT4934, 10.1038/nmat4934]; Stohr J, 1998, SURF REV LETT, V5, P1297, DOI 10.1142/S0218625X98001638; Stohr J, 1999, PHYS REV LETT, V83, P1862, DOI 10.1103/PhysRevLett.83.1862; van der Laan G, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.064409; Wang Y, 2019, SCIENCE, V366, P1125, DOI 10.1126/science.aav8076; Woo S, 2016, NAT MATER, V15, P501, DOI [10.1038/NMAT4593, 10.1038/nmat4593]; Yu XZ, 2018, NATURE, V564, P95, DOI 10.1038/s41586-018-0745-3; Zeissler K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14232-9; Zhang PX, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.247206; Zhang XC, 2020, J PHYS-CONDENS MAT, V32, DOI 10.1088/1361-648X/ab5488; Zhang XC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10293; ZUREK WH, 1985, NATURE, V317, P505, DOI 10.1038/317505a0	53	56	56	26	135	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2021	590	7844					74	+		10.1038/s41586-021-03219-6	http://dx.doi.org/10.1038/s41586-021-03219-6			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP2WO	33536652	Green Submitted			2022-12-28	WOS:000641594500001
J	Shields, BJ; Stevens, J; Li, J; Parasram, M; Damani, F; Alvarado, JIM; Janey, JM; Adams, RP; Doyle, AG				Shields, Benjamin J.; Stevens, Jason; Li, Jun; Parasram, Marvin; Damani, Farhan; Alvarado, Jesus I. Martinez; Janey, Jacob M.; Adams, Ryan P.; Doyle, Abigail G.			Bayesian reaction optimization as a tool for chemical synthesis	NATURE			English	Article							CONTINUOUS-FLOW; DESIGN; DEOXYFLUORINATION; FEASIBILITY; CHEMISTRY; MITSUNOBU; FLUORINE	Reaction optimization is fundamental to synthetic chemistry, from optimizing the yield of industrial processes to selecting conditions for the preparation of medicinal candidates(1). Likewise, parameter optimization is omnipresent in artificial intelligence, from tuning virtual personal assistants to training social media and product recommendation systems(2). Owing to the high cost associated with carrying out experiments, scientists in both areas set numerous (hyper)parameter values by evaluating only a small subset of the possible configurations. Bayesian optimization, an iterative response surface-based global optimization algorithm, has demonstrated exceptional performance in the tuning of machine learning models(3). Bayesian optimization has also been recently applied in chemistry(4-9); however, its application and assessment for reaction optimization in synthetic chemistry has not been investigated. Here we report the development of a framework for Bayesian reaction optimization and an open-source software tool that allows chemists to easily integrate state-of-the-art optimization algorithms into their everyday laboratory practices. We collect a large benchmark dataset for a palladium-catalysed direct arylation reaction, perform a systematic study of Bayesian optimization compared to human decision-making in reaction optimization, and apply Bayesian optimization to two real-world optimization efforts (Mitsunobu and deoxyfluorination reactions). Benchmarking is accomplished via an online game that links the decisions made by expert chemists and engineers to real experiments run in the laboratory. Our findings demonstrate that Bayesian optimization outperforms human decisionmaking in both average optimization efficiency (number of experiments) and consistency (variance of outcome against initially available data). Overall, our studies suggest that adopting Bayesian optimization methods into everyday laboratory practices could facilitate more efficient synthesis of functional chemicals by enabling better-informed, data-driven decisions about which experiments to run.	[Shields, Benjamin J.; Parasram, Marvin; Alvarado, Jesus I. Martinez; Doyle, Abigail G.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Stevens, Jason; Li, Jun; Janey, Jacob M.] Bristol Myers Squibb, Chem Proc Dev, New Brunswick, NJ USA; [Damani, Farhan; Adams, Ryan P.] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA	Princeton University; Bristol-Myers Squibb; Princeton University	Doyle, AG (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.; Adams, RP (corresponding author), Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA.	rpa@princeton.edu; agdoyle@princeton.edu		Stevens, Jason/0000-0003-1671-1539; Li, Jun/0000-0002-0594-7143; Martinez Alvarado, Jesus/0000-0002-7061-8792; Doyle, Abigail/0000-0002-6641-0833; Janey, Jacob/0000-0001-7697-1709; Parasram, Marvin/0000-0002-6052-0417; Shields, Benjamin/0000-0002-3825-0211; Adams, Ryan/0000-0002-5704-6654	Bristol-Myers Squibb; Princeton Catalysis Initiative; NSF under the CCI Center for Computer Assisted Synthesis [CHE1925607]; DataX Program at Princeton University through the Schmidt Futures Foundation	Bristol-Myers Squibb(Bristol-Myers Squibb); Princeton Catalysis Initiative; NSF under the CCI Center for Computer Assisted Synthesis; DataX Program at Princeton University through the Schmidt Futures Foundation	Financial support was provided by Bristol-Myers Squibb, the Princeton Catalysis Initiative, the NSF under the CCI Center for Computer Assisted Synthesis (CHE1925607) and the DataX Program at Princeton University through support from the Schmidt Futures Foundation. We thank A. Zuranski and J. Ash for discussions. We thank all the participants in the reaction optimization game for their time and effort in contributing to this study. We thank B. Hao for help with HTE protocols.	Ahneman DT, 2018, SCIENCE, V360, P186, DOI 10.1126/science.aar5169; Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; Biau G, 2012, J MACH LEARN RES, V13, P1063; Boukouvala F, 2012, COMPUT CHEM ENG, V36, P358, DOI 10.1016/j.compchemeng.2011.06.005; Burger B, 2020, NATURE, V583, P237, DOI 10.1038/s41586-020-2442-2; Carlson R, 2005, DATA HANDL SCI TECHN, V24, P1; Clayton AD, 2019, REACT CHEM ENG, V4, P1545, DOI 10.1039/c9re00209j; Davies HML, 2016, J ORG CHEM, V81, P343, DOI 10.1021/acs.joc.5b02818; Durand DJ, 2019, CHEM REV, V119, P6561, DOI 10.1021/acs.chemrev.8b00588; Duros V, 2017, ANGEW CHEM INT EDIT, V56, P10815, DOI 10.1002/anie.201705721; Feurer M, 2019, SPRING SER CHALLENGE, P3, DOI 10.1007/978-3-030-05318-5_1; Fletcher S, 2015, ORG CHEM FRONT, V2, P739, DOI 10.1039/c5qo00016e; Fox RJ, 2019, J ORG CHEM, V84, P4661, DOI 10.1021/acs.joc.8b02383; Gardner JR, 2018, ADV NEUR IN, V31; Gillis EP, 2015, J MED CHEM, V58, P8315, DOI 10.1021/acs.jmedchem.5b00258; Ginsbourger D, 2010, ADAPT LEARN OPTIM, V2, P131; Griffiths RR, 2020, CHEM SCI, V11, P577, DOI 10.1039/c9sc04026a; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Hase F., 2020, GRYFFIN ALGORITHM BA; Hase F, 2019, TRENDS CHEM, V1, P282, DOI 10.1016/j.trechm.2019.02.007; Hase F, 2018, ACS CENTRAL SCI, V4, P1134, DOI 10.1021/acscentsci.8b00307; Hsieh HW, 2018, ORG PROCESS RES DEV, V22, P542, DOI 10.1021/acs.oprd.8b00018; Hu WL, 2017, SYNTHESIS-STUTTGART, V49, P4917, DOI 10.1055/s-0036-1590881; Ji YN, 2015, J AM CHEM SOC, V137, P13272, DOI 10.1021/jacs.5b01913; Jones DR, 1998, J GLOBAL OPTIM, V13, P455, DOI 10.1023/A:1008306431147; Kandasamy K, 2018, PR MACH LEARN RES, V84; Kondo M, 2020, CHEM COMMUN, V56, P1259, DOI 10.1039/c9cc08526b; Krivak R, 2017, IEEE INT C BIOINFORM, P2278; Lee R, 2019, CHEM-ING-TECH, V91, P191, DOI 10.1002/cite.201800100; Luo G, 2016, NETW MODEL ANAL HLTH, V5, DOI 10.1007/s13721-016-0125-6; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Maceiczyk RM, 2014, J PHYS CHEM C, V118, P20026, DOI 10.1021/jp506259k; Mateos C, 2019, REACT CHEM ENG, V4, P1536, DOI 10.1039/c9re00116f; MITSUNOBU O, 1967, B CHEM SOC JPN, V40, P2380, DOI 10.1246/bcsj.40.2380; Mockus J., 1975, IFAC P, V8, P428, DOI [10.1016/S1474-6670(17)67769-3, DOI 10.1016/S1474-6670(17)67769-3]; Moriwaki H, 2018, J CHEMINFORMATICS, V10, DOI 10.1186/s13321-018-0258-y; Murray PM, 2016, ORG BIOMOL CHEM, V14, P2373, DOI 10.1039/c5ob01892g; Negoescu DM, 2011, INFORMS J COMPUT, V23, P346, DOI 10.1287/ijoc.1100.0417; Nielsen MK, 2018, J AM CHEM SOC, V140, P5004, DOI 10.1021/jacs.8b01523; Nielsen MK, 2015, J AM CHEM SOC, V137, P9571, DOI 10.1021/jacs.5b06307; Olofsson S, 2019, COMPUT CHEM ENG, V125, P54, DOI 10.1016/j.compchemeng.2019.03.010; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Perera D, 2018, SCIENCE, V359, P429, DOI 10.1126/science.aap9112; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Reker D, 2020, CELL REP PHYS SCI, V1, DOI 10.1016/j.xcrp.2020.100247; Reker D, 2015, DRUG DISCOV TODAY, V20, P458, DOI 10.1016/j.drudis.2014.12.004; Requeima J., 2017, PREPRINT; Rogers A, 2015, CHEM ENG SCI, V137, P986, DOI 10.1016/j.ces.2015.06.014; Santanilla AB, 2015, SCIENCE, V347, P49, DOI 10.1126/science.1259203; Schweidtmann AM, 2018, CHEM ENG J, V352, P277, DOI 10.1016/j.cej.2018.07.031; Shahriari B, 2016, P IEEE, V104, P148, DOI 10.1109/JPROC.2015.2494218; Snoek J., 2012, ADV NEURAL INF PROCE, V25; Surowiec I, 2017, ANAL CHEM, V89, P6491, DOI 10.1021/acs.analchem.7b00506; Swamy KCK, 2009, CHEM REV, V109, P2551, DOI 10.1021/cr800278z; Ueno Tsuyoshi, 2016, Materials Discovery, V4, P18, DOI 10.1016/j.md.2016.04.001; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; Wang JL, 2020, OPER RES, V68, P1850, DOI 10.1287/opre.2019.1966; Weissman SA, 2015, ORG PROCESS RES DEV, V19, P1605, DOI 10.1021/op500169m	59	120	121	77	271	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2021	590	7844					89	+		10.1038/s41586-021-03213-y	http://dx.doi.org/10.1038/s41586-021-03213-y			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SB0AJ	33536653				2022-12-28	WOS:000649664700001
J	Guirguis-Blake, JM; Webber, EM; Coppola, EL				Guirguis-Blake, Janelle M.; Webber, Elizabeth M.; Coppola, Erin L.			Screening for Asymptomatic Carotid Artery Stenosis in the General Population Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Guirguis-Blake, Janelle M.] Univ Washington, Dept Family Med, Tacoma, WA USA; [Webber, Elizabeth M.; Coppola, Erin L.] Kaiser Permanente Ctr Hlth Res, Kaiser Permanente Evidence Based Practice Ctr, Portland, OR USA	University of Washington; University of Washington Tacoma; Kaiser Permanente	Guirguis-Blake, JM (corresponding author), Univ Washington, Kaiser Permanente Res Affiliates EPC, Dept Family Med, 521 Martin Luther King Jr Way, Tacoma, WA 98405 USA.	jguirgui@u.washington.edu			Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA290201500007I]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under HHSA290201500007I, Task Order 6, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the US Preventive Services Task Force (USPSTF).	Guirguis-Blake JM, 2020, AHRQ PUBLICATION; Jonas DE, 2014, EVIDENCE SYNTHESIS; Kolos I, 2015, J VASC SURG, V62, P914, DOI 10.1016/j.jvs.2015.05.005; LeFevre ML, 2014, ANN INTERN MED, V161, P356, DOI 10.7326/M14-1333; Reiff T, 2020, INT J STROKE, V15, P638, DOI 10.1177/1747493019833017; US Preventive Services Task Force, PROC MAN	6	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2021	325	5					487	489		10.1001/jama.2020.20364	http://dx.doi.org/10.1001/jama.2020.20364			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QC6JP	33528528	Green Published, Bronze			2022-12-28	WOS:000614941900023
J	Goroll, AH; Greiner, AC; Schoenbaum, SC				Goroll, Allan H.; Greiner, Ann C.; Schoenbaum, Stephen C.			Reform of Payment for Primary Care - From Evolution to Revolution	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goroll, Allan H.] Harvard Med Sch, Boston, MA 02115 USA; [Goroll, Allan H.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Greiner, Ann C.] Primary Care Collaborat, Washington, DC USA; [Schoenbaum, Stephen C.] Josiah Macy Jr Fdn, New York, NY USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Goroll, AH (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Goroll, AH (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							Health Care Payment Learning and Action Network, 2017, ACCELERATING ALIGNIN; Navathe AS, 2019, JAMA-J AM MED ASSOC, V322, P57, DOI 10.1001/jama.2019.8113; Peikes D, 2018, HEALTH AFFAIR, V37, P890, DOI 10.1377/hlthaff.2017.1678; Pickreign J, CAPITAL DISTRICT PHY; Taylor E, 2020, PROSPECTIVE PAYMENT	5	3	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2021	384	9					788	791		10.1056/NEJMp2031640	http://dx.doi.org/10.1056/NEJMp2031640			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QS8DS	33596353				2022-12-28	WOS:000626124800013
J	Hope, TA; Calais, J				Hope, Thomas A.; Calais, Jeremie			PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer	LANCET			English	Editorial Material									[Hope, Thomas A.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Hope, Thomas A.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Hope, Thomas A.] San Francisco VA Med Ctr, Dept Radiol & Biomed Imaging, San Francisco, CA 94121 USA; [Calais, Jeremie] Univ Calif Los Angeles, David Geffen Sch Med, Ahmanson Translat Theranost Div, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Calais, Jeremie] Univ Calif Los Angeles, Inst Urol Oncol, Los Angeles, CA 90095 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Hope, TA (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.; Hope, TA (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Hope, TA (corresponding author), San Francisco VA Med Ctr, Dept Radiol & Biomed Imaging, San Francisco, CA 94121 USA.	thomas.hope@ucsf.edu	CALAIS, JEREMIE/AAG-7119-2020	CALAIS, JEREMIE/0000-0002-8839-4379				de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; de Wit R, 2019, NEW ENGL J MED, V381, P2506, DOI 10.1056/NEJMoa1911206; Hofman MS, 2021, LANCET, V397, P797, DOI 10.1016/S0140-6736(21)00237-3; Hofman MS, 2018, LANCET ONCOL, V19, P825, DOI 10.1016/S1470-2045(18)30198-0; Rahbar K, 2016, J NUCL MED, V57, P563, DOI 10.2967/jnumed.115.169243; Sathekge M, 2019, EUR J NUCL MED MOL I, V46, P129, DOI 10.1007/s00259-018-4167-0; Strosberg J, 2017, NEW ENGL J MED, V376, P125, DOI 10.1056/NEJMoa1607427; Violet J, 2019, J NUCL MED, V60, P517, DOI 10.2967/jnumed.118.219352	8	2	2	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					768	769		10.1016/S0140-6736(21)00349-4	http://dx.doi.org/10.1016/S0140-6736(21)00349-4		FEB 2021	0	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP6DN	33581799				2022-12-28	WOS:000623925500003
J	Logunov, DY; Dolzhikova, IV; Shcheblyakov, DV; Tukhvatulin, AI; Zubkova, OV; Dzharullaeva, AS; Kovyrshina, AV; Lubenets, NL; Grousova, DM; Erokhova, AS; Botikov, AG; Izhaeva, FM; Popova, O; Ozharovskaya, TA; Esmagambetov, IB; Favorskaya, IA; Zrelkin, DI; Voronina, DV; Shcherbinin, DN; Semikhin, AS; Simakova, YV; Tokarskaya, EA; Egorova, DA; Shmarov, MM; Nikitenko, NA; Gushchin, VA; Smolyarchuk, EA; Zyryanov, SK; Borisevich, SV; Naroditsky, BS; Gintsburg, AL				Logunov, Denis Y.; Dolzhikova, Inna V.; Shcheblyakov, Dmitry V.; Tukhvatulin, Amir I.; Zubkova, Olga V.; Dzharullaeva, Alina S.; Kovyrshina, Anna V.; Lubenets, Nadezhda L.; Grousova, Daria M.; Erokhova, Alina S.; Botikov, Andrei G.; Izhaeva, Fatima M.; Popova, Olga; Ozharovskaya, Tatiana A.; Esmagambetov, Ilias B.; Favorskaya, Irina A.; Zrelkin, Denis I.; Voronina, Daria V.; Shcherbinin, Dmitry N.; Semikhin, Alexander S.; Simakova, Yana V.; Tokarskaya, Elizaveta A.; Egorova, Daria A.; Shmarov, Maksim M.; Nikitenko, Natalia A.; Gushchin, Vladimir A.; Smolyarchuk, Elena A.; Zyryanov, Sergey K.; Borisevich, Sergei V.; Naroditsky, Boris S.; Gintsburg, Alexander L.		Gam-COVID-Vac Vaccine Trial Grp	Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia	LANCET			English	Article								Background A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), showed a good safety profile and induced strong humoral and cellular immune responses in participants in phase 1/2 clinical trials. Here, we report preliminary results on the efficacy and safety of Gam-COVID-Vac from the interim analysis of this phase 3 trial. Methods We did a randomised, double-blind, placebo-controlled, phase 3 trial at 25 hospitals and polyclinics in Moscow, Russia. We included participants aged at least 18 years, with negative SARS-CoV-2 PCR and IgG and IgM tests, no infectious diseases in the 14 days before enrolment, and no other vaccinations in the 30 days before enrolment. Participants were randomly assigned (3:1) to receive vaccine or placebo, with stratification by age group. Investigators, participants, and all study staff were masked to group assignment. The vaccine was administered (0.5 mL/dose) intramuscularly in a prime-boost regimen: a 21-day interval between the first dose (rAd26) and the second dose (rAd5), both vectors carrying the gene for the full-length SARS-CoV-2 glycoprotein S. The primary outcome was the proportion of participants with PCR-confirmed COVID-19 from day 21 after receiving the first dose. All analyses excluded participants with protocol violations: the primary outcome was assessed in participants who had received two doses of vaccine or placebo, serious adverse events were assessed in all participants who had received at least one dose at the time of database lock, and rare adverse events were assessed in all participants who had received two doses and for whom all available data were verified in the case report form at the time of database lock. The trial is registered at ClinicalTrials.gov (NCT04530396). Findings Between Sept 7 and Nov 24, 2020, 21 977 adults were randomly assigned to the vaccine group (n=16 501) or the placebo group (n=5476). 19 866 received two doses of vaccine or placebo and were included in the primary outcome analysis. From 21 days after the first dose of vaccine (the day of dose 2), 16 (0.1%) of 14 964 participants in the vaccine group and 62 (1.3%) of 4902 in the placebo group were confirmed to have COVID-19; vaccine efficacy was 91.6% (95% CI 85.6-95.2). Most reported adverse events were grade 1 (7485 [94.0%] of 7966 total events). 45 (0.3%) of 16 427 participants in the vaccine group and 23 (0.4%) of 5435 participants in the placebo group had serious adverse events; none were considered associated with vaccination, with confirmation from the independent data monitoring committee. Four deaths were reported during the study (three [<0.1%] of 16 427 participants in the vaccine group and one [<0.1%] of 5435 participants in the placebo group), none of which were considered related to the vaccine. Interpretation This interim analysis of the phase 3 trial of Gam-COVID-Vac showed 91.6% efficacy against COVID-19 and was well tolerated in a large cohort. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Logunov, Denis Y.; Dolzhikova, Inna V.; Shcheblyakov, Dmitry V.; Tukhvatulin, Amir I.; Zubkova, Olga V.; Dzharullaeva, Alina S.; Kovyrshina, Anna V.; Lubenets, Nadezhda L.; Grousova, Daria M.; Erokhova, Alina S.; Botikov, Andrei G.; Izhaeva, Fatima M.; Popova, Olga; Ozharovskaya, Tatiana A.; Esmagambetov, Ilias B.; Favorskaya, Irina A.; Zrelkin, Denis I.; Voronina, Daria V.; Shcherbinin, Dmitry N.; Semikhin, Alexander S.; Simakova, Yana V.; Tokarskaya, Elizaveta A.; Egorova, Daria A.; Shmarov, Maksim M.; Nikitenko, Natalia A.; Gushchin, Vladimir A.; Naroditsky, Boris S.; Gintsburg, Alexander L.] Minist Hlth Russian Federat, Fed State Budget Inst, Natl Res Ctr Epidemiol & Microbiol, Moscow 123098, Russia; [Smolyarchuk, Elena A.; Gintsburg, Alexander L.] Sechenov Univ, IM Sechenov First Moscow State Med Univ, Minist Hlth Russian Federat, Fed State Autonomous Educ Inst Higher Educ, Moscow, Russia; [Zyryanov, Sergey K.] RUDN Univ, Peoples Friendship Univ Russia, Moscow, Russia; [Borisevich, Sergei V.] Minist Def Russian Federat, Cent Res Inst 48, Moscow, Russia	Ministry of Health of the Russian Federation; Ministry of Health of the Russian Federation; Sechenov First Moscow State Medical University; Peoples Friendship University of Russia	Logunov, DY (corresponding author), Minist Hlth Russian Federat, Fed State Budget Inst, Natl Res Ctr Epidemiol & Microbiol, Moscow 123098, Russia.	ldenisy@gmail.com	Voronina, Daria/AAI-4570-2020; Semikhin, Alexander/R-6760-2019; Shmarov, Maxim M/D-8662-2014; Grousova, Daria/GYA-5916-2022; Voronina, Daria/HHM-9938-2022; Zubkova, Olga/E-4168-2014; Gushchin, Vladimir A/F-7207-2017; Izhaeva, Fatima/AAZ-2099-2021; Tukhvatulin, Amir/E-8183-2014; Nikitenko, Natalia/N-2323-2016; Olga, Popova/R-6742-2019; Smolyarchuk, Elena/HCI-7673-2022; Zrelkin, Denis/HII-6101-2022	Voronina, Daria/0000-0001-6629-744X; Semikhin, Alexander/0000-0003-0560-5589; Zubkova, Olga/0000-0001-7893-8419; Gushchin, Vladimir A/0000-0002-9397-3762; Tukhvatulin, Amir/0000-0001-8506-2339; Olga, Popova/0000-0003-3248-1227; Zrelkin, Denis/0000-0003-0899-8357; Egorova, Daria/0000-0003-3562-9880; Favorskaya, Irina/0000-0003-0639-8390; Grousova, Daria/0000-0002-3299-4818; Zyryanov, Sergey/0000-0002-6348-6867; Ozharovskaia, Tatiana/0000-0001-7147-1553; Esmagambetov, Ilias Bulatovich/0000-0002-2063-2449	Moscow City Health Department; Sberbank; Russian Direct Investment Fund	Moscow City Health Department; Sberbank; Russian Direct Investment Fund	Moscow City Health Department, Russian Direct Investment Fund, and Sberbank.	Altman DG, 1991, PRACTICAL STAT MED R; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Centers for Disease Control and Prevention, INTERIM CLIN GUIDANC; Dolzhikova IV, 2017, HUM VACC IMMUNOTHER, V13, P613, DOI 10.1080/21645515.2016.1238535; Kovyrshina A. V., 2020, Immunologiya, V41, P135, DOI 10.33029/0206-4952-2020-41-2-135-143; Logunov DY, 2020, LANCET, V396, P887, DOI 10.1016/S0140-6736(20)31866-3; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Volpers C, 2004, J GENE MED, V6, pS164, DOI 10.1002/jgm.496; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; WHO, 2020, MODES TRANSMISSION V; Wold WSM, 2013, CURR GENE THER, V13, P421; World Health Organization, 2021, DRAFT LANDSC COVID 1; World Health Organization, 2020, TARGET PRODUCT PROFI; Zhang C, 2016, HUM VACC IMMUNOTHER, V12, P2064, DOI 10.1080/21645515.2016.1165908	16	812	881	11	124	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					671	681		10.1016/S0140-6736(21)00234-8	http://dx.doi.org/10.1016/S0140-6736(21)00234-8		FEB 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL3PK	33545094	Green Published, Bronze			2022-12-28	WOS:000620991800029
J	Biller, LH; Schrag, D				Biller, Leah H.; Schrag, Deborah			Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FOLFOXIRI PLUS BEVACIZUMAB; RANDOMIZED PHASE-III; MOLECULAR SUBGROUP ANALYSES; 1ST-LINE TREATMENT; OPEN-LABEL; RETROSPECTIVE ANALYSIS; INITIAL THERAPY; NON-INFERIORITY; TUMOR LOCATION; GENE-MUTATIONS	ImportanceColorectal cancer (CRC) is the third most common cause of cancer mortality worldwide with more than 1.85 million cases and 850000 deaths annually. Of new colorectal cancer diagnoses, 20% of patients have metastatic disease at presentation and another 25% who present with localized disease will later develop metastases. ObservationsColorectal cancer is the third most common cause of cancer mortality for men and women in the United States, with 53200 deaths projected in 2020. Among people diagnosed with metastatic colorectal cancer, approximately 70% to 75% of patients survive beyond 1 year, 30% to 35% beyond 3 years, and fewer than 20% beyond 5 years from diagnosis. The primary treatment for unresectable metastatic CRC is systemic therapy (cytotoxic chemotherapy, biologic therapy such as antibodies to cellular growth factors, immunotherapy, and their combinations.) Clinical trials completed in the past 5 years have demonstrated that tailoring treatment to the molecular and pathologic features of the tumor improves overall survival. Genomic profiling to detect somatic variants is important because it identifies the treatments that may be effective. For the 50% of patients with metastatic CRC with KRAS/NRAS/BRAF wild-type tumors, cetuximab and panitumumab (monoclonal antibodies to the epithelial growth factor receptor [EGFR]), in combination with chemotherapy, can extend median survival by 2 to 4 months compared with chemotherapy alone. However, for the 35% to 40% of patients with KRAS or NRAS sequence variations (formerly termed mutations), effective targeted therapies are not yet available. For the 5% to 10% with BRAF V600E sequence variations, targeted combination therapy with BRAF and EGFR inhibitors extended overall survival to 9.3 months, compared to 5.9 months for those receiving standard chemotherapy. For the 5% with microsatellite instability (the presence of numerous insertions or deletions at repetitive DNA units) or mismatch repair deficiency, immunotherapy may be used in the first or subsequent line and has improved treatment outcomes with a median overall survival of 31.4 months in previously treated patients. Conclusions and RelevanceAdvances in molecular profiling of metastatic CRC facilitate the ability to direct treatments to the biologic features of the tumor for specific patient subsets. Although cures remain uncommon, more patients can anticipate extended survival. Genomic profiling allows treatment selection so that more patients derive benefit and fewer are exposed to toxicity from ineffective therapies. This narrative review summarizes treatment options for patients with unresectable metastatic colorectal cancer, focusing on the importance of genomic profiling to identify KRAS/NRAS/BRAF variants to guide immunotherapy.	[Biller, Leah H.; Schrag, Deborah] Dana Farber Canc Inst, Div Gastrointestinal Oncol, Boston, MA 02115 USA; [Biller, Leah H.; Schrag, Deborah] Harvard Med Sch, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA; [Schrag, Deborah] Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Schrag, D (corresponding author), Harvard Med Sch, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA.	deb_schrag@dfci.harvard.edu						Amstutz U, 2018, CLIN PHARMACOL THER, V103, P210, DOI 10.1002/cpt.911; Andre T, 2020, NEW ENGL J MED, V383, P2207, DOI 10.1056/NEJMoa2017699; Aparicio T, 2018, J CLIN ONCOL, V36, P674, DOI 10.1200/JCO.2017.75.2931; Baraniskin A, 2019, EUR J CANCER, V106, P37, DOI 10.1016/j.ejca.2018.10.009; Bekaii-Saab TS, 2019, LANCET ONCOL, V20, P1070, DOI 10.1016/S1470-2045(19)30272-4; Cantwell-Dorris ER, 2011, MOL CANCER THER, V10, P385, DOI 10.1158/1535-7163.MCT-10-0799; Chau I, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-605; Cohen R, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0453-5; Cremolini C, 2018, ANN ONCOL, V29, P1528, DOI 10.1093/annonc/mdy140; Cremolini C, 2020, LANCET ONCOL, V21, P497, DOI 10.1016/S1470-2045(19)30862-9; Cremolini C, 2015, LANCET ONCOL, V16, P1306, DOI 10.1016/S1470-2045(15)00122-9; Douillard JY, 2014, ANN ONCOL, V25, P1346, DOI 10.1093/annonc/mdu141; Ebert PJR, 2016, IMMUNITY, V44, P609, DOI 10.1016/j.immuni.2016.01.024; Eng C, 2019, LANCET ONCOL, V20, P849, DOI 10.1016/S1470-2045(19)30027-0; Folprecht G, 2016, ANN ONCOL, V27, P1273, DOI 10.1093/annonc/mdw176; Goey KKH, 2017, ANN ONCOL, V28, P2128, DOI 10.1093/annonc/mdx322; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Goldstein J, 2014, ANN ONCOL, V25, P1032, DOI 10.1093/annonc/mdu100; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Guo Y, 2016, CANCER INVEST, V34, P94, DOI 10.3109/07357907.2015.1104689; Guo YB, 2014, CLIN COLORECTAL CANC, V13, P110, DOI 10.1016/j.clcc.2013.12.004; Hao YX, 2017, ONCOTARGETS THER, V10, P945, DOI 10.2147/OTT.S123954; Hecht JR, 1998, ONCOLOGY-NY, V12, P72; Heinemann V, 2014, LANCET ONCOL, V15, P1065, DOI 10.1016/S1470-2045(14)70330-4; Hochster HS, 2008, J CLIN ONCOL, V26, P3523, DOI 10.1200/JCO.2007.15.4138; Holch JW, 2017, EUR J CANCER, V70, P87, DOI 10.1016/j.ejca.2016.10.007; Howlader N., NATL CANC I WEBSITE; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Husain H, 2017, JAMA-J AM MED ASSOC, V318, P1272, DOI 10.1001/jama.2017.12131; Kahi CJ, 2016, GASTROINTEST ENDOSC, V83, P489, DOI 10.1016/j.gie.2016.01.020; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kerr J, 2017, LANCET ONCOL, V18, pE457, DOI 10.1016/S1470-2045(17)30411-4; Kopetz S, 2019, NEW ENGL J MED, V381, P1632, DOI 10.1056/NEJMoa1908075; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2020, J CLIN ONCOL, V38, P11, DOI 10.1200/JCO.19.02107; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Liu PH, 2019, JAMA ONCOL, V5, P579, DOI 10.1001/jamaoncol.2018.4280; Lo Nigro C, 2016, WORLD J GASTROENTERO, V22, P6944, DOI 10.3748/wjg.v22.i30.6944; Loupakis F, 2014, NEW ENGL J MED, V371, P1609, DOI 10.1056/NEJMoa1403108; Masi G, 2011, JNCI-J NATL CANCER I, V103, P21, DOI 10.1093/jnci/djq456; Mattison LK, 2006, CLIN CANCER RES, V12, P5491, DOI 10.1158/1078-0432.CCR-06-0747; Mayer RJ, 2015, NEW ENGL J MED, V372, P1909, DOI 10.1056/NEJMoa1414325; Meric-Bemstam F, 2019, LANCET ONCOL, V20, P518, DOI 10.1016/S1470-2045(18)30904-5; Modest DP, 2016, ANN ONCOL, V27, P1746, DOI 10.1093/annonc/mdw261; Moreira L, 2012, JAMA-J AM MED ASSOC, V308, P1555, DOI 10.1001/jama.2012.13088; Moreno CC, 2016, CLIN COLORECTAL CANC, V15, P67, DOI 10.1016/j.clcc.2015.07.004; National Cancer Institute Surveillance Epidemiology and End Results Program, CANC STAT FACTS COL; National Comprehensive Cancer Network, RECT CANC VERS 1 202; National Comprehensive Cancer Network, COLON CANC VERSION 2; Nitsche U, 2016, DIGEST SURG, V33, P157, DOI 10.1159/000443644; Overman MJ, 2018, J CLIN ONCOL, V36, P773, DOI 10.1200/JCO.2017.76.9901; Overman MJ, 2017, LANCET ONCOL, V18, P1182, DOI 10.1016/S1470-2045(17)30422-9; Peeters M, 2014, ANN ONCOL, V25, P107, DOI 10.1093/annonc/mdt523; Price T, 2016, EUR J CANCER, V68, P51, DOI 10.1016/j.ejca.2016.08.010; Price TJ, 2014, LANCET ONCOL, V15, P569, DOI 10.1016/S1470-2045(14)70118-4; Qin SK, 2018, J CLIN ONCOL, V36, P3031, DOI 10.1200/JCO.2018.78.3183; Riihimaki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29765; Rivera F, 2017, INT J COLORECTAL DIS, V32, P1179, DOI 10.1007/s00384-017-2800-1; Ruiz-Saenz A, 2018, CANCER RES, V78, P3645, DOI 10.1158/0008-5472.CAN-18-0430; Sartore-Bianchi A, 2016, LANCET ONCOL, V17, P738, DOI 10.1016/S1470-2045(16)00150-9; Shulman K, 2018, JCO PRECIS ONCOL, V2, P1, DOI 10.1200/PO.17.00253; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simkens LHJ, 2015, LANCET, V385, P1843, DOI 10.1016/S0140-6736(14)62004-3; Tabernero J, 2021, J CLIN ONCOL, V39, P273, DOI 10.1200/JCO.20.02088; Tabernero J, 2015, LANCET ONCOL, V16, P499, DOI 10.1016/S1470-2045(15)70127-0; Tabernero J, 2014, EUR J CANCER, V50, P320, DOI 10.1016/j.ejca.2013.09.013; Thompson JA, 2020, J NATL COMPR CANC NE, V18, P230, DOI 10.6004/jnccn.2020.0012; Ulanja MB, 2019, J ONCOL, V2019, DOI 10.1155/2019/4315032; Van Cutsem E, 2016, TARGET ONCOL, V11, P383, DOI 10.1007/s11523-015-0402-9; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; Venook AP, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.3504; Venook AP, 2017, JAMA-J AM MED ASSOC, V317, P2392, DOI 10.1001/jama.2017.7105; Wang JF, 2019, ONCOL LETT, V18, P6046, DOI 10.3892/ol.2019.10970; Wang ZX, 2019, J NATL COMPR CANC NE, V17, P805, DOI 10.6004/jnccn.2018.7279; Win AK, 2017, CANCER EPIDEM BIOMAR, V26, P404, DOI [10.1158/1055-9965.EPI-16-0693, 10.1158/1055-9965.epi-16-0693]; Xu RH, 2018, LANCET ONCOL, V19, P660, DOI 10.1016/S1470-2045(18)30140-2; Xu XJ, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00814; Yamazaki K, 2016, ANN ONCOL, V27, P1539, DOI 10.1093/annonc/mdw206; Yurgelun MB, 2017, J CLIN ONCOL, V35, P1086, DOI 10.1200/JCO.2016.71.0012	80	230	237	80	232	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2021	325	7					669	685		10.1001/jama.2021.0106	http://dx.doi.org/10.1001/jama.2021.0106			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ3QZ	33591350				2022-12-28	WOS:000619608000019
J	Venkataramani, AS; O'Brien, R; Tsai, AC				Venkataramani, Atheendar S.; O'Brien, Rourke; Tsai, Alexander C.			Declining Life Expectancy in the United States: The Need for Social Policy as Health Policy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSOCIATION	This Viewpoint reviews the social and economic drivers of declines in longevity in the US, especially among lower socioeconomic status groups, and proposes policy options for the Biden-Harris administration to mitigate the trend, including an increase in the federally mandated minimum wage.	[Venkataramani, Atheendar S.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Venkataramani, Atheendar S.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [O'Brien, Rourke] Yale Univ, Dept Sociol, New Haven, CT USA; [O'Brien, Rourke] Yale Univ, Inst Social & Policy Studies, New Haven, CT USA; [Tsai, Alexander C.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Tsai, Alexander C.] Massachusetts Gen Hosp, Mongan Inst, Boston, MA 02114 USA; [Tsai, Alexander C.] Harvard Med Sch, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Yale University; Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Venkataramani, AS (corresponding author), 423 Guardian Dr,1129 Blockley Hall, Philadelphia, PA 19146 USA.	atheenv@pennmedicine.upenn.edu	Tsai, Alexander C./F-4247-2015	Tsai, Alexander C./0000-0001-6397-7917				Andrasfay T, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2014746118, DOI 10.1073/PNAS.201474611833446511]; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Cooper LA, 2020, JAMA-J AM MED ASSOC, V324, P1491, DOI 10.1001/jama.2020.19567; Currie J, 2016, J ECON PERSPECT, V30, P29, DOI 10.1257/jep.30.2.29; Dow WH, 2020, J HEALTH ECON, V74, DOI 10.1016/j.jhealeco.2020.102372; Gondi S, 2020, JAMA INTERN MED, V180, P1143, DOI 10.1001/jamainternmed.2020.2348; Montez JK, 2020, MILBANK Q, V98, P668, DOI 10.1111/1468-0009.12469; Sasson I, 2019, JAMA-J AM MED ASSOC, V322, P756, DOI 10.1001/jama.2019.11330; Venkataramani AS, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003319; Woolf SH, 2019, JAMA-J AM MED ASSOC, V322, P1996, DOI 10.1001/jama.2019.16932	10	15	15	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2021	325	7					621	622		10.1001/jama.2020.26339	http://dx.doi.org/10.1001/jama.2020.26339			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QJ3QZ	33591352				2022-12-28	WOS:000619608000009
J	Leslie, M				Leslie, Mitch			A REVEALING FLAW	SCIENCE			English	Editorial Material																			0	1	1	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					663	665		10.1126/science.371.6530.663	http://dx.doi.org/10.1126/science.371.6530.663			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4IS	33574194				2022-12-28	WOS:000617551600020
J	Dance, A				Dance, Amber			How the arts can help you to craft a successful research career	NATURE			English	Editorial Material						Careers; Arts; Lab life		Engaging in a creative pursuit can stimulate creativity and foster boldness and tenacity in the lab and beyond. Engaging in a creative pursuit can stimulate creativity and foster boldness and tenacity in the lab and beyond.										Alexander SHS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.081301; Gal J, 2017, NAT CHEM, V9, P604, DOI 10.1038/nchem.2790; LaMore R, 2013, ECON DEV Q, V27, P221, DOI 10.1177/0891242413486186; Modulevsky DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097835; Root-Bernstein R., 2008, J PSYCHOL SCI TECHNO, V1, P51, DOI DOI 10.1891/1939-7054.1.2.51; Root-Bernstein R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010272; ROOTBERNSTEIN RS, 1995, CREATIVITY RES J, V8, P115, DOI 10.1207/s15326934crj0802_2	7	2	2	2	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2021	590	7845					351	353		10.1038/d41586-021-00334-2	http://dx.doi.org/10.1038/d41586-021-00334-2			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2XL	33564187				2022-12-28	WOS:000616762900016
J	Shepherd, A				Shepherd, Alison			Myanmar medics resist military coup	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	7	7	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2021	372								n368	10.1136/bmj.n368	http://dx.doi.org/10.1136/bmj.n368			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RG0MZ	33563588				2022-12-28	WOS:000635231900005
J	Dyer, C				Dyer, Clare			Puberty blockers do not alleviate negative thoughts in children with gender dysphoria, finds study	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Carmichael P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0243894; Chisholm J., 2021, BMJ; Dyer C, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4717; Dyer C, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4699	4	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2021	372								n356	10.1136/bmj.n356	http://dx.doi.org/10.1136/bmj.n356			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM1AV	33558256				2022-12-28	WOS:000639394000001
J	Francey, N				Francey, Neil			The art of medicine 30th anniversary of Australian legal ruling on second-hand smoke	LANCET			English	Editorial Material												neil.francey2@gmail.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2021	397	10273					466	467						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QF1LZ	33549183				2022-12-28	WOS:000616661900014
J	Geibert, W; Matthiessen, J; Stimac, I; Wollenburg, J; Stein, R				Geibert, Walter; Matthiessen, Jens; Stimac, Ingrid; Wollenburg, Jutta; Stein, Ruediger			Glacial episodes of a freshwater Arctic Ocean covered by a thick ice shelf	NATURE			English	Article							LATE QUATERNARY; LATE PLEISTOCENE; YERMAK PLATEAU; SEA-ICE; SEDIMENTS; TH-230; PA-231; STRATIGRAPHY; RECORD; EVENTS	Following early hypotheses about the possible existence of Arctic ice shelves in the past(1-3), the observation of specific erosional features as deep as 1,000 metres below the current sea level confirmed the presence of a thick layer of ice on the Lomonosov Ridge in the central Arctic Ocean and elsewhere(4-6). Recent modelling studies have addressed how an ice shelf may have built up in glacial periods, covering most of the Arctic Ocean(7,8). So far, however, there is no irrefutable marine-sediment characterization of such an extensive ice shelf in the Arctic, raising doubt about the impact of glacial conditions on the Arctic Ocean. Here we provide evidence for at least two episodes during which the Arctic Ocean and the adjacent Nordic seas were not only covered by an extensive ice shelf, but also filled entirely with fresh water, causing a widespread absence of thorium-230 in marine sediments. We propose that these Arctic freshwater intervals occurred 70,000-62,000 years before present and approximately 150,000-131,000 years before present, corresponding to portions of marine isotope stages 4 and 6. Alternative interpretations of the first occurrence of the calcareous nannofossil Emiliania huxleyi in Arctic sedimentary records would suggest younger ages for the older interval. Our approach explains the unexpected minima in Arctic thorium-230 records(9) that have led to divergent interpretations of sedimentation rates(10,11) and hampered their use for dating purposes. About nine million cubic kilometres of fresh water is required to explain our isotopic interpretation, a calculation that we support with estimates of hydrological fluxes and altered boundary conditions. A freshwater mass of this size-stored in oceans, rather than land-suggests that a revision of sea-level reconstructions based on freshwater-sensitive stable oxygen isotopes may be required, and that large masses of fresh water could be delivered to the north Atlantic Ocean on very short timescales. Unexpected intervals of low Th-230 concentration in marine sediment cores are explained by considering that during at least two such periods, the Arctic Ocean and Nordic seas were composed entirely of fresh water and covered by a thick ice shelf.				walter.geibert@awi.de	Geibert, Walter/ABA-9785-2020	Geibert, Walter/0000-0001-8646-2334; Matthiessen, Jens/0000-0002-6952-2494; Stein, Ruediger/0000-0002-4453-9564; Stimac, Ingrid/0000-0001-6053-2330	Helmholtz Foundation	Helmholtz Foundation(Helmholtz Association)	We thank D. Bethke and L. Schafer for the lab work on the sediment cores. This work was funded through the research programme of the Helmholtz Foundation. Sample requests should be directed to the curator of the Polarstern core repository at the Alfred Wegener Institute (e-mail: curator@awi.de).	Adler RE, 2009, GLOBAL PLANET CHANGE, V68, P18, DOI 10.1016/j.gloplacha.2009.03.026; ANDERSON RF, 1983, EARTH PLANET SC LETT, V62, P7, DOI 10.1016/0012-821X(83)90067-5; Anonymous, 2015, Berichte zur Polar- und Meeresforschung, V688, P3, DOI 10.2312/BzPM_0688_2015; Backman J, 2004, QUATERNARY SCI REV, V23, P1435, DOI 10.1016/j.quascirev.2003.12.005; Backman J, 2009, MAR MICROPALEONTOL, V72, P86, DOI 10.1016/j.marmicro.2009.04.001; Brendryen J, 2020, NAT GEOSCI, V13, P363, DOI 10.1038/s41561-020-0567-4; Brinkhuis H, 2006, NATURE, V441, P606, DOI 10.1038/nature04692; BROECKER WS, 1975, SCIENCE, V188, P1116, DOI 10.1126/science.188.4193.1116; Chauhan T, 2016, GEO-MAR LETT, V36, P81, DOI 10.1007/s00367-015-0430-6; Costa KM, 2020, PALEOCEANOGR PALEOCL, V35, DOI 10.1029/2019PA003820; Darby DA, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006675; EISENHAUER A, 1994, EARTH PLANET SC LETT, V124, P171, DOI 10.1016/0012-821X(94)00069-7; EISENHAUER A, 1990, NATO ADV SCI I C-MAT, V308, P475; Evans JR, 1998, MICROPALEONTOLOGY, V44, P109, DOI 10.2307/1486065; Feyling-Hanssen R. W, 1990, FORAMINIFERAL STRATI, V24; Francois R, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000939; Frank M., 1996, [Radionuclides analysed on sediment core PS1533-3 from the Arctic Ocean, PANGAEA], DOI 10.1594/PANGAEA.50830; FUTTERER DK, 1992, BERICHTE POLARFORSCH, V107, P1, DOI DOI 10.2312/BZP_0107_1992; GARD G, 1990, NATO ADV SCI I C-MAT, V308, P417; Gasson EGW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03707-w; Geibert W, 2019, PALEOCEANOGR PALEOCL, V34, P1895, DOI 10.1029/2019PA003663; Goni MFS, 2010, QUATERNARY SCI REV, V29, P2823, DOI 10.1016/j.quascirev.2009.11.014; GREEN KEITH E., 1960, MICROPALEONTOLOGY, V6, P57, DOI 10.2307/1484317; Henderson GM, 2002, EARTH PLANET SC LETT, V199, P97, DOI 10.1016/S0012-821X(02)00556-3; Henderson GM, 1999, DEEP-SEA RES PT I, V46, P1861, DOI 10.1016/S0967-0637(99)00030-8; Hibbert FD, 2016, QUATERNARY SCI REV, V145, P1, DOI 10.1016/j.quascirev.2016.04.019; Hillaire-Marcel C, 2017, GEOCHEM GEOPHY GEOSY, V18, P4573, DOI 10.1002/2017GC007050; Hoffmann S, 2007, EARTH PLANET SC LETT, V258, P516, DOI 10.1016/j.epsl.2007.04.011; Hoffmann SS, 2013, NATURE, V497, P603, DOI 10.1038/nature12145; HUGHES T, 1977, NATURE, V266, P596, DOI 10.1038/266596a0; Huh CA, 1997, DEEP-SEA RES PT II, V44, P1725, DOI 10.1016/S0967-0645(97)00040-4; Jakobsson M, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000302; Jakobsson M, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000423; Jakobsson M, 2001, GLOBAL PLANET CHANGE, V31, P1, DOI 10.1016/S0921-8181(01)00110-2; Jakobsson M, 2000, GEOLOGY, V28, P23, DOI 10.1130/0091-7613(2000)028<0023:MACCIA>2.3.CO;2; Jakobsson M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10365; Jakobsson M, 2014, QUATERNARY SCI REV, V92, P40, DOI 10.1016/j.quascirev.2013.07.033; Jang K, 2013, EARTH PLANET SC LETT, V369, P148, DOI 10.1016/j.epsl.2013.03.018; Jokat W, 1999, BERICHTE POLARFORSCH, V308, P1, DOI [10.2312/BzP_0308_1999, DOI 10.2312/BZP_0308_1999]; Jokat W, 2009, REPORTS POLAR MARINE, V597, P1; Kremer A, 2018, QUATERNARY SCI REV, V182, P93, DOI 10.1016/j.quascirev.2017.12.016; KU TL, 1965, J GEOPHYS RES, V70, P3457, DOI 10.1029/JZ070i014p03457; KU TL, 1967, PROG OCEANOGR, V4, P95; Kuijpers A, 2007, GEO-MAR LETT, V27, P383, DOI 10.1007/s00367-007-0059-1; Marz C, 2011, GEOCHIM COSMOCHIM AC, V75, P7668, DOI 10.1016/j.gca.2011.09.046; Matthiessen J., 2013, PANGAEA, DOI [10.1594/PANGAEA.817506, DOI 10.1594/PANGAEA.817506]; Matthiessen J, 2013, LINESCANNER IMAGES S, DOI [10.1594/PANGAEA.817507, DOI 10.1594/PANGAEA.817507]; McNeil DH, 2001, CAN J EARTH SCI, V38, P309, DOI 10.1139/e00-098; MERCER JH, 1970, PALAEOGEOGR PALAEOCL, V8, P19, DOI 10.1016/0031-0182(70)90076-3; Missiaen L, 2018, GEOCHEM GEOPHY GEOSY, V19, P2560, DOI 10.1029/2017GC007410; Nilsson J, 2017, CRYOSPHERE, V11, P1745, DOI 10.5194/tc-11-1745-2017; Norgaard-Pedersen N, 1998, PALEOCEANOGRAPHY, V13, P193, DOI 10.1029/97PA03409; Not C, 2010, QUATERNARY SCI REV, V29, P3665, DOI 10.1016/j.quascirev.2010.06.042; NOWACZYK NR, 1994, GEOPHYS J INT, V117, P453, DOI 10.1111/j.1365-246X.1994.tb03944.x; NOWACZYK NR, 1992, DEEP-SEA RES, V39, pS567, DOI 10.1016/S0198-0149(06)80021-X; NURNBERG D, 1994, MAR GEOL, V119, P185, DOI 10.1016/0025-3227(94)90181-3; O'Regan M, 2020, GEOLOGY, V48, P1115, DOI 10.1130/G47479.1; Paetsch H, 1991, 29 CHRIST ALBR U 29 CHRIST ALBR U; Pagels U, 1991, 10 GEOMAR 10 GEOMAR; Pham MK, 2008, APPL RADIAT ISOTOPES, V66, P1711, DOI 10.1016/j.apradiso.2007.10.020; Polyak L, 2004, PALAEOGEOGR PALAEOCL, V203, P73, DOI 10.1016/S0031-0182(03)00661-8; Polyak L, 2001, NATURE, V410, P453, DOI 10.1038/35068536; Polyak L, 2009, GLOBAL PLANET CHANGE, V68, P5, DOI 10.1016/j.gloplacha.2009.03.014; Poore RZ, 1999, GEOLOGY, V27, P759, DOI 10.1130/0091-7613(1999)027<0759:LPAHME>2.3.CO;2; Raffi I, 2006, QUATERNARY SCI REV, V25, P3113, DOI 10.1016/j.quascirev.2006.07.007; Rohling EJ, 2017, QUATERNARY SCI REV, V176, P1, DOI 10.1016/j.quascirev.2017.09.009; Schmidt MW, 2004, NATURE, V428, P160, DOI 10.1038/nature02346; SCHOLTEN JC, 1990, EARTH PLANET SC LETT, V101, P54, DOI 10.1016/0012-821X(90)90123-F; SCHOLTEN JC, 1994, MAR GEOL, V121, P77, DOI 10.1016/0025-3227(94)90158-9; Sidorchuk AY, 2000, INT J EARTH SCI, V89, P541, DOI 10.1007/s005310000132; Spielhagen RF, 1997, GEOLOGY, V25, P783, DOI 10.1130/0091-7613(1997)025<0783:AOEFLQ>2.3.CO;2; Spielhagen RF, 2004, QUATERNARY SCI REV, V23, P1455, DOI 10.1016/j.quascirev.2003.12.015; Starz M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15681; Stein R., 2010, POLARFORSCHUNG, V79, P97; Stein R., 2010, POLARFORSCHUNG, V79, P81; Strobl C., 1998, THESIS U HEIDELBERG; Tarasov L, 2005, NATURE, V435, P662, DOI 10.1038/nature03617; Unterman MB, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049599; Valk O, 2018, GEOPHYS RES LETT, V45, P10539, DOI 10.1029/2018GL079829; Wiers S, 2019, GEOCHEM GEOPHY GEOSY, V20, P3289, DOI 10.1029/2018GC007920; WILLIAMS DF, 1981, EARTH PLANET SC LETT, V56, P157, DOI 10.1016/0012-821X(81)90123-0; Wollenburg I., 1993, BERICHTE POLARFORSCH, V127, P1; Wollenburg JE, 2001, PALEOCEANOGRAPHY, V16, P65, DOI 10.1029/1999PA000454; Wollenburg Jutta, 1995, Berichte zur Polarforschung, V179, P1; Wollenburg JE, 2007, PALAEOGEOGR PALAEOCL, V255, P195, DOI 10.1016/j.palaeo.2007.05.007; YANG HS, 1986, GEOCHIM COSMOCHIM AC, V50, P81, DOI 10.1016/0016-7037(86)90050-5	86	23	23	8	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2021	590	7844					97	+		10.1038/s41586-021-03186-y	http://dx.doi.org/10.1038/s41586-021-03186-y			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TY5HM	33536651	Green Submitted			2022-12-28	WOS:000683815400001
J	Mehrotra, A; Bhatia, RS; Snoswell, CL				Mehrotra, Ateev; Bhatia, R. Sacha; Snoswell, Centaine L.			Paying for Telemedicine After the Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mehrotra, Ateev] Harvard Med Sch, Boston, MA 02115 USA; [Bhatia, R. Sacha] Univ Toronto, Womens Coll Hosp, Inst Hlth Syst Solut & Virtual Care, Toronto, ON, Canada; [Snoswell, Centaine L.] Univ Queensland, Ctr Hlth Serv Res, Ctr Online Hlth, Brisbane, Qld, Australia	Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Queensland	Mehrotra, A (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mehrotra@hcp.med.harvard.edu	Snoswell, Centaine L/G-3668-2016; Mehrotra, Ateev/AAO-8454-2021	Snoswell, Centaine L/0000-0002-4298-9369; Mehrotra, Ateev/0000-0003-2223-1582	National Institutes of Mental Health [R01MH112829-02]	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Dr Mehrotra's time was supported by a grant from the National Institutes of Mental Health (R01MH112829-02).	[Anonymous], 2020, KEEP HLTH CAR PROV I; [Anonymous], MED TEL HLTH CAR PRO; [Anonymous], 2020, TEL COR MED BEN SCHE; Dunham CC, 2018, NATL LAW REV; Patel SY, 2021, JAMA INTERN MED, V181, P388, DOI 10.1001/jamainternmed.2020.5928; Ray KN, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-2491; Snoswell CL, 2021, TELEMED E-HEALTH, V27, P733, DOI 10.1089/tmj.2020.0176	7	52	52	2	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2021	325	5					431	432		10.1001/jama.2020.25706	http://dx.doi.org/10.1001/jama.2020.25706			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QC6JP	33528545	Green Accepted			2022-12-28	WOS:000614941900010
J	Chagla, Z				Chagla, Zain			The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 >= 7 days after the 2nd dose	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chagla, Zain] McMaster Univ, Hamilton, ON, Canada	McMaster University	Chagla, Z (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; ModernaTx Inc, 2020, RUBRACA RUC ACC APPR; Widge AT, 2021, NEW ENGL J MED, V384, P80, DOI 10.1056/NEJMc2032195	3	43	43	5	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2021	174	2					JC15	JC15		10.7326/ACPJ202102160-015	http://dx.doi.org/10.7326/ACPJ202102160-015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ2CK	33524290				2022-12-28	WOS:000619497100005
J	Oni-Orisan, A; Mavura, Y; Banda, Y; Thornton, TA; Sebro, R				Oni-Orisan, Akinyemi; Mavura, Yusuph; Banda, Yambazi; Thornton, Timothy A.; Sebro, Ronnie			Embracing Genetic Diversity to Improve Black Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ISOSORBIDE DINITRATE; HEART-FAILURE; WARFARIN; HISTORY; RACE; HYDRALAZINE; COMBINATION; AMERICANS; ANCESTRY; GENOMICS	Ideally, race will be replaced with genetic ancestry as a variable in medical research and practice. But until more ancestry data are available, ignoring race and extrapolating research findings from European-ancestry populations to others is neither equitable nor safe.	[Oni-Orisan, Akinyemi] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA; [Oni-Orisan, Akinyemi] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Mavura, Yusuph] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Oni-Orisan, Akinyemi] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Thornton, Timothy A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Thornton, Timothy A.] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Sebro, Ronnie] Mayo Clin, Dept Radiol, Jacksonville, FL 32224 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Mayo Clinic	Oni-Orisan, A (corresponding author), Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA.; Oni-Orisan, A (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.; Oni-Orisan, A (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.			Oni-Orisan, Akinyemi/0000-0002-5897-5543				Aquilante CL, 2006, CLIN PHARMACOL THER, V79, P291, DOI 10.1016/j.clpt.2005.11.011; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Covid 19 Host Genetics Initiative, 2020, EUR J HUM GENET, V28, P715, DOI 10.1038/s41431-020-0636-6; Daley GQ, 2020, MED N; Echols MR, 2006, VASC HEALTH RISK MAN, V2, P423, DOI 10.2147/vhrm.2006.2.4.423; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Gorbatenko-Roth K, 2019, JAMA DERMATOL; Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997; Gutierrez KJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMpv2025046; Kealey C, 2007, PHARMACOGENOMICS, V8, P217, DOI 10.2217/14622416.8.3.217; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Limdi NA, 2008, PHARMACOGENOMICS, V9, P511, DOI 10.2217/14622416.9.5.511; Mbow M, 2020, SCIENCE, V369, P624, DOI 10.1126/science.abd3902; Mohsen H, 2020, YALE J BIOL MED, V93, P215; Morales J, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1396-2; Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012; NEI M, 1974, AM J HUM GENET, V26, P421; Perera MA, 2011, CLIN PHARMACOL THER, V89, P408, DOI 10.1038/clpt.2010.322; Perera MA, 2013, LANCET, V382, P790, DOI 10.1016/S0140-6736(13)60681-9; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Powe NR, 2020, JAMA-J AM MED ASSOC, V324, P737, DOI 10.1001/jama.2020.13378; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Scharff DP, 2010, J HEALTH CARE POOR U, V21, P879, DOI 10.1353/hpu.0.0323; Ta R, 2019, PERS MED, V16, P233, DOI 10.2217/pme-2018-0107; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Temple R, 2007, ANN INTERN MED, V146, P57, DOI 10.7326/0003-4819-146-1-200701020-00010; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Tuot DS, 2015, DIABETES CARE, V38, P2059, DOI 10.2337/dc15-0542; Victor RG, 2018, NEW ENGL J MED, V378, P1291, DOI 10.1056/NEJMoa1717250; Vyas DA, 2020, NEW ENGL J MED, V383, P874, DOI 10.1056/NEJMms2004740; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1016/j.jacc.2017.04.025, 10.1161/CIR.0000000000000509]; Zeberg H, 2020, NATURE, V587, P610, DOI 10.1038/s41586-020-2818-3	40	35	35	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2021	384	12					1163	1167		10.1056/NEJMms2031080	http://dx.doi.org/10.1056/NEJMms2031080			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RF4GG	33567186	Bronze			2022-12-28	WOS:000634797200018
J	Christie, B				Christie, Bryan			Covid-19: Scotland failed to apply measures identified in pre-pandemic exercises, says report	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Audit Scotland, 2021, NHS SCOTL 2020	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2021	372								n469	10.1136/bmj.n469	http://dx.doi.org/10.1136/bmj.n469			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK7TO	33597221	Bronze			2022-12-28	WOS:000620584600011
J	Leaf, DE; Ginde, AA				Leaf, David E.; Ginde, Adit A.			Vitamin D-3 to Treat COVID-19 Different Disease, Same Answer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Leaf, David E.] Brigham & Womens Hosp, Div Renal Med, 75 Francis St, Boston, MA 02115 USA; [Ginde, Adit A.] Univ Colorado, Sch Med, Dept Emergency Med, 12401 E 17th Ave,B-215, Aurora, CO 80045 USA	Harvard University; Brigham & Women's Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus	Ginde, AA (corresponding author), Univ Colorado, Sch Med, Dept Emergency Med, 12401 E 17th Ave,B-215, Aurora, CO 80045 USA.	adit.ginde@cuanschutz.edu	Leaf, David/AAO-8977-2021	Leaf, David/0000-0001-7875-090X				ACTIV-3 TICO LY-CoV555 Study Grp, 2021, NEW ENGL J MED, V384, P905, DOI 10.1056/NEJMoa2033130; Ali N, 2020, J INFECT PUBLIC HEAL, V13, P1373, DOI 10.1016/j.jiph.2020.06.021; Amrein K, 2014, JAMA-J AM MED ASSOC, V312, P1520, DOI 10.1001/jama.2014.13204; Bischoff-Ferrari HA, 2020, JAMA-J AM MED ASSOC, V324, P1855, DOI 10.1001/jama.2020.16909; Ginde AA, 2019, NEW ENGL J MED, V381, P2529, DOI 10.1056/NEJMoa1911124; Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202; Horby P, 2020, NEW ENGL J MED, DOI [10.1101/2020.06.22.20137273, DOI 10.1101/2020.06.22.20137273]; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Kong J, 2013, MOL ENDOCRINOL, V27, P2116, DOI 10.1210/me.2013-1146; Leaf DE, 2018, CLIN J AM SOC NEPHRO, V13, P531, DOI 10.2215/CJN.10810917; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; Okereke OI, 2020, JAMA-J AM MED ASSOC, V324, P471, DOI 10.1001/jama.2020.10224; Salama C, 2021, NEW ENGL J MED, V384, P20, DOI 10.1056/NEJMoa2030340; Xu J, 2017, MOL MED REP, V16, P7432, DOI 10.3892/mmr.2017.7546; Zhang YP, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0684-9	16	15	15	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2021	325	11					1047	1048		10.1001/jama.2020.26850	http://dx.doi.org/10.1001/jama.2020.26850		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QZ1BV	33595641	Bronze, Green Accepted			2022-12-28	WOS:000619613600001
J	Oliver, D				Oliver, David			David Oliver: Lack of PPE betrays NHS clinical staff	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2020, BBC NEWS; Bandyopadhyay S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003097; Comas-Herrera A., 2020, COVID 19 LONG TERM C; Lay, 2020, TIMES; Mehta S, 2021, LANCET RESP MED; Oliver D., 2021, BMJ-BRIT MED J, V372; Plimmer G, 2020, FINANCIAL TIMES; Wilson NM, 2020, ANAESTHESIA, V75, P1086, DOI 10.1111/anae.15093; 2020, BMJ	9	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2021	372								n438	10.1136/bmj.n438	http://dx.doi.org/10.1136/bmj.n438			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK7TO	33597121	Bronze			2022-12-28	WOS:000620584600012
J	Weiner, JS				Weiner, Joseph S.			Enjoy the Vase	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay, a psychiatrist finally at peace after his wife's death to cancer learns that his prostate-specific antigen levels have begun to rise, reminding him to embrace uncertainty, a loss of control, and change.	[Weiner, Joseph S.] Zucker Sch Med Hofstra Northwell, Dept Psychiat, Hempstead, NY USA; [Weiner, Joseph S.] Zucker Sch Med Hofstra Northwell, Dept Med, Hempstead, NY USA; [Weiner, Joseph S.] Zucker Sch Med Hofstra Northwell, Dept Sci Educ, Hempstead, NY USA		Weiner, JS (corresponding author), 6 Concord Rd, Port Washington, NY 11050 USA.	joseph.weiner@hofstra.edu							0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2021	325	7					629	629		10.1001/jama.2020.26876	http://dx.doi.org/10.1001/jama.2020.26876			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QJ3QZ	33591349				2022-12-28	WOS:000619608000013
J	Rosell, R; Gonzalez-Cao, M				Rosell, Rafael; Gonzalez-Cao, Maria			Cemiplimab monotherapy in advanced non-squamous and squamous non-small cell lung cancer	LANCET			English	Editorial Material							STAGE IV; NIVOLUMAB		[Rosell, Rafael] Inst Hlth Sci Res Germans Trias & Pujol, Catalan Inst Oncol, Lab Cellular & Mol Biol, Badalona 08916, Spain; [Rosell, Rafael] Univ Autonoma Barcelona, Barcelona, Spain; [Rosell, Rafael; Gonzalez-Cao, Maria] Dexeus Univ Hosp, Inst Oncol Dr Rosell, Translat Canc Res Unit, Barcelona, Spain	Catalan Institute of Oncology; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Autonomous University of Barcelona	Rosell, R (corresponding author), Inst Hlth Sci Res Germans Trias & Pujol, Catalan Inst Oncol, Lab Cellular & Mol Biol, Badalona 08916, Spain.; Rosell, R (corresponding author), Univ Autonoma Barcelona, Barcelona, Spain.; Rosell, R (corresponding author), Dexeus Univ Hosp, Inst Oncol Dr Rosell, Translat Canc Res Unit, Barcelona, Spain.	rrosell@iconcologia.net			La Caixa Foundation; Spanish Association Against Cancer [PROYE18012ROSE]	La Caixa Foundation(La Caixa Foundation); Spanish Association Against Cancer	RR reports grants from La Caixa Foundation and from the Spanish Association Against Cancer (PROYE18012ROSE). MG-C declares no competing interests.	Anagnostou V, 2020, NAT CANCER, V1, P99, DOI 10.1038/s43018-019-0008-8; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Crino L, 2019, LUNG CANCER, V129, P35, DOI 10.1016/j.lungcan.2018.12.025; Gonzalez-Cao M, 2020, JAMA ONCOL, V6, P1063, DOI 10.1001/jamaoncol.2020.0465; Hanna NH, 2020, J CLIN ONCOL, V38, P1608, DOI 10.1200/JCO.19.03022; Herbst RS, 2020, NEW ENGL J MED, V383, P1328, DOI 10.1056/NEJMoa1917346; Kravtsova-Ivantsiv Y, 2020, P NATL ACAD SCI USA, V117, P29823, DOI 10.1073/pnas.2019604117; Marabelle A, 2020, LANCET ONCOL, V21, P1353, DOI 10.1016/S1470-2045(20)30445-9; Mok TSK, 2019, LANCET, V393, P1819, DOI 10.1016/S0140-6736(18)32409-7; Reck M, 2019, J CLIN ONCOL, V37, P537, DOI 10.1200/JCO.18.00149; Rizvi NA, 2020, JAMA ONCOL, V6, P661, DOI 10.1001/jamaoncol.2020.0237; Sezer A, 2021, LANCET, V397, P592, DOI 10.1016/S0140-6736(21)00228-2	12	3	3	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2021	397	10274					557	559						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2TN	33581807				2022-12-28	WOS:000620934000004
J	Cernansky, R				Cernansky, Rachel			TAKING ROOT	SCIENCE			English	Editorial Material																			0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					666	667						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QG4IS	33574195				2022-12-28	WOS:000617551600021
J	Berwanger, O				Berwanger, Otavio			Azithromycin, RECOVERY, and the power of large, simple trials	LANCET			English	Editorial Material									[Berwanger, Otavio] Hosp Israelita Albert Einstein, Acad Res Org, BR-05652900 Sao Paulo, Brazil	Hospital Israelita Albert Einstein	Berwanger, O (corresponding author), Hosp Israelita Albert Einstein, Acad Res Org, BR-05652900 Sao Paulo, Brazil.	otavio.berwanger@einstein.br						Bauchner H, 2020, JAMA-J AM MED ASSOC, V323, P2262, DOI 10.1001/jama.2020.8115; Califf RM, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI146391; Cavalcanti AB, 2020, NEW ENGL J MED, V383, P2041, DOI 10.1056/NEJMoa2019014; Furtado RHM, 2020, LANCET, V396, P959, DOI 10.1016/S0140-6736(20)31862-6; Horby PW, 2021, LANCET, V397, P605, DOI 10.1016/S0140-6736(21)00149-5; Horby P, 2020, NEW ENGL J MED, V383, P2030, DOI 10.1056/NEJMoa2022926; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Horby PW, 2020, LANCET, V396, P1345, DOI 10.1016/S0140-6736(20)32013-4; Kalil AC, 2020, JAMA-J AM MED ASSOC, V323, P1897, DOI 10.1001/jama.2020.4742; Tomazini BM, 2020, JAMA-J AM MED ASSOC, V324, P1307, DOI 10.1001/jama.2020.17021; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421	12	4	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2021	397	10274					559	560		10.1016/S0140-6736(21)00307-X	http://dx.doi.org/10.1016/S0140-6736(21)00307-X		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2TN	33545097	Green Published, Bronze			2022-12-28	WOS:000620934000005
J	Pulla, P				Pulla, Priyanka			Covid-19: India's slow moving treatment guidelines are misleading and harming patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												emailpriyanka@gmail.com						Agarwal A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3939; [Anonymous], 2021, RANDOMISED EVALUATIO; Carabelli AM, 2020, PERSISTENT SARS COV; Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2103417, 10.1056/NEJMoa2100433]; Hermine O, 2021, JAMA INTERN MED, V181, P32, DOI 10.1001/jamainternmed.2020.6820; Indian Council of Medical Research, 2020, EV BAS ADV ADDR IN U; Kumar S, 20239574 MEDRXIV, DOI [10.1101/2020.12.01.20239574v1, DOI 10.1101/2020.12.01.20239574V1]; Libster R, 2021, NEW ENGL J MED, V384, P610, DOI 10.1056/NEJMoa2033700; Pulla P., 2020, WIRE; Rosas I., 2020, TOCILIZUMAB HOSPITAL, DOI [10.1101/2020.08.27.20183442, DOI 10.1101/2020.08.27.20183442]; Salvarani C, 2021, JAMA INTERN MED, V181, P24, DOI 10.1001/jamainternmed.2020.6615; Simonovich VA, 2021, NEW ENGL J MED, V384, P619, DOI 10.1056/NEJMoa2031304; Stone JH, 2020, NEW ENGL J MED, V383, P2333, DOI 10.1056/NEJMoa2028836	13	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2021	372								n278	10.1136/bmj.n278	http://dx.doi.org/10.1136/bmj.n278			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC1VA	33568348	Bronze			2022-12-28	WOS:000686320800001
J	Wise, J				Wise, Jacqui			Long covid: WHO calls on countries to offer patients more rehabilitation	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Davis HE, 2021, ECLINICALMEDICINE, V38, DOI 10.1016/j.eclinm.2021.101019; Patient Led Research for Covid-19, PAT LED RES; World Health Organization, 2021, GLOB COV 19 CLIN PLA	3	24	24	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2021	372								n405	10.1136/bmj.n405	http://dx.doi.org/10.1136/bmj.n405			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC1VA	33568362	Bronze			2022-12-28	WOS:000686320800004
J	Torjesen, I				Torjesen, Ingrid			Covid-19: First UK vaccine safety data are "reassuring," says regulator	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4759; Medicines and Healthcare Products Regulatory Agency, 2021, COR COVID 19 VACC AD; Medicines and Healthcare Products Regulatory Agency, 2021, REP COMM HUM MED EXP; Roderick P., 2020, BMJ; Torjesen I, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n149	5	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2021	372								n363	10.1136/bmj.n363	http://dx.doi.org/10.1136/bmj.n363			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM1AV	33558274	Bronze			2022-12-28	WOS:000639394000006
J	Li, T; Chen, CJ; Brozena, AH; Zhu, JY; Xu, LX; Driemeier, C; Dai, JQ; Rojas, OJ; Isogai, A; Wagberg, L; Hu, LB				Li, Tian; Chen, Chaoji; Brozena, Alexandra H.; Zhu, J. Y.; Xu, Lixian; Driemeier, Carlos; Dai, Jiaqi; Rojas, Orlando J.; Isogai, Akira; Wagberg, Lars; Hu, Liangbing			Developing fibrillated cellulose as a sustainable technological material	NATURE			English	Article							BACTERIAL-CELLULOSE; TRANSPARENT COMPOSITES; MECHANICAL-PROPERTIES; MICROBIAL CELLULOSE; PAPER; WOOD; NANOFIBRILS; ENERGY; NANOCELLULOSE; PERFORMANCE	Cellulose is the most abundant biopolymer on Earth, found in trees, waste from agricultural crops and other biomass. The fibres that comprise cellulose can be broken down into building blocks, known as fibrillated cellulose, of varying, controllable dimensions that extend to the nanoscale. Fibrillated cellulose is harvested from renewable resources, so its sustainability potential combined with its other functional properties (mechanical, optical, thermal and fluidic, for example) gives this nanomaterial unique technological appeal. Here we explore the use of fibrillated cellulose in the fabrication of materials ranging from composites and macrofibres, to thin films, porous membranes and gels. We discuss research directions for the practical exploitation of these structures and the remaining challenges to overcome before fibrillated cellulose materials can reach their full potential. Finally, we highlight some key issues towards successful manufacturing scale-up of this family of materials. Opportunities for the application of fibrillated cellulose materials-which can be extracted from renewable resources-and broader manufacturing issues of scale-up, sustainability and synergy with the paper-making industry are discussed.	[Li, Tian; Chen, Chaoji; Brozena, Alexandra H.; Hu, Liangbing] Univ Maryland, Dept Mat Sci & Engn, College Pk, MD 20742 USA; [Li, Tian; Chen, Chaoji; Hu, Liangbing] Univ Maryland, Ctr Mat Innovat, College Pk, MD 20742 USA; [Zhu, J. Y.] USDA, Forest Prod Lab, Madison, WI 53705 USA; [Xu, Lixian] Sappi Biotech, Maastricht, Netherlands; [Driemeier, Carlos] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian BiorenewabLes Natl Lab LNBR, Campinas, Brazil; [Dai, Jiaqi] Inventwood LLC, College Pk, MD USA; [Rojas, Orlando J.] Univ British Columbia, Bioprod Inst, Dept Chem & Biol Engn, Vancouver, BC, Canada; [Rojas, Orlando J.] Univ British Columbia, Bioprod Inst, Dept Chem & Wood Sci, Vancouver, BC, Canada; [Rojas, Orlando J.] Aalto Univ, Dept Bioprod & Biosyst, Espoo, Finland; [Isogai, Akira] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Wagberg, Lars] KTH Royal Inst Technol, Dept Fibre & Polymer Technol, Stockholm, Sweden; [Wagberg, Lars] KTH Royal Inst Technol, Wallenberg Wood Sci Ctr, Stockholm, Sweden	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA); United States Forest Service; University of British Columbia; University of British Columbia; Aalto University; University of Tokyo; Royal Institute of Technology; Royal Institute of Technology	Hu, LB (corresponding author), Univ Maryland, Dept Mat Sci & Engn, College Pk, MD 20742 USA.; Hu, LB (corresponding author), Univ Maryland, Ctr Mat Innovat, College Pk, MD 20742 USA.	binghu@umd.edu	Li, Tian/ABG-3933-2021; Chen, Chaoji/G-7577-2017; Rojas, Orlando J/O-2890-2014	Li, Tian/0000-0002-1087-0662; Chen, Chaoji/0000-0001-9553-554X; Rojas, Orlando J/0000-0003-4036-4020; Brozena, Alexandra/0000-0002-5045-2123				Ajdary R, 2021, ADV MATER, V33, DOI 10.1002/adma.202001085; Ajdary R, 2019, BIOMACROMOLECULES, V20, P2770, DOI 10.1021/acs.biomac.9b00527; Albertsson AC, 2017, SCIENCE, V358, P872, DOI 10.1126/science.aap8115; An BW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04906-1; [Anonymous], 2014, LIGHTWEIGHT MAT CARS; [Anonymous], REDEFINING BIOECONOM; [Anonymous], 2019, NCV CELLULOSE NANOFI; Arasto A., 2018, GROWTH INTEGRATING B; Babu RP, 2013, PROG BIOMATER, V2, DOI 10.1186/2194-0517-2-8; Bai L, 2019, FOOD HYDROCOLLOID, V96, P709, DOI 10.1016/j.foodhyd.2019.04.039; Benitez AJ, 2017, BIOMACROMOLECULES, V18, P1642, DOI 10.1021/acs.biomac.7b00263; Benitez AJ, 2013, BIOMACROMOLECULES, V14, P4497, DOI 10.1021/bm401451m; Biswas SK, 2017, ACS APPL MATER INTER, V9, P30177, DOI 10.1021/acsami.7b09390; Carosio F, 2015, ACS APPL MATER INTER, V7, P5847, DOI 10.1021/am509058h; Carosio F, 2016, ADV MATER INTERFACES, V3, DOI 10.1002/admi.201600551; Chen CJ, 2020, NAT REV MATER, V5, P642, DOI 10.1038/s41578-020-0195-z; Chen LH, 2016, GREEN CHEM, V18, P3835, DOI 10.1039/c6gc00687f; COUGHLAN MP, 1991, ANIM FEED SCI TECH, V32, P77, DOI 10.1016/0377-8401(91)90012-H; Cowie J, 2014, TAPPI J, V13, P57; Crowther TW, 2015, NATURE, V525, P201, DOI 10.1038/nature14967; Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035; Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d; Drachuk I, 2017, ACS BIOMATER SCI ENG, V3, P2278, DOI 10.1021/acsbiomaterials.7b00367; Dufresne A, 2012, NANOCELLULOSE: FROM NATURE TO HIGH PERFORMANCE TAILORED MATERIALS, P1, DOI 10.1515/9783110254600; Fang ZQ, 2014, NANO LETT, V14, P765, DOI 10.1021/nl404101p; Feng YY, 2012, CARBOHYD POLYM, V87, P644, DOI 10.1016/j.carbpol.2011.08.039; Fukuzumi H, 2009, BIOMACROMOLECULES, V10, P162, DOI 10.1021/bm801065u; Gan WT, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201807444; Geyer R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700782; Ghanadpour M, 2015, BIOMACROMOLECULES, V16, P3399, DOI 10.1021/acs.biomac.5b01117; Greca LG, 2018, MATER HORIZONS, V5, P408, DOI 10.1039/c7mh01139c; Guan QF, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz1114; Hakansson KMO, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5018; Hata Y, 2018, BIOMACROMOLECULES, V19, P1269, DOI 10.1021/acs.biomac.8b00092; HENN AR, 1990, J MATER SCI, V25, P3659, DOI 10.1007/BF00575401; Hickey RJ, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00045; Holland C, 2012, ADV MATER, V24, P105, DOI 10.1002/adma.201103664; Hsieh MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep41590; Hu W, 2018, ACS SUSTAIN CHEM ENG, V6, P12385, DOI 10.1021/acssuschemeng.8b02900; Huan SQ, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201902990; Hubbe MA, 2007, BIORESOURCES, V2, P106; Ifuku S, 2007, BIOMACROMOLECULES, V8, P1973, DOI 10.1021/bm070113b; Imani M, 2019, ADV MATER INTERFACES, V6, DOI 10.1002/admi.201900770; Inglis AJ, 2010, MACROMOLECULES, V43, P5515, DOI 10.1021/ma100945b; Isogai A., 2018, 2018 INT C NAN REN M; Isogai A, 2018, PROG POLYM SCI, V86, P122, DOI 10.1016/j.progpolymsci.2018.07.007; Isogai A, 2018, P JPN ACAD B-PHYS, V94, P161, DOI 10.2183/pjab.94.012; Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e; Jiang B, 2020, ADV FUNCT MATER, V30, DOI 10.1002/adfm.201906307; Jiang QS, 2016, ADV MATER, V28, P9400, DOI 10.1002/adma.201601819; Jung YH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8170; Karim Z, 2016, RSC ADV, V6, P20644, DOI 10.1039/c5ra27059f; Kim JH, 2019, ENERG ENVIRON SCI, V12, P177, DOI 10.1039/c8ee01879k; Kim SH, 2018, ENERG ENVIRON SCI, V11, P321, DOI 10.1039/c7ee01630a; Klein BC, 2019, BIOFUEL BIOPROD BIOR, V13, P809, DOI 10.1002/bbb.1969; Koskela S, 2019, GREEN CHEM, V21, P5924, DOI [10.1039/C9GC02808K, 10.1039/c9gc02808k]; Kracher D, 2016, SCIENCE, V352, P1098, DOI 10.1126/science.aaf3165; La Notte L, 2018, MATER TODAY ENERGY, V7, P105, DOI 10.1016/j.mtener.2017.12.010; Li T., 2019, SCI ADV, V5; Li T, 2019, SCIENCE, V364, P760, DOI 10.1126/science.aau9101; Li T, 2019, NAT MATER, V18, P608, DOI 10.1038/s41563-019-0315-6; Liang HL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07048-6; Lin CM, 2019, CELLULOSE, V26, P4061, DOI 10.1007/s10570-019-02367-3; Lin DH, 2020, INT J BIOL MACROMOL, V158, P1007, DOI 10.1016/j.ijbiomac.2020.04.230; Lin KW, 2004, J FOOD SCI, V69, pS107, DOI 10.1111/j.1365-2621.2004.tb13378.x; Liu AD, 2011, BIOMACROMOLECULES, V12, P633, DOI 10.1021/bm101296z; Liu QK, 2018, NANO ENERGY, V48, P266, DOI 10.1016/j.nanoen.2018.03.029; Lundahl MJ, 2017, IND ENG CHEM RES, V56, P8, DOI 10.1021/acs.iecr.6b04010; Lv TZ, 2020, CASE STUD THERM ENG, V18, DOI 10.1016/j.csite.2020.100596; Ma XT, 2019, J CLEAN PROD, V233, P23, DOI 10.1016/j.jclepro.2019.06.069; Mark R., 1967, CELL WALL MECH TRACH; Mittal N, 2018, ACS NANO, V12, P6378, DOI 10.1021/acsnano.8b01084; Mittal N, 2017, ACS NANO, V11, P5148, DOI 10.1021/acsnano.7b02305; Mohamed A.L., 2015, FLAME RETARDANTS, P247, DOI DOI 10.1007/978-3-319-03467-6_10; Mohammed N, 2018, ENVIRON SCI-NANO, V5, P623, DOI [10.1039/c7en01029j, 10.1039/C7EN01029J]; Moon RJ, 2011, CHEM SOC REV, V40, P3941, DOI 10.1039/c0cs00108b; Nogi M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4804361; Nogi M, 2009, ADV MATER, V21, P1595, DOI 10.1002/adma.200803174; Okahisa Y, 2009, COMPOS SCI TECHNOL, V69, P1958, DOI 10.1016/j.compscitech.2009.04.017; Ong KJ, 2017, NANOIMPACT, V6, P19, DOI 10.1016/j.impact.2017.03.002; PARK HJ, 1993, J FOOD SCI, V58, P1361, DOI 10.1111/j.1365-2621.1993.tb06183.x; Qin S, 2019, ADV MATER INTERFACES, V6, DOI 10.1002/admi.201801424; Ritchie H., 2018, URBANIZATION OUR WOR; Rol F, 2017, ACS SUSTAIN CHEM ENG, V5, P6524, DOI 10.1021/acssuschemeng.7b00630; Rorrer NA, 2016, ACS SUSTAIN CHEM ENG, V4, P6867, DOI 10.1021/acssuschemeng.6b01820; Scherner M, 2014, J SURG RES, V189, P340, DOI 10.1016/j.jss.2014.02.011; Sehaqui H, 2012, ACS APPL MATER INTER, V4, P1043, DOI 10.1021/am2016766; Sharma Amita, 2019, Biotechnology Reports, V21, pe00316, DOI 10.1016/j.btre.2019.e00316; Shi ZJ, 2014, FOOD HYDROCOLLOID, V35, P539, DOI 10.1016/j.foodhyd.2013.07.012; Shoda M, 2005, BIOTECHNOL BIOPROC E, V10, P1, DOI 10.1007/BF02931175; Shoseyov O., 2019, EXTRACELLULAR SUGAR, P693; Song JW, 2018, NATURE, V554, P224, DOI 10.1038/nature25476; STONE JE, 1965, J POLYM SCI POL SYM, P13; Sturcova A, 2005, BIOMACROMOLECULES, V6, P1055, DOI 10.1021/bm049291k; Sun B, 2019, CURR MED CHEM, V26, P2485, DOI 10.2174/0929867324666170705143308; Sun MX, 2018, RENEW SUST ENERG REV, V92, P823, DOI 10.1016/j.rser.2018.04.036; Thakur S, 2018, CURR OPIN GREEN SUST, V13, P68, DOI 10.1016/j.cogsc.2018.04.013; Thoorens G, 2014, INT J PHARMACEUT, V473, P64, DOI 10.1016/j.ijpharm.2014.06.055; Toivonen MS, 2018, ADV MATER, V30, DOI 10.1002/adma.201704050; Torres-Rendon JG, 2014, BIOMACROMOLECULES, V15, P2709, DOI 10.1021/bm500566m; Trovatti E, 2018, CARBOHYD POLYM, V181, P256, DOI 10.1016/j.carbpol.2017.10.073; Voisin H, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7030057; Wang J, 2019, CARBOHYD POLYM, V219, P63, DOI 10.1016/j.carbpol.2019.05.008; Wang JW, 2018, ACS SUSTAIN CHEM ENG, V6, P49, DOI 10.1021/acssuschemeng.7b03523; Wang QQ, 2012, CELLULOSE, V19, P2033, DOI 10.1007/s10570-012-9765-6; Wang QQ, 2012, CELLULOSE, V19, P1631, DOI 10.1007/s10570-012-9745-x; Wang S, 2016, PROG POLYM SCI, V53, P169, DOI 10.1016/j.progpolymsci.2015.07.003; Wang S, 2017, ADV MATER, V29, DOI 10.1002/adma.201702498; World Health Organization, 2017, 2 1 BILL PEOPL LACK; Wu CN, 2014, NANOSCALE, V6, P392, DOI 10.1039/c3nr04102f; Yamada K, 2017, LAB CHIP, V17, P1206, DOI 10.1039/c6lc01577h; Yang X, 2020, ACS NANO, V14, P724, DOI 10.1021/acsnano.9b07659; Yang X, 2018, ACS SUSTAIN CHEM ENG, V6, P501, DOI 10.1021/acssuschemeng.7b02755; Yarbrough JM, 2017, ACS NANO, V11, P3101, DOI 10.1021/acsnano.7b00086; Yu Y, 2014, J MATER SCI, V49, P2559, DOI 10.1007/s10853-013-7951-z; Zhao DW, 2020, MATTER-US, V2, P390, DOI 10.1016/j.matt.2019.10.020; Zhou Ben-zhi, 2005, Journal of Forestry Research (Harbin), V16, P143, DOI 10.1007/BF02857909; Zhou HF, 2019, CELLULOSE, V26, P543, DOI 10.1007/s10570-019-02250-1; Zhou YB, 2019, MATER TODAY, V30, P17, DOI 10.1016/j.mattod.2019.03.016; Zhu HL, 2016, CHEM REV, V116, P9305, DOI 10.1021/acs.chemrev.6b00225; Zhu HL, 2016, ACS NANO, V10, P1369, DOI 10.1021/acsnano.5b06781; Zhu HL, 2015, P NATL ACAD SCI USA, V112, P8971, DOI 10.1073/pnas.1502870112	122	275	277	368	1227	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2021	590	7844					47	56		10.1038/s41586-020-03167-7	http://dx.doi.org/10.1038/s41586-020-03167-7			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TY5HB	33536649	Green Submitted			2022-12-28	WOS:000683814300001
J	Oliver, D				Oliver, David			David Oliver: Wider health determinants aren't just for pandemics	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Adams Richard, 2019, GUARDIAN; Allen L, 2020, SHOULD GOVT RETHINK; Anglican Consultative Council and the Anglican Alliance, 2020, DOM AB COVID 19 CHUR; [Anonymous], 2018, THE GUARDIAN; [Anonymous], 2019, BBC NEWS; Baker C, 2020, MENTAL HLTH ACHIEVIN; BMA, 2016, HLTH POL HLTH AUST W; Cattan S, 2012, HLTH EFFECTS SURE ST; Coughlan S., 2019, BBC NEWS; Croft J., 2018, FINANCIAL TIMES; Faculty of Public Health, ROL NHS PREV; Fiander D., 2020, SOCIAL HOUSING SHORT; Franklin B, 2017, PUBLIC HLTH EUROPE A; Health Foundation, 2020, GOV MUST PUT HLTH HE; Naylor C., 2017, IS THERE PARITY ESTE; OLIVER D, 2000, BMJ-BRIT MED J, V360, pK583, DOI DOI 10.1136/BMJ.K583; RCP London, 2020, HLTH IN COVID 19 HEA; Rhodes D., 2018, BBC NEWS; Rimmer A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4134; Stuckler D, 2017, EUR J PUBLIC HEALTH, V27, P18, DOI 10.1093/eurpub/ckx167	20	1	1	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2021	372								n276	10.1136/bmj.n276	http://dx.doi.org/10.1136/bmj.n276			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QE0PP	33536251	Bronze			2022-12-28	WOS:000615909900003
J	Wise, J				Wise, Jacqui			Covid-19: People who have had infection might only need one dose of mRNA vaccine	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Krammer F, MEDRXIV, DOI [10.1101/2021.01.29.21250653, DOI 10.1101/2021.01.29.21250653]; Saadat S., 2021, SINGLE DOSE VACCINAT, DOI 10.1101/2021.03.10.21253299	2	36	36	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2021	372								n308	10.1136/bmj.n308	http://dx.doi.org/10.1136/bmj.n308			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UD4LK	33531333	Bronze			2022-12-28	WOS:000687179200004
J	Staub, K; Juni, P; Urner, M; Matthes, KL; Leuch, C; Gemperle, G; Bender, N; Fabrikant, SI; Puhan, M; Ruhli, F; Gruebner, O; Floris, J				Staub, Kaspar; Jueni, Peter; Urner, Martin; Matthes, Katarina L.; Leuch, Corina; Gemperle, Gina; Bender, Nicole; Fabrikant, Sara, I; Puhan, Milo; Ruehli, Frank; Gruebner, Oliver; Floris, Joel			Public Health Interventions, Epidemic Growth, and Regional Variation of the 1918 Influenza Pandemic Outbreak in a Swiss Canton and Its Greater Regions	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LESSONS; WAVE; 1ST	Public health interventions implemented during the coronavirus disease 2019 (COVID-19) pandemic are based on experience gained from past pandemics. The 1918 influenza pandemic is the most extensively researched historical influenza outbreak. All 9335 reports available in the State Archives on 121 152 cases of influenza-like illness from the canton of Bern from 473 of 497 municipalities (95.2%) were collected; the cases were registered between 30 June 1918 and 30 June 1919. The overall incidence rates of newly registered cases per week for the 9 greater regions of Bern for both the first and second waves of the pandemic were calculated. Relative incidence rate ratios (RIRRs) were calculated to estimate the change in the slope of incidence curves associated with public health interventions. During the first wave, school closures (RIRR, 0.16 [95% CI, 0.15 to 0.17]) and restrictions of mass gatherings (RIRR, 0.57 [CI, 0.54 to 0.61]) were associated with a deceleration of epidemic growth. During the second wave, in autumn 1918, cantonal authorities initially reacted hesitantly and delegated the responsibility to enact interventions to municipal authorities, which was associated with a lack of containment of the second wave. A premature relaxation of restrictions on mass gatherings was associated with a resurgence of the epidemic (RIRR, 1.18 [CI, 1.12 to 1.25]). Strikingly similar patterns were found in the management of the COVID-19 outbreak in Switzerland, with a considerably higher amplitude and prolonged duration of the second wave and much higher associated rates of hospitalization and mortality.	[Staub, Kaspar; Matthes, Katarina L.; Gemperle, Gina; Bender, Nicole; Ruehli, Frank; Floris, Joel] Univ Zurich, Inst Evolutionary Med, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Staub, Kaspar; Ruehli, Frank] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Staub, Kaspar; Fabrikant, Sara, I; Ruehli, Frank; Gruebner, Oliver; Floris, Joel] Univ Zurich, Digital Soc Initiat, Zurich, Switzerland; [Staub, Kaspar] Univ Bern, Inst Hist, Bern, Switzerland; [Jueni, Peter] Univ Toronto, Appl Hlth Res Ctr, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON, Canada; [Jueni, Peter; Urner, Martin] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Jueni, Peter] Ontario COVID 19 Sci Advisory Table, Toronto, ON, Canada; [Urner, Martin] Univ Toronto, Crit Care Med, Toronto Gen Hosp, Univ Hlth Network, Toronto, ON, Canada; [Leuch, Corina; Fabrikant, Sara, I; Gruebner, Oliver] Univ Zurich, Geog Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Puhan, Milo; Gruebner, Oliver] Univ Zurich, Epidemiol Biostat & Prevent Inst, Hirschengraben 84, CH-8001 Zurich, Switzerland; [Jueni, Peter] St Michaels Hosp, Appl Hlth Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Urner, Martin] Univ Toronto, Interdept Div Crit Care Med, 209 Victoria St, Toronto, ON M5B 1T8, Canada	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University of Bern; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Zurich; University of Zurich; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Staub, K (corresponding author), Univ Zurich, Inst Evolutionary Med, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	kaspar.staub@iem.uzh.ch	Puhan, Milo/ABE-6298-2020; Juni, Peter/Q-8700-2016; Fabrikant, Sara/B-9320-2014	Puhan, Milo/0000-0003-4721-1879; Juni, Peter/0000-0002-5985-0670; Bender, Nicole/0000-0002-3838-587X; Urner, Martin/0000-0003-1133-4885; Fabrikant, Sara/0000-0003-1263-8792; Floris, Joel/0000-0002-8480-6495; Matthes, Katarina/0000-0002-5263-3542; Staub, Kaspar/0000-0002-3951-1807	Canada Research Chairs Program; European Research Council [740426]	Canada Research Chairs Program(Canada Research Chairs); European Research Council(European Research Council (ERC)European Commission)	Dr. Ruhli acknowledges the Maxi Foundation. Dr. Juni is a Tier 1 Canada Research Chair in Clinical Epidemiology of Chronic Diseases. This research was completed, in part, with funding from the Canada Research Chairs Program. Dr. Fabrikant acknowledges the European Research Council grant agreement 740426.	Amato-Gauci A, 2011, EUROSURVEILLANCE, V16, P11; Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; Auger KA, 2020, JAMA-J AM MED ASSOC, V324, P859, DOI 10.1001/jama.2020.14348; Beiner Guy, 2006, CULT SOC HIST, VIII, P496, DOI [DOI 10.1191/1478003806, DOI 10.1191/1478003806CS070RA]; Bengtsson T, 2018, AM J EPIDEMIOL, V187, P2568, DOI 10.1093/aje/kwy151; Bern Kanton, 1918, STATE ARCHIVE OF BER; Berridge V, 2008, MED HIST, V52, P311, DOI 10.1017/S0025727300000168; Bogaert K, 2015, VACCINE, V33, P7232, DOI 10.1016/j.vaccine.2015.10.120; Bolton KJ, 2014, EPIDEMICS-NETH, V8, P18, DOI 10.1016/j.epidem.2014.07.004; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Brack S., 2015, EIN UNSICHTBARER FEI; Davis DA, 2011, SOUTHERN LIT J, V43, P55, DOI 10.1353/slj.2011.0007; Degen B., 2019, INTERNATIONAL ENCYCL; Eidgenossisches Statistisches Bureau, 1919, B SCHWEIZERISCHEN GE, V29, P337; Giles-Vernick T, 2015, INFLUENZA AND PUBLIC; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Islam N, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2743; Juni P, 2020, CAN MED ASSOC J, V192, pE566, DOI 10.1503/cmaj.200920; Mamelund SE, 2018, INFLUENZA OTHER RESP, V12, P307, DOI 10.1111/irv.12541; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Morabia A., 2014, ENIGMAS OF HEALTH AN; Morens DM, 2020, NEW ENGL J MED, V382, P1293, DOI 10.1056/NEJMp2002106; Morens DM, 2018, AM J PUBLIC HEALTH, V108, P1449, DOI 10.2105/AJPH.2018.304631; Morens DM, 2010, CRIT CARE MED, V38, pE10, DOI 10.1097/CCM.0b013e3181ceb25b; Morse SS, 2007, P NATL ACAD SCI USA, V104, P7313, DOI 10.1073/pnas.0702659104; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Nussbaum W, 1982, Gesnerus, V39, P243; Parmet WE, 2018, AM J PUBLIC HEALTH, V108, P1435, DOI 10.2105/AJPH.2018.304695; Phillips H, 2014, SOC HIST MED, V27, P789, DOI 10.1093/shm/hku066; Sanitatsdirektion des Kantons Bern, 1918, VERWALTUNGSBERICHTE; Schweiz Statistisches Bureau, 1923, EIDGENOSSISCHE VOLKS; Schweizerisches Bundesamt fur Statistik (BfS), 2018, DIE SPANISCHE GRIPPE; Sonderegger C, 2016, WOCHE WOCHE NEUE PRE, P259; Sonderegger C., 1991, DIE GRIPPEEPIDEMIE 1; Spreeuwenberg P, 2018, AM J EPIDEMIOL, V187, P2561, DOI 10.1093/aje/kwy191; Taubenberger JK, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau5485; Tomes N, 2010, PUBLIC HEALTH REP, V125, P48, DOI 10.1177/00333549101250S308; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; Viboud C, 2018, AM J EPIDEMIOL, V187, P2493, DOI 10.1093/aje/kwy207; Wakefield J, 2010, CH CRC HANDB MOD STA, P541; Webb JLA, 2015, LANCET, V385, P322, DOI 10.1016/S0140-6736(15)60108-8; Zurcher K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162575	43	6	6	2	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2021	174	4					533	+		10.7326/M20-6231	http://dx.doi.org/10.7326/M20-6231			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RU1WZ	33556268	Green Published			2022-12-28	WOS:000644942400041
J	Wouters, OJ; Shadlen, KC; Salcher-Konrad, M; Pollard, AJ; Larson, HJ; Teerawattananon, Y; Jit, M				Wouters, Olivier J.; Shadlen, Kenneth C.; Salcher-Konrad, Maximilian; Pollard, Andrew J.; Larson, Heidi J.; Teerawattananon, Yot; Jit, Mark			Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment	LANCET			English	Review								The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that protect against severe disease and preferably drive herd immunity. Regulators in numerous countries have authorised or approved COVID-19 vaccines for human use, with more expected to be licensed in 2021. Yet having licensed vaccines is not enough to achieve global control of COVID-19: they also need to be produced at scale, priced affordably, allocated globally so that they are available where needed, and widely deployed in local communities. In this Health Policy paper, we review potential challenges to success in each of these dimensions and discuss policy implications. To guide our review, we developed a dashboard to highlight key characteristics of 26 leading vaccine candidates, including efficacy levels, dosing regimens, storage requirements, prices, production capacities in 2021, and stocks reserved for low- income and middle-income countries. We use a traffic-light system to signal the potential contributions of each candidate to achieving global vaccine immunity, highlighting important trade-offs that policy makers need to consider when developing and implementing vaccination programmes. Although specific datapoints are subject to change as the pandemic response progresses, the dashboard will continue to provide a useful lens through which to analyse the key issues affecting the use of COVID-19 vaccines. We also present original data from a 32-country survey (n=26 758) on potential acceptance of COVID-19 vaccines, conducted from October to December, 2020. Vaccine acceptance was highest in Vietnam (98%), India (91%), China (91%), Denmark (87%), and South Korea (87%), and lowest in Serbia (38%), Croatia (41%), France (44%), Lebanon (44%), and Paraguay (51%).	[Wouters, Olivier J.; Salcher-Konrad, Maximilian] London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England; [Shadlen, Kenneth C.] London Sch Econ & Polit Sci, Dept Int Dev, London, England; [Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Larson, Heidi J.; Jit, Mark] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Larson, Heidi J.] Univ Washington, Dept Hlth Metr Sci, Seattle, WA 98195 USA; [Teerawattananon, Yot] Minist Publ Hlth, Hlth Intervent & Technol Assessment Program, Bangkok, Thailand; [Teerawattananon, Yot] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore	University of London; London School Economics & Political Science; University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of Washington; University of Washington Seattle; Ministry of Public Health - Thailand; National University of Singapore	Wouters, OJ (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England.	o.j.wouters@lse.ac.uk	Salcher-Konrad, Maximilian/CAC-0005-2022; Jit, Mark/HDM-7797-2022; Wouters, Olivier/AAA-6345-2021; Larson, Heidi J./N-1018-2017	Salcher-Konrad, Maximilian/0000-0002-5628-5266; Wouters, Olivier/0000-0002-2514-476X; Jit, Mark/0000-0001-6658-8255; Shadlen, Kenneth/0000-0003-4010-4835; Larson, Heidi J./0000-0002-8477-7583	UK Research and Innovation [MC_PC_19055]; Engineering and Physical Sciences Research Council [EP/R013756/1]; Coalition for Epidemic Preparedness Innovations (CEPI); National Institute for Health Research (NIHR); NIHR Oxford Biomedical Research Centre; German Center for Infection Research (DZIF)	UK Research and Innovation(UK Research & Innovation (UKRI)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Coalition for Epidemic Preparedness Innovations (CEPI); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); German Center for Infection Research (DZIF)	MS-K reports receiving grants from Health Action International, outside the submitted work. AJP is Chair of the UK Department of Health & Social Care's Joint Committee on Vaccination & Immunisation (JCVI) but does not participate in policy advice on coronavirus vaccines. He is also a member of the WHO Strategic Advisory Group of Experts (SAGE) and Chief Investigator of the clinical trials for vaccine candidate AZD1222 against COVID-19, sponsored by the University of Oxford. The University of Oxford has entered into a partnership with AstraZeneca on vaccine development for candidate AZD1222. The trials are funded by UK Research and Innovation (MC_PC_19055), Engineering and Physical Sciences Research Council (EP/R013756/1), the Coalition for Epidemic Preparedness Innovations (CEPI), the National Institute for Health Research (NIHR), the NIHR Oxford Biomedical Research Centre, and the German Center for Infection Research (DZIF). HJL reports receiving grants from Merck and GlaxoSmithKline, and honoraria from Merck (for serving on a vaccine confidence advisory board) and GlaxoSmithKline (for speaking at staff training sessions). MJ reports receiving grants from the Bill & Melinda Gates Foundation (INV-016832), European Commission's Horizon 2020 programme (101003688), and National Institute for Health Research (NIHR200929, NIHR200908), outside the submitted work. All other authors declare no competing interests.	Ahonkhai V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166515; Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007; [Anonymous], 2020, LANCET, V395, P1883, DOI 10.1016/S0140-6736(20)31405-7; Ball P, 2020, NATURE, V581, P371, DOI 10.1038/d41586-020-01452-z; Ball P, 2020, NATURE, V581, P251, DOI 10.1038/d41586-020-01423-4; Baric RS, 2020, NEW ENGL J MED, V383, P2684, DOI 10.1056/NEJMcibr2032888; Berndt ER, 2007, HEALTH ECON, V16, P491, DOI 10.1002/hec.1176; Bill & Melinda Gates Foundation, 2009, PROPOSED PRINCIPLES; Bollyky TJ, 2020, JAMA-J AM MED ASSOC, V323, P2462, DOI 10.1001/jama.2020.6641; Bollyky TJ, 2020, FOREIGN AFF; Burki T, 2020, LANCET DIGIT HEALTH, V2, pE504, DOI 10.1016/S2589-7500(20)30227-2; cakmakli CC, 2021, EC CASE GLOBAL VACCI; Callaway E, 2020, NATURE, V584, P334, DOI 10.1038/d41586-020-02386-2; Center for Health Security, 2020, PUBLICS ROLE COVID 1; Chandler RE, 2020, NAT REV IMMUNOL, V20, P451, DOI 10.1038/s41577-020-0372-8; Chinazzi M., 2020, ESTIMATING EFFECT CO; Cleary EG, 2018, P NATL ACAD SCI USA, V115, P2329, DOI 10.1073/pnas.1715368115; Coalition for Epidemic Preparedness Innovations, 2020, MANUFACTURING SURVEY; Coalition for Epidemic Preparedness Innovations, 2020, SUMMARY EQUITABLE AC; Corbie-Smith G, 2002, ARCH INTERN MED, V162, P2458, DOI 10.1001/archinte.162.21.2458; Crager SE, 2018, AM J PUBLIC HEALTH, V108, pS414, DOI 10.2105/AJPH.2014.302236r; Cyranoski D, 2020, NATURE, V588, P548, DOI 10.1038/d41586-020-03563-z; Cyranoski D, 2020, NATURE, V586, P343, DOI 10.1038/d41586-020-02807-2; Das KN, 2021, REUTERS; Davis MM, 2011, VACCINE, V29, P9414, DOI 10.1016/j.vaccine.2011.09.128; de Figueiredo A, 2020, LANCET, V396, P898, DOI 10.1016/S0140-6736(20)31558-0; Douoguih, 2020, PATHWAY VACCINE EFFO; Dube E, 2015, VACCINE, V33, P4191, DOI 10.1016/j.vaccine.2015.04.041; Duggan J, 2020, IS WORLD BANKS COVID; Duke University Global Health Innovation Center, COVID 19 LAUNCH SCAL; Emanuel EJ, 2020, SCIENCE, V369, P1309, DOI 10.1126/science.abe2803; Fidler DP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000247; Gamble VN, 1997, AM J PUBLIC HEALTH, V87, P1773, DOI 10.2105/AJPH.87.11.1773; Gavi the Vaccine Alliance, 2020, CREATIVE COMMUNICATI; Gavi the Vaccine Alliance, 2020, BIODEFENCE DRC EBOLA; Gavi the Vaccine Alliance, 2020, COVAX EXPLAINED; Gavi the Vaccine Alliance, 2020, COVAX ACT ACCELERATO; Ghinai I, 2013, GLOB PUBLIC HEALTH, V8, P1138, DOI 10.1080/17441692.2013.859720; Gostin LO, 2020, JAMA-J AM MED ASSOC, V324, P335, DOI 10.1001/jama.2020.10802; Halabi S, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2030600; Halbert CH, 2006, ARCH INTERN MED, V166, P896, DOI 10.1001/archinte.166.8.896; Hanney SR, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-020-00571-3; Hecht R, 2010, LANCET, V376, P1254, DOI 10.1016/S0140-6736(10)61255-X; Herlihy N, 2016, HEALTH AFFAIR, V35, P227, DOI 10.1377/hlthaff.2015.1411; Herzog LM, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4853; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; International Monetary Fund, 2020, CRISIS NO OTHER UNCE; Islam MS, 2020, AM J TROP MED HYG, V103, P1621, DOI 10.4269/ajtmh.20-0812; Jarrett C, 2015, VACCINE, V33, P4180, DOI 10.1016/j.vaccine.2015.04.040; Johnson NF, 2020, NATURE, V582, P230, DOI 10.1038/s41586-020-2281-1; Jusu MO, 2018, J INFECT DIS, V217, pS48, DOI 10.1093/infdis/jix336; Karafillakis E, 2017, VACCINE, V35, P4840, DOI 10.1016/j.vaccine.2017.07.061; Karafillakis E, 2016, VACCINE, V34, P5013, DOI 10.1016/j.vaccine.2016.08.029; Kemp A, 2020, ASTRAZENECA ASTRAZEN; Khamsi R, 2020, NATURE, V580, P578, DOI 10.1038/d41586-020-01063-8; King's College London, 2020, WHOS LEAST LIKELY SA; Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033025; Larson H.J., 2020, STUCK VACCINE RUMORS; Larson HJ, 2016, EBIOMEDICINE, V12, P295, DOI 10.1016/j.ebiom.2016.08.042; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Liu YZ, 2020, J MED ETHICS, V46, P499, DOI 10.1136/medethics-2020-106516; Lovie-Toon YG, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3825-z; Lurie N, 2020, JAMA-J AM MED ASSOC, V324, P439, DOI 10.1001/jama.2020.12461; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; MacDonald SE, 2016, PEDIATR INFECT DIS J, V35, pE177, DOI 10.1097/INF.0000000000001125; Milne R., 2020, FINANCIAL TIMES; Murphy F, 2021, EVERY WEEK COUNTSAUS; Murphy F, 2021, NATURE, V588, pS49, DOI 10.1038/d41586-020-03361-7; Ortiz JR, 2020, NATL ROUTINE ADULT I, DOI [10.1101/ 2020.10.16.20213967, DOI 10.1101/2020.10.16.20213967]; Peretti-Watel P, 2020, LANCET INFECT DIS, V20, P769, DOI 10.1016/S1473-3099(20)30426-6; Policy Cures Research, 2020, COVID 19 R D TRACKER; Price WN, 2020, SCIENCE, V369, P912, DOI 10.1126/science.abc9588; Pronker ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057755; Pulla P, 2021, SCI MAGAZINE; Sampat BN, 2021, HEALTH AFFAIR, V40, P400, DOI 10.1377/hlthaff.2020.02097; Schaffer DeRoo S, 2020, JAMA-J AM MED ASSOC, V323, P2458, DOI 10.1001/jama.2020.8711; Schwarzinger M, 2021, LANCET PUBLIC HEALTH, V6, pE210, DOI 10.1016/S2468-2667(21)00012-8; Shah A, 2020, JAMA-J AM MED ASSOC, V324, P931, DOI 10.1001/jama.2020.15725; Simoes E, 2021, REUTERS; So AD, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4750; Struck MM, 1996, NAT BIOTECHNOL, V14, P591, DOI 10.1038/nbt0596-591; Szilagyi PG, 2021, JAMA-J AM MED ASSOC, V325, P396, DOI 10.1001/jama.2020.26419; Thiagarajan K, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n196; Thigpen CaryLynne., 2020, MOST AMERICANS EXPEC; Torjesen I, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3226; Trogen B, 2020, JAMA-J AM MED ASSOC, V323, P2460, DOI 10.1001/jama.2020.8917; UK Medicines & Healthcare products Regulatory Agency, 2021, CONDITIONS AUTHORISA; Uscher-Pines L, 2011, AM J PUBLIC HEALTH, V101, P1252, DOI 10.2105/AJPH.2011.300133; Usher AD, 2021, LANCET, V397, P265, DOI 10.1016/S0140-6736(21)00143-4; Usher AD, 2020, LANCET, V395, P1822, DOI 10.1016/S0140-6736(20)31354-4; Vaidyanathan G, 2021, NATURE NEWS; Wang W, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4704; WHO, 2020, LIST STRINGENT REGUL; WHO, 2020, FAIR ALLOCATION MECH; Wilson SE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192809; World Bank, 2020, WORLD BANK COVID 19; World Bank, 2021, COVID 19 DEBT SERVIC; World Health Organization, 2020, TARGET PRODUCT PROFI; World Health Organization, 2020, COVAX ANNOUNCES ADDI; World Health Organization, 2021, ACCESS COVID 19 TOOL; World Health Organization, 2019, GLOBAL VACCINE MARKE; World Health Organization, 2021, STATUS COVID 19 VACC; World Health Organization, 2012, REPORT WHO PANDEMIC; Xue QC, 2020, J LAW BIOSCI, V7, pA026; Yamada T, 2009, NEW ENGL J MED, V361, P1129, DOI 10.1056/NEJMp0906972; Yamey G, 2020, LANCET, V395, P1405, DOI 10.1016/S0140-6736(20)30763-7	108	446	456	23	134	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2021	397	10278					1023	1034		10.1016/S0140-6736(21)00306-8	http://dx.doi.org/10.1016/S0140-6736(21)00306-8		MAR 2021	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QV2NT	33587887	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000627814200030
J	Zhu, GM; Sushko, ML; Loring, JS; Legg, BA; Song, M; Soltis, JA; Huang, XP; Rosso, KM; De Yoreo, JJ				Zhu, Guomin; Sushko, Maria L.; Loring, John S.; Legg, Benjamin A.; Song, Miao; Soltis, Jennifer A.; Huang, Xiaopeng; Rosso, Kevin M.; De Yoreo, James J.			Self-similar mesocrystals form via interface-driven nucleation and assembly	NATURE			English	Article							DENSITY-FUNCTIONAL THEORY; ORIENTED ATTACHMENT; HEMATITE PARTICLES; CRYSTAL-GROWTH; TRANSFORMATION; AGGREGATION; NANOPARTICLES; DISSOLUTION; PHASE; CRYSTALLIZATION	Crystallization by particle attachment (CPA) is a frequently occurring mechanism of colloidal crystallization that results in hierarchical morphologies(1-4). CPA has been exploited to create nanomaterials with unusual properties(4-6) and is implicated in the development of complex mineral textures(1,7). Oriented attachment(7,8)-a form of CPA in which particles align along specific crystallographic directions-produces mesocrystals that diffract as single crystals do, although the constituent particles are still discernible(2,9). The conventional view of CPA is that nucleation provides a supply of particles that aggregate via Brownian motion biased by attractive interparticle potentials(1,9-12). However, mesocrystals often exhibit regular morphologies and uniform sizes. Although many crystal systems form mesocrystals(1-9) and individual attachment events have been directly visualized(10), how random attachment events lead to well defined, self-similar morphologies remains unknown, as does the role of surface-bound ligands, which are ubiquitous in nanoparticle systems(3,9,11). Attempts to understand mesocrystal formation are further complicated in many systems by the presence of precursor nanoparticles with a phase distinct from that of the bulk(1,13,14). Some studies propose that such particles convert before attachment(15), whereas others attribute conversion to the attachment process itself(16) and yet others conclude that transformation occurs after the mesocrystals exceed a characteristic size(14,17). Here we investigate mesocrystal formation by iron oxides, which are important colloidal phases in natural environments(18,19) and classic examples of systems forming ubiquitous precursor phases and undergoing CPA accompanied by phase transformations(15,19-21). Combining in situ transmission electron microscopy (TEM) at 80 degrees Celsius with 'freeze-and-look' TEM, we tracked the formation of haematite (Hm) mesocrystals in the presence of oxalate (Ox), which is abundant in soils, where iron oxides are common. We find that isolated Hm particles rarely appear, but once formed, interfacial gradients at the Ox-covered surfaces drive Hm particles to nucleate repeatedly about two nanometres from the surfaces, to which they then attach, thereby generating mesocrystals. Comparison to natural and synthetic systems suggests that interface-driven pathways are widespread. Mesocrystal formation is investigated for haematite in the presence of oxalate, showing that chemical gradients at interfaces cause nucleation near surfaces rather than in the bulk, followed by particle attachment.	[Zhu, Guomin; Sushko, Maria L.; Loring, John S.; Legg, Benjamin A.; Song, Miao; Soltis, Jennifer A.; Huang, Xiaopeng; Rosso, Kevin M.; De Yoreo, James J.] Pacific Northwest Natl Lab, Phys Sci Div, Richland, WA 99352 USA; [Zhu, Guomin; Legg, Benjamin A.; De Yoreo, James J.] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Washington; University of Washington Seattle	De Yoreo, JJ (corresponding author), Pacific Northwest Natl Lab, Phys Sci Div, Richland, WA 99352 USA.; De Yoreo, JJ (corresponding author), Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.	james.deyoreo@pnnl.gov	Huang, Xiaopeng/K-8773-2018; Zhu, Guomin/AAH-3785-2021; Sushko, Maria/C-8285-2014	Huang, Xiaopeng/0000-0001-6606-7468; Sushko, Maria/0000-0002-7229-7072; Legg, Benjamin/0000-0002-3055-1829; Soltis, Jennifer/0000-0002-7442-0193; De Yoreo, James/0000-0002-9541-733X	US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division, Geosciences Program at Pacific Northwest National Laboratory (PNNL); Office of Biological and Environmental Research; DOE [DE-AC05-76RL01830]	US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division, Geosciences Program at Pacific Northwest National Laboratory (PNNL)(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DOE(United States Department of Energy (DOE))	We thank C. Wang, J. Tao, M. E. McBriarty, E. Ilton and E. Nakouzi for discussions. We thank D. Li, C. Wang and L. Kovarik for TEM support. This material is based on work supported by the US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division, Geosciences Program at Pacific Northwest National Laboratory (PNNL). High-resolution TEM and STEM imaging and DFT simulations were performed in the Environmental and Molecular Sciences Laboratory, a DOE Office of Science User Facility at PNNL sponsored by the Office of Biological and Environmental Research. PNNL is a multiprogramme national laboratory operated for the DOE by Battelle under contract no. DE-AC05-76RL01830.	ANAND RR, 1987, AUST J SOIL RES, V25, P287, DOI 10.1071/SR9870287; Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; Baumgartner J, 2013, NAT MATER, V12, P310, DOI [10.1038/NMAT3558, 10.1038/nmat3558]; Boneschanscher MP, 2014, SCIENCE, V344, P1377, DOI 10.1126/science.1252642; Chen X, 2012, ACTA MATER, V60, P192, DOI 10.1016/j.actamat.2011.09.047; Cheng YW, 2018, NANOSCALE, V10, P11907, DOI 10.1039/c8nr03408g; Cho KS, 2005, J AM CHEM SOC, V127, P7140, DOI 10.1021/ja050107s; Colfen H., 2008, MESOCRYSTALS NONCLAS, DOI DOI 10.1002/9780470994603; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; De Yoreo JJ, 2015, SCIENCE, V349, DOI 10.1126/science.aaa6760; Deng N, 2019, P NATL ACAD SCI USA, V116, P13221, DOI 10.1073/pnas.1821065116; Dudarev SL, 1998, PHYS REV B, V57, P1505, DOI 10.1103/PhysRevB.57.1505; Egglseder MS, 2019, ORE GEOL REV, V104, P160, DOI 10.1016/j.oregeorev.2018.10.001; Elhadj S, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/10/105304; FISCHER WR, 1975, CLAY CLAY MINER, V23, P33, DOI 10.1346/CCMN.1975.0230105; Frandsen C, 2014, CRYSTENGCOMM, V16, P1451, DOI 10.1039/c3ce40983j; Grotzinger JP, 1999, ANNU REV EARTH PL SC, V27, P313, DOI 10.1146/annurev.earth.27.1.313; Hu Q, 2012, FARADAY DISCUSS, V159, P509, DOI 10.1039/c2fd20124k; Huang XP, 2017, J PHYS CHEM C, V121, P1113, DOI 10.1021/acs.jpcc.6b09281; Jin B, 2018, NANO LETT, V18, P6551, DOI 10.1021/acs.nanolett.8b03139; Laramy CR, 2017, CHEM PHYS LETT, V683, P389, DOI 10.1016/j.cplett.2017.01.050; Lee SO, 2007, HYDROMETALLURGY, V87, P91, DOI 10.1016/j.hydromet.2007.02.005; Legg BA, 2016, CRYST GROWTH DES, V16, P5726, DOI 10.1021/acs.cgd.6b00809; Li DS, 2012, SCIENCE, V336, P1014, DOI 10.1126/science.1219643; Lin XY, 2018, GEMS GEMOL, V54, P28, DOI 10.5741/GEMS.54.1.28; Liu LL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14719-w; Liu Z, 2009, J AM CHEM SOC, V131, P9405, DOI 10.1021/ja9039136; Loh ND, 2017, NAT CHEM, V9, P77, DOI [10.1038/NCHEM.2618, 10.1038/nchem.2618]; Loring JS, 2008, LANGMUIR, V24, P7054, DOI 10.1021/la800785u; Lu Y, 2017, ACS NANO, V11, P8018, DOI 10.1021/acsnano.7b02656; Meng D, 2014, COMMUN COMPUT PHYS, V16, P1298, DOI 10.4208/cicp.040913.120514a; Mosey NJ, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2943142; Navrotsky A, 2008, SCIENCE, V319, P1635, DOI 10.1126/science.1148614; Nielsen MH, 2014, SCIENCE, V345, P1158, DOI 10.1126/science.1254051; Nielsen MH, 2014, MICROSC MICROANAL, V20, P425, DOI 10.1017/S1431927614000294; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Schwertmann U, 1991, IRON OXIDES LAB PREP; Situm A, 2017, J PHYS CHEM A, V121, P5569, DOI 10.1021/acs.jpca.7b03426; Smith BJ, 2017, ACS CENTRAL SCI, V3, P58, DOI 10.1021/acscentsci.6b00331; Songen H, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.116101; Soltis JA, 2016, CRYST GROWTH DES, V16, P922, DOI 10.1021/acs.cgd.5b01471; Sposito G, 1997, COLLOID SURFACE A, V120, P101, DOI 10.1016/S0927-7757(96)03718-1; Stefansson A, 2007, ENVIRON SCI TECHNOL, V41, P6117, DOI 10.1021/es070174h; Sturm EV, 2017, CRYSTALS, V7, DOI 10.3390/cryst7070207; SUGIMOTO T, 1993, J COLLOID INTERF SCI, V158, P420, DOI 10.1006/jcis.1993.1274; Sugimoto T, 1998, J COLLOID INTERF SCI, V205, P42, DOI 10.1006/jcis.1998.5588; Sushko ML, 2016, NANOSCALE, V8, P19714, DOI 10.1039/c6nr06953c; Tan SF, 2018, J AM CHEM SOC, V140, P11680, DOI 10.1021/jacs.8b05217; Van Driessche AES, 2012, SCIENCE, V336, P69, DOI 10.1126/science.1215648; Whitham K, 2016, NAT MATER, V15, P557, DOI [10.1038/NMAT4576, 10.1038/nmat4576]; Wu JZ, 2007, ANNU REV PHYS CHEM, V58, P85, DOI 10.1146/annurev.physchem.58.032806.104650; Xin HLL, 2012, NANO LETT, V12, P1470, DOI 10.1021/nl2041854; Yang J, 2019, NAT MATER, V18, P970, DOI 10.1038/s41563-019-0415-3; Ye JF, 2011, J AM CHEM SOC, V133, P933, DOI 10.1021/ja108205q; Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165; Yuwono VM, 2010, J AM CHEM SOC, V132, P2163, DOI 10.1021/ja909769a; Zhang X, 2017, SCIENCE, V356, P433, DOI 10.1126/science.aah6902; ZHANG Y, 1985, LANGMUIR, V1, P201, DOI 10.1021/la00062a004; Zhang ZP, 2005, ADV MATER, V17, P42, DOI 10.1002/adma.200400401; Zhou L, 2008, SMALL, V4, P1566, DOI 10.1002/smll.200800520; Zhu GM, 2019, MICRON, V118, P35, DOI 10.1016/j.micron.2018.12.001; Zhu GM, 2013, CHEM COMMUN, V49, P10944, DOI 10.1039/c3cc46667a	63	46	46	52	175	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846								10.1038/s41586-021-03300-0	http://dx.doi.org/10.1038/s41586-021-03300-0			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TY5YS	33597761	Green Submitted			2022-12-28	WOS:000683860300004
J	Kar, P				Kar, Partha			Partha Kar: Losing one's faith in leaders	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kar, Partha] Portsmouth Hosp NHS Trust, Diabet & Endocrinol, Portsmouth, Hants, England	Portsmouth Hospitals NHS Trust	Kar, P (corresponding author), Portsmouth Hosp NHS Trust, Diabet & Endocrinol, Portsmouth, Hants, England.	drparthakar@gmail.com						KAR P, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M1143	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2021	372								n424	10.1136/bmj.n424	http://dx.doi.org/10.1136/bmj.n424			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK7TO	33597128	Bronze			2022-12-28	WOS:000620584600006
J	Choo, E				Choo, Esther			Easy in, tough out: the dam of health-care racism	LANCET			English	Editorial Material									[Choo, Esther] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97239 USA	Oregon Health & Science University	Choo, E (corresponding author), Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97239 USA.	chooe@ohsu.edu							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2021	397	10274					570	570						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2TN	33581813	Green Published			2022-12-28	WOS:000620934000012
J	Dyer, O				Dyer, Owen			Covid-19: Russia's statistics agency reports much higher death toll than country's health ministry	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER O, 2020, BMJ-BRIT MED J, V371, DOI DOI 10.1136/BMJ.M4182; Federal State Statistic Service, 2021, NAT POP CHANG SUBJ R; Levada-Center, 2020, COR POLL	3	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2021	372								n440	10.1136/bmj.n440	http://dx.doi.org/10.1136/bmj.n440			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QH8HV	33579671	Bronze			2022-12-28	WOS:000618513500008
J	Koronowski, KB; Sassone-Corsi, P				Koronowski, Kevin B.; Sassone-Corsi, Paolo			Communicating clocks shape circadian homeostasis	SCIENCE			English	Review							REV-ERB-ALPHA; GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; PERIPHERAL CLOCKS; BODY-TEMPERATURE; DRIVE RHYTHMS; TIME; FOOD; REVEALS; LIGHT	Circadian clocks temporally coordinate physiology and align it with geophysical time, which enables diverse life-forms to anticipate daily environmental cycles. In complex organisms, clock function originates from the molecular oscillator within each cell and builds upward anatomically into an organism-wide system. Recent advances have transformed our understanding of how clocks are connected to achieve coherence across tissues. Circadian misalignment, often imposed in modern society, disrupts coordination among clocks and has been linked to diseases ranging from metabolic syndrome to cancer. Thus, uncovering the physiological circuits whereby biological clocks achieve coherence will inform on both challenges and opportunities in human health.	[Koronowski, Kevin B.; Sassone-Corsi, Paolo] Univ Calif Irvine, Ctr Epigenet & Metab, U 1233, Dept Biol Chem,INSERM, Irvine, CA 92697 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Irvine	Koronowski, KB (corresponding author), Univ Calif Irvine, Ctr Epigenet & Metab, U 1233, Dept Biol Chem,INSERM, Irvine, CA 92697 USA.	kkoronow@uci.edu		Koronowski, Kevin/0000-0002-6808-1789	NIH [R21DK114652, R21AG053592]; Novo Nordisk Foundation [NNF-202585]; NIDDK [F32DK121425]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The P.S.-C. laboratory is supported by NIH grants R21DK114652 and R21AG053592 and a Challenge Grant of the Novo Nordisk Foundation (NNF-202585). K.B.K. is supported by the NIDDK grant F32DK121425.	Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Adamovich Y, 2019, CELL METAB, V29, P1092, DOI 10.1016/j.cmet.2019.01.007; Adamovich Y, 2017, CELL METAB, V25, P93, DOI 10.1016/j.cmet.2016.09.014; Aryal RP, 2017, MOL CELL, V67, P770, DOI 10.1016/j.molcel.2017.07.017; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Astiz M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020343; Atger F, 2015, P NATL ACAD SCI USA, V112, pE6579, DOI 10.1073/pnas.1515308112; Benitah SA, 2020, CELL STEM CELL, V26, P817, DOI 10.1016/j.stem.2020.05.002; Bahrami-Nejad Z, 2018, CELL METAB, V27, P854, DOI 10.1016/j.cmet.2018.03.012; Barber AF, 2016, GENE DEV, V30, P2596, DOI 10.1101/gad.288258.116; Barca-Mayo O, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14336; Barnea M, 2015, MOL CELL ENDOCRINOL, V399, P284, DOI 10.1016/j.mce.2014.10.018; Bass J, 2016, SCIENCE, V354, P994, DOI 10.1126/science.aah4965; Benegiamo G, 2018, CELL METAB, V27, P404, DOI 10.1016/j.cmet.2017.12.010; Beytebiere JR, 2019, GENE DEV, V33, P294, DOI 10.1101/gad.322198.118; Bookout AL, 2013, NAT MED, V19, P1147, DOI 10.1038/nm.3249; Brancaccio M, 2019, SCIENCE, V363, P187, DOI 10.1126/science.aat4104; Brancaccio M, 2017, NEURON, V93, P1420, DOI 10.1016/j.neuron.2017.02.030; Breit A, 2018, J BIOL CHEM, V293, P17278, DOI 10.1074/jbc.RA118.004429; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Bruning F, 2019, SCIENCE, V366, P201, DOI 10.1126/science.aav3617; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Buijs FN, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0028-17.2017; Chavan R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10580; Chen SY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11513-1; Cooper SJ, 2008, APPETITE, V51, P419, DOI 10.1016/j.appet.2008.06.005; Crosby P, 2019, CELL, V177, P896, DOI 10.1016/j.cell.2019.02.017; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; de Juan A, 2019, CIRCULATION, V140, P1100, DOI 10.1161/CIRCULATIONAHA.119.040232; Dyar KA, 2018, CELL, V174, P1571, DOI 10.1016/j.cell.2018.08.042; Dyar KA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005886; Erion R, 2016, ELIFE, V5, DOI 10.7554/eLife.13552; Fustin JM, 2017, J BIOL RHYTHM, V32, P609, DOI 10.1177/0748730417735922; Gamble KL, 2014, NAT REV ENDOCRINOL, V10, P466, DOI 10.1038/nrendo.2014.78; Gerber A, 2013, CELL, V152, P492, DOI 10.1016/j.cell.2012.12.027; Godinho-Silva C, 2019, NATURE, V574, P254, DOI 10.1038/s41586-019-1579-3; Goede Paul de, 2018, Neurobiology of Sleep and Circadian Rhythms, V4, P24, DOI 10.1016/j.nbscr.2017.09.002; Gould PD, 2018, ELIFE, V7, DOI [10.7554/eLife.31700, 10.7554/elife.31700]; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Greenwell BJ, 2019, CELL REP, V27, P649, DOI 10.1016/j.celrep.2019.03.064; Guan DY, 2020, SCIENCE, V369, P1388, DOI 10.1126/science.aba8984; Guenthner CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087573; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Hamaguchi Y, 2015, J BIOL RHYTHM, V30, P533, DOI 10.1177/0748730415609727; Hastings MH, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8010013; Hastings MH, 2018, NAT REV NEUROSCI, V19, P453, DOI 10.1038/s41583-018-0026-z; He WY, 2018, IMMUNITY, V49, P1175, DOI 10.1016/j.immuni.2018.10.007; Hennig S, 2009, PLOS BIOL, V7, P836, DOI 10.1371/journal.pbio.1000094; Hirano A, 2016, NAT STRUCT MOL BIOL, V23, P1053, DOI 10.1038/nsmb.3326; Husse J, 2014, FASEB J, V28, P4950, DOI 10.1096/fj.14-256594; Izumo M, 2014, ELIFE, V3, DOI 10.7554/eLife.04617; Kalsbeek A, 2001, ENDOCRINOLOGY, V142, P2677, DOI 10.1210/en.142.6.2677; Kettner NM, 2015, CELL METAB, V22, P448, DOI 10.1016/j.cmet.2015.06.005; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kolbe I, 2019, MOL METAB, V30, P140, DOI 10.1016/j.molmet.2019.09.012; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Koronowski KB, 2019, CELL, V177, P1448, DOI 10.1016/j.cell.2019.04.025; Koshy A, 2019, FASEB J, V33, P6789, DOI 10.1096/fj.201801889R; Kriebs A, 2017, P NATL ACAD SCI USA, V114, P8776, DOI 10.1073/pnas.1704955114; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lande-Diner L, 2015, MOL BIOL CELL, V26, P3940, DOI 10.1091/mbc.E15-06-0403; Landgraf D, 2015, ELIFE, V4, DOI 10.7554/eLife.06253; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Ma X, 2016, DIABETOLOGIA, V59, P354, DOI 10.1007/s00125-015-3807-1; Man K, 2016, SCIENCE, V354, P999, DOI 10.1126/science.aah4966; Manella G, 2020, P NATL ACAD SCI USA, V117, P779, DOI 10.1073/pnas.1914112117; Masri S, 2016, CELL, V165, P896, DOI 10.1016/j.cell.2016.04.039; Masri S, 2014, CELL, V158, P659, DOI 10.1016/j.cell.2014.06.050; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mermet J, 2018, GENE DEV, V32, P347, DOI 10.1101/gad.312397.118; Meyers SR, 2018, P NATL ACAD SCI USA, V115, P6363, DOI 10.1073/pnas.1717689115; MILLS JN, 1974, J PHYSIOL-LONDON, V240, P567, DOI 10.1113/jphysiol.1974.sp010623; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Morioka N, 2015, NEUROCHEM INT, V90, P9, DOI 10.1016/j.neuint.2015.06.013; Mure LS, 2018, SCIENCE, V359, P1232, DOI 10.1126/science.aao0318; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Noguchi T, 2013, J BIOL RHYTHM, V28, P183, DOI 10.1177/0748730413487494; Noguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037093; Noguchi T, 2012, CHRONOBIOL INT, V29, P653, DOI 10.3109/07420528.2012.679330; Noya SB, 2019, SCIENCE, V366, P200, DOI 10.1126/science.aav2642; O'Neill JS, 2008, J BIOL RHYTHM, V23, P483, DOI 10.1177/0748730408326682; Oishi K, 2005, DNA RES, V12, P191, DOI 10.1093/dnares/dsi003; Orozco-Solis R, 2016, CELL METAB, V23, P467, DOI 10.1016/j.cmet.2016.02.003; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Papazyan R, 2016, NAT STRUCT MOL BIOL, V23, P1045, DOI 10.1038/nsmb.3324; Park JS, 2017, CURR BIOL, V27, P2623, DOI 10.1016/j.cub.2017.07.019; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Peek CB, 2017, CELL METAB, V25, P86, DOI 10.1016/j.cmet.2016.09.010; Perrin L, 2015, MOL METAB, V4, P834, DOI 10.1016/j.molmet.2015.07.009; Petrenko V, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.13021; Petrenko V, 2017, GENE DEV, V31, P383, DOI 10.1101/gad.290379.116; Preussner M, 2017, MOL CELL, V67, P433, DOI 10.1016/j.molcel.2017.06.006; Qu M, 2018, P NATL ACAD SCI USA, V115, pE12305, DOI 10.1073/pnas.1816411115; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramanathan C, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007369; Rash JE, 2007, NEUROSCIENCE, V149, P350, DOI 10.1016/j.neuroscience.2007.06.052; Ray S, 2020, SCIENCE, V367, P800, DOI 10.1126/science.aaw7365; Resuehr D, 2019, J BIOL RHYTHM, V34, P167, DOI 10.1177/0748730419826694; Saini C, 2013, GENE DEV, V27, P1526, DOI 10.1101/gad.221374.113; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Schmal C, 2018, J BIOL RHYTHM, V33, P84, DOI 10.1177/0748730417740467; Sengiku A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20379-0; Shostak A, 2019, GENE DEV, V33, P255, DOI 10.1101/gad.324046.119; Solanas G, 2017, CELL, V170, P678, DOI 10.1016/j.cell.2017.07.035; Sotak M, 2016, CHRONOBIOL INT, V33, P520, DOI 10.3109/07420528.2016.1161643; Su Y, 2016, GENES CELLS, V21, P6, DOI 10.1111/gtc.12315; Su Y, 2015, CHRONOBIOL INT, V32, P211, DOI 10.3109/07420528.2014.963198; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Tso CF, 2017, CURR BIOL, V27, P1055, DOI 10.1016/j.cub.2017.02.037; van der Vinne V, 2018, P NATL ACAD SCI USA, V115, pE2437, DOI 10.1073/pnas.1712324115; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wang D, 2017, BRAIN RES, V1671, P93, DOI 10.1016/j.brainres.2017.07.006; Wang JK, 2017, CELL METAB, V25, P102, DOI 10.1016/j.cmet.2016.10.003; Webb AB, 2009, P NATL ACAD SCI USA, V106, P16493, DOI 10.1073/pnas.0902768106; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Welz PS, 2019, CELL, V177, P1436, DOI 10.1016/j.cell.2019.05.009; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Wilkinson MJ, 2020, CELL METAB, V31, P92, DOI 10.1016/j.cmet.2019.11.004; Williams J, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208223; Yamajuku D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00439; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yi CX, 2006, ENDOCRINOLOGY, V147, P283, DOI 10.1210/en.2005-1051; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zeng WW, 2015, CELL, V163, P84, DOI 10.1016/j.cell.2015.08.055; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhang SL, 2018, CELL, V173, P130, DOI 10.1016/j.cell.2018.02.017	135	51	54	7	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2021	371	6530					690	+	eabd0951	10.1126/science.abd0951	http://dx.doi.org/10.1126/science.abd0951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QG4IS	33574181	Green Accepted			2022-12-28	WOS:000617551600035
J	Rentsch, CT; Beckman, JA; Tomlinson, L; Gellad, WF; Alcorn, C; Kidwai-Khan, F; Skanderson, M; Brittain, E; King, JT; Ho, YL; Eden, S; Kundu, S; Lann, MF; Greevy, RA; Ho, PM; Heidenreich, PA; Jacobson, DA; Douglas, IJ; Tate, JP; Evans, SJW; Atkins, D; Justice, AC; Freiberg, MS				Rentsch, Christopher T.; Beckman, Joshua A.; Tomlinson, Laurie; Gellad, Walid F.; Alcorn, Charles; Kidwai-Khan, Farah; Skanderson, Melissa; Brittain, Evan; King, Joseph T., Jr.; Ho, Yuk-Lam; Eden, Svetlana; Kundu, Suman; Lann, Michael F.; Greevy, Robert A., Jr.; Ho, P. Michael; Heidenreich, Paul A.; Jacobson, Daniel A.; Douglas, Ian J.; Tate, Janet P.; Evans, Stephen J. W.; Atkins, David; Justice, Amy C.; Freiberg, Matthew S.			Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFLAMMATORY BIOMARKERS; INVERSE PROBABILITY; COMPETING RISKS; COVID-19; FAILURE; METAANALYSIS; MILITARY; VETERAN; HEPARIN; HEALTH	OBJECTIVE To evaluate whether early initiation of prophylactic anticoagulation compared with no anticoagulation was associated with decreased risk of death among patients admitted to hospital with coronavirus disease 2019 (covid-19) in the United States. DESIGN Observational cohort study. SETTING Nationwide cohort of patients receiving care in the Department of Veterans Affairs, a large integrated national healthcare system. Participants All 4297 patients admitted to hospital from 1 March to 31 July 2020 with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and without a history of anticoagulation. MAIN OUTCOME MEASURES The main outcome was 30 day mortality. Secondary outcomes were inpatient mortality, initiating therapeutic anticoagulation (a proxy for clinical deterioration, including thromboembolic events), and bleeding that required transfusion. RESULTS Of 4297 patients admitted to hospital with covid-19, 3627 (84.4%) received prophylactic anticoagulation within 24 hours of admission. More than 99% (n=3600) of treated patients received subcutaneous heparin or enoxaparin. 622 deaths occurred within 30 days of hospital admission, 513 among those who received prophylactic anticoagulation. Most deaths (510/622, 82%) occurred during hospital stay. Using inverse probability of treatment weighted analyses, the cumulative incidence of mortality at 30 days was 14.3% (95% confidence interval 13.1% to 15.5%) among those who received prophylactic anticoagulation and 18.7% (15.1% to 22.9%) among those who did not. Compared with patients who did not receive prophylactic anticoagulation, those who did had a 27% decreased risk for 30 day mortality (hazard ratio 0.73, 95% confidence interval 0.66 to 0.81). Similar associations were found for inpatient mortality and initiation of therapeutic anticoagulation. Receipt of prophylactic anticoagulation was not associated with increased risk of bleeding that required transfusion (hazard ratio 0.87, 0.71 to 1.05). Quantitative bias analysis showed that results were robust to unmeasured confounding (e-value lower 95% confidence interval 1.77 for 30 day mortality). Results persisted in several sensitivity analyses. CONCLUSIONS Early initiation of prophylactic anticoagulation compared with no anticoagulation among patients admitted to hospital with covid-19 was associated with a decreased risk of 30 day mortality and no increased risk of serious bleeding events. These findings provide strong real world evidence to support guidelines recommending the use of prophylactic anticoagulation as initial treatment for patients with covid-19 on hospital admission.	[Rentsch, Christopher T.; Tomlinson, Laurie; Douglas, Ian J.; Evans, Stephen J. W.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Rentsch, Christopher T.; Kidwai-Khan, Farah; Skanderson, Melissa; King, Joseph T., Jr.; Tate, Janet P.; Justice, Amy C.] US Dept Vet Affairs, VA Connecticut Healthcare Syst, West Haven, CT 06516 USA; [Beckman, Joshua A.] Vanderbilt Univ, Med Ctr, Cardiovasc Div, Nashville, TN USA; [Beckman, Joshua A.; Brittain, Evan] Vanderbilt Translat & Clin Cardiovasc Res Ctr, Nashville, TN USA; [Gellad, Walid F.] Univ Pittsburgh, Ctr Pharmaceut Policy & Prescribing, Hlth Policy Inst, Pittsburgh, PA USA; [Gellad, Walid F.] Univ Pittsburgh, Sch Med, Div Gen Internal Med, Pittsburgh, PA USA; [Gellad, Walid F.] US Dept Vet Affairs, Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Alcorn, Charles; Lann, Michael F.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Ctr Occupat Biostat & Epidemiol, Pittsburgh, PA 15261 USA; [Kidwai-Khan, Farah; Tate, Janet P.; Justice, Amy C.] Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Brittain, Evan] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [King, Joseph T., Jr.] Yale Sch Med, Dept Neurosurg, New Haven, CT USA; [Ho, Yuk-Lam] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr MA, Boston, MA USA; [Eden, Svetlana] Vanderbilt Univ, Sch Med, Dept Biostat, Fac Biostat, Nashville, TN 37212 USA; [Kundu, Suman; Freiberg, Matthew S.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Greevy, Robert A., Jr.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Ho, P. Michael] US Dept Vet Affairs, Rocky Mt Reg VA Med Ctr, Aurora, CO USA; [Heidenreich, Paul A.] US Dept Vet Affairs, VA Palo Alto Healthcare Syst, Palo Alto, CA USA; [Heidenreich, Paul A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Jacobson, Daniel A.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Atkins, David] US Dept Vet Affairs, Hlth Serv Res & Dev, Washington, DC USA; [Justice, Amy C.] Yale Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT USA; [Freiberg, Matthew S.] US Dept Vet Affairs, Tennessee Valley Healthcare Syst, Geriatr Res Educ & Clin Ctr, Nashville, TN USA	University of London; London School of Hygiene & Tropical Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; Vanderbilt University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; United States Department of Energy (DOE); Oak Ridge National Laboratory; US Department of Veterans Affairs; Yale University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Rentsch, CT (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England.; Rentsch, CT (corresponding author), US Dept Vet Affairs, VA Connecticut Healthcare Syst, West Haven, CT 06516 USA.	christopher.rentsch@lshtm.ac.uk	Heidenreich, Paul/AAU-6864-2021; Kundu, Suman/I-2603-2019	Heidenreich, Paul/0000-0001-7730-8490; Tomlinson, Laurie/0000-0001-8848-9493; Rentsch, Christopher/0000-0002-1408-7907; Evans, Stephen/0000-0002-1474-2596; Kundu, Suman/0000-0002-6305-2559	National Institute on Alcohol Abuse and Alcoholism [U01-AA026224, U24-AA020794, U01-AA020790, U10-AA013566]; Department of Veterans Affairs Health Services Research and Development [C19 20-405]; Office of Research and Development [MVP000]; Laboratory Directed Research and Development Program of Oak Ridge National Laboratory [LOIS:10074, DEAC05-00OR22725]	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Department of Veterans Affairs Health Services Research and Development(US Department of Veterans Affairs); Office of Research and Development; Laboratory Directed Research and Development Program of Oak Ridge National Laboratory	This work was supported by the National Institute on Alcohol Abuse and Alcoholism (U01-AA026224, U24-AA020794, U01-AA020790, U10-AA013566) and by the Department of Veterans Affairs Health Services Research and Development (C19 20-405) and Office of Research and Development (MVP000). Research was also sponsored by the Laboratory Directed Research and Development Program (LOIS:10074) of Oak Ridge National Laboratory, managed by UT-Battelle, LLC for the US Department of Energy under contract DEAC05-00OR22725. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication. The views and opinions expressed in this manuscript are those of the authors and do not necessarily represent those	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520; Allenbach Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240711; [Anonymous], FULL DOSE BLOOD THIN; Austin PC, 2016, STAT MED, V35, P5642, DOI 10.1002/sim.7084; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Ayerbe L, 2020, J THROMB THROMBOLYS, V50, P298, DOI 10.1007/s11239-020-02162-z; Barnes GD, 2020, J THROMB THROMBOLYS, V50, P72, DOI 10.1007/s11239-020-02138-z; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031; Bilaloglu S, 2020, JAMA-J AM MED ASSOC, V324, P799, DOI 10.1001/jama.2020.13372; Billett HH, 2020, THROMB HAEMOSTASIS, V120, P1691, DOI 10.1055/s-0040-1720978; Blake HA, 2020, STAT MED, V39, P1641, DOI 10.1002/sim.8503; Blake HA, 2020, BIOMETRICAL J, V62, P428, DOI 10.1002/bimj.201900041; Bozzani A, 2020, SURGERY, V168, P987, DOI 10.1016/j.surg.2020.09.009; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Carvelli J, 2020, NATURE, V588, P146, DOI 10.1038/s41586-020-2600-6; Chau VQ, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.120.007485; Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; D'Agostino RB, 2000, J AM STAT ASSOC, V95, P749, DOI 10.2307/2669455; Darzi AJ, 2020, BLOOD, V135, P1788, DOI 10.1182/blood.2019003603; Daughety MM, 2020, THROMB RES, V196, P483, DOI 10.1016/j.thromres.2020.10.004; Ferguson J, 2020, J CLIN PHARMACOL, V60, P1411, DOI 10.1002/jcph.1749; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Garvin MR, 2020, ELIFE, V9, DOI 10.7554/eLife.59177; Gawalko M, 2020, IJC HEART VASC, V30, DOI 10.1016/j.ijcha.2020.100631; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Hoerster KD, 2012, AM J PREV MED, V43, P483, DOI 10.1016/j.amepre.2012.07.029; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; King JT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241825; King JT, MEDRXIV, DOI [10.1101/2021.01.01.20249069, DOI 10.1101/2021.01.01.20249069]; Kreuziger LB, 2020, COVID 19 VTE ANTICOA; Lala A, 2020, J AM COLL CARDIOL, V76, P533, DOI [10.1016/j.jacc.2020.06.007, 10.1101/2020.04.20.20072702]; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Lehavot K, 2012, AM J PREV MED, V42, P473, DOI 10.1016/j.amepre.2012.01.006; Li XY, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03183-z; Li X, 2020, J INFLAMM-LOND, V17, DOI 10.1186/s12950-020-0238-7; Liu PP, 2020, CIRCULATION, V142, P68, DOI 10.1161/CIRCULATIONAHA.120.047549; Masi P, 2020, CIRCULATION, V142, P611, DOI 10.1161/CIRCULATIONAHA.120.048925; McGinnis KA, 2019, ADDICT BIOL, V24, P1056, DOI 10.1111/adb.12670; Meini S, 2020, MOL BIOL REP, V47, P8301, DOI 10.1007/s11033-020-05831-7; Moores LK, 2020, CHEST, V158, P1143, DOI 10.1016/j.chest.2020.05.559; Most ZM, 2021, CIRCULATION, V143, P4, DOI 10.1161/CIRCULATIONAHA.120.050166; Mousavi S, 2015, ADV PHARMACOL SCI, V2015, DOI 10.1155/2015/507151; Myhre PL, 2020, CIRCULATION, V142, P2128, DOI 10.1161/CIRCULATIONAHA.120.050360; Nadkarni GN, 2020, J AM COLL CARDIOL, V76, P1815, DOI 10.1016/j.jacc.2020.08.041; Nasiripour S, 2014, IRAN J PHARM RES, V13, P583; Naudin I, 2021, J VASC SURG, V73, P18, DOI 10.1016/j.jvs.2020.10.018; Nicolai L, 2020, CIRCULATION, V142, P1176, DOI 10.1161/CIRCULATIONAHA.120.048488; Paolisso P, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01124; Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001; Peltzer B, 2020, J CARDIOVASC ELECTR, V31, P3077, DOI 10.1111/jce.14770; PEPE MS, 1993, STAT MED, V12, P737, DOI 10.1002/sim.4780120803; Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430; RAND Health, 2015, CURRENT PROJECTED CH; Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/S0140-6736(20)31094-1, 10.1016/50140-6736(20)31094-1]; Rossi R, 2020, EUR J INTERN MED, V77, P158, DOI 10.1016/j.ejim.2020.06.006; Salah HM, 2020, AM J CARDIOL, V134, P155, DOI 10.1016/j.amjcard.2020.08.005; Simpson JM, 2020, CIRCULATION, V142, P437, DOI 10.1161/CIRCULATIONAHA.120.048726; Singh B, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.9344; Spyropoulos AC, 2020, J THROMB HAEMOST, V18, P1859, DOI 10.1111/jth.14929; Tandon R, 2021, J VIROL, V95, DOI [10.1128/JVI.01987-20, 10.1101/2020.06.08.140236]; Tang N, 2020, J THROMB HAEMOST, V18, P1094, DOI 10.1111/jth.14817; Tree JA, 2021, BRIT J PHARMACOL, V178, P626, DOI 10.1111/bph.15304; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Wijaya I, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620960797; Wise J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2058; Zhang L, 2020, CIRCULATION, V142, P114, DOI 10.1161/CIRCULATIONAHA.120.046702; Zhang R, 2021, J VASC SURG-VENOUS L, V9, P289, DOI 10.1016/j.jvsv.2020.11.023	71	105	107	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2021	372								n311	10.1136/bmj.n311	http://dx.doi.org/10.1136/bmj.n311			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RM2MY	33574135	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000639500800001
J	Beard, JH; Jacoby, SF; Maher, Z; Dong, BD; Kaufman, EJ; Goldberg, AJ; Morrison, CN				Beard, Jessica H.; Jacoby, Sara F.; Maher, Zoe; Dong, Beidi; Kaufman, Elinore J.; Goldberg, Amy J.; Morrison, Christopher N.			Changes in Shooting Incidence in Philadelphia, Pennsylvania, Between March and November 2020	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study uses police department registry data to describe trends in incidence of firearm shootings and deaths January-November 2020, before and after the closure of nonessential businesses in March, the killing of George Floyd in May, and the partial lifting of containment policies in June.	[Beard, Jessica H.; Maher, Zoe; Goldberg, Amy J.] Temple Univ, Lewis Katz Sch Med, Div Trauma Surg & Surg Crit Care, Philadelphia, PA 19122 USA; [Jacoby, Sara F.] Univ Penn, Sch Nursing, Dept Family & Community Hlth, Philadelphia, PA 19104 USA; [Dong, Beidi] George Mason Univ, Dept Criminol Law & Soc, Fairfax, VA 22030 USA; [Kaufman, Elinore J.] Univ Penn, Perelman Sch Med, Div Traumatol Surg Crit Care & Emergency Surg, Philadelphia, PA 19104 USA; [Morrison, Christopher N.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; George Mason University; University of Pennsylvania; Pennsylvania Medicine; Columbia University	Beard, JH (corresponding author), 3401 N Broad St,4th Floor,Zone C, Philadelphia, PA 19140 USA.	jbeard08@gmail.com		Jacoby, Sara/0000-0001-6206-5078				Abdallah HO, 2021, J AM COLL SURGEONS, V232, DOI 10.1016/j.jamcollsurg.2020.09.028; Box G. E. P., 2016, TIME SERIES ANAL FOR; Jacoby SF, 2018, SOC SCI MED, V199, P87, DOI 10.1016/j.socscimed.2017.05.038; Kaufman E, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000316; Kaufman EJ, 2021, JAMA INTERN MED, V181, P237, DOI 10.1001/jamainternmed.2020.6696; OpenDataPhilly, SHOOT VICT	6	19	19	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2021	325	13					1327	1328		10.1001/jama.2021.1534	http://dx.doi.org/10.1001/jama.2021.1534		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RK4TM	33566087	Green Published, Bronze			2022-12-28	WOS:000617178800003
J	Park, S; Western, LM; Saito, T; Redington, AL; Henne, S; Fang, XK; Prinn, RG; Manning, AJ; Montzka, SA; Fraser, PJ; Ganesan, AL; Harth, CM; Kim, J; Krummel, PB; Liang, Q; Mhle, J; O'Doherty, S; Park, H; Park, MK; Reimann, S; Salameh, PK; Weiss, RF; Rigby, M				Park, Sunyoung; Western, Luke M.; Saito, Takuya; Redington, Alison L.; Henne, Stephan; Fang, Xuekun; Prinn, Ronald G.; Manning, Alistair J.; Montzka, Stephen A.; Fraser, Paul J.; Ganesan, Anita L.; Harth, Christina M.; Kim, Jooil; Krummel, Paul B.; Liang, Qing; Muhle, Jens; O'Doherty, Simon; Park, Hyeri; Park, Mi-Kyung; Reimann, Stefan; Salameh, Peter K.; Weiss, Ray F.; Rigby, Matthew			A decline in emissions of CFC-11 and related chemicals from eastern China	NATURE			English	Article								Emissions of ozone-depleting substances, including trichlorofluoromethane (CFC-11), have decreased since the mid-1980s in response to the Montreal Protocol(1,2). In recent years, an unexpected increase in CFC-11 emissions beginning in 2013 has been reported, with much of the global rise attributed to emissions from eastern China(3,4). Here we use high-frequency atmospheric mole fraction observations from Gosan, South Korea and Hateruma, Japan, together with atmospheric chemical transport-model simulations, to investigate regional CFC-11 emissions from eastern China. We find that CFC-11 emissions returned to pre-2013 levels in 2019 (5.0 +/- 1.0 gigagrams per year in 2019, compared to 7.2 +/- 1.5 gigagrams per year for 2008-2012, +/- 1 standard deviation), decreasing by 10 +/- 3 gigagrams per year since 2014-2017. Furthermore, we find that in this region, carbon tetrachloride (CCl4) and dichlorodifluoromethane (CFC-12) emissions-potentially associated with CFC-11 production-were higher than expected after 2013 and then declined one to two years before the CFC-11 emissions reduction. This suggests that CFC-11 production occurred in eastern China after the mandated global phase-out, and that there was a subsequent decline in production during 2017-2018. We estimate that the amount of the CFC-11 bank (the amount of CFC-11 produced, but not yet emitted) in eastern China is up to 112 gigagrams larger in 2019 compared to pre-2013 levels, probably as a result of recent production. Nevertheless, it seems that any substantial delay in ozone-layer recovery has been avoided, perhaps owing to timely reporting(3,4) and subsequent action by industry and government in China(5,6). Atmospheric data and chemical-transport modelling show that CFC-11 emissions from eastern China have again decreased, after increasing in 2013-2017, and a delay in ozone-layer recovery has probably been avoided.	[Park, Sunyoung; Park, Hyeri] Kyungpook Natl Univ, Dept Oceanog, Daegu, South Korea; [Western, Luke M.; O'Doherty, Simon; Rigby, Matthew] Univ Bristol, Sch Chem, Bristol, Avon, England; [Saito, Takuya] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Redington, Alison L.; Manning, Alistair J.] Met Off, Hadley Ctr, Exeter, Devon, England; [Henne, Stephan; Reimann, Stefan] Swiss Fed Labs Mat Sci & Technol, Empa, Dubendorf, Switzerland; [Fang, Xuekun] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou, Peoples R China; [Fang, Xuekun; Prinn, Ronald G.] MIT, Ctr Global Change Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Montzka, Stephen A.] NOAA, Global Monitoring Lab, Boulder, CO USA; [Fraser, Paul J.; Krummel, Paul B.] CSIRO Oceans & Atmosphere, Climate Sci Ctr, Aspendale, Vic, Australia; [Ganesan, Anita L.] Univ Bristol, Sch Geog Sci, Bristol, Avon, England; [Harth, Christina M.; Kim, Jooil; Muhle, Jens; Salameh, Peter K.; Weiss, Ray F.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Liang, Qing] NASA, Goddard Space Flight Ctr, Greenbelt, MD USA; [Park, Mi-Kyung] Kyungpook Natl Univ, Kyungpook Inst Oceanog, Daegu, South Korea	Kyungpook National University; University of Bristol; National Institute for Environmental Studies - Japan; Met Office - UK; Hadley Centre; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Zhejiang University; Massachusetts Institute of Technology (MIT); National Oceanic Atmospheric Admin (NOAA) - USA; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Bristol; University of California System; University of California San Diego; Scripps Institution of Oceanography; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Kyungpook National University	Western, LM; Rigby, M (corresponding author), Univ Bristol, Sch Chem, Bristol, Avon, England.; Prinn, RG (corresponding author), MIT, Ctr Global Change Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	Luke.western@bristol.ac.uk; rprinn@mit.edu; matt.rigby@bristol.ac.uk	Krummel, Paul B/A-4293-2013; Liang, Qing/B-1276-2011; Reimann, Stefan/A-2327-2009; , Qing/GPX-8988-2022; Henne, Stephan/A-3467-2009; montzka, stephen/V-6162-2019; Ganesan, Anita/D-6230-2016	Krummel, Paul B/0000-0002-4884-3678; Liang, Qing/0000-0002-8430-0515; Reimann, Stefan/0000-0002-9885-7138; , Qing/0000-0002-8430-0515; montzka, stephen/0000-0002-9396-0400; Park, Hyeri/0000-0001-7061-7856; Western, Luke/0000-0002-0043-711X; Ganesan, Anita/0000-0001-5715-8923	NASA Upper Atmosphere Research Program [NNX16AC98G, NNX16AC96G, NNX16AC97G]; UK Department for Business, Energy AMP; Industrial Strategy (BEIS) [1537/06/2018]; Met Office Hadley Centre Climate Programme - UK's Department for Business, Energy and Industrial Strategy; Australian Bureau of Meteorology; Refrigerant Reclaim Australia (RRA); Natural Environment Research Council (NERC) [NE/M014851/1, NE/N016548/1]; NERC Independent Research Fellowship [NE/L010992/1]; National Research Foundation of Korea (NRF) - Korean government (MSIT) [2020R1A2C3003774]; Ministry of the Environment of Japan; Swiss National Supercomputing Centre (CSCS) [s862]; Australian Department of Agriculture, Water and the Environment (DAWE); Met Office Hadley Centre Climate Programme - UK's Department for Environment, Food and Rural Affairs; CSIRO; NERC [NE/L010992/1] Funding Source: UKRI	NASA Upper Atmosphere Research Program(National Aeronautics & Space Administration (NASA)); UK Department for Business, Energy AMP; Industrial Strategy (BEIS); Met Office Hadley Centre Climate Programme - UK's Department for Business, Energy and Industrial Strategy; Australian Bureau of Meteorology; Refrigerant Reclaim Australia (RRA); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC Independent Research Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Research Foundation of Korea (NRF) - Korean government (MSIT)(National Research Foundation of Korea); Ministry of the Environment of Japan(Ministry of the Environment, Japan); Swiss National Supercomputing Centre (CSCS); Australian Department of Agriculture, Water and the Environment (DAWE); Met Office Hadley Centre Climate Programme - UK's Department for Environment, Food and Rural Affairs; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We are indebted to the site operators who oversee the day-to-day running of the AGAGE and NIES stations. We particularly thank the NASA Upper Atmosphere Research Program for its continuing support of AGAGE theory, experiment and selected stations through grant NNX16AC98G to MIT, and grants NNX16AC96G and NNX16AC97G to SIO and their multiple preceding grants. Support also comes from the UK Department for Business, Energy & Industrial Strategy (BEIS contract 1537/06/2018) for Mace Head observations and the maintenance of InTEM. The contributions by A.L.R. and A.J.M. are supported by The Met Office Hadley Centre Climate Programme, funded by the UK's Department for Business, Energy and Industrial Strategy and Department for Environment, Food and Rural Affairs. Observations at Cape Grim are supported largely by the Australian Bureau of Meteorology, CSIRO, the Australian Department of Agriculture, Water and the Environment (DAWE) and Refrigerant Reclaim Australia (RRA). M.R. and L.M.W. were supported by Natural Environment Research Council (NERC) grants NE/M014851/1 and NE/N016548/1. A.L.G. is supported by NERC Independent Research Fellowship NE/L010992/1. S.P., M.-K.P. and H.P. were supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (no. 2020R1A2C3003774). Observations at Hateruma were partly supported by the Ministry of the Environment of Japan. NAME-HB simulations were carried out using the University of Bristol BlueCrystal supercomputing facility. FLEXPART calculations by Empa were carried out at the Swiss National Supercomputing Centre (CSCS) under project ID s862. We acknowledge the late Y. Yokouchi (NIES) for her significant contributions to the Hateruma observations. Q.L. thanks NASA's Modeling, Analysis, and Prediction Program for supporting the GEOSCCM and the NASA High-End Computing (HEC) Program for providing supercomputing resources. We thank N. Harris and P. Seibert for their constructive suggestions to improve the manuscript.	Adcock KE, 2020, ENVIRON SCI TECHNOL, V54, P3814, DOI 10.1021/acs.est.9b06433; Arnold T, 2018, ATMOS CHEM PHYS, V18, P13305, DOI 10.5194/acp-18-13305-2018; Arnold T, 2012, ANAL CHEM, V84, P4798, DOI 10.1021/ac300373e; Bie PJ, 2017, ENVIRON POLLUT, V224, P670, DOI 10.1016/j.envpol.2017.02.051; Braesicke P., 2019, SCI ASSESSMENT OZONE; Brunner D, 2017, ATMOS CHEM PHYS, V17, P10651, DOI 10.5194/acp-17-10651-2017; Chipperfield MP, 2014, J GEOPHYS RES-ATMOS, V119, P2555, DOI 10.1002/2013JD021097; Dhomse SS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13717-x; Engel A., 2019, SCI ASSESSMENT OZONE; European Centre for Medium-Range Weather Forecasts, 2019, CY46RI IFS ECMWF; Executive Committee of the Multilateral Fund for the Implementation of the Montreal Protocol, 2019, UNEPOZLPROEXCOM8311A; Fang XK, 2019, NAT GEOSCI, V12, P89, DOI 10.1038/s41561-018-0278-2; Fang XK, 2018, ENVIRON SCI TECHNOL, V52, P11359, DOI 10.1021/acs.est.8b01280; Fleming EL, 2020, J GEOPHYS RES-ATMOS, V125, DOI 10.1029/2019JD031849; Friedlingstein P, 2019, EARTH SYST SCI DATA, V11, P1783, DOI 10.5194/essd-11-1783-2019; Ganesan AL, 2014, ATMOS CHEM PHYS, V14, P3855, DOI 10.5194/acp-14-3855-2014; Henne S, 2016, ATMOS CHEM PHYS, V16, P3683, DOI 10.5194/acp-16-3683-2016; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Jones A, 2007, NATO-CHAL M, V17, P580; Liang Q., 2016, WCRP132016 ETH, DOI [10.3929/ethz-a-010690647, DOI 10.3929/ETHZ-A-010690647]; Lickley M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15162-7; Lunt MF, 2016, GEOSCI MODEL DEV, V9, DOI 10.5194/gmd-9-3213-2016; Manning AJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014763; Miller BR, 2008, ANAL CHEM, V80, P1536, DOI 10.1021/ac702084k; Montzka S., 2016, 2016 NOAA ESRL GLOB, V31; Montzka SA, 2021, NATURE, V590, P428, DOI 10.1038/s41586-021-03260-5; Montzka SA, 2018, NATURE, V557, P413, DOI 10.1038/s41586-018-0106-2; O'Doherty S, 2001, J GEOPHYS RES-ATMOS, V106, P20429, DOI 10.1029/2000JD900792; Park S, 2018, ATMOS CHEM PHYS, V18, P11729, DOI 10.5194/acp-18-11729-2018; Pisso I, 2019, GEOSCI MODEL DEV, V12, P4955, DOI 10.5194/gmd-12-4955-2019; Pons J., 2019, DEC 30 3 TEAP TASK F, V1; Prinn RG, 2018, EARTH SYST SCI DATA, V10, P985, DOI 10.5194/essd-10-985-2018; Rigby M, 2019, NATURE, V569, P546, DOI 10.1038/s41586-019-1193-4; Salvatier J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.55; Sherry D, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aa9c87; Stein AF, 2015, B AM METEOROL SOC, V96, P2059, DOI 10.1175/BAMS-D-14-00110.1; Stohl A, 2005, ATMOS CHEM PHYS, V5, P2461, DOI 10.5194/acp-5-2461-2005; Stohl A, 2010, ATMOS CHEM PHYS, V10, P3545, DOI 10.5194/acp-10-3545-2010; UNEP, 2018, UNEPOZLPRO3011; Walters DN, 2014, GEOSCI MODEL DEV, V7, P361, DOI 10.5194/gmd-7-361-2014; Woods A., 2006, MEDIUM RANGE WEATHER, DOI [10.4267/2042/20084, DOI 10.4267/2042/20084]	41	29	28	35	151	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2021	590	7846					433	+		10.1038/s41586-021-03277-w	http://dx.doi.org/10.1038/s41586-021-03277-w		FEB 2021	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QJ5CU	33568814	Green Published, Green Accepted			2022-12-28	WOS:000616961600001
J	Escalante, E; Golden, RL; Mason, DJ				Escalante, Eve; Golden, Robyn L.; Mason, Diana J.			Social Isolation and Loneliness: Imperatives for Health Care in a Post-COVID World	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Escalante, Eve; Golden, Robyn L.] Rush Univ, Med Ctr, SocialWork & Community Hlth, Chicago, IL 60612 USA; [Mason, Diana J.] George Washington Univ, Sch Nursing, Ctr Hlth Policy & Media Engagement, 1919 Pennsylvania Ave NW,Ste 500, Washington, DC 20006 USA	Rush University; George Washington University	Mason, DJ (corresponding author), George Washington Univ, Sch Nursing, Ctr Hlth Policy & Media Engagement, 1919 Pennsylvania Ave NW,Ste 500, Washington, DC 20006 USA.	djmasonrn@gmail.com							0	18	18	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2021	325	6					520	521		10.1001/jama.2021.0100	http://dx.doi.org/10.1001/jama.2021.0100			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG0MD	33560310	Bronze			2022-12-28	WOS:000617279600003
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Everyone wants to feel useful	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2021	372								n366	10.1136/bmj.n366	http://dx.doi.org/10.1136/bmj.n366			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RG0MZ	33563591	Bronze			2022-12-28	WOS:000635231900004
J	Hatchi, E; Goehring, L; Landini, S; Skourti-Stathaki, K; DeConti, DK; Abderazzaq, FO; Banerjee, P; Demers, TM; Wang, YE; Quackenbush, J; Livingston, DM				Hatchi, Elodie; Goehring, Liana; Landini, Serena; Skourti-Stathaki, Konstantina; DeConti, Derrick K.; Abderazzaq, Fieda O.; Banerjee, Priyankana; Demers, Timothy M.; Wang, Yaoyu E.; Quackenbush, John; Livingston, David M.			BRCA1 and RNAi factors promote repair mediated by small RNAs and PALB2-RAD52	NATURE			English	Article							DNA-DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; CELL-CYCLE; R-LOOPS; GENOME INTEGRITY; DIRECTED REPAIR; NONCODING RNAS; RECRUITMENT; RAD52; INSTABILITY	Strong connections exist between R-loops (three-stranded structures harbouring an RNA:DNA hybrid and a displaced single-strand DNA), genome instability and human disease(1-5). Indeed, R-loops are favoured in relevant genomic regions as regulators of certain physiological processes through which homeostasis is typically maintained. For example, transcription termination pause sites regulated by R-loops can induce the synthesis of antisense transcripts that enable the formation of local, RNA interference (RNAi)-driven heterochromation(6). Pause sites are also protected against endogenous single-stranded DNA breaks by BRCA1(7). Hypotheses about how DNA repair is enacted at pause sites include a role for RNA, which is emerging as a normal, albeit unexplained, regulator of genome integrity(8). Here we report that a species of single-stranded, DNA-damage-associated small RNA (sdRNA) is generated by a BRCA1-RNAi protein complex. sdRNAs promote DNA repair driven by the PALB2-RAD52 complex at transcriptional termination pause sites that form R-loops and are rich in single-stranded DNA breaks. sdRNA repair operates in both quiescent (G0) and proliferating cells. Thus, sdRNA repair can occur in intact tissue and/or stem cells, and may contribute to tumour suppression mediated by BRCA1.	[Hatchi, Elodie; Goehring, Liana; Landini, Serena; Abderazzaq, Fieda O.; Banerjee, Priyankana; Demers, Timothy M.; Livingston, David M.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Hatchi, Elodie; Goehring, Liana; Landini, Serena; Abderazzaq, Fieda O.; Banerjee, Priyankana; Demers, Timothy M.; Livingston, David M.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Hatchi, Elodie; Goehring, Liana; Landini, Serena; Abderazzaq, Fieda O.; Banerjee, Priyankana; Demers, Timothy M.; Livingston, David M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Skourti-Stathaki, Konstantina] Univ Edinburgh, Wellcome Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [DeConti, Derrick K.; Wang, Yaoyu E.; Quackenbush, John] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Quantitat Biomed Res Ctr, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Edinburgh; Harvard University; Harvard T.H. Chan School of Public Health	Hatchi, E; Livingston, DM (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Hatchi, E; Livingston, DM (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Hatchi, E; Livingston, DM (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	elodie_hatchi@dfci.harvard.edu; david_livingston@dfci.harvard.edu	Banerjee, Priyankana/AAC-8269-2021	HATCHI, Elodie/0000-0001-8494-9851; Quackenbush, John/0000-0002-2702-5879	National Cancer Institute (NCI) [5U24CA194354]; BRCA1 Function in Post Damage Foci [5R01CA136512-05]; Susan B. Komen Foundation for the Cure; Breast Cancer Research Foundation; Gray Foundation; BRCA Foundation; Murray Winsten Foundation; Dana-Farber Cancer Institute (Barr Award project) [9618425]; Dana-Farber Cancer Institute ((Friend's of Dana-Farber); Research Supplement to Promote Diversity in Health-Related Research Programs [3R01CA136512-08S1]; Sir Henry Wellcome Fellowship [101489/Z/13/Z]; NCI [5U24CA194354, 1R35CA220523, 5U01CA190234]; Deciphering the Mechanism Underlying BRCA1 Breast Cancer Development [5R35CA242143-02]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BRCA1 Function in Post Damage Foci; Susan B. Komen Foundation for the Cure(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research Foundation; Gray Foundation; BRCA Foundation; Murray Winsten Foundation; Dana-Farber Cancer Institute (Barr Award project); Dana-Farber Cancer Institute ((Friend's of Dana-Farber); Research Supplement to Promote Diversity in Health-Related Research Programs; Sir Henry Wellcome Fellowship; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Deciphering the Mechanism Underlying BRCA1 Breast Cancer Development	We thank all members of the Livingston laboratory for support, technical advice and discussions; members of the Center for Cancer Computational Biology (CCCB), and, in particular, F. O. Abderazzaq and R. Rubio for their expertise in small-RNA library preparation and sequencing; D. Pellman and M. Brown for their comments during manuscript preparation and W. Foulkes for discussions of PALB2 genetics. E.H. and other members of the D.M.L. laboratory were supported by grants from the National Cancer Institute (NCI), BRCA1 Function in Post Damage Foci (5R01CA136512-05) and Deciphering the Mechanism Underlying BRCA1 Breast Cancer Development (5R35CA242143-02)-as well as by grants from the Susan B. Komen Foundation for the Cure, The Breast Cancer Research Foundation, The Gray Foundation, The BRCA Foundation and the Murray Winsten Foundation. E.H. was also supported by grants from the Dana-Farber Cancer Institute (Barr Award project 9618425 and Friend's of Dana-Farber). L.G. was also supported by a Research Supplement to Promote Diversity in Health-Related Research Programs (3R01CA136512-08S1). K.S.-S. was supported by a Sir Henry Wellcome Fellowship (grant 101489/Z/13/Z). D.K.D. and Y.E.W. were supported by grants from the National Cancer Institute (NCI) (5U24CA194354) and J.Q. by NCI grants 1R35CA220523, 5U24CA194354 and 5U01CA190234.	Bonnet A, 2017, MOL CELL, V67, P608, DOI 10.1016/j.molcel.2017.07.002; Chen CC, 2018, ANNU REV CANC BIOL, V2, P313, DOI 10.1146/annurev-cancerbio-030617-050502; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad T, 2017, METHODS MOL BIOL, V1468, P1, DOI 10.1007/978-1-4939-4035-6_1; Crossley MP, 2019, MOL CELL, V73, P398, DOI 10.1016/j.molcel.2019.01.024; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; di Fagagna FD, 2014, TRENDS CELL BIOL, V24, P171, DOI 10.1016/j.tcb.2013.09.008; Dimitrov SD, 2013, GENE DEV, V27, P2274, DOI 10.1101/gad.225045.113; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ducy M, 2019, TRENDS BIOCHEM SCI, V44, P226, DOI 10.1016/j.tibs.2018.10.008; Durant ST, 2005, CELL CYCLE, V4, P1216, DOI 10.4161/cc.4.9.2027; Elf J, 2016, CELL SYST, V3, P325, DOI 10.1016/j.cels.2016.10.005; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Francia S, 2016, J CELL SCI, V129, P1468, DOI 10.1242/jcs.182188; Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179; Gao M, 2014, CELL RES, V24, P532, DOI 10.1038/cr.2014.36; Gardini A, 2014, EMBO J, V33, P890, DOI 10.1002/embj.201385567; Gregoire MC, 2018, CELL MOL LIFE SCI, V75, P2859, DOI 10.1007/s00018-018-2769-0; Gregoire MC, 2016, DNA REPAIR, V48, P63, DOI 10.1016/j.dnarep.2016.10.005; Hamperl S, 2014, DNA REPAIR, V19, P84, DOI 10.1016/j.dnarep.2014.03.023; Hatchi E, 2015, MOL CELL, V57, P636, DOI 10.1016/j.molcel.2015.01.011; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Keskin H, 2014, NATURE, V515, P436, DOI 10.1038/nature13682; Kleiman FE, 2005, GENE DEV, V19, P1227, DOI 10.1101/gad.1309505; Kleiman FE, 1999, SCIENCE, V285, P1576, DOI 10.1126/science.285.5433.1576; Kleiman FE, 2001, CELL, V104, P743, DOI 10.1016/S0092-8674(02)07059-9; Leduc F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017353; Liu JM, 2002, BIOCHEM BIOPH RES CO, V297, P1191, DOI 10.1016/S0006-291X(02)02353-7; Lok BH, 2012, CLIN CANCER RES, V18, P6400, DOI 10.1158/1078-0432.CCR-11-3150; Mazina OM, 2017, MOL CELL, V67, P19, DOI 10.1016/j.molcel.2017.05.019; McDevitt S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03483-7; Meers C, 2016, DNA REPAIR, V44, P17, DOI 10.1016/j.dnarep.2016.05.002; Miki D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00374-7; Nojima T, 2013, CELL REP, V3, P1080, DOI 10.1016/j.celrep.2013.03.012; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Richard P, 2017, J MOL BIOL, V429, P3168, DOI 10.1016/j.jmb.2016.08.031; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sharma V, 2013, FEBS LETT, V587, P1832, DOI 10.1016/j.febslet.2013.05.006; Skourti-Stathaki K, 2014, NATURE, V516, P436, DOI 10.1038/nature13787; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Tubbs A, 2017, CELL, V168, DOI 10.1016/j.cell.2017.01.002; Wang B, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-6; Wang H, 2019, CELL, V178, P135, DOI 10.1016/j.cell.2019.06.002; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Yang YG, 2015, DNA REPAIR, V32, P82, DOI 10.1016/j.dnarep.2015.04.017; Yasuhara T, 2018, CELL, V175, P558, DOI 10.1016/j.cell.2018.08.056; Zhang CZ, 2015, MUTAT RES-REV MUTAT, V763, P202, DOI 10.1016/j.mrrev.2014.11.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu Q, 2018, MOL CELL, V70, P842, DOI 10.1016/j.molcel.2018.04.023; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371; Zong DL, 2020, NAT REV GENET, V21, P651, DOI 10.1038/s41576-020-0263-7	53	18	18	3	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 25	2021	591	7851					665	+		10.1038/s41586-020-03150-2	http://dx.doi.org/10.1038/s41586-020-03150-2		FEB 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB5UT	33536619	Green Accepted			2022-12-28	WOS:000614414900011
J	Torjesen, I				Torjesen, Ingrid			Covid-19: AstraZeneca vaccine is approved in EU with no upper age limit	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Agenzia Italiana del Farmaco, 2021, AUT VACC ASTRAZENECA; [Anonymous], 2021, BESCHLUSS STIKO 2 AK; Waschinski G, 2021, HANDELSBLATT	3	7	8	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2021	372								n295	10.1136/bmj.n295	http://dx.doi.org/10.1136/bmj.n295			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QE0LS	33526424	Bronze			2022-12-28	WOS:000615899800006
J	Vogel, AB; Kanevsky, I; Che, Y; Swanson, KA; Muik, A; Vormehr, M; Kranz, LM; Walzer, KC; Hein, S; Guler, A; Loschko, J; Maddur, MS; Ota-Setlik, A; Tompkins, K; Cole, J; Lui, BG; Ziegenhals, T; Plaschke, A; Eisel, D; Dany, SC; Fesser, S; Erbar, S; Bates, F; Schneider, D; Jesionek, B; Sanger, B; Wallisch, AK; Feuchter, Y; Junginger, H; Krumm, SA; Heinen, AP; Adams-Quack, P; Schlereth, J; Schille, S; Kroner, C; Garcia, RDG; Hiller, T; Fischer, L; Sellers, RS; Choudhary, S; Gonzalez, O; Vascotto, F; Gutman, MR; Fontenot, JA; Hall-Ursone, S; Brasky, K; Griffor, MC; Han, S; Su, AAH; Lees, JA; Nedoma, NL; Mashalidis, EH; Sahasrabudhe, PV; Tan, CY; Pavliakova, D; Singh, G; Fontes-Garfias, C; Pride, M; Scully, IL; Ciolino, T; Obregon, J; Gazi, M; Carrion, R; Alfson, KJ; Kalina, WV; Kaushal, D; Shi, PY; Klamp, T; Rosenbaum, C; Kuhn, AN; Tureci, O; Dormitzer, PR; Jansen, KU; Sahin, U				Vogel, Annette B.; Kanevsky, Isis; Che, Ye; Swanson, Kena A.; Muik, Alexander; Vormehr, Mathias; Kranz, Lena M.; Walzer, Kerstin C.; Hein, Stephanie; Gueler, Alptekin; Loschko, Jakob; Maddur, Mohan S.; Ota-Setlik, Ayuko; Tompkins, Kristin; Cole, Journey; Lui, Bonny G.; Ziegenhals, Thomas; Plaschke, Arianne; Eisel, David; Dany, Sarah C.; Fesser, Stephanie; Erbar, Stephanie; Bates, Ferdia; Schneider, Diana; Jesionek, Bernadette; Saenger, Bianca; Wallisch, Ann-Kathrin; Feuchter, Yvonne; Junginger, Hanna; Krumm, Stefanie A.; Heinen, Andre P.; Adams-Quack, Petra; Schlereth, Julia; Schille, Stefan; Kroener, Christoph; Garcia, Ramon de la Caridad Guimil; Hiller, Thomas; Fischer, Leyla; Sellers, Rani S.; Choudhary, Shambhunath; Gonzalez, Olga; Vascotto, Fulvia; Gutman, Matthew R.; Fontenot, Jane A.; Hall-Ursone, Shannan; Brasky, Kathleen; Griffor, Matthew C.; Han, Seungil; Su, Andreas A. H.; Lees, Joshua A.; Nedoma, Nicole L.; Mashalidis, Ellene H.; Sahasrabudhe, Parag, V; Tan, Charles Y.; Pavliakova, Danka; Singh, Guy; Fontes-Garfias, Camila; Pride, Michael; Scully, Ingrid L.; Ciolino, Tara; Obregon, Jennifer; Gazi, Michal; Carrion, Ricardo, Jr.; Alfson, Kendra J.; Kalina, Warren, V; Kaushal, Deepak; Shi, Pei-Yong; Klamp, Thorsten; Rosenbaum, Corinna; Kuhn, Andreas N.; Tureci, Ozlem; Dormitzer, Philip R.; Jansen, Kathrin U.; Sahin, Ugur			BNT162b vaccines protect rhesus macaques from SARS-CoV-2	NATURE			English	Article								A safe and effective vaccine against COVID-19 is urgently needed in quantities that are sufficient to immunize large populations. Here we report the preclinical development of two vaccine candidates (BNT162b1 and BNT162b2) that contain nucleoside-modified messenger RNA that encodes immunogens derived from the spike glycoprotein (S) of SARS-CoV-2, formulated in lipid nanoparticles. BNT162b1 encodes a soluble, secreted trimerized receptor-binding domain (known as the RBD-foldon). BNT162b2 encodes the full-length transmembrane S glycoprotein, locked in its prefusion conformation by the substitution of two residues with proline (S(K986P/V987P); hereafter, S(P2) (also known as P2 S)). The flexibly tethered RBDs of the RBD-foldon bind to human ACE2 with high avidity. Approximately 20% of the S(P2) trimers are in the two-RBD 'down', one-RBD 'up' state. In mice, one intramuscular dose of either candidate vaccine elicits a dose-dependent antibody response with high virus-entry inhibition titres and strong T-helper-1 CD4(+) and IFN gamma(+)CD8(+) T cell responses. Prime-boost vaccination of rhesus macaques (Macaca mulatta) with the BNT162b candidates elicits SARS-CoV-2-neutralizing geometric mean titres that are 8.2-18.2x that of a panel of SARS-CoV-2-convalescent human sera. The vaccine candidates protect macaques against challenge with SARS-CoV-2; in particular, BNT162b2 protects the lower respiratory tract against the presence of viral RNA and shows no evidence of disease enhancement. Both candidates are being evaluated in phase I trials in Germany and the USA1-3, and BNT162b2 is being evaluated in an ongoing global phase II/III trial (NCT04380701 and NCT04368728).	[Vogel, Annette B.; Muik, Alexander; Vormehr, Mathias; Kranz, Lena M.; Walzer, Kerstin C.; Hein, Stephanie; Gueler, Alptekin; Lui, Bonny G.; Ziegenhals, Thomas; Plaschke, Arianne; Eisel, David; Dany, Sarah C.; Fesser, Stephanie; Erbar, Stephanie; Bates, Ferdia; Schneider, Diana; Jesionek, Bernadette; Saenger, Bianca; Wallisch, Ann-Kathrin; Feuchter, Yvonne; Junginger, Hanna; Krumm, Stefanie A.; Heinen, Andre P.; Adams-Quack, Petra; Schlereth, Julia; Schille, Stefan; Kroener, Christoph; Garcia, Ramon de la Caridad Guimil; Hiller, Thomas; Fischer, Leyla; Su, Andreas A. H.; Klamp, Thorsten; Rosenbaum, Corinna; Kuhn, Andreas N.; Tureci, Ozlem; Sahin, Ugur] BioNTech, Mainz, Germany; [Kanevsky, Isis; Swanson, Kena A.; Loschko, Jakob; Maddur, Mohan S.; Ota-Setlik, Ayuko; Tompkins, Kristin; Sellers, Rani S.; Choudhary, Shambhunath; Tan, Charles Y.; Pavliakova, Danka; Singh, Guy; Pride, Michael; Scully, Ingrid L.; Ciolino, Tara; Obregon, Jennifer; Kalina, Warren, V; Dormitzer, Philip R.; Jansen, Kathrin U.] Pfizer, Pearl River, NY USA; [Che, Ye; Griffor, Matthew C.; Han, Seungil; Lees, Joshua A.; Nedoma, Nicole L.; Mashalidis, Ellene H.; Sahasrabudhe, Parag, V] Pfizer, Groton, CT USA; [Cole, Journey; Gonzalez, Olga; Hall-Ursone, Shannan; Brasky, Kathleen; Carrion, Ricardo, Jr.; Kaushal, Deepak] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX USA; [Vascotto, Fulvia; Sahin, Ugur] Johannes Gutenberg Univ Mainz, Univ Med Ctr, TRON Translat Oncol, Mainz, Germany; [Gutman, Matthew R.] VCA SouthPaws Vet Specialists & Emergency Ctr, Fairfax, VA USA; [Fontenot, Jane A.] New Iberia Res Ctr, New Iberia, LA USA; [Fontes-Garfias, Camila; Shi, Pei-Yong] Univ Texas Med Branch, Galveston, TX 77555 USA; [Gazi, Michal; Alfson, Kendra J.] Texas Biomed Res Inst, San Antonio, TX USA	BioNTech SE; Pfizer; Pfizer; Texas Biomedical Research Institute; Johannes Gutenberg University of Mainz; University of Louisiana Lafayette; New Iberia Research Center; University of Texas System; University of Texas Medical Branch Galveston; Texas Biomedical Research Institute	Sahin, U (corresponding author), BioNTech, Mainz, Germany.; Sahin, U (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, TRON Translat Oncol, Mainz, Germany.	Ugur.Sahin@biontech.de	Vormehr, Mathias/AAJ-7808-2021	Vormehr, Mathias/0000-0001-7788-3380; Vogel, Annette/0000-0002-9940-5379; Muik, Alexander/0000-0003-4561-2273; Kranz, Lena/0000-0003-1943-3431; Erbar, Stephanie/0000-0003-1898-4776; Guler, Alptekin/0000-0001-7073-2125; Che, Ye/0000-0002-1278-4442	BioNTech	BioNTech	We thank T. Garretson and D. Cooper for advice on, and M. Cutler for coordination of, serology studies in nonhuman primates; R. F. Sommese and K. F. Fennell for technical assistance with molecular cloning and cell-based binding; M. Dvorak, M. Drude, F. Zehner, T. Lapin, B. Ludloff, S. Hinz, F. Bayer, J. Scholz, A.L. Ernst, T. Sticker and S. Wittig for their valuable support and assistance, which resulted in a rapid availability of oligonucleotides and DNA templates; E. Boehm, K. Goebel, R. Frieling, C. Berger, S. Koch, T. Wachtel, J. Leilich, M. Mechler, R. Wysocki, M. Le Gall, A. Czech and S. Klenk for carrying out RNA production and analysis, without which this vaccine candidate could not have been transferred to nonclinical studies with such speed; B. Weber, J. Vogt, S. Krapp, K. Zwadlo, J. Mottl, J. Muhl and P. Windecker for supporting the mouse studies and serological analysis with excellent technical assistance; A. K. Voges and E. Clemmons for interpreting radiographs for the nonhuman primate study; S. Ganatra for radiology services; E. Romero for veterinary services; K. A. Soileau and the staff of the New Iberia Research Centre for care of the nonhuman primates; E. J. Dick for veterinary pathology; Polymun Scientific for excellent formulation services; Acuitas Therapeutics for fruitful discussions; and S. Wigge and C. Lindemann for scientific writing support and manuscript review. BioNTech is the sponsor of the study, and Pfizer is its agent. BioNTech and Pfizer are responsible for the design, data collection, data analysis, data interpretation and writing of the report. The corresponding authors had full access to all the data in the study and had final responsibility for the decision to submit the data for publication. This study was not supported by any external funding at the time of submission.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berensmeier S, 2006, APPL MICROBIOL BIOT, V73, P495, DOI 10.1007/s00253-006-0675-0; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Corbett KS, 2020, NEW ENGL J MED, V383, P1544, DOI 10.1056/NEJMoa2024671; Corbett Kizzmekia S, 2020, bioRxiv, DOI [10.1101/2020.06.11.145920, 10.1038/s41586-020-2622-0]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan X., 2020, NAT COMMUN, V11; Farooq F., 2016, SCI REP-UK, V6; Gautam US, 2018, P NATL ACAD SCI USA, V115, pE62, DOI 10.1073/pnas.1711373114; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Grudzien-Nogalska Ewa, 2013, Methods Mol Biol, V969, P55, DOI 10.1007/978-1-62703-260-5_4; He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106; Henderson R, 2020, NAT STRUCT MOL BIOL, V27, P925, DOI [10.1101/2020.05.18.102087, 10.1038/s41594-020-0479-4]; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; Jafarzadeh A, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118102; Joosten SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000782; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kirchdoerfer RN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34171-7; Laczko D, 2020, IMMUNITY, V53, P724, DOI 10.1016/j.immuni.2020.07.019; Lambert PH, 2020, VACCINE, V38, P4783, DOI 10.1016/j.vaccine.2020.05.064; Lester S, 2019, ACCESS MICROBIOL, V1; Maier MA, 2013, MOL THER, V21, P1570, DOI 10.1038/mt.2013.124; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mehra S, 2013, J INFECT DIS, V207, P1115, DOI 10.1093/infdis/jis778; Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079; Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4; Muruato AE., 2020, NAT COMMUN, V11; Ou X., 2020, NAT COMMUN, V11; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Pardi N, 2019, MOL THER-NUCL ACIDS, V15, P36, DOI 10.1016/j.omtn.2019.03.003; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Pardi N, 2015, J CONTROL RELEASE, V217, P345, DOI 10.1016/j.jconrel.2015.08.007; Rauch S., 2020, MRNA VACCINE CVNCOV, DOI [10.1101/2020.12.23.424138, DOI 10.1101/2020.12.23.424138]; Rauch S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01963; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sahin U, 2020, NATURE, V586, P594, DOI 10.1038/s41586-020-2814-7; Singh DK, 2021, NAT MICROBIOL, V6, P73, DOI 10.1038/s41564-020-00841-4; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421; von Niessen AGO, 2019, MOL THER, V27, P824, DOI 10.1016/j.ymthe.2018.12.011; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu Y, 2020, OPEN FORUM INFECT DI, V368, P1274, DOI [10.1126/science.abc2241, DOI 10.1126/SCIENCE.ABC2241]; Xie XP, 2020, CELL HOST MICROBE, V27, P841, DOI 10.1016/j.chom.2020.04.004; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yang D, 2020, J INFECT DIS, V222, P734, DOI 10.1093/infdis/jiaa356; Yi CY, 2020, CELL MOL IMMUNOL, V17, P621, DOI 10.1038/s41423-020-0458-z; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166; Zost SJ, 2020, NAT MED, V26, DOI [10.1038/s41591-020-0998-x, 10.1101/2020.05.12.091462]	55	237	240	7	82	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 8	2021	592	7853					283	+		10.1038/s41586-021-03275-y	http://dx.doi.org/10.1038/s41586-021-03275-y		FEB 2021	35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8ZE	33524990	Bronze			2022-12-28	WOS:000621335300001
